PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Clendenen, TV; Rendleman, J; Ge, WZ; Koenig, KL; Wirgin, I; Currie, D; Shore, RE; Kirchhoff, T; Zeleniuch-Jacquotte, A				Clendenen, Tess V.; Rendleman, Justin; Ge, Wenzhen; Koenig, Karen L.; Wirgin, Isaac; Currie, Diane; Shore, Roy E.; Kirchhoff, Tomas; Zeleniuch-Jacquotte, Anne			Genotyping of Single Nucleotide Polymorphisms in DNA Isolated from Serum Using Sequenom MassARRAY Technology	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER RISK; ENDOMETRIAL CANCER; LOCI	Background Large epidemiologic studies have the potential to make valuable contributions to the assessment of gene-environment interactions because they prospectively collected detailed exposure data. Some of these studies, however, have only serum or plasma samples as a low quantity source of DNA. Methods We examined whether DNA isolated from serum can be used to reliably and accurately genotype single nucleotide polymorphisms (SNPs) using Sequenom multiplex SNP genotyping technology. We genotyped 81 SNPs using samples from 158 participants in the NYU Women's Health Study. Each participant had DNA from serum and at least one paired DNA sample isolated from a high quality source of DNA, i.e. clots and/or cell precipitates, for comparison. Results We observed that 60 of the 81 SNPs (74%) had high call frequencies (>= 95%) using DNA from serum, only slightly lower than the 85% of SNPs with high call frequencies in DNA from clots or cell precipitates. Of the 57 SNPs with high call frequencies for serum, clot, and cell precipitate DNA, 54 (95%) had highly concordant (>98%) genotype calls across all three sample types. High purity was not a critical factor to successful genotyping. Conclusions Our results suggest that this multiplex SNP genotyping method can be used reliably on DNA from serum in large-scale epidemiologic studies.	[Clendenen, Tess V.; Rendleman, Justin; Ge, Wenzhen; Koenig, Karen L.; Kirchhoff, Tomas; Zeleniuch-Jacquotte, Anne] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA; [Zeleniuch-Jacquotte, Anne] NYU, Langone Med Ctr, Inst Canc, New York, NY USA; [Wirgin, Isaac; Currie, Diane; Shore, Roy E.] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Shore, Roy E.] Radiat Effects Res Fdn, Hiroshima, Japan	New York University; New York University; NYU Langone Medical Center; New York University; Radiation Effects Research Foundation - Japan	Clendenen, TV (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA.	tess.clendenen@nyumc.org	Rendleman, Justin/ABI-2137-2020; Ge, Wenzhen/J-4689-2019	Kirchhoff, Tomas/0000-0002-9055-2364; Rendleman, Justin/0000-0001-8152-7127; Shore, Roy/0000-0002-6842-2248; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303	National Cancer Institute [R01 CA081212, R01 CA098661, P30 CA016087]; National Institute of Environmental Health Sciences [ES000260]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA081212, UM1CA182934, R01CA098661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support was provided by National Cancer Institute (www.cancer.gov) grants R01 CA081212 (AZJ), R01 CA098661 (AZJ) and P30 CA016087; and Center grant ES000260 from the National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clendenen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069367; Clendenen TV, 2008, CANCER LETT, V260, P209, DOI 10.1016/j.canlet.2007.11.002; Gaudet MM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003173; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Hoque A, 2008, UROLOGY, V71, P967, DOI 10.1016/j.urology.2007.11.042; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Lundin E, 2012, CANCER EPIDEMIOL, V36, P445, DOI 10.1016/j.canep.2012.04.006; Mead S, 2008, HUM MUTAT, V29, P1452, DOI 10.1002/humu.20782; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Spurdle AB, 2011, NAT GENET, V43, P451, DOI 10.1038/ng.812; Zheng W, 2013, HUM MOL GENET, V22, P2539, DOI 10.1093/hmg/ddt089	12	5	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135943	10.1371/journal.pone.0135943	http://dx.doi.org/10.1371/journal.pone.0135943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274499	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600134
J	Li, K; Guo, XJ; Jin, Z; Ouyang, X; Zeng, YW; Feng, JS; Wang, Y; Yao, L; Ma, L				Li, Ke; Guo, Xiaojuan; Jin, Zhen; Ouyang, Xin; Zeng, Yawei; Feng, Jinsheng; Wang, Yu; Yao, Li; Ma, Lin			Effect of Simulated Microgravity on Human Brain Gray Matter and White Matter - Evidence from MRI	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; VOXEL-BASED MORPHOMETRY; DIFFUSION-TENSOR; ALZHEIMERS-DISEASE; EXTREME ENVIRONMENTS; SPATIAL ORIENTATION; CEREBRAL-CORTEX; BED REST; SPACEFLIGHT; PERFORMANCE	Background There is limited and inconclusive evidence that space environment, especially microgravity condition, may affect microstructure of human brain. This experiment hypothesized that there would be modifications in gray matter (GM) and white matter (WM) of the brain due to microgravity. Method Eighteen male volunteers were recruited and fourteen volunteers underwent -6 degrees head-down bed rest (HDBR) for 30 days simulated microgravity. High-resolution brain anatomical imaging data and diffusion tensor imaging images were collected on a 3T MR system before and after HDBR. We applied voxel-based morphometry and tract-based spatial statistics analysis to investigate the structural changes in GM and WM of brain. Results We observed significant decreases of GM volume in the bilateral frontal lobes, temporal poles, parahippocampal gyrus, insula and right hippocampus, and increases of GM volume in the vermis, bilateral paracentral lobule, right precuneus gyrus, left precentral gyrus and left postcentral gyrus after HDBR. Fractional anisotropy (FA) changes were also observed in multiple WM tracts. Conclusion These regions showing GM changes are closely associated with the functional domains of performance, locomotion, learning, memory and coordination. Regional WM alterations may be related to brain function decline and adaption. Our findings provide the neuroanatomical evidence of brain dysfunction or plasticity in microgravity condition and a deeper insight into the cerebral mechanisms inmicrogravity condition.	[Li, Ke; Ma, Lin] Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing, Peoples R China; [Li, Ke; Jin, Zhen; Zeng, Yawei] PLA, Hosp 306, Magnet Resonance Ctr, Beijing, Peoples R China; [Guo, Xiaojuan; Ouyang, Xin; Yao, Li] Beijing Normal Univ, Coll Informat Sci & Technol, Beijing 100875, Peoples R China; [Feng, Jinsheng] China Astronaut Res & Training Ctr, Lab 3, Beijing, Peoples R China; [Wang, Yu] PLA, Outpatient Dept, Unit 61599, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Beijing Normal University	Ma, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing, Peoples R China.	cjr.malin@vip.163.com	Ma, Lin/AAF-8728-2019		Scientific Foundation of 306 hospital of the Chinese People's Liberation Army [QN2010005]	Scientific Foundation of 306 hospital of the Chinese People's Liberation Army	This work was supported by the Scientific Foundation of 306 hospital of the Chinese People's Liberation Army (Grant No. QN2010005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2009, NEUROIMAGE, V45, P333, DOI 10.1016/j.neuroimage.2008.12.008; BELICHENKO P V, 1991, Byulleten' Eksperimental'noi Biologii i Meditsiny, V112, P541; Bock O, 2010, AVIAT SPACE ENVIR MD, V81, P819, DOI 10.3357/ASEM.2608.2010; Cannistraro PA, 2007, DEPRESS ANXIETY, V24, P440, DOI 10.1002/da.20246; Caprihan A, 1999, EUR J APPL PHYSIOL O, V79, P367, DOI 10.1007/s004210050522; D'Amelio F, 1998, ADV SPACE RES-SERIES, V22, P235, DOI 10.1016/S0273-1177(98)80015-X; DeFelipe J, 2002, CEREB CORTEX, V12, P883, DOI 10.1093/cercor/12.8.883; DELP MD, 1995, J APPL PHYSIOL, V78, P2079, DOI 10.1152/jappl.1995.78.6.2079; Dyachkova L., 1991, PHYSIOLOGIST, V34, P185; Eddy DR, 1998, ACTA ASTRONAUT, V43, P193, DOI 10.1016/S0094-5765(98)00154-4; FOLKOW B, 1987, AM HEART J, V114, P938, DOI 10.1016/0002-8703(87)90591-6; Grigoriev A I, 1992, Adv Space Biol Med, V2, P1, DOI 10.1016/S1569-2574(08)60016-7; Holstein G.R, 1999, J GRAVIT PHYSL, V6, P47; Hu YZ, 2011, HUM BRAIN MAPP, V32, P10, DOI 10.1002/hbm.20996; Hunter JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036893; HYDE TM, 1992, BRAIN RES, V593, P291, DOI 10.1016/0006-8993(92)91321-5; Iwasaki KI, 2007, J PHYSIOL-LONDON, V579, P799, DOI 10.1113/jphysiol.2006.119636; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Job DE, 2002, NEUROIMAGE, V17, P880, DOI 10.1006/nimg.2002.1180; Kantarci K, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00316; Karemaker JM, 2009, RESP PHYSIOL NEUROBI, V169, pS55, DOI 10.1016/j.resp.2009.05.006; Kawai Yasuaki, 2003, Yonago Acta Medica, V46, P1; Koppelmans V, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-205; Krasnov I B, 1994, Adv Space Biol Med, V4, P85; Kwon SJ, 2013, NEURAL REGEN RES, V8, P922, DOI 10.3969/j.issn.1673-5374.2013.10.007; Leavitt VM, 2014, NEUROCASE, V20, P695, DOI 10.1080/13554794.2013.841951; Lee B, 2010, NEUROIMAGE, V52, P9, DOI 10.1016/j.neuroimage.2010.04.014; Leube DT, 2008, INT J GERIATR PSYCH, V23, P1114, DOI 10.1002/gps.2036; Manzey D, 1998, ERGONOMICS, V41, P537, DOI 10.1080/001401398186991; Mao Q W, 1999, Space Med Med Eng (Beijing), V12, P249; Matsuda H, 2013, AGING DIS, V4, P29; Moore ST, 2010, EXP BRAIN RES, V204, P617, DOI 10.1007/s00221-010-2317-0; Morphew M.E., 2001, MCGILL J MED, V6, P74; NEWBERG AB, 1994, AVIAT SPACE ENVIR MD, V65, P562; Newman DJ, 1999, IEEE T SYST MAN CY C, V29, P387, DOI 10.1109/5326.777074; Nicolas M, 2009, J ENVIRON PSYCHOL, V29, P522, DOI 10.1016/j.jenvp.2009.08.006; Palinkas L A, 2001, Gravit Space Biol Bull, V14, P25; Paola MD, 2008, EUR J NEUROL, V15, P1050, DOI [10.1111/j.1468-1331.2008.02243.x, 10.1111/j.1468-1331.2008.02137.x]; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Renoux J, 2006, AM J NEURORADIOL, V27, P1947; Reschke MF, 1998, BRAIN RES REV, V28, P102, DOI 10.1016/S0165-0173(98)00031-9; Ringman JM, 2007, BRAIN, V130, P1767, DOI 10.1093/brain/awm102; Roberts DR, 2010, AVIAT SPACE ENVIR MD, V81, P30, DOI 10.3357/ASEM.2532.2009; Ross M D, 1994, Acta Otolaryngol Suppl, V516, P1; Ross M D, 1993, J Vestib Res, V3, P241; Sandal G M, 2001, Gravit Space Biol Bull, V14, P47; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Takenobu Y, 2014, NEUROIMAGE-CLIN, V4, P201, DOI 10.1016/j.nicl.2013.12.003; Taylor CR, 2013, FASEB J, V27, P2282, DOI 10.1096/fj.12-222687; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z; Wilkerson MK, 1999, J APPL PHYSIOL, V87, P2115, DOI 10.1152/jappl.1999.87.6.2115; Yoo SY, 2007, ACTA PSYCHIAT SCAND, V116, P211, DOI 10.1111/j.1600-0447.2007.01046.x; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068621; Zhang JX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011449; Zhou Y, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00200	58	32	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135835	10.1371/journal.pone.0135835	http://dx.doi.org/10.1371/journal.pone.0135835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270525	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800117
J	Ren, JH; Jiang, XL; Yao, JR; Li, XR; Liu, XH; Pang, M; Chiang, CLV				Ren, Jianhua; Jiang, Xiaolian; Yao, Jianrong; Li, Xirong; Liu, Xinghui; Pang, Meiche; Chiang, Chung Lim Vico			Depression, Social Support, and Coping Styles among Pregnant Women after the Lushan Earthquake in Ya'an, China	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; PRENATAL DEPRESSION; SICHUAN EARTHQUAKE; SELF-EFFICACY; RISK-FACTORS; SURVIVORS; SYMPTOMS; CULTURE; PREDICTORS	Aim The aim of this study is to assess the depression of pregnant women in the aftermath of an earthquake, and to identify the social support that they obtained, their coping styles and socio-demographic factors associated with depression. Methods A total of 128 pregnant women from three hospitals in the epicenter area were recruited immediately after the Ya'an earthquake. Their depression was investigated using the Edinburgh Postnatal Depression Scale (EPDS) with a cutoff score of 14; the social support that they obtained was measured using the Social Support Questionnaire; and their coping styles were assessed using the Coping Styles Questionnaire. Results Immediately after the earthquake, the incidence rate of depression in pregnant women was 35.2%, higher than that of the general pregnant population (7%-14%). The EPDS scores were significantly correlated with gestation age at the time of the earthquake, objective support, subjective support, use of support, negative coping style, and positive coping style. The regression analysis indicated that risk factors of prenatal depression include the number of children, relatives wounded, subjective support, and coping styles. A further analysis of the interaction between social support and two types of coping styles with depression showed that there was interaction effect between subjective social support and positive coping styles in relation to EPDS scores. There was an inverse relationship between low EPDS scores and positive coping styles and high social support, and vice versa. Conclusion The timing of the occurrence of the earthquake may not necessarily affect the progress of the illness and recovery from depression, and psychological intervention could be conducted in the immediate aftermath after the earthquake. The impact of coping styles on prenatal depression appeared to be linked with social support. Helping pregnant women to adopt positive coping styles with good social support after a recent major earthquake, which is a stressor, may reduce their chances of developing prenatal depression.	[Ren, Jianhua; Yao, Jianrong; Liu, Xinghui] West China Second Univ Hosp, Dept Obstet, Chengdu, Sichuan, Peoples R China; [Jiang, Xiaolian] Sichuan Univ, West China Sch Nursing, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Ren, Jianhua; Pang, Meiche; Chiang, Chung Lim Vico] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Li, Xirong] Yaan Peoples Hosp, Dept Obstet, Yaan, Sichuan, Peoples R China	Sichuan University; Hong Kong Polytechnic University	Jiang, XL (corresponding author), Sichuan Univ, West China Sch Nursing, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	jiang_xiaolian@126.com	Chiang, Vico CL/I-1099-2019	Chiang, Vico CL/0000-0002-6973-7241				Ai D, 2010, POPULATION J, P15; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Borcherding KE, 2009, JOGNN-J OBST GYN NEO, V38, P453, DOI 10.1111/j.1552-6909.2009.01041.x; BURNAND B, 1990, J CLIN EPIDEMIOL, V43, P1273, DOI 10.1016/0895-4356(90)90093-5; Chen JM, 2012, PERS SOC PSYCHOL B, V38, P3, DOI 10.1177/0146167211427309; Chen S., 2000, CHINESE J CLIN PSYCH, V8, P211, DOI DOI 10.16128/J.CNKI.1005-3611.2000.04.005; Choate LH, 2011, J COUNS DEV, V89, P373, DOI 10.1002/j.1556-6678.2011.tb00102.x; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269; COOKE BD, 1988, FAM RELAT, V37, P211, DOI 10.2307/584322; Cox J., 2003, PERINATAL MENTAL HLT; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; CUTRONA CE, 1986, CHILD DEV, V57, P1507, DOI 10.1111/j.1467-8624.1986.tb00475.x; Cyranowski JM, 2012, DEPRESS ANXIETY, V29, P1050, DOI 10.1002/da.21990; de Tychey C, 2005, J AFFECT DISORDERS, V85, P323, DOI 10.1016/J.JAD.2004.11.004; Dong XH, 2013, J AFFECT DISORDERS, V151, P566, DOI 10.1016/j.jad.2013.06.048; Ehring T, 2011, PSYCHIAT RES, V185, P161, DOI 10.1016/j.psychres.2009.10.018; Eksi A, 2009, EUR CHILD ADOLES PSY, V18, P384, DOI 10.1007/s00787-009-0745-9; Everly GS, 2008, AGGRESS VIOLENT BEH, V13, P407, DOI 10.1016/j.avb.2008.05.004; Field T, 2013, J BODYW MOV THER, V17, P397, DOI 10.1016/j.jbmt.2013.03.010; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037/0022-3514.50.3.571; FOLKMAN S, 1988, J PERS SOC PSYCHOL, V54, P466, DOI 10.1037/0022-3514.54.3.466; Gigantesco A, 2013, J AFFECT DISORDERS, V148, P265, DOI 10.1016/j.jad.2012.12.006; Goenjian AK, 2009, J AFFECT DISORDERS, V112, P81, DOI 10.1016/j.jad.2008.04.006; Guardino CM, 2014, HEALTH PSYCHOL REV, V8, P70, DOI 10.1080/17437199.2012.752659; Guo XJ., 2009, CHIN J PRACT NURS, V1, P4; Harville E, 2010, OBSTET GYNECOL SURV, V65, P713, DOI 10.1097/OGX.0b013e31820eddbe; Hause JC, 2006, ECON INQ, V44; Hibino Y, 2009, PSYCHIAT CLIN NEUROS, V63, P107, DOI 10.1111/j.1440-1819.2008.01911.x; Huang Y, 2009, CHINA J HLTH PSYCHOL, V17, P231; Hulbert-Williams L, 2011, J APPL RES INTELLECT, V24, P427, DOI 10.1111/j.1468-3148.2011.00624.x; Hussain A, 2011, J AFFECT DISORDERS, V128, P135, DOI 10.1016/j.jad.2010.06.018; JENEYGAMMON P, 1993, J GENET PSYCHOL, V154, P259, DOI 10.1080/00221325.1993.9914739; Kim HS, 2008, AM PSYCHOL, V63, P518, DOI 10.1037/0003-066X; Koleva H, 2011, ARCH WOMEN MENT HLTH, V14, P99, DOI 10.1007/s00737-010-0184-0; Kolves K, 2013, J AFFECT DISORDERS, V146, P1, DOI 10.1016/j.jad.2012.07.037; KOTLER M, 1993, PSYCHIAT RES, V47, P281, DOI 10.1016/0165-1781(93)90085-U; Kun P, 2010, PUBLIC HEALTH, V124, P573, DOI 10.1016/j.puhe.2010.06.001; Kwon Y S, 2001, Environ Health Prev Med, V6, P97, DOI 10.1007/BF02897953; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Lau Y, 2011, JOGNN-J OBST GYN NEO, V40, P62, DOI 10.1111/j.1552-6909.2010.01208.x; Lazarus R.S., 1984, EMOTION ADAPTATION; Liang L, 2008, NERVOUS DIS MENTAL H, V8, P424; Liang Y, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-18; Liang Y, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-41; Murphy S., 1988, J TRAUMA STRESS, VI, P155, DOI DOI 10.1002/JTS.2490010204; Neter E, 1995, Womens Health, V1, P51; Nylen KJ, 2013, J BEHAV MED, V36, P427, DOI 10.1007/s10865-012-9436-y; Ognibene TC, 1998, J SOC PERS RELAT, V15, P323, DOI 10.1177/0265407598153002; Olhaberry M., 2014, MENT HLTH PREV, V2, P86; Oyarzo C, 2012, J MATERN-FETAL NEO M, V25, P1868, DOI 10.3109/14767058.2012.678437; Palfai TP, 1997, J SOC PSYCHOL, V137, P405, DOI 10.1080/00224549709595455; Park J, 2013, J HEALTH PSYCHOL, V18, P226, DOI 10.1177/1359105312439731; PARKER G, 1986, ARCH GEN PSYCHIAT, V43, P561; Prasertsri N, 2011, LUNG CANCER, V71, P235, DOI 10.1016/j.lungcan.2010.05.009; Qu ZY, 2012, J AFFECT DISORDERS, V136, P117, DOI 10.1016/j.jad.2011.08.021; Raposa EB, 2011, J ABNORM CHILD PSYCH, V39, P1177, DOI 10.1007/s10802-011-9536-0; Ren JH, 2014, DISASTER MED PUBLIC, V8, P315, DOI 10.1017/dmp.2014.62; Reuter K, 2006, PSYCHO-ONCOLOGY, V15, P772, DOI 10.1002/pon.1012; RHODES JE, 1994, J SOC PERS RELAT, V11, P587, DOI 10.1177/0265407594114006; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Ritter C, 2000, HEALTH PSYCHOL, V19, P576, DOI 10.1037/0278-6133.19.6.576; Rudnicki SR, 2001, WOMEN HEALTH, V34, P19, DOI 10.1300/J013v34n03_02; Sultana AM, 2012, ADV NATURAL APPL SCI, V6; Tang Y, 2006, CHINESE MATERNITY CH, V21, P84; Taylor SE, 2004, J PERS SOC PSYCHOL, V87, P354, DOI 10.1037/0022-3514.87.3.354; Toyabe SL, 2006, BMC PUBLIC HEALTH, V230, P1; Uemoto M, 2000, Seishin Shinkeigaku Zasshi, V102, P459; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; Whisman MA, 2011, J FAM PSYCHOL, V25, P375, DOI 10.1037/a0023790; Wisner KL, 2002, NEW ENGL J MED, V347, P194, DOI 10.1056/NEJMcp011542; Woods SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.041; Wu CH, 2009, J TRAUMA STRESS, V22, P451, DOI 10.1002/jts.20447; Xiao S., 1994, J CLIN PSYCHIAT, V4, P98, DOI DOI 10.1186/S12913-016-1423-5; Xie Y., 1998, CHINESE J CLIN PSYCH, V6, P114, DOI DOI 10.16128/J.CNKI.1005-3611.1998.02.018; Xu JP, 2012, PSYCHIAT CLIN NEUROS, V66, P210, DOI 10.1111/j.1440-1819.2012.02331.x; Yang J, 2010, SOC BEHAV PERSONAL, V38, P1219, DOI 10.2224/sbp.2010.38.9.1219; Yingxu Wang, 2009, International Journal of Software Science and Computational Intelligence, V1, P1, DOI 10.4018/jssci.2009070101; [张建人 ZHANG Jianren], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P629; Zhang Y, 2010, CHILD YOUTH SERV REV, V32, P1403, DOI 10.1016/j.childyouth.2010.06.009; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008; [赵立 ZHAO Li], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P349; Zheng Y, 2012, PLOS ONE, V7	84	22	23	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135809	10.1371/journal.pone.0135809	http://dx.doi.org/10.1371/journal.pone.0135809			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JX	26270035	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800114
J	Yamada, T; Shimura, T; Ebi, M; Hirata, Y; Nishiwaki, H; Mizushima, T; Asukai, K; Togawa, S; Takahashi, S; Joh, T				Yamada, Tomonori; Shimura, Takaya; Ebi, Masahide; Hirata, Yoshikazu; Nishiwaki, Hirotaka; Mizushima, Takashi; Asukai, Koki; Togawa, Shozo; Takahashi, Satoru; Joh, Takashi			Subset Analysis of a Multicenter, Randomized Controlled Trial to Compare Magnifying Chromoendoscopy with Endoscopic Ultrasonography for Stage Diagnosis of Early Stage Colorectal Cancer	PLOS ONE			English	Article							PIT PATTERN; INVASION DEPTH; COLONOSCOPY; NEOPLASIA; ACCURACY; CLASSIFICATION; TUMORS	Background Our recent prospective study found equivalent accuracy of magnifying chromoendoscopy (MC) and endoscopic ultrasonography (EUS) for diagnosing the invasion depth of colorectal cancer (CRC); however, whether these tools show diagnostic differences in categories such as tumor size and morphology remains unclear. Hence, we conducted detailed subset analysis of the prospective data. Methods In this multicenter, prospective, comparative trial, a total of 70 patients with early, flat CRC were enrolled from February 2011 to December 2012, and the results of 66 lesions were finally analyzed. Patients were randomly allocated to primary MC followed by EUS or to primary EUS followed by MC. Diagnoses of invasion depth by each tool were divided into intra-mucosal to slight submucosal invasion (invasion depth <1000 mu m) and deep submucosal invasion (invasion depth >= 1000 mu m), and then compared with the final pathological diagnosis by an independent pathologist blinded to clinical data. To standardize diagnoses among examiners, this trial was started after achievement of a mean. value of >= 0.6 which was calculated from the average of. values between each pair of participating endoscopists. Results Both MC and EUS showed similar diagnostic outcomes, with no significant differences in prediction of invasion depth in subset analyses according to tumor size, location, and morphology. Lesions that were consistently diagnosed as Tis/T1-SMS or >= T1-SMD with both tools revealed accuracy of 76-78%. Accuracy was low in borderline lesions with irregular pit pattern in MC and distorted findings of the third layer in EUS (MC, 58.5%; EUS, 50.0%). Conclusions MC and EUS showed the same limited accuracy for predicting invasion depth in all categories of early CRC. Since the irregular pit pattern in MC, distorted findings to the third layer in EUS and inconsistent diagnosis between both tools were associated with low accuracy, further refinements or even novel methods are still needed for such lesions.	[Yamada, Tomonori] Japanese Red Cross Nagoya Daini Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Shimura, Takaya; Ebi, Masahide; Nishiwaki, Hirotaka; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Shimura, Takaya] Boston Childrens Hosp, Vasc Biol Program, Boston, MA USA; [Shimura, Takaya] Boston Childrens Hosp, Dept Surg, Boston, MA USA; [Shimura, Takaya] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Hirata, Yoshikazu] Kasugai Municipal Hosp, Dept Gastroenterol, Kasugai, Aichi, Japan; [Mizushima, Takashi] Gifu Prefectural Tajimi Hosp, Dept Gastroenterol, Tajimi, Gifu, Japan; [Asukai, Koki; Togawa, Shozo] Chukyo Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Takahashi, Satoru] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Nagoya, Aichi, Japan	Japanese Red Cross Nagoya Daini Hospital; Nagoya City University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Nagoya City University	Shimura, T (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan.	tshimura@med.nagoya-cu.ac.jp		Shimura, Takaya/0000-0002-6048-0021				Bianco MA, 2006, ENDOSCOPY, V38, P470, DOI 10.1055/s-2006-925399; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fu KI, 2008, DIGEST DIS SCI, V53, P1886, DOI 10.1007/s10620-007-0104-y; Fujishiro M, 2007, CLIN GASTROENTEROL H, V5, P678, DOI 10.1016/j.cgh.2007.01.006; Haruki S, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/621512; Hizawa K, 1996, AM J GASTROENTEROL, V91, P768; Hurlstone D P, 2004, Colorectal Dis, V6, P369, DOI 10.1111/j.1463-1318.2004.00667.x; Hurlstone DP, 2005, GUT, V54, P1585, DOI 10.1136/gut.2005.069849; Ikehara H, 2010, J GASTROEN HEPATOL, V25, P905, DOI 10.1111/j.1440-1746.2010.06275.x; Kanao H, 2008, WORLD J GASTROENTERO, V14, P211, DOI 10.3748/wjg.14.211; Kitajima K, 2004, J GASTROENTEROL, V39, P534, DOI 10.1007/s00535-004-1339-4; Konishi K, 2003, INT J COLORECTAL DIS, V18, P19, DOI 10.1007/s00384-002-0423-6; Kudo S, 2001, ENDOSCOPY, V33, P367; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Matsumoto T, 2002, GASTROINTEST ENDOSC, V56, P354, DOI 10.1067/mge.2002.127156; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Saito Y, 2007, GASTROINTEST ENDOSC, V66, P966, DOI 10.1016/j.gie.2007.02.053; Saitoh Y, 1996, GASTROINTEST ENDOSC, V44, P34, DOI 10.1016/S0016-5107(96)70226-2; Sakamoto T, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-100; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; SHIMIZU S, 1990, ENDOSCOPY, V22, P31, DOI 10.1055/s-2007-1012783; Shimura T, 2014, CLIN GASTROENTEROL H, V12, P662, DOI 10.1016/j.cgh.2013.06.022; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Sobin L, 2009, TNM CLASSIFICATION M; Tanabe R, 2012, HEPATO-GASTROENTEROL, V59, P1794, DOI 10.5754/hge11777; Tobaru T, 2008, INT J ONCOL, V33, P503, DOI 10.3892/ijo_00000033; Wada Y, 2010, DIGEST ENDOSC, V22, P192, DOI 10.1111/j.1443-1661.2010.00983.x; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2	29	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134942	10.1371/journal.pone.0134942	http://dx.doi.org/10.1371/journal.pone.0134942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270341	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800025
J	Garaicoechea, L; Aguilar, A; Parra, GI; Bok, M; Sosnovtsev, SV; Canziani, G; Green, KY; Bok, K; Parreno, V				Garaicoechea, Lorena; Aguilar, Andrea; Parra, Gabriel I.; Bok, Marina; Sosnovtsev, Stanislav V.; Canziani, Gabriela; Green, Kim Y.; Bok, Karin; Parreno, Viviana			Llama Nanoantibodies with Therapeutic Potential against Human Norovirus Diarrhea	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; BIOSPECIFIC INTERACTION ANALYSIS; REACTIVE MONOCLONAL-ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS; RECOMBINANT CAPSID PROTEIN; SURFACE-PLASMON RESONANCE; BLOOD GROUP ANTIGENS; NORWALK VIRUS; GENOGROUP-I; CONFER PROTECTION	Noroviruses are a major cause of acute gastroenteritis, but no vaccines or therapeutic drugs are available. Llama-derived single chain antibody fragments (also called VHH) are small, recombinant monoclonal antibodies of 15 kDa with several advantages over conventional antibodies. The aim of this study was to generate recombinant monoclonal VHH specific for the two major norovirus (NoV) genogroups (GI and GII) in order to investigate their potential as immunotherapy for the treatment of NoV diarrhea. To accomplish this objective, two llamas were immunized with either GI.1 (Norwalk-1968) or GII. 4 (MD2004) VLPs. After immunization, peripheral blood lymphocytes were collected and used to generate two VHH libraries. Using phage display technology, 10 VHH clones specific for GI.1, and 8 specific for GII.4 were selected for further characterization. All VHH recognized conformational epitopes in the P domain of the immunizing VP1 capsid protein, with the exception of one GII. 4 VHH that recognized a linear P domain epitope. The GI.1 VHHs were highly specific for the immunizing GI.1 genotype, with only one VHH cross-reacting with GI. 3 genotype. The GII.4 VHHs reacted with the immunizing GII.4 strain and showed a varying reactivity profile among different GII genotypes. One VHH specific for GI.1 and three specific for GII.4 could block the binding of homologous VLPs to synthetic HBGA carbohydrates, saliva, and pig gastric mucin, and in addition, could inhibit the hemagglutination of red blood cells by homologous VLPs. The ability of Nov-specific VHHs to perform well in these surrogate neutralization assays supports their further development as immunotherapy for NoV treatment and immunoprophylaxis.	[Garaicoechea, Lorena; Aguilar, Andrea; Bok, Marina; Parreno, Viviana] INTA, Inst Virol, Buenos Aires, DF, Argentina; [Parra, Gabriel I.; Sosnovtsev, Stanislav V.; Green, Kim Y.; Bok, Karin] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Canziani, Gabriela] Inst Leloir, Buenos Aires, DF, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Leloir Institute	Parreno, V (corresponding author), INTA, Inst Virol, Buenos Aires, DF, Argentina.	parreno.viviana@inta.gob.ar	Parra, Gabriel I./H-4339-2019	Parra, Gabriel I./0000-0002-1102-4740; Bok, Marina/0000-0003-4309-8629; parreno, viviana/0000-0003-0385-5592	FONARSEC department of the Argentinean Ministry of Science [INTA BIO AF 03]; INTA specific project [PNBIO-1131033]; Division of Intramural Research in NIAID, NIH, USA; INTA; CONICET; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000897] Funding Source: NIH RePORTER	FONARSEC department of the Argentinean Ministry of Science; INTA specific project; Division of Intramural Research in NIAID, NIH, USA; INTA; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was financially supported by the FONARSEC department of the Argentinean Ministry of Science, with a Grant on Fuctional Food, "INTA BIO AF 03" (VP) (http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/fonarsec), the INTA specific project No PNBIO-1131033 (VP) (www.inta.gob.ar), and the Division of Intramural Research in NIAID, NIH, USA (KG) (www.nih.gov). The salaries of VP and LG were supported by INTA. Salaries of AA and MB were supported by CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DJ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-150; Almanza H, 2008, J CLIN MICROBIOL, V46, P3971, DOI 10.1128/JCM.01204-08; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Ausar SF, 2006, J BIOL CHEM, V281, P19478, DOI 10.1074/jbc.M603313200; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; Bates JT, 2014, VIROLOGY, V454, P139, DOI 10.1016/j.virol.2014.02.010; Batten CA, 2006, VIROLOGY, V356, P179, DOI 10.1016/j.virol.2006.07.034; BERNSTEIN DI, 2014, J INFECT DIS; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Canziani GA, 2004, ANAL BIOCHEM, V325, P301, DOI 10.1016/j.ab.2003.11.004; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Chen ZC, 2013, J VIROL, V87, P9547, DOI 10.1128/JVI.01376-13; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; Cuellar JL, 2010, J GEN VIROL, V91, P2449, DOI 10.1099/vir.0.021212-0; Czako R, 2012, CLIN VACCINE IMMUNOL, V19, P284, DOI 10.1128/CVI.05592-11; Dai YC, 2013, ANTIVIR RES, V97, P293, DOI 10.1016/j.antiviral.2012.12.011; Dai YC, 2012, J VIROL METHODS, V186, P126, DOI 10.1016/j.jviromet.2012.07.002; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; Debbink K, 2014, J VIROL, V88, P7244, DOI 10.1128/JVI.00203-14; Dona V, 2010, J AGR FOOD CHEM, V58, P918, DOI 10.1021/jf902973c; Esseili MA, 2012, APPL ENVIRON MICROB, V78, P786, DOI 10.1128/AEM.07081-11; Florescu DF, 2011, PEDIATR TRANSPLANT, V15, P718, DOI 10.1111/j.1399-3046.2011.01556.x; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Gairard-Dory AC, 2014, TRANSPL P, V46, P3603, DOI 10.1016/j.transproceed.2014.09.095; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; Gomez-Sebastian S, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-59; Green K. Y., 2007, FIELDS VIROLOGY, V1, P949; GREEN KY, 1993, J CLIN MICROBIOL, V31, P2185, DOI 10.1128/JCM.31.8.2185-2191.1993; Green KY, 1997, J CLIN MICROBIOL, V35, P1909, DOI 10.1128/JCM.35.7.1909-1914.1997; Hansman GS, 2014, J VIROL; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Henke-Gendo C, 2009, J CLIN MICROBIOL, V47, P2855, DOI 10.1128/JCM.00448-09; Hinz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010482; Huang W., 2014, NACE CORROSION 2013, P1; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kaufman SS, 2014, ANTIVIR RES, V105, P80, DOI 10.1016/j.antiviral.2014.02.012; Kirby AE, 2014, J MED VIROL, V86, P2055, DOI 10.1002/jmv.23905; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Leite JPG, 1996, ARCH VIROL, V141, P865, DOI 10.1007/BF01718161; Lentz EM, 2012, PLANTA, V236, P703, DOI 10.1007/s00425-012-1642-x; LEW JF, 1994, VIROLOGY, V200, P319, DOI 10.1006/viro.1994.1194; Li XA, 2010, VIRUS RES, V151, P142, DOI 10.1016/j.virusres.2010.04.005; Lindesmith LC, 2013, J VIROL, V87, P2803, DOI 10.1128/JVI.03106-12; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lindesmith LC, 2012, J VIROL, V86, P873, DOI 10.1128/JVI.06200-11; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; LoBue AD, 2006, VACCINE, V24, P5220, DOI 10.1016/j.vaccine.2006.03.080; Lochridge VP, 2005, J GEN VIROL, V86, P2799, DOI 10.1099/vir.0.81134-0; Ludwig A, 2008, J MED VIROL, V80, P1461, DOI 10.1002/jmv.21217; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Oliver SL, 2006, J CLIN MICROBIOL, V44, P992, DOI 10.1128/JCM.44.3.992-998.2006; Onell A, 2005, J MOL RECOGNIT, V18, P307, DOI 10.1002/jmr.745; Pant N, 2006, J INFECT DIS, V194, P1580, DOI 10.1086/508747; Parker TD, 2005, J VIROL, V79, P7402, DOI 10.1128/JVI.79.12.7402-7409.2005; Parra GI, 2014, EMERG INFECT DIS, V20, P1016, DOI 10.3201/eid2006.131627; Parra GI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067592; Parra GI, 2012, J VIROL, V86, P7414, DOI 10.1128/JVI.06729-11; Parra GI, 2012, VACCINE, V30, P3580, DOI 10.1016/j.vaccine.2012.03.050; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Poulsen TR, 2011, J IMMUNOL, V187, P4229, DOI 10.4049/jimmunol.1000928; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; REDMOND MJ, 1993, VACCINE, V11, P273, DOI 10.1016/0264-410X(93)90029-W; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Saito M, 2014, CLIN INFECT DIS, V58, P483, DOI 10.1093/cid/cit763; Sharifzadeh Z, 2013, CANCER LETT, V334, P237, DOI 10.1016/j.canlet.2012.08.010; Sharifzadeh Z, 2013, MOL BIOTECHNOL, V54, P590, DOI 10.1007/s12033-012-9601-0; Shiota T, 2007, J VIROL, V81, P12298, DOI 10.1128/JVI.00891-07; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Tokuhara D, 2013, RICE BASED ORAL ANTI, V123; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Vega CG, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003334; Vega CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042788; Vega E, 2014, J VIROL, V88, P14184, DOI 10.1128/JVI.02494-14; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Walsh EE, 1998, J GEN VIROL, V79, P479, DOI 10.1099/0022-1317-79-3-479; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Yoda T, 2001, BMC Microbiol, V1, P24, DOI 10.1186/1471-2180-1-24; Yoda T, 2003, J CLIN MICROBIOL, V41, P2367, DOI 10.1128/JCM.41.6.2367-2371.2003; Zakikhany K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041625; Zhang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069379; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	95	26	30	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133665	10.1371/journal.pone.0133665	http://dx.doi.org/10.1371/journal.pone.0133665			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267898	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300021
J	Kostopoulou, ON; Magoulas, GE; Papadopoulos, GE; Mouzaki, A; Dinos, GP; Papaioannou, D; Kalpaxis, DL				Kostopoulou, Ourania N.; Magoulas, George E.; Papadopoulos, Georgios E.; Mouzaki, Athanasia; Dinos, George P.; Papaioannou, Dionissios; Kalpaxis, Dimitrios L.			Synthesis and Evaluation of Chloramphenicol Homodimers: Molecular Target, Antimicrobial Activity, and Toxicity against Human Cells	PLOS ONE			English	Article							PEPTIDYL TRANSFERASE CENTER; MULTIDRUG EFFLUX PUMP; NASCENT PEPTIDE; RIBOSOMAL-RNA; BINDING-SITE; ANTIBIOTICS; INHIBITION; PEPTIDYLTRANSFERASE; ERYTHROMYCIN; POLYAMINES	As fight against antibiotic resistance must be strengthened, improving old drugs that have fallen in reduced clinical use because of toxic side effects and/or frequently reported resistance, like chloramphenicol (CAM), is of special interest. Chloramphenicol (CAM), a prototypical wide-spectrum antibiotic has been shown to obstruct protein synthesis via binding to the bacterial ribosome. In this study we sought to identify features intensifying the bacteriostatic action of CAM. Accordingly, we synthesized a series of CAM-dimers with various linker lengths and functionalities and compared their efficiency in inhibiting peptide-bond formation in an Escherichia coli cell-free system. Several CAM-dimers exhibited higher activity, when compared to CAM. The most potent of them, compound 5, containing two CAM bases conjugated via a dicarboxyl aromatic linker of six successive carbon-bonds, was found to simultaneously bind both the ribosomal catalytic center and the exit-tunnel, thus revealing a second, kinetically cryptic binding site for CAM. Compared to CAM, compound 5 exhibited comparable antibacterial activity against MRSA or wild-type strains of Staphylococcus aureus, Enterococcus faecium and E. coli, but intriguingly superior activity against some CAM-resistant E. coli and Pseudomonas aeruginosa strains. Furthermore, it was almost twice as active in inhibiting the growth of T-leukemic cells, without affecting the viability of normal human lymphocytes. The observed effects were rationalized by footprinting tests, crosslinking analysis, and MD-simulations.	[Kostopoulou, Ourania N.; Dinos, George P.; Kalpaxis, Dimitrios L.] Univ Patras, Sch Med, Dept Biochem, GR-26110 Patras, Greece; [Magoulas, George E.; Papaioannou, Dionissios] Univ Patras, Dept Chem, Lab Synthet Organ Chem, Patras, Greece; [Papadopoulos, Georgios E.] Univ Thessaly, Dept Biochem & Biotechnol, Ploutonos, Larissa, Greece; [Mouzaki, Athanasia] Univ Patras, Sch Med, Dept Internal Med, Div Hematol, GR-26110 Patras, Greece	University of Patras; University of Patras; University of Thessaly; University of Patras	Papaioannou, D (corresponding author), Karolinska Univ Sjukhuset, Ctr Mol Med, L8, Stockholm, Sweden.	dimkal@med.upatras.gr	Papaioannou, Dionissios/F-3384-2010; Magoulas, George E./F-3385-2010; Magoulas, George/AAE-5666-2022; kos, nia/ABE-9162-2020; Dinos, George/AAR-8444-2020	Magoulas, George E./0000-0001-8944-1635; Magoulas, George/0000-0001-8944-1635; Dinos, George/0000-0003-3914-7408; Papadopoulos, Georgios/0000-0002-2742-8467	University of Patras	University of Patras	This work was partially supported by the University of Patras. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhill AE, 2012, ANTIMICROB AGENTS CH, V56, P4046, DOI 10.1128/AAC.00678-12; Berkov-Zrihen Y, 2013, J MED CHEM, V56, P5613, DOI 10.1021/jm400707f; Bulkley D, 2010, P NATL ACAD SCI USA, V107, P17158, DOI 10.1073/pnas.1008685107; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P3127, DOI 10.1128/AAC.00239-08; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; DOUTHWAITE S, 1992, J BACTERIOL, V174, P1333, DOI 10.1128/jb.174.4.1333-1338.1992; Dunkle JA, 2010, P NATL ACAD SCI USA, V107, P17152, DOI 10.1073/pnas.1007988107; Egebjerg J, 1991, RIBOSOME STRUCTURE F, P168; Ghisalberti D, 2005, BIOCHEM BIOPH RES CO, V328, P1113, DOI 10.1016/j.bbrc.2005.01.069; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Hansen LH, 1999, MOL MICROBIOL, V31, P623, DOI 10.1046/j.1365-2958.1999.01202.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Koronakis V, 2003, FEBS LETT, V555, P66, DOI 10.1016/S0014-5793(03)01125-6; Kostopoulou ON, 2014, NUCLEIC ACIDS RES, V42, P8621, DOI 10.1093/nar/gku539; Kostopoulou ON, 2012, NUCLEIC ACIDS RES, V40, P5078, DOI 10.1093/nar/gks174; Kourelis T.G., 2011, OPEN ENZYM INHIB J, V4, P1, DOI [10.2174/1874940201104010001, DOI 10.2174/1874940201104010001]; Kumar S, 2012, BIOCHEMISTRY-US, V51, P2331, DOI 10.1021/bi201657k; Lokhande J, 2007, J Indian Med Assoc, V105, P226; Long KS, 2003, NUCLEIC ACIDS RES, V31, P7208, DOI 10.1093/nar/gkg945; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; Michael K, 1999, BIOORGAN MED CHEM, V7, P1361, DOI 10.1016/S0968-0896(99)00071-1; MOAZED D, 1986, J MOL BIOL, V187, P399, DOI 10.1016/0022-2836(86)90441-9; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Morita Y, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00422; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Paez PL, 2008, BASIC CLIN PHARMACOL, V103, P349, DOI 10.1111/j.1742-7843.2008.00290.x; Persaud C, 2010, BIOCHEM BIOPH RES CO, V392, P223, DOI 10.1016/j.bbrc.2010.01.021; Petropoulos AD, 2008, J BIOL CHEM, V283, P4756, DOI 10.1074/jbc.M708371200; Petropoulos AD, 2009, J MOL BIOL, V385, P1179, DOI 10.1016/j.jmb.2008.11.042; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polacek N, 2003, MOL CELL, V11, P103, DOI 10.1016/S1097-2765(02)00825-0; Pongs O., 1979, MECH ACTION ANTIBACT, P26, DOI [10.1007/978-3-642-46403-4, DOI 10.1007/978-3-642-46403-4]; Rodriguez-Fonseca C., 1996, MOL BIOL, V247, P224; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Schwarz S, 2004, FEMS MICROBIOL REV, V28, P519, DOI 10.1016/j.femsre.2004.04.001; SHAW WV, 1983, CRC CR REV BIOCH MOL, V14, P1, DOI 10.3109/10409238309102789; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; Thompson J, 2002, J MOL BIOL, V322, P273, DOI 10.1016/S0022-2836(02)00784-2; Vauquelin G, 2013, N-S ARCH PHARMACOL, V386, P949, DOI 10.1007/s00210-013-0881-0; Vazquez-Laslop N, 2011, P NATL ACAD SCI USA, V108, P10496, DOI 10.1073/pnas.1103474108; VESTER B, 1988, EMBO J, V7, P3577, DOI 10.1002/j.1460-2075.1988.tb03235.x; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; Wimberly BT, 2009, CURR OPIN INVEST DR, V10, P750; Wong ILK, 2014, ANTIMICROB AGENTS CH, V58, P3379, DOI 10.1128/AAC.02425-13; Xaplanteri MA, 2003, NUCLEIC ACIDS RES, V31, P5074, DOI 10.1093/nar/gkg686; Yang KH, 2009, MINI-REV MED CHEM, V9, P1329, DOI 10.2174/138955709789878097; Yuan ZR, 2008, CANCER RES, V68, P4875, DOI 10.1158/0008-5472.CAN-07-6061; Zimmermann M, 2011, METHODS MOL BIOL, V740, P57, DOI 10.1007/978-1-61779-108-6_8	51	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134526	10.1371/journal.pone.0134526	http://dx.doi.org/10.1371/journal.pone.0134526			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267355	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300049
J	Reinardy, HC; Emerson, CE; Manley, JM; Bodnar, AG				Reinardy, Helena C.; Emerson, Chloe E.; Manley, Jason M.; Bodnar, Andrea G.			Tissue Regeneration and Biomineralization in Sea Urchins: Role of Notch Signaling and Presence of Stem Cell Markers	PLOS ONE			English	Article							GENE REGULATORY NETWORK; RELATIVE QUANTIFICATION; TUBE FEET; EXPRESSION; GENOME; DIFFERENTIATION; GROWTH	Echinoderms represent a phylum with exceptional regenerative capabilities that can reconstruct both external appendages and internal organs. Mechanistic understanding of the cellular pathways involved in regeneration in these animals has been hampered by the limited genomic tools and limited ability to manipulate regenerative processes. We present a functional assay to investigate mechanisms of tissue regeneration and biomineralization by measuring the regrowth of amputated tube feet (sensory and motor appendages) and spines in the sea urchin, Lytechinus variegatus. The ability to manipulate regeneration was demonstrated by concentration-dependent inhibition of regrowth of spines and tube feet by treatment with the mitotic inhibitor, vincristine. Treatment with the gamma-secretase inhibitor DAPT resulted in a concentration-dependent inhibition of regrowth, indicating that both tube feet and spine regeneration require functional Notch signaling. Stem cell markers (Piwi and Vasa) were expressed in tube feet and spine tissue, and Vasa-positive cells were localized throughout the epidermis of tube feet by immunohistochemistry, suggesting the existence of multipotent progenitor cells in these highly regenerative appendages. The presence of Vasa protein in other somatic tissues (e.g. esophagus, radial nerve, and a sub-population of coelomocytes) suggests that multipotent cells are present throughout adult sea urchins and may contribute to normal homeostasis in addition to regeneration. Mechanistic insight into the cellular pathways governing the tremendous regenerative capacity of echinoderms may reveal processes that can be modulated for regenerative therapies, shed light on the evolution of regeneration, and enable the ability to predict how these processes will respond to changing environmental conditions.	[Reinardy, Helena C.; Emerson, Chloe E.; Manley, Jason M.; Bodnar, Andrea G.] Bermuda Inst Ocean Sci, Mol Discovery Lab, St Georges, Bermuda	Bermuda Institute of Ocean Sciences	Bodnar, AG (corresponding author), Bermuda Inst Ocean Sci, Mol Discovery Lab, St Georges GE 01, St Georges, Bermuda.	andrea.bodnar@bios.edu	Reinardy, Helena/P-2807-2016	Reinardy, Helena/0000-0002-8614-9820; Manley, Jason/0000-0003-3505-8707	Christian Humann Foundation; Bermuda Charitable Trust; National Science Foundation Research for Undergraduates Program [1262880]; Princeton Environmental Institute internship at the Bermuda Institute for Ocean Sciences; Directorate For Geosciences [1262880] Funding Source: National Science Foundation	Christian Humann Foundation; Bermuda Charitable Trust; National Science Foundation Research for Undergraduates Program; Princeton Environmental Institute internship at the Bermuda Institute for Ocean Sciences; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was gratefully received from the Christian Humann Foundation and a Bermuda Charitable Trust. CEE was supported by the National Science Foundation Research for Undergraduates Program (Grant no 1262880). JMM was funded through a Princeton Environmental Institute internship at the Bermuda Institute for Ocean Sciences.	Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Burns G, 2011, J EXP MAR BIOL ECOL, V407, P315, DOI 10.1016/j.jembe.2011.06.032; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; Campanale JP, 2014, DEV DYNAM, V243, P917, DOI [10.1002/dvdy.24133, 10.1002/DVDY.24133]; Candia-Carnevali MD, 2009, STEM CELLS IN MARINE ORGANISMS, P165, DOI 10.1007/978-90-481-2767-2_7; Carnevali MDC, 2006, ISJ-INVERT SURVIV J, V3, P64; Clark MS, 2007, AQUAT BIOL, V1, P45, DOI 10.3354/ab00004; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Croce JC, 2010, DEVELOPMENT, V137, P83, DOI 10.1242/dev.044149; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; de-Leon SB, 2013, DEV BIOL, V374, P245, DOI 10.1016/j.ydbio.2012.11.013; Dubois P, 2001, MICROSC RES TECHNIQ, V55, P427, DOI 10.1002/jemt.1188; Dupont S, 2006, J EXP BIOL, V209, P3873, DOI 10.1242/jeb.02445; Ettensohn CA, 2013, GENESIS, V51, P383, DOI 10.1002/dvg.22380; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Gao F, 2008, P NATL ACAD SCI USA, V105, P6091, DOI 10.1073/pnas.0801201105; Garcia-Arraras JE, 1999, J COMP NEUROL, V406, P461, DOI 10.1002/(SICI)1096-9861(19990419)406:4<461::AID-CNE4>3.0.CO;2-0; Grotek B, 2013, DEVELOPMENT, V140, P1412, DOI 10.1242/dev.087452; Gustafson EA, 2010, BIOESSAYS, V32, P626, DOI 10.1002/bies.201000001; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hu MY, 2014, J EXP BIOL, V217, P2411, DOI 10.1242/jeb.100024; JACOBS RS, 1981, FED PROC, V40, P26; Juliano CE, 2010, DEVELOPMENT, V137, P4113, DOI 10.1242/dev.047969; Koch U, 2013, DEVELOPMENT, V140, P689, DOI 10.1242/dev.080614; Lesser MP, 2011, P ROY SOC B-BIOL SCI, V278, P3371, DOI 10.1098/rspb.2011.0336; Loram J, 2012, MECH AGEING DEV, V133, P338, DOI 10.1016/j.mad.2012.03.012; Mashanov VS, 2012, GENE EXPR PATTERNS, V12, P24, DOI 10.1016/j.gep.2011.10.003; Miguel-Ruiz JES, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-115; Moulton JD, 2009, MOLECULES, V14, P1304, DOI 10.3390/molecules14031304; Munder S, 2013, DEV BIOL, V383, P146, DOI 10.1016/j.ydbio.2013.08.022; Ortiz-Pineda PA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-262; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Patruno M, 2003, P ROY SOC B-BIOL SCI, V270, P1341, DOI 10.1098/rspb.2003.2367; Peter IS, 2011, NATURE, V474, P635, DOI 10.1038/nature10100; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Purow B, 2012, ADV EXP MED BIOL, V727, P305, DOI 10.1007/978-1-4614-0899-4_23; Rafiq K, 2014, DEVELOPMENT, V141, P950, DOI 10.1242/dev.105585; Santos R, 2013, J PROTEOMICS, V79, P100, DOI 10.1016/j.jprot.2012.12.004; Santos R, 2009, FUNCTIONAL SURFACES IN BIOLOGY: ADHESION RELATED PHENOMENA, VOL 2, P9, DOI 10.1007/978-1-4020-6695-5_2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Vogt G, 2012, STEM CELL REV REP, V8, P305, DOI 10.1007/s12015-011-9303-1; Voronina E, 2008, DEV BIOL, V314, P276, DOI 10.1016/j.ydbio.2007.11.039	45	38	40	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133860	10.1371/journal.pone.0133860	http://dx.doi.org/10.1371/journal.pone.0133860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267358	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300027
J	Soranno, PA; Cheruvelil, KS; Wagner, T; Webster, KE; Bremigan, MT				Soranno, Patricia A.; Cheruvelil, Kendra Spence; Wagner, Tyler; Webster, Katherine E.; Bremigan, Mary Tate			Effects of Land Use on Lake Nutrients: The Importance of Scale, Hydrologic Connectivity, and Region	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; WATER-QUALITY; CATCHMENT CHARACTERISTICS; LANDSCAPE POSITION; BOREAL LAKES; PHOSPHORUS; NITROGEN; MANAGEMENT; DRIVERS; FOREST	Catchment land uses, particularly agriculture and urban uses, have long been recognized as major drivers of nutrient concentrations in surface waters. However, few simple models have been developed that relate the amount of catchment land use to downstream freshwater nutrients. Nor are existing models applicable to large numbers of freshwaters across broad spatial extents such as regions or continents. This research aims to increase model performance by exploring three factors that affect the relationship between land use and downstream nutrients in freshwater: the spatial extent for measuring land use, hydrologic connectivity, and the regional differences in both the amount of nutrients and effects of land use on them. We quantified the effects of these three factors that relate land use to lake total phosphorus (TP) and total nitrogen (TN) in 346 north temperate lakes in 7 regions in Michigan, USA. We used a linear mixed modeling framework to examine the importance of spatial extent, lake hydrologic class, and region on models with individual lake nutrients as the response variable, and individual land use types as the predictor variables. Our modeling approach was chosen to avoid problems of multi-collinearity among predictor variables and a lack of independence of lakes within regions, both of which are common problems in broad-scale analyses of freshwaters. We found that all three factors influence land use-lake nutrient relationships. The strongest evidence was for the effect of lake hydrologic connectivity, followed by region, and finally, the spatial extent of land use measurements. Incorporating these three factors into relatively simple models of land use effects on lake nutrients should help to improve predictions and understanding of land use-lake nutrient interactions at broad scales.	[Soranno, Patricia A.; Bremigan, Mary Tate] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Cheruvelil, Kendra Spence] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA; [Wagner, Tyler] Penn State Univ, Penn Cooperat Fish & Wildlife Res Unit, US Geol Survey, University Pk, PA 16802 USA; [Webster, Katherine E.] Univ Dublin Trinity Coll, Dept Zool, Sch Nat Sci, Dublin 2, Ireland	Michigan State University; Michigan State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; Trinity College Dublin	Soranno, PA (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	soranno@anr.msu.edu		Webster, Katherine/0000-0002-6009-0146; Soranno, Patricia/0000-0003-1668-9271	USDA National Institute of Food and Agriculture [176820]; EPA-Office; Michigan Department of Environmental Quality grant; Michigan Department of Natural Resources - Fisheries Division grant; Direct For Biological Sciences [1065786] Funding Source: National Science Foundation	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); EPA-Office; Michigan Department of Environmental Quality grant; Michigan Department of Natural Resources - Fisheries Division grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the USDA National Institute of Food and Agriculture, Hatch project 176820 of PAS; an EPA-Office PAS, KEW, KSC, MTB; a Michigan Department of Environmental Quality grant to R. J. Stevenson and PAS; and a Michigan Department of Natural Resources - Fisheries Division grant to PAS, MTB, K. Wehrly and J. Breck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell JM, 2011, MAR FRESHWATER RES, V62, P162, DOI 10.1071/MF10180; [Anonymous], 2014, R LANG ENV STAT COMP; Arbuckle KE, 2001, LIMNOL OCEANOGR, V46, P970, DOI 10.4319/lo.2001.46.4.0970; Baker ME, 2006, LANDSCAPE ECOL, V21, P1327, DOI 10.1007/s10980-006-0020-0; Borah DK, 2003, T ASAE, V46, P1553, DOI [10.13031/2013.16110, 10.13031/2013.15644]; Bruesewitz DA, 2011, ECOSYSTEMS, V14, P341, DOI 10.1007/s10021-011-9413-2; Carpenter SR, 2014, AQUAT SCI, V76, P145, DOI 10.1007/s00027-013-0324-5; Cheruvelil KS, 2013, ECOL APPL, V23, P1603, DOI 10.1890/12-1872.1; Cheruvelil KS, 2008, ENVIRON MANAGE, V41, P425, DOI 10.1007/s00267-007-9045-7; Creed IF, 1998, WATER RESOUR RES, V34, P3105, DOI 10.1029/98WR01924; Cross TK, 2013, LAKE RESERV MANAGE, V29, P1, DOI 10.1080/10402381.2012.754808; D'Arcy P, 1997, CAN J FISH AQUAT SCI, V54, P2215, DOI 10.1139/cjfas-54-10-2215; Devito K, 2005, HYDROL PROCESS, V19, P1705, DOI 10.1002/hyp.5881; Devito KJ, 2000, CAN J FISH AQUAT SCI, V57, P1977, DOI 10.1139/cjfas-57-10-1977; Dodds WK, 2004, LIMNOL OCEANOGR-METH, V2, P333, DOI 10.4319/lom.2004.2.333; Epstein DM, 2013, AQUAT SCI, V75, P199, DOI 10.1007/s00027-012-0267-2; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fergus CE, 2011, LIMNOL OCEANOGR, V56, P2127, DOI 10.4319/lo.2011.56.6.2127; Finlay JC, 2013, SCIENCE, V342, P247, DOI 10.1126/science.1242575; FOY RH, 1992, WATER RES, V26, P633, DOI 10.1016/0043-1354(92)90238-Y; Fraterrigo JM, 2008, ECOSYSTEMS, V11, P1021, DOI 10.1007/s10021-008-9176-6; Gergel SE, 1999, ECOL APPL, V9, P1377, DOI 10.1890/1051-0761(1999)009[1377:DOCAAI]2.0.CO;2; Hakanson L, 2005, HYDROBIOLOGIA, V541, P117, DOI 10.1007/s10750-004-5032-7; Higgins JV, 2005, CONSERV BIOL, V19, P432, DOI 10.1111/j.1523-1739.2005.00504.x; HUNSAKER CT, 1995, BIOSCIENCE, V45, P193, DOI 10.2307/1312558; Johnes PJ, 2007, SOIL USE MANAGE, V23, P176, DOI 10.1111/j.1475-2743.2007.00120.x; Jones JR, 2008, LAKE RESERV MANAGE, V24, P1; Jones JR, 2004, CAN J FISH AQUAT SCI, V61, P1503, DOI [10.1139/f04-088, 10.1139/F04-088]; King RS, 2005, ECOL APPL, V15, P137, DOI 10.1890/04-0481; Knoll LB, 2003, LIMNOL OCEANOGR, V48, P608, DOI 10.4319/lo.2003.48.2.0608; Leavitt PR, 2006, LIMNOL OCEANOGR, V51, P2262, DOI 10.4319/lo.2006.51.5.2262; Martin SL, 2006, LIMNOL OCEANOGR, V51, P801, DOI 10.4319/lo.2006.51.2.0801; Nielsen A, 2012, ECOL APPL, V22, P1187, DOI 10.1890/11-1831.1; NOVOTNY V, 1989, J SOIL WATER CONSERV, V44, P568; Read EK, ECOLOGICAL APPL; Sadro S, 2012, ECOSYSTEMS, V15, P363, DOI 10.1007/s10021-011-9515-x; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Smith RA, 2003, ENVIRON SCI TECHNOL, V37, P3039, DOI 10.1021/es020663b; Soranno PA, 1996, ECOL APPL, V6, P865, DOI 10.2307/2269490; Soranno PA, 2010, BIOSCIENCE, V60, P440, DOI 10.1525/bio.2010.60.6.8; Stendera S, 2006, ENVIRON MANAGE, V38, P760, DOI 10.1007/s00267-005-0180-8; Taranu ZE, 2008, ECOSYSTEMS, V11, P715, DOI 10.1007/s10021-008-9153-0; VAITHIYANATHAN P, 1992, J ENVIRON QUAL, V21, P280, DOI 10.2134/jeq1992.00472425002100020021x; Wagner T, 2006, FISHERIES, V31, P180, DOI 10.1577/1548-8446(2006)31[180:AFMDSI]2.0.CO;2; Wagner T, 2008, ENVIRON MONIT ASSESS, V141, P131, DOI 10.1007/s10661-007-9883-z; Wickham JD, 2005, LANDSCAPE ECOL, V20, P791, DOI 10.1007/s10980-005-0067-3; Winter TC, 2001, J AM WATER RESOUR AS, V37, P335, DOI 10.1111/j.1752-1688.2001.tb00973.x; Xenopoulos MA, 2003, LIMNOL OCEANOGR, V48, P2321, DOI 10.4319/lo.2003.48.6.2321; Young WJ, 1996, J ENVIRON MANAGE, V47, P165, DOI 10.1006/jema.1996.0043; Zhang T, 2012, LANDSCAPE ECOL, V27, P1015, DOI 10.1007/s10980-012-9762-z	50	64	68	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135454	10.1371/journal.pone.0135454	http://dx.doi.org/10.1371/journal.pone.0135454			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267813	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300118
J	Zhu, SJ; Levinson, D				Zhu, Shanjiang; Levinson, David			Do People Use the Shortest Path? An Empirical Test of Wardrop's First Principle	PLOS ONE			English	Article							TRAVEL-TIME RELIABILITY; CHOICE SET GENERATION; ROUTE CHOICE; MODEL; INFORMATION; NETWORKS; EQUILIBRIUM; PERCEPTION; ACCURACY; BEHAVIOR	Most recent route choice models, following either the random utility maximization or rule-based paradigm, require explicit enumeration of feasible routes. The quality of model estimation and prediction is sensitive to the appropriateness of the consideration set. However, few empirical studies of revealed route characteristics have been reported in the literature. This study evaluates the widely applied shortest path assumption by evaluating routes followed by residents of the Minneapolis-St. Paul metropolitan area. Accurate Global Positioning System (GPS) and Geographic Information System (GIS) data were employed to reveal routes people used over an eight to thirteen week period. Most people did not choose the shortest path. Using three weeks of that data, we find that current route choice set generation algorithms do not reveal the majority of paths that individuals took. Findings from this study may guide future efforts in building better route choice models.	[Zhu, Shanjiang] George Mason Univ, Dept Civil Environm & Infrastruct Engn, Fairfax, VA 22030 USA; [Levinson, David] Univ Minnesota, Dept Civil Environm & Geoengn, Minneapolis, MN 55455 USA	George Mason University; University of Minnesota System; University of Minnesota Twin Cities	Levinson, D (corresponding author), Univ Minnesota, Dept Civil Environm & Geoengn, 500 Pillsbury Dr SE, Minneapolis, MN 55455 USA.	dlevinson@umn.edu	Levinson, David/A-8554-2012	Levinson, David/0000-0002-4563-2963	National Science Foundation [0825768]; Minnesota Department of Transportation project Traffic Flow and Road User Impacts of the Collapse of the I-35W Bridge over the Mississippi River; Oregon Transportation Research and Education Consortium for the project Value of Reliability; University of Minnesota Metropolitan Consortium	National Science Foundation(National Science Foundation (NSF)); Minnesota Department of Transportation project Traffic Flow and Road User Impacts of the Collapse of the I-35W Bridge over the Mississippi River; Oregon Transportation Research and Education Consortium for the project Value of Reliability; University of Minnesota Metropolitan Consortium	This material is based in part upon work supported by the National Science Foundation under grant no. 0825768, BRIDGE: Behavioral Response to the I-35W Disruption: Gauging Equilibration; Minnesota Department of Transportation project Traffic Flow and Road User Impacts of the Collapse of the I-35W Bridge over the Mississippi River; Oregon Transportation Research and Education Consortium for the project Value of Reliability; and the University of Minnesota Metropolitan Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelAty MA, 1997, TRANSPORT RES C-EMER, V5, P39, DOI 10.1016/S0968-090X(96)00023-X; Arentze TA, 2004, TRANSPORT RES B-METH, V38, P613, DOI 10.1016/j.trb.2002.10.001; Axhausen K, 2004, TRANSP RES BOARD ANN; Balmer KWA M, 2006, 85 ANN M TRANSP RES; Bekhor S, 2006, ANN OPER RES, V144, P235, DOI 10.1007/s10479-006-0009-8; Ben-Akiva M., 1998, TRANSPORTATION MODEL, P4; Bierlaire M, 2010, MODELING ROUTE CHOIC; Bovy P, 2009, TRANSPORT REV, V29, P43, DOI 10.1080/01441640802078673; Broach J, 2012, TRANSPORT RES A-POL, V46, P1730, DOI 10.1016/j.tra.2012.07.005; Cairns S, 2002, P I CIVIL ENG-MUNIC, V151, P13; Carrion C, 2013, TRANSPORT RES C-EMER, V35, P305, DOI 10.1016/j.trc.2012.10.010; Carrion C, 2012, TRANSPORT RES A-POL, V46, P720, DOI 10.1016/j.tra.2012.01.003; Cascetta E, 2002, TRANSPORT RES B-METH, V36, P577, DOI 10.1016/S0191-2615(00)00041-2; Chen TY, 2001, TRANSPORT RES A-POL, V35, P197, DOI 10.1016/S0965-8564(99)00055-5; Cheu RL, 2002, COMPUT-AIDED CIV INF, V17, P53, DOI 10.1111/1467-8667.00252; Conlisk J, 1996, J ECON LIT, V34, P669; Craig W.J., 2005, URISA J, V16, P5; Daganzo C. F., 1977, Transportation Science, V11, P253, DOI 10.1287/trsc.11.3.253; Daly A., 1984, P 9 INT S TRANSP TRA; De La Barra T., 1993, 21 PTRC SUMMER ANN M, P307; DIAL RB, 1971, TRANSPORT RES, V5, P83, DOI 10.1016/0041-1647(71)90012-8; Ding J, 2014, TRANSPORT RES REC, P76, DOI 10.3141/2466-09; Doherty S.T., 2001, MOV OBS OUTC INT GLO MOV OBS OUTC INT GLO, P449; Du J, 2007, TRANSPORT RES A-POL, V41, P220, DOI 10.1016/j.tra.2006.05.001; Giuliano G., 1998, J TRANSP STATIST, V1, P1, DOI DOI 10.21949/1501607; Harvey F., 2008, TRANSP RES BOARD 87; Hood J, 2011, TRANSP LETT, V3, P63, DOI 10.3328/TL.2011.03.01.63-75; Huang Y., 2014, ACCESSIBILITY NONWOR; Jha M, 1998, TRANSPORT RES C-EMER, V6, P189, DOI 10.1016/S0968-090X(98)00015-1; Knight, 1933, RISK UNCERTAINTY PRO; Levinson D, 2010, PORTFOLIO THEORY ROU; Lou Y, 2009, TRANSPORTATION RES B; Ma J, 2013, P E ASIA SOC TRANSPO, V9; MAHMASSANI HS, 1987, TRANSPORT SCI, V21, P89, DOI 10.1287/trsc.21.2.89; Marx RW, 1990, INTRO READINGS GEOGR, P120; Menghini G, 2010, TRANSPORT RES A-POL, V44, P754, DOI 10.1016/j.tra.2010.07.008; MIRCHANDANI P, 1987, TRANSPORT SCI, V21, P133, DOI 10.1287/trsc.21.3.133; Morikawa T, 2005, SIMULATION APPROACHE, V135, P136; Nagel K, 1998, 984389 LA UR; Nakayama S, 2000, TRANSPORT RES REC, P63, DOI 10.3141/1725-09; Nakayama S., 1999, TRANSPORT RES REC, V1676, P30, DOI DOI 10.3141/1676-04; Palat B, 2014, TRANSPORT RES F-TRAF, V22, P104, DOI 10.1016/j.trf.2013.11.004; Papinski D, 2009, TRANSPORT RES F-TRAF, V12, P347, DOI 10.1016/j.trf.2009.04.001; Papinski D, 2011, J TRANSP GEOGR, V19, P434, DOI 10.1016/j.jtrangeo.2010.09.009; Park K, 2007, IET INTELL TRANSP SY, V1, P159, DOI 10.1049/iet-its:20060074; Parthasarathi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077718; Parthasarathi Pavithra ASNG, 2009, IMPORTANCE BEING EAR; Prato CG, 2006, TRANSPORT RES REC, P19, DOI 10.3141/1985-03; Prato CG, 2009, J CHOICE MODEL, V2, P65; Rates E, 2007, ATLANTA COMMUTE VEHI; Ridwan M, 2004, TRANSPORT RES C-EMER, V12, P209, DOI 10.1016/j.trc.2004.07.003; Schonfelder S., 2002, EXPLORING POTENTIALS; Schuessler N, 2010, 89 ANN C TRANSP RES; Spissu E, 2011, TRANSPORT RES REC, P96, DOI 10.3141/2230-11; Stopher P, 2007, TRANSPORTATION, V34, P723, DOI 10.1007/s11116-007-9126-8; Tawfik A.M.A., 2012, 91 ANN M TRANSP RES; Tilahun NY, 2007, TRANSPORT RES A-POL, V41, P287, DOI 10.1016/j.tra.2006.09.007; Train K, 2008, TRANSPORT RES B-METH, V42, P191, DOI 10.1016/j.trb.2007.04.012; Turner A, 2009, LECT NOTES COMPUT SC, V5756, P489, DOI 10.1007/978-3-642-03832-7_30; Vacca A, 2015, TRANSP RES PROC, V5, P56, DOI 10.1016/j.trpro.2015.01.018; Wardrop JG, 1952, P I CIVIL ENG, P325, DOI [10.1680/ipeds.1952.11362, DOI 10.1680/IPEDS.1952.11259]; Wolf J, 2001, TRANSPORT RES REC, P125; Zhang L, 2008, J TRANSP ECON POLICY, V42, P435; Zhang L, 2011, TRANSPORT RES REC, P1, DOI 10.3141/2254-01; Zhang L, 2009, TRANSP RES RECORD, P34, DOI 10.3141/2135-05; Zhang L, 2008, TRANSPORT RES REC, P81, DOI 10.3141/2086-10; Ziliaskopoulos A, 1994, OPTIMUM PATH ALGORIT	69	82	82	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134322	10.1371/journal.pone.0134322	http://dx.doi.org/10.1371/journal.pone.0134322			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267756	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300041
J	Capoor, MN; Stonemetz, JL; Baird, JC; Ahmed, FS; Awan, A; Birkenmaier, C; Inchiosa, MA; Magid, SK; McGoldrick, K; Molmenti, E; Naqvi, S; Parker, SD; Pothula, SM; Shander, A; Steen, RG; Urban, MK; Wall, J; Fischetti, VA				Capoor, Manu N.; Stonemetz, Jerry L.; Baird, John C.; Ahmed, Fahad S.; Awan, Ahsan; Birkenmaier, Christof; Inchiosa, Mario A., Jr.; Magid, Steven K.; McGoldrick, Kathryn; Molmenti, Ernesto; Naqvi, Sajjad; Parker, Stephen D.; Pothula, S. M.; Shander, Aryeh; Steen, R. Grant; Urban, Michael K.; Wall, Judith; Fischetti, Vincent A.			Prothrombin Time and Activated Partial Thromboplastin Time Testing: A Comparative Effectiveness Study in a Million-Patient Sample	PLOS ONE			English	Article							HEALTH-CARE COST; COAGULATION TESTS; TONSILLECTOMY; PHYSICIANS	Background A substantial fraction of all American healthcare expenditures are potentially wasted, and practices that are not evidence-based could contribute to such waste. We sought to characterize whether Prothrombin Time (PT) and activated Partial Thromboplastin Time (aPTT) tests of preoperative patients are used in a way unsupported by evidence and potentially wasteful. Methods and Findings We evaluated prospectively-collected patient data from 19 major teaching hospitals and 8 hospital-affiliated surgical centers in 7 states (Delaware, Florida, Maryland, Massachusetts, New Jersey, New York, Pennsylvania) and the District of Columbia. A total of 1,053,472 consecutive patients represented every patient admitted for elective surgery from 2009 to 2012 at all 27 settings. A subset of 682,049 patients (64.7%) had one or both tests done and history and physical (H&P) records available for analysis. Unnecessary tests for bleeding risk were defined as: PT tests done on patients with no history of abnormal bleeding, warfarin therapy, vitamin K-dependent clotting factor deficiency, or liver disease; or aPTT tests done on patients with no history of heparin treatment, hemophilia, lupus anticoagulant antibodies, or von Willebrand disease. We assessed the proportion of patients who received PT or aPTT tests who lacked evidence-based reasons for testing. Conclusions This study sought to bring the availability of big data together with applied comparative effectiveness research. Among preoperative patients, 26.2% received PT tests, and 94.3% of tests were unnecessary, given the absence of findings on H&P. Similarly, 23.3% of preoperative patients received aPTT tests, of which 99.9% were unnecessary. Among patients with no H&P findings suggestive of bleeding risk, 6.6% of PT tests and 7.1% of aPTT tests were either a false positive or a true positive (i.e. indicative of a previously-undiagnosed potential bleeding risk). Both PT and aPTT, designed as diagnostic tests, are apparently used as screening tests. Use of unnecessary screening tests raises concerns for the costs of such testing and the consequences of false positive results.	[Capoor, Manu N.; Fischetti, Vincent A.] Rockefeller Univ, Dept Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; [Stonemetz, Jerry L.] Johns Hopkins Univ Hosp, Dept Anesthesia, Baltimore, MD 21287 USA; [Capoor, Manu N.; Baird, John C.; Ahmed, Fahad S.; Steen, R. Grant] MMF Syst Inc, New York, NY USA; [Awan, Ahsan; Naqvi, Sajjad; Shander, Aryeh] Englewood Hosp & Med Ctr, Dept Anesthesia, Englewood, NJ USA; [Birkenmaier, Christof] Univ Munich, Munich, Germany; [Inchiosa, Mario A., Jr.; McGoldrick, Kathryn; Pothula, S. M.] New York Med Coll, Westchester Med Ctr, Valhalla, NY 10595 USA; [Magid, Steven K.; Urban, Michael K.] Hosp Special Surg, New York, NY 10021 USA; [Molmenti, Ernesto] N Shore Univ Hosp, Dept Surg, Manhasset, NY USA; [Parker, Stephen D.] Washington Hosp Ctr, Dept Anesthesia, Washington, DC 20010 USA; [Wall, Judith] Atlantic Hlth Syst, Morristown, NJ USA	Rockefeller University; Johns Hopkins University; Johns Hopkins Medicine; Englewood Hospital & Medical Center; University of Munich; New York Medical College; Westchester Medical Center; Northwell Health; North Shore University Hospital; MedStar Washington Hospital Center; Atlantic Health System	Capoor, MN (corresponding author), Rockefeller Univ, Dept Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.	mcapoor@rockefeller.edu		Capoor, Manu/0000-0002-0861-4993; Birkenmaier, Christof/0000-0003-1632-3616; Steen, R. Grant/0000-0003-3386-6575	Rockefeller University Center for Clinical and Translational Science (NCATS, NIH, CTSA Program) [UL1 TR000043]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER	Rockefeller University Center for Clinical and Translational Science (NCATS, NIH, CTSA Program); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Support was provided by Rockefeller University Center for Clinical and Translational Science (grant # UL1 TR000043 from NCATS, NIH, CTSA Program) and application development resources were contributed by MMF Systems, Inc. MMF Systems, of which FA, JCB, MNC, and RGS are employees or consultants, provided access to its proprietary data on de-identified hospital patients.	Acharya SS, 2004, J THROMB HAEMOST, V2, P248, DOI 10.1111/j.1538-7836.2003.t01-1-00553.x; Adcock D, 1998, BLOOD COAGUL FIBRIN, V9, P463, DOI 10.1097/00001721-199809000-00002; Adcock DM, 1998, AM J CLIN PATHOL, V109, P595, DOI 10.1093/ajcp/109.5.595; Adcock DM, 1997, AM J CLIN PATHOL, V107, P105; Amer Soc Anesthesiolgists, 2012, ANESTHESIOLOGY, V116, P522, DOI 10.1097/ALN.0b013e31823c1067; ANDREW M, 1992, BLOOD, V80, P1998, DOI 10.1182/blood.V80.8.1998.1998; Asaf T, 2001, INT J PEDIATR OTORHI, V61, P217, DOI 10.1016/S0165-5876(01)00574-2; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Brook RH, 2011, JAMA-J AM MED ASSOC, V306, P650, DOI 10.1001/jama.2011.1136; Chee Yen-Lin, 2003, Hematol J, V4, P373, DOI 10.1038/sj.thj.6200306; Cobas M, 2001, Int Anesthesiol Clin, V39, P1, DOI 10.1097/00004311-200101000-00003; Cullen KA, 2009, NATL HLTH STAT REPOR, P1; Cunningham MT, 2002, ARCH PATHOL LAB MED, V126, P499; Dugdale DC, 2013, PARTIAL THROMBOPLAST; Dugdale DC, 2013, PROTHROMBIN TIME PT; Dzik Walter H, 2004, Curr Hematol Rep, V3, P324; Eckman Mark H, 2003, Ann Intern Med, V138, pW15; EISENBERG JM, 1982, ARCH SURG-CHICAGO, V117, P48; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P39, DOI 10.1001/jama.2011.1927; Fujikawa K, 2005, THROMB RES, V115, P441, DOI 10.1016/j.thromres.2004.10.013; Gabriel P, 2000, J CLIN ANESTH, V12, P288, DOI 10.1016/S0952-8180(00)00164-1; Garcia Callejo F J, 1997, Acta Otorrinolaringol Esp, V48, P473; Glasziou P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4247; Hall MJ, 2010, NATL HLTH STAT REPOR, V29, p:; Hirsch R, 2014, HIPAA BUSINESS ASS H; Hoffman JR, 2012, ARCH INTERN MED, V172, P1123, DOI 10.1001/archinternmed.2012.3319; Jaffer Amir K, 2009, Cleve Clin J Med, V76 Suppl 4, pS37, DOI 10.3949/ccjm.76.s4.07; Joint Commission on Accreditation of Healthcare Organizations, 2014, 2015 HOSP ACCR STAND; Kamal AH, 2007, MAYO CLIN PROC, V82, P864, DOI 10.4065/82.7.864; Mancuso CA, 1999, J GEN INTERN MED, V14, P166, DOI 10.1046/j.1525-1497.1999.00308.x; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Mannucci PM, 2004, NEW ENGL J MED, V351, P683, DOI 10.1056/NEJMra040403; McMahon LF, 2012, JAMA-J AM MED ASSOC, V307, P671, DOI 10.1001/jama.2012.136; Moynihan R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001655; Newman MF, 2008, PERIOPERATIVE MED MA, pxix; Owren PA, 1947, ACTA MED SCAND, V194, P521; Peterson P, 1998, ARCH SURG-CHICAGO, V133, P134, DOI 10.1001/archsurg.133.2.134; Pilsczek FH, 2005, HEART LUNG, V34, P402, DOI 10.1016/j.hrtlng.2005.07.004; Prasad V, 2013, MAYO CLIN PROC, V88, P790, DOI 10.1016/j.mayocp.2013.05.012; Quick AJ, 1935, J BIOL CHEM, V110, P107; ROHRER MJ, 1988, ANN SURG, V208, P554, DOI 10.1097/00000658-198811000-00002; Scheckenbach K, 2008, HNO, V56, P312, DOI 10.1007/s00106-007-1585-x; Schwaab M, 2008, LARYNGO RHINO OTOL, V87, P100, DOI 10.1055/s-2007-966977; SELIGSOHN U, 1993, THROMB HAEMOSTASIS, V70, P68; SUCHMAN AL, 1986, ANN INTERN MED, V104, P810, DOI 10.7326/0003-4819-104-6-810; VanLare JM, 2010, NEW ENGL J MED, V362, P970, DOI 10.1056/NEJMp1000096	46	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0133317	10.1371/journal.pone.0133317	http://dx.doi.org/10.1371/journal.pone.0133317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26261992	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300007
J	Kalia, M; Yadav, VK; Singh, PK; Sharma, D; Pandey, H; Narvi, SS; Agarwal, V				Kalia, Manmohit; Yadav, Vivek Kumar; Singh, Pradeep Kumar; Sharma, Deepmala; Pandey, Himanshu; Narvi, Shahid Suhail; Agarwal, Vishnu			Effect of Cinnamon Oil on Quorum Sensing-Controlled Virulence Factors and Biofilm Formation in Pseudomonas aeruginosa	PLOS ONE			English	Article							CHROMOBACTERIUM-VIOLACEUM; INHIBITION; BACTERIA; PLANTS	Quorum sensing (QS) is a system of stimuli and responses in bacterial cells governed by their population density, through which they regulate genes that control virulence factors and biofilm formation. Despite considerable research on QS and the discovery of new antibiotics, QS-controlled biofilm formation by microorganisms in clinical settings has remained a problem because of nascent drug resistance, which requires screening of diverse compounds for anti-QS activities. Cinnamon is a dietary phytochemical that is traditionally used to remedy digestive problems and assorted contagions, which suggests that cinnamon might contain chemicals that can hinder the QS process. To test this hypothesis, the anti-QS activity of cinnamon oil against P. aeruginosa was tested, measured by the inhibition of biofilm formation and other QS-associated phenomena, including virulence factors such as pyocyanin, rhamnolipid, protease, alginate production, and swarming activity. To this end, multiple microscopy analyses, including light, scanning electron and confocal microscopy, revealed the ability of cinnamon oil to inhibit P. aeruginosa PAO1 biofilms and their accompanying extracellular polymeric substances. This work is the first to demonstrate that cinnamon oil can influence various QS-based phenomena in P. aeruginosa PAO1, including biofilm formation.	[Kalia, Manmohit; Yadav, Vivek Kumar; Singh, Pradeep Kumar; Agarwal, Vishnu] Motilal Nehru Natl Inst Technol, Dept Biotechnol, Allahabad, Uttar Pradesh, India; [Sharma, Deepmala] Natl Inst Technol, Dept Math, Raipur, Madhya Pradesh, India; [Pandey, Himanshu] Sam Higginbottom Inst Agr Technol & Sci, Fac Pharmaceut Sci, Allahabad, Uttar Pradesh, India; [Narvi, Shahid Suhail] Motilal Nehru Natl Inst Technol, Dept Chem, Allahabad, Uttar Pradesh, India	National Institute of Technology (NIT System); Motilal Nehru National Institute of Technology; National Institute of Technology (NIT System); National Institute of Technology Raipur; Sam Higginbottom University of Agriculture, Technology & Sciences; National Institute of Technology (NIT System); Motilal Nehru National Institute of Technology	Agarwal, V (corresponding author), Motilal Nehru Natl Inst Technol, Dept Biotechnol, Allahabad, Uttar Pradesh, India.	vishnua@mnnit.ac.in	Narvi, Shahid/AAE-4280-2021; Yadav, Vivek Kumar/AFL-8097-2022; Sharma, Deepmala/AAY-6011-2020; Yadav, Vivek Kumar/AAG-8049-2022; Agarwal, Vishnu/L-2581-2019; Kalia, Manmohit/AAB-2283-2021	Yadav, Vivek Kumar/0000-0001-8347-2609; Yadav, Vivek Kumar/0000-0001-8347-2609; Kalia, Manmohit/0000-0002-3745-0449; narvi, shahid/0000-0002-6005-6757	Department of Science and Technology and Department of Biotechnology, Government of India; TEQIP-II	Department of Science and Technology and Department of Biotechnology, Government of India(Department of Science & Technology (India)Department of Biotechnology (DBT) India); TEQIP-II	The Department of Science and Technology and Department of Biotechnology, Government of India, and TEQIP-II are acknowledged for research funding and fellowship for enabling this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonizio AL, 2006, J ETHNOPHARMACOL, V105, P427, DOI 10.1016/j.jep.2005.11.025; Agarwal V, 2008, MYCOPATHOLOGIA, V165, P13, DOI 10.1007/s11046-007-9077-9; Apte ZS, 2013, P NATL ACAD SCI USA, V110, pE1006, DOI 10.1073/pnas.1212277109; Beatson SA, 2002, J BACTERIOL, V184, P3958; Bjamsholt T, 2005, MICROBIOL, V151, P3873; Boddey JA, 2006, INFECT IMMUN, V74, P5374, DOI 10.1128/IAI.00569-06; Borucki MK, 2003, APPL ENVIRON MICROB, V69, P7336, DOI 10.1128/AEM.69.12.7336-7342.2003; Bouhdid S, 2010, J APPL MICROBIOL, V109, P1139, DOI 10.1111/j.1365-2672.2010.04740.x; Brackman G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-149; Choo JH, 2006, LETT APPL MICROBIOL, V42, P637, DOI 10.1111/j.1472-765X.2006.01928.x; Clinical and Laboratory Standards Institute, 2006, CLINICAL AND LABORAT; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; HAWSER SP, 1994, INFECT IMMUN, V62, P915, DOI 10.1128/IAI.62.3.915-921.1994; Hentzer M, 2003, J CLIN INVEST, V112, P1300, DOI [10.1172/JCI20074, 10.1172/JCI200320074]; Herman A, 2013, INDIAN J MICROBIOL, V53, P232, DOI 10.1007/s12088-012-0329-0; Kerekes EB, 2013, J APPL MICROBIOL, V115, P933, DOI 10.1111/jam.12289; Khan MSA, 2009, LETT APPL MICROBIOL, V49, P354, DOI 10.1111/j.1472-765X.2009.02666.x; Kim HS, 2013, PLOS ONE, V8; Kim YG, 2015, INT J FOOD MICROBIOL, V195, P30, DOI 10.1016/j.ijfoodmicro.2014.11.028; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; Krishnan T, 2012, SENSORS-BASEL, V12, P4016, DOI 10.3390/s120404016; Lade H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/162584; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Miller JH., 1972, EXPT MOL GENETICS; Musthafa KS, 2010, CHEMOTHERAPY, V56, P333, DOI 10.1159/000320185; Norizan SNM, 2013, SENSORS-BASEL, V13, P5117, DOI 10.3390/s130405117; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; Ooi LSM, 2006, AM J CHINESE MED, V34, P511, DOI 10.1142/S0192415X06004041; Owlia P., 2007, Pharmacognosy Magazine, V3, P83; Packiavathy IASV, 2014, FOOD CHEM, V148, P453, DOI 10.1016/j.foodchem.2012.08.002; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Rampioni G, 2009, FEMS MICROBIOL LETT, V301, P210, DOI 10.1111/j.1574-6968.2009.01817.x; Rao PV, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/642942; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Stauff DL, 2011, J BACTERIOL, V193, P3871, DOI 10.1128/JB.05125-11; VAZQUEZ SC, 1995, POLAR BIOL, V15, P131; Vijayaraghavan P, 2013, J BIOTECHNOL TECHNOL, V4, P628; Wagner Victoria E., 2008, P129; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WIJESEKERA RO, 1974, J SCI FOOD AGR, V25, P1211, DOI 10.1002/jsfa.2740251004; Yap PS, 2014, J MICROBIOL BIOTECHN, V24; Zhao TM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-140	47	92	94	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135495	10.1371/journal.pone.0135495	http://dx.doi.org/10.1371/journal.pone.0135495			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263486	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300085
J	Ramakrishnan, U; Stinger, A; DiGirolamo, AM; Martorell, R; Neufeld, LM; Rivera, JA; Schnaas, L; Stein, AD; Wang, M				Ramakrishnan, Usha; Stinger, Amanda; DiGirolamo, Ann M.; Martorell, Reynaldo; Neufeld, Lynnette M.; Rivera, Juan A.; Schnaas, Lourdes; Stein, Aryeh D.; Wang, Meng			Prenatal Docosahexaenoic Acid Supplementation and Offspring Development at 18 Months: Randomized Controlled Trial	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACID; VISUAL-ACUITY; EARLY-CHILDHOOD; YOUNG-CHILDREN; LCPUFA SUPPLEMENTATION; MOTOR DEVELOPMENT; HOME INVENTORY; FISH-OIL; PREGNANCY; N-3	Objective We evaluated the effects of prenatal docosahexaenoic acid (DHA) supplementation on offspring development at 18 months of age. Design Randomized placebo double-blind controlled trial. Settings Cuernavaca, Mexico. Participants and Methods We followed up offspring (n = 730; 75% of the birth cohort) of women in Mexico who participated in a trial of DHA supplementation during the latter half of pregnancy. We assessed the effect of the intervention on child development and the potential modifying effects of gravidity, gender, SES, and quality of the home environment. Interventions or Main Exposures 400 mg/day of algal DHA. Outcome Measures Child development at 18 months of age measured using the Spanish version of the Bayley Scales of Infant Development-II. We calculated standardized psychomotor and mental development indices, and behavior rating scale scores. Results Intent-to-treat differences (DHA-control) were: Psychomotor Developmental Index -0.90 (95% CI: -2.35, 0.56), Mental Developmental Index -0.26 (95% CI: -1.63, 1.10) and Behavior Rating Scale -0.01 (95% CI: -0.95, 0.94). Prenatal DHA intake attenuated the positive association between home environment and psychomotor development index observed in the control group (p for interaction = 0.03) suggesting potential benefits for children living in home environments characterized by reduced caregiver interactions and opportunities for early childhood stimulation. Conclusions Prenatal DHA supplementation in a population with low intakes of DHA had no effects on offspring development at 18 months of age although there may be some benefit for infants from poor quality home environments.	[Ramakrishnan, Usha; Martorell, Reynaldo; Stein, Aryeh D.] Emory Univ, Atlanta, GA 30322 USA; [Stinger, Amanda] Univ Washington, Seattle, WA 98195 USA; [DiGirolamo, Ann M.] Georgia State Univ, Atlanta, GA 30303 USA; [Neufeld, Lynnette M.] Global Alliance Improved Nutr GAIN, Geneva, Switzerland; [Rivera, Juan A.] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Schnaas, Lourdes] Natl Inst Perinatol, Mexico City, DF, Mexico; [Wang, Meng] Family Hlth Int 360, Durham, NC USA	Emory University; University of Washington; University of Washington Seattle; University System of Georgia; Georgia State University; Instituto Nacional de Salud Publica	Ramakrishnan, U (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	uramakr@emory.edu	Ramakrishnan, Usha/L-8921-2016; Martorell, Reynaldo/I-2539-2012	Stein, Aryeh/0000-0003-1138-6458; Rivera, Juan A./0000-0003-2586-4908	NIH grant [HD043099]; March of Dimes Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD043099] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The implementation of the study was supported by NIH grant HD043099 and the March of Dimes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayley N, 1993, BAYLEY SCALES INFANT; BRADLEY RH, 1988, CONTEMP EDUC PSYCHOL, V13, P58, DOI 10.1016/0361-476X(88)90006-9; Brenna JT, 2011, MATERN CHILD NUTR, V7, P59, DOI 10.1111/j.1740-8709.2011.00301.x; Burger K, 2010, EARLY CHILD RES Q, V25, P140, DOI 10.1016/j.ecresq.2009.11.001; Caldwell B., 1984, HOME OBSERVATION MEA; Campoy C, 2012, BRIT J NUTR, V107, pS85, DOI 10.1017/S0007114512001493; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colombo J, 2013, AM J CLIN NUTR, V98, P403, DOI 10.3945/ajcn.112.040766; Colombo J, 2012, PEDIATRICS, V129, P1166, DOI 10.1542/peds.2012-0934; Dunstan JA, 2008, ARCH DIS CHILD-FETAL, V93, pF45, DOI 10.1136/adc.2006.099085; Dziechciarz P, 2010, J AM COLL NUTR, V29, P443, DOI 10.1080/07315724.2010.10719881; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; Gabbard C, 2002, J SPORT EXERCISE PSY, V24, P55; Glaser C, 2011, MATERN CHILD NUTR, V7, P27, DOI 10.1111/j.1740-8709.2011.00319.x; Gomaa A, 2002, PEDIATRICS, V110, P110, DOI 10.1542/peds.110.1.110; Gould JF, 2013, AM J CLIN NUTR, V97, P531, DOI 10.3945/ajcn.112.045781; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Helland IB, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e82; Henn BC, 2012, ENVIRON HEALTH PERSP, V120, P126, DOI 10.1289/ehp.1003300; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Huffman SL, 2011, MATERN CHILD NUTR, V7, P44, DOI 10.1111/j.1740-8709.2011.00356.x; Imhoff-Kunsch B, 2011, PEDIATRICS, V128, pE505, DOI 10.1542/peds.2010-1386; Imhoff-Kunsch B, 2011, J NUTR, V141, P321, DOI 10.3945/jn.110.126870; Innis SM, 2008, AM J CLIN NUTR, V87, P548, DOI 10.1093/ajcn/87.3.548; Jacobson JL, 2008, J PEDIATR-US, V152, P356, DOI 10.1016/j.jpeds.2007.07.008; Jensen CL, 2010, J PEDIATR-US, V157, P900, DOI 10.1016/j.jpeds.2010.06.006; Judge MP, 2007, LIPIDS, V42, P117, DOI 10.1007/s11745-006-3007-3; KOLETZKO B, 1989, EUR J PEDIATR, V148, P669, DOI 10.1007/BF00441531; Koletzko B, 2007, BRIT J NUTR, V98, P873, DOI 10.1017/S0007114507764747; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; Larque E, 2012, BRIT J NUTR, V107, pS77, DOI 10.1017/S0007114512001481; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Lo A, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/591531; Makrides M, 2011, MATERN CHILD NUTR, V7, P80, DOI 10.1111/j.1740-8709.2011.00304.x; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; MARTINEZ M, 1992, J PEDIATR-US, V120, pS129, DOI 10.1016/S0022-3476(05)81247-8; McCann JC, 2005, AM J CLIN NUTR, V82, P281, DOI 10.1093/ajcn/82.2.281; McNamara RK, 2010, AM J CLIN NUTR, V91, P1060, DOI 10.3945/ajcn.2009.28549; Mink PJ, 2004, EPIDEMIOLOGY, V15, P385, DOI 10.1097/01.ede.0000128402.86336.7e; Neuringer M, 1993, LIPIDS LEARNING BRAI, P134; Nyaradi A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00097; Oken E, 2008, AM J EPIDEMIOLOGY; Osorio E, 2010, SALUD PUBLICA MEXICO, V52, P14, DOI 10.1590/S0036-36342010000100004; Parra-Cabrera S, 2011, MATERN CHILD NUTR, V7, P140, DOI 10.1111/j.1740-8709.2010.00254.x; Ramakrishnan U, 2010, FOOD NUTR BULL, V31, pS108, DOI 10.1177/15648265100312S203; Raven J., 2004, MANUAL RAVENS PROGR; Smithers LG, 2008, AM J CLIN NUTR, V87, P912, DOI 10.1093/ajcn/87.4.912; Stein AD, 2008, ARCH PEDIAT ADOL MED, V162, P612, DOI 10.1001/archpedi.162.7.612; Stein AD, 2011, J NUTR, V141, P316, DOI 10.3945/jn.110.128215; Tofail F, 2006, J HEALTH POPUL NUTR, V24, P48; Tong S, 2007, J PEDIATR-US, V151, P284, DOI 10.1016/j.jpeds.2007.03.020; Uauy R, 2001, LIPIDS, V36, P885, DOI 10.1007/s11745-001-0798-1; van Wezel-Meijler G, 2002, ACTA PAEDIATR, V91, P942, DOI 10.1080/080352502760272632; Venkataramani AS, 2012, J HEALTH ECON, V31, P767, DOI 10.1016/j.jhealeco.2012.06.003; Wells J., 1998, BNF Nutrition Bulletin, V23, P23; Yousafzai AK, 2014, LANCET, V384, P1282, DOI 10.1016/S0140-6736(14)60455-4	57	27	27	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0120065	10.1371/journal.pone.0120065	http://dx.doi.org/10.1371/journal.pone.0120065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262896	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300001
J	Shih, CA; Chen, WC; Yu, HC; Cheng, JS; Lai, KH; Hsu, JT; Chen, HC; Hsu, PI				Shih, Chih-An; Chen, Wen-Chi; Yu, Hsien-Chung; Cheng, Jin-Shiung; Lai, Kwok-Hung; Hsu, Jui-Ting; Chen, Hui-Chun; Hsu, Ping-I			Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis	PLOS ONE			English	Article							B-VIRUS REACTIVATION; HEPATITIS-B; CYTOTOXIC CHEMOTHERAPY; LAMIVUDINE PROPHYLAXIS; PREVENTION; LYMPHOMA; IDENTIFICATION; REGIMENS; CARRIERS; THERAPY	Background Reactivation of HBV replication with an increase in serum HBV DNA and alanine aminotransferase (ALT) activity has been reported in 20-50% of hepatitis B carriers undergoing cytotoxic chemotherapy for cancer treatment. Manifestation of HBV reactivation ranges from asymptomatic self-limiting hepatitis to severe progressive hepatic failure and fatal consequences. Aim To investigate the risk of severe acute exacerbation of chronic HBV infection in HBsAg-positive cancer patients with solid tumors or hematological malignancies who underwent chemotherapy without antiviral prophylaxis. Methods A retrospective review of charts was conducted for HBsAg-positive cancer patients in our institution who underwent chemotherapy and did not receive anti-viral prophylaxis between the periods of July 2007 to January 2013. We investigate the incidence of severe acute exacerbation of chronic HBV infection if these patients with a variety of solid tumors and hematological malignancies. Results A total of 156 patients (hematological malignancies: 16; solid tumors: 140) were included. The incidence of severe acute HBV exacerbation in the patients with hematological malignancy was higher than that in solid tumors (25.0% [4/16] vs 4.3% [6/140]); P = 0.005). Additionally, patients receiving rituximab-based chemotherapy had higher acute exacerbation rate than those with non-rituximab-based chemotherapy (40.0% vs 4.1%, P = 0.001). Among the patients with solid tumors, the incidences of severe acute exacerbation of chronic HBV in hepatocellular carcinoma, colorectal cancer, lung cancer, breast cancer, gynecological cancer, urological tract cancer, head/neck cancer and other solid malignancies were 2.3%, 4.0%, 7.1%, 9.0%, 16.7%, 6.7%, 0% and 0%, respectively. Conclusion Severe acute exacerbation of chronic HBV infection may occur in HBsAg-positive patients with a variety of solid tumors who received chemotherapy without adequate anti-viral prophylaxis. Hematological malignancy and rituximab-based chemotherapy are the risk factors related to severe acute exacerbation of chronic HBV infection in HBsAg-positive cancer patients undergoing chemotherapy.	[Shih, Chih-An; Chen, Wen-Chi; Yu, Hsien-Chung; Cheng, Jin-Shiung; Lai, Kwok-Hung; Hsu, Ping-I] Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan; [Shih, Chih-An] Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Gen Internal Med, Kaohsiung, Taiwan; [Shih, Chih-An; Chen, Wen-Chi; Yu, Hsien-Chung; Cheng, Jin-Shiung; Lai, Kwok-Hung; Hsu, Ping-I] Natl Yang Ming Univ, Taipei 112, Taiwan; [Hsu, Jui-Ting; Chen, Hui-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital	Chen, HC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan.	jeni1722@adm.cgmh.org.tw; williamhsup@yahoo.com.tw						Cheng AL, 2003, HEPATOLOGY, V37, P1320, DOI 10.1053/jhep.2003.50220; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Dai MS, 2004, LIVER INT, V24, P540, DOI 10.1111/j.1478-3231.2004.0964.x; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Hsu C, 2008, HEPATOLOGY, V47, P844, DOI 10.1002/hep.22106; Hsu PI, 2015, HEPATOLOGY, V62, P387, DOI 10.1002/hep.27843; Huang YH, 2013, J CLIN ONCOL, V31, P2765, DOI 10.1200/JCO.2012.48.5938; Hwang JP, 2012, J ONCOL PRACT, V8, pE32, DOI 10.1200/JOP.2011.000450; Idilman R, 2004, J VIRAL HEPATITIS, V11, P141, DOI 10.1046/j.1365-2893.2003.00479.x; Khokhar OS, 2009, CHEMOTHERAPY, V55, P69, DOI 10.1159/000183731; Koo YX, 2010, CANCER-AM CANCER SOC, V116, P115, DOI 10.1002/cncr.24742; Lau GKK, 1997, BONE MARROW TRANSPL, V19, P795, DOI 10.1038/sj.bmt.1700744; Lau GKK, 2003, GASTROENTEROLOGY, V125, P1742, DOI 10.1053/j.gastro.2003.09.026; Lee R, 2010, CURR ONCOL, V17, P32; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Ling WHY, 2013, BRIT J CANCER, V108, P1931, DOI 10.1038/bjc.2013.225; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; LOK ASF, 1991, GASTROENTEROLOGY, V100, P182, DOI 10.1016/0016-5085(91)90599-G; LOK ASF, 1987, AM J EPIDEMIOL, V126, P492, DOI 10.1093/oxfordjournals.aje.a114681; Loomba R, 2008, ANN INTERN MED, V148, P519, DOI 10.7326/0003-4819-148-7-200804010-00008; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Martyak LA, 2008, LIVER INT, V28, P28, DOI 10.1111/j.1478-3231.2007.01618.x; Palmore TN, 2009, CLIN GASTROENTEROL H, V7, P1130, DOI 10.1016/j.cgh.2009.06.027; Pei SN, 2010, ANN HEMATOL, V89, P255, DOI 10.1007/s00277-009-0806-7; Wang Y, 2013, WORLD J GASTROENTERO, V19, P923, DOI 10.3748/wjg.v19.i6.923; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Yeo W, 2004, J CLIN ONCOL, V22, P927, DOI 10.1200/JCO.2004.05.161; Yeo W, 2004, BRIT J CANCER, V90, P1306, DOI 10.1038/sj.bjc.6601699; Yeo W, 2003, J MED VIROL, V70, P553, DOI 10.1002/jmv.10430; Yeo W, 2000, J MED VIROL, V62, P299, DOI 10.1002/1096-9071(200011)62:3&lt;299::AID-JMV1&gt;3.0.CO;2-0; Yeo W, 2013, J GASTROEN HEPATOL, V28, P31, DOI 10.1111/j.1440-1746.2012.07280.x; Yun J, 2011, BRIT J CANCER, V104, P559, DOI 10.1038/bjc.2011.4	33	21	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0132426	10.1371/journal.pone.0132426	http://dx.doi.org/10.1371/journal.pone.0132426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274393	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600004
J	Andrick, BJ; Schwab, AI; Cauley, B; O'Donnell, LA; Meng, WS				Andrick, Benjamin J.; Schwab, Alexandra I.; Cauley, Brianna; O'Donnell, Lauren A.; Meng, Wilson S.			Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNF alpha Biologics: Implications for Immunogenicity of Pharmaceutical Proteins	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; T-CELL-RECEPTOR; CROSS-REACTIVITY; INFLUENZA-A; MULTIPLE-SCLEROSIS; MOLECULAR MIMICRY; STRUCTURAL BASIS; ANTIBODIES; INFLIXIMAB; EFFICACY	The purpose of this study was to evaluate the extent of overlapping immunogenic peptides between three pharmaceutical biologics and influenza viruses. Clinical studies have shown that subsets of patients with rheumatoid arthritis (RA) develop anti-drug antibodies towards anti-TNF alpha biologics. We postulate that common infectious pathogens, including influenza viruses, may sensitize RA patients toward recombinant proteins. We hypothesize that embedded within infliximab (IFX), adalimumab (ADA), and etanercept (ETN) are ligands of class II major histocompatibility complex (MHC-II) that mimic T cell epitopes derived from influenza hemagglutinin (HA). The rationale is that repeated administration of the biologics would reactivate HA-primed CD4 T cells, stimulating B cells to produce cross-reactive antibodies. Custom scripts were constructed using MATLAB to compare MHC-II ligands of HA and the biologics; all ligands were predicted using tools in Immune Epitope Database and Resources (IEDB). We analyzed three HLA-DR1 alleles (0101, 0401 and 1001) that are prominent in RA patients, and two alleles (0103 and 1502) that are not associated with RA. The results indicate that 0401 would present more analogues of HA ligands in the three anti-TNFa biologics compared to the other alleles. The approach led to identification of potential ligands in IFX and ADA that shares sequence homology with a known HA-specific CD4 T cell epitope. We also discovered a peptide in the complementarity-determining region 3 (CDR-3) of ADA that encompasses both a potential CD4 T cell epitope and a known B cell epitope in HA. The results may help generate new hypotheses for interrogating patient variability of immunogenicity of the anti-TNFa drugs. The approach would aid development of new recombinant biologics by identifying analogues of CD4 T cell epitopes of common pathogens at the preclinical stage.	[Andrick, Benjamin J.; Schwab, Alexandra I.; Cauley, Brianna; O'Donnell, Lauren A.; Meng, Wilson S.] Duquesne Univ, Div Pharmaceut Sci, Pittsburgh, PA 15282 USA	Duquesne University	O'Donnell, LA (corresponding author), Duquesne Univ, Div Pharmaceut Sci, Pittsburgh, PA 15282 USA.	odonnel6@duq.edu; meng@duq.edu	O'Donnnell, Lauren/L-3913-2019	O'Donnell, Lauren/0000-0003-0485-7899				Aarden L, 2008, CURR OPIN IMMUNOL, V20, P431, DOI 10.1016/j.coi.2008.06.011; Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; Bendtzen K, 2011, ARTHRITIS RHEUM-US, V63, P867, DOI 10.1002/art.30207; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Cheng WZ, 2012, FRONT BIOSCI-LANDMRK, V17, P1648, DOI 10.2741/4010; Cousens LP, 2013, AUTOIMMUN REV, V12, P436, DOI 10.1016/j.autrev.2012.08.017; Cousens LP, 2013, J CLIN IMMUNOL, V33, pS43, DOI 10.1007/s10875-012-9762-4; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8293-8, 10.1007/s12016-011-8294-7]; Daien CI, 2014, MEDIAT INFLAMM, V2014; Davis JM, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4389; Davis JM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3706; De Groot AS, 2007, TRENDS IMMUNOL, V28, P482, DOI 10.1016/j.it.2007.07.011; de Vries MK, 2009, ANN RHEUM DIS, V68, P531, DOI 10.1136/ard.2008.089979; Dore RK, 2007, CLIN EXP RHEUMATOL, V25, P40; ELLIOTT MJ, 1994, INT ARCH ALLERGY IMM, V104, P112, DOI 10.1159/000236718; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Greenberg JD, 2012, ANN RHEUM DIS, V71, P1134, DOI 10.1136/annrheumdis-2011-150573; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hermeling S, 2004, PHARM RES-DORDR, V21, P897, DOI 10.1023/B:PHAM.0000029275.41323.a6; Hu S, 2013, J BIOL CHEM, V288, P27059, DOI 10.1074/jbc.M113.491530; Huang SS, 2013, SCIENTIFIC REPORTS, P3; Jawa V, 2013, CLIN IMMUNOL, V149, P534, DOI 10.1016/j.clim.2013.09.006; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Jorgensen KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015877; JOSHI N, 1993, ANN NEUROL, V34, P385, DOI 10.1002/ana.410340313; Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Li Jinze, 2010, Handb Exp Pharmacol, P493, DOI 10.1007/978-3-642-00663-0_18; Liang SY, 2013, J BIOL CHEM, V288, P13799, DOI 10.1074/jbc.M112.433961; Lv QW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089442; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mok CC, 2013, CLIN RHEUMATOL, V32, P1429, DOI 10.1007/s10067-013-2336-x; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; Palese P, 2011, MBIO, V2, DOI 10.1128/mBio.00150-11; RAY CG, 1980, CLIN ENDOCRINOL, V12, P375, DOI 10.1111/j.1365-2265.1980.tb02723.x; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Rose NR, 1996, CLIN IMMUNOL IMMUNOP, V80, pS92, DOI 10.1006/clin.1996.0146; Schanen BC, 2011, VACCINE, V29, P3299, DOI 10.1016/j.vaccine.2011.02.019; Schueler-Furman O, 2000, PROTEIN SCI, V9, P1838, DOI 10.1110/ps.9.9.1838; Scott DW, 2010, ANN RHEUM DIS, V69, P72, DOI 10.1136/ard.2009.117564; Senpuku H, 1996, IMMUNOLOGY, V88, P275, DOI 10.1111/j.1365-2567.1996.tb00015.x; SHANMUGAM A, 1995, J NEUROIMMUNOL, V59, P165, DOI 10.1016/0165-5728(95)00041-Y; SHAW DM, 1993, MOL IMMUNOL, V30, P961, DOI 10.1016/0161-5890(93)90121-Q; Solau-Gervais E, 2006, RHEUMATOLOGY, V45, P1121, DOI 10.1093/rheumatology/kel054; Stern Lawrence J., 1994, CRYSTAL STRUCTURE HU; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Svenson M, 2007, RHEUMATOLOGY, V46, P1828, DOI 10.1093/rheumatology/kem261; Tangri S, 2005, J IMMUNOL, V174, P3187, DOI 10.4049/jimmunol.174.6.3187; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Van Loan CF, 2010, INSIGHT COMPUTING MA; Vaughan K, 2014, J NEUROIMMUNOL, V267, P73, DOI 10.1016/j.jneuroim.2013.12.009; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wolbink GJ, 2006, ARTHRITIS RHEUM-US, V54, P711, DOI 10.1002/art.21671; Woodcock J, 2007, NAT REV DRUG DISCOV, V6, P437, DOI 10.1038/nrd2307; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Xue L, 2013, AAPS J, V15, P852, DOI 10.1208/s12248-013-9492-4; Zandman-Goddard G, 2009, ANN NY ACAD SCI, V1173, P658, DOI 10.1111/j.1749-6632.2009.04754.x; Zhao RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023374; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	64	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135451	10.1371/journal.pone.0135451	http://dx.doi.org/10.1371/journal.pone.0135451			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270649	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800074
J	Bourguignon, T; Drouet, T; Sobotnik, J; Hanus, R; Roisin, Y				Bourguignon, Thomas; Drouet, Thomas; Sobotnik, Jan; Hanus, Robert; Roisin, Yves			Influence of Soil Properties on Soldierless Termite Distribution	PLOS ONE			English	Article							STABLE-ISOTOPE RATIOS; TROPHIC NICHE DIFFERENTIATION; TROPICAL RAIN-FOREST; FEEDING TERMITE; ORIBATID MITES; COMMUNITIES; ECOLOGY; COLLEMBOLA; DIVERSITY; ISOPTERA	In tropical rainforests, termites constitute an important part of the soil fauna biomass, and as for other soil arthropods, variations in soil composition create opportunities for niche partitioning. The aim of this study was twofold: first, we tested whether soil-feeding termite species differ in the foraging substrate; second, we investigated whether soil-feeding termites select their foraging sites to enhance nutrients intake. To do so, we collected termites and analysed the composition and structure of their feeding substrates. Although Anoplotermes-group members are all considered soil-feeders, our results show that some species specifically feed on abandoned termite nests and very rotten wood, and that this substrate selection is correlated with previous stable isotope analyses, suggesting that one component of niche differentiation among species is substrate selection. Our results show that the composition and structure of bare soils on which different termite species foraged do not differ, suggesting that there is no species specialization for a particular type of bare soil. Finally, the bare soil on which termites forage does not differ from random soil samples. Overall, our results suggest that few species of the Anoplotermes-group are specialized toward substrates rich in organic matter, but that the vast majority forage on soil independently of its structural and chemical composition, being ecologically equivalent for this factor.	[Bourguignon, Thomas] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Bourguignon, Thomas; Sobotnik, Jan] Czech Univ Life Sci, Fac Forestry & Wood Sci, Prague 16521 6, Suchdol, Czech Republic; [Drouet, Thomas] Univ Libre Bruxelles, Plant Ecol & Biogeochem, Brussels, Belgium; [Hanus, Robert] Acad Sci Czech Republic, Inst Organ Chem & Biochem, CR-16610 Prague, Czech Republic; [Roisin, Yves] Univ Libre Bruxelles, Evolutionary Biol & Ecol, B-1050 Brussels, Belgium	National University of Singapore; Czech University of Life Sciences Prague; Universite Libre de Bruxelles; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Universite Libre de Bruxelles	Bourguignon, T (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	thomas.bourgui@gmail.com; sobotnik@fld.czu.cz	Hanus, Robert/D-4765-2013	Hanus, Robert/0000-0002-7054-1975; Sobotnik, Jan/0000-0002-8581-637X; Bourguignon, Thomas/0000-0002-4035-8977; Drouet, Thomas/0000-0002-0023-0418; Roisin, Yves/0000-0001-6635-3552	Belgian FRIA; French CNRS (Nouragues grant); Institute of Organic Chemistry and Biochemistry [RVO: 61388963]; Internal Grant Agency of Faculty of Forestry and Wood Sciences (Specific research of the Czech University of Life Sciences) [A08/14]; University of Sydney	Belgian FRIA(Fonds de la Recherche Scientifique - FNRS); French CNRS (Nouragues grant); Institute of Organic Chemistry and Biochemistry; Internal Grant Agency of Faculty of Forestry and Wood Sciences (Specific research of the Czech University of Life Sciences); University of Sydney(University of Sydney)	Financial support was provided by the Belgian FRIA (fellowship to TB), the French CNRS (Nouragues grant), the Institute of Organic Chemistry and Biochemistry (RVO: 61388963), and the Internal Grant Agency of Faculty of Forestry and Wood Sciences (Specific research of the Czech University of Life Sciences) (project: A08/14). TB was supported by the University of Sydney through a postdoctoral fellowship.	Amelung W, 2002, SOIL BIOL BIOCHEM, V34, P367, DOI 10.1016/S0038-0717(01)00192-4; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bourguignon T, 2013, MOL PHYLOGENET EVOL, V69, P694, DOI 10.1016/j.ympev.2013.07.007; Bourguignon T, 2011, ECOL ENTOMOL, V36, P776, DOI 10.1111/j.1365-2311.2011.01328.x; Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Bourguignon T, 2010, INVERTEBR SYST, V24, P357, DOI 10.1071/IS10012; Bourguignon T, 2011, BIOTROPICA, V43, P473, DOI 10.1111/j.1744-7429.2010.00729.x; Bourguignon T, 2009, SOIL BIOL BIOCHEM, V41, P2038, DOI 10.1016/j.soilbio.2009.07.005; Caruso T, 2012, J ANIM ECOL, V81, P214, DOI 10.1111/j.1365-2656.2011.01886.x; Cassagne N, 2004, PEDOBIOLOGIA, V48, P267, DOI 10.1016/j.pedobi.2004.01.004; Cassagne N, 2003, BIOL FERT SOILS, V37, P355, DOI 10.1007/s00374-003-0610-9; Chahartaghi M, 2005, SOIL BIOL BIOCHEM, V37, P1718, DOI 10.1016/j.soilbio.2005.02.006; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Davies RG, 2003, J TROP ECOL, V19, P509, DOI 10.1017/S0266467403003560; Decaens T, 2010, GLOBAL ECOL BIOGEOGR, V19, P287, DOI 10.1111/j.1466-8238.2009.00517.x; Donovan SE, 2002, J NAT HIST, V36, P1823, DOI 10.1080/00222930110062309; Donovan SE, 2001, ECOL ENTOMOL, V26, P356, DOI 10.1046/j.1365-2311.2001.00342.x; Eggleton P, 1996, PHILOS T R SOC B, V351, P51, DOI 10.1098/rstb.1996.0004; Eggleton Paul, 1997, Journal of African Zoology, V111, P489; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; Giller PS, 1996, BIODIVERS CONSERV, V5, P135, DOI 10.1007/BF00055827; Griffiths BS, 2013, SOIL BIOL BIOCHEM, V57, P957, DOI 10.1016/j.soilbio.2012.08.012; Hishi T, 2007, SOIL BIOL BIOCHEM, V39, P1820, DOI 10.1016/j.soilbio.2007.01.028; Holt JA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P389; Ingimarsdottir M, 2012, OECOLOGIA, V170, P745, DOI 10.1007/s00442-012-2334-8; Jacquemin J, 2012, APPL SOIL ECOL, V62, P163, DOI 10.1016/j.apsoil.2012.08.008; Jacquemin J, 2012, SOIL BIOL BIOCHEM, V46, P10, DOI 10.1016/j.soilbio.2011.11.007; Ji R, 2000, SOIL BIOL BIOCHEM, V32, P1281, DOI 10.1016/S0038-0717(00)00046-8; Ji R, 2005, SOIL BIOL BIOCHEM, V37, P1648, DOI 10.1016/j.soilbio.2005.01.026; Jimenez JJ, 2008, APPL SOIL ECOL, V40, P120, DOI 10.1016/j.apsoil.2008.03.009; Kaspari M, 2008, P NATL ACAD SCI USA, V105, P17848, DOI 10.1073/pnas.0804528105; Kaspari M, 2009, P NATL ACAD SCI USA, V106, P19405, DOI 10.1073/pnas.0906448106; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; MARTIUS C, 1994, PEDOBIOLOGIA, V38, P407; Pansu M, 2006, HDB SOIL ANAL, DOI 10.1007/978-3-540-31211-6; Roisin Y, 2004, AUSTRAL ECOL, V29, P637, DOI 10.1111/j.1442-9993.2004.01403.x; Sands W.A., 1972, Bulletin Br Mus nat Hist (Ent), V18, P1; Schneider K, 2005, PEDOBIOLOGIA, V49, P61, DOI 10.1016/j.pedobi.2004.07.010; Schneider K, 2004, SOIL BIOL BIOCHEM, V36, P1769, DOI 10.1016/j.soilbio.2004.04.033; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF	41	16	16	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135341	10.1371/journal.pone.0135341	http://dx.doi.org/10.1371/journal.pone.0135341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270057	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800060
J	Liu, P; Wang, ZH; Zhang, LJ; Li, DM; Lin, JP				Liu, Pi; Wang, Zhonghua; Zhang, Lijie; Li, Dongmei; Lin, Jianping			The Mechanism by which 146-N-Glycan Affects the Active Site of Neuraminidase	PLOS ONE			English	Article							INFLUENZA-VIRUS; OSELTAMIVIR; DISCOVERY; GLYCOSYLATION; 150-CAVITY; DYNAMICS; BINDING; PROFILE	One of the most conserved glycosylation sites of neuraminidase (NA) is 146-N-glycan. This site is adjacent to the 150-cavity of NA, which is found within the active site and thought to be a target for rational drug development against the antiviral resistance of influenza. Here, through a total of 2.4 mu s molecular dynamics (MD) simulations, we demonstrated that 146-N-glycan can stabilize the conformation of the 150-loop that controls the volume of the 150-cavity. Moreover, with 146-N-glycan, our simulation result was more consistent with crystal structures of NAs than simulations conducted without glycans. Cluster analysis of the MD trajectories showed that 146-N-glycan adopted three distinct conformations: monomerbridged, dimer-bridged and standing. Of these conformations, the dimer-bridged 146-N-glycan was the most stable one and contributed to stabilization of the 150-loop conformation. Furthermore, our simulation revealed that various standing conformations of 146-N-glycan could block the entrance of the binding pocket. This result was consistent with experimental data and explained the relatively low activity of inhibitors with flexible substituents toward the 150-cavity. Together, our results lead us to hypothesize that rigid and hydrophobic substituents could serve as better inhibitors targeting the 150-cavity.	[Liu, Pi; Wang, Zhonghua; Zhang, Lijie; Li, Dongmei; Lin, Jianping] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Liu, Pi; Wang, Zhonghua; Zhang, Lijie; Li, Dongmei; Lin, Jianping] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Li, DM (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	dongmeili@nankai.edu.cn; jianpinglin@nankai.edu.cn			National Basic Research Program (973 Program) [2011CBA00800, 2013CB911100]	National Basic Research Program (973 Program)(National Basic Research Program of China)	This work was supported by National Basic Research Program (973 Program, No. 2011CBA00800 and No. 2013CB911100).	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amaro RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1390; [Anonymous], 1980, B WORLD HEALTH ORGAN, V58, P585; [Anonymous], 2010, CDC ANT DRUGS H1N1 F; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Bui JM, 2006, BIOPHYS J, V90, P3280, DOI 10.1529/biophysj.105.075564; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Dunn CJ, 1999, DRUGS, V58, P761, DOI 10.2165/00003495-199958040-00016; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; GOTTSCHALK A, 1957, BIOCHIM BIOPHYS ACTA, V23, P645, DOI 10.1016/0006-3002(57)90389-X; Greenidge PA, 2013, J CHEM INF MODEL, V53, P201, DOI [10.1021/cI300025v, 10.1021/ci300425v]; Grienke U, 2012, NAT PROD REP, V29, P11, DOI 10.1039/c1np00053e; Han NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060995; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kerry PS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02871; KLENK E, 1955, H-S Z PHYSIOL CHEM, V301, P235, DOI 10.1515/bchm2.1955.301.1-2.235; Kolocouris N, 2007, BIOORG MED CHEM LETT, V17, P4358, DOI 10.1016/j.bmcl.2007.04.108; Lew W, 2000, CURR MED CHEM, V7, P663, DOI 10.2174/0929867003374886; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; LI SQ, 1993, J VIROL, V67, P6667, DOI 10.1128/JVI.67.11.6667-6673.1993; Mohan S, 2010, J MED CHEM, V53, P7377, DOI 10.1021/jm100822f; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Schulze Irene T., 1997, Journal of Infectious Diseases, V176, pS24, DOI 10.1086/514170; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844; THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19; VARGHESE JN, 1991, J MOL BIOL, V221, P473, DOI 10.1016/0022-2836(91)80068-6; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wu YKR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01194; Wu ZLL, 2009, BIOCHEM BIOPH RES CO, V379, P749, DOI 10.1016/j.bbrc.2008.12.139; Xie YC, 2014, J MED CHEM, V57, P8445, DOI 10.1021/jm500892k; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08	34	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135487	10.1371/journal.pone.0135487	http://dx.doi.org/10.1371/journal.pone.0135487			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267136	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300124
J	Peyser, ND; Du, Y; Li, H; Lui, V; Xiao, X; Chan, TA; Grandis, JR				Peyser, Noah D.; Du, Yu; Li, Hua; Lui, Vivian; Xiao, Xiao; Chan, Timothy A.; Grandis, Jennifer R.			Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; SQUAMOUS-CELL CARCINOMAS; TUMOR-SUPPRESSOR GENE; IDENTIFIES PTPRD; AMPLIFICATIONS; GLIOBLASTOMA; DELETIONS	Background Protein tyrosine phosphatase receptor type D (PTPRD) is a putative tumor suppressor in several cancers including head and neck squamous cell carcinoma (HNSCC). STAT3 is a frequently hyperactivated oncogene in HNSCC. As STAT3 is a direct substrate of PTPRD, we sought to determine the genetic or epigenetic alterations of PTPRD that contribute to overactive STAT3 in HNSCC. Methods We analyzed data from The Cancer Genome Atlas (TCGA) and our previous whole-exome sequencing study and summarized the mutation, methylation, and copy number status of PTPRD in HNSCC and other cancers. In vitro studies involved standard transfection and MTT protocols, as well as methylation-specific PCR. Results Our findings indicate that PTPRD mutation, rather than methylation or copy number alteration, is the primary mechanism by which PTPRD function is lost in HNSCC. We demonstrate that overexpression of wild-type PTPRD in HNSCC cells significantly inhibits growth and STAT3 activation while PTPRD mutants do not, suggesting that mutation may lead to loss of function and subsequent hyper-phosphorylation of PTPRD substrates, especially STAT3. Importantly, we determined that HNSCC cells harboring an endogenous PTPRD mutation are more sensitive to STAT3 blockade than PTPRD wild-type cells. We additionally found that PTPRD mRNA expression does not correlate with pSTAT3 expression, suggesting that alterations that manifest through altered mRNA expression, including hypermethylation and gene copy number alterations, do not significantly contribute to STAT3 overactivation in HNSCC. Conclusion PTPRD mutation, but not methylation or copy number loss, may serve as a predictive biomarker of sensitivity to STAT3 inhibitors in HNSCC.	[Peyser, Noah D.; Du, Yu; Li, Hua; Xiao, Xiao] Univ Pittsburgh, Dept Otolaryngol, Sch Med, Pittsburgh, PA USA; [Peyser, Noah D.; Du, Yu] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15213 USA; [Du, Yu] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Lui, Vivian] Univ Hong Kong, Pharmacogen & Precis Therapeut Lab, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Lui, Vivian] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Grandis, Jennifer R.] Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University; University of Hong Kong; University of Hong Kong; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco	Grandis, JR (corresponding author), Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA.	Jennifer.Grandis@ucsf.edu	Lui, Vivian W. Y./I-5458-2016; Chan, Timothy A/ABD-5850-2021	Lui, Vivian W. Y./0000-0001-6918-1573; Peyser, Noah/0000-0003-4529-8325	National Institutes of Health [P50CA097190, R01CA77308, F31DE024007]; American Cancer Society; China Scholarship Council; General Research Fund from the Research Grant Council of Hong Kong [17114814]; Seed Funding for Basic Research; NATIONAL CANCER INSTITUTE [P50CA097190, P30CA008748, R01CA077308, R01CA154767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE024007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); China Scholarship Council(China Scholarship Council); General Research Fund from the Research Grant Council of Hong Kong; Seed Funding for Basic Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health (www.nih.gov) funding P50CA097190 and R01CA77308 to JRG, and F31DE024007 to NDP, the American Cancer Society (www.cancer.org) to JRG, the China Scholarship Council (http://en.csc.edu.cn) to YD, and the General Research Fund from the Research Grant Council of Hong Kong (http://www.ugc.edu.hk/) 17114814 and Seed Funding for Basic Research to VL.	Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dutton-Regester K, 2012, GENE CHROMOSOME CANC, V51, P452, DOI 10.1002/gcc.21932; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giefing M, 2011, GENE CHROMOSOME CANC, V50, P154, DOI 10.1002/gcc.20840; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Kohno T, 2010, GENE CHROMOSOME CANC, V49, P342, DOI 10.1002/gcc.20746; Lambert SR, 2012, INT J CANCER, V131, pE216, DOI 10.1002/ijc.27333; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lui VWY, 2014, P NATL ACAD SCI USA, V111, P1114, DOI 10.1073/pnas.1319551111; Meehan M, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-6; Micci F, 2013, GENE CHROMOSOME CANC, V52, P551, DOI 10.1002/gcc.22053; Nakamura M, 2003, CANCER RES, V63, P737; Nalesnik MA, 2012, AM J PATHOL, V180, P1495, DOI 10.1016/j.ajpath.2011.12.021; Ortiz B, 2014, ONCOTARGET, V5, P6976, DOI 10.18632/oncotarget.2106; Ortiz B, 2014, P NATL ACAD SCI USA, V111, P8149, DOI 10.1073/pnas.1401952111; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Purdie KJ, 2007, GENE CHROMOSOME CANC, V46, P661, DOI 10.1002/gcc.20447; Sen M, 2012, CANCER DISCOV, V2, P694, DOI 10.1158/2159-8290.CD-12-0191; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Stallings RL, 2006, CANCER RES, V66, P3673, DOI 10.1158/0008-5472.CAN-05-4154; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Thomas SM, 2004, CANCER TREAT REV, V30, P255, DOI 10.1016/j.ctrv.2003.10.003; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Yin WH, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-15; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	31	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135750	10.1371/journal.pone.0135750	http://dx.doi.org/10.1371/journal.pone.0135750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267899	Green Published, gold, Green Accepted			2022-12-27	WOS:000359492300153
J	Zhu, QY; Yamakuchi, M; Lowenstein, CJ				Zhu, Qiuyu; Yamakuchi, Munekazu; Lowenstein, Charles J.			SNAP23 Regulates Endothelial Exocytosis of von Willebrand Factor	PLOS ONE			English	Article							WEIBEL-PALADE BODIES; ETHYLMALEIMIDE-SENSITIVE-FACTOR; AUTOPHAGOSOME-LYSOSOME FUSION; EXCHANGE FACTOR RALGDS; BODY EXOCYTOSIS; MEMBRANE-FUSION; SNARE PROTEINS; SYNAPTIC-TRANSMISSION; IMAGING REVEALS; BINDING PROTEIN	Endothelial exocytosis regulates vascular thrombosis and inflammation. The trafficking and release of endothelial vesicles is mediated by SNARE (Soluble NSF Attachment protein REceptors) molecules, but the exact identity of endothelial SNAREs has been unclear. Three SNARE molecules form a ternary complex, including isoforms of the syntaxin (STX), vesicle-associated membrane protein (VAMP), and synaptosomal-associated protein (SNAP) families. We now identify SNAP23 as the predominant endothelial SNAP isoform that mediates endothelial exocytosis of von Willebrand Factor (VWF). SNAP23 was localized to the plasma membrane. Knockdown of SNAP23 decreased endothelial exocytosis, suggesting it is important for endothelial exocytosis. SNAP23 interacted with the endothelial exocytic machinery, and formed complexes with other known endothelial SNARE molecules. Taken together, these data suggest that SNAP23 is a key component of the endothelial SNARE machinery that mediates endothelial exocytosis.	[Zhu, Qiuyu; Yamakuchi, Munekazu; Lowenstein, Charles J.] Univ Rochester, Med Ctr, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Zhu, Qiuyu] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Lowenstein, CJ (corresponding author), Univ Rochester, Med Ctr, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA.	charles_lowenstein@urmc.rochester.edu	Zhu, Qiuyu/M-7578-2017	Zhu, Qiuyu/0000-0003-2751-7985; Lowenstein, Charles/0000-0003-0485-7514	National Institutes of Health [R21 HL108372, R56 HL124042]; Howard Hughes Medical Institute "Med-into-Grad" Fellowship in Cardiovascular Sciences at the Aab Cardiovascular Research Institute, University of Rochester Medical Center; American Heart Association [14GRNT19020033, 0835446N, 13PRE17050105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL108372, R56HL124042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute "Med-into-Grad" Fellowship in Cardiovascular Sciences at the Aab Cardiovascular Research Institute, University of Rochester Medical Center; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by the National Institutes of Health (http://nih.gov) grant R21 HL108372 to C.J.L.; by National Institutes of Health R56 HL124042 to C.J.L.; by the Howard Hughes Medical Institute (http://www.hhmi.org) "Med-into-Grad" Fellowship in Cardiovascular Sciences at the Aab Cardiovascular Research Institute, University of Rochester Medical Center to C.J.L. and Q.Z.; and by American Heart Association (http://www.heart.org/HEARTORG/) grants 14GRNT19020033 to C.J.L., 0835446N to M.Y., and 13PRE17050105 to Q.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, JAMA J AM MED ASS, V308, P1492; Araki S, 1997, BIOCHEM BIOPH RES CO, V234, P257, DOI 10.1006/bbrc.1997.6560; Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Bierings R, 2012, BLOOD, V120, P2757, DOI 10.1182/blood-2012-05-429936; Calvert JW, 2007, CIRC RES, V101, P1247, DOI 10.1161/CIRCRESAHA.107.162610; Chen D, 1999, BIOCHEM BIOPH RES CO, V255, P340, DOI 10.1006/bbrc.1999.0173; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Diao JJ, 2015, NATURE, V520, P563, DOI 10.1038/nature14147; Ding BB, 2014, CELL HOST MICROBE, V15, P564, DOI 10.1016/j.chom.2014.04.004; Faure M, 2014, CELL HOST MICROBE, V15, P519, DOI 10.1016/j.chom.2014.04.014; Feldmann A, 2009, J NEUROSCI RES, V87, P1760, DOI 10.1002/jnr.22020; Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200; Grant NJ, 1999, J NEUROCHEM, V72, P363, DOI 10.1046/j.1471-4159.1999.0720363.x; Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066; Hegedus K, 2013, AUTOPHAGY, V9, P1642, DOI 10.4161/auto.25684; Hohenstein AC, 2001, BIOCHEM BIOPH RES CO, V285, P167, DOI 10.1006/bbrc.2001.5141; Itakura E, 2013, AUTOPHAGY, V9, P917, DOI 10.4161/auto.24109; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kang J, 2011, DEV BIOL, V355, P77, DOI 10.1016/j.ydbio.2011.04.013; Kudlyk T, 2013, TRAFFIC, V14, P194, DOI 10.1111/tra.12020; Liu R, 2015, AUTOPHAGY, V11, P847, DOI 10.1080/15548627.2015.1037549; LoMonaco MB, 2014, ANAL BIOCHEM, V452, P19, DOI 10.1016/j.ab.2014.02.015; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Mizushima N, 2014, NAT CELL BIOL, V16, P1132, DOI 10.1038/ncb3078; Morelli E, 2014, AUTOPHAGY, V10, P2251, DOI 10.4161/15548627.2014.981913; Morikawa Y, 1998, BLOOD, V92, P129, DOI 10.1182/blood.V92.1.129.413k07_129_135; Nightingale T, 2013, J THROMB HAEMOST, V11, P192, DOI 10.1111/jth.12225; Nightingale TD, 2009, BLOOD, V113, P5010, DOI 10.1182/blood-2008-09-181206; Pallavi B, 2003, J BIOL CHEM, V278, P12737, DOI 10.1074/jbc.M208598200; Pan PY, 2005, J BIOL CHEM, V280, P25769, DOI 10.1074/jbc.M502356200; Pertsinidis A, 2013, P NATL ACAD SCI USA, V110, pE2812, DOI 10.1073/pnas.1310654110; Predescu SA, 2005, J BIOL CHEM, V280, P37130, DOI 10.1074/jbc.M505659200; Pulido IR, 2011, TRAFFIC, V12, P1371, DOI 10.1111/j.1600-0854.2011.01248.x; Pulido IR, 2011, BBA-MOL CELL RES, V1813, P1038, DOI 10.1016/j.bbamcr.2010.11.007; Rapaport D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009759; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Reales E, 2005, J IMMUNOL, V175, P6686, DOI 10.4049/jimmunol.175.10.6686; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; Salaun C, 2005, J BIOL CHEM, V280, P19449, DOI 10.1074/jbc.M501923200; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Schardt A, 2009, J NEUROSCI RES, V87, P3465, DOI 10.1002/jnr.22005; Sehgal PB, 2007, AM J PHYSIOL-LUNG C, V292, pL1526, DOI 10.1152/ajplung.00463.2006; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Spiel AO, 2008, CIRCULATION, V117, P1449, DOI 10.1161/CIRCULATIONAHA.107.722827; Sprenger RR, 2006, BIOCHEM J, V400, P401, DOI 10.1042/BJ20060355; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Su QN, 2001, P NATL ACAD SCI USA, V98, P14038, DOI 10.1073/pnas.251532398; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; Torisu T, 2013, NAT MED, V19, P1281, DOI 10.1038/nm.3288; van Breevoort D, 2014, BLOOD, V123, P3185, DOI 10.1182/blood-2013-10-535831; van Mourik JA, 2002, HISTOCHEM CELL BIOL, V117, P113, DOI 10.1007/s00418-001-0368-9; Voorberg J, 2005, BLOOD, V106, p1027A, DOI 10.1182/blood.V106.11.3688.3688; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355; Wesolowski J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049886; Yamakuchi M, 2005, CIRC RES, V96, P1185, DOI 10.1161/01.RES.0000170229.49776.81; Yamakuchi Munekazu, 2008, V440, P203, DOI 10.1007/978-1-59745-178-9_15; Zhu QY, 2014, J CLIN INVEST, V124, P4503, DOI 10.1172/JCI71245	64	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0118737	10.1371/journal.pone.0118737	http://dx.doi.org/10.1371/journal.pone.0118737			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266817	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300001
J	Greineisen, WE; Maaetoft-Udsen, K; Speck, M; Balajadia, J; Shimoda, LMN; Sung, C; Turner, H				Greineisen, William E.; Maaetoft-Udsen, Kristina; Speck, Mark; Balajadia, Januaria; Shimoda, Lori M. N.; Sung, Carl; Turner, Helen			Chronic Insulin Exposure Induces ER Stress and Lipid Body Accumulation in Mast Cells at the Expense of Their Secretory Degranulation Response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; EICOSANOID FORMATION; INTRACELLULAR SITES; DROPLET FORMATION; INNATE IMMUNITY; BODIES; OBESITY; MACROPHAGES; METABOLISM; DIFFERENTIATION	Lipid bodies (LB) are reservoirs of precursors to inflammatory lipid mediators in immunocytes, including mast cells. LB numbers are dynamic, increasing dramatically under conditions of immunological challenge. We have previously shown in vitro that insulin-influenced lipogenic pathways induce LB biogenesis in mast cells, with their numbers attaining steatosis-like levels. Here, we demonstrate that in vivo hyperinsulinemia resulting from high fat diet is associated with LB accumulation in murine mast cells and basophils. We characterize the lipidome of purified insulin-induced LB, and the shifts in the whole cell lipid landscape in LB that are associated with their accumulation, in both model (RBL2H3) and primary mast cells. Lipidomic analysis suggests a gain of function associated with LB accumulation, in terms of elevated levels of eicosanoid precursors that translate to enhanced antigen-induced LTC4 release. Loss-of-function in terms of a suppressed degranulation response was also associated with LB accumulation, as were ER reprogramming and ER stress, analogous to observations in the obese hepatocyte and adipocyte. Taken together, these data suggest that chronic insulin elevation drives mast cell LB enrichment in vitro and in vivo, with associated effects on the cellular lipidome, ER status and pro-inflammatory responses.	[Greineisen, William E.; Maaetoft-Udsen, Kristina; Speck, Mark; Balajadia, Januaria; Shimoda, Lori M. N.; Sung, Carl; Turner, Helen] Chaminade Univ, Lab Immunol & Signal Transduct, Honolulu, HI 96816 USA; [Turner, Helen] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	University of Hawaii System	Turner, H (corresponding author), Chaminade Univ, Lab Immunol & Signal Transduct, Honolulu, HI 96816 USA.	hturner@chaminade.edu			Victoria and Bradley Geist Foundation [45408]; National Institutes of Health [P20MD006084, 2P20GM103466]; National Science Foundation EPSCOR [EPS-0903833]; Carlsberg Foundation Post-Doctoral Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK100978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103466] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006084] Funding Source: NIH RePORTER	Victoria and Bradley Geist Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation EPSCOR(National Science Foundation (NSF)); Carlsberg Foundation Post-Doctoral Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding provided by Victoria and Bradley Geist Foundation (grant 45408), National Institutes of Health P20MD006084, National Institutes of Health 2P20GM103466, National Science Foundation EPSCOR EPS-0903833 and the Carlsberg Foundation Post-Doctoral Scholarship (KMU).	ANDRADE ZA, 1984, AM J PATHOL, V114, P137; Bandeira-Melo C, 2011, METHODS MOL BIOL, V717, P277, DOI 10.1007/978-1-61779-024-9_16; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; D'Avila H, 2008, INT IMMUNOPHARMACOL, V8, P1308, DOI 10.1016/j.intimp.2008.01.035; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dichlberger A, 2014, J LIPID RES, V55, P2471, DOI 10.1194/jlr.M048553; Dichlberger A, 2011, J LIPID RES, V52, P2198, DOI 10.1194/jlr.M019737; Digel M, 2010, FEBS LETT, V584, P2168, DOI 10.1016/j.febslet.2010.03.035; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; DVORAK AM, 1983, J IMMUNOL, V131, P2965; DVORAK AM, 1992, J HISTOCHEM CYTOCHEM, V40, P759, DOI 10.1177/40.6.1316915; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Goecks J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-397; Greineisen WE, 2012, J LEUKOCYTE BIOL, V92, P653, DOI 10.1189/jlb.0811406; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kondo H, 2008, TOHOKU J EXP MED, V214, P167, DOI 10.1620/tjem.214.167; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Maeyama K, 2005, J PHARMACOL SCI, V97, P190, DOI 10.1254/jphs.FMJ04008X6; MANN CJ, 1986, ARCH BIOCHEM BIOPHYS, V244, P813, DOI 10.1016/0003-9861(86)90650-8; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Mattos KA, 2010, J LEUKOCYTE BIOL, V87, P371, DOI 10.1189/jlb.0609433; Melo RCN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059578; Melo RCN, 2011, J HISTOCHEM CYTOCHEM, V59, P540, DOI 10.1369/0022155411404073; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Neuwirth E, 2011, RCOLORBREWER COLORBR; Pacheco P, 2002, J IMMUNOL, V169, P6498, DOI 10.4049/jimmunol.169.11.6498; Pietilainen KH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000623; Quehenberger O, 2008, PROSTAG LEUKOTR ESS, V79, P123, DOI 10.1016/j.plefa.2008.09.021; Robenek H, 2009, BBA-MOL CELL BIOL L, V1791, P408, DOI 10.1016/j.bbalip.2008.12.001; Rodrigues HG, 2012, J INVEST DERMATOL, V132, P208, DOI 10.1038/jid.2011.265; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SCHLAME M, 1993, EUR J BIOCHEM, V212, P727, DOI 10.1111/j.1432-1033.1993.tb17711.x; SCHLAME M, 1990, BIOCHEM J, V265, P79, DOI 10.1042/bj2650079; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Theoharides TC, 2011, TRENDS PHARMACOL SCI, V32, P534, DOI 10.1016/j.tips.2011.05.005; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Warnes G. R., 2014, VARIOUS R PROGRAMMIN; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weller PF, 1999, INT ARCH ALLERGY IMM, V118, P450, DOI 10.1159/000024161; WELLER PF, 1994, J ALLERGY CLIN IMMUN, V94, P1151, DOI 10.1016/0091-6749(94)90325-5; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yetukuri L, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-12	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0130198	10.1371/journal.pone.0130198	http://dx.doi.org/10.1371/journal.pone.0130198			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263026	Green Submitted, Green Published, gold			2022-12-27	WOS:000359353300002
J	Hernandez-Castillo, CR; Galvez, V; Mercadillo, R; Diaz, R; Campos-Romo, A; Fernandez-Ruiz, J				Hernandez-Castillo, Carlos R.; Galvez, Victor; Mercadillo, Roberto; Diaz, Rosalinda; Campos-Romo, Aurelio; Fernandez-Ruiz, Juan			Extensive White Matter Alterations and Its Correlations with Ataxia Severity in SCA 2 Patients	PLOS ONE			English	Article							DIFFUSION TENSOR TRACTOGRAPHY; VOXEL-BASED MORPHOMETRY; CORTICOSPINAL TRACT; SPATIAL STATISTICS; MEAN DIFFUSIVITY; IN-VIVO; SPINOCEREBELLAR; DEGENERATION; MRI; TRANSECTION	Background Previous studies of SCA2 have revealed significant degeneration of white matter tracts in cerebellar and cerebral regions. The motor deficit in these patients may be attributable to the degradation of projection fibers associated with the underlying neurodegenerative process. However, this relationship remains unclear. Statistical analysis of diffusion tensor imaging enables an unbiased whole-brain quantitative comparison of the diffusion proprieties of white matter tracts in vivo. Methods Fourteen genetically confirmed SCA2 patients and aged-matched healthy controls participated in the study. Tract-based spatial statistics were performed to analyze structural white matter damage using two differentmeasurements: fractional anisotropy (FA) and mean diffusivity (MD). Significant diffusion differences were correlated with the patient's ataxia impairment. Results Our analysis revealed decreased FA mainly in the inferior/middle/superior cerebellar peduncles, the bilateral posterior limb of the internal capsule and the bilateral superior corona radiata. Increases in MD were found mainly in cerebellar white matter, medial lemniscus, and middle cerebellar peduncle, among other regions. Clinical impairment measured with the SARA score correlated with FA in superior parietal white matter and bilateral anterior corona radiata. Correlations with MD were found in cerebellar white matter and the middle cerebellar peduncle. Conclusion Our findings show significant correlations between diffusion measurements in key areas affected in SCA2 and measures of motor impairment, suggesting a disruption of information flow between motor and sensory-integration areas. These findings result in a more comprehensive view of the clinical impact of the white matter degeneration in SCA2.	[Hernandez-Castillo, Carlos R.] Univ Veracruzana, Inst Neuroetol, Consejo Nacl Ciencia & Tecnol Catedras, Mexico City, DF, Mexico; [Galvez, Victor] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico; [Mercadillo, Roberto] Univ Autonoma Metropolitana, Dept Biol Reprod, Area Neurociencias, Catedras Consejo Nacl Ciencia & Tecnol, Mexico City, DF, Mexico; [Diaz, Rosalinda; Fernandez-Ruiz, Juan] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Lab Neuropsicol, Mexico City 04510, DF, Mexico; [Campos-Romo, Aurelio] Univ Nacl Autonoma Mexico, Fac Med, Unidad Perifer Neurociencias, Inst Nacl Neurol & Neurocirugia, Mexico City 04510, DF, Mexico	Universidad Veracruzana; Universidad Veracruzana; Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Fernandez-Ruiz, J (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Lab Neuropsicol, Mexico City 04510, DF, Mexico.	jfr@unam.mx	Fernandez-Ruiz, Juan/B-6154-2012; Gálvez Zúñiga, Victor Hugo/AFR-5821-2022	Fernandez-Ruiz, Juan/0000-0002-4038-0904; Gálvez Zúñiga, Victor Hugo/0000-0002-6075-9620; Hernandez-Castillo, Carlos Roberto/0000-0003-1208-5577	Universidad Nacional Autonoma de Mexico [PAPIIT IN221413]; Consejo Nacional de Ciencia y Tecnologia [220871]; National Ataxia Foundation (USA)	Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Ataxia Foundation (USA)	This work was supported by Universidad Nacional Autonoma de Mexico (PAPIIT IN221413) www.unam.mx, Consejo Nacional de Ciencia y Tecnologia (220871) www.conacyt.mx, and National Ataxia Foundation (USA) www.ataxia.org.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Alcauter S, 2011, NEUROIMAGE, V55, P1, DOI 10.1016/j.neuroimage.2010.12.014; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Auburger Georg W J, 2012, Handb Clin Neurol, V103, P423, DOI 10.1016/B978-0-444-51892-7.00026-7; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Cho SH, 2007, NEUROSCI LETT, V426, P123, DOI 10.1016/j.neulet.2007.08.049; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Cosottini M, 2005, RADIOLOGY, V237, P258, DOI 10.1148/radiol.2371041506; Della Nave R, 2008, NEUROIMAGE, V43, P10, DOI 10.1016/j.neuroimage.2008.06.036; Della Nave R, 2008, MOVEMENT DISORD, V23, P900, DOI 10.1002/mds.21982; Della Nave R, 2008, NEUROIMAGE, V40, P19, DOI 10.1016/j.neuroimage.2007.11.050; Estrada R, 1999, ACTA NEUROPATHOL, V97, P306, DOI 10.1007/s004010050989; Fernandez-Ruiz J, 2007, NEUROPSYCHOLOGIA, V45, P2692, DOI 10.1016/j.neuropsychologia.2007.04.006; GAFFAN D, 1988, BEHAV BRAIN RES, V31, P149, DOI 10.1016/0166-4328(88)90018-6; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Good C.D., 2002, 5 IEEE EMBS INT SUMM, P16, DOI DOI 10.1109/SSBI.2002.1233974; Guerrini L, 2004, BRAIN, V127, P1785, DOI 10.1093/brain/awh201; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; Hernandez-Castillo Carlos R, 2014, Cerebellum Ataxias, V1, P2, DOI 10.1186/2053-8871-1-2; Hernandez-Castillo CR, 2013, MOVEMENT DISORD, V28, P1708, DOI 10.1002/mds.25618; Hernandez-Castillo CR, 2015, MOV DISORD; HUANG CY, 1984, STROKE, V15, P363, DOI 10.1161/01.STR.15.2.363; Kamali A, 2009, EUR RADIOL, V19, P1480, DOI 10.1007/s00330-009-1305-x; Kawai Y, 2008, J NEUROL SCI, V271, P68, DOI 10.1016/j.jns.2008.03.018; MAHUT H, 1972, NEUROPSYCHOLOGIA, V10, P65, DOI 10.1016/0028-3932(72)90043-7; Mandelli ML, 2007, AM J NEURORADIOL, V28, P1996, DOI 10.3174/ajnr.A0716; Manto MU, 2005, CEREBELLUM, V4, P2, DOI 10.1080/14734220510007914; Mascalchi M, 2015, AM J NEURORADIOL; Mascalchi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089410; Mercadillo RE, 2014, J NEUROL SCI, V347, P50, DOI 10.1016/j.jns.2014.09.018; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pagani E, 2010, RADIOLOGY, V255, P882, DOI 10.1148/radiol.10091742; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; SAGE JI, 1983, ARCH NEUROL-CHICAGO, V40, P449, DOI 10.1001/archneur.1983.04050070079023; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Velazquez-Perez L, 2010, J NEUROL SCI, V290, P22, DOI 10.1016/j.jns.2009.12.013; Vos SB, 2012, NEUROIMAGE, V59, P2208, DOI 10.1016/j.neuroimage.2011.09.086; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Weyer A, 2007, MOVEMENT DISORD, V22, P1633, DOI 10.1002/mds.21544; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245	50	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135449	10.1371/journal.pone.0135449	http://dx.doi.org/10.1371/journal.pone.0135449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263162	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300083
J	Horsch, M; Aguilar-Pimentel, JA; Bonisch, C; Come, C; Kolster-Fog, C; Jensen, KT; Lund, AH; Lee, I; Grossman, LI; Sinkler, C; Huttemann, M; Bohn, E; Fuchs, H; Ollert, M; Gailus-Durner, V; de Angelis, MH; Beckers, J				Horsch, Marion; Aguilar-Pimentel, Juan Antonio; Boenisch, Clemens; Come, Christophe; Kolster-Fog, Cathrine; Jensen, Klaus T.; Lund, Anders H.; Lee, Icksoo; Grossman, Lawrence I.; Sinkler, Christopher; Huettemann, Maik; Bohn, Erwin; Fuchs, Helmut; Ollert, Markus; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Beckers, Johannes			Cox4i2, Ifit2, and Prdm11 Mutant Mice: Effective Selection of Genes Predisposing to an Altered Airway Inflammatory Response from a Large Compendium of Mutant Mouse Lines	PLOS ONE			English	Article							ENVIRONMENT INTERACTIONS; ASTHMA; EXPRESSION; LUNG; MODEL; GENOME; MUSCLE; INFECTION; PATHWAYS; PLATFORM	We established a selection strategy to identify new models for an altered airway inflammatory response from a large compendium of mutant mouse lines that were systemically phenotyped in the German Mouse Clinic (GMC). As selection criteria we included published gene functional data, as well as immunological and transcriptome data from GMC phenotyping screens under standard conditions. Applying these criteria we identified a few from several hundred mutant mouse lines and further characterized the Cox4i2(tm1Hutt), Ifit2(tm1.1Ebsb), and Prdm11(tm1.1ahl) lines following ovalbumin (OVA) sensitization and repeated OVA airway challenge. Challenged Prdm11(tm1.1ahl) mice exhibited changes in B cell counts, CD4(+) T cell counts, and in the number of neutrophils in bronchoalveolar lavages, whereas challenged Ifit2(tm1.1Ebsb) mice displayed alterations in plasma IgE, IgG1, IgG3, and IgM levels compared to the challenged wild type littermates. In contrast, challenged Cox4i2(tm1Hutt) mutant mice did not show alterations in the humoral or cellular immune response compared to challenged wild typemice. Transcriptome analyses from lungs of the challenged mutant mouse lines showed extensive changes in gene expression in Prdm11(tm1.1ahl) mice. Functional annotations of regulated genes of all three mutant mouse lines were primarily related to inflammation and airway smooth muscle (ASM) remodeling. We were thus able to define an effective selection strategy to identify new candidate genes for the predisposition to an altered airway inflammatory response under OVA challenge conditions. Similar selection strategies may be used for the analysis of additional genotype - envirotype interactions for other diseases.	[Horsch, Marion; Aguilar-Pimentel, Juan Antonio; Boenisch, Clemens; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Beckers, Johannes] Helmholtz Zentrum Munchen GmbH, German Mouse Clin, Inst Expt Genet, D-85764 Neuherberg, Germany; [Aguilar-Pimentel, Juan Antonio] TUM, Dept Dermatol & Allergy, Munich, Germany; [Aguilar-Pimentel, Juan Antonio] Clin Res Div Mol & Clin Allergotoxicol, Munich, Germany; [Come, Christophe; Kolster-Fog, Cathrine; Jensen, Klaus T.; Lund, Anders H.] Univ Copenhagen, Lund Grp, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si 330714, Chungcheongnam, South Korea; [Grossman, Lawrence I.; Sinkler, Christopher; Huettemann, Maik] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Bohn, Erwin] Univ Klinikum Tubingen, Inst Med Mikrobiol, D-72076 Tubingen, Germany; [Ollert, Markus] Tech Univ Munich, Ctr Allergy & Environm Munich ZAUM, D-80290 Munich, Germany; [Ollert, Markus] Luxembourg Inst Hlth, Dept Infect & Immun, Esch Sur Alzette, Luxembourg; [Ollert, Markus] Univ Southern Denmark, Dept Dermatol, Odense Res Ctr Anaphylaxis, Odense, Denmark; [Ollert, Markus] Univ Southern Denmark, Allergy Ctr, Odense Res Ctr Anaphylaxis, Odense, Denmark; [de Angelis, Martin Hrabe; Beckers, Johannes] Tech Univ Munich, Chair Expt Genet, D-85354 Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe; Beckers, Johannes] German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Copenhagen; Dankook University; Wayne State University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Munich; Luxembourg Institute of Health; University of Southern Denmark; University of Southern Denmark; Technical University of Munich	Beckers, J (corresponding author), Helmholtz Zentrum Munchen GmbH, German Mouse Clin, Inst Expt Genet, D-85764 Neuherberg, Germany.	beckers@helmholtz-muenchen.de	Lund, Anders H./F-4786-2014; Côme, Christophe/E-8395-2016; Gailus-Durner, Valerie/M-7337-2014; Beckers, Johannes/K-7237-2012; de Angelis, Martin Hrabe/F-5531-2012	Lund, Anders H./0000-0002-7407-3398; Côme, Christophe/0000-0001-5229-4440; Beckers, Johannes/0000-0001-7874-3822; de Angelis, Martin Hrabe/0000-0002-7898-2353; Huttemann, Maik/0000-0001-6310-7081; Fog-Tonnesen, Cathrine/0000-0001-5437-9173; Ollert, Markus W./0000-0002-8055-0103	Novo Nordisk Foundation; Danish Cancer Society; Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease'; Helmholtz Alliance 'Imaging and Curing Environmental Metabolic Diseases'; German Federal Ministry of Education and Research, Infrafrontier grant [01KX1012]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease'; Helmholtz Alliance 'Imaging and Curing Environmental Metabolic Diseases'; German Federal Ministry of Education and Research, Infrafrontier grant	The project was supported by grants from The Novo Nordisk Foundation (AHL), the Danish Cancer Society (CKF, AHL), the Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease' (JB), the Helmholtz Alliance 'Imaging and Curing Environmental Metabolic Diseases' (JB) and by the German Federal Ministry of Education and Research, Infrafrontier grant 01KX1012 (MHA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Pimentel JA, 2010, AM J RESP CRIT CARE, V181, P7, DOI 10.1164/rccm.200902-0190OC; Alessandrini F, 2006, J ALLERGY CLIN IMMUN, V117, P824, DOI 10.1016/j.jaci.2005.11.046; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beckers J, 2009, NAT REV GENET, V10, P371, DOI 10.1038/nrg2578; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; BIENENSTOCK J, 1984, ANNU REV MED, V35, P49, DOI 10.1146/annurev.me.35.020184.000405; Brown SDM, 2005, NAT GENET, V37, P1155, DOI 10.1038/ng1105-1155; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cho H, 2013, J VIROL, V87, P8363, DOI 10.1128/JVI.01097-13; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fensterl V, 2014, J VIROL, V88, P10303, DOI 10.1128/JVI.01341-14; Fog CK, 2015, BLOOD, V125, P1272, DOI 10.1182/blood-2014-03-560805; Follettie MT, 2006, PHARMACOGENOMICS J, V6, P141, DOI 10.1038/sj.tpj.6500357; Fuchs H, 2009, CURR PHARM BIOTECHNO, V10, P236, DOI 10.2174/138920109787315051; Fuchs H, 2012, MAMM GENOME, V23, P611, DOI 10.1007/s00335-012-9415-1; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Grinberg S, 2009, AM J PATHOL, V175, P2439, DOI 10.2353/ajpath.2009.090290; Hassan M, 2010, J ALLERGY CLIN IMMUN, V125, P1037, DOI 10.1016/j.jaci.2010.02.031; Heidenfelder BL, 2009, TOXICOL SCI, V108, P207, DOI 10.1093/toxsci/kfp005; Holmes AM, 2011, DRUG DISCOV TODAY, V16, P659, DOI 10.1016/j.drudis.2011.05.014; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; HOSSAIN S, 1970, J PATHOL, V101, P171, DOI 10.1002/path.1711010212; Huttemann M, 2012, FASEB J, V26, P3916, DOI 10.1096/fj.11-203273; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; Izzotti A, 2005, EUR J CANCER, V41, P1864, DOI 10.1016/j.ejca.2005.04.011; Kabesch M, 2006, TOXICOL LETT, V162, P43, DOI 10.1016/j.toxlet.2005.10.009; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Kuperman DA, 2005, J ALLERGY CLIN IMMUN, V116, P305, DOI 10.1016/j.jaci.2005.03.024; Loth DW, 2014, NAT GENET, V46, P669, DOI 10.1038/ng.3011; Mauderly JL, 2014, INHAL TOXICOL, V26, P651, DOI 10.3109/08958378.2014.925523; Nadadur SS, 2002, J TOXICOL ENV HEAL A, V65, P1333, DOI 10.1080/00984100290071559; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Oh J, 1998, AM J HUM GENET, V62, P593, DOI 10.1086/301757; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; Rosa AC, 2014, J PHARMACOL EXP THER, V351, P308, DOI 10.1124/jpet.114.215152; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Siegfried A, 2013, J IMMUNOL, V191, P3913, DOI 10.4049/jimmunol.1203305; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Stevens T, 2008, TOXICOL SCI, V102, P359, DOI 10.1093/toxsci/kfn006; Thoren LA, 2013, STEM CELL RES, V11, P1129, DOI 10.1016/j.scr.2013.07.009; Tumes DJ, 2009, INT IMMUNOL, V21, P633, DOI 10.1093/intimm/dxp032; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Walker KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018723; Wetzel JL, 2014, J VIROL, V88, P13593, DOI 10.1128/JVI.02201-14	51	4	4	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134503	10.1371/journal.pone.0134503	http://dx.doi.org/10.1371/journal.pone.0134503			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263558	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300030
J	Jaworski, CC; Andalo, C; Raynaud, C; Simon, V; Thebaud, C; Chave, J				Jaworski, Coline C.; Andalo, Christophe; Raynaud, Christine; Simon, Valerie; Thebaud, Christophe; Chave, Jerome			The Influence of Prior Learning Experience on Pollinator Choice: An Experiment Using Bumblebees on Two Wild Floral Types of Antirrhinum majus	PLOS ONE			English	Article							INNATE COLOR PREFERENCES; FLOWER CONSTANCY; BOMBUS-TERRESTRIS; REPRODUCTIVE SUCCESS; PENSTEMON-DIGITALIS; SCENT EMISSION; HYBRID ZONE; SELECTION; HONEYBEES; BEES	Understanding how pollinator behavior may influence pollen transmission across floral types is a major challenge, as pollinator decision depends on a complex range of environmental cues and prior experience. Here we report an experiment using the plant Antirrhinum majus and the bumblebee Bombus terrestris to investigate how prior learning experience may affect pollinator preferences between floral types when these are presented together. We trained naive bumblebees to forage freely on flowering individuals of either A. majus pseudomajus (magenta flowers) or A. majus striatum (yellow flowers) in a flight cage. We then used a Y-maze device to expose trained bumblebees to a dual choice between the floral types. We tested the influence of training on their choice, depending on the type of plant signals available (visual signals, olfactory signals, or both). Bumblebees had no innate preference for either subspecies. Bumblebees trained on the yellow-flowered subspecies later preferred the yellow type, even when only visual or only olfactory signals were available, and their preference was not reinforced when both signal types were available. In contrast, bumblebees trained on the magenta-flowered subspecies showed no further preference between floral types and took slightly more time to make their choice. Since pollinator constancy has been observed in wild populations of A. majus with mixed floral types, we suggest that such constancy likely relies on short-term memory rather than acquired preference through long-term memory induced by prior learning.	[Jaworski, Coline C.; Andalo, Christophe; Thebaud, Christophe; Chave, Jerome] Univ Toulouse 3, CNRS, UMR 5174, Lab Evolut & Divers Biol, F-31062 Toulouse, France; [Raynaud, Christine; Simon, Valerie] Univ Toulouse, INP ENSIACET, LCA, Toulouse, France; [Raynaud, Christine; Simon, Valerie] INRA, UMR CAI 1010, F-31931 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; INRAE	Jaworski, CC (corresponding author), Univ Toulouse 3, CNRS, UMR 5174, Lab Evolut & Divers Biol, F-31062 Toulouse, France.	jaworskicoline@yahoo.fr	Raynaud, Christine/Q-7648-2019; Thébaud, Christophe/N-3916-2016; Jaworski, Coline/AAI-2614-2021; Simon, Valérie/L-8655-2013	Thébaud, Christophe/0000-0002-8586-1234; Jaworski, Coline/0000-0002-6136-8656; Simon, Valérie/0000-0002-2624-157X; Raynaud, Christine/0000-0001-7913-6653	Federation de Recherche Agrobiosciences, Interactions et Biodiversite [FR3450]; Universite Paul Sabatier: bourse de doctorat du Conseil scientifique de l'Ecole doctorale SEVAB; "Investissement d'Avenir" grant [ANR-10-LABX-25-01, ANR-10-LABX-0041]	Federation de Recherche Agrobiosciences, Interactions et Biodiversite; Universite Paul Sabatier: bourse de doctorat du Conseil scientifique de l'Ecole doctorale SEVAB; "Investissement d'Avenir" grant(French National Research Agency (ANR))	The work was supported by the following: Federation de Recherche Agrobiosciences, Interactions et Biodiversite (FR3450): CJ and JC; Universite Paul Sabatier: bourse de doctorat du Conseil scientifique de l'Ecole doctorale SEVAB: CJ and JC; "Investissement d'Avenir" grant managed by the French Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01); and "Investissement d'Avenir" grant managed by the French Agence Nationale de la Recherche (TULIP, ref. ANR-10-LABX-0041).	Adams R.P., 2004, IDENTIFICATION ESSEN, V3rd ed.; Aldridge G, 2009, HEREDITY, V102, P257, DOI 10.1038/hdy.2008.112; Aldridge G, 2007, EVOLUTION, V61, P99, DOI 10.1111/j.1558-5646.2007.00008.x; Andalo C, 2010, PLANT SYST EVOL, V286, P223, DOI 10.1007/s00606-010-0303-4; Anton KA, 2013, J EVOLUTION BIOL, V26, P660, DOI 10.1111/jeb.12083; Avargues-Weber A, 2012, P NATL ACAD SCI USA, V109, P7481, DOI 10.1073/pnas.1202576109; BACKHAUS W, 1987, BIOL CYBERN, V55, P321, DOI 10.1007/BF02281978; Bischoff M, 2015, EVOLUTION, V69, P1, DOI 10.1111/evo.12558; Burkhardt A, 2012, J EVOLUTION BIOL, V25, P461, DOI 10.1111/j.1420-9101.2011.02436.x; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P545; Chittka L., 2001, ANIMAL BEHAV FLORAL; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Dudareva N, 2000, PLANT CELL, V12, P949, DOI 10.1105/tpc.12.6.949; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Frey FM, 2011, PLANT SPEC BIOL, V26, P235, DOI 10.1111/j.1442-1984.2011.00325.x; Gegear RJ, 2005, ANIM BEHAV, V69, P939, DOI 10.1016/j.anbehav.2004.06.029; Gigord LDB, 2001, P NATL ACAD SCI USA, V98, P6253, DOI 10.1073/pnas.111162598; Giurfa M, 1997, CURR OPIN NEUROBIOL, V7, P505, DOI 10.1016/S0959-4388(97)80030-X; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; Goulson D, 2007, BEHAV ECOL SOCIOBIOL, V61, P1523, DOI 10.1007/s00265-007-0384-4; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Gumbert A, 2000, BEHAV ECOL SOCIOBIOL, V48, P36, DOI 10.1007/s002650000213; HATANAKA A, 1993, PHYTOCHEMISTRY, V34, P1201, DOI 10.1016/0031-9422(91)80003-J; Hill PSM, 1997, ANIM BEHAV, V54, P615, DOI 10.1006/anbe.1996.0467; Jaworski CC, J ECOLOGY IN PRESS; Kennedy BF, 2006, OECOLOGIA, V150, P398, DOI 10.1007/s00442-006-0536-7; Khimoun A, 2011, J EVOLUTION BIOL, V24, P1433, DOI 10.1111/j.1420-9101.2011.02276.x; Klahre U, 2011, CURR BIOL, V21, P730, DOI 10.1016/j.cub.2011.03.059; Liberal IM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-146; Lucas-Barbosa D, 2011, PHYTOCHEMISTRY, V72, P1647, DOI 10.1016/j.phytochem.2011.03.013; Lunau K, 2006, NATURWISSENSCHAFTEN, V93, P325, DOI 10.1007/s00114-006-0105-2; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Miller TJ, 2014, ANN BOT-LONDON, V113, P317, DOI 10.1093/aob/mct237; Natalis LC, 2013, EVOLUTION, V67, P1692, DOI 10.1111/evo.12044; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Parachnowitsch AL, 2012, NEW PHYTOL, V195, P667, DOI 10.1111/j.1469-8137.2012.04188.x; Parachnowitsch AL, 2010, NEW PHYTOL, V188, P393, DOI 10.1111/j.1469-8137.2010.03410.x; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; Riffell JA, 2013, SCIENCE, V339, P200, DOI 10.1126/science.1225483; Rohde K, 2013, J COMP PHYSIOL A, V199, P197, DOI 10.1007/s00359-012-0783-5; Rothmaler W., 1956, TAXONOMISCHE MONOGRA; Rousset F, 2014, ECOGRAPHY, V37, P781, DOI 10.1111/ecog.00566; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Sagae M, 2008, BIOSCI BIOTECH BIOCH, V72, P110, DOI 10.1271/bbb.70490; SIMON V, 1995, J CHROMATOGR A, V704, P465, DOI 10.1016/0021-9673(95)00213-7; Skyrms B., 2010, SIGNALS EVOLUTION LE, DOI [DOI 10.1093/ACPROF:OSO/9780199580828.001.0001, 10.1093/acprof:oso/9780199580828.001.0001]; Smithson A, 2007, ECOLOGY, V88, P434, DOI 10.1890/05-1445; Suchet C, 2012, ENVIRON ENG MANAG J, V11, P1201; Suchet C, 2011, BEHAV ECOL SOCIOBIOL, V65, P1015, DOI 10.1007/s00265-010-1106-x; Tastard E, 2012, J EVOLUTION BIOL, V25, P388, DOI 10.1111/j.1420-9101.2011.02433.x; Tastard E, 2008, ARTHROPOD-PLANT INTE, V2, P237, DOI 10.1007/s11829-008-9046-3; Tastard E, 2014, PLANT ECOL DIVERS, V7, P391, DOI 10.1080/17550874.2014.898164; Van Poecke RMP, 2001, J CHEM ECOL, V27, P1911, DOI 10.1023/A:1012213116515; Wang Q, 2013, PLANT SYST EVOL, V299, P1263, DOI 10.1007/s00606-013-0794-x; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; Weiss MR, 1997, ANIM BEHAV, V53, P1043, DOI 10.1006/anbe.1996.0357; Whibley AC, 2006, SCIENCE, V313, P963, DOI 10.1126/science.1129161; Whitney HM, 2013, NATURWISSENSCHAFTEN, V100, P249, DOI 10.1007/s00114-013-1020-y; Wilson P, 1996, OECOLOGIA, V106, P493, DOI 10.1007/BF00329707; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Yuan JS, 2009, TRENDS ECOL EVOL, V24, P323, DOI 10.1016/j.tree.2009.01.012	71	5	5	0	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0130225	10.1371/journal.pone.0130225	http://dx.doi.org/10.1371/journal.pone.0130225			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263186	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000359353300003
J	Kinkel, HT; Karmacharya, D; Shakya, J; Manandhar, S; Panthi, S; Karmacharya, P; Sitaula, D; Thapaliya, R; Prawachan, KC; Rai, A; Dixit, S				Kinkel, Hans-Tilmann; Karmacharya, Dibesh; Shakya, Jivan; Manandhar, Sulochana; Panthi, Santosh; Karmacharya, Prajwola; Sitaula, Deepika; Thapaliya, Reenu; Prawachan, K. C.; Rai, Apurva; Dixit, Sameer			Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal	PLOS ONE			English	Article							VIRUS-INFECTION; INTERLEUKIN-28B POLYMORPHISMS; ANTIRETROVIRAL THERAPY; ASIAN PATIENTS; LIVER-DISEASE; BLOOD-DONORS; RISK-FACTORS; MORTALITY; USERS; SEROPREVALENCE	As part of a comprehensive health care programme for people who use drugs in Nepal, HIV and viral hepatitis B and C status-including risk factors, HCV-genotypes and co-infections- as well as two IL28B Single-nucleotide polymorphisms (SNPs) were assessed for a random sample of 401 people who inject drugs in three regions of Nepal: mid-western Terrai (Nepalgunj), the eastern region (Dharan, Biratnagar) and the central region (Kathmandu, Lalitpur and Chitwan). Individuals were included who showed at least a minimum of health care seeking behaviour. This latter criterion was defined by being registered with any organisation offering health services. The average age of the participants was 30.5 yrs, and the average length of intravenous drug use was 8.5 yrs. The prevalence rates of HBsAg, anti-HIV antibodies and HCV-RNA were 3.5%, 13.8% and 41.9%, respectively. Spontaneous HCV clearance was evident in 16% of all of those who tested positive for anti-HCV antibodies. Independent risk factors for HCV-RNA positivity were age, gender, geographical region, duration of injecting drug use, history of imprisonment and HIV co-infection. In the age group <= 24 yrs, the rate of spontaneous HCV clearance was 43.5%. Overall, 59.8% of HCV infections were caused by HCV genotype 3 and 40.2% by HCV genotype 1. No other HCV genotypes were identified in this study. The IL28B SNP rs12979860 and rs8099917 were identified in 122 patients, and 75.4% of all participants had both favourable genotypes rs12979860 C/C and rs8099917 T/T.	[Kinkel, Hans-Tilmann] GIZ, Kathmandu, Nepal; [Karmacharya, Dibesh; Shakya, Jivan; Manandhar, Sulochana; Panthi, Santosh; Karmacharya, Prajwola; Dixit, Sameer] Ctr Mol Dynam Nepal, Kathmandu, Nepal; [Karmacharya, Prajwola; Thapaliya, Reenu] Trichandra Multiple Coll, Kathmandu, Nepal; [Sitaula, Deepika] St Xavier Coll, Kathmandu, Nepal; [Prawachan, K. C.; Rai, Apurva] SPARSHA Nepal, Latitpur, Nepal		Dixit, S (corresponding author), Ctr Mol Dynam Nepal, Kathmandu, Nepal.	s.dixit@cmdn.org	Karmacharya, Dibesh/GVU-4782-2022; RAI, APURVA/GRX-4998-2022; Dixit, Sameer/AAF-6289-2020	KC, Prawchan/0000-0001-9519-8184; Karmacharya, Dibesh/0000-0001-5093-6737; Shakya, Jivan/0000-0001-9469-2148	Nepali-German Project "HIV prevention for the high-risk group of injecting drug users"	Nepali-German Project "HIV prevention for the high-risk group of injecting drug users"	This work was supported by Nepali-German Project "HIV prevention for the high-risk group of injecting drug users" and commissioned by the German Federal Ministry of Economic Cooperation and Development (BMZ). The analysis, results and recommendations in this paper represent the opinion of the authors and are not necessarily representative of the position of the Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH (www.giz.de; www.mohp.gov.np). No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behal Rachna, 2008, Arq. Gastroenterol., V45, P137, DOI 10.1590/S0004-28032008000200009; Chander Anil, 2003, Journal of Communicable Diseases, V35, P188; Csete J., 2008, VIRAL TIME BOMB HLTH; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; Firdaus R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099126; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Gibson A, 2011, ADDICTION, V106, P2186, DOI 10.1111/j.1360-0443.2011.03575.x; Government of Nepal Central Bureau of Statistics, 2014, SURV REP CURR HARD D; Government of Nepal National Center for AIDS and STD Control, 2012, NAT EST HIV INF NEP; Grebely J, 2011, J VIRAL HEPATITIS, V18, P32, DOI 10.1111/j.1365-2893.2010.01279.x; Guo XY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-123; Hayes CN, 2011, GUT, V60, P261, DOI 10.1136/gut.2010.223495; Jia ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045698; Jimenez-Sousa MA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-6; Karki S, 2008, Kathmandu Univ Med J (KUMJ), V6, P491; Karki S, 2008, JPN J INFECT DIS, V61, P324; Kawaoka T, 2011, J HEPATOL, V54, P408, DOI 10.1016/j.jhep.2010.07.032; Khamduang W, 2013, CLIN INFECT DIS, V56, P1704, DOI 10.1093/cid/cit166; Kong F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/527030; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Marcellin P, 2013, 64 ANN M AM ASS STUD; Mauss S, 2013, SHORT GUIDE HEPATITI; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; NCASC and ASHA Project, 2011, INT BIOL BEH SURV IB; Ojha SP, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-17; Rai S K, 1994, Kansenshogaku Zasshi, V68, P1492; Sawayama Y, 1999, J Epidemiol, V9, P350; Shrestha AC, 2009, J INFECT DEV COUNTR, V3, P794, DOI 10.3855/jidc.311; Shrestha I L, 2003, Kathmandu Univ Med J (KUMJ), V1, P101; Shrestha S M, 1996, Trop Gastroenterol, V17, P212; Shrestha S M, 1998, Trop Gastroenterol, V19, P102; Shrestha Santosh Man, 2012, Trop Gastroenterol, V33, P95; Sinn DH, 2011, J GASTROEN HEPATOL, V26, P1374, DOI 10.1111/j.1440-1746.2011.06744.x; Sivaprasad S, 2012, J CLIN EXP HEPATOL, V2, P112, DOI 10.1016/S0973-6883(12)60098-X; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Tiwari B R, 2010, Asian J Transfus Sci, V4, P91, DOI 10.4103/0973-6247.67026; United Nations Office on Drugs & Crime (UNODC), 2011, PROF DRUG US PATT RI; Verma S, 2006, CLIN INFECT DIS, V42, P262, DOI 10.1086/499055; Vogel M, 2009, CURR OPIN HIV AIDS, V4, P171, DOI 10.1097/COH.0b013e328329c602; WHO, 2014, GUID SCREEN CAR TREA; World Health Organization, 2011, GLOB HLTH OBS DAT RE; Wu LS, 2012, EXP THER MED, V3, P200, DOI 10.3892/etm.2011.385; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976	46	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134455	10.1371/journal.pone.0134455	http://dx.doi.org/10.1371/journal.pone.0134455			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263394	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300028
J	Kogure, Y; Saka, H; Oki, M; Saito, TI; Ahmed, SNM; Kitagawa, C; Imaizumi, K				Kogure, Yoshihito; Saka, Hideo; Oki, Masahide; Saito, Toshiki I.; Ahmed, Shimaa Nour Moursi; Kitagawa, Chiyoe; Imaizumi, Kazuyoshi			Post-Progression Survival after EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; FACTOR RECEPTOR MUTATIONS; 1ST-LINE TREATMENT; GEFITINIB THERAPY; OPEN-LABEL; CHEMOTHERAPY; ERLOTINIB; METASTASES; MULTICENTER; PACLITAXEL	Background Non-small cell lung cancer (NSCLC) patients that harbor epidermal growth factor receptor (EGFR) mutations benefit from receiving an EGFR-tyrosine kinase inhibitor (TKI); however, post-progression survival (PPS) after EGFR-TKI treatment has not been sufficiently studied. Methods We retrospectively reviewed the clinical data from stage IV or recurrent NSCLC patients who harbored EGFR mutations and who received EGFR-TKI as their first-line treatment in our institute between 2009 and 2011. Results In total, 36 patients received EGFR-TKI treatment as their first-line therapy. Of those 36 patients, 30 experienced recurrence and were enrolled in this study. The median progression- free survival (PFS) of these patients was 8.2 months. Twelve patients received EGFR-TKI treatment beyond the diagnosis of progressive disease (PD), and 8 received second-line therapy. The PPS after EGFR-TKI treatment was 9.1 months, and survival after the termination of EGFR-TKI treatment in those patients treated with second-line chemotherapy was 13.9 months. The site of relapse was investigated and PFS in EGFR-TKI-treated patients with relapse in the brain (11.6 months) showed a trend toward a longer PFS compared with patients with relapse at other sites (8.2 months). The median PPS after EGFR-TKI treatment also showed the same trend in each group (12.9 and 9.2 months, respectively). Conclusions The PPS after EGFR-TKI treatment failure was 9.1 months, while the survival of patients who underwent second-line chemotherapy after the termination of EGFR-TKI treatment was 13.9 months, comparable with the overall survival of EGFR mutation-negative patients, as previously reported. The prognosis of these NSCLC patients with EGFR mutations varied according to the sites of recurrence after first-line EGFR-TKI treatment. Of particular note was the prognosis of patients with brain metastases, which tended to be better than that of patients with metastases to other sites.	[Kogure, Yoshihito; Saka, Hideo; Oki, Masahide; Ahmed, Shimaa Nour Moursi; Kitagawa, Chiyoe] Natl Hosp Org, Nagoya Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan; [Saito, Toshiki I.] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Imaizumi, Kazuyoshi] Fujita Hlth Univ, Sch Med, Dept Resp Med, Toyoake, Aichi 47011, Japan	Nagoya Medical Center; Nagoya Medical Center; Fujita Health University	Kogure, Y (corresponding author), Natl Hosp Org, Nagoya Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan.	yo-kogure@umin.ac.jp	Kogure, Yoshihito/ABA-1172-2020	Kogure, Yoshihito/0000-0001-7935-7202				Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Conforti F, 2013, LUNG CANCER, V81, P440, DOI 10.1016/j.lungcan.2013.05.019; Grommes C, 2011, NEURO-ONCOLOGY, V13, P1364, DOI 10.1093/neuonc/nor121; Heon S, 2012, CLIN CANCER RES, V18, P4406, DOI 10.1158/1078-0432.CCR-12-0357; Heon S, 2010, CLIN CANCER RES, V16, P5873, DOI 10.1158/1078-0432.CCR-10-1588; Jackman DM, 2006, J CLIN ONCOL, V24, P4517, DOI 10.1200/JCO.2006.06.6126; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nishie K, 2012, J THORAC ONCOL, V7, P1722, DOI 10.1097/JTO.0b013e31826913f7; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; Okamoto I, 2010, J CLIN ONCOL, V28, P5240, DOI 10.1200/JCO.2010.31.0326; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Watanabe S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-1; Wu YL, 2007, J THORAC ONCOL, V2, P430, DOI 10.1097/01.JTO.0000268677.87496.4c; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	18	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135393	10.1371/journal.pone.0135393	http://dx.doi.org/10.1371/journal.pone.0135393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262682	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300080
J	Salama, R; Masson, N; Simpson, P; Sciesielski, LK; Sun, M; Tian, YM; Ratcliffe, PJ; Mole, DR				Salama, Rafik; Masson, Norma; Simpson, Peter; Sciesielski, Lina Katrin; Sun, Min; Tian, Ya-Min; Ratcliffe, Peter John; Mole, David Robert			Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OPEN-ACCESS DATABASE; INDUCIBLE FACTOR-1; DNA-BINDING; HIF; HIF-2-ALPHA; EXPRESSION; HIF1-ALPHA; REVEALS; ALPHA	General activation of hypoxia-inducible factor (HIF) pathways is classically associated with adverse prognosis in cancer and has been proposed to contribute to oncogenic drive. In clear cell renal carcinoma (CCRC) HIF pathways are upregulated by inactivation of the von-Hippel-Lindau tumor suppressor. However HIF-1 alpha and HIF-2 alpha have contrasting effects on experimental tumor progression. To better understand this paradox we examined pan-genomic patterns of HIF DNA binding and associated gene expression in response to manipulation of HIF-1 alpha and HIF-2 alpha and related the findings to CCRC prognosis. Our findings reveal distinct pan-genomic organization of canonical and non-canonical HIF isoform-specific DNA binding at thousands of sites. Overall associations were observed between HIF-1 alpha-specific binding, and genes associated with favorable prognosis and between HIF-2 alpha-specific binding and adverse prognosis. However within each isoform-specific set, individual gene associations were heterogeneous in sign and magnitude, suggesting that activation of each HIF-alpha isoform contributes a highly complex mix of pro- and anti-tumorigenic effects.	[Salama, Rafik; Masson, Norma; Simpson, Peter; Sciesielski, Lina Katrin; Sun, Min; Tian, Ya-Min; Ratcliffe, Peter John; Mole, David Robert] Univ Oxford, Nuffield Dept Med, Oxford, England	University of Oxford	Ratcliffe, PJ (corresponding author), Univ Oxford, Nuffield Dept Med, Henry Wellcome Bldg Mol Physiol, Oxford, England.	pjr@well.ox.ac.uk; drmole@well.ox.ac.uk	Sciesielski, Lina/G-3716-2017	Sciesielski, Lina/0000-0003-3458-0309; Ratcliffe, Peter/0000-0002-2853-806X; Mole, David/0000-0002-0984-300X; Salama, Rafik/0000-0001-5549-7796	Cancer Research UK [A16016]; Ludwig Institute for Cancer Research; Higher Education Funding Council for England; Wellcome Trust [078333/Z/05/Z, WT091857MA]; German Research Foundation [SC132/2-1]; Cancer Research UK [16016] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Ludwig Institute for Cancer Research; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Wellcome Trust(Wellcome TrustEuropean Commission); German Research Foundation(German Research Foundation (DFG)); Cancer Research UK(Cancer Research UK)	This work was supported by a Cancer Research UK (grant number A16016) to RS, NM and DRM, the Ludwig Institute for Cancer Research to PJR and MS, the Higher Education Funding Council for England to DRM, the Wellcome Trust (grant numbers 078333/Z/05/Z, WT091857MA) to PJR, YMT and PS, and the German Research Foundation (grant number SC132/2-1) to LKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Choudhry H, 2014, EMBO REP, V15, P70, DOI 10.1002/embr.201337642; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hower V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-15; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kanno T, 2012, ONCOGENE, V31, P3098, DOI 10.1038/onc.2011.475; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Laderoute KR, 2005, SEMIN CELL DEV BIOL, V16, P502, DOI 10.1016/j.semcdb.2005.03.005; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Ratcliffe PJ, 2013, J PHYSIOL-LONDON, V591, P2027, DOI 10.1113/jphysiol.2013.251470; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Schodel J, 2013, BIOL CHEM, V394, P507, DOI 10.1515/hsz-2012-0351; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanimoto Kousuke, 2010, Hugo J, V4, P35, DOI 10.1007/s11568-011-9150-9; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Xiao YF, 2014, BIOINFORMATICS, V30, P801, DOI 10.1093/bioinformatics/btr671; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	49	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134645	10.1371/journal.pone.0134645	http://dx.doi.org/10.1371/journal.pone.0134645			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262842	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300033
J	van Bijnen, EME; Paget, J; de Lange-de Klerk, ESM; den Heijer, CDJ; Versporten, A; Stobberingh, EE; Goossens, H; Schellevis, FG				van Bijnen, Evelien M. E.; Paget, John; de lange-de Klerk, Elly S. M.; den Heijer, Casper D. J.; Versporten, Ann; Stobberingh, Ellen E.; Goossens, Herman; Schellevis, Francois G.		APRES Study Team	Antibiotic Exposure and Other Risk Factors for Antimicrobial Resistance in Nasal Commensal Staphylococcus aureus: An Ecological Study in 8 European Countries	PLOS ONE			English	Article							ACQUIRED METHICILLIN-RESISTANT; PRIMARY-CARE; SKIN INFECTIONS; COMMUNITY; PREVALENCE; MRSA; COLONIZATION; EPIDEMIOLOGY; APPROPRIATENESS; METAANALYSIS	Objectives Antimicrobial resistance (AMR) has become a global public health concern which threatens the effective treatment of bacterial infections. Resistant Staphylococcus aureus (including MRSA) increasingly appears in individuals with no healthcare associated risks. Our study assessed risk factors for nasal carriage of resistant S. aureus in a multinational, healthy, community-based population, including ecological exposure to antibiotics. Methods Data were collected in eight European countries (Austria, Belgium, Croatia, France, Hungary, the Netherlands, Spain and Sweden). Commensal AMR patterns were assessed by collecting 28,929 nasal swabs from healthy persons (aged 4+). Ecological exposure to antibiotics was operationalized as systemic antibiotic treatment patterns, extracted from electronic medical records of primary care practices in which the participants were listed (10-27 per country). A multilevel analysis related AMR in nasal commensal S. aureus to antibiotic exposure and other risk factors (e.g. age and profession). Results Of the 6,093 S. aureus isolates, 77% showed resistance to at least one antibiotic. 7.1% exhibited multidrug resistance (defined as resistance to 3 or more antibiotic classes), and we found 78 cases MRSA (1.3%). A large variation in antibiotic exposure was found between and within countries. Younger age and a higher proportion of penicillin prescriptions in a practice were associated with higher odds for carriage of a resistant S. aureus. Also, we found higher multidrug resistance rates in participants working in healthcare or nurseries. Conclusions This study indicates that in a population with no recent antibiotic use, the prescription behavior of the general practitioner affects the odds for carriage of a resistant S. aureus, highlighting the need for cautious prescribing in primary care. Finally, since variation in AMR could partly be explained on a national level, policy initiatives to decrease AMR should be encouraged at the national level within Europe.	[van Bijnen, Evelien M. E.; Paget, John; Schellevis, Francois G.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [de lange-de Klerk, Elly S. M.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [den Heijer, Casper D. J.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Sch Publ Hlth & Primary Care CAPHRI, Maastricht, Netherlands; [Versporten, Ann; Stobberingh, Ellen E.; Goossens, Herman] Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Med Microbiol, B-2020 Antwerp, Belgium; [Schellevis, Francois G.] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice & Elderly Care Med, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam; Maastricht University; University of Antwerp; Vrije Universiteit Amsterdam	van Bijnen, EME (corresponding author), Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands.	emevanbijnen@gmail.com	Coenen, Samuel JA/A-6410-2011; Kolozsvari, L. R./G-7730-2017; /AAI-2589-2019	Coenen, Samuel JA/0000-0002-1238-8052; Kolozsvari, L. R./0000-0001-9426-0898; Adriaenssens, Niels/0000-0002-7957-1177	European Commission - DG Research, under their 7th Framework Program [223083]	European Commission - DG Research, under their 7th Framework Program	This study was funded by the European Commission - DG Research, under their 7th Framework Program (Grant Agreement number 223083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; [Anonymous], 2010, ANT ANT RES; Beardsley JR, 2006, CHEST, V130, P787, DOI 10.1378/chest.130.3.787; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Carleton HA, 2004, J INFECT DIS, V190, P1730, DOI 10.1086/425019; Carrie AG, 1999, DRUGS, V57, P871, DOI 10.2165/00003495-199957060-00004; Catry B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089579; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Communication from the Commission to the European Parliament and the Council, ACT PLAN RIS THREATS; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P1433, DOI 10.1086/375081; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Lastours V, 2010, ANTIMICROB AGENTS CH, V54, P5193, DOI 10.1128/AAC.00823-10; den Heijer CDJ, 2013, LANCET INFECT DIS, V13, P409, DOI 10.1016/S1473-3099(13)70036-7; EUCAST, 2000, CLIN MICROBIOL INFEC, V6, P570; European Academies Science Advisory Counsil (EASAC), 2007, TACKL ANT RES; European Centre for Disease Prevention and Control (ECDC), 2014, ANT RES SURV EUR 201; European Commission, STAFF WORK PAP SERV; Fritz SA, 2008, PEDIATRICS, V121, P1090, DOI 10.1542/peds.2007-2104; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Graffunder EM, 2002, J ANTIMICROB CHEMOTH, V49, P999, DOI 10.1093/jac/dkf009; Guidos RJ, 2011, CLIN INFECT DIS, V52, pS397, DOI 10.1093/cid/cir153; Hammerum AM, 2007, EMERG INFECT DIS, V13, P1632, DOI 10.3201/eid1311.070421; Hay AD, 2005, J ANTIMICROB CHEMOTH, V56, P146, DOI 10.1093/jac/dki181; Hidron AI, 2005, CLIN INFECT DIS, V41, P159, DOI 10.1086/430910; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V52, P128, DOI 10.1093/jac/dkg280; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Kristinsson KG, 1997, MICROB DRUG RESIST, V3, P117, DOI 10.1089/mdr.1997.3.117; Lloyd DH, 2010, SCHWEIZ ARCH TIERH, V152, P131, DOI 10.1024/0036-7281/a000031; May L, 2011, TRAVEL MED INFECT DI, V9, P213, DOI 10.1016/j.tmaid.2011.06.001; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Miller LG, 2012, CLIN INFECT DIS, V54, P1523, DOI 10.1093/cid/cis213; Miller LG, 2009, INFECT DIS CLIN N AM, V23, P35, DOI 10.1016/j.idc.2008.10.002; Miller MB, 2011, J CLIN MICROBIOL, V49, P1041, DOI 10.1128/JCM.02235-10; MOLSTAD S, 2008, EUROSURVEILL, V13; Nys S, 2005, INT J ANTIMICROB AG, V26, P133, DOI 10.1016/j.ijantimicag.2005.04.010; Prins J. M., 2008, Eurosurveillance, V13, P19037; Ray GT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-252; Salgado CD, 2003, CLIN INFECT DIS, V36, P131, DOI 10.1086/345436; Sommer MOA, 2010, VIRULENCE, V1, P299, DOI 10.4161/viru.1.4.12010; van Bijnen EME, 2014, EUR J GEN PRACT, V20, P294, DOI 10.3109/13814788.2013.872621; van Bijnen EME, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-293; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; World Health Organization, 2014, ANT RES GLOB REP SUR; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	45	38	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135094	10.1371/journal.pone.0135094	http://dx.doi.org/10.1371/journal.pone.0135094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262679	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300056
J	Wang, SK; Jin, BS; Qin, HM; Sheng, Q; Wu, JH				Wang, Sikai; Jin, Binsong; Qin, Haiming; Sheng, Qiang; Wu, Jihua			Trophic Dynamics of Filter Feeding Bivalves in the Yangtze Estuarine Intertidal Marsh: Stable Isotope and Fatty Acid Analyses	PLOS ONE			English	Article							ORGANIC-MATTER; FOOD SOURCES; PLACOPECTEN-MAGELLANICUS; SPARTINA-ALTERNIFLORA; SEASONAL VARIABILITY; SPATIAL VARIABILITY; CERASTODERMA-EDULE; TEMPORAL-CHANGES; MACOMA-BALTHICA; SALT MARSHES	Benthic bivalves are important links between primary production and consumers, and are essential intermediates in the flow of energy through estuarine systems. However, information on the diet of filter feeding bivalves in estuarine ecosystems is uncertain, as estuarine waters contain particulate matter from a range of sources and as bivalves are opportunistic feeders. We surveyed bivalves at different distances from the creek mouth at the Yangtze estuarine marsh in winter and summer, and analyzed trophic dynamics using stable isotope (SI) and fatty acid (FA) techniques. Different bivalve species had different spatial distributions in the estuary. Giauconome chinensis mainly occurred in marshes near the creek mouth, while Sinonovacula constricta preferred the creek. Differences were found in the diets of different species. S. constricta consumed more diatoms and bacteria than G. chinensis, while G. chinensis assimilated more macrophyte material. FA markers showed that plants contributed the most (38.86 +/- 4.25%) to particular organic matter (POM) in summer, while diatoms contributed the most (12.68 +/- 1.17%) during winter. Diatoms made the largest contribution to the diet of S. constricta in both summer (24.73 +/- 0.44%) and winter (25.51 +/- 0.59%), and plants contributed no more than 4%. This inconsistency indicates seasonal changes in food availability and the active feeding habits of the bivalve. Similar FA profiles for S. constricta indicated that the bivalve had a similar diet composition at different sites, while different delta C-13 results suggested the diet was derived from different carbon sources (C-4 plant Spartina alterniflora and C-3 plant Phragmites australis and Scirpus mariqueter) at different sites. Species-specific and temporal and/or spatial variability in bivalve feeding may affect their ecological functions in intertidal marshes, which should be considered in the study of food webs and material flows in estuarine ecosystems.	[Wang, Sikai; Sheng, Qiang; Wu, Jihua] Fudan Univ, Coastal Ecosyst Res Stn Yangtze River Estuary, Minist Educ, Key Lab Biodivers Sci & Ecol Engn,Sch Life Sci, Shanghai 200438, Peoples R China; [Jin, Binsong; Qin, Haiming] Nanchang Univ, Ctr Watershed Ecol, Inst Life Sci, Nanchang 330031, Peoples R China	Fudan University; Nanchang University	Wu, JH (corresponding author), Fudan Univ, Coastal Ecosyst Res Stn Yangtze River Estuary, Minist Educ, Key Lab Biodivers Sci & Ecol Engn,Sch Life Sci, Shanghai 200438, Peoples R China.	jihuawu@fudan.edu.cn	Sheng, Qiang/AAG-2548-2019	Sheng, Qiang/0000-0002-7385-0407; Wu, Jihua/0000-0001-8623-8519	National Science and Technology Ministry [2013CB430404]; NSFC fund [41371258]; Science and Technology Department of Shanghai [13231203503]	National Science and Technology Ministry; NSFC fund(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Shanghai	This study was financially supported by National Science and Technology Ministry (2013CB430404), NSFC fund (41371258) and Science and Technology Department of Shanghai (13231203503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RR, 1993, PALAIOS, V8, P289, DOI 10.2307/3515151; Alfaro AC, 2006, ESTUAR COAST SHELF S, V70, P271, DOI 10.1016/j.ecss.2006.06.017; Allan EL, 2010, ESTUAR COAST SHELF S, V87, P463, DOI 10.1016/j.ecss.2010.02.004; Allen JRL, 2000, QUATERNARY SCI REV, V19, P1155, DOI 10.1016/S0277-3791(99)00034-7; Bachok Z, 2009, AQUAT ECOSYST HEALTH, V12, P390, DOI 10.1080/14634980903347589; Bacon GS, 1998, J EXP MAR BIOL ECOL, V219, P105, DOI 10.1016/S0022-0981(97)00177-9; Bartoli M, 2001, HYDROBIOLOGIA, V455, P203, DOI 10.1023/A:1011910422400; Belicka LL, 2012, MAR FRESHWATER RES, V63, P1085, DOI 10.1071/MF12027; BENNER R, 1987, NATURE, V329, P708, DOI 10.1038/329708a0; Bergamino L, 2014, HYDROBIOLOGIA, V732, P133, DOI 10.1007/s10750-014-1853-1; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; BREWER D, 1985, J MOLLUS STUD, V51, P350; Budge SM, 1998, ORG GEOCHEM, V29, P1547, DOI 10.1016/S0146-6380(98)00177-6; Budge SM, 2007, MAR ECOL PROG SER, V336, P305, DOI 10.3354/meps336305; Buhadi YAESM, 2013, PAC SCI, V67, P539, DOI 10.2984/67.4.5; Cai RX, 1991, FAUNA OF ZHEJIANG MO; Callaway R, 2013, J APPL ECOL, V50, P1050, DOI 10.1111/1365-2664.12114; Cattrijsse A, 2006, MAR ECOL PROG SER, V324, P293, DOI 10.3354/meps324293; Chen JinSong, 2003, Chinese Rural Economy, P4; Chen ZB, 2009, ESTUAR COAST SHELF S, V82, P265, DOI 10.1016/j.ecss.2009.01.014; Cheng XL, 2006, SOIL BIOL BIOCHEM, V38, P3380, DOI 10.1016/j.soilbio.2006.05.016; Choi CY, 2014, WETLANDS, V34, P1085, DOI 10.1007/s13157-014-0568-4; Choi KH, 2010, J OCEANOGR, V66, P307, DOI 10.1007/s10872-010-0027-7; Coelho H, 2011, ESTUAR COAST SHELF S, V92, P181, DOI 10.1016/j.ecss.2011.01.005; CURRIN CA, 1995, MAR ECOL PROG SER, V121, P99, DOI 10.3354/meps121099; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Deegan LA, 1997, MAR ECOL PROG SER, V147, P31, DOI 10.3354/meps147031; Doi H, 2005, ESTUAR COAST SHELF S, V64, P316, DOI 10.1016/j.ecss.2005.02.028; Dubois S, 2014, J SEA RES, V88, P87, DOI 10.1016/j.seares.2014.01.004; Falk-Petersen S, 2002, MAR ECOL PROG SER, V227, P187, DOI 10.3354/meps227187; Faye D, 2011, ESTUAR COAST SHELF S, V92, P607, DOI 10.1016/j.ecss.2011.02.017; FRY B, 1984, CONTRIB MAR SCI, V27, P13; GERRITSEN J, 1994, ESTUARIES, V17, P403, DOI 10.2307/1352673; Grant J, 1997, J MAR RES, V55, P965, DOI 10.1357/0022240973224193; HARVEY HR, 1994, DEEP-SEA RES PT II, V41, P783, DOI 10.1016/0967-0645(94)90048-5; Hill JM, 2008, MAR BIOL, V154, P899, DOI 10.1007/s00227-008-0983-2; [黄华梅 HUANG Huamei], 2005, [生态学报, Acta Ecologica Sinica], V25, P2686; HUMMEL H, 1985, NETH J SEA RES, V19, P84, DOI 10.1016/0077-7579(85)90045-6; Irisarri J, 2014, COMP BIOCHEM PHYS B, V172, P105, DOI 10.1016/j.cbpb.2014.04.006; Jin BS, 2010, ESTUAR COAST SHELF S, V88, P419, DOI 10.1016/j.ecss.2010.04.023; Jorgensen CB, 1996, MAR ECOL PROG SER, V142, P287, DOI 10.3354/meps142287; Kanaya G, 2005, MAR ECOL PROG SER, V299, P67, DOI 10.3354/meps299067; Kang CK, 1999, MAR ECOL PROG SER, V187, P147, DOI 10.3354/meps187147; Karlsson O, 2003, MAR ECOL PROG SER, V261, P161, DOI 10.3354/meps261161; Kasai A, 2005, FISHERIES SCI, V71, P151, DOI 10.1111/j.1444-2906.2005.00942.x; Kasai A, 2004, FISHERIES SCI, V70, P11, DOI 10.1111/j.1444-2906.2003.00764.x; Kelly JR, 2012, MAR ECOL PROG SER, V446, P1, DOI 10.3354/meps09559; Kendrick AJ, 2015, MAR FRESHWATER RES, V66, P41, DOI 10.1071/MF13209; Lebreton B, 2011, ESTUAR COAST SHELF S, V92, P140, DOI 10.1016/j.ecss.2010.12.027; LOOSANOFF VL, 1949, SCIENCE, V110, P122, DOI 10.1126/science.110.2848.122; Lowe AT, 2014, OIKOS, V123, P1341, DOI 10.1111/oik.01392; Maloy AP, 2009, MAR ECOL PROG SER, V381, P109, DOI 10.3354/meps07959; Mattos G, 2012, HELGOLAND MAR RES, V66, P393, DOI 10.1007/s10152-011-0280-1; Mettam C, 2014, PALAEOGEOGR PALAEOCL, V399, P187, DOI 10.1016/j.palaeo.2014.01.010; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; MORTON B, 1984, J ZOOL, V202, P299, DOI 10.1111/j.1469-7998.1984.tb05085.x; Olin JA, 2013, MAR ECOL PROG SER, V487, P55, DOI 10.3354/meps10402; Page HM, 2003, MAR BIOL, V143, P519, DOI 10.1007/s00227-003-1102-z; PAGE HM, 1992, J EXP MAR BIOL ECOL, V157, P247, DOI 10.1016/0022-0981(92)90165-7; Parrish CC, 2000, HANDB ENVIRON CHEM, V5, P193; PETERSON BJ, 1987, LIMNOL OCEANOGR, V32, P1195, DOI 10.4319/lo.1987.32.6.1195; PETERSON CH, 1994, OECOLOGIA, V100, P256, DOI 10.1007/BF00316953; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Prins T.C., 1998, AQUAT ECOL, V31, P349, DOI DOI 10.1023/A:1009924624259; Riera P, 1996, ESTUAR COAST SHELF S, V42, P347, DOI 10.1006/ecss.1996.0023; Rooker JR, 2006, MAR ECOL PROG SER, V313, P249, DOI 10.3354/meps313249; Ryba SA, 2002, CHEMOSPHERE, V48, P139, DOI 10.1016/S0045-6535(02)00027-9; Safi KA, 2007, J EXP MAR BIOL ECOL, V344, P136, DOI 10.1016/j.jembe.2006.12.023; Saraiva S, 2011, ECOL MODEL, V222, P514, DOI 10.1016/j.ecolmodel.2010.09.031; Savina M, 2008, J MARINE SYST, V70, P63, DOI 10.1016/j.jmarsys.2007.03.001; Sousa R, 2008, ESTUAR COAST, V31, P1198, DOI 10.1007/s12237-008-9090-3; SWANBERG IL, 1991, J EXP MAR BIOL ECOL, V151, P93, DOI 10.1016/0022-0981(91)90018-R; Turner TF, 2010, ECOLOGY, V91, P2227, DOI 10.1890/09-1454.1; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Volkman JK, 1998, ORG GEOCHEM, V29, P1163, DOI 10.1016/S0146-6380(98)00062-X; Wang SW, 2015, MAR ECOL PROG SER, V518, P31, DOI 10.3354/meps11076; Wang WX, 1997, MAR ECOL PROG SER, V148, P71, DOI 10.3354/meps148071; Ward JE, 2004, J EXP MAR BIOL ECOL, V300, P83, DOI 10.1016/j.jembe.2004.03.002; Ward JE, 1998, MAR BIOL, V131, P283, DOI 10.1007/s002270050321; Yamanaka T, 2013, ESTUAR COAST SHELF S, V126, P87, DOI 10.1016/j.ecss.2013.04.011; Yokoyama H, 2005, MAR ECOL PROG SER, V296, P115, DOI 10.3354/meps296115; Ysebaert T, 2005, HYDROBIOLOGIA, V540, P197, DOI 10.1007/s10750-004-7144-5	82	8	8	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135604	10.1371/journal.pone.0135604	http://dx.doi.org/10.1371/journal.pone.0135604			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26261984	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300095
J	Okango, E; Mwambi, H; Ngesa, O; Achia, T				Okango, Elphas; Mwambi, Henry; Ngesa, Oscar; Achia, Thomas			Semi-Parametric Spatial Joint Modeling of HIV and HSV-2 among Women in Kenya	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; VIRUS; RISK	Several diseases have common risk factors. The joint modeling of disease outcomes within a spatial statistical context may provide more insight on the interaction of diseases both at individual and at regional level. Spatial joint modeling allows for studying of the relationship between diseases and also between regions under study. One major approach for joint spatial modeling is the multivariate conditional autoregressive approach. In this approach, it is assumed that all the covariates in the study have linear effects on the multiple response variables. In this study, we relax this linearity assumption and allow some covariates to have nonlinear effects using the penalized regression splines. This model was used to jointly model the spatial variation of human immunodeficiency virus (HIV) and herpes simplex virus-type 2 (HSV-2) among women in Kenya. The model was applied to HIV and HSV-2 prevalence data among women aged 15-49 years in Kenya, derived from the 2007 Kenya AIDS indicator survey. A full Bayesian approach was used and the models were implemented in WinBUGS software. Both diseases showed significant spatial variation with highest disease burdens occurring around the Lake Victoria region. There was a nonlinear association between age of an individual and HIV and HSV-2 infection. The peak age for HIV was around 30 years while that of HSV-2 was about 40 years. A positive significant spatial correlation between HIV and HSV-2 was observed with a correlation of 0.6831(95% CI: 0.3859, 0.871).	[Okango, Elphas; Mwambi, Henry; Ngesa, Oscar] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, ZA-3201 Pietermaritzburg, South Africa; [Achia, Thomas] Univ Witwatersrand, Sch Publ Hlth, Div Epidemiol & Biostat, ZA-2193 Parktown, South Africa; [Ngesa, Oscar] Taita Taveta Univ Coll, Dept Math & Informat, Voi, Kenya	University of Kwazulu Natal; University of Witwatersrand	Okango, E (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Private Bag X01, ZA-3201 Pietermaritzburg, South Africa.	kangphas@gmail.com	Achia, Thomas N. O./I-3674-2013	Achia, Thomas N. O./0000-0002-0700-9468	University of Kwazulu-Natal	University of Kwazulu-Natal	The authors would like to thank the University of Kwazulu-Natal for funding the work through EO's PHD work.	Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; [Anonymous], 1993, NONPARAMETRIC REGRES; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Burgoyne Amy D, 2008, Afr J Reprod Health, V12, P14; Carlin BP, 2003, BAYESIAN STATISTICS 7, P45; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; DiMatteo I, 2001, BIOMETRIKA, V88, P1055, DOI 10.1093/biomet/88.4.1055; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Fahrmeir L., 2001, MULTIVARIATE STAT MO, P69; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Ghebremichael M, 2009, SEX TRANSM DIS, V36, P570, DOI 10.1097/OLQ.0b013e3181a866b8; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Johnson K, 2006, JAIDS-J ACQ IMM DEF, V42, P627, DOI 10.1097/01.qai.0000225870.87456.ae; Kammann EE, 2003, J R STAT SOC C-APPL, V52, P1, DOI 10.1111/1467-9876.00385; Kazembe LN, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-6; Kleinschmidt I, 2007, AM J TROP MED HYG, V77, P1163, DOI 10.4269/ajtmh.2007.77.1163; Knorr-Held L, 2001, J R STAT SOC A STAT, V164, P73, DOI 10.1111/1467-985X.00187; Langford IH, 1999, J R STAT SOC C-APPL, V48, P253, DOI 10.1111/1467-9876.00153; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Lucas AM, 2012, AM ECON J-APPL ECON, V4, P226, DOI 10.1257/app.4.4.226; Manda SOM, 2007, S AFR STAT J, V41, P1; MARDIA KV, 1988, J MULTIVARIATE ANAL, V24, P265, DOI 10.1016/0047-259X(88)90040-1; Mishra V, 2007, DEMOGRAPHIC HLTH RES; NASCOP, 2012, MIN HLTH KEN KEN AID; NASCOP, 2007, MIN HLTH KEN KEN AID; Ngesa O, 2014, PLOS ONE, V9; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spiegelhalter TD, 2007, WINBUGS USER MANUAL; UNAIDS, 2013, REP GLOB AIDS EP; Wand H, 2001, INT J HEALTH GEOGR, V10, P1; Weiss H, 2004, HERPES S, V11, p24A; WHO, 2014, REP GLOB HLTH OBS DA; WHO, 2013, REP SEX TRANSM INF S	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135212	10.1371/journal.pone.0135212	http://dx.doi.org/10.1371/journal.pone.0135212			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258939	Green Published, Green Submitted, gold			2022-12-27	WOS:000359352600047
J	Ng, PC; Chan, KYY; Leung, KT; Tam, YH; Ma, TPY; Lam, HS; Cheung, HM; Lee, KH; To, KF; Li, KR				Ng, Pak Cheung; Chan, Kathy Yuen Yee; Leung, Kam Tong; Tam, Yuk Him; Ma, Terence Ping Yuen; Lam, Hugh Simon; Cheung, Hon Ming; Lee, Kim Hung; To, Ka Fai; Li, Karen			Comparative MiRNA Expressional Profiles and Molecular Networks in Human Small Bowel Tissues of Necrotizing Enterocolitis and Spontaneous Intestinal Perforation	PLOS ONE			English	Article							MICRORNAS; DISEASE; COLITIS; TARGETS	Background Necrotizing enterocolitis (NEC) and spontaneous intestinal perforation (SIP) are acute intestinal conditions which could result in mortality and severe morbidity in preterm infants. Our objective was to identify dysregulated micro-RNAs (miRNAs) in small bowel tissues of NEC and SIP, and their possible roles in disease pathophysiology. Methods We performed differential miRNA arrays on tissues of NEC (n = 4), SIP (n = 4) and surgical-control (Surg-CTL; n = 4), and validated target miRNAs by qPCR (n = 10 each group). The association of target miRNAs with 52 dysregulated mRNAs was investigated by bioinformatics on functional and base-pair sequence algorithms, and correlation in same tissue samples. Results We presented the first miRNA profiles of NEC, SIP and Surg-CTL intestinal tissues in preterm infants. Of 28 validated miRNAs, 21 were significantly different between NEC or SIP and Surg-CTL. Limited overlapping in the aberrant expression of miRNAs between NEC and SIP indicated their distinct molecular mechanisms. A proposed network of dysregulated miRNA/mRNA pairs in NEC suggested interaction at bacterial receptor TLR4 (miR-31, miR-451, miR-203, miR-4793-3p), mediated via key transcription factors NFKB2 (miR-203), AP1/FOSL1 (miR-194-3p), FOXA1 (miR-21-3p, miR-431 and miR-1290) and HIF1A (miR-31),and extended downstream to pathways of angiogenesis, arginine metabolism, cell adhesion and chemotaxis, extracellular matrix remodeling, hypoxia/oxidative stress, inflammation and muscle contraction. In contrast, upregulation of miR-451 and miR-223 in SIP suggested modulation of G-protein-mediated muscle contraction. Conclusions The robust response of miRNA dysregulation in NEC and SIP, and concerted involvement of specific miRNAs in the molecular networks indicated their crucial roles in mucosa integrity and disease pathophysiology.	[Ng, Pak Cheung; Chan, Kathy Yuen Yee; Leung, Kam Tong; Ma, Terence Ping Yuen; Lam, Hugh Simon; Cheung, Hon Ming; Li, Karen] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Shatin, Hong Kong, Peoples R China; [Tam, Yuk Him; Lee, Kim Hung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China; [To, Ka Fai] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Ng, PC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Shatin, Hong Kong, Peoples R China.	pakcheungng@cuhk.edu.hk	Lam, Hugh Simon/G-8373-2015; Chan, Kathy/AAE-8538-2021; Leung, Kam Tong/I-8569-2017	Lam, Hugh Simon/0000-0001-9912-0544; Chan, Kathy/0000-0002-6501-9592; Leung, Kam Tong/0000-0002-7695-2513	charity organization Providence Foundation Limited	charity organization Providence Foundation Limited	This project was supported by the donation from the charity organization Providence Foundation Limited. The funding organizations did not play any role in the study design, data collection, analysis of results, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Chan KYY, 2014, ANN SURG, V260, P1128, DOI 10.1097/SLA.0000000000000374; Chen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095665; Coskun M, 2012, WORLD J GASTROENTERO, V18, P4629, DOI 10.3748/wjg.v18.i34.4629; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Fasseu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013160; Holland AJA, 2003, PEDIATR SURG INT, V19, P489, DOI 10.1007/s00383-003-0967-8; Huang Z, 2014, GUT, V63, P1247, DOI 10.1136/gutjnl-2012-304213; Iborra M, 2013, CLIN EXP IMMUNOL, V173, P250, DOI 10.1111/cei.12104; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kubota A, 2007, PEDIATR SURG INT, V23, P997, DOI 10.1007/s00383-007-1984-9; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Maharshak N, 2013, INFLAMM BOWEL DIS, V19, P1346, DOI 10.1097/MIB.0b013e318281f47d; Murata K, 2014, ARTHRITIS RHEUMATOL, V66, P549, DOI 10.1002/art.38269; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Olaru AV, 2012, INFLAMM BOWEL DIS, V18, P641, DOI 10.1002/ibd.21826; Paraskevi A, 2012, J CROHNS COLITIS, V6, P900, DOI 10.1016/j.crohns.2012.02.006; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Pumberger W, 2002, J AM COLL SURGEONS, V195, P796, DOI 10.1016/S1072-7515(02)01344-3; Rangrez AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047807; Rossi S, 2011, GENOMICS, V97, P71, DOI 10.1016/j.ygeno.2010.10.004; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Shrivastava S, 2013, HEPATOLOGY, V58, P863, DOI 10.1002/hep.26296; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wei J, 2013, MOL IMMUNOL, V55, P303, DOI 10.1016/j.molimm.2013.03.004; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Zahm AM, 2014, J CROHNS COLITIS, V8, P1108, DOI 10.1016/j.crohns.2014.02.012	37	54	58	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135737	10.1371/journal.pone.0135737	http://dx.doi.org/10.1371/journal.pone.0135737			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274503	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600104
J	Pettengill, JB				Pettengill, James B.			The Time to Most Recent Common Ancestor Does Not (Usually) Approximate the Date of Divergence	PLOS ONE			English	Article							MODEL	With the advent of more sophisticated models and increase in computational power, an ever-growing amount of information can be extracted from DNA sequence data. In particular, recent advances have allowed researchers to estimate the date of historical events for a group of interest including time to most recent common ancestor (TMRCA), dates of specific nodes in a phylogeny, and the date of divergence or speciation date. Here I use coalescent simulations and re-analyze an empirical dataset to illustrate the importance of taxon sampling, in particular, on correctly estimating such dates. I show that TMRCA of representatives of a single taxon is often not the same as divergence date due to issues such as incomplete lineage sorting. Of critical importance is when estimating divergence or speciation dates a representative from a different taxonomic lineage must be included in the analysis. Without considering these issues, studies may incorrectly estimate the times at which historical events occurred, which has profound impacts within both research and applied (e.g., those related to public health) settings.	US FDA, Div rPubl Hlth Informat & Analyt, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA	US Food & Drug Administration (FDA)	Pettengill, JB (corresponding author), US FDA, Div rPubl Hlth Informat & Analyt, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	james.pettengill@fda.hhs.gov						Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Didelot X, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004041; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Heled J., 2014, DENSITREE, DOI [10.1101/012401, DOI 10.1101/012401]; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Pettengill JB, 2012, MOL ECOL, V21, P4578, DOI 10.1111/j.1365-294X.2012.05715.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Timme RE, 2013, GENOME BIOL EVOL, V5, P2109, DOI 10.1093/gbe/evt159; Zhou ZM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003471	14	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0128407	10.1371/journal.pone.0128407	http://dx.doi.org/10.1371/journal.pone.0128407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26273822	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600002
J	Antal, MC; Samama, B; Ghandour, MS; Boehm, N				Antal, M. Cristina; Samama, Brigitte; Ghandour, M. Said; Boehm, Nelly			Human Neural Cells Transiently Express Reelin during Olfactory Placode Development	PLOS ONE			English	Article							NEURONAL MIGRATION; HUMAN-PAPILLOMAVIRUS; PERIPHERAL-NERVE; P16 EXPRESSION; VLDL RECEPTOR; PHOSPHORYLATION; PATHWAY; SYSTEM; SIGNAL; MOUSE	Reelin, an extracellular glycoprotein is essential for migration and correct positioning of neurons during development. Since the olfactory system is known as a source of various migrating neuronal cells, we studied Reelin expression in the two chemosensory olfactory systems, main and accessory, during early developmental stages of human foetuses/embryos from Carnegie Stage (CS) 15 to gestational week (GW) 14. From CS 15 to CS 18, but not at later stages, a transient expression of Reelin was detected first in the presumptive olfactory and then in the presumptive vomeronasal epithelium. During the same period, Reelin-positive cells detach from the olfactory/vomeronasal epithelium and migrate through the mesenchyme beneath the telencephalon. Dab 1, an adaptor protein of the Reelin pathway, was simultaneously expressed in the migratory mass from CS16 to CS17 and, at later stages, in the presumptive olfactory ensheathing cells. Possible involvements of Reelin and Dab 1 in the peripheral migrating stream are discussed.	[Antal, M. Cristina; Samama, Brigitte; Boehm, Nelly] Univ Strasbourg, Inst Histol, Fac Med, Strasbourg, France; [Antal, M. Cristina; Samama, Brigitte; Boehm, Nelly] Federat Med Translat Strasbourg, Strasbourg, France; [Antal, M. Cristina; Samama, Brigitte; Boehm, Nelly] Hop Univ Strasbourg, Strasbourg, France; [Ghandour, M. Said] CNRS, Lab Imagerie & Neurosci Cognit, UMR 7237, Strasbourg, France; [Antal, M. Cristina; Ghandour, M. Said] CNRS, UMR 7357, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Samama, B (corresponding author), Univ Strasbourg, Inst Histol, Fac Med, Strasbourg, France.	samama@unistra.fr			Conseil Scientifique de la Faculte de Medecine de Strasbourg; Programme Hospitalier de Recherche Clinique, Hopitaux Universitaires de Strasbourg	Conseil Scientifique de la Faculte de Medecine de Strasbourg; Programme Hospitalier de Recherche Clinique, Hopitaux Universitaires de Strasbourg	This study was supported in part by the Conseil Scientifique de la Faculte de Medecine de Strasbourg and by the Programme Hospitalier de Recherche Clinique, Hopitaux Universitaires de Strasbourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparetion of the manuscript.	Andrade N, 2007, P NATL ACAD SCI USA, V104, P8508, DOI 10.1073/pnas.0611391104; Bar I, 2000, EUR J MORPHOL, V38, P321, DOI 10.1076/ejom.38.5.321.7361; BOEHM N, 1993, NEUROREPORT, V4, P867, DOI 10.1097/00001756-199307000-00007; BOEHM N, 1994, DEV BRAIN RES, V82, P175, DOI 10.1016/0165-3806(94)90160-0; BOSSY J, 1980, ANAT EMBRYOL, V161, P225, DOI 10.1007/BF00305346; Bystron I, 2006, NAT NEUROSCI, V9, P880, DOI 10.1038/nn1726; Cariboni A, 2005, DEVELOPMENT, V132, P4709, DOI 10.1242/dev.02033; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; Eckberg JAK, 2012, MIGRATION OLFACTORY, V20, P147; Fairless R, 2005, INT J BIOCHEM CELL B, V37, P693, DOI 10.1016/j.biocel.2004.10.010; Forster E, 2006, EUR J NEUROSCI, V23, P901, DOI 10.1111/j.1460-9568.2006.04612.x; Gonzalez-Martinez D, 2004, FRONT NEUROENDOCRIN, V25, P108, DOI 10.1016/j.yfrne.2004.06.001; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell KR, 2013, NEUROSCI LETT, V552, P30, DOI 10.1016/j.neulet.2013.07.032; Jalabi W, 2003, J HISTOCHEM CYTOCHEM, V51, P913, DOI 10.1177/002215540305100706; Jalabi W, 2005, J NEUROSCI, V25, P2885, DOI 10.1523/JNEUROSCI.2748-04.2005; Kim CH, 2004, LARYNGOSCOPE, V114, P1791, DOI 10.1097/00005537-200410000-00022; Larroche, 1987, DEV CERVEAU FOETAL H; Lorenzetto E, 2008, EUR J NEUROSCI, V27, P12, DOI 10.1111/j.1460-9568.2007.05978.x; Lutter S, 2012, J CELL BIOL, V197, P837, DOI 10.1083/jcb.201110132; Meyer G, 2000, J NEUROSCI, V20, P1858; O'Rahilly R, 1999, TERATOLOGY, V60, P39, DOI 10.1002/(SICI)1096-9926(199907)60:1<39::AID-TERA11>3.0.CO;2-I; ORAHILLY R, 1967, ANAT REC, V157, P380; Panteri R, 2006, MOL CELL NEUROSCI, V32, P133, DOI 10.1016/j.mcn.2006.03.004; Perez-Garcia CG, 2004, EUR J NEUROSCI, V20, P2827, DOI 10.1111/j.1460-9568.2004.03733.x; Rice DS, 1999, ANNU REV NEUROSCI, V24, P1005; Samama B, 2006, HUM PATHOL, V37, P513, DOI 10.1016/j.humpath.2006.01.001; Samama B, 2005, ANAT REC PART A, V285A, P595, DOI 10.1002/ar.a.20202; Samama B, 2002, J HISTOCHEM CYTOCHEM, V50, P1417, DOI 10.1177/002215540205001014; Samama B, 2008, GYNECOL ONCOL, V109, P285, DOI 10.1016/j.ygyno.2008.01.043; Schnaufer C, 2009, CELL TISSUE RES, V337, P393, DOI 10.1007/s00441-009-0762-5; SchwanzelFukuda M, 1996, J COMP NEUROL, V366, P547; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Smalheiser NR, 2000, P NATL ACAD SCI USA, V97, P1281, DOI 10.1073/pnas.97.3.1281; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Stolt PC, 2006, CELL SIGNAL, V18, P1560, DOI 10.1016/j.cellsig.2006.03.008; Teillon SM, 2003, DEV BRAIN RES, V140, P303, DOI 10.1016/S0165-3806(02)00616-8; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; VALVERDE F, 1992, NEUROSCIENCE, V49, P255, DOI 10.1016/0306-4522(92)90094-I; Whitlock KE, 1998, J NEUROSCI, V18, P8919; Wolff-Quenot, 1997, ATLAS EMBRYOLOGIE CL	44	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135710	10.1371/journal.pone.0135710	http://dx.doi.org/10.1371/journal.pone.0135710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270645	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800101
J	Grey, EK; Chiasson, SC; Williams, HG; Troeger, VJ; Taylor, CM				Grey, Erin K.; Chiasson, Susan C.; Williams, Hannah G.; Troeger, Victoria J.; Taylor, Caz M.			Evaluation of Blue Crab, Callinectes sapidus, Megalopal Settlement and Condition during the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							BRACHYURAN MEGALOPAE; ARTIFICIAL COLLECTORS; PATTERNS; BAY; TRANSPORT; CAROLINA; POSTLARVAE; LOUISIANA; MORTALITY; RESPONSES	The Blue Crab, Callinectes sapidus, is a commercially, culturally, and ecologically significant species in the Gulf of Mexico (GOM), whose offshore stages were likely impacted by the Deepwater Horizon oil spill (DWH). To test for DWH effects and to better understand the planktonic ecology of this species, we monitored Callinectes spp. megalopal settlement and condition at sites within and outside of the spill extent during and one year after the DWH. We tested for DWH effects by comparing 2010 settlement against baseline data available for two sites, and by testing for differences in settlement and condition inside and outside of the spill extent. We also developed time series models to better understand natural drivers of daily settlement variation (seasonal and lunar trends, hydrodynamics, wind) during 2010 and 2011. Overall, we found that neither megalopal settlement nor body weight were significantly reduced at oiled sites, but that high unexplained variation and low statistical power made detection of even large effects unlikely. Time series models revealed remarkably consistent and relatively strong seasonal and lunar trends within sites (explaining on average 28% and 9% of variation, respectively), while wind and hydrodynamic effects were weak (1-5% variation explained) and variable among sites. This study provides insights into DWH impacts as well as the natural drivers of Callinectes spp. megalopal settlement across the northern GOM.	[Grey, Erin K.] Governors State Univ, Div Chem & Biol Sci, University Pk, IL 60484 USA; [Chiasson, Susan C.; Taylor, Caz M.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Williams, Hannah G.] Univ Florida, Coll Vet Med, Gainesville, FL USA; [Troeger, Victoria J.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Governors State University; Tulane University; State University System of Florida; University of Florida; Emory University; Rollins School Public Health	Grey, EK (corresponding author), Governors State Univ, Div Chem & Biol Sci, University Pk, IL 60484 USA.	egrey@govst.edu		Grey, Erin/0000-0001-5883-0013; Taylor, Caz/0000-0002-8293-1014	National Science Foundation [OCE-1042792]; Gulf of Mexico Research Initiative	National Science Foundation(National Science Foundation (NSF)); Gulf of Mexico Research Initiative	Funding for this study was provided by the National Science Foundation (Award #OCE-1042792, PI Taylor), and two grants from the Gulf of Mexico Research Initiative (RFP III, PI Taylor and RFP II, PIs Neigel and Taylor). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson JA, 2014, B ENVIRON CONTAM TOX, V92, P375, DOI 10.1007/s00128-014-1216-7; BERMAN MS, 1980, MAR BIOL, V56, P59, DOI 10.1007/BF00390594; Bianchi TS, 2011, MAR ENVIRON RES, V72, P248, DOI 10.1016/j.marenvres.2011.09.007; BIGFORD TE, 1977, MAR BIOL, V43, P137, DOI 10.1007/BF00391261; Bishop TD, 2010, ESTUAR COAST, V33, P688, DOI 10.1007/s12237-009-9259-4; BOOKHOUT CG, 1977, B MAR SCI, V27, P704; Box G.E., 2013, TIME SERIES ANAL FOR; BOYLAN JM, 1993, MAR ECOL PROG SER, V97, P237, DOI 10.3354/meps097237; Carassou L, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/12/124003; Champely S., 2012, PWR BASIC FUNCTIONS; Darnell MZ, 2010, J EXP MAR BIOL ECOL, V391, P112, DOI 10.1016/j.jembe.2010.06.014; Eggleston DB, 2010, FISH OCEANOGR, V19, P89, DOI 10.1111/j.1365-2419.2009.00530.x; Epifanio CE, 2008, J MAR RES, V66, P723, DOI 10.1357/002224008788064586; Fodrie FJ, 2014, BIOSCIENCE, V64, P778, DOI 10.1093/biosci/biu123; Forward RB, 2004, MAR ECOL PROG SER, V269, P237, DOI 10.3354/meps269237; Forward RB, 2003, B MAR SCI, V72, P347; Forward RB, 2003, MAR BIOL, V142, P67, DOI 10.1007/s00227-002-0923-5; Fucik Kenneth W., 1995, V1252, P135; Fulford R., 2014, IMPACTS OIL SPILL DI, P247; Gelpi CG, 2009, B MAR SCI, V85, P203; GOODRICH DM, 1989, ESTUAR COAST SHELF S, V29, P247, DOI 10.1016/0272-7714(89)90056-5; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; GUILLORY V, 2001, BLUE CRAB FISHERY GU; Hasek BE, 2001, ESTUARIES, V24, P796, DOI 10.2307/1353171; Johnson DR, 1999, B MAR SCI, V65, P129; Jones BT, 2015, MAR ECOL PROG SER, V527, P143, DOI 10.3354/meps11238; JONES MB, 1995, MAR ECOL PROG SER, V125, P67, DOI 10.3354/meps125067; La Peyre MK, 2013, ESTUAR COAST SHELF S, V135, P146, DOI 10.1016/j.ecss.2013.10.001; Lively JAA, 2014, B ENVIRON CONTAM TOX, V93, P649, DOI 10.1007/s00128-014-1370-y; Mense DJ, 1995, B MAR SCI, V57, P793; Metcalf KS, 1995, B MAR SCI, V57, P781; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Moody RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058376; Morgan SG, 1996, MAR ECOL PROG SER, V133, P73, DOI 10.3354/meps133073; NOAA (National Oceanic and Atmospheric Administration), DEEPW HOR BP OIL SPI; Ogburn MB, 2009, MAR ECOL PROG SER, V389, P181, DOI 10.3354/meps08139; Ogburn MB, 2012, FISH OCEANOGR, V21, P20, DOI 10.1111/j.1365-2419.2011.00606.x; Ogburn MB, 2011, J CRUSTACEAN BIOL, V31, P106, DOI 10.1651/09-3241.1; PEARSON WH, 1981, MAR ENVIRON RES, V5, P3, DOI 10.1016/0141-1136(81)90018-0; Perry HM, 1995, B MAR SCI, V57, P821; R Core Team, 2018, R LANG ENV STAT COMP; Rabalais NN, 1995, B MAR SCI, V57, P855; Sammarco PW, 2013, MAR POLLUT BULL, V73, P129, DOI 10.1016/j.marpolbul.2013.05.029; Shuba P J, 1989, INT OIL SPILL C P FE, V1989, p309 , DOI DOI 10.7901/2169-3358-1989-1-309; Spitzer PM, 2003, B MAR SCI, V72, P435; STUCK KC, 1981, GULF RES REP, V7, P93; VanderKooy S., 2013, 01 GDAR GULF STAT MA, P313; vanMontfrans J, 1995, B MAR SCI, V57, P834; VANMONTFRANS J, 1990, B MAR SCI, V46, P214; Vukovich F. M., 2012, INT J OCEANOGR, P18, DOI [10.1155/2012/439042, DOI 10.1155/2012/439042]; WANG SY, 1988, MAR BIOL, V98, P23, DOI 10.1007/BF00392655	52	16	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135791	10.1371/journal.pone.0135791	http://dx.doi.org/10.1371/journal.pone.0135791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270970	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800111
J	Kang, SY; Im, CH; Shim, M; Nahab, FB; Park, J; Kim, DW; Kakareka, J; Miletta, N; Hallett, M				Kang, Suk Yun; Im, Chang-Hwan; Shim, Miseon; Nahab, Fatta B.; Park, Jihye; Kim, Do-Won; Kakareka, John; Miletta, Nathanial; Hallett, Mark			Brain Networks Responsible for Sense of Agency: An EEG Study	PLOS ONE			English	Article							ALPHA-BAND OSCILLATIONS; NEURONAL SYNCHRONIZATION; SPATIAL ATTENTION; CORTICAL NETWORKS; OCCIPITAL CORTEX; TOP-DOWN; SELF; PERFORMANCE; MOVEMENT; ELECTROENCEPHALOGRAPHY	Background Self-agency (SA) is a person's feeling that his action was generated by himself. The neural substrates of SA have been investigated in many neuroimaging studies, but the functional connectivity of identified regions has rarely been investigated. The goal of this study is to investigate the neural network related to SA. Methods SA of hand movements was modulated with virtual reality. We examined the cortical network relating to SA modulation with electroencephalography (EEG) power spectrum and phase coherence of alpha, beta, and gamma frequency bands in 16 right-handed, healthy volunteers. Results In the alpha band, significant relative power changes and phase coherence of alpha band were associated with SA modulation. The relative power decrease over the central, bilateral parietal, and right temporal regions (C4, Pz, P3, P4, T6) became larger as participants more effectively controlled the virtual hand movements. The phase coherence of the alpha band within frontal areas (F7-FP2, F7-Fz) was directly related to changes in SA. The functional connectivity was lower as the participants felt that they could control their virtual hand. In the other frequency bands, significant phase coherences were observed in the frontal (or central) to parietal, temporal, and occipital regions during SA modulation (Fz-O1, F3-O1, Cz-O1, C3-T4L in beta band; FP1-T6, FP1-O2, F7-T4L, F8-Cz in gamma band). Conclusions Our study suggests that alpha band activity may be the main neural oscillation of SA, which suggests that the neural network within the anterior frontal area may be important in the generation of SA.	[Kang, Suk Yun] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Dept Neurol, Hwaseong Si, Gyeonggi Do, South Korea; [Kang, Suk Yun; Nahab, Fatta B.; Miletta, Nathanial; Hallett, Mark] NINDS, Human Motor Control Sect, NIH, Bethesda, MD 20892 USA; [Im, Chang-Hwan; Shim, Miseon; Kim, Do-Won] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Nahab, Fatta B.] Univ Calif San Diego, Dept Neurol, San Diego, CA 92103 USA; [Park, Jihye; Kim, Do-Won] Yonsei Univ, Dept Biomed Engn, Wonju, Kangwon Do, South Korea; [Kakareka, John] NIH, Signal Proc & Instrumentat Sect, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA	Hallym University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Hanyang University; University of California System; University of California San Diego; Yonsei University; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Hallett, M (corresponding author), NINDS, Human Motor Control Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	hallettm@ninds.nih.gov	Im, Chang-Hwan/ABB-4391-2021	Im, Chang-Hwan/0000-0003-3795-3318; Kakareka, John/0000-0003-0072-0035	National Institute of Neurological Disorders and Stroke (NINDS) at the NIH; Public Welfare and Safety Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2011-0027859]; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000261] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS) at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Public Welfare and Safety Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT))	This work was supported by the intramural research program of the National Institute of Neurological Disorders and Stroke (NINDS) at the NIH and in part by the Public Welfare and Safety Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. NRF-2011-0027859).	Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; Bazanova OM, 2014, NEUROSCI BIOBEHAV R, V44, P94, DOI 10.1016/j.neubiorev.2013.05.007; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; Britz J, 2010, NEUROIMAGE, V52, P1162, DOI 10.1016/j.neuroimage.2010.02.052; Brookes MJ, 2011, NEUROIMAGE, V55, P1804, DOI 10.1016/j.neuroimage.2010.10.074; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G., 2006, RHYTHMS BRAIN; Capilla A, 2014, CEREB CORTEX, V24, P550, DOI 10.1093/cercor/bhs343; Chaminade T, 2002, NEUROREPORT, V13, P1975, DOI 10.1097/00001756-200210280-00029; Chen XG, 2013, NEUROSCI LETT, V541, P238, DOI 10.1016/j.neulet.2013.02.036; Cochin S, 1999, EUR J NEUROSCI, V11, P1839, DOI 10.1046/j.1460-9568.1999.00598.x; David N, 2008, CONSCIOUS COGN, V17, P523, DOI 10.1016/j.concog.2008.03.004; David N, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00161; Deeny SP, 2009, J MOTOR BEHAV, V41, P106, DOI 10.3200/JMBR.41.2.106-116; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Farrer C, 2002, NEUROIMAGE, V15, P587, DOI 10.1006/nimg.2001.0996; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fu KMG, 2001, COGNITIVE BRAIN RES, V12, P145, DOI 10.1016/S0926-6410(01)00034-9; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gentsch A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00608; Gomez-Ramirez M, 2011, J NEUROSCI, V31, P18556, DOI 10.1523/JNEUROSCI.2164-11.2011; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 2012, CURR BIOL, V22, pR390, DOI 10.1016/j.cub.2012.02.040; Hallett M, 2007, CLIN NEUROPHYSIOL, V118, P1179, DOI 10.1016/j.clinph.2007.03.019; Hars M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025903; Hascalovitz A, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00013; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Hodzic A, 2009, HUM BRAIN MAPP, V30, P951, DOI 10.1002/hbm.20558; Jeannerod M, 2004, NAT NEUROSCI, V7, P422, DOI 10.1038/nn0504-422; Joundi RA, 2012, CURR BIOL, V22, P403, DOI 10.1016/j.cub.2012.01.024; Lenggenhager B, 2011, EUR J NEUROSCI, V33, P1935, DOI 10.1111/j.1460-9568.2011.07647.x; Lepage JF, 2006, EUR J NEUROSCI, V23, P2505, DOI 10.1111/j.1460-9568.2006.04769.x; Leube DT, 2003, NEUROIMAGE, V20, P2084, DOI 10.1016/j.neuroimage.2003.07.033; Mathewson KE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00099; Moore JW, 2010, P ROY SOC B-BIOL SCI, V277, P2503, DOI 10.1098/rspb.2010.0404; Nahab FB, 2011, CEREB CORTEX, V21, P48, DOI 10.1093/cercor/bhq059; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; Ogawa K, 2007, CORTEX, V43, P289, DOI 10.1016/S0010-9452(08)70455-6; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Quandt LC, 2012, NEUROPSYCHOLOGIA, V50, P2745, DOI 10.1016/j.neuropsychologia.2012.08.005; Rihs TA, 2009, NEUROIMAGE, V44, P190, DOI 10.1016/j.neuroimage.2008.08.022; Rilk AJ, 2011, NEUROPSYCHOLOGIA, V49, P3704, DOI 10.1016/j.neuropsychologia.2011.09.026; Safford AS, 2010, J NEUROSCI, V30, P9064, DOI 10.1523/JNEUROSCI.1779-10.2010; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Sperduti M, 2011, BRAIN STRUCT FUNCT, V216, P151, DOI 10.1007/s00429-010-0298-1; Synofzik M, 2008, CONSCIOUS COGN, V17, P411, DOI 10.1016/j.concog.2008.03.008; Toma K, 2002, J NEUROPHYSIOL, V88, P3377, DOI 10.1152/jn.00281.2002; Uddin LQ, 2011, CONSCIOUS COGN, V20, P94, DOI 10.1016/j.concog.2010.09.009; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; White DJ, 2012, J COGNITIVE NEUROSCI, V24, P686, DOI 10.1162/jocn_a_00098; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Worden MS, 2000, J NEUROSCI, V20; Yomogida Y, 2010, NEUROIMAGE, V50, P198, DOI 10.1016/j.neuroimage.2009.12.054; Yoshie M, 2013, CURR BIOL, V23, P2028, DOI 10.1016/j.cub.2013.08.034	66	20	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135261	10.1371/journal.pone.0135261	http://dx.doi.org/10.1371/journal.pone.0135261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270552	Green Published, gold			2022-12-27	WOS:000359492800046
J	Schmidt, C; Morard, R; Almogi-Labin, A; Weinmann, AE; Titelboim, D; Abramovich, S; Kucera, M				Schmidt, Christiane; Morard, Raphael; Almogi-Labin, Ahuva; Weinmann, Anna E.; Titelboim, Danna; Abramovich, Sigal; Kucera, Michal			Recent Invasion of the Symbiont-Bearing Foraminifera Pararotalia into the Eastern Mediterranean Facilitated by the Ongoing Warming Trend	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BENTHIC FORAMINIFERA; LARGER FORAMINIFERA; ALGAL SYMBIOSIS; CLIMATE-CHANGE; ENDOSYMBIOTIC DIATOMS; BIOGEOGRAPHIC RANGE; THERMAL POLLUTION; SEA; AMPHISTEGINA	The eastern Mediterranean is a hotspot of biological invasions. Numerous species of Indo-pacific origin have colonized the Mediterranean in recent times, including tropical symbiont-bearing foraminifera. Among these is the species Pararotalia calcariformata. Unlike other invasive foraminifera, this species was discovered only two decades ago and is restricted to the eastern Mediterranean coast. Combining ecological, genetic and physiological observations, we attempt to explain the recent invasion of this species in the Mediterranean Sea. Using morphological and genetic data, we confirm the species attribution to P. calcariformata McCulloch 1977 and identify its symbionts as a consortium of diatom species dominated by Minutocellus polymorphus. We document photosynthetic activity of its endosymbionts using Pulse Amplitude Modulated Fluorometry and test the effects of elevated temperatures on growth rates of asexual offspring. The culturing of asexual offspring for 120 days shows a 30-day period of rapid growth followed by a period of slower growth. A subsequent 48-day temperature sensitivity experiment indicates a similar developmental pathway and high growth rate at 28 degrees C, whereas an almost complete inhibition of growth was observed at 20 degrees C and 35 degrees C. This indicates that the offspring of this species may have lower tolerance to cold temperatures than what would be expected for species native to the Mediterranean. We expand this hypothesis by applying a Species Distribution Model (SDM) based on modern occurrences in the Mediterranean using three environmental variables: irradiance, turbidity and yearly minimum temperature. The model reproduces the observed restricted distribution and indicates that the range of the species will drastically expand westwards under future global change scenarios. We conclude that P. calcariformata established a population in the Levant because of the recent warming in the region. In line with observations from other groups of organisms, our results indicate that continued warming of the eastern Mediterranean will facilitate the invasion of more tropical marine taxa into the Mediterranean, disturbing local biodiversity and ecosystem structure.	[Schmidt, Christiane; Morard, Raphael; Kucera, Michal] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany; [Almogi-Labin, Ahuva] Geol Survey Israel, IL-95501 Jerusalem, Israel; [Weinmann, Anna E.] Univ Georgia, Dept Geol, Athens, GA 30602 USA; [Weinmann, Anna E.] Univ Bonn, Steinmann Inst Geol Mineral & Paleontol, Bonn, Germany; [Titelboim, Danna; Abramovich, Sigal] Ben Gurion Univ Negev, Dept Geol & Environm Sci, IL-84105 Beer Sheva, Israel	University of Bremen; Geological Survey Israel; University System of Georgia; University of Georgia; University of Bonn; Ben Gurion University	Schmidt, C (corresponding author), Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany.	cschmidt@marum.de	Kucera, Michal/B-9277-2009; Abramovich, Sigal/AAR-5034-2021; Kucera, Michal/ABH-6065-2020; Weinmann, Anna E./AAS-7145-2021; Kucera, Michal/AAE-8115-2020	Kucera, Michal/0000-0002-7817-9018; Abramovich, Sigal/0000-0003-3124-1387; Weinmann, Anna E./0000-0002-7999-0486; Kucera, Michal/0000-0002-7817-9018; Almogi-Labin, Ahuva/0000-0002-4082-7120; Schmidt, Christiane/0000-0001-8461-3485	joint German-Israeli Marine Science Grant by Bundesministerium fur Bildung und Forschung BMBF), Germany [WTZ Israel 03F0639A]; Ministry of Science and Technology, Israel	joint German-Israeli Marine Science Grant by Bundesministerium fur Bildung und Forschung BMBF), Germany; Ministry of Science and Technology, Israel	Funding was provided through the joint German-Israeli Marine Science Grant by the Bundesministerium fur Bildung und Forschung BMBF), Germany to MK (WTZ Israel 03F0639A), and by the Ministry of Science and Technology, Israel to SA, AAL and Barak Herut.	Alve E, 2003, LIMNOL OCEANOGR, V48, P2163, DOI 10.4319/lo.2003.48.6.2163; Alve E, 2002, J MICROPALAEONTOL, V21, P95, DOI 10.1144/jm.21.1.95; Alve E, 1999, EARTH-SCI REV, V46, P167, DOI 10.1016/S0012-8252(99)00016-1; Arieli RN, 2011, MAR POLLUT BULL, V62, P1002, DOI 10.1016/j.marpolbul.2011.02.036; Belanger CL, 2012, P NATL ACAD SCI USA, V109, P14046, DOI 10.1073/pnas.1212381109; BRESLER V, 1995, J FORAMIN RES, V25, P267, DOI 10.2113/gsjfr.25.3.267; BRESLER V, 1995, ENVIRON TOXICOL CHEM, V14, P1687, DOI 10.1002/etc.5620141008; Briguglio A, 2014, PALEOBIOLOGY, V40, P494, DOI 10.1666/13051; Byrne M, 2012, MAR ENVIRON RES, V76, P3, DOI 10.1016/j.marenvres.2011.10.004; Carlton TC, 1999, INVASIVE SPECIES BIO; Caruso A, 2014, MAR MICROPALEONTOL, V111, P38, DOI 10.1016/j.marmicro.2014.05.002; Cedhagen Tomas, 1998, Phuket Marine Biological Center Special Publication, V18, P117; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Nooijer LJ, 2009, P NATL ACAD SCI USA, V106, P15374, DOI 10.1073/pnas.0904306106; Debenay Jean-Pierre, 2011, Revue de Micropaleontologie, V54, P87, DOI 10.1016/j.revmic.2010.04.001; deVargas C, 1997, J MOL EVOL, V45, P285, DOI 10.1007/PL00006232; Edelist D, 2013, DIVERS DISTRIB, V19, P69, DOI 10.1111/ddi.12002; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elshanawany R, 2011, J FORAMIN RES, V41, P326, DOI 10.2113/gsjfr.41.4.326; Frontalini F, 2014, MAR BIODIVERS, P1; Goldstein ST, 1997, J FORAMIN RES, V27, P319, DOI 10.2113/gsjfr.27.4.319; Goldstein ST, 2011, MAR ECOL PROG SER, V437, P1, DOI 10.3354/meps09296; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALLOCK P, 1981, MAR BIOL, V62, P249, DOI 10.1007/BF00397691; Haunold TG, 1997, MAR MICROPALEONTOL, V29, P185, DOI 10.1016/S0377-8398(96)00031-X; Herut B, 2000, OCEANOL ACTA, V23, P771, DOI 10.1016/S0399-1784(00)01118-X; Hesemann M., PARAROTALIA SP; Hesemann M., 2010, FOR 2010 INT S FOR R; Hiddink JG, 2012, GLOBAL CHANGE BIOL, V18, P2161, DOI 10.1111/j.1365-2486.2012.02698.x; Hill R, 2004, MAR BIOL, V144, P633, DOI 10.1007/s00227-003-1226-1; Hohenegger J., 2011, BULLETIN, V5; Hohenegger J, 2014, ENVIRON SCI ENG, P13, DOI 10.1007/978-4-431-54388-6_2; HOTTINGER L, 1991, J PALEONTOL, V65, P18, DOI 10.1017/S0022336000020151; Hyams Orit, 2002, Israel Journal of Earth Sciences, V51, P169, DOI 10.1560/QAE1-KTEE-2K2L-QPCH; Hyams-Kaphzan O, 2014, GEOLOGICAL SURVEY IS; Hyams-Kaphzan O, 2008, NEUES JAHRB GEOL P-A, V248, P315, DOI 10.1127/0077-7749/2008/0248-0315; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jueterbock A, 2013, ECOL EVOL, V3, P1356, DOI 10.1002/ece3.541; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koukousioura O, 2011, J MARINE SYST, V88, P489, DOI 10.1016/j.jmarsys.2011.06.004; Langer M.R., 2008, AQABA EILAT IMPROBAB, P399; Langer MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054443; Langer MR, 2012, J FORAMIN RES, V42, P234, DOI 10.2113/gsjfr.42.3.234; LANGER MR, 1993, MAR MICROPALEONTOL, V20, P235, DOI 10.1016/0377-8398(93)90035-V; Langer MR, 2000, MICROPALEONTOLOGY, V46, P105; Lee J.J., 1991, P157; LEE JJ, 1987, ANN NY ACAD SCI, V503, P330, DOI 10.1111/j.1749-6632.1987.tb40619.x; Lee JJ, 1995, MAR MICROPALEONTOL, V26, P99, DOI 10.1016/0377-8398(95)00004-6; LEE JJ, 1995, BIOSCIENCE, V45, P252, DOI 10.2307/1312418; LEE JJ, 1979, NATURE, V280, P57, DOI 10.1038/280057a0; Lee JJ, 2005, SYMBIOSIS, V38, P251; Lee' JJ, 2000, MICROPALEONTOLOGY, V46, P170; Lee JJ, 2006, SYMBIOSIS, V42, P63; Lee John J., 1992, P63; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; LOCARNINI RA, 2006, NOAA ATLAS NESDIS, V61; Loeblich AR., 1987, FORAMINIFERAL GENERA; Macias D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081591; Madkour H, 2013, GLOB ADV RES J GEOL, V2, P5; Mancin Nicoletta, 2000, Bollettino della Societa Paleontologica Italiana, V39, P341; McCulloch I., 1977, QUALIATATIVE OBSER 1; McGann M, 2000, HYDROBIOLOGIA, V421, P25, DOI 10.1023/A:1003808517945; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Meric Engin, 2013, Marine Biodiversity Records, V6, pe31, DOI 10.1017/S1755267212001108; Meric E, 2008, MICROPALEONTOLOGY, V54, P307; Merkado G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077725; Mouanga GH, 2014, NEUES JAHRB GEOL P-A, V271, P141, DOI 10.1127/0077-7749/2014/0381; Nixon SW, 2003, AMBIO, V32, P30, DOI 10.1639/0044-7447(2003)032[0030:RTNAAN]2.0.CO;2; Nobes K, 2008, J EXP MAR BIOL ECOL, V363, P48, DOI 10.1016/j.jembe.2008.06.015; Oczkowski A, 2008, ESTUAR COAST SHELF S, V77, P309, DOI 10.1016/j.ecss.2007.11.028; Parker JH, 2012, MAR MICROPALEONTOL, V86-87, P59, DOI 10.1016/j.marmicro.2012.02.002; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; Parmesan C., ANN REV ECOLOGY EVOL, V372006, P637; Pawlowski J, 2013, MAR MICROPALEONTOL, V100, P1, DOI 10.1016/j.marmicro.2013.04.002; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Reinhardt EG, 2003, J FORAMIN RES, V33, P262, DOI 10.2113/33.3.262; REINHARDT EG, 1994, J FORAMIN RES, V24, P37, DOI 10.2113/gsjfr.24.1.37; Reiss Z., 1984, GULF AQABA ECOLOGICA; Reiss Z, 1993, RECENT FORAMINIFERA; Reiss Z, 1961, B GEOLOGICAL SURVEY, V32; Rilov Gil, 2009, V204, P549; Samir Ashraf Mohamed, 2003, Revue de Micropaleontologie, V46, P111, DOI 10.1016/S0035-1598(03)00018-7; SARNO D, 1993, HYDROBIOLOGIA, V271, P27, DOI 10.1007/BF00005692; SAS, 2014, JMP STAT SOFTW VERS; Schmidt C, 2014, CORAL REEFS, V33, P805, DOI 10.1007/s00338-014-1151-4; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; Schweizer M, 2008, MAR MICROPALEONTOL, V66, P233, DOI 10.1016/j.marmicro.2007.10.003; Shaltout M, 2014, OCEANOLOGIA, V56, P411, DOI 10.5697/oc.56-3.411; Sinutok S, 2013, MAR ECOL PROG SER, V478, P127, DOI 10.3354/meps10187; Sisma-Ventura G, 2014, GEOPHYS RES LETT, V41, P5158, DOI 10.1002/2014GL060393; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Stamou AI, 2009, J ENVIRON MANAGE, V90, P931, DOI 10.1016/j.jenvman.2008.02.008; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; TERKUILE B, 1984, J FORAMIN RES, V14, P262, DOI 10.2113/gsjfr.14.4.262; Tsuchiya M, 2014, ENVIRON SCI ENG, P133, DOI 10.1007/978-4-431-54388-6_9; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; UNEP/MAP, 2012, IG20INF8 UNDPDEPIMEG; Uthicke S, 2012, CORAL REEFS, V31, P401, DOI 10.1007/s00338-011-0851-2; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Weinmann AE, 2013, MAR MICROPALEONTOL, V105, P30, DOI 10.1016/j.marmicro.2013.10.002; Weinmann AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062182; Wolf MA, 2014, ESTUAR COAST SHELF S, V147, P11, DOI 10.1016/j.ecss.2014.05.020; YANKO V, 1994, J FORAMIN RES, V24, P1, DOI 10.2113/gsjfr.24.1.1; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zenetos A, 2012, MEDITERR MAR SCI, V13, P328, DOI 10.12681/mms.327; Ziegler M, 2011, J EXP MAR BIOL ECOL, V407, P70, DOI 10.1016/j.jembe.2011.07.009	112	42	43	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0132917	10.1371/journal.pone.0132917	http://dx.doi.org/10.1371/journal.pone.0132917			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270964	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492800004
J	de Paola, M; Bello, OD; Michaut, MA				de Paola, Matilde; Daniel Bello, Oscar; Alejandra Michaut, Marcela			Cortical Granule Exocytosis Is Mediated by Alpha-SNAP and N-Ethilmaleimide Sensitive Factor in Mouse Oocytes	PLOS ONE			English	Article							MEMBRANE-FUSION; IN-VITRO; NSF; PROTEIN; COMPLEX; TRANSPORT; SNARES; ACTIVATION; MATURATION; MACHINERY	Cortical granule exocytosis (CGE), also known as cortical reaction, is a calcium- regulated secretion that represents a membrane fusion process during meiotic cell division of oocytes. The molecular mechanism of membrane fusion during CGE is still poorly understood and is thought to be mediated by the SNARE pathway; nevertheless, it is unkown if SNAP (acronym for soluble NSF attachment protein) and NSF (acronym for N-ethilmaleimide sensitive factor), two key proteins in the SNARE pathway, mediate CGE in any oocyte model. In this paper, we documented the gene expression of alpha-SNAP, gamma-SNAP and NSF in mouse oocytes. Western blot analysis showed that the expression of these proteins maintains a similar level during oocyte maturation and early activation. Their localization was mainly observed at the cortical region of metaphase II oocytes, which is enriched in cortical granules. To evaluate the function of these proteins in CGE we set up a functional assay based on the quantification of cortical granules metaphase II oocytes activated parthenogenetically with strontium. Endogenous alpha-SNAP and NSF proteins were perturbed by microinjection of recombinant proteins or antibodies prior to CGE activation. The microinjection of wild type alpha-SNAP and the negative mutant of alpha-SNAP L294A in metaphase II oocytes inhibited CGE stimulated by strontium. NEM, an irreversibly inhibitor of NSF, and the microinjection of the negative mutant NSF D1EQ inhibited cortical reaction. The microinjection of anti-alpha-SNAP and anti-NSF antibodies was able to abolish CGE in activated metaphase II oocytes. The microinjection of anti-gamma SNAP antibody had no effect on CGE. Our findings indicate, for the first time in any oocyte model, that alpha-SNAP, gamma-SNAP, and NSF are expressed in mouse oocytes. We demonstrate that alpha-SNAP and NSF have an active role in CGE and propose a working model.	[de Paola, Matilde; Daniel Bello, Oscar; Alejandra Michaut, Marcela] Univ Nacl Cuyo, Consejo Nacl Invest Cient Tecnol, Inst Histol & Embriol, RA-5500 Mendoza, Argentina; [Alejandra Michaut, Marcela] Univ Nacl Cuyo, Fac Ciencias Exactas & Nat, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza	Michaut, MA (corresponding author), Univ Nacl Cuyo, Consejo Nacl Invest Cient Tecnol, Inst Histol & Embriol, RA-5500 Mendoza, Argentina.	mmichaut@gmail.com	Bello, Oscar/K-5605-2014; Michaut, Marcela Alejandra/D-3725-2015	Bello, Oscar/0000-0001-5701-8365; Michaut, Marcela Alejandra/0000-0002-0528-6605	NIH Research Grant - Fogarty International Center, USA [R01 TW007571]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2012-0218]; CONICET [PIP 11420110100402]; Universidad Nacional de Cuyo, Argentina [06/M071]; FOGARTY INTERNATIONAL CENTER [R01TW007571] Funding Source: NIH RePORTER	NIH Research Grant - Fogarty International Center, USA; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Cuyo, Argentina; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by NIH Research Grant # R01 TW007571, funded by the Fogarty International Center, USA, and by Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2012-0218), CONICET (PIP 11420110100402), and Universidad Nacional de Cuyo (06/M071), Argentina, to M.A.M.	Andreeva AV, 2006, EXPERT OPIN THER TAR, V10, P723, DOI 10.1517/14728222.10.5.723; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Burkart AD, 2012, J CELL BIOL, V197, P37, DOI 10.1083/jcb.201112094; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; DUCIBELLA T, 1988, DEV BIOL, V130, P184, DOI 10.1016/0012-1606(88)90425-3; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; Ikebuchi Y, 1998, AM J PHYSIOL-CELL PH, V274, pC1496, DOI 10.1152/ajpcell.1998.274.6.C1496; Iwahashi K, 2003, REPRODUCTION, V126, P73, DOI 10.1530/reprod/126.1.73; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kasai H, 2012, PHYSIOL REV, V92, P1915, DOI 10.1152/physrev.00007.2012; Kawasaki F, 2009, P NATL ACAD SCI USA, V106, P14658, DOI 10.1073/pnas.0907144106; Kuner T, 2008, P NATL ACAD SCI USA, V105, P347, DOI 10.1073/pnas.0707197105; Littleton JT, 2001, P NATL ACAD SCI USA, V98, P12233, DOI 10.1073/pnas.221450198; Liu M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-149; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Morgan A, 1996, NATURE, V382, P680, DOI 10.1038/382680a0; MORGAN A, 1995, EMBO J, V14, P232, DOI 10.1002/j.1460-2075.1995.tb06996.x; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Park Y, 2014, J BIOL CHEM, V289, P16326, DOI 10.1074/jbc.M114.556803; Sanyal S, 2001, NEUROSCI LETT, V311, P21, DOI 10.1016/S0304-3940(01)02125-5; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Tani K, 2003, J BIOL CHEM, V278, P13531, DOI 10.1074/jbc.M213205200; Tsai PS, 2011, BIOL REPROD, V84, P327, DOI 10.1095/biolreprod.110.085647; Wang J, 2015, BIOCH BIOPHYS ACTA; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; Woodman PG, 1997, BBA-MOL CELL RES, V1357, P155, DOI 10.1016/S0167-4889(97)00039-6; Zhao CX, 2012, BBA-MOL CELL RES, V1823, P159, DOI 10.1016/j.bbamcr.2011.06.003	35	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135679	10.1371/journal.pone.0135679	http://dx.doi.org/10.1371/journal.pone.0135679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267363	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300148
J	Meyer, FW; Vogel, N; Teichberg, M; Uthicke, S; Wild, C				Meyer, Friedrich Wilhelm; Vogel, Nikolas; Teichberg, Mirta; Uthicke, Sven; Wild, Christian			The Physiological Response of Two Green Calcifying Algae from the Great Barrier Reef towards High Dissolved Inorganic and Organic Carbon (DIC and DOC) Availability	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CORAL-REEFS; REDUCED CALCIFICATION; BENTHIC FORAMINIFERA; MATTER RELEASE; CLIMATE-CHANGE; WATER-QUALITY; HALIMEDA; PRODUCTIVITY; PHOTOSYNTHESIS	Increasing dissolved inorganic carbon (DIC) concentrations associated with ocean acidification can affect marine calcifiers, but local factors, such as high dissolved organic carbon (DOC) concentrations through sewage and algal blooms, may interact with this global factor. For calcifying green algae of the genus Halimeda, a key tropical carbonate producer that often occurs in coral reefs, no studies on these interactions have been reported. These data are however urgently needed to understand future carbonate production. Thus, we investigated the independent and combined effects of DIC (pCO(2) 402 mu atm/pH(tot) 8.0 and 996 mu atm/pH(tot) 7.7) and DOC (added as glucose in 0 and 294 mu mol L-1) on growth, calcification and photosynthesis of H. macroloba and H. opuntia from the Great Barrier Reef in an incubation experiment over 16 days. High DIC concentrations significantly reduced dark calcification of H. opuntia by 130 % and led to net dissolution, but did not affect H. macroloba. High DOC concentrations significantly reduced daily oxygen production of H. opuntia and H. macroloba by 78% and 43 %, respectively, and significantly reduced dark calcification of H. opuntia by 70%. Combined high DIC and DOC did not show any interactive effects for both algae, but revealed additive effects for H. opuntia where the combination of both factors reduced dark calcification by 162 % compared to controls. Such species-specific differences in treatment responses indicate H. opuntia is more susceptible to a combination of high DIC and DOC than H. macroloba. From an ecological perspective, results further suggest a reduction of primary production for Halimeda-dominated benthic reef communities under high DOC concentrations and additional decreases of carbonate accretion under elevated DIC concentrations, where H. opuntia dominates the benthic community. This may reduce biogenic carbonate sedimentation rates and hence the buffering capacity against further ocean acidification.	[Meyer, Friedrich Wilhelm; Vogel, Nikolas; Teichberg, Mirta; Wild, Christian] Leibniz Ctr Trop Marine Ecol ZMT, Dept Ecol, Bremen, Germany; [Vogel, Nikolas; Uthicke, Sven] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Wild, Christian] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Australian Institute of Marine Science; University of Bremen	Meyer, FW (corresponding author), Leibniz Ctr Trop Marine Ecol ZMT, Dept Ecol, Bremen, Germany.	friedrich.meyer@zmt-bremen.de	Uthicke, Sven/F-1810-2010; /AAL-3738-2021	Uthicke, Sven/0000-0002-3476-6595; Teichberg, Mirta/0000-0003-1586-738X	German Leibniz Association; Australian Government's National Environmental Research Program NERP 5.2; Australian Research Council Discovery Grant	German Leibniz Association; Australian Government's National Environmental Research Program NERP 5.2(Australian Government); Australian Research Council Discovery Grant(Australian Research Council)	The study was conducted with the support from the German Leibniz Association (WGL;http://www.leibniz-gemeinschaft.de/en/home/), the Australian Government's National Environmental Research Program NERP 5.2 (http://www.environment.gov.au/science/nerp) and an Australian Research Council Discovery Grant to SU (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2013, BIOGEOSCIENCES, V10, P4897, DOI 10.5194/bg-10-4897-2013; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; COLE JJ, 1982, ANNU REV ECOL SYST, V13, P291, DOI 10.1146/annurev.es.13.110182.001451; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Crook ED, 2013, P NATL ACAD SCI USA, V110, P11044, DOI 10.1073/pnas.1301589110; DELGADO O, 1994, CORAL REEFS, V13, P151, DOI 10.1007/BF00301191; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dlugokencky E., 2013, TRENDS ATMOSPHERIC C; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabricius KE, 2004, ECOL APPL, V14, P1448, DOI 10.1890/03-5320; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Ford P, 2005, MAR POLLUT BULL, V51, P119, DOI 10.1016/j.marpolbul.2004.10.019; FREILE D, 1995, CORAL REEFS, V14, P27, DOI 10.1007/BF00304068; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gregg AK, 2013, PEERJ, V1, DOI 10.7717/peerj.107; Haas A, 2009, J EXP MAR BIOL ECOL, V380, P99, DOI 10.1016/j.jembe.2009.09.005; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Haas AF, 2010, AQUAT BIOL, V10, P131, DOI 10.3354/ab00271; Haas AF, 2010, J EXP MAR BIOL ECOL, V389, P53, DOI 10.1016/j.jembe.2010.03.018; Haas AF, 2010, MAR ECOL PROG SER, V409, P27, DOI 10.3354/meps08631; Hauri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012685; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann LC, 2014, PLANTA, V239, P231, DOI 10.1007/s00425-013-1982-1; Jokiel P, 1978, CORAL GROWTH BUOYANT; Kleypas J a, 2005, WORK HELD 18 20 APR; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; MARSHALL JF, 1988, CORAL REEFS, V6, P139, DOI 10.1007/BF00302010; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; MULTER HG, 1988, CORAL REEFS, V6, P179, DOI 10.1007/BF00302014; Nelson CE, 2013, ISME J, V7, P962, DOI 10.1038/ismej.2012.161; Nusch E.A., 1980, ARCH HYDROBIOLOGIE B, V14, P14; Packett R, 2009, MAR POLLUT BULL, V58, P976, DOI 10.1016/j.marpolbul.2009.02.017; PAINTER HA, 1959, J BIOCHEM MICROBIOL, V1, P143, DOI 10.1002/jbmte.390010203; Piontek J, 2010, BIOGEOSCIENCES, V7, P1615, DOI 10.5194/bg-7-1615-2010; Price NN, 2011, MAR ECOL PROG SER, V440, P67, DOI 10.3354/meps09309; Rees SA, 2007, CORAL REEFS, V26, P177, DOI 10.1007/s00338-006-0166-x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Robbins L, 2010, 20101280 US GEOL SUR, V7, DOI DOI 10.1007/978-3-642-52335-9_1; Robbins L. L., 2009, BIOGEOSCI DISCUSS, V6, P4895, DOI DOI 10.5194/bgd-6-4895-2009; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Rusch A, 2006, AQUAT GEOCHEM, V12, P1, DOI 10.1007/s10498-005-0784-x; Schaffelke B, 2008, WATER QUALITY AND EC; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; Sinutok S, 2012, CORAL REEFS, V31, P1201, DOI 10.1007/s00338-012-0952-6; Sinutok S, 2011, LIMNOL OCEANOGR, V56, P1200, DOI 10.4319/lo.2011.56.4.1200; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Uthicke S, 2012, GLOBAL CHANGE BIOL, V18, P2781, DOI 10.1111/j.1365-2486.2012.02715.x; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Vogel N, 2012, J EXP MAR BIOL ECOL, V424, P15, DOI 10.1016/j.jembe.2012.05.008; Vroom PS, 2003, HYDROBIOLOGIA, V501, P149, DOI 10.1023/A:1026287816324; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; WEFER G, 1980, NATURE, V285, P323, DOI 10.1038/285323a0; Wild C, 2005, MAR ECOL PROG SER, V287, P87, DOI 10.3354/meps287087; Wild C, 2008, 11 INT COR REEF S, P7; Witt V, 2011, ENVIRON MICROBIOL, V13, P2976, DOI 10.1111/j.1462-2920.2011.02571.x	64	8	9	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133596	10.1371/journal.pone.0133596	http://dx.doi.org/10.1371/journal.pone.0133596			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267650	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300018
J	Ocana, S; Seoane, P; Bautista, R; Palomino, C; Claros, GM; Torres, AM; Madrid, E				Ocana, Sara; Seoane, Pedro; Bautista, Rocio; Palomino, Carmen; Claros, Gonzalo M.; Torres, Ana M.; Madrid, Eva			Large-Scale Transcriptome Analysis in Faba Bean (Vicia faba L.) under Ascochyta fabae Infection	PLOS ONE			English	Article							DISEASE RESISTANCE; BLIGHT RESISTANCE; HIGH-THROUGHPUT; GENES; IDENTIFICATION; QTLS; SEQUENCE; GENOME; DISCOVERY; PROTEINS	Faba bean is an important food crop worldwide. However, progress in faba bean genomics lags far behind that of model systems due to limited availability of genetic and genomic information. Using the Illumina platform the faba bean transcriptome from leaves of two lines (29H and Vf136) subjected to Ascochyta fabae infection have been characterized. De novo transcriptome assembly provided a total of 39,185 different transcripts that were functionally annotated, and among these, 13,266 were assigned to gene ontology against Arabidopsis. Quality of the assembly was validated by RT-qPCR amplification of selected transcripts differentially expressed. Comparison of faba bean transcripts with those of better-characterized plant genomes such as Arabidopsis thaliana, Medicago truncatula and Cicer arietinum revealed a sequence similarity of 68.3%, 72.8% and 81.27%, respectively. Moreover, 39,060 single nucleotide polymorphism (SNP) and 3,669 InDels were identified for genotyping applications. Mapping of the sequence reads generated onto the assembled transcripts showed that 393 and 457 transcripts were overexpressed in the resistant (29H) and susceptible genotype (Vf136), respectively. Transcripts involved in plant-pathogen interactions such as leucine rich proteins (LRR) or plant growth regulators involved in plant adaptation to abiotic and biotic stresses were found to be differently expressed in the resistant line. The results reported here represent the most comprehensive transcript database developed so far in faba bean, providing valuable information that could be used to gain insight into the pathways involved in the resistance mechanism against A. fabae and to identify potential resistance genes to be further used in marker assisted selection.	[Ocana, Sara; Palomino, Carmen; Torres, Ana M.] IFAPA Ctr Alameda Obispo, Area Mejora & Biotecnol, E-14080 Cordoba, Spain; [Seoane, Pedro; Claros, Gonzalo M.] Univ Malaga, Dept Biol Mol & Bioquim, E-29071 Malaga, Spain; [Bautista, Rocio; Claros, Gonzalo M.] Univ Malaga, Plataforma Andaluza Bioinformat, E-29071 Malaga, Spain; [Madrid, Eva] CSIC, Inst Sustainable Agr, E-14080 Cordoba, Spain	Universidad de Malaga; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Torres, AM (corresponding author), IFAPA Ctr Alameda Obispo, Area Mejora & Biotecnol, Apdo 3092, E-14080 Cordoba, Spain.	anam.torres.romero@juntadeandalucia.es	Torres, Ana M./C-5660-2016; Bautista, Rocio/L-1155-2014; Claros, Manuel Gonzalo/K-2274-2014; Torres, Ana M./ABE-7989-2021; Madrid, Eva/O-7587-2019; Moreno, Rocío Bautista/P-7143-2019; Madrid, Eva/L-4910-2014	Torres, Ana M./0000-0002-2907-4287; Bautista, Rocio/0000-0003-1685-8119; Claros, Manuel Gonzalo/0000-0002-0112-3550; Torres, Ana M./0000-0002-2907-4287; Madrid, Eva/0000-0001-8257-9156; Moreno, Rocío Bautista/0000-0003-1685-8119; Madrid, Eva/0000-0001-8257-9156; Seoane Zonjic, Pedro/0000-0002-3020-1415	European Community [FP7-613551]; Programa Operativo de Crecimiento Inteligente [RTA2013-00025]; ERDF [RTA2010-00059, IPT-2011-1259-010000, P10-CVI-6075]; Andalusian regional government	European Community(European Commission); Programa Operativo de Crecimiento Inteligente; ERDF(European Commission); Andalusian regional government	This research was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under the grant agreement noFP7-613551, LEGATO project; the 2014-2020 "Programa Operativo de Crecimiento Inteligente" (RTA2013-00025) and RTA2010-00059, the IPT-2011-1259-010000 project and the P10-CVI-6075, all co-financed by ERDF and the last by the Andalusian regional government.	Almeida NF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00178; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avila CM, 2004, THEOR APPL GENET, V108, P1071, DOI 10.1007/s00122-003-1514-7; Avila CM, 2003, THEOR APPL GENET, V107, P353, DOI 10.1007/s00122-003-1254-8; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; Bevan M, 2005, GENOME RES, V15, P1632, DOI 10.1101/gr.3723405; Bogdanova EA, 2008, MOL BIOSYST, V4, P205, DOI 10.1039/b715110c; Bohra A, 2014, THEOR APPL GENET, P1; BOND DA, 1994, CURR PLANT SCI BIOT, V19, P592; Cottage A, 2012, MOL BREEDING, V30, P1799, DOI 10.1007/s11032-012-9745-4; Cruz-Izquierdo S, 2012, THEOR APPL GENET, V125, P1767, DOI 10.1007/s00122-012-1952-1; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Rojas-Molina MD, 2007, PHYTOPATHOLOGY, V97, P60, DOI 10.1094/PHYTO-97-0060; Derksen H, 2013, PLANT SCI, V207, P79, DOI 10.1016/j.plantsci.2013.03.004; Diaz-Ruiz R, 2009, CROP PASTURE SCI, V60, P353, DOI 10.1071/CP08190; Diaz-Ruiz R, 2010, THEOR APPL GENET, V120, P909, DOI 10.1007/s00122-009-1220-1; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Doyle JJ, 2003, PLANT PHYSIOL, V131, P900, DOI 10.1104/pp.102.018150; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; Fofana B, 2005, PHYTOPATHOLOGY, V95, P114, DOI 10.1094/PHYTO-95-0114; Fondevilla S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-28; Graham MA, 2004, PLANT PHYSIOL, V135, P1179, DOI 10.1104/pp.104.037531; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Gutierrez N, 2013, MOL BREEDING, V32, P909, DOI 10.1007/s11032-013-9920-2; Gutierrez N, 2011, MOL BREEDING, V28, P13, DOI 10.1007/s11032-010-9456-7; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Hospital F, 2009, GENETICA, V136, P303, DOI 10.1007/s10709-008-9307-1; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Humphry M, 2011, MOL PLANT PATHOL, V12, P866, DOI [10.1111/J.1364-3703.2011.00718.X, 10.1111/j.1364-3703.2011.00718.x]; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; Kaur S, 2014, PLANT SCI, V217, P47, DOI 10.1016/j.plantsci.2013.11.014; Kaur S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-104; Khazaei H, 2014, THEOR APPL GENET, V127, P2371, DOI 10.1007/s00122-014-2383-y; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kudapa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086039; Kumar J, 2011, PLANT BREEDING, V130, P297, DOI 10.1111/j.1439-0523.2011.01851.x; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2002, CURR PROTOC BIOINFOR; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin HN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-41; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Ma Y, 2013, PLANT BREEDING, V132, P397, DOI 10.1111/pbr.12074; Madrid E, 2012, PLANT CELL REP, V31, P1033, DOI 10.1007/s00299-011-1221-9; Madrid E, 2013, PHYTOPATHOL MEDITERR, V52, P166; MAURIN N, 1992, PLANT PATHOL, V41, P737, DOI 10.1111/j.1365-3059.1992.tb02557.x; MAXTED N, 1991, PLANT SYST EVOL, V177, P221, DOI 10.1007/BF00937959; Nakano RT, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00073; Nelson JC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-352; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; PRITCHARD PR, 1989, PLANT PATHOL, V38, P266, DOI 10.1111/j.1365-3059.1989.tb02142.x; Rejeb Ines Ben, 2014, Plants (Basel), V3, P458, DOI 10.3390/plants3040458; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roman B, 2003, AUST J AGR RES, V54, P85, DOI 10.1071/AR02034; Roman B, 2002, GENOME, V45, P1057, DOI 10.1139/G02-082; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Rozen S, 2000, Methods Mol Biol, V132, P365; Satovic Z, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-932; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Seoane P, CURR BIOINFO J INPRE, P20015; Sillero JC, 2001, PLANT BREEDING, V120, P529, DOI 10.1046/j.1439-0523.2001.00653.x; Tivoli B, 1998, FABIS NEWSLETTER, V21, P36; Torres AM, 2010, FIELD CROP RES, V115, P243, DOI 10.1016/j.fcr.2008.12.002; Torres AM, 2012, GENETICS GENOMICS AN; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Varshney RK, 2013, BIOTECHNOL ADV, V31, P1120, DOI 10.1016/j.biotechadv.2013.01.001; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Wan JR, 2008, PLANT SIGNAL BEHAV, V3, P831, DOI 10.4161/psb.3.10.5916; Witcombe JRaE W., 1984, THE HAGUE; Yang T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-602; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	75	33	35	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135143	10.1371/journal.pone.0135143	http://dx.doi.org/10.1371/journal.pone.0135143			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267359	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300082
J	Gamil, AAA; Evensen, O; Mutoloki, S				Gamil, Amr A. A.; Evensen, Oystein; Mutoloki, Stephen			Infection Profiles of Selected Aquabirnavirus Isolates in CHSE Cells	PLOS ONE			English	Article							PANCREATIC NECROSIS VIRUS; GENOME SEGMENT-A; IN-VITRO; ANTIVIRAL ACTIVITY; ANGUILLA-JAPONICA; SEQUENCE-ANALYSIS; FISH VIRUSES; MARINE FISH; KAPPA-B; INTERFERON	The wide host range and antigenic diversity of aquabirnaviruses are reflected by the presence of a collection of isolates with different sero- and genotypic properties that have previously been classified as such. Differences in cytopathogenic mechanisms and host responses induced by these isolates have not been previously examined. In the present study, we investigated infection profiles induced by genetically and serologically closely related as well as distant isolates in-vitro. CHSE-214 cells were infected with either E1S (serotype A3, genogroup 3), VR-299 (serotype A1, genogroup 1), highly virulent Sp (TA) or avirulent Sp (PT) (serotype A2, genogroup 5). The experiments were performed at temperatures most optimum for each of the isolates namely 15 degrees C for VR-299, TA and PT strains and 20 degrees C for E1S. Differences in virus loads and ability to induce cytopathic effect, inhibition of protein synthesis, apoptosis, and induction of IFNa, Mx1, PKR or TNF alpha gene expression at different times post infection were examined. The results showed on one hand, E1S with the highest ability to replicate, induce apoptosis and IFNa gene expression while VR-299 inhibited protein synthesis and induced Mx1 and PKR gene expression the most. The two Sp isolates induced the highest TNFa gene expression but differed in their ability to replicate, inhibit protein synthesis, and induce gene expression, with TA being more superior. Collectively, these findings point towards the adaptation by different virus isolates to suit environments and hosts that they patronize. Furthermore, the results also suggest that genetic identity is not prerequisite to functional similarities thus results of one aquabirnavirus isolate cannot necessarily be extrapolated to another.	[Gamil, Amr A. A.; Evensen, Oystein; Mutoloki, Stephen] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Fac Vet Med & Biosci, N-0033 Oslo, Norway	Norwegian University of Life Sciences	Mutoloki, S (corresponding author), Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Fac Vet Med & Biosci, POB 8146, N-0033 Oslo, Norway.	stephen.mutoloki@nmbu.no	Evensen, Øystein/O-3011-2015	Evensen, Øystein/0000-0002-4856-3043; Gamil, Amr/0000-0001-9920-6487	Norwegian University of Life Sciences "Aquaculture initiative"; Research Council of Norway (RCN) [183204]	Norwegian University of Life Sciences "Aquaculture initiative"; Research Council of Norway (RCN)(Research Council of Norway)	This study was supported by funds from the Norwegian University of Life Sciences "Aquaculture initiative" and partly by the Research Council of Norway (RCN) project no. 183204 "Indo-Norwegian platform on fish and shellfish vaccine development (VaccInAqua)". The grant recipient was OE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzberger S, 2010, J VIROL, V84, P11994, DOI 10.1128/JVI.00653-10; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Blake S, 2001, DIS AQUAT ORGAN, V45, P89, DOI 10.3354/dao045089; Chen LH, 2014, J VIROL METHODS, V195, P228, DOI 10.1016/j.jviromet.2013.10.020; Chung IYW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198812; Collet B, 2007, FISH SHELLFISH IMMUN, V22, P44, DOI 10.1016/j.fsi.2006.03.011; Dobos Peter, 1995, Annual Review of Fish Diseases, V5, P25, DOI 10.1016/0959-8030(95)00003-8; DUNCAN R, 1986, NUCLEIC ACIDS RES, V14, P5934, DOI 10.1093/nar/14.14.5934; DUNCAN R, 1987, J VIROL, V61, P3655, DOI 10.1128/JVI.61.12.3655-3664.1987; DUNCAN R, 1991, VIROLOGY, V181, P541, DOI 10.1016/0042-6822(91)90887-H; Espinoza JC, 2005, VIRUS RES, V109, P133, DOI 10.1016/j.virusres.2004.10.014; Gadan K, 2013, PLOS ONE, P8; Gamil AAA, 2015, VIRUSES-BASEL, V7, P1987, DOI 10.3390/v7041987; HAAGMANS BL, 1994, J VIROL, V68, P2297, DOI 10.1128/JVI.68.4.2297-2304.1994; HEDRICK RP, 1986, DIS AQUAT ORGAN, V1, P219; HEPPELL J, 1995, J GEN VIROL, V76, P2091, DOI 10.1099/0022-1317-76-8-2091; Hill B. J., 1995, Annual Review of Fish Diseases, V5, P55, DOI 10.1016/0959-8030(95)00011-9; Hong JR, 1998, VIROLOGY, V250, P76, DOI 10.1006/viro.1998.9347; HOSONO N, 1994, J FISH DIS, V17, P433, DOI 10.1111/j.1365-2761.1994.tb00239.x; Isshiki T, 2001, DIS AQUAT ORGAN, V46, P109, DOI 10.3354/dao046109; Jensen I, 2002, FISH SHELLFISH IMMUN, V13, P221, DOI 10.1006/fsim.2001.0397; John KR, 1999, J GEN VIROL, V80, P2061, DOI 10.1099/0022-1317-80-8-2061; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kim SH, 2015, VIRUS RES, V195, P203, DOI 10.1016/j.virusres.2014.10.013; Kleinschmidt MC, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-49; LANNAN CN, 1984, IN VITRO CELL DEV B, V20, P671, DOI 10.1007/BF02618871; Lester K, 2012, J VIROL METHODS, V182, P1, DOI 10.1016/j.jviromet.2012.01.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo ME, 2001, SEMIN IMMUNOL, V13, P1, DOI 10.1006/smim.2000.0290; MACDONALD RD, 1981, VIROLOGY, V114, P414, DOI 10.1016/0042-6822(81)90222-1; MAGYAR G, 1994, VIROLOGY, V204, P580, DOI 10.1006/viro.1994.1572; Makibelo CM, 2010, THESIS NORWEGIAN SCH; NICHOLSON BL, 1971, J GEN VIROL, V13, P369, DOI 10.1099/0022-1317-13-2-369; Nishizawa T, 2005, J GEN VIROL, V86, P1973, DOI 10.1099/vir.0.80438-0; RIMSTAD E, 2003, IPN SALMONIDS REV, P17; ROBERTS TE, 1983, J GEN VIROL, V64, P331, DOI 10.1099/0022-1317-64-2-331; Robertsen B, 2003, J INTERF CYTOK RES, V23, P601, DOI 10.1089/107999003322485107; Saint-Jean SR, 2006, VET IMMUNOL IMMUNOP, V110, P1, DOI 10.1016/j.vetimm.2005.08.023; SANO T, 1981, J FISH DIS, V4, P127, DOI 10.1111/j.1365-2761.1981.tb01117.x; Santi N, 2005, VIROLOGY, V342, P13, DOI 10.1016/j.virol.2005.07.028; Santi N, 2004, VIROLOGY, V322, P31, DOI 10.1016/j.virol.2003.12.016; Skjesol A, 2009, VIRUS RES, V143, P53, DOI 10.1016/j.virusres.2009.03.004; Song HC, 2005, J VIROL, V79, P10289, DOI 10.1128/JVI.79.16.10289-10299.2005; SORIMACHI M, 1985, Fish Pathology, V19, P231; Wang WL, 2011, FISH SHELLFISH IMMUN, V31, P10, DOI 10.1016/j.fsi.2011.01.015; Wang WL, 2011, PLOS ONE, P6; WOLF K, 1963, VIROLOGY, V21, P317, DOI 10.1016/0042-6822(63)90192-2; WOLF K, 1962, SCIENCE, V135, P1065, DOI 10.1126/science.135.3508.1065; WU JL, 1987, B I ZOOL ACAD SINICA, V26, P201; Zhang CX, 2004, J FISH DIS, V27, P633, DOI 10.1111/j.1365-2761.2004.00585.x; Zou J, 2011, DEV COMP IMMUNOL, V35, P1376, DOI 10.1016/j.dci.2011.07.001	52	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134173	10.1371/journal.pone.0134173	http://dx.doi.org/10.1371/journal.pone.0134173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263557	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300022
J	Kang, SC; Kim, SK; Chai, JC; Kim, SH; Won, KJ; Lee, YS; Jung, KH; Chai, YG				Kang, Sung Chul; Kim, Se Kye; Chai, Jin Choul; Kim, Sun Hwa; Won, Kyoung-Jae; Lee, Young Seek; Jung, Kyoung Hwa; Chai, Young Gyu			Transcriptomic Profiling and H3K27me3 Distribution Reveal Both Demethylase-Dependent and Independent Regulation of Developmental Gene Transcription in Cell Differentiation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; RETINOIC ACID; NEURAL STEM; EPIGENETIC REGULATION; FUNCTIONAL-ANALYSIS; RNA-SEQ; JMJD3; UTX; PLURIPOTENT; EXPRESSION	The removal of histone H3 trimethylation at lysine residue 27 (H3K27me3) plays a critical role in the transcriptional initiation of developmental genes. The H3K27me3-specific KDM6 demethylases JMJD3 and UTX are responsible for the transcriptional initiation of various developmental genes, but some genes are expressed in a KDM6 demethylase-independent manner. To address the role of H3K27me3 in the retinoic acid (RA)-induced differentiation of the human carcinoma NCCIT cell line, we inhibited JMJD3 and UTX using the H3K27me3 demethylase inhibitor GSK-J4. The commitment of JMJD3/UTX-inhibited cells to a specific fate was delayed, and transcriptome profiling also revealed the differential expression of genes related to cell fate specification in demethylase-inactivated cells; the expression levels of RA metabolism and HOX family genes significantly decreased. We observed a weak correlation between H3K27me3 enrichment and transcriptional repression in the control and JMJD/UTX-inhibited cells, except for a few sets of developmental genes that are indispensable for cell fate specification. Taken together, these results provide the H3K27me3 landscape of a differentiating cell line and suggest that both demethylase-dependent and demethylase-independent transcriptional regulation play a role in early differentiation and developmental gene expression activated by H3K27me3 demethylation.	[Kang, Sung Chul; Kim, Sun Hwa; Chai, Young Gyu] Hanyang Univ, Dept Nanobiotechnol, Seoul 133791, South Korea; [Kim, Se Kye; Chai, Jin Choul; Lee, Young Seek; Jung, Kyoung Hwa; Chai, Young Gyu] Hanyang Univ, Dept Mol & Life Sci, Ansan, South Korea; [Won, Kyoung-Jae] Univ Penn, Perelman Sch Med, Smilow Ctr Translat Res, Inst Diabet Obes & Metab,Genet Dept, Philadelphia, PA 19104 USA	Hanyang University; Hanyang University; University of Pennsylvania; Pennsylvania Medicine	Jung, KH (corresponding author), Hanyang Univ, Dept Mol & Life Sci, Ansan, South Korea.	khjung2@gmail.com; ygchai@hanyang.ac.kr	Kim, Sun/GSN-4867-2022	Won, Kyoung Jae/0000-0002-2924-9630	National Research Foundation of Korea - Korean Government [20110030049]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by by grant 20110030049 from the National Research Foundation of Korea (www.nrf.re.kr) funded by the Korean Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Akizu N, 2010, DEVELOPMENT, V137, P2915, DOI 10.1242/dev.049395; ANDREWS PW, 1986, DIFFERENTIATION, V31, P119, DOI 10.1111/j.1432-0436.1986.tb00392.x; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Burgold T, 2012, CELL REP, V2, P1244, DOI 10.1016/j.celrep.2012.09.013; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Choi MR, 2011, ARCH TOXICOL, V85, P293, DOI 10.1007/s00204-010-0591-z; Dai JP, 2010, J CELL BIOCHEM, V110, P1457, DOI 10.1002/jcb.22703; DAMJANOV I, 1993, LAB INVEST, V68, P220; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Fuchs H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111637; Gouti M, 2008, STEM CELLS, V26, P1985, DOI 10.1634/stemcells.2008-0182; Halder D, 2015, HUM EXP TOX IN PRESS; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jiang W, 2013, CELL RES, V23, P122, DOI 10.1038/cr.2012.119; Jung KH, 2010, TOXICOL IN VITRO, V24, P1696, DOI 10.1016/j.tiv.2010.05.017; Kashyap V, 2010, J BIOL CHEM, V285, P14534, DOI 10.1074/jbc.M110.115345; KENYON C, 1994, CELL, V78, P175, DOI 10.1016/0092-8674(94)90288-7; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lane AA, 2014, NAT GENET, V46, P618, DOI 10.1038/ng.2949; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langston AW, 1997, J BIOL CHEM, V272, P2167, DOI 10.1074/jbc.272.4.2167; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LEWIS EB, 1992, JAMA-J AM MED ASSOC, V267, P1524, DOI 10.1001/jama.267.11.1524; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Mortazavi A, NAT METHODS; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Park DH, 2014, CELL REP, V8, P1290, DOI 10.1016/j.celrep.2014.07.060; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Ramadoss S, 2012, J BIOL CHEM, V287, P44508, DOI 10.1074/jbc.M112.424903; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; Shpargel KB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004507; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Smith S, 2014, FASEB J, P28; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stewart R, 2004, STEM CELLS DEV, V13, P646, DOI 10.1089/scd.2004.13.646; Torres CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060020; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Villasante A, 2011, CELL CYCLE, V10, P1488, DOI 10.4161/cc.10.9.15658; Walport LJ, 2014, J BIOL CHEM, V289, P18302, DOI 10.1074/jbc.M114.555052; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Wang K, 2009, CLONING STEM CELLS, V11, P483, DOI 10.1089/clo.2009.0019; Watson M, 2014, CYTOM PART A, V85A, P78, DOI 10.1002/cyto.a.22344; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237	63	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135276	10.1371/journal.pone.0135276	http://dx.doi.org/10.1371/journal.pone.0135276			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263556	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300070
J	Liu, CL; Qin, SS; Xu, H; Xu, LJ; Zhao, D; Liu, XC; Lang, SL; Feng, XJ; Liu, HM				Liu, Cailin; Qin, Shangshang; Xu, Hui; Xu, Lijuan; Zhao, Di; Liu, Xuchun; Lang, Shaolei; Feng, Xianju; Liu, Hong-Min			New Delhi Metallo-beta-Lactamase 1(NDM-1), the Dominant Carbapenemase Detected in Carbapenem-Resistant Enterobacter cloacae from Henan Province, China	PLOS ONE			English	Article							EMERGENCE; SPREAD; OUTBREAK; GENES	The emergence of New Delhi metallo-beta-lactamase 1 (NDM-1) has become established as a major public health threat and represents a new challenge in the treatment of infectious diseases. In this study, we report a high incidence and endemic spread of NDM-1-producing carbapenem-resistant Enterobacter cloacae isolates in Henan province, China. Eight (72.7%) out of eleven non-duplicated carbapenem-resistant E. cloacae isolates collected between June 2011 and May 2013 were identified as NDM-1 positive. The bla(NDM-1) gene surrounded by an entire ISAba125 element and a bleomycin resistance gene ble(MBL) in these isolates were carried by diverse conjugatable plasmids (IncA/C, IncN, IncHI2 and untypeable) ranging from similar to 55 to similar to 360 kb. Molecular epidemiology analysis revealed that three NDM-1-producing E. cloacae belonged to the same multilocus sequence type (ST), ST120, two of which were classified as extensively drug-resistant (XDR) isolates susceptible only to tigecycline and colistin. The two XDR ST120 E. cloacae isolates co-harbored bla(NDM-1), armA and fosA3 genes and could transfer resistance to carbapenems, fosfomycin and aminoglycosides simultaneously via a conjugation experiment. Our study demonstrated NDM-1 was the most prevalent metallo-beta-lactamase (MBL) among carbapenem-resistant E. cloacae isolates and identified a potential endemic clone of ST120 in Henan province. These findings highlight the need for enhanced efforts to monitor the further spread of NDM-1 and XDR ST120 E. cloacae in this region.	[Liu, Cailin; Xu, Hui; Xu, Lijuan; Feng, Xianju] Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Lab, Zhengzhou 450052, Peoples R China; [Liu, Cailin; Xu, Hui; Xu, Lijuan; Feng, Xianju] Henan Prov Key Lab Med, Zhengzhou, Peoples R China; [Qin, Shangshang; Zhao, Di; Liu, Hong-Min] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450052, Peoples R China; [Liu, Xuchun] Cent Hosp Zhumadian City, Dept Clin Lab, Zhumadian, Peoples R China; [Lang, Shaolei] Cent Hosp Sanmenxia City, Dept Clin Lab, Sanmenxia, Peoples R China	Zhengzhou University; Zhengzhou University	Feng, XJ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Lab, Zhengzhou 450052, Peoples R China.	xjfeng62688@163.com; liuhm@zzu.edu.cn		Qin, Shangshang/0000-0002-6017-6548	Medical Science and Technique Foundation of Henan Province [112102310165, 201303046]	Medical Science and Technique Foundation of Henan Province	Funding provided by Medical Science and Technique Foundation of Henan Province (Grant no. 112102310165 and no. 201303046).	BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bennett JW, 2009, ANTIMICROB AGENTS CH, V53, P292, DOI 10.1128/AAC.00931-08; Bogaerts P, 2013, J ANTIMICROB CHEMOTH, V68, P2414, DOI 10.1093/jac/dkt201; Borgia S, 2012, CLIN INFECT DIS, V55, pE109, DOI 10.1093/cid/cis737; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Doi Y, 2007, CLIN INFECT DIS, V45, P88, DOI 10.1086/518605; Doyle D, 2012, J CLIN MICROBIOL, V50, P3877, DOI 10.1128/JCM.02117-12; Heller I, 2012, J MED MICROBIOL, V61, P567, DOI 10.1099/jmm.0.038646-0; Izdebski R, 2015, J ANTIMICROB CHEMOTH, V70, P48, DOI 10.1093/jac/dku359; Leflon-Guibout V, 2004, ANTIMICROB AGENTS CH, V48, P3736, DOI 10.1128/AAC.48.10.3736-3742.2004; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Miyoshi-Akiyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066358; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P6065, DOI 10.1128/AAC.00117-12; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Qin SS, 2014, ANTIMICROB AGENTS CH, V58, P4275, DOI 10.1128/AAC.02813-13; Rafailidis PI, 2014, CURR OPIN INFECT DIS, V27, P479, DOI 10.1097/QCO.0000000000000109; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106555; Villa J, 2014, INT J ANTIMICROB AG, V43, P451, DOI 10.1016/j.ijantimicag.2014.02.006; Wang B, 2015, J ANTIMICROB CHEMOTH, V70, P611, DOI 10.1093/jac/dku405; Wang XJ, 2014, MICROB DRUG RESIST, V20, P144, DOI 10.1089/mdr.2013.0100; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; Yan JJ, 2002, J ANTIMICROB CHEMOTH, V50, P503, DOI 10.1093/jac/dkf170; Yang FC, 2012, J CLIN MICROBIOL, V50, P223, DOI 10.1128/JCM.01263-11; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064857	27	32	39	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135044	10.1371/journal.pone.0135044	http://dx.doi.org/10.1371/journal.pone.0135044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263489	Green Submitted, Green Published, gold			2022-12-27	WOS:000359353300053
J	Wang, AQ; Chen, JD; Jing, CW; Ye, GQ; Wu, JP; Huang, ZX; Zhou, CS				Wang, Anqi; Chen, Jiadai; Jing, Changwei; Ye, Guanqiong; Wu, Jiaping; Huang, Zhixing; Zhou, Chaosheng			Monitoring the Invasion of Spartina alterniflora from 1993 to 2014 with Landsat TM and SPOT 6 Satellite Data in Yueqing Bay, China	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; PLANT INVASION; SALT-MARSHES; CLASSIFICATION; PLANTATIONS; CONSEQUENCES; JIANGSU	The exotic plant Spartina alterniflora was introduced to Yueqing Bay more than 20 years ago for tidal land reclamation and as a defense against typhoons, but it has rapidly expanded and caused enormous ecological consequences. Mapping the spread and distribution of S. alterniflora is the first step toward understanding the factors that determine the population expansion patterns. Remote sensing is a promising tool to monitor the expansion of S. alterniflora. Twelve Landsat TM images and Support Vector Machine (SVM) were used to delineate the invasion of S. alterniflora from 1993 to 2009, and SPOT 6 images and Object-Based Image Analysis (OBIA) were used to map the distribution of S. alterniflora in 2014. In situ data and Unmanned Aerial Vehicle (UAV) images were used as supplementary data. S. alterniflora spread rapidly in Yueqing Bay over the past 21 years. Between 1993 and 2009, the area of S. alterniflora increased by 608 times (from 4 to 2432 ha). The rapid expansion of S. alterniflora covered almost all of the bare mudflats around the mangrove forests and the cultivated mudflats. However, from 2009 to 2014, the rate of expansion of S. alterniflora began to slow down in Yueqing Bay, and the total area of S. alterniflora in Yantian decreased by 275 ha. These phenomena can be explained by the landscape changes and ecological niches. Through the expansion of S. alterniflora, it was found that the ecological significance and environmental impact of S. alterniflora was different in different regions in Yueqing Bay. The conservation plans for Yueqing Bay should consider both the positive and negative effects of S. alterniflora, and the governmental policy should be based on the different circumstances of the regions.	[Wang, Anqi; Chen, Jiadai; Jing, Changwei; Ye, Guanqiong; Wu, Jiaping] Zhejiang Univ, Inst Islands & Coastal Ecosyst, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Zhixing; Zhou, Chaosheng] Zhejiang Mariculture Res Inst, Wenzhou, Peoples R China	Zhejiang University	Jing, CW (corresponding author), Zhejiang Univ, Inst Islands & Coastal Ecosyst, Hangzhou 310003, Zhejiang, Peoples R China.	changweij@zju.edu.cn	Wu, Jiaping/AAD-8800-2022		Fundamental Research Funds for the Central Universities; International Science & Technology Cooperation Program of China [2015DFA01410]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); International Science & Technology Cooperation Program of China	This project was supported by the Fundamental Research Funds for the Central Universities and the International Science & Technology Cooperation Program of China (grant no. 2015DFA01410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LWJ, 2007, J AQUAT PLANT MANAGE, V45, P100; [Anonymous], 2000, ESA BULL-EUR SPACE; Baatz M., 2004, ECOGNITION PROFESSIO; Baatz M., 2000, P ANGEW GEOGRAPHISCH, P12, DOI [DOI 10.3390/RS5010183, 10.1207/s15326888chc1304_3]; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Calvino-Cancela M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102381; Chen LZ, 2009, J PLANT ECOL, V2, P45, DOI 10.1093/jpe/rtp009; Chen Z, 2006, INT J REMOTE SENS, V27, P4991, DOI 10.1080/01431160600658131; CHUNG CH, 1993, ECOL ENG, V2, P261, DOI 10.1016/0925-8574(93)90019-C; Chung CH, 2006, ECOL ENG, V27, P49, DOI 10.1016/j.ecoleng.2005.09.012; Cohen WB, 2004, BIOSCIENCE, V54, P535, DOI 10.1641/0006-3568(2004)054[0535:LRIEAO]2.0.CO;2; CRIST EP, 1984, IEEE T GEOSCI REMOTE, V22, P256, DOI 10.1109/TGRS.1984.350619; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Davis HG, 2004, J ECOL, V92, P321, DOI 10.1111/j.0022-0477.2004.00873.x; Foody GM, 2004, IEEE T GEOSCI REMOTE, V42, P1335, DOI 10.1109/TGRS.2004.827257; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Gao S, 2014, SCI CHINA EARTH SCI, V57, P2567, DOI 10.1007/s11430-014-4954-9; Gavier-Pizarro GI, 2012, REMOTE SENS ENVIRON, V122, P134, DOI 10.1016/j.rse.2011.09.023; Grevstad FS, 2012, ENVIRON ENTOMOL, V41, P448, DOI 10.1603/EN11243; Hellmann M, 2015, HDB SPACE SECURITY, P831; Huang H, 2007, ECOL ENG, V29, P164, DOI 10.1016/j.ecoleng.2006.06.005; Im J, 2008, GISCI REMOTE SENS, V45, P209, DOI 10.2747/1548-1603.45.2.209; Lee JY, 2006, INT J REMOTE SENS, V27, P3403, DOI 10.1080/01431160600606866; Leonard LA, 2006, ESTUAR COAST SHELF S, V69, P325, DOI 10.1016/j.ecss.2006.05.004; Levin LA, 2006, ECOLOGY, V87, P419, DOI 10.1890/04-1752; Li B, 2009, ECOL ENG, V35, P511, DOI 10.1016/j.ecoleng.2008.05.013; Liu HY, 2014, ECOL RES, V29, P905, DOI 10.1007/s11284-014-1181-y; Liu J, 2007, ECOL ENG, V30, P240, DOI 10.1016/j.ecoleng.2007.01.010; Lu JB, 2013, ECOL ENG, V52, P175, DOI 10.1016/j.ecoleng.2012.12.107; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Myint SW, 2011, REMOTE SENS ENVIRON, V115, P1145, DOI 10.1016/j.rse.2010.12.017; Ouyang ZT, 2011, ECOL INFORM, V6, P136, DOI 10.1016/j.ecoinf.2011.01.002; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Pfauth M, 2007, OREGON SPARTINA RESP; Qin P, 1998, ECOL ENG, V11, P147, DOI 10.1016/S0925-8574(98)00030-5; Qin P, 1997, ECOL ENG, V8, P5, DOI 10.1016/S0925-8574(96)00227-3; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schmidt KS, 2003, REMOTE SENS ENVIRON, V85, P92, DOI 10.1016/S0034-4257(02)00196-7; Su Y, 2004, VISION IMAGE SIGNAL; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Vitousek PM, 1996, AM SCI, V84, P468; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; Zhang RS, 2004, ECOL ENG, V23, P95, DOI 10.1016/j.ecoleng.2004.07.007; Zhang YH, 2012, ECOLOGY, V93, P588, DOI 10.1890/11-1302.1; Zuo P, 2012, ECOL ENG, V40, P160, DOI 10.1016/j.ecoleng.2011.12.014	47	38	43	7	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135538	10.1371/journal.pone.0135538	http://dx.doi.org/10.1371/journal.pone.0135538			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263172	Green Submitted, gold, Green Published			2022-12-27	WOS:000359353300091
J	Grashorn, W; Schunke, O; Buhmann, C; Forkmann, K; Diedrich, S; Wesemann, K; Bingel, U				Grashorn, Wiebke; Schunke, Odette; Buhmann, Carsten; Forkmann, Katarina; Diedrich, Sabrina; Wesemann, Katharina; Bingel, Ulrike			Influence of Dopaminergic Medication on Conditioned Pain Modulation in Parkinson's Disease Patients	PLOS ONE			English	Article							NOXIOUS INHIBITORY CONTROLS; AGE-RELATED DIFFERENCES; BASAL GANGLIA; DORSAL-HORN; DEPRESSION; LEVODOPA; STIMULATION; PROGRESSION; THRESHOLD; SEROTONIN	Background Pain is highly prevalent in patients with Parkinson's disease (PD), but little is known about the underlying pathophysiological mechanisms. The susceptibility to pain is known to depend on ascending and descending pathways. Because parts of the descending pain inhibitory system involve dopaminergic pathways, dysregulations in dopaminergic transmission might contribute to altered pain processing in PD. Deficits in endogenous pain inhibition can be assessed using conditioned pain modulation (CPM) paradigms. Methods Applying such a paradigm, we investigated i) whether CPM responses differ between PD patients and healthy controls, ii) whether they are influenced by dopaminergic medication and iii) whether there are effects of disease-specific factors. 25 patients with idiopathic PD and 30 healthy age-and gender-matched controls underwent an established CPM paradigm combining heat pain test stimuli at the forearm and the cold pressor task on the contralateral foot as the conditioning stimulus. PD patients were tested under dopaminergic medication and after at least 12 hours of medication withdrawal. Results No significant differences between CPM responses of PD patients and healthy controls or between PD patients "on" and "off" medication were found. These findings suggest (i) that CPM is insensitive to dopaminergic modulations and (ii) that PD is not related to general deficits in descending pain inhibition beyond the known age-related decline. However, at a trend level, we found differences between PD subtypes (akinetic-rigid, tremor-dominant, mixed) with the strongest impairment of pain inhibition in the akinetic-rigid subtype. Conclusions There were no significant differences between CPM responses of patients compared to healthy controls or between patients "on" and "off" medication. Differences between PD subtypes at a trend level point towards different pathophysiological mechanisms underlying the three PD subtypes which warrant further investigation and potentially differential therapeutic strategies in the future.	[Grashorn, Wiebke; Schunke, Odette; Buhmann, Carsten; Diedrich, Sabrina; Wesemann, Katharina] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Forkmann, Katarina; Bingel, Ulrike] Univ Duisburg Essen, Fac Med, Neurol Clin, Essen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Duisburg Essen	Grashorn, W (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	w.grashorn@uke.uni-hamburg.de			German Research Foundation [SFB 936/1]; German Parkinson foundation (Deutsche Parkinson Vereinigung (dpv) e.V.; LIIRA Grant by Pfizer	German Research Foundation(German Research Foundation (DFG)); German Parkinson foundation (Deutsche Parkinson Vereinigung (dpv) e.V.; LIIRA Grant by Pfizer	This work was supported by grants from the German Research Foundation (SFB 936/1,(UB)), the German Parkinson foundation (Deutsche Parkinson Vereinigung (dpv) e.V. (WG)) and the LIIRA Grant by Pfizer (UB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnow BA, 2006, PSYCHOSOM MED, V68, P262, DOI 10.1097/01.psy.0000204851.15499.fc; Baumann CR, 2014, MOVEMENT DISORD, V29, P207, DOI 10.1002/mds.25650; Becker S, 2013, EUR J NEUROSCI, V38, P3080, DOI 10.1111/ejn.12303; Beiske AG, 2009, PAIN, V141, P173, DOI 10.1016/j.pain.2008.12.004; Benarroch EE, 2008, NEUROLOGY, V71, P217, DOI 10.1212/01.wnl.0000318225.51122.63; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Borsook D, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-27; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brefel-Courbon C, 2005, MOVEMENT DISORD, V20, P1557, DOI 10.1002/mds.20629; Brichta L, 2013, TRENDS NEUROSCI, V36, P543, DOI 10.1016/j.tins.2013.06.003; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Brooks DJ, 2000, J NEUROL NEUROSUR PS, V68, P685, DOI 10.1136/jnnp.68.6.685; Burkey AR, 1999, J NEUROSCI, V19, P4169; Castillo RC, 2013, PAIN; CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016/0304-3959(94)00172-B; Conte A, 2013, NAT REV NEUROL, V9, P687, DOI 10.1038/nrneurol.2013.224; Contin M, 2010, J NEUROL, V257, pS253, DOI 10.1007/s00415-010-5728-8; Cormier S, 2013, J PAIN, V14, P114, DOI 10.1016/j.jpain.2012.10.006; Djaldetti R, 2004, NEUROLOGY, V62, P2171, DOI 10.1212/01.WNL.0000130455.38550.9D; Edwards RR, 2003, PAIN, V101, P155, DOI 10.1016/S0304-3959(02)00324-X; Eggers C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046813; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Fil A, 2013, PARKINSONISM RELAT D, V19, P285, DOI 10.1016/j.parkreldis.2012.11.009; Ford B, 2010, MOVEMENT DISORD, V25, pS98, DOI 10.1002/mds.22716; Ford B, 2009, NAT REV NEUROL, V5, P242, DOI 10.1038/nrneurol.2009.50; Fox SH, 2009, MOVEMENT DISORD, V24, P1255, DOI 10.1002/mds.22473; Garcia-Ruiz PJ, 2014, J NEUROL SCI, V338, P30, DOI 10.1016/j.jns.2014.01.002; Gerdelat-Mas A, 2007, J NEUROL NEUROSUR PS, V78, P1140, DOI 10.1136/jnnp.2007.120212; Goffaux P, 2007, PAIN, V130, P137, DOI 10.1016/j.pain.2006.11.011; Granovsky Y, 2013, EUR J NEUROL, V20, P1375, DOI 10.1111/ene.12188; Grashorn W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075629; Ha AD, 2012, MOVEMENT DISORD, V27, P485, DOI 10.1002/mds.23959; Hagelberg N, 2004, EUR J PHARMACOL, V500, P187, DOI 10.1016/j.ejphar.2004.07.024; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Kalbe E, 2008, PARKINSONISM RELAT D, V14, P93, DOI 10.1016/j.parkreldis.2007.06.008; Kang GA, 2005, MOVEMENT DISORD, V20, P1133, DOI 10.1002/mds.20513; Lariviere M, 2007, CLIN J PAIN, V23, P506, DOI 10.1097/AJP.0b013e31806a23e8; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Lewis GN, 2012, PAIN RES MANAG, V17, P98, DOI 10.1155/2012/610561; Lim SY, 2008, MOVEMENT DISORD, V23, P1689, DOI 10.1002/mds.22111; Marras C, 2013, J NEUROL NEUROSUR PS, V84, P409, DOI 10.1136/jnnp-2012-303455; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Moont R, 2011, PAIN, V152, P1469, DOI 10.1016/j.pain.2011.01.036; Mylius V, 2009, J NEUROL NEUROSUR PS, V80, P24, DOI 10.1136/jnnp.2008.145995; Nir RR, 2012, PAIN, V153, P170, DOI 10.1016/j.pain.2011.10.010; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; PAULUS W, 1991, J NEUROPATH EXP NEUR, V50, P743, DOI 10.1097/00005072-199111000-00006; Piche M, 2009, J NEUROSCI, V29, P14236, DOI 10.1523/JNEUROSCI.2341-09.2009; Potvin S, 2009, J PAIN, V10, P969, DOI 10.1016/j.jpain.2009.03.013; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Quittenbam BH, 2004, PARKINSONISM RELAT D, V10, P129, DOI 10.1016/j.parkreldis.2003.12.001; RILEY D, 1989, J NEUROL NEUROSUR PS, V52, P63, DOI 10.1136/jnnp.52.1.63; Sandrini G, 2006, CEPHALALGIA, V26, P782, DOI 10.1111/j.1468-2982.2006.01130.x; SCHOUENBORG J, 1985, BRAIN RES, V328, P23, DOI 10.1016/0006-8993(85)91318-6; Sprenger C, 2011, PAIN, V152, P428, DOI 10.1016/j.pain.2010.11.018; Starkstein SE, 1998, MOVEMENT DISORD, V13, P29, DOI 10.1002/mds.870130109; Thenganatt MA, 2014, JAMA NEUROL, V71, P499, DOI 10.1001/jamaneurol.2013.6233; Tinazzi M, 2008, PAIN, V136, P117, DOI 10.1016/j.pain.2007.06.022; Tolosa E, 2007, PARKINSONISM RELAT D, V13, pS2, DOI 10.1016/j.parkreldis.2007.06.007; Tracey I, 2012, CELL, V148, P1308, DOI 10.1016/j.cell.2012.03.004; Treister R, 2013, NEUROSCI LETT, V548, P115, DOI 10.1016/j.neulet.2013.05.041; Treister R, 2011, J PAIN, V12, P875, DOI 10.1016/j.jpain.2011.02.348; Washington LL, 2000, PAIN, V89, P89, DOI 10.1016/S0304-3959(00)00352-3; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b; Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	69	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135287	10.1371/journal.pone.0135287	http://dx.doi.org/10.1371/journal.pone.0135287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270817	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800048
J	Morioka, K; Fukai, K; Yoshida, K; Kitano, R; Yamazoe, R; Yamada, M; Nishi, T; Kanno, T				Morioka, Kazuki; Fukai, Katsuhiko; Yoshida, Kazuo; Kitano, Rie; Yamazoe, Reiko; Yamada, Manabu; Nishi, Tatsuya; Kanno, Toru			Development and Evaluation of a Rapid Antigen Detection and Serotyping Lateral Flow Antigen Detection System for Foot-and-Mouth Disease Virus	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; LINKED-IMMUNOSORBENT-ASSAY; SWINE VESICULAR DISEASE; CELL-LINE; JAPAN; EPIDEMIOLOGY; STRAIN	We developed a lateral flow strip using monoclonal antibodies (MAbs) which allows for rapid antigen detection and serotyping of foot-and-mouth disease virus (FMDV). This FMDV serotyping strip was able to detect all 7 serotypes and distinguish serotypes O, A, C and Asia1. Its sensitivities ranged from 10(3) to 10(4) of a 50% tissue culture infectious dose of each FMDV stain; this is equal to those of the commercial product Svanodip (Boehringer Ingelheim Svanova, Uppsala, Sweden), which can detect all seven serotypes of FMDV, but does not distinguish them. Our evaluation of the FMDV serotyping strip using a total of 118 clinical samples (vesicular fluids, vesicular epithelial emulsions and oral and/or nasal swabs) showed highly sensitive antigen detection and accuracy in serotyping in accordance with ELISA or RT-PCR. To the best of our knowledge, this is the first report on any FMDV serotyping strip that provides both rapid antigen detection and serotyping of FMDV at the same time on one strip without extra devices. This method will be useful in both FMD-free countries and FMD-infected countries, especially where laboratory diagnosis cannot be carried out.	[Morioka, Kazuki; Fukai, Katsuhiko; Yoshida, Kazuo; Kitano, Rie; Yamazoe, Reiko; Yamada, Manabu; Nishi, Tatsuya; Kanno, Toru] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Exot Dis Res Stn, Tokyo, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Kanno, T (corresponding author), Natl Agr & Food Res Org, Natl Inst Anim Hlth, Exot Dis Res Stn, Tokyo, Japan.	kannot@affrc.go.jp	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	scientific technique research promotion program for agriculture, forestry, fisheries and food industry [25044B]	scientific technique research promotion program for agriculture, forestry, fisheries and food industry	This study was supported by scientific technique research promotion program for agriculture, forestry, fisheries and food industry, grant No. 25044B (http://www.s.affrc.go.jp/docs/research_fund/2013/sinki_koubo_2013.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAPMAN WG, 1971, APPL MICROBIOL, V22, P1; Chen BJ, 1999, REV SCI TECH OIE, V18, P186, DOI 10.20506/rst.18.1.1154; Fukai K, 2015, ARCH VIROL, V160, P129, DOI 10.1007/s00705-014-2239-4; Fukai K, 2011, J VET MED SCI, V73, P1207, DOI 10.1292/jvms.11-0063; Hall MD, 2013, MBIO, V4, DOI 10.1128/mBio.00591-13; Huang CC, 2000, J VET MED SCI, V62, P677, DOI 10.1292/jvms.62.677; INOUE T, 1993, NUCLEIC ACIDS RES, V21, P3896, DOI 10.1093/nar/21.16.3896; Jamal SM, 2011, INFECT GENET EVOL, V11, P2049, DOI 10.1016/j.meegid.2011.09.015; Kanno T, 2002, VIRUS GENES, V25, P119, DOI 10.1023/A:1020103700108; Kitching RP, 2005, CURR TOP MICROBIOL, V288, P133; Klein J, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-122; Knight-Jones TJD, 2014, VACCINE, V32, P1848, DOI 10.1016/j.vaccine.2014.01.071; Knowles NJ, 2009, TRANSBOUND EMERG DIS, V56, P157, DOI 10.1111/j.1865-1682.2009.01074.x; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Longjam Neeta, 2011, Vet Med Int, V2011, P905768, DOI 10.4061/2011/905768; Mohapatra JK, 2007, J VIROL METHODS, V143, P117, DOI 10.1016/j.jviromet.2007.02.008; Morioka K, 2008, J VET MED SCI, V70, P653, DOI 10.1292/jvms.70.653; Morioka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094143; Morioka K, 2009, J CLIN MICROBIOL, V47, P3663, DOI 10.1128/JCM.00695-09; Office International des Epizooties, 2012, OIE MAN DIAGN TESTS, P190; OIE SEAFMD home page, MONTHL FMD MAPS COUN; Reid SM, 1998, J VIROL METHODS, V70, P213, DOI 10.1016/S0166-0934(97)00181-X; ROEDER PL, 1987, RES VET SCI, V43, P225, DOI 10.1016/S0034-5288(18)30778-1; Sakamoto K, 2002, J VET MED SCI, V64, P91, DOI 10.1292/jvms.64.91; STOKER M, 1964, NATURE, V203, P1355, DOI 10.1038/2031355a0; TOKUI T, 1975, NATL I ANIM HEALTH Q, V15, P165	26	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134931	10.1371/journal.pone.0134931	http://dx.doi.org/10.1371/journal.pone.0134931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270053	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800024
J	Rockwell, CA; Guariguata, MR; Menton, M; Quispe, EA; Quaedvlieg, J; Warren-Thomas, E; Silva, HF; Rojas, EEJ; Arrunategui, JAHK; Vega, LAM; Vera, OR; Hancco, RQ; Tito, JFV; Panduro, BTV; Salas, JJY				Rockwell, Cara A.; Guariguata, Manuel R.; Menton, Mary; Arroyo Quispe, Eriks; Quaedvlieg, Julia; Warren-Thomas, Eleanor; Fernandez Silva, Harol; Jurado Rojas, Edwin Eduardo; Kohagura Arrunategui, Jose Andres Hideki; Meza Vega, Luis Alberto; Revilla Vera, Olivia; Quenta Hancco, Roger; Valera Tito, Jonatan Frank; Villarroel Panduro, Betxy Tabita; Yucra Salas, Juan Jose			Nut Production in Bertholletia excelsa across a Logged Forest Mosaic: Implications for Multiple Forest Use	PLOS ONE			English	Article							MADRE-DE-DIOS; LAND-COVER CHANGE; TROPICAL FORESTS; RAIN-FOREST; POPULATION-STRUCTURE; TIMBER PRODUCTION; SEED DISPERSAL; BRAZIL NUTS; TREES; MANAGEMENT	Although many examples of multiple-use forest management may be found in tropical smallholder systems, few studies provide empirical support for the integration of selective timber harvesting with non-timber forest product (NTFP) extraction. Brazil nut (Bertholletia excelsa, Lecythidaceae) is one of the world's most economically-important NTFP species extracted almost entirely from natural forests across the Amazon Basin. An obligate out-crosser, Brazil nut flowers are pollinated by large-bodied bees, a process resulting in a hard round fruit that takes up to 14 months to mature. As many smallholders turn to the financial security provided by timber, Brazil nut fruits are increasingly being harvested in logged forests. We tested the influence of tree and stand-level covariates (distance to nearest cut stump and local logging intensity) on total nut production at the individual tree level in five recently logged Brazil nut concessions covering about 4000 ha of forest in Madre de Dios, Peru. Our field team accompanied Brazil nut harvesters during the traditional harvest period (January-April 2012 and January-April 2013) in order to collect data on fruit production. Three hundred and ninety-nine (approximately 80%) of the 499 trees included in this study were at least 100 m from the nearest cut stump, suggesting that concessionaires avoid logging near adult Brazil nut trees. Yet even for those trees on the edge of logging gaps, distance to nearest cut stump and local logging intensity did not have a statistically significant influence on Brazil nut production at the applied logging intensities (typically 1-2 timber trees removed per ha). In one concession where at least 4 trees ha-1 were removed, however, the logging intensity covariate resulted in a marginally significant (0.09) P value, highlighting a potential risk for a drop in nut production at higher intensities. While we do not suggest that logging activities should be completely avoided in Brazil nut rich forests, when	[Rockwell, Cara A.; Guariguata, Manuel R.; Menton, Mary; Arroyo Quispe, Eriks; Quaedvlieg, Julia; Warren-Thomas, Eleanor; Fernandez Silva, Harol; Jurado Rojas, Edwin Eduardo; Kohagura Arrunategui, Jose Andres Hideki; Meza Vega, Luis Alberto; Revilla Vera, Olivia; Quenta Hancco, Roger; Valera Tito, Jonatan Frank; Villarroel Panduro, Betxy Tabita; Yucra Salas, Juan Jose] Ctr Int Forestry Res CIFOR, Lima, Peru; [Rockwell, Cara A.] Florida Int Univ FIU, Dept Earth & Environm, Int Ctr Trop Bot, Miami, FL USA; [Menton, Mary] Solut & Evidence Environm & Dev SEED, Oxford, England; [Arroyo Quispe, Eriks; Fernandez Silva, Harol; Jurado Rojas, Edwin Eduardo; Kohagura Arrunategui, Jose Andres Hideki; Meza Vega, Luis Alberto; Revilla Vera, Olivia; Quenta Hancco, Roger; Valera Tito, Jonatan Frank; Villarroel Panduro, Betxy Tabita; Yucra Salas, Juan Jose] Univ Nacl Amazonica Madre de Dios UNAMAD, Fac Ingn Forestal & Medio Ambiente, Puerto Maldonado, Madre De Dios, Peru; [Warren-Thomas, Eleanor] Univ E Anglia, Sch Environm Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England	CGIAR; Center for International Forestry Research (CIFOR); State University System of Florida; Florida International University; Universidad Nacional Amazonica De Madre De Dios; University of East Anglia	Rockwell, CA (corresponding author), Ctr Int Forestry Res CIFOR, Lima, Peru.	rockwell_cara@yahoo.com		Quaedvlieg, Julia/0000-0003-4412-6759; Warren-Thomas, Eleanor/0000-0001-5746-1738; Menton, Mary/0000-0002-9892-2657; Jurado Rojas, Edwin Eduardo/0000-0003-1102-3438; Rockwell, Cara/0000-0003-4873-2529	United States Agency for International Development (USAID); CGIAR Research Program on Forests, Trees and Agroforestry	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); CGIAR Research Program on Forests, Trees and Agroforestry(CGIAR)	This work was funded by the United States Agency for International Development (USAID) and the CGIAR Research Program on Forests, Trees and Agroforestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher GS, 2009, ECOL ECON, V68, P1787, DOI 10.1016/j.ecolecon.2008.11.018; Baraloto C., 2007, Ethnobotany Research and Applications, V5, P77; Baraloto C, 2014, ECOL SOC, V19, DOI 10.5751/ES-06911-190456; Barreto P, 1998, FOREST ECOL MANAG, V108, P9, DOI 10.1016/S0378-1127(97)00251-X; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beneker C., 2010, ETFRN News, P59; Brienen RJW, 2006, J ECOL, V94, P481, DOI 10.1111/j.1365-2745.2005.01080.x; Camargo P. B. de, 1994, Scientia Agricola, V51, P389; Cano W., 2014, LAND USE POLICY, V39, P224; Cavalcante M.C., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/978019; Cerdan Rojas C, 2007, ILLEGAL LOGGING INT; Chambers JQ, 1998, NATURE, V391, P135, DOI 10.1038/34325; CLAY J.W., 1997, HARVESTING WILD SPEC, P246; Corvera-Gomringer R, 2010, CASTANA AMAZONICA BE; Coslovsky SV, 2014, WORLD DEV, V54, P32, DOI 10.1016/j.worlddev.2013.07.012; Cossio-Solano RE, 2011, 56 CIFOR; Cronkleton P, 2012, FOREST ECOL MANAG, V268, P49, DOI 10.1016/j.foreco.2011.04.035; Denslow JS, 1998, J ECOL, V86, P597, DOI 10.1046/j.1365-2745.1998.00295.x; Duchelle AE, 2014, SOC NATUR RESOUR, V27, P121, DOI 10.1080/08941920.2013.840022; Duchelle AE, 2014, WORLD DEV, V55, P53, DOI 10.1016/j.worlddev.2013.01.014; Duchelle AE, 2012, FOREST ECOL MANAG, V268, P39, DOI 10.1016/j.foreco.2011.05.023; Dykstra D.P., 1996, FAO MODEL CODE FORES; Fearnside PM, 2001, WORLD DEV, V29, P1361, DOI 10.1016/S0305-750X(01)00039-0; Fonseca MG, 2009, BIOTROPICA, V41, P179, DOI 10.1111/j.1744-7429.2008.00480.x; Fortini LB, 2014, J FOREST ECON, V20, P223, DOI 10.1016/j.jfe.2014.06.001; Fredericksen TS, 2000, FOREST ECOL MANAG, V131, P47, DOI 10.1016/S0378-1127(99)00199-1; Garcia-Fernandez C, 2008, FOREST ECOL MANAG, V256, P1468, DOI 10.1016/j.foreco.2008.04.029; Garrish V., 2014, REDD GROUND CASE BOO, P147; Ghazoul J, 1998, J ECOL, V86, P462, DOI 10.1046/j.1365-2745.1998.00270.x; Ghazoul J, 2001, PLANT ECOL, V153, P335, DOI 10.1023/A:1017542124699; Giudice R, 2012, ECOL ECON, V77, P158, DOI 10.1016/j.ecolecon.2012.02.024; Griscom BW, 2006, J TROP ECOL, V22, P587, DOI 10.1017/S0266467406003361; Griscom BW, 2003, FOREST ECOL MANAG, V175, P445, DOI 10.1016/S0378-1127(02)00214-1; Guariguata MR, 2010, FOREST ECOL MANAG, V259, P237, DOI 10.1016/j.foreco.2009.11.013; Guariguata MR, 2009, FOREST ECOL MANAG, V258, P788, DOI 10.1016/j.foreco.2009.05.022; Guariguata MR, 2002, FOREST ECOL MANAG, V167, P285, DOI 10.1016/S0378-1127(01)00700-9; HARTSHORN GS, 1995, ANNU REV ECOL SYST, V26, P155, DOI 10.1146/annurev.es.26.110195.001103; Haugaasen JMT, 2012, BIOTROPICA, V44, P205, DOI 10.1111/j.1744-7429.2011.00796.x; Haugaasen T, 2010, MAMMALIA, V74, P423, DOI 10.1515/MAMM.2010.054; Herault B, 2010, J APPL ECOL, V47, P821, DOI 10.1111/j.1365-2664.2010.01826.x; Herrero-Jauregui C, 2013, J ENVIRON MANAGE, V130, P40, DOI 10.1016/j.jenvman.2013.08.044; Holmes TP, 2002, FOREST ECOL MANAG, V163, P93, DOI 10.1016/S0378-1127(01)00530-8; Humphries S, 2012, ECOL ECON, V77, P62, DOI 10.1016/j.ecolecon.2011.10.018; JOHNS AD, 1988, BIOTROPICA, V20, P31, DOI 10.2307/2388423; Johns JS, 1996, FOREST ECOL MANAG, V89, P59, DOI 10.1016/S0378-1127(96)03869-8; Kainer KA, 2006, J TROP ECOL, V22, P147, DOI 10.1017/S0266467405002981; Kainer KA, 2007, FOREST ECOL MANAG, V250, P244, DOI 10.1016/j.foreco.2007.05.024; Kainer KA, 2014, J APPL ECOL, V51, P655, DOI 10.1111/1365-2664.12231; Klimas CA, 2012, FOREST ECOL MANAG, V268, P81, DOI 10.1016/j.foreco.2011.03.006; Lawrence A, 2003, INT FOREST REV, V5, P87, DOI 10.1505/IFOR.5.2.87.17411; Lawrence A, 2005, BIODIVERS CONSERV, V14, P45, DOI 10.1007/s10531-005-4050-8; Licona JC, 2010, MONITOREO CASTANA TR; Lima E, 2006, ENVIRONMENT, V48, P26, DOI 10.3200/ENVT.48.1.26-38; MALMER A, 1990, FOREST ECOL MANAG, V38, P1, DOI 10.1016/0378-1127(90)90081-L; Maues MM, 2002, CONSERVATION LINK AG, P245; Menton MCS, 2009, ECOL SOC, V14; Mori S. A., 1990, Advances in Economic Botany, V8, P130; Muller CH, 1980, MISCELANEA, V2, P1; Nabe-Nielsen J, 2009, FOREST ECOL MANAG, V257, P987, DOI 10.1016/j.foreco.2008.10.033; ORTIZ E. G., 2002, TAPPING GREEN MARKET, P61; Padoch C., 1996, CURRENT ISSUES NONTI, P103; Panayotou, 1992, NOT TIMBER ALONE EC; Pattanayak SK, 2001, LAND ECON, V77, P595, DOI 10.2307/3146943; Pearce D, 2003, FOREST ECOL MANAG, V172, P229, DOI 10.1016/S0378-1127(01)00798-8; Peres CA, 1997, J TROP ECOL, V13, P595, DOI 10.1017/S0266467400010749; Peres CA, 2003, SCIENCE, V302, P2112, DOI 10.1126/science.1091698; Perz SG, 2013, LAND USE POLICY, V34, P27, DOI 10.1016/j.landusepol.2013.01.009; Phillips OL, 2006, CONSERV BIOL, V20, P1698, DOI 10.1111/j.1523-1739.2006.00523.x; Pinard M, 1996, BIOTROPICA, V28, P2, DOI 10.2307/2388766; PINARD MA, 1995, J FOREST, V93, P41; Pinedo-Vasquez M, 2001, HUM ECOL, V29, P219, DOI 10.1023/A:1011064031078; Pires JM, 1984, AMAZON LIMNOLOGY LAN, P581, DOI DOI 10.1007/978-94-009-6542-3; Plumptre A. J., 1995, Commonwealth Forestry Review, V74, P253; Putz FE, 2012, CONSERV LETT, V5, P296, DOI 10.1111/j.1755-263X.2012.00242.x; Quaedvlieg J, 2014, J RURAL STUD, V33, P41, DOI 10.1016/j.jrurstud.2013.10.004; Rist L, 2012, FOREST ECOL MANAG, V268, P57, DOI 10.1016/j.foreco.2011.04.037; Rockwell CA, 2007, FOREST ECOL MANAG, V242, P108, DOI 10.1016/j.foreco.2006.12.028; Ros-Tonen M. A. F., 2005, Forests, Trees and Livelihoods, V15, P129; Rubio F, 2000, ESTUDIO PRELIMINAR D; Sabogal C, 2013, 173 FAO; Salomao Rafael De Paiva, 1991, Boletim do Museu Paraense Emilio Goeldi Serie Botanica, V7, P47; Santos Silva V, 2014, THESIS U FEDERAL ACR; Schulze M, 2008, FOREST ECOL MANAG, V256, P1443, DOI 10.1016/j.foreco.2008.02.051; Schulze M, 2006, FOREST ECOL MANAG, V236, P56, DOI 10.1016/j.foreco.2006.08.333; Scullion JJ, 2014, BIOL CONSERV, V171, P247, DOI 10.1016/j.biocon.2014.01.036; Sears RR, 2011, DEV CHANGE, V42, P609, DOI 10.1111/j.1467-7660.2011.01697.x; Shackleton S, 2007, INT FOREST REV, V9, P697, DOI 10.1505/ifor.9.3.697; Shanley P, 2012, FOREST ECOL MANAG, V268, P70, DOI 10.1016/j.foreco.2011.05.041; Shearman P, 2012, BIOL CONSERV, V151, P17, DOI 10.1016/j.biocon.2011.10.036; Sheil D, 2002, CONSERV ECOL, V6; Shepard GH, 2011, ECON BOT, V65, P44, DOI 10.1007/s12231-011-9151-6; Sist P, 1998, FOREST ECOL MANAG, V108, P251, DOI 10.1016/S0378-1127(98)00228-X; Soriano M., 2012, FOREST ECOL MANAG, V268, P39, DOI DOI 10.1016/J.FORECO.2011.05.023; Staudhammer CL, 2013, OECOLOGIA, V173, P45, DOI 10.1007/s00442-013-2603-1; Sujii PS, 2015, CONSERV GENET, V16, P955, DOI 10.1007/s10592-015-0714-4; Synnott TJ, 1979, TROPICAL FORESTRY PA, V14; Terborgh J, 2000, CONSERV BIOL, V14, P1358, DOI 10.1046/j.1523-1739.2000.00136.x; Tobler M, 2007, BIODIVERS CONSERV, V16, P659, DOI 10.1007/s10531-005-3373-9; Tobler MW, 2009, J TROP ECOL, V25, P261, DOI 10.1017/S0266467409005896; Tonini H, 2008, FLORESTA, P38; Trivedi MR, 2004, BIOTROPICA, V36, P118, DOI 10.1111/j.1744-7429.2004.tb00302.x; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Viana VM, 1998, FLORESTA AMAZONICA D, P277; Vidal E, 1997, FOREST ECOL MANAG, V98, P105, DOI 10.1016/S0378-1127(97)00051-0; Vieira S, 2005, P NATL ACAD SCI USA, V102, P18502, DOI 10.1073/pnas.0505966102; Wadt LHO, 2005, FOREST ECOL MANAG, V211, P371, DOI 10.1016/j.foreco.2005.02.061; Wadt LHO, 2008, SUSTAINABLE FOREST U; Zenteno M, 2014, ENVIRON SCI POLICY, V40, P36, DOI 10.1016/j.envsci.2014.03.006; Zenteno M, 2013, FOREST POLICY ECON, V26, P12, DOI 10.1016/j.forpol.2012.09.011; Zuidema PA, 2002, J TROP ECOL, V18, P1, DOI 10.1017/S0266467402002018; Zuidema PA, 2003, PROMAB SCI SERIES, V6	111	30	31	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135464	10.1371/journal.pone.0135464	http://dx.doi.org/10.1371/journal.pone.0135464			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271042	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000359492800077
J	Wennstrom, M; Surova, Y; Hall, S; Nilsson, C; Minthon, L; Hansson, O; Nielsen, HM				Wennstrom, Malin; Surova, Yulia; Hall, Sara; Nilsson, Christer; Minthon, Lennart; Hansson, Oskar; Nielsen, Henrietta M.			The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies	PLOS ONE			English	Article							NF-KAPPA-B; MILD COGNITIVE IMPAIRMENT; FIBRILLARY ACIDIC PROTEIN; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; EXPRESSION; BIOMARKERS; RECOMMENDATIONS; ASTROCYTES	A major difference in the revised diagnostic criteria for Alzheimer's disease (AD) is the incorporation of biomarkers to support a clinical diagnosis and allow the identification of preclinical AD due to AD neuropathological processes. However, AD-specific fluid biomarkers which specifically distinguish clinical AD dementia from other dementia disorders are still missing. Here we aimed to evaluate the disease-specificity of increased YKL-40 levels in cerebrospinal fluid (CSF) from AD patients with mild to moderate dementia (n = 49) versus Parkinson's disease (PD) (n = 61) and dementia with Lewy bodies (DLB) patients (n = 36), and non-demented controls (n = 44). Second we aimed to investigate whether altered YKL-40 levels are associated with CSF levels of other inflammation-associated molecules. When correcting for age, AD patients exhibited 21.3%, 27.7% and 38.8% higher YKL-40 levels compared to non-demented controls (p = 0.0283), DLB (p = 0.0027) and PD patients (p<0.0001). The AD-associated increase in YKL-40 was not associated with CSF P-tau, T-tau or A beta 42. No relationship between increased YKL-40 and levels of the astrocytic marker glial-fibrillary acidic protein (GFAP), interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1) and interferon gamma-induced protein 10 (IP-10) could be identified. Our results confirm previous reports of an age-associated increased in CSF YKL-40 levels and further demonstrate increased CSF YKL-40 in AD patients versus non-demented controls and patients with DLB or PD. The increase in YKL-40 levels in the AD patients was unrelated to the established CSF AD biomarkers and the inflammatory markers GFAP, MCP-1, IP-10 and IL-8, proposing YKL-40 as a marker of yet to be identified AD-related pathological processes.	[Wennstrom, Malin; Surova, Yulia; Hall, Sara; Nilsson, Christer; Minthon, Lennart; Hansson, Oskar; Nielsen, Henrietta M.] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden; [Surova, Yulia; Hall, Sara; Nilsson, Christer] Skane Univ Hosp, Dept Neurol, Lund, Sweden; [Minthon, Lennart; Hansson, Oskar] Skane Univ Hosp, Memory Clin, Malmo, Sweden; [Nielsen, Henrietta M.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Mayo Clinic	Wennstrom, M (corresponding author), Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden.	malin.wennstrom@med.lu.se	Nielsen, Henrietta M/B-1746-2013; Hansson, Oskar/A-7134-2013	Hansson, Oskar/0000-0001-8467-7286; Nielsen, Henrietta M/0000-0001-9664-7068	Swedish Dementia Foundation; Swedish Alzheimers Foundation; ALF	Swedish Dementia Foundation; Swedish Alzheimers Foundation; ALF	This study was supported by Swedish Dementia Foundation (HMN) (http://www.demensforbundet.se/se/stoed_oss/demensfonden); Swedish Alzheimers Foundation (HMN) (http://www.alzheimerfonden.se); ALF (LM) (http://www.med.lu.se/intramed/styrning_organisation/ekonomi_alf/alf_medel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Antonell A, 2014, J ALZHEIMERS DIS, V42, P901, DOI 10.3233/JAD-140624; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Balabanov R, 2007, J NEUROSCI, V27, P2013, DOI 10.1523/JNEUROSCI.4689-06.2007; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bonneh-Barkay D, 2012, BRAIN PATHOL, V22, P530, DOI 10.1111/j.1750-3639.2011.00550.x; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Coughlan CM, 2000, NEUROSCIENCE, V97, P591, DOI 10.1016/S0306-4522(00)00024-5; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; Fiandaca MS, 2014, ALZHEIMERS DEMENT, V10, pS196, DOI 10.1016/j.jalz.2014.04.015; Galimberti D, 2006, ARCH NEUROL-CHICAGO, V63, P538, DOI 10.1001/archneur.63.4.538; Galimberti D, 2006, NEUROLOGY, V66, P146, DOI 10.1212/01.wnl.0000191324.08289.9d; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Guijarro-Munoz I, 2014, J BIOL CHEM, V289, P2457, DOI 10.1074/jbc.M113.521161; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Jansson D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-104; Jesse S, 2009, J ALZHEIMERS DIS, V17, P541, DOI 10.3233/JAD-2009-1075; Johansen JS, 2006, CANCER EPIDEM BIOMAR, V15, P194, DOI 10.1158/1055-9965.EPI-05-0011; Liu C, 2014, INT J CLIN EXP PATHO, V7, P8342; Mattsson N, 2011, NEUROMOL MED, V13, P151, DOI 10.1007/s12017-011-8147-9; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Nielsen HM, 2014, J ALZHEIMERS DIS, V40, P343, DOI 10.3233/JAD-132246; Olsson B, 2013, MOVEMENT DISORD, V28, P1882, DOI 10.1002/mds.25589; Olsson B, 2013, J ALZHEIMERS DIS, V33, P45, DOI 10.3233/JAD-2012-120787; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Ramesh G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-72; Rehli M, 2003, J BIOL CHEM, V278, P44058, DOI 10.1074/jbc.M306792200; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Rosen C, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-20; Shimizu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122000; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; Tateno F, 2012, ALZ DIS ASSOC DIS, V26, P213, DOI 10.1097/WAD.0b013e31823899cc; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Wang XK, 1998, J NEUROCHEM, V71, P1194; Wennstrom M, 2012, J ALZHEIMERS DIS, V29, P125, DOI [10.3233/JAD-2011-111655, 10.3233/JAD-2012-111655]; Wennstrom M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053250, 10.1371/journal.pone.0109387]; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Wildsmith KR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-22; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003	46	70	74	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135458	10.1371/journal.pone.0135458	http://dx.doi.org/10.1371/journal.pone.0135458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270969	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800076
J	Brouns, SHA; Stassen, PM; Lambooij, SLE; Dieleman, J; Vanderfeesten, ITP; Haak, HR				Brouns, Steffie H. A.; Stassen, Patricia M.; Lambooij, Suze L. E.; Dieleman, Jeanne; Vanderfeesten, Irene T. P.; Haak, Harm R.			Organisational Factors Induce Prolonged Emergency Department Length of Stay in Elderly Patients - A Retrospective Cohort Study	PLOS ONE			English	Article							ADVERSE OUTCOMES; OLDER-ADULTS; PATIENTS SPEND; CARE; TIME; MORTALITY; TARGET; MEDICINE; NETHERLANDS; VALIDATION	Study objective To assess the association of patient and organisational factors with emergency department length of stay (ED-LOS) in elderly ED patients (226565 years old) and in younger patients (<65 years old). Methods A retrospective cohort study of internal medicine patients visiting the emergency department between September 1st 2010 and August 31st 2011 was performed. All emergency department visits by internal medicine patients 226565 years old and a random sample of internal medicine patients <65 years old were included. Organisational factors were defined as non-medical factors. ED-LOS is defined as the time between ED arrival and ED discharge or admission. Prolonged ED-LOS is defined as >= 75th percentile of ED-LOS in the study population, which was 208 minutes. Results Data on 1782 emergency department visits by elderly patients and 597 emergency department visits by younger patients were analysed. Prolonged ED-LOS in elderly patients was associated with three organisational factors: >1 consultation during the emergency department visit (odds ratio (OR) 3.2, 95% confidence interval (CI) 2.3-4.3), a higher number of diagnostic tests (OR 1.2, 95% CI 1.16-1.33) and evaluation by a medical student or non-trainee resident compared with a medical specialist (OR 4.2, 95% CI 2.0-8.8 and OR 2.3, 95% CI 1.4-3.9). In younger patients, prolonged ED-LOS was associated with >1 consultation (OR 2.6, 95% CI 1.4-4.6). Factors associated with shorter ED-LOS were arrival during nights or weekends as well as a high urgency level in elderly patients and self-referral in younger patients. Conclusion Organisational factors, such as a higher number of consultations and tests in the emergency department and a lower seniority of the physician, were the main aspects associated with prolonged ED-LOS in elderly patients. Optimisation of the organisation and coordination of emergency care is important to accommodate the needs of the continuously growing number of elderly patients in a better way.	[Brouns, Steffie H. A.; Lambooij, Suze L. E.; Haak, Harm R.] Maxima Med Ctr, Dept Internal Med, Eindhoven, Netherlands; [Stassen, Patricia M.; Haak, Harm R.] Maastricht Univ Med Ctr, Div Gen Med, Sect Acute Med, Dept Internal Med, Maastricht, Netherlands; [Dieleman, Jeanne] Maxima Med Ctr Acad, Maxima Med Ctr, Eindhoven, Netherlands; [Vanderfeesten, Irene T. P.] Eindhoven Univ Technol, Sch Ind Engn, NL-5600 MB Eindhoven, Netherlands; [Haak, Harm R.] Maastricht Univ, Dept Hlth Serv Res, Maastricht, Netherlands; [Haak, Harm R.] CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands	Maxima Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC); Maxima Medical Center; Eindhoven University of Technology; Maastricht University; Maastricht University	Brouns, SHA (corresponding author), Maxima Med Ctr, Dept Internal Med, Eindhoven, Netherlands.	S.Brouns@mmc.nl	Vanderfeesten, Irene/B-6181-2019	Vanderfeesten, Irene/0000-0002-6670-5519				Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; Asplin BR, 2003, ANN EMERG MED, V42, P173, DOI 10.1067/mem.2003.302; Barba R, 2006, EUR J INTERN MED, V17, P322, DOI 10.1016/j.ejim.2006.01.003; Becker DJ, 2007, HEALTH SERV RES, V42, P1589, DOI 10.1111/j.1475-6773.2006.00663.x; Becker David J, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P23, DOI 10.1586/14737167.8.1.23; Bernstein SL, 2003, ACAD EMERG MED, V10, P938, DOI 10.1197/S1069-6563(03)00311-7; Bernstein SL, 2006, EMERG MED CLIN N AM, V24, P821, DOI 10.1016/j.emc.2006.06.013; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Bucheli B, 2004, EUR J EMERG MED, V11, P29, DOI 10.1097/00063110-200402000-00006; Carr BG, 2011, ARCH SURG-CHICAGO, V146, P810, DOI 10.1001/archsurg.2011.60; Casalino E, 2014, EMERG MED J, V31, P361, DOI 10.1136/emermed-2012-202155; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; Cram P, 2004, AM J MED, V117, P151, DOI 10.1016/j.amjmed.2004.02.035; Di Bari M, 2010, J GERONTOL A-BIOL, V65, P159, DOI 10.1093/gerona/glp043; Ding R, 2010, ACAD EMERG MED, V17, P813, DOI 10.1111/j.1553-2712.2010.00812.x; Elmer J, 2012, NEUROCRIT CARE, V17, P334, DOI 10.1007/s12028-011-9629-1; Gnjidic D, 2012, J CLIN EPIDEMIOL, V65, P989, DOI 10.1016/j.jclinepi.2012.02.018; Hastings SN, 2008, J AM GERIATR SOC, V56, P1651, DOI 10.1111/j.1532-5415.2008.01840.x; Herring A, 2009, ACAD EMERG MED, V16, P609, DOI 10.1111/j.1553-2712.2009.00428.x; Hollander JE, 2007, ANN EMERG MED, V50, P497, DOI 10.1016/j.annemergmed.2007.05.002; Holmes JL, 2010, EMERG MED AUSTRALAS, V22, P75, DOI 10.1111/j.1742-6723.2009.01259.x; Hwang U, 2006, J AM GERIATR SOC, V54, P270, DOI 10.1111/j.1532-5415.2005.00587.x; Hwang U, 2011, ACAD EMERG MED, V18, P526, DOI 10.1111/j.1553-2712.2011.01054.x; Jones P, 2010, EMERG MED AUSTRALAS, V22, P391, DOI 10.1111/j.1742-6723.2010.01330.x; Kocher KE, 2012, ACAD EMERG MED, V19, P525, DOI 10.1111/j.1553-2712.2012.01353.x; Kocher KE, 2010, ACAD EMERG MED, V17, P1306, DOI 10.1111/j.1553-2712.2010.00932.x; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; Liew D, 2003, MED J AUSTRALIA, V179, P524, DOI 10.5694/j.1326-5377.2003.tb05676.x; Locker TE, 2005, BRIT MED J, V330, P1188, DOI 10.1136/bmj.38440.588449.AE; Mackway-Jones K, 2005, EMERGENCY TRIAGE; Mason S, 2012, ANN EMERG MED, V59, P341, DOI 10.1016/j.annemergmed.2011.08.017; McCarthy ML, 2011, ACAD EMERG MED, V18, P1269, DOI 10.1111/j.1553-2712.2011.01232.x; Needham DM, 2005, J CRIT CARE, V20, P12, DOI 10.1016/j.jcrc.2004.09.007; Rathlev NK, 2007, ANN EMERG MED, V49, P265, DOI 10.1016/j.annemergmed.2006.11.007; Retezar R, 2011, ANN EMERG MED, V57, P89, DOI 10.1016/j.annemergmed.2010.05.016; Richardson DB, 2006, MED J AUSTRALIA, V184, P213, DOI 10.5694/j.1326-5377.2006.tb00204.x; Roberts DC, 2008, ANN EMERG MED, V51, P769, DOI 10.1016/j.annemergmed.2007.09.011; Salvi F, 2007, INTERN EMERG MED, V2, P292, DOI 10.1007/s11739-007-0081-3; Salvi F, 2008, J AM GERIATR SOC, V56, P2131, DOI 10.1111/j.1532-5415.2008.01991.x; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015; Schull MJ, 2004, ANN EMERG MED, V44, P577, DOI 10.1016/j.annemergmed.2004.05.004; Singer AJ, 2011, ACAD EMERG MED, V18, P1324, DOI 10.1111/j.1553-2712.2011.01236.x; Thijssen WAMH, 2012, EMERG MED J, V29, P6, DOI 10.1136/emermed-2011-200090; Vegting IL, 2011, NETH J MED, V69, P392; Weber EJ, 2012, ANN EMERG MED, V60, P699, DOI 10.1016/j.annemergmed.2012.08.009; Weber EJ, 2011, ANN EMERG MED, V57, P79, DOI 10.1016/j.annemergmed.2010.08.013; Wilber ST, 2006, ACAD EMERG MED, V13, P1345, DOI 10.1197/j.aem.2006.09.050; Wilber ST, 2003, ACAD EMERG MED, V10, P251, DOI 10.1111/j.1553-2712.2003.tb01999.x	48	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135066	10.1371/journal.pone.0135066	http://dx.doi.org/10.1371/journal.pone.0135066			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267794	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300074
J	Gupta, B; Reddy, BPN; Fan, Q; Yan, GY; Sirichaisinthop, J; Sattabongkot, J; Escalante, AA; Cui, LW				Gupta, Bhavna; Reddy, B. P. Niranjan; Fan, Qi; Yan, Guiyun; Sirichaisinthop, Jeeraphat; Sattabongkot, Jetsumon; Escalante, Ananias A.; Cui, Liwang			Molecular Evolution of PvMSP3 alpha Block II in Plasmodium vivax from Diverse Geographic Origins	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; GENETIC DIVERSITY; MALARIA VACCINE; MITOCHONDRIAL GENOMES; BALANCING SELECTION; CANDIDATE ANTIGENS; NATURAL-SELECTION; POLYMORPHISM; FALCIPARUM; RECOMBINATION	Block II of Plasmodium vivax merozoite surface protein 3 alpha (PvMSP3 alpha) is conserved and has been proposed as a potential candidate for a malaria vaccine. The present study aimed to compare sequence diversity in PvMSP3a block II at a local microgeographic scale in a village as well as from larger geographic regions (countries and worldwide). Blood samples were collected from asymptomatic carriers of P. vivax in a village at the western border of Thailand and PvMSP3 alpha was amplified and sequenced. For population genetic analysis, 237 PvMSP3 alpha block II sequences from eleven P. vivax endemic countries were analyzed. PvMSP3 alpha sequences from 20 village-level samples revealed two length variant types with one type containing a large deletion in block I. In contrast, block II was relatively conserved; especially, some non-synonymous mutations were extensively shared among 11 parasite populations. However, the majority of the low-frequency synonymous variations were population specific. The conserved pattern of nucleotide diversity in block II sequences was probably due to functional/structural constraints, which were further supported by the tests of neutrality. Notably, a small region in block II that encodes a predicted B cell epitope was highly polymorphic and showed signs of balancing selection, signifying that this region might be influenced by the immune selection and may serve as a starting point for designing multi-antigen/stage epitope based vaccines against this parasite.	[Gupta, Bhavna; Reddy, B. P. Niranjan; Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Fan, Qi] Dalian Inst Biotechnol, Dalian, Liaoning, Peoples R China; [Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA; [Sirichaisinthop, Jeeraphat] Vector Borne Dis Training Ctr, Pra Budhabat 18120, Saraburi, Thailand; [Sattabongkot, Jetsumon] Mahidol Univ, Mahidol Vivax Res Unit, Fac Trop Med, Bangkok 10400, Thailand; [Escalante, Ananias A.] Temple Univ, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Irvine; Mahidol University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Cui, LW (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	luc2@psu.edu	Prachumsri, Jetsumon/AAZ-7732-2021	Sattabongkot, Jetsumon/0000-0002-3938-4588; Gupta, Bhavna/0000-0002-9037-9987	National Institutes of Health, US [U19AI089672, GM080586]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080586] Funding Source: NIH RePORTER	National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, US (http://www.nih.gov), grants U19AI089672 to LC and National Institutes of Health, US (http://www.nih.gov) GM080586 to AE.	Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barry AE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00359; Beeson JG, 2007, PLOS MED, V4, P1862, DOI 10.1371/journal.pmed.0040350; Belard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022525; Carvalho LJM, 2002, SCAND J IMMUNOL, V56, P327, DOI 10.1046/j.1365-3083.2002.01160.x; Cerritos R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-35; Chaudhuri R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-184; Chenet SM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-68; Conway DJ, 2002, PARASITOLOGY, V125, pS3, DOI 10.1017/S0031182002002214; Conway DJ, 1997, PARASITOL TODAY, V13, P26, DOI 10.1016/S0169-4758(96)10077-6; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Cui LW, 2003, AM J TROP MED HYG, V68, P613, DOI 10.4269/ajtmh.2003.68.613; de Sousa TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022944; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; Escalante AA, 2004, TRENDS PARASITOL, V20, P388, DOI 10.1016/j.pt.2004.06.002; Ezawa K, 2013, HEREDITY, V111, P364, DOI 10.1038/hdy.2013.59; Fluck C, 2004, INFECT IMMUN, V72, P6300, DOI 10.1128/IAI.72.11.6300-6305.2004; FU YX, 1993, GENETICS, V133, P693; Garzon-Ospina D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045962; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Giraldo MA, 2009, VACCINE, V28, P7, DOI 10.1016/j.vaccine.2009.09.046; Gomez A, 2006, PARASITOLOGY, V133, P661, DOI 10.1017/S0031182006001168; Gunasekera AM, 2007, MOL BIOL EVOL, V24, P939, DOI 10.1093/molbev/msm013; Herrera S, 2007, TRENDS PARASITOL, V23, P122, DOI 10.1016/j.pt.2007.01.008; HUDSON RR, 1985, GENETICS, V111, P147; Jiang JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063888; Kang JM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-104; Li PP, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-175; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mascorro CN, 2005, PARASITOLOGY, V131, P25, DOI 10.1017/S0031182005007547; Miao M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-22; Moon SU, 2009, ACTA TROP, V109, P30, DOI 10.1016/j.actatropica.2008.09.006; Mourao LC, 2012, MICROBES INFECT, V14, P730, DOI 10.1016/j.micinf.2012.02.011; Nam DH, 2010, AM J TROP MED HYG, V82, P522, DOI 10.4269/ajtmh.2010.08-0332; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 1987, MOL EVOLUTIONARY GEN; Ord R, 2005, MOL BIOCHEM PARASIT, V144, P86, DOI 10.1016/j.molbiopara.2005.08.005; Orjuela-Sanchez P, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-65; Pacheco MA, 2007, INFECT GENET EVOL, V7, P180, DOI 10.1016/j.meegid.2006.08.002; Pacheco M Andreina, 2012, Infect Genet Evol, V12, P978, DOI 10.1016/j.meegid.2012.02.009; Pacheco MA, 2010, INFECT GENET EVOL, V10, P655, DOI 10.1016/j.meegid.2010.03.013; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Parker DM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0712-5; Parobek CM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002796; Patarroyo MA, 2012, EXPERT REV VACCINES, V11, P1249, DOI [10.1586/ERV.12.91, 10.1586/erv.12.91]; Polley SD, 2003, GENETICS, V165, P555; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Putaporntip C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003336; Rayner JC, 2002, PARASITOLOGY, V125, P393, DOI 10.1017/S0031182002002317; Rice BL, 2014, MOL PHYLOGENET EVOL, V78, P172, DOI 10.1016/j.ympev.2014.05.013; Rice BL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-288; Rungsihirunrat K, 2011, TROP MED INT HEALTH, V16, P794, DOI 10.1111/j.1365-3156.2011.02771.x; SMITH JM, 1992, J MOL EVOL, V34, P126; Stanisic DI, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002498; TAJIMA F, 1989, GENETICS, V123, P585; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Takala SL, 2007, PLOS MED, V4, P523, DOI 10.1371/journal.pmed.0040093; Takala SL, 2007, AM J TROP MED HYG, V76, P855, DOI 10.4269/ajtmh.2007.76.855; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe K, 2007, MOL BIOCHEM PARASIT, V156, P74, DOI 10.1016/j.molbiopara.2007.07.002; Taylor JE, 2013, MOL BIOL EVOL, V30, P2050, DOI 10.1093/molbev/mst104; Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0; Wickramarachchi T, 2010, ANN TROP MED PARASIT, V104, P95, DOI 10.1179/136485910X12607012374190; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zeyrek FY, 2010, AM J TROP MED HYG, V83, P1230, DOI 10.4269/ajtmh.2010.10-0353	73	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135396	10.1371/journal.pone.0135396	http://dx.doi.org/10.1371/journal.pone.0135396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266539	Green Published, gold			2022-12-27	WOS:000359492300110
J	Meinema, JG; van Dijk, N; Beune, EJAJ; Jaarsma, DADC; van Weert, HCPM; Haafkens, JA				Meinema, Jennita G.; van Dijk, Nynke; Beune, Erik J. A. J.; Jaarsma, Debbie A. D. C.; van Weert, Henk C. P. M.; Haafkens, Joke A.			Determinants of Adherence to Treatment in Hypertensive Patients of African Descent and the Role of Culturally Appropriate Education	PLOS ONE			English	Article							SELF-EFFICACY SCALE; QUALITY-OF-CARE; MEDICATION ADHERENCE; MINORITY PATIENTS; BLOOD-PRESSURE; DEPRESSIVE SYMPTOMS; PREDICTIVE-VALIDITY; PATIENTS BELIEFS; GENERAL-PRACTICE; SURINAMESE	Background In Western countries, better knowledge about patient-related determinants of treatment adherence (medication and lifestyle) is needed to improve treatment adherence and outcomes among hypertensive ethnic minority patients of African descent. Objective To identify patient-related determinants of adherence to lifestyle and medication recommendations among hypertensive African Surinamese and Ghanaian patients with suboptimal treatment results (SBP >= 140) living in the Netherlands and how culturally appropriate hypertension education (CAHE) influenced those determinants. Methods This study analysed data of 139 patients who participated in the CAHE trial. Univariate logistic regression analysis was used to measure the association between patient-related determinants (medication self-efficacy, beliefs about medication and hypertension, social support, and satisfaction with care) and treatment adherence. We also tested whether CAHE influenced the determinants. Results Medication self-efficacy and social support were associated with medication adherence at baseline. At six months, more medication self-efficacy and fewer concerns about medication use were associated with improved medication adherence. Self-efficacy was also associated with adherence to lifestyle recommendations at baseline. CAHE influenced patients' illness perceptions by creating more understanding of hypertension, its chronic character, and more concerns about the associated risks. Conclusion In this high-risk population, health care providers can support medication adherence by paying attention to patients' medication self-efficacy, the concerns they may have about medication use and patients' perceptions on hypertension. The CAHE intervention improved patients' perception on hypertension.	[Meinema, Jennita G.; van Dijk, Nynke; van Weert, Henk C. P. M.; Haafkens, Joke A.] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice Family Med, NL-1105 AZ Amsterdam, Netherlands; [Beune, Erik J. A. J.] Univ Amsterdam, Acad Med Ctr, Dept Social Med, NL-1105 AZ Amsterdam, Netherlands; [Jaarsma, Debbie A. D. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Evidence Based Med Educ, NL-9713 AV Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Meinema, JG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gen Practice Family Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.g.meinema@amc.uva.nl		Zeeb, Hajo/0000-0001-7509-242X; Jaarsma, Debbie/0000-0003-1668-2002	ZonMw; Netherlands organisation for health research and development [122000008, 12010095425]	ZonMw(Netherlands Organization for Health Research and Development); Netherlands organisation for health research and development(Netherlands Organization for Health Research and Development)	This study was funded by ZonMw, the Netherlands organisation for health research and development (grants no. 122000008 and 12010095425), http://www.zonmw.nl/en/. The study sponsor carried out annual reviews of the study's progress but had no active role in the study design, data collection, analysis and reporting, nor in the preparation of this manuscript.	Agyemang C, 2012, Ghana Med J, V46, P12; Agyemang C, 2003, J HUM HYPERTENS, V17, P523, DOI 10.1038/sj.jhh.1001586; Agyemang C, 2005, J HYPERTENS, V23, P1971, DOI 10.1097/01.hjh.0000186835.63996.d4; Agyemang C, 2015, INT J CARDIOL, V183, P180, DOI 10.1016/j.ijcard.2015.01.061; Beune EJAJ, 2006, J HUM HYPERTENS, V20, P946, DOI 10.1038/sj.jhh.1002094; Beune EJAJ, 2008, J HYPERTENS, V26, P648, DOI 10.1097/HJH.0b013e3282f4d20b; Beune EJAJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090103; Bray P, 2005, J RURAL HEALTH, V21, P317, DOI 10.1111/j.1748-0361.2005.tb00101.x; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Brus H, 1999, PATIENT EDUC COUNS, V36, P57, DOI 10.1016/S0738-3991(98)00087-1; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Connell P, 2008, HEALTH SOC CARE COMM, V16, P165, DOI 10.1111/j.1365-2524.2007.00737.x; Consumer Quality Index-diabetes, 2009, CONS QUAL IND DIAB; Cooper LA, 2002, J GEN INTERN MED, V17, P477, DOI 10.1046/j.1525-1497.2002.10633.x; Criswell TJ, 2010, PHARMACOTHERAPY, V30, P432, DOI 10.1592/phco.30.5.432; De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Fernandez S, 2008, J BEHAV MED, V31, P453, DOI 10.1007/s10865-008-9170-7; Gallant MP, 2010, J CROSS-CULT GERONTO, V25, P21, DOI 10.1007/s10823-010-9112-z; Haafkens JA, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-193; Harmsen JAM, 2008, PATIENT EDUC COUNS, V72, P155, DOI 10.1016/j.pec.2008.03.018; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Khatib R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084238; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Kohinor MJE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-399; Kressin NR, 2007, J GEN INTERN MED, V22, P768, DOI 10.1007/s11606-007-0165-9; Kressin NR, 2010, CIRC-CARDIOVASC QUAL, V3, P173, DOI 10.1161/CIRCOUTCOMES.109.860841; Kronish IM, 2012, J CLIN HYPERTENS, V14, P38, DOI 10.1111/j.1751-7176.2011.00558.x; Lewis LM, 2012, EXPERT REV CARDIOVAS, V10, P1375, DOI [10.1586/ERC.12.138, 10.1586/erc.12.138]; Maguire LK, 2008, PATIENT EDUC COUNS, V73, P371, DOI 10.1016/j.pec.2008.06.016; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Netto G, 2010, HEALTH PROMOT INT, V25, P248, DOI 10.1093/heapro/daq012; NICE, 2009, CLIN GUIDELINE CG76; Nieuwlaat R, 2013, EUR HEART J, V34, P1262, DOI 10.1093/eurheartj/ehs481; Odedosu T, 2012, CLEV CLIN J MED, V79, P46, DOI 10.3949/ccjm.79a.11068; Ogedegbe G, 2004, ETHNIC DIS, V14, P3; Ogedegbe G, 2003, J CLIN EPIDEMIOL, V56, P520, DOI 10.1016/S0895-4356(03)00053-2; Ogedegbe Gbenga, 2006, J Clin Hypertens (Greenwich), V8, P174, DOI 10.1111/j.1524-6175.2006.04872.x; Ogedegbe G, 2007, CONTEMP CLIN TRIALS, V28, P169, DOI 10.1016/j.cct.2006.04.002; Parkerson G R Jr, 1991, Fam Med, V23, P357; Rahaghi FF, 2014, PULM CIRC, V4, P53, DOI 10.1086/674883; Ross S, 2004, J HUM HYPERTENS, V18, P607, DOI 10.1038/sj.jhh.1001721; Schoenthaler A, 2012, ANN BEHAV MED, V43, P372, DOI 10.1007/s12160-011-9342-5; Schoenthaler A, 2009, PATIENT EDUC COUNS, V75, P185, DOI 10.1016/j.pec.2008.09.018; Schoenthaler A, 2009, HEALTH EDUC BEHAV, V36, P127, DOI 10.1177/1090198107309459; Schofield P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X567126; Serour M, 2007, BRIT J GEN PRACT, V57, P291; SHEA S, 1992, AM J PUBLIC HEALTH, V82, P1607, DOI 10.2105/AJPH.82.12.1607; Smulders YM, 2008, NETH J MED, V66, P169; Stubbe J H, 2007, BMC Ophthalmol, V7, P14, DOI 10.1186/1471-2415-7-14; Stubbe JH, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-60; Theunissen NCM, 2003, PATIENT EDUC COUNS, V51, P247, DOI 10.1016/S0738-3991(02)00224-0; van Es SM, 2002, PATIENT EDUC COUNS, V47, P165, DOI 10.1016/S0738-3991(01)00195-1; Warren-Findlow J, 2012, J COMMUN HEALTH, V37, P15, DOI 10.1007/s10900-011-9410-6; Whitlock EP, 2002, AM J PREV MED, V22, P267, DOI 10.1016/S0749-3797(02)00415-4; World Health Organization, 2007, PREV CARD DIS POCK G; Ye SQ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00267	61	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133560	10.1371/journal.pone.0133560	http://dx.doi.org/10.1371/journal.pone.0133560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267453	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300017
J	Wang, XD; Lu, H; Shi, ZH; Cai, L; Liu, S; Liu, SL; Han, T; Wang, Y; Zhou, YY; Wang, XP; Gao, S; Ji, Y				Wang, Xiao-Dan; Lu, Hui; Shi, Zhihong; Cai, Li; Liu, Shuai; Liu, Shuling; Han, Tong; Wang, Ying; Zhou, Yuying; Wang, Xinping; Gao, Shuo; Ji, Yong			A Pilot Study on Clinical and Neuroimaging Characteristics of Chinese Posterior Cortical Atrophy: Comparison with Typical Alzheimer's Disease	PLOS ONE			English	Article							VISUAL VARIANT; CORTICOBASAL DEGENERATION; COGNITIVE IMPAIRMENT; CSF BIOMARKERS; DEMENTIA; DYSFUNCTION; PRESENTATIONS; DISCONNECTION; DIAGNOSIS; PATHWAYS	Posterior cortical atrophy (PCA) is a clinicoradiologic neurodegenerative syndrome characterized by predominant impairment of higher visual functions. Neuroimaging and neuropathological studies show that PCA is probably an atypical presentation of Alzheimer's disease. However, in China PCA has rarely been studied and remains largely unknown. Our study therefore aimed to analyze the clinical manifestations and patterns of cerebral atrophy, amyloid beta deposition and regional glucose metabolism in Chinese PCA patients, comparing them directly with those of typical Alzheimer's disease (TAD). Seven PCA patients, 6 TAD patients and 5 controls underwent neuropsychological assessment, MRI scan, C-11-PIB PET scan and F-18-FDG PET scan. Cerebral atrophy including ventricular enlargement, posterior atrophy and medial temporal lobe atrophy were evaluated with MRI. The uptake of C-11-PIB was quantified at the voxel level using the standardized uptake value ratio. Comparisons of regional cerebral glucose metabolism were calculated with statistical parametric mapping. PCA patients showed significant impairment on visuospatial function in neuropsychological assessment. And PCA patients showed more severe posterior atrophy and less severe left medial temporal lobe atrophy compared with TAD patients. The data from C-11-PIB PET scanning showed that amyloid beta deposition in PCA was comparable to TAD. Moreover, in PCA the results from F-18-FDG PET scanning revealed significant hypometabolism in the temporoparietooccipital region and identified specific hypometabolism in the right occipital lobe, compared with TAD. Our study thus provides a preliminary view of PCA in Chinese patients. A further study with a larger number of subjects would be recommended to confirm these findings.	[Wang, Xiao-Dan; Lu, Hui; Shi, Zhihong; Liu, Shuai; Liu, Shuling; Zhou, Yuying; Wang, Xinping; Ji, Yong] Tianjin Huanhu Hosp, Dept Neurol, Tianjin 300060, Peoples R China; [Han, Tong] Tianjin Huanhu Hosp, Dept Radiol, Tianjin 300060, Peoples R China; [Cai, Li; Wang, Ying; Gao, Shuo] Tianjin Med Univ, Gen Hosp, PET CT Ctr, Tianjin 300052, Peoples R China	Tianjin Medical University	Ji, Y (corresponding author), Tianjin Huanhu Hosp, Dept Neurol, Tianjin 300060, Peoples R China.	jiyongusa@126.com	Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Wang, Xin/0000-0002-4457-7376; 	National Natural Science Foundation of China [81300947]; Tianjin Science and Technology Support Programs [12ZCZDSY02900, 12ZCZDSY01600]; Science and Technology Project of the Tianjin Municipal Health Bureau [2013KY15]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Support Programs; Science and Technology Project of the Tianjin Municipal Health Bureau	This work was supported by National Natural Science Foundation of China (to X-DW; funding number: 81300947; URL: http://www.nsfc.gov.cn/), Tianjin Science and Technology Support Programs (to YJ; funding numbers: 12ZCZDSY02900 and 12ZCZDSY01600; URL: http://www.tstc.gov.cn/), and the Science and Technology Project of the Tianjin Municipal Health Bureau (to X-DW; funding number: 2013KY15; URL: http://www.tjwsj.gov.cn/html/WSJn/portal/index/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alladi S, 2007, BRAIN, V130, P2636, DOI 10.1093/brain/awm213; Baumann TP, 2010, DEMENT GERIATR COGN, V29, P530, DOI 10.1159/000314679; BENSON DF, 1988, ARCH NEUROL-CHICAGO, V45, P789, DOI 10.1001/archneur.1988.00520310107024; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Coppi E, 2014, NEUROL SCI, V35, P785, DOI 10.1007/s10072-014-1644-5; Crutch SJ, 2013, ALZHEIMERS DEMENT, V9, P463, DOI 10.1016/j.jalz.2012.11.004; Crutch SJ, 2012, LANCET NEUROL, V11, P170, DOI 10.1016/S1474-4422(11)70289-7; de Souza LC, 2011, BRAIN, V134, P2036, DOI 10.1093/brain/awr130; Feldmann A, 2008, PSYCHIAT RES-NEUROIM, V164, P178, DOI 10.1016/j.pscychresns.2008.01.006; Formaglio M, 2011, J NEUROL, V258, P1841, DOI 10.1007/s00415-011-6030-0; FRIEDLAND RP, 1983, J COMPUT ASSIST TOMO, V7, P590, DOI 10.1097/00004728-198308000-00003; Galton CJ, 2000, BRAIN, V123, P484, DOI 10.1093/brain/123.3.484; Hof PR, 1997, VISION RES, V37, P3609, DOI 10.1016/S0042-6989(96)00240-4; HOF PR, 1990, J NEUROPATH EXP NEUR, V49, P168, DOI 10.1097/00005072-199003000-00008; Jellinger KA, 2011, ACTA NEUROPATHOL, V121, P267, DOI 10.1007/s00401-010-0712-z; Kas A, 2011, BRAIN, V134, P1464, DOI 10.1093/brain/awr055; Kennedy J, 2012, NEUROCASE, V18, P248, DOI 10.1080/13554794.2011.588180; Klunk WE, 2011, NEUROBIOL AGING, V32, pS20, DOI 10.1016/j.neurobiolaging.2011.09.006; Koch G, 2004, J NEUROL, V251, P1530, DOI 10.1007/s00415-004-0573-2; Koedam ELGE, 2011, EUR RADIOL, V21, P2618, DOI 10.1007/s00330-011-2205-4; Korf ESC, 2004, NEUROLOGY, V63, P94, DOI 10.1212/01.WNL.0000133114.92694.93; Lehmann M, 2011, NEUROBIOL AGING, V32, P1466, DOI 10.1016/j.neurobiolaging.2009.08.017; LEVINE DN, 1993, NEUROLOGY, V43, P305, DOI 10.1212/WNL.43.2.305; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McMonagle P, 2006, NEUROLOGY, V66, P331, DOI 10.1212/01.wnl.0000196477.78548.db; Mendez MF, 2002, DEMENT GERIATR COGN, V14, P33, DOI 10.1159/000058331; Nestor PJ, 2003, J NEUROL NEUROSUR PS, V74, P1521, DOI 10.1136/jnnp.74.11.1521; O'Donovan J, 2013, INT PSYCHOGERIATR, V25, P111, DOI 10.1017/S1041610212001214; Renner JA, 2004, NEUROLOGY, V63, P1175, DOI 10.1212/01.WNL.0000140290.80962.BF; Ross SK, 1996, J NEUROL NEUROSUR PS, V61, P388, DOI 10.1136/jnnp.61.4.388; Salmon E, 2000, HUM BRAIN MAPP, V10, P39, DOI 10.1002/(SICI)1097-0193(200005)10:1<39::AID-HBM50>3.0.CO;2-B; Schmidtke K, 2005, J NEUROL, V252, P27, DOI 10.1007/s00415-005-0594-5; Seguin J, 2011, NEUROLOGY, V76, P1782, DOI 10.1212/WNL.0b013e31821ccc98; Snowden JS, 2007, CORTEX, V43, P835, DOI 10.1016/S0010-9452(08)70683-X; Spehl TS, 2014, J NEUROIMAGING; Tang-Wai DF, 2004, NEUROLOGY, V63, P1168, DOI 10.1212/01.WNL.0000140289.18472.15; Tang-Wai DF, 2003, NEUROLOGY, V61, P1134, DOI 10.1212/01.WNL.0000086814.35352.B3; Tang-Wai DF, 2003, J NEUROL NEUROSUR PS, V74, P389, DOI 10.1136/jnnp.74.3.389; VICTOROFF J, 1994, ARCH NEUROL-CHICAGO, V51, P269, DOI 10.1001/archneur.1994.00540150063018; Whitwell JL, 2007, NEUROBIOL AGING, V28, P1051, DOI 10.1016/j.neurobiolaging.2006.05.026	40	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134956	10.1371/journal.pone.0134956	http://dx.doi.org/10.1371/journal.pone.0134956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267071	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300069
J	Chojnacka, D; Isler, K; Barski, JJ; Bshary, R				Chojnacka, Dominika; Isler, Karin; Barski, Jaroslaw Jerzy; Bshary, Redouan			Relative Brain and Brain Part Sizes Provide Only Limited Evidence that Machiavellian Behaviour in Cleaner Wrasse Is Cognitively Demanding	PLOS ONE			English	Article							SONG REPERTOIRE SIZE; CORAL-REEF FISH; TACTILE STIMULATION; TELEOST FISHES; SOCIAL BRAIN; EVOLUTIONARY HISTORY; LABROIDES-DIMIDIATUS; SERVICE QUALITY; CICHLID FISHES; ENCEPHALIZATION	It is currently widely accepted that the complexity of a species' social life is a major determinant of its brain complexity, as predicted by the social brain hypothesis. However, it remains a challenge to explain what social complexity exactly is and what the best corresponding measures of brain anatomy are. Absolute and relative size of the brain and of the neocortex have often been used as a proxy to predict cognitive performance. Here, we apply the logic of the social brain hypothesis to marine cleaning mutualism involving the genus Labroides. These wrasses remove ectoparasites from 'client' reef fish. Conflict occurs as wrasse prefer client mucus over ectoparasites, where mucus feeding constitutes cheating. As a result of this conflict, cleaner wrasse show remarkable Machiavellian-like behaviour. Using own data as well as available data from the literature, we investigated whether the general brain anatomy of Labroides provides any indication that their Machiavellian behaviour is associated with a more complex brain. Neither data set provided evidence for an increased encephalisation index compared to other wrasse species. Published data on relative sizes of brain parts in 25 species of the order Perciformes suggests that only the diencephalon is relatively enlarged in Labroides dimidiatus. This part contains various nuclei of the social decision making network. In conclusion, gross brain anatomy yields little evidence for the hypothesis that strategic behaviour in cleaning selects for larger brains, while future research should focus on more detailed aspects like the sizes of specific nuclei as well as their cryoarchitectonic structure and connectivity.	[Chojnacka, Dominika; Barski, Jaroslaw Jerzy] Med Univ Silesia, Ctr Med Expt, PL-40752 Katowice, Poland; [Chojnacka, Dominika] Univ Wroclaw, Dept Zool, PL-50335 Wroclaw, Poland; [Isler, Karin] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [Barski, Jaroslaw Jerzy] Med Univ Silesia, Dept Physiol, PL-40752 Katowice, Poland; [Bshary, Redouan] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	Medical University Silesia; University of Wroclaw; University of Zurich; Medical University Silesia; University of Neuchatel	Chojnacka, D (corresponding author), Med Univ Silesia, Ctr Med Expt, PL-40752 Katowice, Poland.	dchojnacka@sum.edu.pl	Barski, Jaroslaw/C-4792-2008; Isler, Karin/A-9566-2008; Barski, Jaroslaw/O-8090-2019	Barski, Jaroslaw/0000-0003-4590-1534; Isler, Karin/0000-0002-2391-1523; Barski, Jaroslaw/0000-0003-4590-1534; Bshary, Redouan/0000-0001-7198-8472	University of Wroclaw's [2020/W/IZ/2006, 2020/W/IZ/2007, 2020/W/IZ/2008]	University of Wroclaw's	DC was funded by the University of Wroclaw's internal grants 2020/W/IZ/2006, 2020/W/IZ/2007 and 2020/W/IZ/2008.	Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Barbu L, 2011, ANIM BEHAV, V82, P1067, DOI 10.1016/j.anbehav.2011.07.043; BAUCHOT R, 1989, J HIRNFORSCH, V30, P645; Broglio C, 2005, BRAIN RES BULL, V66, P277, DOI 10.1016/j.brainresbull.2005.03.021; Broglio C, 2003, FISH FISH, V4, P247, DOI 10.1046/j.1467-2979.2003.00128.x; Brown C., 2011, FISH COGNITION BEHAV, V2nd; Bshary R, 2002, ECOL LETT, V5, P130, DOI 10.1046/j.1461-0248.2002.00295.x; Bshary R, 2001, P ROY SOC B-BIOL SCI, V268, P1495, DOI 10.1098/rspb.2001.1495; Bshary R., 2011, FISH COGNITION BEHAV, P277; Bshary R, 2008, NATURE, V455, P964, DOI 10.1038/nature07184; Bshary R, 2006, PLOS BIOL, V4, P2393, DOI 10.1371/journal.pbio.0040431; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Bshary Redouan, 2001, P146, DOI 10.1017/CBO9780511752421.010; Butler A.B., 2005, COMP VERTEBRATE NEUR, DOI DOI 10.1017/CBO9780511525636.010; Byrne R., 1988, MACHIAVELLIAN INTELL; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Demski LS, 2013, BRAIN BEHAV EVOLUT, V82, P31, DOI 10.1159/000351994; Demski LS, 2001, BRAIN COGNITIVE FUNC; DEVOOGD TJ, 1993, P ROY SOC B-BIOL SCI, V254, P75, DOI 10.1098/rspb.1993.0129; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Ebbesson LOE, 2012, J FISH BIOL, V81, P2151, DOI 10.1111/j.1095-8649.2012.03486.x; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Fernald RD, 2012, P NATL ACAD SCI USA, V109, P17194, DOI 10.1073/pnas.1202552109; Ferrari MCO, 2007, P ROY SOC B-BIOL SCI, V274, P1853, DOI 10.1098/rspb.2007.0297; Gahr M, 1998, J NEUROSCI, V18, P1124; Gingins S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0553; Gonda A, 2009, J EVOLUTION BIOL, V22, P1721, DOI 10.1111/j.1420-9101.2009.01782.x; Gonda A, 2012, BIOL LETTERS, V8, P249, DOI 10.1098/rsbl.2011.0837; Gonzalez-Voyer A, 2011, J EVOLUTION BIOL, V24, P2378, DOI 10.1111/j.1420-9101.2011.02365.x; Gonzalez-Voyer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014355; Gonzalez-Voyer A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-238; Gonzalez-Voyer A, 2009, P ROY SOC B-BIOL SCI, V276, P161, DOI 10.1098/rspb.2008.0979; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; HELFMAN GS, 1984, ANIM BEHAV, V32, P379, DOI 10.1016/S0003-3472(84)80272-9; Hibi M, 2012, DEV NEUROBIOL, V72, P282, DOI 10.1002/dneu.20875; Humphrey N., 1976, GROWING POINTS ETHOL, P303; Huntingford FA, 2012, J FISH BIOL, V81, P2103, DOI 10.1111/j.1095-8649.2012.03480.x; Hurtado-Parrado C, 2010, UNIV PSYCHOL, V9, P663, DOI 10.11144/Javeriana.upsy9-3.nmol; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kendal JR, 2009, BEHAV ECOL, V20, P238, DOI 10.1093/beheco/arp016; Kondoh M, 2010, FUNCT ECOL, V24, P35, DOI 10.1111/j.1365-2435.2009.01631.x; Kotrschal A, 2013, CURR BIOL, V23, P168, DOI 10.1016/j.cub.2012.11.058; Kotrschal K, 1998, REV FISH BIOL FISHER, V8, P373, DOI 10.1023/A:1008839605380; Maddison WP, 2011, MESQUITE MODULAR SYS; Maruska KP, 2013, J NEUROENDOCRINOL, V25, P145, DOI 10.1111/j.1365-2826.2012.02382.x; Midford P. E, 2010, PDAP PACKAGE VERSION; Nunn C. L., 2011, COMP APPROACH EVOLUT; O'Connell LA, 2012, SCIENCE, V336, P1154, DOI 10.1126/science.1218889; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; Oates J, 2012, J FISH BIOL, V81, P210, DOI 10.1111/j.1095-8649.2012.03330.x; Oates J, 2010, CURR BIOL, V20, pR472, DOI 10.1016/j.cub.2010.04.022; Oates J, 2010, ETHOLOGY, V116, P309, DOI 10.1111/j.1439-0310.2010.01742.x; Odling-Smee L, 2003, FISH FISH, V4, P235, DOI 10.1046/j.1467-2979.2003.00127.x; Oliveira RF, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00131; Orme D., 2013, CAPER COMP ANAL PHYL; Pike TW, 2010, BIOL LETTERS, V6, P466, DOI 10.1098/rsbl.2009.1014; Pinto A, 2011, CURR BIOL, V21, P1140, DOI 10.1016/j.cub.2011.05.021; Pollen AA, 2007, BRAIN BEHAV EVOLUT, V70, P21, DOI 10.1159/000101067; Raihani NJ, 2011, J EVOLUTION BIOL, V24, P1628, DOI 10.1111/j.1420-9101.2011.02307.x; Raihani NJ, 2011, EVOLUTION, V65, P2725, DOI 10.1111/j.1558-5646.2011.01383.x; RIDET JM, 1990, J HIRNFORSCH, V31, P433; RIDET JM, 1991, J HIRNFORSCH, V32, P439; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Salwiczek LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049068; Salwiczek LH, 2011, ETHOLOGY, V117, P939, DOI 10.1111/j.1439-0310.2011.01959.x; Shultz S, 2010, P NATL ACAD SCI USA, V107, P21582, DOI 10.1073/pnas.1005246107; Shultz S, 2010, BIOL J LINN SOC, V100, P111, DOI 10.1111/j.1095-8312.2010.01427.x; Shumway CA, 2008, BRAIN BEHAV EVOLUT, V72, P123, DOI 10.1159/000151472; Shumway CA, 2010, CURR ZOOL, V56, P144, DOI 10.1093/czoolo/56.1.144; Soares MC, 2008, J ZOOL, V276, P306, DOI 10.1111/j.1469-7998.2008.00489.x; Soares MC, 2015, CURR ZOOL, V61, P274, DOI 10.1093/czoolo/61.2.274; Soares MC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1547; TABORSKY M, 1984, ANIM BEHAV, V32, P1236, DOI 10.1016/S0003-3472(84)80241-9; Vail AL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2781; van Schaik CP, 2012, TRENDS COGN SCI, V16, P277, DOI 10.1016/j.tics.2012.04.004; VANSTAADEN MJ, 1994, ZOOL-ANAL COMPLEX SY, V98, P165; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; WARNER RR, 1988, NATURE, V335, P719, DOI 10.1038/335719a0; Westneat MW, 2005, MOL PHYLOGENET EVOL, V36, P370, DOI 10.1016/j.ympev.2005.02.001; Wismer S, 2014, ETHOLOGY, V120, P519, DOI 10.1111/eth.12223	89	10	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135373	10.1371/journal.pone.0135373	http://dx.doi.org/10.1371/journal.pone.0135373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263490	Green Accepted, Green Published, gold			2022-12-27	WOS:000359353300077
J	Govus, AD; Garvican-Lewis, LA; Abbiss, CR; Peeling, P; Gore, CJ				Govus, Andrew D.; Garvican-Lewis, Laura A.; Abbiss, Chris R.; Peeling, Peter; Gore, Christopher J.			Pre-Altitude Serum Ferritin Levels and Daily Oral Iron Supplement Dose Mediate Iron Parameter and Hemoglobin Mass Responses to Altitude Exposure	PLOS ONE			English	Article							TRAIN LOW-ALTITUDE; REBREATHING METHOD; PERFORMANCE; HYPOXIA; ERYTHROPOIETIN; DEFICIENCY; METABOLISM; BLOOD	Purpose To investigate the influence of daily oral iron supplementation on changes in hemoglobin mass (Hb(mass)) and iron parameters after 2-4 weeks of moderate altitude exposure. Methods Hematological data collected from 178 athletes (98 males, 80 females) exposed to moderate altitude (1,350-3,000 m) were analysed using linear regression to determine how altitude exposure combined with oral iron supplementation influenced Hb(mass), total iron incorporation (TII) and blood iron parameters [ferritin and transferrin saturation (TSAT)]. Results Altitude exposure (mean +/- s: 21 +/- 3 days) increased Hbmass by 1.1% [-0.4, 2.6], 3.3% [1.7, 4.8], and 4.0% [2.0, 6.1] from pre-altitude levels in athletes who ingested nil, 105 mg and 210 mg respectively, of oral iron supplement daily. Serum ferritin levels decreased by -33.2% [-46.9, -15.9] and 13.8% [-32.2, 9.7] from pre-altitude levels in athletes who supplemented with nil and 105 mg of oral iron supplement daily, but increased by 36.8%[1.3, 84.8] in athletes supplemented with 210 mg of oral iron daily. Finally, athletes who ingested either 105 mg or 210 mg of oral iron supplement daily had a greater TII compared with non-supplemented athletes (0 versus 105 mg: effect size (d) = -1.88 [-2.56, -1.17]; 0 versus 210 mg: effect size (d) = -2.87 [-3.88, -1.66]). Conclusion Oral iron supplementation during 2-4 weeks of moderate altitude exposure may enhance Hb(mass) production and assist the maintenance of iron balance in some athletes with low pre-altitude iron stores.	[Govus, Andrew D.; Abbiss, Chris R.] Edith Cowan Univ, Sch Exercise & Hlth Sci, Ctr Exercise & Sports Sci Res, Joondalup, WA, Australia; [Peeling, Peter] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Crawley, WA, Australia; [Garvican-Lewis, Laura A.; Gore, Christopher J.] Australian Inst Sport, Dept Physiol, Bruce, ACT, Australia; [Gore, Christopher J.] Flinders Univ S Australia, Exercise Physiol Lab, Bedford Pk, SA 5042, Australia; [Garvican-Lewis, Laura A.; Gore, Christopher J.] Univ Canberra, Res Inst Sport & Exercise, Bruce, ACT, Australia	Edith Cowan University; University of Western Australia; Australian Institute of Sport; Flinders University South Australia; University of Canberra	Govus, AD (corresponding author), Edith Cowan Univ, Sch Exercise & Hlth Sci, Ctr Exercise & Sports Sci Res, Joondalup, WA, Australia.	a.govus@ecu.edu.au		Govus, Andrew/0000-0001-6224-0454; Abbiss, Chris/0000-0003-3940-5542; Peeling, Peter/0000-0002-3895-0015				BERGLUND B, 1992, SPORTS MED, V14, P289, DOI 10.2165/00007256-199214050-00002; BRUGNARA C, 1993, BLOOD, V81, P956; Clark SA, 2009, EUR J APPL PHYSIOL, V106, P399, DOI 10.1007/s00421-009-1027-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; Feelders RA, 1998, EUR J CLIN INVEST, V28, P520; Friedmann B, 1999, INT J SPORTS MED, V20, P78, DOI 10.1055/s-1999-970269; Friedmann B, 2005, BRIT J SPORT MED, V39, P148, DOI 10.1136/bjsm.2003.011387; Garvican L, 2012, SCAND J MED SCI SPOR, V22, P95, DOI 10.1111/j.1600-0838.2010.01145.x; Garvican LA, 2010, EXP PHYSIOL, V95, P1156, DOI 10.1113/expphysiol.2010.054031; Garvican-Lewis LA, 2015, J SPORT SCI MED, V14, P413; Garvican-Lewis LA, 2013, BRIT J SPORT MED, V47, P70; Goetze O, 2013, HEPATOLOGY, V58, P2153, DOI 10.1002/hep.26581; Gore CJ, 2013, BRIT J SPORT MED, V47, P31, DOI 10.1136/bjsports-2013-092840; Gore CJ, 2007, MED SCI SPORT EXER, V39, P1600, DOI 10.1249/mss.0b013e3180de49d3; Gough CE, 2013, INT J SPORTS MED, V34, P763, DOI 10.1055/s-0033-1333692; Humberstone-Gough CE, 2013, J SPORT SCI MED, V12, P394; Mast AE, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.1351.1351; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; McLean BD, 2013, INT J SPORT PHYSIOL, V8, P391, DOI 10.1123/ijspp.8.4.391; Nielsen P, 1998, SPORTS MED, V26, P207, DOI 10.2165/00007256-199826040-00001; Peeling P, 2007, INT J SPORT NUTR EXE, V17, P221, DOI 10.1123/ijsnem.17.3.221; Peeling P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093002; Piperno A, 2011, BLOOD, V117, P2953, DOI 10.1182/blood-2010-08-299859; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmussen P, 2013, MED SCI SPORT EXER, V45, P1767, DOI 10.1249/MSS.0b013e31829047e5; Reynafarje C, 1961, INFLUENCE ALTITUDE C; Robertson EY, 2010, EUR J APPL PHYSIOL, V110, P379, DOI 10.1007/s00421-010-1516-5; Robertson EY, 2010, MED SCI SPORT EXER, V42, P394, DOI 10.1249/MSS.0b013e3181b34b57; Ryan BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108788; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Schmidt W, 2005, EUR J APPL PHYSIOL, V95, P486, DOI 10.1007/s00421-005-0050-3; Sowade O, 1998, EUR J HAEMATOL, V60, P252; STRAY-GUNDERSEN J, 1992, Medicine and Science in Sports and Exercise, V24, pS90, DOI 10.1249/00005768-199205001-00541; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Talbot NP, 2012, BLOOD, V119, P857, DOI 10.1182/blood-2011-03-341776; Talbot NP, 2011, HIGH ALT MED BIOL, V12, P265, DOI 10.1089/ham.2011.1005; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; Tolkien Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117383; Wachsmuth NB, 2015, MED SCI SPORT EXER, V47, P419, DOI 10.1249/MSS.0000000000000420; WALTERS GO, 1973, J CLIN PATHOL, V26, P770, DOI 10.1136/jcp.26.10.770; Wilber RL, 2007, MED SCI SPORT EXER, V39, P1590, DOI 10.1249/mss.0b013e3180de49bd; Wilson C, 2010, NURS CLIN N AM, V45, P95, DOI 10.1016/j.cnur.2010.02.005; ZAMAN Z, 1993, J AUTOM CHEM, V15, P189, DOI 10.1155/S1463924693000264	43	41	43	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135120	10.1371/journal.pone.0135120	http://dx.doi.org/10.1371/journal.pone.0135120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263553	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300062
J	Hu, YC; Kang, CK; Tang, CH; Lee, TH				Hu, Yau-Chung; Kang, Chao-Kai; Tang, Cheng-Hao; Lee, Tsung-Han			Transcriptomic Analysis of Metabolic Pathways in Milkfish That Respond to Salinity and Temperature Changes	PLOS ONE			English	Article							PARR-SMOLT TRANSFORMATION; BREAM SPARUS-AURATA; ATLANTIC SALMON; CHANOS-CHANOS; THERMAL-ACCLIMATION; COLD-ACCLIMATION; GENE-EXPRESSION; ION REGULATION; RAINBOW-TROUT; GILL	Milkfish (Chanos chanos), an important marine aquaculture species in southern Taiwan, show considerable euryhalinity but have low tolerance to sudden drops in water temperatures in winter. Here, we used high throughput next-generation sequencing (NGS) to identify molecular and biological processes involved in the responses to environmental changes. Preliminary tests revealed that seawater (SW)-acclimated milkfish tolerated lower temperatures than the fresh water (FW)-acclimated group. Although FW- and SW-acclimated milkfish have different levels of tolerance for hypothermal stress, to date, the molecular physiological basis of this difference has not been elucidated. Here, we performed a next-generation sequence analysis of mRNAs from four groups of milkfish. We obtained 29669 unigenes with an average length of approximately 1936 base pairs. Gene ontology (GO) analysis was performed after gene annotation. A large number of genes for molecular regulation were identified through a transcriptomic comparison in a KEGG analysis. Basal metabolic pathways involved in hypothermal tolerance, such as glycolysis, fatty acid metabolism, amino acid catabolism and oxidative phosphorylation, were analyzed using PathVisio and Cytoscape software. Our results indicate that in response to hypothermal stress, genes for oxidative phosphorylation, e.g., succinate dehydrogenase, were more highly up-regulated in SW than FW fish. Moreover, SW and FW milkfish used different strategies when exposed to hypothermal stress: SW milkfish up-regulated oxidative phosphorylation and catabolism genes to produce more energy budget, whereas FW milkfish down-regulated genes related to basal metabolism to reduce energy loss.	[Hu, Yau-Chung] Natl Chung Hsing Univ, Program Microbial Genom, Taichung 40227, Taiwan; [Hu, Yau-Chung] Acad Sinica, Taipei 115, Taiwan; [Kang, Chao-Kai] Natl Cheng Kung Univ, Tainan Hydraul Lab, Tainan 70101, Taiwan; [Tang, Cheng-Hao] Natl Dong Hwa Univ, Grad Inst Marine Biol, Pingtung, Taiwan; [Tang, Cheng-Hao] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Lee, Tsung-Han] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Lee, Tsung-Han] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan	National Chung Hsing University; Academia Sinica - Taiwan; National Cheng Kung University; National Dong Hwa University; National Museum of Marine Biology & Aquarium; National Chung Hsing University; China Medical University Taiwan	Tang, CH (corresponding author), Natl Dong Hwa Univ, Grad Inst Marine Biol, Pingtung, Taiwan.	wtang@mail.ndhu.edu.tw; thlee@email.nchu.edu.tw		Lee, Tsung-Han/0000-0002-3542-4335	Ministry of Science and Technology of Taiwan [MoST 99-2321-B-005-013-MY3]; Taiwan Comprehensive University System [103TCUS03]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Comprehensive University System	This study was supported by grants to THL from the Ministry of Science and Technology of Taiwan (MoST 99-2321-B-005-013-MY3) and the Taiwan Comprehensive University System (103TCUS03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; BAGARINAO T, 1994, ENVIRON BIOL FISH, V39, P23, DOI 10.1007/BF00004752; Bilyk KT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-634; BLAKE RL, 1984, CAN J FISH AQUAT SCI, V41, P199, DOI 10.1139/f84-021; Chang JCH, 2007, J EXP BIOL, V210, P3494, DOI 10.1242/jeb.007146; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Crear D., 1980, Proceedings of the Annual Meeting of the World Mariculture Society, V11, P548; Crockett Elizabeth L., 2006, P231; Cullum R, 2011, RESPIROLOGY, V16, P210, DOI 10.1111/j.1440-1843.2010.01899.x; de la Serrana DG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-181; DEAN JM, 1969, COMP BIOCHEM PHYSIOL, V29, P185, DOI 10.1016/0010-406X(69)91734-4; dos Santos RS, 2013, BIOL OPEN, V2, P82, DOI 10.1242/bio.20122295; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; GUDERLEY H, 1992, FISH PHYSIOL BIOCHEM, V10, P123, DOI 10.1007/BF00004523; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hochachka P., 2002, BIOCH ADAPTATION MEC; Hsieh SL, 2003, AQUACULTURE, V220, P903, DOI 10.1016/S0044-8486(02)00579-3; JENNINGS DP, 1991, ENVIRON BIOL FISH, V31, P185, DOI 10.1007/BF00001019; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kamaraju S, 2011, INTL J CURR RES, V3, P53; Kang CK, 2015, CHANOS CHANOS AQUACU; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kuo CM, 2006, AQUACULTURE, V251, P525, DOI 10.1016/j.aquaculture.2005.05.044; Kyprianou TD, 2010, J COMP PHYSIOL B, V180, P1005, DOI 10.1007/s00360-010-0481-y; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lauder George V., 2006, P3; Lin YM, 2003, COMP BIOCHEM PHYS A, V135, P489, DOI 10.1016/S1095-6433(03)00136-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Marshall William S., 2006, P177; McCormick SD, 2000, AM J PHYSIOL-REG I, V278, pR1352, DOI 10.1152/ajpregu.2000.278.5.R1352; MCCORMICK SD, 1989, FISH PHYSIOL BIOCHEM, V6, P231, DOI 10.1007/BF01875026; MCCORMICK SD, 1989, FISH PHYSIOL BIOCHEM, V6, P243, DOI 10.1007/BF01875027; McCormick Stephen D., 1995, V14, P285, DOI 10.1016/S1546-5098(08)60250-2; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUIR WD, 1994, AQUACULTURE, V123, P387, DOI 10.1016/0044-8486(94)90073-6; O'Brien KM, 2011, J EXP BIOL, V214, P275, DOI 10.1242/jeb.046854; Olsvik PA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-817; Pinto PIS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-476; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Scott GR, 2012, P NATL ACAD SCI USA, V109, P14247, DOI 10.1073/pnas.1205012109; Seear PJ, 2010, MAR BIOTECHNOL, V12, P126, DOI 10.1007/s10126-009-9218-x; SHAFFI SA, 1978, ACTA PHYSIOL HUNG, V52, P435; STANLEY JG, 1971, T AM FISH SOC, V100, P624, DOI 10.1577/1548-8659(1971)100<624:EOTOEB>2.0.CO;2; Swanson C, 1998, J EXP BIOL, V201, P3355; TRANULIS MA, 1991, COMP BIOCHEM PHYS B, V99, P687, DOI 10.1016/0305-0491(91)90355-H; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tseng YC, 2007, AM J PHYSIOL-REG I, V293, pR482, DOI 10.1152/ajpregu.00681.2006; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Vargas-Chacoff L, 2009, COMP BIOCHEM PHYS A, V154, P417, DOI 10.1016/j.cbpa.2009.07.015; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426; Xia JH, 2011, DNA RES, V18, P513, DOI 10.1093/dnares/dsr036; ZALE AV, 1989, T AM FISH SOC, V118, P718, DOI 10.1577/1548-8659(1989)118<0718:EOSOCT>2.3.CO;2	61	37	39	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134959	10.1371/journal.pone.0134959	http://dx.doi.org/10.1371/journal.pone.0134959			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263550	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300046
J	Kellman, L; Myette, A; Beltrami, H				Kellman, Lisa; Myette, Amy; Beltrami, Hugo			Depth-Dependent Mineral Soil CO2 Production Processes: Sensitivity to Harvesting-Induced Changes in Soil Climate	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; TEMPERATURE SENSITIVITY; CLEAR-CUT; FORESTED WETLANDS; CARBON; RESPIRATION; MOISTURE; EFFLUX; IMPACT; STILL	Forest harvesting induces a step change in the climatic variables (temperature and moisture), that control carbon dioxide (CO2) production arising from soil organic matter decomposition within soils. Efforts to examine these vertically complex relationships in situ within soil profiles are lacking. In this study we examined how the climatic controls on CO2 production change within vertically distinct layers of the soil profile in intact and clearcut forest soils of a humid temperate forest system of Atlantic Canada. We measured mineral soil temperature (0, 5, 10, 20, 50 and 100 cm depth) and moisture (0-15 cm and 30-60 cm depth), along with CO2 surface efflux and subsurface concentrations (0, 2.5, 5, 10, 20, 35, 50, 75 and 100 cm depth) in 1 m deep soil pits at 4 sites represented by two forest-clearcut pairs over a complete annual cycle. We examined relationships between surface efflux at each site, and soil heat, moisture, and mineral soil CO2 production. Following clearcut harvesting we observed increases in temperature through depth (1-2 degrees C annually; often in excess of 4 degrees C in summer and spring), alongside increases in soil moisture (30%). We observed a systematic breakdown in the expected exponential relationship between CO2 production and heat with mineral soil depth, consistent with an increase in the role moisture plays in constraining CO2 production. These findings should be considered in efforts to model and characterize mineral soil organic matter decomposition in harvested forest soils.	[Kellman, Lisa; Myette, Amy] St Francis Xavier Univ, Dept Earth Sci, Antigonish, NS B2G 1C0, Canada; [Kellman, Lisa; Myette, Amy; Beltrami, Hugo] St Francis Xavier Univ, Climate & Atmospher Sci Inst, Antigonish, NS B2G 1C0, Canada; [Beltrami, Hugo] Univ Quebec, Ctr Etud & Simulat Climat Echelle Reg ESCER, Montreal, PQ H3C 3P8, Canada	Saint Francis Xavier University - Canada; Saint Francis Xavier University - Canada; University of Quebec; University of Quebec Montreal	Kellman, L (corresponding author), St Francis Xavier Univ, Dept Earth Sci, Antigonish, NS B2G 1C0, Canada.	lkellman@stfx.ca			Natural Sciences and Engineering Research Council of Canada; Atlantic Canada Opportunities Agency; Canadian Foundation for Climate and Atmospheric Sciences; Canada Research Chairs Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Atlantic Canada Opportunities Agency; Canadian Foundation for Climate and Atmospheric Sciences; Canada Research Chairs Program(Canada Research Chairs)	This work was supported by Natural Sciences and Engineering Research Council of Canada (LK, HB), Atlantic Canada Opportunities Agency (LK, HB), Canadian Foundation for Climate and Atmospheric Sciences (LK, HB), and Canada Research Chairs Program (LK, HB).	Agren GI, 2002, SOIL BIOL BIOCHEM, V34, P129, DOI 10.1016/S0038-0717(01)00156-0; Bekele A, 2007, FOREST ECOL MANAG, V242, P587, DOI 10.1016/j.foreco.2007.01.088; Beltrami H, 2003, GLOBAL PLANET CHANGE, V38, P291, DOI 10.1016/S0921-8181(03)00112-7; Beltrami H, 2001, GLOBAL PLANET CHANGE, V29, P327, DOI 10.1016/S0921-8181(01)00098-4; Bond-Lamberty B, 2006, CAN J FOREST RES, V36, P2794, DOI 10.1139/X06-160; Buchholz T, 2014, GCB BIOENERGY, V6, P305, DOI 10.1111/gcbb.12044; Cann D. B., 1954, SOIL SURVEY ANTIGONI; Carrera-Hernandez JJ, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009684; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; DAVIDSON EA, 1995, TELLUS B, V47, P550, DOI 10.1034/j.1600-0889.47.issue5.3.x; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P944, DOI 10.1111/j.1365-2486.2005.01142.x; Diochon A, 2009, FOREST ECOL MANAG, V257, P413, DOI 10.1016/j.foreco.2008.09.015; Diochon AC, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000844; Diochon A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034795; DUBE S, 1995, WATER RESOUR RES, V31, P1741, DOI 10.1029/95WR00427; Dungait JAJ, 2012, GLOBAL CHANGE BIOL, V18, P1781, DOI 10.1111/j.1365-2486.2012.02665.x; Fang CM, 2005, PLANT SOIL, V268, P243, DOI 10.1007/s11104-004-0278-4; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Gabriel CE, 2014, SOIL BIOL BIOCHEM, V68, P373, DOI 10.1016/j.soilbio.2013.10.009; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hashimoto S, 2004, J FOREST RES-JPN, V9, P125, DOI 10.1007/s10310-003-0063-x; Hillel D., 2003, INTRO ENV SOIL PHYS; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; JOHNSON CE, 1995, CARBON FORMS AND FUNCTIONS IN FOREST SOILS, P463; Kellman L, 2006, BIOGEOCHEMISTRY; Kemmitt SJ, 2008, SOIL BIOL BIOCHEM, V40, P61, DOI 10.1016/j.soilbio.2007.06.021; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Kleber M, 2011, GLOBAL CHANGE BIOL, V17, P1097, DOI 10.1111/j.1365-2486.2010.02278.x; Koehler B, 2010, BIOGEOSCIENCES, V7, P2311, DOI 10.5194/bg-7-2311-2010; Kreutzweiser DP, 2008, ENVIRON REV, V16, P157, DOI 10.1139/A08-006; Kuzyakov Y, 2005, J PLANT NUTR SOIL SC, V168, P503, DOI 10.1002/jpln.200421703; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P425, DOI 10.1016/j.soilbio.2005.08.020; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lalonde RG, 2007, CAN J FOREST RES, V37, P1287, DOI 10.1139/X07-019; Lewis TJ, 1998, GEOPHYS RES LETT, V25, P535, DOI 10.1029/98GL00181; MacDougall AH, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013170; MacDougall AH, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034639; Marcotte P, 2008, HYDROL PROCESS, V22, P4163, DOI 10.1002/hyp.7020; MCCARTHY KA, 1995, J ENVIRON QUAL, V24, P49, DOI 10.2134/jeq1995.00472425002400010007x; Mosseler A., 2003, Environmental Reviews, V11, pS1, DOI 10.1139/a03-018; Nabuurs GJ, 2013, NAT CLIM CHANGE, V3, P792, DOI [10.1038/NCLIMATE1853, 10.1038/nclimate1853]; Nitoiu D, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000151; Prest D, 2014, GEODERMA, V214, P62, DOI 10.1016/j.geoderma.2013.10.002; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1754, DOI 10.1111/j.1365-2486.2005.001010.x; Risk D, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014002; Risk D, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001831; Risk D, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000445; Sanderman J, 2010, SOIL SCI SOC AM J, V74, P1356, DOI 10.2136/sssaj2009.0290; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; SKOPP J, 1990, SOIL SCI SOC AM J, V54, P1619, DOI 10.2136/sssaj1990.03615995005400060018x; STREET JO, 1988, AM STAT, V42, P152, DOI 10.2307/2684491; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Waldchen J, 2013, FOREST ECOL MANAG, V289, P243, DOI 10.1016/j.foreco.2012.10.014; Yanai RD, 2003, SOIL SCI SOC AM J, V67, P1583, DOI 10.2136/sssaj2003.1583; Zummo LM, 2011, FOREST ECOL MANAG, V261, P1016, DOI 10.1016/j.foreco.2010.12.022	60	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134171	10.1371/journal.pone.0134171	http://dx.doi.org/10.1371/journal.pone.0134171			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263510	Green Submitted, gold, Green Published			2022-12-27	WOS:000359353300021
J	Stoppelkamp, S; Veseli, K; Stang, K; Schlensak, C; Wendel, HP; Walker, T				Stoppelkamp, Sandra; Veseli, Kujtim; Stang, Katharina; Schlensak, Christian; Wendel, Hans Peter; Walker, Tobias			Identification of Predictive Early Biomarkers for Sterile-SIRS after Cardiovascular Surgery	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; C-REACTIVE PROTEIN; INTENSIVE-CARE UNITS; CARDIOPULMONARY BYPASS; MITOCHONDRIAL-DNA; PROGNOSTIC MARKER; DIAGNOSTIC MARKER; SEPSIS PATIENTS; HUMAN MONOCYTES; SEPTIC SHOCK	Systemic inflammatory response syndrome (SIRS) is a common complication after cardiovascular surgery that in severe cases can lead to multiple organ dysfunction syndrome and even death. We therefore set out to identify reliable early biomarkers for SIRS in a prospective small patient study for timely intervention. 21 Patients scheduled for planned cardiovascular surgery were recruited in the study, monitored for signs of SIRS and blood samples were taken to investigate biomarkers at pre-assigned time points: day of admission, start of surgery, end of surgery, days 1, 2, 3, 5 and 8 post surgery. Stored plasma and cryopreserved blood samples were analyzed for cytokine expression (IL1 beta, IL2, IL6, IL8, IL10, TNF alpha, IFN gamma), other pro-inflammatory markers (sCD163, sTREM-1, ESM-1) and response to endotoxin. Acute phase proteins CRP, PCT and pro-inflammatory cytokines IL6 and IL8 were significantly increased (p<0.001) at the end of surgery in all patients but could not distinguish between groups. Normalization of samples revealed significant increases in IL1 beta changes (p<0.05) and decreased responses to endotoxin (p<0.01) in the SIRS group at the end of surgery. Soluble TREM-1 plasma concentrations were significantly increased in patients with SIRS (p<0.01). This small scale patient study could show that common sepsis markers PCT, CRP, IL6 and TNF alpha had low predictive value for early diagnosis of SIRS after cardiovascular surgery. A combination of normalized IL1 beta plasma levels, responses to endotoxin and soluble TREM-1 plasma concentrations at the end of surgery are predictive markers of SIRS development in this small scale study and could act as an indicator for starting early therapeutic interventions.	[Stoppelkamp, Sandra; Veseli, Kujtim; Stang, Katharina; Schlensak, Christian; Wendel, Hans Peter; Walker, Tobias] Univ Tubingen Hosp, Dept Thorac Cardiac & Vasc Surg, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Wendel, HP (corresponding author), Univ Tubingen Hosp, Dept Thorac Cardiac & Vasc Surg, Tubingen, Germany.	hans-peter.wendel@med.uni-tuebingen.de						Artero A, 2012, EPIDEMIOLOGY SEVERE; Aung K L, 2010, Hugo J, V4, P11, DOI 10.1007/s11568-011-9149-2; Baehner T, 2012, ANAESTHESIST, V61, P846, DOI 10.1007/s00101-012-2050-0; Bechard D, 2000, J VASC RES, V37, P417, DOI 10.1159/000025758; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Breitbach S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087838; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Cardoso T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070806; Comstedt P, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-67; Daniels R, 2011, J ANTIMICROB CHEMOTH, V66, pII11, DOI 10.1093/jac/dkq515; Day J R S, 2005, Int J Surg, V3, P129, DOI 10.1016/j.ijsu.2005.04.002; De Somer Filip, 2012, Recent Pat Cardiovasc Drug Discov, V7, P180; Delano MJ, 2011, J IMMUNOL, V186, P195, DOI 10.4049/jimmunol.1002104; Dereli Y, 2008, J INT MED RES, V36, P1248, DOI 10.1177/147323000803600611; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; El-Menyar A., 2012, INT J CLIN MED, V03, P722, DOI DOI 10.4236/IJCM.2012.37A127; Feng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038400; Ferat-Osorio E, 2008, J SURG RES, V150, P110, DOI 10.1016/j.jss.2007.12.805; Forsblom E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087741; Friedman G, 1997, J CRIT CARE, V12, P183, DOI 10.1016/S0883-9441(97)90030-7; Gaini S, 2006, APMIS, V114, P103, DOI 10.1111/j.1600-0463.2006.apm_341.x; Garnacho-Montero J, 2014, CRIT CARE, V18, DOI 10.1186/cc13908; GEWURZ H, 1982, ADV INTERNAL MED, V27, P345; Goldstein JI, 2003, ATHEROSCLEROSIS, V170, P325, DOI 10.1016/S0021-9150(03)00297-1; Grigoriu BD, 2006, CLIN CANCER RES, V12, P4575, DOI 10.1158/1078-0432.CCR-06-0185; Hagel S., 2011, Intensivmedizin und Notfallmedizin, V48, P57, DOI 10.1007/s00390-010-0249-3; Hoffmann J., 2013, SEPSISTHERAPIE CHIRU, P727; Hoffmann S, 2005, J IMMUNOL METHODS, V298, P161, DOI 10.1016/j.jim.2005.01.010; Huttunen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021700; Jekarl DW, 2013, DIAGN MICR INFEC DIS, V75, P342, DOI 10.1016/j.diagmicrobio.2012.12.011; Jekarl DW, 2014, CLIN CHEM LAB MED CC; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kung CT, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-130; Landis RC, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/980327; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Luzzani A, 2003, CRIT CARE MED, V31, P1737, DOI 10.1097/01.CCM.0000063440.19188.ED; MacCallum NS, 2014, CHEST, V145, P1197, DOI 10.1378/chest.13-1023; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Marshall JC, 2014, VIRULENCE, V5, P27, DOI 10.4161/viru.26908; Mihajlovic DM, 2014, MICROVASC RES, V93, P92, DOI 10.1016/j.mvr.2014.04.004; Moller HJ, 2006, CRIT CARE MED, V34, P2561, DOI 10.1097/01.CCM.0000239120.32490.AB; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Nargis Waheeda, 2014, Int J Crit Illn Inj Sci, V4, P195, DOI 10.4103/2229-5151.141356; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Pachot A, 2005, CRIT CARE MED, V33, P31, DOI 10.1097/01.CCM.0000150958.20209.A3; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Philippidis P, 2010, EUR J CARDIO-THORAC, V37, P1360, DOI 10.1016/j.ejcts.2009.12.043; Prucha M, 2015, CLIN CHIM ACTA, V440, P97, DOI 10.1016/j.cca.2014.11.012; Pugin J, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-27; Puskarich MA, 2012, SHOCK, V38, P337, DOI 10.1097/SHK.0b013e318266a169; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Rodriguez-Gaspar M, 2001, CYTOKINE, V15, P232, DOI 10.1006/cyto.2001.0932; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; SEATTER SC, 1995, SHOCK, V3, P252, DOI 10.1097/00024382-199504000-00002; Stang K, 2014, MAT SCI ENG C-MATER, V42, P422, DOI 10.1016/j.msec.2014.05.070; Stoecklein VM, 2012, J LEUKOCYTE BIOL, V92, P539, DOI 10.1189/jlb.0212072; Su Longxiang, 2013, Mediators Inflamm, V2013, P969875, DOI 10.1155/2013/969875; Su LX, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-157; Sulahian TH, 2004, J LEUKOCYTE BIOL, V76, P271, DOI 10.1189/jlb.1003523; Takahashi H, 2006, J LEUKOCYTE BIOL, V79, P789, DOI 10.1189/jlb.0705372; Tamayo E, 2009, J CARDIOVASC SURG, V50, P687; Tamayo E, 2011, EUR CYTOKINE NETW, V22, P82, DOI 10.1684/ecn.2011.0281; Tang L, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/625180; Villanueva J, 2005, J PROTEOME RES, V4, P1060, DOI 10.1021/pr050034b; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Warren OJ, 2009, J CARDIOTHOR VASC AN, V23, P223, DOI 10.1053/j.jvca.2008.08.007; Weaver LK, 2006, J LEUKOCYTE BIOL, V80, P26, DOI 10.1189/jlb.1205756; Williams MA, 1998, J INFECT DIS, V178, P1421, DOI 10.1086/314447; Wong-Baeza I, 2006, CLIN EXP IMMUNOL, V145, P448, DOI 10.1111/j.1365-2249.2006.03158.x; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570; Zhang J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-53; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	79	25	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135527	10.1371/journal.pone.0135527	http://dx.doi.org/10.1371/journal.pone.0135527			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263001	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300090
J	Sun, ZQ; Xu, RW; Li, XY; Ren, WG; Ou, CL; Wang, QS; Zhang, H; Zhang, XM; Ma, J; Wang, HJ; Li, GY				Sun, Zhenqiang; Xu, Ruiwei; Li, Xiayu; Ren, Weiguo; Ou, Chunlin; Wang, Qisan; Zhang, Han; Zhang, Xuemei; Ma, Jian; Wang, Haijiang; Li, Guiyuan			Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RANDOM-EFFECTS MODELS; ORGAN SIZE CONTROL; HIPPO PATHWAY; POOR-PROGNOSIS; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; OVARIAN-CANCER; EXPRESSION	Background Yes-associated protein 1 (YAP1) is an effector of Hippo pathway, which is critical for regulating organ size, cell proliferation and tumor growth in mammals. Many previous studies have explored the relationship between YAP1 and various types of cancer. However, these studies were limited by the small samples size and the findings were inconsistent among them. Therefore, a meta-analysis was conducted to assess the association between YAP1 and malignancies. Methods A systematic literature search was conducted for eligible studies in the PubMed, Corchane Library, Web of Knowledge, EMBASE and CBM disc databases from inception to August 1st 2014. After heterogeneity analysis, pooled harzad ratio (HR) with 95% confidence interval (95% CI) using both fixed and random effect models were estimated in STATA 10.0. Meta regression analysis, subgroup analysis and sensitivity analysis were performed to explore the potential sources of heterogeneity and to evaluate the robustness of the result. Publication bias was assessed by Egger's test and funnel plot. Results A total of 21 unique articles from 2009 to 2014, comprising 2983 patients, were analyzed in the meta-analysis. The association of YAP1 expression and overall survival time (OS) was evaluated in 20 studies including 2067 patients. Positive YAP1 showed poorer OS (HR = 1.826; 95% CI = 1.465-2.275; p < 0.002). For evaluating disease-free survival time (DFS), 10 studies with 1139 patients were analyzed. Positive YAP1 indicated worse DFS (HR = 2.114; 95% CI = 1.406-3.179; p < 0.001). Subgroup analysis showed that both positive nuclear YAP1 (HR = 1.390, 95% CI: 0.810-2.400, p = 0.729) and up-regulation overall YAP1 (HR = 2.237, 95% CI: 1.548-3.232, p < 0.001) had poorer OS for patients with malignancies. Similarly, both positive nuclear YAP1 (HR = 3.733, 95% CI: 1.469-9.483, p = 0.001) and up-regulation overall YAP1 (HR = 1.481, 95% CI: 1.163-1.886, p = 0.554) showed worse DFS. The patients with urogenital system cancer had the poorest OS (HR = 2.133, 95% CI: 1.549-2.937, p = 0.020). The patients with alimentary system cancer had the most significant impact on DFS (HR = 1.879, 95% CI: 1.537-2.297, p < 0.001). Conclusion Both overall and nuclear YAP1 overexpression are intimately associated with adverse OS and DFS in numerous cancers, suggesting that YAP1 may act as a potential therapeutic targets of these malignancies in the future.	[Sun, Zhenqiang; Li, Xiayu; Ou, Chunlin; Zhang, Han; Zhang, Xuemei; Ma, Jian; Li, Guiyuan] Cent S Univ, Minist Hlth, Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Sun, Zhenqiang; Li, Xiayu; Ou, Chunlin; Zhang, Han; Zhang, Xuemei; Ma, Jian; Li, Guiyuan] Cent S Univ, Minist Educ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Changsha, Hunan, Peoples R China; [Sun, Zhenqiang; Wang, Qisan; Wang, Haijiang] Xinjiang Med Univ, Affiliated Tumor Hosp, Dept Gastrointestinal Surg, Urumqi, Xinjiang, Peoples R China; [Xu, Ruiwei] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Xu, Ruiwei] Xinjiang Med Univ, Affiliated Tumor Hosp, Dept Infect Control, Urumqi, Xinjiang, Peoples R China; [Li, Xiayu; Ren, Weiguo; Ma, Jian; Li, Guiyuan] Cent S Univ, Xiangya Hosp 3, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha, Hunan, Peoples R China; [Li, Xiayu; Ren, Weiguo; Ma, Jian; Li, Guiyuan] Cent S Univ, Xiangya Hosp 3, Dis Genome Res Ctr, Changsha, Hunan, Peoples R China; [Ma, Jian; Li, Guiyuan] Cent S Univ, Hunan Prov Tumor Hosp, Changsha, Hunan, Peoples R China; [Ma, Jian; Li, Guiyuan] Cent S Univ, Xiangya Med Sch, Affiliated Tumor Hosp, Changsha, Hunan, Peoples R China	Central South University; Central South University; Xinjiang Medical University; Central South University; Xinjiang Medical University; Central South University; Central South University; Central South University; Central South University	Ma, J (corresponding author), Cent S Univ, Minist Hlth, Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China.	majianhn@qq.com; wanghaijiang0129@163.com; ligy@xysm.net	li, xia/HHZ-7468-2022	Ou, Chunlin/0000-0003-2313-4186	National High Technology Research and Development Program of China [2012AA02A206]; National Natural Science Foundation of China [91229122, 81071644]; Fundamental Research Funds for the Central Universities of Central South University [2014zzts067]; Scientific Research Innovation Fund of Xinjiang Medical University [XJC201267]; Natural Science Foundation of Xinjiang Uygur Autonomous Region [2015211C136]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of Central South University; Scientific Research Innovation Fund of Xinjiang Medical University; Natural Science Foundation of Xinjiang Uygur Autonomous Region	This work was supported by funding from the National High Technology Research and Development Program of China (2012AA02A206), the National Natural Science Foundation of China (91229122, 81071644), the Fundamental Research Funds for the Central Universities of Central South University (2014zzts067), Scientific Research Innovation Fund of Xinjiang Medical University (XJC201267) and the Natural Science Foundation of Xinjiang Uygur Autonomous Region (2015211C136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Da CL, 2009, WORLD J GASTROENTERO, V15, P4055, DOI 10.3748/wjg.15.4055; Diepenbruck M, 2014, J CELL SCI, V127, P1523, DOI 10.1242/jcs.139865; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Han SX, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/261365; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jeong W, 2014, ANTICANCER RES, V34, P811; Kim DH, 2013, HISTOL HISTOPATHOL, V28, P1483, DOI 10.14670/HH-28.1483; Kim G.-H., 2013, J BUILD CONSTR PLAN, V1, P29576, DOI [10.4236/jbcpr.2013.11001, DOI 10.4236/JBCPR.2013.11001, DOI 10.1371/J0URNAL.P0NE.0062300]; Kim SK, 2014, INT J CLIN EXP PATHO, V7, P3224; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Liu JY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-349; Liu TB, 2013, INT J GYNECOL CANCER, V23, P735, DOI 10.1097/IGC.0b013e31828c8619; Luo H., 2013, ZHONG GUO LAO NIAN Y, V33, P6140; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Schmidt FL, 2009, BRIT J MATH STAT PSY, V62, P97, DOI 10.1348/000711007X255327; Schuchardt BJ, 2014, BIOCHIMIE, V101, P192, DOI 10.1016/j.biochi.2014.01.011; Song M, 2012, ANTICANCER RES, V32, P3827; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Touil Y, 2014, CLIN CANCER RES, V20, P837, DOI 10.1158/1078-0432.CCR-13-1854; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Tsujiura M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100974; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wang XD, 2012, EUR J CANCER, V48, P1227, DOI 10.1016/j.ejca.2011.10.001; Wang Y, 2013, TUMOR BIOL, V34, P2169, DOI 10.1007/s13277-013-0751-x; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091770; Xu B, 2013, P NATL ACAD SCI USA, V110, P17480, DOI 10.1073/pnas.1312022110; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yeo MK, 2012, ANTICANCER RES, V32, P3835; Yi CL, 2010, GENE DEV, V24, P1673, DOI 10.1101/gad.1964810; Yu SJ, 2013, CLIN CANCER RES, V19, P1389, DOI 10.1158/1078-0432.CCR-12-1959; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang ZZ, 2014, ACS MED CHEM LETT, V5, P993, DOI 10.1021/ml500160m; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhi X, 2012, AM J PATHOL, V180, P2452, DOI 10.1016/j.ajpath.2012.02.025	56	23	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135119	10.1371/journal.pone.0135119	http://dx.doi.org/10.1371/journal.pone.0135119			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263504	gold, Green Submitted, Green Published			2022-12-27	WOS:000359353300061
J	Ge, JP; Apicella, M; Mills, JA; Garcon, L; French, DL; Weiss, MJ; Bessler, M; Mason, PJ				Ge, Jingping; Apicella, Marisa; Mills, Jason A.; Garcon, Loic; French, Deborah L.; Weiss, Mitchell J.; Bessler, Monica; Mason, Philip J.			Dysregulation of the Transforming Growth Factor beta Pathway in Induced Pluripotent Stem Cells Generated from Patients with Diamond Blackfan Anemia	PLOS ONE			English	Article							TGF-BETA; RIBOSOME BIOGENESIS; MARROW CULTURES; GATA1 MUTATIONS; SMAD4; PROGENITORS; TGF-BETA-1; INHIBITOR; DIFFERENTIATION; HEMATOPOIESIS	Diamond Blackfan Anemia (DBA) is an inherited bone marrow failure syndrome with clinical features of red cell aplasia and variable developmental abnormalities. Most affected patients have heterozygous loss of function mutations in ribosomal protein genes but the pathogenic mechanism is still unknown. We generated induced pluripotent stem cells from DBA patients carrying RPS19 or RPL5 mutations. Transcriptome analysis revealed the striking dysregulation of the transforming growth factor beta (TGF beta) signaling pathway in DBA lines. Expression of TGF beta target genes, such as TGFBI, BAMBI, COL3A1 and SERPINE1 was significantly increased in the DBA iPSCs. We quantified intermediates in canonical and non-canonical TGF beta pathways and observed a significant increase in the levels of the noncanonical pathway mediator p-JNK in the DBA iPSCs. Moreover, when the mutant cells were corrected by ectopic expression of WT RPS19 or RPL5, levels of p-JNK returned to normal. Surprisingly, nuclear levels of SMAD4, a mediator of canonical TGF beta signaling, were decreased in DBA cells due to increased proteolytic turnover. We also observed the up-regulation of TGF beta 1R, TGF beta 2, CDKN1A and SERPINE1 mRNA, and the significant decrease of GATA1 mRNA in the primitive multilineage progenitors. In summary our observations identify for the first time a dysregulation of the TGF beta pathway in the pathobiology of DBA.	[Ge, Jingping; Apicella, Marisa; Bessler, Monica; Mason, Philip J.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Mills, Jason A.; French, Deborah L.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Garcon, Loic] Univ Paris 06, UMR S938, Paris, France; [Garcon, Loic] Assistance Publ Hop Paris, Paris, France; [Weiss, Mitchell J.] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; St Jude Children's Research Hospital	Ge, JP (corresponding author), Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA.	jingpingge@gmail.com	Weiss, Mitchell J/W-9814-2018	Weiss, Mitchell J/0000-0003-2460-3036	US Department of Defense [BM090168]; National Cancer Institute, National Institutes of Health [2R01CA106995, 2R01 CA105312]; Jane Fishman Grinberg endowed chair for stem cell research; Diamond Blackfan Anemia Foundation; NATIONAL CANCER INSTITUTE [R01CA106995, R01CA105312] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jane Fishman Grinberg endowed chair for stem cell research; Diamond Blackfan Anemia Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US Department of Defense grant BM090168 (MW, PM, and MB), National Cancer Institute, National Institutes of Health grants 2R01CA106995 (PM) and 2R01 CA105312 (MB), the Jane Fishman Grinberg endowed chair for stem cell research (MW), and a grant from the Diamond Blackfan Anemia Foundation to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal K, 2012, NAT CELL BIOL, V14, P656, DOI 10.1038/ncb2534; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Benazet JD, 2012, DEVELOPMENT, V139, P4250, DOI 10.1242/dev.084822; Bibikova E, 2014, BLOOD; Blank U, 2011, LEUKEMIA, V25, P1379, DOI 10.1038/leu.2011.95; Boria I, 2010, HUM MUTAT, V31, P1269, DOI 10.1002/humu.21383; Brophy TM, 2013, J BIOL CHEM, V288, P10628, DOI 10.1074/jbc.M112.439034; CASHMAN JD, 1990, BLOOD, V75, P96; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Dennler S, 2000, J BIOL CHEM, V275, P28858, DOI 10.1074/jbc.M910358199; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Dussiot M, 2014, NAT MED, V20, P398, DOI 10.1038/nm.3468; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Falk S, 2014, CEREB CORTEX, V24, P2951, DOI 10.1093/cercor/bht149; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Garcon L, 2013, BLOOD, V122, P912, DOI 10.1182/blood-2013-01-478321; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gazda HT, 2004, BRIT J HAEMATOL, V127, P105, DOI 10.1111/j.1365-2141.2004.05152.x; HAYASHI S, 1989, BLOOD, V74, P1711; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hideshima T, 2001, CANCER RES, V61, P3071; Horbelt D, 2012, INT J BIOCHEM CELL B, V44, P469, DOI 10.1016/j.biocel.2011.12.013; Horos R, 2012, BLOOD, V119, P262, DOI 10.1182/blood-2011-06-358200; Huang T, 2011, EMBO J, V30, P1263, DOI 10.1038/emboj.2011.54; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Iwata J, 2013, DEVELOPMENT, V140, P1220, DOI 10.1242/dev.089615; Klar J, 2014, BRIT J HAEMATOL, V166, P949, DOI 10.1111/bjh.12919; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LAIHO M, 1986, J CELL BIOL, V103, P2403, DOI 10.1083/jcb.103.6.2403; Lan Y, 2014, BLOOD, V123, P2161, DOI 10.1182/blood-2013-09-526053; Langdon JM, 2014, AM J HEMATOL; Lipton JM, 2009, HEMATOL ONCOL CLIN N, V23, P261, DOI 10.1016/j.hoc.2009.01.004; Liu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032009; Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557; Ma Y, 2011, BIOCHEM PHARMACOL, V81, P1228, DOI 10.1016/j.bcp.2011.03.009; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Paluru P, 2014, STEM CELL RES, V12, P441, DOI 10.1016/j.scr.2013.12.003; Parrella S, 2014, PEDIATR BLOOD CANCER, V61, P1319, DOI 10.1002/pbc.24944; Quigley JG, 2005, BLOOD CELL MOL DIS, V35, P189, DOI 10.1016/j.bcmd.2005.01.005; Rorby E, 2012, BLOOD, V120, P4343, DOI 10.1182/blood-2012-02-408658; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; Sherman ML, 2013, J CLIN PHARMACOL, V53, P1121, DOI 10.1002/jcph.160; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sloan KE, 2013, CELL REP, V5, P237, DOI 10.1016/j.celrep.2013.08.049; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Sujoy B., 2013, EUR J HUM GENET, V9, P21; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Zingariello M, 2013, BLOOD, V121, P3345, DOI 10.1182/blood-2012-06-439661	51	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134878	10.1371/journal.pone.0134878	http://dx.doi.org/10.1371/journal.pone.0134878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258650	Green Published, gold, Green Submitted			2022-12-27	WOS:000359352600028
J	Urs, ANN; Ramakrishnan, C; Joshi, V; Suvilesh, KN; Gowda, TV; Velmurugan, D; Vishwanath, BS				Urs, Ankanahalli N. Nanjaraj; Ramakrishnan, Chandrasekaran; Joshi, Vikram; Suvilesh, Kanve Nagaraj; Gowda, Teregowda Veerabasappa; Velmurugan, Devadasan; Vishwanath, Bannikuppe Sannanaik			Progressive Hemorrhage and Myotoxicity Induced by Echis carinatus Venom in Murine Model: Neutralization by Inhibitor Cocktail of N,N,N ',N '-Tetrakis (2-Pyridylmethyl) Ethane-1,2-Diamine and Silymarin	PLOS ONE			English	Article							SNAKE-VENOM; PHOSPHOLIPASE A(2); ASCORBIC-ACID; HYALURONIDASE; TRIMERESURUS; INTEGRATION; TOXICITY; DAMAGE	Viperbite is often associated with severe local toxicity, including progressive hemorrhage and myotoxicity, persistent even after the administration of anti-snake venom (ASV). In the recent past, investigations have revealed the orchestrated actions of Zn2+ metalloproteases (Zn(2+)MPs), phospholipase A(2)s (PLA(2)s) and hyaluronidases (HYs) in the onset and progression of local toxicity from the bitten site. As a consequence, venom researchers and medical practitioners are in deliberate quest of potent molecules alongside ASV to tackle the brutal local manifestations induced by aforesaid venom toxins. Based on these facts, we have demonstrated the protective efficacy of inhibitor cocktail containing equal ratios of N,N,N', N'-tetrakis (2-pyridylmethyl) ethane-1,2-diamine (TPEN) and silymarin (SLN) against progressive local toxicity induced by Echis carinatus venom (ECV). In our previous study we have shown the inhibitory potentials of TPEN towards Zn(2+)MPs of ECV (IC50: 6.7 mu M). In this study we have evaluated in vitro inhibitory potentials of SLN towards PLA(2)s (IC50: 12.5 mu M) and HYs (IC50: 8 mu M) of ECV in addition to docking studies. Further, we have demonstrated the protection of ECV induced local toxicity with 10 mM inhibitor cocktail following 15, 30 min (for hemorrhage and myotoxicity); 60 min (for hemorrhage alone) of ECV injection in murine model. The histological examination of skin and thigh muscle sections taken out from the site of ECV injection substantiated the overall protection offered by inhibitor cocktail. In conclusion, the protective efficacy of inhibitor cocktail is of high interest and can be administered locally alongside ASV to treat severe local toxicity.	[Urs, Ankanahalli N. Nanjaraj; Joshi, Vikram; Suvilesh, Kanve Nagaraj; Gowda, Teregowda Veerabasappa; Vishwanath, Bannikuppe Sannanaik] Univ Mysore, Dept Studies Biochem, Mysuru, Karnataka, India; [Ramakrishnan, Chandrasekaran; Velmurugan, Devadasan] Univ Madras, Ctr Adv Study Crystallog & Biophys, Chennai, Tamil Nadu, India; [Velmurugan, Devadasan] Univ Madras, Bioinformat Infrastruct Facil, Chennai, Tamil Nadu, India	University of Mysore; University of Madras; University of Madras	Vishwanath, BS (corresponding author), Univ Mysore, Dept Studies Biochem, Mysuru, Karnataka, India.	vishmy@yahoo.co.uk	Urs, Ankanahalli N Nanjaraj/AAP-3745-2021; Chandrasekaran, Ramakrishnan/AAP-6328-2021; Joshi, Vikram/M-2160-2019	Urs, Ankanahalli N Nanjaraj/0000-0002-1357-6733; Joshi, Vikram/0000-0002-4625-9427; Chandrasekaran, Ramakrishnan/0000-0003-4622-2496	UGC-BSR [F4-1/2006(BSR)/7-366/2012(BSR), F4-1/2006(BSR)/7-366/2012-13(BSR)]; UGC-NON NET [DV9/192/NON-NETFS/2013-14]	UGC-BSR; UGC-NON NET	ANNU was supported by UGC-BSR [No. F4-1/2006(BSR)/7-366/2012(BSR) dated 22-10-2013]. VJ was supported by UGC-BSR [No. F4-1/2006(BSR)/7-366/2012-13(BSR) dated 25-02-2013]. KNS was supported by UGC-NON NET (DV9/192/NON-NETFS/2013-14).	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; Ashkavanda Z., 2013, BIOMEDICINE PREVENTI, V3, P209, DOI DOI 10.1016/J.BIONUT.2013.03.003; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Botzki A, 2004, J BIOL CHEM, V279, P45990, DOI 10.1074/jbc.M406146200; Chao KL, 2007, BIOCHEMISTRY-US, V46, P6911, DOI 10.1021/bi700382g; Chen IJ, 2010, J CHEM INF MODEL, V50, P822, DOI 10.1021/ci100026x; Dharmappa KK, 2009, PLANTA MED, V75, P211, DOI 10.1055/s-0028-1088374; ECKER DJ, 1995, BIO-TECHNOL, V13, P351, DOI 10.1038/nbt0495-351; Escalante T, 2011, J PROTEOMICS, V74, P1781, DOI 10.1016/j.jprot.2011.03.026; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Fox JW, 2013, TOXICON, V62, P75, DOI 10.1016/j.toxicon.2012.09.009; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gazak R, 2007, CURR MED CHEM, V14, P315, DOI 10.2174/092986707779941159; Girish KS, 2002, MOL CELL BIOCHEM, V240, P105, DOI 10.1023/A:1020651607164; Gowda CDR, 2011, CURR TOP MED CHEM, V11, P2578; GUTIERREZ JM, 1990, EXP MOL PATHOL, V52, P25, DOI 10.1016/0014-4800(90)90055-I; Gutierrez JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002162; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Harrison RA, 2007, GENE, V392, P22, DOI 10.1016/j.gene.2006.10.026; Hiremath V, 2014, TOXIN REV, V33, P23, DOI 10.3109/15569543.2013.856923; Jasti J, 2004, ACTA CRYSTALLOGR D, V60, P66, DOI 10.1107/S090744490302208X; Katkar GD, 2014, J PINEAL RES, V56, P295, DOI 10.1111/jpi.12123; Kemparaju K, 2006, CELL BIOCHEM FUNCT, V24, P7, DOI 10.1002/cbf.1261; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042573; Mahadeswaraswamy YH, 2011, CURR TOP MED CHEM, V11, P2520; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Mohamed R, 2011, CURR TOP MED CHEM, V11, P2531, DOI 10.2174/156802611797633429; Mohamed R, 2010, MOL CELL BIOCHEM, V345, P69, DOI 10.1007/s11010-010-0561-z; Nargotra A, 2011, J MOL MODEL, V17, P3063, DOI 10.1007/s00894-011-0994-7; Nataraju A, 2007, CURR TOP MED CHEM, V7, P801, DOI 10.2174/156802607780487696; Paul M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003344.pub3; Peng Y, 2005, J PHYS CHEM B, V109, P15145, DOI 10.1021/jp0511956; Rael E.D., 2014, J CLIN TOXICOL, V4; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; REISSIG JL, 1955, J BIOL CHEM, V217, P959; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santhosh MS, 2013, INFLAMM RES, V62, P721, DOI 10.1007/s00011-013-0627-y; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Simpson ID, 2007, WILD ENVIRON MED, V18, P2, DOI 10.1580/06-WEME-CO-023R1.1; Teixeira CFP, 2003, TOXICON, V42, P947, DOI 10.1016/j.toxicon.2003.11.006; Uma B, 2000, TOXICON, V38, P1129, DOI 10.1016/S0041-0101(99)00228-7; Urs ANN, 2015, J NAT MED-TOKYO, V69, P111, DOI 10.1007/s11418-014-0875-3; Urs ANN, 2015, TOXICON, V93, P68, DOI 10.1016/j.toxicon.2014.11.224; Urs NAN, 2014, TOXIN REV, V33, P60, DOI 10.3109/15569543.2013.854255; VISHWANATH BS, 1987, TOXICON, V25, P501; VISHWANATH BS, 1987, TOXICON, V25, P929, DOI 10.1016/0041-0101(87)90155-3; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yingprasertchai S, 2003, TOXICON, V42, P635, DOI 10.1016/j.toxicon.2003.09.001	51	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135843	10.1371/journal.pone.0135843	http://dx.doi.org/10.1371/journal.pone.0135843			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274501	Green Published, Green Accepted, gold			2022-12-27	WOS:000359493600124
J	Barros, VV; Kozasa, EH; Formagini, TDB; Pereira, LH; Ronzani, TM				Barros, Vviam Vargas; Kozasa, Elisa Harumi; Batista Formagini, Taynara Dutra; Pereira, Lais Helena; Ronzani, Telmo Mota			Smokers Show Lower Levels of Psychological Well-Being and Mindfulness than Non-Smokers	PLOS ONE			English	Article							CIGARETTE-SMOKING	Mindfulness is defined as "paying attention in a particular way, on purpose, in the present moment, and nonjudgmentally". Mindfulness is associated with positive affect, life satisfaction, self-esteem, lower negative affect and rumination. Conversely, evidence suggests a relationship between nicotine dependence and psychiatric disorders. This study aimed to compare the levels of Mindfulness and Subjective Well-Being (SWB) between smokers and non-smokers. Ninety seven smokers and eighty four non-smokers participated in the study (n = 181). The Five Facet Mindfulness Questionnaire (FFMQ-BR) and the Subjective Well-Being Scale (SWBS) were used. In all the factors of SWBS, the total scores in the FFMQ-BR and in the facets of Observing and Non-Reactivity, the non-smokers scored higher than the smokers. This study suggests that smokers present lower levels of Mindfulness and SWB than non-smokers. Consequently, we propose that Mindfulness-Based Interventions (MBI) may help smokers deal with treatment and abstinence by increasing their level of SWB.	[Barros, Vviam Vargas; Batista Formagini, Taynara Dutra; Pereira, Lais Helena; Ronzani, Telmo Mota] Univ Fed Juiz de Fora, Human Sci Inst, Dept Psychol, Juiz De Fora, MG, Brazil; [Kozasa, Elisa Harumi] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, SP, Brazil; [Kozasa, Elisa Harumi] Hosp Israelita Albert Einstein, Inst Cerebro, Sao Paulo, SP, Brazil	Universidade Federal de Juiz de Fora; Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein	Kozasa, EH (corresponding author), Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, SP, Brazil.	ehkozasa@gmail.com	Kozasa, Elisa Harumi/F-9222-2010; Ronzani, Telmo Mota/F-8722-2012	Kozasa, Elisa Harumi/0000-0003-4723-6099; Ronzani, Telmo Mota/0000-0002-8927-5793; Formagini, Taynara/0000-0001-9318-5734	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-04279-10]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (APQ-04279-10) (http://www.fapemig.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 2014, MINDFULNESS, V5, P179, DOI 10.1007/s12671-012-0163-9; Albuquerque Anelise Salazar, 2004, Psic.: Teor. e Pesq., V20, P153, DOI 10.1590/S0102-37722004000200008; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Barros Víviam Vargas de, 2014, Psic.: Teor. e Pesq., V30, P317, DOI 10.1590/S0102-37722014000300009; Bowen S, 2006, PSYCHOL ADDICT BEHAV, V20, P343, DOI 10.1037/0893-164X.20.3.343; Calheiros PRV, 2006, ALETHEIA, V23, P65, DOI [10.1177/1073191105283504, DOI 10.1177/1073191105283504]; Carmo J.T., 2002, RBM REV BRAS MED, V59, P73, DOI DOI 10.1590/S1806-37132009000100011; Davis James M, 2007, BMC Complement Altern Med, V7, P2, DOI 10.1186/1472-6882-7-2; Hendershot CS, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-17; Kabat-Zinn J., 1994, WHEREVER YOU GO THER; Kahler CW, 2009, EXP CLIN PSYCHOPHARM, V17, P413, DOI 10.1037/a0017690; Malbergier André, 2005, Arch. Clin. Psychiatry (São Paulo), V32, P276; Maroco J., 2010, ANALISE ESTATISTICA; Ostafin BD, 2012, J SOC CLIN PSYCHOL, V31, P729, DOI 10.1521/jscp.2012.31.7.729; Rogojanski J., 2011, MINDFULNESS, V2, P14, DOI [10.1007/s12671-010-0038-x, DOI 10.1007/S12671-010-0038-X]; Schmitz N, 2003, AM J PSYCHIAT, V160, P1670, DOI 10.1176/appi.ajp.160.9.1670; Schroevers MJ, 2010, BRIT J PSYCHOL, V101, P95, DOI 10.1348/000712609X424195; Shapiro SL, 2008, J CLIN PSYCHOL, V64, P840, DOI 10.1002/jclp.20491; Singh NN, 2011, RES DEV DISABIL, V32, P1180, DOI 10.1016/j.ridd.2011.01.003; Soler J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086622; Upadhyaya HP, 2002, J AM ACAD CHILD PSY, V41, P1294, DOI 10.1097/00004583-200211000-00010	21	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135377	10.1371/journal.pone.0135377	http://dx.doi.org/10.1371/journal.pone.0135377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JX	26270556	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800064
J	Ishii, T; Iwasawa, S; Kurimoto, R; Maeda, A; Takiguchi, Y; Kaneda, M				Ishii, Toshiyuki; Iwasawa, Shunichiro; Kurimoto, Ryota; Maeda, Akemi; Takiguchi, Yuichi; Kaneda, Makoto			Crizotinib-Induced Abnormal Signal Processing in the Retina	PLOS ONE			English	Article							CELL LUNG-CANCER; OPEN-LABEL; PHASE-III; CHEMOTHERAPY; ERLOTINIB; LYMPHOMA; PLACEBO; INHIBITION; GEFITINIB; ALECTINIB	Molecular target therapy for cancer is characterized by unique adverse effects that are not usually observed with cytotoxic chemotherapy. For example, the anaplastic lymphoma kinase (ALK)-tyrosine kinase inhibitor crizotinib causes characteristic visual disturbances, whereas such effects are rare when another ALK-tyrosine kinase inhibitor, alectinib, is used. To elucidate the mechanism responsible for these visual disturbances, the responses to light exhibited by retinal ganglion cells treated with these agents were evaluated using a C57BL6 mouse ex vivo model. Both crizotinib and alectinib changed the firing rate of ON and OFF type retinal ganglion cells. However, the ratio of alectinib-affected cells (15.7%) was significantly lower than that of crizotinib-affected cells (38.6%). Furthermore, these drugs changed the response properties to light stimuli of retinal ganglion cells in some of the affected cells, i.e., OFF cells responded to both ON and OFF stimuli, etc. Finally, the expressions of ALK (a target receptor of both crizotinib and alectinib) and of MET and ROS1 (additional target receptors of crizotinib) were observed at the mRNA level in the retina. Our findings suggest that these drugs might target retinal ganglion cells and that the potency of the drug actions on the light responses of retinal ganglion cells might be responsible for the difference in the frequencies of visual disturbances observed between patients treated with crizotinib and those treated with alectinib. The present experimental system might be useful for screening new molecular target agents prior to their use in clinical trials.	[Ishii, Toshiyuki; Maeda, Akemi; Kaneda, Makoto] Nippon Med Sch, Dept Physiol, Bunkyo Ku, Tokyo 1138602, Japan; [Iwasawa, Shunichiro; Kurimoto, Ryota; Takiguchi, Yuichi] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chuo Ku, Chiba 2608670, Japan; [Maeda, Akemi] Tokyo Med Care & Welf Vocat Sch, Chuo Ku, Tokyo 1040032, Japan	Nippon Medical School; Chiba University	Takiguchi, Y (corresponding author), Chiba Univ, Grad Sch Med, Dept Med Oncol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	takiguchi@faculty.chiba-u.jp	Ishii, Toshiyuki/ABD-1165-2020	Kurimoto, Ryota/0000-0003-3029-5287	JSPS [26860150, 26462670]; Nippon Medical School	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nippon Medical School	This work was supported by a Grant-in-Aid for Young Scientists (B) from JSPS (KAKENHI No. 26860150) to T. Ishii, a Grant-in-Aid for Scientific Research (C) from JSPS (KAKENHI No. 26462670), and a Nippon Medical School Grant-in-Aid for Medical Research to M. Kaneda.	Adrian ED, 1926, J PHYSIOL-LONDON, V61, P151, DOI 10.1113/jphysiol.1926.sp002281; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Chugai Pharmaceutical Co. Ltd, 2014, AL INT FORM; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Gambacorti-Passerini C, 2011, NEW ENGL J MED, V364, P775, DOI 10.1056/NEJMc1013224; Kaneda M, 2008, EUR J NEUROSCI, V28, P128, DOI 10.1111/j.1460-9568.2008.06317.x; Kodama T, 2014, MOL CANCER THER, V13, P2910, DOI 10.1158/1535-7163.MCT-14-0274; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Liu CN, 2015, TOXICOL SCI, V143, P116, DOI 10.1093/toxsci/kfu213; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mano H, 2008, CANCER SCI, V99, P2349, DOI 10.1111/j.1349-7006.2008.00972.x; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; Ou SHI, 2011, J THORAC ONCOL, V6, P942, DOI 10.1097/JTO.0b013e31821528d3; Paz-Ares LG, 2013, J CLIN ONCOL, V31, P2895, DOI 10.1200/JCO.2012.47.1102; Perez CA, 2014, LUNG CANCER, V84, P110, DOI 10.1016/j.lungcan.2014.02.001; Phizer Inc, 2012, CRIZ INT FORM; Rieke F., 1997, SPIKES EXPLORING NEU; Santoro A, 2013, LANCET ONCOL, V14, P55, DOI 10.1016/S1470-2045(12)70490-4; Segaert S, 2005, ANN ONCOL, V16, P1425, DOI 10.1093/annonc/mdi279; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	31	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135521	10.1371/journal.pone.0135521	http://dx.doi.org/10.1371/journal.pone.0135521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271036	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800086
J	Oh, S; Kato, M; Zhang, C; Guo, Y; Beachy, PA				Oh, Sekyung; Kato, Masaki; Zhang, Chi; Guo, Yurong; Beachy, Philip A.			A Comparison of Ci/Gli Activity as Regulated by Sufu in Drosophila and Mammalian Hedgehog Response	PLOS ONE			English	Article							VERTEBRATE NEURAL-TUBE; CUBITUS-INTERRUPTUS; SIGNALING PATHWAY; GLI PROTEINS; TRANSCRIPTIONAL ACTIVATION; ATYPICAL KINESIN; GENE-EXPRESSION; CELL-LINES; BETA-TRCP; SUPPRESSOR	Suppressor of fused (Su(fu)/Sufu), one of the most conserved components of the Hedgehog (Hh) signaling pathway, binds Ci/Gli transcription factors and impedes activation of target gene expression. In Drosophila, the Su(fu) mutation has a minimal phenotype, and we show here that Ci transcriptional activity in large part is regulated independently of Su(fu) by other pathway components. Mutant mice lacking Sufu in contrast show excessive pathway activity and die as embryos with patterning defects. Here we show that in cultured cells Hh stimulation can augment transcriptional activity of a Gli2 variant lacking Sufu interaction and, surprisingly, that regulation of Hh pathway targets is nearly normal in the neural tube of Sufu(-/-) mutant embryos that also lack Gli1 function. Some degree of Hh-induced transcriptional activation of Ci/Gli thus can occur independently of Sufu in both flies and mammals. We further note that Sufu loss can also reduce Hh induction of high-threshold neural tube fates, such as floor plate, suggesting a possible positive pathway role for Sufu.	[Oh, Sekyung; Kato, Masaki; Beachy, Philip A.] Stanford Univ, Howard Hughes Med Inst, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Oh, Sekyung; Kato, Masaki; Zhang, Chi; Beachy, Philip A.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Beachy, Philip A.] Stanford Univ, Howard Hughes Med Inst, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Guo, Yurong] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Stanford University; Johns Hopkins University	Beachy, PA (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	pbeachy@stanford.edu	Oh, Sekyung/J-9331-2017; Masaki, Kato/AAW-2603-2020	Oh, Sekyung/0000-0002-6880-5281; 	Howard Hughes Medical Institute; National Insitutes of Health [5R01GM102498]; NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102498] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by funding from the Howard Hughes Medical Institute to PAB and by National Insitutes of Health Award 5R01GM102498 to PAB. PAB is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascano M, 2004, MOL CELL BIOL, V24, P10397, DOI 10.1128/MCB.24.23.10397-10405.2004; Ascano M, 2002, MOL CELL BIOL, V22, P1555, DOI 10.1128/MCB.22.5.1555-1566.2002; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen MH, 2005, MOL CELL BIOL, V25, P7042, DOI 10.1128/MCB.25.16.7042-7053.2005; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Cherry AL, 2013, ACTA CRYSTALLOGR D, V69, P2563, DOI 10.1107/S0907444913028473; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Croker JA, 2006, DEV BIOL, V291, P368, DOI 10.1016/j.ydbio.2005.12.020; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Dussillol-Godar F, 2006, DEV BIOL, V291, P53, DOI 10.1016/j.ydbio.2005.12.004; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Fukumoto T, 2001, J BIOL CHEM, V276, P38441, DOI 10.1074/jbc.M105871200; GUILLEN I, 1995, DEVELOPMENT, V121, P3447; Hepker J, 1997, DEVELOPMENT, V124, P549; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Huynh CQ, 1999, J MOL BIOL, V288, P13, DOI 10.1006/jmbi.1999.2674; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lipinski RJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-49; Liu YJ, 2007, GENE DEV, V21, P1949, DOI 10.1101/gad.1557407; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Merchant M, 2005, MOL CELL BIOL, V25, P7054, DOI 10.1128/MCB.25.16.7054-7068.2005; Merchant M, 2004, MOL CELL BIOL, V24, P8627, DOI 10.1128/MCB.24.19.8627-8641.2004; Methot N, 2000, DEVELOPMENT, V127, P4001; Monnier V, 1998, CURR BIOL, V8, P583, DOI 10.1016/S0960-9822(98)70227-1; Monnier Veronique, 2002, BMC Dev Biol, V2, P4, DOI 10.1186/1471-213X-2-4; Ocbina PJR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006839; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Park HL, 2000, DEVELOPMENT, V127, P1593; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; PREAT T, 1992, GENETICS, V132, P725; PREAT T, 1993, GENETICS, V135, P1047; PREAT T, 1990, NATURE, V347, P87, DOI 10.1038/347087a0; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Ribes V, 2010, GENE DEV, V24, P1186, DOI 10.1101/gad.559910; Ruel L, 2007, DEVELOPMENT, V134, P3677, DOI 10.1242/dev.011577; Stegman MA, 2000, J BIOL CHEM, V275, P21809, DOI 10.1074/jbc.C000043200; Stone DM, 1999, J CELL SCI, V112, P4437; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wang GL, 2000, GENE DEV, V14, P2893, DOI 10.1101/gad.843900; Wang GL, 2004, DEV BIOL, V268, P493, DOI 10.1016/j.ydbio.2004.01.008; Wang QT, 2000, DEVELOPMENT, V127, P3131; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3608; Zhou QH, 2010, DEV BIOL, V348, P47, DOI 10.1016/j.ydbio.2010.09.004	72	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135804	10.1371/journal.pone.0135804	http://dx.doi.org/10.1371/journal.pone.0135804			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271100	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492800113
J	Crane, BT				Crane, Benjamin Thomas			Coordinates of Human Visual and Inertial Heading Perception	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; SPATIAL REFERENCE FRAMES; SELF-MOTION PERCEPTION; EYE-MOVEMENTS; PARIETAL CORTEX; VESTIBULAR STIMULATION; CUE INTEGRATION; VERTICAL AXIS; FLOW; MACAQUE	Heading estimation involves both inertial and visual cues. Inertial motion is sensed by the labyrinth, somatic sensation by the body, and optic flow by the retina. Because the eye and head are mobile these stimuli are sensed relative to different reference frames and it remains unclear if a perception occurs in a common reference frame. Recent neurophysiologic evidence has suggested the reference frames remain separate even at higher levels of processing but has not addressed the resulting perception. Seven human subjects experienced a 2s, 16 cm/s translation and/or a visual stimulus corresponding with this translation. For each condition 72 stimuli (360 degrees in 5 degrees increments) were delivered in random order. After each stimulus the subject identified the perceived heading using a mechanical dial. Some trial blocks included interleaved conditions in which the influence of +/- 28 degrees of gaze and/or head position were examined. The observations were fit using a two degree-of-freedom population vector decoder (PVD) model which considered the relative sensitivity to lateral motion and coordinate system offset. For visual stimuli gaze shifts caused shifts in perceived head estimates in the direction opposite the gaze shift in all subjects. These perceptual shifts averaged 13 +/- 2 degrees for eye only gaze shifts and 17 +/- 2 degrees for eye-head gaze shifts. This finding indicates visual headings are biased towards retina coordinates. Similar gaze and head direction shifts prior to inertial headings had no significant influence on heading direction. Thus inertial headings are perceived in body-centered coordinates. Combined visual and inertial stimuli yielded intermediate results.	[Crane, Benjamin Thomas] Univ Rochester, Dept Otolaryngol, Rochester, NY 14627 USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Bioengn, Rochester, NY USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester	Crane, BT (corresponding author), Univ Rochester, Dept Otolaryngol, Rochester, NY 14627 USA.	craneb@gmail.com			National Institute on Deafness and Other Communication Disorders (NIDCD) [K23 DC011298, R01 DC0135580]; Triological Society Career Scientist Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC011298] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Triological Society Career Scientist Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Institute on Deafness and Other Communication Disorders (NIDCD) K23 DC011298 and R01 DC0135580. It was also supported by a Triological Society Career Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; BENSON AJ, 1989, AVIAT SPACE ENVIR MD, V60, P205; Ceyte H, 2006, EXP BRAIN RES, V170, P136, DOI 10.1007/s00221-006-0389-7; Chen AH, 2011, J NEUROSCI, V31, P12036, DOI 10.1523/JNEUROSCI.0395-11.2011; Chen AH, 2011, J NEUROSCI, V31, P11617, DOI 10.1523/JNEUROSCI.1266-11.2011; Chen XD, 2014, J NEUROPHYSIOL, V112, P353, DOI 10.1152/jn.00057.2014; Chen XD, 2013, NEURON, V80, P1310, DOI 10.1016/j.neuron.2013.09.006; Chen XD, 2013, J NEUROSCI, V33, P18574, DOI 10.1523/JNEUROSCI.2837-13.2013; Cinelli M, 2012, EXP BRAIN RES, V219, P175, DOI 10.1007/s00221-012-3077-9; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Crane BT, 2014, EXP BRAIN RES, V232, P3897, DOI 10.1007/s00221-014-4060-4; Crane BT, 2014, JARO-J ASSOC RES OTO, V15, P87, DOI 10.1007/s10162-013-0423-y; Crane BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051383; Cuturi LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056862; de Winkel KN, 2010, J VISION, V10, DOI 10.1167/10.12.1; DeAngelis GC, 2012, THE NEURAL BASES OF; Edwards M, 2010, PERCEPTION, V39, P1303, DOI 10.1068/p6653; Fetsch CR, 2007, J NEUROSCI, V27, P700, DOI 10.1523/JNEUROSCI.3553-06.2007; Fetsch CR, 2013, NAT REV NEUROSCI, V14, P429, DOI 10.1038/nrn3503; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Grabherr L, 2008, EXP BRAIN RES, V186, P677, DOI 10.1007/s00221-008-1350-8; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Guipponi O, 2013, J NEUROSCI, V33, P4128, DOI 10.1523/JNEUROSCI.1421-12.2013; HOLLANDS MA, 1995, J MOTOR BEHAV, V27, P155, DOI 10.1080/00222895.1995.9941707; KARNATH HO, 1994, EXP BRAIN RES, V101, P140; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; LARISH JF, 1990, J EXP PSYCHOL HUMAN, V16, P295, DOI 10.1037/0096-1523.16.2.295; Maciokas JB, 2010, J NEUROPHYSIOL, V104, P239, DOI 10.1152/jn.01083.2009; MacNeilage PR, 2010, J NEUROSCI, V30, P9084, DOI 10.1523/JNEUROSCI.1304-10.2010; Marple-Horvat DE, 2005, EXP BRAIN RES, V163, P411, DOI 10.1007/s00221-004-2192-7; McIntyre S, 2007, J VISION, V7, DOI 10.1167/7.5.9; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P186, DOI 10.1152/jn.00904.2004; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Palmisano S, 2008, PERCEPTION, V37, P22, DOI 10.1068/p5806; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Readinger WO, 2001, PERCEPTION SUPPLEMEN, V30; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; Roditi RE, 2011, 34 ANN M BALT MD, P1006; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Soyka F, 2012, EXP BRAIN RES, V220, P89, DOI 10.1007/s00221-012-3120-x; STEIN BE, 1993, PROG BRAIN RES, V95, P79, DOI 10.1016/S0079-6123(08)60359-3; Wann JP, 2000, NAT NEUROSCI, V3, P647, DOI 10.1038/76602; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; Wilkie RM, 2003, J VISION, V3, P677, DOI 10.1167/3.11.3; Wilkie RM, 2002, CURR BIOL, V12, P2014, DOI 10.1016/S0960-9822(02)01337-4	50	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135539	10.1371/journal.pone.0135539	http://dx.doi.org/10.1371/journal.pone.0135539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267865	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492300130
J	Dalboge, LS; Pedersen, PJ; Hansen, G; Fabricius, K; Hansen, HB; Jelsing, J; Vrang, N				Dalboge, Louise S.; Pedersen, Philip J.; Hansen, Gitte; Fabricius, Katrine; Hansen, Henrik B.; Jelsing, Jacob; Vrang, Niels			A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BODY-WEIGHT; FOOD-INTAKE; METABOLIC SYNDROME; CHOLESTEROL ABSORPTION; TRANSFER PROTEIN; IV INHIBITOR; NEUROMEDIN U; RECEPTOR; GLUCOSE	Aim Unlike rats and mice, hamsters develop hypercholesterolemia, and hypertriglyceridemia when fed a cholesterol-rich diet. Because hyperlipidemia is a hallmark of human obesity, we aimed to develop and characterize a novel diet-induced obesity (DIO) and hypercholesterolemia Golden Syrian hamster model. Methods and Results Hamsters fed a highly palatable fat-and sugar-rich diet (HPFS) for 12 weeks showed significant body weight gain, body fat accumulation and impaired glucose tolerance. Cholesterol supplementation to the diet evoked additional hypercholesterolemia. Chronic treatment with the GLP-1 analogue, liraglutide (0.2 mg/kg, SC, BID, 27 days), normalized body weight and glucose tolerance, and lowered blood lipids in the DIO-hamster. The dipeptidyl peptidase- 4 (DPP-4) inhibitor, linagliptin (3.0 mg/kg, PO, QD) also improved glucose tolerance. Treatment with peptide YY3-36 (PYY3-36, 1.0 mg/kg/day) or neuromedin U (NMU, 1.5 mg/kg/day), continuously infused via a subcutaneous osmotic minipump for 14 days, reduced body weight and energy intake and changed food preference from HPFS diet towards chow. Co-treatment with liraglutide and PYY3-36 evoked a pronounced synergistic decrease in body weight and food intake with no lower plateau established. Treatment with the cholesterol uptake inhibitor ezetimibe (10 mg/kg, PO, QD) for 14 days lowered plasma total cholesterol with a more marked reduction of LDL levels, as compared to HDL, indicating additional sensitivity to cholesterol modulating drugs in the hyperlipidemic DIO-hamster. In conclusion, the features of combined obesity, impaired glucose tolerance and hypercholesterolemia in the DIO-hamster make this animal model useful for preclinical evaluation of novel anti-obesity, anti-diabetic and lipid modulating agents.	[Dalboge, Louise S.; Pedersen, Philip J.; Hansen, Gitte; Fabricius, Katrine; Hansen, Henrik B.; Jelsing, Jacob; Vrang, Niels] Gubra, Horsholm, Denmark		Dalboge, LS (corresponding author), Gubra, Horsholm, Denmark.	lsd@gubra.dk		Dalboge, Louise Schjellerup/0000-0001-7773-6313	Danish Agency for Science, Technology and Innovation [12-122836]; Gubra ApS	Danish Agency for Science, Technology and Innovation; Gubra ApS	The authors would like to acknowledge the Danish Agency for Science, Technology and Innovation for co-financing an industrial Ph.D. stipend to LSD. Grant number: 12-122836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was funded by Gubra ApS. JJ and NV are the owners of Gubra ApS and contributed with an unbiased and impartial role in the study design and manuscript revision.	Batterham RL, 2007, NATURE, V450, P106, DOI 10.1038/nature06212; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Benzon CR, 2014, NEUROSCIENCE, V258, P270, DOI 10.1016/j.neuroscience.2013.11.023; BISHOP RW, 1992, J LIPID RES, V33, P549; Dalboge LS, 2014, J PHARMACOL EXP THER, V350, P353, DOI 10.1124/jpet.114.215293; Deacon CF, 2010, EXPERT OPIN INV DRUG, V19, P133, DOI 10.1517/13543780903463862; Dickson SL, 2012, J NEUROSCI, V32, P4812, DOI 10.1523/JNEUROSCI.6326-11.2012; Dillard A, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-89; Dorfman SE, 2003, J NUTR, V133, P4183, DOI 10.1093/jn/133.12.4183; Egecioglu E, 2009, AM J PHYSIOL-ENDOC M, V297, pE708, DOI 10.1152/ajpendo.91022.2008; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hansen G, 2012, ACTA PHARMACOL SIN, V33, P194, DOI 10.1038/aps.2011.168; Hansen HH, 2014, EUR J PHARMACOL, V741, P254, DOI 10.1016/j.ejphar.2014.08.010; Heyne A, 2009, ADDICT BIOL, V14, P373, DOI 10.1111/j.1369-1600.2009.00175.x; Higa Talita S, 2014, Int J Physiol Pathophysiol Pharmacol, V6, P47; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; KasimKarakas SE, 1996, J LAB CLIN MED, V128, P208, DOI 10.1016/S0022-2143(96)90013-X; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Kimberly MM, 1999, CLIN CHEM, V45, P1803; Knudsen LB, 2004, J MED CHEM, V47, P4128, DOI 10.1021/jm030630m; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LIU GL, 1991, COMP BIOCHEM PHYS A, V99, P223, DOI 10.1016/0300-9629(91)90263-C; Lutz Thomas A, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0561s58; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Neary NM, 2005, ENDOCRINOLOGY, V146, P5120, DOI 10.1210/en.2005-0237; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; NISTOR A, 1987, ATHEROSCLEROSIS, V68, P159, DOI 10.1016/0021-9150(87)90106-7; O'Rahilly S, 2008, DIABETES, V57, P2905, DOI 10.2337/db08-0210; Pocai A, 2009, DIABETES, V58, P2258, DOI 10.2337/db09-0278; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621; Russell JC, 2006, CARDIOVASC PATHOL, V15, P318, DOI 10.1016/j.carpath.2006.09.001; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Souidi M, 2001, J NUTR, V131, P1803, DOI 10.1093/jn/131.6.1803; Srivastava RAK, 2010, MOL CELL BIOCHEM, V345, P197, DOI 10.1007/s11010-010-0573-8; Sudhop T, 2002, CIRCULATION, V106, P1943, DOI 10.1161/01.CIR.0000034044.95911.DC; Taghibiglou C, 2000, J BIOL CHEM, V275, P8416, DOI 10.1074/jbc.275.12.8416; Tsutsumi K, 2001, BIOL PHARM BULL, V24, P579, DOI 10.1248/bpb.24.579; van Heek M, 2001, DIABETES, V50, P1330, DOI 10.2337/diabetes.50.6.1330; Vrang N, 2006, AM J PHYSIOL-REG I, V291, pR367, DOI 10.1152/ajpregu.00726.2005	40	33	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135634	10.1371/journal.pone.0135634	http://dx.doi.org/10.1371/journal.pone.0135634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266945	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300145
J	Megnekou, R; Djontu, JC; Bigoga, JD; Medou, FM; Tenou, S; Lissom, A				Megnekou, Rosette; Djontu, Jean Claude; Bigoga, Jude Daiga; Medou, Fabrice Mbah; Tenou, Sandrine; Lissom, Abel			Impact of Placental Plasmodium falciparum Malaria on the Profile of Some Oxidative Stress Biomarkers in Women Living in Yaounde, Cameroon	PLOS ONE			English	Article							PREGNANCY; BLOOD; ERYTHROCYTES; CYTOKINES; RECEPTOR; MARKERS; ASSAY; ACID	Background Impact of the pathophysiology of Plasmodium falciparum placental malaria (PM) on the profile of some oxidative stress biomarkers and their relationship with poor pregnancy outcomes in women remain unknown. Methods Between 2013 and 2014, peripheral blood and placenta tissue from 120 Cameroonian women at delivery were assessed for maternal haemoglobin and, parasitaemia respectively. Parasite accumulation in the placenta was investigated histologically. The levels of oxidative stress biomarkers Malondialdehyde (MDA), Nitric Oxide (NO), Superoxide dismutase (SOD), Catalase (CAT) and Gluthatione (GSH) in the supernatant of teased placenta tissues were determined by Colorimetric enzymatic assays. Results Parasitaemia was inversely related to haemoglobin levels and birth weight (P < 0.001 and 0.012, respectively). The level of lipid peroxide product (MDA) was significantly higher in the malaria infected (P = 0.0047) and anaemic (P = 0.024) women compared to their noninfected and non-anaemic counterparts, respectively. A similar trend was observed with SOD levels, though not significant. The levels of MDA also correlated positively with parasitaemia (P = 0.0024) but negatively with haemoglobin levels (P = 0.002). There was no association between parasitaemia, haemoglobin level and the other oxidative stress biomarkers. From histological studies, levels of MDA associated positively and significantly with placenta malaria infection and the presence of malaria pigments. The levels of SOD, NO and CAT increased with decreasing leukocyte accumulation in the intervillous space. Baby birth weight increased significantly with SOD and CAT levels, but decreased with levels of GSH. Conclusions Placental P. falciparum infection may cause oxidative stress of the placenta tissue with MDA as a potential biomarker of PM, which alongside GSH could lead to poor pregnancy outcomes (anaemia and low birth weight). This finding contributes to the understanding of the pathophysiology of P. falciparum placental malaria in women.	[Megnekou, Rosette; Djontu, Jean Claude; Medou, Fabrice Mbah; Tenou, Sandrine; Lissom, Abel] Univ Yaounde I, Dept Anim Biol & Physiol, Fac Sci, Yaounde, Cameroon; [Megnekou, Rosette; Djontu, Jean Claude; Bigoga, Jude Daiga; Medou, Fabrice Mbah; Tenou, Sandrine; Lissom, Abel] Univ Yaounde I, Ctr Biotechnol, Yaounde, Cameroon; [Bigoga, Jude Daiga] Univ Yaounde I, Dept Biochem, Fac Sci, Yaounde, Cameroon	University of Yaounde I; University of Yaounde I; University of Yaounde I	Megnekou, R (corresponding author), Univ Yaounde I, Dept Anim Biol & Physiol, Fac Sci, Yaounde, Cameroon.	megnekor@yahoo.fr	Lissom, Abel/A-2097-2019	Bigoga, Jude/0000-0001-7206-3308	World Academy of Sciences (TWAS) [12-081 RG/BIO/AF : AC_I-UNESCO FR :3240271366]	World Academy of Sciences (TWAS)	The research leading to these results was supported by The World Academy of Sciences (TWAS), Research Grant No. 12-081 RG/BIO/AF : AC_I-UNESCO FR :3240271366.	ATAMNA H, 1993, MOL BIOCHEM PARASIT, V61, P231, DOI 10.1016/0166-6851(93)90069-A; Bachmann J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004038; BERNHEIM F, 1948, J BIOL CHEM, V174, P257; BULMER JN, 1993, HISTOPATHOLOGY, V22, P211, DOI 10.1111/j.1365-2559.1993.tb00110.x; Djossou F, 1996, B SOC PATHOL EXOT, V89, P17; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fried M, 1998, J IMMUNOL, V160, P2523; Guha M, 2006, FASEB J, V20, pE439; Ifoue SHT, 2009, INDIAN J CLIN BIOCHE, V24, P288, DOI 10.1007/s12291-009-0054-6; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; KAY MMB, 1986, P NATL ACAD SCI USA, V83, P2463, DOI 10.1073/pnas.83.8.2463; Kedziora-Kornatowska K, 2004, CELL MOL BIOL LETT, V9, P635; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Megnekou R, 2015, ACTA TROP, V147, P23, DOI 10.1016/j.actatropica.2015.04.001; Megnekou R, 2015, ACTA TROP, V141, P97, DOI 10.1016/j.actatropica.2014.10.007; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mockenhaupt FP, 2002, J CLIN MICROBIOL, V40, P306, DOI 10.1128/JCM.40.1.306-308.2002; Muthusamy A, 2007, AM J PATHOL, V170, P1989, DOI 10.2353/ajpath.2007.061238; Ostrowski SR, 2007, PARASITE IMMUNOL, V29, P37, DOI 10.1111/j.1365-3024.2006.00916.x; Pereira AC, 2014, CELL BIOL TOXICOL, V30, P301, DOI 10.1007/s10565-014-9285-2; REILLY PM, 1991, AM J SURG, V161, P488, DOI 10.1016/0002-9610(91)91120-8; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Shantha Kumari, 2013, JEMDS; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Sohail M, 2007, CLIN BIOCHEM, V40, P377, DOI 10.1016/j.clinbiochem.2007.01.005; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Thevenon AD, 2010, J IMMUNOL, V185, P7115, DOI 10.4049/jimmunol.1002293; TURI S, 1994, PEDIATR NEPHROL, V8, P26, DOI 10.1007/BF00868253	29	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134633	10.1371/journal.pone.0134633	http://dx.doi.org/10.1371/journal.pone.0134633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267795	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300052
J	Murphy, CFB; Moore, DR; Schochat, E				Murphy, Cristina F. B.; Moore, David R.; Schochat, Eliane			Generalization of Auditory Sensory and Cognitive Learning in Typically Developing Children	PLOS ONE			English	Article							TEMPORAL PROCESSING DEFICITS; TIME-COMPRESSED SPEECH; WORKING-MEMORY; FREQUENCY DISCRIMINATION; LANGUAGE IMPAIRMENT; FAST FORWORD; ATTENTION; INTERVENTION; DIFFICULTIES; PERCEPTION	Despite the well-established involvement of both sensory ("bottom-up") and cognitive ("top-down") processes in literacy, the extent to which auditory or cognitive (memory or attention) learning transfers to phonological and reading skills remains unclear. Most research has demonstrated learning of the trained task or even learning transfer to a closely related task. However, few studies have reported "far-transfer" to a different domain, such as the improvement of phonological and reading skills following auditory or cognitive training. This study assessed the effectiveness of auditory, memory or attention training on far-transfer measures involving phonological and reading skills in typically developing children. Mid-transfer was also assessed through untrained auditory, attention and memory tasks. Sixty 5- to 8-year-old children with normal hearing were quasi-randomly assigned to one of five training groups: attention group (AG), memory group (MG), auditory sensory group (SG), placebo group (PG; drawing, painting), and a control, untrained group (CG). Compliance, mid-transfer and far-transfer measures were evaluated before and after training. All trained groups received 12 x 45-min training sessions over 12 weeks. The CG did not receive any intervention. All trained groups, especially older children, exhibited significant learning of the trained task. On pre- to post-training measures (test-retest), most groups exhibited improvements on most tasks. There was significant mid-transfer for a visual digit span task, with highest span in the MG, relative to other groups. These results show that both sensory and cognitive (memory or attention) training can lead to learning in the trained task and to mid-transfer learning on a task (visual digit span) within the same domain as the trained tasks. However, learning did not transfer to measures of language (reading and phonological awareness), as the PG and CG improved as much as the other trained groups. Further research is required to investigate the effects of various stimuli and lengths of training on the generalization of sensory and cognitive learning to literacy skills.	[Murphy, Cristina F. B.; Schochat, Eliane] Univ Sao Paulo, Sch Med, Dept Phys Therapy Speech Language Pathol & Occupa, Sao Paulo, Brazil; [Moore, David R.] Univ Cincinnati, Med Ctr, Coll Med, Cincinnati Childrens Hosp, Cincinnati, OH 45267 USA; [Moore, David R.] Univ Cincinnati, Coll Med, Dept Otolaryngol, Cincinnati, OH USA	Universidade de Sao Paulo; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Murphy, CFB (corresponding author), Univ Sao Paulo, Sch Med, Dept Phys Therapy Speech Language Pathol & Occupa, Sao Paulo, Brazil.	crist78@yahoo.com	Schochat, Eliane/B-5460-2014; Murphy, Cristina F/C-4104-2012	Schochat, Eliane/0000-0002-1775-7603; Dick, Frederic/0000-0002-2933-3912; Murphy, Cristina/0000-0002-2732-2283	CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [23038.001073/2012-39]	CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, grant number: 23038.001073/2012-39. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Amitay S, 2014, VISION RES, V99, P69, DOI 10.1016/j.visres.2013.11.006; Capovilla A. G. S., 1998, TEMAS DESENVOLVIMENT, V7, P14; Chrysochoou E, 2011, AM J PSYCHOL, V124, P275, DOI 10.5406/amerjpsyc.124.3.0275; Cohen W, 2005, J SPEECH LANG HEAR R, V48, P715, DOI 10.1044/1092-4388(2005/049); Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; de Carvalho CA, 2011, FRONT PSYCHOL, V18, P746; Dege F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00124; Dunning DL, 2003, DEVELOPMENTAL SCI, V16, P915; Gathercole SE, 2006, J EXP CHILD PSYCHOL, V93, P265, DOI 10.1016/j.jecp.2005.08.003; Gillarn RB, 2008, J SPEECH LANG HEAR R, V51, P97, DOI 10.1044/1092-4388(2008/007); Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Halliday LF, 2008, J ACOUST SOC AM, V123, P4393, DOI 10.1121/1.2890749; Halliday LF, 2014, DYSLEXIA, V20, P101, DOI 10.1002/dys.1470; Halliday LF, 2012, J SPEECH LANG HEAR R, V55, P168, DOI 10.1044/1092-4388(2011/09-0213); Hawkey DJC, 2004, NAT NEUROSCI, V7, P1055, DOI 10.1038/nn1315; Hoeft F, 2011, P NATL ACAD SCI USA, V108, P361, DOI 10.1073/pnas.1008950108; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; HUGDAHL K, 1986, CORTEX, V22, P417, DOI 10.1016/S0010-9452(86)80005-3; Hugdahl K, 2001, DEV NEUROPSYCHOL, V20, P445, DOI 10.1207/S15326942DN2001_8; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P11, DOI 10.1111/j.1467-9450.2008.00676.x; Karbach J, 2014, CHILD NEUROPSYCHOL; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kraus N, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01403; Kujala T, 2001, P NATL ACAD SCI USA, V98, P10509, DOI 10.1073/pnas.181589198; Lakshminarayanan K, 2007, RESTOR NEUROL NEUROS, V25, P263; Levi DM, 2009, VISION RES, V49, P2535, DOI 10.1016/j.visres.2009.02.010; Lim CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046692; Linden DEJ, 2007, NEUROSCIENTIST, V13, P257, DOI 10.1177/1073858406298480; Loosli Sandra V, 2012, Child Neuropsychol, V18, P62, DOI 10.1080/09297049.2011.575772; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Meng X, 2014, PLOS ONE, V9, P23; Merzenich MM, 1996, SCIENCE, V271, P77, DOI 10.1126/science.271.5245.77; Merzenich MM, 1993, TEMPORAL INFORM PROC, P247; Moore DR, 2008, HEARING RES, V238, P147, DOI 10.1016/j.heares.2007.11.013; Moore DR, 2012, J COMMUN DISORD, V45, P411, DOI 10.1016/j.jcomdis.2012.06.006; Moore DR, 2005, BRAIN LANG, V94, P72, DOI 10.1016/j.bandl.2004.11.009; Murphy CFB, 2011, FOLIA PHONIATR LOGO, V63, P147, DOI 10.1159/000316327; Murphy CFB, 2009, BRAZ J MED BIOL RES, V42, P647, DOI 10.1590/S0100-879X2009000700009; Murphy CB, 2015, J AM ACAD AUDIOL, V26, P19, DOI 10.3766/jaaa.26.1.3; Murphy CFB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093091; OBRZUT JE, 1982, J GEN PSYCHOL, V107, P165, DOI 10.1080/00221309.1982.9709922; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Rabelo CM, 2007, CLINICS, V62, P261, DOI 10.1590/S1807-59322007000300010; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Salles, 2001, THESIS U FEDERAL RIO; Schaffler T, 2004, DYSLEXIA, V10, P119, DOI 10.1002/dys.267; Smallwood J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00734; Soveri A, 2013, EXP PSYCHOL, V60, P44, DOI 10.1027/1618-3169/a000172; Strait DL, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-44; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Van Ingelghem M, 2001, NEUROREPORT, V12, P3603, DOI 10.1097/00001756-200111160-00046; Versfeld NJ, 2002, J ACOUST SOC AM, V111, P401, DOI 10.1121/1.1426376; Wang SM, 2013, J EXP CHILD PSYCHOL, V115, P188, DOI 10.1016/j.jecp.2012.11.015; Wilson R H, 1994, J Am Acad Audiol, V5, P269; Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262; Xiong QJ, 2015, NATURE, V521, P348, DOI 10.1038/nature14225	59	6	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135422	10.1371/journal.pone.0135422	http://dx.doi.org/10.1371/journal.pone.0135422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267275	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000359492300114
J	Cui, WN; Jang, A; Zhang, PY; Thompson, B; Townsend, D; Metzger, JM; Zhang, JY				Cui, Weina; Jang, Albert; Zhang, Pengyuan; Thompson, Brian; Townsend, DeWayne; Metzger, Joseph M.; Zhang, Jianyi			Early Detection of Myocardial Bioenergetic Deficits: A 9.4 Tesla Complete Non Invasive P-31 MR Spectroscopy Study in Mice with Muscular Dystrophy	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; GLYCOPROTEIN COMPLEX; PRESSURE-OVERLOAD; MDX MICE; IN-VIVO; CARDIOMYOPATHY; HEARTS; DYSFUNCTION; EVOLUTION; RESERVE	Background Duchenne muscular dystrophy (DMD) is the most common fatal form of muscular dystrophy characterized by striated muscle wasting and dysfunction. Patients with DMD have a very high incidence of heart failure, which is increasingly the cause of death in DMD patients. We hypothesize that in the in vivo system, the dystrophic cardiac muscle displays bioenergetic deficits prior to any functional or structural deficits. To address this we developed a complete non invasive 31P magnetic resonance spectroscopy (31P MRS) approach to measure myocardial bioenergetics in the heart in vivo. Methods and Results Six control and nine mdx mice at 5 months of age were used for the study. A standard 3D -Image Selected In vivo Spectroscopy (3D-ISIS) sequence was used to provide complete gradient controlled three-dimensional localization for heart 31P MRS. These studies demonstrated dystrophic hearts have a significant reduction in PCr/ATP ratio compare to normal (1.59 +/- 0.13 vs 2.37 +/- 0.25, p<0.05). Conclusion Our present study provides the direct evidence of significant cardiac bioenergetic deficits in the in vivo dystrophic mouse. These data suggest that energetic defects precede the development of significant hemodynamic or structural changes. The methods provide a clinically relevant approach to use myocardial energetics as an early marker of disease in the dystrophic heart. The new method in detecting the in vivo bioenergetics abnormality as an early non-invasive marker of emerging dystrophic cardiomyopathy is critical in management of patients with DMD, and optimized therapies aimed at slowing or reversing the cardiomyopathy.	[Cui, Weina; Jang, Albert; Zhang, Pengyuan; Zhang, Jianyi] Univ Minnesota, Sch Med, Dept Med Cardiol, Minneapolis, MN 55455 USA; [Thompson, Brian; Townsend, DeWayne; Metzger, Joseph M.] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zhang, JY (corresponding author), Univ Minnesota, Sch Med, Dept Med Cardiol, Minneapolis, MN 55455 USA.	zhang047@umn.edu	Zhang, Jianyi/N-1949-2018	Zhang, Jianyi/0000-0002-3955-6554	National Institutes of Health [RO1s HL67828, HL95077, HL 114120, UO1 HL100407]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067828, R01HL114120, R01HL114832, U01HL100407, R01HL095077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health RO1s HL67828, HL95077, HL 114120 and UO1 HL100407, www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Janssen PML, 2005, AM J PHYSIOL-HEART C, V289, pH2373, DOI 10.1152/ajpheart.00448.2005; Kamogawa Y, 2001, CARDIOVASC RES, V50, P509, DOI 10.1016/S0008-6363(01)00205-X; Khairallah M, 2007, J MOL CELL CARDIOL, V43, P119, DOI 10.1016/j.yjmcc.2007.05.015; Maslov MY, 2010, AM J PHYSIOL-HEART C, V299, pH332, DOI 10.1152/ajpheart.00727.2009; Masoud WGT, 2014, CARDIOVASC RES, V101, P30, DOI 10.1093/cvr/cvt216; McNally EM, 2015, CIRCULATION, V131, P1590, DOI 10.1161/CIRCULATIONAHA.114.015151; Meyers TA, 2015, AM J PHYSIOL-HEART C, V308, pH303, DOI 10.1152/ajpheart.00485.2014; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; NIGRO G, 1990, INT J CARDIOL, V26, P271, DOI 10.1016/0167-5273(90)90082-G; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Strakova J, 2014, J MOL CELL CARDIOL, V76, P106, DOI 10.1016/j.yjmcc.2014.08.013; Tian R, 1996, AM J PHYSIOL-HEART C, V270, pH1207, DOI 10.1152/ajpheart.1996.270.4.H1207; Viola HM, 2013, AM J PHYSIOL-HEART C, V304, pH767, DOI 10.1152/ajpheart.00700.2012; Yasuda S, 2005, NATURE, V436, P1025, DOI 10.1038/nature03844; Ye Y, 2001, CIRCULATION, V103, P1570; Yue YP, 2004, HUM MOL GENET, V13, P1669, DOI 10.1093/hmg/ddh174; ZHANG JY, 1993, J CLIN INVEST, V92, P993, DOI 10.1172/JCI116676; ZHANG JY, 1995, CIRCULATION, V92, P1274, DOI 10.1161/01.CIR.92.5.1274; ZHANG JY, 1995, CIRCULATION, V92, P1011, DOI 10.1161/01.CIR.92.4.1011	24	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135000	10.1371/journal.pone.0135000	http://dx.doi.org/10.1371/journal.pone.0135000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262993	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300050
J	Gelardi, M; Vizzini, A; Ercole, E; Horak, E; Ming, Z; Li, TH				Gelardi, Matteo; Vizzini, Alfredo; Ercole, Enrico; Horak, Egon; Ming, Zhang; Li, Tai-Hui			Circumscription and Taxonomic Arrangement of Nigroboletus roseonigrescens Gen. Et Sp Nov., a New Member of Boletaceae from Tropical South-Eastern China	PLOS ONE			English	Article							PHYLOGENETIC INFERENCE; MOLECULAR PHYLOGENY; BOLETALES; XEROCOMUS; SEQUENCES; BOLETUS; ACCOMMODATE; MUSHROOMS; FUNGI	Nigroboletus is proposed as a novel genus in family Boletaceae, subfamily Boletoideae, to include N. roseonigrescens, a new boletoid species from tropical environment in southeastern China. Detailed morphological description, color pictures of both fresh basidiomes in habitat and dried material along with photomicrographs and line drawings of the main anatomical features are provided, supported by a comprehensive phylogeny based on multigene molecular analysis (nrITS, nrLSU, rpb1, rpb2 and tef1-alpha datasets). Taxonomic placement and evolutionary relationships of Nigroboletus are investigated.	[Vizzini, Alfredo; Ercole, Enrico] Univ Turin, Dept Life Sci & Syst Biol, I-10125 Turin, Italy; [Horak, Egon] Univ Innsbruck, Mikrobiol Inst, A-6020 Innsbruck, Austria; [Ming, Zhang; Li, Tai-Hui] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Ming, Zhang; Li, Tai-Hui] Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangzhou 510070, Guangdong, Peoples R China	University of Turin; University of Innsbruck; South China University of Technology; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Vizzini, A (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Viale PA Mattioli 25, I-10125 Turin, Italy.	alfredo.vizzini@unito.it		Lumbsch, Thorsten/0000-0003-1512-835X; Vizzini, Alfredo/0000-0001-8390-6446	Natural Science Foundation of Guangdong Province [S2013010015544]; National Natural Science Foundation of China [31370071]; Ministry of Science and Technology of the People's Republic of China [2014CB460613, 2013FY111200]; State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences	This study was supported by the Natural Science Foundation of Guangdong Province (No. S2013010015544), the National Natural Science Foundation of China (Nos. 31370071), the Ministry of Science and Technology of the People's Republic of China (Nos. 2014CB460613, 2013FY111200) and the State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime MC, 2012, BIODIVERS CONSERV, V21, P2177, DOI 10.1007/s10531-012-0338-7; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bessette A.E., 2000, N AM BOLETES COLOR G; Bi ZS, 1997, PRELIMINARY AGARIC F; Bi ZS, 1984, ACTA MYCOL SIN, V3, P199; Bi ZS, 1982, ACTA BOT YUNNANICA, V4, P55; Bi ZS., 1994, MACROFUNGUS FLORA GU; Bi ZS., 1990, MACROFUNGUS FLORA MO; Both EE, 1993, BOLETES N AM; Chiu W. F., 1948, MYCOLOGIA, V40, P199, DOI DOI 10.2307/3755085; Corner E. J. H., 1972, Boletus in Malaysia.; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond A.J., 2010, GENEIOUS 5 3; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037567; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gelardi M, 2014, MYCOL PROG, V13, P333, DOI 10.1007/s11557-013-0919-1; Gelardi M, 2013, SYDOWIA, V65, P45; Gelardi M, 2013, MYCOL PROG, V12, P575, DOI 10.1007/s11557-012-0865-3; Hawksworth DL, 2012, BIODIVERS CONSERV, V21, P2425, DOI 10.1007/s10531-012-0335-x; Heinemann P., 1995, Bulletin du Jardin Botanique National de Belgique, V64, P215, DOI 10.2307/3668381; Horak E., 2011, MALAYAN FOREST RECOR, V51; Imazeki R, 1952, NAGAOA, V2, P30; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Ladurner H, 2003, FUNGI EUROPAEI, V8; Lannoy G, 2001, DOCUMENTS MYCOLOGIQU, V6; Li YC, 2009, FUNGAL DIVERS, V38, P85; Li YC, 2011, FUNGAL DIVERS, V49, P125, DOI 10.1007/s13225-011-0096-y; Li YC, 2014, MYCOL PROG, V13, P1207, DOI 10.1007/s11557-014-1011-1; Li YC, 2014, MYCOLOGIA, V106, P291, DOI 10.3852/106.2.291; Matheny PB, 2007, MOL PHYLOGENET EVOL, V43, P430, DOI 10.1016/j.ympev.2006.08.024; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Miller M.A., 2010, P GAT COMP ENV WORKS; Muuoz, 2005, FUNGI EUROPAEI; Nagasawa E, 1989, COLORED ILLUSTRATION, VII, P1; Nuhn ME, 2013, FUNGAL BIOL-UK, V117, P479, DOI 10.1016/j.funbio.2013.04.008; Orihara T, 2012, MYCOTAXON, V120, P139, DOI 10.5248/120.139; Ortiz-Santana B, 2007, FUNGAL DIVERS, V27, P247; PEGLER DN, 1981, T BRIT MYCOL SOC, V76, P103, DOI 10.1016/S0007-1536(81)80013-7; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Ridgway R., 1912, COLOR STANDARDS COLO; SINGER R, 1947, AM MIDL NAT, V37, P1, DOI 10.2307/2421647; Smith A.H., 1971, BOLETES MICHIGAN; Snell W.H., 1970, BOLETI NE N AM; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sutara Josef, 2008, Czech Mycology, V60, P29; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tedersoo L, 2013, FUNGAL BIOL REV, V27, P83, DOI 10.1016/j.fbr.2013.09.001; Thiers B., 2015, INDEX HERBARIORUM GL; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wang SR, 2014, MYCOTAXON, V129, P79, DOI 10.5248/129.79; Watling R., 1999, AUSTR BOLETES PRELIM; Watling R, 2008, SYNOPSIS FUNGORUM, V24; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wu G, 2016, FUNGAL DIVERS, V81, P1, DOI 10.1007/s13225-015-0322-0; Wu G, 2014, FUNGAL DIVERS, V69, P93, DOI 10.1007/s13225-014-0283-8; Yan WJ, 2013, MYCOTAXON, V124, P255, DOI 10.5248/124.255; Zang M, 2013, BOLETACEAE 2 FLORA F, V44; Zang M., 2006, FLORA FUNGORUM SINIC, V22; Zeng NK, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-014-1015-x; Zeng NK, 2014, PHYTOTAXA, V175, P133; Zeng NK, 2014, MYCOSCIENCE, V55, P159, DOI 10.1016/j.myc.2013.07.004; Zeng NK, 2013, FUNGAL DIVERS, V58, P73, DOI 10.1007/s13225-012-0184-7; Zeng NK, 2012, MYCOLOGIA, V104, P1420, DOI 10.3852/11-326; Zhang M, 2015, MYCOSCIENCE, V56, P481, DOI 10.1016/j.myc.2015.02.002; Zhang M, 2014, MYCOTAXON, V128, P195, DOI 10.5248/128.195; Zhang M, 2012, MYCOTAXON, V121, P23, DOI 10.5248/121.23; Zhang MX, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-10; Zhao K, 2014, PHYTOTAXA, V188, P61, DOI 10.11646/phytotaxa.188.2.1; Zhao K, 2014, MYCOL PROG, V13, P1127, DOI 10.1007/s11557-014-1001-3; Zhu XT, 2014, PHYTOTAXA, V191, P81, DOI 10.11646/phytotaxa.191.1.5	71	13	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134295	10.1371/journal.pone.0134295	http://dx.doi.org/10.1371/journal.pone.0134295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263180	Green Submitted, gold, Green Published			2022-12-27	WOS:000359353300027
J	Khanna, AS; Roberts, ST; Cassels, S; Ying, R; John-Stewart, G; Goodreau, SM; Baeten, JM; Murnane, PM; Celum, C; Barnabas, RV				Khanna, Aditya S.; Roberts, Sarah T.; Cassels, Susan; Ying, Roger; John-Stewart, Grace; Goodreau, Steven M.; Baeten, Jared M.; Murnane, Pamela M.; Celum, Connie; Barnabas, Ruanne V.			Estimating PMTCT's Impact on Heterosexual HIV Transmission: A Mathematical Modeling Analysis	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; OPTION B PLUS; SOUTH-AFRICA; CERVICOVAGINAL SECRETIONS; DISEASE PROGRESSION; VIRAL LOADS; TYPE-1 RNA; COITAL-ACT; WOMEN; INFECTION	Introduction Prevention of mother-to-child HIV transmission (PMTCT) strategies include combined short-course antiretrovirals during pregnancy (Option A), triple-drug antiretroviral treament (ART) during pregnancy and breastfeeding (Option B), or lifelong ART (Option B+). The WHO also recommends ART for HIV treatment and prevention of sexual transmission of HIV. The impact of PMTCT strategies on prevention of sexual HIV transmission of HIV is not known. We estimated the population-level impact of PMTCT interventions on heterosexual HIV transmission in southwestern Uganda and KwaZulu-Natal, South Africa, two regions with different HIV prevalence and fertility rates. Materials and Methods We constructed and validated dynamic, stochastic, network-based HIV transmission models for each region. PMTCT Options A, B, and B+ were simulated over ten years under three scenarios: 1) current ART and PMTCT coverage, 2) current ART and high PMTCT coverage, and 3) high ART and PMTCT coverage. We compared adult HIV incidence after ten years of each intervention to Option A (and current ART) at current coverage. Results At current coverage, Options B and B+ reduced heterosexual HIV incidence by about 5% and 15%, respectively, in both countries. With current ART and high PMTCT coverage, Option B+ reduced HIV incidence by 35% in Uganda and 19% in South Africa, while Option B had smaller, but meaningful, reductions. The greatest reductions in HIV incidence were achieved with high ART and PMTCT coverage. In this scenario, all PMTCT strategies yielded similar results. Discussion Implementation of Options B/B+ reduces adult HIV incidence, with greater effect (relative to Option A at current levels) in Uganda than South Africa. These results are likely driven by Uganda's higher fertility rates.	[Khanna, Aditya S.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Roberts, Sarah T.; Ying, Roger; John-Stewart, Grace; Baeten, Jared M.; Celum, Connie; Barnabas, Ruanne V.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Roberts, Sarah T.; Cassels, Susan; John-Stewart, Grace; Baeten, Jared M.; Celum, Connie] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [John-Stewart, Grace; Baeten, Jared M.; Celum, Connie; Barnabas, Ruanne V.] Univ Washington, Dept Med, Seattle, WA USA; [John-Stewart, Grace] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Goodreau, Steven M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Cassels, Susan] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Murnane, Pamela M.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Barnabas, Ruanne V.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Chicago; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Santa Barbara; Columbia University; Fred Hutchinson Cancer Center	Khanna, AS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	akhanna@medicine.bsd.uchicago.edu	John-Stewart, Grace/U-3351-2019; Roberts, Sarah/AAG-2768-2020; John-Stewart, Grace/L-3650-2019; Goodreau, Steven/P-2366-2017; Khanna, Aditya/AAR-1305-2021	Roberts, Sarah/0000-0002-3318-9781; Khanna, Aditya/0000-0003-1049-3374; John-Stewart, Grace/0000-0002-4301-1573	NIH [RC4 AI092552, KL2 TR000421, P30 AI027757, R24 HD042828, R00 HD057533, R01 DA033875]; HIV Modeling Consortium [RFA 3.2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314, R00HD057553, R24HD042828, R01HD068395, P2CHD042828, T32HD007543] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000654] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000421, UL1TR002319, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, R01AI083060, U01AI043638, RC4AI092552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022116, R01DA033875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HIV Modeling Consortium; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIH (RC4 AI092552, KL2 TR000421, P30 AI027757, R24 HD042828, R00 HD057533, R01 DA033875) and the HIV Modeling Consortium (RFA 3.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, CHANGING PATTERN ADU; Barnabas R, 2014, C RETR OPP INF BOST; Barnabas RV, 2014, LANCET HIV, V1, pE68, DOI 10.1016/S2352-3018(14)70024-4; Bassett IV, 2008, HIV MED, V9, P863, DOI 10.1111/j.1468-1293.2008.00635.x; Bassett IV, 2007, JAIDS-J ACQ IMM DEF, V46, P181, DOI 10.1097/QAI.0b013e31814277c8; Bureau USC, INT DAT; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Celum C, 2013, J INFECT DIS, V208, P189, DOI 10.1093/infdis/jit154; Chung MH, 2008, ANTIVIR THER, V13, P799; Ciaranello AL, 2013, CLIN INFECT DIS, V56, P430, DOI 10.1093/cid/cis858; Ciaranello AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020224; CLEMETSON DBA, 1993, JAMA-J AM MED ASSOC, V269, P2860, DOI 10.1001/jama.269.22.2860; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Danel C, 2009, J INFECT DIS, V199, P66, DOI 10.1086/595298; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Eaton JW, 2014, LANCET GLOB HEAL, V2; El-Sadr WM, 2008, ANN INTERN MED, V149, P289, DOI 10.7326/0003-4819-149-5-200809020-00003; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Fao P, 2012, CLIN INFECT DIS, V55, P449, DOI 10.1093/cid/cis461; Fielding K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025571; Garcia-Bujalance S, 2004, EUR J CLIN MICROBIOL, V23, P111, DOI 10.1007/s10096-003-1058-4; Gardella B, 2011, CURR HIV RES, V9, P313, DOI 10.2174/157016211797636017; Geng EH, 2013, JAIDS-J ACQ IMM DEF, V63, pE64, DOI 10.1097/QAI.0b013e31828af5a6; Goga A, 2012, EVALUATION EFFECTIVE; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Gopalappa C, 2014, AIDS S1, V28, P5; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Handcock Mark S., 2003, STATNET SOFTWARE TOO; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jain V, 2014, JAIDS-J ACQ IMM DEF, V65, P327, DOI 10.1097/QAI.0000000000000021; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; Khanna AS, 2014, AIDS BEHAV, V18, P1523, DOI 10.1007/s10461-013-0646-2; Kieffer MP, 2014, JAIDS-J ACQ IMM DEF, V67, pS188, DOI 10.1097/QAI.0000000000000372; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V68, pE77, DOI 10.1097/QAI.0000000000000517; Lurie MN, 2014, HEALTH PSYCHOL BEHAV, V2, P34, DOI 10.1080/21642850.2013.866898; Martin NK, 2014, AIDS, V28, pS35, DOI 10.1097/QAD.0000000000000084; Mbikusita-Lewanika M, 2009, PSYCHOL HEALTH MED, V14, P227, DOI 10.1080/13548500802270364; Ministry of Health, 2013, ADD NAT ANT TREATM G; Morrison CS, 2010, AIDS, V24, P573, DOI 10.1097/QAD.0b013e32833433df; Mountain E, 2014, EXPERT REV ANTI-INFE, V12, P1203, DOI 10.1586/14787210.2014.948422; Mudaly V, 2020, W CAPE CONSOLIDATED; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Ngarina M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085310; Pantazis N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032369; Pilcher CD, 2004, AIDS, V18, P517, DOI 10.1097/00002030-200402200-00019; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rizzardi GP, 2000, J CLIN INVEST, V105, P777, DOI 10.1172/JCI9079; Rosenberg NE, 2014, JAIDS-J ACQ IMM DEF, V67, pS114, DOI 10.1097/QAI.0000000000000319; Ross A, 2004, AIDS, V18, P799, DOI 10.1097/00002030-200403260-00012; Ruzagira E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020684; Shisana O., 2009, S AFRICAN NATL HIV P; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Uganda Bureau of Statistics, UG DEM HLTH SURV 201; Uganda Ministry of Health and ICF International, 2011, 2011 UG AIDS IND SUR; United Nations Statistics Division, UN DAT WORLD INF; United States Census Bureau, INT DAT; Van der Paal L, 2007, AIDS, V21, pS21, DOI 10.1097/01.aids.0000299407.52399.05; Walter BL, 2009, AIDS, V23, P1047, DOI 10.1097/QAD.0b013e32832a1806; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2021, ANT DRUGS TREAT PREG	64	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134271	10.1371/journal.pone.0134271	http://dx.doi.org/10.1371/journal.pone.0134271			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262889	Green Published, gold			2022-12-27	WOS:000359353300025
J	Krause, J; Geginat, G; Tammer, I				Krause, Jan; Geginat, Gernot; Tammer, Ina			Prostaglandin E-2 from Candida albicans Stimulates the Growth of Staphylococcus aureus in Mixed Biofilms	PLOS ONE			English	Article							QUORUM-SENSING MOLECULE; KILLER CELL-ACTIVITY; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; INNATE IMMUNITY; DEFICIENT MICE; CYCLIC-AMP; FARNESOL; SUSCEPTIBILITY; INFECTION	Background Previous studies showed that Staphylococcus aureus and Candida albicans interact synergistically in dual species biofilms resulting in enhanced mortality in animal models. Methodology/Principal Findings The aim of the current study was to test possible candidate molecules which might mediate this synergistic interaction in an in vitro model of mixed biofilms, such as farnesol, tyrosol and prostaglandin (PG) E-2. In mono-microbial and dual biofilms of C. albicans wild type strains PGE(2) levels between 25 and 250 pg/mL were measured. Similar concentrations of purified PGE(2) significantly enhanced S. aureus biofilm formation in a mode comparable to that observed in dual species biofilms. Supernatants of the null mutant deficient in PGE(2) production did not stimulate the proliferation of S. aureus and the addition of the cyclooxygenase inhibitor indomethacin blocked the S. aureus biofilm formation in a dose-dependent manner. Additionally, S. aureus biofilm formation was boosted by low and inhibited by high farnesol concentrations. Supernatants of the farnesol-deficient C. albicans ATCC10231 strain significantly enhanced the biofilm formation of S. aureus but at a lower level than the farnesol producer SC5314. However, C. albicans ATCC10231 also produced PGE(2) but amounts were significantly lower compared to SC5314. Conclusion/Significance In conclision, we identified C. albicans PGE(2) as a key molecule stimulating the growth and biofilm formation of S. aureus in dual S. aureus/C. albicans biofilms, although C. albicans derived farnesol, but not tyrosol, may also contribute to this effect but to a lesser extent.	[Krause, Jan; Geginat, Gernot; Tammer, Ina] Otto Von Guericke Univ, Inst Med Microbiol Hosp Control & Prevent, Magdeburg, Germany	Otto von Guericke University	Tammer, I (corresponding author), Otto Von Guericke Univ, Inst Med Microbiol Hosp Control & Prevent, Magdeburg, Germany.	ina.tammer@med.ovgu.de		Geginat, Gernot/0000-0002-4723-2023				Agard M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00045; Alem MAS, 2005, J MED MICROBIOL, V54, P1001, DOI 10.1099/jmm.0.46172-0; Alem MAS, 2006, EUKARYOT CELL, V5, P1770, DOI 10.1128/EC.00219-06; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; BANKHURST AD, 1982, J CLIN LAB IMMUNOL, V7, P85; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Bowman CC, 2004, J IMMUNOL, V172, P2469, DOI 10.4049/jimmunol.172.4.2469; Bozyk PD, 2011, AM J RESP CELL MOL, V45, P445, DOI 10.1165/rcmb.2011-0025RT; CARLSON E, 1985, INFECT IMMUN, V50, P655, DOI 10.1128/IAI.50.3.655-659.1985; CARLSON E, 1982, INFECT IMMUN, V38, P921, DOI 10.1128/IAI.38.3.921-924.1982; Cassat James E., 2007, V391, P127; Chen P, 2012, J MICROBIOL METH, V90, P115, DOI 10.1016/j.mimet.2012.04.009; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cugini C, 2007, MOL MICROBIOL, V65, P896, DOI 10.1111/j.1365-2958.2007.05840.x; DEREPENTIGNY J, 1979, CAN J MICROBIOL, V25, P429, DOI 10.1139/m79-066; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Eck R, 1999, MICROBIOL-UK, V145, P2415, DOI 10.1099/00221287-145-9-2415; Efthimiadis A, 2002, EUR RESPIR J, V20, p19S, DOI 10.1183/09031936.02.00001902; Ejima K, 2003, FASEB J, V17, P1325, DOI 10.1096/fj.02-1078fje; El-Azizi MA, 2004, J APPL MICROBIOL, V96, P1067, DOI 10.1111/j.1365-2672.2004.02213.x; Erb-Downward JR, 2007, INFECT IMMUN, V75, P3498, DOI 10.1128/IAI.00232-07; Fernandez-Arenas E, 2009, CELL MICROBIOL, V11, P560, DOI 10.1111/j.1462-5822.2008.01274.x; FONZI WA, 1993, GENETICS, V134, P717; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; GOTO T, 1983, J IMMUNOL, V130, P1350; Gupta N, 2005, BURNS, V31, P375, DOI 10.1016/j.burns.2004.11.012; Harmon GS, 2010, NAT MED, V16, P313, DOI 10.1038/nm.2101; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; Harrison JJ, 2010, NAT PROTOC, V5, P1236, DOI 10.1038/nprot.2010.71; Hogan DA, 2004, MOL MICROBIOL, V54, P1212, DOI 10.1111/j.1365-2958.2004.04349.x; Hornby JM, 2004, ANTIMICROB AGENTS CH, V48, P2305, DOI 10.1128/AAC.48.6.2305-2307.2004; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Jabra-Rizk MA, 2006, ANTIMICROB AGENTS CH, V50, P1463, DOI 10.1128/AAC.50.4.1463-1469.2006; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kaneko M, 2011, J ANTIBIOT, V64, P547, DOI 10.1038/ja.2011.49; Kaplan JB, 2011, INT J ARTIF ORGANS, V34, P737, DOI 10.5301/ijao.5000027; Kaplan JB, 2011, RES MICROBIOL, V162, P535, DOI 10.1016/j.resmic.2011.03.008; KERR JR, 1994, J CLIN MICROBIOL, V32, P525, DOI 10.1128/JCM.32.2.525-527.1994; Klotz SA, 2007, DIAGN MICR INFEC DIS, V59, P401, DOI 10.1016/j.diagmicrobio.2007.07.001; Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002; Kuroda M, 2007, FEMS MICROBIOL LETT, V273, P28, DOI 10.1111/j.1574-6968.2007.00772.x; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lucidi V, 2008, FREE RADICAL BIO MED, V45, P913, DOI 10.1016/j.freeradbiomed.2008.06.026; Musken M, 2010, NAT PROTOC, V5, P1460, DOI 10.1038/nprot.2010.110; Noverr MC, 2002, INFECT IMMUN, V70, P400, DOI 10.1128/IAI.70.1.400-402.2002; Obermajer N, 2012, IMMUNOL INVEST, V41, P635, DOI 10.3109/08820139.2012.695417; Ovchinnikova ES, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-281; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Peters BM, 2013, INFECT IMMUN, V81, P2178, DOI 10.1128/IAI.00265-13; Peters BM, 2012, MICROBIOL-SGM, V158, P2975, DOI 10.1099/mic.0.062109-0; Peters BM, 2010, FEMS IMMUNOL MED MIC, V59, P493, DOI 10.1111/j.1574-695X.2010.00710.x; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Ramage G, 2002, ANTIMICROB AGENTS CH, V46, P3634, DOI 10.1128/AAC.46.11.3634-3636.2002; Ramage G, 2001, Am Clin Lab, V20, P42; Ramage G, 2002, J ANTIMICROB CHEMOTH, V49, P973, DOI 10.1093/jac/dkf049; RIGAS B, 1989, AM J GASTROENTEROL, V84, P1408; Roux D, 2013, CRIT CARE MED, V41, pE191, DOI 10.1097/CCM.0b013e31828a25d6; Roux D, 2009, CRIT CARE MED, V37, P1062, DOI 10.1097/CCM.0b013e31819629d2; Sadikot RT, 2007, EUR J IMMUNOL, V37, P1001, DOI 10.1002/eji.200636636; STAIB F, 1976, ZBL BAKT-INT J MED M, V234, P450; Takeuchi K, 2010, J PHARMACOL SCI, V114, P248, DOI 10.1254/jphs.10R06CR; Tammer I, 2014, J ANTIMICROB CHEMOTH, V69, P1282, DOI 10.1093/jac/dkt521; Wachtler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036952; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Wang Yue, 2008, Commun Integr Biol, V1, P137; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014	67	46	48	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135404	10.1371/journal.pone.0135404	http://dx.doi.org/10.1371/journal.pone.0135404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262843	Green Submitted, gold, Green Published			2022-12-27	WOS:000359353300081
J	Larson, E; Vail, D; Mbaruku, GM; Kimweri, A; Freedman, LP; Kruk, ME				Larson, Elysia; Vail, Daniel; Mbaruku, Godfrey M.; Kimweri, Angela; Freedman, Lynn P.; Kruk, Margaret E.			Moving Toward Patient-Centered Care in Africa: A Discrete Choice Experiment of Preferences for Delivery Care among 3,003 Tanzanian Women	PLOS ONE			English	Article							RURAL TANZANIA; MIXED LOGIT; HEALTH-CARE; QUALITY; CHILDBIRTH; SATISFACTION; ACCESS	Objective In order to develop patient-centered care we need to know what patients want and how changing socio-demographic factors shape their preferences. Methods We fielded a structured questionnaire that included a discrete choice experiment to investigate women's preferences for place of delivery care in four rural districts of Pwani Region, Tanzania. The discrete choice experiment consisted of six attributes: kind treatment by the health worker, health worker medical knowledge, modern equipment and medicines, facility privacy, facility cleanliness, and cost of visit. Each woman received eight choice questions. The influence of potential supply- and demand- side factors on patient preferences was evaluated using mixed logit models. Results 3,003 women participated in the discrete choice experiment (93% response rate) completing 23,947 choice tasks. The greatest predictor of health facility preference was kind treatment by doctor (beta = 1.13, p<0.001), followed by having a doctor with excellent medical knowledge (beta = 0.89 p<0.001) and modern medical equipment and drugs (beta = 0.66 p<0.001). Preferences for all attributes except kindness and cost were changed with changes to education, primiparity, media exposure and distance to nearest hospital. Conclusions Care quality, both technical and interpersonal, was more important than clinic inputs such as equipment and cleanliness. These results suggest that while basic clinic infrastructure is necessary, it is not sufficient for provision of high quality, patient-centered care. There is an urgent need to build an adequate, competent, and kind health workforce to raise facility delivery and promote patient-centered care.	[Larson, Elysia; Kruk, Margaret E.] Harvard Univ, Dept Global Hlth & Populat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Vail, Daniel] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Mbaruku, Godfrey M.; Kimweri, Angela] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Freedman, Lynn P.] Columbia Univ, Averting Maternal Death & Disabil Program, Mailman Sch Publ Hlth, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; Ifakara Health Institute; Columbia University	Larson, E (corresponding author), Harvard Univ, Dept Global Hlth & Populat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	ell539@mail.harvard.edu	Kruk, Margaret E/E-3058-2010	Kruk, Margaret E/0000-0002-9549-8432; Vail, Daniel/0000-0001-8769-2369	National Institute of Allergy and Infectious Diseases [1R01 AI093182]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093182] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institute of Allergy and Infectious Diseases (grant 1R01 AI093182). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The sponsor of the study had no role in study design; data gathering, analysis and interpretation; or writing of the report.	Aker JC, 2010, J ECON PERSPECT, V24, P207, DOI 10.1257/jep.24.3.207; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Blaauw D, 2010, B WORLD HEALTH ORGAN, V88, P350, DOI 10.2471/BLT.09.072918; Exavery A, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-48; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Hanson K, 2005, HEALTH ECON, V14, P687, DOI 10.1002/hec.959; Heatley ML, 2015, J HEALTH COMMUN, V20, P827, DOI 10.1080/10810730.2015.1018587; Hole AR, 2008, J HEALTH ECON, V27, P1078, DOI 10.1016/j.jhealeco.2007.11.006; Hole AR, 2007, STATA J, V7, P388, DOI 10.1177/1536867X0700700306; Institute of Medicine (US) Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Karkee R, 2013, HLTH POLICY PLAN; Kassebaum N.J, 2014, LANCET; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Kruk ME, 2009, HEALTH POLICY PLANN, V24, P279, DOI 10.1093/heapol/czp011; Kruk ME, 2014, HLTH POLICY PLANNING; Kruk ME, 2015, AM J PUBLIC HEALTH, pe1; Krukz ME, 2011, HEALTH SERV RES, V46, P2057, DOI 10.1111/j.1475-6773.2011.01266.x; Kujawski S, 2015, MATERN CHILD HLTH J; Larson E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-483; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S10; Leonard KL, 2014, HEALTH POLICY PLANN, V29, P85, DOI 10.1093/heapol/czs137; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; National Bureau of Statistics Dar es Salaam Tanzania, 2005, TANZ DEM HLTH SURV 2; Parkhurst JO, 2009, HEALTH POLICY PLANN, V24, P377, DOI 10.1093/heapol/czp023; Regier DA, 2009, J HEALTH ECON, V28, P598, DOI 10.1016/j.jhealeco.2008.11.003; Revelt D, 1999, CUSTOMER SPECIFIC TA; Roberts M., 2008, GETTING HLTH REFORM, DOI DOI 10.1093/ACPROF:OSO/9780195371505.001.0001; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Sato Y, 2005, J URBAN ECON, V58, P45, DOI 10.1016/j.jue.2005.01.004; Scott KW, 2014, NEW ENGL J MED, V371, P3, DOI 10.1056/NEJMp1402157; Sirven N, 2012, SOC INDIC RES, V105, P255, DOI 10.1007/s11205-011-9880-z; Valentine N, 2015, SOC SCI MED, V138, P152, DOI 10.1016/j.socscimed.2015.04.022; Woldeyohanes Tirsit Retta, 2015, BMC Res Notes, V8, P285, DOI 10.1186/s13104-015-1179-8; Wolf DM, 2008, J NURS CARE QUAL, V23, P316, DOI 10.1097/01.NCQ.0000336672.02725.a5; World Bank Group, 2015, GLOB EC PROSP JAN 20	38	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135621	10.1371/journal.pone.0135621	http://dx.doi.org/10.1371/journal.pone.0135621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO7PP	26262840	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300097
J	Putra, AC; Eguchi, H; Lee, KL; Yamane, Y; Gustine, E; Isobe, T; Nishiyama, M; Hiyama, K; Poellinger, L; Tanimoto, K				Putra, Andika C.; Eguchi, Hidetaka; Lee, Kian Leong; Yamane, Yuko; Gustine, Ewita; Isobe, Takeshi; Nishiyama, Masahiko; Hiyama, Keiko; Poellinger, Lorenz; Tanimoto, Keiji			The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; FACTOR-1-ALPHA POLYMORPHISMS; TRANSCRIPTION FACTORS; HIGH-ALTITUDE; GENE; TUMORIGENESIS; TRANSACTIVATION; CARCINOGENESIS; HIF-2-ALPHA; ADAPTATION	Hypoxia-inducible factor-2 alpha (HIF-2 alpha, or EPAS1) is important for cancer progression, and is a putative biomarker for poor prognosis for non-small cell lung cancer (NSCLC). However, molecular mechanisms underlying the EPAS1 overexpression are not still fully understood. We explored a role of a single nucleotide polymorphism (SNP), rs13419896 located within intron 1 of the EPAS1 gene in regulation of its expression. Bioinformatic analyses suggested that a region including the rs13419896 SNP plays a role in regulation of the EPAS1 gene expression and the SNP alters the binding activity of transcription factors. In vitro analyses demonstrated that a fragment containing the SNP locus function as a regulatory region and that a fragment with A allele showed higher transactivation activity than one with G, especially in the presence of overexpressed c-Fos or c-Jun. Moreover, NSCLC patients with the A allele showed poorer prognosis than those with G at the SNP even after adjustment with various variables. In conclusion, the genetic polymorphism of the EPAS1 gene may lead to variation of its gene expression levels to drive progression of the cancer and serve as a prognostic marker for NSCLC.	[Putra, Andika C.; Yamane, Yuko; Gustine, Ewita; Tanimoto, Keiji] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Radiat Med, Hiroshima, Japan; [Eguchi, Hidetaka] Saitama Med Univ, Div Translat Res, Res Ctr Genom Med, Saitama, Japan; [Lee, Kian Leong; Poellinger, Lorenz] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Isobe, Takeshi] Shimane Univ, Sch Med, Div Clin Oncol & Resp Med, Dept Internal Med, Matsue, Shimane, Japan; [Nishiyama, Masahiko] Gunma Univ, Dept Mol & Cellular Pharmacol, Grad Sch Med, Gunma, Japan; [Hiyama, Keiko] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan; [Poellinger, Lorenz] Karolinska Inst, Dept Cell & Mol Biol, Med Nobel Inst, Stockholm, Sweden	Hiroshima University; Saitama Medical University; National University of Singapore; Shimane University; Gunma University; Hiroshima University; Karolinska Institutet	Tanimoto, K (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Radiat Med, Hiroshima, Japan.	ktanimo@hiroshima-u.ac.jp	Keiji, Tanimoto/U-1839-2019; LEE, Kian Leong/E-3584-2013	Keiji, Tanimoto/0000-0003-4912-4197; LEE, Kian Leong/0000-0002-0443-2746	Japan Society for the Promotion of Science (JSPS) [23592766]; Japanese Ministry of Education, Culture, Sports, Science and Technology [221S0001]; Strategic Research Foundation Grant-aided Project for Private Universities, MEXT; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Foundation Grant-aided Project for Private Universities, MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by Grant-in-Aid for Scientific Research (C) (No. 23592766) from Japan Society for the Promotion of Science (JSPS), Grants-in-Aid for Scientific Research on "Innovative Areas (No. 221S0001)" from Japanese Ministry of Education, Culture, Sports, Science and Technology, and the Strategic Research Foundation Grant-aided Project for Private Universities, MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker T, 2002, J MOL MED-JMM, V80, P562, DOI 10.1007/s00109-002-0355-1; Arfin M, 2007, ONCOL REP, V17, P1405; Arifin M, 2010, INT J ONCOL, V36, P1217, DOI 10.3892/ijo_00000605; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080337; Ciampa J, 2011, CANCER RES, V71, P3287, DOI 10.1158/0008-5472.CAN-10-2646; Giatromanolaki A, 2011, BRIT J CANCER, V85, P881; Gong L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075094; Groenman F, 2007, J HISTOCHEM CYTOCHEM, V55, P355, DOI 10.1369/jhc.6A7129.2006; Han SS, 2012, HUM MOL GENET, V21, P1190, DOI 10.1093/hmg/ddr551; Hanaoka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050566; Hansen AE, 2011, VET COMP ONCOL, V9, P16, DOI 10.1111/j.1476-5829.2010.00233.x; Henderson J, 2005, HUM GENET, V118, P416, DOI 10.1007/s00439-005-0066-0; Kim WY, 2009, J CLIN INVEST, V119, P2160, DOI 10.1172/JCI38443; Li C, 2013, ASIAN PAC J CANCER P, V14, P3607, DOI 10.7314/APJCP.2013.14.6.3607; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mazumdar J, 2010, P NATL ACAD SCI USA, V107, P14182, DOI 10.1073/pnas.1001296107; Mendoza C, 2000, LUNG CANCER-J IASLC, V28, P117, DOI 10.1016/S0169-5002(99)00125-7; Mishra A, 2010, INT J CANCER, V126, P819, DOI 10.1002/ijc.24807; Mohamed S, 2009, PEDIATR RES, V65, P193, DOI 10.1203/PDR.0b013e31818d1dbd; Nakamura H, 2008, ONCOGENE, V27, P4200, DOI 10.1038/onc.2008.58; Noguchi T, 2004, CLIN CANCER RES, V10, P7100, DOI 10.1158/1078-0432.CCR-04-0337; ORIDATE N, 1994, BBA-GENE STRUCT EXPR, V1219, P499, DOI 10.1016/0167-4781(94)90077-9; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Putra AC, 2011, RESPIROLOGY, V16, P796, DOI 10.1111/j.1440-1843.2011.01972.x; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; SOBIN LH, 1988, CANCER, V61, P2310, DOI 10.1002/1097-0142(19880601)61:11<2310::AID-CNCR2820611127>3.0.CO;2-X; Szabo E, 1996, CANCER RES, V56, P305; Tanaka T, 2004, INT J CANCER, V111, P617, DOI 10.1002/ijc.20289; Tanimoto K, 2003, CARCINOGENESIS, V24, P1779, DOI 10.1093/carcin/bgg132; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; WODRICH W, 1993, CARCINOGENESIS, V14, P1121, DOI 10.1093/carcin/14.6.1121; Wu XH, 2011, CHINESE MED J-PEKING, V124, P11, DOI 10.3760/cma.j.issn.0366-6999.2011.01.004; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang WH, 2005, AM J CLIN PATHOL, V124, P11, DOI 10.1309/T1H2Y2CHWY7PD2BN	40	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134496	10.1371/journal.pone.0134496	http://dx.doi.org/10.1371/journal.pone.0134496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263511	Green Submitted, Green Published, gold			2022-12-27	WOS:000359353300029
J	Jin, GH; Zhao, YL; Chen, C; Wang, WJ; Du, J; Lu, XQ				Jin, Guanghui; Zhao, Yali; Chen, Chao; Wang, Wenji; Du, Juan; Lu, Xiaoqin			The Length and Content of General Practice Consultation in Two Urban Districts of Beijing: A Preliminary Observation Study	PLOS ONE			English	Article							CHINA; REFORM; CARE	Background Community health service center (CHSC) and community health service station (CHSS) are the main institutions where general practitioners (GPs) deliver primary care in the urban area of China. Motivated by incentive policies, visits to community health service institutions (CHSIs) increased gradually in recent years, but concerns had been raised on the quality of general practice consultation. This is a preliminary study aimed to investigate the existing problems of general practice consultation in Beijing and provide practical evidence for developing relevant policies. Methods Six GPs from 2 CHSCs and 3 CHSSs were selected by purposive sampling. The GPs were observed for 4 or 5 consecutive days during January 2013 to March 2013. The length and content of consultations were recorded in structured observation forms. Quantitative description was applied to describe the median, percentage and frequency of variables. Results A total of 1135 consultations were observed. The most frequent reason for consultations was specific prescription (61.6%), followed by presenting symptoms (20.7%), check-up (9.1%), counseling (5.4%), transfusion & injection (3.0%) and sickness certificate (0.2%). The median consultation length of all consultations was 2.0 minutes. The GPs prescribed in 81.0% of the consultations, on the other hand, history taking, physical examination, explanation of illness and health education only took place in 27.0%, 28.0%, 21.9% and 17.7% of the consultations respectively. Conclusions The adequacy of consultation length in CHSIs is in doubt. Most patients visited the CHSIs for prescription renewal. Health promotion e.g. health education are not adequately provided in consultations. The quality of general practice consultations was jeopardized by the large amount of patient flow for medicine renewal. Policies should be adjusted to reduce unnecessary consultations. Further studies are in need to evaluate the outcome and influencing factors of general practice consultation in China.	[Jin, Guanghui; Zhao, Yali; Chen, Chao; Du, Juan; Lu, Xiaoqin] Capital Med Univ, Sch Gen Practice & Continuing Educ, Dept Gen Practice, Beijing, Peoples R China; [Wang, Wenji] Puren Hosp, Beijing, Peoples R China	Capital Medical University	Lu, XQ (corresponding author), Capital Med Univ, Sch Gen Practice & Continuing Educ, Dept Gen Practice, Beijing, Peoples R China.	xq6518@163.com			Humanities and Social Science Research Program of Beijing Municipal Commission of Education [SQSM201210025006]	Humanities and Social Science Research Program of Beijing Municipal Commission of Education	XQL receieved funding from the Humanities and Social Science Research Program of Beijing Municipal Commission of Education (SQSM201210025006, http://kjch.in.ccmu.edu.cn/art/2012/3/21/art_239_34604.html; http://www.bjedu.gov.cn/publish/portal0/tab40/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankfield RP, 2002, J URBAN HEALTH, V79, P173, DOI 10.1093/jurban/79.2.173; Chai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021718; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; Dong XX, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-503; Freeman GK, 2002, BRIT MED J, V324, P880, DOI 10.1136/bmj.324.7342.880; Gong YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098095; HOWIE JGR, 1991, BRIT J GEN PRACT, V41, P48; [贾鸿雁 Jia Hongyan], 2015, [中国全科医学, Chinese General Practice], V18, P466; [金光辉 Jin Guanghui], 2013, [中国全科医学, Chinese General Practice], V16, P1469; Li YB, 2011, CHIN J HLTH POLICY, V4, P11; Ministry of Health, 2007, GUID PRESCR REG; Ministry of Health, 2001, MED LONG TERM PLAN D; Ministry of Health and National Administration of Chinese Traditional Medicine, 2006, BAS STAND URB COMM H; Ministry of Labor and Social Security, 2006, FAC INS CIT UT COMM; National Development and Reform Commission and Ministry of Health, 2006, REINF REG HLTH SERV; National Health and Family Planning Commission, 2014, CHIN HLTH STAT DIG; [彭迎春 Peng Yingchun], 2012, [中国全科医学, Chinese General Practice], V15, P726; Shao S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082446; The State Council, 2009, GUID FURTH HLTH CAR; The State Council, 1999, PROP DEV URB COMM HL; The State Council, 2006, GUID DEV URB COMM HL; The State Council, 1997, DEC HLTH CAR REF DEV; Tongco M. D. C., 2007, Ethnobotany Research and Applications, V5, P147; [王娜 Wang Na], 2011, [中国全科医学, Chinese General Practice], V14, P26; Wang YD, 2006, CHINESE GEN PRACT, V9, P1050; WHITEHOUSE CR, 1987, J ROY COLL GEN PRACT, V37, P112; Wilson A, 2002, BRIT J GEN PRACT, V52, P1012; WILSON A, 1991, BRIT J GEN PRACT, V41, P119; Winefield HR, 1995, FAM PRACT, V12, P402, DOI 10.1093/fampra/12.4.402; [吴浩 Wu Hao], 2014, [中国全科医学, Chinese General Practice], V17, P773; Wu W, 2011, CHIN PRIM HLTH CARE, V25, P7; Xie Y, 2015, CHIN GEN PRACT, V13, P1621; Yang J, 2008, ANN FAM MED, V6, P421, DOI 10.1370/afm.888; Zhang XC, 2011, HEALTH POLICY, V100, P181, DOI 10.1016/j.healthpol.2010.10.003; Zhao WH, 2008, LANCET, V372, P1697, DOI [10.1016/S0140-6736(08)61366-5, DOI 10.1016/S0140-6736(08)61366-5]; Zhao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094301; Zhou W, 2013, J EVAL CLIN PRACT, V19, P167, DOI 10.1111/j.1365-2753.2011.01788.x	37	22	22	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135121	10.1371/journal.pone.0135121	http://dx.doi.org/10.1371/journal.pone.0135121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258911	gold, Green Published, Green Submitted			2022-12-27	WOS:000359352600039
J	Merken, R; Deboelpaep, E; Teunen, J; Saura, S; Koedam, N				Merken, Ronny; Deboelpaep, Evelien; Teunen, Joachim; Saura, Santiago; Koedam, Nico			Wetland Suitability and Connectivity for Trans-Saharan Migratory Waterbirds	PLOS ONE			English	Article							HABITAT AVAILABILITY; BIRD MIGRATION; DISTURBANCE; IMPACTS; LINKS; SHOREBIRDS; DISTANCES; BEHAVIOR; PATCHES	To complete their life cycle waterbirds rely on patchily distributed and often ephemeral wetlands along their migration route in a vast unsuitable matrix. However, further loss and degradation of remaining wetland habitats might lead to a configuration and size of stopovers that is no longer sufficient to ensure long-term survival of waterbird populations. By identifying optimal conservation targets to maintain overall habitat availability en route, we can accommodate an as yet absent functional connectivity component in larger management frameworks for migratory waterbirds, such as the Ramsar Convention and the EU Natura 2000 Network. Using a graph-based habitat availability metric (Equivalent Connected Area) we determine the functional connectivity of wetland networks for seven migratory waterbirds with divergent habitat requirements. Analyses are performed at two spatial extents both spanning the Mediterranean Sea and centered around Greece (Balkan-Cyrenaica and Greece-Cyrenaica). We create species-specific suitable habitat maps and account for human disturbance by species-specific disturbance buffers, based on expert estimates of Flight Initiation Distances. At both spatial extents we quantitatively determine the habitat networks' overall functional connectivity and identify wetland sites that are crucial for maintaining a well-connected network. We show that the wetland networks for both spatial extents are relatively well connected and identify several wetland sites in Greece and Libya as important for maintaining connectivity. The application of disturbance buffers results in wetland site-specific reduction of suitable habitat area (0.90-7.36%) and an overall decrease of the network's connectivity (0.65-6.82%). In addition, we show that the habitat networks of a limited set of species can be combined into a single network which accounts for their autoecological requirements. We conclude that targeted management in few but specific wetland complexes could benefit migratory waterbird populations. Deterioration of these vital wetland sites in Greece and Libya will have disproportionate consequences to the waterbird populations they support.	[Merken, Ronny; Deboelpaep, Evelien; Teunen, Joachim; Koedam, Nico] Vrije Univ Brussel, Lab Plant Sci & Nat Management, Brussels, Belgium; [Saura, Santiago] Univ Politecn Madrid, Dept Nat Syst & Resources, Madrid, Spain	Vrije Universiteit Brussel; Universidad Politecnica de Madrid	Deboelpaep, E (corresponding author), Vrije Univ Brussel, Lab Plant Sci & Nat Management, Brussels, Belgium.	evelien.deboelpaep@vub.ac.be	Saura, Santiago/A-9994-2008	Saura, Santiago/0000-0002-5239-0763	Universitaire Stichting of Belgium	Universitaire Stichting of Belgium	This work has been funded with support from the Universitaire Stichting of Belgium.	[Anonymous], 2005, EC HUM WELL BEING WE; Bellisario B, 2014, ACTA OECOL, V58, P5, DOI 10.1016/j.actao.2014.04.002; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bibby CJ, 2003, AVIAN MIGRATION, P407; BirdGuides, 2006, BWPI BIRDS W PAL INT; Blanc R, 2006, REV ECOL-TERRE VIE, V61, P117; Blankespoor B., 2012, SEA LEVEL RISE COAST; Bossard M, 2000, CORINE LAND COVER TE; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Colwell MA, 2010, SHOREBIRD ECOLOGY, CONSERVATION, AND MANAGEMENT, P1; Crooks K. R., 2006, CONNECTIVITY CONSERV; Downs JA, 2008, INT J GEOGR INF SCI, V22, P687, DOI 10.1080/13658810701674962; European Commission, 2007, LIFE 3 LIFE EUR WETL; European Environment Agency, COR LAND COV SEAML V; European Environment Agency, SHAP EUR BORD 2013; Fatoric S, 2014, INT J SUST DEV WORLD, V21, P346, DOI 10.1080/13504509.2014.888377; Gawlik DE, 2002, ECOL MONOGR, V72, P329, DOI 10.1890/0012-9615(2002)072[0329:TEOPAO]2.0.CO;2; GlobWetland II European Space Agency, GLOBWETLAND 2 WEBGIS; Glover HK, 2011, LANDSCAPE URBAN PLAN, V103, P326, DOI 10.1016/j.landurbplan.2011.08.006; Hagemeijer Ward, 2006, P697; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Henningsson SS, 2005, P ROY SOC B-BIOL SCI, V272, P2251, DOI 10.1098/rspb.2005.3221; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; HOCKIN D, 1992, J ENVIRON MANAGE, V36, P253, DOI 10.1016/S0301-4797(08)80002-3; Horvath G, 2009, FRONT ECOL ENVIRON, V7, P317, DOI 10.1890/080129; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Kreakie BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030142; Krijgsveld KL, 2009, 08173 VOG NED BUR WA; Legagneux P, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0417; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; Ma ZJ, 2010, WETLANDS, V30, P15, DOI 10.1007/s13157-009-0001-6; Mayor SJ, 2009, ECOSCIENCE, V16, P238, DOI 10.2980/16-2-3238; Mazaris AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059640; Mitchell Laura R., 2006, Studies in Avian Biology, P155; Moritz C, 2009, ECOLOGICAL MODELLING, V220; Navedo JG, 2008, J EXP MAR BIOL ECOL, V355, P59, DOI 10.1016/j.jembe.2007.11.016; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nilsson C, 2013, AM NAT, V181, P837, DOI 10.1086/670335; Piersma T, 2004, IBIS, V146, P61, DOI 10.1111/j.1474-919X.2004.00329.x; Robertson P, 2001, IMPORTANT BIRD AREAS, P481; Rosa S, 2007, J EXP MAR BIOL ECOL, V353, P35, DOI 10.1016/j.jembe.2007.08.019; Rubio L, 2015, ECOGRAPHY, V38, P782, DOI 10.1111/ecog.00935; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Sandvik B., SHAPEFILE WORLD BORD; Saura S., 2007, CONEFOR SENSINODE 2; Saura S, 2012, CONEFOR 2 6 USER MAN; Saura S., 2011, ECOLOGICAL INDICATOR, V11, P407, DOI DOI 10.1016/J.EC0LIND.2010.06.011; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Saura S, 2007, LANDSCAPE URBAN PLAN, V83, P91, DOI 10.1016/j.landurbplan.2007.03.005; Saura S, 2014, J APPL ECOL, V51, P171, DOI 10.1111/1365-2664.12179; Saura S, 2010, ECOGRAPHY, V33, P523, DOI 10.1111/j.1600-0587.2009.05760.x; Sokos CK, 2013, WILDLIFE BIOL, V19, P113, DOI 10.2981/12-032; Stralberg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006825; Strubbe D, 2013, GLOBAL ECOL BIOGEOGR, V22, P962, DOI 10.1111/geb.12050; Tankersley R, 2003, CONSERV ECOL, V7; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118; Votsi NE, 2012, NAT CONSERV-BULGARIA, P53, DOI 10.3897/natureconservation.1.2086; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; West AD, 2002, BIOL CONSERV, V106, P319, DOI 10.1016/S0006-3207(01)00257-9; WFF Greece, YGROT ISL 2014; Whitfield DP, 2008, BIOL CONSERV, V141, P2708, DOI 10.1016/j.biocon.2008.08.007; Wings Over Wetlands, 2014, CRIT SIT NETW TOOL W; Wings Over Wetlands UNEP GEF African Eurasian Flyways Project, 2011, CRIT SIT NETW CONS I; Woolf A, 2003, W141R1 SO ILL U CARB; WWF Greece, OIK 2014; Zwarts L., 2009, LIVING EDGE WETLANDS	68	22	25	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135445	10.1371/journal.pone.0135445	http://dx.doi.org/10.1371/journal.pone.0135445			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258590	gold, Green Published			2022-12-27	WOS:000359352600068
J	Chronakova, A; Schloter-Hai, B; Radl, V; Endesfelder, D; Quince, C; Elhottova, D; Simek, M; Schloter, M				Chronakova, Alica; Schloter-Hai, Brigitte; Radl, Viviane; Endesfelder, David; Quince, Christopher; Elhottova, Dana; Simek, Miloslav; Schloter, Michael			Response of Archaeal and Bacterial Soil Communities to Changes Associated with Outdoor Cattle Overwintering	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MICROBIAL COMMUNITIES; METHANOGENIC ARCHAEA; FUNGAL COMMUNITIES; GRASSLAND SOILS; LAND-USE; DIVERSITY; PASTURE; PH; HUSBANDRY	Archaea and bacteria are important drivers for nutrient transformations in soils and catalyse the production and consumption of important greenhouse gases. In this study, we investigate changes in archaeal and bacterial communities of four Czech grassland soils affected by outdoor cattle husbandry. Two show short-term (3 years; STI) and long-term impact (17 years; LTI), one is regenerating from cattle impact (REG) and a control is unaffected by cattle (CON). Cattle manure (CMN), the source of allochthonous microbes, was collected from the same area. We used pyrosequencing of 16S rRNA genes to assess the composition of archaeal and bacterial communities in each soil type and CMN. Both short-and long-term cattle impact negatively altered archaeal and bacterial diversity, leading to increase of homogenization of microbial communities in overwintering soils over time. Moreover, strong shifts in the prokaryotic communities were observed in response to cattle overwintering, with the greatest impact on archaea. Oligotrophic and acidophilic microorganisms (e.g. Thaumarchaeota, Acidobacteria, and alpha-Proteobacteria) dominated in CON and expressed strong negative response to increased pH, total C and N. Whereas copiotrophic and alkalophilic microbes (e.g. methanogenic Euryarchaeota, Firmicutes, Chloroflexi, Actinobacteria, and Bacteroidetes) were common in LTI showing opposite trends. Crenarchaeota were also found in LTI, though their trophic interactions remain cryptic. Firmicutes, Bacteroidetes, Methanobacteriaceae, and Methanomicrobiaceae indicated the introduction and establishment of faecal microbes into the impacted soils, while Chloroflexi and Methanosarcinaceae suggested increased abundance of soil-borne microbes under altered environmental conditions. The observed changes in prokaryotic community composition may have driven corresponding changes in soil functioning.	[Chronakova, Alica; Elhottova, Dana; Simek, Miloslav] Acad Sci Czech Republic, Inst Soil Biol, Ctr Biol, Vvi, CR-37005 Ceske Budejovice, Czech Republic; [Schloter-Hai, Brigitte; Radl, Viviane; Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Neuherberg, Germany; [Endesfelder, David] Helmholtz Zentrum Munchen, Res Unit Sci Comp, Neuherberg, Germany; [Quince, Christopher] Univ Glasgow, Dept Civil Engn, Glasgow G12 8QQ, Lanark, Scotland	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Glasgow	Chronakova, A (corresponding author), Acad Sci Czech Republic, Inst Soil Biol, Ctr Biol, Vvi, Na Sadkach 7, CR-37005 Ceske Budejovice, Czech Republic.	alicach@upb.cas.cz	Šimek, Miloslav/G-1532-2014; Chronakova, Alica/G-1422-2014; Elhottová, Dana/G-1168-2014; Chroňáková, Alica/AAS-1476-2020; Schloter, 1Michael/H-9151-2013	Chronakova, Alica/0000-0002-3316-6862; Chroňáková, Alica/0000-0002-3316-6862; Quince, Christopher/0000-0003-1884-8440	German Academic Exchange Service (DAAD); Ministry of Education, Youth and Sports of the Czech Republic (MEYS) [LC06066]; Grant Agency of the Czech Republic (GACR) [526/09/1570]; EPSRC [EP/H003851/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H003851/1] Funding Source: researchfish	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Ministry of Education, Youth and Sports of the Czech Republic (MEYS)(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This project was funded by a grant from the German Academic Exchange Service (DAAD, www.daad.de) providing travel grants for VR and MS, from the Ministry of Education, Youth and Sports of the Czech Republic (MEYS, No. LC06066, www.msmt.cz), and from the Grant Agency of the Czech Republic (GACR, No. 526/09/1570, www.gacr.cz).	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Bannert A, 2012, BIOGEOSCIENCES, V9, P3891, DOI 10.5194/bg-9-3891-2012; Bano N, 2004, APPL ENVIRON MICROB, V70, P781, DOI 10.1128/AEM.70.2.781-789.2004; Bardgett RD, 2001, SOIL BIOL BIOCHEM, V33, P1653, DOI 10.1016/S0038-0717(01)00086-4; BEEMAN RE, 1990, J IND MICROBIOL, V5, P45, DOI 10.1007/BF01569605; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Bradley RL, 2012, SOIL BIOL BIOCHEM, V53, P64, DOI 10.1016/j.soilbio.2012.04.025; Chan OC, 2008, FEMS MICROBIOL ECOL, V64, P449, DOI 10.1111/j.1574-6941.2008.00488.x; Chronakova A, 2009, FOLIA MICROBIOL, V54, P436, DOI 10.1007/s12223-009-0061-2; Chronakova A, 2009, SOIL BIOL BIOCHEM, V41, P1132, DOI 10.1016/j.soilbio.2009.02.019; Clarke K.R., 2006, PRIMER V6 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clegg CD, 2006, APPL SOIL ECOL, V31, P73, DOI 10.1016/j.apsoil.2005.04.003; Cookson WR, 2002, SOIL BIOL BIOCHEM, V34, P1461, DOI 10.1016/S0038-0717(02)00090-1; Ding G, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092958, DOI 10.1371/J0URNAL.P0NE.0092958]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elhottova D, 2012, APPL SOIL ECOL, V58, P56, DOI 10.1016/j.apsoil.2012.03.009; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Gattinger A, 2007, ENVIRON MICROBIOL, V9, P612, DOI 10.1111/j.1462-2920.2006.01181.x; Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; Hill P, 2011, MICROB ECOL, V61, P286, DOI 10.1007/s00248-010-9752-0; Hook SE, 2010, ARCHAEA, V2010, DOI 10.1155/2010/945785; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Hynst J, 2007, AGR ECOSYST ENVIRON, V120, P269, DOI 10.1016/j.agee.2006.10.003; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; Kemnitz D, 2007, FEMS MICROBIOL ECOL, V60, P442, DOI 10.1111/j.1574-6941.2007.00310.x; Koubova A, 2012, EUR J SOIL BIOL, V48, P32, DOI 10.1016/j.ejsobi.2011.09.007; Krzmarzick MJ, 2012, APPL ENVIRON MICROB, V78, P393, DOI 10.1128/AEM.06510-11; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lanzen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049334; Laughlin RJ, 2009, APPL SOIL ECOL, V42, P25, DOI 10.1016/j.apsoil.2009.01.004; Lehtovirta LE, 2009, FEMS MICROBIOL ECOL, V70, P367, DOI 10.1111/j.1574-6941.2009.00748.x; Li R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051897, DOI 10.1371/J0URNAL.P0NE.0051897]; Mackie RI, 1998, J ANIM SCI, V76, P1331; Meng J, 2014, ISME J, V8, P650, DOI 10.1038/ismej.2013.174; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nicol GW, 2005, ENVIRON MICROBIOL, V7, P337, DOI 10.1111/j.1462-2920.2005.00698.x; Nicol GW, 2004, ENVIRON MICROBIOL, V6, P861, DOI 10.1111/j.1462-2920.2004.00627.x; Nicol GW, 2003, APPL ENVIRON MICROB, V69, P7420, DOI 10.1128/AEM.69.12.7420-7429.2003; O'Callaghan M, 2010, SOIL BIOL BIOCHEM, V42, P1425, DOI 10.1016/j.soilbio.2010.05.003; Oksanen J, THE VEGAN PACKAGE, P16; Oton E, 2015, ISME J; PAUL JW, 1989, BIOL WASTE, V29, P313, DOI 10.1016/0269-7483(89)90022-0; Philippot L, 2009, ENVIRON MICROBIOL, V11, P1518, DOI 10.1111/j.1462-2920.2009.01879.x; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Radl V, 2007, ISME J, V1, P443, DOI 10.1038/ismej.2007.60; Radl V, 2014, APPL SOIL ECOL, V77, P68, DOI 10.1016/j.apsoil.2014.01.008; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; STUMM CK, 1982, BRIT J NUTR, V47, P95, DOI 10.1079/BJN19820013; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Warnes G B, GPLOTS VARIOUS PROGR; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Yamamoto N, 2011, APPL MICROBIOL BIOT, V90, P1501, DOI 10.1007/s00253-011-3153-2; Yang YF, 2013, GLOBAL CHANGE BIOL, V19, P637, DOI 10.1111/gcb.12065; Yuan YL, 2014, FEMS MICROBIOL ECOL, V87, P121, DOI 10.1111/1574-6941.12197; Zbiral J, 2011, SOIL ANALYSIS, P253; Zbiral J, 2010, SOIL ANALYSIS, P290; Zhou XQ, 2010, BIOL FERT SOILS, V46, P817, DOI 10.1007/s00374-010-0487-3	67	12	13	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135627	10.1371/journal.pone.0135627	http://dx.doi.org/10.1371/journal.pone.0135627			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274496	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000359493600084
J	Sugimoto, M; Ichio, A; Kondo, M				Sugimoto, Masahiko; Ichio, Atsushi; Kondo, Mineo			Short Pulse Duration High-Power Laser Photocoagulation during Vitrectomy for Diabetic Retinopathy Reduces Postoperative Inflammation	PLOS ONE			English	Article							AQUEOUS FLARE INTENSITY; PATTERN SCAN LASER; PANRETINAL PHOTOCOAGULATION; VISUAL-LOSS; CYTOKINES; NUMBER	The aim of this preliminary study was to determine the effectiveness of short pulse duration, high-power laser photocoagulation (PC) during vitrectomy for diabetic retinopathy (DR). The effects of short pulse duration PC with power of 340-360 mW and duration of 0.02 second were compared to conventional PC with power of 120-150 mW and duration of 0.2 second. The degree of inflammation was quantified by laser flare cell photometry before and at 1 day, 1 week, 4 week, and 12 weeks postoperatively. Twenty-two eyes of 22 consecutive patients were studied. Ten eyes were treated with short pulse duration PC and 12 eyes with conventional PC. The total energy was significantly lower in the short pulse duration PC group than in the conventional PC group (P = 0.007). The flare cell values were not significantly different between the two groups after 1 day, but at 1 week, the flare cell value was significantly lower in the short pulse duration PC group than in the conventional PC group (P = 0.04). This difference was also present at 4 and 12 weeks (P<0.05). The significant lower inflammation after short pulse duration PC than conventional PC indicates that the short pulse duration PC protocol should be considered to treat DR.	[Sugimoto, Masahiko; Ichio, Atsushi; Kondo, Mineo] Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan	Mie University	Sugimoto, M (corresponding author), Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan.	Sugimochi@clin.medic.mie-u.ac.jp			Ministry of Education, Culture, Science, and Technology, Japan [18591913]	Ministry of Education, Culture, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a grant from Ministry of Education, Culture, Science, and Technology, Japan (No. 18591913).	[Anonymous], 1976, AM J OPHTHALMOL, V81, P383; [Anonymous], 1985, Ophthalmology, V92, P492; Blumenkranz MS, 2006, RETINA-J RET VIT DIS, V26, P370, DOI 10.1097/00006982-200603000-00024; Chalam KV, 2003, OPHTHALMIC SUR LA IM, V34, P188, DOI 10.3928/1542-8877-20030501-04; Chappelow AV, 2012, AM J OPHTHALMOL, V153, P137, DOI 10.1016/j.ajo.2011.05.035; Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233; Eter N, 2004, GRAEF ARCH CLIN EXP, V242, P120, DOI 10.1007/s00417-003-0806-6; FLYNN HW, 1992, OPHTHALMOLOGY, V99, P1351; Gunduz Kaan, 2007, Compr Ophthalmol Update, V8, P245; Hoerster R, 2013, BRIT J OPHTHALMOL, V97, P450, DOI 10.1136/bjophthalmol-2012-302636; Hoshi S, 2012, RETINA-J RET VIT DIS, V32, P1862, DOI 10.1097/IAE.0b013e3182456f38; INOUE M, 1994, BRIT J OPHTHALMOL, V78, P694, DOI 10.1136/bjo.78.9.694; Inoue Y, 2009, RETINA-J RET VIT DIS, V29, P477, DOI 10.1097/IAE.0b013e31819a6004; Jain A, 2008, ARCH OPHTHALMOL-CHIC, V126, P78, DOI 10.1001/archophthalmol.2007.29; Jain A, 2010, RETINA-J RET VIT DIS, V30, P1622, DOI 10.1097/IAE.0b013e3181e095d8; Larsson LI, 2001, ACTA OPHTHALMOL SCAN, V79, P414, DOI 10.1034/j.1600-0420.2001.079004414.x; MCDONALD HR, 1985, OPHTHALMOLOGY, V92, P388; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Muqit MMK, 2013, BRIT J OPHTHALMOL, V97, P220, DOI 10.1136/bjophthalmol-2012-302189; Muqit MMK, 2010, ARCH OPHTHALMOL-CHIC, V128, P448, DOI 10.1001/archophthalmol.2010.36; Muraly P, 2011, RETINA-J RET VIT DIS, V31, P1359, DOI 10.1097/IAE.0b013e318203c140; Pitcher JD, 2012, SEMIN OPHTHALMOL, V27, P69, DOI 10.3109/08820538.2011.643272; SAWA M, 1988, JPN J OPHTHALMOL, V32, P132; Shimura M, 2009, GRAEF ARCH CLIN EXP, V247, P1617, DOI 10.1007/s00417-009-1147-x; The Early Treatment Diabetic Retinopathy Study Research Group, 1987, INT OPHTHALMOL CLIN, V27, P254, DOI DOI 10.1097/00004397-198702740-00005; Tugal-Tutkun Ilknur, 2010, International Ophthalmology, V30, P453, DOI 10.1007/s10792-009-9310-2; Velez-Montoya R, 2010, BRIT J OPHTHALMOL, V94, P720, DOI 10.1136/bjo.2009.164996; Williams Michael D, 2007, Curr Diab Rep, V7, P242, DOI 10.1007/s11892-007-0038-y; Zaczek A, 1999, EUR J OPHTHALMOL, V9, P158, DOI 10.1177/112067219900900303	29	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135126	10.1371/journal.pone.0135126	http://dx.doi.org/10.1371/journal.pone.0135126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26273824	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600052
J	Svejgaard, B; Wehland, M; Ma, X; Kopp, S; Sahana, J; Warnke, E; Aleshcheva, G; Hemmersbach, R; Hauslage, J; Grosse, J; Bauer, J; Corydon, TJ; Islam, T; Infanger, M; Grimm, D				Svejgaard, Benjamin; Wehland, Markus; Ma, Xiao; Kopp, Sascha; Sahana, Jayashree; Warnke, Elisabeth; Aleshcheva, Ganna; Hemmersbach, Ruth; Hauslage, Jens; Grosse, Jirka; Bauer, Johann; Corydon, Thomas Juhl; Islam, Tawhidul; Infanger, Manfred; Grimm, Daniela			Common Effects on Cancer Cells Exerted by a Random Positioning Machine and a 2D Clinostat	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DIFFERENTIAL GENE-EXPRESSION; PAPILLARY THYROID-CARCINOMA; ALTERED GRAVITY CONDITIONS; SIMULATED MICROGRAVITY; SPHEROID FORMATION; HUMAN CHONDROCYTES; INCREASES APOPTOSIS; HUMAN-LYMPHOCYTES; UP-REGULATION	In this study we focused on gravity-sensitive proteins of two human thyroid cancer cell lines (ML-1; RO82-W-1), which were exposed to a 2D clinostat (CLINO), a random positioning machine (RPM) and to normal 1g-conditions. After a three (3d)-or seven-day-culture (7d) on the two devices, we found both cell types growing three-dimensionally within multicellular spheroids (MCS) and also cells remaining adherent (AD) to the culture flask, while 1g-control cultures only formed adherent monolayers, unless the bottom of the culture dish was covered by agarose. In this case, the cytokines IL-6 and IL-8 facilitated the formation of MCS in both cell lines using the liquid-overlay technique at 1g. ML-1 cells grown on the RPM or the CLINO released amounts of IL-6 and MCP-1 into the supernatant, which were significantly elevated as compared to 1g-controls. Release of IL-4, IL-7, IL-8, IL-17, eotaxin-1 and VEGF increased time-dependently, but was not significantly influenced by the gravity conditions. After 3d on the RPM or the CLINO, an accumulation of F-actin around the cellular membrane was detectable in AD cells of both cell lines. IL-6 and IL-8 stimulation of ML-1 cells for 3d and 7d influenced the protein contents of beta(1)-integrin, talin-1, Ki-67, and beta-actin dose-dependently in adherent cells. The beta(1)-integrin content was significantly decreased in AD and MCS samples compared with 1g, while talin-1 was higher expressed in MCS than AD populations. The proliferation marker Ki-67 was elevated in AD samples compared with 1g and MCS samples. The beta-actin content of R082-W-1 cells remained unchanged. ML-1 cells exhibited no change in beta-actin in RPM cultures, but a reduction in CLINO samples. Thus, we concluded that simulated microgravity influences the release of cytokines in follicular thyroid cancer cells, and the production of beta(1)-integrin and talin-1 and predicts an identical effect under real microgravity conditions.	[Svejgaard, Benjamin; Ma, Xiao; Kopp, Sascha; Sahana, Jayashree; Corydon, Thomas Juhl; Islam, Tawhidul; Grimm, Daniela] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Wehland, Markus; Warnke, Elisabeth; Aleshcheva, Ganna; Infanger, Manfred] Univ Magdeburg, Clin Plast Aesthet & Hand Surg, D-39106 Magdeburg, Germany; [Hemmersbach, Ruth; Hauslage, Jens] German Aerosp Ctr, Inst Aerosp Med, DLR, Cologne, Germany; [Grosse, Jirka] Univ Regensburg, Dept Nucl Med, D-93053 Regensburg, Germany; [Bauer, Johann] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Aarhus University; Otto von Guericke University; Helmholtz Association; German Aerospace Centre (DLR); University of Regensburg; Max Planck Society	Grimm, D (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	daniela.grimm@farm.au.dk		Sahana, Jayashree/0000-0002-6606-6315; Grimm, Daniela/0000-0002-4991-3105; Islam, Tawhidul/0000-0002-2513-1088; Wehland, Markus/0000-0002-8160-859X; Corydon, Thomas Juhl/0000-0003-3588-6350; Hauslage, Jens/0000-0003-2184-7000	German Space Agency (DLR project); European Space Agency (ESA) [ESA-CORA-GBF-2011-005, ESA-CORA-GBF-2013-001]; Aarhus University, Denmark; University of Regensburg; DGLRM; German Space Agency (BMWi project) [50WB1124, 50WB1524]	German Space Agency (DLR project); European Space Agency (ESA)(European Space Agency); Aarhus University, Denmark; University of Regensburg; DGLRM; German Space Agency (BMWi project)	The authors would like to thank the German Space Agency (DLR; (DG) BMWi projects 50WB1124 and 50WB1524), the European Space Agency (ESA; ESA-CORA-GBF-2011-005 project Device Comparison; ESA-CORA-GBF-2013-001 project THYROID 3) (DG), Aarhus University, Denmark (DG), the University of Regensburg (JG), and DGLRM (Young Fellow Program for EW and GA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshcheva G, 2015, FASEB J, V29, P2303, DOI 10.1096/fj.14-268151; Aleshcheva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079057; Balkwill F, 2015, CANC RES; Becker JL, 2013, NAT REV CANCER, V13, P315, DOI 10.1038/nrc3507; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Buravkova LB, 2001, ACTA ASTRONAUT, V48, P647, DOI 10.1016/S0094-5765(01)00023-6; DELEURAN B, 1994, SCAND J RHEUMATOL, V23, P2, DOI 10.3109/03009749409102126; DEMEURE MJ, 1992, WORLD J SURG, V16, P770, DOI 10.1007/BF02067383; Eiermann P, 2013, MICROGRAVITY SCI TEC, V25, P153, DOI 10.1007/s12217-013-9341-1; Ensinger C, 1998, ANTICANCER RES, V18, P33; ESTOUR B, 1989, VIRCHOWS ARCH B, V57, P167, DOI 10.1007/BF02899078; Griffoni C, 2011, J CELL BIOCHEM, V112, P265, DOI 10.1002/jcb.22921; GRIMM D, 1995, THYROID, V5, P155, DOI 10.1089/thy.1995.5.155; Grimm D, 2002, FASEB J, V16, P604, DOI 10.1096/fj.01-0673fje; Grimm D, 2014, TISSUE ENG PART B-RE, V20, P555, DOI [10.1089/ten.teb.2013.0704, 10.1089/ten.TEB.2013.0704]; Grimm D, 2014, EXPERT REV PROTEOMIC, V11, P465, DOI 10.1586/14789450.2014.926221; Grimm D, 2011, EXPERT REV PROTEOMIC, V8, P13, DOI 10.1586/EPR.10.105; Grimm D, 2010, TISSUE ENG PT A, V16, P1559, DOI [10.1089/ten.tea.2009.0524, 10.1089/ten.TEA.2009.0524]; Grimm D, 2009, CURR VASC PHARMACOL, V7, P347, DOI 10.2174/157016109788340640; Grosse J, 2012, FASEB J, V26, P5124, DOI 10.1096/fj.12-215749; Grosse J, 2012, FASEB J, V26, P639, DOI 10.1096/fj.11-194886; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; Herranz R, 2013, ASTROBIOLOGY, V13, P1, DOI 10.1089/ast.2012.0876; Hughes-Fulford M, 2011, FASEB J, V25, P2858, DOI 10.1096/fj.11-0902ufm; Infanger M, 2004, J GRAVIT PHYSL, V11, P169; Infanger M, 2007, J CELL BIOCHEM, V101, P1439, DOI 10.1002/jcb.21261; Kristensen TB, 2014, INT J MOL SCI, V15, P23024, DOI 10.3390/ijms151223024; Kumei Y, 2006, ANN NY ACAD SCI, V1090, P311, DOI 10.1196/annals.1378.034; Lee YC, 2015, CYTOKINE, V71, P283, DOI 10.1016/j.cyto.2014.11.011; Lewis ML, 1998, FASEB J, V12, P1007, DOI 10.1096/fasebj.12.11.1007; Li XM, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0069-0; Ma X, 2014, FASEB J, V28, P813, DOI 10.1096/fj.13-243287; Ma X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068140; Ma X, 2012, ELECTROPHORESIS, V33, P1349, DOI 10.1002/elps.201100598; Maccarrone M, 2003, J LEUKOCYTE BIOL, V73, P472, DOI 10.1189/jlb.0602295; Pietsch J, 2011, CURR MOL MED, V11, P350, DOI 10.2174/156652411795976600; Pietsch J, 2013, BIOMATERIALS, V34, P7694, DOI 10.1016/j.biomaterials.2013.06.054; Pietsch J, 2013, INT J MOL SCI, V14, P1164, DOI 10.3390/ijms14011164; Pietsch J, 2011, PROTEOMICS, V11, P2095, DOI 10.1002/pmic.201000817; Pietsch J, 2010, PROTEOMICS, V10, P904, DOI 10.1002/pmic.200900226; Provatopoulou X, 2014, INFLAMM RES, V63, P667, DOI 10.1007/s00011-014-0739-z; Riecke K, 2002, ARCH TOXICOL, V76, P360, DOI 10.1007/s00204-002-0338-6; Riwaldt S, 2015, PROTEOMICS; Rochfort KD, 2015, MICROVASC RES, V100, P48, DOI 10.1016/j.mvr.2015.04.010; Rothermund L, 2002, AM J HYPERTENS, V15, P644, DOI 10.1016/S0895-7061(02)02956-4; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Schonberger J, 2000, J MOL MED, V78, P102, DOI 10.1007/s001090000085; Sun Q, 2014, CANCER LETT, V354, P245, DOI 10.1016/j.canlet.2014.08.021; Tanaka K, 2009, THYROID, V19, P21, DOI 10.1089/thy.2008.0237; Terada H, 2005, EUR SURG RES, V37, P166, DOI 10.1159/000085964; Todaro M, 2006, CANCER RES, V66, P1491, DOI 10.1158/0008-5472.CAN-05-2514; Tuttle RM, 2002, J CLIN ENDOCR METAB, V87, P1737, DOI 10.1210/jc.87.4.1737; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; Ulbrich C, 2010, CELL PHYSIOL BIOCHEM, V25, P551, DOI 10.1159/000303059; Uva BM, 2002, EUR J HISTOCHEM, V46, P209; van Loon JJWA, 2007, ADV SPACE RES, V39, P1161, DOI 10.1016/j.asr.2007.02.016; Versari S, 2007, BBA-MOL CELL RES, V1773, P1645, DOI 10.1016/j.bbamcr.2007.05.014; Vignoud L, 1997, J CELL SCI, V110, P1421; Warnke E, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-32; Wehland M, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0095-9; Wehland M, 2012, CURR PHARM DESIGN, V18, P4244, DOI 10.2174/138161212802430468; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Xu J, 2013, HEPATO-GASTROENTEROL, V60, P620, DOI 10.5754/hge11038; Zeng J, 2012, COMB CHEM HIGH T SCR, V15, P276, DOI 10.2174/138620712799218608	64	51	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135157	10.1371/journal.pone.0135157	http://dx.doi.org/10.1371/journal.pone.0135157			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274317	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000359493600053
J	Ferrarotti, I; Poplawska-Wisniewska, B; Trevisan, MT; Koepke, J; Dresel, M; Koczulla, R; Ottaviani, S; Baldo, R; Gorrini, M; Sala, G; Cavallon, L; Welte, T; Chorostowska-Wynimko, J; Luisetti, M; Janciauskiene, S				Ferrarotti, Ilaria; Poplawska-Wisniewska, Beata; Trevisan, Maria Teresa; Koepke, Janine; Dresel, Marc; Koczulla, Rembert; Ottaviani, Stefania; Baldo, Raffaele; Gorrini, Marina; Sala, Giorgia; Cavallon, Luana; Welte, Tobias; Chorostowska-Wynimko, Joanna; Luisetti, Maurizio; Janciauskiene, Sabina			How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?	PLOS ONE			English	Article							ALPHA-1-ANTITRYPSIN DEFICIENCY; ALPHA(1)-ANTITRYPSIN DEFICIENCY; CAPILLARY-ELECTROPHORESIS; LIVER-DISEASE; POLYMERS	The Z deficiency in alpha 1-antitrypsin (A1ATD) is an under-recognized condition. Alpha1-anti-trypsin (A1AT) is the main protein in the alpha 1-globulin fraction of serum protein electrophoresis (SPE); however, evaluation of the alpha 1-globulin protein fraction has received very little attention. Serum Z-type A1AT manifests in polymeric forms, but their interference with quantitative immunoassays has not been reported. Here, 214 894 samples were evaluated by SPE at the G. Fracastoro Hospital of Verona, Italy. Patients with an A1AT level <= 0.92 g/L were recalled to complete A1ATD diagnosis. In parallel, to qualitatively and quantitatively characterize A1AT, sera samples from 10 PiZZ and 10 PiMM subjects obtained at the National Institute of Tuberculosis and Lung Diseases in Warsaw, Poland, were subjected to non-denaturing 7.5% PAGE and 7.5% SDS-PAGE followed by Western blot. Moreover, purified A1AT was heated at 60 degrees C and analyzed by a non-denaturing PAGE and 4-15% gradient SDS-PAGE followed by Western blot as well as by isolelectrofocusing and nephelometry. A total of 966 samples manifested percentages <= 2.8 or a double band in the alpha1-zone. According to the nephelometry data, 23 samples were classified as severe (A1AT <= 0.49 g/L) and 462 as intermediate (A1AT > 0.49 <= 1.0 g/L) A1ATD. Twenty subjects agreed to complete the diagnosis and an additional 21 subjects agreed to family screening. We detected 9 cases with severe and 26 with intermediate A1ATD. Parallel experiments revealed that polymerization of M-type A1AT, when measured by nephelometry or isolelectrofocusing, yields inaccurate results, leading to the erroneous impression that it was Z type and not M-type A1AT. We illustrate the need for confirmation of Z A1AT values by "state of the art" method. Clinicians should consider a more in-depth investigation of A1ATD in patients when they exhibit serum polymers and low alpha 1-globulin protein levels by SPE.	[Ferrarotti, Ilaria; Ottaviani, Stefania; Gorrini, Marina; Sala, Giorgia; Luisetti, Maurizio] Fdn IRCCS Policlin San Matteo, Pneumol Unit, Dept Mol Med, Pavia, Italy; [Poplawska-Wisniewska, Beata; Chorostowska-Wynimko, Joanna] Natl Inst TB & Lung Dis, Dept Genet & Clin Immunol, Warsaw, Poland; [Trevisan, Maria Teresa; Baldo, Raffaele; Cavallon, Luana] Osped G Fracastoro, ULSS20, Lab Anal, Verona, Italy; [Koepke, Janine; Dresel, Marc; Koczulla, Rembert] Univ Marburg, German Ctr Lung Res DZL, Dept Internal Med, Div Pulm Dis, D-35037 Marburg, Germany; [Welte, Tobias; Janciauskiene, Sabina] German Ctr Lung Res DZL, Biomed Res End Stage & Obstruct Lung Dis Hannover, Hannover Med Sch, Dept Resp Med, D-30625 Hannover, Germany	IRCCS Fondazione San Matteo; University of Pavia; Philipps University Marburg; Hannover Medical School	Janciauskiene, S (corresponding author), German Ctr Lung Res DZL, Biomed Res End Stage & Obstruct Lung Dis Hannover, Hannover Med Sch, Dept Resp Med, D-30625 Hannover, Germany.	janciauskiene.sabina@mh-hannover.de	Ottaviani, Stefania/AAD-4644-2022; Ferrarotti, Ilaria/AEX-4579-2022; Ottaviani, Stefania/K-6356-2016	Ottaviani, Stefania/0000-0002-2039-230X; Ottaviani, Stefania/0000-0002-2039-230X; ferrarotti, ilaria/0000-0003-4892-4192	Fondazione IRCCS Policlinico San Matteo [RC345]; Laboratorio Analisi	Fondazione IRCCS Policlinico San Matteo; Laboratorio Analisi	The work was supported by the Ricerca Corrente (RC345) provided by Fondazione IRCCS Policlinico San Matteo. Laboratorio Analisi provided support in the form of salaries for authors MTT, RB and LC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aboussouan LS, 2009, RESP MED, V103, P335, DOI 10.1016/j.rmed.2008.10.006; Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; de Serres FJ, 2002, CHEST, V122, P1818, DOI 10.1378/chest.122.5.1818; de Serres FJ, 2003, ENVIRON HEALTH PERSP, V111, P1851, DOI 10.1289/ehp.6511; FAGERHOL MK, 1970, PROG MED GENET, V7, P96; Ferrarotti I, 2008, RESP MED, V102, P354, DOI 10.1016/j.rmed.2007.10.015; Ferrarotti I, 2007, TRANSL RES, V150, P267, DOI 10.1016/j.trsl.2007.08.001; Ferrarotti I, 2012, THORAX, V67, P669, DOI 10.1136/thoraxjnl-2011-201321; Gershagen S, 2004, CLIN CHEM, V50, P2407, DOI 10.1373/clinchem.2004.042424; Gonzalez-Sagrado M, 2000, CLIN BIOCHEM, V33, P79, DOI 10.1016/S0009-9120(99)00089-2; Greene CM, 2008, J INHERIT METAB DIS, V31, P21, DOI 10.1007/s10545-007-0748-y; Greulich T, 2013, RESP MED, V107, P1400, DOI 10.1016/j.rmed.2013.04.023; Janciauskiene S, 2002, J BIOL CHEM, V277, P26540, DOI 10.1074/jbc.M203832200; Jenkins MA, 2000, MOL BIOTECHNOL, V15, P201, DOI 10.1385/MB:15:3:201; JEPPSSON JO, 1976, FEBS LETT, V65, P195, DOI 10.1016/0014-5793(76)80478-4; Kohnlein Thomas, 2010, Ther Adv Respir Dis, V4, P279, DOI 10.1177/1753465810376407; Luisetti M, 2004, THORAX, V59, P164, DOI 10.1136/thorax.2003.006494; Luraschi P, 2004, ELECTROPHORESIS, V25, P1551, DOI 10.1002/elps.200305828; Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760; OBRIEN ML, 1978, J PEDIATR-US, V92, P1006, DOI 10.1016/S0022-3476(78)80388-6; Ottaviani S, 2011, TRANSL RES, V157, P332, DOI 10.1016/j.trsl.2010.12.014; Poplawska Beata, 2013, Pneumonol Alergol Pol, V81, P45; Seixas S, 2001, HUM GENET, V108, P20, DOI 10.1007/s004390000434; Slev PR, 2008, AM J CLIN PATHOL, V130, P568, DOI 10.1309/JWEWE4QRQKJ5EJEU; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Struniawski R, 2013, ADV EXP MED BIOL, V756, P29, DOI 10.1007/978-94-007-4549-0_5; SVEGER T, 1976, NEW ENGL J MED, V294, P1316, DOI 10.1056/NEJM197606102942404; Tan L, 2014, EUR RESPIR J, V43, P1501, DOI 10.1183/09031936.00111213; Zerimech F, 2008, CLIN CHEM LAB MED, V46, P260, DOI 10.1515/CCLM.2008.036	29	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135316	10.1371/journal.pone.0135316	http://dx.doi.org/10.1371/journal.pone.0135316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270547	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800055
J	Sahay, S; Deshpande, S; Bembalkar, S; Kharat, M; Parkhe, A; Brahme, RG; Paranjape, R; Bollinger, RC; Mehendale, SM				Sahay, Seema; Deshpande, Swapna; Bembalkar, Shilpa; Kharat, Mahesh; Parkhe, Aparna; Brahme, Radhika G.; Paranjape, Ramesh; Bollinger, Robert C.; Mehendale, Sanjay M.			Failure to Use and Sustain Male Condom Usage: Lessons Learned from a Prospective Study among Men Attending STI Clinic in Pune, India	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSMITTED-DISEASE CLINICS; FEMALE SEX WORKERS; RISK-FACTORS; HIV PREVALENCE; BEHAVIOR; PREVENTION; TRANSMISSION; INFECTIONS; CHALLENGES	Background Sustained or consistent use of condoms by men remains a challenge. A study was carried out to identify factors associated with failure to use condoms consistently by men attending STD clinics in Pune, India. Method Among 14137 STI clinic attendees, 8360 HIV sero-negative men were enrolled in a cohort study. The changes in condom usage behavior were studied among 1284 men who returned for first scheduled quarterly follow up, 309 reported consistent condom use at the time of enrollment in the cohort. Data pertaining to heterosexual men practicing high risk behavior were analyzed to identify factors associated with change in condom use behavior using logistic regression model. Demographic, behavioral and biological factors observed to be associated with condom use were fitted in five Cox proportional hazards models to calculate hazard ratios and their 95% confidence intervals to identify independent predictors of failure to sustain condom use behavior. Results The univariate analysis showed that men who were 30 years or older in age (p = 0.002) and those who did not have contact female sex worker (FSW) were more likely to fail to sustain consistent condom use. However both these factors did not show significant association in multivariable analysis. Marital status and contact with Hijra (eunuch) in lifetime were associated with failure to change in their condom use behavior [AOR 0.33 (CI 0.13-0.82; p = 0.017)]. During the follow up of 2 years, 61 events (15.5 per 100 person years, 95% CI 12.3-19.5 years) of 'failure of condom use' were recorded despite counseling. Older age, contact with non CSW partner and presence of genital ulcer disease / discharge syndrome were significant predictors of failure to sustain condom use. Discussion Married monogamous older men, who report contact with sex worker and present with genital ulcer disease are at risk of failure to use condom after first exposure to voluntary HIV counseling and testing. This is a scenario of primary prevention program. Condom promotion and counseling needs to be reinforced through follow up counseling among this population.	[Sahay, Seema; Bembalkar, Shilpa; Kharat, Mahesh; Parkhe, Aparna; Brahme, Radhika G.; Paranjape, Ramesh] Natl AIDS Res Inst, Pune, Maharashtra, India; [Deshpande, Swapna] CYTEL, Pune, Maharashtra, India; [Bollinger, Robert C.] Johns Hopkins Univ, Baltimore, MD USA; [Mehendale, Sanjay M.] Natl Inst Epidemiol, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Johns Hopkins University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE)	Mehendale, SM (corresponding author), Natl Inst Epidemiol, Madras, Tamil Nadu, India.	sanjaymehendale@icmr.org.in		Sahay, Seema/0000-0001-6064-827X; Paranjape, Ramesh/0000-0003-2948-9148; Bollinger, Robert/0000-0002-6798-6834	National Institutes of Health (NIH) [AI-33879, NIH AI-47968, RR-00722]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI033879] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by National Institutes of Health (NIH) AI-33879, NIH AI-47968 and RR-00722. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; Ali MM, 2004, B WORLD HEALTH ORGAN, V82, P180; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Beksinska ME, 2012, SEX HEALTH, V9, P51, DOI 10.1071/SH11011; Bentley ME, 1998, AIDS, V12, P1869, DOI 10.1097/00002030-199814000-00019; Bhattacharya G, 2004, HEALTH EDUC BEHAV, V31, P101, DOI 10.1177/1090198103259204; Bisika I, 2013, MALAWI SEX WORKERS B; Brahme R, 2006, JAIDS-J ACQ IMM DEF, V41, P107, DOI 10.1097/01.qai.0000179428.49907.6d; Brahme RG, 2005, AIDS CARE, V17, P377, DOI 10.1080/09540120412331299771; CAMERON DW, 1989, LANCET, V2, P403; Chatterjee N, 2006, J HEALTH POPUL NUTR, V24, P81; Chitwarakorn A, 2004, HIV AIDS SEX TRANSM; Coleman S, 2007, AIDS PATIENT CARE ST, V21, P691, DOI 10.1089/apc.2006.0205; Copas AJ, 2009, EPIDEMIOLOGY, V20, P44, DOI 10.1097/EDE.0b013e318187ac81; COX DR, 1972, J R STAT SOC B, V34, P187; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; DiClemente RJ, 1999, IMPORTANCE HLTH PROM; DUNNE MP, 1994, INT J STD AIDS, V5, P41, DOI 10.1177/095646249400500110; Erens B, 2001, NATL SURVEY SEXUAL A; Family_Health_International, 2000, BEH SURV SURV GUIDEL; Foster V, 2012, J ASSOC NURSE AIDS C, V23, P487, DOI 10.1016/j.jana.2011.12.008; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2; Gari S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-198; Godbole S, 2005, INDIAN J MED RES, V121, P356; Grunbaum Jo Anne, 2002, MMWR Surveill Summ, V51, P1; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Jung M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066867; Kang M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-12; Madhivanan P, 2005, SEX TRANSM DIS, V32, P685, DOI 10.1097/01.olq.0000175405.36124.3b; Makasa M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-407; Mayaud P M D, 2001, BRIT MED B, V58; MEHENDALE SM, 1995, J INFECT DIS, V172, P1486, DOI 10.1093/infdis/172.6.1486; Mercer CH C A, 1993, J ROYAL SOC MED, V86, P2; Mimiaga MJ, 2014, ARCH SEX BEHAV; NACO, 2012, NACO TECHN REP IND H; NACO, 2010, ANN REPORT; NACO, 2010, UNGASS COUNTR REP IN; NACO, 2012, ANN REPORT; NACO: National AIDS Control Organization Department of AIDS Control, 2011, ANN REPORT; Nambiar D, 2012, SOCIOL HEALTH ILL, V34, P714, DOI 10.1111/j.1467-9566.2011.01428.x; Narayanan B, 2005, INDIAN J DERMATOL VE, V71, P5; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Parker W N Z, 2004, BREAKING BARRIERS AN, P1; Peltzer K, 2000, E AFRICAN MED J, V77; RODRIGUES JJ, 1995, BRIT MED J, V311, P283, DOI 10.1136/bmj.311.7000.283; Ruchi Sogarwal, 2009, Health and Population - Perspectives and Issues, V32, P148; Sahastrabuddhe S, 2012, JAIDS-J ACQ IMM DEF, V59, P72, DOI 10.1097/QAI.0b013e318236bd6f; Sahay S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017448; Santhya KG, 2011, INT PERSPECT SEX R H, V37, P170, DOI 10.1363/3717011; Sarkar NN, 2008, EUR J CONTRACEP REPR, V13, P114, DOI 10.1080/13625180802011302; Setia Maninder Singh, 2008, J LGBT Health Res, V4, P51; Solomon SS, 2015, AIDS, V29, P723, DOI 10.1097/QAD.0000000000000602; Solomon Sunil S, 2010, J Int AIDS Soc, V13 Suppl 2, pS7, DOI 10.1186/1758-2652-13-S2-S7; Thappa DM K S, 2007, INDIAN J DERMATOLOGY, V52, P5; Therneau TM, 2000, MODELLING SURVIVAL D, P31; Vermund SH, 2013, JAIDS-J ACQ IMM DEF, V63, pS12, DOI 10.1097/QAI.0b013e31829202a2; Weiss HA, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-8	58	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135071	10.1371/journal.pone.0135071	http://dx.doi.org/10.1371/journal.pone.0135071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JX	26270464	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800035
J	Xie, SS; Zhang, X; Chen, WM; Xie, CC; Chen, WW; Cheng, P; Zhou, Y; Chen, BC				Xie, Shuangshuang; Zhang, Xing; Chen, Wenming; Xie, Chichi; Chen, Wenwei; Cheng, Pu; Zhou, Ying; Chen, Bicheng			Developmental Status: Impact of Short-Term Ischemia on Follicular Survival of Whole Ovarian Transplantation in a Rabbit Model	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; DNA FRAGMENTATION; GENE-EXPRESSION; GRANULOSA-CELLS; WARM ISCHEMIA; THECA CELLS; MOUSE OVARY; OOCYTES; TISSUE; SHEEP	Ischemia is the first mechanism that provokes the loss of follicles in ovarian grafts over the long term. In whole ovarian transplantation, it remains unknown, however, how changes in follicular development are influenced by short-term ischemia. Fresh whole ovarian orthotopic auto-transplantation was performed in rabbits with 45 min ischemia, and the impact of ischemia on follicular survival and development status was evaluated at different time-points (1 day, 3 days, 1 week, 2 weeks and 1 month). Assessment of follicular quantity and morphology was carried out via histologic analysis. Follicle proliferating status was evidenced by immunostaining with proliferating cell nuclear antigen (PCNA), and the Hedgehog signaling pathway (Patched and Gli); was verified via TUNEL assay. Quantitative PCR was carried out to quantify the mRNA of target genes including PCNA, Patched, Gli, Caspase 3, Bax, and Bcl-2. Compared with its contralateral fresh controls, the morphology, proliferation and apoptosis of the follicles in the grafts showed no significant differences and most primordial follicles were quiescent. However, morphology and proliferation status were significantly decreased 1 week after grafting, in comparison with the longitudinal grafting time. Patched and Gli in the Hedgehog signaling pathway were activated in only the follicles of the grafts. Short-term ischemia slightly impacts follicular survival and development status in whole ovarian grafting. Receiving intervention in the first week post-transplantation might be helpful.	[Xie, Shuangshuang] Wenzhou Med Univ, Affiliated Hosp 2, Obstet Dept, Wenzhou 325000, Zhejiang, Peoples R China; [Chen, Wenming; Xie, Chichi; Zhou, Ying] Wenzhou Med Univ, Affiliated Hosp 1, Ctr Reprod Med, Wenzhou 325000, Zhejiang, Peoples R China; [Zhang, Xing] Wenzhou Med Univ, Affiliated Hosp 1, Surg Lab, Wenzhou 325000, Zhejiang, Peoples R China; [Chen, Wenwei; Chen, Bicheng] Wenzhou Med Univ, Affiliated Hosp 1, Transplantat Ctr, Wenzhou 325000, Zhejiang, Peoples R China; [Cheng, Pu] Zhejiang Univ, Affiliated Hosp 2, Sch Medcine, Oncol Surg, Hangzhou 310000, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Zhejiang University	Zhou, Y (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Ctr Reprod Med, Wenzhou 325000, Zhejiang, Peoples R China.	zy-yin@163.com; chenbicheng@hotmail.com		Shuangshuang, Xie/0000-0002-7774-2999				Anderson RA, 2013, FERTIL STERIL, V99, P1469, DOI 10.1016/j.fertnstert.2013.03.014; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Bedaiwy MA, 2003, FERTIL STERIL, V79, P594, DOI 10.1016/S0015-0282(02)04842-2; Brannstrom M, 2010, MIDDLE EAST FERTIL S, V15, P125, DOI 10.1016/j.mefs.2010.06.003; Brannstrom M, 2011, J OBSTET GYNAECOL RE, V37, P271, DOI 10.1111/j.1447-0756.2010.01416.x; David A, 2012, HUM REPROD, V27, P1088, DOI 10.1093/humrep/des013; Demirci B, 2002, FERTIL STERIL, V77, P595, DOI 10.1016/S0015-0282(01)03205-8; Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030; Gajecka M, 2013, POL J VET SCI, V16, P45, DOI 10.2478/pjvs-2013-0007; Gao JM, 2013, HUM REPROD, V28, P2784, DOI 10.1093/humrep/det296; Hussein MR, 2006, FERTIL STERIL, V85, P1082, DOI 10.1016/j.fertnstert.2005.10.020; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Jiang ZL, 2011, GYNECOL ONCOL, V122, P418, DOI 10.1016/j.ygyno.2011.04.051; King PJ, 2008, J ENDOCRINOL, V198, P439, DOI 10.1677/JOE-08-0161; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Liu L, 2002, HUM REPROD, V17, P2678, DOI 10.1093/humrep/17.10.2678; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes S, 1998, HUM REPROD, V13, P896, DOI 10.1093/humrep/13.4.896; Nguyen NT, 2009, REPROD FERT DEVELOP, V21, P805, DOI 10.1071/RD08277; Pan JY, 2012, PHARMAZIE, V67, P475, DOI 10.1691/ph.2012.1744; Pola R, 2003, CIRCULATION, V108, P479, DOI 10.1161/01.CIR.0000080338.60981.FA; Pratap A, 2011, MOL PHARMACEUT, V8, P958, DOI 10.1021/mp200115v; Pratap A, 2010, PHARM RES-DORDR, V27, P2492, DOI 10.1007/s11095-010-0246-z; Qiu MN, 2013, J STEROID BIOCHEM, V138, P325, DOI 10.1016/j.jsbmb.2013.06.005; Ren Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099176; Ren Y, 2009, MOL ENDOCRINOL, V23, P711, DOI 10.1210/me.2008-0391; Russell MC, 2007, BIOL REPROD, V77, P226, DOI 10.1095/biolreprod.106.053629; Sadeu JC, 2007, THERIOGENOLOGY, V68, P1228, DOI 10.1016/j.theriogenology.2007.08.028; Schmidt KT, 2011, FERTIL STERIL, V95, P695, DOI 10.1016/j.fertnstert.2010.07.1080; Silber SJ, 2008, NEW ENGL J MED, V359, P2617, DOI 10.1056/NEJMc0804321; Spicer LJ, 2009, REPRODUCTION, V138, P329, DOI 10.1530/REP-08-0317; Tarin JJ, 1996, MOL HUM REPROD, V2, P895, DOI 10.1093/molehr/2.12.895; Tomanek M, 2006, FOLIA HISTOCHEM CYTO, V44, P269; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wallace WHB, 2005, INT J RADIAT ONCOL, V62, P738, DOI 10.1016/j.ijrobp.2004.11.038; Walterhouse DO, 2003, BIOL REPROD, V69, P8, DOI 10.1095/biolreprod.103.015941; Wijgerde M, 2005, ENDOCRINOLOGY, V146, P3558, DOI 10.1210/en.2005-0311; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Zuelke KA, 1997, BIOL REPROD, V57, P1413, DOI 10.1095/biolreprod57.6.1413	39	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135049	10.1371/journal.pone.0135049	http://dx.doi.org/10.1371/journal.pone.0135049			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271079	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800032
J	Clemente, A; Arques, MC; Dalmais, M; Le Signor, C; Chinoy, C; Olias, R; Rayner, T; Isaac, PG; Lawson, DM; Bendahmane, A; Domoney, C				Clemente, Alfonso; Arques, Maria C.; Dalmais, Marion; Le Signor, Christine; Chinoy, Catherine; Olias, Raquel; Rayner, Tracey; Isaac, Peter G.; Lawson, David M.; Bendahmane, Abdelhafid; Domoney, Claire			Eliminating Anti-Nutritional Plant Food Proteins: The Case of Seed Protease Inhibitors in Pea	PLOS ONE			English	Article							BOWMAN-BIRK INHIBITOR; HORSEGRAM DOLICHOS-BIFLORUS; CRYSTAL-STRUCTURE; SERINE PROTEASES; WEANED PIGLETS; CANCER CELLS; TRYPSIN; L.; EXPRESSION; MUTANT	Several classes of seed proteins limit the utilisation of plant proteins in human and farm animal diets, while plant foods have much to offer to the sustainable intensification of food/feed production and to human health. Reduction or removal of these proteins could greatly enhance seed protein quality and various strategies have been used to try to achieve this with limited success. We investigated whether seed protease inhibitor mutations could be exploited to enhance seed quality, availing of induced mutant and natural Pisum germplasm collections to identify mutants, whilst acquiring an understanding of the impact of mutations on activity. A mutant (TILLING) resource developed in Pisum sativum L. (pea) and a large germplasm collection representing Pisum diversity were investigated as sources of mutations that reduce or abolish the activity of the major protease inhibitor (Bowman-Birk) class of seed protein. Of three missense mutations, predicted to affect activity of the mature trypsin / chymotrypsin inhibitor TI1 protein, a C77Y substitution in the mature mutant inhibitor abolished inhibitor activity, consistent with an absolute requirement for the disulphide bond C77-C92 for function in the native inhibitor. Two further classes of mutation (S85F, E109K) resulted in less dramatic changes to isoform or overall inhibitory activity. The alternative strategy to reduce anti-nutrients, by targeted screening of Pisum germplasm, successfully identified a single accession (Pisum elatius) as a double null mutant for the two closely linked genes encoding the TI1 and TI2 seed protease inhibitors. The P. elatius mutant has extremely low seed protease inhibitory activity and introgression of the mutation into cultivated germplasm has been achieved. The study provides new insights into structure-function relationships for protease inhibitors which impact on pea seed quality. The induced and natural germplasm variants identified provide immediate potential for either halving or abolishing the corresponding inhibitory activity, along with associated molecular markers for breeding programmes. The potential for making large changes to plant protein profiles for improved and sustainable food production through diversity is illustrated. The strategy employed here to reduce anti-nutritional proteins in seeds may be extended to allergens and other seed proteins with negative nutritional effects. Additionally, the novel variants described for pea will assist future studies of the biological role and health-related properties of so-called anti-nutrients.	[Clemente, Alfonso; Arques, Maria C.; Olias, Raquel] Estac Expt Zaidin CSIC, Dept Physiol & Biochem Anim Nutr, Granada 18008, Spain; [Dalmais, Marion; Bendahmane, Abdelhafid] CNRS, URGV, INRA, UMR 1165,8114,UEVE 2, F-91000 Evry, France; [Le Signor, Christine] Pole Genet & Ecophysiol GEAPSI, UMR 1347, Agroecol AgroSup, INRA,uB, F-21065 Dijon, France; [Chinoy, Catherine; Rayner, Tracey; Domoney, Claire] John Innes Ctr, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England; [Isaac, Peter G.] IDna Genet Ltd, Norwich NR4 7UH, Norfolk, England; [Lawson, David M.] John Innes Inst, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Domoney, C (corresponding author), John Innes Ctr, Dept Metab Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	claire.domoney@jic.ac.uk	del Carmen Arques, María/AAC-1755-2020; Olías, Raquel/F-3182-2016; Clemente, Alfonso/A-1192-2010	del Carmen Arques, María/0000-0003-2234-849X; Olías, Raquel/0000-0003-2571-4539; Clemente, Alfonso/0000-0003-2424-4416; Bendahmane, Abdelhafid/0000-0003-3246-868X; Dalmais, Marion/0000-0002-1673-3095; Le Signor, Christine/0000-0002-3204-3537	European Regional Development Fund/The Ministry of Economy and Competitiveness [AGL2011-26353]; EU COST Action FA1005 INFOGEST on Food Digestion; Biotechnology and Biological Sciences Research Council [BB/J004561/1]; Department for Environment and Rural Affairs [AR0711, IF0147]; Saclay Plant Sciences [ANR-10-LABX-40]; Institut National de la Recherche Agronomique, Centre National de la Recherche Scientifique PeaMUST [ANR-11-BTBR-0002]; European Union [FOOD-CT-2004-506223]; IDna Genetics Ltd; BBSRC [BBS/E/J/000CA392, BBS/E/J/000C0653] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0653, BBS/E/J/000CA392] Funding Source: researchfish	European Regional Development Fund/The Ministry of Economy and Competitiveness; EU COST Action FA1005 INFOGEST on Food Digestion; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment and Rural Affairs; Saclay Plant Sciences; Institut National de la Recherche Agronomique, Centre National de la Recherche Scientifique PeaMUST; European Union(European Commission); IDna Genetics Ltd; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by European Regional Development Fund/The Ministry of Economy and Competitiveness AGL2011-26353 (AC, MA); EU COST Action FA1005 INFOGEST on Food Digestion, https://www.cost-infogest.eu (AC); Biotechnology and Biological Sciences Research Council BB/J004561/1, http://www.bbsrc.ac.uk/ (CC, TR, DML, CD); Department for Environment and Rural Affairs AR0711, www.defra.gov.uk (CC, CD); Department for Environment and Rural Affairs IF0147, www.defra.gov.uk (CC, CD); Saclay Plant Sciences ANR-10-LABX-40, https://www6.inra.fr/saclay-plant-sciences_eng/ (MD, CLS, AB); Institut National de la Recherche Agronomique, Centre National de la Recherche Scientifique PeaMUST ANR-11-BTBR-0002, http://www.inra.fr/en (MD, CLS, AB); European Union FOOD-CT-2004-506223, http://www.pcgin.org/GLIP/pubrep.pdf (CC, CD); European Union FOOD-CT-2004-506223, http://www.pcgin.org/GLIP/pubrep.pdf (MD, CLS, AB). AC is involved in COST Action FA1005 INFOGEST on Food Digestion. Additionally, IDna Genetics Ltd provided support in the form of salary for author Peter G. Isaac but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Capaldi S, 2007, J STRUCT BIOL, V158, P71, DOI 10.1016/j.jsb.2006.10.017; Carbonaro M, 2014, FOOD RES INT IN PRES, DOI [10.1016/j.foodres.2014.11.007, DOI 10.1016/J.F00DRES.2014.11.007]; Arques MC, 2014, FOOD CHEM, V155, P24, DOI 10.1016/j.foodchem.2014.01.024; Chen YW, 2005, CARCINOGENESIS, V26, P1296, DOI 10.1093/carcin/bgi062; Chinoy C, 2011, EUPHYTICA, V180, P107, DOI 10.1007/s10681-011-0363-8; Clemente A, 2005, J AGR FOOD CHEM, V53, P8979, DOI 10.1021/jf051528w; Clemente A, 2004, PROTEIN EXPRES PURIF, V36, P106, DOI 10.1016/j.pep.2004.03.015; Clemente A, 2006, CURR PROTEIN PEPT SC, V7, P201, DOI 10.2174/138920306777452349; Clemente A, 2012, BRIT J NUTR, V108, pS135, DOI 10.1017/S000711451200075X; Clemente A, 2010, MOL NUTR FOOD RES, V54, P396, DOI 10.1002/mnfr.200900122; Crevieu I, 1997, J AGR FOOD CHEM, V45, P1295, DOI 10.1021/jf960806b; D'Erfurth I, 2012, NEW PHYTOL, V196, P738, DOI 10.1111/j.1469-8137.2012.04296.x; Dalmais M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r43; de la Sierra IL, 1999, J MOL BIOL, V285, P1195, DOI 10.1006/jmbi.1998.2351; Domoney C, 1999, SEED PROTEINS, P635; Domoney C, 2002, PLANT MOL BIOL, V48, P319, DOI 10.1023/A:1013379430582; Domoney C., 1992, Seed Science Research, V2, P147, DOI 10.1017/S0960258500001276; DOMONEY C, 1995, FEBS LETT, V360, P15, DOI 10.1016/0014-5793(95)00070-P; Domoney C, 2013, FUNCT PLANT BIOL, V40, P1261, DOI 10.1071/FP13147; ERLANGER BF, 1966, ARCH BIOCHEM BIOPHYS, V115, P206, DOI 10.1016/S0003-9861(66)81058-5; Forster C, 1999, PLANT MOL BIOL, V39, P1209, DOI 10.1023/A:1006173313548; Galasso I, 2009, MOL BREEDING, V23, P617, DOI 10.1007/s11032-009-9260-4; Gariani T, 1999, BBA-PROTEIN STRUCT M, V1431, P232, DOI 10.1016/S0167-4838(99)00035-7; Ha BK, 2014, PLANT GENET RESOUR-C, V12, pS54, DOI 10.1017/S1479262114000264; Hellens RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013230; Hofer J, 2009, PLANT CELL, V21, P420, DOI 10.1105/tpc.108.064071; Jing RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-44; JOFUKU KD, 1989, PLANT CELL, V1, P427, DOI 10.1105/tpc.1.4.427; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DS, 2010, THEOR APPL GENET, V121, P751, DOI 10.1007/s00122-010-1346-1; Kumar P, 2004, J BIOL CHEM, V279, P30425, DOI 10.1074/jbc.M402972200; Kumar V, 2013, ARCH BIOCHEM BIOPHYS, V537, P49, DOI 10.1016/j.abb.2013.06.002; Le Gall M, 2007, J ANIM SCI, V85, P2972, DOI 10.2527/jas.2006-795; Li P, 2007, J MED CHEM, V50, P5976, DOI 10.1021/jm0704898; Livingstone D, 2007, PLANT MOL BIOL, V64, P397, DOI 10.1007/s11103-007-9163-x; Lu WY, 1997, J MOL BIOL, V266, P441, DOI 10.1006/jmbi.1996.0781; Muricken DG, 2010, BBA-PROTEINS PROTEOM, V1804, P1413, DOI 10.1016/j.bbapap.2010.02.012; Page D, 2002, MOL GENET GENOMICS, V267, P359, DOI 10.1007/s00438-002-0667-4; PERONA JJ, 1995, PROTEIN SCI, V4, P337; RAMASARMA PR, 1995, BBA-PROTEIN STRUCT M, V1248, P35, DOI 10.1016/0167-4838(95)00004-E; Rao KN, 2007, BBA-PROTEINS PROTEOM, V1774, P1264, DOI 10.1016/j.bbapap.2007.07.009; Rubio LA, 2006, J SCI FOOD AGR, V86, P979, DOI 10.1002/jsfa.2446; Salgado P, 2003, J SCI FOOD AGR, V83, P1571, DOI 10.1002/jsfa.1581; Schillinger JA, 2012, US patent application, Patent No. [US2012/ 0317675, 20120317675]; Souza LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086600; Patto MCV, 2015, CRIT REV PLANT SCI, V34, P105, DOI 10.1080/07352689.2014.897907; Vigeolas H, 2008, PLANT PHYSIOL, V146, P74, DOI 10.1104/pp.107.111369; Wang KJ, 2010, PLANT BREEDING, V129, P264, DOI 10.1111/j.1439-0523.2009.01734.x; Wiseman J, 2003, J SCI FOOD AGR, V83, P644, DOI 10.1002/jsfa.1340; Wu K, 2014, US patent application, Patent No. [US2014/ 0259196, 20140259196]	51	23	23	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134634	10.1371/journal.pone.0134634	http://dx.doi.org/10.1371/journal.pone.0134634			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267859	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300053
J	Connor, JL; Kydd, RM; Dickson, NP				Connor, Jennie L.; Kydd, Robyn M.; Dickson, Nigel P.			Alcohol Involvement in Sexual Behaviour and Adverse Sexual Health Outcomes from 26 to 38 Years of Age	PLOS ONE			English	Article							TRANSMITTED INFECTION; COLLEGE-STUDENTS; DRINKING; GENDER; INDIVIDUALS; CONSUMPTION; PARTNERS; BRITAIN	Background Research on alcohol and sexual behaviour has focused on young adults or high-risk groups, showing alcohol use contributing to riskier sexual choices. Adults now in their late thirties have been exposed to heavier drinking norms than previously, raising questions about effects on sexual wellbeing. We examined self-reported use and consequences of alcohol in sexual contexts, and its association with usual drinking pattern at age 38, and also associations of heavy drinking occasion (HDO) frequency with number of sexual partners, sexually transmitted infections (STIs), and terminations of pregnancy (TOPs), from 26-32 and 32-38 years of age. Methods Members of the Dunedin Study birth cohort answered computer-presented questions about sexual behaviour and outcomes, and interviewer-administered alcohol consumption questions, at age 26, 32 and 38 years. Results Response level was >90% at each assessment. At 38, drinking before or during sex in the previous year was common (8.2% of men; 14.6% of women reported "usually/always"), and unwanted consequences were reported by 13.5% of men and 11.9% of women, including regretted sex or failure to use contraception or condoms. Frequent heavy drinkers were more likely to "use alcohol to make it easier to have sex" and regret partner choice, particularly women. Heavy drinking frequency was strongly associated with partner numbers for men and women at 32, but only for women at 38. Significantly higher odds of STIs amongst the heaviest drinking men, and TOPs amongst the heaviest drinking women were seen at 32-38. Conclusions Alcohol involvement in sex continues beyond young adulthood where it has been well documented, and is common at 38. Women appear to be more affected than men, and heavy drinking is associated with poorer outcomes for both. Improving sexual health and wellbeing throughout the life course needs to take account of the role of alcohol in sexual behaviour.	[Connor, Jennie L.; Kydd, Robyn M.; Dickson, Nigel P.] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand	University of Otago	Connor, JL (corresponding author), Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand.	jennie.connor@otago.ac.nz		Connor, Jennie/0000-0002-3209-8693	Health Research Council of New Zealand [12/ 1086]; US-National Institute of Aging [R01AG032282]; UK Medical Research Council [MR/K00381X]; MRC [MR/K00381X/1] Funding Source: UKRI; Medical Research Council [MR/K00381X/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG032282] Funding Source: NIH RePORTER	Health Research Council of New Zealand(Health Research Council of New Zealand); US-National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the Health Research Council of New Zealand [Grant 12/ 1086], the US-National Institute of Aging [Grant R01AG032282] and the UK Medical Research Council [Grant MR/K00381X]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey A, 2007, PSYCHOL ADDICT BEHAV, V21, P76, DOI 10.1037/0893-164X.21.1.76; Aicken CRH, 2011, J PUBLIC HEALTH-UK, V33, P262, DOI 10.1093/pubmed/fdq056; Alati R, 2014, JAMA PSYCHIAT, V71, P952, DOI 10.1001/jamapsychiatry.2014.513; [Anonymous], 2013, STAT STAT SOFTW REL; Boden JM, 2013, DRUG ALCOHOL DEPEND; Boden JM, 2011, DRUG ALCOHOL DEPEN, V113, P200, DOI 10.1016/j.drugalcdep.2010.08.005; Burgess E, 2014, CHANGES OPINIONS SEX; Caldwell TM, 2006, ALCOHOL ALCOHOLISM, V41, P650, DOI 10.1093/alcalc/agl088; Connor J, 2013, ALCOHOL CLIN EXP RES, V37, P1971, DOI 10.1111/acer.12175; Cooper ML, 2002, J STUD ALCOHOL, P101, DOI 10.15288/jsas.2002.s14.101; Dickson N, 1996, NEW ZEAL MED J, V109, P308; Dickson N, 2013, ARCH SEX BEHAV, V42, P753, DOI 10.1007/s10508-012-0063-z; HalpernFelsher BL, 1996, J ADOLESCENT HEALTH, V19, P331, DOI 10.1016/S1054-139X(96)00024-9; Huckle T, 2012, J STUD ALCOHOL DRUGS, V73, P53, DOI 10.15288/jsad.2012.73.53; Johnson AMWJ, 1994, SEXUAL ATTITUDES LIF, P68; Keyes KM, 2011, ALCOHOL CLIN EXP RES, V35, P2101, DOI 10.1111/j.1530-0277.2011.01562.x; Kiene SA, 2009, J ADOLESCENT HEALTH, V44, P73, DOI 10.1016/j.jadohealth.2008.05.008; Kydd RM, 2015, ALCOHOL ALCOHOLISM, V50, P333, DOI 10.1093/alcalc/agu106; Kypri K, 2004, ALCOHOL CLIN EXP RES, V28, P630, DOI 10.1097/01.ALC.0000121654.99277.26; LEIGH BC, 1994, SOC SCI MED, V39, P1527, DOI 10.1016/0277-9536(94)90004-3; Levitt A, 2010, PERS SOC PSYCHOL B, V36, P1706, DOI 10.1177/0146167210388420; McPherson M, 2004, ADDICTION, V99, P738, DOI 10.1111/j.1360-0443.2004.00758.x; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Milne BJ., 2013, NZ SOCIOECONOMIC IND; Paul C, 2009, SEX TRANSM DIS, V36, P63, DOI 10.1097/OLQ.0b013e318188bf51; Poulton R, 2015, SOC PSYCH PSYCH EPID, V50, P679, DOI 10.1007/s00127-015-1048-8; Ramrakha S, 2013, ARCH SEX BEHAV, V42, P863, DOI 10.1007/s10508-012-0053-1; Rehm J, 1999, ADDICTION, V94, P899, DOI 10.1046/j.1360-0443.1999.94689912.x; Rehm J, 2012, ADDICTION, V107, P51, DOI 10.1111/j.1360-0443.2011.03621.x; Scott-Sheldon LAJ, 2013, CURR HIV-AIDS REP, V10, P314, DOI 10.1007/s11904-013-0177-5; Standerwick K, 2007, INT J STD AIDS, V18, P810, DOI 10.1258/095646207782717027; Stoner SA, 2007, AIDS BEHAV, V11, P227, DOI 10.1007/s10461-006-9137-z; Swartz LHG, 2011, J WOMEN AGING, V23, P342, DOI 10.1080/08952841.2011.613255; Taylor J, 1999, ADDICTION, V94, P1209, DOI 10.1046/j.1360-0443.1999.948120911.x; Thompson JC, 2005, PREV MED, V41, P247, DOI 10.1016/j.ypmed.2004.11.008; US Department of the Treasury Alcohol and Tobacco Tax and Trade Bureau, 2007, 20075 US DEP TREAS A; van Roode T, 2009, CHILD ABUSE NEGLECT, V33, P161, DOI 10.1016/j.chiabu.2008.09.006	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135660	10.1371/journal.pone.0135660	http://dx.doi.org/10.1371/journal.pone.0135660			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267272	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300147
J	Kumar, P; Thirkill, TL; Ji, J; Monte, LH; Douglas, GC				Kumar, Priyadarsini; Thirkill, Twanda L.; Ji, Jennifer; Monte, Louise H.; Douglas, Gordon C.			Differential Effects of Sodium Butyrate and Lithium Chloride on Rhesus Monkey Trophoblast Differentiation	PLOS ONE			English	Article							ADHESION MOLECULES; GENE-EXPRESSION; EXTRAVILLOUS TROPHOBLASTS; ENDOTHELIAL-CELLS; IN-VITRO; CYTOTROPHOBLAST DIFFERENTIATION; FUNCTIONAL-CHARACTERIZATION; UP-REGULATION; TNF-ALPHA; INVASION	Trophoblast differentiation during early placental development is critical for successful pregnancy and aberrant differentiation causes preeclampsia and early pregnancy loss. During the first trimester, cytotrophoblasts are exposed to low oxygen tension (equivalent to similar to 2%-3% O-2) and differentiation proceeds along an extravillous pathway (giving rise to invasive extravillous cytotrophoblasts) and a villous pathway (giving rise to multinucleated syncytiotrophoblast). Interstitial extravillous cytotrophoblasts invade the decidua, while endovascular extravillous cytotrophoblasts are involved in re-modelling uterine spiral arteries. We tested the idea that sodium butyrate (an epigenetic modulator) induces trophoblast differentiation in early gestation rhesus monkey trophoblasts through activation of the Wnt/beta-catenin pathway. The results show that syncytiotrophoblast formation was increased by butyrate, accompanied by nuclear accumulation of beta-catenin, and increased expression of EnvV2 and galectin-1 (two factors thought to be involved in trophoblast fusion). Surprisingly, the expression of GCM1 and syncytin-2 was not affected by sodium butyrate. When trophoblasts were incubated with lithium chloride, a GSK3 inhibitor that mimics Wnt activation, nuclear accumulation of beta-catenin also occurred but differentiation into syncytiotrophoblast was not observed. Instead the cells differentiated to mononucleated spindle-shaped cells and showed molecular and behavioral characteristics of endovascular trophoblasts. Another highly specific inhibitor of GSK3, CHIR99021, failed to induce endovascular trophoblast characteristics. These observations suggest that activation of the Wnt/beta-catenin pathway correlates with both trophoblast differentiation pathways, but that additional factors determine specific cell fate decisions. Other experiments suggested that the differential effects of sodium butyrate and lithium chloride might be explained by their effects on TNF alpha production. The results provide valuable tools to manipulate trophoblast differentiation in vitro and to better understand the differentiation pathways that occur during early gestation.	[Kumar, Priyadarsini; Thirkill, Twanda L.; Ji, Jennifer; Monte, Louise H.; Douglas, Gordon C.] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	University of California System; University of California Davis	Douglas, GC (corresponding author), Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA.	gcdouglas@ucdavis.edu	kumar, priyadarsini/AAG-7494-2019	kumar, priyadarsini/0000-0001-6800-9632	National Institutes of Health [5R01HL068035]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by National Institutes of Health, 5R01HL068035, http://www.nih.gov/, PI: GCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AboagyeMathiesen G, 1996, CLIN DIAGN LAB IMMUN, V3, P14, DOI 10.1128/CDLI.3.1.14-22.1996; Abu-Baker A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.342; Ashton SV, 2005, ARTERIOSCL THROM VAS, V25, P102, DOI 10.1161/01.ATV.0000148547.70187.89; Baczyk D, 2006, PLACENTA, V27, P367, DOI 10.1016/j.placenta.2005.03.006; Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Blaise S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-19; Blankenship TN, 1996, ANAT REC, V245, P525; Blankenship TN, 1997, ANAT REC, V247, P413, DOI 10.1002/(SICI)1097-0185(199703)247:3<413::AID-AR13>3.0.CO;2-S; Bordonaro M, 2002, INT J CANCER, V97, P42, DOI 10.1002/ijc.1577; Bordonaro M, 2007, EXP CELL RES, V313, P1652, DOI 10.1016/j.yexcr.2007.02.008; BURROWS TD, 1994, PLACENTA, V15, P21, DOI 10.1016/S0143-4004(05)80233-4; Caceres M, 2006, J HERED, V97, P100, DOI 10.1093/jhered/esj011; Carter AM, 2007, PLACENTA SUPPLEMENT, V28; Carter AM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0070; Cartwright JE, 2002, PLACENTA, V23, P232, DOI 10.1053/plac.2001.0760; Chen JG, 2004, TOXICOL SCI, V78, P166, DOI 10.1093/toxsci/kfh046; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; DOUGLAS GC, 1990, J CELL SCI, V96, P131; Douglas GC, 1999, BBA-MOL CELL RES, V1452, P36, DOI 10.1016/S0167-4889(99)00109-3; DOUGLAS GC, 1993, PLACENTA, V14, P187, DOI 10.1016/S0143-4004(05)80260-7; Dunk C, 2003, LAB INVEST, V83, P1821, DOI 10.1097/01.LAB.0000101730.69754.5A; Esnault C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003400; Fischer I, 2010, PLACENTA, V31, P825, DOI 10.1016/j.placenta.2010.06.016; Fischer I, 2011, J REPROD IMMUNOL, V90, P35, DOI 10.1016/j.jri.2011.04.004; Floridon C, 2000, MOL HUM REPROD, V6, P943, DOI 10.1093/molehr/6.10.943; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; Gaudier E, 2004, BIOCHEM BIOPH RES CO, V325, P1044, DOI 10.1016/j.bbrc.2004.10.141; Giambelluca MS, 2014, FASEB J, V28, P3679, DOI 10.1096/fj.14-251900; Harris LK, 2009, PLACENTA, V30, P299, DOI 10.1016/j.placenta.2008.12.003; Ho H H, 1997, Early Pregnancy, V3, P291; IRVING JA, 1995, EXP CELL RES, V217, P419, DOI 10.1006/excr.1995.1105; James JL, 2005, REPRODUCTION, V130, P95, DOI 10.1530/rep.1.00723; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Kaufmann P., 1997, PLACENTA, V18, P21, DOI [10.1016/S0143-4004(97)80079-3, DOI 10.1016/S0143-4004(97)80079-3]; KINOSHITA F, 1981, J CANCER RES CLIN, V100, P321, DOI 10.1007/BF00410692; Kjeldbjerg AL, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-266; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; LaMarca HL, 2005, PLACENTA, V26, P709, DOI 10.1016/j.placenta.2004.11.003; Lappas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115854; Lazarova Darina L, 2014, BMC Res Notes, V7, P226, DOI 10.1186/1756-0500-7-226; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Leisser C, 2006, MOL HUM REPROD, V12, P601, DOI 10.1093/molehr/gal066; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Liu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116183; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lokossou AG, 2014, VIRUSES-BASEL, V6, P4609, DOI 10.3390/v6114609; Luo Q, 2015, PLACENTA, V36, P567, DOI 10.1016/j.placenta.2015.02.009; Lyall F, 2001, AM J PATHOL, V158, P1713, DOI 10.1016/S0002-9440(10)64127-2; Matsuura K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1551; Meinhardt G, 2014, ENDOCRINOLOGY, V155, P1908, DOI 10.1210/en.2013-2042; Millard AL, 2002, CLIN EXP IMMUNOL, V130, P245; Murakami S, 2001, MICROVASC RES, V62, P383, DOI 10.1006/mvre.2001.2356; OHANNESIAN DW, 1994, CANCER RES, V54, P5992; Raso GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068626; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Saemann MD, 2000, FASEB J, V14, P2380; Scholz D, 1996, CELL TISSUE RES, V284, P415, DOI 10.1007/s004410050602; Soghomonians A, 2005, BIOL REPROD, V73, P14, DOI 10.1095/biolreprod.104.036509; Stewart RJ, 1996, J IMMUNOL, V156, P1221; Takao T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021990; Tarrade A, 2001, LAB INVEST, V81, P1199, DOI 10.1038/labinvest.3780334; Thirkill TL, 2007, BBA-MOL CELL RES, V1773, P1007, DOI 10.1016/j.bbamcr.2007.04.006; Thirkill Twanda L, 2004, Cell Commun Signal, V2, P4, DOI 10.1186/1478-811X-2-4; Wang YP, 2004, J CLIN ENDOCR METAB, V89, P2421, DOI 10.1210/jc.2003-031707; Xu B, 2011, PLACENTA, V32, P241, DOI 10.1016/j.placenta.2010.12.005; Yoo DY, 2015, NEUROL RES, V37, P69, DOI 10.1179/1743132814Y.0000000416; Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387	70	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135089	10.1371/journal.pone.0135089	http://dx.doi.org/10.1371/journal.pone.0135089			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266541	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300077
J	Shiwa, M; Yoneda, M; Okubo, H; Ohno, H; Kobuke, K; Monzen, Y; Kishimoto, R; Nakatsu, Y; Asano, T; Kohno, N				Shiwa, Mami; Yoneda, Masayasu; Okubo, Hirofumi; Ohno, Haruya; Kobuke, Kazuhiro; Monzen, Yuko; Kishimoto, Rui; Nakatsu, Yusuke; Asano, Tomoichiro; Kohno, Nobuoki			Distinct Time Course of the Decrease in Hepatic AMP-Activated Protein Kinase and Akt Phosphorylation in Mice Fed a High Fat Diet	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; MODERATE WEIGHT-REDUCTION; SKELETAL-MUSCLE; TISSUE INFLAMMATION; GLUCOSE-METABOLISM; LIVER; RATS; METFORMIN; REVERSAL; OBESITY	AMP-activated protein kinase (AMPK) plays an important role in insulin resistance, which is characterized by the impairment of the insulin-Akt signaling pathway. However, the time course of the decrease in AMPK and Akt phosphorylation in the liver during the development of obesity and insulin resistance caused by feeding a high fat diet (HFD) remains controversial. Moreover, it is unclear whether the impairment of AMPK and Akt signaling pathways is reversible when changing from a HFD to a standard diet (SD). Male ddY mice were fed the SD or HFD for 3 to 28 days, or fed the HFD for 14 days, followed by the SD for 14 days. We examined the time course of the expression and phosphorylation levels of AMPK and Akt in the liver by immunoblotting. After 3 days of feeding on the HFD, mice gained body weight, resulting in an increased oil red O staining, indicative of hepatic lipid accumulation, and significantly decreased AMPK phosphorylation, in comparison with mice fed the SD. After 14 days on the HFD, systemic insulin resistance occurred and Akt phosphorylation significantly decreased. Subsequently, a change from the HFD to SD for 3 days, after 14 days on the HFD, ameliorated the impairment of AMPK and Akt phosphorylation and systemic insulin resistance. Our findings indicate that AMPK phosphorylation decreases early upon feeding a HFD and emphasizes the importance of prompt lifestyle modification for decreasing the risk of developing diabetes.	[Shiwa, Mami; Yoneda, Masayasu; Okubo, Hirofumi; Ohno, Haruya; Kobuke, Kazuhiro; Monzen, Yuko; Kishimoto, Rui; Kohno, Nobuoki] Hiroshima Univ, Dept Mol & Internal Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Nakatsu, Yusuke; Asano, Tomoichiro] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Biomed Chem, Hiroshima, Japan	Hiroshima University; Hiroshima University	Yoneda, M (corresponding author), Hiroshima Univ, Dept Mol & Internal Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	masayone17@hiroshima-u.ac.jp	祐介, 中津/AAP-8396-2020; Hiyama, Eiso/A-2013-2019	Hiyama, Eiso/0000-0001-9179-5037; Okubo, Hirofumi/0000-0002-9220-9084; Ohno, Haruya/0000-0001-5400-1162; Nakatsu, Yusuke/0000-0003-3279-1276				Ben-Shlomo S, 2012, OBESITY, V20, P151, DOI 10.1038/oby.2011.261; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Ha SK, 2011, J COMP PATHOL, V145, P88, DOI 10.1016/j.jcpa.2010.11.011; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hasenour CM, 2013, MOL CELL ENDOCRINOL, V366, P152, DOI 10.1016/j.mce.2012.06.018; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Jung DY, 2013, AM J PHYSIOL-ENDOC M, V304, pE964, DOI 10.1152/ajpendo.00462.2012; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Lam TKT, 2002, AM J PHYSIOL-ENDOC M, V283, pE682, DOI 10.1152/ajpendo.00038.2002; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Lindholm CR, 2013, J PHYSIOL BIOCHEM, V69, P165, DOI 10.1007/s13105-012-0199-2; Liu Y, 2006, BIOCHEM BIOPH RES CO, V339, P701, DOI 10.1016/j.bbrc.2005.11.068; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sato F, 2007, J CLIN ENDOCR METAB, V92, P3326, DOI 10.1210/jc.2006-2384; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Wiedemann MSF, 2013, AM J PHYSIOL-ENDOC M, V305, pE388, DOI 10.1152/ajpendo.00179.2013; Woo SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091111; Yang SM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/429207; Yoneda M, 2010, OBES RES CLIN PRACT, V4, pE201, DOI 10.1016/j.orcp.2010.02.002; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	35	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135554	10.1371/journal.pone.0135554	http://dx.doi.org/10.1371/journal.pone.0135554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266809	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300133
J	Liu, JL; Wang, YH; Song, SJ; Wang, XJ; Qin, YY; Si, SY; Guo, YC				Liu, JunLi; Wang, YiHu; Song, ShuJun; Wang, XiJie; Qin, YaYa; Si, ShaoYan; Guo, YanChuan			Combined Oral Administration of Bovine Collagen Peptides with Calcium Citrate Inhibits Bone Loss in Ovariectomized Rats	PLOS ONE			English	Article							MINERAL DENSITY; DOUBLE-BLIND; HYDROLYSATE; BISPHOSPHONATE; OSTEOPOROSIS; ALENDRONATE; OSTEOPENIA; TURNOVER; EFFICACY; GELATIN	Purpose Collagen peptides (CPs) and calcium citrate are commonly used as bone health supplements for treating osteoporosis. However, it remains unknown whether the combination of oral bovine CPs with calcium citrate is more effective than administration of either agent alone. Methods Forty 12-week-old Sprague-Dawley rats were randomly divided into five groups (n = 8) for once-daily intragastric administration of different treatments for 3 months at 3 months after ovariectomy (OVX) as follows: sham + vehicle; OVX + vehicle; OVX + 750 mg/kg CP; OVX + CP-calcium citrate (75 mg/kg); OVX + calcium citrate (75 mg/kg). After euthanasia, the femurs were removed and analyzed by dual energy X-ray absorptiometry and micro-computed tomography, and serum samples were analyzed for bone metabolic markers. Results OVX rats supplemented with CPs or CP-calcium citrate showed osteoprotective effects, with reductions in the OVX-induced decreases in their femoral bone mineral density. Moreover, CP-calcium citrate prevented trabecular bone loss, improved the microarchitecture of the distal femur, and significantly inhibited bone loss with increased bone volume, connectivity density, and trabecular number compared with OVX control rats. CP or CP-calcium citrate administration significantly increased serum procollagen type I N-terminal propeptide levels and reduced serum bone-specific alkaline phosphatase, osteocalcin, and C-telopeptide of type I collagen levels. Conclusions Our data indicate that combined oral administration of bovine CPs with calcium citrate inhibits bone loss in OVX rats. The present findings suggest that combined oral administration of bovine CPs with calcium citrate is a promising alternative for reducing bone loss in osteopenic postmenopausal women.	[Liu, JunLi; Wang, YiHu; Wang, XiJie; Guo, YanChuan] Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Photochem Convers & Optoelect Mat, Beijing, Peoples R China; [Liu, JunLi; Song, ShuJun; Qin, YaYa; Si, ShaoYan] 306 Hosp PLA, Ctr Special Med & Expt Res, Beijing, Peoples R China	Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS	Guo, YC (corresponding author), Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Photochem Convers & Optoelect Mat, Beijing, Peoples R China.	Sishy306@126.com; guoyanchuan79@163.com			Cooperation Project from the Technical Institute of Physics and Chemistry, CAS [LHS-DBSW2013-01]	Cooperation Project from the Technical Institute of Physics and Chemistry, CAS	Funded by The Cooperation Project from the Technical Institute of Physics and Chemistry, CAS (Grant No. LHS-DBSW2013-01).	Ammann P, 1996, OSTEOPOROSIS INT, V6, P219, DOI 10.1007/BF01622738; Bello AE, 2006, CURR MED RES OPIN, V22, P2221, DOI 10.1185/030079906X148373; Bhutani Garima, 2013, J Midlife Health, V4, P147, DOI 10.4103/0976-7800.118991; Bialek P, 2014, BONE, V60, P162, DOI 10.1016/j.bone.2013.12.002; Chen H, 2008, OSTEOPOROSIS INT, V19, P1473, DOI 10.1007/s00198-008-0593-3; Chen H, 2010, OSTEOPOROSIS INT, V21, P627, DOI 10.1007/s00198-009-0993-z; Chen HY, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/213234; Chen ML, 2014, EXPERT OPIN THER TAR, V18, P817, DOI 10.1517/14728222.2014.912632; Clark KL, 2008, CURR MED RES OPIN, V24, P1485, DOI 10.1185/030079908X291967 ; Cohen S, 1999, ARTHRITIS RHEUM, V42, P2309, DOI 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K; Durao SF, 2014, OSTEOPOROSIS INT, V25, P1535, DOI 10.1007/s00198-014-2656-y; Elam ML, 2013, RESEARCHGATENET, V2, P1, DOI [DOI 10.4172/2324-9323.1000102, 10.4172/2324-9323.1000102]; Goldstein SR, 2009, MENOPAUSE, V16, P413, DOI 10.1097/gme.0b013e3181883dae; Guillerminet F, 2012, OSTEOPOROSIS INT, V23, P1909, DOI 10.1007/s00198-011-1788-6; Guillerminet F, 2010, BONE, V46, P827, DOI 10.1016/j.bone.2009.10.035; Hale LV, 2007, BONE, V40, P1103, DOI 10.1016/j.bone.2006.11.027; Ichikawa S, 2010, INT J FOOD SCI NUTR, V61, P52, DOI 10.3109/09637480903257711; Inzana JA, 2013, BONE, V57, P174, DOI 10.1016/j.bone.2013.08.003; Jackix ED, 2010, J MED FOOD, V13, P1385, DOI 10.1089/jmf.2009.0256; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; Kim HK, 2013, MOLECULES, V18, P15474, DOI 10.3390/molecules181215474; Knopp-Sihota JA, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-36; Liu JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099920; Mackey DC, 2011, J BONE MINER RES, V26, P2411, DOI 10.1002/jbmr.446; McClung M, 1998, ANN INTERN MED, V128, P253, DOI 10.7326/0003-4819-128-4-199802150-00001; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nomura Y, 2005, NUTRITION, V21, P1120, DOI 10.1016/j.nut.2005.03.007; Peng YL, 2014, OSTEOPOROSIS INT, V25, P1617, DOI 10.1007/s00198-014-2647-z; Singer FR, 2008, CLEV CLIN J MED, V75, P739, DOI 10.3949/ccjm.75.10.739; Surve VV, 2001, ACTA ORTHOP SCAND, V72, P525, DOI 10.1080/000164701753532880; Thomsen JS, 2005, J MICROSC-OXFORD, V218, P171, DOI 10.1111/j.1365-2818.2005.01469.x; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Watanabe-Kamiyama M, 2010, J AGR FOOD CHEM, V58, P835, DOI 10.1021/jf9031487; WRONSKI TJ, 1989, ENDOCRINOLOGY, V125, P810, DOI 10.1210/endo-125-2-810	34	16	21	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135019	10.1371/journal.pone.0135019	http://dx.doi.org/10.1371/journal.pone.0135019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258559	gold, Green Submitted, Green Published			2022-12-27	WOS:000359352600036
J	Wiechmann, ML; Hurteau, MD; Kaye, JP; Miesel, JR				Wiechmann, Morgan L.; Hurteau, Matthew D.; Kaye, Jason P.; Miesel, Jessica R.			Macro-Particle Charcoal C Content following Prescribed Burning in a Mixed-Conifer Forest, Sierra Nevada, California	PLOS ONE			English	Article							FIRE RESTORATION TREATMENTS; SOIL ORGANIC-MATTER; BLACK CARBON; PYROGENIC CARBON; AROMATIC CONDENSATION; CLIMATE-CHANGE; WOODY DEBRIS; OLD-GROWTH; REDUCTION; WILDFIRE	Fire suppression and changing climate have resulted in increased large wildfire frequency and severity in the western United States, causing carbon cycle impacts. Forest thinning and prescribed burning reduce high-severity fire risk, but require removal of biomass and emissions of carbon from burning. During each fire a fraction of the burning vegetation and soil organic matter is converted into charcoal, a relatively stable carbon form. We sought to quantify the effects of pre-fire fuel load and type on charcoal carbon produced by biomass combusted in a prescribed burn under different thinning treatments and to identify more easily measured predictors of charcoal carbon mass in a historically frequent-fire mixed-conifer forest. We hypothesized that charcoal carbon produced from coarse woody debris (CWD) during prescribed burning would be greater than that produced from fine woody debris (FWD). We visually quantified post-treatment charcoal carbon content in the O-horizon and the A-horizon beneath CWD (> 30 cm diameter) and up to 60 cm from CWD that was present prior to treatment. We found no difference in the size of charcoal carbon pools from CWD (treatment means ranged from 0.3-2.0 g m(-2) of A-horizon and 0.0-1.7 g m(-2) of O-horizon charcoal) and FWD (treatment means ranged from 0.2-1.7 g m(-2) of A-horizon and 0.0-1.5 g m(-2) of O-horizon charcoal). We also compared treatments and found that the burn-only, understory-thin and burn, and overstory-thin and burn treatments had significantly more charcoal carbon than the control. Charcoal carbon represented 0.29% of total ecosystem carbon. We found that char mass on CWD was an important predictor of charcoal carbon mass, but only explained 18-35% of the variation. Our results help improve our understanding of the effects forest restoration treatments have on ecosystem carbon by providing additional information about charcoal carbon content.	[Wiechmann, Morgan L.] Penn State Univ, IGDP Ecol, University Pk, PA 16802 USA; [Wiechmann, Morgan L.; Hurteau, Matthew D.; Kaye, Jason P.] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA; [Miesel, Jessica R.] Michigan State Univ, Dept Forestry, E Lansing, MI 48824 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Michigan State University	Hurteau, MD (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	mhurteau@unm.edu	Hurteau, Matthew D/D-2301-2009	Hurteau, Matthew D/0000-0001-8457-8974	Joint Fire Science Program	Joint Fire Science Program	This research was funded by the Joint Fire Science Program (www.firescience.gov) through a Graduate Research Innovation Award to MLW, MDH, and JPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Alexis MA, 2007, BIOGEOCHEMISTRY, V82, P201, DOI 10.1007/s10533-006-9063-1; Alexis MA, 2012, GEODERMA, V189, P98, DOI 10.1016/j.geoderma.2012.05.003; Alexis MA, 2010, ORG GEOCHEM, V41, P690, DOI 10.1016/j.orggeochem.2010.03.003; [Anonymous], 2007, 2003 ANN BOOK ASTM S, V11.05; Ascough PL, 2011, GEOCHIM COSMOCHIM AC, V75, P2361, DOI 10.1016/j.gca.2011.02.002; Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; Bird MI, 2015, ANNU REV EARTH PL SC, V43, P273, DOI 10.1146/annurev-earth-060614-105038; Briggs C, 2012, SOIL SCI, V177, P263, DOI 10.1097/SS.0b013e3182482784; Brimmer RJ, 2006, CHARCOAL QUANTITY AD; Brown JK, 1974, INT16 USDA FOR SERV; Buma B, 2014, ECOSYSTEMS, V17, P947, DOI 10.1007/s10021-014-9770-8; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carvalho EO, 2011, INT J WILDLAND FIRE, V20, P474, DOI 10.1071/WF10061; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Czimczik CI, 2005, EUR J SOIL SCI, V56, P417, DOI 10.1111/j.1365-2389.2004.00665.x; DeLuca TH, 2008, FRONT ECOL ENVIRON, V6, P18, DOI 10.1890/070070; Donato D. C., 2009, Fire Ecology, V5, P104; Dore S, 2008, GLOBAL CHANGE BIOL, V14, P1801, DOI 10.1111/j.1365-2486.2008.01613.x; Finkral AJ, 2008, FOREST ECOL MANAG, V255, P2743, DOI 10.1016/j.foreco.2008.01.041; Forbes MS, 2006, SCI TOTAL ENVIRON, V370, P190, DOI 10.1016/j.scitotenv.2006.06.007; Fule PZ, 2002, FOREST ECOL MANAG, V170, P19, DOI 10.1016/S0378-1127(01)00759-9; Hurteau M, 2009, FRONT ECOL ENVIRON, V7, P409, DOI 10.1890/080049; Hurteau MD, 2008, FRONT ECOL ENVIRON, V6, P493, DOI 10.1890/070187; Hurteau MD, 2014, FOREST ECOL MANAG, V315, P30, DOI 10.1016/j.foreco.2013.12.012; Hurteau MD, 2011, BIOSCIENCE, V61, P139, DOI 10.1525/bio.2011.61.2.9; Hurteau MD, 2010, FOREST ECOL MANAG, V260, P930, DOI 10.1016/j.foreco.2010.06.015; Innes JC, 2006, CAN J FOREST RES, V36, P3183, DOI 10.1139/X06-184; Jerman JL, 2004, WEST J APPL FOR, V19, P149, DOI 10.1093/wjaf/19.3.149; Kaye JP, 2005, ECOL APPL, V15, P1581, DOI 10.1890/04-0868; Knicker H, 2007, BIOGEOCHEMISTRY, V85, P91, DOI 10.1007/s10533-007-9104-4; Kurth VJ, 2006, GEODERMA, V137, P135, DOI 10.1016/j.geoderma.2006.08.003; Lehmann J, SOIL BIOL BIOGEOCHEM, V43, P1812; Lehmann J, 2008, NAT GEOSCI, V1, P832, DOI 10.1038/ngeo358; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Licata C, 2012, FORESTS, V3, P944, DOI 10.3390/f3040944; MacKenzie MD, 2008, SOIL SCI SOC AM J, V72, P1774, DOI 10.2136/sssaj2007.0363; Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043; McBeath AV, 2011, ORG GEOCHEM, V42, P1194, DOI 10.1016/j.orggeochem.2011.08.008; Meigs GW, 2009, ECOSYSTEMS, V12, P1246, DOI 10.1007/s10021-009-9285-x; Meyer MD, 2005, CAN J FOREST RES, V35, P1061, DOI 10.1139/x05-032; Michelotti LA, 2015, FORESTS, V6, P1325, DOI 10.3390/f6041325; Miller JD, 2009, ECOSYSTEMS, V12, P16, DOI 10.1007/s10021-008-9201-9; Mitchell SR, 2009, ECOL APPL, V19, P643, DOI 10.1890/08-0501.1; Myers-Pigg AN, 2015, GEOPHYS RES LETT, V42, P377, DOI 10.1002/2014GL062762; Nocentini C, 2010, ORG GEOCHEM, V41, P682, DOI 10.1016/j.orggeochem.2010.03.010; North M, 2005, FOREST SCI, V51, P187; NORTH M, 2002, PSWGTR186 USDA FOR S; North M, 2007, CAN J FOREST RES, V37, P331, DOI 10.1139/X06-236; North M, 2009, ECOL APPL, V19, P1385, DOI 10.1890/08-1173.1; Pan YD, 2009, FOREST ECOL MANAG, V259, P151, DOI 10.1016/j.foreco.2009.09.049; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; Pingree MRA, 2012, FORESTS, V3, P353, DOI 10.3390/f3020353; Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006; Preston CM, 2009, NAT GEOSCI, V2, P674, DOI 10.1038/ngeo642; Robichaud PR, 2009, FIRE EFFECTS SOILS R; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schmidt MWI, 2000, GLOBAL BIOGEOCHEM CY, V14, P777, DOI 10.1029/1999GB001208; Scholl AE, 2010, ECOL APPL, V20, P362, DOI 10.1890/08-2324.1; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Seager R, 2010, P NATL ACAD SCI USA, V107, P21277, DOI 10.1073/pnas.0910856107; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Stephens SL, 2009, CAN J FOREST RES, V39, P1538, DOI 10.1139/X09-081; Stephens SL, 2005, ECOL APPL, V15, P532, DOI 10.1890/04-0545; Tinker DB, 2000, ECOSYSTEMS, V3, P472, DOI 10.1007/s100210000041; Van Zwieten L, 2009, BIOCHAR ENV MANAGEME, P227, DOI DOI 10.4324/9781849770552; Wayman RB, 2007, FOREST ECOL MANAG, V239, P32, DOI 10.1016/j.foreco.2006.11.011; Westerling AL, 2008, CLIMATIC CHANGE, V87, pS231, DOI 10.1007/s10584-007-9363-z; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; Wiechmann ML, CLIMATE CHA IN PRESS; Wiedemeier DB, 2015, ORG GEOCHEM, V78, P135, DOI 10.1016/j.orggeochem.2014.10.002; Wiedemeier DB, 2013, J CHROMATOGR A, V1304, P246, DOI 10.1016/j.chroma.2013.06.012; Wiedinmyer Christine, 2007, Carbon Balance Manag, V2, P10, DOI 10.1186/1750-0680-2-10; Wiedinmyer C, 2010, ENVIRON SCI TECHNOL, V44, P1926, DOI 10.1021/es902455e; Zald HSJ, 2008, FOREST ECOL MANAG, V256, P168, DOI 10.1016/j.foreco.2008.04.022	76	11	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135014	10.1371/journal.pone.0135014	http://dx.doi.org/10.1371/journal.pone.0135014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258533	Green Published, Green Submitted, gold			2022-12-27	WOS:000359352600035
J	Bai, S; Xu, ZF; Duan, WY; Liu, FY; Huang, DH; Sun, CF				Bai, Shuang; Xu, Zhong-Fei; Duan, Wei-Yi; Liu, Fa-Yu; Huang, Dong-Hui; Sun, Chang-Fu			Single Superficial versus Dual Systems Venous Anastomoses in Radial Forearm Free Flap: A Meta-Analysis	PLOS ONE			English	Article							PERFORATOR FLAP; DRAINAGE; RECONSTRUCTION; VEIN; HETEROGENEITY; MORBIDITY; DEEP; HEAD	Background The radial forearm free flap (RFFF) has been widely used with increasing frequency in head and neck reconstruction following extirpative surgery. The controversy of the venous anastomoses patterns still exists. Thus, we conducted a meta-analysis to assess the relationship between the venous anastomoses patterns and venous compromise. Methods MEDLINE, PubMed, Web of Science, and Wanfang databases were searched for studies reporting the different venous anastomoses patterns of the RFFF. A meta-analysis was conducted using the random effects models. Publication bias and sensitivity analysis were also assessed. Results 6 studies with 992 cases were included in this meta-analysis. The dual anastomosis group tended to have a lower incidence of venous compromise (RR = 1.39). However, the difference was not statistically significant (95%CI: 0.59, 3.24). Conclusions This meta-analysis indicated that performing dual venous anatomoses consisting of superficial and deep systems conferred a tendency of the reduction with regard to venous compromise.	[Bai, Shuang; Xu, Zhong-Fei; Duan, Wei-Yi; Liu, Fa-Yu; Sun, Chang-Fu] China Med Univ, Sch Stomatol, Dept Oromaxillofacial Head & Neck Surg, Shenyang, Liaoning, Peoples R China; [Bai, Shuang; Xu, Zhong-Fei; Duan, Wei-Yi; Liu, Fa-Yu; Sun, Chang-Fu] China Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Shenyang, Liaoning, Peoples R China; [Huang, Dong-Hui] China Med Univ, Affiliated Hosp 1, Dept Clin Epidemiol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Sun, CF (corresponding author), China Med Univ, Sch Stomatol, Dept Oromaxillofacial Head & Neck Surg, 117 Nanjing North St, Shenyang, Liaoning, Peoples R China.	changfusun@hotmail.com	SUN, CHANG/GXM-3680-2022	Bai, Shuang/0000-0002-2994-9768				BECKINGHAM IJ, 1992, MICROSURG, V13, P348, DOI 10.1002/micr.1920130613; Bruner TW, 2011, CAN J PLAST SURG, V19, P102; COLDITZ GA, 1995, AM J EPIDEMIOL, V142, P371, DOI 10.1093/oxfordjournals.aje.a117644; Dermirkan F, 1998, PLAST RECONSTR SURG, V102, P1544; Futran ND, 1996, AM J OTOLARYNG, V17, P112, DOI 10.1016/S0196-0709(96)90006-X; GOTTLIEB LJ, 1993, J RECONSTR MICROSURG, V9, P281, DOI 10.1055/s-2007-1006668; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ichinose A, 2003, J RECONSTR MICROSURG, V19, P371; Ichinose A, 2003, SCAND J PLAST RECONS, V37, P145, DOI 10.1080/-2844310310007746; Kao HK, 2009, PLAST RECONSTR SURG, V124, P1125, DOI 10.1097/PRS.0b013e3181b457cf; KHASHABA AA, 1986, BRIT J PLAST SURG, V39, P441, DOI 10.1016/0007-1226(86)90110-4; Liu Y, 2012, INT J ORAL MAX SURG, V41, P448, DOI 10.1016/j.ijom.2012.01.016; Liu Y, 2008, MICROSURG, V28, P243, DOI 10.1002/micr.20489; Netscher DT, 1996, ANN PLAS SURG, V36, P536, DOI 10.1097/00000637-199605000-00017; Rohleder NH, 2011, ANN SURG ONCOL, V18, P1980, DOI 10.1245/s10434-011-1555-0; Selber JC, 2011, ANN PLAS SURG, V66, P347, DOI 10.1097/SAP.0b013e3181f46631; Serletti JM, 2000, PLAST RECONSTR SURG, V106, P66, DOI 10.1097/00006534-200007000-00012; Shi Rong-hua, 2012, J ORAL MAXILLOFAC SU, V22, P252; Shima H, 1996, J CRANIO MAXILL SURG, V24, P293, DOI 10.1016/S1010-5182(96)80062-X; Sieg P, 2012, HEAD NECK-J SCI SPEC, V34, P1312, DOI 10.1002/hed.21918; SONG RY, 1982, CLIN PLAST SURG, V9, P21; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; SWANSON E, 1990, PLAST RECONSTR SURG, V85, P258, DOI 10.1097/00006534-199002000-00016; THOMA A, 1994, PLAST RECONSTR SURG, V93, P54, DOI 10.1097/00006534-199401000-00008; Valentino J, 1996, LARYNGOSCOPE, V106, P648, DOI 10.1097/00005537-199605000-00025; VAUGHAN ED, 1990, J CRANIO MAXILL SURG, V18, P2, DOI 10.1016/S1010-5182(05)80596-7; Yang G, 1981, NATIONAL MED J CHINA, V61, P139; Yang WG, 2006, PLAST RECONSTR SURG, V117, P1004, DOI 10.1097/01.prs.0000200615.77678.f1; Yap LH, 2006, ANN PLAS SURG, V57, P666, DOI 10.1097/01.sap.0000229958.57126.21	29	11	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134805	10.1371/journal.pone.0134805	http://dx.doi.org/10.1371/journal.pone.0134805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270854	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800021
J	Birko, S; Dove, ES; Ozdemir, V				Birko, Stanislav; Dove, Edward S.; Ozdemir, Vural			Evaluation of Nine Consensus Indices in Delphi Foresight Research and Their Dependency on Delphi Survey Characteristics: A Simulation Study and Debate on Delphi Design and Interpretation	PLOS ONE			English	Article							RESPONSIBLE INNOVATION; SCIENCE; DIAGNOSTICS; AGREEMENT; MODELS; FUTURE; CALL	The extent of consensus (or the lack thereof) among experts in emerging fields of innovation can serve as antecedents of scientific, societal, investor and stakeholder synergy or conflict. Naturally, how we measure consensus is of great importance to science and technology strategic foresight. The Delphi methodology is a widely used anonymous survey technique to evaluate consensus among a panel of experts. Surprisingly, there is little guidance on how indices of consensus can be influenced by parameters of the Delphi survey itself. We simulated a classic three-round Delphi survey building on the concept of clustered consensus/dissensus. We evaluated three study characteristics that are pertinent for design of Delphi foresight research: (1) the number of survey questions, (2) the sample size, and (3) the extent to which experts conform to group opinion (the Group Conformity Index) in a Delphi study. Their impacts on the following nine Delphi consensus indices were then examined in 1000 simulations: Clustered Mode, Clustered Pairwise Agreement, Conger's Kappa, De Moivre index, Extremities Version of the Clustered Pairwise Agreement, Fleiss' Kappa, Mode, the Interquartile Range and Pairwise Agreement. The dependency of a consensus index on the Delphi survey characteristics was expressed from 0.000 (no dependency) to 1.000 (full dependency). The number of questions (range: 6 to 40) in a survey did not have a notable impact whereby the dependency values remained below 0.030. The variation in sample size (range: 6 to 50) displayed the top three impacts for the Interquartile Range, the Clustered Mode and the Mode (dependency = 0.396, 0.130, 0.116, respectively). The Group Conformity Index, a construct akin to measuring stubbornness/flexibility of experts' opinions, greatly impacted all nine Delphi consensus indices (dependency = 0.200 to 0.504), except the Extremity CPWA and the Interquartile Range that were impacted only beyond the first decimal point (dependency = 0.087 and 0.083, respectively). Scholars in technology design, foresight research and future(s) studies might consider these new findings in strategic planning of Delphi studies, for example, in rational choice of consensus indices and sample size, or accounting for confounding factors such as experts' variable degrees of conformity (stubbornness/flexibility) in modifying their opinions.	[Birko, Stanislav] McGill Univ, Fac Med, Dept Human Genet, Ctr Genom & Policy, Montreal, PQ, Canada; [Dove, Edward S.] Univ Edinburgh, Sch Law, J Kenyon Mason Inst Med Life Sci & Law, Edinburgh, Midlothian, Scotland; [Ozdemir, Vural] Gaziantep Univ, Off President Int Technol & Innovat Policy, Fac Commun, TR-27310 Sehitkamil, Gaziantep, Turkey; [Ozdemir, Vural] Gaziantep Univ, Fac Engn, Dept Ind Engn, TR-27310 Sehitkamil, Gaziantep, Turkey; [Ozdemir, Vural] Amrita Univ, Amrita Vishwa Vidyapeetham, Amrita Sch Biotechnol, Kollam, Kerala, India	McGill University; University of Edinburgh; Gaziantep University; Gaziantep University; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri	Birko, S (corresponding author), McGill Univ, Fac Med, Dept Human Genet, Ctr Genom & Policy, Montreal, PQ, Canada.	sbirko@gmail.com; vural.ozdemir@alumni.utoronto.ca	Dalal, Koustuv/O-6737-2017	Dalal, Koustuv/0000-0001-7393-796X	Genome British Columbia, Canada [2124]; Scientific and Technological Research Council of Turkey	Genome British Columbia, Canada; Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The research presented here is supported fully by an operating grant (LSARP #2124) for social science and humanities (SSH) research on new technology governance from Genome British Columbia, Canada to Dr. Vural Ozdemir. Dr. Ozdemir is the recipient of a senior interdisciplinary scholar career award from the Scientific and Technological Research Council of Turkey. The sponsors did not influence the design, collection, analysis and interpretation of data, the writing of the report, nor the decision to submit the paper for publication.	Adelson M, 1975, DELPHI METHOD TECHNI, P433; Beech B, 1997, J ADV NURS, V25, P331, DOI 10.1046/j.1365-2648.1997.1997025331.x; Berkson J, 1938, J AM STAT ASSOC, V33, P526, DOI 10.2307/2279690; Birch K, 2013, SCI TECHNOL HUM VAL, V38, P299, DOI 10.1177/0162243912442398; Birko S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129706; Conger AJ, 1971, PSYCHOL BULL, V76, P378; Dandara C, 2014, OMICS, V18, P733, DOI 10.1089/omi.2014.0145; Delbecq AL, 1975, GROUP TECHNIQUES FOR; Di Mare A, 2007, INT J MOD PHYS C, V18, P1377, DOI 10.1142/S012918310701139X; Dove ES, 2013, EMBO REP, V14, P113, DOI 10.1038/embor.2012.205; Faucheux S, 2001, J HAZARD MATER, V86, P223, DOI 10.1016/S0304-3894(01)00260-6; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fitch K., 2001, RAND UCLA APPROPRIAT; FLEISS JL, 1975, BIOMETRICS, V31, P651, DOI 10.2307/2529549; French Peter, 2002, J Nurs Manag, V10, P265, DOI 10.1046/j.1365-2834.2002.00314.x; Green B, 1999, HEALTH SOC CARE COMM, V7, P198, DOI 10.1046/j.1365-2524.1999.00176.x; Gungor K, 2014, OMICS, V18, P275, DOI 10.1089/omi.2014.0040; Gwet K., 2002, STAT METHODS INTERRA, V1, P1; Hatchard JL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003757; Hekim N, 2014, OMICS, V18, P415, DOI 10.1089/omi.2014.0079; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Keeney S, 2011, THE DELPHI TECHNIQUE; Meijering JV, 2013, TECHNOL FORECAST SOC, V80, P1607, DOI 10.1016/j.techfore.2013.01.003; Nowack M, 2011, TECHNOL FORECAST SOC, V78, P1603, DOI 10.1016/j.techfore.2011.03.006; Ozdemir V, 2014, SMART GOVERNANCE FOR, P12; Ozdemir V, 2015, AM J BIOETHICS, V15, P64, DOI 10.1080/15265161.2015.1021976; Ozdemir V, 2014, OMICS, V18, P211, DOI 10.1089/omi.2014.0029; Ozdemir V, 2014, OMICS, V18, P1, DOI 10.1089/omi.2013.0170; PROCTER S, 1994, J ADV NURS, V19, P1003, DOI 10.1111/j.1365-2648.1994.tb01180.x; Thoreau F, 2012, POLITICA SOC, V11, P205, DOI DOI 10.5007/2175-7984.2012v11n20p205; Twycross A, 2001, J ADV NURS, V34, P51, DOI 10.1046/j.1365-2648.2001.3411734.x; UEBERSAX JS, 1987, PSYCHOL BULL, V101, P140, DOI 10.1037/0033-2909.101.1.140; Ulucanlar S, 2013, SOC SCI MED, V98, P95, DOI 10.1016/j.socscimed.2013.09.008; von der Gracht HA, 2012, TECHNOL FORECAST SOC, V79, P1525, DOI 10.1016/j.techfore.2012.04.013; Warrens MJ, 2010, ADV DATA ANAL CLASSI, V4, P271, DOI 10.1007/s11634-010-0073-4; White JW, 2014, OIKOS, V123, P385, DOI 10.1111/j.1600-0706.2013.01073.x; Wonkam A, 2014, OMICS, V18, P472, DOI 10.1089/omi.2013.0167	38	41	41	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135162	10.1371/journal.pone.0135162	http://dx.doi.org/10.1371/journal.pone.0135162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JX	26270647	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800037
J	Samartzis, D; Leung, Y; Shigematsu, H; Natarajan, D; Stokes, O; Mak, KC; Yao, G; Luk, KDK; Cheung, KMC				Samartzis, Dino; Leung, Yee; Shigematsu, Hideki; Natarajan, Deepa; Stokes, Oliver; Mak, Kin-Cheung; Yao, Guanfeng; Luk, Keith D. K.; Cheung, Kenneth M. C.			Selection of fusion levels using the fulcrum bending radiograph for the management of adolescent idiopathic scoliosis patients with alternate level pedicle screw strategy: clinical decision-making and outcomes	PLOS ONE			English	Article							TERM FOLLOW-UP; POSTERIOR SPINAL-FUSION; HYBRID INSTRUMENTATION; SURGICAL-TREATMENT; FLEXIBILITY; PREDICTION; FIXATION; CURVE; INDEX	Objective Selecting fusion levels based on the Luk et al criteria for operative management of thoracic adolescent idiopathic scoliosis (AIS) with hook and hybrid systems yields acceptable curve correction and balance parameters; however, it is unknown whether utilizing a purely pedicle screw strategy is effective. Utilizing the fulcrum bending radiographic (FBR) to assess curve flexibility to select fusion levels, the following study assessed the efficacy of pedicle screw fixation with alternate level screw strategy (ALSS) for thoracic AIS. Methods A retrospective study with prospective radiographic data collection/analyses (preoperative, postoperative 1-week and minimum 2-year follow-up) of 28 operative thoracic AIS patients undergoing ALSS was performed. Standing coronal/sagittal and FBR Cobb angles, FBR flexibility, fulcrum bending correction index (FBCI), trunkal shift, radiographic shoulder height (RSH), and list were assessed on x-rays. Fusion level selection was based on the Luk et al criteria and compared to conventional techniques. Results In the primary curve, the mean preoperative and postoperative 1 week and last follow-up standing coronal Cobb angles were 59.9, 17.2 and 20.0 degrees, respectively. Eighteen patients (64.3%) had distal levels saved (mean: 1.6 levels) in comparison to conventional techniques. Mean immediate and last follow-up FBCIs were 122.6% and 115.0%, respectively. Sagittal alignment did not statistically differ between any assessment intervals (p>0.05). A decrease in trunkal shift was noted from preoperative to last follow-up (p = 0.003). No statistically significant difference from preoperative to last follow-up was noted in RSH and list (p>0.05). No "add-on" of other vertebra or decompensation was noted and all patients achieved fusion. Conclusions This is the first report to note that using the FBR for decision-making in selecting fusion levels in thoracic AIS patients undergoing management with pedicle screw constructs (e.g. ALSS) is a cost-effective strategy that can achieve clinically-relevant deformity correction that is maintained and without compromising fusion levels.	[Samartzis, Dino; Leung, Yee; Shigematsu, Hideki; Natarajan, Deepa; Stokes, Oliver; Mak, Kin-Cheung; Yao, Guanfeng; Luk, Keith D. K.; Cheung, Kenneth M. C.] Univ Hong Kong, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Samartzis, D (corresponding author), Univ Hong Kong, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China.	dsamartzis@msn.com	; Leung, Victor Yu-Leong/C-4648-2009	Samartzis, Dino/0000-0002-7473-1311; Leung, Victor Yu-Leong/0000-0002-3406-7225; Cheung, Kenneth/0000-0001-8304-0419				Cheung KMC, 2014, J ORTHOP SURG-HONG K, V22, P248, DOI 10.1177/230949901402200229; Cheung KMC, 1997, J BONE JOINT SURG AM, V79A, P1144, DOI 10.2106/00004623-199708000-00005; Cheung WY, 2010, SPINE, V35, P557, DOI 10.1097/BRS.0b013e3181b9cfa9; COCHRAN T, 1983, SPINE, V8, P576, DOI 10.1097/00007632-198309000-00003; COLLIS DK, 1969, J BONE JOINT SURG AM, VA 51, P425, DOI 10.2106/00004623-196951030-00001; Di Silvestre M, 2008, EUR SPINE J, V17, P1336, DOI 10.1007/s00586-008-0731-9; DICKSON JH, 1990, J BONE JOINT SURG AM, V72A, P678, DOI 10.2106/00004623-199072050-00006; Dobbs MB, 2006, SPINE, V31, P2400, DOI 10.1097/01.brs.0000240212.31241.8e; DUVALBEAUPERE G, 1985, SPINE, V10, P428, DOI 10.1097/00007632-198506000-00005; EDGAR MA, 1988, J BONE JOINT SURG BR, V70, P712, DOI 10.1302/0301-620X.70B5.3192566; Goldstein L A, 1971, Clin Orthop Relat Res, V77, P32; GOLDSTEIN LA, 1973, CLIN ORTHOP RELAT R, P131, DOI 10.1097/00003086-197306000-00015; Hamzaoglu A, 2005, SPINE, V30, P1637, DOI 10.1097/01.brs.0000170580.92177.d2; Harrington P R, 1972, Orthop Clin North Am, V3, P49; HARRINGTON PR, 1962, J BONE JOINT SURG AM, V44, P591, DOI 10.2106/00004623-196244040-00001; Hee HT, 2007, SPINE, V32, P1533, DOI 10.1097/BRS.0b013e318067dc3d; Karatoprak O, 2008, INT ORTHOP, V32, P523, DOI 10.1007/s00264-007-0359-0; Kim YJ, 2006, SPINE, V31, P291, DOI 10.1097/01.brs.0000197865.20803.d4; Kim YJ, 2004, SPINE, V29, P2040, DOI 10.1097/01.brs.0000138268.12324.1a; KING HA, 1983, J BONE JOINT SURG AM, V65, P1302, DOI 10.2106/00004623-198365090-00012; KLEINMAN RG, 1982, CLIN ORTHOP RELAT R, P47; LARGE DF, 1991, J BONE JOINT SURG BR, V73, P121, DOI 10.1302/0301-620X.73B1.1991744; Lenke LG, 2001, J BONE JOINT SURG AM, V83A, P1169, DOI 10.2106/00004623-200108000-00006; Li JF, 2011, EUR SPINE J, V20, P105, DOI 10.1007/s00586-010-1495-6; Luk KDK, 2004, SPINE, V29, P560, DOI 10.1097/01.BRS.0000106494.14707.B2; Luk KDK, 1998, SPINE, V23, P2303, DOI 10.1097/00007632-199811010-00011; Luk KDK, 2008, SPINE, V33, P2192, DOI 10.1097/BRS.0b013e31817bd86a; MIELKE CH, 1989, J BONE JOINT SURG AM, V71A, P1170, DOI 10.2106/00004623-198971080-00008; Moe J H, 1972, Orthop Clin North Am, V3, P17; MOE JH, 1980, CLIN ORTHOP RELAT R, P137; MOE JH, 1958, J BONE JOINT SURG AM, V40, P529, DOI 10.2106/00004623-195840030-00005; Mok FPS, 2010, SPINE, V35, P1944, DOI 10.1097/BRS.0b013e3181d534f3; MORRISSY RT, 1990, J BONE JOINT SURG AM, V72A, P320, DOI 10.2106/00004623-199072030-00002; Quan GMY, 2010, SPINE, V35, P562, DOI 10.1097/BRS.0b013e3181b4af34; RISSER JC, 1964, J BONE JOINT SURG AM, V46, P167, DOI 10.2106/00004623-196446010-00020; Suk SI, 2005, SPINE, V30, P1602, DOI 10.1097/01.brs.0000169452.50705.61; Sun YQ, 2011, EUR SPINE J, V20, P144, DOI 10.1007/s00586-010-1534-3; WEINSTEIN SL, 1981, J BONE JOINT SURG AM, V63, P702, DOI 10.2106/00004623-198163050-00003; Yu Bin, 2004, Chinese Medical Sciences Journal, V19, P216	39	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0120302	10.1371/journal.pone.0120302	http://dx.doi.org/10.1371/journal.pone.0120302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270549	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492800001
J	Tonkin, JD; Sundermann, A; Jahnig, SC; Haase, P				Tonkin, Jonathan D.; Sundermann, Andrea; Jaehnig, Sonja C.; Haase, Peter			Environmental Controls on River Assemblages at the Regional Scale: An Application of the Elements of Metacommunity Structure Framework	PLOS ONE			English	Article							NETWORK STRUCTURE; SPECIES COOCCURRENCE; DISPERSAL MODE; BIODIVERSITY; DIVERSITY; COMMUNITY; PATTERNS; REGRESSION; GRADIENTS; DISTANCE	Understanding factors that structure regional biodiversity is important for linking ecological and biogeographic processes. Our objective was to explore regional patterns in riverine benthic invertebrate assemblages in relation to their broad positioning along the river network and examine differences in composition, biodiversity (alpha and beta diversity), and environmental drivers. We up-scaled methods used to examine patterns in metacommunity structure (Elements of Metacommunity Structure framework) to examine faunal distribution patterns at the regional extent for 168 low-mountain stream invertebrate assemblages in central Germany. We then identified the most influential environmental factors using boosted regression trees. Faunal composition patterns were compartmentalised (Clementsian or quasi-Clementsian), with little difference from headwaters to large rivers, potentially reflecting the regional scale of the study, by crossing major catchment boundaries and incorporating different species pools. While idealised structures did not vary, environmental drivers of composition varied considerably between river sections and with alpha diversity. Prediction was substantially weaker, and the importance of space was greater, in large rivers compared to other sections suggesting a weakening in species sorting downstream. Further, there was a stronger transition in composition than for alpha diversity downstream. The stronger links with regional faunal composition than with richness further emphasises the importance of considering the alternative ways in which anthropogenic stressors are operating to affect biodiversity patterns. Our approach allowed bridging the gap between local (or metacommunity) and regional scales, providing key insights into drivers of regional biodiversity patterns.	[Tonkin, Jonathan D.; Sundermann, Andrea; Haase, Peter] Senckenberg Res Inst, Dept River Ecol & Conservat, D-63571 Gelnhausen, Germany; [Tonkin, Jonathan D.; Sundermann, Andrea; Haase, Peter] Nat Hist Museum Frankfurt, D-63571 Gelnhausen, Germany; [Jaehnig, Sonja C.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecosyst Res, D-12587 Berlin, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Tonkin, JD (corresponding author), Senckenberg Res Inst, Dept River Ecol & Conservat, D-63571 Gelnhausen, Germany.	jdtonkin@gmail.com	Haase, Peter/A-5644-2011; Sundermann, Andrea/A-2938-2009; Jähnig, Sonja C/D-7126-2011; Tonkin, Jonathan D/J-4120-2013	Jähnig, Sonja C/0000-0002-6349-9561; Tonkin, Jonathan D/0000-0002-6053-291X; Sundermann, Andrea/0000-0003-2304-1967				Altermatt F, 2013, AQUAT ECOL, V47, P365, DOI 10.1007/s10452-013-9450-3; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Besemer K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1760; Boschilia SM, 2008, OECOLOGIA, V156, P203, DOI 10.1007/s00442-008-0983-4; BOSSARD M, 2000, CORINE LAND COVER TE; Brown BL, 2010, J ANIM ECOL, V79, P571, DOI 10.1111/j.1365-2656.2010.01668.x; Brown BL, 2011, J N AM BENTHOL SOC, V30, P310, DOI 10.1899/10-129.1; Buston PM, 2011, J ANIM ECOL, V80, P528, DOI 10.1111/j.1365-2656.2011.01803.x; Carrara F, 2012, P NATL ACAD SCI USA, V109, P5761, DOI 10.1073/pnas.1119651109; Chase JM, 2013, ECOL LETT, V16, P17, DOI 10.1111/ele.12112; Clarke A, 2008, FRESHWATER BIOL, V53, P1707, DOI 10.1111/j.1365-2427.2008.02041.x; Clements F. E., 1916, PLANT SUCCESSION ANA; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; Dallas T, 2014, ECOGRAPHY, V37, P402, DOI 10.1111/j.1600-0587.2013.00695.x; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; de la Sancha NU, 2014, DIVERS DISTRIB, V20, P1058, DOI 10.1111/ddi.12210; Diamond J.M., 1975, P342; Driscoll DA, 2009, ECOL MONOGR, V79, P485, DOI 10.1890/08-1114.1; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Eros T, 2014, HYDROBIOLOGIA, V722, P31, DOI 10.1007/s10750-013-1673-8; Finn DS, 2011, J N AM BENTHOL SOC, V30, P963, DOI 10.1899/11-012.1; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; GAUCH HG, 1977, J ECOL, V65, P157; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Gothe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072237; Gothe E, 2013, J ANIM ECOL, V82, P449, DOI 10.1111/1365-2656.12004; Grant EHC, 2007, ECOL LETT, V10, P165, DOI 10.1111/j.1461-0248.2006.01007.x; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; Gutierrez-Canovas C, 2013, GLOBAL ECOL BIOGEOGR, V22, P796, DOI 10.1111/geb.12060; Haase P, 2004, LIMNOLOGICA, V34, P349, DOI 10.1016/S0075-9511(04)80005-7; Haase P, 2006, INFORMATIONSTEXT OPE; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Heino J, 2005, ECOL ENTOMOL, V30, P590, DOI 10.1111/j.0307-6946.2005.00728.x; Heino J, 2008, ECOL ENTOMOL, V33, P614, DOI 10.1111/j.1365-2311.2008.01012.x; Heino J, 2015, FRESHWATER BIOL, V60, P973, DOI 10.1111/fwb.12556; Heino J, 2015, FRESHWATER BIOL, V60, P845, DOI 10.1111/fwb.12533; Heino J, 2015, J ANIM ECOL, V84, P427, DOI 10.1111/1365-2656.12287; Heino J, 2014, J BIOGEOGR, V41, P2234, DOI 10.1111/jbi.12369; Heino J, 2013, BIOL REV, V88, P166, DOI 10.1111/j.1469-185X.2012.00244.x; Heino J, 2012, OIKOS, V121, P537, DOI 10.1111/j.1600-0706.2011.19715.x; Henriques-Silva R, 2013, ECOLOGY, V94, P627, DOI 10.1890/12-0683.1; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hoopes MF, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P35; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jacobson B, 2010, LANDSCAPE ECOL, V25, P495, DOI 10.1007/s10980-009-9442-9; Keith SA, 2011, OIKOS, V120, P302, DOI 10.1111/j.1600-0706.2010.18775.x; Larsen S, 2014, GLOBAL CHANGE BIOL, V20, P51, DOI 10.1111/gcb.12355; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2002, OIKOS, V97, P237, DOI 10.1034/j.1600-0706.2002.970210.x; Leps M, 2015, SCI TOTAL ENVIRON, V536, P546, DOI 10.1016/j.scitotenv.2015.07.083; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Matias MG, 2013, OIKOS, V122, P395, DOI 10.1111/j.1600-0706.2012.20479.x; Meynard CN, 2013, J BIOGEOGR, V40, P1560, DOI 10.1111/jbi.12116; Morisita M., 1971, Researches Popul Ecol Kyoto Univ, V13, P1, DOI 10.1007/BF02522010; Oksanen J., 2020, VEGAN COMMUNITY ECOL; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Presley SJ, 2010, OIKOS, V119, P908, DOI 10.1111/j.1600-0706.2010.18544.x; Presley SJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P185, DOI 10.1111/j.1466-8238.2009.00505.x; Presley SJ, 2009, OECOLOGIA, V160, P781, DOI 10.1007/s00442-009-1341-x; R Core Team, 2021, R LANGUAGE ENV STAT; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stoll S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084741; Sundermann A, 2013, ECOL INDIC, V27, P83, DOI 10.1016/j.ecolind.2012.12.003; Swan CM, 2014, ECOGRAPHY, V37, P993, DOI 10.1111/ecog.00496; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Tonkin J.D., 2015, PEERJ PREPRINTS, V3, pe1261, DOI DOI 10.7287/PEERJ.PREPRINTS.1026V1; Tonkin JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123250; Tonkin JD, 2014, FRESHWATER BIOL, V59, P1843, DOI 10.1111/fwb.12387; Tonkin JD, 2013, FUND APPL LIMNOL, V182, P283, DOI 10.1127/1863-9135/2013/0402; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Willig MR, 2011, OIKOS, V120, P1497, DOI 10.1111/j.1600-0706.2011.19218.x; Wright DH, 1998, OECOLOGIA, V113, P1, DOI 10.1007/s004420050348	76	28	28	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135450	10.1371/journal.pone.0135450	http://dx.doi.org/10.1371/journal.pone.0135450			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270550	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800073
J	Vitorino, M; Silva, AC; Inacio, JM; Ramalho, JS; Gur, M; Fainsod, A; Steinbeisser, H; Belo, JA				Vitorino, Marta; Silva, Ana Cristina; Inacio, Jose Manuel; Ramalho, Jose Silva; Gur, Michal; Fainsod, Abraham; Steinbeisser, Herbert; Belo, Jose Antonio			Xenopus Pkdcc1 and Pkdcc2 Are Two New Tyrosine Kinases Involved in the Regulation of JNK Dependent Wnt/PCP Signaling Pathway	PLOS ONE			English	Article							PLANAR CELL POLARITY; NEURAL-TUBE CLOSURE; ANTERIOR PRIMITIVE ENDODERM; CONVERGENT EXTENSION; VERTEBRATE GASTRULATION; APICAL CONSTRICTION; SECRETED FACTOR; PCP PATHWAY; WNT; PROTEIN	Protein Kinase Domain Containing, Cytoplasmic (PKDCC) is a protein kinase which has been implicated in longitudinal bone growth through regulation of chondrocytes formation. Nevertheless, the mechanism by which this occurs remains unknown. Here, we identified two new members of the PKDCC family, Pkdcc1 and Pkdcc2 from Xenopus laevis. Interestingly, our knockdown experiments revealed that these two proteins are both involved on blastopore and neural tube closure during gastrula and neurula stages, respectively. In vertebrates, tissue polarity and cell movement observed during gastrulation and neural tube closure are controlled by Wnt/Planar Cell Polarity (PCP) molecular pathway. Our results showed that Pkdcc1 and Pkdcc2 promote the recruitment of Dvl to the plasma membrane. But surprisingly, they revealed different roles in the induction of a luciferase reporter under the control of Atf2 promoter. While Pkdcc1 induces Atf2 expression, Pkdcc2 does not, and furthermore inhibits its normal induction by Wnt11 and Wnt5a. Altogether our data show, for the first time, that members of the PKDCC family are involved in the regulation of JNK dependent Wnt/PCP signaling pathway.	[Vitorino, Marta; Inacio, Jose Manuel; Belo, Jose Antonio] Univ Algarve, Dept Ciencias Biomed & Med, Regenerat Med Program, Faro, Portugal; [Vitorino, Marta; Silva, Ana Cristina; Inacio, Jose Manuel; Belo, Jose Antonio] Univ Algarve, Ctr Biomed Res CBMR, Faro, Portugal; [Gur, Michal; Fainsod, Abraham] Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [Steinbeisser, Herbert] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; [Inacio, Jose Manuel; Ramalho, Jose Silva; Belo, Jose Antonio] Univ Nova Lisboa, Fac Ciencias Med, NOVA Med Sch, CEDOC, P-1200 Lisbon, Portugal	Universidade do Algarve; Universidade do Algarve; Hebrew University of Jerusalem; Ruprecht Karls University Heidelberg; Universidade Nova de Lisboa	Belo, JA (corresponding author), Univ Algarve, Dept Ciencias Biomed & Med, Regenerat Med Program, Faro, Portugal.	jose.belo@fcm.unl.pt	Vitorino, Marta/U-9947-2018; Inacio, Jose M/O-1455-2018; Belo, José A. A/F-4444-2012; Ramalho, Jose/M-6415-2015; Fainsod, Abraham/AAE-5633-2019	Vitorino, Marta/0000-0001-8563-8975; Inacio, Jose M/0000-0002-9790-8335; Belo, José A. A/0000-0001-7384-0949; Ramalho, Jose/0000-0002-1927-164X; 	Fundacao Ciencia e Tecnologia - IP; IBB/CBME, LA [PTDC/BIA-BCM/69912/2006, Pest-OE/EQB/LA0023/2013]; FCT; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/69912/2006, Incentivo/EQB/LA0023/2013] Funding Source: FCT	Fundacao Ciencia e Tecnologia - IP; IBB/CBME, LA; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by research grants from the Fundacao Ciencia e Tecnologia - IP (http://www.fct.pt/index.phtml.pt), and from IBB/CBME, LA to J. A. Belo in the frame of Projects ref degrees PTDC/BIA-BCM/69912/2006 and Pest-OE/EQB/LA0023/2013. M. Vitorino, A. C. Silva and J. M. Inacio are recipients of FCT post-doc fellowships.	ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Cai CQ, 2014, FRONT MED-PRC, V8, P68, DOI 10.1007/s11684-014-0308-4; Choi SC, 2009, DEV BIOL, V336, P68, DOI 10.1016/j.ydbio.2009.09.033; Copp AJ, 2003, TRENDS NEUROSCI, V26, P453, DOI 10.1016/S0166-2236(03)00212-1; Doudney K, 2005, AM J MED GENET A, V136A, P90, DOI 10.1002/ajmg.a.30766; DRYSDALE TA, 1994, DEV BIOL, V165, P432, DOI 10.1006/dbio.1994.1265; Epstein M, 1997, DEVELOPMENT, V124, P3805; Gao B, 2012, CURR TOP DEV BIOL, V101, P263, DOI 10.1016/B978-0-12-394592-1.00008-9; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Goncalves L, 2011, INT J DEV BIOL, V55, P281, DOI 10.1387/ijdb.103273lg; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Imuta Y, 2009, DEV DYNAM, V238, P210, DOI 10.1002/dvdy.21822; Itoh K, 2000, MOL CELL BIOL, V20, P2228, DOI 10.1128/MCB.20.6.2228-2238.2000; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Kibar Z, 2001, GENOMICS, V72, P331, DOI 10.1006/geno.2000.6493; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kinoshita M, 2009, DEVELOPMENT, V136, P2069, DOI 10.1242/dev.026435; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kumburegama S, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-2; Kurth T, 2000, MECH DEVELOP, V97, P117, DOI 10.1016/S0925-4773(00)00428-7; Lapebie P, 2011, BIOESSAYS, V33, P759, DOI 10.1002/bies.201100023; Lee JY, 2012, WIRES DEV BIOL, V1, P286, DOI 10.1002/wdev.19; Lopes VS, 2007, TRAFFIC, V8, P486, DOI 10.1111/j.1600-0854.2007.00548.x; Lustig KD, 1996, DEVELOPMENT, V122, P4001; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.0.CO;2-9; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Morita H, 2010, DEVELOPMENT, V137, P1315, DOI 10.1242/dev.043190; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Nieuwkoop PD, 1967, NORMAL TABLE OF XENO; Ohkawara B, 2011, DEV DYNAM, V240, P188, DOI 10.1002/dvdy.22500; PANNESE M, 1995, DEVELOPMENT, V121, P707; Perestrelo AR, 2016, J TISSUE ENG REGEN M, V10, pE475, DOI 10.1002/term.1838; Poliakov A, 2006, NAT CELL BIOL, V8, P7, DOI 10.1038/ncb0106-7; Probst S, 2013, DIFFERENTIATION, V85, P121, DOI 10.1016/j.diff.2013.03.002; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Silva AC, 2011, DEV GENES EVOL, V221, P29, DOI 10.1007/s00427-011-0357-5; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Sive H, 2000, EARLY DEVELOPMENT OF; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wansleeben C, 2011, DEV DYNAM, V240, P616, DOI 10.1002/dvdy.22564; Wu J, 2009, TRENDS CELL BIOL, V19, P295, DOI 10.1016/j.tcb.2009.04.003; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087	69	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135504	10.1371/journal.pone.0135504	http://dx.doi.org/10.1371/journal.pone.0135504			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270962	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800085
J	Coetzer, WG; Downs, CT; Perrin, MR; Willows-Munro, S				Coetzer, Willem G.; Downs, Colleen T.; Perrin, Mike R.; Willows-Munro, Sandi			Molecular Systematics of the Cape Parrot (Poicephalus robustus): Implications for Taxonomy and Conservation	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; FUSCICOLLIS-SUAHELICUS; GREYHEADED PARROT; GENETIC-STRUCTURE; BREEDING BIOLOGY; PSITTACIFORMES; BIOGEOGRAPHY; AVES; PSITTACIDAE; EVOLUTIONARY	The taxonomic position of the Cape Parrot (Poicephalus robustus robustus) has been the focus of much debate. A number of authors suggest that the Cape Parrot should be viewed as a distinct species separate from the other two P. robustus subspecies (P. r. fuscicollis and P. r. suahelicus). These recommendations were based on morphological, ecological, and behavioural assessments. In this study we investigated the validity of these recommendations using multilocus DNA analyses. We genotyped 138 specimens from five Poicephalus species (P. cryptoxanthus, P. gulielmi, P. meyeri, P. robustus, and P. rueppellii) using 11 microsatellite loci. Additionally, two mitochondrial (cytochrome oxidase I gene and 16S ribosomal RNA) and one nuclear intron (intron 7 of the beta-fibrinogen gene) markers were amplified and sequenced. Bayesian clustering analysis and pairwise F-ST analysis of microsatellite data identified P. r. robustus as genetically distinct from the other P. robustus subspecies. Phylogenetic and molecular clock analyses on sequence data also supported the microsatellite analyses, placing P. r. robustus in a distinct clade separate from the other P. robustus subspecies. Molecular clock analysis places the most recent common ancestor between P. r. robustus and P. r. fuscicollis / P. r. suahelicus at 2.13 to 2.67 million years ago. Our results all support previous recommendations to elevate the Cape Parrot to species level. This will facilitate better planning and implementation of international and local conservation management strategies for the Cape Parrot.	[Coetzer, Willem G.; Downs, Colleen T.; Perrin, Mike R.; Willows-Munro, Sandi] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa	University of Kwazulu Natal	Willows-Munro, S (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa.	willows-munro@ukzn.ac.za	Coetzer, Willem/U-4793-2017; Downs, Colleen T./A-7770-2010	Coetzer, Willem/0000-0003-2189-5539; Downs, Colleen T./0000-0001-8334-1510; Willows-Munro, Sandi/0000-0003-0572-369X	South African National Biodiversity Institute (SANBI)	South African National Biodiversity Institute (SANBI)	South African National Biodiversity Institute (SANBI) provided funding for the running expenses of the project (SWM and MRP). A National Research Foundation Scarce Skills grant, as well as a College of Agriculture, Engineering and Science, University of KwaZulu-Natal Doctoral research grant, was awarded to WGC.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AMERICAN ORNITHOLOGISTS' UNION, 1998, CHECKL N AM BIRDS; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BARROWCLOUGH GF, 1980, AUK, V97, P655; BirdLife International, 2012, POIC ROB; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Brandstrom M, 2008, GENOME RES, V18, P881, DOI 10.1101/gr.075242.107; Calderon L, 2014, MOL PHYLOGENET EVOL, V72, P42, DOI 10.1016/j.ympev.2013.12.011; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Clancey P.A., 1997, Honeyguide, V43, P61; Cracraft J., 1983, Current Ornithology, V1, P159; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Downs CT, 2014, OSTRICH, V85, P273, DOI 10.2989/00306525.2014.959088; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Earl DA, 2009, STRUCTURE HARVESTER; Eberhard JR, 2005, MOL PHYLOGENET EVOL, V36, P288, DOI 10.1016/j.ympev.2005.01.022; Eberhard JR, 2004, AUK, V121, P318, DOI 10.1642/0004-8038(2004)121[0318:PABOTA]2.0.CO;2; Eldredge N., 1980, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faria PJ, 2008, BIODIVERS CONSERV, V17, P765, DOI 10.1007/s10531-007-9312-1; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Forshaw J.M., 1978, PARROTS WORLD; Forshaw Joseph, 2010, P15; Fry CH., 1988, BIRDS AFRICA, V3; Gippoliti S, 2007, FOLIA ZOOL, V56, P113; Gmelin JF, 1788, SYSTEMA NATURAE, P334; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hazevoet C. J., 1996, Bird Conservation International, V6, P181; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Juniper T, 1998, PARROTS GUIDE PARROT; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kupper C, 2009, AUK, V126, P839, DOI 10.1525/auk.2009.08174; Kuhl, 1820, NOVA ACTA ACAD CAESA, P93; Kundu S, 2012, MOL PHYLOGENET EVOL, V62, P296, DOI 10.1016/j.ympev.2011.09.025; LAWES MJ, 1990, J BIOGEOGR, V17, P669, DOI 10.2307/2845148; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Manegold A, 2013, IBIS, V155, P127, DOI 10.1111/ibi.12009; Masello Juan F, 2011, Front Zool, V8, P16, DOI 10.1186/1742-9994-8-16; Massa R, 2000, ITAL J ZOOL, V67, P313, DOI 10.1080/11250000009356330; Mayr E., 1942, P1; MAYR E, 1982, AUK, V99, P593; MISHLER BD, 1985, BRYOLOGIST, V88, P207, DOI 10.2307/3243030; MOREAU R. E., 1963, PROC ZOOL SOC LONDON, V141, P395; Nelson G., 1981, SYSTEMATICS BIOGEOGR; Palumbi S.R, 1991, SIMPLE FOOLS GUIDE P; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrin MR, 2005, OSTRICH, V76, P195; Perrin MR, 2012, PARROTS AFRICA MEDAG; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Pillay K, 2010, MOL ECOL RESOUR, V10, P142, DOI 10.1111/j.1755-0998.2009.02673.x; Pritchard JK, 2013, STRUCTURE; Prychitko TM, 1997, MOL PHYLOGENET EVOL, V8, P193, DOI 10.1006/mpev.1997.0420; Rambaut A, 2014, FIGTREE V1 4 0 2012; Rambaut A, 2014, MOL EVOLUTION PHYLOG; Reichenow ANT, 1898, J ORNITHOL, V46, P314; Rheindt FE, 2014, J AVIAN BIOL, V45, P140, DOI 10.1111/j.1600-048X.2013.00200.x; Rheindt FE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026995; Rocha AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108096; Russello MA, 2010, CONSERV GENET, V11, P1809, DOI 10.1007/s10592-010-0074-z; Saunders DA, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou001; Schweizer M, 2011, J BIOGEOGR, V38, P2176, DOI 10.1111/j.1365-2699.2011.02555.x; Sibley CG, 1990, DISTRIBUTION TAXONOM; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Snow DW, 1978, ATLAS SPECIATION AFR; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Symes Craig T., 2004, Durban Museum Novitates, V29, P5; Symes CT, 2004, EMU, V104, P45, DOI 10.1071/MU01062; Symes CT, 2003, EMU, V103, P49, DOI 10.1071/MU01038; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavares ES, 2006, SYST BIOL, V55, P454, DOI 10.1080/10635150600697390; Taylor M., 2014, ESKOM RED DATA BOOK; Taylor TD, 2011, OSTRICH, V82, P65, DOI 10.2989/00306525.2010.538445; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vilaca ST, 2010, MOL PHYLOGENET EVOL, V57, P585, DOI 10.1016/j.ympev.2010.07.010; Wenner TJ, 2012, CONSERV GENET, V13, P1427, DOI 10.1007/s10592-012-0364-8; White NE, 2011, MOL PHYLOGENET EVOL, V59, P615, DOI 10.1016/j.ympev.2011.03.011; Wirminghaus J. Olaf, 2000, Durban Museum Novitates, V25, P12; Wirminghaus JO, 2002, J NAT HIST, V36, P361, DOI 10.1080/00222930010004250; Wirminghaus JO, 2002, OSTRICH, V73, P20, DOI 10.2989/00306520209485347; Wirminghaus JO, 2001, OSTRICH, V72, P159, DOI 10.2989/00306520109485310; Wirminghaus JO, 1999, S AFR J WILDL RES, V29, P118; XLSTAT, 2014, XLSTAT VERS 2014 1 0; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617; Zwickl D. J, 2006, GENETIC ALGORITHM AP	92	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133376	10.1371/journal.pone.0133376	http://dx.doi.org/10.1371/journal.pone.0133376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267261	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300015
J	Seely, B; Welham, C; Scoullar, K				Seely, Brad; Welham, Clive; Scoullar, Kim			Application of a Hybrid Forest Growth Model to Evaluate Climate Change Impacts on Productivity, Nutrient Cycling and Mortality in a Montane Forest Ecosystem	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; WATER-USE EFFICIENCY; DOUGLAS-FIR; TREE MORTALITY; LODGEPOLE PINE; LITTER DECOMPOSITION; PRIESTLEY-TAYLOR; ATMOSPHERIC CO2; ELEVATED CO2; RISING CO2	Climate change introduces considerable uncertainty in forest management planning and outcomes, potentially undermining efforts at achieving sustainable practices. Here, we describe the development and application of the FORECAST Climate model. Constructed using a hybrid simulation approach, the model includes an explicit representation of the effect of temperature and moisture availability on tree growth and survival, litter decomposition, and nutrient cycling. The model also includes a representation of the impact of increasing atmospheric CO2 on water use efficiency, but no direct CO2 fertilization effect. FORECAST Climate was evaluated for its ability to reproduce the effects of historical climate on Douglas-fir and lodge-pole pine growth in a montane forest in southern British Columbia, Canada, as measured using tree ring analysis. The model was subsequently used to project the long-term impacts of alternative future climate change scenarios on forest productivity in young and established stands. There was a close association between predicted sapwood production and measured tree ring chronologies, providing confidence that model is able to predict the relative impact of annual climate variability on tree productivity. Simulations of future climate change suggest a modest increase in productivity in young stands of both species related to an increase in growing season length. In contrast, results showed a negative impact on stem wood biomass production (particularly in the case of lodgepole pine) for established stands due to increased moisture stress mortality.	[Seely, Brad; Welham, Clive] Univ British Columbia, Dept Forest Resources Management, Vancouver, BC V5Z 1M9, Canada; [Scoullar, Kim] Life Sci Programming Inc, Naramata, BC, Canada	University of British Columbia	Seely, B (corresponding author), Univ British Columbia, Dept Forest Resources Management, Vancouver, BC V5Z 1M9, Canada.	brad.seely@ubc.ca			Future Forest Ecosystems Scientific Council (FFESC) of British Columbia; Cumulative Environmental Management Association (CEMA) of Alberta, Canada; Alberta Environment; Life Sciences Programming	Future Forest Ecosystems Scientific Council (FFESC) of British Columbia; Cumulative Environmental Management Association (CEMA) of Alberta, Canada; Alberta Environment; Life Sciences Programming	This study was supported by the Future Forest Ecosystems Scientific Council (FFESC) of British Columbia (https://www.for.gov.bc.ca/hfp/future_forests/council/index.htm) (to BS), Cumulative Environmental Management Association (CEMA) of Alberta, Canada (http://www.cemaonline.ca/index.php/about-us) (to CW), Alberta Environment (http://esrd.alberta.ca/) (to CW), Life Sciences Programming (to KS). Other than Life Sciences Programming, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Life Sciences Programming, on the other hand, provided support in the form of salaries for author KS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anchukaitis KJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025050; Andrews SF, 2012, TREE PHYSIOL, V32, P146, DOI 10.1093/treephys/tpr136; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Barron-Gafford GA, 2012, GLOBAL CHANGE BIOL, V18, P1389, DOI 10.1111/j.1365-2486.2011.02599.x; Battaglia M, 2004, FOREST ECOL MANAG, V193, P251, DOI 10.1016/j.foreco.2004.01.033; Battipaglia G, 2013, NEW PHYTOL, V197, P544, DOI 10.1111/nph.12044; Bi J, 2007, CAN J FOREST RES, V37, P1615, DOI 10.1139/X07-018; Blanco JA, 2007, CAN J FOREST RES, V37, P1808, DOI 10.1139/X07-041; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; Bond-Lamberty B, 2007, NATURE, V450, P89, DOI 10.1038/nature06272; Case MJ, 2007, NORTHWEST SCI, V81, P62, DOI 10.3955/0029-344X-81.1.62; Case MJ, 2005, CAN J FOREST RES, V35, P2743, DOI 10.1139/X05-191; Chung H, 2013, J PLANT RES, V126, P447, DOI 10.1007/s10265-013-0565-3; Coops NC, 2011, CLIMATIC CHANGE, V105, P313, DOI 10.1007/s10584-010-9861-2; Crookston NL, 2010, FOREST ECOL MANAG, V260, P1198, DOI 10.1016/j.foreco.2010.07.013; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Daniels LD, 2011, CAN J PLANT PATHOL, V33, P108, DOI 10.1080/07060661.2011.563906; Dordel J, 2011, ECOL MODEL, V222, P3226, DOI 10.1016/j.ecolmodel.2011.05.027; DYKSTRA G F, 1974, Canadian Journal of Forest Research, V4, P201, DOI 10.1139/x74-030; EAMUS D, 1989, ADV ECOL RES, V19, P1; Edenhofer O., 2014, CONTRIBUTION WORKING; FLINT AL, 1991, AGR FOREST METEOROL, V56, P247, DOI 10.1016/0168-1923(91)90094-7; Franks PJ, 2013, NEW PHYTOL, V197, P1077, DOI 10.1111/nph.12104; Fritts H.C., 1976, TREE RINGS AND CLIMA; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Girardin MP, 2008, ECOL MODEL, V213, P209, DOI 10.1016/j.ecolmodel.2007.12.010; Girardin MP, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001287; Grant RF, 2006, ECOL MODEL, V196, P289, DOI 10.1016/j.ecolmodel.2006.02.035; Green DS, CAN J FOR RES, V40, P308; HADLEY KS, 1993, CAN J FOREST RES, V23, P479, DOI 10.1139/x93-066; Hogg EH, 2013, AGR FOREST METEOROL, V178, P173, DOI 10.1016/j.agrformet.2013.04.025; Hogg EH, 2008, CAN J FOREST RES, V38, P1373, DOI 10.1139/X08-001; Hua C., 2001, ACTA ECOL SIN, V21, P1549; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Kimmins J.P., 2010, FORECASTING FOREST F; Kimmins JP, 1999, ECOL MODEL, V122, P195, DOI 10.1016/S0304-3800(99)00138-6; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; Krusic PJ, 2005, ARSTAN V 41D A TREE; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Landsberg JJ, 1997, FOREST ECOL MANAG, V95, P209, DOI 10.1016/S0378-1127(97)00026-1; Lara W, AGR FOR METEOROL, V178-179, P140; Lewis JD, 2001, PLANT CELL ENVIRON, V24, P539, DOI 10.1046/j.1365-3040.2001.00700.x; Littell JS, 2008, ECOL MONOGR, V78, P349, DOI 10.1890/07-0712.1; MACKINNON A, 1992, FOREST CHRON, V68, P100, DOI 10.5558/tfc68100-1; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McMahon SM, 2010, P NATL ACAD SCI USA, V107, pE88, DOI 10.1073/pnas.1003726107; Medlyn BE, 2011, WIRES CLIM CHANGE, V2, P332, DOI 10.1002/wcc.108; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Melillo JM, 2011, P NATL ACAD SCI USA, V108, P9508, DOI 10.1073/pnas.1018189108; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Monserud RA, 2008, CAN J FOREST RES, V38, P343, DOI 10.1139/X07-166; Nelson H, 2011, FINAL REPORT; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Norby RJ, 1999, PLANT CELL ENVIRON, V22, P683, DOI 10.1046/j.1365-3040.1999.00391.x; O'Grady AP, 2013, NEW PHYTOL, V200, P294, DOI 10.1111/nph.12451; Pederson GT, 2006, EARTH INTERACT, V10; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Powell TL, 2013, NEW PHYTOL, V200, P350, DOI 10.1111/nph.12390; Prescott CE, 2004, BC J ECOSYS MANAGE, V5, P30; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Quillet A, 2010, ENVIRON REV, V18, P333, DOI 10.1139/A10-016; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Rao LY, 2011, T ASABE, V54, P2067, DOI 10.13031/2013.40666; Seely B, 2008, FOREST CHRON, V84, P181, DOI 10.5558/tfc84181-2; Seely B, 1999, J FOREST, V97, P4; Seely B, 1997, P EMP PROC BAS MOD F, P463; Seely B, 2010, ECOL INDIC, V10, P999, DOI 10.1016/j.ecolind.2010.02.008; Silva LCR, 2013, GLOBAL ECOL BIOGEOGR, V22, P83, DOI 10.1111/j.1466-8238.2012.00783.x; Silva LCR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011543; Smiley T, 1968, AN INTRODUCTION TO T; Spittlehouse D., 2003, ADAPTATION CLIMATE C, DOI DOI 10.1186/S40663-016-0082-7; SPITTLEHOUSE DL, 1981, WATER RESOUR RES, V17, P1651, DOI 10.1029/WR017i006p01651; STAGNITTI F, 1989, HYDROL PROCESS, V3, P137, DOI 10.1002/hyp.3360030204; Sumner DM, 2005, J HYDROL, V308, P81, DOI 10.1016/j.jhydrol.2004.10.023; Titus BD, 2006, FOREST CHRON, V82, P844, DOI 10.5558/tfc82844-6; Trofymow JA, 2002, CAN J FOREST RES, V32, P789, DOI 10.1139/X01-117; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Wang WF, 2012, ENVIRON REV, V20, P109, DOI [10.1139/A2012-004, 10.1139/a2012-004]; Warren JM, 2005, AGR FOREST METEOROL, V130, P39, DOI 10.1016/j.agrformet.2005.01.004; Xu CG, 2013, NEW PHYTOL, V200, P298, DOI 10.1111/nph.12450; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590; Zhou GY, 2008, PLANT SOIL, V311, P61, DOI 10.1007/s11104-008-9658-5	85	23	23	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135034	10.1371/journal.pone.0135034	http://dx.doi.org/10.1371/journal.pone.0135034			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267446	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492300072
J	Wolf, M; Krause, J; Carney, PA; Bogart, A; Kurvers, RHJM				Wolf, Max; Krause, Jens; Carney, Patricia A.; Bogart, Andy; Kurvers, Ralf H. J. M.			Collective Intelligence Meets Medical Decision-Making: The Collective Outperforms the Best Radiologist	PLOS ONE			English	Article							GROUP-PERFORMANCE; CANCER-DETECTION; ACCURACY; MAMMOGRAMS; CONFIDENCE; PREDICTION	While collective intelligence (CI) is a powerful approach to increase decision accuracy, few attempts have been made to unlock its potential in medical decision-making. Here we investigated the performance of three well-known collective intelligence rules ("majority", "quorum", and "weighted quorum") when applied to mammography screening. For any particular mammogram, these rules aggregate the independent assessments of multiple radiologists into a single decision (recall the patient for additional workup or not). We found that, compared to single radiologists, any of these CI-rules both increases true positives (i.e., recalls of patients with cancer) and decreases false positives (i.e., recalls of patients without cancer), thereby overcoming one of the fundamental limitations to decision accuracy that individual radiologists face. Importantly, we find that all CI-rules systematically outperform even the best-performing individual radiologist in the respective group. Our findings demonstrate that CI can be employed to improve mammography screening; similarly, CI may have the potential to improve medical decision-making in a much wider range of contexts, including many areas of diagnostic imaging and, more generally, diagnostic decisions that are based on the subjective interpretation of evidence.	[Wolf, Max; Krause, Jens; Kurvers, Ralf H. J. M.] Leibniz Inst Freshwater Ecol & Inland Fisheries, D-12587 Berlin, Germany; [Carney, Patricia A.] Oregon Hlth & Sci Univ, Dept Family Med, Knight Canc Inst, Portland, OR 97201 USA; [Carney, Patricia A.] Oregon Hlth & Sci Univ, Dept Pubic Hlth & Prevent Med, Knight Canc Inst, Portland, OR 97201 USA; [Bogart, Andy] RAND Corp, Santa Monica, CA 90407 USA; [Krause, Jens] Humboldt Univ, Fac Life Sci, D-10099 Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Oregon Health & Science University; Oregon Health & Science University; RAND Corporation; Humboldt University of Berlin	Wolf, M (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Muggelseedamm 310, D-12587 Berlin, Germany.	m.wolf@igb-berlin.de	Kurvers, Ralf/Q-8830-2017	Kurvers, Ralf/0000-0002-3460-0392	B-Types project through Leibniz Competition [SAW-2013-IGB-2]; American Cancer Society [SIRSG-07-271, SIRSG-07-272, SIRSG-07-273, SIRSG-07-274-01, SIRSG-07-275, SIRSG-06-281, SIRSG-09-270-01, SIRSG-09-271-01, SIRSG-06-290-04]; Breast Cancer Stamp Fund; National Cancer Institute Breast Cancer Surveillance Consortium [U01CA63740, U01CA86076, U01CA86082, U01CA70013, U01CA69976, U01CA63731, U01CA70040, HHSN261201100031C]; NATIONAL CANCER INSTITUTE [U01CA063731, U01CA070040, U01CA069976, U01CA086076, U01CA070013, U01CA086082, U01CA063740] Funding Source: NIH RePORTER	B-Types project through Leibniz Competition; American Cancer Society(American Cancer Society); Breast Cancer Stamp Fund; National Cancer Institute Breast Cancer Surveillance Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the B-Types project, funded through the Leibniz Competition (SAW-2013-IGB-2); by the American Cancer Society using a donation from the Longaberger Company's Horizon of Hope Campaign (SIRSG-07-271, SIRSG-07-272, SIRSG-07-273, SIRSG-07-274-01, SIRSG-07-275, SIRSG-06-281, SIRSG-09-270-01, SIRSG-09-271-01, SIRSG-06-290-04); by the Breast Cancer Stamp Fund; and by the National Cancer Institute Breast Cancer Surveillance Consortium (U01CA63740, U01CA86076, U01CA86082, U01CA70013, U01CA69976, U01CA63731, U01CA70040, HHSN261201100031C). The collection of cancer and vital status data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. For a full description of these sources, please see www.breastscreening.cancer.gov/work/acknowledgement.html.	Arrow KJ, 2008, SCIENCE, V320, P877, DOI 10.1126/science.1157679; Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Bankier AA, 2010, RADIOLOGY, V257, P14, DOI 10.1148/radiol.10100252; Barr S, 2014, J EXP PSYCHOL HUMAN, V40, P2124, DOI 10.1037/a0038224; Berdahl A, 2013, SCIENCE, V339, P574, DOI 10.1126/science.1225883; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Carney PA, 2013, ACAD RADIOL, V20, P1389, DOI 10.1016/j.acra.2013.08.017; Carney PA, 2012, AM J ROENTGENOL, V198, P970, DOI 10.2214/AJR.11.6988; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Dinnes J, 2001, BREAST, V10, P455, DOI 10.1054/brst.2001.0350; Dromain C, 2013, EUR J RADIOL, V82, P417, DOI 10.1016/j.ejrad.2012.03.005; Eckstein MP, 2012, NEUROIMAGE, V59, P94, DOI 10.1016/j.neuroimage.2011.07.009; FERRELL WR, 1989, INVEST RADIOL, V24, P456, DOI 10.1097/00004424-198906000-00008; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Geller BM, 2014, AM J ROENTGENOL, V202, pW586, DOI 10.2214/AJR.13.11147; Geller BM, 2012, AM J ROENTGENOL, V199, pW134, DOI 10.2214/AJR.11.7701; Giordano L, 2012, J MED SCREEN, V19, P72, DOI 10.1258/jms.2012.012085; GROFMAN B, 1983, THEOR DECIS, V15, P261, DOI 10.1007/BF00125672; Gromet M, 2008, AM J ROENTGENOL, V190, P854, DOI 10.2214/AJR.07.2812; Harvey SC, 2003, AM J ROENTGENOL, V180, P1461, DOI 10.2214/ajr.180.5.1801461; Hastie R, 2005, PSYCHOL REV, V112, P494, DOI 10.1037/0033-295X.112.2.494; Helvie M, 2007, RADIOL CLIN N AM, V45, P801, DOI 10.1016/j.rcl.2007.06.004; Katsikopoulos KV, 2006, J MATH PSYCHOL, V50, P488, DOI 10.1016/j.jmp.2006.06.001; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; Kurvers RHJM, 2014, BEHAV ECOL SOCIOBIOL, V68, P449, DOI 10.1007/s00265-013-1659-6; Landman BA, 2012, NEUROIMAGE, V59, P530, DOI 10.1016/j.neuroimage.2011.07.085; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; METZ CE, 1992, MED DECIS MAKING, V12, P60, DOI 10.1177/0272989X9201200110; Onega T, 2013, ACAD RADIOL, V20, P731, DOI 10.1016/j.acra.2013.01.012; Ross-Gillespie A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00054; Shaw CM, 2009, RADIOLOGY, V250, P354, DOI 10.1148/radiol.2502080224; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sorkin RD, 2001, PSYCHOL REV, V108, P183, DOI 10.1037//0033-295X.108.1.183; Sorkin RD, 1998, PSYCHOL SCI, V9, P456, DOI 10.1111/1467-9280.00085; Surowiecki J., 2005, WISDOM CROWDS; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; Wolf M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2777; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147	41	64	64	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134269	10.1371/journal.pone.0134269	http://dx.doi.org/10.1371/journal.pone.0134269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267331	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300038
J	Abdelhamid, SHE; Kuhlman, CJ; Marathe, MV; Mortveit, HS; Ravi, SS				Abdelhamid, Sherif H. Elmeligy; Kuhlman, Chris J.; Marathe, Madhav V.; Mortveit, Henning S.; Ravi, S. S.			GDSCalc: A Web-Based Application for Evaluating Discrete Graph Dynamical Systems	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; SIMULATION; MODELS; AUTOMATA	Discrete dynamical systems are used to model various realistic systems in network science, from social unrest in human populations to regulation in biological networks. A common approach is to model the agents of a system as vertices of a graph, and the pairwise interactions between agents as edges. Agents are in one of a finite set of states at each discrete time step and are assigned functions that describe how their states change based on neighborhood relations. Full characterization of state transitions of one system can give insights into fundamental behaviors of other dynamical systems. In this paper, we describe a discrete graph dynamical systems (GDSs) application called GDSCalc for computing and characterizing system dynamics. It is an open access system that is used through a web interface. We provide an overview of GDS theory. This theory is the basis of the web application; i.e., an understanding of GDS provides an understanding of the software features, while abstracting away implementation details. We present a set of illustrative examples to demonstrate its use in education and research. Finally, we compare GDSCalc with other discrete dynamical system software tools. Our perspective is that no single software tool will perform all computations that may be required by all users; tools typically have particular features that are more suitable for some tasks. We situate GDSCalc within this space of software tools.	[Abdelhamid, Sherif H. Elmeligy] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA; [Kuhlman, Chris J.; Marathe, Madhav V.; Mortveit, Henning S.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Ravi, S. S.] SUNY Albany, Dept Comp Sci, Albany, NY 12222 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Kuhlman, CJ (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	ckuhlman@vbi.vt.edu	Abdelhamid, Sherif/GOH-2757-2022	Abdelhamid, Sherif/0000-0002-6574-0187; Mortveit, Henning/0000-0003-3363-2947	Defense Threat Reduction Agency (DTRA) Comprehensive National Incident Management System Contract (CNIMS) [HDTRA1-11-D-0016-0001]; DTRA Grant [HDTRA1-11-1-0016]; National Institutes of Health (NIH) MIDAS Grant [5U01GM070694-11]; Department of Energy (DOE) Grant [DE-SC0003957]; NSF NetSE Grant [CNS-1011769]; NSF SDCI Grant [OCI-1032677]; government of Egypt; NSF NetSE contract; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070694] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1032677] Funding Source: National Science Foundation	Defense Threat Reduction Agency (DTRA) Comprehensive National Incident Management System Contract (CNIMS); DTRA Grant; National Institutes of Health (NIH) MIDAS Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy (DOE) Grant(United States Department of Energy (DOE)); NSF NetSE Grant; NSF SDCI Grant; government of Egypt; NSF NetSE contract; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by Defense Threat Reduction Agency (DTRA) Comprehensive National Incident Management System Contract (CNIMS) Contract HDTRA1-11-D-0016-0001; DTRA Grant HDTRA1-11-1-0016; National Institutes of Health (NIH) MIDAS Grant 5U01GM070694-11; Department of Energy (DOE) Grant DE-SC0003957; NSF NetSE Grant CNS-1011769; and NSF SDCI Grant OCI-1032677. SHEA is funded as a graduate student by the government of Egypt. CJK, MVM, and HSM are funded on all contracts. SSR is funded by NSF NetSE contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MATLAB RAND BOOL NET; [Anonymous], READY CROSS PLATFORM; [Anonymous], 2004, P WORKSH TUT 9 INT C; [Anonymous], 2002, DISCRETE DYNAMICAL S; Barrett CL, 2006, J COMPUT SYST SCI, V72, P1317, DOI 10.1016/j.jcss.2006.03.006; Beaudouin-Lafon M, 2006, INTERACT COMPUT NEW, P227, DOI [10.1007/3-540-34874-3_10, DOI 10.1007/3-540-34874-3_10, 10.1007/3-540-34874- 3_10]; Berntenis N, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-361; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Chaouiya C, 2012, METHODS MOL BIOL, V804, P463, DOI 10.1007/978-1-61779-361-5_23; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Demongeot J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011793; Dubrova E, 2013, BNS BOOLEAN NETWORKS; Elster J., 1989, CEMENT SOC; Epstein JM, 2002, P NATL ACAD SCI USA, V99, P7243, DOI 10.1073/pnas.092080199; Fates N, 2013, FIATLUX; Freiwald U, 2002, FUTURE GENER COMP SY, V18, P995, DOI 10.1016/S0167-739X(02)00078-X; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Garg A, 2007, LECT NOTES COMPUT SC, V4453, P62; Gershenson C., 2002, PROC 8 INT C ARTIFIC, P1; Goles E., 1990, NEURAL AUTOMATA NETW, DOI 10.1007/978-94-009-0529-0; Gonzalez AG, 2006, BIOSYSTEMS, V84, P91, DOI 10.1016/j.biosystems.2005.10.003; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Hatfield E., 1994, REV PERSONALITY SOCI; Helikar T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-96; Helikar T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-58; Hermans M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086696; Hinkelmann F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-295; I. Wolfram Research, 2012, MATHEMATICA; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Klamt S, 2003, BIOINFORMATICS, V19, P261, DOI 10.1093/bioinformatics/19.2.261; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Kuhlman CJ, 2014, THEOR COMPUT SCI, V559, P20, DOI 10.1016/j.tcs.2014.08.010; Kuhlman CJ, 2012, DISCRETE MATH THEOR, P29; Kuhlman CJ, 2013, THESIS VIRGINIA TECH; Kuhlman CJ, J CELLULAR AUTOMATA; Kules B, 2004, INTERACT COMPUT, V16, P1171, DOI 10.1016/j.intcom.2004.07.005; Lee EA, 2005, LECT NOTES COMPUT SC, V3414, P25; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Luo JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036010; Macauley M, 2008, J CELL AUTOM, V3, P37; Macauley M, 2009, NONLINEARITY, V22, P421, DOI 10.1088/0951-7715/22/2/010; MACY MW, 1991, AM SOCIOL REV, V56, P730, DOI 10.2307/2096252; MATLAB, 2012, MATLAB STAT TOOLB RE; Melnik S, 2013, CHAOS, V23, DOI 10.1063/1.4790836; Mortveit H. S., 2007, INTRO SEQUENTIAL DYN; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Ptolemaeus Claudius, 2013, SYSTEM DESIGN MODELI; Reid J, 2011, PYBOOL PYTHON PACKAG; Ruz G. A., 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), P397, DOI 10.1109/CIBCB.2012.6217257; Shmulevich I, 2002, P IEEE, V90, P1778, DOI 10.1109/JPROC.2002.804686; Stigler B, 2006, AMS 2006 P S APPL MA, P59; Stoll G, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-116; Stone JE, 2010, COMPUT SCI ENG, V12, P66, DOI 10.1109/MCSE.2010.69; Te'eni D., 2007, HUMAN COMPUTER INTER; THOMAS R, 1991, J THEOR BIOL, V153, P1, DOI 10.1016/S0022-5193(05)80350-9; Trevorrow A, 2009, GOLLY OPEN SOURCE CR; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Wegner K., 2007, BMC SYST BIOL, V1, P1, DOI [10.1186/1752-0509-1-S1-P72, DOI 10.1186/1752-0509-1-S1-P72, DOI 10.1186/1752-0509-1-1]; WOLFRAM S, 1983, REV MOD PHYS, V55, P601, DOI 10.1103/RevModPhys.55.601; Wuensche A., 2011, EXPLORING DISCRETE D	63	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0133660	10.1371/journal.pone.0133660	http://dx.doi.org/10.1371/journal.pone.0133660			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263006	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300010
J	Liu, XJ; Zeng, SM; Dong, SJ; Jin, C; Li, JL				Liu, Xiaojun; Zeng, Shimei; Dong, Shaojian; Jin, Can; Li, Jiale			A Novel Matrix Protein Hic31 from the Prismatic Layer of Hyriopsis Cumingii Displays a Collagen-Like Structure	PLOS ONE			English	Article							OYSTER PINCTADA-MARTENSII; WATER PEARL MUSSEL; ORGANIC MATRIX; CRYSTAL-GROWTH; SOLUBLE MATRIX; SHELL; GENE; MINERALIZATION; INDUCTION; ARAGONITE	In this study, we clone and characterize a novel matrix protein, hic31, from the mantle of Hyriopsis cumingii. The amino acid composition of hic31 consists of a high proportion of Glycine residues (26.67%). Tissue expression detection by RT-PCR indicates that hic31 is expressed specifically at the mantle edge. In situ hybridization results reveals strong signals from the dorsal epithelial cells of the outer fold at the mantle edge, and weak signals from inner epithelial cells of the same fold, indicating that hic31 is a prismatic-layer matrix protein. Although BLASTP results identify no shared homology with other shell-matrix proteins or any other known proteins, the hic31 tertiary structure is similar to that of collagen I, alpha 1 and alpha 2. It has been well proved that collagen forms the basic organic frameworks in way of collagen fibrils and minerals present within or outside of these fibrils. Therefore, hic31 might be a framework-matrix protein involved in the prismatic-layer biomineralization. Besides, the gene expression of hic31 increase in the early stages of pearl sac development, indicating that hic31 may play important roles in biomineralization of the pearl prismatic layer.	[Liu, Xiaojun; Zeng, Shimei; Dong, Shaojian; Jin, Can; Li, Jiale] Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Aquat Genet Resources, Shanghai, Peoples R China; [Liu, Xiaojun; Li, Jiale] Shanghai Ocean Univ, Shanghai Engn Res Ctr Aquaculture ZF1206, Shanghai, Peoples R China; [Liu, Xiaojun; Li, Jiale] Shanghai Ocean Univ, Aquat Anim Breeding Ctr ZF1206, Shanghai Univ Knowledge Serv Platform, Shanghai, Peoples R China; [Li, Jiale] Shanghai Ocean Univ, E Inst Shanghai Univ, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Shanghai Ocean University; Shanghai Ocean University; Shanghai Ocean University	Li, JL (corresponding author), Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Aquat Genet Resources, Shanghai, Peoples R China.	jlli@shou.edu.cn	li, jia/GVT-7587-2022	Liu, Xiaojun/0000-0002-0332-2940	national science and technology support program [2012BAD26B04]; ability improvement project for engineering and technology research center of the Shanghai Municipal Science and Technology Commission [13DZ228050031272657]; National Natural Science Foundation of China [31272657]	national science and technology support program; ability improvement project for engineering and technology research center of the Shanghai Municipal Science and Technology Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the national science and technology support program (2012BAD26B04), the ability improvement project for engineering and technology research center of the Shanghai Municipal Science and Technology Commission (13DZ228050031272657), and the National Natural Science Foundation of China (31272657).	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Bai ZY, 2014, MOL GENET GENOMICS, V289, P717, DOI 10.1007/s00438-014-0837-1; Bai ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053617; Bedouet L, 2007, MAR BIOTECHNOL, V9, P638, DOI 10.1007/s10126-007-9017-1; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Beniash E, 2000, J STRUCT BIOL, V132, P212, DOI 10.1006/jsbi.2000.4320; Berland S, 2013, PROTEIN PEPTIDE LETT, V20, P1170; Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p; Cuif JP, 2008, MICROSC MICROANAL, V14, P405, DOI 10.1017/S1431927608080859; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Feng QL, 2000, J CRYST GROWTH, V216, P459, DOI 10.1016/S0022-0248(00)00396-1; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hunter GK, 2001, J BIOMED MATER RES, V55, P496, DOI 10.1002/1097-4636(20010615)55:4<496::AID-JBM1042>3.0.CO;2-2; Iijima M, 1995, CONNECT TISSUE RES, V32, P519, DOI 10.3109/03008209509017002; Jiao Y, 2012, BIOCHEM BIOPH RES CO, V425, P679, DOI 10.1016/j.bbrc.2012.07.099; Joubert C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103944; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Lin JY, 2013, GENE, V526, P210, DOI 10.1016/j.gene.2013.05.029; Liu XJ, 2015, ACTA ZOOL-STOCKHOLM, V96, P30, DOI 10.1111/azo.12048; Liu XJ, 2015, GENE, V555, P217, DOI 10.1016/j.gene.2014.11.006; Liu XJ, 2012, P ROY SOC B-BIOL SCI, V279, P1000, DOI 10.1098/rspb.2011.1661; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowenstam HA, 1989, BIOMINERALIZATION; Ma HY, 2009, PROG NAT SCI-MATER, V19, P817, DOI 10.1016/j.pnsc.2008.11.005; Ma YF, 2010, J CRYST GROWTH, V312, P3165, DOI 10.1016/j.jcrysgro.2010.07.053; Ma YF, 2012, MAT SCI ENG C-MATER, V32, P1963, DOI 10.1016/j.msec.2012.05.030; Ma YF, 2011, MAT SCI ENG C-MATER, V31, P1338, DOI 10.1016/j.msec.2011.04.016; Mann S., 2001, BIOMINERALIZATION PR; Natoli A, 2010, MICRON, V41, P359, DOI 10.1016/j.micron.2010.01.002; Ren DN, 2014, CRYST GROWTH DES, V14, P1149, DOI 10.1021/cg401657d; Ren G, 2014, GENE, V546, P56, DOI 10.1016/j.gene.2014.05.039; Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X; Sarashina I, 1998, AM MINERAL, V83, P1510, DOI 10.2138/am-1998-11-1239; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Simkiss K, 1989, BIOMINERALIZATION CE; Thompson JB, 2000, BIOPHYS J, V79, P3307, DOI 10.1016/S0006-3495(00)76562-3; TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822; Veis A., 1981, CHEM BIOL MINERALIZE; [汪桂玲 WANG Guiling], 2007, [水产学报, Journal of Fisheries of China], V31, P152; WATABE N, 1960, NATURE, V188, P334, DOI 10.1038/188334a0; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Weiner S, 2003, BIOMINERALIZATION BI; WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397; WILBUR KM, 1963, ANN NY ACAD SCI, V109, P82, DOI 10.1111/j.1749-6632.1963.tb13463.x; Xiang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066564; Yan F, 2014, BIOCHEM BIOPH RES CO, V450, P300, DOI 10.1016/j.bbrc.2014.05.118	49	13	15	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135123	10.1371/journal.pone.0135123	http://dx.doi.org/10.1371/journal.pone.0135123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262686	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300064
J	van Liere, GAFS; Dirks, JAMC; Hoebe, CJPA; Wolffs, PF; Dukers-Muijrers, NHTM				van Liere, Genevileve A. F. S.; Dirks, Jeanne A. M. C.; Hoebe, Christian J. P. A.; Wolffs, Petra F.; Dukers-Muijrers, Nicole H. T. M.			Anorectal Chlamydia trachomatis Load Is Similar in Men Who Have Sex with Men and Women Reporting Anal Sex	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTION; NEISSERIA-GONORRHOEAE; RECTAL CHLAMYDIA; PERSISTENCE; SWABS	Background Anorectal Chlamydia trachomatis (chlamydia) is frequently diagnosed in men who have sex with men (MSM) and in women, but it is unknown whether these infections are comparable in clinical impact and transmission potential. Quantifying bacterial load and identifying determinants associated with high bacterial load could provide more insight. Methods We selected a convenience sample of MSM who reported anal sex (n = 90) and women with concurrent urogenital/anorectal chlamydia who reported anal sex (n = 51) or did not report anal sex (n = 61) from the South Limburg Public Health Service's STI unit. Bacterial load (Chlamydia/ml) was quantified for all samples and log transformed for analyses. Samples with an unquantifiable human leukocyte antigen (n = 9) were excluded from analyses, as they were deemed inadequately sampled. Results The mean log anorectal chlamydia load (3.50) was similar for MSM and women who reported having anal sex (3.80, P = 0.21). The anorectal chlamydia load was significantly higher in these groups than in women who did not report having anal sex (2.76, P = 0.001). Detectable load values ranged from 1.81-6.32 chlamydia/ml for MSM, 1.74-7.33 chlamydia/ml for women who reported having anal sex and 1.84-6.31 chlamydia/ml for women who did not report having anal sex. Symptoms and several other determinants were not associated with anorectal chlamydia load. Conclusions Women who did not report anal sex had lower anorectal loads, but they were within a similar range to the other two groups. Anorectal chlamydia load was comparable between MSM and women who reported anal sex, suggesting similar transmission potential.	[van Liere, Genevileve A. F. S.; Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.] South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [van Liere, Genevileve A. F. S.; Dirks, Jeanne A. M. C.; Hoebe, Christian J. P. A.; Wolffs, Petra F.; Dukers-Muijrers, Nicole H. T. M.] Maastricht Univ Med Ctr, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	van Liere, GAFS (corresponding author), South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands.	genevieve.vanliere@ggdzl.nl	Dukers-Muijrers, Nicole/M-7178-2014	Hoebe, Christian/0000-0003-1815-0974; Dukers-Muijrers, Nicole/0000-0003-4896-758X; Wolffs, Petra/0000-0002-5326-3985; van Liere, Genevieve/0000-0002-9286-4548	Public Health Service South Limburg; Department of Medical Microbiology, Maastricht University Medical Center+	Public Health Service South Limburg; Department of Medical Microbiology, Maastricht University Medical Center+	This work was investigator initiated, and supported by the Public Health Service South Limburg and the Department of Medical Microbiology, Maastricht University Medical Center+.	Barry PM, 2010, OBSTET GYNECOL, V115, P753, DOI 10.1097/AOG.0b013e3181d444f6; Bax CJ, 2011, SEX TRANSM INFECT, V87, P503, DOI 10.1136/sti.2010.048173; Cachay ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008504; Caldwell HD, 2003, J CLIN INVEST, V111, P1757, DOI [10.1172/JCI200317993, 10.1172/JCI17993]; Centers for Disease Control and Prevention, 2006, MMWR Recomm Rep, V55, P1; Ding A, 2014, INT J STD AIDS, V25, P587, DOI 10.1177/0956462413515637; Dirks JAMC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121433; Dukers-Muijrers NHTM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081236; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Hunte T, 2010, INT J STD AIDS, V21, P819, DOI 10.1258/ijsa.2010.009279; Jalal H, 2006, J CLIN MICROBIOL, V44, P206, DOI 10.1128/JCM.44.1.206-213.2006; Jalal H, 2011, J MED MICROBIOL, V60, P881, DOI 10.1099/jmm.0.028076-0; Javanbakht M, 2012, SEX TRANSM DIS, V39, P917, DOI 10.1097/OLQ.0b013e31826ae9a2; John R, 2014, RECOMMENDATIONS LAB; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; Koedijk FDH, 2012, INT J STD AIDS, V23, P626, DOI 10.1258/ijsa.2012.011378; Linssen CFM, 2008, INTENS CARE MED, V34, P2202, DOI 10.1007/s00134-008-1231-4; Moncada J, 2009, J CLIN MICROBIOL, V47, P1657, DOI 10.1128/JCM.02269-08; MOORMAN DR, 1986, J GEN MICROBIOL, V132, P1055; Patton ME, 2014, CLIN INFECT DIS, V58, P1564, DOI 10.1093/cid/ciu184; Peters RPH, 2014, SEX TRANSM DIS, V41, P564, DOI 10.1097/OLQ.0000000000000175; Price MJ, 2013, STAT MED, V32, P1547, DOI 10.1002/sim.5603; Rank RG, 2014, INFECT IMMUN, V82, P1362, DOI 10.1128/IAI.01244-13; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schachter J, 2011, SEX TRANSM DIS, V38, P925, DOI 10.1097/OLQ.0b013e318230f3d6; Sethupathi M, 2010, INT J STD AIDS, V21, P93, DOI 10.1258/ijsa.2008.008406; Twin J, 2011, SEX TRANSM DIS, V38, P279, DOI 10.1097/OLQ.0b013e3181fc6944; van der Helm JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032122; van der Helm JJ, 2009, SEX TRANSM DIS, V36, P493, DOI 10.1097/OLQ.0b013e3181a44b8c; van Liere GAFS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-274; van Liere GAFS, 2014, SEX TRANSM INFECT, V90, P58, DOI 10.1136/sextrans-2013-051248; van Liere GAFS, 2013, SEX TRANSM DIS, V40, P285, DOI 10.1097/OLQ.0b013e31828098f8; Vliegen I, 2004, MICROBES INFECT, V6, P1056, DOI 10.1016/j.micinf.2004.05.020; Vodstrcil LA, 2015, J INFECT DIS, V211, P1628, DOI 10.1093/infdis/jiu670; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052	36	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134991	10.1371/journal.pone.0134991	http://dx.doi.org/10.1371/journal.pone.0134991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262680	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300048
J	Teng, CLJ; Wang, CY; Chen, YH; Lin, CH; Hwang, WL				Teng, Chieh-Lin Jerry; Wang, Chen-Yu; Chen, Yi-Huei; Lin, Ching-Heng; Hwang, Wen-Li			Optimal Sequence of Irinotecan and Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer: A Population-Based Observational Study	PLOS ONE			English	Article							1ST-LINE TREATMENT; FLUOROURACIL; CHEMOTHERAPY; LEUCOVORIN; MULTICENTER; FOLFIRI; TRIALS	The optimal sequence of irinotecan and oxaliplatin-based regimens for metastatic colorectal cancer remains unclear. We conducted a population-based observational study by retrospectively reviewing records from Taiwan's National Health Insurance Research Database to explore this issue. Patients aged >= 20 years with metastatic colorectal cancer newly diagnosed between 2004 and 2008 (n = 9490) were enrolled in current study. Among these 9490 patients, 3895 patients (41.04%) did not receive any chemotherapy within the first three months after catastrophic illness registration. Patients who received best supportive care were older and had higher Charlson comorbidity indexes and incidences of comorbidities than those who received irinotecan-based regimens, oxaliplatin-based regimens, and 5-fluorouracil/capecitabine alone. Patients who received irinotecan followed by oxaliplatin-based regimens and those who received the reverse sequence were further stratified into arm A (n = 542) and arm B (n = 1156), respectively. The median first time to next treatment was not significantly different between arm A and arm B (210 days vs. 196 days; p = 0.17). However, the median second time to next treatment was longer in arm A than in arm B (155 days vs. 123 days; p = 0.006), which translated into a better overall survival (487 days vs. 454 days; p = 0.02). The crossover rate was higher in arm A than in arm B (47.84% vs. 41.61%; p<0.001). Multivariate Cox regression analyses showed that overall survival was comparable between the two chemotherapy sequences (p = 0.27). Our study suggested that irinotecan followed by oxaliplatin-based regimens might be a better chemotherapy treatment option for metastatic colorectal cancer than the reverse sequence given the higher crossover rate and potential overall survival benefit.	[Teng, Chieh-Lin Jerry; Hwang, Wen-Li] Taichung Vet Gen Hosp, Dept Med, Div Hematol Med Oncol, Taichung, Taiwan; [Teng, Chieh-Lin Jerry] Chung Shan Med Univ, Dept Med, Taichung, Taiwan; [Teng, Chieh-Lin Jerry] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Wang, Chen-Yu] Taichung Vet Gen Hosp, Dept Intens Care, Taichung, Taiwan; [Chen, Yi-Huei; Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan	Taichung Veterans General Hospital; Chung Shan Medical University; Tunghai University; Taichung Veterans General Hospital; Taichung Veterans General Hospital	Lin, CH (corresponding author), Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan.	epid@vghtc.gov.tw; kevinhwl@gmail.com			Taichung Veterans General Hospital [TCVGH-T1017802, TCVGH-1023703D, TCVGH-T1027802]	Taichung Veterans General Hospital	This work was supported in part by research grant TCVGH-T1017802, TCVGH-1023703D, TCVGH-1023703D, and TCVGH-T1027802 from Taichung Veterans General Hospital (Chieh-Lin Jerry Teng, MD, PhD) for laboratory maintenance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland SP, 2005, BRIT J CANCER, V93, P1236, DOI 10.1038/sj.bjc.6602841; CALGB/ SWOG C80405, 2006, CLIN ADV HEMATOLOGY, P452; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colucci G, 2005, J CLIN ONCOL, V23, P4866, DOI 10.1200/JCO.2005.07.113; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Goldberg RM, 2004, CANCER CHEMOTH PHARM, V54, pS57, DOI 10.1007/s00280-004-0888-9; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lin CH, 2013, J INTERN MED, V273, P102, DOI 10.1111/joim.12000; Lin YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086789; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Teng CLJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086714; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019	15	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135673	10.1371/journal.pone.0135673	http://dx.doi.org/10.1371/journal.pone.0135673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26273837	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600092
J	Gautam, US; Mehra, S; Kaushal, D				Gautam, Uma Shankar; Mehra, Smriti; Kaushal, Deepak			In-Vivo Gene Signatures of Mycobacterium tuberculosis in C3HeB/FeJ Mice	PLOS ONE			English	Article							SIGMA-FACTOR; 2-COMPONENT SYSTEM; HYPOXIC RESPONSE; ACYL-COENZYME; MOUSE MODEL; EXPRESSION; STRESS; PROTEIN; ADAPTATION; INFECTION	Despite considerable progress in understanding the pathogenesis of Mycobacterium tuberculosis (Mtb), development of new therapeutics and vaccines against it has proven difficult. This is at least in part due to the use of less than optimal models of in-vivo Mtb infection, which has precluded a study of the physiology of the pathogen in niches where it actually persists. C3HeB/FeJ (Kramnik) mice develop human-like lesions when experimentally infected with Mtb and thus make available, a faithful and highly tractable system to study the physiology of the pathogen in-vivo. We compared the transcriptomics of Mtb and various mutants in the DosR (DevR) regulon derived from Kramnik mouse granulomas to those cultured in-vitro. We recently showed that mutant Delta dosS is attenuated in C3HeB/FeJ mice. Aerosol exposure of mice with the mutant mycobacteria resulted in a substantially different and a relatively weaker transcriptional response (< = 20 genes were induced) for the functional category 'Information Pathways' in Mtb:Delta dosR; 'Lipid Metabolism' in Mtb:Delta dosT; 'Virulence, Detoxification, Adaptation' in both Mtb:Delta dosR and Mtb:Delta dosT; and 'PE/PPE' family in all mutant strains compare to wild-type Mtb H37Rv, suggesting that the inability to induce DosR functions to different levels can modulate the interaction of the pathogen with the host. The Mtb genes expressed during growth in C3HeB/FeJ mice appear to reflect adaptation to differential nutrient utilization for survival in mouse lungs. The genes such as glnB, Rv0744c, Rv3281, sdhD/B, mce4A, dctA etc. downregulated in mutant Delta dosS indicate their requirement for bacterial growth and flow of carbon/energy source from host cells. We conclude that genes expressed in Mtb during in-vivo chronic phase of infection in Kramnik mice mainly contribute to growth, cell wall processes, lipid metabolism, and virulence.	[Gautam, Uma Shankar; Mehra, Smriti; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; [Mehra, Smriti] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Kaushal, Deepak] Tulane Univ, Sch Med, Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Tulane University	Gautam, US (corresponding author), Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.	ugautam@tulane.edu; dkaushal@tulane.edu	GAUTAM, UMA/AAI-1531-2021; Uma S Gautam, MSc/H-3474-2019	Uma S Gautam, MSc/0000-0003-0326-6325	National Institutes of Health [AI089323, HL106790, 578 AI091457, RR026006, RR020159, RR000164/OD011104, C06AI058609]; Howard Hughes Medical Institutions; Office of the Director, Tulane National Primate Research Center; Tulane National Primate Research Center Pilot Projects Program; Louisiana Vaccine Center; Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Tulane Office of Vice-President for Research; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR026006, P20RR020159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089323, R21AI091457] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institutions; Office of the Director, Tulane National Primate Research Center; Tulane National Primate Research Center Pilot Projects Program; Louisiana Vaccine Center; Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Tulane Office of Vice-President for Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants AI089323, HL106790, 578 AI091457, RR026006, RR020159, RR000164/OD011104 and C06AI058609 and by awards from Howard Hughes Medical Institutions, the Office of the Director, Tulane National Primate Research Center, the Tulane National Primate Research Center Pilot Projects Program, Louisiana Vaccine Center, Tulane Research Enhancement Fund, Tulane Center for Infectious Diseases, and a Bridge Fund from the Tulane Office of Vice-President for Research. The funders had no role in either the conception or the analysis of experiments.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; Basu D, 2009, NUCLEIC ACIDS RES, V37, P4944, DOI 10.1093/nar/gkp502; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Booth M, 2004, T ROY SOC TROP MED H, V98, P125, DOI 10.1016/S0035-9203(03)00018-X; Commandeur S, 2013, J IMMUNOL, V190, P1659, DOI 10.4049/jimmunol.1201593; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Datta P, 2011, J BACTERIOL, V193, P1154, DOI 10.1128/JB.00459-10; Santangelo MD, 2009, MICROBIOL-SGM, V155, P2245, DOI 10.1099/mic.0.027086-0; Deng WY, 2011, J CELL BIOCHEM, V112, P2655, DOI 10.1002/jcb.23193; Derrick SC, 2013, VACCINE, V31, P4641, DOI 10.1016/j.vaccine.2013.07.032; Driver ER, 2012, ANTIMICROB AGENTS CH, V56, P3181, DOI 10.1128/AAC.00217-12; Dunphy KY, 2010, J INFECT DIS, V201, P1232, DOI 10.1086/651452; Durbach SI, 2003, INFECT IMMUN, V71, P997, DOI 10.1128/IAI.71.2.997-1000.2003; Dutta NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010069; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Fenhalls G, 2002, INFECT IMMUN, V70, P6330, DOI 10.1128/IAI.70.11.6330-6338.2002; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Gago G, 2006, J BACTERIOL, V188, P477, DOI 10.1128/JB.188.2.477-486.2006; Garbe TR, 1999, INFECT IMMUN, V67, P460, DOI 10.1128/IAI.67.1.460-465.1999; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Gautam US, 2015, AM J RESP CELL MOL, V52, P708, DOI 10.1165/rcmb.2014-0230OC; Gautam US, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095220; Gautam US, 2014, J BACTERIOL, V196, P790, DOI 10.1128/JB.01270-13; Gautam US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016500; Gerth U, 1998, MOL MICROBIOL, V28, P787, DOI 10.1046/j.1365-2958.1998.00840.x; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Gui LZ, 1996, J BACTERIOL, V178, P4704, DOI 10.1128/jb.178.15.4704-4709.1996; Hahn MY, 2005, J BACTERIOL, V187, P7062, DOI 10.1128/JB.187.20.7062-7071.2005; Han JS, 2010, BIOCHEM BIOPH RES CO, V400, P293, DOI 10.1016/j.bbrc.2010.08.023; Harper J, 2012, J INFECT DIS, V205, P595, DOI 10.1093/infdis/jir786; Hatzios SK, 2009, J BIOL CHEM, V284, P12745, DOI 10.1074/jbc.M809088200; He HJ, 2006, J BACTERIOL, V188, P2134, DOI 10.1128/JB.188.6.2134-2143.2006; Honaker RW, 2009, INFECT IMMUN, V77, P3258, DOI 10.1128/IAI.01449-08; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Jang J, 2010, MICROBIOL-SGM, V156, P1619, DOI 10.1099/mic.0.038133-0; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Kaushal Deepak, 2004, Curr Protoc Bioinformatics, VChapter 7, DOI 10.1002/0471250953.bi0709s7; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kernodle DS, 2012, J INFECT DIS, V205, P1186, DOI 10.1093/infdis/jis108; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Kirksey MA, 2011, INFECT IMMUN, V79, P2829, DOI 10.1128/IAI.00097-11; Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Le Moigne V, 2008, MOL IMMUNOL, V45, P2499, DOI 10.1016/j.molimm.2008.01.005; Lukowski JK, 2014, BIOCHEMISTRY-US, V53, P7386, DOI 10.1021/bi501108u; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McGillivray A, 2015, J BIOL CHEM, V290, P2351, DOI 10.1074/jbc.M114.615534; McGillivray A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093604; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mehra S, 2015, AM J RESP CRIT CARE, V191, P1185, DOI 10.1164/rccm.201408-1502OC; Mehra S, 2012, J INFECT DIS, V205, P1203, DOI 10.1093/infdis/jis102; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Miner MD, 2009, INDIAN J EXP BIOL, V47, P407; Parish T, 2003, MICROBIOL-SGM, V149, P1423, DOI 10.1099/mic.0.26245-0; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Parthasarathy G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043429; Parveen N, 2013, J BIOL CHEM, V288, P24956, DOI 10.1074/jbc.M113.461004; Perez E, 2004, J BIOL CHEM, V279, P42574, DOI 10.1074/jbc.M406246200; Price CTD, 2008, J BACTERIOL, V190, P3955, DOI 10.1128/JB.01476-07; Raju RM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003994; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Russell DG, 2002, J CELL BIOL, V158, P421, DOI 10.1083/jcb.200205034; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Saini NK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-200; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Sharma K, 2006, FEBS J, V273, P2711, DOI 10.1111/j.1742-4658.2006.05289.x; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Shoen CM, 2004, J ANTIMICROB CHEMOTH, V53, P641, DOI 10.1093/jac/dkh124; Skeiky YAW, 2000, J IMMUNOL, V165, P7140, DOI 10.4049/jimmunol.165.12.7140; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; SUNNARBORG A, 1990, J BACTERIOL, V172, P2642, DOI 10.1128/jb.172.5.2642-2649.1990; Talaat AM, 2007, J BACTERIOL, V189, P4265, DOI 10.1128/JB.00011-07; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tischler AD, 2013, INFECT IMMUN, V81, P317, DOI 10.1128/IAI.01136-12; Tiwari BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051686; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; Wu SP, 2004, MOL MICROBIOL, V51, P1551, DOI 10.1111/j.1365-2958.2003.03922.x; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; Zhang M, 1997, INFECT IMMUN, V65, P692, DOI 10.1128/IAI.65.2.692-698.1997; Zhou HF, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S2	96	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135208	10.1371/journal.pone.0135208	http://dx.doi.org/10.1371/journal.pone.0135208			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270051	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800042
J	Han, C; He, X; Xia, XH; Li, YZ; Shi, XG; Shan, ZY; Teng, WP				Han, Cheng; He, Xue; Xia, Xinghai; Li, Yongze; Shi, Xiaoguang; Shan, Zhongyan; Teng, Weiping			Subclinical Hypothyroidism and Type 2 Diabetes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; THYROID-DISEASE; HEART-DISEASE; DOUBLE-BLIND; RISK-FACTOR; ASSOCIATION; DYSFUNCTION; PREVALENCE; NEPHROPATHY; GUIDELINES	Background Abundant evidence suggests an association between subclinical hypothyroidism (SCH) and type 2 diabetes mellitus (T2DM), but small sample sizes and inconclusive data in the literature complicate this assertion. Objective We measured the prevalence of SCH in T2DM population, and investigated whether T2DM increase the risk of SCH and whether SCH was associated with diabetic complications. METHODS We conducted a meta-analysis using PubMed, EMBASE, Web of Science, Wan Fang, CNKI and VIP databases for literature search. We obtained studies published between January 1, 1980 to December 1, 2014. The studies were selected to evaluate the prevalence of SCH in T2DM subjects, compare the prevalence of SCH in T2DM subjects with those nondiabetics, and investigate whether diabetic complications were more prevalent in SCH than those who were euthyroid. Fixed and random effects meta-analysis models were used, and the outcome was presented as a pooled prevalence with 95% confidence interval (95% CI) or a summary odds ratio (OR) with 95% CI. RESULTS Through literature search, 36 articles met the inclusion criteria and these articles contained a total of 61 studies. Funnel plots and Egger's tests showed no publication bias in our studies, except for the pooled prevalence of SCH in T2DM (P = 0.08) and OR for SCH in T2DM (P = 0.04). Trim and fill method was used to correct the results and five potential missing data were replaced respectively. The adjusted pooled prevalence of SCH in T2DM patients was 10.2%, meanwhile, T2DM was associated with a 1.93-fold increase in risk of SCH (95% CI: 1.66, 2.24). Furthermore, SCH might affect the development of diabetic complications with an overall OR of 1.74 (95% CI: 1.34, 2.28) for diabetic nephropathy, 1.42 (95% CI: 1.21, 1.67) for diabetic retinopathy, 1.85 (95% CI: 1.35, 2.54) for peripheral arterial disease, and 1.87 (95% CI: 1.06, 3.28) for diabetic peripheral neuropathy. Conclusions T2DM patients are more likely to have SCH when compared with healthy population and SCH may be associated with increased diabetic complications. It is necessary to screen thyroid function in patients with T2DM, and appropriate individualized treatments in addition to thyroid function test should be given to T2DM patients with SCH as well.	[Han, Cheng; He, Xue; Xia, Xinghai; Li, Yongze; Shi, Xiaoguang; Shan, Zhongyan; Teng, Weiping] China Med Univ, Affiliated Hosp 1, Liaoning Prov Key Lab Endocrine Dis, Dept Endocrinol & Metab,Inst Endocrinol, Shenyang, Liaoning Provin, Peoples R China	China Medical University	Shi, XG (corresponding author), China Med Univ, Affiliated Hosp 1, Liaoning Prov Key Lab Endocrine Dis, Dept Endocrinol & Metab,Inst Endocrinol, Shenyang, Liaoning Provin, Peoples R China.	xiaoguangshi_cmu@163.com	He, Xue/I-9721-2018	LI, YONGZE/0000-0001-8782-3314; Han, Cheng/0000-0001-8553-4420; Xia, Xinghai/0000-0002-4860-4562	National Natural Science Foundation [81370893]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation (81370893) (URL: http://npd.nsfc.gov.cn/fundingProjectSearchAction.action). Sponsors had no role in study design, data collection and analysis, decision to publish, or in manuscript preparation.	Al-Hamodi Z, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-99; Asvold BO, 2011, EUR J ENDOCRINOL, V164, P101, DOI 10.1530/EJE-10-0705; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Cappelli C, 2009, DIABETES CARE, V32, P1589, DOI 10.2337/dc09-0273; Chen HS, 2007, DIABETIC MED, V24, P1336, DOI 10.1111/j.1464-5491.2007.02270.x; Chen Y, 2014, MED INFORM, V27, P169; Deng X, 2011, CHINESE COMMUNITY DO, V13, P124; Diez JJ, 2012, DIABETIC MED, V29, P1510, DOI 10.1111/j.1464-5491.2012.03687.x; Diez JJ, 2011, EXP CLIN ENDOCR DIAB, V119, P201, DOI 10.1055/s-0031-1271691; Distiller LA, 2014, DIABETIC MED, V31, P172, DOI 10.1111/dme.12342; Duan Q, 2014, ACTA ACAD MED NEIMON, V36, P439; [付秀立 Fu Xiuli], 2013, [中国全科医学, Chinese General Practice], V16, P2674; Furukawa S, 2014, ENDOCR J, V61, P1011, DOI 10.1507/endocrj.EJ14-0206; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Ghazali S M, 2010, Niger J Physiol Sci, V25, P173; Gopinath Bamini, 2008, Diabetes Res Clin Pract, V82, pe11, DOI 10.1016/j.diabres.2008.08.017; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Hellstrom A, 2002, J CLIN ENDOCR METAB, V87, P3413, DOI 10.1210/jc.87.7.3413; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; KABADI UM, 1993, ARCH INTERN MED, V153, P957, DOI 10.1001/archinte.153.8.957; Kadiyala R, 2010, INT J CLIN PRACT, V64, P1130, DOI 10.1111/j.1742-1241.2010.02376.x; Kim SK, 2009, ENDOCR J, V56, P753, DOI 10.1507/endocrj.K09E-049; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1; Kotsis V, 2007, J HYPERTENS, V25, P993, DOI 10.1097/HJH.0b013e328082e2ff; Li JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108315; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu C, 2014, J CLIN RES, V31, P323; [刘红 Liu Hong], 2014, [中国糖尿病杂志, Chinese Journal of Diabetes], V22, P511; Liu W, 2009, CLIN FOCUS, V24, P2063; Liu W, 2007, CLIN FOCUS, V22, P1558; Liu X, 2012, GUIDE CHINA MED, V10, P55; Lu L, 2014, SHANXI MED J, V43, P2374; Lv B, 2014, GUIDE CHINA MED, V12, P135; Meng FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081294; Monami M, 2011, DIABETES-METAB RES, V27, P362, DOI 10.1002/dmrr.1184; Monzani F, 2004, J CLIN ENDOCR METAB, V89, P2099, DOI 10.1210/jc.2003-031669; Nagasaki T, 2009, EUR J ENDOCRINOL, V160, P409, DOI 10.1530/EJE-08-0742; Navegantes LCC, 1996, BRAZ J MED BIOL RES, V29, P665; Ortiga-Carvalho TM, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740121; Owen PJD, 2006, J CLIN ENDOCR METAB, V91, P2126, DOI 10.1210/jc.2005-2108; Pearce SHS, 2013, EUR THYROID J, V2, P215, DOI 10.1159/000356507; PERNEGER TV, 1994, ANN INTERN MED, V121, P912, DOI 10.7326/0003-4819-121-12-199412150-00002; Razvi S, 2008, J CLIN ENDOCR METAB, V93, P2998, DOI 10.1210/jc.2008-0167; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Reusch CE, 1999, J AM VET MED ASSOC, V215, P1297; Ripoli A, 2005, J AM COLL CARDIOL, V45, P439, DOI 10.1016/j.jacc.2004.10.044; Rivolta G, 1999, J ENDOCRINOL INVEST, V22, P693, DOI 10.1007/BF03343631; SAWIN CT, 1985, ARCH INTERN MED, V145, P1386, DOI 10.1001/archinte.145.8.1386; Sevilla-Romero E, 2002, OPHTHALMIC RES, V34, P181, DOI 10.1159/000063885; Shao F, 2014, J CLIN RES, V31, P1291; Shen Yanjun, 2012, Wuhan Daxue Xuebao (Yixue Ban), V33, P415; Shi Y, 2012, GUIDE CHINA MED, V10, P25; SHIRABE T, 1975, J NEUROL NEUROSUR PS, V38, P241, DOI 10.1136/jnnp.38.3.241; Sun L, 2013, ZEEJIANG PRACTICAL M, V17, P342; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Tamez-Perez HE, 2012, MED CLIN-BARCELONA, V138, P475, DOI 10.1016/j.medcli.2011.08.009; Tang J, 2012, CLIN J PREV CONTR CH, V20, P591; Taylor PN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6681; TUNBRIDGE WMG, 1981, BRIT MED J, V282, P258, DOI 10.1136/bmj.282.6260.258; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; Turemen EE, 2011, ENDOCR J, V58, P349; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Wang C, 1997, ENDOCRIN METAB CLIN, V26, P189, DOI 10.1016/S0889-8529(05)70240-1; [王玫 Wang Mei], 2012, [中国现代医学杂志, China Journal of Modern Medicine], V22, P66; Wang Y, 2012, J MODERN LAB MED, V27, P132, DOI DOI 10.3969/J.ISSN.1671-7414.2012.06.043; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xi W, 2014, INNER MONGOLIA MED, P686; Xu J, 2014, SCI WORLD J, DOI 10.1155/2014/926932; Xu X, 2013, ACTA U MED ANHUI, V48, P675; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yerdelen D, 2010, J NEUROL SCI, V294, P89, DOI 10.1016/j.jns.2010.03.026; Zang S, 2011, J MED RES, V40, P114; Zeng Xiantao, 2015, J Evid Based Med, V8, P2, DOI 10.1111/jebm.12141; [张冬梅 Zhang Dongmei], 2014, [中国糖尿病杂志, Chinese Journal of Diabetes], V22, P25; Zhang H, 2012, SHANDONG MED J, V52, P52; Zhang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078151; Zhang M, 2012, J NANCHANG U MED SCI, V52, P42; Zhang NiYa, 2009, Zhongguo Shiyong Neike Zazhi / Chinese Journal of Practical Internal Medicine, V29, P1106; Zhao F, 2012, CHIN J DIABETES, V11, P417; Zhao R, 2013, NINGXIA MED J, V35, P810; Zhao W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109549; Zhou J, 2013, MED RECAPITULATE, V19, P4383; Zhu Y, 2014, ZHEJIANG CLIN MED J, V16, P1451; Zou SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040718; 洪畋, 2012, [中国老年学杂志, Chinese Journal of Gerontology], V32, P3909	88	75	82	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135233	10.1371/journal.pone.0135233	http://dx.doi.org/10.1371/journal.pone.0135233			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270348	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492800043
J	Jamal, SM; Belsham, GJ				Jamal, Syed M.; Belsham, Graham J.			Development and Characterization of Probe-Based Real Time Quantitative RT-PCR Assays for Detection and Serotyping of Foot-And-Mouth Disease Viruses Circulating in West Eurasia	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; LABORATORY DIAGNOSIS; VIRAL-RNA; DIFFERENTIATION; AFGHANISTAN; PAKISTAN; EMERGENCE; PRIMERS; SAMPLES; AFRICA	Rapid and accurate diagnosis of foot-and-mouth disease (FMD) and virus serotyping are of paramount importance for control of this disease in endemic areas where vaccination is practiced. Ideally this virus characterization should be achieved without the need for virus amplification in cell culture. Due to the heterogeneity of FMD viruses (FMDVs) in different parts of the world, region specific diagnostic tests are required. In this study, hydrolysable probe-based real time reverse transcription quantitative polymerase chain reaction (RT-qPCR) assays were developed for specific detection and serotyping of the FMDVs currently circulating in West Eurasia. These assays were evaluated, in parallel with pan-FMDV diagnostic assays and earlier serotype-specific assays, using field samples originating from Pakistan and Afghanistan containing FMD viruses belonging to different sublineages of O-PanAsia, A-Iran05 and Asia-1 (Group-II and Group-VII (Sindh-08)). In addition, field samples from Iran and Bulgaria, containing FMDVs belonging to the O-PanAsia(ANT-10) sublineage were also tested. Each of the three primer/probe sets was designed to be specific for just one of the serotypes O, A and Asia-1 of FMDV and detected the RNA from the target viruses with cycle threshold (C-T) values comparable with those obtained with the serotype-independent pan-FMDV diagnostic assays. No cross-reactivity was observed in these assays between the heterotypic viruses circulating in the region. The assays reported here have higher diagnostic sensitivity (100% each for serotypes O and Asia-1, and 92% [95% CI = 81.4-100%] for serotype A positive samples) and specificity (100% each for serotypes O, A and Asia-1 positive samples) for the viruses currently circulating in West Eurasia compared to the serotyping assays reported earlier. Comparisons of the sequences of the primers and probes used in these assays and the corresponding regions of the circulating viruses provided explanations for the poor recognition of some of the viruses by the earlier assays. These new assays should help in the early detection and typing of serotype O, A and Asia-1 FMDVs circulating in West Eurasia to enable improved disease control.	[Jamal, Syed M.] Univ Malakand, Dept Biotechnol, Dir L, Khyber Pakhtunk, Pakistan; [Belsham, Graham J.] Tech Univ Denmark, Natl Vet Inst, Lindholm, Kalvehave, Denmark	University of Malakand; Technical University of Denmark	Belsham, GJ (corresponding author), Tech Univ Denmark, Natl Vet Inst, Lindholm, Kalvehave, Denmark.	grbe@vet.dtu.dk	Jamal, Syed M./H-5394-2011; Ibrahim, Essam Hassan/G-1960-2018; Belsham, Graham/J-3132-2019; Belsham, Graham J./H-8589-2019; Hegde, Nagendra/J-5920-2014	Jamal, Syed M./0000-0002-0768-4471; Ibrahim, Essam Hassan/0000-0003-0130-2257; Belsham, Graham/0000-0003-1187-4873; Belsham, Graham J./0000-0003-1187-4873; Hegde, Nagendra/0000-0001-5260-2159	DTU (Technical University of Denmark) National Veterinary Institute; European Commission for the Control of Foot-and-mouth disease (EuFMD)	DTU (Technical University of Denmark) National Veterinary Institute; European Commission for the Control of Foot-and-mouth disease (EuFMD)	The work was funded internally within the DTU (Technical University of Denmark) National Veterinary Institute (www.vet.dtu.dk) and in part by the European Commission for the Control of Foot-and-mouth disease (EuFMD) (http://www.fao.org/ag/againfo/commissions/eufmd/commissions/eufmd-home/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HA, 2012, TRANSBOUND EMERG DIS, V59, P476, DOI 10.1111/tbed.12015; Alexandersen S, 2000, J CLIN MICROBIOL, V38, P4604, DOI 10.1128/JCM.38.12.4604-4613.2000; Bachanek-Bankowska K, 2014, OP SESS STAND TECHN, P198; Belsham GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014621; Brito BP, 2015, TRANSBOUND EMERG DIS; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Callens M, 1997, J VIROL METHODS, V67, P35, DOI 10.1016/S0166-0934(97)00074-8; Cottam EM, 2008, P ROY SOC B-BIOL SCI, V275, P887, DOI 10.1098/rspb.2007.1442; Di Nardo A, 2011, REV SCI TECH OIE, V30, P63; FERRIS NP, 1988, VET MICROBIOL, V16, P201, DOI 10.1016/0378-1135(88)90024-7; FOX G, 1989, J GEN VIROL, V70, P625, DOI 10.1099/0022-1317-70-3-625; Giridharan P, 2005, J VIROL METHODS, V126, P1, DOI 10.1016/j.jviromet.2005.01.015; Jackson T, 1997, J VIROL, V71, P8357, DOI 10.1128/JVI.71.11.8357-8361.1997; Jamal SM, 2012, TRANSBOUND EMERG DIS, V59, P429, DOI 10.1111/j.1865-1682.2011.01295.x; Jamal SM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-116; Jamal SM, 2011, INFECT GENET EVOL, V11, P2049, DOI 10.1016/j.meegid.2011.09.015; Jamal SM, 2011, J GEN VIROL, V92, P2849, DOI 10.1099/vir.0.035626-0; Jamal SM, 2011, INFECT GENET EVOL, V11, P1229, DOI 10.1016/j.meegid.2011.03.006; King DP, 2006, J VET DIAGN INVEST, V18, P93, DOI 10.1177/104063870601800114; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Moniwa M, 2007, J VET DIAGN INVEST, V19, P9, DOI 10.1177/104063870701900103; Reid SM, 2014, J VIROL METHODS, V207, P146, DOI 10.1016/j.jviromet.2014.07.002; Reid SM, 1999, J VIROL METHODS, V83, P113, DOI 10.1016/S0166-0934(99)00113-5; Reid SM, 2003, J VIROL METHODS, V107, P129, DOI 10.1016/S0166-0934(02)00210-0; Reid SM, 2002, J VIROL METHODS, V105, P67, DOI 10.1016/S0166-0934(02)00081-2; Reid SM, 2001, ARCH VIROL, V146, P2421, DOI 10.1007/s007050170012; Reid SM, 2001, J VIROL METHODS, V96, P189, DOI 10.1016/S0166-0934(01)00334-2; Sakamoto K, 2002, J VET MED SCI, V64, P91, DOI 10.1292/jvms.64.91; Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609; Shaw AE, 2004, REV SCI TECH OIE, V23, P1003, DOI 10.20506/rst.23.3.1544; Shin JH, 2003, J VET MED SCI, V65, P1, DOI 10.1292/jvms.65.1; Sumption K, 2008, TRANSBOUND EMERG DIS, V55, P5, DOI 10.1111/j.1865-1682.2007.01017.x; Sumption K, 2012, VET REC, V170, P637, DOI 10.1136/vr.e4180; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valarcher JF, 2008, TRANSBOUND EMERG DIS, V55, P14, DOI 10.1111/j.1865-1682.2007.01010.x; Valdazo-Gonzalez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049650; Vangrysperre W, 1996, ARCH VIROL, V141, P331, DOI 10.1007/BF01718403	37	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135559	10.1371/journal.pone.0135559	http://dx.doi.org/10.1371/journal.pone.0135559			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270532	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800090
J	Meyer, SU; Sass, S; Mueller, NS; Krebs, S; Bauersachs, S; Kaiser, S; Blum, H; Thirion, C; Krause, S; Theis, FJ; Pfaffl, MW				Meyer, Swanhild U.; Sass, Steffen; Mueller, Nikola S.; Krebs, Stefan; Bauersachs, Stefan; Kaiser, Sebastian; Blum, Helmut; Thirion, Christian; Krause, Sabine; Theis, Fabian J.; Pfaffl, Michael W.			Integrative Analysis of MicroRNA and mRNA Data Reveals an Orchestrated Function of MicroRNAs in Skeletal Myocyte Differentiation in Response to TNF-alpha or IGF1	PLOS ONE			English	Article							MUSCLE DIFFERENTIATION; MYOGENIC DIFFERENTIATION; GROWTH-FACTORS; EXPRESSION; PROLIFERATION; TARGETS; MIRNA; MYOD; REGULARIZATION; TRANSCRIPTOME	Introduction Skeletal muscle cell differentiation is impaired by elevated levels of the inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) with pathological significance in chronic diseases or inherited muscle disorders. Insulin like growth factor-1 (IGF1) positively regulates muscle cell differentiation. Both, TNF-alpha and IGF1 affect gene and microRNA (miRNA) expression in this process. However, computational prediction of miRNA-mRNA relations is challenged by false positives and targets which might be irrelevant in the respective cellular transcriptome context. Thus, this study is focused on functional information about miRNA affected target transcripts by integrating miRNA and mRNA expression profiling data. Methodology/Principal Findings Murine skeletal myocytes PMI28 were differentiated for 24 hours with concomitant TNF-alpha or IGF1 treatment. Both, mRNA and miRNA expression profiling was performed. The data-driven integration of target prediction and paired mRNA/miRNA expression profiling data revealed that i) the quantity of predicted miRNA-mRNA relations was reduced, ii) miRNA targets with a function in cell cycle and axon guidance were enriched, iii) differential regulation of anti-differentiation miR-155-5p and miR-29b-3p as well as pro-differentiation miR335-3p, miR-335-5p, miR-322-3p, and miR-322-5p seemed to be of primary importance during skeletal myoblast differentiation compared to the other miRNAs, iv) the abundanceof targets and affected biological processes was miRNA specific, and v) subsets of miRNAs may collectively regulate gene expression. Conclusions Joint analysis of mRNA and miRNA profiling data increased the process-specificity and quality of predicted relations by statistically selecting miRNA-target interactions. Moreover, this study revealed miRNA-specific predominant biological implications in skeletal muscle cell differentiation and in response to TNF-alpha or IGF1 treatment. Furthermore, myoblast differentiation-associated miRNAs are suggested to collectively regulate gene clusters and targets associated with enriched specific gene ontology terms or pathways. Predicted miRNA functions of this study provide novel insights into defective regulation at the transcriptomic level during myocyte proliferation and differentiation due to inflammatory stimuli.	[Meyer, Swanhild U.; Pfaffl, Michael W.] Tech Univ Munich, Physiol Weihenstephan, Freising Weihenstephan, Germany; [Sass, Steffen; Mueller, Nikola S.; Theis, Fabian J.] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Computat Biol, Neuherberg, Germany; [Krebs, Stefan; Bauersachs, Stefan; Blum, Helmut] Univ Munich, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany; [Kaiser, Sebastian] Univ Munich, Dept Stat, Munich, Germany; [Thirion, Christian] SIRION Biotech GmbH, Martinsried, Germany; [Krause, Sabine] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany; [Theis, Fabian J.] Tech Univ Munich, Dept Math, Garching, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Munich; Technical University of Munich	Meyer, SU (corresponding author), Tech Univ Munich, Physiol Weihenstephan, Freising Weihenstephan, Germany.	meyers@wzw.tum.de	Krause, Sabine/AAJ-1163-2020; Mueller, Nikola/I-6366-2013; Kaiser, Sebastian/AAF-1120-2020; Pfaffl, Michael/G-6622-2013; Theis, Fabian J/ABD-5212-2021	Krause, Sabine/0000-0002-3141-886X; Mueller, Nikola/0000-0001-8659-4548; Pfaffl, Michael/0000-0002-3192-1019; Theis, Fabian J/0000-0002-2419-1943; Bauersachs, Stefan/0000-0003-2450-1216	German Ministry of Education and Research (BMBF, Bonn, Germany) [S1, 01GM0601]; German Federal Ministry of Education and Research [01GM0887]; SIRION Biotech GmbH	German Ministry of Education and Research (BMBF, Bonn, Germany)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); SIRION Biotech GmbH	The "Muscle Tissue Culture Collection" is part of the German network on muscular dystrophies (MD-NET, service structure S1, 01GM0601) funded by the German Ministry of Education and Research (BMBF, Bonn, Germany, http://www.bmbf.de/). The Muscle Tissue Culture Collection is a partner of EuroBioBank (www.eurobiobank.org) and TREAT-NMD (EC, 6th FP, proposal #036825). This work was an individual research project within the MD-NET and was supported by a grant from the German Federal Ministry of Education and Research [01GM0887] which was granted to CT. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. SIRION Biotech GmbH provided support in the form of salaries for author CT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; [Anonymous], 2014, R LANG ENV STAT COMP; Armand AS, 2008, J BIOL CHEM, V283, P29004, DOI 10.1074/jbc.M801297200; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chen BH, 2013, CLINICS, V68, P825, DOI 10.6061/clinics/2013(06)17; Chen YX, 2011, PHYSIOL GENOMICS, V43, P621, DOI 10.1152/physiolgenomics.00136.2010; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Dopazo J, 1997, J MOL EVOL, V44, P226, DOI 10.1007/PL00006139; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Foulstone EJ, 2004, EXP CELL RES, V294, P223, DOI 10.1016/j.yexcr.2003.10.034; Foulstone EJ, 2001, J CELL PHYSIOL, V189, P207, DOI 10.1002/jcp.10017; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Friday BB, 2003, DIFFERENTIATION, V71, P217, DOI 10.1046/j.1432-0436.2003.710303.x; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Genomatix Software GmbH, GEN PATHW SYST GEPS; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Guo H, 2004, NATURE, V7308, P835; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Heyn H, 2011, INT J CANCER, V129, P2797, DOI 10.1002/ijc.25962; Hidaka H, 2012, ONCOTARGET, V3, P44; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Karalaki M, 2009, IN VIVO, V23, P779; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZZ, 2012, DEV CELL, V23, P1176, DOI 10.1016/j.devcel.2012.10.019; Luo W, 2013, J GENET GENOMICS, V40, P107, DOI 10.1016/j.jgg.2013.02.002; Lynch J, 2012, CARCINOGENESIS, V33, P976, DOI 10.1093/carcin/bgs114; Meyer SU, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0083-0; Meyer SU, 2014, METHODS MOL BIOL, V1160, P165, DOI 10.1007/978-1-4939-0733-5_15; Meyer SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038946; Muniategui A, 2013, BRIEF BIOINFORM, V14, P263, DOI 10.1093/bib/bbs028; Na YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S5-S17; Nakashima T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014334; Panguluri SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008760; Perbellini R, 2011, NEUROMUSCULAR DISORD, V21, P81, DOI 10.1016/j.nmd.2010.11.012; Polesskaya A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071927; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Ren HX, 2010, P NATL ACAD SCI USA, V107, P5857, DOI 10.1073/pnas.0909570107; Rinck A, 2013, RNA BIOL, V10, P1125, DOI 10.4161/rna.24955; Risso D, 2009, BIOINFORMATICS, V25, P2685, DOI 10.1093/bioinformatics/btp443; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Scarola M, 2010, CANCER RES, V70, P6925, DOI 10.1158/0008-5472.CAN-10-0141; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Seok HY, 2011, J BIOL CHEM, V286, P35339, DOI 10.1074/jbc.M111.273276; Shen H, 2013, MOL CELL BIOCHEM, V381, P105, DOI 10.1007/s11010-013-1692-9; Shu MF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-59; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Storz P, 1998, FEBS LETT, V440, P41, DOI 10.1016/S0014-5793(98)01421-5; Stupka N, 2006, NEUROMUSCULAR DISORD, V16, P337, DOI 10.1016/j.nmd.2006.03.003; Tili E, 2001, P NATL ACAD SCI USA, V12, P4908; Torgan CE, 2006, J HISTOCHEM CYTOCHEM, V54, P119, DOI 10.1369/jhc.5A6769.2005; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Xiong SW, 2013, PATHOL ONCOL RES, V19, P529, DOI 10.1007/s12253-013-9613-5; Xu J, 2013, ONCOGENE, V32, P976, DOI 10.1038/onc.2012.121; Yin LD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S19; Yusuf F, 2012, HISTOCHEM CELL BIOL, V138, P187, DOI 10.1007/s00418-012-0972-x; Zhao HP, 2013, STROKE, V44, P1706, DOI 10.1161/STROKEAHA.111.000504; Zhou R, 2013, PLOS ONE, V5; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	71	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135284	10.1371/journal.pone.0135284	http://dx.doi.org/10.1371/journal.pone.0135284			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270642	Green Published, gold			2022-12-27	WOS:000359492800047
J	Wu, SI; Chen, SC; Liu, SI; Sun, FJ; Juang, JJM; Lee, HC; Kao, KL; Dewey, ME; Prince, M; Stewart, R				Wu, Shu-I; Chen, Su-Chiu; Liu, Shen-Ing; Sun, Fang-Ju; Juang, Jimmy J. M.; Lee, Hsin-Chien; Kao, Kai-Liang; Dewey, Michael E.; Prince, Martin; Stewart, Robert			Relative Risk of Acute Myocardial Infarction in People with Schizophrenia and Bipolar Disorder: A Population-Based Cohort Study	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; CARDIOVASCULAR RISK; EXCESS MORTALITY; SCHIZOAFFECTIVE DISORDER; MENTAL-DISORDERS; FOLLOW-UP; INDIVIDUALS; BURDEN; ANTIPSYCHOTICS; PREVALENCE	Objective Despite high mortality associated with serious mental illness, risk of acute myocardial infarction (AMI) remains unclear, especially for patients with bipolar disorder. The main objective was to investigate the relative risk of AMI associated with schizophrenia and bipolar disorders in a national sample. Method Using nationwide administrative data, an 11-year historic cohort study was assembled, comprised of cases aged 18 and above who had received a diagnosis of schizophrenia or bipolar disorder, compared to a random sample of all other adults excluding those with diagnoses of serious mental illness. Incident AMI as a primary diagnosis was ascertained. Hazard ratios stratified by age and gender were calculated and Cox regression models were used to adjust for other covariates. Results A total of 70,225 people with schizophrenia or bipolar disorder and 207,592 people without serious mental illness were compared. Hazard ratios in men adjusted for age, income and urbanization were 1.15 (95% CI 1.01 similar to 1.32) for schizophrenia and 1.37 (1.08 similar to 1.73) for bipolar disorder, and in women, 1.85 (1.58 similar to 2.18) and 1.88(1.47 similar to 2.41) respectively. Further adjustment for treated hypertension, diabetes and hyperlipidaemia attenuated the hazard ratio for men with schizophrenia but not the other comparison groups. Hazard ratios were significantly stronger in women than men and were stronger in younger compared to older age groups for both disorders; however, gender modification was only significant in people with schizophrenia, and age modification only significant in people with bipolar disorder. Conclusions In this large national sample, schizophrenia and bipolar disorder were associated with raised risk of AMI in women and in the younger age groups although showed differences in potential confounding and modifying factors.	[Wu, Shu-I; Liu, Shen-Ing] Mackay Mem Hosp, Dept Psychiat, Taipei, Taiwan; [Wu, Shu-I] Mackay Med Coll, Dept Audiol & Speech Language Pathol, Taipei, Taiwan; [Chen, Su-Chiu] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Liu, Shen-Ing; Sun, Fang-Ju] Mackay Jr Coll Nursing, Taipei, Taiwan; [Liu, Shen-Ing; Sun, Fang-Ju] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Juang, Jimmy J. M.] Natl Taiwan Univ Hosp, Cardiovasc Ctr, Taipei, Taiwan; [Juang, Jimmy J. M.] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan; [Juang, Jimmy J. M.] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Lee, Hsin-Chien] Shuang Ho Hosp, Dept Psychiat, Taipei, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat, Taipei, Taiwan; [Kao, Kai-Liang] Far Eastern Mem Hosp, Dept Pediat, Taipei, Taiwan; [Dewey, Michael E.; Prince, Martin; Stewart, Robert] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London, England	Mackay Memorial Hospital; Mackay Medical College; National Taipei University of Nursing & Health Science (NTUNHS); Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Far Eastern Memorial Hospital; University of London; King's College London	Kao, KL (corresponding author), Far Eastern Mem Hosp, 21 Sec 2,Nan Ya South Rd, New Taipei City 220, Taiwan.	shuiwu624@gmail.com	Prince, Martin J/A-9170-2010; Wu, Shu-I./AGS-4856-2022; Dewey, Michael E/E-2049-2010; Stewart, Robert/B-1667-2010	Prince, Martin J/0000-0003-1379-7146; Wu, Shu-I./0000-0002-8461-5613; Dewey, Michael E/0000-0002-7522-3677; Stewart, Robert/0000-0002-4435-6397; Juang, Jyh-Ming Jimmy/0000-0003-4767-7636; lee, hsin-chien/0000-0002-7557-8259	NIHR Specialist Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	NIHR Specialist Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	The work received no financial support. All authors have completed the Unified Competing Interest form at and declare that (1) RS is funded by the NIHR Specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London; (2) all the other authors have no relationships with any company that might have an interest in the submitted work in the previous 3 years; (3) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) all the authors have no non-financial interests that may be relevant to the submitted work.	Allison DB, 1999, J CLIN PSYCHIAT, V60, P215, DOI 10.4088/JCP.v60n0402; Bak M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094112; Bellivier F, 2005, EUR PSYCHIAT, V20, pS335, DOI 10.1016/S0924-9338(05)80187-7; Bergemann N, 2005, SCHIZOPHR RES, V73, P357, DOI 10.1016/j.schres.2004.06.013; Bobes J, 2010, SCHIZOPHR RES, V119, P101, DOI 10.1016/j.schres.2010.02.1030; Bresee LC, 2010, SCHIZOPHR RES, V117, P75, DOI 10.1016/j.schres.2009.12.016; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212; Brown S, 1997, BRIT J PSYCHIAT, V171, P502, DOI 10.1192/bjp.171.6.502; Brown S, 2010, BRIT J PSYCHIAT, V196, P116, DOI 10.1192/bjp.bp.109.067512; Callaghan RC, 2010, J AFFECT DISORDERS, V122, P118, DOI 10.1016/j.jad.2009.06.029; Callaghan RC, 2009, SCHIZOPHR RES, V115, P325, DOI 10.1016/j.schres.2009.07.018; Cengel A, 2009, J POSTGRAD MED, V55, P305, DOI 10.4103/0022-3859.58944; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Cohn T, 2004, CAN J PSYCHIAT, V49, P753, DOI 10.1177/070674370404901106; Correll CU, 2015, WORLD PSYCHIATRY, V14, P56, DOI 10.1002/wps.20187; Cramer JA, 1998, PSYCHIATR SERV, V49, P196, DOI 10.1176/ps.49.2.196; Curkendall SM, 2004, J CLIN PSYCHIAT, V65, P715; de Baumont A, 2015, SCHIZOPHR RES, V161, P215, DOI 10.1016/j.schres.2014.10.055; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Dickey B, 2002, PSYCHIATR SERV, V53, P861, DOI 10.1176/appi.ps.53.7.861; Fountoulakis KN, 2010, PSYCHIAT RES, V176, P13, DOI 10.1016/j.psychres.2008.11.018; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Hirasawa-Fujita M, 2014, CLIN SCHIZOPHR RELAT, V20, P1, DOI [10.3371/csrp.mhmb.061314), DOI 10.3371/CSRP.MHMB.061314]; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2546, DOI 10.1001/jama.283.19.2546; Jakobsen AH, 2008, J AFFECT DISORDERS, V109, P177, DOI 10.1016/j.jad.2007.10.012; Joukamaa M, 2001, BRIT J PSYCHIAT, V179, P498, DOI 10.1192/bjp.179.6.498; Katon WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7; Kemp DE, 2013, J AFFECT DISORDERS, V148, P84, DOI 10.1016/j.jad.2012.11.054; Kilbourne AM, 2004, BIPOLAR DISORD, V6, P368, DOI 10.1111/j.1399-5618.2004.00138.x; Kilbourne AM, 2007, PSYCHOSOMATICS, V48, P412, DOI 10.1176/appi.psy.48.5.412; Kilbourne AM, 2009, GEN HOSP PSYCHIAT, V31, P555, DOI 10.1016/j.genhosppsych.2009.07.008; Kisely S, 2005, BRIT J PSYCHIAT, V187, P552, DOI 10.1192/bjp.187.6.552; Kisely S, 2009, BRIT J PSYCHIAT, V195, P545, DOI 10.1192/bjp.bp.109.067082; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P1673, DOI 10.4088/JCP.v68n1106; Laursen TM, 2009, ARCH GEN PSYCHIAT, V66, P713, DOI 10.1001/archgenpsychiatry.2009.61; Lawrence DM, 2003, BRIT J PSYCHIAT, V182, P31, DOI 10.1192/bjp.182.1.31; LEFF JP, 1971, BRIT MED J, V3, P599, DOI 10.1136/bmj.3.5775.599; Lin HC, 2008, PSYCHOSOM MED, V70, P73, DOI 10.1097/PSY.0b013e31815c1e93; Lin HC, 2010, AUST NZ J PSYCHIAT, V44, P273, DOI 10.3109/00048670903487209; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; National Health Insurance Research Database Taiwain, 2006, INTR NAT HLTH INS RE; National Health Insurance Research Database Taiwan, 2009, RAND PROC LONG HLTH; Newcomer JW, 2007, AM J MANAG CARE, V13, pS170; Newcomer JW, 2005, CNS DRUGS, V19, P1; Osborn DPJ, 2015, JAMA PSYCHIAT, V72, P143, DOI 10.1001/jamapsychiatry.2014.2133; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; Therneau TM, 2015, USING TIME DEPENDENT; Van Winkel R, 2008, J CLIN PSYCHIAT, V69, P472, DOI 10.4088/JCP.v69n0320; Vancampfort D, 2013, WORLD PSYCHIATRY, V12, P240, DOI 10.1002/wps.20069; Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502; Wu SI, 2015, ACTA PSYCHIAT SCAND, V131, P213, DOI 10.1111/acps.12345; Wu SI, 2013, PSYCHOSOM MED, V75, P52, DOI 10.1097/PSY.0b013e31827612a6; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	57	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134763	10.1371/journal.pone.0134763	http://dx.doi.org/10.1371/journal.pone.0134763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JX	26270347	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800016
J	Zheng, L; Hui, Q; Tang, L; Zheng, LL; Jin, Z; Yu, BJ; Wang, ZT; Lin, P; Yu, WD; Li, HY; Li, XK; Wang, XJ				Zheng, Long; Hui, Qi; Tang, Lu; Zheng, Lulu; Jin, Zi; Yu, Bingjie; Wang, Zhitao; Lin, Peng; Yu, Weidan; Li, Haiyan; Li, Xiaokun; Wang, Xiaojie			TAT-Mediated Acidic Fibroblast Growth Factor Delivery to the Dermis Improves Wound Healing of Deep Skin Tissue in Rat	PLOS ONE			English	Article							TNF-ALPHA; PROTEIN; EXPRESSION; PROTECTION; APOPTOSIS; BETA; FGF	Background The definition of deep tissue injury was derived from multiple clinical cases as "A purple or maroon localized area of discolored intact skin or blood-filled blister due to damage of underlying soft tissue from pressure and/or shear". Acidic fibroblast growth factor (aFGF) significantly improves wound healing under diabetic conditions. However, to date, the therapeutic application of aFGF has been limited, due to its low delivery efficiency and short half-life. Methodology/Principal Findings Using an animal model of magnet-induced pressure ulcers, transactivator of transcription protein (TAT)-aFGF was evaluated for transdermal delivery and wound healing. Immunohistochemistry and Western blotting were also performed to determine the expression of transforming growth factor (TGF)-beta 1, alpha-smooth muscle actin (alpha-SMA), CD68, proliferating cell nuclear antigen (PCNA) and TGF-beta-receptor II (TGF-beta RII) in cultured human dermal fibroblasts. We found that that mice treated with TAT-aFGF had higher accumulation of aFGF in both dermis and subcutaneous tissues compared with mice treated with aFGF alone. In the remodeling phase, TAT-aFGF treatment decreased the expression of alpha-SMA to normal levels, thereby facilitating normal wound healing processes and abrogating hypertrophic scarring. In human dermal fibroblasts, TAT-aFGF reversed the suppressive effect of TNF-alpha on alpha-SMA expression and restored TGF-beta RII and TGF-beta 1 expression. Conclusions/Significance Our results demonstrate that TAT-aFGF has a favorable therapeutic effect on the healing of subcutaneous deep tissue injury.	[Zheng, Long; Hui, Qi; Tang, Lu; Zheng, Lulu; Jin, Zi; Yu, Bingjie; Wang, Zhitao; Lin, Peng; Yu, Weidan; Li, Haiyan; Li, Xiaokun; Wang, Xiaojie] Wenzhou Med Univ, Sch Pharm, Wenzhou 325035, Peoples R China; [Li, Haiyan; Li, Xiaokun; Wang, Xiaojie] Jilin Agr Univ, Minist Educ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Changchun 130118, Peoples R China	Wenzhou Medical University; Jilin Agricultural University	Li, HY (corresponding author), Wenzhou Med Univ, Sch Pharm, Chashan Univ Pk, Wenzhou 325035, Peoples R China.	hyli99@163.com; lixk1964@163.com; wangxiaojie1972@126.com	zheng, lu/GXH-7035-2022; zheng, long/AFT-4046-2022	Dettman, Robert/0000-0002-3074-5922; ZHENG, LONG/0000-0003-3899-105X	National High Technology Research and Development Program (863 program) of China [2011AA100606]; National Natural Science Foundation of China [81070714]; Significant new drugs creation [2013ZX09103003-005]	National High Technology Research and Development Program (863 program) of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Significant new drugs creation	This work was supported by Grants from the National High Technology Research and Development Program (863 program) of China (N0.2011AA100606), the National Natural Science Foundation of China (No. 81070714) and Significant new drugs creation (2013ZX09103003-005).	Ankrom Michael A, 2005, Adv Skin Wound Care, V18, P35, DOI 10.1097/00129334-200501000-00016; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bing M, 2007, WOUND REPAIR REGEN, V15, P795, DOI 10.1111/j.1524-475X.2007.00307.x; Black Joyce, 2007, Dermatol Nurs, V19, P343; Cuevas P, 1997, Eur J Med Res, V2, P465; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fu XB, 2004, WORLD J GASTROENTERO, V10, P3590, DOI 10.3748/wjg.v10.i24.3590; Goldberg MT, 2007, J INVEST DERMATOL, V127, P2645, DOI 10.1038/sj.jid.5700890; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Huang Y, 2008, APPL MICROBIOL BIOT, V77, P1015, DOI 10.1007/s00253-007-1249-5; Huang ZF, 2011, WOUND REPAIR REGEN, V19, P633, DOI 10.1111/j.1524-475X.2011.00722.x; Jin KM, 2008, J CONTROL RELEASE, V127, P249, DOI 10.1016/j.jconrel.2008.01.015; Kimura M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/592791; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Lee J, 2009, J CONTROL RELEASE, V137, P196, DOI 10.1016/j.jconrel.2009.04.008; Lim KS, 2013, J CONTROL RELEASE, V169, P306, DOI 10.1016/j.jconrel.2013.01.023; Liu LH, 2008, BIOPOLYMERS, V90, P617, DOI 10.1002/bip.20998; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; Mao CL, 2010, ANN PHARMACOTHER, V44, P325, DOI 10.1345/aph.1M315; MATUSZEWSKA B, 1994, PHARM RES-DORDR, V11, P65, DOI 10.1023/A:1018993610801; MAUVIEL A, 1993, CURR BIOL, V3, P822, DOI 10.1016/0960-9822(93)90216-B; Murthy S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/972028; Roy SG, 2001, INT J BIOCHEM CELL B, V33, P723, DOI 10.1016/S1357-2725(01)00041-3; Shi HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059966; Stadler I, 2004, J INVEST SURG, V17, P221, DOI 10.1080/08941930490472046; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tong M, 2009, WOUND REPAIR REGEN, V17, P840, DOI 10.1111/j.1524-475X.2009.00548.x; Wang SC, 2014, TRENDS PHARMACOL SCI, V35, P178, DOI 10.1016/j.tips.2014.02.004; Wang Y, 2010, J CELL MOL MED, V14, P1998, DOI 10.1111/j.1582-4934.2009.00786.x; Xie LY, 2011, DIABETES RES CLIN PR, V93, P396, DOI 10.1016/j.diabres.2011.05.016; Yamane K, 2003, J IMMUNOL, V171, P3855, DOI 10.4049/jimmunol.171.7.3855; Yang JB, 2010, LASER MED SCI, V25, P251, DOI 10.1007/s10103-009-0721-0; Zhang Y, 2012, J CLIN IMMUNOL, V32, P1270, DOI 10.1007/s10875-012-9724-x; Zou XY, 2012, EXP BIOL MED, V237, P1023, DOI 10.1258/ebm.2012.012033	35	16	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135291	10.1371/journal.pone.0135291	http://dx.doi.org/10.1371/journal.pone.0135291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271041	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800050
J	Coleman, S; Hornig, J; Maddux, S; Choi, KY; McGregor, A				Coleman, Stewart; Hornig, Julia; Maddux, Sarah; Choi, K. Yeon; McGregor, Alistair			Viral Glycoprotein Complex Formation, Essential Function and Immunogenicity in the Guinea Pig Model for Cytomegalovirus	PLOS ONE			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; COMPLETE DNA-SEQUENCE; MOLECULAR CHARACTERIZATION; ANIMAL-MODELS; GPCMV GENOME; INFECTION; IDENTIFICATION; ANTIBODY; HCMV; ENVELOPE	Development of a cytomegalovirus (CMV) vaccine is a major public health priority due to the risk of congenital infection. A key component of a vaccine is thought to be an effective neutralizing antibody response against the viral glycoproteins necessary for cell entry. Species specificity of human CMV (HCMV) precludes direct studies in an animal model. The guinea pig is the only small animal model for congenital cytomegalovirus infection. Analysis of the guinea pig CMV (GPCMV) genome indicates that it potentially encodes homologs to the HCMV glycoproteins (including gB, gH, gL, gM, gN and gO) that form various cell entry complexes on the outside of the virus: gCI (gB); gCII (gH/gL/gO); gCIII (gM/gN). The gB homolog (GP55) has been investigated as a candidate subunit vaccine but little is known about the other homolog proteins. GPCMV glycoproteins were investigated by transient expression studies which indicated that homolog glycoproteins to gN and gM, or gH, gL and gO were able to co-localize in cells and generate respective homolog complexes which could be verified by immunoprecipitation assays. ELISA studies demonstrated that the individual complexes were highly immunogenic in guinea pigs. The gO (GP74) homolog protein has 13 conserved N-glycosylation sites found in HCMV gO. In transient expression studies, only the glycosylated protein is detected but in virus infected cells both N-glycosylated and non-glycosylated gO protein were detected. In protein interaction studies, a mutant gO that lacked N-glycosylation sites had no impact on the ability of the protein to interact with gH/gL which indicated a potential alternative function associated with these sites. Knockout GPCMV BAC mutagenesis of the respective glycoprotein genes (GP55 for gB, GP75 for gH, GP115 for gL, GP100 for gM, GP73 for gN and GP74 for gO) in separate reactions was lethal for virus regeneration on fibroblast cells which demonstrated the essential nature of the GPCMV glycoproteins. The gene knockout results were similar to HCMV, except in the case of the gO homolog, which was non-essential in epithelial tropic virus but essential in lab adapted GPCMV. Overall, the findings demonstrate the similarity between HCMV and GPCMV glycoproteins and strengthen the relevance of this model for development of CMV intervention strategies.	[Coleman, Stewart; Hornig, Julia; Maddux, Sarah; Choi, K. Yeon; McGregor, Alistair] Texas A&M Univ, Coll Med, Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	McGregor, A (corresponding author), Texas A&M Univ, Coll Med, Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77843 USA.	mcgregor@medicine.tamhsc.edu		Maddux, Sarah/0000-0002-7160-566X	National Institute of Health (NIH); National Institute of Allergy and Infectious Disease (NIAID) [R01AI100933, R01AI098984, R21AI090156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080972, R01AI100933, R01AI098984, R21AI090156] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institute of Health (NIH); National Institute of Allergy and Infectious Disease (NIAID) (http://www.niaid.nih.gov/Pages/default.aspx) R01AI100933; R01AI098984; R21AI090156.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Auerbach M, 2013, VIROLOGY, V441, P75, DOI 10.1016/j.virol.2013.03.008; Auerbach MR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004060; BIA FJ, 1980, J INFECT DIS, V142, P732, DOI 10.1093/infdis/142.5.732; BOPPANA SB, 1995, J INFECT DIS, V171, P182, DOI 10.1093/infdis/171.1.182; Brady RC, 1996, ARCH VIROL, V141, P2409, DOI 10.1007/BF01718640; BRATCHER DF, 1995, J INFECT DIS, V172, P944, DOI 10.1093/infdis/172.4.944; Britt WJ, 1996, INTERVIROLOGY, V39, P401, DOI 10.1159/000150510; BRITT WJ, 1990, J VIROL, V64, P1079, DOI 10.1128/JVI.64.3.1079-1085.1990; BRITT WJ, 1994, VIROLOGY, V201, P294, DOI 10.1006/viro.1994.1294; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Cheng TP, 2010, J VIROL, V84, P2623, DOI 10.1128/JVI.02142-09; Ciferri C, 2015, P NATL ACAD SCI USA, V112, P1767, DOI 10.1073/pnas.1424818112; Colugnati FAB, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-71; Cui XH, 2008, J VIROL METHODS, V149, P231, DOI 10.1016/j.jviromet.2008.01.031; Dargan DJ, 2010, J GEN VIROL, V91, P1535, DOI 10.1099/vir.0.018994-0; Davison AJ, 2003, J GEN VIROL, V84, P17, DOI 10.1099/vir.0.18606-0; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Fouts AE, 2012, J VIROL, V86, P7444, DOI 10.1128/JVI.00467-12; Fowler KB, 2003, JAMA-J AM MED ASSOC, V289, P1008, DOI 10.1001/jama.289.8.1008; GAO M, 1984, J VIROL, V52, P436, DOI 10.1128/JVI.52.2.436-447.1984; GRETCH DR, 1988, J VIROL, V62, P875, DOI 10.1128/JVI.62.3.875-881.1988; GRIFFITH BP, 1985, J VIROL, V55, P402, DOI 10.1128/JVI.55.2.402-409.1985; Griffiths PD, 2005, CURR OPIN INFECT DIS, V18, P241, DOI 10.1097/01.qco.0000168385.39390.1b; Hansen SG, 2003, J VIROL, V77, P6620, DOI 10.1128/JVI.77.12.6620-6636.2003; HARRISON CJ, 1995, J INFECT DIS, V172, P1212, DOI 10.1093/infdis/172.5.1212; Hashimoto K, 2013, VACCINE, V31, P3199, DOI 10.1016/j.vaccine.2013.04.078; Hobom U, 2000, J VIROL, V74, P7720, DOI 10.1128/JVI.74.17.7720-7729.2000; Huber MT, 1998, J VIROL, V72, P8191, DOI 10.1128/JVI.72.10.8191-8197.1998; Kanai K, 2011, J GEN VIROL, V92, P1005, DOI 10.1099/vir.0.027789-0; KARI B, 1993, J GEN VIROL, V74, P255, DOI 10.1099/0022-1317-74-2-255; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kern ER, 2006, ANTIVIR RES, V71, P164, DOI 10.1016/j.antiviral.2006.05.018; Kropff B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002999; KUMAR ML, 1978, J INFECT DIS, V138, P650, DOI 10.1093/infdis/138.5.650; Lilleri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059863; Mach M, 2005, J VIROL, V79, P2160, DOI 10.1128/JVI.79.4.2160-2170.2005; Marsh AK, 2011, J VIROL, V85, P12995, DOI 10.1128/JVI.05840-11; Mattick C, 2004, VIROLOGY, V318, P582, DOI 10.1016/j.virol.2003.09.036; McGregor A, 2004, J VIROL, V78, P9872, DOI 10.1128/JVI.78.18.9872-9889.2004; McGregor A, 2004, VIRUS RES, V101, P101, DOI 10.1016/j.virusres.2003.12.030; McGregor A, 2011, VIROLOGY, V410, P76, DOI 10.1016/j.virol.2010.10.028; McGregor A, 2001, MOL GENET METAB, V72, P15, DOI 10.1006/mgme.2000.3102; McGregor A, 2013, CYTOMEGALOVIRUSES: FROM MOLECULAR PATHOGENESIS TO INTERVENTION, VOL II, P88; McGregor A, 2013, ANIMAL MODELS FOR THE STUDY OF HUMAN DISEASE, P905, DOI 10.1016/B978-0-12-415894-8.00037-3; McGregor A, 2011, EXPERT OPIN DRUG MET, V7, P1245, DOI 10.1517/17425255.2011.613824; McGregor Alistair, 2010, Inflammation & Allergy Drug Targets, V9, P286; McGregor A, 2010, ANTIVIR RES, V86, pA23, DOI 10.1016/j.antiviral.2010.02.344; McGregora A, 2008, ANTIVIR RES, V78, P250, DOI 10.1016/j.antiviral.2008.01.008; Mess A, 2007, PLACENTA, V28, P812, DOI 10.1016/j.placenta.2007.02.005; Nozawa N, 2008, VIROLOGY, V379, P45, DOI 10.1016/j.virol.2008.06.018; Paglino JC, 1999, ARCH VIROL, V144, P447, DOI 10.1007/s007050050517; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pignatelli S, 2003, J GEN VIROL, V84, P647, DOI 10.1099/vir.0.18704-0; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Ross Shannon A, 2005, Semin Pediatr Infect Dis, V16, P44, DOI 10.1053/j.spid.2004.09.011; Ryckman BJ, 2008, J VIROL, V82, P60, DOI 10.1128/JVI.01910-07; Ryckman BJ, 2010, J VIROL, V84, P2597, DOI 10.1128/JVI.02256-09; Schleiss MR, 2006, VACCINE, V24, P6175, DOI 10.1016/j.vaccine.2006.06.077; Schleiss MR, 2014, VIRUSES-BASEL, V6, P448, DOI 10.3390/v6020448; Schleiss MR, 2013, FUTURE VIROL, V8, P1151, DOI 10.2217/fvl.13.107; Schleiss MR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-139; Schleiss MR, 1999, VIRUS GENES, V19, P205, DOI 10.1023/A:1008136714136; SCHLEISS MR, 1994, VIROLOGY, V202, P173, DOI 10.1006/viro.1994.1333; Schleiss MR, 2004, J INFECT DIS, V189, P1374, DOI 10.1086/382751; Schleiss MR, 2003, J INFECT DIS, V188, P1868, DOI 10.1086/379839; SCHLEISS MR, 1995, J GEN VIROL, V76, P1827, DOI 10.1099/0022-1317-76-7-1827; Schleiss MR, 2013, GENOME ANNOUC, V1, DOI [10.1128/genomeA.01052-13, DOI 10.1128/GEN0MEA.01052-13]; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Shen SY, 2007, VACCINE, V25, P3319, DOI 10.1016/j.vaccine.2007.01.011; Shimamura M, 2006, J VIROL, V80, P4591, DOI 10.1128/JVI.80.9.4591-4600.2006; Vink C, 2000, J VIROL, V74, P7656, DOI 10.1128/JVI.74.16.7656-7665.2000; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wang D, 2005, J VIROL, V79, P10330, DOI 10.1128/JVI.79.16.10330-10338.2005; Wille PT, 2010, J VIROL, V84, P2585, DOI 10.1128/JVI.02249-09; WOOLF NK, 1991, TRANSPLANT P, V23, P32; Yamada S, 2009, VIROLOGY, V391, P99, DOI 10.1016/j.virol.2009.05.034; YIN CY, 1990, J VIROL, V64, P1537, DOI 10.1128/JVI.64.4.1537-1548.1990; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100; Zhou MM, 2013, J VIROL, V87, P9680, DOI 10.1128/JVI.01167-13	82	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135567	10.1371/journal.pone.0135567	http://dx.doi.org/10.1371/journal.pone.0135567			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267274	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300136
J	Gao, M; Tian, RL; Wen, JH; Xiong, QY; Ling, B; Yang, LD				Gao, Min; Tian, Renli; Wen, Junhao; Xiong, Qingyu; Ling, Bin; Yang, Linda			Item Anomaly Detection Based on Dynamic Partition for Time Series in Recommender Systems	PLOS ONE			English	Article							ATTACKS	In recent years, recommender systems have become an effective method to process information overload. However, recommendation technology still suffers from many problems. One of the problems is shilling attacks-attackers inject spam user profiles to disturb the list of recommendation items. There are two characteristics of all types of shilling attacks: 1) Item abnormality: The rating of target items is always maximum or minimum; and 2) Attack promptness: It takes only a very short period time to inject attack profiles. Some papers have proposed item anomaly detection methods based on these two characteristics, but their detection rate, false alarm rate, and universality need to be further improved. To solve these problems, this paper proposes an item anomaly detection method based on dynamic partitioning for time series. This method first dynamically partitions item-rating time series based on important points. Then, we use chi square distribution (chi(2)) to detect abnormal intervals. The experimental results on MovieLens 100K and 1M indicate that this approach has a high detection rate and a low false alarm rate and is stable toward different attack models and filler sizes.	[Gao, Min; Tian, Renli; Wen, Junhao; Xiong, Qingyu] Minist Educ, Key Lab Dependable Serv Comp Cyber Phys Soc, Chongqing 400044, Peoples R China; [Gao, Min; Tian, Renli; Wen, Junhao; Xiong, Qingyu] Chongqing Univ, Sch Software Engn, Chongqing 400044, Peoples R China; [Ling, Bin; Yang, Linda] Univ Portsmouth, Sch Engn, Portsmouth PO1 3AH, Hants, England	Chongqing University; University of Portsmouth	Gao, M (corresponding author), Minist Educ, Key Lab Dependable Serv Comp Cyber Phys Soc, Chongqing 400044, Peoples R China.	gaomin@cqu.edu.cn		Yang, Yanyan/0000-0003-1047-2274	National Natural Science Foundation of China [71102065]; National Key Basic Research Program of China (973 Program) [2013CB328903]; China Postdoctoral Science Foundation [2012M521680]; Fundamental Research Funds for the Central Universities [106112014CDJZR095502, CDJZR12090001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (71102065, http://www.nsfc.gov.cn/,MG), National Key Basic Research Program of China (973 Program, 2013CB328903, http://www.973.gov.cn/AreaAppl.aspx), China Postdoctoral Science Foundation (2012M521680, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx, MG), and Fundamental Research Funds for the Central Universities (106112014CDJZR095502&CDJZR12090001, http://www.edu.cn/zheng_ce_fa_gui_1115/20090820/t20090820_400962.shtml, MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilge A, 2014, PROCEDIA COMPUT SCI, V31, P165, DOI 10.1016/j.procs.2014.05.257; Bobadilla J, 2013, KNOWL-BASED SYST, V46, P109, DOI 10.1016/j.knosys.2013.03.012; Bryan K, 2008, RECSYS'08: PROCEEDINGS OF THE 2008 ACM CONFERENCE ON RECOMMENDER SYSTEMS, P155; Burke R, 2005, DAT MIN 5 IEEE INT C; Burke R, 2006, P 12 ACM SIGKDD INT, P542, DOI [10.1145/1150402.1150465, DOI 10.1145/1150402.1150465]; Burke R, 2005, PERS WORKSH NEXT GEN; Cao J, 2013, WORLD WIDE WEB, V16, P729, DOI 10.1007/s11280-012-0164-6; Chirita P.-A., 2005, 7 ACM INT WORKSH WEB, P67, DOI DOI 10.1145/1097047.1097061; Dellarocas C., 2000, EC'00. Proceedings of the 2nd ACM Conference on Electronic Commerce, P150, DOI 10.1145/352871.352889; Gao M, 2014, SCI WORLD J, DOI 10.1155/2014/845897; Hurley N., 2009, P 2009 ACM C REC SYS, P149; Mehta B., 2007, AAAI, P1402, DOI [10.5555/1619797.1619870, DOI 10.5555/1619797.1619870]; Mehta B, 2007, 2007 INTERNATIONAL CONFERENCE ON INTELLIGENT USER INTERFACES, P14; Mehta B, 2009, USER MODEL USER-ADAP, V19, P65, DOI 10.1007/s11257-008-9050-4; Mobasher B., 2005, P 2005 WEBKDD WORKSH; Mobasher B, 2006, LECT NOTES ARTIF INT, V4198, P96; OMahony M., 2004, ACM T INTERNET TECHN, V4, DOI DOI 10.1145/1031114.1031116; Palmisano C, 2008, IEEE T KNOWL DATA EN, V20, P1535, DOI 10.1109/TKDE.2008.110; PAVLIDIS T, 1974, IEEE T COMPUT, VC 23, P860, DOI 10.1109/T-C.1974.224041; Rong WG, 2015, INFORM SYST FRONT, V17, P1265, DOI 10.1007/s10796-014-9495-4; Williams C., 2006, DEPAUL U CTI TECHNIC, P1; Wu Z., 2012, P 18 INT C KNOWLEDGE, P985, DOI 10.1145/2339530.2339684; Zhang F, 2014, KNOWL-BASED SYST, V65, P96, DOI 10.1016/j.knosys.2014.04.020; Zhang S., 2006, ACM SIGKDD INT C KNO, P809, DOI 10.1145/1150402.1150508; Zhang ZK, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/28002; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648	27	5	5	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135155	10.1371/journal.pone.0135155	http://dx.doi.org/10.1371/journal.pone.0135155			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267477	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300083
J	Jorgenrud, B; Jalanko, M; Helio, T; Jaaskelainen, P; Laine, M; Hilvo, M; Nieminen, MS; Laakso, M; Hyotylainen, T; Oresic, M; Kuusisto, J				Jorgenrud, Benedicte; Jalanko, Mikko; Helio, Tiina; Jaaskelainen, Pertti; Laine, Mika; Hilvo, Mika; Nieminen, Markku S.; Laakso, Markku; Hyotylainen, Tuulia; Oresic, Matej; Kuusisto, Johanna			The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							BINDING PROTEIN-C; LEFT-VENTRICULAR HYPERTROPHY; AMINO-ACID-METABOLISM; MASS-SPECTROMETRY; DILATED CARDIOMYOPATHY; FOUNDER MUTATIONS; ALPHA-TROPOMYOSIN; EASTERN FINLAND; GENE; HEART	Aims Mutations in the cardiac myosin-binding protein C gene (MYBPC3) are the most common genetic cause of hypertrophic cardiomyopathy (HCM) worldwide. The molecular mechanisms leading to HCM are poorly understood. We investigated the metabolic profiles of mutation carriers with the HCM-causing MYBPC3-Q1061X mutation with and without left ventricular hypertrophy (LVH) and non-affected relatives, and the association of the meta-bolome to the echocardiographic parameters. Methods and Results 34 hypertrophic subjects carrying the MYBPC3-Q1061X mutation, 19 non-hypertrophic mutation carriers and 20 relatives with neither mutation nor hypertrophy were examined using comprehensive echocardiography. Plasma was analyzed for molecular lipids and polar metabolites using two metabolomics platforms. Concentrations of branched chain amino acids, triglycerides and ether phospholipids were increased in mutation carriers with hypertrophy as compared to controls and non-hypertrophic mutation carriers, and correlated with echocardiographic LVH and signs of diastolic and systolic dysfunction in subjects with the MYBPC3-Q1061X mutation. Conclusions Our study implicates the potential role of branched chain amino acids, triglycerides and ether phospholipids in HCM, as well as suggests an association of these metabolites with remodeling and dysfunction of the left ventricle.	[Jorgenrud, Benedicte] Oslo Univ Hosp, Aker Hosp, Hormone Lab, Oslo, Norway; [Jorgenrud, Benedicte] Oslo Univ Hosp, Dept Pediat Res, Div Women & Childrens Hlth, Oslo, Norway; [Jalanko, Mikko; Helio, Tiina; Laine, Mika; Nieminen, Markku S.] Univ Helsinki, Cent Hosp, Dept Cardiol, Helsinki, Finland; [Jaaskelainen, Pertti] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Laakso, Markku; Kuusisto, Johanna] Univ Eastern Finland, Kuopio, Finland; [Laakso, Markku; Kuusisto, Johanna] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland; [Hyotylainen, Tuulia; Oresic, Matej] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Hilvo, Mika; Hyotylainen, Tuulia; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland	University of Oslo; University of Oslo; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Steno Diabetes Center; VTT Technical Research Center Finland	Oresic, M (corresponding author), Steno Diabet Ctr, DK-2820 Gentofte, Denmark.	mtjo@steno.dk	Oresic, Matej/K-7673-2016; Hilvo, Mika/AAC-7468-2020; Hyötyläinen, Tuulia/AAP-6266-2020; Oresic, Matej/AAV-3978-2020	Oresic, Matej/0000-0002-2856-9165; Jalanko, Mikko/0000-0001-5409-3300; Hyotylainen, Tuulia/0000-0002-1389-8302; Jorgenrud, Benedicte/0000-0001-5917-8776; Hilvo, Mika/0000-0003-0663-5843	Finnish Foundation of Cardiovascular Research; University Hospital of Kuopio [5101048/2009, 5101056/2012]; Finnish Academy [114396/2006]; Finnish Medical Foundation; University Hospital of Helsinki [TYH2012120, TYH2014208]; Aarne Koskelo Foundation; Research Council of Norway [214191]	Finnish Foundation of Cardiovascular Research; University Hospital of Kuopio; Finnish Academy(Academy of Finland); Finnish Medical Foundation; University Hospital of Helsinki; Aarne Koskelo Foundation; Research Council of Norway(Research Council of Norway)	The work was supported by the following: The Finnish Foundation of Cardiovascular Research (31.3.2007; 19.3.2009; 23.3.2010; 22.3.2012) to J.K., URL: http://www.sydantutkimussaatio.fi/welcome-to-the-finnish-foundation-for-cardiovascular-research/?lang=en; The special governmental subsidy for health sciences research of the University Hospital of Kuopio (5101048/2009; 5101056/2012) to J.K., URL: https://www.psshp.fi/web/en/frontpage; The Finnish Academy (114396/2006) to J.K., URL: http://www.aka.fi/en-GB/A/; The Finnish Medical Foundation to T. Helio, URL: http://www.european-funding-guide.eu/scholarship/14778-scholarship; The special governmental subsidy for health sciences research of the University Hospital of Helsinki (TYH2012120; TYH2014208) to T. Helio, URL: http://www.hyksin.com/en/index.php/Company/Helsinki%20University%20Hospital; The Aarne Koskelo Foundation to M.J., URL: http://www.aarnekoskelonsaatio.fi/; and The Research Council of Norway (214191) to B.J., URL: http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D, 2011, EUR J CLIN INVEST, V41, P527, DOI 10.1111/j.1365-2362.2010.02441.x; Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; Castillo S, 2011, ANAL CHEM, V83, P3058, DOI 10.1021/ac103308x; Charron P, 1998, CIRCULATION, V97, P2230, DOI 10.1161/01.CIR.97.22.2230; Crilley JG, 2003, J AM COLL CARDIOL, V41, P1776, DOI 10.1016/S0735-1097(02)03009-7; Dalgaard P, 2008, STAT COMPUT SER, P1, DOI 10.1007/978-0-387-79054-1_1; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Fraley C., 2007, J STAT SOFTW, V18, P1, DOI DOI 10.18637/JSS.V018.I06; Griffin JL, 2011, NAT REV CARDIOL, V8, P630, DOI 10.1038/nrcardio.2011.138; Huang Y, 2011, CARDIOVASC RES, V90, P220, DOI 10.1093/cvr/cvr070; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jaaskelainen P, 2004, ANN MED, V36, P23, DOI 10.1080/07853890310017161; Jaaskelainen P, 2002, J MOL MED-JMM, V80, P412, DOI 10.1007/s00109-002-0323-9; Jaaskelainen P, 2013, ANN MED, V45, P85, DOI 10.3109/07853890.2012.671534; Kampstra P, 2008, J STAT SOFT; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Lenz EM, 2004, J PHARMACEUT BIOMED, V36, P841, DOI 10.1016/j.jpba.2004.08.002; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Maekawa K, 2013, J MOL CELL CARDIOL, V59, P76, DOI 10.1016/j.yjmcc.2013.02.008; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; MARON BJ, 1986, NEW ENGL J MED, V315, P610, DOI 10.1056/NEJM198609043151003; Marston S, 2009, CIRC RES, V105, P219, DOI 10.1161/CIRCRESAHA.109.202440; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Nikkila Janne, 2008, Mol Syst Biol, V4, P197, DOI 10.1038/msb.2008.34; Nishimura RA, 2003, CIRCULATION, V108, pE133, DOI 10.1161/01.CIR.0000097621.97566.96; Novak F, 2009, PHYSIOL RES, V58, pS13, DOI 10.33549/physiolres.931924; Nygren H, 2011, METHODS MOL BIOL, V708, P247, DOI 10.1007/978-1-61737-985-7_15; Oresic M, 2009, NUTR METAB CARDIOVAS, V19, P816, DOI 10.1016/j.numecd.2009.04.018; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Peddinti G, 2013, R PACKAGE FOR METABO; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; SPIRITO P, 1987, J AM COLL CARDIOL, V9, P1013, DOI 10.1016/S0735-1097(87)80301-7; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Sysi-Aho M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015744; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Timmer SAJ, 2011, EUR J HEART FAIL, V13, P1283, DOI 10.1093/eurjhf/hfr135; Tuunanen H, 2007, J NUCL CARDIOL, V14, P354, DOI 10.1016/j.nuclcard.2006.12.329; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023	43	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134184	10.1371/journal.pone.0134184	http://dx.doi.org/10.1371/journal.pone.0134184			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267065	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300036
J	Teyhan, A; Galobardes, B; Henderson, J				Teyhan, Alison; Galobardes, Bruna; Henderson, John			Child Allergic Symptoms and Well-Being at School: Findings from ALSPAC, a UK Cohort Study	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; QUALITY-OF-LIFE; PROSPECTIVE BIRTH COHORT; INNER-CITY CHILDREN; ATOPIC-DERMATITIS; MENTAL-HEALTH; ASTHMA; ECZEMA; SLEEP; ANXIETY	Background Eczema and asthma are common conditions in childhood that can influence children's mental health. Despite this, little is known about how these conditions affect the well-being of children in school. This study examines whether symptoms of eczema or asthma are associated with poorer social and mental well-being in school as reported by children and their teachers at age 8 years. Methods Participants were from the Avon Longitudinal Study of Parents and Children. Measures of child well-being in school were child-reported (n = 6626) and teacher reported (n = 4366): children reported on their enjoyment of school and relationships with peers via a self-complete questionnaire; teachers reported child mental well-being using the Strengths and Difficulties Questionnaire [binary outcomes were high 'internalizing' (anxious/depressive) and 'externalizing' (oppositional/hyperactive) problems (high was > 90th percentile)]. Child rash and wheeze status were maternally reported and symptoms categorised as: 'none'; 'early onset transient' (infancy/preschool only); 'persistent' (infancy/preschool and at school age); and 'late onset' (school age only). Results Children with persistent (OR 1.29, 95% CI 1.02 to 1.63) and late onset (OR 1.48, 95% CI 1.02 to 2.14) rash were more likely to report being bullied, and children with persistent wheeze to feel left out (OR 1.42, 95% CI 1.10 to 1.84). Late onset rash was associated with high teacher-reported internalising behaviours (OR 1.61, 95% CI 1.02 to 2.54), and persistent rash with high externalising behaviours (OR 1.37, 95% CI 1.02 to 1.84). Child sleep and maternal mental health explained some of the associations with teacher-reported mental well-being. Conclusion Symptoms of eczema or asthma can adversely affect a child's social and mental well-being at primary school. This suggests interventions, such as additional support or education of peers, should begin at early stages in schooling.	[Teyhan, Alison; Galobardes, Bruna; Henderson, John] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Bristol	Teyhan, A (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	alison.teyhan@bristol.ac.uk		Teyhan, Alison/0000-0002-4965-3139	UK Medical Research Council; Wellcome Trust [102215/2/13/2, 089979]; University of Bristol; Medical Research Council [MC_PC_15018] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council (www.mrc.ac.uk) and the Wellcome Trust (www.wellcome.ac.uk) (Grant ref: 102215/2/13/2) and the University of Bristol (www.bris.ac.uk) provide core support for ALSPAC. Bruna Galobardes is funded by a Wellcome Trust fellowship (grant number: 089979). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SE, 2012, J PEDIATR PSYCHOL, V37, P580, DOI 10.1093/jpepsy/jss007; Ben-Gashir MA, 2004, BRIT J DERMATOL, V150, P284, DOI 10.1111/j.1365-2133.2004.05776.x; Berger KS, 2007, DEV REV, V27, P90, DOI 10.1016/j.dr.2006.08.002; Blackman JA, 2007, J DEV BEHAV PEDIATR, V28, P92, DOI 10.1097/01.DBP.0000267557.80834.e5; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Calam R, 2005, PSYCHOSOM MED, V67, P105, DOI 10.1097/01.psy.0000151490.77622.37; Camfferman D, 2010, J CLIN SLEEP MED, V6, P581; Collins JE, 2008, J ASTHMA, V45, P489, DOI 10.1080/02770900802074802; Cookson H, 2009, J ALLERGY CLIN IMMUN, V123, P847, DOI 10.1016/j.jaci.2009.01.042; Dean BB, 2010, J ASTHMA, V47, P539, DOI 10.3109/02770900903580868; Drake L, 2001, J AM ACAD DERMATOL S, V44, pS65, DOI [http://dx.doi.org/10.1067/mjd.2001.109814, DOI 10.1067/MJD.2001.109814.PMID:11145797]; Fagnano M, 2009, PEDIATRICS, V124, P218, DOI 10.1542/peds.2008-2525; Feitosa CA, 2011, J PSYCHOSOM RES, V71, P160, DOI 10.1016/j.jpsychores.2011.02.004; Genuneit J, 2014, PEDIAT ALLERG IMM-UK, V25, P51, DOI 10.1111/pai.12152; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Haavet OR, 2004, ACTA PAEDIATR, V93, P405, DOI 10.1080/08035250410023584; Hon KLE, 2008, CLIN EXP DERMATOL, V33, P705, DOI 10.1111/j.1365-2230.2008.02853.x; Hysing M, 2009, CHILD CARE HLTH DEV, V35, P527, DOI 10.1111/j.1365-2214.2009.00967.x; Jenkins MA, 1996, INT J EPIDEMIOL, V25, P609, DOI 10.1093/ije/25.3.609; Kozyrskyj AL, 2008, AM J RESP CRIT CARE, V177, P142, DOI 10.1164/rccm.200703-381OC; Lefevre F, 2011, PEDIAT ALLERG IMM-UK, V22, P608, DOI 10.1111/j.1399-3038.2011.01155.x; Lewis-Jones S, 2006, INT J CLIN PRACT, V60, P984, DOI 10.1111/j.1742-1241.2006.01047.x; Magin P, 2008, SCAND J CARING SCI, V22, P430, DOI 10.1111/j.1471-6712.2007.00547.x; Magin P, 2013, CLIN DERMATOL, V31, P66, DOI 10.1016/j.clindermatol.2011.11.009; Nordhagen R, 2005, CHILD CARE HLTH DEV, V31, P693, DOI 10.1111/j.1365-2214.2005.00559.x; O'Connell EJ, 2004, ALLERGY, V59, P7, DOI 10.1111/j.1398-9995.2004.00563.x; Reyes M, 2011, ANN ALLERG ASTHMA IM, V107, P42, DOI 10.1016/j.anai.2011.03.004; Rodder I, 2003, J ASTHMA, V40, P777, DOI 10.1081/JAS-120023505; Romanos M, 2010, J EPIDEMIOL COMMUN H, V64, P269, DOI 10.1136/jech.2009.093534; Schmitt J, 2011, ALLERGY, V66, P404, DOI 10.1111/j.1398-9995.2010.02487.x; Sentenac M, 2012, EPIDEMIOL REV, V34, P120, DOI 10.1093/epirev/mxr024; Shyu CS, 2012, J MICROBIOL IMMUNOL, V45, P237, DOI 10.1016/j.jmii.2011.11.008; Spielberger C., 1983, MANUAL STATE TRAIT I; Stewart M, 2012, J PEDIATR NURS, V27, P479, DOI 10.1016/j.pedn.2011.06.011; Teyhan A, 2014, J PEDIATR-US, V165, P592, DOI 10.1016/j.jpeds.2014.05.023; Thorpe K., 1993, J REPROD INFANT PSYC, V11, P119, DOI [10.1080/02646839308403204, DOI 10.1080/02646839308403204]; Tsai JD, 2013, ANN EPIDEMIOL, V23, P185, DOI 10.1016/j.annepidem.2012.12.015; van den Bemt L, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-5; Vuillermin PJ, 2010, ARCH DIS CHILD, V95, P624, DOI 10.1136/adc.2009.166967; Yuksel H, 2008, J ASTHMA, V45, P545, DOI 10.1080/02770900801990016	41	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135271	10.1371/journal.pone.0135271	http://dx.doi.org/10.1371/journal.pone.0135271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26266935	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300090
J	Wappler, T; Guilbert, E; Labandeira, CC; Hornschemeyer, T; Wedmann, S				Wappler, Torsten; Guilbert, Eric; Labandeira, Conrad C.; Hoernschemeyer, Thomas; Wedmann, Sonja			Morphological and Behavioral Convergence in Extinct and Extant Bugs: The Systematics and Biology of a New Unusual Fossil Lace Bug from the Eocene	PLOS ONE			English	Article							GREEN RIVER FORMATION; AMBER HEMIPTERA; SP N.; HETEROPTERA; TINGIDAE; GENUS; CANTACADERINAE; COLORADO; BASIN; RECONSTRUCTION	The bug Gyaclavator kohlsi Wappler, Guilbert, Wedmann et Labandeira, gen. et sp. nov., represents a new extinct genus of lace bugs (Insecta: Heteroptera: Tingidae) occurring in latest early Eocene deposits of the Green River Formation, from the southern Piceance Basin of Northwestern Colorado, in North America. Gyaclavator can be placed within the Tingidae with certainty, perhaps it is sistergroup to Cantacaderinae. If it belongs to Cantacaderinae, it is the first fossil record of this group for North America. Gyaclavator has unique, conspicuous antennae bearing a specialized, highly dilated distiflagellomere, likely important for intra-or intersex reproductive competition and attraction. This character parallels similar antennae in leaf-footed bugs (Coreidae), and probably is associated with a behavioral convergence as well.	[Wappler, Torsten; Wedmann, Sonja] Forschungsstn Grube Messel, Senckenberg Forschungsinst, Messel, Germany; [Wappler, Torsten; Wedmann, Sonja] Forschungsstn Grube Messel, Nat Museum Frankfurt, Messel, Germany; [Wappler, Torsten; Wedmann, Sonja] Senckenberg Biodiversitat & Klima Forschungszentr, Frankfurt, Germany; [Wappler, Torsten] Univ Bonn, Steinmann Inst Geol, Mineral, Palaontol, Bonn, Germany; [Guilbert, Eric] Museum Natl Hist Nat, CNRS, UMR 7205, Dept Systemat & Evolut, Paris, France; [Labandeira, Conrad C.] Smithsonian Inst, Dept Paleobiol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Labandeira, Conrad C.] Univ Maryland, Dept Entomol & Behav, Ecol Evolut & Systemat Program, College Pk, MD 20742 USA; [Labandeira, Conrad C.] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Hoernschemeyer, Thomas] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Abt Morphol & Systemat, Zool Museum, D-37073 Gottingen, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Bonn; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park; Capital Normal University; University of Gottingen	Wappler, T (corresponding author), Forschungsstn Grube Messel, Senckenberg Forschungsinst, Messel, Germany.	twappler@uni-bonn.de; sonja.wedmann@senckenberg.de	Wappler, Torsten/D-4287-2011; Hörnschemeyer, Thomas/AAU-9813-2020; guilbert, eric/A-1293-2017; Wappler, Torsten/P-6831-2019; Rahbe, Yvan/B-9389-2009	Wappler, Torsten/0000-0003-1592-0988; Hörnschemeyer, Thomas/0000-0002-4924-5389; guilbert, eric/0000-0001-8319-6667; Wappler, Torsten/0000-0003-1592-0988; Rahbe, Yvan/0000-0002-0074-4443; Wedmann, Sonja/0000-0002-9778-4125	Deutsche Forschungsgemeinschaft (DFG) [WE 2942/6-1, WE 2942/6-2, HO 2306/6-1, HO 2306/6-2]; Hesse's Ministry of Higher Education, Research, and the Arts	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Hesse's Ministry of Higher Education, Research, and the Arts	This research was possible thanks to grants of the Deutsche Forschungsgemeinschaft (DFG, grant no WE 2942/6-1 to S. W., grant no WE 2942/6-2 to S. W. and T. W., and grant no HO 2306/6-1 6-2 to T. H.) (www.dfg.de) and by the research funding programme "LOEWE-Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts. (https://wissenschaft.hessen.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beehler BM, 1998, THE BIRDS OF PARADIS; Blum M, 2012, SEXUAL SELECTION REP; Carroll AR, 2006, GEOLOGY, V34, P197, DOI 10.1130/G22148.1; Chaboo CS, 2009, SYST ENTOMOL, V34, P202, DOI 10.1111/j.1365-3113.2008.00456.x; Choe J., 1997, MATING SYSTEMS INSEC; COLE RD, 1978, GEOL SOC AM BULL, V89, P1441, DOI 10.1130/0016-7606(1978)89<1441:CMONAO>2.0.CO;2; Coty D, 2014, ANN SOC ENTOMOL FR, V50, P286, DOI 10.1080/00379271.2014.982024; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; Distant WL, 1902, ANN MAGAZINE NATURAL, V9, P353; Dlussky Gennady M., 2002, Russian Entomological Journal, V11, P411; Drake C. J., 1962, Great Basin Naturalist, V22, P8; DRAKE CARL J., 1960, PROC U S NATL MUS, V112, P1; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Froeschner R. C., 1996, SMITHSONIAN CONTRIBU, V574, P1, DOI DOI 10.5479/SI.00810282.574; Golub VB, 2008, PALEONTOL J+, V42, P86, DOI 10.1134/S0031030108010140; Golub VB, 2012, ZOOTAXA, P41; Golub V. B., 2000, Acta Geologica Hispanica, V35, P165; Golub VB, 2012, PALEONTOL J+, V46, P258, DOI 10.1134/S0031030112020050; Golub V.B., 2007, Evraziatskii Entomologicheskii Zhurnal, V6, P223; Golub V.B., 2005, Evraziatskii Entomologicheskii Zhurnal, V4, P279; Golub V.B., 2001, MITTEILUNGEN GEOLOGI, V85, P263; Golub Viktor B., 2003, Annals of the Upper Silesian Museum in Bytom Entomology, V12, P101; Golub Viktor B., 2000, P231; Golub Viktor B., 2008, Acta Entomologica Musei Nationalis Pragae, V48, P485; Gorochov Andrej V., 2012, Russian Entomological Journal, V21, P357; Graham ML, 1993, WESTERN INTERIOR PAL, P1; Grande L, 1984, GEOLOGICAL SURVEY WY, V63, P1, DOI DOI 10.1021/MA0493168); Grande L, 2013, THE LOST WORLD OF FO; Guilbert E, 2004, INSECT SYST EVOL, V35, P147, DOI 10.1163/187631204788912382; Guilbert E, 2012, INVERTEBR SYST, V26, P316, DOI 10.1071/IS12010; Guilbert E, 2012, EUR J ENTOMOL, V109, P111, DOI 10.14411/eje.2012.014; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Heiss E., 2013, Linzer Biologische Beitraege, V45, P1865; Heiss E., 2013, Linzer Biologische Beitraege, V45, P689; Heiss E, 2013, ZOOTAXA, V 3736, P379, DOI 10.11646/zootaxa.3736.4.5; Heiss Ernst, 2009, Zeitschrift der Arbeitsgemeinschaft Oesterreichischer Entomologen, V61, P9; Heiss Ernst, 2008, Zeitschrift der Arbeitsgemeinschaft Oesterreichischer Entomologen, V60, P133; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jepson JE, 2011, ZOOTAXA, P59; Johnson RC, 2014, USGS OPEN-FILE REP, V1059, P1, DOI DOI 10.3133/ofr20141059; Kormilev N. A., 1955, Revista Ecuatoriana de Entomologia y Parasitologia Guayaquil, V2, P465; Krogmann L, 2013, HIST BIOL, V25, P43, DOI 10.1080/08912963.2012.685729; Laporte F.L.N., 1833, MAG ZOOL, V2, P1; Latreille P.A., 1810, CONSIDERATIONS GENER; MacGinitie H.D., 1969, U CALIF PUBLS GEOL S, V83, P1; Murphy D.H., 1989, Raffles Bulletin of Zoology, V37, P168; Nel A., 2004, Geologica Acta, V2, P37; Nixon K.C., 2002, WINCLADA VER 1 00 08; Nudds J, 2008, FOSSIL ECOSYSTEMS OF, P186; OBERHAUSER KS, 1989, BEHAV ECOL SOCIOBIOL, V25, P237, DOI 10.1007/BF00300049; PETRIE M, 1991, ANIM BEHAV, V41, P323, DOI 10.1016/S0003-3472(05)80484-1; Petrulevicius JF, 2007, BIOGEOGRAPHIC IMPLIC, V1, P15; Plotnick RE, 2012, J PALEONTOL, V86, P19, DOI 10.1666/11-072.1; Popov Y.A., 1989, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1989, P166; Redei D., 2004, Applied Ecology and Environmental Research, V2, P73; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; RUCKES HERBERT, 1955, AMER MUS NOVITATES, V1721, P1; Schaeffer Carl W., 2005, P231; Schuh RT, 2006, J NEW YORK ENTOMOL S, V114, P38, DOI 10.1664/0028-7199(2006)114[38:DOTFRM]2.0.CO;2; Scudder S.H., 1890, REPORT US GEOLOGICAL, V13, P1, DOI [10.5962/bhl.title.44698, DOI 10.5962/BHL.TITLE.44698, 10.5962/bhl.title.2507]; Shcherbakov Dmitry E., 2006, Russian Entomological Journal, V15, P315; Shuker DM, 2014, EVOLUTION OF INSECT MATING SYSTEMS, P20; Smith DM, 2012, PALAIOS, V27, P346, DOI 10.2110/palo.2011.p11-107r; Smith ME, 2008, GEOL SOC AM BULL, V120, P54, DOI 10.1130/B26073.1; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Thornhill R., 1983, pi; Thunberg C.P., 1822, THESIS; Vrsansky P, 2014, ANN ENTOMOL SOC AM, V107, P28, DOI 10.1603/AN13042; Vrsansky P, 2012, INSECT SCI, V19, P143, DOI 10.1111/j.1744-7917.2010.01390.x; Wappler T, 2006, PALAEONTOLOGY, V49, P435, DOI 10.1111/j.1475-4983.2006.00547.x; Wappler T, 2003, ZOOTAXA, V374, P1; Weber WA, 2000, THE AMERICAN COCKERE; Westwood JO, 1840, AN INTRODUCTION TO T; Wilf P, 2000, GEOL SOC AM BULL, V112, P292, DOI 10.1130/0016-7606(2000)112<0292:LPEECC>2.3.CO;2; WILSON M V H, 1978, Quaestiones Entomologicae, V14, P13; WILSON MVH, 1988, PALAEOGEOGR PALAEOCL, V62, P609, DOI 10.1016/0031-0182(88)90074-0	76	18	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133330	10.1371/journal.pone.0133330	http://dx.doi.org/10.1371/journal.pone.0133330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267108	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300014
J	Wu, ZY; Haack, SE; Lin, WX; Li, BL; Wu, LK; Fang, CX; Zhang, ZX				Wu, Zeyan; Haack, Stacey Elizabeth; Lin, Wenxiong; Li, Bailian; Wu, Linkun; Fang, Changxun; Zhang, Zhixing			Soil Microbial Community Structure and Metabolic Activity of Pinus elliottii Plantations across Different Stand Ages in a Subtropical Area	PLOS ONE			English	Article							PLANT DIVERSITY; ORGANIC-CARBON; CHINESE FIR; FOREST; DYNAMICS; GROWTH; L.	Soil microbes play an essential role in the forest ecosystem as an active component. This study examined the hypothesis that soil microbial community structure and metabolic activity would vary with the increasing stand ages in long-term pure plantations of Pinus elliottii. The phospholipid fatty acids (PLFA) combined with community level physiological profiles (CLPP) method was used to assess these characteristics in the rhizospheric soils of P. elliottii. We found that the soil microbial communities were significantly different among different stand ages of P. elliottii plantations. The PLFA analysis indicated that the bacterial biomass was higher than the actinomycic and fungal biomass in all stand ages. However, the bacterial biomass decreased with the increasing stand ages, while the fungal biomass increased. The four maximum biomarker concentrations in rhizospheric soils of P. elliottii for all stand ages were 18:1 omega 9c, 16:1 omega 7c, 18:3 omega 6c (6,9,12) and cy19:0, representing measures of fungal and gram negative bacterial biomass. In addition, CLPP analysis revealed that the utilization rate of amino acids, polymers, phenolic acids, and carbohydrates of soil microbial community gradually decreased with increasing stand ages, though this pattern was not observed for carboxylic acids and amines. Microbial community diversity, as determined by the Simpson index, Shannon-Wiener index, Richness index and McIntosh index, significantly decreased as stand age increased. Overall, both the PLFA and CLPP illustrated that the long-term pure plantation pattern exacerbated the microecological imbalance previously described in the rhizospheric soils of P. elliottii, and markedly decreased the soil microbial community diversity and metabolic activity. Based on the correlation analysis, we concluded that the soil nutrient and C/N ratio most significantly contributed to the variation of soil microbial community structure and metabolic activity in different stand ages of P. elliottii plantations.	[Wu, Zeyan; Lin, Wenxiong; Wu, Linkun; Fang, Changxun; Zhang, Zhixing] Fujian Agr & Forestry Univ, Fujian, Peoples R China; [Haack, Stacey Elizabeth] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Li, Bailian] Univ Calif Riverside, Ecol Complex & Modeling Lab, Riverside, CA 92521 USA	Fujian Agriculture & Forestry University; University of California System; University of California Riverside; University of California System; University of California Riverside	Lin, WX (corresponding author), Fujian Agr & Forestry Univ, Fujian, Peoples R China.	wenxiong1810@163.com	Wu, Linkun/GLN-5951-2022					An Ran, 2011, Chinese Journal of Plant Ecology, V35, P389, DOI 10.3724/SP.J.1258.2011.00389; Andersen R, 2010, SOIL BIOL BIOCHEM, V42, P291, DOI 10.1016/j.soilbio.2009.11.006; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Chen FL, 2013, FOREST ECOL MANAG, V291, P65, DOI 10.1016/j.foreco.2012.11.016; Chen YL, 2006, MYCORRHIZA, V16, P251, DOI 10.1007/s00572-006-0039-8; Chmura DJ, 2008, TREE PHYSIOL, V28, P729, DOI 10.1093/treephys/28.5.729; Chowdhury TR, 2012, J MICROBIOL METH, V88, P285, DOI 10.1016/j.mimet.2011.12.008; Corneo PE, 2013, FEMS MICROBIOL ECOL, V84, P588, DOI 10.1111/1574-6941.12087; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; Dittrich S, 2013, FLORA, V208, P238, DOI 10.1016/j.flora.2013.03.006; Gonzalez-Benecke CA, 2014, FOREST SCI, V60, P109, DOI 10.5849/forsci.12-144; HAACK SK, 1995, APPL ENVIRON MICROB, V61, P1458, DOI 10.1128/AEM.61.4.1458-1468.1995; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Huygens D, 2011, APPL SOIL ECOL, V48, P270, DOI 10.1016/j.apsoil.2011.04.012; Izumi H, 2008, FEMS MICROBIOL LETT, V282, P196, DOI 10.1111/j.1574-6968.2008.01122.x; Li Yanma, 2005, Ying Yong Sheng Tai Xue Bao, V16, P1275; Liu Yang, 2012, Chinese Journal of Plant Ecology, V36, P382, DOI 10.3724/SP.J.1258.2012.00382; Lu S, 2013, J ENVIRON BIOL, V34, P471; [马泽清 Ma Zeqing], 2011, [生态学报, Acta Ecologica Sinica], V31, P1525; McKinley VL, 2005, SOIL BIOL BIOCHEM, V37, P1946, DOI 10.1016/j.soilbio.2005.02.033; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Mudge PL, 2014, SOIL RES, V52, P27, DOI 10.1071/SR13183; Patra AK, 2008, BIORESOURCE TECHNOL, V99, P3545, DOI 10.1016/j.biortech.2007.07.051; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2009, NONLINEAR DYNAM, V58, P75, DOI 10.1007/s11071-008-9462-z; Ushioa M, 2013, SOIL BIOL BIOCHEM, V40, P2699; Wang WJ, 2013, ENVIRON EARTH SCI, V69, P1559, DOI 10.1007/s12665-012-1990-7; Wen L, 2014, FOREST ECOL MANAG, V328, P150, DOI 10.1016/j.foreco.2014.05.037; Wu LK, 2013, APPL SOIL ECOL, V67, P1, DOI 10.1016/j.apsoil.2013.02.008; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; ZELLES L, 1995, BIOL FERT SOILS, V19, P115, DOI 10.1007/BF00336146; Zhai L, 2015, FOREST ECOL MANAG, V337, P28, DOI 10.1016/j.foreco.2014.10.030; Zhang Wei-dong, 2009, Yingyong Shengtai Xuebao, V20, P2345; Zhou LL, 2015, J FORESTRY RES, V26, P79, DOI 10.1007/s11676-014-0011-y	36	32	35	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135354	10.1371/journal.pone.0135354	http://dx.doi.org/10.1371/journal.pone.0135354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267338	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300104
J	Yan, JC; Gao, WG; Qian, LB; Han, L; Chen, Y; Chen, MF				Yan, Jingchun; Gao, Weiguo; Qian, Linbo; Han, Lu; Chen, Yun; Chen, Mengfang			Remediation of Nitrobenzene Contaminated Soil by Combining Surfactant Enhanced Soil Washing and Effluent Oxidation with Persulfate	PLOS ONE			English	Article							PHOTOCATALYTIC DEGRADATION; POROUS-MEDIA; ADSORPTION; SOLUBILIZATION; DESORPTION; EFFICIENT; DODECYLBENZENESULFONATE; DECOMPOSITION; MECHANISM; SYSTEMS	The combination of surfactant enhanced soil washing and degradation of nitrobenzene (NB) in effluent with persulfate was investigated to remediate NB contaminated soil. Aqueous solution of sodium dodecylbenzenesulfonate (SDBS, 24.0 mmol L-1) was used at a given mass ratio of solution to soil (20: 1) to extract NB contaminated soil (47.3 mg kg(-1)), resulting in NB desorption removal efficient of 76.8%. The washing effluent was treated in Fe2+/persulfate and Fe2+/H2O2 systems successively. The degradation removal of NB was 97.9%, being much higher than that of SDBS (51.6%) with addition of 40.0 mmol L-1 Fe2+ and 40.0 mmol L-1 persulfate after 15 min reaction. The preferential degradation was related to the lone pair electron of generated SO4 center dot(-), which preferably removes electrons from aromatic parts of NB over long alkyl chains of SDBS through hydrogen abstraction reactions. No preferential degradation was observed in center dot OH based oxidation because of its hydrogen abstraction or addition mechanism. The sustained SDBS could be reused for washing the contaminated soil. The combination of the effective surfactant-enhanced washing and the preferential degradation of NB with Fe2+/persulfate provide a useful option to remediate NB contaminated soil.	[Yan, Jingchun; Gao, Weiguo; Qian, Linbo; Han, Lu; Chen, Yun; Chen, Mengfang] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing 210008, Jiangsu, Peoples R China; [Gao, Weiguo; Han, Lu; Chen, Yun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, MF (corresponding author), Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing 210008, Jiangsu, Peoples R China.	mfchen@issas.ac.cn	Qian, Linbo/H-3736-2019		National Science Foundation of China [51309214]; National Environmental Protection Public Welfare Industry Targeted Research Fund [201309005]; National High Technology Research and Development Program (863 Program) [2013AA06A208]; Knowledge Innovative Program of the Chinese Academy of Sciences [KZCX2-YW-BR-19]; Environmental Protection Research Program of Jiangsu Province, China [2012039]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Environmental Protection Public Welfare Industry Targeted Research Fund; National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Knowledge Innovative Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Environmental Protection Research Program of Jiangsu Province, China	This work was supported by the National Science Foundation of China (Grant No. 51309214), the National Environmental Protection Public Welfare Industry Targeted Research Fund (201309005), the National High Technology Research and Development Program (863 Program) (2013AA06A208), the Knowledge Innovative Program of the Chinese Academy of Sciences (KZCX2-YW-BR-19) and the Environmental Protection Research Program of Jiangsu Province, China (No. 2012039).	Bhatkhande DS, 2003, WATER RES, V37, P1223, DOI 10.1016/S0043-1354(02)00490-6; Burbano A, 2003, WATER SCI TECHNOL, V47, P165, DOI 10.2166/wst.2003.0517; Chu W, 2003, SCI TOTAL ENVIRON, V307, P83, DOI 10.1016/S0048-9697(02)00461-8; Chu W., 2003, WASTE MANAGEMENT, V7, P19; Davezza M, 2012, CHEMOSPHERE, V86, P335, DOI 10.1016/j.chemosphere.2011.09.011; Fabbri D, 2006, APPL CATAL B-ENVIRON, V62, P21, DOI 10.1016/j.apcatb.2005.06.011; Fabbri D, 2009, APPL CATAL B-ENVIRON, V92, P318, DOI 10.1016/j.apcatb.2009.08.010; Francesco M., 1983, ACCOUNTS CHEM RES, V16, P27; Hayworth JS, 1997, ENVIRON SCI TECHNOL, V31, P1277, DOI 10.1021/es960322w; Hori H, 2005, ENVIRON SCI TECHNOL, V39, P2383, DOI 10.1021/es0484754; Johnson DN, 2004, ENVIRON SCI TECHNOL, V38, P5149, DOI 10.1021/es0344765; KILE DE, 1989, ENVIRON SCI TECHNOL, V23, P832, DOI 10.1021/es00065a012; KOLTHOFF IM, 1951, J AM CHEM SOC, V73, P3055, DOI 10.1021/ja01151a024; Liang CJ, 2010, ENVIRON SCI TECHNOL, V44, P8203, DOI 10.1021/es903411a; Liang CJ, 2004, CHEMOSPHERE, V55, P1213, DOI 10.1016/j.chemosphere.2004.01.029; Liu JG, 2012, FRONT ENV SCI ENG, V6, P437, DOI 10.1007/s11783-012-0406-y; Lv T, 2013, BIORESOURCE TECHNOL, V133, P529, DOI 10.1016/j.biortech.2013.02.003; Mulligan CN, 2001, ENG GEOL, V60, P371, DOI 10.1016/S0013-7952(00)00117-4; Nichela DA, 2013, CHEM ENG J, V228, P1148, DOI 10.1016/j.cej.2013.05.002; Ou ZQ, 1996, CHEMOSPHERE, V32, P827, DOI 10.1016/0045-6535(95)00350-9; Rao PH, 2006, CHEMOSPHERE, V63, P1214, DOI 10.1016/j.chemosphere.2005.08.067; Rastogi A, 2009, APPL CATAL B-ENVIRON, V85, P171, DOI 10.1016/j.apcatb.2008.07.010; Sanchez-Martin MJ, 2003, WATER RES, V37, P3110, DOI 10.1016/S0043-1354(03)00155-6; SIRACUSA PA, 1987, COLLOID SURFACE, V26, P55, DOI 10.1016/0166-6622(87)80106-3; Sun HW, 2010, J HAZARD MATER, V182, P184, DOI 10.1016/j.jhazmat.2010.06.013; SUN SB, 1995, ENVIRON SCI TECHNOL, V29, P903, DOI 10.1021/es00004a010; Alcantara MT, 2009, J HAZARD MATER, V166, P462, DOI 10.1016/j.jhazmat.2008.11.050; Torn LH, 2003, J COLLOID INTERF SCI, V260, P1, DOI 10.1016/S0021-9797(03)00046-8; Villa RD, 2010, J HAZARD MATER, V174, P770, DOI 10.1016/j.jhazmat.2009.09.118; Yan JC, 2012, CHEMOSPHERE, V87, P111, DOI 10.1016/j.chemosphere.2011.11.069; Yan JC, 2011, J HAZARD MATER, V186, P1398, DOI 10.1016/j.jhazmat.2010.12.017; Yang K, 2005, J COLLOID INTERF SCI, V291, P59, DOI 10.1016/j.jcis.2005.04.088; Yergeau E, 2014, PLOS ONE, V7; Yuan SH, 2007, J COLLOID INTERF SCI, V314, P167, DOI 10.1016/j.jcis.2007.05.034; Zeng QR, 2006, WATER RES, V40, P1351, DOI 10.1016/j.watres.2006.01.036; Zhao S, 2009, FEMS MICROBIOL ECOL, V70, P315, DOI 10.1111/j.1574-6941.2009.00773.x; Zhou ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108765; Zhu LZ, 2003, CHEMOSPHERE, V53, P459, DOI 10.1016/S0045-6535(03)00541-1	38	16	18	9	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0132878	10.1371/journal.pone.0132878	http://dx.doi.org/10.1371/journal.pone.0132878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266532	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300011
J	Martin, P; Krsnik, I; Navarro, B; Provencio, M; Garcia, JF; Bellas, C; Vilches, C; Gomez-Lozano, N				Martin, Paloma; Krsnik, Isabel; Navarro, Belen; Provencio, Mariano; Garcia, Juan F.; Bellas, Carmen; Vilches, Carlos; Gomez-Lozano, Natalia			HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NATURAL-KILLER-CELLS; HUMAN NK CELLS; INFECTIOUS-MONONUCLEOSIS; E POLYMORPHISM; E EXPRESSION; CLASS-I; DISEASE; TRANSPLANTATION; CD94/NKG2A	Background An inefficient immune response against Epstein-Barr virus (EBV) infection is related to the pathogenesis of a subgroup of classical Hodgkin lymphomas (cHL). Some EBV immuneevasion mechanisms target HLA presentation, including the non-classical HLA-E molecule. HLA-E can be recognized by T cells via the TCR, and it also regulates natural killer (NK) cell signaling through the inhibitory CD94/NKG2A receptor. Some evidences indicate that EBV-infected B-cells promote the proliferation of NK subsets bearing CD94/NKG2A, suggesting a relevant function of these cells in EBV control. Variations in CD94/NKG2A-HLA-E interactions could affect NK cell-mediated immunity and, consequently, play a role in EBV-driven transformation and lymphomagenesis. The two most common HLA-E alleles, E*01: 01 and E*01: 03, differ by a single amino acid change that modifies the molecule function. We hypothesized that the functional differences in these variants might participate in the pathogenicity of EBV. Aim We studied two series of cHL patients, both with EBV-positive and-negative cases, and a cohort of unrelated controls, to assess the impact of HLA-E variants on EBV-related cHL susceptibility. Results We found that the genotypes with at least one copy of E*01:01 (i.e., E*01: 01 homozygous and heterozygous) were underrepresented among cHL patients from both series compared to controls (72.6% and 71.6% vs 83%, p = 0.001). After stratification by EBV status, we found low rates of E*01:01-carriers mainly among EBV-positive cases (67.6%). These reduced frequencies are seen independently of other factors such as age, gender, HLA-A*01 and HLA-A*02, HLA alleles positively and negatively associated with the disease (adjusted OR = 0.4, p = 0.001). Furthermore, alleles from both HLA loci exert a cumulative effect on EBV-associated cHL susceptibility. Conclusions These results indicate that E*01:01 is a novel protective genetic factor in EBV-associated cHL and support a role for HLA-E recognition on the control of EBV infection and lymphomagenesis.	[Martin, Paloma; Bellas, Carmen] Inst Invest Sanitaria Puerta de Hierro IDIPHIM, Grp Mol Pathol, Majadahonda, Spain; [Krsnik, Isabel; Navarro, Belen] Inst Invest Sanitaria Puerta de Hierro IDIPHIM, Dept Hematol, Majadahonda, Spain; [Provencio, Mariano] Inst Invest Sanitaria Puerta de Hierro IDIPHIM, Dept Oncol, Majadahonda, Spain; [Garcia, Juan F.] MD Anderson Canc Ctr, Dept Pathol, Madrid, Spain; [Vilches, Carlos] Inst Invest Sanitaria Puerta de Hierro IDIPHIM, Grp Immunogenet & Histocompatibil, Majadahonda, Spain; [Gomez-Lozano, Natalia] Inst Invest Sanitaria Puerta de Hierro IDIPHIM, Grp Immun & Lymphoproliferat Dis, Majadahonda, Spain	University of Texas System; UTMD Anderson Cancer Center	Gomez-Lozano, N (corresponding author), Inst Invest Sanitaria Puerta de Hierro IDIPHIM, Grp Immun & Lymphoproliferat Dis, Majadahonda, Spain.	ngomez@idiphim.org	Vilches, Carlos/G-1471-2012; Acosta, Paloma Martin/AAF-7998-2021; Gomez-Lozano, Natalia/K-6488-2014; Provencio, Mariano/ABE-8586-2020; GARCIA, JUAN/L-2118-2016; Vilches, Carlos/AAG-9203-2021	Vilches, Carlos/0000-0002-0300-9225; Acosta, Paloma Martin/0000-0002-3274-4595; Gomez-Lozano, Natalia/0000-0003-3959-9519; Provencio, Mariano/0000-0001-9053-9197; Krsnik, Isabel/0000-0002-2912-5072; Provencio Pulla, Mariano/0000-0001-6315-7919	Miguel Servet programs [CP09/00182, CP08/00218]; Instituto de Salud Carlos III (FEDER) [RD 06/0020/0047]	Miguel Servet programs; Instituto de Salud Carlos III (FEDER)(Instituto de Salud Carlos III)	This work was supported by Miguel Servet programs CP09/00182 (NGL) and CP08/00218 (PM) and the Spanish Cancer Network (RTICC RD 06/0020/0047) all from Instituto de Salud Carlos III (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoun A, 2009, TISSUE ANTIGENS, V73, P39, DOI 10.1111/j.1399-0039.2008.01170.x; Azzi T, 2014, BLOOD, V124, P2533, DOI 10.1182/blood-2014-01-553024; Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Chijioke O, 2013, CELL REP, V5, P1489, DOI 10.1016/j.celrep.2013.11.041; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Danzer M, 2009, TRANSPLANTATION, V88, P528, DOI 10.1097/TP.0b013e3181b0e79e; Eidenschenk C, 2006, AM J HUM GENET, V78, P721, DOI 10.1086/503269; Felicio LP, 2014, TISSUE ANTIGENS, V83, P82, DOI 10.1111/tan.12283; GERAGHTY DE, 1992, HUM IMMUNOL, V33, P174, DOI 10.1016/0198-8859(92)90069-Y; Glaser SL, 2014, CANCER CAUSE CONTROL, V25, P709, DOI 10.1007/s10552-014-0374-6; Glaser SL, 2008, INT J CANCER, V123, P1499, DOI 10.1002/ijc.23741; Glaser SL, 1997, INT J CANCER, V70, P375, DOI 10.1002/(SICI)1097-0215(19970207)70:4&lt;375::AID-IJC1&gt;3.0.CO;2-T; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Gooden M, 2011, P NATL ACAD SCI USA, V108, P10656, DOI 10.1073/pnas.1100354108; Griffin BD, 2013, J IMMUNOL, V190, P1672, DOI 10.4049/jimmunol.1102462; Grimsley C, 1997, HUM IMMUNOL, V52, P33, DOI 10.1016/S0198-8859(96)00241-8; GULLEY ML, 1994, BLOOD, V83, P1595; Hassen E, 2011, DNA CELL BIOL, V30, P603, DOI 10.1089/dna.2010.1140; Hendricks DW, 2014, J IMMUNOL, V192, P4492, DOI 10.4049/jimmunol.1303211; Hirankarn N, 2004, TISSUE ANTIGENS, V64, P588, DOI 10.1111/j.1399-0039.2004.00311.x; Hjalgrim H, 2010, P NATL ACAD SCI USA, V107, P6400, DOI 10.1073/pnas.0915054107; Jarrett RF, 2005, BLOOD, V106, P2444, DOI 10.1182/blood-2004-09-3759; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; Jorgensen PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046120; Keating S, 2002, J VIROL, V76, P8179, DOI 10.1128/JVI.76.16.8179-8188.2002; Kren L, 2012, PATHOL RES PRACT, V208, P45, DOI 10.1016/j.prp.2011.11.004; Lauterbach N, 2012, METHOD MOL BIOL; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Levy EM, 2008, INT J ONCOL, V32, P633, DOI 10.3892/ijo.32.3.633; Ludajic K, 2009, TRANSPLANTATION, V88, P1227, DOI 10.1097/TP.0b013e3181bbb8fe; Lunemann A, 2013, J IMMUNOL, V191, P4989, DOI 10.4049/jimmunol.1301046; Marin R, 2003, IMMUNOGENETICS, V54, P767, DOI 10.1007/s00251-002-0526-9; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; Mosaad YM, 2011, SCAND J IMMUNOL, V74, P205, DOI 10.1111/j.1365-3083.2011.02559.x; Mukherjee S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016959; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Pappworth IY, 2007, J VIROL, V81, P474, DOI 10.1128/JVI.01777-06; Park KS, 2007, TISSUE ANTIGENS, V69, P139, DOI 10.1111/j.1399-0039.2006.00742.x; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Quinn LL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004322; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Romero V, 2007, BMC GENET, P814; Schulte D, 2009, J INFECT DIS, V200, P1397, DOI 10.1086/605889; Shaw RK, 2012, BLOOD, V119, P4009, DOI 10.1182/blood-2011-10-385377; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Strong RK, 2003, J BIOL CHEM, V278, P5082, DOI 10.1074/jbc.M208268200; Tamouza R, 2006, TRANSPLANTATION, V82, P1436, DOI 10.1097/01.tp.0000244598.92049.dd; Williams H, 2005, BRIT J HAEMATOL, V129, P266, DOI 10.1111/j.1365-2141.2005.05452.x; Zeidler R, 1997, BLOOD, V90, P2390; Zuo JM, 2011, J VIROL, V85, P1604, DOI 10.1128/JVI.01608-10	51	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135512	10.1371/journal.pone.0135512	http://dx.doi.org/10.1371/journal.pone.0135512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26261988	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300087
J	Fabeni, L; Alteri, C; Orchi, N; Gori, C; Bertoli, A; Forbici, F; Montella, F; Pennica, A; De Carli, G; Giuliani, M; Continenza, F; Pinnetti, C; Nicastri, E; Ceccherini-Silberstein, F; Mastroianni, CM; Girardi, E; Andreoni, M; Antinori, A; Santoro, MM; Perno, CF				Fabeni, Lavinia; Alteri, Claudia; Orchi, Nicoletta; Gori, Caterina; Bertoli, Ada; Forbici, Federica; Montella, Francesco; Pennica, Alfredo; De Carli, Gabriella; Giuliani, Massimo; Continenza, Fabio; Pinnetti, Carmela; Nicastri, Emanuele; Ceccherini-Silberstein, Francesca; Mastroianni, Claudio Maria; Girardi, Enrico; Andreoni, Massimo; Antinori, Andrea; Santoro, Maria Mercedes; Perno, Carlo Federico			Recent Transmission Clustering of HIV-1C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TREATMENT-NAIVE INDIVIDUALS; NON-B INFECTIONS; DRUG-RESISTANCE; ANTIRETROVIRAL TREATMENT; INCREASING PREVALENCE; REVERSE-TRANSCRIPTASE; PHYLOGENETIC TREES; CORECEPTOR USAGE; SUBTYPE	Background Increased evidence of relevant HIV-1 epidemic transmission in European countries is being reported, with an increased circulation of non-B-subtypes. Here, we present two recent HIV-1 non-B transmission clusters characterized by NNRTI-related amino-acidic mutations among newly diagnosed HIV-1 infected men, living in Rome (Central-Italy). Methods Pol and V3 sequences were available at the time of diagnosis for all individuals. Maximum-Likelihood and Bayesian phylogenetic-trees with bootstrap and Bayesian-probability supports defined transmission-clusters. HIV-1 drug-resistance and V3-tropism were also evaluated. Results Among 534 new HIV-1 non-B cases, diagnosed from 2011 to 2014, in Central-Italy, 35 carried virus gathering in two distinct clusters, including 27 HIV-1 C and 8 CRF17_BF subtypes, respectively. Both clusters were centralized in Rome, and their origin was estimated to have been after 2007. All individuals within both clusters were males and 37.1% of them had been recently-infected. While C-cluster was entirely composed by Italian men-who-have-sex-with-men, with a median-age of 34 years (IQR:30-39), individuals in CRF17_BF-cluster were older, with a median-age of 51 years (IQR:48-59) and almost all reported sexual-contacts with men and women. All carried R5-tropic viruses, with evidence of atypical or resistance amino-acidic mutations related to NNRTI-drugs (K103Q in C-cluster, and K101E+E138K in CRF17_BF-cluster). Conclusions These two epidemiological clusters provided evidence of a strong and recent circulation of C and CRF17_BF strains in central Italy, characterized by NNRTI-related mutations among men engaging in high-risk behaviours. These findings underline the role of molecular epidemiology in identifying groups at increased risk of HIV-1 transmission, and in enhancing additional prevention efforts.	[Fabeni, Lavinia; Orchi, Nicoletta; Gori, Caterina; Forbici, Federica; De Carli, Gabriella; Continenza, Fabio; Pinnetti, Carmela; Nicastri, Emanuele; Girardi, Enrico; Antinori, Andrea; Perno, Carlo Federico] Natl Inst Infect Dis L Spallanzani IRCCS, Rome, Italy; [Alteri, Claudia; Bertoli, Ada; Ceccherini-Silberstein, Francesca; Santoro, Maria Mercedes] Univ Roma Tor Vergata, Rome, Italy; [Bertoli, Ada; Andreoni, Massimo] Univ Hosp Tor Vergata, Rome, Italy; [Montella, Francesco] S Giovanni Addolorata Hosp, Div Clin Immunol, Rome, Italy; [Pennica, Alfredo] Univ Roma La Sapienza, S Andrea Hosp, I-00185 Rome, Italy; [Giuliani, Massimo] IRCSS San Gallicano, Rome, Italy; [Mastroianni, Claudio Maria] Sapienza Univ, Infect Dis Unit, Latina, Italy	IRCCS Lazzaro Spallanzani; University of Rome Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome	Alteri, C (corresponding author), Univ Roma Tor Vergata, Rome, Italy.	claudia.alteri@uniroma2.it	FABENI, LAVINIA/J-6626-2016; Andreoni, Masimo/AAL-2214-2020; Di Maio, Velia Chiara/AGH-2628-2022; Pinnetti, Carmela/K-5392-2016; SANTORO, MARIA/K-3250-2018; perno, carlo federico/O-1544-2016; Alteri, Claudia/AAB-9956-2019; Continenza, Fabio/B-5378-2017; Alteri, Claudia/J-9116-2016; nicastri, emanuele/K-7780-2016; Giuliani, Massimo/J-2788-2018; De Carli, Gabriella/B-9258-2013; Antinori, Andrea/K-7125-2016; MASTROIANNI, Claudio Maria/O-9741-2019; Ceccherini-Silberstein, Francesca/K-4762-2016; gori, caterina/B-7836-2017; orchi, nicoletta/B-5098-2017; Forbici, Federica/B-6765-2017	FABENI, LAVINIA/0000-0002-2975-8611; Pinnetti, Carmela/0000-0003-1350-4032; SANTORO, MARIA/0000-0002-6228-1114; Alteri, Claudia/0000-0003-4270-5079; Continenza, Fabio/0000-0002-6801-3786; Alteri, Claudia/0000-0003-4270-5079; nicastri, emanuele/0000-0002-5606-8712; Giuliani, Massimo/0000-0002-4523-8261; De Carli, Gabriella/0000-0002-3972-8301; Antinori, Andrea/0000-0003-2121-4684; MASTROIANNI, Claudio Maria/0000-0002-1286-467X; gori, caterina/0000-0002-6042-7570; BERTOLI, ADA/0000-0003-0663-2503; orchi, nicoletta/0000-0001-8657-7115; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Forbici, Federica/0000-0002-3954-5679; Girardi, Enrico/0000-0001-8182-5896; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101	European Commission Framework 7 Programme (CHAIN, the Collaborative HIV and Anti-HIV Drug Resistance Network, Integrated Project) [223131]; Italian Ministry of Health (Progetto Ricerca Finalizzata) [RF-2009 -1539999]; Italian Ministry of Instruction, University and Research (MIUR) (Bandiera InterOmics Protocollo) [PB05 1degrees]; AVIRALIA foundation	European Commission Framework 7 Programme (CHAIN, the Collaborative HIV and Anti-HIV Drug Resistance Network, Integrated Project); Italian Ministry of Health (Progetto Ricerca Finalizzata); Italian Ministry of Instruction, University and Research (MIUR) (Bandiera InterOmics Protocollo)(Ministry of Education, Universities and Research (MIUR)); AVIRALIA foundation	Supported by the European Commission Framework 7 Programme (CHAIN, the Collaborative HIV and Anti-HIV Drug Resistance Network, Integrated Project no. 223131), the Italian Ministry of Health (Progetto Ricerca Finalizzata, grant no. RF-2009 -1539999), the Italian Ministry of Instruction, University and Research (MIUR) (Bandiera InterOmics Protocollo PB05 1 degrees) and an unrestricted grant from AVIRALIA foundation.	Aulicino PC, 2011, INFECT GENET EVOL, V11, P349, DOI 10.1016/j.meegid.2010.11.008; Baggaley RF, 2015, JAIDS-J ACQ IMM DEF, V68, P594, DOI 10.1097/QAI.0000000000000511; Balotta C, 2001, J ACQ IMMUN DEF SYND, V27, P499, DOI 10.1097/00126334-200108150-00012; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brand D, 2014, J CLIN MICROBIOL, V52, P4010, DOI 10.1128/JCM.01141-14; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Callegaro A, 2011, INFECT GENET EVOL, V11, P624, DOI 10.1016/j.meegid.2011.01.019; Chaix ML, 2013, CLIN INFECT DIS, V56, P880, DOI 10.1093/cid/cis999; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Chen MJ, 2013, BIOINFORMATICS, V29, P451, DOI 10.1093/bioinformatics/btt002; Drescher SM, 2014, CLIN INFECT DIS, V58, P285, DOI 10.1093/cid/cit694; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; ECDC, 2012, SURC REP; Fernandez-Garcia A, 2010, AIDS RES HUM RETROV, V26, P827, DOI 10.1089/aid.2009.0311; Fisher M, 2007, AIDS, V21, P2309, DOI 10.1097/QAD.0b013e3282ef9fed; Fox J, 2010, AIDS, V24, P2397, DOI 10.1097/QAD.0b013e32833cbb5b; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Giuliani M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/810617; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Harrigan PR, 2005, AIDS, V19, P549, DOI 10.1097/01.aids.0000163930.68907.37; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2014, AIDS, V28, P1967, DOI 10.1097/QAD.0000000000000383; Hue S, 2009, J VIROL, V83, P2645, DOI 10.1128/JVI.01556-08; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lai A, 2010, HIV MED, V11, P593, DOI 10.1111/j.1468-1293.2010.00832.x; Lai A, 2014, J MED VIROL, V86, P729, DOI 10.1002/jmv.23891; Lospitao E, 2005, HIV MED, V6, P313, DOI 10.1111/j.1468-1293.2005.00313.x; Marcus U, 2006, Euro Surveill, V11, P157, DOI 10.2807/esm.11.09.00645-en; Orchi N, 2008, AIDS CARE, V20, P419, DOI 10.1080/09540120701867073; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Parczewski M, 2015, J ANTIMICROB CHEMOTH, V70, P233, DOI 10.1093/jac/dku372; Rimsky L, 2012, JAIDS-J ACQ IMM DEF, V59, P39, DOI 10.1097/QAI.0b013e31823df4da; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santoro MM, 2014, CLIN INFECT DIS, V58, P1156, DOI 10.1093/cid/ciu020; Santoro MM, 2012, AIDS RES HUM RETROV, V28, P1285, DOI 10.1089/aid.2011.0142; Selleri M, 2007, JAIDS-J ACQ IMM DEF, V46, P145, DOI 10.1097/QAI.0b013e318120039b; Semaille C, 2009, EURO SURVEILL, V14, P19425; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Suligoi B., 2013, SORVEGLIANZA NUOVE D, P26; Suligoi B, 2008, J CLIN VIROL, V41, P288, DOI 10.1016/j.jcv.2007.11.020; Svicher V, 2011, ANTIVIR THER, V16, P1035, DOI 10.3851/IMP1862; Svicher V, 2010, NEW MICROBIOL, V33, P195; Tao J, 2013, AIDS PATIENT CARE ST, V27, P524, DOI 10.1089/apc.2013.0161; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Yebra G, 2012, J CLIN MICROBIOL, V50, P407, DOI 10.1128/JCM.05798-11; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad	54	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135325	10.1371/journal.pone.0135325	http://dx.doi.org/10.1371/journal.pone.0135325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270824	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800057
J	Noreen, S; MacLeod, MD				Noreen, Saima; MacLeod, Malcolm D.			What Do We Really Know about Cognitive Inhibition? Task Demands and Inhibitory Effects across a Range of Memory and Behavioural Tasks	PLOS ONE			English	Article							UNWANTED MEMORIES; INDIVIDUAL-DIFFERENCES; EYEWITNESS-MEMORY; UNIFIED THEORY; GO/NO-GO; RETRIEVAL; SUPPRESSION; THINK; OLDER; INTERFERENCE	Our study explores inhibitory control across a range of widely recognised memory and behavioural tasks. Eighty-seven never-depressed participants completed a series of tasks designed to measure inhibitory control in memory and behaviour. Specifically, a variant of the selective retrieval-practice and the Think/No-Think tasks were employed as measures of memory inhibition. The Stroop-Colour Naming and the Go/No-Go tasks were used as measures of behavioural inhibition. Participants completed all 4 tasks. Task presentation order was counterbalanced across 3 separate testing sessions for each participant. Standard inhibitory forgetting effects emerged on both memory tasks but the extent of forgetting across these tasks was not correlated. Furthermore, there was no relationship between memory inhibition tasks and either of the main behavioural inhibition measures. At a time when cognitive inhibition continues to gain acceptance as an explanatory mechanism, our study raises fundamental questions about what we actually know about inhibition and how it is affected by the processing demands of particular inhibitory tasks.	[Noreen, Saima; MacLeod, Malcolm D.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews	Noreen, S (corresponding author), Goldsmiths Univ, Dept Psychol, London, England.	s.noreen@gold.ac.uk; malcolm.macleod@stir.ac.uk	MACLEOD, MALCOLM D/B-3736-2017	MACLEOD, MALCOLM D/0000-0003-2678-6948	British Academy for this research [SG111104]	British Academy for this research	The authors (SN, principal investigator and MDM as co-investigator) received funding from the British Academy for this research (http://www.britac.ac.uk/). The grant number was SG111104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M. C., 2010, SUCCESSFUL REMEMBERI, P107; Anderson M.C., 2009, ENCY NEUROSCIENCE, P153, DOI [10.1016/B978-008045046-9.00421-6, DOI 10.1016/B978-008045046-9.00421-6]; Anderson MC, 2000, J EXP PSYCHOL LEARN, V26, P1141, DOI 10.1037/0278-7393.26.5.1141; Anderson MC, 2005, DYNAMIC COGNITIVE PROCESSES, P159, DOI 10.1007/4-431-27431-6_8; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2003, J MEM LANG, V49, P415, DOI 10.1016/j.jml.2003.08.006; ANDERSON MC, 1995, PSYCHOL REV, V102, P68, DOI 10.1037/0033-295X.102.1.68; ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; Anderson MC, 2001, J EXP PSYCHOL GEN, V130, P544, DOI 10.1037//0096-3445.130.3.544; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Anderson MC, 2011, TRUE FALSE RECOVERED; Anderson MC, 2011, PSYCHOL AGING, V26, P397, DOI 10.1037/a0022505; Anderson MC, 2009, CURR DIR PSYCHOL SCI, V18, P189, DOI 10.1111/j.1467-8721.2009.01634.x; ARNETT JA, 1995, PSYCHOL ASSESSMENT, V7, P220; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aslan A, 2007, PSYCHOL SCI, V18, P72, DOI 10.1111/j.1467-9280.2007.01851.x; Aslan A, 2011, J EXP PSYCHOL LEARN, V37, P264, DOI 10.1037/a0021324; Aslan A, 2010, MEMORY, V18, P442, DOI 10.1080/09658211003742698; Barbarotto R, 1998, NEUROPSYCHOLOGIA, V36, P397, DOI 10.1016/S0028-3932(97)00124-3; Barnier A, 2004, COGNITION EMOTION, V18, P457, DOI 10.1080/0269993034000392; Beck A.T., 1996, PSYCHOL ASSESS, V2, DOI DOI 10.1037/T00742-000; Bjork EL, 1998, INTENTIONAL FORGETTING: INTERDISCIPLINARY APPROACHES, P103; Bjork EL, 2006, MEMORY AND SOCIETY: PSYCHOLOGICAL PERSPECTIVES, P134; Bjork R. A., 2003, NBU SERIES COGNITIVE, P55; Bjork R.A., 1989, VARIETIES MEMORY CON, P309; Bulevich JB, 2006, MEM COGNITION, V34, P1569, DOI 10.3758/BF03195920; Butler KM, 2001, J EXP PSYCHOL LEARN, V27, P1314, DOI 10.1037/0278-7393.27.5.1314; Camp G, 2007, J EXP PSYCHOL LEARN, V33, P950, DOI 10.1037/0278-7393.33.5.950; Camp G, 2009, J EXP PSYCHOL LEARN, V35, P934, DOI 10.1037/a0015536; Carroll JB, 1988, STEVENS HDB EXPT PSY, V2, P813; Ciranni MA, 1999, J EXP PSYCHOL LEARN, V25, P1403, DOI 10.1037/0278-7393.25.6.1403; Conway MA, 2000, J MEM LANG, V43, P409, DOI 10.1006/jmla.2000.2706; Conway MA, 2003, CORTEX, V39, P667, DOI 10.1016/S0010-9452(08)70859-1; Dagenbach D., 1994, INHIBITORY PROCESSES; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; Denckla M. B., 1996, ATTENTION MEMORY EXE, P263; Depue BE, 2016, CEREB CORTEX, V26, P1634, DOI 10.1093/cercor/bhu324; Depue BE, 2010, NEUROPSYCHOLOGIA, V48, P3909, DOI 10.1016/j.neuropsychologia.2010.09.013; Depue BE, 2006, PSYCHOL SCI, V17, P441, DOI 10.1111/j.1467-9280.2006.01725.x; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Dunn EW, 2003, J EXP SOC PSYCHOL, V39, P420, DOI 10.1016/S0022-1031(03)00032-5; Erdelyi MH, 2006, BEHAV BRAIN SCI, V29, P499, DOI 10.1017/S0140525X06009113; FRICK RW, 1995, MEM COGNITION, V23, P132, DOI 10.3758/BF03210562; Hanslmayr S, 2010, MEMORY, V18, P252, DOI 10.1080/09658210903476548; Hanslmayr S, 2009, J NEUROSCI, V29, P2742, DOI 10.1523/JNEUROSCI.4703-08.2009; Harris CB, 2010, CURR ISS MEM, P253; Hart RE, 2012, CONSCIOUS COGN, V21, P1541, DOI 10.1016/j.concog.2012.06.005; Hertel P, 2010, COGNITION EMOTION, V24, P1239, DOI 10.1080/02699930903172377; Hertel PT, 2005, PSYCHON B REV, V12, P484, DOI 10.3758/BF03193792; Hotta C, 2009, PSYCHOLOGIA, V52, P41, DOI 10.2117/psysoc.2009.41; Huddleston E, 2012, J EXP PSYCHOL LEARN, V38, P1408, DOI 10.1037/a0027092; Hulbert JC, 2012, EXP PSYCHOL, V59, P11, DOI 10.1027/1618-3169/a000120; Jakab E, 2009, J EXP PSYCHOL LEARN, V35, P607, DOI 10.1037/a0015264; Joormann J, 2009, J ABNORM PSYCHOL, V118, P34, DOI 10.1037/a0013794; Lamm C, 2006, NEUROPSYCHOLOGIA, V44, P2139, DOI 10.1016/j.neuropsychologia.2005.10.013; Levy BJ, 2008, ACTA PSYCHOL, V127, P623, DOI 10.1016/j.actpsy.2007.12.004; Levy BJ, 2002, TRENDS COGN SCI, V6, P299, DOI 10.1016/S1364-6613(02)01923-X; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; MacLeod, 2007, INHIBITION COGNITION, P3, DOI [10.1037/11587-001, DOI 10.1037/11587-001]; MacLeod CM, 2003, PSYCHOL LEARN MOTIV, V43, P163, DOI 10.1016/S0079-7421(03)01014-4; MacLeod CM, 2007, SCI MEMORY CONCEPTS, P301; Macleod M, 2002, APPL COGNITIVE PSYCH, V16, P135, DOI 10.1002/acp.782; MacLeod MD, 2001, PSYCHOL SCI, V12, P148, DOI 10.1111/1467-9280.00325; Macrae CN, 1999, J PERS SOC PSYCHOL, V77, P463, DOI 10.1037/0022-3514.77.3.463; Mecklinger A, 2009, BRAIN RES, V1255, P132, DOI 10.1016/j.brainres.2008.11.073; MENSINK GJ, 1988, PSYCHOL REV, V95, P434, DOI 10.1037/0033-295X.95.4.434; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2001, J EXP PSYCHOL GEN, V130, P621, DOI 10.1037/0096-3445.130.4.621; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Noreen S, 2014, ACTA PSYCHOL, V145, P84, DOI 10.1016/j.actpsy.2013.10.011; Noreen S, 2013, J EXP PSYCHOL LEARN, V39, P375, DOI 10.1037/a0028888; Norman KA, 2007, PSYCHOL REV, V114, P887, DOI 10.1037/0033-295X.114.4.887; Norman KA, 2008, CAMB HANDB PSYCHOL, P189; Oram MW, 2001, P 23 ANN C COGN SCI, P738; Perfect TJ, 2004, J MEM LANG, V51, P399, DOI 10.1016/j.jml.2004.06.003; Raaijmakers JGW, 2013, J MEM LANG, V68, P98, DOI 10.1016/j.jml.2012.10.002; RAAIJMAKERS JGW, 1981, PSYCHOL REV, V88, P93, DOI 10.1037/0033-295X.88.2.93; Rabbitt P., 1997, METHODOLOGY FRONTAL, P1; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rush BK, 2006, AGING NEUROPSYCHOL C, V13, P588, DOI 10.1080/13825580600680703; Sahakyan L, 2008, PSYCHOL AGING, V23, P621, DOI 10.1037/a0012766; Saunders J, 2006, MEM COGNITION, V34, P307, DOI 10.3758/BF03193409; Schilling CJ, 2014, COGNITION, V133, P358, DOI 10.1016/j.cognition.2014.07.003; Schulz KP, 2007, ARCH CLIN NEUROPSYCH, V22, P151, DOI 10.1016/j.acn.2006.12.001; SHAW JS, 1995, PSYCHON B REV, V2, P249, DOI 10.3758/BF03210965; Shilling VM, 2002, NEUROPSYCHOLOGIA, V40, P605, DOI 10.1016/S0028-3932(01)00157-9; Smith R., 1992, INHIBITION HIST MEAN; Stephens E, 2013, CLIN PSYCHOL SCI, V1, P163, DOI 10.1177/2167702612467773; Storm BC, 2006, PSYCHON B REV, V13, P1023, DOI 10.3758/BF03213919; Storm BC, 2012, PSYCHOL SCI, V23, P1356, DOI 10.1177/0956797612443837; Storm BC, 2012, MEM COGNITION, V40, P827, DOI 10.3758/s13421-012-0211-7; Storm BC, 2010, MEMORY, V18, P99, DOI 10.1080/09658210903107853; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tomlinson TD, 2009, P NATL ACAD SCI USA, V106, P15588, DOI 10.1073/pnas.0813370106; Trenerry MR., 1989, STROOP NEUROPSYCHOLO; van den Wildenberg WPM, 2006, J COGNITIVE NEUROSCI, V18, P626, DOI 10.1162/jocn.2006.18.4.626; Verbruggen F, 2009, J EXP PSYCHOL LEARN, V35, P1381, DOI 10.1037/a0016645; Verde MF, 2012, PSYCHOL LEARN MOTIV, V56, P47, DOI 10.1016/B978-0-12-394393-4.00002-9; Weller PD, 2013, J EXP PSYCHOL LEARN, V39, P1232, DOI 10.1037/a0030335; Wessel I, 2005, PERS INDIV DIFFER, V39, P1461, DOI 10.1016/j.paid.2005.05.009; Zacks Rose T., 1994, P241; Zacks RT, 1996, J EXP PSYCHOL LEARN, V22, P143, DOI 10.1037/0278-7393.22.1.143	103	25	25	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134951	10.1371/journal.pone.0134951	http://dx.doi.org/10.1371/journal.pone.0134951			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JX	26270470	Green Published, gold, Green Accepted			2022-12-27	WOS:000359492800026
J	Ying, LH; Ma, FL; Huang, HH; Guo, XL; Chen, CS; Xu, F				Ying, Liuhua; Ma, Fengling; Huang, Huahua; Guo, Xiaolin; Chen, Chuansheng; Xu, Fen			Parental Monitoring, Parent-Adolescent Communication, and Adolescents' Trust in Their Parents in China	PLOS ONE			English	Article							DEVELOPMENTAL-CHANGES; INTERPERSONAL-TRUST; REINTERPRETATION; DEPRESSION; SUPPORT	Purpose Trust is an important aspect of interpersonal relationships, but little is known about adolescents' interpersonal trust. The aim of the present study was to examine the associations among parental monitoring, parent-adolescent communication, and adolescents' trust in their parents in China. Methods Data in this study were collected as part of the cross-sectional study of children in China. 3349 adolescents (female 48.6%, age range of 12-15 years) were randomly selected from 35 secondary schools in April, 2009 and administered to the Adolescent Interpersonal Trust Scale, the Parental Monitoring Scale, and the Parent-Adolescent Communication Scale. Results Adolescents' trust in their parents was positively related to parental monitoring and parent-adolescent communication. Furthermore, parent-adolescent communication mediated the association between parental monitoring and adolescents' trust in their parents. The mediation model fit data of both genders and three age groups equally well. Conclusions Parental monitoring and parent-adolescent communication play an importance role in fostering adolescents' trust in their parents.	[Ying, Liuhua; Ma, Fengling; Huang, Huahua; Xu, Fen] Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China; [Guo, Xiaolin] Beijing Normal Univ, Natl Innovat Ctr Assessment Basic Educ Qual, Beijing 100875, Peoples R China; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA	Zhejiang Sci-Tech University; Beijing Normal University; University of California System; University of California Irvine	Xu, F (corresponding author), Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China.	fenxu@zstu.edu.cn	Eapen, Valsamma/N-9608-2017	Eapen, Valsamma/0000-0001-6296-8306; Chen, Chuansheng/0000-0002-8224-1005	National Foundation of Natural Science, China [31170996]	National Foundation of Natural Science, China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Foundation of Natural Science, China (Grant Number: 31170996). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, J RES ADOLESCENCE; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Borawski EA, 2003, J ADOLESCENT HEALTH, V33, P60, DOI 10.1016/S1054-139X(03)00100-9; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Bridges LJ, 2003, CROSS CONT, P177; Bureau JS, 2014, J ADOLESCENCE, V37, P225, DOI 10.1016/j.adolescence.2013.12.007; Clark-Lempers DS, 1991, J ADOLESCENT RES, V6, P296, DOI DOI 10.1177/074355489163003; De Goede IHA, 2009, J YOUTH ADOLESCENCE, V38, P75, DOI 10.1007/s10964-008-9286-7; Dishion T J, 1998, Clin Child Fam Psychol Rev, V1, P61, DOI 10.1023/A:1021800432380; Erikson E. H., 1963, CHILDHOOD SOC; Finkenauer C, 2002, J YOUTH ADOLESCENCE, V31, P123, DOI 10.1023/A:1014069926507; Flanagan CA, 2010, J RES ADOLESCENCE, V20, P748, DOI 10.1111/j.1532-7795.2010.00658.x; Guilamo-Ramos V, 2006, J MARRIAGE FAM, V68, P1229, DOI 10.1111/j.1741-3737.2006.00325.x; Henry CL, 1989, J ADOLESCENT RES, V4, P15, DOI DOI 10.1177/074355488941002; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Keijsers L, 2013, DEV PSYCHOL, V49, P2301, DOI 10.1037/a0032217; Kerr M, 1999, J ADOLESCENCE, V22, P737, DOI 10.1006/jado.1999.0266; Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037/0012-1649.36.3.366; Kerr M, 2010, J RES ADOLESCENCE, V20, P39, DOI 10.1111/j.1532-7795.2009.00623.x; Koepke S, 2012, DEV REV, V32, P67, DOI 10.1016/j.dr.2012.01.001; Leas L, 2000, BEHAV CHANGE, V17, P155, DOI 10.1375/bech.17.3.155; LESTER D, 1990, PSYCHOL REP, V67, P786, DOI 10.2466/PR0.67.7.786-786; Li J., 2008, PSYCHOL DEV ED, V24, P80, DOI [10.16187/j.cnki.issn1001-4918.2008.04.018, DOI 10.16187/J.CNKI.ISSN1001-4918.2008.04.018]; Lin S., 2001, THESIS U NEBRASKA LI; Liu MM, 2005, INT J BEHAV DEV, V29, P489, DOI 10.1080/01650250500147063; Metzger A, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/396163; MILLER JB, 1991, J ADOLESCENCE, V14, P179, DOI 10.1016/0140-1971(91)90030-U; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Rotenberg K.J., 2010, INTERPERSONAL TRUST, DOI [10.1017/CBO9780511750946.002, DOI 10.1017/CBO9780511750946.002]; Rotenberg KJ, 2004, J GENET PSYCHOL, V165, P233, DOI 10.3200/GNTP.165.3.233-249; Shek DTL, 2010, AM J FAM THER, V38, P251, DOI 10.1080/01926180902945855; Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Tilton-Weaver L, 2010, J ADOLESCENCE, V33, P333, DOI 10.1016/j.adolescence.2009.07.011; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Wang B, 2013, SOC SCI MED, V97, P161, DOI 10.1016/j.socscimed.2013.08.013; Wang L, 2011, J SPEC ED CHINESE, V5, P62; Yang X., 2008, PSYCHOL DEV ED CHINE, V24, P49	39	16	17	8	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134730	10.1371/journal.pone.0134730	http://dx.doi.org/10.1371/journal.pone.0134730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JX	26271080	Green Published, gold			2022-12-27	WOS:000359492800014
J	Kummari, E; Alugubelly, N; Hsu, CY; Dong, B; Nanduri, B; Edelmann, MJ				Kummari, Evangel; Alugubelly, Navatha; Hsu, Chuan-Yu; Dong, Brittany; Nanduri, Bindu; Edelmann, Mariola J.			Activity-Based Proteomic Profiling of Deubiquitinating Enzymes in Salmonella-Infected Macrophages Leads to Identification of Putative Function of UCH-L5 in Inflammasome Regulation	PLOS ONE			English	Article							NEGATIVE REGULATOR; CYLD; ACTIVATION; UBIQUITIN; NLRP3; RECRUITMENT; INHIBITORS; CASPASE-1; INVASION; LUNG	Although protein ubiquitination has been shown to regulate multiple processes during host response to Salmonella enterica serovar Typhimurium infection, specific functions of host deubiquitinating enzymes remain unknown in this bacterial infection. By using chemical proteomics approach, in which deubiquitinating enzymes were labeled by an active-site probe and analyzed by quantitative proteomics, we identified novel deubiquitinases in chicken macrophages based on their reactivity with the probe. Also, we detected down-regulation of UCH-L3, and USP4 as well as up-regulation of USP5 and UCH-L5 deubiquitinating enzymes in macrophages infected with Salmonella Typhimurium. We showed that decrease in either UCH-L5 activity, or in UCH-L5 protein amount in chicken and human macrophages infected or stimulated with LPS/nigericin, led to decreased IL-1 beta release. These data point towards a putative role of UCH-L5 in inflammasome regulation during Salmonella infection. Because inflammasome activation is important in innate resistance to these bacteria, one would expect that naturally occurring or therapeutically induced alteration in UCH-L5 activation would influence disease outcome and could represent a target for new therapeutic approaches.	[Kummari, Evangel; Alugubelly, Navatha; Nanduri, Bindu; Edelmann, Mariola J.] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Hsu, Chuan-Yu; Dong, Brittany; Edelmann, Mariola J.] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University	Edelmann, MJ (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	medelmann@ufl.edu	Kummari, Evangel/J-6019-2019; Alugubelly, Navatha/AAC-2489-2020		National Institutes of Health fund [5P20GM103646-02]; United States Department of Agriculture - Agricultural Research Service agreement [58-6402-2-729]; Mississippi Agricultural and Forestry Experiment Station, Special Research Initiative grant [160000-018100-027100-329210]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103646, P20GM103476] Funding Source: NIH RePORTER	National Institutes of Health fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture - Agricultural Research Service agreement; Mississippi Agricultural and Forestry Experiment Station, Special Research Initiative grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institutes of Health fund No. 5P20GM103646-02, The United States Department of Agriculture - Agricultural Research Service agreement No. 58-6402-2-729 and Mississippi Agricultural and Forestry Experiment Station, Special Research Initiative grant No. 160000-018100-027100-329210.	Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; Basseres E, 2010, CELL MICROBIOL, V12, P1622, DOI 10.1111/j.1462-5822.2010.01495.x; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Borodovsky A, 2005, CHEMBIOCHEM, V6, P287, DOI 10.1002/cbic.200400236; Brodsky IE, 2011, CURR BIOL, V21, pR72, DOI 10.1016/j.cub.2010.12.008; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Coombs N, 2011, INT J MED MICROBIOL, V301, P213, DOI 10.1016/j.ijmm.2010.09.004; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Harker KS, 2014, EPIDEMIOL INFECT, V142, P601, DOI 10.1017/S0950268813001210; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Lim JH, 2008, CELL MICROBIOL, V10, P2247, DOI 10.1111/j.1462-5822.2008.01204.x; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Mather AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/science.1240578; Mesquita FS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002743; Nallamilli BRR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089283; Nanduri B, 2013, CURR PHARM DESIGN, V19, P3234, DOI 10.2174/1381612811319180008; Narayanan LA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00558; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Puri AW, 2012, NAT CHEM BIOL, V8, P745, DOI [10.1038/NCHEMBIO.1023, 10.1038/nchembio.1023]; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Sakai A, 2007, FEBS J, V274, P3655, DOI 10.1111/j.1742-4658.2007.05899.x; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Wang R, 2013, BIOCHEMISTRY-US, V52, P7559, DOI 10.1021/bi401138s; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460	33	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135531	10.1371/journal.pone.0135531	http://dx.doi.org/10.1371/journal.pone.0135531			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267804	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300129
J	Masika, MM; Ogembo, JG; Chabeda, SV; Wamai, RG; Mugo, N				Masika, Moses Muia; Ogembo, Javier Gordon; Chabeda, Sophie Vusha; Wamai, Richard G.; Mugo, Nelly			Knowledge on HPV Vaccine and Cervical Cancer Facilitates Vaccine Acceptability among School Teachers in Kitui County, Kenya	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; ADOLESCENT GIRLS; HIGH COVERAGE; DELIVERY; WORLDWIDE; AWARENESS; PARENTS; BURDEN; INFECTION; ATTITUDES	Background Vaccines against human papillomavirus (HPV) infection have the potential to reduce the burden of cervical cancer. School-based delivery of HPV vaccines is cost-effective and successful uptake depends on school teachers' knowledge and acceptability of the vaccine. The aim of this study is to assess primary school teachers' knowledge and acceptability of HPV vaccine and to explore facilitators and barriers of an ongoing Gavi Alliance-supported vaccination program in Kitui County, Kenya. Methods This was a cross-sectional, mixed methods study in Central Division of Kitui County where the Ministry of Health is offering the quadrivalent HPV vaccine to grade four girls. Data on primary school teachers' awareness, knowledge and acceptability of HPV vaccine as well as facilitators and barriers to the project was collected through self-administered questionnaires and two focus group discussions. Results 339 teachers (60% female) completed the survey (62% response rate) and 13 participated in 2 focus group discussions. Vaccine awareness among teachers was high (90%), the level of knowledge about HPV and cervical cancer among teachers was moderate (48%, SD = 10.9) and females scored higher than males (50% vs. 46%, p = 0.002). Most teachers (89%) would recommend the vaccine to their daughter or close relatives. Those who would recommend the vaccine had more knowledge than those who would not (p = <0.001). The main barriers were insufficient information about the vaccine, poor accessibility of schools, absenteeism of girls on vaccine days, and fear of side effects. Conclusions Despite low to moderate levels of knowledge about HPV vaccine among school teachers, vaccine acceptability is high. Teachers with little knowledge on HPV vaccine are less likely to accept the vaccine than those who know more; this may affect uptake if not addressed. Empowering teachers to be vaccine champions in their community may be a feasible way of disseminating information about HPV vaccine and cervical cancer.	[Masika, Moses Muia] Univ Nairobi, Sch Med, Dept Med Microbiol, Nairobi, Kenya; [Ogembo, Javier Gordon] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Chabeda, Sophie Vusha] Partners Hlth Res & Dev, Thika, Kenya; [Wamai, Richard G.] Northeastern Univ, Dept African Amer Studies, Boston, MA 02115 USA; [Mugo, Nelly] Kenya Med Res Inst KEMRI, Nairobi, Kenya	University of Nairobi; University of Massachusetts System; University of Massachusetts Worcester; Northeastern University; Kenya Medical Research Institute	Masika, MM (corresponding author), Univ Nairobi, Sch Med, Dept Med Microbiol, Nairobi, Kenya.	mosmasika@gmail.com		Chabeda, Sophie/0000-0001-5172-7320; Masika, Moses Muia/0000-0003-3385-0821; Ogembo, Javier Gordon/0000-0001-6949-8693	Academic Model Providing Access to Healthcare (AMPATH)	Academic Model Providing Access to Healthcare (AMPATH)	MMM received funding for this study from Academic Model Providing Access to Healthcare (AMPATH) - (http://www.ampathkenya.org/) through a postgraduate support program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; [Anonymous], 2013, LANCET, V381, P1688, DOI 10.1016/S0140-6736(13)61058-2; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Arrossi S, 2012, VACCINE, V30, P2467, DOI 10.1016/j.vaccine.2012.01.032; Ayissi CA, 2012, J COMMUN HEALTH, V37, P1127, DOI 10.1007/s10900-012-9554-z; Becker-Dreps S, 2010, VACCINE, V28, P4864, DOI 10.1016/j.vaccine.2010.05.034; Binagwaho A, 2012, B WORLD HEALTH ORGAN, V90, P623, DOI 10.2471/BLT.11.097253; Binagwaho A, 2011, LANCET, V378, P1916, DOI 10.1016/S0140-6736(11)61837-0; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bosze P, 2013, ORVOSI HETILAP, V154, P603, DOI 10.1556/OH.2013.29593; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; Cates JR, 2010, J ADOLESCENT HEALTH, V47, P305, DOI 10.1016/j.jadohealth.2010.04.003; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Coleman MA, 2011, VACCINE, V29, P3945, DOI 10.1016/j.vaccine.2011.03.093; Commission on Revenue Allocation, 2011, KEN COUNT FACT SHEET; Commission on Revenue Allocation, 2013, KEN COUNT FACT SHEET; DiAngi YT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025481; Ferlay J., 2013, IARC CANCERBASE; Fesenfeld M, 2013, VACCINE, V31, P3786, DOI 10.1016/j.vaccine.2013.06.060; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Galagan SR, 2013, VACCINE, V31, P3072, DOI 10.1016/j.vaccine.2013.04.056; GAVI, 2014, 206000 MOR GIRLS BEN; GAVI Alliance, 2013, HUM PAP VACC SUPP; GAVI Alliance, 2014, COUNTR EL GAVI NEW V; Gilmour S, 2013, LANCET, V382, P768, DOI 10.1016/S0140-6736(13)61831-0; Guichon JR, 2013, PREV MED, V57, P409, DOI 10.1016/j.ypmed.2013.06.005; Haesebaert J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1034; Hayashi Y, 2012, VACCINE, V30, P5547, DOI 10.1016/j.vaccine.2012.06.038; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Katz IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072094; Kenya OpenData, 2011, KEN PRIM SCH 2007; Ladner J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-370; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Larson HJ, 2010, LANCET, V376, P572, DOI 10.1016/S0140-6736(10)60881-1; Levin CE, 2013, B WORLD HEALTH ORGAN, V91, P585, DOI 10.2471/BLT.12.113837; Lindley MC, 2008, PEDIATRICS, V121, pS46, DOI 10.1542/peds.2007-1115F; Manzo-Merino J, 2013, EXPERT OPIN THER TAR, V17, P1357, DOI 10.1517/14728222.2013.832204; Moodley I, 2013, SAMJ S AFR MED J, V103, P318, DOI 10.7196/SAMJ.6414; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nakato A, 2012, PROPOSAL HPV VACCINE; Ogembo JG, 2014, VACCINE, V32, P4399, DOI 10.1016/j.vaccine.2014.06.064; Onsomu EO, 2015, MATERN CHILD HLTH J; Ortashi O, 2014, ASIAN PAC J CANCER P, V15, P2007, DOI 10.7314/APJCP.2014.15.5.2007; Ovedraogo N, 2011, LANCET, V378, P315, DOI 10.1016/S0140-6736(11)61164-1; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Perlman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090912; Poole DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056402; Remes P, 2012, VACCINE, V30, P5363, DOI 10.1016/j.vaccine.2012.06.025; Rositch AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040766; Salmon DA, 2004, PEDIATRICS, V113, pE552, DOI 10.1542/peds.113.6.e552; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Syrjanen S, 2011, ORAL DIS, V17, P58, DOI 10.1111/j.1601-0825.2011.01792.x; Von Krogh G, 2001, EUR J DERMATOL, V11, P598; Wamai RG, 2013, INT J NURS STUD, V50, P1399, DOI 10.1016/j.ijnurstu.2012.12.020; Wamai RG, 2012, J COMMUN HEALTH, V37, P917, DOI 10.1007/s10900-012-9540-5; Watson-Jones D, 2012, J INFECT DIS, V206, P678, DOI 10.1093/infdis/jis407; WHO, 2009, WHO POS PAP HUM PAP; WHO Regional Office for Africa, 2014, 87 COV 1 ROUND INTR; Woo YL, 2012, ASIAN PAC J CANCER P, V13, P4651, DOI 10.7314/APJCP.2012.13.9.4651	60	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135563	10.1371/journal.pone.0135563	http://dx.doi.org/10.1371/journal.pone.0135563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26266949	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300134
J	Mignon-Grasteau, S; Narcy, A; Rideau, N; Chantry-Darmon, C; Boscher, MY; Sellier, N; Chabault, M; Konsak-Ilievski, B; Le Bihan-Duval, E; Gabriel, I				Mignon-Grasteau, Sandrine; Narcy, Agnes; Rideau, Nicole; Chantry-Darmon, Celine; Boscher, Marie-Yvonne; Sellier, Nadine; Chabault, Marie; Konsak-Ilievski, Barbara; Le Bihan-Duval, Elisabeth; Gabriel, Irene			Impact of Selection for Digestive Efficiency on Microbiota Composition in the Chicken	PLOS ONE			English	Article							REAL-TIME PCR; GROUP-SPECIFIC PRIMERS; BROILER-CHICKENS; GUT MICROBIOTA; NUTRIENT DIGESTIBILITY; PREDOMINANT BACTERIA; FECAL MICROBIOTA; QTL DETECTION; FATTY-ACIDS; LACTOBACILLUS	Objectives Feed efficiency and its digestive component, digestive efficiency, are key factors in the environmental impact and economic output of poultry production. The interaction between the host and intestinal microbiota has a crucial role in the determination of the ability of the bird to digest its food and to the birds' feed efficiency. We therefore investigated the phenotypic and genetic relationships between birds' efficiency and the composition of the cecal microbiota in a F2 cross between broiler lines divergently selected for their high or low digestive efficiency. Methods Analyses were performed on 144 birds with extreme feed efficiency values at 3 weeks, with feed conversion values of 1.41 +/- 0.05 and 2.02 +/- 0.04 in the efficient and non-efficient groups, respectively. The total numbers of Lactobacillus, L. salivarius, L. crispatus, C. coccoides, C. leptum and E. coli per gram of cecal content were measured. Results The two groups mainly differed in larger counts of Lactobacillus, L. salivarius and E. coli in less efficient birds. The equilibrium between bacterial groups was also affected, efficient birds showing higher C. leptum, C. coccoides and L. salivarius to E. coli ratios. The heritability of the composition of microbiota was also estimated and L. crispatus, C. leptum, and C. coccoides to E. coli ratios were moderately but significantly heritable (0.16 to 0.24). The coefficient of fecal digestive use of dry matter was genetically and positively correlated with L. crispatus, C. leptum, C. coccoides (0.50 to 0.76) and negatively with E. coli (-0.66). Lipid digestibility was negatively correlated with E. coli (-0.64), and AMEn positively correlated with C. coccoides and with the C. coccoides to Lactobacillus ratio (0.48 to 0.64). We also detected 14 Quantitative Trait Loci (QTL) for microbiota on the host genome, mostly on C. leptum and Lactobacillus. The QTL for C. leptum on GGA6 was close to genome-wide significance. This region mainly includes genes involved in anti-inflammatory responses and in the motility of the gastrointestinal tract.	[Mignon-Grasteau, Sandrine; Narcy, Agnes; Rideau, Nicole; Chabault, Marie; Konsak-Ilievski, Barbara; Le Bihan-Duval, Elisabeth; Gabriel, Irene] INRA, Rech Avicoles UR83, F-37380 Nouzilly, France; [Chantry-Darmon, Celine; Boscher, Marie-Yvonne] INRA, LABOGENA, Jouy En Josas, France; [Sellier, Nadine] INRA, PEAT UE1295, F-37380 Nouzilly, France	INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Mignon-Grasteau, S (corresponding author), INRA, Rech Avicoles UR83, F-37380 Nouzilly, France.	sandrine.grasteau@tours.inra.fr		CHANTRY DARMON, Celine/0000-0002-1313-7650	Agence Nationale de la Recherche [ANR-09-GENM-007]	Agence Nationale de la Recherche(French National Research Agency (ANR))	The study was funded by Agence Nationale de la Recherche (www.agence-nationale-recherche.fr), grant number ANR-09-GENM-007, attributed to SMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration UFaD, 1996, ENV ASS CLINACOXTM T, P64; Asano Y, 2012, AM J PHYSIOL-GASTR L, V303, pG1288, DOI 10.1152/ajpgi.00341.2012; Bastianelli D, 2010, J NEAR INFRARED SPEC, V18, P69, DOI 10.1255/jnirs.864; BRAUN EJ, 1989, J EXP ZOOL, P70, DOI 10.1002/jez.1402520512; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Cantorna MT, 2014, EXP BIOL MED, V239, P1524, DOI 10.1177/1535370214523890; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; de Verdal H, 2010, POULTRY SCI, V89, P1955, DOI 10.3382/ps.2010-813; de Verdal H, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-59; ELSDEN SR, 1976, ARCH MICROBIOL, V107, P283, DOI 10.1007/BF00425340; Elsen JM, 1999, GENET SEL EVOL, V31, P213, DOI 10.1051/gse:19990302; Gabriel I, 2007, PROCEEDINGS OF THE 7, P224; Gabriel I, 2011, PROCEEDINGS OF THE 9, P760; Gilbert H, 2008, ANN HUM GENET, V72, P694; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Guardia S, 2011, POULTRY SCI, V90, P1878, DOI 10.3382/ps.2010-01311; Guardia S, 2009, PROCEEDINGS OF THE 8, P135; Harrow SA, 2007, APPL ENVIRON MICROB, V73, P7123, DOI 10.1128/AEM.01289-07; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Hemarajata P, 2013, THER ADV GASTROENTER, V6, P39, DOI 10.1177/1756283X12459294; Hiroi M, 2011, OBESITY, V19, P882, DOI 10.1038/oby.2010.275; Holzer P, 2012, NEUROPEPTIDES, V46, P261, DOI 10.1016/j.npep.2012.08.005; Huijsdens XW, 2002, J CLIN MICROBIOL, V40, P4423, DOI 10.1128/JCM.40.12.4423-4427.2002; Jacquier V, 2014, THESIS; Jozefiak D, 2004, ANIM FEED SCI TECH, V113, P1, DOI 10.1016/j.anifeedsci.2003.09.007; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Kohl KD, 2012, J COMP PHYSIOL B, V182, P591, DOI 10.1007/s00360-012-0645-z; Kovac M, 2008, VCE 6 USER S MANUAL; Kramer J, 2003, ANIM GENET, V34, P339, DOI 10.1046/j.1365-2052.2003.01027.x; Kumar A, 2007, EMBO J, V26, P4457, DOI 10.1038/sj.emboj.7601867; LANDER ES, 1989, GENETICS, V121, P185; Le Roy P, 1998, 6 WORLD C GEN APPL L, V26, P257; Lee YD, 2012, ANAT CELL BIOL, V45, P160, DOI 10.5115/acb.2012.45.3.160; Li YN, 2014, HUM IMMUNOL, V75, P1232, DOI 10.1016/j.humimm.2014.09.017; Lopetuso LR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-23; Rodriguez ML, 2012, J SCI FOOD AGR, V92, P184, DOI 10.1002/jsfa.4561; Lumpkins BS, 2010, POULTRY SCI, V89, P1614, DOI 10.3382/ps.2010-00747; Lyte M, 2010, MED HYPOTHESES, V74, P895, DOI 10.1016/j.mehy.2009.11.001; Madsen K, 2011, PROCEEDINGS OF THE 1, P1; Mathlouthi N, 2002, ANIM RES, V51, P395, DOI 10.1051/animres:2002034; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; MEAD GC, 1989, J EXP ZOOL, P48, DOI 10.1002/jez.1402520508; Meng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089862; Mignon-Grasteau S, 2004, POULTRY SCI, V83, P860, DOI 10.1093/ps/83.6.860; Mignon-Grasteau S, 2010, PROCEEDINGS OF THE 9, P0249; Mignon-Grasteau S, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0156-y; Monteils V, 2008, FEMS MICROBIOL ECOL, V66, P620, DOI 10.1111/j.1574-6941.2008.00611.x; Mroz Z., 2006, Biology of nutrition in growing animals, P81, DOI 10.1016/S1877-1823(09)70091-8; NANTEL G, 1973, BIOCHIM BIOPHYS ACTA, V316, P156, DOI 10.1016/0005-2760(73)90005-2; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rideau N, 2014, POULTRY SCI, V93, P1245, DOI 10.3382/ps.2013-03756; Rosenstiel P, 2007, J IMMUNOL, V178, P8203, DOI 10.4049/jimmunol.178.12.8203; Rougiere N, 2012, POULTRY SCI, V91, P460, DOI 10.3382/ps.2011-01494; Rougiere N, 2009, POULTRY SCI, V88, P1206, DOI 10.3382/ps.2008-00408; Sauvant D, 2004, TABLES DE COMPOSITIO; Sekelja M, 2012, APPL ENVIRON MICROB, V78, P2941, DOI 10.1128/AEM.05391-11; Singh KM, 2012, MOL BIOL REP, V39, P10595, DOI 10.1007/s11033-012-1947-7; Sorriento D, 2008, P NATL ACAD SCI USA, V105, P17818, DOI 10.1073/pnas.0804446105; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Stanley D, 2013, VET MICROBIOL, V164, P85, DOI 10.1016/j.vetmic.2013.01.030; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Szylit O, 2014, REPROD NUT DEV, V20, P1701; Tappenden KA, 1998, DIGEST DIS SCI, V43, P1526, DOI 10.1023/A:1018819032620; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Tilquin P, 2005, GENET SEL EVOL, V37, P539, DOI 10.1051/gse:2005015; Torok VA, 2011, APPL ENVIRON MICROB, V77, P5868, DOI 10.1128/AEM.00165-11; Tran TS, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-25; Vijay-Kumar M, 2010, EUR J IMMUNOL, V40, P3528, DOI 10.1002/eji.201040421; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163; Zhou AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081146	76	40	41	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135488	10.1371/journal.pone.0135488	http://dx.doi.org/10.1371/journal.pone.0135488			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267269	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300125
J	Nah, G; Im, JH; Kim, JW; Park, HR; Yook, MJ; Yang, TJ; Fischer, AJ; Kim, DS				Nah, Gyoungju; Im, Ji-Hoon; Kim, Jin-Won; Park, Hae-Rim; Yook, Min-Jung; Yang, Tae-Jin; Fischer, Albert J.; Kim, Do-Soon			Uncovering the Differential Molecular Basis of Adaptive Diversity in Three Echinochloa Leaf Transcriptomes	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; OSMOTIC-STRESS RESPONSES; PROTEIN-KINASE; FREEZING TOLERANCE; ABSCISIC-ACID; SUBMERGENCE TOLERANCE; POSITIVE REGULATOR; FOXTAIL MILLET; GENE FAMILY; ARABIDOPSIS	Echinochloa is a major weed that grows almost everywhere in farmed land. This high prevalence results from its high adaptability to various water conditions, including upland and paddy fields, and its ability to grow in a wide range of climates, ranging from tropical to temperate regions. Three Echinochloa crus-galli accessions (EC-SNU1, EC-SNU2, and EC-SNU3) collected in Korea have shown diversity in their responses to flooding, with EC-SNU1 exhibiting the greatest growth among three accessions. In the search for molecular components underlying adaptive diversity among the three Echinochloa crus-galli accessions, we performed de novo assembly of leaf transcriptomes and investigated the pattern of differentially expressed genes (DEGs). Although the overall composition of the three leaf transcriptomes was well-conserved, the gene expression patterns of particular gene ontology (GO) categories were notably different among the three accessions. Under non-submergence growing conditions, five protein categories (serine/threonine kinase, leucinerich repeat kinase, signaling-related, glycoprotein, and glycosidase) were significantly (FDR, q < 0.05) enriched in up-regulated DEGs from EC-SNU1. These up-regulated DEGs include major components of signal transduction pathways, such as receptor-like kinase (RLK) and calcium-dependent protein kinase (CDPK) genes, as well as previously known abiotic stress-responsive genes. Our results therefore suggest that diversified gene expression regulation of upstream signaling components conferred the molecular basis of adaptive diversity in Echinochloa crus-galli.	[Nah, Gyoungju; Im, Ji-Hoon; Kim, Jin-Won; Park, Hae-Rim; Yook, Min-Jung; Yang, Tae-Jin; Kim, Do-Soon] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Plant Sci, Coll Agr & Life Sci, Seoul 151921, South Korea; [Fischer, Albert J.] Univ Calif Davis, Dept Plant Sci, Coll Agr & Environm Sci, Davis, CA 95616 USA	Seoul National University (SNU); University of California System; University of California Davis	Kim, DS (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Plant Sci, Coll Agr & Life Sci, Seoul 151921, South Korea.	dosoonkim@snu.ac.kr	Yang, Tae-Jin/AAT-5274-2020		"Cooperative Research Program for Agriculture Science & Technology Development", Rural Development Administration, Korea [PJ00907801]	"Cooperative Research Program for Agriculture Science & Technology Development", Rural Development Administration, Korea	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ00907801)", Rural Development Administration, Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Blanco-Herrera F, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0525-2; Bui LT, 2015, PLANT SCI, V236, P37, DOI 10.1016/j.plantsci.2015.03.008; Burdiak P, 2015, J EXP BOT, V66, P3325, DOI 10.1093/jxb/erv143; Byun MY, 2015, PLANT SCI, V236, P61, DOI 10.1016/j.plantsci.2015.03.020; Carvallo MA, 2011, J EXP BOT, V62, P3807, DOI 10.1093/jxb/err066; Chauhan BS, 2010, FIELD CROP RES, V117, P177, DOI 10.1016/j.fcr.2010.02.014; Chen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080818; de Lorenzo L, 2009, PLANT CELL, V21, P668, DOI 10.1105/tpc.108.059576; Ding YL, 2015, DEV CELL, V32, P278, DOI 10.1016/j.devcel.2014.12.023; Ding Y, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-229; Diray-Arce J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1553-x; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Feki K, 2014, PLANT CELL REP, V33, P277, DOI 10.1007/s00299-013-1528-9; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Fukao T, 2008, P NATL ACAD SCI USA, V105, P16814, DOI 10.1073/pnas.0807821105; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Gao LL, 2012, MOL PLANT, V5, P143, DOI 10.1093/mp/ssr062; Giri J, 2011, NEW PHYTOL, V191, P721, DOI 10.1111/j.1469-8137.2011.03740.x; GOULD FW, 1972, AM MIDL NAT, V87, P36, DOI 10.2307/2423880; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Hu HT, 2015, RICE, V8, DOI 10.1186/s12284-014-0034-1; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Jisha V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127831; Kidokoro S, 2015, PLANT J, V81, P505, DOI 10.1111/tpj.12746; Kim DS, 1993, THESIS SEOUL NATL U, P29; Kim Y, 2013, PLANT J, V75, P364, DOI 10.1111/tpj.12205; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee DJ, 2014, PLANT MOL BIOL, V86, P255, DOI 10.1007/s11103-014-0227-4; Lee E, 2013, THESIS, P1; Lin HX, 2014, PLANT PHYSIOL, V164, P2197, DOI 10.1104/pp.113.232272; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mennan H, 2012, CROP PROT, V41, P1, DOI 10.1016/j.cropro.2012.04.027; Michael PW, 2003, FLORA N AM N MEXICO, P390; Moon BC, 2014, WEED RES, V54, P484, DOI 10.1111/wre.12102; Moon ByeongChul, 2010, Journal of Crop Science and Biotechnology, V13, P121; Osakabe Y, 2005, PLANT CELL, V17, P1105, DOI 10.1105/tpc.104.027474; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Osakabe Y, 2010, J BIOL CHEM, V285, P9190, DOI 10.1074/jbc.M109.051938; Ouyang SQ, 2010, PLANT J, V62, P316, DOI 10.1111/j.1365-313X.2010.04146.x; Papdi C, 2015, PLANT J, V82, P772, DOI 10.1111/tpj.12848; Park S, 2014, J PLANT PHYSIOL, V171, P1645, DOI 10.1016/j.jplph.2014.08.002; Peng XJ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0489-2; Pitorre D, 2010, PLANTA, V232, P1339, DOI 10.1007/s00425-010-1260-4; Qi WW, 2011, PLANT PHYSIOL, V157, P216, DOI 10.1104/pp.111.179945; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuraba Y, 2015, PLANT CELL; Shang JZ, 2014, FUNCT INTEGR GENOMIC, V14, P767, DOI 10.1007/s10142-014-0403-2; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; STAUBER LG, 1991, WEED SCI, V39, P163, DOI 10.1017/S0043174500071411; Suzuki N, 2005, PLANT PHYSIOL, V139, P1313, DOI 10.1104/pp.105.070110; Tanaka H, 2012, PLANT J, V70, P599, DOI 10.1111/j.1365-313X.2012.04901.x; Tena G, 2011, CURR OPIN PLANT BIOL, V14, P519, DOI 10.1016/j.pbi.2011.05.006; Tseng IC, 2013, PLANT PHYSIOL, V163, P118, DOI 10.1104/pp.113.217547; Voesenek LACJ, 2013, CURR OPIN PLANT BIOL, V16, P647, DOI 10.1016/j.pbi.2013.06.008; von Schaewen A, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1024397; Wang F, 2015, PLANT J, V83, P224, DOI 10.1111/tpj.12879; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Xu ZY, 2012, PLANT CELL, V24, P2184, DOI 10.1105/tpc.112.095935; Yabuno T, 1983, P C IRRI WEED CONTR, P308; YAMASUE Y, 1989, JPN J BREED, V39, P159; Yang L, 2014, PLANT SCI, V215, P19, DOI 10.1016/j.plantsci.2013.10.009; Yang LA, 2010, J EXP BOT, V61, P2519, DOI 10.1093/jxb/erq084; Yang TB, 2010, J BIOL CHEM, V285, P7119, DOI 10.1074/jbc.M109.035659; Yang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069168; Yang Y, 2015, PLANT BIOTECHNOL J, V13, P962, DOI 10.1111/pbi.12335; Ye CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113657; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang XJ, 2013, PLANT PHYSIOL BIOCH, V67, P189, DOI 10.1016/j.plaphy.2013.03.013; Zhou HP, 2014, PLANT CELL, V26, P1166, DOI 10.1105/tpc.113.117069	79	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134419	10.1371/journal.pone.0134419	http://dx.doi.org/10.1371/journal.pone.0134419			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266806	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492300045
J	Stenger, M; Hendel, K; Bollen, P; Licht, PB; Kolmos, HJ; Klitgaard, JK				Stenger, Michael; Hendel, Kristoffer; Bollen, Peter; Licht, Peter B.; Kolmos, Hans Jorn; Klitgaard, Janne K.			Assessments of Thioridazine as a Helper Compound to Dicloxacillin against Methicillin-Resistant Staphylococcus aureus: In Vivo Trials in a Mouse Peritonitis Model	PLOS ONE			English	Article							ANTIBIOTICS; BACTEREMIA; EFFICACY	Introduction The rise in antimicrobial resistance is a major global concern and requires new treatment strategies. The use of helper compounds, such as thioridazine (TDZ), an antipsychotic drug, in combination with traditional antibiotics must be investigated. Objectives The aim of this study was to investigate the efficacy of TDZ as a helper compound for dicloxacillin (DCX) against methicillin-resistant Staphylococcus aureus (MRSA) in vivo, and compare the combination treatment of DCX+TDZ with vancomycin (VAN). Methods Mice were inoculated with an intraperitoneal (IP) injection of MRSA (10(8) CFU) and treated in a 12-hour cycle for 48 hours. By termination, bacterial quantities in a peritoneal flush, spleen and kidneys were obtained. In the main trial the drugs were administered subcutaneously in five treatment groups: 1) DCX, 2) TDZ, 3) DCX+TDZ, 4) VAN, 5) SALINE. Additional smaller studies with IP administration and higher subcutaneous dosages (x1.5 and x4) of the drugs were subsequently performed. Results In the main trial no significant differences were found between DCX+TDZ and DCX or TDZ alone (p >= 0.121-0.999). VAN performed significantly better than DCX+TDZ on all bacteriological endpoints (p<0.001). Higher subcutaneous dosages of DCX and TDZ improved the antibacterial efficacy, but the combination treatment was still not significantly better than monotherapy. IP drug administration of DCX+TDZ revealed a significantly better antibacterial effect than DCX or TDZ alone (p<0.001) but not significantly different from VAN (p>0.999). Conclusion In conclusion, TDZ did not prove to be a viable helper compound for dicloxacillin against MRSA in subcutaneous systemic treatment. However, IP-administration of DCX+TDZ, directly at the infection site resulted in a synergetic effect, with efficacy comparable to that of VAN.	[Stenger, Michael; Hendel, Kristoffer; Kolmos, Hans Jorn; Klitgaard, Janne K.] Univ Southern Denmark, Res Unit Clin Microbiol, Odense, Denmark; [Stenger, Michael; Licht, Peter B.] Odense Univ Hosp, Dept Cardiothorac Surg, DK-5000 Odense, Denmark; [Bollen, Peter] Univ Southern Denmark, Biomed Lab, Odense, Denmark; [Klitgaard, Janne K.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark	Stenger, M (corresponding author), Univ Southern Denmark, Res Unit Clin Microbiol, Odense, Denmark.	mstenger@health.sdu.dk	Hendel, Kristoffer/Q-1536-2018; Hendel, Kristoffer/U-2490-2019; Klitgaard, Janne Kudsk/F-8952-2010; Bollen, Peter/AIB-5594-2022; Bollen, Peter/HHR-8704-2022	Hendel, Kristoffer/0000-0003-1845-1224; Klitgaard, Janne Kudsk/0000-0001-5255-2980; Licht, Peter/0000-0003-1270-8068; Bollen, Peter/0000-0003-3796-1609	Danish Agriculture Food Council [132337]; Danish Foundation "TrygFonden" [7-11-1210]; Danish Foundation "Fionia Fond"	Danish Agriculture Food Council; Danish Foundation "TrygFonden"; Danish Foundation "Fionia Fond"	This work was financially supported by research grants from The Danish Agriculture & Food Council, "Svineafgiftsfonden" (grant number: 132337) received by MS; The Danish Foundation "TrygFonden" (grant number: 7-11-1210) received by MS; and The Danish Foundation "Fionia Fond" (no grant number) received by KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral Leonard, 2004, In Vivo (Attiki), V18, P725; Bonde M, 2011, FEMS MICROBIOL LETT, V318, P168, DOI 10.1111/j.1574-6968.2011.02255.x; Christensen JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057493; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Daniel WA, 1999, TOXICOL APPL PHARM, V158, P115, DOI 10.1006/taap.1999.8688; Dasgupta A, 2010, INT J ANTIMICROB AG, V35, P174, DOI 10.1016/j.ijantimicag.2009.09.027; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Docobo-Perez F, 2012, J ANTIMICROB CHEMOTH, V67, P1961, DOI 10.1093/jac/dks142; Dutta NK, 2013, J ANTIMICROB CHEMOTH, V68, P1327, DOI 10.1093/jac/dkt037; FRIMODTMOLLER N, 1993, J ANTIMICROB CHEMOTH, V31, P55, DOI 10.1093/jac/31.suppl_D.55; Hahn BL, 2014, IN VIVO, V28, P33; Hendricks O, 2003, INT J ANTIMICROB AG, V22, P262, DOI 10.1016/S0924-8579(03)00205-X; Klitgaard JK, 2008, J ANTIMICROB CHEMOTH, V62, P1215, DOI 10.1093/jac/dkn417; KRISTIANSEN JE, 1988, APMIS, V96, P1079, DOI 10.1111/j.1699-0463.1988.tb00984.x; Kristiansen Malthe M, 2006, In Vivo, V20, P361; Kristiansen MM, 2003, INT J ANTIMICROB AG, V22, P250, DOI 10.1016/S0924-8579(03)00200-0; LEMK W., 2013, PRIORITY MED EUROPE; Martins M, 2004, IN VIVO, V18, P787; Martins M, 2007, IN VIVO, V21, P771; Meyer RE, 2008, AM COLL LAB, P27; NIEDZWIECKI DM, 1984, J PHARMACOL EXP THER, V228, P636; NYBERG G, 1982, N-S ARCH PHARMACOL, V319, P189, DOI 10.1007/BF00495864; Olfert E D, 2000, ILAR J, V41, P99; Poulsen MO, 2014, J MED MICROBIOL, V63, P1174, DOI 10.1099/jmm.0.071837-0; Poulsen MO, 2013, RES MICROBIOL, V164, P181, DOI 10.1016/j.resmic.2012.10.007; Reyes N, 2006, J ANTIMICROB CHEMOTH, V58, P462, DOI 10.1093/jac/dkl222; Sandberg A, 2011, ANTIMICROB AGENTS CH, V55, P1443, DOI 10.1128/AAC.00205-10; Sandberg A, 2009, ANTIMICROB AGENTS CH, V53, P1874, DOI 10.1128/AAC.01605-07; Thorsing M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064518; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521	31	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135571	10.1371/journal.pone.0135571	http://dx.doi.org/10.1371/journal.pone.0135571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267376	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300137
J	Ali, MA; El-Abhar, HS; Kamel, MA; Attia, AS				Ali, Mennatallah A.; El-Abhar, Hanan S.; Kamel, Maher A.; Attia, Ahmed S.			Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; IMPROVED GLUCOSE-HOMEOSTASIS; WNT SIGNALING PATHWAY; NF-KAPPA-B; OXIDATIVE STRESS; INSULIN-RESISTANCE; ACETYLCHOLINESTERASE ACTIVITY; CHOLINESTERASE INHIBITOR; DENSITY-LIPOPROTEIN; ALZHEIMERS-DISEASE	The cholinergic anti-inflammatory pathway is one of the putative biochemical pathways that link diabetes with Alzheimer disease. Hence, we aimed to verify the potential antidiabetic effect of galantamine, unveil the possible mechanisms and evaluate its interaction with vildagliptin. The n5-STZ rat model was adopted and the diabetic animals were treated with galantamine and/or vildagliptin for 4 weeks. Galantamine lowered the n5-STZ-induced elevation in body weight, food/water intake, serum levels of glucose, fructosamine, and ALT/AST, as well as AChE in the tested organs. Moreover, it modulated successfully the lipid profile assessed in serum, liver, and muscle, and increased serum insulin level, as well as % beta-cell function, in a pattern similar to that of vildagliptin. Additionally, galantamine confirmed its antioxidant (Nrf2, TAC, MDA), anti-inflammatory (NF-kappa B, TNF-alpha, visfatin, adiponectin) and anti-apoptotic (caspase-3, cytochrome c) capabilities by altering the n5-STZ effect on all the aforementioned parameters. On the molecular level, galantamine/vildagliptin have improved the insulin (p-insulin receptor, p-Akt, GLUT4/GLUT2) and Wnt/beta-catenin (p-GSK-3 beta, beta-catenin) signaling pathways. On almost all parameters, the galantamine effects surpassed that of vildagliptin, while the combination regimen showed the best effects. The present results clearly proved that galantamine modulated glucose/lipid profile possibly through its anti-oxidant, -apoptotic, -inflammatory and -cholinesterase properties. These effects could be attributed partly to the enhancement of insulin and Wnt/beta-catenin signaling pathways. Galantamine can be strongly considered as a potential antidiabetic agent and as an add-on therapy with other oral antidiabetics.	[Ali, Mennatallah A.] Pharos Univ, Fac Pharm & Drug Mfg, Dept Pharmacol & Toxicol, Alexandria, Egypt; [El-Abhar, Hanan S.] Cairo Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt; [Kamel, Maher A.] Univ Alexandria, Med Res Inst, Dept Biochem, Alexandria, Egypt; [Attia, Ahmed S.] Cairo Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Pharos University in Alexandria; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Cairo University	El-Abhar, HS (corresponding author), Cairo Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt.	hanan.elabhar@pharma.cu.edu.eg	Attia, Ahmed S./F-6875-2011; Kamel, Maher/S-2397-2019; El-Abhar, Hanan/L-2289-2019	Attia, Ahmed S./0000-0003-0491-1007; Kamel, Maher/0000-0002-6791-9850; El-Abhar, Hanan/0000-0001-8819-9891; Ali, Mennatallah/0000-0003-0732-924X				Abdelsalam RM, 2015, J NEUROCHEM, V133, P700, DOI 10.1111/jnc.13087; Abiola M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008509; Akarte AS, 2012, J DIABETES COMPLICAT, V26, P266, DOI 10.1016/j.jdiacomp.2012.03.013; Akarte AS, 2012, BIOCHEM PHARMACOL, V83, P241, DOI 10.1016/j.bcp.2011.10.003; Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x; Allam AR, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-28; Altuncu ME, 2012, CARDIOL J, V19, P501, DOI 10.5603/CJ.2012.0091; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Avila DD, 2013, ARCH MED RES, V44, P194, DOI 10.1016/j.arcmed.2013.03.004; Balkan B, 1999, DIABETOLOGIA, V42, P1324, DOI 10.1007/s001250051445; Bernsmeier C, 2009, SWISS MED WKLY, V139, P678, DOI smw-12765; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burkey BF, 2005, J PHARMACOL EXP THER, V315, P688, DOI 10.1124/jpet.105.087064; Chistyakova OV, 2011, ENDOCRINOLOGY STUDIE, V1, pe16; Choe EY, 2014, DIABETES METAB J, V38, P211, DOI 10.4093/dmj.2014.38.3.211; Das UN, 2011, MED HYPOTHESES, V76, P429, DOI 10.1016/j.mehy.2010.11.013; de Oliveira AC, 2012, ENDOCRINOLOGY, V153, P2178, DOI 10.1210/en.2011-1675; Derosa G, 2014, METABOLISM, V63, P957, DOI 10.1016/j.metabol.2014.04.008; Drucker DJ, 2011, DIABETES CARE, V34, P2133, DOI 10.2337/dc11-0986; El-Abhar HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037757; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garber JC, 2010, GUIDE CARE USE LAB A, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Garcia-Bailo B, 2011, BIOL-TARGETS THER, V5, P7, DOI 10.2147/BTT.S14417; Giunta B, 2004, BRAIN RES BULL, V64, P165, DOI 10.1016/j.brainresbull.2004.06.008; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hayes MR, 2012, PHYSIOL BEHAV, V106, P413, DOI 10.1016/j.physbeh.2012.02.017; Ip W, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-28; Javed H, 2013, NEUROL SCI, V34, P2181, DOI 10.1007/s10072-013-1444-3; Jin T, 2008, MOL ENDOCRINOL, V22, P2383, DOI 10.1210/me.2008-0135; Jo YH, 2005, J NEUROSCI, V25, P11133, DOI 10.1523/JNEUROSCI.3638-05.2005; Kandhare A.D., 2012, BIOMED AGING PATHOL, V2, P173, DOI [10.1016/j.biomag.2012.10.002, DOI 10.1016/J.BIOMAG.2012.10.002]; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Kuhad A, 2007, EUR J PHARMACOL, V576, P34, DOI 10.1016/j.ejphar.2007.08.001; Kwon Hyokjoon, 2013, Front Endocrinol (Lausanne), V4, P71, DOI 10.3389/fendo.2013.00071; Liu ZH, 2010, CHINESE MED J-PEKING, V123, P1727, DOI 10.3760/cma.j.issn.0366-6999.2010.13.021; LOPESVIRELLA MFL, 1977, DIABETOLOGIA, V13, P285, DOI 10.1007/BF01223267; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marrero MB, 2010, J PHARMACOL EXP THER, V332, P173, DOI 10.1124/jpet.109.154633; Martinez-Rodriguez R, 2012, NUTR HOSP, V27, P46, DOI [10.1590/S0212-16112012000100006, 10.3305/nh.2012.27.1.5437]; Masha'our RS, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00069; Melo JB, 2009, EUR J NEUROSCI, V29, P455, DOI 10.1111/j.1460-9568.2009.06612.x; Monbaliu J, 2003, ARZNEIMITTEL-FORSCH, V53, P486; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Oida E, 1999, ACTA PHYSIOL SCAND, V165, P129; Okada M, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/4/046004; Pan CY, 2013, THER CLIN RISK MANAG, V9, P247, DOI 10.2147/TCRM.S30071; Paradies G, 2014, WORLD J GASTROENTERO, V20, P14205, DOI 10.3748/wjg.v20.i39.14205; Park HJ, 2008, J CLIN INVEST, V118, P259, DOI 10.1172/JCI32011; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; Ponnappan Usha, 1998, Frontiers in Bioscience, V3, pD152; Portha B., 2007, ANIMAL MODELS DIABET, P223; Prakash A, 2013, INT J NEUROSCI, V123, P636, DOI 10.3109/00207454.2013.785542; Psyrogiannis Agathoklis, 2003, Hormones (Athens), V2, P161; Puddu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/750540; Qi WW, 2015, DIABETES, V64, P1407, DOI 10.2337/db14-1111; Richter WO, 1996, INT J OBESITY, V20, P966; Romero A, 2010, J PINEAL RES, V49, P141, DOI 10.1111/j.1600-079X.2010.00778.x; Sadis C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079984; Sajja RK, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-8; Satapathy SK, 2011, MOL MED, V17, P599, DOI 10.2119/molmed.2011.00083; Schmatz R, 2009, EUR J PHARMACOL, V610, P42, DOI 10.1016/j.ejphar.2009.03.032; Smith JAH, 2008, AM J PHYSIOL-ENDOC M, V295, pE698, DOI 10.1152/ajpendo.00747.2007; Swati Tilethe, 2013, Research Journal of Pharmaceutical Sciences, V2, P1; Takata K, 2010, J BIOL CHEM, V285, P40180, DOI 10.1074/jbc.M110.142356; Takeshita Y, 2015, J DIABETES INVEST, V6, P192, DOI 10.1111/jdi.12269; Tavares FL, 2008, CELL BIOCHEM FUNCT, V26, P557, DOI 10.1002/cbf.1476; Traykova M, 2003, Z NATURFORSCH C, V58, P361; Tuzcu M, 2006, EUR J PHARMACOL, V537, P106, DOI 10.1016/j.ejphar.2006.03.024; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Val-Laillet D, 2010, APPETITE, V55, P245, DOI 10.1016/j.appet.2010.06.008; van Raalte DH, 2011, DIABETES RES CLIN PR, V93, pS37, DOI 10.1016/S0168-8227(11)70012-2; Wang YJ, 2012, J THEOR BIOL, V297, P137, DOI 10.1016/j.jtbi.2011.12.014; Williams KH, 2014, J DIABETES, DOI [10.1111/753-0407.12237, DOI 10.1111/753-0407.12237]; Wills S, 2009, US, Patent No. [2009/0081314A1, 20090081314]; Yang WM, 2014, BIOCHEM BIOPH RES CO, V452, P715, DOI 10.1016/j.bbrc.2014.08.145; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Yu ZW, 2010, CELL SIGNAL, V22, P1, DOI 10.1016/j.cellsig.2009.09.032; Zhao CS, 2005, BEHAV BRAIN RES, V156, P85, DOI 10.1016/j.bbr.2004.05.011	80	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134648	10.1371/journal.pone.0134648	http://dx.doi.org/10.1371/journal.pone.0134648			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262991	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300034
J	Gallay, PA; Bobardt, MD; Chatterji, U; Trepanier, DJ; Ure, D; Ordonez, C; Foster, R				Gallay, Philippe A.; Bobardt, Michael D.; Chatterji, Udayan; Trepanier, Daniel J.; Ure, Daren; Ordonez, Cosme; Foster, Robert			The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USERS; NS5A DOMAIN-II; CYCLOSPORINE-A; IN-VITRO; ANTIRETROVIRAL THERAPY; REPLICATION COMPLEX; TYPE-1 REPLICATION; NATURAL-HISTORY	HCV-related liver disease is the main cause of morbidity and mortality of HCV/HIV-1 co-infected patients. Despite the recent advent of anti-HCV direct acting antivirals (DAAs), the treatment of HCV/HIV-1 co-infected patients remains a challenge, as these patients are refractory to most therapies and develop liver fibrosis, cirrhosis and liver cancer more often than HCV mono-infected patients. Until the present study, there was no suitable in vitro assay to test the inhibitory activity of drugs on HCV/HIV-1 co-infection. Here we developed a novel in vitro "co-infection" model where HCV and HIV-1 concurrently replicate in their respective main host target cells-human hepatocytes and CD4+ T-lymphocytes. Using this co-culture model, we demonstrate that cyclophilin inhibitors (CypI), including a novel cyclosporin A (CsA) analog, CPI-431-32, simultaneously inhibits replication of both HCV and HIV-1 when added pre- and post-infection. In contrast, the HIV-1 protease inhibitor nelfinavir or the HCV NS5A inhibitor daclatasvir only blocks the replication of a single virus in the "co-infection" system. CPI-431-32 efficiently inhibits HCV and HIV-1 variants, which are normally resistant to DAAs. CPI-431-32 is slightly, but consistently more efficacious than the most advanced clinically tested CypI-alisporivir (ALV)-at interrupting an established HCV/HIV-1 co-infection. The superior antiviral efficacy of CPI-431-32 over ALV correlates with its higher potency inhibition of cyclophilin A (CypA) isomerase activity and at preventing HCV NS5A-CypA and HIV-1 capsid-CypA interactions known to be vital for replication of the respective viruses. Moreover, we obtained evidence that CPI-431-32 prevents the cloaking of both the HIV-1 and HCV genomes from cellular sensors. Based on these results, CPI-431-32 has the potential, as a single agent or in combination with DAAs, to inhibit both HCV and HIV-1 infections.	[Gallay, Philippe A.; Bobardt, Michael D.; Chatterji, Udayan] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Trepanier, Daniel J.; Ure, Daren; Ordonez, Cosme; Foster, Robert] Ciclofilin Pharmaceut Inc, San Diego, CA USA	Scripps Research Institute	Gallay, PA (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	gallay@scripps.edu; rfoster@ciclofilin.com			U.S. Public Health Service [AI087746]; Canadian Institutes of Health Research (CIHR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087746] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge financial support from the U.S. Public Health Service grants no. AI087746 (P.A.G.) and a research grant from the Canadian Institutes of Health Research (CIHR). The funder provided support in the form of salaries for authors [P.A.G, M. B. and U.C.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Harthi L, 2006, J INFECT DIS, V193, P1202, DOI 10.1086/500843; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Ansari IUH, 2013, VIROLOGY, V436, P268, DOI 10.1016/j.virol.2012.11.018; Ansari IUH, 2012, VIRUSES-BASEL, V4, P3303, DOI 10.3390/v4123303; Baugh JM, 2013, ANTIVIR RES, V100, P555, DOI 10.1016/j.antiviral.2013.09.020; Berger C, 2014, GASTROENTEROLOGY, V147, P1094, DOI 10.1053/j.gastro.2014.07.019; Bobardt MD, 2008, P NATL ACAD SCI USA, V105, P5525, DOI 10.1073/pnas.0801388105; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; Chatterji U, 2005, J BIOL CHEM, V280, P40293, DOI 10.1074/jbc.M506314200; Chatterji U, 2015, ANTIMICROB AGENTS CH; Chatterji U, 2014, ANTIMICROB AGENTS CH, V58, P3327, DOI 10.1128/AAC.00016-14; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Colgan J, 2005, J IMMUNOL, V174, P6030, DOI 10.4049/jimmunol.174.10.6030; Coste J, 2005, VOX SANG, V88, P289, DOI 10.1111/j.1423-0410.2005.00636_1.x; Dorner M, 2013, NATURE, V501, P237, DOI 10.1038/nature12427; FISCHER G, 1984, BIOCHIM BIOPHYS ACTA, V791, P87, DOI 10.1016/0167-4838(84)90285-1; Flisiak R, 2008, HEPATOLOGY, V47, P817, DOI 10.1002/hep.22131; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gaither LA, 2010, VIROLOGY, V397, P43, DOI 10.1016/j.virol.2009.10.043; Garcia-Rivera JA, 2012, ANTIMICROB AGENTS CH, V56, P5113, DOI 10.1128/AAC.00919-12; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Gawlik K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088866; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Goto K, 2006, BIOCHEM BIOPH RES CO, V343, P879, DOI 10.1016/j.bbrc.2006.03.059; Grise H, 2012, J VIROL, V86, P4811, DOI 10.1128/JVI.06641-11; Hansson MJ, 2015, CHEM BIOL, V22, P285, DOI 10.1016/j.chembiol.2014.10.023; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; Hilditch L, 2014, CURR OPIN VIROL, V4, P32, DOI 10.1016/j.coviro.2013.11.003; Hopkins S, 2015, BBA-GEN SUBJECTS, V1850, P2103, DOI 10.1016/j.bbagen.2014.11.011; Hopkins S, 2012, J HEPATOL, V57, P47, DOI 10.1016/j.jhep.2012.02.024; Hopkins S, 2012, ANTIMICROB AGENTS CH, V56, P3888, DOI 10.1128/AAC.00693-12; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; JACOBSEN H, 1995, VIROLOGY, V206, P527, DOI 10.1016/S0042-6822(95)80069-7; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Larsen MV, 2010, ADDICTION, V105, P529, DOI 10.1111/j.1360-0443.2009.02827.x; Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Loko MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-303; Lopez-Dieguez M, 2011, AIDS, V25, P899, DOI 10.1097/QAD.0b013e3283454174; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Madan V, 2014, GASTROENTEROLOGY, V146, P1361, DOI 10.1053/j.gastro.2014.01.055; Marini B, 2015, NATURE, V521, P227, DOI 10.1038/nature14226; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Naoumov NV, 2014, J HEPATOL, V61, P1166, DOI 10.1016/j.jhep.2014.07.008; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; RICHMAN D, 1991, P NATL ACAD SCI USA, V88, P11241, DOI 10.1073/pnas.88.24.11241; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; ROSENWIRTH B, 1994, ANTIMICROB AGENTS CH, V38, P1763, DOI 10.1128/AAC.38.8.1763; Sherman Kenneth E, 2004, Rev Gastroenterol Disord, V4 Suppl 1, pS48; Smit C, 2008, JAIDS-J ACQ IMM DEF, V47, P221, DOI 10.1097/QAI.0b013e31815d2f59; Sulkowski MS, 2003, ANN INTERN MED, V138, P197, DOI 10.7326/0003-4819-138-3-200302040-00012; Sweeney ZK, 2014, J MED CHEM, V57, P7145, DOI 10.1021/jm500223x; Tai AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026300; Tang HL, 2010, VIRUSES-BASEL, V2, P1621, DOI 10.3390/v2081621; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Villano SA, 1997, J CLIN MICROBIOL, V35, P3274, DOI 10.1128/JCM.35.12.3274-3277.1997; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	77	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134707	10.1371/journal.pone.0134707	http://dx.doi.org/10.1371/journal.pone.0134707			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263487	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300037
J	Wai, KM; Yu, PKN; Lam, KS				Wai, Ka-Ming; Yu, Peter K. N.; Lam, Ka-Se			Reduction of Solar UV Radiation Due to Urban High-Rise Buildings - A Coupled Modelling Study	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; VITAMIN-D; COASTAL CITY; EXPOSURE; OZONE; AEROSOLS; BODY; PHOTOSYNTHESIS; IRRADIANCES; SUNLIGHT	Solar UV radiation has both adverse and beneficial effects to human health. Using models (a radiative transfer model coupled to a building shading model), together with satellite and surface measurements, we studied the un-obstructed and obstructed UV environments in a sub-tropical urban environment featured with relatively high pollution (aerosol) loadings and high-rise buildings. Seasonal patterns of the erythemal UV exposure rates were governed by solar zenith angles, seasonal variations of aerosol loadings and cloud effects. The radiative transfer modelling results agreed with measurements of erythemal UV exposure rates and spectral irradiances in UVA and UVB ranges. High-rise buildings and narrow road width (height to width, H/W, ratios up to 15) reduced the modelled total UV (UVA+UVB) radiation and leave 10% of the un-obstructed exposure rate at ground-level at noon. No more than 80% of the un-obstructed exposure rate was received in the open area surrounded by 20-storey buildings. Our modelled reduction of UVB radiation in the urban environment was consistent with similar measurements obtained for Australia. However, our results in more extreme environments (higher H/W ratios) were for the first time reported, with 18% of the un-obstructed exposure rate remained at the ground-level center of the street canyon.	[Wai, Ka-Ming; Yu, Peter K. N.] City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China; [Lam, Ka-Se] Hong Kong Polytech Univ, Dept Civil & Environm Engn, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong; Hong Kong Polytechnic University	Wai, KM (corresponding author), City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China.	bhkmwai@cityu.edu.hk; peter.yu@cityu.edu.hk		YU, Kwan Ngok Peter/0000-0003-1669-5348	General Research Fund CityU from the Research Grants Council of the Hong Kong SAR [125013]	General Research Fund CityU from the Research Grants Council of the Hong Kong SAR	This work was supported by a General Research Fund CityU 125013 from the Research Grants Council of the Hong Kong SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aculinin A, 2012, MOLDAVIAN J PHYS SCI, V11, pN4; Bernhard G, 1997, J GEOPHYS RES-ATMOS, V102, P8719, DOI 10.1029/97JD00072; Buntoung S, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013567; Butson ET, 2010, PHYS MED BIOL, V55, pN487, DOI 10.1088/0031-9155/55/20/N01; Chun SL, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4898162; Ecotect, 2011, AUT EC AN 2011 HELP; Erdelyi R, 2014, SOL ENERGY, V101, P63, DOI 10.1016/j.solener.2013.12.023; Gomez I, 2005, AQUACULTURE, V244, P369, DOI 10.1016/j.aquaculture.2004.11.037; Greenwald R, 2006, AGR SYST, V89, P390, DOI 10.1016/j.agsy.2005.10.004; Halliday GM, 2011, SEMIN CUTAN MED SURG, V30, P214, DOI 10.1016/j.sder.2011.08.002; Hoeppe P, 2004, INT J BIOMETEOROL, V49, P18, DOI 10.1007/s00484-004-0211-9; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; IARC, 2008, IARC WORK GROUP REP, V5; Ilyas M, 2001, J ATMOS CHEM, V40, P111, DOI 10.1023/A:1011999026576; Kim J, 2013, J PHOTOCH PHOTOBIO B, V119, P46, DOI 10.1016/j.jphotobiol.2012.11.007; Lakkala K, 2010, FINNISH METEOROLOGIC; Lam KS, 2002, ATMOS ENVIRON, V36, P2003, DOI 10.1016/S1352-2310(02)00140-1; Lazovich D, 2010, CANCER EPIDEM BIOMAR, V19, P1557, DOI 10.1158/1055-9965.EPI-09-1249; Lee J, 2013, ASIA-PAC J ATMOS SCI, V49, P271, DOI 10.1007/s13143-013-0026-x; Mac-Mary S, 2010, CLIN INTERV AGING, V5, P277, DOI 10.2147/CIA.S13044; MACLAUGHLIN JA, 1982, SCIENCE, V216, P1001, DOI 10.1126/science.6281884; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Madronich S, 1997, NATO ASI SERIES, VI52; McKinlay AF., 1987, CIE J, P83; McKinley A, 2011, PHOTOCHEM PHOTOBIOL, V87, P447, DOI 10.1111/j.1751-1097.2010.00865.x; Micheletti MI, 2002, PHOTOCHEM PHOTOBIOL, V76, P294, DOI 10.1562/0031-8655(2002)076&lt;0294:SUAPDI&gt;2.0.CO;2; Parisi AV, 1996, PHOTODERMATOL PHOTO, V12, P66, DOI 10.1111/j.1600-0781.1996.tb00177.x; Pehnec Gordana, 2007, Arhiv za Higijenu Rada i Toksikologiju, V58, P387, DOI 10.2478/v10004-007-0031-5; Sabziparvar AA, 1999, PHOTOCHEM PHOTOBIOL, V69, P193, DOI 10.1111/j.1751-1097.1999.tb03273.x; SCHARF SR, 1983, DEV BIOL, V99, P75, DOI 10.1016/0012-1606(83)90255-5; SCHAUBERGER G, 1990, PHOTOCHEM PHOTOBIOL, V52, P1029, DOI 10.1111/j.1751-1097.1990.tb01821.x; Schmalwieser AW, 2002, PHOTOCH PHOTOBIO SCI, V1, P251, DOI 10.1039/c1pp05271c; Seckmeyer G, 2013, PHOTOCHEM PHOTOBIOL, V89, P974, DOI 10.1111/php.12074; STAMNES K, 1988, APPL OPTICS, V27, P2502, DOI 10.1364/AO.27.002502; Turner J, 2013, PHOTOCHEM PHOTOBIOL, V89, P730, DOI 10.1111/php.12025; Wai KM, 2010, ENVIRON CHEM, V7, P359, DOI 10.1071/EN10020; Wai KM, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005385; Wai KM, 2005, J ATMOS CHEM, V50, P103, DOI 10.1007/s10874-005-5897-5; Weihs P, 2013, PHOTOCHEM PHOTOBIOL, V89, P1004, DOI 10.1111/php.12085; Xia X, 2008, ANN GEOPHYS-GERMANY, V26, P2043, DOI 10.5194/angeo-26-2043-2008	40	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135562	10.1371/journal.pone.0135562	http://dx.doi.org/10.1371/journal.pone.0135562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263507	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300093
J	Tsai, YC; Lee, CS; Chiu, YW; Kuo, HT; Lee, SC; Hwang, SJ; Kuo, MC; Chen, HC				Tsai, Yi-Chun; Lee, Chee-Siong; Chiu, Yi-Wen; Kuo, Hung-Tien; Lee, Su-Chu; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun			Angiopoietin-2 as a Prognostic Biomarker of Major Adverse Cardiovascular Events and All-Cause Mortality in Chronic Kidney Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LEVELS PREDICT MORTALITY; SOLUBLE RECEPTOR TIE-2; CIRCULATING ANGIOPOIETIN-2; PLASMA ANGIOPOIETIN-1; CELL-SURVIVAL; RISK; CKD; POPULATION	Background Chronic kidney disease (CKD) patients have higher prevalence of major adverse cardiovascular events (MACE) and all-cause mortality. Endothelial damage and dysfunction have been regarded as early portents of MACE in CKD patients. Angiopoietin-2 (Ang-2) impairs endothelial function and promotes aberrant neovascularization. The aim of the study was to assess the relationship between circulating Ang-2 and MACE or all-cause mortality in a CKD cohort. Methods A total of 621 pre-dialysis stage 3-5 CKD patients were enrolled from January 2006 to December 2011 and were followed up till October 2014. Plasma Ang-2 was measured in duplicate using commercial enzyme-linked immunosorbent assays (ELISA). Clinical outcomes included MACE or all-cause mortality Results Of all patients, 122 (19.8%) reached MACE or all-cause mortality. Seventy-two had MACE, 79 died, and 29 had both MACE and all-cause mortality during the follow-up period of 41.5 +/- 28.3 months. Ang-2 quintile was divided at 1405.0, 1730.0, 2160.9, and 2829.9 pg/ml. The adjusted HR of MACE or all-cause mortality for every single higher log Ang-2 was 5.69 (95% CI: 2.00-16.20, P = 0.001). The adjusted HR of MACE or all-cause mortality was 2.48 (95% CI: 1.25-4.90) for patients of quintile 5 compared with those of quintile 1. A longitudinal association between MACE or all-cause mortality and stepwise increases in Ang-2 levels was found (P-trend = 0.008). Conclusions Ang-2 is an independent predictor of MACE or all-cause mortality in CKD patients. Additional study is necessary in order to explore the mechanism of the association of Ang-2 with adverse outcomes in patients with CKD.	[Tsai, Yi-Chun; Hwang, Shang-Jyh; Kuo, Mei-Chuan] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Lee, Chee-Siong] Kaohsiung Med Univ Hosp, Div Gen Med, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Chiu, Yi-Wen; Kuo, Hung-Tien; Lee, Su-Chu; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung, Taiwan; [Lee, Chee-Siong] Kaohsiung Med Univ Hosp, Div Cardiol, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Chiu, Yi-Wen; Kuo, Hung-Tien; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun] Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan; [Hwang, Shang-Jyh] Natl Hlth Res Inst, Inst Populat Sci, Miaoli, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Health Research Institutes - Taiwan	Kuo, MC (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan.	mechku@cc.kmu.edu.tw		lee, su-chu/0000-0002-8587-7324; Kuo, Hung-Tien/0000-0002-9931-4354	Kaohsiung Medical University Hospital [KMUH103-3T14]	Kaohsiung Medical University Hospital	Dr. Tsai's research was supported by a grant from the Kaohsiung Medical University Hospital (KMUH103-3T14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054668; Chen JX, 2012, AM J PHYSIOL-HEART C, V302, pH1003, DOI 10.1152/ajpheart.00866.2011; Chong AY, 2004, J AM COLL CARDIOL, V43, P423, DOI 10.1016/j.jacc.2003.08.042; David S, 2012, NEPHROL DIAL TRANSPL, V27, P1867, DOI 10.1093/ndt/gfr551; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; David S, 2009, AM J KIDNEY DIS, V53, P770, DOI 10.1053/j.ajkd.2008.11.030; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Hwang SJ, 2008, NEPHROL DIAL TRANSPL, V23, P3192, DOI 10.1093/ndt/gfn222; Lee J. Y., 2014, Journal of Pulmonary and Respiratory Medicine, V4, P1000172; Lee KW, 2004, CIRCULATION, V110, P2355, DOI 10.1161/01.CIR.0000138112.90641.7F; Lemieux C, 2005, BLOOD, V105, P1523, DOI 10.1182/blood-2004-09-3531; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lilien MR, 2009, NAT REV NEPHROL, V5, P229, DOI 10.1038/nrneph.2009.10; Lim HS, 2004, DIABETES CARE, V27, P2918, DOI 10.2337/diacare.27.12.2918; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Lorbeer R, 2015, HEART, V101, P178, DOI 10.1136/heartjnl-2014-306056; Lorbeer R, 2013, EUR J HEART FAIL, V15, P1327, DOI 10.1093/eurjhf/hft117; Molnar MZ, 2014, TRANSPL INT, V27, P541, DOI 10.1111/tri.12293; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Papapetropoulos A, 1999, LAB INVEST, V79, P213; Patel JV, 2008, ANN MED, V40, P215, DOI 10.1080/07853890701779586; Ricciuto DR, 2011, CRIT CARE MED, V39, P702, DOI 10.1097/CCM.0b013e318206d285; Roviezzo F, 2005, J PHARMACOL EXP THER, V314, P738, DOI 10.1124/jpet.105.086553; Shroff RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056273; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Tsai YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108862; Tsigkos S, 2003, EXPERT OPIN INV DRUG, V12, P933, DOI 10.1517/eoid.12.6.933.21790; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; Weiner DE, 2006, AM J KIDNEY DIS, V48, P392, DOI 10.1053/j.ajkd.2006.05.021; Witzenbichler B, 1998, J BIOL CHEM, V273, P18514, DOI 10.1074/jbc.273.29.18514	33	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135181	10.1371/journal.pone.0135181	http://dx.doi.org/10.1371/journal.pone.0135181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274392	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600054
J	Kovacs, L; Kezer, FL; Jurkovich, V; Kulcsar-Huszenicza, M; Tozser, J				Kovacs, Levente; Kezer, Fruzsina Luca; Jurkovich, Viktor; Kulcsar-Huszenicza, Margit; Tozser, Janos			Heart Rate Variability as an Indicator of Chronic Stress Caused by Lameness in Dairy Cows	PLOS ONE			English	Article							ENDOGENOUS OPIOID-PEPTIDES; CORTISOL METABOLITES; ADRENAL AXIS; GLUCOCORTICOID METABOLITES; NONLINEAR DYNAMICS; BLOOD-PRESSURE; CATTLE; WELFARE; FECES; PREVALENCE	Most experimental studies on animal stress physiology have focused on acute stress, while chronic stress, which is also encountered in intensive dairy cattle farming-e.g. in case of lameness-, has received little attention. We investigated heart rate (HR) and heart rate variability (HRV) as indicators of the autonomic nervous system activity and fecal glucocorticoid concentrations as the indicator of the hypothalamic-pituitary-adrenal axis activity in lame (with locomotion scores 4 and 5; n = 51) and non-lame (with locomotion scores 1 and 2; n = 52) Holstein-Friesian cows. Data recorded during the periods of undisturbed lying-representing baseline cardiac activity-were involved in the analysis. Besides linear analysis methods of the cardiac inter-beat interval (time-domain geometric, frequency domain and Poincare analyses) non-linear HRV parameters were also evaluated. With the exception of standard deviation 1 (SD1), all HRV indices were affected by lameness. Heart rate was lower in lame cows than in non-lame ones. Vagal tone parameters were higher in lame cows than in non-lame animals, while indices of the sympathovagal balance reflected on a decreased sympathetic activity in lame cows. All geometric and non-linear HRV measures were lower in lame cows compared to non-lame ones suggesting that chronic stress influenced linear and non-linear characteristics of cardiac function. Lameness had no effect on fecal glucocorticoid concentrations. Our results demonstrate that HRV analysis is a reliable method in the assessment of chronic stress, however, it requires further studies to fully understand the elevated parasympathetic and decreased sympathetic tone in lame animals.	[Kovacs, Levente; Kezer, Fruzsina Luca; Tozser, Janos] MTA SZIE Large Anim Clin Res Grp, Ullo Dora Major, Hungary; [Kovacs, Levente; Kezer, Fruzsina Luca] Szent Istvan Univ, Fac Agr & Environm Sci, Inst Anim Husb, Godollo, Hungary; [Jurkovich, Viktor] Szent Istvan Univ, Fac Vet Sci, Dept Anim Hyg Herd Hlth & Vet Ethol, Budapest, Hungary; [Kulcsar-Huszenicza, Margit] Szent Istvan Univ, Fac Vet Sci, Dept & Clin Reprod, Budapest, Hungary	Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences	Kovacs, L (corresponding author), MTA SZIE Large Anim Clin Res Grp, Ullo Dora Major, Hungary.	Kovacs.Levente@mkk.szie.hu	Hillmann, Edna/A-6077-2012; Jurkovich, Viktor/AAJ-2114-2020	Hillmann, Edna/0000-0001-5544-1151; Jurkovich, Viktor/0000-0002-6019-3508	Gazdasagfejlesztesi Operativ Program (GOP) [1.1.1-11-2012-0153]; Research Centre of Excellence [8526-5/2014/TUDPOL]	Gazdasagfejlesztesi Operativ Program (GOP); Research Centre of Excellence	This study was supported by 1. Gazdasagfejlesztesi Operativ Program (GOP)-1.1.1-11-2012-0153 project. URL: (http://palyazat.gov.hu/doc/4), 2. Research Centre of Excellence - 8526-5/2014/TUDPOL project. URL: (http://www.nemzetikivalosag.hu/site/).	Acharya R, 2004, PHYSIOL MEAS, V25, P1139, DOI 10.1088/0967-3334/25/5/005; Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; AKSELROD S, 1985, AM J PHYSIOL, V249, pH867, DOI 10.1152/ajpheart.1985.249.4.H867; Almeida PE, 2008, DOMEST ANIM ENDOCRIN, V34, P89, DOI 10.1016/j.domaniend.2006.11.006; Austin AR, 1997, VET REC, V141, P352, DOI 10.1136/vr.141.14.352; Camm AJ, 1996, CIRCULATION, V93, P1043; Castiglioni P, 2011, J PHYSIOL-LONDON, V589, P355, DOI 10.1113/jphysiol.2010.196428; Comin A, 2013, LIVEST SCI, V152, P36, DOI 10.1016/j.livsci.2012.11.021; Csernus V., 1982, ADV STEROID ANAL, P171; de Carvalho TD, 2011, REV PORT PNEUMOL, V17, P260, DOI 10.1016/j.rppneu.2011.06.007; FADEN AI, 1983, BRIT J PHARMACOL, V79, P997, DOI 10.1111/j.1476-5381.1983.tb10547.x; FARRELL TG, 1991, J AM COLL CARDIOL, V18, P687, DOI 10.1016/0735-1097(91)90791-7; FEUERSTEIN G, 1987, CIRCULATION, V75, P125; Flak JN, 2011, PHYSIOL BEHAV, V104, P228, DOI 10.1016/j.physbeh.2011.03.002; FREDERICKSON RCA, 1982, PROG NEUROBIOL, V19, P19, DOI 10.1016/0301-0082(82)90020-X; Frondelius L, 2015, PHYSIOL BEHAV, V139, P437, DOI 10.1016/j.physbeh.2014.12.002; Galindo Francisco, 2002, Journal of Applied Animal Welfare Science, V5, P193, DOI 10.1207/S15327604JAWS0503_03; Giuliani A, 1998, AM J PHYSIOL-HEART C, V275, pH1455, DOI 10.1152/ajpheart.1998.275.4.H1455; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Gonzalez JJ, 2000, AM J PHYSIOL-HEART C, V279, pH3040, DOI 10.1152/ajpheart.2000.279.6.H3040; Gudaj R, 2013, ACTA VET-BEOGRAD, V63, P405, DOI 10.2298/AVB1304405G; Hagen K, 2005, PHYSIOL BEHAV, V85, P195, DOI 10.1016/j.physbeh.2005.03.019; Hejjel L, 2001, Acta Physiol Hung, V88, P219, DOI 10.1556/APhysiol.88.2001.3-4.4; Jurkovich V, 2007, MAGY ALLATORVOSOK, V129, P468; Jurkovich V, 2012, MAGY ALLATORVOSOK, V134, P605; Kanters JK, 1996, CARDIOVASC RES, V31, P400; Kovacs L, 2015, PHYSIOL BEHAV, V139, P281, DOI 10.1016/j.physbeh.2014.11.039; Kovacs L, 2014, J DAIRY SCI, V97, P6955, DOI 10.3168/jds.2014-8327; Kovacs L, 2014, ANIMAL, V8, P316, DOI 10.1017/S1751731113002140; Kovacs L, 2013, J DAIRY SCI, V96, P7743, DOI 10.3168/jds.2013-7030; Kovacs L., 2013, Scientific Papers: Animal Science and Biotechnologies, V46, P213; Krstacic G, 2012, MED BIOL ENG COMPUT, V50, P1037, DOI 10.1007/s11517-012-0947-z; Langbein J, 2004, PHYSIOL BEHAV, V82, P601, DOI 10.1016/j.physbeh.2004.05.007; Langewitz W, 1991, HOMEOSTASIS HLTH DIS, V33, P1; LEMAIRE V, 1995, PHYSIOL BEHAV, V58, P1181, DOI 10.1016/0031-9384(95)02064-0; Li LP, 2012, J MED BIOL ENG, V32, P287, DOI 10.5405/jmbe.1008; Little CJL, 1996, VET REC, V139, P527; Loijens LWS, 2002, PHYSIOL BEHAV, V75, P621, DOI 10.1016/S0031-9384(01)00650-3; Makikallio Timo H, 2002, Card Electrophysiol Rev, V6, P250, DOI 10.1023/A:1016381025759; MALIK M, 1989, EUR HEART J, V10, P1060, DOI 10.1093/oxfordjournals.eurheartj.a059428; Marchant-Forde RM, 2004, PHYSIOL BEHAV, V80, P449, DOI 10.1016/j.physbeh.2003.09.007; Vanderlei LCM, 2010, ARQ BRAS CARDIOL, V95, P35, DOI 10.1590/S0066-782X2010005000082; Meeus M, 2013, SEMIN ARTHRITIS RHEU, V43, P279, DOI 10.1016/j.semarthrit.2013.03.004; Melillo P, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-96; Merl S, 2000, J EQUINE VET SCI, V20, P586, DOI 10.1016/S0737-0806(00)70267-X; Minero M, 2001, VET REC, V149, P772, DOI 10.1136/vr.149.25.772; Mohr E, 2002, PHYSIOL BEHAV, V75, P251, DOI 10.1016/S0031-9384(01)00651-5; Morrow CJ, 2002, GEN COMP ENDOCR, V126, P229, DOI 10.1006/gcen.2002.7797; Mostl E, 2002, VET RES COMMUN, V26, P127, DOI 10.1023/A:1014095618125; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Mourot L., 2014, J CLIN EXPT RES CARD, V104, P2394, DOI [10.15744/2394-6504.1.104, 10.13070/rs.en.1.618, DOI 10.13070/RS.EN.1.618]; NANDA AS, 1992, DOMEST ANIM ENDOCRIN, V9, P181, DOI 10.1016/0739-7240(92)90031-R; Ohmura H, 2006, AM J VET RES, V67, P455, DOI 10.2460/ajvr.67.3.455; Orsila R, 2008, INT J OCCUP SAF ERGO, V14, P275, DOI 10.1080/10803548.2008.11076767; Palme R, 1999, WIEN TIERARZTL MONAT, V86, P237; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Palme R, 1996, ANIM REPROD SCI, V43, P43, DOI 10.1016/0378-4320(95)01458-6; Palme R, 1997, Z SAUGETIERKD, V62, P192; Parikh D, 2011, EUR J PHARMACOL, V650, P563, DOI 10.1016/j.ejphar.2010.10.050; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Perkiomaki JS, 2002, ANN NONINVAS ELECTRO, V7, P326, DOI 10.1111/j.1542-474X.2002.tb00181.x; Pomfrett CJD, 2004, VET REC, V154, P687, DOI 10.1136/vr.154.22.687; Porges SW, 2003, PHYSIOL BEHAV, V79, P503, DOI 10.1016/S0031-9384(03)00156-2; Radostits O., 2007, VET MED TXB DIS CATT, V10; Ramaekers D, 1998, PACE, V21, P1546, DOI 10.1111/j.1540-8159.1998.tb00241.x; Rumball CWH, 2008, ENDOCRINOLOGY, V149, P1163, DOI 10.1210/en.2007-1306; Schmid M, 2010, ADDICTION, V105, P1265, DOI 10.1111/j.1360-0443.2010.02982.x; Schrader L, 1999, PHYSIOL BEHAV, V66, P775, DOI 10.1016/S0031-9384(99)00015-3; SIGNORINI MG, 1994, METHOD INFORM MED, V33, P81; Sprecher DJ, 1997, THERIOGENOLOGY, V47, P1179, DOI 10.1016/S0093-691X(97)00098-8; Stadnitski T, 2012, NONLIN DYNAM PSYCHOL, V16, P137; STECKLER T, 2005, HDB STRESS BRAIN 1; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Tarvainen MP, 2014, KUBIOS HRV VERSION 2; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Ventura BA, 2015, J AGR ENVIRON ETHIC, V28, P109, DOI 10.1007/s10806-014-9523-x; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Walker SL, 2008, HORM BEHAV, V53, P493, DOI 10.1016/j.yhbeh.2007.12.003; Whay H, 2002, IN PRACTICE, V24, P444; Zbilut JP, 2002, MED ENG PHYS, V24, P53, DOI 10.1016/S1350-4533(01)00112-6	81	36	36	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134792	10.1371/journal.pone.0134792	http://dx.doi.org/10.1371/journal.pone.0134792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270563	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800019
J	Bickel, B; Witzlack-Makarevich, A; Choudhary, KK; Schlesewsky, M; Bornkessel-Schlesewsky, I				Bickel, Balthasar; Witzlack-Makarevich, Alena; Choudhary, Kamal K.; Schlesewsky, Matthias; Bornkessel-Schlesewsky, Ina			The Neurophysiology of Language Processing Shapes the Evolution of Grammar: Evidence from Case Marking	PLOS ONE			English	Article							ANCESTRAL CHARACTER STATES; WORD-ORDER; COMPREHENSION; PREFERENCE; TIME	Do principles of language processing in the brain affect the way grammar evolves over time or is language change just a matter of socio-historical contingency? While the balance of evidence has been ambiguous and controversial, we identify here a neurophysiological constraint on the processing of language that has a systematic effect on the evolution of how noun phrases are marked by case (i.e. by such contrasts as between the English base form she and the object form her). In neurophysiological experiments across diverse languages we found that during processing, participants initially interpret the first base-form noun phrase they hear (e.g. she...) as an agent (which would fit a continuation like... greeted him), even when the sentence later requires the interpretation of a patient role (as in... was greeted). We show that this processing principle is also operative in Hindi, a language where initial base-form noun phrases most commonly denote patients because many agents receive a special case marker ("ergative") and are often left out in discourse. This finding suggests that the principle is species-wide and independent of the structural affordances of specific languages. As such, the principle favors the development and maintenance of case-marking systems that equate base-form cases with agents rather than with patients. We confirm this evolutionary bias by statistical analyses of phylogenetic signals in over 600 languages worldwide, controlling for confounding effects from language contact. Our findings suggest that at least one core property of grammar systematically adapts in its evolution to the neurophysiological conditions of the brain, independently of socio-historical factors. This opens up new avenues for understanding how specific properties of grammar have developed in tight interaction with the biological evolution of our species.	[Bickel, Balthasar] Univ Zurich, Dept Comparat Linguist, CH-8032 Zurich, Switzerland; [Witzlack-Makarevich, Alena] Univ Kiel, Dept Gen Linguist, D-24098 Kiel, Germany; [Choudhary, Kamal K.] Indian Inst Technol Ropar, Dept Humanities & Social Sci, Rupnagar 140001, India; [Schlesewsky, Matthias] Johannes Gutenberg Univ Mainz, Dept English & Linguist, D-55099 Mainz, Germany; [Schlesewsky, Matthias; Bornkessel-Schlesewsky, Ina] Univ S Australia, Sch Psychol Social Work & Social Policy, Adelaide, SA 5001, Australia; [Bornkessel-Schlesewsky, Ina] Univ Marburg, Dept German Linguist, D-35032 Marburg, Germany	University of Zurich; University of Kiel; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Ropar; Johannes Gutenberg University of Mainz; University of South Australia; Philipps University Marburg	Bickel, B (corresponding author), Univ Zurich, Dept Comparat Linguist, CH-8032 Zurich, Switzerland.	balthasar.bickel@uzh.ch		Choudhary, Kamal Kumar/0000-0002-0232-0003; Bornkessel-Schlesewsky, Ina/0000-0002-3238-6492; Witzlack-Makarevich, Alena/0000-0003-0138-4635	Deutsche Forschungsgemeinschaft [BI 799/3-1/2, BO 2471/32]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grant nos. BI 799/3-1/2 (BB) and BO 2471/32 (IBS) from the Deutsche Forschungsgemeinschaft (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader M, 1999, J PSYCHOLINGUIST RES, V28, P121, DOI 10.1023/A:1023206208142; Barber H, 2005, J COGNITIVE NEUROSCI, V17, P137, DOI 10.1162/0898929052880101; Bavin EL, 2013, THE ACQUISITION OF E; Bickel Balthasar., 2011, LINGUIST TYPOL, V15, P401, DOI [10.1515/lity.2011.027, DOI 10.1515/LITY.2011.027]; Bickel Balthasar, 2011, OXFORD HDB LANGUAGE, P399; Bickel Balthasar., 2013, LANGUAGE TYPOLOGY HI, P415; Blevins Juliette, 2004, EVOLUTIONARY PHONOLO; Bornkessel I, 2004, J MEM LANG, V51, P495, DOI 10.1016/j.jml.2004.06.011; Bornkessel I, 2002, COGNITION, V85, pB21, DOI 10.1016/S0010-0277(02)00076-8; Bornkessel-Schlesewsky I., 2008, SCALES LINGUISTICHE, P397; Bornkessel-Schlesewsky I, 2013, BRAIN LANG, V125, P60, DOI 10.1016/j.bandl.2013.01.010; Butt Miriam, 2001, TIME MATTER DIACHRON, P105; Choudhary KK, 2009, NEUROPSYCHOLOGIA, V47, P3012, DOI 10.1016/j.neuropsychologia.2009.05.009; Choudhary KK, 2011, INCREMENTAL ARGUMENT; Christiansen MH, 2008, BEHAV BRAIN SCI, V31, P489, DOI 10.1017/S0140525X08004998; CROCKER MW, 1994, PERSPECTIVES ON SENTENCE PROCESSING, P245; Culbertson J, 2012, COGNITION, V122, P306, DOI 10.1016/j.cognition.2011.10.017; Cysouw Michael., 2011, LINGUIST TYPOL, V15, P415, DOI [10.1515/lity.2011.028, DOI 10.1515/LITY.2011.028]; De Vincenzi M., 1991, SYNTACTIC PARSING ST; Dediu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045198; Demiral SB, 2008, COGNITION, V106, P484, DOI 10.1016/j.cognition.2007.01.008; Deutsche Forschungsgemeinschaft, 2014, DEUTSCHE FORSCHUNGSG; Dillon B, 2012, LANG COGNITIVE PROC, V27, P313, DOI 10.1080/01690965.2010.544582; Dixon R. M. W., 1994, ERGATIVITY; Dryer Matthew S, 2013, THE WORLD ATLAS OF L; Dunn M, 2011, NATURE, V473, P79, DOI 10.1038/nature09923; Enfield N.J., 2014, SOCIAL ORIGINS LANGU, P92, DOI DOI 10.1093/ACPROF:OSO/9780199665327.001.0001; FRAZIER L, 1989, J MEM LANG, V28, P331, DOI 10.1016/0749-596X(89)90037-5; Gildea S, 1998, ON RECONSTRUCTING GR; Gorrell P., 1995, SYNTAX AND PARSING; Haig GLJ, 2008, ALIGNMENT CHANGE IN; Hammarstrom H., 2014, GLOTTOLOG 2 3; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Haupt FS, 2008, J MEM LANG, V59, P54, DOI 10.1016/j.jml.2008.02.003; Haupt FS, 2008, MPI SERIES IN HUMAN; Hawkins JA, 2004, EFFICIENCY AND COMPL; Kemmerer D, 2012, LANG LINGUIST COMPAS, V6, P50, DOI 10.1002/lnc3.322; Kemp C, 2012, SCIENCE, V336, P1049, DOI 10.1126/science.1218811; Kiyama S, 2013, OPEN J MOD LING, V3, P203, DOI [10.4236/ojml.2013.33027, DOI 10.4236/ojml.2013.33027]; Koizumi M, 2014, LANGUAGE, V90, P722; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lawrence MA, 2013, R PACKAGE VERSION 4; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; McGregor WB, 2009, LANG LINGUIST COMPAS, V3, P480, DOI 10.1111/j.1749-818x.2008.00118.x; Meade A, 2013, SOFTWARE AND MANUAL; Meyer D, 2006, J STAT SOFTW, V17, P1, DOI [DOI 10.18637/JSS.V017.I03, 10.18637/jss.v017.i03]; Nichols J., 1993, AUST J LINGUIST, V13, P39, DOI [10.1080/07268609308599489, DOI 10.1080/07268609308599489]; Nichols J, 2013, THE AUTOTYP GENEALOG; Nichols Johanna, 2003, HDB HIST LINGUISTICS, P283, DOI DOI 10.1002/9780470756393.CH5; Nichols Johanna, 1992, LINGUISTIC DIVERSITY; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; PETERSON John, 1998, GRAMMATICAL RELATION; Prasad R, 2000, PROCEEDINGS OF THE D, P66; Primus B, 1999, CASES AND THEMATIC R; R Development Core Team, 2014, STATISTICAL COMPUTIN; Sassenhagen J, 2014, BRAIN LANG, V137, P29, DOI 10.1016/j.bandl.2014.07.010; Schlesewsky M., 2000, GERMAN SENTENCE PROC, P65, DOI DOI 10.1007/978-94-015-9618-3_3; Schlesewsky M, 2009, PROCESSING SYNTAX AN; Sinnemaki K, 2014, COGNITIVE PROCESSING; Wang LM, 2009, LANG COGNITIVE PROC, V24, P1180, DOI 10.1080/01690960802159937; Wolff S, 2008, BRAIN LANG, V107, P133, DOI 10.1016/j.bandl.2008.06.003; Zakharko Taras, 2011, FAMILYBIAS FAMILY BI	64	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0132819	10.1371/journal.pone.0132819	http://dx.doi.org/10.1371/journal.pone.0132819			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267884	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000359492300009
J	Costa, C; Ponte, A; Pais, P; Santos, R; Cavalheiro, M; Yaguchi, T; Chibana, H; Teixeira, MC				Costa, Catarina; Ponte, Andreia; Pais, Pedro; Santos, Rui; Cavalheiro, Mafalda; Yaguchi, Takashi; Chibana, Hiroji; Teixeira, Miguel Cacho			New Mechanisms of Flucytosine Resistance in C. glabrata Unveiled by a Chemogenomics Analysis in S. cerevisiae	PLOS ONE			English	Article							CANDIDA-GLABRATA; SACCHAROMYCES-CEREVISIAE; ANTIFUNGAL AGENTS; DRUG-RESISTANCE; MOLECULAR-MECHANISMS; TRANSCRIPTION FACTOR; ACETIC-ACID; YEAST; GLYCEROL; ALBICANS	5-Flucytosine is currently used as an antifungal drug in combination therapy, but fungal pathogens are rapidly able to develop resistance against this drug, compromising its therapeutic action. The understanding of the underlying resistance mechanisms is crucial to deal with this problem. In this work, the S. cerevisiae deletion mutant collection was screened for increased resistance to flucytosine. Through this chemogenomics analysis, 183 genes were found to confer resistance to this antifungal agent. Consistent with its known effect in DNA, RNA and protein synthesis, the most significant Gene Ontology terms over-represented in the list of 5-flucytosine resistance determinants are related to DNA repair, RNA and protein metabolism. Additional functional classes include carbohydrate and nitrogen-particularly arginine-metabolism, lipid metabolism and cell wall remodeling. Based on the results obtained for S. cerevisiae as a model system, further studies were conducted in the pathogenic yeast Candida glabrata. Arginine supplementation was found to relieve the inhibitory effect exerted by 5-flucytosine in C. glabrata. Lyticase susceptibility was found to increase within the first 30min of 5-flucytosine exposure, suggesting this antifungal drug to act as a cell wall damaging agent. Upon exponential growth resumption in the presence of 5-flucytosine, the cell wall exhibited higher resistance to lyticase, suggesting that cell wall remodeling occurs in response to 5-flucytosine. Additionally, the aquaglyceroporin encoding genes CgFPS1 and CgFPS2, from C. glabrata, were identified as determinants of 5-flucytosine resistance. CgFPS1 and CgFPS2 were found to mediate 5-flucytosine resistance, by decreasing 5-flucytosine accumulation in C. glabrata cells.	[Costa, Catarina; Ponte, Andreia; Pais, Pedro; Santos, Rui; Cavalheiro, Mafalda; Teixeira, Miguel Cacho] Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal; [Costa, Catarina; Ponte, Andreia; Pais, Pedro; Santos, Rui; Cavalheiro, Mafalda; Teixeira, Miguel Cacho] Inst Super Tecn, Biol Sci Res Grp, iBB Inst Bioengn & Biosci, Lisbon, Portugal; [Yaguchi, Takashi; Chibana, Hiroji] Chiba Univ, MMRC, Chiba, Japan	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Chiba University	Teixeira, MC (corresponding author), Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal.	mnpct@tecnico.ulisboa.pt	Costa, Catarina/K-4264-2014; Pais, Pedro/AAR-6637-2021; Pais, Pedro/AAL-8248-2020; Teixeira, Miguel Cacho/A-3870-2008	Costa, Catarina/0000-0002-1974-3547; Pais, Pedro/0000-0001-5628-416X; Teixeira, Miguel Cacho/0000-0002-5676-6174; Santos, Rui/0000-0001-6003-9079; Cavalheiro, Mafalda/0000-0002-4071-7351	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/EBB-BIO/119356/2010, UID/BIO/04565/2013]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia" (FCT) (Contracts PTDC/EBB-BIO/119356/2010, UID/BIO/04565/2013 and post-doctoral and PhD grants to CC and PP, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI T, 1977, ANTIMICROB AGENTS CH, V12, P255, DOI 10.1128/AAC.12.2.255; Armengou A, 2003, J CEREBR BLOOD F MET, V23, P978, DOI 10.1097/01.WCB.0000080651.64357.C6; Beese-Sims SE, 2012, EUKARYOT CELL, V11, P1512, DOI 10.1128/EC.00231-12; Costa C, 2014, J ANTIMICROB CHEMOTH, V69, P1767, DOI 10.1093/jac/dku044; Costa C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00170; Costa C, 2013, ANTIMICROB AGENTS CH, V57, P3159, DOI 10.1128/AAC.00811-12; Edlind TD, 2010, ANTIMICROB AGENTS CH, V54, P4733, DOI 10.1128/AAC.00605-10; Espinel-Ingroff A, 2008, REV IBEROAM MICOL, V25, P101, DOI 10.1016/S1130-1406(08)70027-5; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; GREGOIRE AT, 1959, ANN NY ACAD SCI, V83, P185; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hope WW, 2004, ANTIMICROB AGENTS CH, V48, P4377, DOI 10.1128/AAC.48.11.4377-4386.2004; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Kontoyiannis DP, 2002, LANCET, V359, P1135, DOI 10.1016/S0140-6736(02)08162-X; Liu TT, 2005, ANTIMICROB AGENTS CH, V49, P2226, DOI 10.1128/AAC.49.6.2226-2236.2005; Lourenco AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055439; Mishra Nagendra Nath, 2007, Acta Microbiologica et Immunologica Hungarica, V54, P201, DOI 10.1556/AMicr.54.2007.3.1; Mollapour M, 2007, MOL CELL BIOL, V27, P6446, DOI 10.1128/MCB.02205-06; Nozawa A, 2006, FEMS MICROBIOL LETT, V262, P216, DOI 10.1111/j.1574-6968.2006.00395.x; Papon N, 2007, ANTIMICROB AGENTS CH, V51, P369, DOI 10.1128/AAC.00824-06; Rosa MF, 1996, FEMS MICROBIOL LETT, V135, P271, DOI 10.1016/0378-1097(95)00465-3; Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0; Schwarzmuller T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004211; Simoes T, 2003, APPL ENVIRON MICROB, V69, P4019, DOI 10.1128/AEM.69.7.4019-4028.2003; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Teixeira MC, 2009, APPL ENVIRON MICROB, V75, P5761, DOI 10.1128/AEM.00845-09; Toh TH, 2001, FEMS YEAST RES, V1, P205, DOI 10.1111/j.1567-1364.2001.tb00035.x; Ueno K, 2007, EUKARYOT CELL, V6, P1239, DOI 10.1128/EC.00414-06; Ueno K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024759; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Vermitsky JP, 2004, ANTIMICROB AGENTS CH, V48, P3773, DOI 10.1128/AAC.48.10.3773-3781.2004; Wysocki R, 2001, MOL MICROBIOL, V40, P1391, DOI 10.1046/j.1365-2958.2001.02485.x; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Zhang L, 2002, INT J ANTIMICROB AG, V20, P444, DOI 10.1016/S0924-8579(02)00201-7	35	24	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135110	10.1371/journal.pone.0135110	http://dx.doi.org/10.1371/journal.pone.0135110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267134	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300080
J	Hashimoto, M; Morales, J; Uemura, H; Mikoshiba, K; Nara, T				Hashimoto, Muneaki; Morales, Jorge; Uemura, Haruki; Mikoshiba, Katsuhiko; Nara, Takeshi			A Novel Method for Inducing Amastigote-To-Trypomastigote Transformation In Vitro in Trypanosoma cruzi Reveals the Importance of Inositol 1,4,5-Trisphosphate Receptor	PLOS ONE			English	Article							TOXOPLASMA-GONDII; INTRACELLULAR CALCIUM; CELL-DIFFERENTIATION; PARASITIC PROTIST; MAMMALIAN-CELLS; TRANS-SIALIDASE; CYCLIC-AMP; PLASMODIUM; INVASION; TRANSDUCTION	Background Trypanosoma cruzi is a parasitic protist that causes Chagas disease, which is prevalent in Latin America. Because of the unavailability of an effective drug or vaccine, and because about 8 million people are infected with the parasite worldwide, the development of novel drugs demands urgent attention. T. cruzi infects a wide variety of mammalian nucleated cells, with a preference for myocardial cells. Non-dividing trypomastigotes in the bloodstream infect host cells where they are transformed into replication-capable amastigotes. The amastigotes revert to trypomastigotes (trypomastigogenesis) before being shed out of the host cells. Although trypomastigote transformation is an essential process for the parasite, the molecular mechanisms underlying this process have not yet been clarified, mainly because of the lack of an assay system to induce trypomastigogenesis in vitro. Methodology/Principal Findings Cultivation of amastigotes in a transformation medium composed of 80% RPMI-1640 and 20% Grace's Insect Medium mediated their transformation into trypomastigotes. Grace's Insect Medium alone also induced trypomastigogenesis. Furthermore, trypomastigogenesis was induced more efficiently in the presence of fetal bovine serum. Trypomastigotes derived from in vitro trypomastigogenesis were able to infect mammalian host cells as efficiently as tissue-culture-derived trypomastigotes (TCT) and expressed a marker protein for TCT. Using this assay system, we demonstrated that T. cruzi inositol 1,4,5-trisphosphate receptor (TcIP3R)-an intracellular Ca2+ channel and a key molecule involved in Ca2+ signaling in the parasite-is important for the transformation process. Conclusion/Significance Our findings provide a new tool to identify the molecular mechanisms of the amastigote-to-trypomastigote transformation, leading to a new strategy for drug development against Chagas disease.	[Hashimoto, Muneaki; Morales, Jorge; Nara, Takeshi] Juntendo Univ, Sch Med, Dept Mol & Cellular Parasitol, Bunkyo Ku, Tokyo 1138421, Japan; [Uemura, Haruki] Nagasaki Univ, Inst Trop Med, Dept Protozool, Nagasaki 8528523, Japan; [Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Saitama 3510198, Japan; [Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Int Cooperat Res Project, Kawaguchi, Saitama 3320012, Japan; [Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Juntendo University; Nagasaki University; RIKEN; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Hashimoto, M (corresponding author), Juntendo Univ, Sch Med, Dept Mol & Cellular Parasitol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	muneaki@juntendo.ac.jp	Mikoshiba, Katsuhiko/N-7943-2015; Morales, Jorge/AAJ-9381-2020; Hashimoto, Muneaki/L-6386-2018	Morales, Jorge/0000-0002-2828-1567; Hashimoto, Muneaki/0000-0001-7215-7558	JSPS KAKENHI Grant [15K08452, 24390102]; Pharmacological Reserch Foundation, Tokyo; Foundation of Strategic Research Projects in Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan [S1201013]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pharmacological Reserch Foundation, Tokyo; Foundation of Strategic Research Projects in Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan	This work was supported by JSPS KAKENHI Grant Numbers 15K08452 (to MH), 24390102 (to TN) (https://www.jsps.go.jp/english/index.html). This work was supported by The Pharmacological Reserch Foundation, Tokyo (to MH) (http://www.disclo-koeki.org/08a/00994/1.pdf#search='%E5%85%AC%E7%9B%8A%E8%B2%A1%E5%9B%A3%E6%B3%95%E4%BA%BA+%E8%96%AC%E7%90%86%E7%A0%94%E7%A9%B6%E4%BC%9A'). This work was supported in part by the Foundation of Strategic Research Projects in Private Universities (S1201013) from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (to TN) (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesse D, 2010, AM J TROP MED HYG, V82, P846, DOI 10.4269/ajtmh.2010.09-0399; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Burleigh BA, 2002, CELL MICROBIOL, V4, P701, DOI 10.1046/j.1462-5822.2002.00226.x; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Contreras VT, 2002, MEM I OSWALDO CRUZ, V97, P1213, DOI 10.1590/S0074-02762002000800025; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; de Diego JL, 2001, BIOCHEMISTRY-US, V40, P1053, DOI 10.1021/bi001659k; Enomoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039499; Fernandes MC, 2013, CELL MICROBIOL, V15, P977, DOI 10.1111/cmi.12090; FREVERT U, 1992, INFECT IMMUN, V60, P2349, DOI 10.1128/IAI.60.6.2349-2360.1992; Gluenz E, 2007, INT J PARASITOL, V37, P617, DOI 10.1016/j.ijpara.2006.11.016; GONZALESPERDOMO M, 1988, EXP PARASITOL, V66, P205, DOI 10.1016/0014-4894(88)90092-6; Gonzalez J, 1996, J EXP MED, V184, P1909, DOI 10.1084/jem.184.5.1909; Hashimoto M, 2013, MOL MICROBIOL, V87, P1133, DOI 10.1111/mmi.12155; Iizumi K, 2006, BBA-BIOMEMBRANES, V1758, P738, DOI 10.1016/j.bbamem.2006.04.025; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Koyama FC, 2009, MOL BIOCHEM PARASIT, V165, P1, DOI 10.1016/j.molbiopara.2009.01.003; Lammel EM, 1996, EXP PARASITOL, V83, P240, DOI 10.1006/expr.1996.0070; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Morlon-Guyot J, 2014, CELL MICROBIOL, V16, P95, DOI 10.1111/cmi.12186; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; NakajimaShimada J, 1996, ANTIMICROB AGENTS CH, V40, P2455, DOI 10.1128/AAC.40.11.2455; Queiroz RML, 2014, MOL CELL PROTEOMICS, V13, P3457, DOI 10.1074/mcp.M114.040329; RANGELALDAO R, 1988, BIOCHEM INT, V17, P337; RANGELALDAO R, 1988, ARCH BIOL MED EXP, V21, P403; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rubin-de-Celis SSC, 2006, CELL MICROBIOL, V8, P1888, DOI 10.1111/j.1462-5822.2006.00755.x; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; SULLIVAN JJ, 1982, T ROY SOC TROP MED H, V76, P300, DOI 10.1016/0035-9203(82)90173-0; TOMLINSON S, 1995, PARASITOLOGY, V110, P547, DOI 10.1017/S0031182000065264; Tonelli RR, 2004, CELL MICROBIOL, V6, P733, DOI 10.1111/j.1462-5822.2004.00397.x; Tyler KM, 2000, CELL MOTIL CYTOSKEL, V46, P269, DOI 10.1002/1097-0169(200008)46:4&lt;269::AID-CM4&gt;3.0.CO;2-V; Wainszelbaum MJ, 2003, BIOCHEM J, V375, P705, DOI 10.1042/BJ20021907; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495	34	7	7	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135726	10.1371/journal.pone.0135726	http://dx.doi.org/10.1371/journal.pone.0135726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267656	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300150
J	Cho, HY; Park, YW; Kim, YH; Jung, I; Kwon, JY				Cho, Hee Young; Park, Yong Won; Kim, Young Han; Jung, Inkyung; Kwon, Ja-Young			Efficacy of Intrauterine Bakri Balloon Tamponade in Cesarean Section for Placenta Previa Patients	PLOS ONE			English	Article							POSTPARTUM HEMORRHAGE; ARTERIAL EMBOLIZATION; MANAGEMENT	Purpose The aims of this study were to analyze the predictive factors for the use of intrauterine balloon insertion and to evaluate the efficacy and factors affecting failure of uterine tamponade with a Bakri balloon during cesarean section for abnormal placentation. Methods We reviewed the medical records of 137 patients who underwent elective cesarean section for placenta previa between July 2009 and March 2014. Cesarean section and Bakri balloon insertion were performed by a single qualified surgeon. The Bakri balloon was applied when blood loss during cesarean delivery exceeded 1,000 mL. Results Sixty-four patients (46.7%) required uterine balloon tamponade during cesarean section due to postpartum bleeding from the lower uterine segment, of whom 50 (78.1%) had placenta previa totalis. The overall success rate was 75% (48/64) for placenta previa patients. Previous cesarean section history, anterior placenta, peripartum platelet count, and disseminated intravascular coagulopathy all significantly differed according to balloon success or failure (all p < 0.05). The drainage amount over 1 hour was 500 mL (20-1200 mL) in the balloon failure group and 60 mL (5-500 mL) in the balloon success group (p < 0.01). Conclusion Intrauterine tamponade with a Bakri balloon is an adequate adjunct management for postpartum hemorrhage following cesarean section for placenta previa to preserve the uterus. This method is simple to apply, non-invasive, and inexpensive. However, possible factors related to failure of Bakri balloon tamponade for placenta previa patients such as prior cesarean section history, anterior placentation, thrombocytopenia, presence of DIC at the time of catheter insertion, and catheter drainage volume more than 500 mL within 1 hour of catheter placement should be recognized, and the next-line management should be prepared in advance.	[Cho, Hee Young; Park, Yong Won; Kim, Young Han; Kwon, Ja-Young] Yonsei Univ, Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol,Yonsei Univ Hlth Syst,Inst, Seoul, South Korea; [Jung, Inkyung] Yonsei Univ, Coll Med, Dept Biostat, Yonsei Univ Hlth Syst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kwon, JY (corresponding author), Yonsei Univ, Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol,Yonsei Univ Hlth Syst,Inst, Seoul, South Korea.	jaykwon@yuhs.ac		Cho, Hee Young/0000-0001-7064-5056; Kim, Young-Han/0000-0003-0645-6028; Kwon, Ja-Young/0000-0003-3009-6325; Jung, Inkyung/0000-0003-3780-3213				Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; Ananth CV, 1997, AM J OBSTET GYNECOL, V177, P1071, DOI 10.1016/S0002-9378(97)70017-6; [Anonymous], 2002, OBSTET GYNECOL, V99, P169; [Anonymous], 2017, BJOG-INT J OBSTET GY, V124, pe106; BAKRI YN, 1992, INT J GYNECOL OBSTET, V37, P302, DOI 10.1016/0020-7292(92)90336-H; Bakri YN, 2001, INT J GYNECOL OBSTET, V74, P139, DOI 10.1016/S0020-7292(01)00395-2; Chauleur C, 2008, HUM REPROD, V23, P1553, DOI 10.1093/humrep/den122; Dabelea V, 2007, AM J PERINAT, V24, P359, DOI 10.1055/s-2007-984402; Dildy GA, 2002, CLIN OBSTET GYNECOL, V45, P330, DOI 10.1097/00003081-200206000-00005; Doumouchtsis SK, 2007, OBSTET GYNECOL SURV, V62, P540, DOI 10.1097/01.ogx.0000271137.81361.93; Frenzel D, 2005, BJOG-INT J OBSTET GY, V112, P676, DOI 10.1111/j.1471-0528.2005.00491.x; IYASU S, 1993, AM J OBSTET GYNECOL, V168, P1424, DOI 10.1016/S0002-9378(11)90776-5; Jang Dong Gyu, 2011, Int J Med Sci, V8, P439; Joshi VM, 2007, BJOG-INT J OBSTET GY, V114, P356, DOI 10.1111/j.1471-0528.2006.01235.x; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Laas E, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.028; Majumdar A, 2010, J OBSTET GYNAECOL, V30, P586, DOI 10.3109/01443615.2010.494202; Touboul C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003819; Vrachnis N, 2012, CLIN EXP OBSTET GYN, V39, P255; Wagaarachchi PT, 2001, INT J GYNECOL OBSTET, V74, P119, DOI 10.1016/S0020-7292(01)00427-1; Wright CE, 2014, AM J PERINAT, V31, P957, DOI 10.1055/s-0034-1372422; Zwart JJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.003	22	33	36	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134282	10.1371/journal.pone.0134282	http://dx.doi.org/10.1371/journal.pone.0134282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263014	gold, Green Submitted, Green Published			2022-12-27	WOS:000359353300026
J	Kieffer-Kwon, P; Happel, C; Uldrick, TS; Ramalingam, D; Ziegelbauer, JM				Kieffer-Kwon, Philippe; Happel, Christine; Uldrick, Thomas S.; Ramalingam, Dhivya; Ziegelbauer, Joseph M.			KSHV MicroRNAs Repress Tropomyosin 1 and Increase Anchorage-Independent Growth and Endothelial Tube Formation	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; MOLECULAR-WEIGHT KININOGEN; TUMOR-SUPPRESSOR; INDUCED APOPTOSIS; GENE-EXPRESSION; ACTIN DYNAMICS; MESSENGER-RNA; DNA-SEQUENCES; BREAST-CANCER; CELL-LINE	Kaposi's sarcoma (KS) is characterized by highly vascularized spindle-cell tumors induced after infection of endothelial cells by Kaposi's sarcoma-associated herpesvirus (KSHV). In KS tumors, KSHV expresses only a few latent proteins together with 12 pre-microRNAs. Previous microarray and proteomic studies predicted that multiple splice variants of the tumor suppressor protein tropomyosin 1 (TPM1) were targets of KSHV microRNAs. Here we show that at least two microRNAs of KSHV, miR-K2 and miR-K5, repress protein levels of specific isoforms of TPM1. We identified a functional miR-K5 binding site in the 3' untranslated region (UTR) of one TPM1 isoform. Furthermore, the inhibition or loss of miR-K2 or miR-K5 restores expression of TPM1 in KSHV-infected cells. TPM1 protein levels were also repressed in KSHV-infected clinical samples compared to uninfected samples. Functionally, miR-K2 increases viability of unanchored human umbilical vein endothelial cells (HUVEC) by inhibiting anoikis (apoptosis after cell detachment), enhances tube formation of HUVECs, and enhances VEGFA expression. Taken together, KSHV miR-K2 and miR-K5 may facilitate KSHV pathogenesis.	[Kieffer-Kwon, Philippe; Happel, Christine; Uldrick, Thomas S.; Ramalingam, Dhivya; Ziegelbauer, Joseph M.] NCI, NIH, HIV & AIDS Malignancy Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ziegelbauer, JM (corresponding author), NCI, NIH, HIV & AIDS Malignancy Branch, Bethesda, MD 20892 USA.	ziegelbauerjm@mail.nih.gov	Ziegelbauer, Joseph/L-2628-2013; Happel, Christine/AAW-7558-2020	Ziegelbauer, Joseph/0000-0001-6464-6941; Happel, Christine/0000-0002-9882-2998	Center for Cancer Research, National Cancer Institute, National Institutes of Health [1ZIABC011176-06]	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health (1ZIABC011176-06 nih.gov).	Abend JR, 2010, J VIROL, V84, P12139, DOI 10.1128/JVI.00884-10; Bharadwaj S, 2005, ONCOGENE, V24, P8291, DOI 10.1038/sj.onc.1208993; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Bruneel A, 2005, PROTEOMICS, V5, P3876, DOI 10.1002/pmic.200401239; Bruneel A, 2003, PROTEOMICS, V3, P714, DOI 10.1002/pmic.200300409; Carroll PA, 2004, VIROLOGY, V328, P7, DOI 10.1016/j.virol.2004.07.008; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Cheng F, 2011, CELL HOST MICROBE, V10, P577, DOI 10.1016/j.chom.2011.10.011; Choi C, 2012, J STRUCT BIOL, V177, P63, DOI 10.1016/j.jsb.2011.11.016; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; Crawford JB, 2006, MOL CELL BIOL, V26, P8791, DOI 10.1128/MCB.01677-06; Donate F, 2004, CURR CANCER DRUG TAR, V4, P543, DOI 10.2174/1568009043332781; Donate F, 2004, CANCER RES, V64, P5812, DOI 10.1158/0008-5472.CAN-04-0440; Efklidou S, 2008, J CELL SCI, V121, P450, DOI 10.1242/jcs.022343; Franzen B, 1996, BRIT J CANCER, V73, P909, DOI 10.1038/bjc.1996.162; Gallaher AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003584; Gooding C, 2008, ADV EXP MED BIOL, V644, P27; Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012; Gottwein E, 2010, J VIROL, V84, P5229, DOI 10.1128/JVI.00202-10; Goudsmit J, 2000, P NATL ACAD SCI USA, V97, P4838, DOI 10.1073/pnas.97.9.4838; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guan XJ, 2004, THROMB HAEMOSTASIS, V92, P403, DOI 10.1160/TH04-02-0073; Guilluy C, 2011, BLOOD, V118, P5344, DOI 10.1182/blood-2011-03-341552; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Helfman DM, 2008, ADV EXP MED BIOL, V644, P124; HERNDIER BG, 1994, AIDS, V8, P575, DOI 10.1097/00002030-199405000-00002; Hughes JAI, 2003, GLIA, V42, P25, DOI 10.1002/glia.10174; Jalilian I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126214; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Liang DG, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00271; Lin JC, 2005, MOL CELL BIOL, V25, P10111, DOI 10.1128/MCB.25.22.10111-10121.2005; Lin JJC, 2008, ADV EXP MED BIOL, V644, P201; Ma ZY, 2008, CELL CYCLE, V7, P2462, DOI 10.4161/cc.7.16.6463; MacDonald NJ, 2001, J BIOL CHEM, V276, P25190, DOI 10.1074/jbc.M100743200; Mahadev K, 2002, EXP CELL RES, V279, P40, DOI 10.1006/excr.2002.5583; Mallery SR, 2003, J CELL BIOCHEM, V89, P133, DOI 10.1002/jcb.10489; Mansouri M, 2008, J VIROL, V82, P9615, DOI 10.1128/JVI.02633-07; Marquitz AR, 2012, P NATL ACAD SCI USA, V109, P9593, DOI 10.1073/pnas.1202910109; Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403; Martin JN, 2007, EPIDEMIOLOGY KSHV IT; Melbye M, 1998, INT J CANCER, V77, P543, DOI 10.1002/(SICI)1097-0215(19980812)77:4&lt;543::AID-IJC12&gt;3.0.CO;2-7; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Qian LW, 2007, J VIROL, V81, P7001, DOI 10.1128/JVI.00016-07; Ramalingam D, 2012, VIRUSES-BASEL, V4, P1687, DOI 10.3390/v4091687; Raval GN, 2003, ONCOGENE, V22, P6194, DOI 10.1038/sj.onc.1206719; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Schevzov Galina, 2011, Bioarchitecture, V1, P135; Sharma-Walia N, 2004, J VIROL, V78, P4207, DOI 10.1128/JVI.78.8.4207-4223.2004; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Suffert G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002405; TAKENAGA K, 1988, MOL CELL BIOL, V8, P3934, DOI 10.1128/MCB.8.9.3934; Thomson DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055214; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Varga AE, 2005, ONCOGENE, V24, P5043, DOI 10.1038/sj.onc.1208688; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Wang FL, 1996, CANCER RES, V56, P3634; Wang L, 2008, CANCER RES, V68, P4640, DOI 10.1158/0008-5472.CAN-07-5988; Wang M, 2011, ARTERIOSCL THROM VAS, V31, P2046, DOI 10.1161/ATVBAHA.111.229559; Zhang JC, 2000, FASEB J, V14, P2589, DOI 10.1096/fj.99-1025com; Zhang JC, 2002, P NATL ACAD SCI USA, V99, P12224, DOI 10.1073/pnas.192668299; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200; Ziegelbauer JM, 2011, BBA-GENE REGUL MECH, V1809, P623, DOI 10.1016/j.bbagrm.2011.05.003; Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266	66	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135560	10.1371/journal.pone.0135560	http://dx.doi.org/10.1371/journal.pone.0135560			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263384	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300092
J	Lakshmi, B; Mishra, M; Srinivasan, N; Archunan, G				Lakshmi, Balasubramanian; Mishra, Madhulika; Srinivasan, Narayanaswamy; Archunan, Govindaraju			Structure-Based Phylogenetic Analysis of the Lipocalin Superfamily	PLOS ONE			English	Article							PROSTAGLANDIN-D SYNTHASE; BINDING PROTEIN; FAMILY; GENE	Lipocalins constitute a superfamily of extracellular proteins that are found in all three kingdoms of life. Although very divergent in their sequences and functions, they show remarkable similarity in 3-D structures. Lipocalins bind and transport small hydrophobic molecules. Earlier sequence-based phylogenetic studies of lipocalins highlighted that they have a long evolutionary history. However the molecular and structural basis of their functional diversity is not completely understood. The main objective of the present study is to understand functional diversity of the lipocalins using a structure-based phylogenetic approach. The present study with 39 protein domains from the lipocalin superfamily suggests that the clusters of lipocalins obtained by structure-based phylogeny correspond well with the functional diversity. The detailed analysis on each of the clusters and sub-clusters reveals that the 39 lipocalin domains cluster based on their mode of ligand binding though the clustering was performed on the basis of gross domain structure. The outliers in the phylogenetic tree are often from single member families. Also structure-based phylogenetic approach has provided pointers to assign putative function for the domains of unknown function in lipocalin family. The approach employed in the present study can be used in the future for the functional identification of new lipocalin proteins and may be extended to other protein families where members show poor sequence similarity but high structural similarity.	[Lakshmi, Balasubramanian; Archunan, Govindaraju] Bharathidasan Univ, Dept Anim Sci, Tiruchirappalli 620024, Tamil Nadu, India; [Lakshmi, Balasubramanian; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Mishra, Madhulika] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Bharathidasan University; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Srinivasan, N (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@mbu.iisc.ernet.in; garchu56@yahoo.co.in	Mishra, Madhulika/AAL-2287-2020; GOVINDARAJU, ARCHUNAN/A-9072-2019	Mishra, Madhulika/0000-0001-7133-4743; GOVINDARAJU, ARCHUNAN/0000-0002-7094-0351	Department of Biotechnology, Government of India; Department of Science and Technology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This research is supported by the Department of Biotechnology, Government of India as well as by the Mathematical Biology Program sponsored by Department of Science and Technology, Government of India.	Agarwal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005736; Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Balaji S, 2007, J BIOSCIENCES, V32, P83, DOI 10.1007/s12038-007-0008-1; Bianchetti CM, 2010, PROTEINS, V78, P917, DOI 10.1002/prot.22617; Chaudhuri BN, 1999, ACTA CRYSTALLOGR D, V55, P1850, DOI 10.1107/S0907444999011026; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; FLOWER DR, 1991, BIOCHEM BIOPH RES CO, V180, P69, DOI 10.1016/S0006-291X(05)81256-2; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; FLOWER DR, 1995, J MOL RECOGNIT, V8, P185, DOI 10.1002/jmr.300080304; Flower DR, 1996, BIOCHEM J, V318, P1; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; GANFORNINA MD, 1995, DEVELOPMENT, V121, P123; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; Gutierrez G, 2000, BBA-PROTEIN STRUCT M, V1482, P35, DOI 10.1016/S0167-4838(00)00151-5; HAUNERLAND NH, 1994, BIOCHEMISTRY-US, V33, P12378, DOI 10.1021/bi00207a004; Hoedemaeker FJ, 2002, ACTA CRYSTALLOGR D, V58, P480, DOI 10.1107/S0907444902000616; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; IGARASHI M, 1992, P NATL ACAD SCI USA, V89, P5376, DOI 10.1073/pnas.89.12.5376; JOHNSON MS, 1990, J MOL EVOL, V30, P43, DOI 10.1007/BF02102452; LALONDE JM, 1994, FASEB J, V8, P1240, DOI 10.1096/fasebj.8.15.8001736; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NAGATA A, 1991, P NATL ACAD SCI USA, V88, P4020, DOI 10.1073/pnas.88.9.4020; Piotte CP, 1998, J MOL EVOL, V46, P361, DOI 10.1007/PL00006313; Schrodinger L., 2010, THE PYMOL MOLECULAR, P1; Smathers Rebecca L., 2011, Human Genomics, V5, P170; THOMPSON JR, 1995, J MOL BIOL, V252, P433, DOI 10.1006/jmbi.1995.0509; Toh H, 1996, PROTEIN ENG, V9, P1067, DOI 10.1093/protein/9.12.1067	31	31	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135507	10.1371/journal.pone.0135507	http://dx.doi.org/10.1371/journal.pone.0135507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263546	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300086
J	Sahillioglu, AC; Ozoren, N				Sahillioglu, Ali Can; Ozoren, Nesrin			Artificial Loading of ASC Specks with Cytosolic Antigens	PLOS ONE			English	Article							INFLAMMASOME ADAPTER ASC; DENDRITIC CELLS; MISFOLDED PROTEINS; ACTIVATION; DEATH; POLYMERIZATION; CASPASE-1; SECRETION; AUTOPHAGY; DEFENSE	Inflammasome complexes form upon interaction of Nod Like Receptor (NLR) proteins with pathogen associated molecular patterns (PAPMS) inside the cytosol. Stimulation of a subset of inflammasome receptors including NLRP3, NLRC4 and AIM2 triggers formation of the micrometer-sized spherical supramolecular complex called the ASC speck. The ASC speck is thought to be the platform of inflammasome activity, but the reason why a supramolecular complex is preferred against oligomeric platforms remains elusive. We observed that a set of cytosolic proteins, including the model antigen ovalbumin, tend to co-aggregate on the ASC speck. We suggest that co-aggregation of antigenic proteins on the ASC speck during intracellular infection might be instrumental in antigen presentation.	[Sahillioglu, Ali Can; Ozoren, Nesrin] Bogazici Univ, Apoptosis & Canc Immunol Lab AKiL, Dept Mol Biol & Genet, Istanbul, Turkey; [Ozoren, Nesrin] Bogazici Univ, Life Sci & Technol Res Ctr, Istanbul, Turkey	Bogazici University; Bogazici University	Ozoren, N (corresponding author), Bogazici Univ, Apoptosis & Canc Immunol Lab AKiL, Dept Mol Biol & Genet, Istanbul, Turkey.	nesrin.ozoren@boun.edu.tr	Ozoren, Nesrin/AAS-3279-2020	OZOREN, NESRIN/0000-0002-8580-618X; Sahillioglu, Ali Can/0000-0002-6297-4009	European Molecular Biology Organization Installation Grant [EMBO-SDIG 1468]; Bogazici University Research Fund [BAP-6526, BAP-TUG 8400]	European Molecular Biology Organization Installation Grant; Bogazici University Research Fund(Bogazici University)	This project was supported by the European Molecular Biology Organization Installation Grant (EMBO-SDIG 1468) and Bogazici University Research Fund (BAP-6526 and BAP-TUG 8400 Grants) Grant to N.O.	Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Cheng J, 2010, J CELL PHYSIOL, V222, P738, DOI 10.1002/jcp.22005; Crotzer VL, 2009, J IMMUNOL, V182, P3335, DOI 10.4049/jimmunol.0803458; De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gram AM, 2012, J GEN VIROL, V93, P2063, DOI 10.1099/vir.0.042978-0; Guo XY, 2012, HUM IMMUNOL, V73, P871, DOI 10.1016/j.humimm.2012.06.008; Herter S, 2005, J IMMUNOL, V175, P891, DOI 10.4049/jimmunol.175.2.891; Higgins Sarah C, 2010, Curr Infect Dis Rep, V12, P4, DOI 10.1007/s11908-009-0080-9; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Koizumi Y, 2012, CELL MICROBIOL, V14, P149, DOI 10.1111/j.1462-5822.2011.01707.x; Kondylis V, 2013, AUTOPHAGY, V9, P861, DOI 10.4161/auto.24111; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Pannerden HEVT, 2010, BIOL CELL, V102, P581, DOI 10.1042/BC20100046; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Sahillioglu AC, 2014, STRUCTURE, V22, P1722, DOI 10.1016/j.str.2014.09.011; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Stephen TL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030032; Yazdi AS, 2010, J CLIN IMMUNOL, V30, P623, DOI 10.1007/s10875-010-9437-y; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134912	10.1371/journal.pone.0134912	http://dx.doi.org/10.1371/journal.pone.0134912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258904	gold, Green Published, Green Submitted			2022-12-27	WOS:000359352600030
J	Tong, Y; Zhang, Y; Huang, JM; Xiao, S; Zhang, YH; Li, J; Chen, JH; Yu, ZN				Tong, Ying; Zhang, Yang; Huang, Jiaomei; Xiao, Shu; Zhang, Yuehuan; Li, Jun; Chen, Jinhui; Yu, Ziniu			Transcriptomics Analysis of Crassostrea hongkongensis for the Discovery of Reproduction-Related Genes	PLOS ONE			English	Article							VASA-LIKE GENE; STEROID 5-ALPHA-REDUCTASE; MOLECULAR-CLONING; SEX DETERMINATION; PACIFIC OYSTER; MICROSATELLITE LOCI; BETA-CATENIN; HONG-KONG; EXPRESSION; GERMLINE	Background The reproductive mechanisms of mollusk species have been interesting targets in biological research because of the diverse reproductive strategies observed in this phylum. These species have also been studied for the development of fishery technologies in molluscan aquaculture. Although the molecular mechanisms underlying the reproductive process have been well studied in animal models, the relevant information from mollusks remains limited, particularly in species of great commercial interest. Crassostrea hongkongensis is the dominant oyster species that is distributed along the coast of the South China Sea and little genomic information on this species is available. Currently, high-throughput sequencing techniques have been widely used for investigating the basis of physiological processes and facilitating the establishment of adequate genetic selection programs. Results The C.hongkongensis transcriptome included a total of 1,595,855 reads, which were generated by 454 sequencing and were assembled into 41,472 contigs using de novo methods. Contigs were clustered into 33,920 isotigs and further grouped into 22,829 isogroups. Approximately 77.6% of the isogroups were successfully annotated by the Nr database. More than 1,910 genes were identified as being related to reproduction. Some key genes involved in germline development, sex determination and differentiation were identified for the first time in C.hongkongensis (nanos, piwi, ATRX, FoxL2, beta-catenin, etc.). Gene expression analysis indicated that vasa, nanos, piwi, ATRX, FoxL2, beta-catenin and SRD5A1 were highly or specifically expressed in C. hongkongensis gonads. Additionally, 94,056 single nucleotide polymorphisms (SNPs) and 1,699 simple sequence repeats (SSRs) were compiled. Conclusions Our study significantly increased C.hongkongensis genomic information based on transcriptomics analysis. The group of reproduction-related genes identified in the present study constitutes a new tool for research on bivalve reproduction processes. The large group of molecular markers discovered in this study will be useful for population screening and marker assisted selection programs in C.hongkongensis aquaculture.	[Tong, Ying; Zhang, Yang; Huang, Jiaomei; Xiao, Shu; Zhang, Yuehuan; Li, Jun; Yu, Ziniu] Chinese Acad Sci, South China Sea Inst Oceanol, Lab Appl Marine Biol, Key Lab Marine Bioresource Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China; [Tong, Ying; Zhang, Yang; Huang, Jiaomei; Xiao, Shu; Zhang, Yuehuan; Li, Jun; Yu, Ziniu] South China Sea Bioresource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China; [Chen, Jinhui] Qingyuan Polytech, Qingyuan, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Lab Appl Marine Biol, Key Lab Marine Bioresource Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China.	yzhang@scsio.ac.cn; carlzyu@scsio.ac.cn		Zhang, Yang/0000-0002-0789-4938	High Tech Research and Development Program of China (863 program) [2012AA10A405-3]; National Natural Science Foundation of China [41306145, 31101927]; Pearl River S&T Nova Program of Guangzhou [2013J2200095]	High Tech Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Pearl River S&T Nova Program of Guangzhou	Support was provided by High Tech Research and Development Program of China (863 program) [http://www.863.gov.cn/] no. 2012AA10A405-3 to YZ; National Natural Science Foundation of China [http://www.nsfc.gov.cn/] no. 41306145 to YT; National Natural Science Foundation of China [http://www.nsfc.gov.cn/] no. 31101927 to JC; Pearl River S&T Nova Program of Guangzhou [http://www.gzsi.gov.cn/] no. 2013J2200095 to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell T, 2004, GENE, V334, P35, DOI 10.1016/j.gene.2004.02.036; Alavi SMH, 2014, REPRODUCTION, V147, P331, DOI 10.1530/REP-13-0418; ANDERSSON S, 1989, J BIOL CHEM, V264, P16249; Andrew MN, 2008, AQUAT TOXICOL, V88, P39, DOI 10.1016/j.aquatox.2008.03.003; [Anonymous], 2012, CHINESE FISHERY YB; Badens C, 2006, CLIN GENET, V70, P57, DOI 10.1111/j.1399-0004.2006.00641.x; Bender AM, 2004, DEV BIOL, V273, P335, DOI 10.1016/j.ydbio.2004.06.009; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bettencourt R, 2010, BMC GENOMICS, P11; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Bigot L, 2012, PEPTIDES, V34, P303, DOI 10.1016/j.peptides.2012.01.017; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chavez-Villalba J, 2011, J SHELLFISH RES, V30, P231, DOI 10.2983/035.030.0206; Chen XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073218; Clark MS, 2010, BMC GENOMICS, P11; Colas P, 1998, SEMIN CELL DEV BIOL, V9, P539, DOI 10.1006/scdb.1998.0248; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox DN, 2000, DEVELOPMENT, V127, P503; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Dhayalan A, 2011, HUM MOL GENET, V20, P2195, DOI 10.1093/hmg/ddr107; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V320, P592, DOI 10.1016/j.bbrc.2004.06.009; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V315, P897, DOI 10.1016/j.bbrc.2004.01.145; Fabioux C, 2009, FEBS J, V276, P2566, DOI 10.1111/j.1742-4658.2009.06982.x; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Frank-Vaillant M, 2001, DEV BIOL, V231, P279, DOI 10.1006/dbio.2000.0142; Georges A, 2014, J MOL ENDOCRINOL, V52, pR17, DOI 10.1530/JME-13-0159; GUO XM, 1994, GENETICS, V138, P1199; Hamano K, 2005, J ENDOCRINOL, V187, P55, DOI 10.1677/joe.1.06284; Hayes TB, 1998, J EXP ZOOL, V281, P373, DOI 10.1002/(SICI)1097-010X(19980801)281:5<373::AID-JEZ4>3.0.CO;2-L; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huyhn K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-39; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Kranz AM, 2010, J EXP ZOOL PART B, V314B, P267, DOI 10.1002/jez.b.21336; Lam K, 2003, AQUACULTURE, V228, P1, DOI 10.1016/S0044-8486(03)00215-1; Li L, 2011, J GENET, V90, pE58; Li L, 2010, CONSERV GENET RESOUR, V2, P93, DOI 10.1007/s12686-010-9205-6; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Lopez-Falcon B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113182; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Matsumoto T, 2007, GEN COMP ENDOCR, V151, P195, DOI 10.1016/j.ygcen.2007.01.016; Matsumoto T, 2013, ZOOL SCI, V30, P826, DOI 10.2108/zsj.30.826; Mellon SH, 2002, TRENDS ENDOCRIN MET, V13, P35, DOI 10.1016/S1043-2760(01)00503-3; Meng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064485; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Naimi A, 2009, COMP BIOCHEM PHYS A, V152, P189, DOI 10.1016/j.cbpa.2008.09.019; Naimi A, 2009, COMP BIOCHEM PHYS B, V154, P134, DOI 10.1016/j.cbpb.2009.05.011; NORMINGTON K, 1992, J BIOL CHEM, V267, P19548; PASMANIK M, 1988, ENDOCRINOLOGY, V122, P1349, DOI 10.1210/endo-122-4-1349; Patte-Mensah C, 2005, P NATL ACAD SCI USA, V102, P9044, DOI 10.1073/pnas.0502968102; Philipp E.E.R., 2012, PLOS ONE, V7; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043653; Rabinowitz JS, 2008, CURR BIOL, V18, P331, DOI 10.1016/j.cub.2008.01.055; Ribas L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-180; Rodet F, 2005, BBA-GENE STRUCT EXPR, V1730, P187, DOI 10.1016/j.bbaexp.2005.05.012; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Santerre C, 2014, COMP BIOCHEM PHYS A, V167, P68, DOI 10.1016/j.cbpa.2013.09.018; Segovia S, 1996, NEUROREPORT, V7, P2553, DOI 10.1097/00001756-199611040-00030; Soma KK, 1999, J NEUROBIOL, V41, P176, DOI 10.1002/(SICI)1097-4695(19991105)41:2<176::AID-NEU2>3.3.CO;2-U; Stephano JL, 2000, DEV BIOL, V222, P420, DOI 10.1006/dbio.2000.9726; Stewart MJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-840; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka SS, 2014, CELL MOL LIFE SCI, V71, P4781, DOI 10.1007/s00018-014-1703-3; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; Thiele S, 2005, EUR J ENDOCRINOL, V152, P875, DOI 10.1530/eje.1.01927; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Tu Q, 2006, DEV BIOL, V300, P49, DOI 10.1016/j.ydbio.2006.09.031; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Urbatzka R, 2007, GEN COMP ENDOCR, V153, P280, DOI 10.1016/j.ygcen.2007.01.041; Villard L, 1999, GENE, V236, P13, DOI 10.1016/S0378-1119(99)00279-6; Wang Q, 2014, GEN COMP ENDOCR, V204, P71, DOI 10.1016/j.ygcen.2014.05.010; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063927; Xia JJ, 2009, CONSERV GENET, V10, P1829, DOI 10.1007/s10592-009-9826-z; Zha GC, 2013, CHEM-BIOL INTERACT, V203, P277, DOI 10.1016/j.cbi.2012.09.005; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhang N, 2014, G3 BETHESDA     0911; Zhang Y, 2011, FISH SHELLFISH IMMUN, V31, P894, DOI 10.1016/j.fsi.2011.08.005; Zhang ZH, 2012, GENE, V497, P172, DOI 10.1016/j.gene.2012.01.058	81	42	43	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134280	10.1371/journal.pone.0134280	http://dx.doi.org/10.1371/journal.pone.0134280			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258576	Green Submitted, Green Published, gold			2022-12-27	WOS:000359352600012
J	Chen, KL; Chen, JH; Liao, SH; Chieh, JJ; Horng, HE; Wang, LM; Yang, HC				Chen, Kuen-Lin; Chen, Jean-Hong; Liao, Su-Hsien; Chieh, Jen-Je; Horng, Herng-Er; Wang, Li-Min; Yang, Hong-Chang			Magnetic Clustering Effect during the Association of Biofunctionalized Magnetic Nanoparticles with Biomarkers	PLOS ONE			English	Article							C-REACTIVE PROTEIN; QUANTUM INTERFERENCE DEVICE; IMMUNOASSAY; SENSITIVITY; REDUCTION; BIOSENSOR	We report herein an investigation into dynamic magnetic clustering that occurs during immunoassays as biofunctionalized magnetic nanoparticles (BMNs) become associated with biotargets. We measure the dynamic effective relaxation time tau(eff)(t) and use scanning electron microscopy (SEM) and transmission electron microscopy (TEM) to investigate the C-reactive protein (CRP) as it associates with the BMN Fe3O4-antiCRP to form the magnetic cluster Fe3O4-antiCRP-CRP. The results indicate that tau(eff)(t) increases with increasing association time. In addition, the ration Delta tau(eff)/tau(0) as a function of CRP concentration follows a characteristic logistic function, which provides a basis for estimating the quantity of biomolecules with a detection sensitivity close to 0.1 ppm. After the association, SEM and TEM images show that CRP and Fe3O4-antiCRP conjugate to form Fe3O4-antiCRP-CRP clusters hundreds of nanometers in size. The SEM and TEM images provide direct evidence of the formation of magnetic clustering.	[Chen, Kuen-Lin] Natl Chung Hsing Univ, Dept Phys, Taichung 40227, Taiwan; [Chen, Jean-Hong] Kun Shan Univ, Dept Mat Engn, Tainan, Taiwan; [Liao, Su-Hsien; Chieh, Jen-Je; Horng, Herng-Er] Natl Taiwan Normal Univ, Inst Electroopt Sci & Technol, Taipei, Taiwan; [Wang, Li-Min] Natl Taiwan Univ, Grad Inst Appl Phys, Taipei 10764, Taiwan; [Wang, Li-Min] Natl Taiwan Univ, Dept Phys, Taipei, Taiwan; [Yang, Hong-Chang] Kun Shan Univ, Dept Electroopt Engn, Tainan, Taiwan	National Chung Hsing University; Kun Shan University; National Taiwan Normal University; National Taiwan University; National Taiwan University; Kun Shan University	Chen, KL (corresponding author), Natl Chung Hsing Univ, Dept Phys, Taichung 40227, Taiwan.	klchen@phys.nchu.edu.tw		Chieh, Jen-Jie/0000-0002-7144-2637; Liao, Shu-Hsien/0000-0002-5794-7583; WANG, LI-MIN/0000-0002-8208-7079	Ministry of Science and Technology of Taiwan [MOST103-2112-M-005-005-MY3, NSC101-2120-M-168-001, NSC99-2112-M-168-001-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology of Taiwan under grants: MOST103-2112-M-005-005-MY3, NSC101-2120-M-168-001 and NSC99-2112-M-168-001-MY3. http://www.most.gov.tw/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CH, 2012, INT J NANOMED, V7, P4335, DOI 10.2147/IJN.S31030; Chieh JJ, 2008, J APPL PHYS, V103, DOI 10.1063/1.2827359; Clyne B, 1999, J EMERG MED, V17, P1019, DOI 10.1016/S0736-4679(99)00135-3; Enpuku K, 1999, JPN J APPL PHYS 2, V38, pL1102, DOI 10.1143/JJAP.38.L1102; Frantzen F, 1998, CLIN CHEM, V44, P311; Hong CY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206557; Hong CY, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2536127; Horng HE, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2207990; Jiang WQ, 2004, J MAGN MAGN MATER, V283, P210, DOI 10.1016/j.jmmm.2004.05.022; Kotitz R, 1999, J MAGN MAGN MATER, V194, P62, DOI 10.1016/S0304-8853(98)00580-0; Lee H, 2008, NAT MED, V14, P869, DOI 10.1038/nm.1711; Lee S, 2002, APPL PHYS LETT, V81, P3094, DOI 10.1063/1.1515122; Liao SH, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4846536; OSMAND AP, 1977, P NATL ACAD SCI USA, V74, P739, DOI 10.1073/pnas.74.2.739; Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0; Tamanaha CR, 2008, BIOSENS BIOELECTRON, V24, P1, DOI 10.1016/j.bios.2008.02.009; Tu L, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3595273; VANOSS CJ, 1986, J CHROMATOGR, V376, P111, DOI 10.1016/S0378-4347(00)80828-2; Yang CC, 2012, J APPL PHYS, V112, DOI 10.1063/1.4739735; Yang CC, 2012, IEEE MAGN LETT, V3, DOI 10.1109/LMAG.2012.2183858; Yang SY, 2013, IEEE T NANOBIOSCI, V12, P65, DOI 10.1109/TNB.2013.2240009; Yang SY, 2013, J APPL PHYS, V113, DOI 10.1063/1.4800536	22	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135290	10.1371/journal.pone.0135290	http://dx.doi.org/10.1371/journal.pone.0135290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270967	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800049
J	Maugars, G; Dufour, S				Maugars, Gersende; Dufour, Sylvie			Demonstration of the Coexistence of Duplicated LH Receptors in Teleosts, and Their Origin in Ancestral Actinopterygians	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; CATFISH GONADOTROPIN RECEPTORS; JAPANESE EEL; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; CDNA CLONING; MOLECULAR CHARACTERIZATION; CHROMOSOMAL LOCALIZATION; GLYCOPROTEIN HORMONES; THYROTROPIN RECEPTORS	Pituitary gonadotropins, FSH and LH, control gonad activity in vertebrates, via binding to their respective receptors, FSHR and LHR, members of GPCR superfamily. Until recently, it was accepted that gnathostomes possess a single FSHR and a single LHR, encoded by fshr and lhcgr genes. We reinvestigated this question, focusing on vertebrate species of key-phylogenetical positions. Genome analyses supported the presence of a single fshr and a single lhcgr in chondrichthyans, and in sarcopterygians including mammals, birds, amphibians and coelacanth. In contrast, we identified a single fshr but two lhgcr in basal teleosts, the eels. We further showed the coexistence of duplicated lhgcr in other actinopterygians, including a non-teleost, the gar, and other teleosts, e.g. Mexican tetra, platyfish, or tilapia. Phylogeny and synteny analyses supported the existence in actinopterygians of two lhgcr paralogs (lhgcr1/lhgcr2), which do not result from the teleost-specific whole-genome duplication (3R), but likely from a local gene duplication that occurred early in the actinopterygian lineage. Due to gene losses, there was no impact of 3R on the number of gonadotropin receptors in extant teleosts. Additional gene losses during teleost radiation, led to a single lhgcr (lhgcr1 or lhgcr2) in some species, e.g. medaka and zebrafish. Sequence comparison highlighted divergences in the extracellular and intracellular domains of the duplicated lhgcr, suggesting differential properties such as ligand binding and activation mechanisms. Comparison of tissue distribution in the European eel, revealed that fshr and both lhgcr transcripts are expressed in the ovary and testis, but are differentially expressed in non-gonadal tissues such as brain or eye. Differences in structure-activity relationships and tissue expression may have contributed as selective drives in the conservation of the duplicated lhgcr. This study revises the evolutionary scenario and nomenclature of gonadotropin receptors, and opens new research avenues on the roles of duplicated LHR in actinopterygians.	[Maugars, Gersende; Dufour, Sylvie] Univ Paris 04, Museum Natl Hist Nat, CNRS 7208,UPMC,UCBN, Res Unit BOREA,Biol Aquat Organisms & Ecosyst,IRD, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Maugars, G (corresponding author), Univ Paris 04, Museum Natl Hist Nat, CNRS 7208,UPMC,UCBN, Res Unit BOREA,Biol Aquat Organisms & Ecosyst,IRD, Paris, France.	maugars@mnhn.fr		Maugars, Gersende/0000-0002-2090-6585	MNHN; CNRS-INEE; European Community [ProEEL EU-FP7-KBBE-2009-3, 245257]	MNHN; CNRS-INEE; European Community(European Commission)	The work was supported by the MNHN, CNRS-INEE and a grant from the European Community (ProEEL EU-FP7-KBBE-2009-3 No. 245257) to SD. MG is a recipient of post-doctoral fellowships from the MNHN and CNRS-INEE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen J, 2012, MOL CELL ENDOCRINOL, V364, P89, DOI 10.1016/j.mce.2012.08.013; AlHader AA, 1997, BIOL REPROD, V56, P1071, DOI 10.1095/biolreprod56.5.1071; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson E, 2009, GEN COMP ENDOCR, V163, P329, DOI 10.1016/j.ygcen.2009.05.001; Angelova K, 2011, CELL MOL LIFE SCI, V68, P1227, DOI 10.1007/s00018-010-0519-z; Angelova K, 2010, J BIOL CHEM, V285, P34813, DOI 10.1074/jbc.M110.148221; Aroua S, 2012, GEN COMP ENDOCR, V175, P82, DOI 10.1016/j.ygcen.2011.10.002; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Bhaskaran RS, 2003, BIOCHEMISTRY-US, V42, P13950, DOI 10.1021/bi034907w; Bogerd J, 2001, BIOL REPROD, V64, P1633, DOI 10.1095/biolreprod64.6.1633; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; Chang WC, 2009, J COMPUT CHEM, V30, P2526, DOI 10.1002/jcc.21258; Chauvigne F, 2014, P NATL ACAD SCI USA, V111, P1427, DOI 10.1073/pnas.1317838111; Chauvigne F, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100784; Chauvigne F, 2010, BIOL REPROD, V82, P1088, DOI 10.1095/biolreprod.109.082289; Chen JN, 2014, MOL PHYLOGENET EVOL, V70, P152, DOI 10.1016/j.ympev.2013.09.002; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Cui HX, 2012, J LIPID RES, V53, P909, DOI 10.1194/jlr.M025403; DAVIS D, 1995, MOL ENDOCRINOL, V9, P159, DOI 10.1210/me.9.2.159; Davis DP, 1997, MOL ENDOCRINOL, V11, P550, DOI 10.1210/me.11.5.550; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dukic-Stefanovic S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052567; Fan QR, 2007, MOL CELL ENDOCRINOL, V260, P73, DOI 10.1016/j.mce.2005.12.055; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Garcia-Lopez A, 2009, ENDOCRINOLOGY, V150, P357, DOI 10.1210/en.2008-0447; Garcia-Lopez A, 2010, ENDOCRINOLOGY, V151, P2349, DOI 10.1210/en.2009-1227; George JW, 2011, BIOL REPROD, V84, P7, DOI 10.1095/biolreprod.110.085043; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Henkel CV, 2012, GENE, V511, P195, DOI 10.1016/j.gene.2012.09.064; Henkel CV, 2012, ZEBRAFISH, V9, P59, DOI 10.1089/zeb.2012.0773; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hu L, 2006, J BIOL CHEM, V281, P25231, DOI 10.1074/jbc.M603768200; Jeng SR, 2007, GEN COMP ENDOCR, V154, P161, DOI 10.1016/j.ygcen.2007.05.026; Jiang XL, 2014, MOL CELL ENDOCRINOL, V382, P424, DOI 10.1016/j.mce.2013.08.021; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Johnson AL, 1996, BIOL REPROD, V55, P304, DOI 10.1095/biolreprod55.2.304; Kazeto Y, 2008, BIOL REPROD, V79, P938, DOI 10.1095/biolreprod.108.070052; Kazeto Y, 2012, ZOOL SCI, V29, P204, DOI 10.2108/zsj.29.204; Kobayashi T, 2008, GEN COMP ENDOCR, V156, P595, DOI 10.1016/j.ygcen.2008.02.010; Kobayashi Y, 2009, ENDOCRINOLOGY, V150, P1503, DOI 10.1210/en.2008-0569; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kumar RS, 2001, BIOL REPROD, V64, P1010, DOI 10.1095/biolreprod64.3.1010; Kumar RS, 2001, COMP BIOCHEM PHYS B, V129, P347, DOI 10.1016/S1096-4959(01)00317-7; Kumar RS, 2001, BIOL REPROD, V65, P710, DOI 10.1095/biolreprod65.3.710; Kumari B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089246; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; LEI ZM, 1993, ENDOCRINOLOGY, V132, P2262, DOI 10.1210/en.132.5.2262; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; LOOSFELT H, 1989, SCIENCE, V245, P525, DOI 10.1126/science.2502844; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Maugars G, 2006, GEN COMP ENDOCR, V149, P108, DOI 10.1016/j.ygcen.2006.04.011; Maugars G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111361; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; Menon KMJ, 2005, ENDOCRINE, V26, P249, DOI 10.1385/ENDO:26:3:249; MINEGISH T, 1990, BIOCHEM BIOPH RES CO, V172, P1049, DOI 10.1016/0006-291X(90)91552-4; MINEGISH T, 1991, BIOCHEM BIOPH RES CO, V175, P1125, DOI 10.1016/0006-291X(91)91682-3; Minegishi Y, 2012, GEN COMP ENDOCR, V178, P145, DOI 10.1016/j.ygcen.2012.04.030; Moles G, 2011, BIOL REPROD, V84, P1171, DOI 10.1095/biolreprod.110.086470; MONTGOMERY GW, 1995, J MOL ENDOCRINOL, V15, P259, DOI 10.1677/jme.0.0150259; Moyle WR, 2004, J BIOL CHEM, V279, P44442, DOI 10.1074/jbc.M406948200; Mu WJ, 2013, FISH PHYSIOL BIOCHEM, V39, P287, DOI 10.1007/s10695-012-9699-9; Munshi UM, 2005, MOL ENDOCRINOL, V19, P749, DOI 10.1210/me.2004-0335; Nyuji M, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107292; Oba Y, 1999, BIOCHEM BIOPH RES CO, V263, P584, DOI 10.1006/bbrc.1999.1346; Oba Y, 1999, BIOCHEM BIOPH RES CO, V265, P366, DOI 10.1006/bbrc.1999.1700; Oba Y, 2001, COMP BIOCHEM PHYS B, V129, P441, DOI 10.1016/S1096-4959(01)00374-8; Ogiwara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054482; Ohkubo M, 2013, GEN COMP ENDOCR, V184, P75, DOI 10.1016/j.ygcen.2012.12.019; Ohta T, 2007, BIOL REPROD, V77, P970, DOI 10.1095/biolreprod.107.062299; Pasquier J, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-30; Pasquier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048931; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Querat B, 2001, GEN COMP ENDOCR, V124, P308, DOI 10.1006/gcen.2001.7715; REMY JJ, 1995, GENE, V163, P257, DOI 10.1016/0378-1119(95)00385-J; Rocha A, 2007, MOL CELL ENDOCRINOL, V272, P63, DOI 10.1016/j.mce.2007.04.007; ROUSSEAUMERCK MF, 1993, GENOMICS, V15, P222, DOI 10.1006/geno.1993.1041; Saha A, 2011, INDIAN J SCI TECHNOL, V4, P8; SALMON C, 1988, REPROD NUTR DEV, V28, P1165, DOI 10.1051/rnd:19880712; Sambroni E, 2007, J ENDOCRINOL, V195, P213, DOI 10.1677/JOE-06-0122; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Smits G, 2003, EMBO J, V22, P2692, DOI 10.1093/emboj/cdg260; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; Suda M, 2011, GEN COMP ENDOCR, V172, P475, DOI 10.1016/j.ygcen.2011.04.011; Troppmann B, 2013, HUM REPROD UPDATE, V19, P583, DOI 10.1093/humupd/dmt023; Ulloa-Aguirre A, 2007, ENDOCRINE, V32, P251, DOI 10.1007/s12020-008-9041-6; Ulloa-Aguirre A, 2011, REV ENDOCR METAB DIS, V12, P259, DOI 10.1007/s11154-011-9176-2; Urbatzka R, 2010, GEN COMP ENDOCR, V168, P239, DOI 10.1016/j.ygcen.2010.02.012; Uribe A, 2008, BIOL REPROD, V78, P869, DOI 10.1095/biolreprod.107.063925; Vischer HF, 2004, MOL CELL ENDOCRINOL, V224, P55, DOI 10.1016/j.mce.2004.06.011; Vischer HF, 2003, BIOL REPROD, V68, P262, DOI 10.1095/biolreprod.102.004515; Wakabayashi N, 1997, GENE, V197, P121, DOI 10.1016/S0378-1119(97)00250-3; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Yang EJ, 2007, P NATL ACAD SCI USA, V104, P2477, DOI 10.1073/pnas.0608391104; You S, 2000, BIOL REPROD, V62, P108, DOI 10.1095/biolreprod62.1.108	101	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135184	10.1371/journal.pone.0135184	http://dx.doi.org/10.1371/journal.pone.0135184			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271038	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800040
J	Agodi, A; Barchitta, M; Quattrocchi, A; Maugeri, A; Vinciguerra, M				Agodi, Antonella; Barchitta, Martina; Quattrocchi, Annalisa; Maugeri, Andrea; Vinciguerra, Manlio			DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis	PLOS ONE			English	Article							ABERRANT DNA METHYLATION; TUMOR-SUPPRESSOR GENES; HUMAN-PAPILLOMAVIRUS; PROTEIN-KINASE; MULTIPLE GENES; HYPERMETHYLATED GENES; CPG ISLANDS; STEM-CELLS; CARCINOMA; ASSOCIATION	Objective The Death-Associated Protein Kinase 1 (DAPK1) gene has been frequently investigated in cervical cancer (CC). The aim of the present study was to carry out a systematic review and a meta-analysis in order to evaluate DAPK1 promoter methylation as an epigenetic marker for CC risk. Methods A systematic literature search was carried out. The Cochrane software package Review Manager 5.2 was used. The fixed-effects or random-effects models, according to heterogeneity across studies, were used to calculate odds ratios (ORs) and 95% Confidence Intervals (CIs). Furthermore, subgroup analyses were conducted by histological type, assays used to evaluate DAPK1 promoter methylation, and control sample source. Results A total of 20 papers, published between 2001 and 2014, on 1929 samples, were included in the meta-analysis. DAPK1 promoter methylation was associated with an increased CC risk based on the random effects model (OR: 21.20; 95% CI = 11.14-40.35). Omitting the most heterogeneous study, the between study heterogeneity decreased and the association increased (OR: 24.13; 95% CI = 15.83-36.78). The association was also confirmed in all the subgroups analyses. Conclusions A significant strong association between DAPK1 promoter methylation and CC was shown and confirmed independently by histological tumor type, method used to evaluate methylation and source of control samples. Methylation markers may have value in early detection of CC precursor lesions, provide added reassurances of safety for women who are candidates for less frequent screens, and predict outcomes of women infected with human papilloma virus.	[Agodi, Antonella; Barchitta, Martina; Quattrocchi, Annalisa; Maugeri, Andrea] Univ Catania, Dept Med & Surg Sci & Adv Technol GF Ingrassia, Catania, Italy; [Agodi, Antonella; Barchitta, Martina] Univ Catania, Lab Policies & Social Serv, LaPoSS, Catania, Italy; [Vinciguerra, Manlio] UCL, Inst Liver & Digest Hlth, London, England	University of Catania; University of Catania; University of London; University College London	Agodi, A (corresponding author), Univ Catania, Dept Med & Surg Sci & Adv Technol GF Ingrassia, Catania, Italy.	agodia@unict.it	Agodi, Antonella/B-3501-2011; Vinciguerra, Manlio/N-1309-2015; Agodi, Antonella/AIF-3938-2022; Quattrocchi, Annalisa/S-8119-2019; Quattrocchi, Annalisa/AAU-5458-2020; Maugeri, Andrea/K-1018-2017; Barchitta, Martina/AFV-8723-2022; Barchitta, Martina/A-1362-2015	Agodi, Antonella/0000-0002-4405-8162; Vinciguerra, Manlio/0000-0002-1768-3894; Agodi, Antonella/0000-0002-4405-8162; Quattrocchi, Annalisa/0000-0002-5764-6721; Maugeri, Andrea/0000-0003-2655-8574; Barchitta, Martina/0000-0002-0905-5003				Banzai C, 2014, INT J CLIN ONCOL, V19, P127, DOI 10.1007/s10147-013-0530-0; Barchitta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109478; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Chan MWY, 2002, CLIN CANCER RES, V8, P464; Collins Y, 2006, INT J GYNECOL CANCER, V16, P195, DOI 10.1111/j.1525-1438.2006.00506.x; Cottrell SE, 2003, ANN NY ACAD SCI, V983, P120, DOI 10.1111/j.1749-6632.2003.tb05967.x; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dong SM, 2001, CLIN CANCER RES, V7, P1982; Duffy MJ, 2009, EUR J CANCER, V45, P335, DOI 10.1016/j.ejca.2008.12.008; Esteller M, 1999, CANCER RES, V59, P67; Fackler MJ, 2006, CLIN CANCER RES, V12, P3306, DOI 10.1158/1078-0432.CCR-05-2733; Feng QH, 2005, JNCI-J NATL CANCER I, V97, P273, DOI 10.1093/jnci/dji041; Feng QH, 2007, CANCER EPIDEM BIOMAR, V16, P1178, DOI 10.1158/1055-9965.EPI-06-0694; Flatley JE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-803; Flatley JE, 2009, CANCER EPIDEM BIOMAR, V18, P2782, DOI 10.1158/1055-9965.EPI-09-0493; Gustafson KS, 2004, CANCER CYTOPATHOL, V102, P259, DOI 10.1002/cncr.20425; Henken FE, 2007, BRIT J CANCER, V97, P1457, DOI 10.1038/sj.bjc.6604055; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JP, 2010, STAT METHODS GROUP C, P1, DOI DOI 10.1371/JOURNAL.PONE.0069930; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang LW, 2011, INT J GYNECOL CANCER, V21, P452, DOI 10.1097/IGC.0b013e31821091ea; Ikegami K, 2009, INT J DEV BIOL, V53, P203, DOI 10.1387/ijdb.082741ki; Iliopoulos D, 2009, ONCOL REP, V22, P199, DOI 10.3892/or_00000425; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Jeong DH, 2006, INT J GYNECOL CANCER, V16, P1234, DOI 10.1111/j.1525-1438.2006.00522.x; Jeronimo C, 2001, J NATL CANCER I, V93, P1747, DOI 10.1093/jnci/93.22.1747; Kahn SL, 2008, CANCER CYTOPATHOL, V114, P57, DOI 10.1002/cncr.23258; Kalantari M, 2014, VIROLOGY, V448, P314, DOI 10.1016/j.virol.2013.10.032; Kang S, 2006, INT J CANCER, V118, P2168, DOI 10.1002/ijc.21609; Kang S, 2005, GYNECOL ONCOL, V96, P173, DOI 10.1016/j.ygyno.2004.09.031; Katzenellenbogen RA, 1993, BLOOD, V93, P4347; Ki Kyung-Do, 2008, J Gynecol Oncol, V19, P117, DOI 10.3802/jgo.2008.19.2.117; Kim DH, 2001, CANCER RES, V61, P3419; Kim DH, 2001, ONCOGENE, V20, P1765, DOI 10.1038/sj.onc.1204302; Kim JH, 2010, GYNECOL ONCOL, V116, P99, DOI 10.1016/j.ygyno.2009.09.032; Kissil JL, 1998, MOL MED TODAY, V4, P268, DOI 10.1016/S1357-4310(98)01263-5; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Leung RCY, 2008, ONCOL REP, V19, P1339; Li LC, 2004, BBA-REV CANCER, V1704, P87, DOI 10.1016/j.bbcan.2004.06.001; Lin ZH, 2005, J CANCER RES CLIN, V131, P364, DOI 10.1007/s00432-004-0657-5; Missaoui N, 2011, PATHOL RES PRACT, V207, P37, DOI 10.1016/j.prp.2010.11.001; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Narayan Gopeshwar, 2003, Mol Cancer, V2, P24, DOI 10.1186/1476-4598-2-24; Nephew KP, 2003, CANCER LETT, V190, P125, DOI 10.1016/S0304-3835(02)00511-6; Niyazi Mayinuer, 2012, Zhonghua Zhong Liu Za Zhi, V34, P31; Rauch T, 2005, LAB INVEST, V85, P1172, DOI 10.1038/labinvest.3700311; Raveh T, 2000, P NATL ACAD SCI USA, V97, P1572, DOI 10.1073/pnas.020519497; Raveh T, 2001, EXP CELL RES, V264, P185, DOI 10.1006/excr.2000.5134; Reesink-Peters N, 2004, MOL CANCER RES, V2, P289; ROBERTSON JH, 1993, J CLIN PATHOL, V46, P700, DOI 10.1136/jcp.46.8.700; Rositch AF, 2013, INT J CANCER, V133, P1271, DOI 10.1002/ijc.27828; Sanchez-Cespedes M, 2000, CANCER RES, V60, P892; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P930; Shivapurkar N, 2007, GYNECOL ONCOL, V107, P549, DOI 10.1016/j.ygyno.2007.08.057; Soria JC, 2002, CANCER RES, V62, P351; Sun LL, 2012, ARCH GYNECOL OBSTET, V285, P1433, DOI 10.1007/s00404-011-2149-6; Tang XM, 2000, JNCI-J NATL CANCER I, V92, P1511, DOI 10.1093/jnci/92.18.1511; Tost J, 2010, MOL BIOTECHNOL, V44, P71, DOI 10.1007/s12033-009-9216-2; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012; Widschwendter A, 2004, CLIN CANCER RES, V10, P3396, DOI 10.1158/1078-0432.CCR-03-0143; Wisman GBA, 2006, INT J CANCER, V119, P1908, DOI 10.1002/ijc.22060; Wong TS, 2002, CLIN CANCER RES, V8, P433; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Xiong JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107272; Yang HJ, 2004, GYNECOL ONCOL, V93, P435, DOI 10.1016/j.ygyno.2004.01.039; Yang HJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-212; Yang N, 2010, CELL ONCOL, V32, P131, DOI 10.3233/CLO-2009-0510; Zhao XL, 2008, CHIN J CANCER, V27, P212	69	27	31	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135078	10.1371/journal.pone.0135078	http://dx.doi.org/10.1371/journal.pone.0135078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267895	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300076
J	Barros, T; Carvalho, J; Pereira, MJR; Ferreira, JP; Fonseca, C				Barros, Tania; Carvalho, Joao; Ramos Pereira, Maria Joao; Ferreira, Joaquim P.; Fonseca, Carlos			Following The Trail: Factors Underlying the Sudden Expansion of the Egyptian Mongoose (Herpestes ichneumon) in Portugal	PLOS ONE			English	Article							GEOGRAPHIC RANGE LIMITS; GENET GENETTA-GENETTA; CLIMATE-CHANGE; ROE DEER; ELEVATIONAL GRADIENTS; FOREST FRAGMENTATION; SPECIES DISTRIBUTION; DISTRIBUTION MODELS; CAPRA-PYRENAICA; HUMAN DENSITIES	Species range-limits are influenced by a combination of several factors. In our study we aimed to unveil the drivers underlying the expansion of the Egyptian mongoose in Portugal, a carnivore that was confined to southern Portugal and largely increased its range during the last three decades. We evaluated the expansion of the species in three periods (1980-1990, 1990-2000 and 2000-2010), by projecting the presence/absence data of the species in each temporal range and proposed four hypotheses to explain this sudden expansion associated to changes in the barrier effects of human infrastructure and topographic features, and in the availability of suitable areas due to climate change or land use. An exploratory analysis was made using Spearman rank correlation, followed by a hierarchical partitioning analysis to select uncorrelated potential explanatory variables associated with the different hypotheses. We then ran Generalized Linear Models (GLM) for every period for each hypothesis and for every combination of hypotheses. Our main findings suggest that dynamic transitions of land-use coupled with temperature and rainfall variations over the decades are the main drivers promoting the mongoose expansion. The geographic barriers and the human infrastructures functioned as barriers for mongoose expansion and have shaped its distribution. The expansion of the Egyptian mongoose across the Portuguese territory was due to a variety of factors. Our results suggest a rapid shift in species range in response to land-use and climate changes, underlining the close link between species ranges and a changing environment.	[Barros, Tania; Carvalho, Joao; Ramos Pereira, Maria Joao; Ferreira, Joaquim P.; Fonseca, Carlos] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Barros, Tania; Carvalho, Joao; Ramos Pereira, Maria Joao; Ferreira, Joaquim P.; Fonseca, Carlos] Univ Aveiro, CESAM Ctr Estudos Ambiente & Mar, P-3810193 Aveiro, Portugal; [Carvalho, Joao] Univ Autonoma Barcelona, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, E-08193 Barcelona, Spain; [Ramos Pereira, Maria Joao] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Zool, PPGBAN, BR-91540000 Porto Alegre, RS, Brazil	Universidade de Aveiro; Universidade de Aveiro; Autonomous University of Barcelona; Universidade Federal do Rio Grande do Sul	Barros, T (corresponding author), Univ Aveiro, Dept Biol, Campus Univ Santiago, P-3810193 Aveiro, Portugal.	taniabarros@ua.pt	Pereira, Maria João Ramos/AAH-9411-2021; Ramos Pereira, Maria João/P-6221-2014; Carvalho, João L. O./V-4043-2018; Fonseca, Carlos MMS/D-9744-2011; Barros, Tânia/E-1408-2019	Pereira, Maria João Ramos/0000-0002-9365-5166; Ramos Pereira, Maria João/0000-0002-9365-5166; Carvalho, João L. O./0000-0002-9792-9259; Fonseca, Carlos MMS/0000-0001-6559-7133; Barros, Tânia/0000-0001-7541-2278; Ferreira, Joaquim/0000-0002-0469-1529	Confederacao Nacional dos Cacadores Portugueses (CNCP); Instituto da Conservacao da Natureza e das Florestas (ICNF);  [SFRH/BD/71112/2010];  [SFRH/BD/98387/2013];  [SFRH/BPD/72845/2010];  [SFRH/BPD/72193/2010]	Confederacao Nacional dos Cacadores Portugueses (CNCP); Instituto da Conservacao da Natureza e das Florestas (ICNF); ; ; ; 	TB, JC, MJRP and JPF were supported by doctoral and post-doctoral grants (SFRH/BD/71112/2010, SFRH/BD/98387/2013, SFRH/BPD/72845/2010, SFRH/BPD/72193/2010). Our gratitude also to Confederacao Nacional dos Cacadores Portugueses (CNCP) and Instituto da Conservacao da Natureza e das Florestas (ICNF) for co-funding the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2005, J BIOGEOGR, V32, P1671, DOI 10.1111/j.1365-2699.2005.01310.x; Acevedo P, 2007, DIVERS DISTRIB, V13, P587, DOI 10.1111/j.1472-4642.2007.00374.x; Acevedo P, 2011, LANDSCAPE ECOL, V26, P19, DOI 10.1007/s10980-010-9538-2; Aguas A, 2014, FOREST ECOL MANAG, V323, P47, DOI 10.1016/j.foreco.2014.03.012; ALES RF, 1992, LANDSCAPE ECOL, V7, P3, DOI 10.1007/BF02573953; [Anonymous], 2006, PARASITISM ECOSYSTEM; [Anonymous], 2003, PORTUGAL CARACTERIZA; Barbosa Ana Marcia, 2001, Diversity and Distributions, V7, P137, DOI 10.1046/j.1472-4642.2001.00104.x; Barja Isabel, 2005, Galemys, V17, P29; Barros Tania, 2011, Galemys, V23, P9; Barros TSL, 2009, THESIS; Barry RG, 1992, MOUNTAIN WEATHER AND; Basille M, 2009, ECOGRAPHY, V32, P683, DOI 10.1111/j.1600-0587.2009.05712.x; Blackburn T, 2008, PATTERN AND PROCESS; Blanco JC, 1998, EDITORIAL PLANETA; Borkowski J, 2008, FOREST ECOL MANAG, V255, P468, DOI 10.1016/j.foreco.2007.09.013; Borralho R, 1996, MAMMAL REV, V26, P1, DOI 10.1111/j.1365-2907.1996.tb00143.x; Brook BW, 2008, WILDLIFE RES, V35, P249, DOI 10.1071/WR07116; Burt CC, 2004, EXTREME WEATHER A GU; Cain AT, 2003, BIOL CONSERV, V114, P189, DOI 10.1016/S0006-3207(03)00023-5; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Caro TM, 2000, AM MIDL NAT, V144, P362, DOI 10.1674/0003-0031(2000)144[0362:FOMSMR]2.0.CO;2; Cavaco C, 1996, DINAMISMOS ECONOMICO; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Colwell RK, 2010, PHILOS T R SOC B, V365, P3695, DOI 10.1098/rstb.2010.0293; Costa J. C., 1998, QUERCETEA, V0, P5; De Juana E, 2004, ARDEOLA, V51, P19; Debussche M, 1999, GLOBAL ECOL BIOGEOGR, V8, P3, DOI 10.1046/j.1365-2699.1999.00316.x; Delibes M., 1982, Donana Acta Vertebrata, V9, P341; DELIBES M, 1984, ACTA THERIOL, V29, P205, DOI 10.4098/AT.arch.84-21; Delibes M, 1998, BIOLOGICA, V17, P52; Detry C, 2011, J ARCHAEOL SCI, V38, P3518, DOI 10.1016/j.jas.2011.08.014; Diaz Mario, 1997, P178; Diogo V, 2010, GUIMARAES THE 13TH A; Dobson M, 1998, MAMMAL REV, V28, P77, DOI 10.1046/j.1365-2907.1998.00027.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Falcucci A, 2007, LANDSCAPE ECOL, V22, P617, DOI 10.1007/s10980-006-9056-4; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Francois C, 2008, LANDSCAPE ECOL, V23, P527, DOI 10.1007/s10980-008-9211-1; Fulgione D, 2009, EUR J WILDLIFE RES, V55, P385, DOI 10.1007/s10344-009-0256-5; Garcia-Diaz P, 2013, EUR J WILDLIFE RES, V59, P823, DOI 10.1007/s10344-013-0736-5; Garia-Perea R, 1996, CARNIVOROS EVOLUCION; Gaston KJ, 2009, P ROY SOC B-BIOL SCI, V276, P1391, DOI [10.1098/rspb.2009.0100, 10.1098/rspb.2008.1480]; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Gaubert P, 2011, J BIOGEOGR, V38, P341, DOI 10.1111/j.1365-2699.2010.02406.x; Gil-Sanchez J.M., 2001, Galemys, V13, P37; Gisbert J, 2007, ATLAS Y LIBRO ROJO D; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guo HY, 2013, GLOBAL CHANGE BIOL, V19, P2765, DOI 10.1111/gcb.12221; Harrell FE, 2001, REGRESSION MODELING; Hays WST, 2007, PAC SCI, V61, P3, DOI 10.1353/psc.2007.0006; Hoving CL, 2003, NORTHEAST NAT, V10, P363; ICNF-Instituto de Conservacao da Natureza e das Florestas, 2013, INVENTARIO FLORESTAL; INE, 2011, RECENSEAMENTO AGRICO; Iuell B, 2003, WILDLIFE AND TRAFFIC; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kadoya T, 2010, BIOL CONSERV, V143, P1228, DOI 10.1016/j.biocon.2010.02.030; Kingdon J, 2003, THE KINGDON FIELD GU; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kramer-Schadt S, 2004, J APPL ECOL, V41, P711, DOI 10.1111/j.0021-8901.2004.00933.x; La Sorte F, 2010, EFFECTS OF GLOBAL WA; Levinsky I, 2007, BIODIVERS CONSERV, V16, P3803, DOI 10.1007/s10531-007-9181-7; Li JS, 2003, GLOBAL ECOL BIOGEOGR, V12, P449, DOI 10.1046/j.1466-822X.2003.00052.x; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2592, DOI 10.1111/j.1365-2486.2007.01451.x; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lozano J, 2003, BIODIVERS CONSERV, V12, P921, DOI 10.1023/A:1022821708594; Mac Nally R, 1996, AUST J ECOL, V21, P224; MacNeil Calum, 2013, NeoBiota, V19, P1; Mangas JG, 2008, BIODIVERS CONSERV, V17, P43, DOI 10.1007/s10531-007-9229-8; Marcelli M, 2012, DIVERS DISTRIB, V18, P1001, DOI 10.1111/j.1472-4642.2012.00898.x; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Mestre FM, 2007, REV ECOL-TERRE VIE, V62, P35; Millington A, 2011, THE SAGE HANDBOOK OF; Miranda P., 2006, ALTERACOES CLIMATICA; Mitchell T., 2001, AFRICA RAINFALL CLIM; Moreira F, 2007, LANDSCAPE ECOL, V22, P1461, DOI 10.1007/s10980-007-9125-3; Moreno P.A., 2002, Galemys, V14, P64; Nicholson S.E., 2011, DRYLAND CLIMATOLOGY; Nogales M, 2006, MAMMAL REV, V36, P49, DOI 10.1111/j.1365-2907.2006.00077.x; Olea PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011698; PALOMARES F, 1993, J APPL ECOL, V30, P752, DOI 10.2307/2404253; Palomares F, 2000, CONSERV BIOL, V14, P809, DOI 10.1046/j.1523-1739.2000.98539.x; PALOMARES F, 1992, J MAMMAL, V73, P173, DOI 10.2307/1381880; Palomares F., 1991, Donana Acta Vertebrata, V18, P5; PALOMARES F, 1991, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Biologica, V87, P257; PALOMARES F, 1993, J ZOOL, V230, P557, DOI 10.1111/j.1469-7998.1993.tb02706.x; Palomares F., 1991, Donana Acta Vertebrata, V18, P187; Palomares F, 1993, B INFORM SECEM, V3, P4; Pardini R, 2004, BIODIVERS CONSERV, V13, P2567, DOI 10.1023/B:BIOC.0000048452.18878.2d; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Perez JM, 2002, MAMMAL REV, V32, P26, DOI 10.1046/j.1365-2907.2002.00097.x; Putman RJ, 1998, MAMMAL REV, V28, P141, DOI 10.1046/j.1365-2907.1998.00031.x; R Core Team, 2013, R A LANGUAGE AND ENV; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Reed RA, 1996, CONSERV BIOL, V10, P1098, DOI 10.1046/j.1523-1739.1996.10041098.x; Revilla E, 2001, J ZOOL, V255, P291, DOI 10.1017/S0952836901001388; Rico A, 2007, FOLIA ZOOL, V56, P1; Roemer GW, 2001, ANIM CONSERV, V4, P307, DOI 10.1017/S1367943001001366; Rondinini C, 2002, FUNCT ECOL, V16, P504, DOI 10.1046/j.1365-2435.2002.00651.x; Rosalino LM, 2009, ACTA OECOL, V35, P507, DOI 10.1016/j.actao.2009.03.006; Santos SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025383; Shreve F, 1924, ECOLOGY, V5, P128, DOI 10.2307/1929010; Sidorovich VE, 2005, FOLIA ZOOL, V54, P39; Suarez-Seoane S, 2002, BIOL CONSERV, V105, P333, DOI 10.1016/S0006-3207(01)00213-0; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; Tang ZY, 2006, AGR FOREST METEOROL, V139, P200, DOI 10.1016/j.agrformet.2006.07.001; Teixeira J, 2002, BIODIVERS CONSERV, V11, P2167, DOI 10.1023/A:1021342611769; Tews J, 2004, ANN ARID ZONE, V43, P413; Torres RT, 2012, MAMM BIOL, V77, P140, DOI 10.1016/j.mambio.2011.11.002; Underhill J, 2002, THESIS; Urban M, 2007, PROC R SOC LOND B BI, V27, P1413; Virgos E, 2001, CAN J ZOOL, V79, P1544, DOI 10.1139/cjz-79-9-1544; Virgos E, 1997, ACTA THERIOL, V42, P169, DOI 10.4098/AT.arch.97-19; Walsh C, 2013, R PACKAGE VERSION 1; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Yu XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069177; Zabala Jabi, 2004, Lutra, V47, P101; Zhang HM, 2014, BEHAVIOUR, V151, P1579, DOI 10.1163/1568539X-00003201; Zhao SQ, 2006, ECOL RES, V21, P890, DOI 10.1007/s11284-006-0048-2	126	19	19	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133768	10.1371/journal.pone.0133768	http://dx.doi.org/10.1371/journal.pone.0133768			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266939	Green Published, gold			2022-12-27	WOS:000359492300024
J	Haass, W; Kleiner, H; Muller, MC; Hofmann, WK; Fabarius, A; Seifarth, W				Haass, Wiltrud; Kleiner, Helga; Mueller, Martin C.; Hofmann, Wolf-Karsten; Fabarius, Alice; Seifarth, Wolfgang			Measurement of Separase Proteolytic Activity in Single Living Cells by a Fluorogenic Flow Cytometry Assay	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; CENTROSOME AMPLIFICATION; HUMAN CANCERS; ANEUPLOIDY; OVEREXPRESSION; TUMORIGENESIS; CENTRIOLES; SECURIN; DISEASE; BOVERI	ESPL1/Separase, an endopeptidase, is required for centrosome duplication and separation of sister-chromatides in anaphase of mitosis. Overexpression and deregulated proteolytic activity of Separase as frequently observed in human cancers is associated with the occurrence of supernumerary centrosomes, chromosomal missegregation and aneuploidy. Recently, we have hypothesized that increased Separase proteolytic activity in a small sub-population of tumor cells may serve as driver of tumor heterogeneity and clonal evolution in chronic myeloid leukemia (CML). Currently, there is no quantitative assay to measure Separase activity levels in single cells. Therefore, we have designed a flow cytometry-based assay that utilizes a Cy5- and rhodamine 110 (Rh110)-biconjugated Rad21 cleavage site peptide ([Cy5-D-R-E-I-M-R](2)-Rh110) as smart probe and intracellular substrate for detection of Separase enzyme activity in living cells. As measured by Cy5 fluorescence the cellular uptake of the fluorogenic peptide was fast and reached saturation after 210 min of incubation in human histiocytic lymphoma U937 cells. Separase activity was recorded as the intensity of Rh110 fluorescence released after intracellular peptide cleavage providing a linear signal gain within a 90-180 min time slot. Compared to conventional cell extract-based methods the flow cytometric assay delivers equivalent results but is more reliable, bypasses the problem of vague loading controls and unspecific proteolysis associated with whole cell extracts. Especially suited for the investigaton of blood- and bone marrow-derived hematopoietic cells the flow cytometric Separase assay allows generation of Separase activity profiles that tell about the number of Separase positive cells within a sample i.e. cells that currently progress through mitosis and about the range of intercellular variation in Separase activity levels within a cell population. The assay was used to quantify Separase proteolytic activity in leukemic cell lines and peripheral blood samples from leukemia patients.	[Haass, Wiltrud; Kleiner, Helga; Mueller, Martin C.; Hofmann, Wolf-Karsten; Fabarius, Alice; Seifarth, Wolfgang] Heidelberg Univ, Med Fak Mannheim, Med Univ Klin 3, Hamatol & Onkol, Mannheim, Germany	Ruprecht Karls University Heidelberg	Seifarth, W (corresponding author), Heidelberg Univ, Med Fak Mannheim, Med Univ Klin 3, Hamatol & Onkol, Mannheim, Germany.	wolfgang.seifarth@medma.uni-heidelberg.de			Deutsche Krebshilfe [110625]; Ruprecht-Karls-Universitat Heidelberg	Deutsche Krebshilfe(Deutsche Krebshilfe); Ruprecht-Karls-Universitat Heidelberg	WS received a grant from the Deutsche Krebshilfe (www.krebshilfe.de, no. 110625). The authors acknowledge financial support by the Open Access Publishing programme of the Ruprecht-Karls-Universitat Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agircan FG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004672; Basu D, 2009, ANAL BIOCHEM, V392, P133, DOI 10.1016/j.ab.2009.05.046; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Dietel M, 2014, J PATHOL, V234, P135, DOI 10.1002/path.4410; Finetti P, 2014, BREAST CANCER RES TR, V147, P51, DOI 10.1007/s10549-014-3070-z; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gerashchenko TS, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1201, DOI 10.1134/S0006297913110011; Gerlinger M, 2014, ANNU REV GENET, V48, P215, DOI 10.1146/annurev-genet-120213-092314; Giehl M, 2005, LEUKEMIA, V19, P1192, DOI 10.1038/sj.leu.2403779; Godinho SA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0467; Haa&szlig; W, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042863, DOI 10.1371/J0URNAL.P0NE.0042863]; Hellmuth S, 2014, EMBO J, V33, P1134, DOI 10.1002/embj.201488098; Hiley Crispin T, 2014, Clin Med (Lond), V14 Suppl 6, ps33, DOI 10.7861/clinmedicine.14-6-s33; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jeannot V, 1997, J HISTOCHEM CYTOCHEM, V45, P403, DOI 10.1177/002215549704500308; Koshikawa N, 1998, AM J PATHOL, V153, P937, DOI 10.1016/S0002-9440(10)65635-0; Kovacs LAS, 2010, CELL CYCLE, V9, P1750, DOI 10.4161/cc.9.9.11792; LAMPIDIS TJ, 1989, BIOCHEM PHARMACOL, V38, P4267, DOI 10.1016/0006-2952(89)90525-X; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Meyer R, 2009, CLIN CANCER RES, V15, P2703, DOI 10.1158/1078-0432.CCR-08-2454; Mukherjee M, 2014, ONCOGENE, V33, P5511, DOI 10.1038/onc.2013.493; Nicholson JM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00148; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Pati D, 2008, CELL CYCLE, V7, P3481, DOI 10.4161/cc.7.22.7048; Pihan GA, 2003, CANCER RES, V63, P1398; Prosser SL, 2012, J CELL SCI, V125, P5353, DOI 10.1242/jcs.106096; Ried T, 2012, BBA-GENE REGUL MECH, V1819, P784, DOI 10.1016/j.bbagrm.2012.02.020; Schockel L, 2011, NAT CELL BIOL, V13, P966, DOI 10.1038/ncb2280; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Uhlmann F, 2001, EMBO REP, V2, P487, DOI 10.1093/embo-reports/kve113; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Yim H, 2011, CELL CYCLE, V10, P1374, DOI 10.4161/cc.10.9.15489; Zhang NG, 2008, P NATL ACAD SCI USA, V105, P13033, DOI 10.1073/pnas.0801610105; Zhang NG, 2014, J BIOMOL SCREEN, V19, P878, DOI 10.1177/1087057114520972	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133769	10.1371/journal.pone.0133769	http://dx.doi.org/10.1371/journal.pone.0133769			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267133	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300025
J	Krause, L; Haubold, B; Borsch-Haubold, AG				Krause, Linda; Haubold, Bernhard; Boersch-Haubold, Angelika G.			Social Exclusion Changes Histone Modifications H3K4me3 and H3K27ac in Liver Tissue of Wild House Mice	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MUS-MUSCULUS-DOMESTICUS; GENE-EXPRESSION; HUMAN GENOME; EARLY-LIFE; GLUCOCORTICOID-RECEPTOR; NATURAL-POPULATIONS; TERRITORY FORMATION; METABOLIC DISEASE; SUPER-ENHANCERS	Wild house mice form social hierarchies with aggressive males defending territories, in which females, young mice and submissive adult males share nests. In contrast, socially excluded males are barred from breeding groups, have numerous bite wounds and patches of thinning fur. Since their feeding times are often disrupted, we investigated whether social exclusion leads to changes in epigenetic marks of metabolic genes in liver tissue. We used chromatin immunoprecipitation and quantitative PCR to measure enrichment of two activating histone marks at 15 candidate loci. The epigenetic profiles of healthy males sampled from nest boxes differed significantly from the profiles of ostracized males caught outside of nests and showing bite wounds indicative of social exclusion. Enrichment of histone-3 lysine-4 trimethylation (H3K4me3) changed significantly at genes Cyp4a14, Gapdh, Nr3c1, Pck1, Ppara, and Sqle. Changes at histone-3 lysine-27 acetylation (H3K27ac) marks were detected at genes Fasn, Nr3c1, and Plin5. A principal components analysis separated the socialized from the ostracized mice. This was independent of body weight for the H3K4me3 mark, and partially dependent for H3K27ac. There was no separation, however, between healthy males that had been sampled from two different nests. A hierarchical cluster analysis also separated the two phenotypes, which was independent of body weight for both markers. Our study shows that a period of social exclusion during adult life leads to quantitative changes in histone modification patterns in mouse liver tissue. Similar epigenetic changes might occur during the development of stress-induced metabolic disorders in humans.	[Krause, Linda] Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Haubold, Bernhard; Boersch-Haubold, Angelika G.] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society	Borsch-Haubold, AG (corresponding author), Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany.	aboersch@evolbio.mpg	Krause, Linda/ACQ-7999-2022	Krause, Linda/0000-0002-8490-5717	Max Planck Society, Germany	Max Planck Society, Germany(Max Planck Society)	The study was funded by the Max Planck Society, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado S, 2014, THE DYNAMIC NATURE O; ANDERSON PK, 1965, SCIENCE, V148, P1753, DOI 10.1126/science.148.3678.1753; Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; BARNETT SA, 1960, J PSYCHOSOM RES, V4, P251, DOI 10.1016/0022-3999(60)90001-5; BERRY R J, 1970, Field Studies, V3, P219; Bjorntorp P, 1997, NUTRITION, V13, P795, DOI 10.1016/S0899-9007(97)00191-3; Borsch-Haubold AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097568; Bruinstroop E, 2012, DIABETES, V61, P1043, DOI 10.2337/db11-1142; Bryk J, 2013, ECOL EVOL, V3, P558, DOI 10.1002/ece3.447; Burdge GC, 2009, BRIT J NUTR, V101, P619, DOI 10.1017/S0007114508145883; Champagne FA, 2013, BEHAV NEUROSCI, V127, P628, DOI 10.1037/a0034186; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Crowcroft P, 1955, MUS MUSCULUS L J MAM, V36, P299; Crowcroft P., 1966, MICE ALL OVER; CROWCROFT PETER, 1963, PROC ZOOL SOC LONDON, V140, P517; Dedert EA, 2010, ANN BEHAV MED, V39, P61, DOI 10.1007/s12160-010-9165-9; Doege H, 2006, GASTROENTEROLOGY, V130, P1245, DOI 10.1053/j.gastro.2006.02.006; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Fam BC, 2012, ADIPOCYTE, V1, P259, DOI 10.4161/adip.21448; Faulk C, 2011, EPIGENETICS-US, V6, P791, DOI 10.4161/epi.6.7.16209; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Fisher CD, 2008, ARCH TOXICOL, V82, P959, DOI 10.1007/s00204-008-0312-z; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gerlach G, 1996, BEHAV ECOL SOCIOBIOL, V39, P159, DOI 10.1007/s002650050277; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huynh FK, 2013, HEPATOLOGY, V57, P543, DOI 10.1002/hep.26043; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kibler JL, 2014, WORLD J CARDIOL, V6, P455, DOI 10.4330/wjc.v6.i6.455; Koolhaas JM, 1997, ACTA PHYSIOL SCAND, V161, P69; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Krause L, 2014, QUANTITATIVE EPIGENE; Li CCY, 2013, EPIGENETICS-US, V8, P602, DOI 10.4161/epi.24656; MACKINTO.JH, 1970, ANIM BEHAV, V18, P177, DOI 10.1016/0003-3472(70)90088-6; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MEANEY MJ, 1985, BEHAV NEUROSCI, V99, P765, DOI 10.1037/0735-7044.99.4.765; Mehta D, 2013, P NATL ACAD SCI USA, V110, P8302, DOI 10.1073/pnas.1217750110; Montero I, 2010, MATE CHOICE AND REPR; Montero I, 2013, MOL ECOL, V22, P2549, DOI 10.1111/mec.12271; Mulligan CJ, 2012, EPIGENETICS-US, V7, P853, DOI 10.4161/epi.21180; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nishikawa S, 2012, TOXICOL PATHOL, V40, P71, DOI 10.1177/0192623311422078; Patterson ZR, 2013, ENDOCRINOLOGY, V154, P1080, DOI 10.1210/en.2012-1834; POSHIVALOV VP, 1980, BRIT J PHARMACOL, V70, P367, DOI 10.1111/j.1476-5381.1980.tb08712.x; Priyadarshini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043232; REIMER JD, 1967, J MAMMAL, V48, P88, DOI 10.2307/1378173; Richard EM, 2010, ENDOCRINOLOGY, V151, P649, DOI 10.1210/en.2009-0862; Sabin Matthew A, 2011, Pediatr Endocrinol Rev, V8, P382; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; SELANDER RK, 1970, AM ZOOL, V10, P53; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Stylianou IM, 2005, PHYSIOL GENOMICS, V20, P224, DOI 10.1152/physiolgenomics.00183.2004; Szyf M, 2011, EPIGENETICS-US, V6, P971, DOI 10.4161/epi.6.8.16793; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Uhrich J, 1938, J COMP PSYCHOL, V25, P373, DOI 10.1037/h0056350; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visinoni S, 2012, DIABETES, V61, P1122, DOI 10.2337/db11-1511; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xu X., 2013, EPIGENETICS, V8; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zucchi Fabiola C. R., 2012, Frontiers in Genetics, V3, P96, DOI 10.3389/fgene.2012.00096	66	3	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133988	10.1371/journal.pone.0133988	http://dx.doi.org/10.1371/journal.pone.0133988			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267652	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492300029
J	Lehman, J; Miikkulainen, R				Lehman, Joel; Miikkulainen, Risto			Extinction Events Can Accelerate Evolution	PLOS ONE			English	Article							RED QUEEN; COURT JESTER; EVOLVABILITY; DIVERSITY; IMPACTS	Extinction events impact the trajectory of biological evolution significantly. They are often viewed as upheavals to the evolutionary process. In contrast, this paper supports the hypothesis that although they are unpredictably destructive, extinction events may in the long term accelerate evolution by increasing evolvability. In particular, if extinction events extinguish indiscriminately many ways of life, indirectly they may select for the ability to expand rapidly through vacated niches. Lineages with such an ability are more likely to persist through multiple extinctions. Lending computational support for this hypothesis, this paper shows how increased evolvability will result from simulated extinction events in two computational models of evolved behavior. The conclusion is that although they are destructive in the short term, extinction events may make evolution more prolific in the long term.	[Lehman, Joel] IT Univ Copenhagen, Ctr Comp Games Res, Copenhagen, Denmark; [Miikkulainen, Risto] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA	IT University Copenhagen; University of Texas System; University of Texas Austin	Lehman, J (corresponding author), IT Univ Copenhagen, Ctr Comp Games Res, Copenhagen, Denmark.	joel@cs.utexas.edu	Lehman, Joel/AAH-9977-2019	Lehman, Joel/0000-0002-9535-1123	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105042] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM105042] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Barnosky AD, 2001, J VERTEBR PALEONTOL, V21, P172, DOI 10.1671/0272-4634(2001)021[0172:DTEOTR]2.0.CO;2; Bedau MA, 2003, BIOSYSTEMS, V69, P143, DOI 10.1016/S0303-2647(02)00137-5; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Bongard J, 2011, P NATL ACAD SCI USA, V108, P1234, DOI 10.1073/pnas.1015390108; Brookfield JFY, 2001, CURR BIOL, V11, pR106, DOI 10.1016/S0960-9822(01)00041-0; CHAO L, 1983, EVOLUTION, V37, P125, DOI 10.1111/j.1558-5646.1983.tb05521.x; Dichtel-Danjoy ML, 2004, TRENDS GENET, V20, P268, DOI 10.1016/j.tig.2004.03.010; Doncieux S, 2015, FRONTIERS ROBOTICS A, V2, P4, DOI [10.3389/frobt.2015.00004, DOI 10.3389/FR0BT.2015.00004]; Floreano D, 2000, EVOLUTIONARY ROBOTIC; Floreano D, 2007, CURR BIOL, V17, P514, DOI 10.1016/j.cub.2007.01.058; Foote M, 2005, JOURNAL INFORMATION, V31; Gould SJ, 2000, WONDERFUL LIFE THE B; Grant BR, 2003, BIOSCIENCE, V53, P965, DOI 10.1641/0006-3568(2003)053[0965:WDFCTU]2.0.CO;2; Hallam A., 1990, P249; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Howitt P, 1990, NATIONAL BUREAU OF E; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ivanovic Ana, 2012, Int J Evol Biol, V2012, P740605, DOI 10.1155/2012/740605; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Jablonski D., 1986, P183; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Lehman J, 2013, PROCEEDINGS OF THE G; Lehman J, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P211; Lehman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062186; Lehman J, 2011, IEEE C EVOL COMPUTAT, P2693; Lehman J, 2011, EVOL COMPUT, V19, P189, DOI 10.1162/EVCO_a_00025; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; Lipson H, 2000, NATURE, V406, P974, DOI 10.1038/35023115; McElwain JC, 2007, TRENDS ECOL EVOL, V22, P548, DOI 10.1016/j.tree.2007.09.003; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Mouret JB, 2012, EVOL COMPUT, V20, P91, DOI 10.1162/EVCO_a_00048; Newman MEJ, 1997, J THEOR BIOL, V189, P235, DOI 10.1006/jtbi.1997.0508; Palmer ME, 2011, EVOLUTION, V65, P2345, DOI 10.1111/j.1558-5646.2011.01283.x; PARSONS DJ, 1979, FOREST ECOL MANAG, V2, P21, DOI 10.1016/0378-1127(79)90034-3; Pianka E. R, 2011, EVOL ECOL, V7; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Raup D.M., 1992, EXTINCTION BAD GENES; RAUP DM, 1986, SCIENCE, V231, P1528, DOI 10.1126/science.11542058; Sareni B., 1998, IEEE Transactions on Evolutionary Computation, V2, P97, DOI 10.1109/4235.735432; SCHLUTER D, 1984, AM NAT, V123, P175, DOI 10.1086/284196; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; Thornton C, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P847, DOI 10.1145/2487575.2487629; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]	48	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0132886	10.1371/journal.pone.0132886	http://dx.doi.org/10.1371/journal.pone.0132886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266804	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300012
J	Millar, SR; Perry, IJ; Phillips, CM				Millar, Sean R.; Perry, Ivan J.; Phillips, Catherine M.			HbA(1c) Alone Is a Poor Indicator of Cardiometabolic Risk in Middle-Aged Subjects with Pre-Diabetes but Is Suitable for Type 2 Diabetes Diagnosis: A Cross-Sectional Study	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; GLYCATED HEMOGLOBIN; OLDER-ADULTS; HBA1C; INFLAMMATION; A1C; ASSOCIATION; STATEMENT	Objectives Glycated haemoglobin A(1c) (HbA(1c)) measurement is recommended as an alternative to fasting plasma glucose (FPG) for the diagnosis of pre-diabetes and type 2 diabetes. However, evidence suggests discordance between HbA(1c) and FPG. In this study we examine a range of metabolic risk features, pro-inflammatory cytokines, acute-phase response proteins, coagulation factors and white blood cell counts to determine which assay more accurately identifies individuals at increased cardiometabolic risk. Materials and Methods This was a cross-sectional study involving a random sample of 2,047 men and women aged 46-73 years. Binary and multinomial logistic regression were employed to examine risk feature associations with pre-diabetes [either HbA1c levels 5.7-6.4%(39-46 mmol/mol) or impaired FPG levels 5.6-6.9 mmol/l] and type 2 diabetes [either HbA1c levels > 6.5% (> 48 mmol/mol) or FPG levels > 7.0 mmol/l]. Receiver operating characteristic curve analysis was used to evaluate the ability of HbA(1c) to discriminate pre-diabetes and diabetes defined by FPG. Results Stronger associations with diabetes-related phenotypes were observed in pre-diabetic subjects diagnosed by FPG compared to those detected by HbA(1c). Individuals with type 2 diabetes exhibited cardiometabolic profiles that were broadly similar according to diagnosis by either assay. Pre-diabetic participants classified by both assays displayed a more pro-inflammatory, pro-atherogenic, hypertensive and insulin resistant profile. Odds ratios of having three or more metabolic syndrome features were also noticeably increased (OR: 4.0, 95% CI: 2.8-5.8) when compared to subjects diagnosed by either HbA(1c) (OR: 1.4, 95% CI: 1.2-1.8) or FPG (OR: 3.0, 95% CI: 1.7-5.1) separately. Conclusions In middle-aged Caucasian-Europeans, HbA(1c) alone is a poor indicator of cardiometabolic risk but is suitable for diagnosing diabetes. Combined use of HbA(1c) and FPG may be of additional benefit for detecting individuals at highest odds of type 2 diabetes development.	[Millar, Sean R.; Perry, Ivan J.; Phillips, Catherine M.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, HRB Ctr Hlth & Diet Res, Cork, Ireland	Health Research Board - Ireland; University College Cork	Millar, SR (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, HRB Ctr Hlth & Diet Res, Cork, Ireland.	s.millar@ucc.ie		Perry, Ivan/0000-0002-4965-9792	Irish Health Research Board [HRC/2007/13]	Irish Health Research Board	This work was supported by a research grant from the Irish Health Research Board (reference HRC/2007/13). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Balanda KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078406; Barton B, 2008, MEDICAL STATISTICS A; Bonora E, 2011, DIABETES CARE, V34, pS184, DOI 10.2337/dc11-s216; Calle MC, 2012, DIABETES METAB, V38, P183, DOI 10.1016/j.diabet.2011.11.006; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Church D, 2014, J INTERN MED, V276, P171, DOI 10.1111/joim.12200; Cohen RM, 2010, J CLIN ENDOCR METAB, V95, P5203, DOI 10.1210/jc.2010-2352; Connor JMO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080504; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Davies M, 2012, BMJ-BRIT MED J, P345; Du TT, 2013, CLIN EXP PHARMACOL P, V40, P63, DOI 10.1111/1440-1681.12038; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Hinchion Rita, 2002, Ir Med J, V95, P249; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Inoue K, 2008, DIABETIC MED, V25, P1157, DOI 10.1111/j.1464-5491.2008.02572.x; Inoue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040375; Kearney PM, 2013, INT J EPIDEMIOL, V42, P1253, DOI 10.1093/ije/dys131; Kharroubi AT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088123; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Kim JH, 2011, DIABETES RES CLIN PR, V94, pE27, DOI 10.1016/j.diabres.2011.07.013; Lapolla A, 2011, NUTR METAB CARDIOVAS, V21, P467, DOI 10.1016/j.numecd.2011.02.006; Leahy S, 2014, OBESITY IN AN AGEING; Lipska KJ, 2013, DIABETES CARE, V36, P3923, DOI 10.2337/dc12-2631; Lipska KJ, 2010, J CLIN ENDOCR METAB, V95, P5289, DOI 10.1210/jc.2010-1171; Lorenzo C, 2010, DIABETES CARE, V33, P2104, DOI 10.2337/dc10-0679; Lowry R, 2012, THE CONFIDENCE INTER; Mainous AG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005002; Mann DM, 2010, DIABETES CARE, V33, P2190, DOI 10.2337/dc10-0752; Marini MA, 2012, DIABETES CARE, V35, P1144, DOI 10.2337/dc11-2032; Morris DH, 2013, DIABETOLOGIA, V56, P1489, DOI 10.1007/s00125-013-2902-4; Mostafa SA, 2010, DIABETES RES CLIN PR, V90, P100, DOI 10.1016/j.diabres.2010.06.008; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Olson DE, 2010, DIABETES CARE, V33, P2184, DOI 10.2337/dc10-0433; Organization WH, 2003, SCREENING FOR TYPE 2; Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038; Rathmann W, 2012, ANN MED, V44, P170, DOI 10.3109/07853890.2010.531759; Sato KK, 2009, DIABETES CARE, V32, P644, DOI 10.2337/dc08-1631; Saukkonen T, 2011, DIABETES CARE, V34, P2314, DOI 10.2337/dc11-0183; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Twigg SM, 2007, MED J AUSTRALIA, V186, P461, DOI 10.5694/j.1326-5377.2007.tb00998.x; van Greevenbroek MMJ, 2013, NETH J MED, V71, P174; Wareham NJ, 2001, BMJ-BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wolffenbuttel BHR, 2013, DIABETES CARE, V36, P2931, DOI 10.2337/dc12-2711; YUDKIN JS, 2014, BMJ-BRIT MED J, V349, pNIL11, DOI [10.1136/bmj.g4485, DOI 10.1136/BMJ.G4485]	50	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134154	10.1371/journal.pone.0134154	http://dx.doi.org/10.1371/journal.pone.0134154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266799	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300034
J	Rother, AK; Schwerk, N; Brinkmann, F; Klawonn, F; Lechner, W; Grigull, L				Rother, Ann-Katrin; Schwerk, Nicolaus; Brinkmann, Folke; Klawonn, Frank; Lechner, Werner; Grigull, Lorenz			Diagnostic Support for Selected Paediatric Pulmonary Diseases Using Answer-Pattern Recognition in Questionnaires Based on Combined Data Mining Applications-A Monocentric Observational Pilot Study	PLOS ONE			English	Article							PRIMARY CILIARY DYSKINESIA; RESPIRATORY-TRACT INFECTIONS; CYSTIC-FIBROSIS; ADVERSE EVENTS; CHRONIC COUGH; CHILDREN; ASTHMA; CONFIRMATION; MEDICATIONS; MANAGEMENT	Background Clinical symptoms in children with pulmonary diseases are frequently non-specific. Rare diseases such as primary ciliary dyskinesia (PCD), cystic fibrosis (CF) or protracted bacterial bronchitis (PBB) can be easily missed at the general practitioner (GP). Objective To develop and test a questionnaire-based and data mining-supported tool providing diagnostic support for selected pulmonary diseases. Methods First, interviews with parents of affected children were conducted and analysed. These parental observations during the pre-diagnostic time formed the basis for a new questionnaire addressing the parents' view on the disease. Secondly, parents with a sick child (e.g. PCD, PBB) answered the questionnaire and a data base was set up. Finally, a computer program consisting of eight different classifiers (support vector machine (SVM), artificial neural network (ANN), fuzzy rule-based, random forest, logistic regression, linear discriminant analysis, naive Bayes and nearest neighbour) and an ensemble classifier was developed and trained to categorise any given new questionnaire and suggest a diagnosis. For estimating the diagnostic accuracy, we applied ten-fold stratified cross validation. Results All questionnaires of patients suffering from CF, asthma (AS), PCD, acute bronchitis (AB) and the healthy control group were correctly diagnosed by the fusion algorithm. For the pneumonia (PM) group 19/21 (90.5%) and for the PBB group 17/18 (94.4%) correct diagnoses could be reached. The program detected the correct diagnoses with an overall sensitivity of 98.8%. Receiver operating characteristics (ROC) analyses confirmed the accuracy of this diagnostic tool. Case studies highlighted the applicability of the tool in the daily work of a GP. Conclusion For children with symptoms of pulmonary diseases a questionnaire-based diagnostic support tool using data mining techniques exhibited good results in arriving at diagnostic suggestions. In the hands of a doctor, this tool could be of value in arousing awareness for rare pulmonary diseases such as PCD or CF.	[Rother, Ann-Katrin; Grigull, Lorenz] Univ Childrens Hosp, Hanover Med Sch, Dept Paediat Haematol & Oncol, Hannover, NH, Germany; [Schwerk, Nicolaus] Univ Childrens Hosp, Hanover Med Sch, Dept Paediat Pneumol Allergy & Neonatol, Hannover, NH, Germany; [Brinkmann, Folke] Ruhr Univ Bochum, Univ Childrens Hosp, Dept Paediat Pneumol, Bochum, Germany; [Klawonn, Frank] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Lechner, Werner] Improved Med Diagnost Ptd Ltd, Singapore, Singapore; [Klawonn, Frank] Ostfalia Univ Appl Sci, Wolfenbuettel, Germany	Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruhr University Bochum; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center for Infection Research	Grigull, L (corresponding author), Univ Childrens Hosp, Hanover Med Sch, Dept Paediat Haematol & Oncol, Hannover, NH, Germany.	Grigull.lorenz@mh-hannover.de	schwerk, nicolaus/AAU-5676-2020; Brinkmann, Folke/GQA-9081-2022; Klawonn, Frank/HFH-5887-2022	Brinkmann, Folke/0000-0002-4307-4232; Klawonn, Frank/0000-0001-9613-182X	Improved Medical Diagnostics (IMD) Ptd Ltd., Singapore	Improved Medical Diagnostics (IMD) Ptd Ltd., Singapore	The authors received no funding for this work. One of the authors [WL] received salaries through Improved Medical Diagnostics (IMD) Ptd Ltd., Singapore. The specific role of this author is articulated in the 'author contributions' section.	Anuradha B., 2008, J THEORETICAL APPL I, V4, P353; Boon M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-11; Bush A, 1998, EUR RESPIR J, V12, P982, DOI 10.1183/09031936.98.12040982; Cane RS, 2000, ARCH DIS CHILD, V82, P327, DOI 10.1136/adc.82.4.327; Chang AB, 2006, MED J AUSTRALIA, V184, P398, DOI 10.5694/j.1326-5377.2006.tb00290.x; Coren ME, 2002, ACTA PAEDIATR, V91, P667, DOI 10.1080/080352502760069089; Dennis Tanya, 2008, Community Pract, V81, P24; Dimou Ioannis N, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5334; Donnelly D, 2007, THORAX, V62, P80, DOI 10.1136/thx.2006.058933; Fahey T, 1998, ARCH DIS CHILD, V79, P225, DOI 10.1136/adc.79.3.225; Ferreira D, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-143; Foeldvari Anett, 2012, Orvosi Hetilap, V153, P1185, DOI 10.1556/OH.2012.29418; GOLDMAN L, 1982, NEW ENGL J MED, V307, P588, DOI 10.1056/NEJM198209023071004; Grigull L, 2012, PEDIATR RES, V71, P725, DOI 10.1038/pr.2012.34; Hampton LM, 2013, PEDIATRICS, V132, P1047, DOI 10.1542/peds.2013-2236; Hay AD, 2003, FAM PRACT, V20, P696, DOI 10.1093/fampra/cmg613; Horani A, 2014, PEDIATR RES, V75, P158, DOI 10.1038/pr.2013.200; Hughes D, 2008, PAED CHILD HEALT-CAN, V13, P672, DOI 10.1093/pch/13.8.672; KOSS LG, 1979, ANAL QUANT CYTOL, V1, P202; Kuehni CE, 2010, EUR RESPIR J, V36, P1248, DOI 10.1183/09031936.00001010; Lai HC, 2002, AM J EPIDEMIOL, V156, P165, DOI 10.1093/aje/kwf014; Luks VP, 2010, EUR RESPIR J, V36, P255, DOI 10.1183/09031936.00165109; Marchant JM, 2006, CHEST, V129, P1132, DOI 10.1378/chest.129.5.1132; Maus J, 2011, DTSCH ARZTEBL, V108, pA; MAYRING P, 1987, Z GERONTOL, V20, P367; McCallum GB, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006595.pub3; Meyer D, 2003, NEUROCOMPUTING, V55, P169, DOI 10.1016/S0925-2312(03)00431-4; Pakhale S, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-27; Pifferi M, 2013, EUR RESPIR J, V41, P960, DOI 10.1183/09031936.00039412; Rodman DM, 2005, AM J RESP CRIT CARE, V171, P621, DOI 10.1164/rccm.200403-404OC; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Rosenthal G, 2012, TRADITION RENEWAL SH, P202; Schaefer MK, 2008, PEDIATRICS, V121, P783, DOI 10.1542/peds.2007-3638; Schwerk N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027913; Skytt N, 2012, J ALLERGY CLIN IMMUN, V130, P403, DOI 10.1016/j.jaci.2012.04.043; STOTT NCH, 1979, BRIT MED J, V1, P29, DOI 10.1136/bmj.1.6155.29; Strauss A, 1998, THE DISCOVERY OF GRO, P69; Tabatabaei SA, 2012, J RES MED SCI, V17, P182; Thakur Ankita, 2011, Sci Pharm, V79, P493, DOI 10.3797/scipharm.1105-11; Thomson F, 2002, J PAEDIATR CHILD H, V38, P578, DOI 10.1046/j.1440-1754.2002.00045.x; Truschkat I, 2005, FORUM QUALITATIVE SO, V6, P22; Weinberger M, 2007, PEDIATRICS, V120, P855, DOI 10.1542/peds.2007-0078; Weinberger M, 2014, ALLERGY ASTHMA PROC, V35, P95, DOI 10.2500/aap.2014.35.3711; Wong SH, 2015, EUR J HUM GENET; Yoo I, 2012, J MED SYST, V36, P2431, DOI 10.1007/s10916-011-9710-5; Zimmerman DR, 2012, PEDIATR EMERG CARE, V28, P646, DOI 10.1097/PEC.0b013e31825cfd53	46	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135180	10.1371/journal.pone.0135180	http://dx.doi.org/10.1371/journal.pone.0135180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267801	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492300085
J	Wang, Q; Li, M; Lou, EHM; Wong, MS				Wang, Q.; Li, M.; Lou, Edmond H. M.; Wong, M. S.			Reliability and Validity Study of Clinical Ultrasound Imaging on Lateral Curvature of Adolescent Idiopathic Scoliosis	PLOS ONE			English	Article							INTRAOBSERVER RELIABILITY; SPINAL CURVATURE; COBB-ANGLE; INTEROBSERVER; RADIOGRAPHS; AIS	Background Non-ionizing radiation imaging assessment has been advocated for the patients with adolescent idiopathic scoliosis (AIS). As one of the radiation-free methods, ultrasound imaging has gained growing attention in scoliosis assessment over the past decade. The center of laminae (COL) method has been proposed to measure the spinal curvature in the coronal plane of ultrasound image. However, the reliability and validity of this ultrasound method have not been validated in the clinical setting. Objectives To evaluate the reliability and validity of clinical ultrasound imaging on lateral curvature measurements of AIS with their corresponding magnetic resonance imaging (MRI) measurements. Methods Thirty curves (ranged 10.2 degrees-68.2 degrees) from sixteen patients with AIS were eligible for this study. The ultrasound scan was performed using a 3-D ultrasound unit within the same morning of MRI examination. Two researchers were involved in data collection of these two examinations. The COL method was used to measure the coronal curvature in ultrasound image, compared with the Cobb method in MRI. The intra-and inter-rater reliability of the COL method was evaluated by intra-class correlation coefficient (ICC). The validity of this method was analyzed by paired Student's t-test, Bland-Altman statistics and Pearson correlation coefficient. The level of significance was set as 0.05. Results The COL method showed high intra-and inter-rater reliabilities (both with ICC (2, K) > 0.9, p<0.05) to measure the coronal curvature. Compared with Cobb method, COL method showed no significant difference (p<0.05) when measuring coronal curvature. Furthermore, Bland-Altman method demonstrated an agreement between these two methods, and Pearson's correlation coefficient (r) was high (r>0.9, p<0.05). Conclusion The ultrasound imaging could provide a reliable and valid measurement of spinal curvature in the coronal plane using the COL method. Further research is needed to validate the proposed ultrasound measurement in larger clinical trial and to optimize the ultrasound scanning and measuring procedure.	[Wang, Q.; Li, M.; Wong, M. S.] Hong Kong Polytech Univ, Interdisciplinary Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Wang, Q.] Sichuan Univ, West China Hosp, Ctr Rehabil Med, Chengdu 610064, Peoples R China; [Wang, Q.] Hong Kong Polytech Univ, Sichuan Univ, Inst Disaster Management & Reconstruct, Chengdu, Peoples R China; [Lou, Edmond H. M.] Univ Alberta, Dept Surg, Glenrose Rehabil Res Ctr, Edmonton, AB, Canada	Hong Kong Polytechnic University; Sichuan University; Hong Kong Polytechnic University; Sichuan University; University of Alberta	Wong, MS (corresponding author), Hong Kong Polytech Univ, Interdisciplinary Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China.	m.s.wong@polyu.edu.hk		WONG, MS/0000-0002-4157-9528	Research Grants Council of Hong Kong Special Administrative Region, PRC [PolyU 5634/13M]	Research Grants Council of Hong Kong Special Administrative Region, PRC	This work was supported by General Research Fund from Research Grants Council of Hong Kong Special Administrative Region, PRC. The grant numbers are PolyU 5634/13M and the URLs is http://www.ugc.edu.hk/eng/rgc/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Chan Amanda C Y, 2014, Spine Deform, V2, P168, DOI 10.1016/j.jspd.2014.02.006; Chen W, 2011, ENG MED BIOL SOC EMB; Chen W., 2012, OPEN J ACOUST, V2, P95, DOI DOI 10.4236/OJA.2012.23011; Chen W, 2013, J CHILD ORTHOP, V7, P521, DOI 10.1007/s11832-013-0539-y; Cheung CWJ, 2013, IEEE ENG MED BIO, P6474, DOI 10.1109/EMBC.2013.6611037; Currier DP, 1984, ELEMENTS RES PHYS TH; Gstoettner M, 2007, EUR SPINE J, V16, P1587, DOI 10.1007/s00586-007-0401-3; Hong JY, 2011, SPINE, V36, pE855, DOI 10.1097/BRS.0b013e3181fde346; Hresko MT, 2013, NEW ENGL J MED, V368, P834, DOI 10.1056/NEJMcp1209063; Knott P, 2014, SCOLIOSIS SPINAL DIS, V9, DOI 10.1186/1748-7161-9-4; Lee MC, 2013, SPINE, V38, pE656, DOI 10.1097/BRS.0b013e31828d255d; LETTS M, 1988, SPINE, V13, P1106, DOI 10.1097/00007632-198810000-00009; Li M, 2012, EUR SPINE J, V21, P1926, DOI 10.1007/s00586-012-2273-4; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; Mehta SS, 2009, J PEDIATR ORTHOPED, V29, P749, DOI 10.1097/BPO.0b013e3181b72550; Meng L, 2014, SPINE, V39, P1408, DOI [10.1097/BRS.0000000000000423, DOI 10.1097/BRS.0000000000000423]; Nguyen DV, 2015, MED ENG PHYS, V37, P239, DOI 10.1016/j.medengphy.2014.11.007; Purnama KE, 2010, TECHNOL HEALTH CARE, V18, P1, DOI 10.3233/THC-2010-0565; SUZUKI S, 1989, J BONE JOINT SURG BR, V71, P252, DOI 10.1302/0301-620X.71B2.2647754; Tanure MC, 2010, SPINE J, V10, P769, DOI 10.1016/j.spinee.2010.02.020; Thaler M, 2008, EUR SPINE J, V17, P1251, DOI 10.1007/s00586-008-0726-6; Ungi T, 2014, ULTRASOUND MED BIOL, V40, P447, DOI 10.1016/j.ultrasmedbio.2013.09.021; Vrtovec T, 2009, EUR SPINE J, V18, P593, DOI 10.1007/s00586-009-0913-0; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; Wong MS, 2012, STUD HEALTH TECHNOL, V176, P375, DOI 10.3233/978-1-61499-067-3-375; Wu HF, 2011, EUR SPINE J, V20, P112, DOI 10.1007/s00586-010-1512-9; Young M, 2015, EUR SPINE J, V24, P1427, DOI 10.1007/s00586-015-3855-8; Zaki R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037908; Zheng Rui, 2015, Spine Deform, V3, P151, DOI 10.1016/j.jspd.2014.08.008	31	29	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135264	10.1371/journal.pone.0135264	http://dx.doi.org/10.1371/journal.pone.0135264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266802	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300089
J	Eusemann, TN; Willmroth, F; Fiebich, B; Biber, K; van Calker, D				Eusemann, Till Nicolas; Willmroth, Frank; Fiebich, Bernd; Biber, Knut; van Calker, Dietrich			Adenosine Receptors Differentially Regulate the Expression of Regulators of G-Protein Signalling (RGS) 2, 3 and 4 in Astrocyte-Like Cells	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; IN-VIVO; SYNAPTIC-TRANSMISSION; CULTURED ASTROCYTES; GENE POLYMORPHISMS; BRAIN-FUNCTION; EPHRIN-B; ANXIETY; DEPRESSION; INHIBITION	The "regulators of g-protein signalling" (RGS) comprise a large family of proteins that limit by virtue of their GTPase accelerating protein domain the signal transduction of G-protein coupled receptors. RGS proteins have been implicated in various neuropsychiatric diseases such as schizophrenia, drug abuse, depression and anxiety and aggressive behaviour. Since conditions associated with a large increase of adenosine in the brain such as seizures or ischemia were reported to modify the expression of some RGS proteins we hypothesized that adenosine might regulate RGS expression in neural cells. We measured the expression of RGS-2,-3, and -4 in both transformed glia cells (human U373 MG astrocytoma cells) and in primary rat astrocyte cultures stimulated with adenosine agonists. Expression of RGS-2 mRNA as well as RGS2 protein was increased up to 30-fold by adenosine agonists in astrocytes. The order of potency of agonists and the blockade by the adenosine A2B-antagonist MRS1706 indicated that this effect was largely mediated by adenosine A2B receptors. However, a smaller effect was observed due to activation of adenosine A2A receptors. In astrocytoma cells adenosine agonists elicited an increase in RGS-2 expression solely mediated by A2B receptors. Expression of RGS-3 was inhibited by adenosine agonists in both astrocytoma cells and astrocytes. However while this effect was mediated by A2B receptors in astrocytoma cells it was mediated by A2A receptors in astrocytes as assessed by the order of potency of agonists and selective blockade by the specific antagonists MRS1706 and ZM241385 respectively. RGS-4 expression was inhibited in astrocytoma cells but enhanced in astrocytes by adenosine agonists.	[Eusemann, Till Nicolas; Willmroth, Frank; Fiebich, Bernd; Biber, Knut; van Calker, Dietrich] Univ Freiburg, Med Ctr, Dept Psychiat & Psychotherapy, Freiburg, Germany	University of Freiburg	van Calker, D (corresponding author), Univ Freiburg, Med Ctr, Dept Psychiat & Psychotherapy, Freiburg, Germany.	dietrich.calker@uniklinik-freiburg.de		Fiebich, Bernd L./0000-0002-9261-6771	Deutsche Forschungsgemeinschaft [115/5-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (grant No. 115/5-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biber K, 1997, J NEUROSCI, V17, P4956; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Calker D, 2005, NEUROCHEM RES, V30, P1205, DOI 10.1007/s11064-005-8792-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Cui H, 2008, NEUROPSYCHOPHARMACOL, V33, P1537, DOI 10.1038/sj.npp.1301557; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; Ding S, 2007, J NEUROSCI, V27, P10674, DOI 10.1523/JNEUROSCI.2001-07.2007; Ding SH, 2009, GLIA, V57, P767, DOI 10.1002/glia.20804; Dulin NO, 2000, J BIOL CHEM, V275, P21317, DOI 10.1074/jbc.M910079199; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; Fellin T, 2004, J PHYSIOL-LONDON, V559, P3, DOI 10.1113/jphysiol.2004.063214; Fellin T, 2009, P NATL ACAD SCI USA, V106, P15037, DOI 10.1073/pnas.0906419106; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Geurts M, 2002, NEUROSCI LETT, V333, P146, DOI 10.1016/S0304-3940(02)01004-2; Gold SJ, 2002, J NEUROCHEM, V82, P828, DOI 10.1046/j.1471-4159.2002.01002.x; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Han J, 2006, NEURON, V51, P575, DOI 10.1016/j.neuron.2006.07.012; Hasko G, 2005, TRENDS PHARMACOL SCI, V26, P511, DOI 10.1016/j.tips.2005.08.004; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heo K, 2006, CELL SIGNAL, V18, P2182, DOI 10.1016/j.cellsig.2006.05.006; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Ingi T, 1998, J NEUROSCI, V18, P7178; Kato T, 2007, PSYCHIAT CLIN NEUROS, V61, P3, DOI 10.1111/j.1440-1819.2007.01604.x; Lalo U, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001747; Lan KL, 2000, J BIOL CHEM, V275, P33497, DOI 10.1074/jbc.M005785200; Levitt P, 2006, BIOL PSYCHIAT, V60, P534, DOI 10.1016/j.biopsych.2006.04.028; Leygraf A, 2006, J NEURAL TRANSM, V113, P1921, DOI 10.1007/s00702-006-0484-8; Lifschytz T, 2012, INT J NEUROPSYCHOPH, V15, P1307, DOI 10.1017/S1461145711001453; Lin JHC, 2008, J NEUROSCI, V28, P681, DOI 10.1523/JNEUROSCI.3827-07.2008; Lomazzi M, 2008, TRENDS PHARMACOL SCI, V29, P544, DOI 10.1016/j.tips.2008.07.011; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Luo X, 2001, MOL CELL, V7, P651, DOI 10.1016/S1097-2765(01)00211-8; MA H, 1994, N-S ARCH PHARMACOL, V349, P81; Matos M, 2012, GLIA, V60, P702, DOI 10.1002/glia.22290; Moidunny S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-198; Muma NA, 2012, INT J NEUROPSYCHOPH, V15, P1199, DOI 10.1017/S1461145711002008; Neitzel KL, 2006, SEMIN CELL DEV BIOL, V17, P383, DOI 10.1016/j.semcdb.2006.03.002; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Porter JT, 1997, PROG NEUROBIOL, V51, P439, DOI 10.1016/S0301-0082(96)00068-8; Qiu RX, 2008, J CELL BIOL, V181, P973, DOI 10.1083/jcb.200708091; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Sebastiao AM, 2014, BRAIN RES; Shelat PB, 2006, NEUROSCI LETT, V403, P157, DOI 10.1016/j.neulet.2006.04.037; Smoller JW, 2008, ARCH GEN PSYCHIAT, V65, P298, DOI 10.1001/archgenpsychiatry.2007.48; Tatenhorst L, 2004, J NEUROPATH EXP NEUR, V63, P210, DOI 10.1093/jnen/63.3.210; Taymans JM, 2003, J NEUROCHEM, V84, P1118, DOI 10.1046/j.1471-4159.2003.01610.x; Traynor JR, 2005, MOL INTERV, V5, P30, DOI 10.1124/mi.5.1.7; Wall MJ, 2013, J PHYSIOL-LONDON, V591, P3853, DOI 10.1113/jphysiol.2013.253450; Xie GX, 2007, J MOL BIOL, V366, P349, DOI 10.1016/j.jmb.2006.11.045; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450	59	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134934	10.1371/journal.pone.0134934	http://dx.doi.org/10.1371/journal.pone.0134934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263491	Green Submitted, Green Published, gold			2022-12-27	WOS:000359353300045
J	Shang, N; Saleem, A; Musallam, L; Walshe-Roussel, B; Badawi, A; Cuerrier, A; Arnason, JT; Haddad, PS				Shang, Nan; Saleem, Ammar; Musallam, Lina; Walshe-Roussel, Brendan; Badawi, Alaa; Cuerrier, Alain; Arnason, John T.; Haddad, Pierre S.			Novel Approach to Identify Potential Bioactive Plant Metabolites: Pharmacological and Metabolomics Analyses of Ethanol and Hot Water Extracts of Several Canadian Medicinal Plants of the Cree of Eeyou Istchee	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NUCLEAR RECEPTOR SHP; HEPATIC GLUCONEOGENESIS; SKELETAL-MUSCLE; METFORMIN; CELLS; ADIPOCYTES; NATION; QUEBEC	We evaluated and compared the antidiabetic potential and molecular mechanisms of 17 Cree plants' ethanol extracts (EE) and hot water extracts (HWE) on glucose homeostasis in vitro and used metabolomics to seek links with the content of specific phytochemicals. Several EE of medical plants stimulated muscle glucose uptake and inhibited hepatic G6Pase activity. Some HWE partially or completely lost these antidiabetic activities in comparison to EE. Only R. groenlandicum retained similar potential between EE and HWE in both assays. In C2C12 muscle cells, EE of R. groenlandicum, A. incana and S. purpurea stimulated glucose uptake by activating AMP-activated protein kinase (AMPK) pathway and increasing glucose transporter type 4 (GLUT4) expression. In comparison to EE, HWE of R. groenlandicum exhibited similar activities; HWE of A. incana completely lost its effect on all parameters; interestingly, HWE of S. purpurea activated insulin pathway instead of AMPK pathway to increase glucose uptake. In the liver, for a subset of 5 plants, HWE and EE activated AMPK pathway whereas the EE and HWE of S. purpurea and K. angustifolia also activated insulin pathways. Quercetin-3-O-galactoside and quercetin 3-O-alpha-L-arabinopyranoside, were successfully identified by discriminant analysis as biomarkers of HWE plant extracts that stimulate glucose uptake in vitro. More importantly, the latter compound was not identified by previous bioassay-guided fractionation.	[Shang, Nan; Musallam, Lina; Haddad, Pierre S.] Univ Montreal, Dept Pharmacol, Nat Hlth Prod & Metab Dis Lab, Montreal, PQ H3C 3J7, Canada; [Shang, Nan; Musallam, Lina; Haddad, Pierre S.] Univ Montreal, Montreal Diabet Res Ctr, Montreal, PQ H3C 3J7, Canada; [Shang, Nan; Saleem, Ammar; Musallam, Lina; Walshe-Roussel, Brendan; Cuerrier, Alain; Arnason, John T.; Haddad, Pierre S.] Canadian Inst Hlth Res, Team Aboriginal Antidiabet Med, Montreal, PQ, Canada; [Shang, Nan; Haddad, Pierre S.] Univ Laval, Inst Nutraceut & Funct Foods, Quebec City, PQ, Canada; [Saleem, Ammar; Walshe-Roussel, Brendan; Arnason, John T.] Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Badawi, Alaa] Publ Hlth Agcy Canada, Off Biotechnol Genom & Populat Hlth, Toronto, ON, Canada; [Cuerrier, Alain] Univ Montreal, Jardin Bot Montreal, Inst Rech Biol Vegetale, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Institute for Work & Health; Laval University; University of Ottawa; Public Health Agency of Canada; Universite de Montreal	Haddad, PS (corresponding author), Univ Montreal, Dept Pharmacol, Nat Hlth Prod & Metab Dis Lab, Montreal, PQ H3C 3J7, Canada.	pierre.haddad@umontreal.ca	Arnason, John Thor/GXM-3860-2022; Badawi, Alaa/ABC-1300-2021		Canadian Institutes of Health Research (CIHR Team in Aboriginal Antidiabetic Medicines) [CTP-79855]; Office of Biotechnology; Genomics and Population Health of Health Canada [4500252806]	Canadian Institutes of Health Research (CIHR Team in Aboriginal Antidiabetic Medicines)(Canadian Institutes of Health Research (CIHR)); Office of Biotechnology; Genomics and Population Health of Health Canada	This work was supported by a Team Grant from the Canadian Institutes of Health Research (CTP-79855) (CIHR Team in Aboriginal Antidiabetic Medicines) to PSH, JTA and AC, and by funding from the Office of Biotechnology, Genomics and Population Health of Health Canada (4500252806), http://www.cihr-irsc.gc.ca/e/193.html.	Boustead JN, 2004, J MOL ENDOCRINOL, V32, P33, DOI 10.1677/jme.0.0320033; CHANDLER RF, 1979, J ETHNOPHARMACOL, V1, P49, DOI 10.1016/0378-8741(79)90016-3; CONSOLI A, 1992, DIABETES CARE, V15, P430, DOI 10.2337/diacare.15.3.430; Dufour D, 2007, J ETHNOPHARMACOL, V111, P22, DOI 10.1016/j.jep.2006.10.021; Eid HM, 2010, MOL NUTR FOOD RES, V54, P991, DOI 10.1002/mnfr.200900218; FERRANNINI E, 1988, METABOLISM, V37, P79, DOI 10.1016/0026-0495(88)90033-9; GARVEY WT, 1991, J CLIN INVEST, V87, P1072, DOI 10.1172/JCI115068; Gunther E., 1973, ETHNOBOTANY W WASHIN; Haddad PS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/893426; Harbilas D, 2009, CAN J PHYSIOL PHARM, V87, P479, DOI [10.1139/Y09-029, 10.1139/y09-029]; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; KLIP A, 1990, DIABETES CARE, V13, P696, DOI 10.2337/diacare.13.6.696; Leduc C, 2006, J ETHNOPHARMACOL, V105, P55, DOI 10.1016/j.jep.2005.09.038; Moerman DE, 2000, NATIVE AM ETHNOBOTAN; Muhammad A, 2012, J NAT PROD, V75, P1284, DOI 10.1021/np3001317; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Nachar A, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/189819, DOI 10.1155/2013/189819]; Niu WY, 2010, AM J PHYSIOL-ENDOC M, V298, pE1058, DOI 10.1152/ajpendo.00773.2009; Peyron-Caso E, 2002, HORM METAB RES, V34, P360, DOI 10.1055/s-2002-33467; Spoor DCA, 2006, CAN J PHYSIOL PHARM, V84, P847, DOI 10.1139/Y06-018; Takazawa Kazuo, 2008, Kobe J Med Sci, V54, pE14; Yuan HD, 2012, CHEM-BIOL INTERACT, V195, P35, DOI 10.1016/j.cbi.2011.10.006; Zhang M, 2012, MOL CELL ENDOCRINOL, V363, P122, DOI 10.1016/j.mce.2012.08.006	23	28	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135721	10.1371/journal.pone.0135721	http://dx.doi.org/10.1371/journal.pone.0135721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263160	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300099
J	Smith, CF; Heneghan, C; Ward, A				Smith, Claire Friedemann; Heneghan, Carl; Ward, Alison			Moving Focus from Weight to Health. What Are the Components Used in Interventions to Improve Cardiovascular Health in Children?	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SCHOOL-BASED INTERVENTION; LIFE-STYLE-PROGRAM; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; RISK-FACTORS; NUTRITION EDUCATION; BLOOD-PRESSURE; SHORT-TERM; ADOLESCENTS	Introduction Obesity in childhood impacts on many areas of the child's current and future health, including their cardiovascular health. To date many attempts have been made to design interventions to tackle excess childhood weight but with limited success. We aimed to establish the components common to interventions in children that improve cardiovascular health parameters. Methods We searched the following databases: EMBASE 1974-week 3 November 2014, Ovid Medline 1946 Present, and PsychINFO 1967-Present for studies reporting interventions in healthy young people under the age of 18. Included interventions had to contain an education component and have been carried out in a community, school, or clinical setting. Papers had to report on at least one of the pre-specified CVD risk parameters and at least one non-biological outcome from knowledge, attitudes or behaviours. Results We retrieved 2451 papers, from which 12 studies (18 papers) of 3046 participants were included. From the selected papers we identified four component themes; Health Behaviours, Self-Concept, Practical and Cognitive Tools, and Intervention Characteristics. The subcomponents that made up these themes were fairly consistent across the studies analysed although the studies varied in their duration, settings and children with which they were carried out. Nine of the studies were able to bring about positive change in at least one biological and one non-biological aspect of child cardiovascular health. Conclusion The component themes identified here were common to intervention studies that had success in improving parameters of cardiovascular health. We suggest that the focus of childhood health interventions be moved from weight onto cardiovascular health parameters and that future interventions use the lessons learned by their predecessors to incorporate those components that are associated with successful interventions.	[Smith, Claire Friedemann] UCL, Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, London, England; [Heneghan, Carl; Ward, Alison] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England	University of London; University College London; University of Oxford	Smith, CF (corresponding author), UCL, Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, London, England.	claire.smith@ucl.ac.uk	Smith, Claire Friedemann/J-4491-2019	Smith, Claire Friedemann/0000-0001-9934-5882	Medical Research Council doctoral training support grant	Medical Research Council doctoral training support grant	The authors disclosed receipt of the following financial support for the research, authorship, or publication of this article: a Medical Research Council doctoral training support grant for Claire Friedemann Smith paid to the University of Oxford but did not contribute funding to this work.	Aggoun Y, 2008, EUR HEART J, V29, P792, DOI 10.1093/eurheartj/ehm633; Angelopoulos PD, 2009, EUR J PUBLIC HEALTH, V19, P319, DOI 10.1093/eurpub/ckp004; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Bayne-Smith M, 2004, AM J PUBLIC HEALTH, V94, P1538, DOI 10.2105/AJPH.94.9.1538; Beck J. S., 2005, BECK YOUTH INVENTORI; Nguyen B, 2012, ARCH PEDIAT ADOL MED, V166, P170, DOI 10.1001/archpediatrics.2011.841; Bond M, 2011, OBES REV, V12, P242, DOI 10.1111/j.1467-789X.2010.00713.x; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Caballero B, 2004, INT J OBESITY, V28, pS90, DOI 10.1038/sj.ijo.0802797; Campbell K., 2001, SYSTEMATIC REV OBSER, V2, P149, DOI DOI 10.1046/J.1467-789X.2001.00035.X; Ciampa PJ, 2010, ARCH PEDIAT ADOL MED, V164, P1098, DOI 10.1001/archpediatrics.2010.232; Collins CE, 2006, ARCH PEDIAT ADOL MED, V160, P906, DOI 10.1001/archpedi.160.9.906; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Harter S., 1988, MANUAL SELF PERCEPTI; JOHNSON CC, 1991, SOUTHERN MED J, V84, P1305, DOI 10.1097/00007611-199111000-00004; Li M, 2008, OBES REV, V9, P548, DOI 10.1111/j.1467-789X.2008.00495.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lueke L, 2011, J LEGAL MED, V32, P205, DOI 10.1080/01947648.2011.576621; Melnyk BM, 2009, J SCHOOL HEALTH, V79, P575, DOI 10.1111/j.1746-1561.2009.00451.x; Morrison KM, 2015, J AFFECT DISORDERS, V172, P18, DOI 10.1016/j.jad.2014.09.014; National Obesity Observatory, 2009, INT COMP OB PREV; Nemet D, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-2172; Nguyen B, 2011, OBES REV, V12, P278; O'Connor J, 2008, NUTR DIET, V65, P121, DOI 10.1111/j.1747-0080.2008.00222.x; Park TG, 2007, ANN NUTR METAB, V51, P197, DOI 10.1159/000104137; Pensions Commission, 2005, 2 PENS COMM; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Sacher PM, 2010, OBESITY, V18, pS62, DOI 10.1038/oby.2009.433; Scanlon JW, 1977, EVALUATION MANAGEMEN; Schofield L, 2005, MED SCI SPORT EXER, V37, P1414, DOI 10.1249/01.mss.0000174889.89600.e3; SHANNON B, 1991, J AM DIET ASSOC, V91, P208; SHANNON BM, 1994, PEDIATRICS, V94, P923; Shrewsbury VA, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-13; Shrewsbury VA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-119; Silveira JAC, 2011, J PEDIAT-BRAZIL, V87, P382, DOI [10.2223/JPED.2123, 10.1590/S0021-75572011000500004]; Stabouli S, 2005, J PEDIATR-US, V147, P651, DOI 10.1016/j.jpeds.2005.06.008; Stock S, 2007, PEDIATRICS, V120, pe1059, DOI 10.1542/peds.2006-3003; Taylor RW, 2007, AM J CLIN NUTR, V86, P735, DOI 10.1093/ajcn/86.3.735; Taylor RW, 2006, INT J PEDIATR OBES, V1, P146, DOI 10.1080/17477160600881247; Tershakovec AM, 1998, AM J PUBLIC HEALTH, V88, P258, DOI 10.2105/AJPH.88.2.258; van Grieken A, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-61; Ward AM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-105; WHO, 2000, OB PREV MAN GLOB EP	44	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135115	10.1371/journal.pone.0135115	http://dx.doi.org/10.1371/journal.pone.0135115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO7PP	26263386	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300060
J	Zhang, Y; Yu, J; Liu, H; Ma, WH; Yan, L; Wang, JF; Li, GX				Zhang, Yan; Yu, Jiang; Liu, Hao; Ma, Wenhui; Yan, Li; Wang, Jiefu; Li, Guoxin			Novel Epigenetic CREB-miR-630 Signaling Axis Regulates Radiosensitivity in Colorectal Cancer	PLOS ONE			English	Article							NONCODING RNAS; BCL-W; EXPRESSION; PROGRESSION; ACTIVATION; INITIATION; APOPTOSIS; KINASE	Background miR-630 has been reported to be a modulator of several cancers, but the mechanism by which is it influences radioresistance remains unknown. We aimed to identify the molecular function of miR-630 and its regulatory mechanism in colorectal cancer (CRC) cell lines. Methodology Overexpression and loss-of-function analyses of miR-630 were performed in CRC cell lines by measuring their levels of growth and apoptosis after ionic radiation (IR). Target genes were detected via a dual-luciferase assay and Western blot. Chromatin immunoprecipitation assay was carried out to identify the transcription factor regulating miR-630, and a demethylation experiment was also conducted. Results miR-630 expression was found to be positively correlated with radiosensitivity in CRC cell lines (p<0.05). After IR treatment, miR-630 induced apoptosis in cells; however, the opposite was observed when miR-630 was downregulated (p<0.05). BCL2L2 and TP53RK were identified as the target genes of miR-630, and the function of miR-630 was found to depend on these two genes (p<0.05). In addition, evidence showed that CREB regulates the level of miR-630, and demethylation can elevate miR-630 levels (p<0.05). Conclusion CREB-miR-630-BCL2L2 and TP53RK comprise a novel signaling cascade regulating radiosensitivity in CRC cell lines by inducing cell apoptosis and death.	[Zhang, Yan; Yu, Jiang; Liu, Hao; Ma, Wenhui; Yan, Li; Wang, Jiefu; Li, Guoxin] Southern Med Univ, Dept Gen Surg, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China	Yu, J (corresponding author), Southern Med Univ, Dept Gen Surg, Nanfang Hosp, 1838 Guangzhou Ave North, Guangzhou 510515, Guangdong, Peoples R China.	balbc@163.com; gzliguoxin@163.com	Liu, Hao/I-9884-2019; ma, wenhui/GQZ-0052-2022	Liu, Hao/0000-0003-1227-2954; Zhang, Yan/0000-0002-0103-9172	Major Program of Science and Technology Program of Guangzhou [201300000087]; Research Fund of Public welfare in Health Industry of National Health and Family Planning Commission of China [201402015, 201502039]; National Key Technology RD Program [2013BAI05B05]; Key Clinical Specialty Discipline Construction Program	Major Program of Science and Technology Program of Guangzhou; Research Fund of Public welfare in Health Industry of National Health and Family Planning Commission of China; National Key Technology RD Program(National Key Technology R&D Program); Key Clinical Specialty Discipline Construction Program	This work was supported by Major Program of Science and Technology Program of Guangzhou (No. 201300000087), Research Fund of Public welfare in Health Industry of National Health and Family Planning Commission of China (No. 201402015 and No. 201502039), National Key Technology R&D Program (No. 2013BAI05B05) and Key Clinical Specialty Discipline Construction Program.	Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Allsopp TE, 2000, CELL DEATH DIFFER, V7, P984, DOI 10.1038/sj.cdd.4400733; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Biondo S, 2005, COLORECTAL DIS, V7, P472, DOI 10.1111/j.1463-1318.2005.00864.x; Cao JX, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.386; Cao JX, 2014, BIOCHEM BIOPH RES CO, V450, P470, DOI 10.1016/j.bbrc.2014.05.138; Corcoran C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-71; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Farhana L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061015; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Gibson L, 1996, ONCOGENE, V13, P665; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelley Scott T, 2005, Clin Colorectal Cancer, V5, P114, DOI 10.3816/CCC.2005.n.023; Kim SS, 2013, J CELL BIOCHEM, V114, P1115, DOI 10.1002/jcb.24452; Nana-Sinkam SP, 2011, MOL ONCOL, V5, P483, DOI 10.1016/j.molonc.2011.10.003; Peterson D, 2010, CANCER RES, V70, P6325, DOI 10.1158/0008-5472.CAN-10-0015; Saika Kumiko, 2013, Gan To Kagaku Ryoho, V40, P2475; Sakurai MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100124; Santos-Beneit AM, 2000, J LEUKOCYTE BIOL, V67, P712, DOI 10.1002/jlb.67.5.712; Scarpati GD, 2012, INT J RADIAT ONCOL, V83, P1113, DOI 10.1016/j.ijrobp.2011.09.030; Sun Q, 2014, INT J CANC; Wang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065661; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wilson JW, 2000, BRIT J CANCER, V82, P178, DOI 10.1054/bjoc.1999.0897; Xiao SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108810	25	38	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0133870	10.1371/journal.pone.0133870	http://dx.doi.org/10.1371/journal.pone.0133870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263387	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300012
J	Bradford, AP; Jones, K; Kechris, K; Chosich, J; Montague, M; Warren, WC; May, MC; Al-Safi, Z; Kuokkanen, S; Appt, SE; Polotsky, AJ				Bradford, Andrew P.; Jones, Kenneth; Kechris, Katerina; Chosich, Justin; Montague, Michael; Warren, Wesley C.; May, Margaret C.; Al-Safi, Zain; Kuokkanen, Satu; Appt, Susan E.; Polotsky, Alex J.			Joint MiRNA/mRNA Expression Profiling Reveals Changes Consistent with Development of Dysfunctional Corpus Luteum after Weight Gain	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NITRIC-OXIDE SYNTHASE; BODY-MASS INDEX; LUTEINIZING-HORMONE; GENE-EXPRESSION; MATERNAL OBESITY; GRANULOSA-CELLS; SMALL RNAS; MICRORNA EXPRESSION; MENSTRUAL-CYCLE	Obese women exhibit decreased fertility, high miscarriage rates and dysfunctional corpus luteum (CL), but molecular mechanisms are poorly defined. We hypothesized that weight gain induces alterations in CL gene expression. RNA sequencing was used to identify changes in the CL transcriptome in the vervet monkey (Chlorocebus aethiops) during weight gain. 10 months of high-fat, high-fructose diet (HFHF) resulted in a 20% weight gain for HFHF animals vs. 2% for controls (p = 0.03) and a 66% increase in percent fat mass for HFHF group. Ovulation was confirmed at baseline and after intervention in all animals. CL were collected on luteal day 7-9 based on follicular phase estradiol peak. 432 mRNAs and 9 miRNAs were differentially expressed in response to HFHF diet. Specifically, miR-28, miR-26, and let-7b previously shown to inhibit sex steroid production in human granulosa cells, were up-regulated. Using integrated miRNA and gene expression analysis, we demonstrated changes in 52 coordinately regulated mRNA targets corresponding to opposite changes in miRNA. Specifically, 2 targets of miR-28 and 10 targets of miR-26 were down-regulated, including genes linked to follicular development, steroidogenesis, granulosa cell proliferation and survival. To the best of our knowledge, this is the first report of dietary-induced responses of the ovulating ovary to developing adiposity. The observed HFHF diet-induced changes were consistent with development of a dysfunctional CL and provide new mechanistic insights for decreased sex steroid production characteristic of obese women. MiRNAs may represent novel biomarkers of obesity-related subfertility and potential new avenues for therapeutic intervention.	[Bradford, Andrew P.; Chosich, Justin; Al-Safi, Zain; Polotsky, Alex J.] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO 80045 USA; [Jones, Kenneth] Univ Colorado, Sch Med, Dept Biochem, Aurora, CO 80045 USA; [Kechris, Katerina] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA; [Montague, Michael; Warren, Wesley C.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [May, Margaret C.; Appt, Susan E.] Wake Forest Univ, Ctr Primate, Dept Pathol Comparat Med, Winston Salem, NC 27157 USA; [Kuokkanen, Satu] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10461 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Washington University (WUSTL); Wake Forest University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Polotsky, AJ (corresponding author), Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO 80045 USA.	Alex.Polotsky@ucdenver.edu	Montague, Michael/AAT-7079-2020; Jones, Kenneth/GXF-4945-2022	Montague, Michael/0000-0003-0253-4404; Kechris, Katerina/0000-0002-3725-5459	NIH [R21HD060944]; VRC grant [RR019963, OD010965]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD060944] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR019963] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010965] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VRC grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by: NIH R21HD060944 (AJP and SEA), and the VRC grant RR019963 (currently OD010965). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arianmanesh M, 2011, J ENDOCRINOL, V210, P47, DOI 10.1530/JOE-10-0336; Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508; Baley J, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-8; Bogan RL, 2009, ENDOCRINOLOGY, V150, P1521, DOI 10.1210/en.2008-1201; Bordini B, 2009, J CLIN ENDOCR METAB, V94, P1168, DOI 10.1210/jc.2008-1655; Borengasser SJ, 2014, PHYSIOLOGICAL GENOMI, P00059, DOI [10.1152/physiolgenomics.00059.2014, DOI 10.1152/PHYSIOLGEN0MICS.00059.2014]; Brogan RS, 2010, FERTIL STERIL, V93, P1421, DOI 10.1016/j.fertnstert.2008.12.096; Brown KA, 2007, J STEROID BIOCHEM, V103, P10, DOI 10.1016/j.jsbmb.2006.07.005; Canty-Laird E, 2010, BIOL REPROD, V83, P138, DOI 10.1095/biolreprod.109.082115; Carroll RL, 2007, AM J PRIMATOL, V69, P901, DOI 10.1002/ajp.20396; Carvajal R, 2013, HUM REPROD, V28, P2235, DOI 10.1093/humrep/det116; Christenson L. K., 2010, Animal Reproduction, V7, P129; Civelek M, 2013, HUM MOL GENET, V22, P3023, DOI 10.1093/hmg/ddt159; Civitarese AE, 2008, ENDOCRINOLOGY, V149, P950, DOI 10.1210/en.2007-1444; Civitarese AE, 2010, CELL METAB, V11, P412, DOI 10.1016/j.cmet.2010.04.004; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Dey BK, 2012, MOL BIOL CELL, V23, P4664, DOI 10.1091/mbc.E12-10-0716; Dorfman MD, 2014, ENDOCRINOLOGY, V155, P3098, DOI 10.1210/en.2014-1111; Duffy DM, 1999, J CLIN ENDOCR METAB, V84, P342, DOI 10.1210/jc.84.1.342; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Fogli A, 2003, AM J HUM GENET, V72, P1544, DOI 10.1086/375404; Fogli Anne, 2004, BMC Womens Health, V4, P8, DOI 10.1186/1472-6874-4-8; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002705; GALLO RV, 1981, BIOL REPROD, V24, P771, DOI 10.1095/biolreprod24.4.771; Griffith GJ, 2011, BIOL REPROD, V84, P654, DOI 10.1095/biolreprod.110.087213; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Hayashi KG, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-11; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Hennebold JD, 2010, BIOL REPROD, V83, P165, DOI 10.1095/biolreprod.110.086173; Higgins PB, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-71; Hossain MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-443; Hsieh M, 2005, BIOL REPROD, V73, P1135, DOI 10.1095/biolreprod.105.042739; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Iwanaga R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3219; Jain A, 2007, J CLIN ENDOCR METAB, V92, P2468, DOI 10.1210/jc.2006-2274; Jasinska AJ, 2013, ILAR J, V54, P122, DOI 10.1093/ilar/ilt049; Jasinska AJ, 2012, HUM MOL GENET, V21, P3307, DOI 10.1093/hmg/dds160; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Jungheim ES, 2010, ENDOCRINOLOGY, V151, P4039, DOI 10.1210/en.2010-0098; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Kavanagh K, 2007, OBESITY, V15, P1666, DOI 10.1038/oby.2007.199; Kerr B, 2009, REPRODUCTION, V138, P131, DOI 10.1530/REP-08-0474; Khalaf M, 2013, EUR J ENDOCRINOL, V168, P437, DOI 10.1530/EJE-12-0891; Khan S, 2013, CYTOKINE GROWTH F R, V24, P503, DOI 10.1016/j.cytogfr.2013.10.001; Kim SH, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-8; Kim SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046194; Kim YJ, 2012, STEM CELLS DEV, V21, P1749, DOI 10.1089/scd.2011.0429; Koomen M, 2002, HUM MOL GENET, V11, P273, DOI 10.1093/hmg/11.3.273; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; Kundu MC, 2013, SYST BIOL REPROD MED, V59, P74, DOI 10.3109/19396368.2012.752547; Lake JK, 1997, INT J OBESITY, V21, P432, DOI 10.1038/sj.ijo.0800424; Law DCG, 2007, HUM REPROD, V22, P414, DOI 10.1093/humrep/de1400; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LEWIS DS, 1989, AM J PHYSIOL, V257, pR1128, DOI 10.1152/ajpregu.1989.257.5.R1128; Li FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041844; Li Hong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P2367; Ma TH, 2011, J APPL GENET, V52, P481, DOI 10.1007/s13353-011-0055-z; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; McLaughlin M, 2014, MOL HUM REPROD, V20, P736, DOI 10.1093/molehr/gau037; McReynolds S, 2012, FERTIL STERIL, V98, P1574, DOI 10.1016/j.fertnstert.2012.08.012; Meerson A, 2013, DIABETOLOGIA, V56, P1971, DOI 10.1007/s00125-013-2950-9; Metwally M, 2008, FERTIL STERIL, V90, P714, DOI 10.1016/j.fertnstert.2007.07.1290; Metwally M, 2010, FERTIL STERIL, V94, P290, DOI 10.1016/j.fertnstert.2009.03.021; Mitchell LM, 2004, HUM REPROD, V19, P30, DOI 10.1093/humrep/deh032; Molskness TA, 2007, AM J PRIMATOL, V69, P890, DOI 10.1002/ajp.20395; Mubiru JN, 2011, J MED PRIMATOL, V40, P335, DOI 10.1111/j.1600-0684.2011.00495.x; MUNRO CJ, 1991, CLIN CHEM, V37, P838; Nakayama K, 2013, HUM GENET, V132, P201, DOI 10.1007/s00439-012-1240-9; Ndiaye K, 2005, BIOL REPROD, V73, P324, DOI 10.1095/biolreprod.104.038026; Newman TK, 2002, AM J PRIMATOL, V56, P237, DOI 10.1002/ajp.1078; Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050; Nothnick WB, 2012, REPRODUCTION, V143, P559, DOI 10.1530/REP-11-0240; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Park Hyeong-Kyu, 2014, F1000Prime Rep, V6, P73, DOI 10.12703/P6-73; Polotsky AJ, 2010, FERTIL STERIL, V93, P2004, DOI 10.1016/j.fertnstert.2008.12.059; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ramachandran N, 2013, ACTA NEUROPATHOL, V125, P439, DOI 10.1007/s00401-012-1073-6; Rao JU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020754; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Garcia-Silva MR, 2012, GENES-BASEL, V3, P603, DOI 10.3390/genes3040603; Russell DL, 2003, ENDOCRINOLOGY, V144, P1020, DOI 10.1210/en.2002-220434; Ryter SW, 2014, CURR OPIN CLIN NUTR, V17, P329, DOI 10.1097/MCO.0000000000000068; Salilew-Wondim D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106795; Sano M, 2012, GLYCOBIOLOGY, V22, P714, DOI 10.1093/glycob/cws010; Santoro N, 2004, J CLIN ENDOCR METAB, V89, P2622, DOI 10.1210/jc.2003-031578; SHERMAN BM, 1974, J CLIN ENDOCR METAB, V39, P145, DOI 10.1210/jcem-39-1-145; Sirotkin AV, 2009, J CELL PHYSIOL, V219, P415, DOI 10.1002/jcp.21689; Smith GCS, 2007, AM J PUBLIC HEALTH, V97, P157, DOI 10.2105/AJPH.2005.074294; SMITH MS, 1975, ENDOCRINOLOGY, V96, P219, DOI 10.1210/endo-96-1-219; Stephens SM, 2013, COMPARATIVE MED, V63, P432; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Taylor AE, 1997, J CLIN ENDOCR METAB, V82, P2248, DOI 10.1210/jc.82.7.2248; Tworoger SS, 2006, CANCER EPIDEM BIOMAR, V15, P2494, DOI 10.1158/1055-9965.EPI-06-0671; Urano Y, 2008, P NATL ACAD SCI USA, V105, P16513, DOI 10.1073/pnas.0807450105; Vanorny DA, 2014, MOL ENDOCRINOL, V28, P499, DOI 10.1210/me.2013-1288; Vickers KC, 2014, P NATL ACAD SCI USA, V111, P14518, DOI 10.1073/pnas.1215767111; Wang FC, 2010, PROSTAG OTH LIPID M, V92, P25, DOI 10.1016/j.prostaglandins.2010.02.002; Weiss J, 2012, MAMM GENOME, V23, P346, DOI 10.1007/s00335-011-9388-5; World Health Organization, WORLD HEALTH STATIST; Wozny M, 2012, COMP BIOCHEM PHYS C, V156, P221, DOI 10.1016/j.cbpc.2012.05.005; Wu LL, 2015, DEVELOPMENT, V142, P681, DOI 10.1242/dev.114850; Wu LLY, 2010, ENDOCRINOLOGY, V151, P5438, DOI 10.1210/en.2010-0551; Wu S, 2011, J NEUROSCI, V31, P184, DOI 10.1523/JNEUROSCI.2974-10.2011; Yang YZ, 2013, THERIOGENOLOGY, V79, P633, DOI 10.1016/j.theriogenology.2012.11.017; Yeung EH, 2013, INT J OBESITY, V37, P237, DOI 10.1038/ijo.2012.9; Yuan Y, 2014, BIORESOURCE TECHNOL, V174, P1, DOI 10.1016/j.biortech.2014.07.104; Zamberlam G, 2014, FREE RADICAL BIO MED, V74, P237, DOI 10.1016/j.freeradbiomed.2014.06.018; Zhang J, 2012, FRONTIERS IN BIOSCIE, V18, P588; Zhang J, 2013, ACTA BIOCH BIOPH SIN, V45, P289, DOI 10.1093/abbs/gmt008; Zhao YL, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-72	118	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135163	10.1371/journal.pone.0135163	http://dx.doi.org/10.1371/journal.pone.0135163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258540	Green Published, gold, Green Submitted			2022-12-27	WOS:000359352600043
J	Casillas-Espinosa, PM; Hicks, A; Jeffreys, A; Snutch, TP; O'Brien, TJ; Powell, KL				Casillas-Espinosa, Pablo Miguel; Hicks, Ashleigh; Jeffreys, Amy; Snutch, Terrance P.; O'Brien, Terence J.; Powell, Kim L.			Z944, a Novel Selective T-Type Calcium Channel Antagonist Delays the Progression of Seizures in the Amygdala Kindling Model	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; STATUS EPILEPTICUS; PILOCARPINE MODEL; ACQUIRED EPILEPSY; ELECTRICAL STIMULATION; HOMEOSTATIC MECHANISMS; ABSENCE EPILEPSY; ALPHA(1) SUBUNIT; GENE-EXPRESSION; CA2+ CHANNELS	Temporal lobe epilepsy (TLE) is the most common form of drug resistant epilepsy. Current treatment is symptomatic, suppressing seizures, but has no disease modifying effect on epileptogenesis. We examined the effects of Z944, a potent T-type calcium channel antagonist, as an anti-seizure agent and against the progression of kindling in the amygdala kindling model of TLE. The anti-seizure efficacy of Z944 (5mg/kg, 10mg/kg, 30mg/kg and 100mg/kg) was assessed in fully kindled rats (5 class V seizures) as compared to vehicle, ethosuximide (ETX, 100mg/kg) and carbamazepine (30mg/kg). Each animal received the seven treatments in a randomised manner. Seizure class and duration elicited by six post-drug stimulations was determined. To investigate for effects in delaying the progression of kindling, naive animals received Z944 (30mg/kg), ETX (100mg/kg) or vehicle 30-minutes prior to each kindling stimulation up to a maximum of 30 stimulations, with seizure class and duration recorded after each stimulation. At the completion of drug treatment, Ca(V)3.1, Ca(V)3.2 and Ca(V)3.3 mRNA expression levels were assessed in the hippocampus and amygdala using qPCR. Z944 was not effective at suppressing seizures in fully kindled rats compared to vehicle. Animals receiving Z944 required significantly more stimulations to evoke a class III (p<0.05), IV (p<0.01) or V (p<0.0001) seizure, and to reach a fully kindled state (p<0.01), than animals receiving vehicle. There was no significant difference in the mRNA expression of the T-type Ca2+ channels in the hippocampus or amygdala. Our results show that selectively targeting T-type Ca2+ channels with Z944 inhibits the progression of amygdala kindling. This could be a potential for a new therapeutic intervention to mitigate the development and progression of epilepsy.	[Casillas-Espinosa, Pablo Miguel; Hicks, Ashleigh; Jeffreys, Amy; O'Brien, Terence J.; Powell, Kim L.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Snutch, Terrance P.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	Royal Melbourne Hospital; University of Melbourne; University of British Columbia	Powell, KL (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia.	kpowell@unimelb.edu.au	O'Brien, Terence/L-8102-2013; Snutch, Terrance P/L-3464-2019; O'Brien, Terence/AAU-5525-2021	O'Brien, Terence/0000-0002-7198-8621; Snutch, Terrance P/0000-0001-5182-1296; Powell, Kim/0000-0002-9007-4614	Canadian Institutes of Health Research [10677]; Canada Research Chair in Biotechnology and Genomics-Neurobiology; Melbourne Research Scholarship; NH&MRC Project Grant [628723]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biotechnology and Genomics-Neurobiology; Melbourne Research Scholarship; NH&MRC Project Grant	Work in the laboratory of Terrance P. Snutch was supported by an operating grant from the Canadian Institutes of Health Research (#10677) and a Canada Research Chair in Biotechnology and Genomics-Neurobiology. Pablo M. Casillas-Espinosa was funded by a Melbourne Research Scholarship. Work for this project was supported in part by a NH&MRC Project Grant to Kim Powell (#628723).	Beck H, 1998, EPILEPSY RES, V32, P321, DOI 10.1016/S0920-1211(98)00062-X; Becker AJ, 2008, J NEUROSCI, V28, P13341, DOI 10.1523/JNEUROSCI.1421-08.2008; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Blair RE, 2004, J PHARMACOL EXP THER, V310, P871, DOI 10.1124/jpet.104.068478; Cain S. M., 2012, JASPERS BASIC MECHAN; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Compan V, 2004, J NEUROSCI, V24, P412, DOI 10.1523/JNEUROSCI.2806-03.2004; David LS, 2010, CHANNELS, V4, P375, DOI 10.4161/chan.4.5.12874; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Faas GC, 1996, NEUROSCIENCE, V75, P57, DOI 10.1016/0306-4522(96)00254-0; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Liang JM, 2006, NEUROSCI LETT, V406, P27, DOI 10.1016/j.neulet.2006.06.073; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOSCHER W, 1993, EUR J PHARMACOL, V232, P147, DOI 10.1016/0014-2999(93)90768-D; MATHERN GW, 1995, EPILEPSY RES, V21, P133, DOI 10.1016/0920-1211(95)00014-2; McIntyre DC, 2002, EPILEPSY RES, V50, P79, DOI 10.1016/S0920-1211(02)00071-2; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; Mittman S, 1999, NEUROSCI LETT, V269, P121, DOI 10.1016/S0304-3940(99)00319-5; Mittman S, 1999, NEUROSCI LETT, V274, P143, DOI 10.1016/S0304-3940(99)00716-8; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Murbartian J, 2004, J NEUROPHYSIOL, V92, P3399, DOI 10.1152/jn.00498.2004; Otsuki K, 1998, EPILEPSY RES, V31, P101, DOI 10.1016/S0920-1211(98)00018-7; Pal S, 2000, CELL CALCIUM, V28, P181, DOI 10.1054/ceca.2000.0146; Pal S, 1999, BRAIN RES, V851, P20, DOI 10.1016/S0006-8993(99)02035-1; Paxinos G., 2007, THE RAT BRAIN IN STE; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Powell KL, 2014, BRIT J CLIN PHARMACO, V77, P729, DOI 10.1111/bcp.12205; Powell KL, 2009, J NEUROSCI, V29, P371, DOI 10.1523/JNEUROSCI.5295-08.2009; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raza M, 2004, P NATL ACAD SCI USA, V101, P17522, DOI 10.1073/pnas.0408155101; Raza M, 2001, BRAIN RES, V903, P1, DOI 10.1016/S0006-8993(01)02127-8; Sanabria ERC, 2001, J PHYSIOL-LONDON, V532, P205, DOI 10.1111/j.1469-7793.2001.0205g.x; Su H, 2002, J NEUROSCI, V22, P3645; Tringham E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003120; Yaari Y, 2007, J PHYSIOL-LONDON, V580, P435, DOI 10.1113/jphysiol.2007.127670	37	34	35	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0130012	10.1371/journal.pone.0130012	http://dx.doi.org/10.1371/journal.pone.0130012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274319	Green Published, gold			2022-12-27	WOS:000359493600003
J	Davies, MN; Verdi, S; Burri, A; Trzaskowski, M; Lee, M; Hettema, JM; Jansen, R; Boomsma, DI; Spector, TD				Davies, Matthew N.; Verdi, Serena; Burri, Andrea; Trzaskowski, Maciej; Lee, Minyoung; Hettema, John M.; Jansen, Rick; Boomsma, Dorret I.; Spector, Tim D.			Generalised Anxiety Disorder - A Twin Study of Genetic Architecture, Genome-Wide Association and Differential Gene Expression	PLOS ONE			English	Article							GABA(A) RECEPTOR FUNCTION; SENSITIVITY INDEX; HERITABILITY; DEPRESSION; MODULATION; NETWORK	Generalised Anxiety Disorder (GAD) is a common anxiety-related diagnosis, affecting approximately 5% of the adult population. One characteristic of GAD is a high degree of anxiety sensitivity (AS), a personality trait which describes the fear of arousal-related sensations. Here we present a genome-wide association study of AS using a cohort of 730 MZ and DZ female twins. The GWAS showed a significant association for a variant within the RBFOX1 gene. A heritability analysis of the same cohort also confirmed a significant genetic component with h2 of 0.42. Additionally, a subset of the cohort (25 MZ twins discordant for AS) was studied for evidence of differential expression using RNA-seq data. Significant differential expression of two exons with the ITM2B gene within the discordant MZ subset was observed, a finding that was replicated in an independent cohort. While previous research has shown that anxiety has a high comorbidity with a variety of psychiatric and neurodegenerative disorders, our analysis suggests a novel etiology specific to AS.	[Davies, Matthew N.; Verdi, Serena; Burri, Andrea; Spector, Tim D.] Kings Coll London, Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Davies, Matthew N.] Inst Canc Res, Translat Oncogen Lab, Ctr Evolut & Canc, Div Mol Pathol, London SW3 6JB, England; [Trzaskowski, Maciej] Kings Coll London, Social Genet & Dev Psychiat, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Lee, Minyoung; Hettema, John M.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA USA; [Jansen, Rick] Vrije Univ Amsterdam, Dept Biol Psychol, Neurosci Campus, Amsterdam, Netherlands; [Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Psychiat, Neurosci Campus, Amsterdam, Netherlands	University of London; King's College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; King's College London; Virginia Commonwealth University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Davies, MN (corresponding author), Kings Coll London, Twin Res & Genet Epidemiol, London WC2R 2LS, England.	matthew.davies@icr.ac.uk	Boomsma, Dorret I/AAX-4470-2020	Jansen, Rick/0000-0002-3333-6737; Burri, Andrea/0000-0002-4705-3551; Trzaskowski, Maciej/0000-0001-8559-6525; Verdi, Serena/0000-0002-2421-4818	EU FP7 grant EuroBATS [259749]; National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; Swiss National Science Foundation	EU FP7 grant EuroBATS; National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study is supported by the EU FP7 grant EuroBATS (No. 259749) and also receives support from the National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust and NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. Tim Spector is holder of an ERC Advanced Principal Investigator award. Andrea Burri holds an Ambizione personal career fellowship from the Swiss National Science Foundation. SNP Genotyping was performed by The Wellcome Trust Sanger Institute and National Eye Institute via NIH/CIDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Allan NP, 2014, J ANXIETY DISORD, V28, P266, DOI 10.1016/j.janxdis.2013.12.004; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beckmann H, 2000, World J Biol Psychiatry, V1, P35, DOI 10.3109/15622970009150564; Bedrosian TA, 2011, P NATL ACAD SCI USA, V108, P11686, DOI 10.1073/pnas.1103098108; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Burri A, 2012, J SEX MED, V9, P1887, DOI 10.1111/j.1743-6109.2012.02710.x; Castillo-Fernandez JE, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0060-z; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Davies MN, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r56; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; De Ayala RJ, 2005, EDUC PSYCHOL MEAS, V65, P836, DOI 10.1177/0013164405278557; de Carvalho HW, 2014, REV BRAS PSIQUIATR, V36, P285, DOI 10.1590/1516-4446-2013-1329; Deacon BJ, 2003, BEHAV RES THER, V41, P1427, DOI 10.1016/S0005-7967(03)00065-2; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Espana J, 2010, BIOL PSYCHIAT, V67, P513, DOI 10.1016/j.biopsych.2009.06.015; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Farb DH, 2014, PHARMACOL REV, V66, P1002, DOI 10.1124/pr.114.009126; Ferretti L, 2001, J GERIATR PSYCH NEUR, V14, P52, DOI 10.1177/089198870101400111; Fogel BL, 2012, HUM MOL GENET, V21, P4171, DOI 10.1093/hmg/dds240; Frances A., 2013, MAKING DSM 5 CONCEPT, P95, DOI [10.1007/978-1-4614-6504-1, DOI 10.1007/978-1-4614-6504-1, 10.1007/978-1-4614-6504-1_7, DOI 10.1007/978-1-4614-6504-1_1]; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; Gray J A, 1983, Encephale, V9, p161B; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hettema JM, 2015, MOL PSYCHIATRY UNDER; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jansen R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-33; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kilger E, 2011, J BIOL CHEM, V286, P37446, DOI 10.1074/jbc.M111.288373; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; KOFUJI P, 1991, J NEUROCHEM, V56, P713, DOI 10.1111/j.1471-4159.1991.tb08209.x; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; Lamprianou Iasonas, 2013, J Appl Meas, V14, P79; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lilienfeld SO, 1996, J ANXIETY DISORD, V10, P411, DOI 10.1016/0887-6185(96)00020-5; Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207; Mostafavi S., 2013, MOL PSYCHIAT; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Naragon-Gainey K, 2010, PSYCHOL BULL, V136, P128, DOI 10.1037/a0018055; Neale M. C., 2015, PSYCHOMETRIKA; Olatunji BO, 2009, PSYCHOL BULL, V135, P974, DOI 10.1037/a0017428; Parts L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001276; Plehn K, 2002, J ANXIETY DISORD, V16, P455, DOI 10.1016/S0887-6185(02)00129-9; Poisbeau P, 1999, J NEUROSCI, V19, P674; Rector NA, 2007, BEHAV RES THER, V45, P1967, DOI 10.1016/j.brat.2006.09.017; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; REISS S, 1988, BEHAV RES THER, V26, P341, DOI 10.1016/0005-7967(88)90088-5; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rodriguez BF, 2004, BEHAV RES THER, V42, P79, DOI 10.1016/S0005-7967(03)00074-3; SCHEELKRUGER J, 1980, BRAIN RES BULL, V5, P261, DOI 10.1016/0361-9230(80)90043-X; Schienle A, 2011, EUR ARCH PSY CLIN N, V261, P303, DOI 10.1007/s00406-010-0147-5; SHOSTAK BB, 1990, BEHAV RES THER, V28, P513, DOI 10.1016/0005-7967(90)90138-9; Simon NM, 2009, J CLIN PSYCHIAT, V70, P10, DOI 10.4088/JCP.s.7002.02; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Stein MB, 1999, AM J PSYCHIAT, V156, P246; Trzaskowski M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058676; Tyrer P, 2006, LANCET, V368, P2156, DOI 10.1016/S0140-6736(06)69865-6; Viana AG, 2008, BEHAV RES THER, V46, P737, DOI 10.1016/j.brat.2008.03.002; Waszczuk MA, 2013, J ANXIETY DISORD, V27, P475, DOI 10.1016/j.janxdis.2013.05.008; Wittchen HU, 2002, DEPRESS ANXIETY, V16, P162, DOI 10.1002/da.10065; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhao WW, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-26; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	71	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134865	10.1371/journal.pone.0134865	http://dx.doi.org/10.1371/journal.pone.0134865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274327	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600043
J	Tiedke, J; Borner, J; Beeck, H; Kwiatkowski, M; Schmidt, H; Thiel, R; Fabrizius, A; Burmester, T				Tiedke, Jessica; Borner, Janus; Beeck, Hendrik; Kwiatkowski, Marcel; Schmidt, Hanno; Thiel, Ralf; Fabrizius, Andrej; Burmester, Thorsten			Evaluating the Hypoxia Response of Ruffe and Flounder Gills by a Combined Proteome and Transcriptome Approach	PLOS ONE			English	Article							GENE-EXPRESSION; PLATICHTHYS-FLESUS; ENERGY-METABOLISM; GLOBIN EXPRESSION; JUVENILE FLOUNDER; OXYGEN; PROTEINS; FISH; TOLERANCE; STRESS	Hypoxia has gained ecological importance during the last decades, and it is the most dramatically increasing environmental factor in coastal areas and estuaries. The gills of fish are the prime target of hypoxia and other stresses. Here we have studied the impact of the exposure to hypoxia (1.5 mg O-2/l for 48 h) on the protein expression of the gills of two estuarine fish species, the ruffe (Gymnocephalus cernua) and the European flounder (Platichthys flesus). First, we obtained the transcriptomes of mixed tissues (gills, heart and brain) from both species by Illumina next-generation sequencing. Then, the gill proteomes were investigated using two-dimensional gel electrophoresis and mass spectrometry. Quantification of the normalized proteome maps resulted in a total of 148 spots in the ruffe, of which 28 (18.8%) were significantly regulated (> 1.5-fold). In the flounder, 121 spots were found, of which 27 (22.3%) proteins were significantly regulated. The transcriptomes were used for the identification of these proteins, which was successful for 15 proteins of the ruffe and 14 of the flounder. The ruffe transcriptome dataset comprised 87,169,850 reads, resulting in an assembly of 72,108 contigs (N50 = 1,828 bp). 20,860 contigs (26.93%) had blastx hits with E < 1e-5 in the human sequences in the RefSeq database, representing 14,771 unique accession numbers. The flounder transcriptome with 78,943,030 reads assembled into 49,241 contigs (N50 = 2,106 bp). 20,127 contigs (40.87%) had a hit with human proteins, corresponding to 14,455 unique accession numbers. The regulation of selected genes was confirmed by quantitative real-time RT-PCR. Most of the regulated proteins that were identified by this approach function in the energy metabolism, while others are involved in the immune response, cell signalling and the cytoskeleton.	[Tiedke, Jessica; Borner, Janus; Beeck, Hendrik; Fabrizius, Andrej; Burmester, Thorsten] Univ Hamburg, Inst Zool, Martin Luther King Pl 3, Hamburg, Germany; [Kwiatkowski, Marcel] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany; [Schmidt, Hanno] Johannes Gutenberg Univ Mainz, Inst Mol Genet, D-55122 Mainz, Germany; [Thiel, Ralf] Univ Hamburg, Zool Museum, Ctr Nat Hist, Hamburg, Germany	University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; University of Hamburg	Burmester, T (corresponding author), Univ Hamburg, Inst Zool, Martin Luther King Pl 3, Hamburg, Germany.	thorsten.burmester@uni-hamburg.de	Schmidt, Hanno/H-3345-2018; Burmester, Thorsten/I-7225-2013; Borner, Janus/E-1430-2012; Kwiatkowski, Marcel/M-3384-2016	Schmidt, Hanno/0000-0001-8915-891X; Burmester, Thorsten/0000-0002-5772-7863; Borner, Janus/0000-0001-9612-6668; Kwiatkowski, Marcel/0000-0002-5804-6031	Estuary and Wetland Research Graduate School Hamburg (ESTRADE) - Hamburg Science and Research Foundation	Estuary and Wetland Research Graduate School Hamburg (ESTRADE) - Hamburg Science and Research Foundation	This study was supported by the Estuary and Wetland Research Graduate School Hamburg (ESTRADE) as member of the State Excellence Initiative (LExI) funded by the Hamburg Science and Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaraju NV, 2012, FISH PHYSIOL BIOCHEM, V38, P615, DOI 10.1007/s10695-011-9542-8; Adams SM, 2005, MAR POLLUT BULL, V51, P649, DOI 10.1016/j.marpolbul.2004.11.040; [Anonymous], [No title captured]; BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Breitburg D, 2002, ESTUARIES, V25, P767, DOI 10.1007/BF02804904; Burmester T, 2007, ADV EXP MED BIOL, V618, P169; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; DALLA VIA J, 1994, MAR ECOL PROG SER, V111, P17, DOI 10.3354/meps111017; Diaz RJ, 2001, J ENVIRON QUAL, V30, P275, DOI 10.2134/jeq2001.302275x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Elliott M., 2002, FISHES ESTUARIES; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; Holker F, 1998, J GREAT LAKES RES, V24, P186; JORGENSEN JB, 1980, COMP BIOCHEM PHYS B, V67, P243, DOI 10.1016/0305-0491(80)90139-X; Kohlbacher O, 2007, BIOINFORMATICS, V23, pE191, DOI 10.1093/bioinformatics/btl299; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Leveelahti L, 2011, COMP BIOCHEM PHYS D, V6, P370, DOI 10.1016/j.cbd.2011.08.001; Liao XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062308, DOI 10.1371/J0URNAL.P0NE.0062308]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandic M, 2014, MOL ECOL, V23, P6091, DOI 10.1111/mec.12991; McLean M, 2007, RUFFE A NEW THREAT T, P8; McLusky D.S., 2004, ESTUARINE ECOSYSTEM; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Nikinmaa M, 2005, AM J PHYSIOL-REG I, V288, pR1079, DOI 10.1152/ajpregu.00626.2004; Nikinmaa M, 2001, RESP PHYSIOL, V128, P317, DOI 10.1016/S0034-5687(01)00309-7; Nilsson GE, 2007, J EXP BIOL, V210, P2403, DOI 10.1242/jeb.000281; Ogle DH, 1998, J GREAT LAKES RES, V24, P170, DOI 10.1016/S0380-1330(98)70811-1; Perry S., 1998, FISH RESP; Petersen LH, 2011, PHYSIOL BIOCHEM ZOOL, V84, P18, DOI 10.1086/657286; Pritchard D.W., 1967, ESTUARIES NO 83, P3; Rabalais NN, 2001, J ENVIRON QUAL, V30, P320, DOI 10.2134/jeq2001.302320x; Rabalais NN, 2002, BIOSCIENCE, V52, P129, DOI 10.1641/0006-3568(2002)052[0129:BSIPGO]2.0.CO;2; Richards J, 2009, FISH PHYSL; Roberts JJ, 2009, J EXP MAR BIOL ECOL, V381, pS132, DOI 10.1016/j.jembe.2009.07.017; Roesner A, 2008, FEBS J, V275, P3633, DOI 10.1111/j.1742-4658.2008.06508.x; Roesner A, 2006, J EXP BIOL, V209, P2129, DOI 10.1242/jeb.02243; Sanders BM, 1995, COMP BIOCHEM PHYS C, V112, P335, DOI 10.1016/0742-8413(95)02029-2; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sollid J, 2003, J EXP BIOL, V206, P3667, DOI 10.1242/jeb.00594; Sollid J, 2006, RESP PHYSIOL NEUROBI, V154, P241, DOI 10.1016/j.resp.2006.02.006; STANLEY DW, 1992, ESTUARIES, V15, P270, DOI 10.2307/1352775; STEFFENSEN JF, 1982, ENVIRON BIOL FISH, V7, P157, DOI 10.1007/BF00001786; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Tallqvist M, 1999, J EXP MAR BIOL ECOL, V242, P75, DOI 10.1016/S0022-0981(99)00096-9; Tiedke J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090778; Tiedke J, 2013, BIOCHEM BIOPH RES CO, V441, P624, DOI 10.1016/j.bbrc.2013.10.104; Tomanek L, 2011, J EXP BIOL, V214, P1836, DOI 10.1242/jeb.055475; Ton C, 2003, PHYSIOL GENOMICS, V13, P97, DOI 10.1152/physiolgenomics.00128.2002; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; van der Meer DLM, 2005, AM J PHYSIOL-REG I, V289, pR1512, DOI 10.1152/ajpregu.00089.2005; VANRAAIJ MTM, 1994, COMP BIOCHEM PHYS A, V109, P755, DOI 10.1016/0300-9629(94)90219-4; Waede M., 1954, Kieler Meeresforschungen, V10, P58; Wawrowski A, 2011, J COMP PHYSIOL B, V181, P199, DOI 10.1007/s00360-010-0518-2; Wenger RH, 2000, J EXP BIOL, V203, P1253	61	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135911	10.1371/journal.pone.0135911	http://dx.doi.org/10.1371/journal.pone.0135911			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26273839	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600132
J	Gawlitza, M; Purz, S; Kubiessa, K; Boehm, A; Barthel, H; Kluge, R; Kahn, T; Sabri, O; Stumpp, P				Gawlitza, Matthias; Purz, Sandra; Kubiessa, Klaus; Boehm, Andreas; Barthel, Henryk; Kluge, Regine; Kahn, Thomas; Sabri, Osama; Stumpp, Patrick			In Vivo Correlation of Glucose Metabolism, Cell Density and Microcirculatory Parameters in Patients with Head and Neck Cancer: Initial Results Using Simultaneous PET/MRI	PLOS ONE			English	Article							APPARENT DIFFUSION-COEFFICIENT; F-18-FDG UPTAKE; WEIGHTED MRI; FDG PET/CT; CARCINOMA; SURVIVAL; LESIONS	Objective To demonstrate the feasibility of simultaneous acquisition of F-18-FDG-PET, diffusion-weighted imaging (DWI) and T1-weighted dynamic contrast-enhanced MRI (T1w-DCE) in an integrated simultaneous PET/MRI in patients with head and neck squamous cell cancer (HNSCC) and to investigate possible correlations between these parameters. Methods 17 patients that had given informed consent (15 male, 2 female) with biopsy-proven HNSCC underwent simultaneous F-18-FDG-PET/MRI including DWI and T1w-DCE. SUVmax, SUVmean, ADC(mean), ADC(min) and K-trans, k(ep) and v(e) were measured for each tumour and correlated using Spearman's rho. Results Significant correlations were observed between SUVmean and K-trans (rho = 0.43; p <= 0.05); SUVmean and kep (rho = 0.44; p <= 0.05); K-trans and kep (rho = 0.53; p <= 0.05); and between kep and v(e) (rho = -0.74; p <= 0.01). There was a trend towards statistical significance when correlating SUVmax and ADC(min) (rho = -0.35; p = 0.08); SUVmax and K-trans (rho = 0.37; p = 0.07); SUVmax and kep (rho = 0.39; p = 0.06); and ADC(mean) and v(e) (rho = 0.4; p = 0.06). Conclusion Simultaneous F-18-FDG-PET/MRI including DWI and T1w-DCE in patients with HNSCC is feasible and allows depiction of complex interactions between glucose metabolism, microcirculatory parameters and cellular density.	[Gawlitza, Matthias; Kubiessa, Klaus; Kahn, Thomas; Stumpp, Patrick] Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, D-04103 Leipzig, Germany; [Purz, Sandra; Barthel, Henryk; Kluge, Regine; Sabri, Osama] Univ Hosp Leipzig, Dept Nucl Med, D-04103 Leipzig, Germany; [Boehm, Andreas] Univ Hosp Leipzig, ENT Dept, D-04103 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Gawlitza, M (corresponding author), Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Liebigstr 20, D-04103 Leipzig, Germany.	matthias.gawlitza@medizin.uni-leipzig.de		Sabri, Osama/0000-0002-6425-3504; Boehm, Andreas/0000-0001-9511-9167	German Research Foundation (DFG) [SA669/9-1]; German Research Foundation (DFG); Universitat Leipzig	German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig	This study has received funding by the German Research Foundation (DFG - project SA669/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors' acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing.	Ahn SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071571; Arlinghaus LR, 2011, MAGN RESON IMAGING, V29, P630, DOI 10.1016/j.mri.2011.02.004; Berrak S, 2011, ACAD RADIOL, V18, P1225, DOI 10.1016/j.acra.2011.06.009; Bisdas S, 2008, AM J NEURORADIOL, V29, P1376, DOI 10.3174/ajnr.A1111; Bisdas S, 2010, EUR RADIOL, V20, P2358, DOI 10.1007/s00330-010-1803-x; Cheng HLM, 2009, J MAGN RESON IMAGING, V30, P864, DOI 10.1002/jmri.21916; Choi HS, 2013, KOREAN J RADIOL, V14, P487, DOI 10.3348/kjr.2013.14.3.487; Choi SH, 2011, J NUCL MED, V52, P1056, DOI 10.2967/jnumed.111.089334; Choyke PL, 2003, J MAGN RESON IMAGING, V17, P509, DOI 10.1002/jmri.10304; Chu JP, 2012, CANCER IMAGING, V12, P1, DOI 10.1102/1470-7330.2012.0001; Fruehwald-Pallamar J, 2011, EUR J NUCL MED MOL I, V38, P1009, DOI 10.1007/s00259-010-1718-4; George ML, 2001, BRIT J SURG, V88, P1628, DOI 10.1046/j.0007-1323.2001.01947.x; Ginat DT, 2012, AM J ROENTGENOL, V198, pW597, DOI 10.2214/AJR.11.7424; Gu J, 2011, MOL IMAGING BIOL, V13, P1020, DOI 10.1007/s11307-010-0433-7; Ho KC, 2009, EUR J NUCL MED MOL I, V36, P200, DOI 10.1007/s00259-008-0936-5; Jansen JFA, 2012, INT J RADIAT ONCOL, V82, P299, DOI 10.1016/j.ijrobp.2010.11.022; Kim S, 2010, AM J NEURORADIOL, V31, P262, DOI 10.3174/ajnr.A1817; Knopp MV, 1999, JMRI-J MAGN RESON IM, V10, P260, DOI 10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7; Kobayashi M, 2012, CLIN NUCL MED, V37, P447, DOI 10.1097/RLU.0b013e31823924bb; Kostakoglu L, 2004, J NUCL MED, V45, P56; Kubiessa K, 2014, EUR J NUCL MED MOL I, V41, P639, DOI 10.1007/s00259-013-2633-2; Loeffelbein DJ, 2012, J ORAL MAXIL SURG, V70, P473, DOI 10.1016/j.joms.2011.02.120; Mills SJ, 2010, AM J NEURORADIOL, V31, P549, DOI 10.3174/ajnr.A1844; Minn H, 1997, J NUCL MED, V38, P1907; MINN H, 1995, J NUCL MED, V36, P252; Nakajo M, 2012, CLIN NUCL MED, V37, P475, DOI 10.1097/RLU.0b013e318248524a; Nakajo M, 2010, EUR J NUCL MED MOL I, V37, P2011, DOI 10.1007/s00259-010-1529-7; Ng SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072230; Platzek I, 2013, EUR J NUCL MED MOL I, V40, P6, DOI 10.1007/s00259-012-2248-z; Powell C, 2013, RADIOTHER ONCOL, V106, P112, DOI 10.1016/j.radonc.2012.09.009; Regier M, 2012, EUR J RADIOL, V81, P2913, DOI 10.1016/j.ejrad.2011.11.050; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Sattler B, 2013, MAGN RESON MATER PHY, V26, P159, DOI 10.1007/s10334-012-0347-2; Sauter AW, 2010, TRENDS MOL MED, V16, P508, DOI 10.1016/j.molmed.2010.08.003; Schmidt H, 2013, INVEST RADIOL, V48, P247, DOI 10.1097/RLI.0b013e31828d56a1; Schwenzer NF, 2012, RADIOLOGY, V264, P551, DOI 10.1148/radiol.12111942; Semple SIK, 2004, EUR RADIOL, V14, P2038, DOI 10.1007/s00330-004-2454-6; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Vandecaveye V, 2012, INT J RADIAT ONCOL, V82, P1098, DOI 10.1016/j.ijrobp.2011.02.044; Varoquaux A, 2013, EUR J NUCL MED MOL I, V40, P842, DOI 10.1007/s00259-013-2351-9; von Schulthess GK, 2013, SEMIN NUCL MED, V43, P3, DOI 10.1053/j.semnuclmed.2012.08.005	41	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134749	10.1371/journal.pone.0134749	http://dx.doi.org/10.1371/journal.pone.0134749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270054	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800015
J	Saidi, EA; Davey, PG; Cameron, DJ				Saidi, Eric A.; Davey, Pinakin Gunvant; Cameron, D. Joshua			The Effect of Zeaxanthin on the Visual Acuity of Zebrafish	PLOS ONE			English	Article							PIGMENT OPTICAL-DENSITY; AGE-RELATED MACULOPATHY; MACULAR PIGMENT; LUTEIN SUPPLEMENTATION; OXIDATIVE STRESS; ADULT ZEBRAFISH; EYE DISEASE; CAROTENOIDS; DEGENERATION; RETINA	Oral supplementation of carotenoids such as zeaxanthin or lutein which naturally occur in human retina have been shown to improve vision and prevent progression of damage to advanced AMD in some studies. The zebrafish eye shares many physiological similarities with the human eye and is increasingly being used as model for vision research. We hypothesized that injection of zeaxanthin into the zebrafish eye would improve the visual acuity of the zebrafish over time. Visual acuity, calculated in cycles per degree, was measured in adult zebrafish to establish a consistent baseline using the optokinetic response. Zeaxanthin dissolved into phosphate buffered saline (PBS) or PBS only was injected into the anterior chamber of the right and left eyes of the Zebrafish. Visual acuities were measured at 1 week and 3, 8 and 12 weeks post-injection to compare to baseline values. Repeated measures ANOVA was used to compare visual acuities between fish injected with PBS and zeaxanthin. A significant improvement in visual acuity, 14% better than before the injection (baseline levels), was observed one week after injection with zeaxanthin (p = 0.04). This improvement peaked at more than 30% for some fish a few weeks after the injection and improvement in vision persisted at 3 weeks after injection (p = 0.006). The enhanced visual function was not significantly better than baseline at 8 weeks (p = 0.19) and returned to baseline levels 12 weeks after the initial injection (p = 0.50). Zeaxanthin can improve visual acuity in zebrafish eyes. Further studies are required to develop a better understanding of the role zeaxanthin and other carotenoids play during normal visual function.	[Saidi, Eric A.; Davey, Pinakin Gunvant; Cameron, D. Joshua] Western Univ Hlth Sci, Coll Optometry, Pomona, CA 91766 USA; [Saidi, Eric A.] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA USA	Western University of Health Sciences; Western University of Health Sciences	Cameron, DJ (corresponding author), Western Univ Hlth Sci, Coll Optometry, Pomona, CA 91766 USA.	jcameron@westernu.edu	Davey, Pinakin/AAI-9869-2021; Davey, Pinakin/AAK-9804-2021	Davey, Pinakin/0000-0002-6683-7052; Cameron, Joshua/0000-0002-4821-2761	Western University of Health Sciences	Western University of Health Sciences	Funding was provided by an Intramural Research grant provided by the Western University of Health Sciences to DJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal EM, 2013, NUTRIENTS, V5, P1169, DOI 10.3390/nu5041169; Akuffo KO, 2014, OPHTHAL EPIDEMIOL, V21, P111, DOI 10.3109/09286586.2014.888085; Aronow ME, 2014, CURR OPIN OPHTHALMOL, V25, P186, DOI 10.1097/ICU.0000000000000046; Berendschot TTJM, 2000, INVEST OPHTH VIS SCI, V41, P3322; BONE RA, 1988, INVEST OPHTH VIS SCI, V29, P843; Cameron DJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50832; Chew EY, 2014, JAMA OPHTHALMOL, V132, P272, DOI 10.1001/jamaophthalmol.2013.6636; Chhetri J, 2014, EYE, V28, P367, DOI 10.1038/eye.2014.19; Chucair AJ, 2007, INVEST OPHTH VIS SCI, V48, P5168, DOI 10.1167/iovs.07-0037; Cunvong K, 2013, INVEST OPHTH VIS SCI, V54, P1516, DOI 10.1167/iovs.12-10821; Delcourt C, 2006, INVEST OPHTH VIS SCI, V47, P2329, DOI 10.1167/iovs.05-1235; ENGSTROM KJELL, 1960, ACTA ZOOL [STOCKHOLM], V41, P277; Fadool JM, 2003, DEV BIOL, V258, P277, DOI 10.1016/S0012-1606(03)00125-8; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Gale CR, 2003, INVEST OPHTH VIS SCI, V44, P2461, DOI 10.1167/iovs.02-0929; Gray MP, 2009, INVEST OPHTH VIS SCI, V50, P1515, DOI 10.1167/iovs.08-3010; HANDELMAN GJ, 1988, INVEST OPHTH VIS SCI, V29, P850; Khachik F, 2006, INVEST OPHTH VIS SCI, V47, P5234, DOI 10.1167/iovs.06-0504; Koh HH, 2004, EXP EYE RES, V79, P21, DOI 10.1016/j.exer.2004.03.001; Le HGT, 2012, VISUAL NEUROSCI, V29, P219, DOI 10.1017/S0952523812000296; Loskutova E, 2013, NUTRIENTS, V5, P1962, DOI 10.3390/nu5061962; Ma L, 2012, OPHTHALMOLOGY, V119, P2290, DOI 10.1016/j.ophtha.2012.06.014; Moeller SM, 2006, ARCH OPHTHALMOL-CHIC, V124, P1151, DOI 10.1001/archopht.124.8.1151; Murthy RK, 2014, CUTAN OCUL TOXICOL, V33, P132, DOI 10.3109/15569527.2013.812108; Nolan JM, 2011, VISION RES, V51, P459, DOI 10.1016/j.visres.2010.12.016; Richer Stuart, 2007, Optometry, V78, P213, DOI 10.1016/j.optm.2006.10.019; Rosen R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/687386; Stringham JM, 2010, J FOOD SCI, V75, pR24, DOI 10.1111/j.1750-3841.2009.01447.x; Tan JSL, 2008, OPHTHALMOLOGY, V115, P334, DOI 10.1016/j.ophtha.2007.03.083; Tappeiner C, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-10; Trieschmann M, 2007, EXP EYE RES, V84, P718, DOI 10.1016/j.exer.2006.12.010; Weigert G, 2011, INVEST OPHTH VIS SCI, V52, P8174, DOI 10.1167/iovs.11-7522; Westerfield M, 2007, GUIDE LAB ZEBRAFISH	33	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135211	10.1371/journal.pone.0135211	http://dx.doi.org/10.1371/journal.pone.0135211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267864	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300086
J	Wang, L; Haberland, C; Thurm, C; Bhattacharya, J; Park, KT				Wang, Louise; Haberland, Corinna; Thurm, Cary; Bhattacharya, Jay; Park, K. T.			Health Outcomes in US Children with Abdominal Pain at Major Emergency Departments Associated with Race and Socioeconomic Status	PLOS ONE			English	Article							RACIAL DISPARITIES; CARE; MANAGEMENT; VISITS; ETHNICITY; BURDEN; BIAS	Objective Over 9.6 million ED visits occur annually for abdominal pain in the US, but little is known about the medical outcomes of these patients based on demographics. We aimed to identify disparities in outcomes among children presenting to the ED with abdominal pain linked to race and SES. Methods Data from 4.2 million pediatric encounters of abdominal pain were analyzed from 43 tertiary US children's hospitals, including 2.0 million encounters in the emergency department during 2004-2011. Abdominal pain was categorized as functional or organic abdominal pain. Appendicitis (with and without perforation) was used as a surrogate for abdominal pain requiring emergent care. Multivariate analysis estimated likelihood of hospitalizations, radiologic imaging, ICU admissions, appendicitis, appendicitis with perforation, and time to surgery and hospital discharge. Results Black and low income children had increased odds of perforated appendicitis (aOR, 1.42, 95% CI, 1.32-1.53; aOR, 1.20, 95% CI 1.14 - 1.25). Blacks had increased odds of an ICU admission (aOR, 1.92, 95% CI 1.53 - 2.42) and longer lengths of stay (aHR, 0.91, 95% CI 0.86 - 0.96) than Whites. Minorities and low income also had lower rates of imaging for their appendicitis, including CT scans. The combined effect of race and income on perforated appendicitis, hospitalization, and time to surgery was greater than either separately. Conclusions Based on race and SES, disparity of health outcomes exists in the acute ED setting among children presenting with abdominal pain, with differences in appendicitis with perforation, length of stay, and time until surgery.	[Wang, Louise] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Haberland, Corinna] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Thurm, Cary] Childrens Hosp Assoc, Overland Pk, KS USA; [Bhattacharya, Jay; Park, K. T.] Stanford Univ, Ctr Hlth Policy Primary Care Outcomes Res, Stanford, CA 94305 USA; [Bhattacharya, Jay] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Bhattacharya, Jay] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Park, K. T.] Stanford Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Stanford, CA 94305 USA	Stanford University; Stanford University; Children's Mercy Hospital; Stanford University; Stanford University; Stanford University; Stanford University	Park, KT (corresponding author), Stanford Univ, Ctr Hlth Policy Primary Care Outcomes Res, Stanford, CA 94305 USA.	ktpark@stanford.edu			Medical Scholars Program at Stanford University School of Medicine; NASPGHAN Foundation; CDEHA [P30 AG17253]; NIH [R21 AG041112, DK094868]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK094868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG041112] Funding Source: NIH RePORTER	Medical Scholars Program at Stanford University School of Medicine; NASPGHAN Foundation; CDEHA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	LW received research support from the Medical Scholars Program at Stanford University School of Medicine and the NASPGHAN Foundation for this study. JB is supported by CDEHA P30 AG17253 and NIH R21 AG041112. KP is supported by NIH DK094868. The manuscript contents are solely the responsibility of the authors, performed independent of all funding sources, and do not necessarily represent the official views of the NIH, NASPGHAN, or Stanford University.	Ben-Isaac E, 2010, PEDIATRICS, V125, P454, DOI 10.1542/peds.2009-0544; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Byrne A, 2015, ADV HEALTH SCI EDUC, V20, P1255, DOI 10.1007/s10459-015-9600-6; Cone DC, 2003, ACAD EMERG MED, V10, P1176, DOI 10.1197/S1069-6563(03)00486-X; Dhroove G, 2010, J PEDIATR GASTR NUTR, V51, P579, DOI 10.1097/MPG.0b013e3181de0639; Doobinin KA, 2003, PEDIATR EMERG CARE, V19, P10, DOI 10.1097/00006565-200302000-00003; Groholt EK, 2003, EUR J EPIDEMIOL, V18, P965, DOI 10.1023/A:1025889912964; Haltiwanger Katherine A, 2006, Cal J Emerg Med, V7, P26; Hambrook JT, 2010, CONGENIT HEART DIS, V5, P285, DOI 10.1111/j.1747-0803.2010.00414.x; Henneman PL, 2009, ANN EMERG MED, V53, P249, DOI 10.1016/j.annemergmed.2008.07.016; Hofer TP, 1998, HEALTH SERV RES, V33, P243; Horwitz L., 2009, ARCH INTERN MED, V169, P1857, DOI DOI 10.1001/ARCHINTERNMED.2009.336; Hyams JS, 1998, J PEDIATR-US, V133, P473, DOI 10.1016/S0022-3476(98)70053-8; Inst Med, 2006, ACAD EMERG MED, V13, P1081, DOI 10.1197/j.aem.2006.07.011; JOHNSON PA, 1993, ANN INTERN MED, V118, P593, DOI 10.7326/0003-4819-118-8-199304150-00004; Johnson TJ, 2013, PEDIATRICS, V132, pE851, DOI 10.1542/peds.2012-3127; Kokoska ER, 2007, J SURG RES, V137, P83, DOI 10.1016/j.jss.2006.06.020; Lester C W, 1941, Bull N Y Acad Med, V17, P844; Leung AKC, 2003, AM FAM PHYSICIAN, V67, P2321; Lowe RA, 2001, ACAD EMERG MED, V8, P259, DOI 10.1111/j.1553-2712.2001.tb01302.x; Luo X, 2011, AM ACAD PEDIAT, V112, P314, DOI [10.1542/peds.112.2.314, DOI 10.1542/PEDS.112.2.314]; Macy ML, 2012, J HOSP MED, V7, P530, DOI 10.1002/jhm.1923; Mendoza Fernando S, 2009, Pediatrics, V124 Suppl 3, pS187, DOI 10.1542/peds.2009-1100F; Mills AM, 2011, AM J EMERG MED, V29, P752, DOI 10.1016/j.ajem.2010.02.023; Myer PA, 2013, AM J GASTROENTEROL, V108, P1496, DOI 10.1038/ajg.2013.199; National Health Insurance Service and Health Insurance Review and Assessment Service, 2012, NAT SAMPL CENS AGR 2, P1; Park CY, 2009, HEALTH SERV RES, V44, P2022, DOI 10.1111/j.1475-6773.2009.01020.x; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Petersen LA, 1998, MED CARE, V36, P1249, DOI 10.1097/00005650-199808000-00012; Pines JM, 2008, ANN EMERG MED, V51, P1, DOI 10.1016/j.annemergmed.2007.07.008; Pines JM, 2009, ACAD EMERG MED, V16, P403, DOI 10.1111/j.1553-2712.2009.00381.x; Ponsky TA, 2004, JAMA-J AM MED ASSOC, V292, P1977, DOI 10.1001/jama.292.16.1977; Rinderknecht AS, 2010, PEDIATRICS, V126, P917, DOI 10.1542/peds.2010-0364; Rust G, 2008, ARCH INTERN MED, V168, P1705, DOI 10.1001/archinte.168.15.1705; Schrader CD, 2013, J EMERG MED, V44, P511, DOI 10.1016/j.jemermed.2012.05.010; Schwille IJD, 2009, CLIN GASTROENTEROL H, V7, P1062, DOI 10.1016/j.cgh.2009.07.002; Smink DS, 2005, PEDIATRICS, V115, P920, DOI 10.1542/peds.2004-1363; Sonnenfeld N, 2012, MED CARE, V50, P335, DOI 10.1097/MLR.0b013e318245a53c; Stone J, 2011, MED EDUC, V45, P768, DOI 10.1111/j.1365-2923.2011.04026.x; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Teal CR, 2010, J GEN INTERN MED, V25, pS115, DOI 10.1007/s11606-009-1243-y; Torpy Janet M, 2007, JAMA, V297, P2836, DOI 10.1001/jama.297.24.2836; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; Yu Stella M, 2009, Pediatrics, V124 Suppl 4, pS414, DOI 10.1542/peds.2009-1255M; Ziv A, 1998, PEDIATRICS, V101, P987, DOI 10.1542/peds.101.6.987	46	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0132758	10.1371/journal.pone.0132758	http://dx.doi.org/10.1371/journal.pone.0132758			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267816	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300008
J	Yegros-Yegros, A; Rafols, I; D'Este, P				Yegros-Yegros, Alfredo; Rafols, Ismael; D'Este, Pablo			Does Interdisciplinary Research Lead to Higher Citation Impact? The Different Effect of Proximal and Distal Interdisciplinarity	PLOS ONE			English	Article							SCIENCE; FRAMEWORK; EUROPE	This article analyses the effect of degree of interdisciplinarity on the citation impact of individual publications for four different scientific fields. We operationalise interdisciplinarity as disciplinary diversity in the references of a publication, and rather than treating interdisciplinarity as a monodimensional property, we investigate the separate effect of different aspects of diversity on citation impact: i.e. variety, balance and disparity. We use a Tobit regression model to examine the effect of these properties of interdisciplinarity on citation impact, controlling for a range of variables associated with the characteristics of publications. We find that variety has a positive effect on impact, whereas balance and disparity have a negative effect. Our results further qualify the separate effect of these three aspects of diversity by pointing out that all three dimensions of interdisciplinarity display a curvilinear (inverted U-shape) relationship with citation impact. These findings can be interpreted in two different ways. On the one hand, they are consistent with the view that, while combining multiple fields has a positive effect in knowledge creation, successful research is better achieved through research efforts that draw on a relatively proximal range of fields, as distal interdisciplinary research might be too risky and more likely to fail. On the other hand, these results may be interpreted as suggesting that scientific audiences are reluctant to cite heterodox papers that mix highly disparate bodies of knowledge-thus giving less credit to publications that are too groundbreaking or challenging.	[Yegros-Yegros, Alfredo] Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands; [Rafols, Ismael; D'Este, Pablo] Univ Politecn Valencia, Ingenio CSIC UPV, E-46071 Valencia, Spain; [Rafols, Ismael] Univ Sussex, SPRU Sci & Technol Policy Res, Brighton, E Sussex, England; [Rafols, Ismael] OST HCERES, Paris, France	Leiden University; Leiden University - Excl LUMC; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Gestion de la Innovacion y del Conocimiento (INGENIO); University of Sussex	Rafols, I (corresponding author), Univ Politecn Valencia, Ingenio CSIC UPV, E-46071 Valencia, Spain.	i.rafols@ingenio.upv.es	Rafols, Ismael/D-1509-2009	Rafols, Ismael/0000-0002-6527-7778; Yegros-Yegros, Alfredo/0000-0002-0544-7878; D'Este, Pablo/0000-0002-4040-8209	US National Science Foundation [1064146]; EC Marie Curie Integration Grant	US National Science Foundation(National Science Foundation (NSF)); EC Marie Curie Integration Grant	Funding was provided by US National Science Foundation (Award #1064146 - "Revealing Innovation Pathways: Hybrid Science Maps for Technology Assessment and Foresight"), and EC Marie Curie Integration Grant.	Abbot A., 2001, CHAOS DISCIPLINES; Aciman A, 1999, LETT TRANSIT REFL EX; Adams J., 2007, BIBLIOMETRIC ANAL IN; Barry A, 2008, ECON SOC, V37, P20, DOI 10.1080/03085140701760841; Bauman Zygmunt, 2005, LIQUID LIFE; Boyack K., 2014, P SCI TECHN IND C 20, P64; Braun T, 2003, SCIENTOMETRICS, V58, P183, DOI 10.1023/A:1025439910278; Bruce A, 2004, FUTURES, V36, P457, DOI 10.1016/j.futures.2003.10.003; Bruhn JG, 1995, INTEGR PHYS BEH SCI, V30, P331, DOI 10.1007/BF02691605; Carayol N, 2005, RES EVALUAT, V14, P70, DOI 10.3152/147154405781776355; Chavarro D, 2014, RES EVALUAT, V23, P195, DOI 10.1093/reseval/rvu012; Corsi M, 2010, AM J ECON SOCIOL, V69, P1495, DOI 10.1111/j.1536-7150.2010.00754.x; ERC. ERC Grant Schemes, ERC GRANT SCH GUID A; Fleming L, 2001, MANAGE SCI, V47, P117, DOI 10.1287/mnsc.47.1.117.10671; Frenken K, 2009, J INFORMETR, V3, P222, DOI 10.1016/j.joi.2009.03.005; Gibbons M, 1999, NATURE, V402, pC81, DOI 10.1038/35011576; Gunn J, 1999, DEV SOCIAL SCI US CA, P97; Hessels LK, 2011, IND HIGHER EDUC, V25, P347, DOI 10.5367/ihe.2011.0056; Hessels LK, 2011, SCI PUBL POLICY, V38, P555, DOI 10.3152/030234211X12960315267976; Hollingsworth R., 2000, PRACTISING INTERDISC, P215; Huutoniemi K, 2010, RES POLICY, V39, P79, DOI 10.1016/j.respol.2009.09.011; Ioannidis JPA, 2014, NATURE, V514, P561, DOI 10.1038/514561a; Jacobs JA, 2009, ANNU REV SOCIOL, V35, P43, DOI 10.1146/annurev-soc-070308-115954; Karim SSA, 2011, NATURE, V474, P29, DOI 10.1038/474029a; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Katz JS, 1997, SCIENTOMETRICS, V40, P541, DOI 10.1007/BF02459299; Kiesler S, 2005, SOC STUD SCI, V35, P733; Klein JT, 2008, AM J PREV MED, V35, pS116, DOI 10.1016/j.amepre.2008.05.010; Lariviere V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122565; Lariviere V, 2010, J AM SOC INF SCI TEC, V61, P126, DOI 10.1002/asi.21226; Laudel G, 2006, RES EVALUAT, V15, P2, DOI 10.3152/147154406781776066; Levitt JM, 2008, J AM SOC INF SCI TEC, V59, P1973, DOI 10.1002/asi.20914; Leydesdorff L, 2013, J AM SOC INF SCI TEC, V64, P2573, DOI 10.1002/asi.22946; Llerena P., 2004, SCI INNOVATION RETHI, P69; Lowe P, 2006, J AGR ECON, V57, P165, DOI 10.1111/j.1477-9552.2006.00045.x; Mallard G, 2009, SCI TECHNOL HUM VAL, V34, P573, DOI 10.1177/0162243908329381; Molas-Gallart J., 2014, J SCI POLICY RES MAN, V9, P69, DOI [10.20801/jsrpim.29.2_3_69, DOI 10.20801/JSRPIM.29.2_3_69]; Morillo F, 2003, J AM SOC INF SCI TEC, V54, P1237, DOI 10.1002/asi.10326; NARIN F, 1991, SCIENTOMETRICS, V21, P313, DOI 10.1007/BF02093973; National Academy of Sciences, 2004, FAC INT RES; Nightingale P, 2007, SCI PUBL POLICY, V34, P543, DOI DOI 10.3152/030234207X254396; Nooteboom B, 2007, RES POLICY, V36, P1016, DOI 10.1016/j.respol.2007.04.003; Page SE, 2007, DIFFERENCE POWER DIV; PETERS HPF, 1994, J AM SOC INFORM SCI, V45, P39, DOI 10.1002/(SICI)1097-4571(199401)45:1<39::AID-ASI5>3.0.CO;2-Q; Phillips N, 2009, REV INT POLIT ECON, V16, P85, DOI 10.1080/09692290802524125; Porter AL, 2006, RES EVALUAT, V15, P187, DOI 10.3152/147154406781775841; Porter AL, 2009, SCIENTOMETRICS, V81, P719, DOI 10.1007/s11192-008-2197-2; Rafols I, 2007, INNOVATION-ABINGDON, V20, P395, DOI 10.1080/13511610701760770; Rafols I, 2012, RES POLICY, V41, P1262, DOI 10.1016/j.respol.2012.03.015; Rafols I, 2010, SCIENTOMETRICS, V82, P263, DOI 10.1007/s11192-009-0041-y; Rhoten D, 2009, THESIS ELEV, V96, P83, DOI 10.1177/0725513608099121; Rinia EJ, 2001, RES POLICY, V30, P357, DOI 10.1016/S0048-7333(00)00082-2; Salter A, 2002, DIVERSITY EXCELLENCE, P66; Sarewitz D, 2004, ENVIRON SCI POLICY, V7, P385, DOI 10.1016/j.envsci.2004.06.001; Sarewitz D, 2007, ENVIRON SCI POLICY, V10, P5, DOI 10.1016/j.envsci.2006.10.001; Steele TW, 2000, J AM SOC INFORM SCI, V51, P476, DOI 10.1002/(SICI)1097-4571(2000)51:5<476::AID-ASI8>3.3.CO;2-7; Stirling A., 1998, SPRU ELECT WORKING P, V28; Stirling A, 2007, J R SOC INTERFACE, V4, P707, DOI 10.1098/rsif.2007.0213; Turner S., 2000, PRACTISING INTERDISC, P46, DOI DOI 10.3138/9781442678729-005; Uzzi B, 2013, SCIENCE, V342, P468, DOI 10.1126/science.1240474; van Eck NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062395; van Rijnsoever FJ, 2011, RES POLICY, V40, P463, DOI 10.1016/j.respol.2010.11.001; Wagner CS, 2011, J INFORMETR, V5, P14, DOI 10.1016/j.joi.2010.06.004; Waltman L, 2013, J INFORMETR, V7, P833, DOI 10.1016/j.joi.2013.08.002; Waltman L, 2011, SCIENTOMETRICS, V87, P467, DOI 10.1007/s11192-011-0354-5; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127298; Willmott H, 2011, ORGANIZATION, V18, P447, DOI 10.1177/1350508411403536; Zhang L, 2016, J ASSOC INF SCI TECH, V67, P1257, DOI 10.1002/asi.23487	68	132	140	12	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135095	10.1371/journal.pone.0135095	http://dx.doi.org/10.1371/journal.pone.0135095			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26266805	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492300078
J	Heinz, T; Cardenas, JM; Alvarez-Iglesias, V; Pardo-Seco, J; Gomez-Carballa, A; Santos, C; Taboada-Echalar, P; Martinon-Torres, F; Salas, A				Heinz, Tanja; Mario Cardenas, Jorge; Alvarez-Iglesias, Vanesa; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Santos, Carla; Taboada-Echalar, Patricia; Martinon-Torres, Federico; Salas, Antonio			The Genomic Legacy of the Transatlantic Slave Trade in the Yungas Valley of Bolivia	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DIVERSITY; AMERINDIAN POPULATIONS; MTDNA; ANCESTRY; ADMIXTURE; SELECTION; LINEAGES; AMERICA	During the period of the Transatlantic Slave Trade (TAST) some enslaved Africans were forced to move to Upper Peru (nowadays Bolivia). At first they were sent to Potosi, but later to the tropical Yungas valley where the Spanish colonizers established a so-called "hacienda system" that was based on slave labor, including African-descendants. Due to their isolation, very little attention has been paid so far to 'Afro-Bolivian' communities either within the research field of TAST or in genetic population studies. In this study, a total of 105 individuals from the Yungas were sequenced for their mitochondrial DNA (mtDNA) control region, and mitogenomes were obtained for a selected subset of these samples. We also genotyped 46 Ancestry Informative Markers (AIM) in order to investigate continental ancestry at the autosomal level. In addition, Y-chromosome STR and SNP data for a subset of the same individuals was also available from the literature. The data indicate that the partitioning of mtDNA ancestry in the Yungas differs significantly from that in the rest of the country: 81% Native American, 18% African, and 1% European. Interestingly, the great majority of 'Afro-descendant' mtDNA haplotypes in the Yungas (84%) concentrates in the locality of Tocana. This high proportion of African ancestry in the Tocana is also manifested in the Y-chromosome (44%) and in the autosomes (56%). In sharp contrast with previous studies on the TAST, the ancestry of about 1/3 of the 'Afro-Bolivian' mtDNA haplotypes can be traced back to East and South East Africa, which may be at least partially explained by the Arab slave trade connected to the TAST.	[Heinz, Tanja; Mario Cardenas, Jorge; Alvarez-Iglesias, Vanesa; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Santos, Carla; Taboada-Echalar, Patricia; Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Inst Ciencias Forenses, Fac Med, Santiago De Compostela, Galicia, Spain; [Heinz, Tanja; Mario Cardenas, Jorge; Alvarez-Iglesias, Vanesa; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Santos, Carla; Taboada-Echalar, Patricia; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Dept Anat Patol & Ciencias Forenses, Santiago De Compostela, Galicia, Spain; [Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Federico; Salas, Antonio] Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Santiago De Compostela, Galicia, Spain; [Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Federico; Salas, Antonio] Univ Santiago de Compostela USC, Santiago De Compostela, Galicia, Spain; [Martinon-Torres, Federico] Hosp Clin Univ Santiago, Dept Pediat, Translat Pediat & Infect Dis, Santiago De Compostela, Galicia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Salas, A (corresponding author), Univ Santiago de Compostela, Unidade Xenet, Inst Ciencias Forenses, Fac Med, Santiago De Compostela, Galicia, Spain.	antonio.salas@usc.es	Salas, Antonio/U-2029-2019; Gómez-Carballa, Alberto/I-4610-2014; Salas, Antonio/E-3977-2012; Martinon-Torres, Federico/E-4982-2016; Santos, Carla/C-4472-2013; Pardo-Seco, Jacobo J/G-3752-2016	Salas, Antonio/0000-0002-2336-702X; Gómez-Carballa, Alberto/0000-0003-0927-1272; Salas, Antonio/0000-0002-2336-702X; Martinon-Torres, Federico/0000-0002-9023-581X; Santos, Carla/0000-0002-4575-1807; Pardo-Seco, Jacobo J/0000-0002-8059-8908	People Program (Marie Curie Actions) of the European Union's Seventh Framework Program FP7 under REA grant from the "Ministerio de Ciencia e Innovacion" [290344, SAF2011-26983]; Plan Galego IDT [EM 2012/045]; Sistema Universitario Gallego-Modalidad REDES from the Xunta de Galicia [2012-PG226]; Portuguese Foundation for Science and Technology (FCT); European Social Fund (Human Potential Thematic Operational Program) [SFRH/BD/75627/2010]	People Program (Marie Curie Actions) of the European Union's Seventh Framework Program FP7 under REA grant from the "Ministerio de Ciencia e Innovacion"; Plan Galego IDT; Sistema Universitario Gallego-Modalidad REDES from the Xunta de Galicia; Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Social Fund (Human Potential Thematic Operational Program)(European Social Fund (ESF))	The research leading to these results has received funding from the People Program (Marie Curie Actions) of the European Union's Seventh Framework Program FP7/2007-2013/ under REA grant agreement no. 290344 from the "Ministerio de Ciencia e Innovacion" (SAF2011-26983), the Plan Galego IDT (EM 2012/045), and a grant from the Sistema Universitario Gallego-Modalidad REDES (2012-PG226) from the Xunta de Galicia (to A.S.). C.S. is supported by funding awarded by the Portuguese Foundation for Science and Technology (FCT) and co-financed by the European Social Fund (Human Potential Thematic Operational Program SFRH/BD/75627/2010).	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2008, BIOESSAYS, V30, P1246, DOI 10.1002/bies.20837; Bandelt HJ, 2012, INT J LEGAL MED, V126, P901, DOI 10.1007/s00414-012-0762-y; Barbieri C, 2011, AM J HUM BIOL, V23, P89, DOI 10.1002/ajhb.21107; Bert F, 2004, ANN HUM BIOL, V31, P9, DOI 10.1080/03014460310001616464; Bert F, 2001, HUM BIOL, V73, P1, DOI 10.1353/hub.2001.0001; Brehm A, 2002, ANN HUM GENET, V66, P49, DOI 10.1017/S0003480001001002; Busdiecker S, 2009, RADICAL HIST REV, P105, DOI 10.1215/01636545-2008-033; Cann HM, 2002, SCIENCE, V296, P261; Cardoso S, 2013, FORENSIC SCI INT-GEN, V7, pE52, DOI 10.1016/j.fsigen.2013.01.007; Catelli L, 2010, FORENSIC SC IN PRESS; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Corella A, 2007, ANN HUM BIOL, V34, P34, DOI 10.1080/03014460601075819; Costa HA, 2010, J FORENSIC LEG MED, V17, P247, DOI 10.1016/j.jflm.2010.02.011; Davies C.A.B., 2008, ENCY AFRICAN DIASPOR; Dornelles CL, 2004, AM J HUM BIOL, V16, P479, DOI 10.1002/ajhb.20038; Eltis D, 2008, BRIEF OVERVIEW TRANS; Ely B, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-34; Fejerman L, 2012, HUM MOL GENET, V21, P1907, DOI 10.1093/hmg/ddr617; Fuselli S, 2003, MOL BIOL EVOL, V20, P1682, DOI 10.1093/molbev/msg188; Gaya-Vidal M, 2011, AM J PHYS ANTHROPOL, V145, P215, DOI 10.1002/ajpa.21487; Gomez-Carballa A, 2015, PLOS ONE IN PRESS; Hall EJ, 2005, SLAVERY AFRICAN ETHN; Heinz T, 2013, FORENSIC SCI INT-GEN, V7, P537, DOI 10.1016/j.fsigen.2013.05.012; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Klein HS, 2010, NEW APPROACHES AM; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lipski J.M., 2006, AFROHISPANIC REV, V25, P179; Lipski J.M., 2006, PAPIA, V16, P96; Lovejoy P. E., 2011, TRANSFORMATIONS SLAV; Maconde Juan Angola., 2007, J LAT AM CARIBB ANTH, V12, P246; Cardenas JM, 2015, FORENSIC SCI INT-GEN, V14, P210, DOI 10.1016/j.fsigen.2014.10.023; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Newman SP, 2012, SLAVERY ABOLIT, P1; Pardo-Seco J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-543; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029684; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Salas A, 2008, J HUM GENET, V53, P662, DOI 10.1007/s10038-008-0297-8; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; Salas A, 2004, AM J HUM GENET, V75, P524, DOI 10.1086/423824; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2012, FORENSIC SCI INT-GEN, V6, pE182, DOI 10.1016/j.fsigen.2012.06.015; Sandoval K, 2009, HUM GENET, V126, P521, DOI 10.1007/s00439-009-0693-y; Silva WA, 2006, HUM BIOL, V78, P29, DOI 10.1353/hub.2006.0028; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stefflova K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014495; Taboada-Echalar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058980; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vullo C., 2014, INT J LEGAL MED; Watkins WS, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-39; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023	62	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134129	10.1371/journal.pone.0134129	http://dx.doi.org/10.1371/journal.pone.0134129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263179	Green Submitted, Green Published, gold			2022-12-27	WOS:000359353300019
J	Lamberti, M; Capasso, R; Lombardi, A; Di Domenico, M; Fiorelli, A; Feola, A; Perna, AF; Santini, M; Caraglia, M; Ingrosso, D				Lamberti, Monica; Capasso, Rosanna; Lombardi, Angela; Di Domenico, Marina; Fiorelli, Alfonso; Feola, Antonia; Perna, Alessandra F.; Santini, Mario; Caraglia, Michele; Ingrosso, Diego			Two Different Serum MiRNA Signatures Correlate with the Clinical Outcome and Histological Subtype in Pleural Malignant Mesothelioma Patients	PLOS ONE			English	Article							UP-REGULATION; CANCER; EXPRESSION; PROFILES; SURVIVAL; CENTENARIANS; PROGNOSIS; PATHWAY; MIR-25	Pleural malignant mesothelioma (MPM) is a detrimental neoplasm affecting pleural sheets and determining a high rate of mortality. In this study, we have enrolled 14 consecutive patients (13 males and 1 female) with MPM (mean age: 70.3 +/- 4.6 years). We have collected serum for the determination of a miRNA profiling using a low-density microarray real time PCR system in the serum of patients and comparing it with that one of 10 control counterparts affected by not-cancer-related pleural effusions. In the patients 5 miRNAs were upregulated (miR101, miR25, miR26b, miR335 and miR433), 2 miRNA were downregulated (miR191, miR223) and two miRNAs were expressed exclusively in patients (miR29a and miR516). Based upon the changes in the expression of the above mentioned miRNAs we detected two distinctive miRNA signatures predicting histotype and survival in these patients: I) patients with more than 3/9 upregulated miRNAs or 3/9 upregulated miRNAs and miR516 not recordable or unchanged (signature A); II) patients with at least 3/9 downregulated or unchanged miRNAs and/or miR29a downregulated (signature B). Based upon these criteria, 5 patients were stratified in signature A and the remaining 9 in signature B. Patients with signature A had a significant shorter median survival than those with signature B (7 months vs. 17 months, 95% CI: 0.098-1.72, p = 0.0021), had a sarcomatoid or mixed histological MPM subtype and were diagnosed in stage II (3/5) and stage III (2/5). In conclusion, we suggest that miRNA signature A is predictive of sarcomatoid histotype and of worse prognosis in MPM.	[Lamberti, Monica] Univ Naples 2, Sch Med, Dept Expt Med, Sect Hyg Occupat Med & Forens Med, Naples, Italy; [Capasso, Rosanna; Lombardi, Angela; Di Domenico, Marina; Feola, Antonia; Caraglia, Michele; Ingrosso, Diego] Univ Naples 2, Sch Med, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Fiorelli, Alfonso; Santini, Mario] Univ Naples 2, Sch Med, Dept Thorac Surg, Naples, Italy; [Perna, Alessandra F.] Univ Naples 2, Dept Cardiothorac & Resp Sci, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Caraglia, M (corresponding author), Univ Naples 2, Sch Med, Dept Biochem Biophys & Gen Pathol, Naples, Italy.	michele.caraglia@unina2.it	Ingrosso, Diego/AHE-4980-2022; SANTINI, Mario/AAE-9589-2022; SANTINI, Mario/AFE-6002-2022; Fiorelli, Alfonso/AAO-2709-2020; Caraglia, Michele/AFY-9729-2022; SANTINI, Mario/AAE-9516-2022; Perna, Alessandra F/AAC-3952-2022; Caraglia, Michele/AAK-4569-2020; Caraglia, Michele/N-5670-2015; SANTINI, Mario/AFE-1150-2022; feola, antonia/AAV-2415-2021	SANTINI, Mario/0000-0003-1162-7805; SANTINI, Mario/0000-0003-1162-7805; Caraglia, Michele/0000-0003-2408-6091; SANTINI, Mario/0000-0003-1162-7805; Caraglia, Michele/0000-0003-2408-6091; Caraglia, Michele/0000-0003-2408-6091; SANTINI, Mario/0000-0003-1162-7805; feola, antonia/0000-0003-0436-4621; Di Domenico, Marina/0000-0002-6201-4200; PERNA, Alessandra/0000-0003-4048-9392; LOMBARDI, ANGELA/0000-0001-5421-9970; Fiorelli, Alfonso/0000-0002-0628-613X	Regione Campania Laboratori Pubblici "Hauteville" [RT02]	Regione Campania Laboratori Pubblici "Hauteville"	This work was supported by a grant from from Regione Campania Laboratori Pubblici "Hauteville" to MC, grant number: RT02.	Amodio N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.175; Amodio N, 2012, ONCOTARGET, V3, P1246; Carbone M, 2007, NAT REV CANCER, V7, P147, DOI 10.1038/nrc2068; Cheng JJ, 2013, CELL REP, V5, P471, DOI 10.1016/j.celrep.2013.08.050; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Espinosa-Parrilla Y, 2014, INT J CANCER, V135, P2065, DOI 10.1002/ijc.28850; Feng SJ, 2014, TUMOR BIOL, V35, P12339, DOI 10.1007/s13277-014-2546-0; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Gentilini D, 2013, AGE, V35, P1961, DOI 10.1007/s11357-012-9463-1; Gentilini D, 2012, AGING CELL, V11, P277, DOI 10.1111/j.1474-9726.2012.00790.x; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Hausler SFM, 2010, BRIT J CANCER, V103, P693, DOI 10.1038/sj.bjc.6605833; Kirschner MB, 2015, MOL ONCOL, V9, P715, DOI 10.1016/j.molonc.2014.11.007; Li BS, 2015, ONCOGENE, V34, P2556, DOI 10.1038/onc.2014.214; Liz J., 2015, BIOCH BIOPHYS ACTA; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Matsumoto S, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0303-2; Pass HI, 2004, CURR PROB CANCER, V28, P85; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Rossi M, 2013, J CELL PHYSIOL, V228, P1506, DOI 10.1002/jcp.24306; Sartore-Bianchi A, 2007, CLIN CANCER RES, V13, P5942, DOI 10.1158/1078-0432.CCR-07-0536; Su ZX, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-47; Takei Y, 2011, CANCER RES, V71, P1442, DOI 10.1158/0008-5472.CAN-10-2530; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Xu FX, 2014, ASIAN PAC J CANCER P, V15, P1197, DOI 10.7314/APJCP.2014.15.3.1197; Yang HN, 2006, P NATL ACAD SCI USA, V103, P10397, DOI 10.1073/pnas.0604008103; Zhang P, 2013, BIOCHEM BIOPH RES CO, V437, P368, DOI 10.1016/j.bbrc.2013.06.082	27	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135331	10.1371/journal.pone.0135331	http://dx.doi.org/10.1371/journal.pone.0135331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262875	gold, Green Submitted, Green Published			2022-12-27	WOS:000359353300073
J	Teraoka, M; Kyougoku, M				Teraoka, Mutsumi; Kyougoku, Makoto			Development of the Final Version of the Classification and Assessment of Occupational Dysfunction Scale	PLOS ONE			English	Article								Occupational therapy is involved in disability prevention and health enhancement through the prevention of occupational dysfunction. Although many occupational dysfunction scales exist, no standard method is available for the assessment and classification of occupational dysfunction, which may include occupational imbalance, occupational deprivation, occupational alienation, and occupational marginalization. The purpose of this study was to develop the final version of Classification and Assessment of Occupational Dysfunction (CAOD). Our study demonstrated the validity and reliability of CAOD in a group of undergraduate students. The CAOD scale includes 16 items and addresses the following 4 domains: occupational imbalance, occupational deprivation, occupational alienation, and occupational marginalization.	[Teraoka, Mutsumi] Kibi Int Univ, Doctor Course, Grad Sch Hlth Sci, Okayama, Japan; [Teraoka, Mutsumi] Oosugi Hosp, Okayama, Japan; [Kyougoku, Makoto] Kibi Int Univ, Dept Occupat Therapy, Sch Hlth Sci, Okayama, Japan		Teraoka, M (corresponding author), Kibi Int Univ, Doctor Course, Grad Sch Hlth Sci, Okayama, Japan.	mutsu13t@gmail.com						Anaby D, 2010, APPL RES QUAL LIFE, V5, P81, DOI 10.1007/s11482-010-9094-6; Asaoka S, 2004, SLEEP BIOL RHYTHMS, V2, P192, DOI [DOI 10.1111/j.1479-8425.2004.00138.x, 10.4172/1522-4821.1000312, DOI 10.4172/1522-4821.1000312]; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bryant Wendy, 2004, Can J Occup Ther, V71, P282; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Iwata M, 2011, JAPANESE J RES OCCUP, V11, P80; Kielhofner G., 1995, MODEL HUMAN OCCUPATI, V2nd; Kielhofner G., 1997, CONCEPTUAL FDN OCCUP; Kielhofner Gary, 1999, Work, V12, P37; Kline R.B., 2011, PRINCIPLES PRACTICE; Kobayashi N., 2010, JAPANESE J OCCUPATIO, V14, P33; Kogawa M, 1993, HEART HYOKYO I REPOS, V13, P103; Kosugi K, 2014, STRUCTURAL EQUATION, P103; Kyougoku M, 2011, JAPANESE J NURSING E, V52, P436; Kyougoku M, 2011, DISSOLUTION APPROACH; Kyougoku M, 2010, UNSTRUCTURED ASSESSM; Kyougoku M., 2012, INTRO DISSOLUTION AP; Kyougoku M., 2014, PROBLEM CLARIFICATIO; Kyougoku M., 2012, J JAPAN ACAD DIABETE, V16, P44; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Molineux M., 2004, OCCUPATION OCCUPATIO; Muthen LK., 2012, MPLUS USERS GUIDE, V7th, P153; Ochiai Y, 1983, JAP J ED PSYCHOL, V31, P332; Saito S., 2010, J JAPANESE OCCUPATIO, V29, P317, DOI DOI 10.11477/MF.6003900943; Teraoka M, 2013, SOGO REHABILITATION, V41, P475; Teraoka M, 2014, JAPANESE OCCUPATIONA, V33, P249, DOI DOI 10.11477/mf.6003200030; Teraoka M, 2013, J PREVENTIVE MED, V8, P53; Teraoka M, 2014, J JAPANESE OCCUPATIO, V33, P203; Townsend E., 2002, ENABLING OCCUPATION; Townsend Elizabeth, 2004, Can J Occup Ther, V71, P75; Watai Izumi, 2006, Sangyo Eiseigaku Zasshi, V48, P71, DOI 10.1539/sangyoeisei.48.71; Whiteford G., 2000, BRIT J OCCUP THER, V63, P200, DOI [10.1177/030802260006300503, https://doi.org/10.1177/030802260006300503]; Wilcock A.A., 2002, CAN J OCCUP THER, V46, P1, DOI [https://doi.org/10.1046/j.1440-1630.1999.00174.x, DOI 10.1046/J.1440-1630.1999.00174.X, 10.1046/j.1440-1630.1999.00174.x, DOI 10.1177/000841749806500501]; Wilcock A.A, 2006, OCCUPATIONAL PERSPEC	35	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134695	10.1371/journal.pone.0134695	http://dx.doi.org/10.1371/journal.pone.0134695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263375	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300036
J	Bartsch, DU; Kozak, I; Grant, I; Knudsen, VL; Weinreb, RN; Lee, BR; Freeman, WR				Bartsch, Dirk-Uwe; Kozak, Igor; Grant, Igor; Knudsen, Victoria L.; Weinreb, Robert N.; Lee, Byung Ro; Freeman, William R.			Retinal Nerve Fiber and Optic Disc Morphology in Patients with Human Immunodeficiency Virus Using the Heidelberg Retina Tomography 3	PLOS ONE			English	Article							SCANNING LASER POLARIMETRY; HIV-POSITIVE PATIENTS; LAYER THICKNESS; COHERENCE TOMOGRAPHY; INFECTIOUS RETINITIS; OBJECTIVE ANALYSIS; DIABETIC-PATIENTS; FIELD LOSS; RETINOPATHY; OPHTHALMOSCOPY	Purpose To use novel confocal scanning ophthalmoscopy technology to test hypothesis that HIV-seropositive patients without history of retinitis with a history of a low CD4 count are more likely to have damage to their retinal nerve fiber layer (RNFL) when compared to patients with high CD4 count. In addition, we compared optic disc morphologic changes with glaucoma. Design Cross-sectional study. Participants and Controls 171 patients were divided into four groups. The control group consisted of 40 eyes of 20 HIV-seronegative patients. The second group consisted of 80 eyes of 41 HIV-positive patients whose CD4 cell count never dropped below 100 (1.0 x 10(9)/L). The third group consisted of 44 eyes of 26 HIV-positive patients with a history of low CD4 counts <100. Fourth group consisted of 79 eyes of 79 patients with confirmed glaucoma who served as positive controls. Testing Confocal scanning laser ophthalmoscopy was performed with the Heidelberg Retina Tomograph (HRT3) and data were analyzed with HRT3, software (Heyex version 1.5.10.0). Main Outcome Measures Disc area, cup area, cup volume, rim volume, mean cup depth, maximum cup depth, cup-to-disc ration, mean RNFL thickness, and RNFL cross-sectional area. Results Analysis of the global optic nerve and cup parameters showed no difference in disk area among the four groups. There was also no difference in cup, rim volume, mean cup depth, or maximum cup depth among the first three groups but they were all different from glaucoma group. The RNFL was thinner in glaucoma and both HIV-positive groups compared to HIV-seronegative subjects. The cross sectional RNFL area was thinner in both high and low CD4 HIV-positive groups compared to HIV-seronegative group in the nasal and temporal/inferior sectors, respectively. Glaucoma group showed thinning in all sectors. Conclusions HIV retinopathy results in retinal nerve fiber layer loss without structural optic nerve supportive tissue change. RNFL damage may occur early in HIV disease by mechanism different than in glaucoma.	[Bartsch, Dirk-Uwe; Kozak, Igor; Lee, Byung Ro; Freeman, William R.] Univ Calif San Diego, Shiley Eye Inst, Jacobs Retina Ctr, La Jolla, CA 92093 USA; [Grant, Igor] HIV Neurobehav Res Ctr, San Diego, CA USA; [Knudsen, Victoria L.] Retina Associates Utah, Salt Lake City, UT USA; [Weinreb, Robert N.] Univ Calif San Diego, Shiley Eye Inst, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Lee, Byung Ro] Hanyang Univ, Seoul 133791, South Korea; [Kozak, Igor] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia	University of California System; University of California San Diego; University of California System; University of California San Diego; Hanyang University; King Khaled Eye Specialist Hospital	Bartsch, DU (corresponding author), Univ Calif San Diego, Shiley Eye Inst, Jacobs Retina Ctr, La Jolla, CA 92093 USA.	dbartsch@ucsd.edu	Kozak, Igor/AAC-4645-2019		National Eye Institute [R01EY016323, R01EY007366]; Core Grant for Vision Research [P30EY022589]; Research to Prevent Blindness, New York City, NY; NATIONAL EYE INSTITUTE [R01EY007366, P30EY022589, R01EY016323] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Core Grant for Vision Research; Research to Prevent Blindness, New York City, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by National Eye Institute grants R01EY016323 (DUB), R01EY007366 (WRF), and Core Grant for Vision Research (P30EY022589); Research to Prevent Blindness, New York City, NY (Unrestricted grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EST HIV INC US 2007; Badala F, 2007, AM J OPHTHALMOL, V144, P724, DOI 10.1016/j.ajo.2007.07.010; BARTSCH DU, 1989, AM J OPHTHALMOL, V108, P277, DOI 10.1016/0002-9394(89)90118-9; Besada E, 2007, OPTOMETRY VISION SCI, V84, P189, DOI 10.1097/OPX.0b013e31803399f3; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; CDC, 2012, MON SEL NAT HIV PREV; Cheng S, 2011, GRAEF ARCH CLIN EXP, V249, P1643, DOI 10.1007/s00417-011-1735-4; de Faria JML, 2002, BRIT J OPHTHALMOL, V86, P725; De Leon-Ortega JE, 2007, AM J OPHTHALMOL, V144, P525, DOI 10.1016/j.ajo.2007.06.021; Falkenstein IA, 2008, AM J OPHTHALMOL, V146, P579, DOI 10.1016/j.ajo.2007.12.021; Freeman WR, 2008, AM J OPHTHALMOL, V145, P453, DOI 10.1016/j.ajo.2007.10.013; FREEMAN WR, 1989, ANN OPHTHALMOL, V21, P468; Garvin MK, 2013, INVEST OPHTH VIS SCI, V54, P6998, DOI 10.1167/iovs.13-12131; Goldbaum Michael H, 2008, Trans Am Ophthalmol Soc, V106, P196; Gomez ML, 2009, OPHTHALMOLOGY, V116, P2407, DOI 10.1016/j.ophtha.2009.05.012; Iester M, 2001, AM J OPHTHALMOL, V132, P57, DOI 10.1016/S0002-9394(01)00938-2; Iragui VJ, 1996, NEUROLOGY, V47, P1452, DOI 10.1212/WNL.47.6.1452; JABS DA, 1989, OPHTHALMOLOGY, V96, P1092; Kalyani PS, 2012, AM J OPHTHALMOL, V153, P734, DOI 10.1016/j.ajo.2011.09.019; Kozak I, 2005, AM J OPHTHALMOL, V139, P295, DOI 10.1016/j.ajo.2004.09.039; Kozak Igor, 2007, Trans Am Ophthalmol Soc, V105, P111; Kozak I, 2007, RETINA-J RET VIT DIS, V27, P1267, DOI 10.1097/IAE.0b013e31806463fb; Kozak I, 2007, OPHTHALMOLOGY, V114, P537, DOI 10.1016/j.ophtha.2006.06.054; Kozak I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074712; Letendre Scott L, 2010, Top HIV Med, V18, P45; Lin D, 2009, J GLAUCOMA, V18, P101, DOI 10.1097/IJG.0b013e318179f879; Miglior S, 2002, OPHTHALMOLOGY, V109, P1072, DOI 10.1016/S0161-6420(02)01032-1; Mikelberg F S, 1993, J Glaucoma, V2, P101; Moschos MM, 2007, OCUL IMMUNOL INFLAMM, V15, P319, DOI 10.1080/09273940701375154; Ozdek S, 2002, EYE, V16, P761, DOI 10.1038/sj.eye.6700207; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Philippin H, 2006, GRAEF ARCH CLIN EXP, V244, P460, DOI 10.1007/s00417-005-0094-4; Plummer DJ, 2001, AM J OPHTHALMOL, V131, P216, DOI 10.1016/S0002-9394(00)00787-X; Sample PA, 1999, ARCH OPHTHALMOL-CHIC, V117, P755; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; van Dijk HW, 2009, INVEST OPHTH VIS SCI, V50, P3404, DOI 10.1167/iovs.08-3143; Vellozzi C, 2009, AM J EPIDEMIOL, V169, P642, DOI 10.1093/aje/kwn361; Wollstein G, 1998, OPHTHALMOLOGY, V105, P1557, DOI 10.1016/S0161-6420(98)98047-2	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0133144	10.1371/journal.pone.0133144	http://dx.doi.org/10.1371/journal.pone.0133144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258547	Green Published, Green Submitted, gold			2022-12-27	WOS:000359352600004
J	Batson, MA; Petridou, N; Klomp, DWJ; Frens, MA; Neggers, SFW				Batson, Melissa A.; Petridou, Natalia; Klomp, Dennis W. J.; Frens, Maarten A.; Neggers, Sebastiaan F. W.			Single Session Imaging of Cerebellum at 7 Tesla: Obtaining Structure and Function of Multiple Motor Subsystems in Individual Subjects	PLOS ONE			English	Article							WORKING-MEMORY; FMRI; MRI; ORGANIZATION; REPRESENTATIONS; ACTIVATION; NUCLEUS; CORTEX; CONNECTIVITY; INVOLVEMENT	The recent increase in the use of high field MR systems is accompanied by a demand for acquisition techniques and coil systems that can take advantage of increased power and accuracy without being susceptible to increased noise. Physical location and anatomical complexity of targeted regions must be considered when attempting to image deeper structures with small nuclei and/or complex cytoarchitechtonics (i.e. small microvasculature and deep nuclei), such as the brainstem and the cerebellum (Cb). Once these obstacles are overcome, the concomitant increase in signal strength at higher field strength should allow for faster acquisition of MR images. Here we show that it is technically feasible to quickly and accurately detect blood oxygen level dependent (BOLD) signal changes and obtain anatomical images of Cb at high spatial resolutions in individual subjects at 7 Tesla in a single one-hour session. Images were obtained using two high-density multi-element surface coils (32 channels in total) placed beneath the head at the level of Cb, two channel transmission, and three-dimensional sensitivity encoded (3D, SENSE) acquisitions to investigate sensorimotor activations in Cb. Two classic sensorimotor tasks were used to detect Cb activations. BOLD signal changes during motor activity resulted in concentrated clusters of activity within the Cb lobules associated with each task, observed consistently and independently in each subject: Oculomotor vermis (VI/VII) and CrusI/II for pro- and anti-saccades; ipsilateral hemispheres IV-VI for finger tapping; and topographical separation of eye- and hand-activations in hemispheres VI and VIIb/VIII. Though fast temporal resolution was not attempted here, these functional patches of highly specific BOLD signal changes may reflect small-scale shunting of blood in the microvasculature of Cb. The observed improvements in acquisition time and signal detection are ideal for individualized investigations such as differentiation of functional zones prior to surgery.	[Batson, Melissa A.; Neggers, Sebastiaan F. W.] Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Petridou, Natalia; Klomp, Dennis W. J.] Univ Med Ctr Utrecht, Dept Radiol, Imaging Div, Utrecht, Netherlands; [Batson, Melissa A.; Frens, Maarten A.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Frens, Maarten A.] Erasmus Univ Coll, Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam	Batson, MA (corresponding author), Indian Inst Sci, Ctr Neurosci, Bangalore 560012, Karnataka, India.	melbatson@gmail.com		, Natalia/0000-0002-0783-0387	Trans Channel Neuroscience Network (TC2N) Interreg Initiative (MAB	Trans Channel Neuroscience Network (TC2N) Interreg Initiative (MAB	Funded by Trans Channel Neuroscience Network (TC2N) Interreg Initiative (MAB) www.tc2n. org/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nederlandse Organisatie voor Wetenschappelijk Onderzoek Aard-en Levenswetenschappen (NWO ALW) 834.14.004 (NP, DWJK) www.nwo.nl/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. C7 European Union Initial Training Network (MAB, MAF) http://cordis.europa.eu/result/rcn/149358_en. html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahyane N, 2008, CEREBELLUM, V7, P595, DOI 10.1007/s12311-008-0065-5; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Ashburner John, 1997, HUMAN BRAIN FUNCTION, P43; Balsters JH, 2010, NEUROIMAGE, V49, P2045, DOI 10.1016/j.neuroimage.2009.10.045; Balsters JH, 2011, J NEUROSCI, V31, P2305, DOI 10.1523/JNEUROSCI.4358-10.2011; Bazin PL, 2013, 19 ANN M ORG HUM BRA; Boer VO, 2011, NMR BIOMED, V24, P1038, DOI 10.1002/nbm.1641; Braitenberg V, 1997, BEHAV BRAIN SCI, V20, P229, DOI 10.1017/S0140525X9700143X; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Claeys KG, 2003, NEUROIMAGE, V20, P840, DOI 10.1016/S1053-8119(03)00366-5; Cloos MA, 2010, P INT SOC MAGN RES, P1; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; De Cocker LJL, 2015, NEUROIMAGE-CLIN, V8, P314, DOI 10.1016/j.nicl.2015.02.001; De Cocker LJL, 2014, CEREBROVASC DIS, V38, P17, DOI 10.1159/000365411; Desmond JE, 1997, J NEUROSCI, V17, P9675; DEUBEL H, 1995, VISION RES, V35, P3529, DOI 10.1016/0042-6989(95)00058-M; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; Di Ieva A, 2011, NEUROIMAGE, V54, P74, DOI 10.1016/j.neuroimage.2010.07.045; Diedrichsen J, 2011, NEUROIMAGE, V54, P1786, DOI 10.1016/j.neuroimage.2010.10.035; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; Dietrich O, 2008, EUR J RADIOL, V65, P29, DOI 10.1016/j.ejrad.2007.11.005; Dum RP, 2003, J NEUROPHYSIOL, V89, P634, DOI 10.1152/jn.00626.2002; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; ECCLES JC, 1972, EXP BRAIN RES, V15, P498, DOI 10.1007/BF00236405; Ettinger U, 2005, NEUROIMAGE, V24, P487, DOI 10.1016/j.neuroimage.2004.08.019; Fielding J, 2010, NEUROPSYCHOLOGIA, V48, P235, DOI 10.1016/j.neuropsychologia.2009.09.009; Filippopulos F, 2013, EXP BRAIN RES, V224, P541, DOI 10.1007/s00221-012-3332-0; Gizewski ER, 2007, NEUROIMAGE, V37, P761, DOI 10.1016/j.neuroimage.2007.06.005; Gizewski ER, 2008, CLIN NEURORADIOL, V18, P65, DOI 10.1007/s00062-008-8008-6; Glickstein M, 2007, CURR BIOL, V17, pR824, DOI 10.1016/j.cub.2007.08.009; Glickstein M, 2011, CORTEX, V47, P59, DOI 10.1016/j.cortex.2009.09.001; Glickstein M, 2008, CEREBELLUM, V7, P589, DOI 10.1007/s12311-008-0074-4; Gorgolewski KJ, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00245; Grabner G, 2014, NEUROIMAGE, V100, P710, DOI 10.1016/j.neuroimage.2014.06.045; Grodd W, 2001, HUM BRAIN MAPP, V13, P55, DOI 10.1002/hbm.1025; Halko MA, 2014, J NEUROSCI, V34, P12049, DOI 10.1523/JNEUROSCI.1776-14.2014; Hoover JE, 1999, J NEUROSCI, V19, P1446; Ito M, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00001; Jamadar SD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00749; Kellermann T, 2012, J NEUROSCI, V32, P11453, DOI 10.1523/JNEUROSCI.0678-12.2012; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kheradmand Amir, 2011, Front Neurol, V2, P53, DOI 10.3389/fneur.2011.00053; Kojima Y, 2010, J NEUROPHYSIOL, V104, P3667, DOI 10.1152/jn.00558.2010; Kozlov M, 2011, IEEE ENG MED BIO, P547, DOI 10.1109/IEMBS.2011.6090101; Kuper M, 2011, NEUROIMAGE, V54, P2612, DOI 10.1016/j.neuroimage.2010.11.028; Kuper M, 2012, HUM BRAIN MAPP, V33, P2741, DOI 10.1002/hbm.21400; Kuper M, 2012, CEREBELLUM, V11, P314, DOI 10.1007/s12311-010-0194-5; Kuper M, 2011, J NEUROPHYSIOL, V105, P2018, DOI 10.1152/jn.00834.2010; Liem EIML, 2013, CEREBELLUM, V12, P224, DOI 10.1007/s12311-012-0417-z; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Logothetis NK, 2004, MAGN RESON IMAGING, V22, P1517, DOI 10.1016/j.mri.2004.10.018; Manni E, 2004, NAT REV NEUROSCI, V5, P241, DOI 10.1038/nrn1347; Marmolino D, 2010, CURR NEUROPHARMACOL, V8, P41, DOI 10.2174/157015910790909476; Marques JP, 2010, RADIOLOGY, V254, P942, DOI 10.1148/radiol.09091136; Mottolese C, 2013, BRAIN, V136, P330, DOI 10.1093/brain/aws186; Neggers SFW, 2008, NMR BIOMED, V21, P663, DOI 10.1002/nbm.1235; Neggers SFW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029517; Nitschke MF, 1996, BRAIN, V119, P1023; Nonaka H, 2003, NEUROPATHOLOGY, V23, P129, DOI 10.1046/j.1440-1789.2003.00487.x; Ozden I, 2009, J NEUROSCI, V29, P10463, DOI 10.1523/JNEUROSCI.0967-09.2009; Panouilleres M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054641; Peeters RR, 1999, EUR J NEUROSCI, V11, P2720, DOI 10.1046/j.1460-9568.1999.00687.x; Petridou N, 2013, NMR BIOMED, V26, P65, DOI 10.1002/nbm.2820; Poser BA, 2010, NEUROIMAGE, V51, P261, DOI 10.1016/j.neuroimage.2010.01.108; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; Rancillac A, 2006, J NEUROSCI, V26, P6997, DOI 10.1523/JNEUROSCI.5515-05.2006; Rijntjes M, 1999, NEUROREPORT, V10, P3653, DOI 10.1097/00001756-199911260-00035; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Schmahmann JD, 1996, HUM BRAIN MAPP, V4, P174, DOI 10.1002/(SICI)1097-0193(1996)4:3<174::AID-HBM3>3.0.CO;2-0; Siero JCW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054560; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Thier P, 2006, PROG BRAIN RES, V151, P293, DOI 10.1016/S0079-6123(05)51010-0; Thoma P, 2008, CEREBELLUM, V7, P433, DOI 10.1007/s12311-008-0046-8; Thurling M, 2012, NEUROIMAGE, V62, P1537, DOI 10.1016/j.neuroimage.2012.05.037; van Broekhoven PCA, 2009, CEREBELLUM, V8, P403, DOI 10.1007/s12311-009-0116-6; van der Zwaag W, 2013, NEUROIMAGE, V67, P354, DOI 10.1016/j.neuroimage.2012.11.041; Vargas MI, 2009, J NEURORADIOLOGY, V36, P74, DOI 10.1016/j.neurad.2008.08.001; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; Voogd J, 2012, CEREBELLUM, V11, P392, DOI 10.1007/s12311-010-0204-7; Wiestler T, 2011, J NEUROPHYSIOL, V105, P3042, DOI 10.1152/jn.00106.2011	86	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134933	10.1371/journal.pone.0134933	http://dx.doi.org/10.1371/journal.pone.0134933			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26259014	Green Published, gold, Green Submitted			2022-12-27	WOS:000359352600031
J	Long, X; Chen, Q; Zhao, JP; Rafaels, N; Mathias, P; Liang, HF; Potee, J; Campbell, M; Zhang, BX; Gao, L; Georas, SN; Vercelli, D; Beaty, TH; Ruczinski, I; Mathias, R; Barnes, KC; Chen, XP				Long, Xin; Chen, Qian; Zhao, Jianping; Rafaels, Nicholas; Mathias, Priyanka; Liang, Huifang; Potee, Joseph; Campbell, Monica; Zhang, Bixiang; Gao, Li; Georas, Steve N.; Vercelli, Donata; Beaty, Terri H.; Ruczinski, Ingo; Mathias, Rasika; Barnes, Kathleen C.; Chen, Xiaoping			An IL-13 Promoter Polymorphism Associated with Liver Fibrosis in Patients with Schistosoma japonicum	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; HEPATIC-FIBROSIS; CYTOKINE PRODUCTION; INFECTION LEVELS; MANSONI; INTERLEUKIN-13; EXPRESSION; CELLS; RISK; INFLAMMATION	The aim of this study was to determine whether two polymorphisms in the gene encoding IL13 previously associated with Schistosoma hematobium (S. hematobium) and S. mansoni infection are associated with S. japonicum infection. Single nucleotide polymorphisms (SNPs) rs1800925 (IL13/-1112C>T) and rs20541 (IL13R130Q) were genotyped in 947 unrelated individuals (307 chronically infected, 339 late-stage with liver fibrosis, 301 uninfected controls) from a schistosomiasis-endemic area of Hubei province in China. Regression models were used to evaluate allelic and haplotypic associations with chronic and late-stage schistosomiasis adjusted for non-genetic covariates. Expression of IL-13 was measured in S. japonicun-infected liver fibrosis tissue and normal liver tissue from uninfected controls by immunohistochemistry (IHC). The role of rs1800925 in IL-13 transcription was further determined by Luciferase report assay using the recombinant PGL4.17-rs180092 plasmid. We found SNP rs1800925T was associated with late-stage schistosomiasis caused by S. japonicum but not chronic schistosomiasis (OR = 1.39, 95% CI = 1.02-1.91, p = 0.03) and uninfected controls (OR = 1.49, 95% CI = 1.03-2.13, p = 0.03). Moreover, the haplotype rs1800925T-rs20541C increased the risk of disease progression to late-stage schistosomiasis (OR = 1.46, p = 0.035), whereas haplotype rs1800925C-rs20541A showed a protective role against development of late-stage schistosomiasis (F = 0.188, OR = 0.61, p = 0.002). Furthermore, S. japonicum-induced fibrotic liver tissue had higher IL13 expression than normal liver tissue. Plasmid PGL4.17-rs1800925T showed a stronger relative luciferase activity than Plasmid PGL4.17-rs1800925C in 293FT, QSG-7701 and HL-7702 cell lines. In conclusion, the functional IL13 polymorphism, rs1800925T, previously associated with risk of schistosomiasis, also contributes to risk of late-stage schistosomiasis caused by S. japonicum.	[Long, Xin; Zhao, Jianping; Liang, Huifang; Zhang, Bixiang; Chen, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Hepat Surg Ctr, Wuhan 430074, Hubei Province, Peoples R China; [Long, Xin; Rafaels, Nicholas; Mathias, Priyanka; Potee, Joseph; Campbell, Monica; Gao, Li; Mathias, Rasika; Barnes, Kathleen C.] Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21218 USA; [Chen, Qian] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Gastroenterol & Hepatol, Wuhan 430074, Hubei Province, Peoples R China; [Beaty, Terri H.; Ruczinski, Ingo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Vercelli, Donata] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Georas, Steve N.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins Medicine; Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Arizona; University of Rochester	Barnes, KC (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21218 USA.	kbarnes@jhmi.edu; chenxp@medmail.com.cn		Long, Xin/0000-0002-9817-5858; Zhao, Jianping/0000-0003-3057-5617	Mary Beryl Patch Turnbull Scholar Program [2012ZX10002016-004]; Major and Special Program of National Science and Technology in Twelfth Five-year Plan of China [81471612];  [R01HL112088]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112088] Funding Source: NIH RePORTER	Mary Beryl Patch Turnbull Scholar Program; Major and Special Program of National Science and Technology in Twelfth Five-year Plan of China; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by R01HL112088 (http://www.nih.gov/), The Mary Beryl Patch Turnbull Scholar Program 2012ZX10002016-004, and The Major and Special Program of National Science and Technology in Twelfth Five-year Plan of China 81471612 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Blanton RE, 2005, EUR J HUM GENET, V13, P660, DOI 10.1038/sj.ejhg.5201388; Brombacher F, 2000, BIOESSAYS, V22, P646, DOI 10.1002/1521-1878(200007)22:7&lt;646::AID-BIES7&gt;3.0.CO;2-9; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Cai YC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-138; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Chen HB, 2012, ACTA OCEANOL SIN, V31, P31, DOI 10.1007/s13131-012-0218-8; Chen L, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-18; Chen ZM, 2010, ACTA TROP, V115, P119, DOI 10.1016/j.actatropica.2010.02.012; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Chiaramonte MG, 2001, HEPATOLOGY, V34, P273, DOI 10.1053/jhep.2001.26376; Co DO, 2004, IMMUNOL LETT, V92, P135, DOI 10.1016/j.imlet.2003.11.023; Coutinho HM, 2007, J INFECT DIS, V195, P288, DOI 10.1086/510313; de Jesus AR, 2002, J INFECT DIS, V185, P98, DOI 10.1086/324668; Fraga LAD, 2010, J INFECT DIS, V201, P464, DOI 10.1086/649841; Ding ZY, 2014, HEPATOLOGY, V60, P1620, DOI 10.1002/hep.27273; Ding ZY, 2014, J CELL PHYSIOL, V229, P651, DOI 10.1002/jcp.24488; Ellis MK, 2008, INT J PARASITOL, V38, P717, DOI 10.1016/j.ijpara.2007.09.013; Fairfax K, 2012, SEMIN IMMUNOPATHOL, V34, P863, DOI 10.1007/s00281-012-0354-4; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Fried B, 2011, CANCER LETT, V305, P239, DOI 10.1016/j.canlet.2010.07.008; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao PS, 2009, J ALLERGY CLIN IMMUN, V124, P507, DOI 10.1016/j.jaci.2009.07.034; Gatlin MR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000375; Gazzinelli G, 1992, Rev Soc Bras Med Trop, V25, P125, DOI 10.1590/S0037-86821992000200006; Grant AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035863; He H, 2008, GENES IMMUN, V9, P195, DOI 10.1038/gene.2008.2; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Isnard A, 2011, GENES IMMUN, V12, P31, DOI 10.1038/gene.2010.43; Justesen-van Sloterdijk D.W., 1977, Acta Leidensia, V45, P61; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Kouriba B, 2005, J IMMUNOL, V174, P6274, DOI 10.4049/jimmunol.174.10.6274; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; Lemos Clarice P. Abrantes, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P471, DOI 10.1590/S0036-46651995000500015; Li Shi-Zhu, 2013, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V25, P557; Li XY, 2010, PARASITOLOGY, V137, P1213, DOI 10.1017/S003118201000003X; Liu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031876; Ma Y, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-85; Marillier RG, 2010, AM J PHYSIOL-GASTR L, V298, pG943, DOI 10.1152/ajpgi.00321.2009; Mata-Santos HA, 2014, ANTIMICROB AGENTS CH, V58, P2076, DOI 10.1128/AAC.01936-13; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125, P336, DOI 10.1016/j.jaci.2009.08.031; McKenzie ANJ, 2000, PHARMACOL THERAPEUT, V88, P143, DOI 10.1016/S0163-7258(00)00088-7; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Mentink-Kane MM, 2004, P NATL ACAD SCI USA, V101, P586, DOI 10.1073/pnas.0305064101; Murray T, 2010, GENET EPIDEMIOL, V34, P561, DOI 10.1002/gepi.20512; Nausch N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00472; Oliveira LFA, 2006, INFECT IMMUN, V74, P1215, DOI 10.1128/IAI.74.2.1215-1221.2006; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Singh KP, 2004, ANN TROP MED PARASIT, V98, P581, DOI 10.1179/000349804225021316; UPATHAM ES, 1976, PARASITOLOGY, V73, P253, DOI 10.1017/S0031182000046941; van Dam GJ, 2015, ACTA TROP, V141, P190, DOI 10.1016/j.actatropica.2014.08.004; Vergara C, 2013, GENET EPIDEMIOL, V37, P393, DOI 10.1002/gepi.21702; Wang LD, 2009, TROP MED INT HEALTH, V14, P1475, DOI 10.1111/j.1365-3156.2009.02403.x; Weng HL, 2009, HEPATOLOGY, V50, P230, DOI 10.1002/hep.22934; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; WILLIAMS ME, 1994, J INFECT DIS, V170, P946, DOI 10.1093/infdis/170.4.946; Wilson MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002171; Wu W, 2015, PARASITOL RES, V114, P17, DOI 10.1007/s00436-014-4225-x; Xia X, 2013, INT J ENV RES PUB HE, V10, P2799, DOI 10.3390/ijerph10072799; Yu JM, 2007, PARASITOL INT, V56, P45, DOI 10.1016/j.parint.2006.11.002; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005; Zhou YB, 2007, AM J TROP MED HYG, V76, P1138, DOI 10.4269/ajtmh.2007.76.1138	64	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135360	10.1371/journal.pone.0135360	http://dx.doi.org/10.1371/journal.pone.0135360			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258681	gold, Green Published, Green Submitted			2022-12-27	WOS:000359352600061
J	Zhang, GD; Shi, HB; Wang, L; Zhou, M; Wang, ZZ; Liu, X; Cheng, L; Li, WM; Li, XQ				Zhang, Guangde; Shi, Hongbo; Wang, Lin; Zhou, Meng; Wang, Zhenzhen; Liu, Xiaoxia; Cheng, Liang; Li, Weimin; Li, Xueqi			MicroRNA and Transcription Factor Mediated Regulatory Network Analysis Reveals Critical Regulators and Regulatory Modules in Myocardial Infarction	PLOS ONE			English	Article							NF-KAPPA-B; TARGET PREDICTION; FEEDFORWARD LOOPS; GENE-EXPRESSION; DATABASE; HEART; ACTIVATION; PATHWAY; IDENTIFICATION; KNOWLEDGEBASE	Myocardial infarction (MI) is a severe coronary artery disease and a leading cause of mortality and morbidity worldwide. However, the molecular mechanisms of MI have yet to be fully elucidated. In this study, we compiled MI-related genes, MI-related microRNAs (miRNAs) and known human transcription factors (TFs), and we then identified 1,232 feed-forward loops (FFLs) among these miRNAs, TFs and their co-regulated target genes through integrating target prediction. By merging these FFLs, the first miRNA and TF mediated regulatory network for MI was constructed, from which four regulators (SP1, ESR1, miR-21-5p and miR-155-5p) and three regulatory modules that might play crucial roles in MI were then identified. Furthermore, based on the miRNA and TF mediated regulatory network and literature survey, we proposed a pathway model for miR-21-5p, the miR-29 family and SP1 to demonstrate their potential co-regulatory mechanisms in cardiac fibrosis, apoptosis and angiogenesis. The majority of the regulatory relations in the model were confirmed by previous studies, which demonstrated the reliability and validity of this miRNA and TF mediated regulatory network. Our study will aid in deciphering the complex regulatory mechanisms involved in MI and provide putative therapeutic targets for MI.	[Zhang, Guangde; Liu, Xiaoxia; Li, Xueqi] Harbin Med Univ, Affiliated Hosp 4, Dept Cardiol, Harbin 150001, Heilongjiang, Peoples R China; [Shi, Hongbo; Wang, Lin; Zhou, Meng; Wang, Zhenzhen; Cheng, Liang] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Heilongjiang, Peoples R China; [Li, Weimin] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin 150001, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Li, XQ (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Cardiol, Harbin 150001, Heilongjiang, Peoples R China.	liweimin_2009@163.com; lixueqi_06@163.com	Zhou, Meng/G-7674-2011	Zhou, Meng/0000-0001-9987-9024; Cheng, Liang/0000-0002-6665-6710	National High Technology Research and Development Program of China [863 Program] [2014AA021102]; National Program on Key Basic Research Project [973 Program] [2014CB910504]; National Natural Science Foundation of China [61473106]; Natural Science Foundation of Heilongjiang Province, China [QC2013C019]; Science Foundation of Heilongjiang Provincial Health Department [2013126]	National High Technology Research and Development Program of China [863 Program](National High Technology Research and Development Program of China); National Program on Key Basic Research Project [973 Program](National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province, China(Natural Science Foundation of Heilongjiang Province); Science Foundation of Heilongjiang Provincial Health Department	This work was supported in part by the National High Technology Research and Development Program of China [863 Program, Grant Nos. 2014AA021102], the National Program on Key Basic Research Project [973 Program, Grant Nos. 2014CB910504], the National Natural Science Foundation of China [Grant Nos. 61473106], the Natural Science Foundation of Heilongjiang Province, China (Grant No. QC2013C019) and the Science Foundation of Heilongjiang Provincial Health Department (Grant Nos. 2013126).	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arora S, 2013, MOL GENET GENOMICS, V288, P77, DOI 10.1007/s00438-013-0734-z; Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chandrasekar B, 1997, FEBS LETT, V401, P30, DOI 10.1016/S0014-5793(96)01426-3; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Choy MK, 2010, GENOME MED, V2, DOI 10.1186/gm158; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Du B, 2010, FEBS LETT, V584, P811, DOI 10.1016/j.febslet.2009.12.053; Echtermeyer F, 2011, CARDIOVASC RES, V92, P123, DOI 10.1093/cvr/cvr149; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gatsios P, 1996, EUR J BIOCHEM, V241, P56, DOI 10.1111/j.1432-1033.1996.0056t.x; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; HERSKOWITZ A, 1995, AM J PATHOL, V146, P419; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Huang Y, 2014, EXPERT OPIN THER TAR, V18, P1355, DOI 10.1517/14728222.2014.961424; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kavurma MM, 2002, J BIOL CHEM, V277, P36244, DOI 10.1074/jbc.M200463200; Kazi AA, 2009, BIOL REPROD, V81, P378, DOI 10.1095/biolreprod.109.076117; Koyanagi M, 2010, CIRC RES, V106, P1290, DOI 10.1161/CIRCRESAHA.109.206045; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Kuwabara Y, 2011, CIRC-CARDIOVASC GENE, V4, P446, DOI 10.1161/CIRCGENETICS.110.958975; Law SK, 2013, INT J CARDIOL, V168, P3458, DOI 10.1016/j.ijcard.2013.04.178; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li KN, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-122; Li N, 2012, INVEST OPHTH VIS SCI, V53, P1670, DOI 10.1167/iovs.11-8670; Lin Ying-zhong, 2013, Mediators Inflamm, V2013, P635672, DOI 10.1155/2013/635672; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Peng C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078197; Qin S, 2015, BIOINFORMATICS, V31, P76, DOI 10.1093/bioinformatics/btu597; Reynen K, 2004, ANN ONCOL, V15, P375, DOI 10.1093/annonc/mdh086; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; SIMBENI R, 1993, BIOCHIM BIOPHYS ACTA, V1145, P1, DOI 10.1016/0005-2736(93)90374-9; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Steele Robert, 2010, Genes Cancer, V1, P381; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Tang Y, 2015, CARDIOVASC RES; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Vilahur G, 2013, EUR HEART J, V34, P2082, DOI 10.1093/eurheartj/ehs211; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395; Yang GD, 2012, J CELL PHYSIOL, V227, P3192, DOI 10.1002/jcp.24006; Ye HS, 2012, NUCLEIC ACIDS RES, V40, P5201, DOI 10.1093/nar/gks175; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Yu XJ, 2013, CARDIOVASC TOXICOL, V13, P381, DOI 10.1007/s12012-013-9219-x; Zhang HM, 2015, BRIEF BIOINFORM, V16, P45, DOI 10.1093/bib/bbt085; Zhu HY, 2012, CARDIOVASC RES, V94, P284, DOI 10.1093/cvr/cvr291	71	29	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135339	10.1371/journal.pone.0135339	http://dx.doi.org/10.1371/journal.pone.0135339			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258537	Green Submitted, gold, Green Published			2022-12-27	WOS:000359352600059
J	Brunner, D; Kabitzke, P; He, DS; Cox, K; Thiede, L; Hanania, T; Sabath, E; Alexandrov, V; Saxe, M; Peles, E; Mills, A; Spooren, W; Ghosh, A; Feliciano, P; Benedetti, M; Clayton, AL; Biemans, B				Brunner, Daniela; Kabitzke, Patricia; He, Dansha; Cox, Kimberly; Thiede, Lucinda; Hanania, Taleen; Sabath, Emily; Alexandrov, Vadim; Saxe, Michael; Peles, Elior; Mills, Alea; Spooren, Will; Ghosh, Anirvan; Feliciano, Pamela; Benedetti, Marta; Clayton, Alice Luo; Biemans, Barbara			Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder	PLOS ONE			English	Article							ULTRASONIC VOCALIZATIONS; HUNTINGTONS-DISEASE; KNOCKOUT MICE; VALPROIC ACID; RETT-SYNDROME; BEHAVIOR; INFANT; GENE; ABNORMALITIES; PHENOTYPES	Autism spectrum disorder comprises several neurodevelopmental conditions presenting symptoms in social communication and restricted, repetitive behaviors. A major roadblock for drug development for autism is the lack of robust behavioral signatures predictive of clinical efficacy. To address this issue, we further characterized, in a uniform and rigorous way, mouse models of autism that are of interest because of their construct validity and wide availability to the scientific community. We implemented a broad behavioral battery that included but was not restricted to core autism domains, with the goal of identifying robust, reliable phenotypes amenable for further testing. Here we describe comprehensive findings from two known mouse models of autism, obtained at different developmental stages, using a systematic behavioral test battery combining standard tests as well as novel, quantitative, computer-vision based systems. The first mouse model recapitulates a deletion in human chromosome 16p11.2, found in 1% of individuals with autism. The second mouse model harbors homozygous null mutations in Cntnap2, associated with autism and Pitt-Hopkins-like syndrome. Consistent with previous results, 16p11.2 heterozygous null mice, also known as Del(7Slx1b-Sept1)4Aam weighed less than wild type littermates displayed hyperactivity and no social deficits. Cntnap2 homozygous null mice were also hyperactive, froze less during testing, showed a mild gait phenotype and deficits in the three-chamber social preference test, although less robust than previously published. In the open field test with exposure to urine of an estrous female, however, the Cntnap2 null mice showed reduced vocalizations. In addition, Cntnap2 null mice performed slightly better in a cognitive procedural learning test. Although finding and replicating robust behavioral phenotypes in animal models is a challenging task, such functional readouts remain important in the development of therapeutics and we anticipate both our positive and negative findings will be utilized as a resource for the broader scientific community.	[Brunner, Daniela; Kabitzke, Patricia; He, Dansha; Cox, Kimberly; Thiede, Lucinda; Hanania, Taleen; Sabath, Emily; Alexandrov, Vadim] PsychoGenics Inc, Tarrytown, NY 10591 USA; [Brunner, Daniela; Kabitzke, Patricia] Columbia Univ, Dept Psychiat, New York, NY USA; [Saxe, Michael; Spooren, Will; Ghosh, Anirvan; Biemans, Barbara] Roche, Basel, Switzerland; [Peles, Elior] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Mills, Alea] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Feliciano, Pamela; Benedetti, Marta; Clayton, Alice Luo] Simons Fdn Autism Res Initiat, New York, NY USA	Columbia University; Roche Holding; Weizmann Institute of Science; Cold Spring Harbor Laboratory	Brunner, D (corresponding author), PsychoGenics Inc, Tarrytown, NY 10591 USA.	Dani.Brunner@psychogenics.com			Simons Foundation; Roche; PsychoGenics	Simons Foundation; Roche(Roche Holding); PsychoGenics	This project was funded by the Simons Foundation and Roche as a contract to PsychoGenics. Simons Foundation, Roche, and PsychoGenics contributed to the conception and design of the experiments and to the writing of the manuscript. PsychoGenics provided support in the form of salaries for authors DB, PK, DH, KC, LT, TH, ES and VA. Roche provided support in the form of salaries for authors MS, WS, AG and BB. The specific roles of these authors are articulated in the 'author contributions' section. All aspects of experimental design, data collection and analysis, and decision to publish the manuscript were made jointly by Roche, PsychoGenics, and the Simons Foundation.	Alexandrov V, 2015, EUROPEAN J PHARM; Ament K, 2015, J AUTISM DEV DISORD, V45, P742, DOI 10.1007/s10803-014-2229-0; Bachmann-Gagescu R, 2010, GENET MED, V12, P641, DOI 10.1097/GIM.0b013e3181ef4286; Bailey KR, 2006, ILAR J, V47, P124, DOI 10.1093/ilar.47.2.124; BAKKER CE, 1994, CELL, V78, P23; Balci Fuat, 2013, PLoS Curr, V5, DOI 10.1371/currents.hd.124aa0d16753f88215776fba102ceb29; Barge-Schaapveld DQCM, 2011, AM J MED GENET A, V155A, P1066, DOI 10.1002/ajmg.a.33991; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; BLUMBERG MS, 1990, BEHAV NEUROSCI, V104, P808, DOI 10.1037/0735-7044.104.5.808; Bolivar VJ, 2007, BEHAV BRAIN RES, V176, P21, DOI 10.1016/j.bbr.2006.09.007; BROEKKAMP CL, 1986, EUR J PHARMACOL, V126, P223, DOI 10.1016/0014-2999(86)90051-8; Brunner D, 1999, BEHAV NEUROSCI, V113, P587; Brunner D, 2002, DRUG DISCOV TODAY, V7, pS107, DOI 10.1016/S1359-6446(02)02423-6; CARDEN SE, 1992, BEHAV NEUROSCI, V106, P421, DOI 10.1037/0735-7044.106.2.421; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Egashira N, 2007, BEHAV BRAIN RES, V178, P123, DOI 10.1016/j.bbr.2006.12.009; El-Khodor BF, 2004, INT J DEV NEUROSCI, V22, P405, DOI 10.1016/j.ijdevneu.2004.06.001; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Girirajan S, 2010, HUM MOL GENET, V19, pR176, DOI 10.1093/hmg/ddq366; Green D, 2009, DEV MED CHILD NEUROL, V51, P311, DOI 10.1111/j.1469-8749.2008.03242.x; GYERTYAN I, 1995, BEHAV PHARMACOL, V6, P24; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Hilton CL, 2012, AUTISM, V16, P430, DOI 10.1177/1362361311423018; HOFER MA, 1991, BEHAV NEUROSCI, V105, P41, DOI 10.1037/0735-7044.105.1.41; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Houghten RA, 2008, J COMB CHEM, V10, P3, DOI 10.1021/cc7001205; Ingram JL, 2000, NEUROTOXICOL TERATOL, V22, P319, DOI 10.1016/S0892-0362(99)00083-5; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; JAILER JW, 1950, ENDOCRINOLOGY, V46, P420, DOI 10.1210/endo-46-5-420; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; LeBarton ES, 2013, DEVELOPMENTAL SCI, V16, P815, DOI 10.1111/desc.12069; Lehmann ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069822; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; Menalled L, 2014, MOVEMENT DISORD, V29, P1375, DOI 10.1002/mds.26006; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011; Miller DT, 1993, MICRODELETION; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nebel MB, 2014, HUM BRAIN MAPP, V35, P567, DOI 10.1002/hbm.22188; NJUNGE K, 1991, BRIT J PHARMACOL, V104, P105, DOI 10.1111/j.1476-5381.1991.tb12392.x; NOVOTNY M, 1990, EXPERIENTIA, V46, P109, DOI 10.1007/BF01955433; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Peippo M, 2011, MOL SYNDROMOL, V2, P171, DOI 10.1159/000335287; Penagarikano O, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010257; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017073; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Portmann T, 2014, CELL REP, V7, P1077, DOI 10.1016/j.celrep.2014.03.036; Roberds SL, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00103; Roullet FI, 2011, BEHAV BRAIN RES, V216, P19, DOI 10.1016/j.bbr.2010.06.004; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schneider T, 2006, NEUROPSYCHOPHARMACOL, V31, P36, DOI 10.1038/sj.npp.1300767; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Spooren W, 2012, TRENDS PHARMACOL SCI, V33, P669, DOI 10.1016/j.tips.2012.09.004; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; SWERDLOW NR, 1986, BIOL PSYCHIAT, V21, P23, DOI 10.1016/0006-3223(86)90005-3; Tanimura Y, 2008, BEHAV BRAIN RES, V189, P250, DOI 10.1016/j.bbr.2008.01.001; Tian D, 2015, NAT NEUROSCI, V18, P182, DOI 10.1038/nn.3911; Trevarthen C, 2005, BRAIN DEV-JPN, V27, pS25, DOI 10.1016/j.braindev.2005.03.016; Walsh KM, 2011, GENET MED, V13, P377, DOI 10.1097/GIM.0b013e3182076c0c; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weller A, 2003, DEV PSYCHOBIOL, V42, P194, DOI 10.1002/dev.10079; Wohr M, 2011, GENES BRAIN BEHAV, V10, P35, DOI 10.1111/j.1601-183X.2010.00582.x; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a; Yang M, 2015, AUTISM RES, V8, P507, DOI 10.1002/aur.1465; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Zufferey F, 2012, J MED GENET, V49, P660, DOI 10.1136/jmedgenet-2012-101203; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	80	52	63	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134572	10.1371/journal.pone.0134572	http://dx.doi.org/10.1371/journal.pone.0134572			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26273832	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000359493600032
J	Zhang, LL; Si, T; Fischer, AJ; Letson, A; Yuan, S; Roberts, CJ; Xu, RX				Zhang, Leilei; Si, Ting; Fischer, Andrew J.; Letson, Alan; Yuan, Shuai; Roberts, Cynthia J.; Xu, Ronald X.			Coaxial Electrospray of Ranibizumab-Loaded Microparticles for Sustained Release of Anti-VEGF Therapies	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; PHOTORECEPTOR CELL-DEATH; MACULAR DEGENERATION; MULLER GLIA; PIGMENTED EPITHELIUM; RETINITIS-PIGMENTOSA; CHICKEN RETINA; NANOPARTICLES; DELIVERY; DAMAGE	Age-related macular degeneration (AMD) is the leading cause of vision loss and blindness in people over age 65 in industrialized nations. Intravitreous injection of anti-VEGF (vascular endothelial growth factor) therapies, such as ranibizumab (trade name: Lucentis), provides an effective treatment option for neovascular AMD. We have developed an improved coaxial electrospray (CES) process to encapsulate ranibizumab in poly(lactic-co-glycolic) acid (PLGA) microparticles (MPs) for intravitreous injection and sustained drug release. This microencapsulation process is advantageous for maintaining the stability of the coaxial cone-jet configurations and producing drug-loaded MPs with as high as 70% encapsulation rate and minimal loss of bioactivitiy. The utility of this emerging process in intravitreous drug delivery has been demonstrated in both benchtop and in vivo experiments. The benchtop test simulates ocular drug release using PLGA MPs encapsulating a model drug. The in vivo experiment evaluates the inflammation and retinal cell death after intravitreal injection of the MPs in a chick model. The experimental results show that the drug-load MPs are able to facilitate sustained drug release for longer than one month. No significant long term microglia reaction or cell death is observed after intravitreal injection of 200 mu g MPs. The present study demonstrates the technical feasibility of using the improved CES process to encapsulate water-soluble drugs at a high concentration for sustained release of anti-VEGF therapy.	[Zhang, Leilei; Si, Ting; Roberts, Cynthia J.; Xu, Ronald X.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Si, Ting; Yuan, Shuai; Xu, Ronald X.] Univ Sci & Technol China, Sch Engn Sci, Hefei 230027, Anhui, Peoples R China; [Fischer, Andrew J.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Letson, Alan; Roberts, Cynthia J.] Ohio State Univ, Dept Ophthalmol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Xu, RX (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.	xu.ronald@hotmail.com	Si, Ting/D-9203-2018	Si, Ting/0000-0001-9071-8646	Ohio Lion's Eye Research Foundation; National Natural Science Foundation of China [11472270, 81327803]; Fundamental Research Funds for the Central Universities	Ohio Lion's Eye Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Leilei Zhang is supported by a research fellowship provided by Ohio Lion's Eye Research Foundation. This work is partially supported by the National Natural Science Foundation of China (11472270, 81327803) and the Fundamental Research Funds for the Central Universities.	Aiello LP, 2004, RETINA-J RET VIT DIS, V24, pS3, DOI 10.1097/00006982-200410001-00002; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Arroba AI, 2011, INVEST OPHTH VIS SCI, V52, P9124, DOI 10.1167/iovs.11-7736; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; Bejjani R, 2005, MOL VIS, V11, P124; Bourges JL, 2003, INVEST OPHTH VIS SCI, V44, P3562, DOI 10.1167/iovs.02-1068; Cebulla CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044257; Cruysberg LPJ, 2002, J OCUL PHARMACOL TH, V18, P559, DOI 10.1089/108076802321021108; D'Amico DJ, 2006, OPHTHALMOLOGY, V113, P992, DOI 10.1016/j.ophtha.2006.02.027; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Fischer AJ, 1999, J COMP NEUROL, V405, P1, DOI 10.1002/(SICI)1096-9861(19990301)405:1<1::AID-CNE1>3.0.CO;2-U; Fischer AJ, 2004, MOL VIS, V10, P973; Fischer AJ, 2004, MOL CELL NEUROSCI, V27, P531, DOI 10.1016/j.mcn.2004.08.007; Fischer AJ, 1999, VISION RES, V39, P685, DOI 10.1016/S0042-6989(98)00178-3; Fischer AJ, 1998, J COMP NEUROL, V393, P1; Fischer AJ, 2002, J NEUROSCI, V22, P9387; Fischer AJ, 2010, GLIA, V58, P633, DOI 10.1002/glia.20950; Fischer AJ, 2009, GLIA, V57, P166, DOI 10.1002/glia.20743; Ghai K, 2010, J NEUROSCI, V30, P3101, DOI 10.1523/JNEUROSCI.4919-09.2010; Hubschman JP, 2009, CLIN OPHTHALMOL, V3, P155; Kaur C, 2008, CLIN OPHTHALMOL, V2, P879, DOI 10.2147/opth.s3361; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Muller RH, 2004, J BIOTECHNOL, V113, P151, DOI 10.1016/j.jbiotec.2004.06.007; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Putney SD, 1998, NAT BIOTECHNOL, V16, P153, DOI 10.1038/nbt0298-153; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Ritchey ER, 2012, EXP EYE RES, V99, P1, DOI 10.1016/j.exer.2012.03.019; Ritchey ER, 2011, MOL VIS, V17, P2440; Rosenfeld PJ, 2006, OPHTHALMOLOGY, V113, P623, DOI 10.1016/j.ophtha.2006.01.027; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P5347, DOI 10.1167/iovs.10-7119; SHAHINFAR S, 1991, CURR EYE RES, V10, P47, DOI 10.3109/02713689109007610; Si T, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.075003; Singh RP, 2006, AM J OPHTHALMOL, V142, P160, DOI 10.1016/j.ajo.2006.03.051; Tomlinson IM, 2004, NAT BIOTECHNOL, V22, P521, DOI 10.1038/nbt0504-521; Votruba M, 2001, EYE, V15, P424, DOI 10.1038/eye.2001.147; Zhang LL, 2012, EXPERT REV MED DEVIC, V9, P595, DOI [10.1586/erd.12.58, 10.1586/ERD.12.58]; Zulliger R, 2011, GRAEF ARCH CLIN EXP, V249, P859, DOI 10.1007/s00417-010-1584-6	38	22	26	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135608	10.1371/journal.pone.0135608	http://dx.doi.org/10.1371/journal.pone.0135608			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26273831	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600082
J	Garrett, CK; Broadwell, LJ; Hayne, CK; Neher, SB				Garrett, Christopher K.; Broadwell, Lindsey J.; Hayne, Cassandra K.; Neher, Saskia B.			Modulation of the Activity of Mycobacterium tuberculosis LipY by Its PE Domain	PLOS ONE			English	Article							VII SECRETION SYSTEM; PATHOGENIC MYCOBACTERIA; IN-VITRO; LIPASE; TRIACYLGLYCEROL; ESX-5; PPE; INHIBITION; EVOLUTION; VIRULENCE	Mycobacterium tuberculosis harbors over 160 genes encoding PE/PPE proteins, several of which have roles in the pathogen's virulence. A number of PE/PPE proteins are secreted via Type VII secretion systems known as the ESX secretion systems. One PE protein, LipY, has a triglyceride lipase domain in addition to its PE domain. LipY can regulate intracellular triglyceride levels and is also exported to the cell wall by one of the ESX family members, ESX-5. Upon export, LipY's PE domain is removed by proteolytic cleavage. Studies using cells and crude extracts suggest that LipY's PE domain not only directs its secretion by ESX-5, but also functions to inhibit its enzymatic activity. Here, we attempt to further elucidate the role of LipY's PE domain in the regulation of its enzymatic activity. First, we established an improved purification method for several LipY variants using detergent micelles. We then used enzymatic assays to confirm that the PE domain down-regulates LipY activity. The PE domain must be attached to LipY in order to effectively inhibit it. Finally, we determined that full length LipY and the mature lipase lacking the PE domain (LipY Delta PE) have similar melting temperatures. Based on our improved purification strategy and activity-based approach, we concluded that LipY's PE domain down-regulates its enzymatic activity but does not impact the thermal stability of the enzyme.	[Garrett, Christopher K.; Hayne, Cassandra K.; Neher, Saskia B.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA; [Broadwell, Lindsey J.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Neher, SB (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	neher@email.unc.edu		Neher, Saskia/0000-0003-4165-6674; Hayne, Cassandra/0000-0002-2485-5949; Broadwell, Lindsey/0000-0002-7559-3977	National Heart Lung and Blood Institute at the National Institutes of Health [ROOHL098277-01]; UNC Summer Undergraduate Research Fellowship; NSF [DGE-1144081]	National Heart Lung and Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UNC Summer Undergraduate Research Fellowship; NSF(National Science Foundation (NSF))	Grant ROOHL098277-01 from the National Heart Lung and Blood Institute at the National Institutes of Health to SBN: (http://www.nhlbi.nih.gov). SBN is a Pew Scholar: (http://www.pewtrusts.org/en/projects/pew-biomedical-scholars). LJB was supported by a UNC Summer Undergraduate Research Fellowship: (http://our.unc.edu/students/funding-opportunities/surf/). CKH is supported by graduate research fellowship DGE-1144081 from the NSF. For all funders, there was no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Carrasco-Lopez C, 2009, J BIOL CHEM, V284, P4365, DOI 10.1074/jbc.M808268200; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Chen TA, 2010, MICROB PATHOGENESIS, V49, P311, DOI 10.1016/j.micpath.2010.07.004; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Fishbein S, 2015, MOL MICROBIOL, V96, P901, DOI 10.1111/mmi.12981; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; HADVARY P, 1988, BIOCHEM J, V256, P357, DOI 10.1042/bj2560357; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Jha RK, 2011, J MOL BIOL, V413, P513, DOI 10.1016/j.jmb.2011.08.022; Lafferty MJ, 2013, J BIOL CHEM, V288, P28524, DOI 10.1074/jbc.M113.497602; Ligon LS, 2012, TUBERCULOSIS, V92, P121, DOI 10.1016/j.tube.2011.11.005; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; McGuire AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-120; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Ransac S, 1997, METHOD ENZYMOL, V286, P190; Riley R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000174; ROLLOF J, 1988, EUR J CLIN MICROBIOL, V7, P505, DOI 10.1007/BF01962601; Salameh Moh'd A, 2010, Open Biochem J, V4, P22, DOI 10.2174/1874091X01004010022; Scandura JM, 1997, BIOCHEMISTRY-US, V36, P412, DOI 10.1021/bi9612576; Schlieben NH, 2004, PROTEIN EXPRES PURIF, V34, P103, DOI 10.1016/j.pep.2003.11.014; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Segel IH, 1975, ENZYME KINETICS BEHA; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Singh VK, 2014, TUBERCULOSIS, V94, P252, DOI 10.1016/j.tube.2014.02.001; Solomonson M, 2015, STRUCTURE, V23, P571, DOI 10.1016/j.str.2015.01.002; Strong M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r59; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Vaux DL, 2014, ANNU REV CELL DEV BI, V30, P23, DOI 10.1146/annurev-cellbio-100913-013303	39	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135447	10.1371/journal.pone.0135447	http://dx.doi.org/10.1371/journal.pone.0135447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270534	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800072
J	Hong, HC; Hwang, SY; Park, S; Ryu, JY; Choi, HY; Yoo, HJ; Seo, JA; Kim, SG; Kim, NH; Baik, SH; Choi, DS; Kim, S; Choi, KM				Hong, Ho Cheol; Hwang, Soon Young; Park, Soyeon; Ryu, Ja Young; Choi, Hae Yoon; Yoo, Hye Jin; Seo, Ji-A; Kim, Sin Gon; Kim, Nan Hee; Baik, Sei Hyun; Choi, Dong Seop; Kim, Sungeun; Choi, Kyung Mook			Implications of Pericardial, Visceral and Subcutaneous Adipose Tissue on Vascular Inflammation Measured Using (18)FDG-PET/CT	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-ARTERY-DISEASE; DEEP VENOUS THROMBOSIS; CARDIOVASCULAR-DISEASE; PLAQUE INFLAMMATION; INTRATHORACIC FAT; EPICARDIAL FAT; ABDOMINAL FAT; F-18-FDG PET; RISK-FACTOR	Objective Pericardial adipose tissue (PAT) is associated with adverse cardiometabolic risk factors and cardiovascular disease (CVD). However, the relative implications of PAT, abdominal visceral and subcutaneous adipose tissue on vascular inflammation have not been explored. Method and Results We compared the association of PAT, abdominal visceral fat area (VFA), and subcutaneous fat area (SFA) with vascular inflammation, represented as the target-to-background ratio (TBR), the blood-normalized standardized uptake value measured using F-18-Fluorodeoxy-glucose Positron Emission Tomography ((18)FDG-PET) in 93 men and women without diabetes or CVD. Age-and sex-adjusted correlation analysis showed that PAT, VFA, and SFA were positively associated with most cardiometabolic risk factors, including systolic blood pressure, LDL-cholesterol, triglycerides, glucose, insulin resistance and high sensitive C-reactive proteins (hsCRP), whereas they were negatively associated with HDL-cholesterol. In particular, the maximum TBR (maxTBR) values were positively correlated with PAT and VFA (r = 0.48 and r = 0.45, respectively; both P < 0.001), whereas SFA showed a relatively weak positive relationship with maxTBR level (r = 0.31, P = 0.003). Conclusion This study demonstrated that both PAT and VFA are significantly and similarly associated with vascular inflammation and various cardiometabolic risk profiles.	[Hong, Ho Cheol; Ryu, Ja Young; Choi, Hae Yoon; Yoo, Hye Jin; Seo, Ji-A; Kim, Sin Gon; Kim, Nan Hee; Baik, Sei Hyun; Choi, Dong Seop; Choi, Kyung Mook] Korea Univ, Coll Med, Div Endocrinol & Metab, Dept Internal Med, Seoul 136705, South Korea; [Hwang, Soon Young] Korea Univ, Coll Med, Dept Biostat, Seoul 136705, South Korea; [Park, Soyeon; Kim, Sungeun] Korea Univ, Coll Med, Dept Nucl Med, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Choi, KM (corresponding author), Korea Univ, Coll Med, Div Endocrinol & Metab, Dept Internal Med, Seoul 136705, South Korea.	medica7@gmail.com	Choi, Kyung Mook/C-4195-2018; SEO, JI A/AAU-7968-2020; Kim, Nan Hee/T-8627-2019	Choi, Kyung Mook/0000-0001-6175-0225; SEO, JI A/0000-0002-1927-2618; Kim, Nan Hee/0000-0003-4378-520X; Kim, Sin Gon/0000-0002-7430-3675	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C0133]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. (HI14C0133) (KMC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos N, 2013, J AM COLL CARDIOL, V61, P1956, DOI 10.1016/j.jacc.2012.12.051; Brinkley TE, 2011, NUTR METAB CARDIOVAS, V21, P332, DOI 10.1016/j.numecd.2009.10.010; Chen WG, 2009, EUR J NUCL MED MOL I, V36, P144, DOI 10.1007/s00259-008-0947-2; Cheng KH, 2008, INT J OBESITY, V32, P268, DOI 10.1038/sj.ijo.0803726; Cheng VY, 2010, JACC-CARDIOVASC IMAG, V3, P352, DOI 10.1016/j.jcmg.2009.12.013; Cherian S, 2012, AM J PHYSIOL-ENDOC M, V303, pE937, DOI 10.1152/ajpendo.00061.2012; Choi HY, 2011, ARTERIOSCL THROM VAS, V31, P944, DOI 10.1161/ATVBAHA.110.220673; CIRCULATIONAHA, 2008, CIRCULATION, V117, P605, DOI DOI 10.1161/CIRCULATIONAHA.107.743062; Clement K, 2009, ARTERIOSCL THROM VAS, V29, P615, DOI 10.1161/ATVBAHA.108.182907; Corradi D, 2004, CARDIOVASC PATHOL, V13, P313, DOI 10.1016/j.carpath.2004.08.005; Fox CS, 2009, CIRCULATION, V119, P1586, DOI 10.1161/CIRCULATIONAHA.108.828970; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grandpierre S, 2011, CLIN NUCL MED, V36, P85, DOI 10.1097/RLU.0b013e318203bb42; Greif M, 2012, CARDIOLOGY, V121, P220, DOI 10.1159/000337083; Greif M, 2009, ARTERIOSCL THROM VAS, V29, P781, DOI 10.1161/ATVBAHA.108.180653; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Iacobellis G, 2011, TRENDS ENDOCRIN MET, V22, P450, DOI 10.1016/j.tem.2011.07.003; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Kim TH, 2011, OBESITY, V19, P1028, DOI 10.1038/oby.2010.246; Kim TN, 2010, CIRC-CARDIOVASC IMAG, V3, P142, DOI 10.1161/CIRCIMAGING.109.888909; Konishi M, 2012, J CARDIOL, V59, P344, DOI 10.1016/j.jjcc.2012.01.006; Konishi M, 2010, ATHEROSCLEROSIS, V213, P649, DOI 10.1016/j.atherosclerosis.2010.10.007; Konishi M, 2010, ATHEROSCLEROSIS, V209, P573, DOI 10.1016/j.atherosclerosis.2009.10.008; Liu JK, 2011, DIABETES CARE, V34, P341, DOI 10.2337/dc10-1312; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Mazurek T, 2014, KARDIOL POL, V72, P410, DOI 10.5603/KP.a2013.0320; Mazurek T, 2014, AM J CARDIOL, V113, P1505, DOI 10.1016/j.amjcard.2014.02.005; Mazzoccoli G, 2012, J BIOL REG HOMEOS AG, V26, P81; Mazzoccoli G, 2012, ATHEROSCLEROSIS, V223, P378, DOI 10.1016/j.atherosclerosis.2012.05.033; McAuley PA, 2011, OBESITY, V19, P1855, DOI 10.1038/oby.2011.191; Miao CL, 2011, RADIOLOGY, V261, P109, DOI 10.1148/radiol.11110346; Moustafa RR, 2010, CIRC-CARDIOVASC IMAG, V3, P536, DOI 10.1161/CIRCIMAGING.110.938225; Narumi H, 2009, INT J CARDIOL, V135, P150, DOI 10.1016/j.ijcard.2008.03.044; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Rudd JHF, 2008, NAT CLIN PRACT CARD, V5, pS11, DOI 10.1038/ncpcardio1160; Rudd JHF, 2008, J NUCL MED, V49, P871, DOI 10.2967/jnumed.107.050294; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Schlett CL, 2012, ATHEROSCLEROSIS, V222, P129, DOI 10.1016/j.atherosclerosis.2012.02.029; Surti S, 2007, J NUCL MED, V48, P471; Tadros TM, 2010, OBESITY, V18, P1039, DOI 10.1038/oby.2009.343; Vela D, 2007, ARCH PATHOL LAB MED, V131, P481; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yoo HJ, 2011, J NUCL MED, V52, P10, DOI 10.2967/jnumed.110.080838	45	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135294	10.1371/journal.pone.0135294	http://dx.doi.org/10.1371/journal.pone.0135294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270050	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492800051
J	Inagaki, N; Kinoshita, K; Kagawa, T; Tanaka, A; Ueno, O; Shimada, H; Takano, M				Inagaki, Noritoshi; Kinoshita, Keisuke; Kagawa, Takatoshi; Tanaka, Ayumi; Ueno, Osamu; Shimada, Hiroaki; Takano, Makoto			Phytochrome B Mediates the Regulation of Chlorophyll Biosynthesis through Transcriptional Regulation of ChlH and GUN4 Rice Seedlings	PLOS ONE			English	Article							MG-CHELATASE; TETRAPYRROLE BIOSYNTHESIS; FEEDBACK INHIBITION; GENE-EXPRESSION; DE-ETIOLATION; ARABIDOPSIS; LIGHT; SUBUNIT; GROWTH; PHOTORECEPTORS	Accurate regulation of chlorophyll synthesis is crucial for chloroplast formation during the greening process in angiosperms. In this study, we examined the role of phytochrome B (phyB) in the regulation of chlorophyll synthesis in rice seedlings (Oryza sativa L.) through the characterization of a pale-green phenotype observed in the phyB mutant grown under continuous red light (Rc) irradiation. Our results show that the Rc-induced chlorophyll accumulation can be divided into two components-a phyB-dependent and a phyB-independent component, and that the pale-green phenotype is caused by the absence of the phyB-dependent component. To elucidate the role of the missing component we established an Rc-induced greening experiment, the results of which revealed that several genes encoding proteins on the chlorophyll branch were repressed in the phyB mutant. Notable among them were ChlH and GUN4 genes, which encode subunit H and an activating factor of magnesium chelatase (Mg-chelatase), respectively, that were largely repressed in the mutant. Moreover, the kinetic profiles of chlorophyll precursors suggested that Mg-chelatase activity simultaneously decreased with the reduction in the transcript levels of ChlH and GUN4. These results suggest that phyB mediates the regulation of chlorophyll synthesis through transcriptional regulation of these two genes, whose products exert their action at the branching point of the chlorophyll biosynthesis pathway. Reduction of 5-aminolevulinic acid (5-ALA) synthesis could be detected in the mutant, but the kinetic profiles of chlorophyll precursors indicated that it was an event posterior to the reduction of the Mg-chelatase activity. It means that the repression of 5-ALA synthesis should not be a triggering event for the appearance of the pale-green phenotype. Instead, the repression of 5-ALA synthesis might be important for the subsequent stabilization of the pale-green phenotype for preventing excessive accumulation of hazardous chlorophyll precursors, which is an inevitable consequence of the reduction of Mg-chelatase activity.	[Inagaki, Noritoshi; Kinoshita, Keisuke; Kagawa, Takatoshi; Takano, Makoto] Natl Inst Agrobiol Sci, Photobiol & Photosynth Res Unit, Tsukuba, Ibaraki, Japan; [Inagaki, Noritoshi; Kagawa, Takatoshi] Natl Inst Agrobiol Sci, Funct Plant Res Unit, Tsukuba, Ibaraki, Japan; [Kinoshita, Keisuke; Shimada, Hiroaki] Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo 162, Japan; [Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Plant Adaptat Biol Grp, Sapporo, Hokkaido 060, Japan; [Ueno, Osamu] Kyushu Univ, Fac Agr, Fukuoka, Fukuoka, Japan; [Takano, Makoto] Natl Inst Agrobiol Sci, Genetically Modified Organism Res Ctr, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; Tokyo University of Science; Hokkaido University; Kyushu University; National Institute of Agrobiological Sciences - Japan	Inagaki, N (corresponding author), Natl Inst Agrobiol Sci, Photobiol & Photosynth Res Unit, Tsukuba, Ibaraki, Japan.	ninagaki@affrc.go.jp	Tanaka, Ayumi/D-9003-2012	Inagaki, Noritoshi/0000-0001-8738-6636	Ministry of Agriculture, Forestry and Fisheries of Japan [GPN-0003]; Institute of Low Temperature Science, Hokkaidou University [H20-III-7]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Institute of Low Temperature Science, Hokkaidou University	NI was funded by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation; GPN-0003). NI was also supported by a research program (Joint Research Program of the Institute of Low Temperature Science, Hokkaidou University; H20-III-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarti D, 2007, PHOTOCHEM PHOTOBIOL, V83, P171, DOI 10.1562/2006-03-06-RA-835; Adhikari ND, 2011, PLANT CELL, V23, P1449, DOI 10.1105/tpc.110.082503; Barros T, 2009, BBA-BIOENERGETICS, V1787, P753, DOI 10.1016/j.bbabio.2009.03.012; Basu D, 2000, PLANT MOL BIOL, V44, P27, DOI 10.1023/A:1006488119301; Berry JO, 2013, PHOTOSYNTH RES, V117, P91, DOI 10.1007/s11120-013-9880-8; BORTHWICK HA, 1952, P NATL ACAD SCI USA, V38, P662, DOI 10.1073/pnas.38.8.662; BRIGGS WR, 1988, PLANT PHYSIOL, V86, P435, DOI 10.1104/pp.86.2.435; Casal JJ, 1998, J EXP BOT, V49, P127, DOI 10.1093/jexbot/49.319.127; DEHESH K, 1991, MOL GEN GENET, V225, P305, DOI 10.1007/BF00269863; Demarsy E, 2009, CURR OPIN PLANT BIOL, V12, P69, DOI 10.1016/j.pbi.2008.09.002; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Goslings D, 2004, PLANT J, V40, P957, DOI 10.1111/j.1365-313X.2004.02262.x; Hansson A, 2009, PHYSIOL PLANTARUM, V135, P214, DOI 10.1111/j.1399-3054.2008.01181.x; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Hirose F, 2012, PLANT CELL PHYSIOL, V53, P1570, DOI 10.1093/pcp/pcs097; HORWITZ BA, 1988, PLANT PHYSIOL, V86, P299, DOI 10.1104/pp.86.1.299; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; Ishikawa R, 2005, PLANT CELL, V17, P3326, DOI 10.1105/tpc.105.037028; Jung KH, 2003, PLANT CELL PHYSIOL, V44, P463, DOI 10.1093/pcp/pcg064; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; KAY SA, 1989, PLANT CELL, V1, P351, DOI 10.1105/tpc.1.3.351; LIFSCHITZ S, 1990, PLANTA, V181, P234, DOI 10.1007/BF02411544; Matsumoto F, 2004, PLANT PHYSIOL, V135, P2379, DOI 10.1104/pp.104.042408; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; Nakamura H, 2009, PLANT CELL PHYSIOL, V50, P1933, DOI 10.1093/pcp/pcp138; Papenbrock J, 1997, PLANT J, V12, P981, DOI 10.1046/j.1365-313X.1997.12050981.x; Papenbrock J, 2000, PLANT PHYSIOL, V122, P1161, DOI 10.1104/pp.122.4.1161; Papenbrock J, 2000, PLANT J, V22, P155, DOI 10.1046/j.1365-313x.2000.00724.x; Peter E, 2009, MOL PLANT, V2, P1198, DOI 10.1093/mp/ssp072; PJON CJ, 1967, PLANT CELL PHYSIOL, V8, P709; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Sawers RJH, 2005, TRENDS PLANT SCI, V10, P138, DOI 10.1016/j.tplants.2005.01.004; Smith H, 1997, PLANT CELL ENVIRON, V20, P840, DOI 10.1046/j.1365-3040.1997.d01-104.x; Solymosi K, 2010, PHOTOSYNTH RES, V105, P143, DOI 10.1007/s11120-010-9568-2; Stephenson PG, 2008, PHOTOCH PHOTOBIO SCI, V7, P1243, DOI 10.1039/b802596g; Stephenson PG, 2009, P NATL ACAD SCI USA, V106, P7654, DOI 10.1073/pnas.0811684106; Sullivan JA, 2003, DEV BIOL, V260, P289, DOI 10.1016/S0012-1606(03)00212-4; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Takano M, 2001, PLANT CELL, V13, P521, DOI 10.1105/tpc.13.3.521; Takano M, 2009, P NATL ACAD SCI USA, V106, P14705, DOI 10.1073/pnas.0907378106; Tanaka A, 2006, CURR OPIN PLANT BIOL, V9, P248, DOI 10.1016/j.pbi.2006.03.011; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Terry MJ, 1999, PLANT PHYSIOL, V119, P143, DOI 10.1104/pp.119.1.143; Waters MT, 2009, EMBO J, V28, P2861, DOI 10.1038/emboj.2009.264; Xie XZ, 2007, PHOTOCHEM PHOTOBIOL, V83, P131, DOI 10.1562/2006-03-17-RA-850; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	49	26	27	10	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135408	10.1371/journal.pone.0135408	http://dx.doi.org/10.1371/journal.pone.0135408			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270815	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800066
J	Lanceta, L; Mattingly, JM; Li, C; Eaton, JW				Lanceta, Lilibeth; Mattingly, Jacob M.; Li, Chi; Eaton, John W.			How Heme Oxygenase-1 Prevents Heme-Induced Cell Death	PLOS ONE			English	Article							IRON DISTRIBUTION; OXIDATIVE STRESS; METABOLISM; OVEREXPRESSION; INJURY	Earlier observations indicate that free heme is selectively toxic to cells lacking heme oxygenase-1 (HO-1) but how this enzyme prevents heme toxicity remains unexplained. Here, using A549 (human lung cancer) and immortalized human bronchial epithelial cells incubated with exogenous heme, we find knock-down of HO-1 using siRNA does promote the accumulation of cell-associated heme and heme-induced cell death. However, it appears that the toxic effects of heme are exerted by "loose" (probably intralysosomal) iron because cytotoxic effects of heme are lessened by pre-incubation of HO-1 deficient cells with desferrioxamine (which localizes preferentially in the lysosomal compartment). Desferrioxamine also decreases lysosomal rupture promoted by intracellularly generated hydrogen peroxide. Supporting the importance of endogenous oxidant production, both chemical and siRNA inhibition of catalase activity predisposes HO-1 deficient cells to heme-mediated killing. Importantly, it appears that HO-1 deficiency somehow blocks the induction of ferritin; control cells exposed to heme show similar to 10-fold increases in ferritin heavy chain expression whereas in heme-exposed HO-1 deficient cells ferritin expression is unchanged. Finally, overexpression of ferritin H chain in HO-1 deficient cells completely prevents heme-induced cytotoxicity. Although two other products of HO-1 activity-CO and bilirubin-have been invoked to explain HO-1-mediated cytoprotection, we conclude that, at least in this experimental system, HO-1 activity triggers the induction of ferritin and the latter is actually responsible for the cytoprotective effects of HO-1 activity.	[Lanceta, Lilibeth; Mattingly, Jacob M.; Li, Chi; Eaton, John W.] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA	University of Louisville	Li, C (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA.	chi.li@louisville.edu; eatonredox@aol.com			Kentucky Lung Cancer Research Program, National Institutes of Health [AA018016-01]; Commonwealth of Kentucky Research Challenge Trust Fund; National Institutes of Health [CA106599, RR018733, CA175003]; James Graham Brown Summer Research Internship Program; NATIONAL CANCER INSTITUTE [K01CA106599, R01CA175003] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018016] Funding Source: NIH RePORTER	Kentucky Lung Cancer Research Program, National Institutes of Health; Commonwealth of Kentucky Research Challenge Trust Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James Graham Brown Summer Research Internship Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by the Kentucky Lung Cancer Research Program, National Institutes of Health Grant AA018016-01 and the Commonwealth of Kentucky Research Challenge Trust Fund (to JWE), National Institutes of Health Grant CA106599, RR018733 and CA175003 (to CL) and the James Graham Brown Summer Research Internship Program (to JMM).	Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; Gozzelino R, 2014, ANTIOXID REDOX SIGN, V20, P1754, DOI 10.1089/ars.2013.5666; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Kurz T, 2011, INT J BIOCHEM CELL B, V43, P1686, DOI 10.1016/j.biocel.2011.08.016; Lanceta L, 2013, BIOCHEM J, V449, P189, DOI 10.1042/BJ20120936; Nagy E, 2010, ARTERIOSCL THROM VAS, V30, P1347, DOI 10.1161/ATVBAHA.110.206433; Persson HL, 2003, FREE RADICAL BIO MED, V34, P1295, DOI 10.1016/S0891-5849(03)00106-0; QIAN MW, 1991, AM J PATHOL, V139, P1425; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yu ZQ, 2003, FREE RADICAL BIO MED, V34, P1243, DOI 10.1016/S0891-5849(03)00109-6; Zhang M, 2002, CELL RES, V12, P123, DOI 10.1038/sj.cr.7290118	16	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134144	10.1371/journal.pone.0134144	http://dx.doi.org/10.1371/journal.pone.0134144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270345	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800007
J	Lee, BS; Oh, J; Kang, SK; Park, S; Lee, SH; Choi, D; Chung, JH; Chung, YW; Kang, SM				Lee, Beom Seob; Oh, Jaewon; Kang, Sung Ku; Park, Sungha; Lee, Sang-Hak; Choi, Donghoon; Chung, Ji Hyung; Chung, Youn Wook; Kang, Seok-Min			Insulin Protects Cardiac Myocytes from Doxorubicin Toxicity by Sp1-Mediated Transactivation of Survivin	PLOS ONE			English	Article							HUMAN BREAST-CANCER; WILD-TYPE P53; GENE-EXPRESSION; MYOCARDIAL ISCHEMIA/REPERFUSION; TRANSCRIPTIONAL REPRESSION; INDUCED CARDIOMYOPATHY; SIGNALING PATHWAY; INDUCED APOPTOSIS; RECEPTOR; CELLS	Insulin inhibits ischemia/reperfusion-induced myocardial apoptosis through the PI3K/Akt/mTOR pathway. Survivin is a key regulator of anti-apoptosis against doxorubicin-induced cardiotoxicity. Insulin increases survivin expression in cardiac myocytes to mediate cytoprotection. However, the mechanism by which survivin mediates the protective effect of insulin against doxorubicin-associated injury remains to be determined. In this study, we demonstrated that pretreatment of H9c2 cardiac myocytes with insulin resulted in a significant decrease in doxorubicin-induced apoptotic cell death by reducing cytochrome c release and caspase-3 activation. Doxorubicin-induced reduction of survivin mRNA and protein levels was also significantly perturbed by insulin pretreatment. Reducing survivin expression with survivin siRNA abrogated insulin-mediated inhibition of caspase-3 activation, suggesting that insulin signals to survivin inhibited caspase-3 activation. Interestingly, pretreatment of H9c2 cells with insulin or MG132, a proteasome inhibitor, inhibited doxorubicin-induced degradation of the transcription factor Sp1. ChIP assay showed that pretreatment with insulin inhibited doxorubicin-stimulated Sp1 dissociation from the survivin promoter. Finally using pharmacological inhibitors of the PI3K pathway, we showed that insulin-mediated activation of the PI3K/Akt/mTORC1 pathway prevented doxorubicin-induced proteasome-mediated degradation of Sp1. Taken together, insulin pretreatment confers a protective effect against doxorubicin-induced cardiotoxicity by promoting Sp1-mediated transactivation of survivin to inhibit apoptosis. Our study is the first to define a role for survivin in cellular protection by insulin against doxorubicin-associated injury and show that Sp1 is a critical factor in the transcriptional regulation of survivin.	[Lee, Beom Seob] Yonsei Univ, Grad Program Sci Aging, Seoul 120749, South Korea; [Oh, Jaewon; Park, Sungha; Lee, Sang-Hak; Choi, Donghoon; Kang, Seok-Min] Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea; [Lee, Beom Seob; Oh, Jaewon; Park, Sungha; Lee, Sang-Hak; Choi, Donghoon; Chung, Youn Wook; Kang, Seok-Min] Yonsei Univ, Coll Med, Yonsei Cardiovasc Res Inst, Seoul, South Korea; [Lee, Beom Seob; Choi, Donghoon; Kang, Seok-Min] Yonsei Univ Hlth Syst, Severance Integrat Res Inst Cerebral & Cardiovasc, Seoul, South Korea; [Kang, Sung Ku] Avon Old Farms Sch, Avon, CT USA; [Chung, Ji Hyung] CHA Univ, Coll Life Sci, Dept Appl Biosci, Gyeonggi Do, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University	Chung, YW (corresponding author), Yonsei Univ, Coll Med, Yonsei Cardiovasc Res Inst, Seoul, South Korea.	chungyw@yuhs.ac; smkang@yuhs.ac		Park, Sungha/0000-0001-5362-478X; Chung, Youn Wook/0000-0002-4382-1410; Kang, Seok-Min/0000-0001-9856-9227; Choi, Donghoon/0000-0002-2009-9760; Oh, Jaewon/0000-0002-4585-1488	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A2A1A11052412]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2014R1A2A1A11052412). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2006, INT J CARDIOL, V111, P371, DOI 10.1016/j.ijcard.2005.07.061; Aikawa R, 2000, CIRCULATION, V102, P2873; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Beech DJ, 2003, ONCOL REP, V10, P181; Boidot R, 2014, MOL BIOL REP, V41, P233, DOI 10.1007/s11033-013-2856-0; Chen YQ, 2011, ANAT REC, V294, P774, DOI 10.1002/ar.21378; Cosgrave N, 2006, J MOL ENDOCRINOL, V37, P377, DOI 10.1677/jme.1.02118; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Esteve PO, 2007, J BIOL CHEM, V282, P2615, DOI 10.1074/jbc.M606203200; Fukuda S, 2004, J MOL CELL CARDIOL, V36, P547, DOI 10.1016/j.yjmcc.2004.02.002; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Grossman D, 2001, J CLIN INVEST, V108, P991, DOI 10.1172/JCI200113345; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hsu YF, 2011, BBA-GEN SUBJECTS, V1810, P504, DOI 10.1016/j.bbagen.2011.02.006; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Jonassen AK, 2001, CIRC RES, V89, P1191, DOI 10.1161/hh2401.101385; Kaga S, 2006, J MOL CELL CARDIOL, V40, P138, DOI 10.1016/j.yjmcc.2005.09.009; Kim KH, 2008, J PHARMACOL EXP THER, V324, P160, DOI 10.1124/jpet.107.125773; Lee BS, 2013, KOREAN CIRC J, V43, P400, DOI 10.4070/kcj.2013.43.6.400; Lee PJH, 2014, CARDIOVASC RES, V101, P423, DOI 10.1093/cvr/cvu001; Levkau B, 2008, CIRCULATION, V117, P1583, DOI 10.1161/CIRCULATIONAHA.107.734160; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Li FZ, 1999, CANCER RES, V59, P3143; Li J, 2009, J MOL CELL CARDIOL, V47, P512, DOI 10.1016/j.yjmcc.2009.07.010; Liu WH, 2011, INT J BIOCHEM CELL B, V43, P1708, DOI 10.1016/j.biocel.2011.08.004; Lucibello FC, 1997, NUCLEIC ACIDS RES, V25, P4921, DOI 10.1093/nar/25.24.4921; Ma H, 2006, CARDIOVASC RES, V69, P57, DOI 10.1016/j.cardiores.2005.08.019; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Mityaev M, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1183, DOI 10.1134/S0006297908110035; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nabilsi NH, 2009, ONCOGENE, V28, P2046, DOI 10.1038/onc.2009.62; PEACOCK JL, 1987, CANCER RES, V47, P4318; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Raj D, 2008, CARCINOGENESIS, V29, P194, DOI 10.1093/carcin/bgm219; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shirley SH, 2009, CANCER RES, V69, P3405, DOI 10.1158/0008-5472.CAN-08-3628; Si R, 2011, J MOL CELL CARDIOL, V50, P16, DOI 10.1016/j.yjmcc.2010.08.017; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Song K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061896; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Tong YG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023754; Vaira V, 2007, ONCOGENE, V26, P2678, DOI 10.1038/sj.onc.1210094; Vejpongsa P, 2014, J AM COLL CARDIOL, V64, P938, DOI 10.1016/j.jacc.2014.06.1167; Venkatesan B, 2010, CELL SIGNAL, V22, P809, DOI 10.1016/j.cellsig.2010.01.005; Wohlschlaeger J, 2010, J HEART LUNG TRANSPL, V29, P1286, DOI 10.1016/j.healun.2010.06.015; Xia F, 2006, CANCER RES, V66, P3392, DOI 10.1158/0008-5472.CAN-05-4537; Xu R, 2007, BIOCHEM BIOPH RES CO, V356, P286, DOI 10.1016/j.bbrc.2007.02.140; Yang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037205; Yao LL, 2007, J CELL SCI, V120, P895, DOI 10.1242/jcs.03393; Zhao P, 2010, BIOCHEM BIOPH RES CO, V395, P219, DOI 10.1016/j.bbrc.2010.03.165	55	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135438	10.1371/journal.pone.0135438	http://dx.doi.org/10.1371/journal.pone.0135438			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271039	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800068
J	Wu, W; Guo, JQ; An, SY; Guan, P; Ren, YW; Xia, LZ; Zhou, BS				Wu, Wei; Guo, Junqiao; An, Shuyi; Guan, Peng; Ren, Yangwu; Xia, Linzi; Zhou, Baosen			Comparison of Two Hybrid Models for Forecasting the Incidence of Hemorrhagic Fever with Renal Syndrome in Jiangsu Province, China	PLOS ONE			English	Article							NEURAL-NETWORKS; TRANSMISSION; PREDICTION; RESERVOIR	Background Cases of hemorrhagic fever with renal syndrome (HFRS) are widely distributed in eastern Asia, especially in China, Russia, and Korea. It is proved to be a difficult task to eliminate HFRS completely because of the diverse animal reservoirs and effects of global warming. Reliable forecasting is useful for the prevention and control of HFRS. Methods Two hybrid models, one composed of nonlinear autoregressive neural network (NARNN) and autoregressive integrated moving average (ARIMA) the other composed of generalized regression neural network (GRNN) and ARIMA were constructed to predict the incidence of HFRS in the future one year. Performances of the two hybrid models were compared with ARIMA model. Results The ARIMA, ARIMA-NARNN ARIMA-GRNN model fitted and predicted the seasonal fluctuation well. Among the three models, the mean square error (MSE), mean absolute error (MAE) and mean absolute percentage error (MAPE) of ARIMA-NARNN hybrid model was the lowest both in modeling stage and forecasting stage. As for the ARIMA-GRNN hybrid model, the MSE, MAE and MAPE of modeling performance and the MSE and MAE of forecasting performance were less than the ARIMA model, but the MAPE of forecasting performance did not improve. Conclusion Developing and applying the ARIMA-NARNN hybrid model is an effective method to make us better understand the epidemic characteristics of HFRS and could be helpful to the prevention and control of HFRS.	[Wu, Wei; Guan, Peng; Ren, Yangwu; Xia, Linzi; Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Peoples R China; [Guo, Junqiao; An, Shuyi] Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Peoples R China	China Medical University	Zhou, BS (corresponding author), China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Peoples R China.	bszhou@mail.cmu.edu.cn	Guan, Peng/GWM-9170-2022		National Natural Science Foundation of China [81202254, 30771860]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant no. 81202254 from National Natural Science Foundation of China, grant no. 30771860 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083848; Bi P, 1998, AM J EPIDEMIOL, V148, P276, DOI 10.1093/oxfordjournals.aje.a009636; Bi P, 2002, INT J EPIDEMIOL, V31, P189, DOI 10.1093/ije/31.1.189; Cao SY, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-56; CONNOR JT, 1994, IEEE T NEURAL NETWOR, V5, P240, DOI 10.1109/72.279188; Fang Li-qun, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P265; Guan P, 2004, WORLD J GASTROENTERO, V10, P3579, DOI 10.3748/wjg.v10.i24.3579; He XZ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-394; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; Liu X, 2012, EPIDEMIOL INFECT, V140, P851, DOI 10.1017/S0950268811001063; Moreno JJM, 2011, PSICOTHEMA, V23, P322; Olsson GE, 2009, EMERG INFECT DIS, V15, P104, DOI 10.3201/eid1501.080502; Ozyildirim BM, 2013, NEURAL NETWORKS, V39, P18, DOI 10.1016/j.neunet.2012.12.001; Ren H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-421; Song G, 1999, CHINESE MED J-PEKING, V112, P472; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Xiao H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002615; Yan L, 2007, EMERG INFECT DIS, V13, P1301, DOI 10.3201/eid1309.061481; Yan WR, 2010, JPN J INFECT DIS, V63, P264; Yu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098241; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063116; Zhou L, 2014, PATHOL ONCOL RES, V8, P8, DOI DOI 10.1371/J0URNAL.P0NE.0104875; Zivko-Babic J, 2008, DENT MATER, V24, P18, DOI 10.1016/j.dental.2007.01.008	25	26	34	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135492	10.1371/journal.pone.0135492	http://dx.doi.org/10.1371/journal.pone.0135492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270814	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800084
J	Chow, PM; Chiang, IN; Chen, CY; Huang, KH; Hsu, JS; Wang, SM; Lee, YJ; Yu, HJ; Pu, YS; Huang, CY				Chow, Po-Ming; Chiang, I-Ni; Chen, Chia-Yen; Huang, Kuo-How; Hsu, Jui-Shan; Wang, Shuo-Meng; Lee, Yuan-Ju; Yu, Hong-Jeng; Pu, Yeong-Shiau; Huang, Chao-Yuan			Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents	PLOS ONE			English	Article							INITIAL-EXPERIENCE; MANAGEMENT	Background Ureteral obstruction caused by extrinsic compression is often associated with intra-abdominal cancers. Internal drainage with ureteral stents is typically the first-line therapy to relieve such obstructions. Novel designs of ureteral stents made of different materials have been invented to achieve better drainage. In this study, we described the functional outcomes of a Resonance metallic ureteral stent (Cook Medical, Bloomington, Indiana, USA) in patients with malignant ureteral obstruction and compare the functional duration of Resonance stents with regular polymeric stents in the same cohort. Methods Cancer patients who received polymeric stents and subsequent Resonance stents for ureteral obstruction between July 2009 and November 2012 were included in a chart review. Stent failure was detected by clinical symptoms, imaging studies, and renal function tests. The functional durations of each stent were calculated, and possible factors affecting stent patency were investigated. Results A total of 50 stents were successfully inserted into 50 ureteral units in 42 patients with malignant ureteral obstruction. There were 7 antegrade stents and 43 retrograde stents. There were no major complications. Stent-related symptoms were similar in both kinds of stents. After polymeric stents were replaced with Resonance metallic stents, hydronephrosis subsided or remained stable in 90% (45/50) of the ureteral units. Serum creatinine decreased or remained stable in 90% (38/42) of these patients. The Resonance stent exhibited a mean increase in functional duration of 4 months compared with the polymeric stents (p<0.0001), and 50% (25/50) of the Resonance stents exhibited a significant increase in functional duration ( more than 3 months). Pre-operative serum creatinine < 2 was associated with a substantial increase in stent duration. Conclusions Resonance stents are effective and safe in relieving malignant ureteral obstructions after polymeric stents failure. Resonance stents can provide a longer functional duration than polymeric stents and should be offered as an option for internal drainage.	[Chow, Po-Ming; Chiang, I-Ni; Huang, Kuo-How; Wang, Shuo-Meng; Lee, Yuan-Ju; Yu, Hong-Jeng; Pu, Yeong-Shiau; Huang, Chao-Yuan] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Chow, Po-Ming; Chiang, I-Ni; Huang, Kuo-How; Hsu, Jui-Shan; Wang, Shuo-Meng; Lee, Yuan-Ju; Yu, Hong-Jeng; Pu, Yeong-Shiau; Huang, Chao-Yuan] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Chia-Yen] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Chen, Chia-Yen] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Hsu, Jui-Shan] Fu Jen Catholic Univ, Sch Med, Cardinal Tien Hosp, Dept Med Imaging, New Taipei City, Taiwan; [Hsu, Jui-Shan] Natl Taiwan Univ, Dept Med Imaging, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Cardinal Tien Hospital; Fu Jen Catholic University; National Taiwan University	Huang, CY (corresponding author), Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan.	cyh540909@gmail.com	Chow, Po-Ming/J-9203-2019	Chow, Po-Ming/0000-0002-3183-1830; PU, YEONG-SHIAU/0000-0002-2859-3966; YU, HONG-JENG/0000-0003-3287-5736; Chen, Chia-Yen/0000-0001-9548-5597; WANG, SHUO-MENG/0000-0003-2090-1757; HUANG, CHAO-YUAN/0000-0002-9322-6062				Benson AD, 2011, J UROLOGY, V185, P2217, DOI 10.1016/j.juro.2011.02.008; Borin JF, 2006, J ENDOUROL, V20, P300, DOI 10.1089/end.2006.20.300; Brown JA, 2010, THESCIENTIFICWORLDJO, V10, P1566, DOI 10.1100/tsw.2010.162; Chung SY, 2004, J UROLOGY, V172, P592, DOI 10.1097/01.ju.0000130510.28768.f5; DOCIMO SG, 1989, J UROLOGY, V142, P277, DOI 10.1016/S0022-5347(17)38729-3; Ganatra AM, 2005, J UROLOGY, V174, P2125, DOI 10.1097/01.ju.0000181807.56114.b7; Garg T, 2009, J ENDOUROL, V23, P1199, DOI 10.1089/end.2008.0454; Goldsmith ZG, 2012, J UROLOGY, V188, P851, DOI 10.1016/j.juro.2012.04.113; Jeong IG, 2007, BJU INT, V100, P1288, DOI 10.1111/j.1464-410X.2007.07172.x; Kadlec AO, 2013, J UROLOGY, V190, P937, DOI 10.1016/j.juro.2013.02.070; Liatsikos E, 2010, EUR UROL, V57, P480, DOI 10.1016/j.eururo.2009.02.004; Liatsikos EN, 2009, J UROLOGY, V182, P2613, DOI 10.1016/j.juro.2009.08.040; Lopez-Huertas HL, 2010, J ENDOUROL, V24, P483, DOI 10.1089/end.2009.0192; LUGMAYR H, 1992, AM J ROENTGENOL, V159, P1091, DOI 10.2214/ajr.159.5.1384298; Modi AP, 2010, J ENDOUROL, V24, P1189, DOI 10.1089/end.2010.0121; Nagele U, 2008, WORLD J UROL, V26, P257, DOI 10.1007/s00345-008-0245-4; Polcari AJ, 2010, EXPERT REV PHARM OUT, V10, P11, DOI [10.1586/erp.09.74, 10.1586/ERP.09.74]; Russo P, 2000, SEMIN ONCOL, V27, P284; Sountoulides P, 2010, BJU INT, V105, P1066, DOI 10.1111/j.1464-410X.2009.09140.x; Wah TM, 2007, CARDIOVASC INTER RAD, V30, P705, DOI 10.1007/s00270-007-9043-4; Wang HJ, 2011, BJU INT, V108, P428, DOI 10.1111/j.1464-410X.2010.09842.x; Yossepowitch O, 2001, J UROLOGY, V166, P1746, DOI 10.1016/S0022-5347(05)65666-2	22	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135566	10.1371/journal.pone.0135566	http://dx.doi.org/10.1371/journal.pone.0135566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267140	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492300135
J	Huang, YM; Merkatz, RB; Hillier, SL; Roberts, K; Blithe, DL; Sitruk-Ware, R; Creinin, MD				Huang, Yongmei; Merkatz, Ruth B.; Hillier, Sharon L.; Roberts, Kevin; Blithe, Diana L.; Sitruk-Ware, Regine; Creinin, Mitchell D.			Effects of a One Year Reusable Contraceptive Vaginal Ring on Vaginal Microflora and the Risk of Vaginal Infection: An Open-Label Prospective Evaluation	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; ACCEPTABILITY; ETHINYLESTRADIOL; EFFICACY; FLORA	Background A contraceptive vaginal ring (CVR) containing Nestorone (R) (NES) and ethinyl estradiol (EE) that is reusable for 1-year (13 cycles) is under development. This study assessed effects of this investigational CVR on the incidence of vaginal infections and change in vaginal microflora. Methods There were 120 women enrolled into a NES/EE CVR Phase III trial and a microbiology sub-study for up to 1-year of cyclic product use. Gynecological examinations were conducted at baseline, the first week of cycle 6 and last week of cycle 13 (or during early discontinuation visits). Vaginal swabs were obtained for wet mount microscopy, Gram stain and culture. The CVR was removed from the vagina at the last study visit and cultured. Semi-quantitative cultures for Lactobacillus, Gardnerella vaginalis, Enterococcus faecalis, Staphylococcus aureus, Escherichia coli, anaerobic gram negative rods (GNRs), Candida albicans and other yeasts were performed on vaginal and CVR samples. Vaginal infections were documented throughout the study. Results Over 1-year of use, 3.3% of subjects were clinically diagnosed with bacterial vaginosis, 15.0% with vulvovaginal candidiasis, and 0.8% with trichomoniasis. The detection rate of these three infections did not change significantly from baseline to either Cycle 6 or 13. Nugent scores remained stable. H2O2-positive Lactobacillus dominated vaginal flora with a non-significant prevalence increase from 76.7% at baseline to 82.7% at cycle 6 and 90.2% at cycle 13, and a median concentration of 10(7) colony forming units (cfu) per gram. Although anaerobic GNRs prevalence increased significantly, the median concentration decreased slightly (10(4) to 10(3) cfu per gram). There were no significant changes in frequency or concentrations of other pathogens. High levels of agreement between vaginal and ring surface microbiota were observed. Conclusion Sustained use of the NES/EE CVR did not increase the risk of vaginal infection and was not disruptive to the vaginal ecosystem.	[Huang, Yongmei; Merkatz, Ruth B.; Roberts, Kevin; Sitruk-Ware, Regine] Populat Council, Ctr Biomed Res, New York, NY 10021 USA; [Hillier, Sharon L.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Hillier, Sharon L.] Magee Womens Res Inst, Pittsburgh, PA USA; [Blithe, Diana L.] NICHHD, Contracept Discovery & Dev Branch, Bethesda, MD 20892 USA; [Creinin, Mitchell D.] Univ Calif Davis, Dept Obstet & Gynecol, Sacramento, CA 95817 USA	Population Council; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Davis	Merkatz, RB (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10027 USA.	RMerkatz@popcouncil.org	Creinin, Mitchell/AAH-3488-2020	Creinin, Mitchell/0000-0001-5967-8180; Sitruk-Ware, Regine/0000-0001-5183-9875	National Institute of Child Health and Human Development of the National Institutes of Health (NICHD) [HHSN27500403372]; US Aid for International Development (USAID) [GPO-A-00-04-00019]; Population Council	National Institute of Child Health and Human Development of the National Institutes of Health (NICHD); US Aid for International Development (USAID)(United States Agency for International Development (USAID)); Population Council	This study was supported by the National Institute of Child Health and Human Development of the National Institutes of Health (NICHD, Contract Number: HHSN27500403372; URL-http://www.nichd.nih.gov). Diana Blithe, as project officer from NICHD for this study, did review the study protocol for contractual purposes. However, NICHD had no other role in study design, data collection, or analysis. Dr. Diana Blithe participated in the decision to publish, and the preparation of the manuscript. Drs. Ruth Merkatz, Regine Stiruk Ware, and Kevin Roberts were supported by US Aid for International Development (USAID GPO-A-00-04-00019; www.usaid.gov) for work associated with the conduct of this trial and analysis of data. USAID had no role in the design of this clinical trial, the conduct of the study, collection of data, or in the decision to publish results. Dr. Yongmei Huang was supported by the Fred H. Bixby fellowship program of the Population Council.	Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; [Anonymous], 2013, QUICK FACT BETA UNIT; Brache V, 2013, CONTRACEPTION, V87, P264, DOI 10.1016/j.contraception.2012.08.037; Cicinelli E, 2003, AM J OBSTET GYNECOL, V189, P55, DOI 10.1067/mob.2003.341; Citron DM, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P911; Cleland J, 2013, LANCET, V381, P1604, DOI 10.1016/S0140-6736(13)60588-7; DAVIES GC, 1992, CONTRACEPTION, V45, P511, DOI 10.1016/0010-7824(92)90163-N; De Seta F, 2012, CONTRACEPTION, V86, P526, DOI 10.1016/j.contraception.2012.02.012; Dieben TOM, 2002, OBSTET GYNECOL, V100, P585, DOI 10.1016/S0029-7844(02)02124-5; Ganguly T, 2005, BIOTECHNIQUES, V39, P304, DOI 10.2144/05393BM02; Gupta K, 2000, J INFECT DIS, V181, P595, DOI 10.1086/315267; Hobbs MM, 2013, SEX TRANSM INFECT, V89, P434, DOI 10.1136/sextrans-2013-051057; HOOTEN TM, 1994, CLIN INFECT DIS, V19, P274, DOI 10.1093/clinids/19.2.274; Jespers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109670; Kimber I, 2013, TOXICOL SCI, V134, P49, DOI 10.1093/toxsci/kft099; Lete I, 2013, EUR J CONTRACEP REPR, V18, P234, DOI 10.3109/13625187.2013.801954; Linhares I. M., 2011, AM J OBSTET GYNECOL, V120, P1, DOI [10.1016/j.ajog.2010.07.010, DOI 10.1016/J.AJOG.2010.07.010, DOI 10.1016/J.AJ0G.2010.07.010]; Linhares IM, 2010, REV ASSOC MED BRAS, V56, P370, DOI 10.1590/S0104-42302010000300026; Merkatz RB, 2014, CONTRACEPTION, V90, P514, DOI 10.1016/j.contraception.2014.05.015; Miller L, 2005, CONTRACEPTION, V71, P65, DOI 10.1016/j.contraception.2004.07.015; Nelson AL, 1997, AM J OBSTET GYNECOL, V176, P1376, DOI 10.1016/S0002-9378(97)70362-4; Ness RB, 2005, AM J EPIDEMIOL, V162, P585, DOI 10.1093/aje/kwi243; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Rabe L, 2014, AIDS RES HUM RETROV, V30, pA290, DOI 10.1089/aid.2014.5657.abstract; Riggs M, 2007, SEX TRANSM DIS, V34, P954, DOI 10.1097/OLQ.0b013e31811ed0e4; Roumen FJME, 1999, CONTRACEPTION, V59, P59, DOI 10.1016/S0010-7824(98)00145-0; Roumen FJME, 1996, HUM REPROD, V11, P2443; ROY S, 1981, CONTRACEPTION, V24, P481, DOI 10.1016/0010-7824(81)90011-1; Rugpao S, 2008, SEX TRANSM DIS, V35, P643, DOI 10.1097/OLQ.0b013e31816f70f2; Sankar SA, 2015, SYST APPL MICROBIOL, V38, P276, DOI 10.1016/j.syapm.2015.03.004; SCHWAN A, 1983, CONTRACEPTION, V28, P341, DOI 10.1016/0010-7824(83)90036-7; Schwebke JR, 1999, J INFECT DIS, V180, P1632, DOI 10.1086/315065; Sivin I, 2005, CONTRACEPTION, V71, P122, DOI 10.1016/j.contraception.2004.08.010; SIVIN I, 1981, CONTRACEPTION, V24, P359, DOI 10.1016/0010-7824(81)90004-4; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Stoner KA, 2008, J CLIN MICROBIOL, V46, P2739, DOI 10.1128/JCM.00161-08; Veres S, 2004, OBSTET GYNECOL, V104, P555, DOI 10.1097/01.AOG.0000136082.59644.13	37	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134460	10.1371/journal.pone.0134460	http://dx.doi.org/10.1371/journal.pone.0134460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267119	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000359492300047
J	Kadungure, T; Ucher, AJ; Linehan, EK; Schrader, CE; Stavnezer, J				Kadungure, Tatenda; Ucher, Anna J.; Linehan, Erin K.; Schrader, Carol E.; Stavnezer, Janet			Individual Substitution Mutations in the AID C Terminus That Ablate IgH Class Switch Recombination	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; ACTIVATION-INDUCED DEAMINASE; SOMATIC HYPERMUTATION; MISMATCH REPAIR; DNA BREAKS; ANTIBODY DIVERSIFICATION; GENE CONVERSION; NUCLEAR-EXPORT; DEFICIENT MICE; REGION	Activation-induced cytidine deaminase (AID) is essential for class switch recombination (CSR) and somatic hypermutation (SHM) of Ig genes. The C terminus of AID is required for CSR but not for SHM, but the reason for this is not entirely clear. By retroviral transduction of mutant AID proteins into aid(-/-) mouse splenic B cells, we show that 4 amino acids within the C terminus of mouse AID, when individually mutated to specific amino acids (R190K, A192K, L196S, F198S), reduce CSR about as much or more than deletion of the entire C terminal 10 amino acids. Similar to Delta AID, the substitutions reduce binding of UNG to Ig S mu regions and some reduce binding of Msh2, both of which are important for introducing S region DNA breaks. Junctions between the IgH donor switch (S)mu and acceptor S alpha regions from cells expressing Delta AID or the L196S mutant show increased microhomology compared to junctions in cells expressing wild-type AID, consistent with problems during CSR and the use of alternative end-joining, rather than non-homologous end-joining (NHEJ). Unlike deletion of the AID C terminus, 3 of the substitution mutants reduce DNA double-strand breaks (DSBs) detected within the S mu region in splenic B cells undergoing CSR. Cells expressing these 3 substitution mutants also have greatly reduced mutations within unrearranged S mu regions, and they decrease with time after activation. These results might be explained by increased error-free repair, but as the C terminus has been shown to be important for recruitment of NHEJ proteins, this appears unlikely. We hypothesize that S mu DNA breaks in cells expressing these C terminus substitution mutants are poorly repaired, resulting in destruction of S mu segments that are deaminated by these mutants. This could explain why these mutants cannot undergo CSR.	[Kadungure, Tatenda; Ucher, Anna J.; Linehan, Erin K.; Schrader, Carol E.; Stavnezer, Janet] Univ Massachusetts, Dept Microbiol & Physiol Syst, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Stavnezer, J (corresponding author), Univ Massachusetts, Dept Microbiol & Physiol Syst, Sch Med, Worcester, MA 01605 USA.	janet.stavnezer@umassmed.edu		Schrader, Carol/0000-0001-8920-6803	NIH.GOV [RO1 AI23283, R21 AI99988]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023283, R21AI099988] Funding Source: NIH RePORTER	NIH.GOV; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH.GOV, RO1 AI23283 (JS, CES) and R21 AI99988 (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Boboila C, 2010, J EXP MED, V207, P417, DOI 10.1084/jem.20092449; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Cortizas EM, 2013, J IMMUNOL, V191, P5751, DOI 10.4049/jimmunol.1301300; Dingler FA, 2014, EUR J IMMUNOL; Doi T, 2009, P NATL ACAD SCI USA, V106, P2758, DOI 10.1073/pnas.0813253106; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Ellyard JI, 2011, EUR J IMMUNOL, V41, P485, DOI 10.1002/eji.201041011; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; HUMMEL M, 1987, J IMMUNOL, V138, P3539; Imai K, 2005, CLIN IMMUNOL, V115, P277, DOI 10.1016/j.clim.2005.02.003; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Jeevan-Raj BP, 2011, J EXP MED, V208, P1649, DOI 10.1084/jem.20110118; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Kracker S, 2010, P NATL ACAD SCI USA, V107, P22225, DOI 10.1073/pnas.1012591108; Larijani M, 2012, SEMIN IMMUNOL, V24, P255, DOI 10.1016/j.smim.2012.05.003; Li ZQ, 2004, J EXP MED, V200, P47, DOI 10.1084/jem.20040355; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Min IM, 2003, IMMUNITY, V19, P515, DOI 10.1016/S1074-7613(03)00262-0; Mu YX, 2012, J BIOL CHEM, V287, P28007, DOI 10.1074/jbc.M112.370189; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Pannunzio NR, 2014, DNA REPAIR, V17, P74, DOI 10.1016/j.dnarep.2014.02.006; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pena-Diaz J, 2012, MOL CELL, V47, P669, DOI 10.1016/j.molcel.2012.07.006; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ranjit S, 2014, J IMMUNOL, V192, P4934, DOI 10.4049/jimmunol.1490015; Ranjit S, 2011, J IMMUNOL, V187, P2464, DOI 10.4049/jimmunol.1101406; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sabouri S, 2014, P NATL ACAD SCI USA, V111, P2253, DOI 10.1073/pnas.1324057111; Schrader CE, 2007, J IMMUNOL, V179, P6064, DOI 10.4049/jimmunol.179.9.6064; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Schrader CE, 2003, EMBO J, V22, P5893, DOI 10.1093/emboj/cdg550; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stavnezer J, 2014, J IMMUNOL, V193, P5370, DOI 10.4049/jimmunol.1401849; Stavnezer J, 2014, P NATL ACAD SCI USA, V111, P9217, DOI 10.1073/pnas.1405590111; Stavnezer J, 2010, ADV IMMUNOL, V108, P45, DOI 10.1016/S0065-2776(10)08003_X; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Ucher AJ, 2014, J IMMUNOL, V193, P1440, DOI 10.4049/jimmunol.1400365; Vuong BQ, 2013, NAT IMMUNOL, V14, P1183, DOI 10.1038/ni.2732; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wu XS, 2005, J IMMUNOL, V174, P934, DOI 10.4049/jimmunol.174.2.934; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Zahn A, 2014, P NATL ACAD SCI USA, V111, pE988, DOI 10.1073/pnas.1320486111	52	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134397	10.1371/journal.pone.0134397	http://dx.doi.org/10.1371/journal.pone.0134397			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267846	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300042
J	Kim, Y; Park, T				Kim, Yongkang; Park, Taesung			Robust Gene-Gene Interaction Analysis in Genome Wide Association Studies	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; EPISTASIS; VARIANTS; INDEX	Genome-wide association studies (GWAS) have successfully discovered hundreds of associations between genetic variants and complex traits. Most GWAS have focused on the identification of single variants. It has been shown that most of the variants that were discovered by GWAS could only partially explain disease heritability. The explanation for this missing heritability is generally believed to be gene-gene (GG) or gene-environment (GE) interactions and other structural variants. Generalized multifactor dimensionality reduction (GMDR) has been proven to be reasonably powerful in detecting GG and GE interactions; however, its performance has been found to decline when outlying quantitative traits are present. This paper proposes a robust GMDR estimation method (based on the L-estimator and M-estimator estimation methods) in an attempt to reduce the effects caused by outlying traits. A comparison of robust GMDR with the original MDR based on simulation studies showed the former method to outperform the latter. The performance of robust GMDR is illustrated through a real GWA example consisting of 8,577 samples from the Korean population using the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) level as a phenotype. Robust GMDR identified the KCNH1 gene to have strong interaction effects with other genes on the function of insulin secretion.	[Kim, Yongkang; Park, Taesung] Seoul Natl Univ, Dept Stat, Seoul 151741, South Korea; [Park, Taesung] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul 151741, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Park, T (corresponding author), Seoul Natl Univ, Dept Stat, Seoul 151741, South Korea.	tspark@stats.snu.ac.kr	Kim, Yongkang/AAC-7436-2020	Kim, Yongkang/0000-0002-8837-2620	National Research Foundation of Korea - Republic of Korea [2012R1A3A2026438, 2008-0062618, 2013M3A9C4078158]	National Research Foundation of Korea - Republic of Korea(National Research Foundation of Korea)	This study was supported by the National Research Foundation of Korea grants funded by the Republic of Korea (2012R1A3A2026438, 2008-0062618, 2013M3A9C4078158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett SN, 2011, GENET EPIDEMIOL, V35, P159, DOI 10.1002/gepi.20564; BICKEL PJ, 1975, ANN STAT, V3, P1045, DOI 10.1214/aos/1176343240; Cattaert T, 2011, ANN HUM GENET, V75, P78, DOI 10.1111/j.1469-1809.2010.00604.x; Cho S, 2010, ANN HUM GENET, V74, P416, DOI 10.1111/j.1469-1809.2010.00597.x; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Freitas AA, 2001, ARTIF INTELL REV, V16, P177, DOI 10.1023/A:1011996210207; Gayoso-Diz P, 2011, DIABETES RES CLIN PR, V94, P146, DOI 10.1016/j.diabres.2011.07.015; Gui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066545; Koenker R., 1994, J NONPARAMETR STAT, V3, P223, DOI DOI 10.1080/10485259408832584; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Moore JH, 2011, CURRENT PROTOCOLS HU, V70; Most PJ, 2014, BIOINFORMATICS, V30, P1185; Namkung J, 2009, BIOINFORMATICS, V25, P338, DOI 10.1093/bioinformatics/btn629; Oh S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S9-S5; OWEN M., 2010, THESIS POMONA COLL; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Wang H, 2005, MOL GENET METAB, V86, P384, DOI 10.1016/j.ymgme.2005.07.008; Yan LZ, 2004, DIABETES, V53, P597, DOI 10.2337/diabetes.53.3.597; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Yaras N, 2005, DIABETES, V54, P3082, DOI 10.2337/diabetes.54.11.3082	22	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135016	10.1371/journal.pone.0135016	http://dx.doi.org/10.1371/journal.pone.0135016			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267341	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300071
J	Rocha, JC; Peterson, GD; Biggs, R				Rocha, Juan Carlos; Peterson, Garry D.; Biggs, Reinette			Regime Shifts in the Anthropocene: Drivers, Risks, and Resilience	PLOS ONE			English	Article							SAFE OPERATING SPACE; CLIMATE-CHANGE; DYNAMICS; SAVANNA; COLLAPSE; ECOLOGY; MODELS; FOREST; FIRE	Many ecosystems can experience regime shifts: surprising, large and persistent changes in the function and structure of ecosystems. Assessing whether continued global change will lead to further regime shifts, or has the potential to trigger cascading regime shifts has been a central question in global change policy. Addressing this issue has, however, been hampered by the focus of regime shift research on specific cases and types of regime shifts. To systematically assess the global risk of regime shifts we conducted a comparative analysis of 25 generic types of regime shifts across marine, terrestrial and polar systems; identifying their drivers, and impacts on ecosystem services. Our results show that the drivers of regime shifts are diverse and co-occur strongly, which suggests that continued global change can be expected to synchronously increase the risk of multiple regime shifts. Furthermore, many regime shift drivers are related to climate change and food production, whose links to the continued expansion of human activities makes them difficult to limit. Because many regime shifts can amplify the drivers of other regime shifts, continued global change can also be expected to increase the risk of cascading regime shifts. Nevertheless, the variety of scales at which regime shift drivers operate provides opportunities for reducing the risk of many types of regime shifts by addressing local or regional drivers, even in the absence of rapid reduction of global drivers.	[Rocha, Juan Carlos; Peterson, Garry D.; Biggs, Reinette] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Biggs, Reinette] Univ Stellenbosch, Ctr Studies Complex, ZA-7602 Stellenbosch, South Africa	Stockholm University; Stellenbosch University	Rocha, JC (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Kraftriket 2B, S-10691 Stockholm, Sweden.	juan.rocha@su.se	Peterson, Garry D/C-1309-2008; Biggs, Reinette/A-5155-2010; Rocha, Juan Carlos/T-8188-2017	Peterson, Garry D/0000-0003-0173-0112; Biggs, Reinette/0000-0003-0300-4149; Rocha, Juan Carlos/0000-0003-2322-5459	Swedish Research Council Formas [2009-6966-139149-41]; Branco Weiss Society in Science Fellowship	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Branco Weiss Society in Science Fellowship	This work was supported by The Swedish Research Council Formas (http://www.formas.se/en/) grant 2009-6966-139149-41 to GP and a Branco Weiss Society in Science Fellowship (http://www.society-in-science.org) to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abades SR, 2014, J ECOL, V102, P1386, DOI 10.1111/1365-2745.12321; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Biggs RO, 2015, COLD SPRING HARBOR L, DOI [10.1101/018473, DOI 10.1101/018473]; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brook BW, 2013, TRENDS ECOL EVOL, V28, P396, DOI 10.1016/j.tree.2013.01.016; Carpenter SR, 2003, REGIME SHIFTS IN LAK; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Crona BI, 2016, FISH FISH, V17, P1175, DOI 10.1111/faf.12109; Dent CL, 2002, PHILOS T R SOC B, V357, P635, DOI 10.1098/rstb.2001.0991; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Duke NC, 2007, SCIENCE; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Geist HJ, 2004, BIOSCIENCE, V54, P817, DOI 10.1641/0006-3568(2004)054[0817:DCPOD]2.0.CO;2; Gordon LJ, 2008, TRENDS ECOL EVOL, V23, P211, DOI 10.1016/j.tree.2007.11.011; Greene CH, 2008, ECOLOGY, V89, pS24, DOI 10.1890/07-0550.1; Gregory JM, 2004, NATURE, V428, P616, DOI 10.1038/428616a; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holmgren M, 2001, ECOSYSTEMS, V4, P151, DOI 10.1007/s100210000065; Hughes BB, 2013, P NATL ACAD SCI USA, V110, P15313, DOI 10.1073/pnas.1302805110; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P389, DOI 10.1016/j.tree.2013.05.019; Hunter DR, 2007, SOC NETWORKS, V29, P216, DOI 10.1016/j.socnet.2006.08.005; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Karlsson JM, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014015; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Kinzig AP, 2006, ECOL SOC, V11; Krivitsky PN, 2012, ELECTRON J STAT, V6, P1100, DOI 10.1214/12-EJS696; Lane DC, 2008, SYST RES BEHAV SCI, V25, P3, DOI 10.1002/sres.826; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lenton TM, 2013, TRENDS ECOL EVOL, V28, P380, DOI 10.1016/j.tree.2013.06.001; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Livina VN, 2013, CRYOSPHERE, V7, P275, DOI 10.5194/tc-7-275-2013; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS AND HUMAN; Nelson GC, 2006, ECOL SOC, V11; Newman ME, 2001, PHYS REV E, V64; Noy-Meir I, 1975, THE JOURNAL OF ECOLO; Paolo FS, 2015, SCIENCE, V348, P327, DOI 10.1126/science.aaa0940; Peters DPC, 2007, FRONT ECOL ENVIRON, V5, P221, DOI 10.1890/1540-9295(2007)5[221:CEILEA]2.0.CO;2; Peters DPC, 2004, P NATL ACAD SCI USA, V101, P15130, DOI 10.1073/pnas.0403822101; Powell EN, 2008, J SHELLFISH RES, V27, P729, DOI 10.2983/0730-8000(2008)27[729:LTIOPD]2.0.CO;2; R Core Team, 2012, R LANG ENV STAT COMP; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; ROBERTS A, 1990, OECOLOGIA, V83, P560, DOI 10.1007/BF00317210; Robins G, 2007, SOC NETWORKS, V29, P169, DOI 10.1016/j.socnet.2006.08.004; Rocha J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0273; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Roques KG, 2001, J APPL ECOL, V38, P268, DOI 10.1046/j.1365-2664.2001.00567.x; Rozema J, 2008, SCIENCE, V322, P1478, DOI 10.1126/science.1168572; Ryan A., 2008, J STAT SOFTW, V24, P1; Sahana AS, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/5/054006; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2015, SCIENCE, V347, P1317, DOI 10.1126/science.aaa3769; Scheffer M, 2003, P NATL ACAD SCI USA, V100, P4040, DOI 10.1073/pnas.0737918100; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Snijders TAB., 2002, J SOCIAL STRUCTURE, V3(2), P1, DOI DOI 10.1016/j.socnet.2006.08.001; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Steffen W, 2015, ANTHROPOCENE REV, V2, P81, DOI 10.1177/2053019614564785; Stouffer RJ, 2006, J CLIMATE, V19, P1365, DOI 10.1175/JCLI3689.1; Turetsky MR, 2015, NAT GEOSCI, V8, P11, DOI [10.1038/ngeo2325, 10.1038/NGEO2325]; van de Koppel J, 2005, AM NAT, V165, pE1; Wang P, 2013, SOC NETWORKS, V35, P211, DOI 10.1016/j.socnet.2011.12.004; Warnes G.R., Various R Programming Tools for Plotting Data 2020; Zimov SA, 1995, AM NAT	72	84	87	10	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134639	10.1371/journal.pone.0134639	http://dx.doi.org/10.1371/journal.pone.0134639			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267896	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300054
J	Vantangoli, MM; Madnick, SJ; Huse, SM; Weston, P; Boekelheide, K				Vantangoli, Marguerite M.; Madnick, Samantha J.; Huse, Susan M.; Weston, Paula; Boekelheide, Kim			MCF-7 Human Breast Cancer Cells Form Differentiated Microtissues in Scaffold-Free Hydrogels	PLOS ONE			English	Article							ESTROGEN; CULTURE; LINE; GENE; MORPHOGENESIS; EXPRESSION; TISSUE; CHIP; PHENOTYPE; AROMATASE	Three-dimensional (3D) cultures are increasing in use because of their ability to represent in vivo human physiology when compared to monolayer two-dimensional (2D) cultures. When grown in 3D using scaffold-free agarose hydrogels, MCF-7 human breast cancer cells self-organize to form directionally-oriented microtissues that contain a luminal space, reminiscent of the in vivo structure of the mammary gland. When compared to MCF-7 cells cultured in 2D monolayer culture, MCF-7 microtissues exhibit increased mRNA expression of luminal epithelial markers keratin 8 and keratin 19 and decreased expression of basal marker keratin 14 and the mesenchymal marker vimentin. These 3D MCF-7 microtissues remain responsive to estrogens, as demonstrated by induction of known estrogen target mRNAs following exposure to 17 beta-estradiol. Culture of MCF-7 cells in scaffold-free conditions allows for the formation of more differentiated, estrogen-responsive structures that are a more relevant system for evaluation of estrogenic compounds than traditional 2D models.	[Vantangoli, Marguerite M.; Madnick, Samantha J.; Huse, Susan M.; Weston, Paula; Boekelheide, Kim] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Brown University	Boekelheide, K (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Kim_Boekelheide@brown.edu		Vantangoli, Marguerite/0000-0001-8757-440X	NIEHS (National Institute of Environmental Health Sciences) [T32 ES007272]; NIH (National Institute of Health) [RO1 ES 020750]; Unilever; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020750, T32ES007272] Funding Source: NIH RePORTER	NIEHS (National Institute of Environmental Health Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH (National Institute of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Unilever(Unilever); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Major support for this research was provided by NIEHS (National Institute of Environmental Health Sciences) Training Grant T32 ES007272, Unilever, and the generous gift of Donna McGraw Weiss '89 and Jason Weiss, with additional support and useful discussions with the Human Toxome Consortium supported by NIH (National Institute of Health) RO1 ES 020750. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli TM, 2012, TISSUE ENG PART C-ME, V18, P302, DOI [10.1089/ten.tec.2011.0478, 10.1089/ten.TEC.2011.0478]; Akhtar N, 2013, NAT CELL BIOL, V15, P17, DOI 10.1038/ncb2646; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; Bao B, 2011, FASEB J, V25, P255, DOI 10.1096/fj.10-155291; Bissell, 2002, DIFFERENTIATION, V70, P10; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Buijs JT, 2007, CANCER RES, V67, P8742, DOI 10.1158/0008-5472.CAN-06-2490; Come C, 2004, J MAMMARY GLAND BIOL, V9, P183, DOI 10.1023/B:JOMG.0000037161.91969.de; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Desroches BR, 2012, AM J PHYSIOL-HEART C, V302, pH2031, DOI 10.1152/ajpheart.00743.2011; do Amaral JB, 2011, TISSUE ENG PART C-ME, V17, P1097, DOI 10.1089/ten.tec.2011.0260; do Amaral JB, 2010, CELL BIOL INT, V34, P267, DOI 10.1042/CBI20090024; Doria ML, 2014, FASEB J, V28, P4247, DOI 10.1096/fj.14-249672; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Essmann F, 2004, CANCER RES, V64, P7065, DOI 10.1158/0008-5472.CAN-04-1082; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Green CD, 1983, REGULATION OESTROGEN; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Harada N, 1997, J STEROID BIOCHEM, V61, P175; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hassiotou F, 2013, CLIN ANAT, V26, P29, DOI 10.1002/ca.22165; HORWITZ KB, 1975, STEROIDS, V26, P785, DOI 10.1016/0039-128X(75)90110-5; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Kabos P, 2011, BREAST CANCER RES TR, V128, P45, DOI 10.1007/s10549-010-1078-6; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kohl M, 2007, SLQPCR FUNCTIONS ANA; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Levenson AS, 1997, CANCER RES, V57, P3071; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; LUKAS J, 1995, ONCOGENE, V10, P2125; Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591; Napolitano AP, 2007, TISSUE ENG, V13, P2087, DOI 10.1089/ten.2006.0190; NOEL A, 1988, IN VITRO CELL DEV B, V24, P373; Okubo T, 2001, CANCER RES, V61, P1338; Pearson JF, 2009, CELL DEATH DIFFER, V16, P475, DOI 10.1038/cdd.2008.181; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Planas-Silva MD, 2007, J STEROID BIOCHEM, V104, P11, DOI 10.1016/j.jsbmb.2006.09.039; R Core Team, 2012, R LANG ENV STAT COMP; Sanchez VC, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-17; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soares CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038147; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Stein MP, 2002, TRENDS CELL BIOL, V12, P374, DOI 10.1016/S0962-8924(02)02331-0; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; Tejavibulya N, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034110; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Torisawa Y, 2005, BIOMATERIALS, V26, P2165, DOI 10.1016/j.biomaterials.2004.05.028; Torisawa YS, 2014, NAT METHODS, V11, P663, DOI [10.1038/NMETH.2938, 10.1038/nmeth.2938]; WANG AZ, 1990, J CELL SCI, V95, P137; WANG TTY, 1995, CANCER RES, V55, P2487; Webber MM, 1997, ACINAR DIFFERENTIATI; Wrzesinski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106973; Zhu ZY, 2008, PROTEOMICS, V8, P1987, DOI 10.1002/pmic.200700901	64	42	44	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135426	10.1371/journal.pone.0135426	http://dx.doi.org/10.1371/journal.pone.0135426			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267486	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300116
J	Wang, BX; Zhang, Q; Yao, RY; Liu, XP; Qu, ZQ				Wang, Bingxiang; Zhang, Qian; Yao, Ruyong; Liu, Xiangping; Qu, Zhiqiang			7, 8-Dihydroxyflavone Protects an Endothelial Cell Line from H2O2 Damage	PLOS ONE			English	Article							NF-KAPPA-B; VASCULAR INFLAMMATION; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; PC12 CELLS; TNF-ALPHA; APOPTOSIS; HYPERTENSION; MOLECULE; SURVIVAL	7, 8-dihydroxyflavone (7, 8-DHF), a selective agonist for TrkB receptors, has been well studied for its neurotrophic functions. However, its roles outside the neural tissues have scarcely been studied as yet. In this study, we investigated the protecting roles of 7, 8-DHF in EA. hy926 cells, a human umbilic vein endothelial cell line which was exposed to hydrogen peroxide (H2O2). We found that 7, 8-DHF significantly protected the cells from being damaged by H2O2 through suppression of apoptosis, attenuation of inflammatory factor releasing and inhibition of reactive oxygen species generation. The potent biological effects of 7, 8-DHF were probably executed via its binding to TrkB receptors because the receptor specific antagonist ANA-12 significantly blocked its protecting effects. The protecting roles of 7, 8-DHF in EA. hy926 cells suggest that it will be a promising compound to be developed into a health product that definitely benefits endothelial functions and prevents cardiovascular diseases.	[Wang, Bingxiang; Zhang, Qian; Yao, Ruyong; Liu, Xiangping; Qu, Zhiqiang] Qingdao Univ, Affiliated Hosp 1, Med Res Ctr, Qingdao 266555, Peoples R China; [Wang, Bingxiang] Taishan Med Coll, Dept Physiol, Tai An 271000, Shandong, Peoples R China	Qingdao University; Shandong First Medical University & Shandong Academy of Medical Sciences	Wang, BX (corresponding author), Qingdao Univ, Affiliated Hosp 1, Med Res Ctr, Qingdao 266555, Peoples R China.	wangbingxiang352@163.com; quzq@qduhospital.cn			National Natural Science Foundation of China (NSFC) [30840004, 81070215, 31371152]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NSFC 30840004, 81070215, and 31371152) to ZQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2; Bondia-Pons I, 2012, J PHYSIOL BIOCHEM, V68, P701, DOI 10.1007/s13105-012-0154-2; Breton-Romero R, 2014, REDOX BIOL, V2, P529, DOI 10.1016/j.redox.2014.02.005; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Favero G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/801896; Fujita K, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/324256; Gonzalez J, 2014, WORLD J CARDIOL, V6, P353, DOI 10.4330/wjc.v6.i6.353; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Han XH, 2014, NEUROSCI LETT, V581, P85, DOI 10.1016/j.neulet.2014.08.016; Han XH, 2014, NEUROCHEM INT, V64, P18, DOI 10.1016/j.neuint.2013.10.018; Hinz M, 2012, IMMUNOL REV, V246, P59, DOI 10.1111/j.1600-065X.2012.01102.x; Huai RT, 2014, AM J HYPERTENS, V27, P750, DOI 10.1093/ajh/hpt220; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Kawakami T, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/740203; Liu W, 2000, APOPTOSIS, V5, P323, DOI 10.1023/A:1009679307513; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; Obianyo O, 2013, BBA-PROTEINS PROTEOM, V1834, P2213, DOI 10.1016/j.bbapap.2012.08.021; Park HY, 2014, INT J MOL MED, V33, P1027, DOI 10.3892/ijmm.2014.1652; Polovina MM, 2014, POSTGRAD MED, V126, P38, DOI 10.3810/pgm.2014.03.2739; Ragen BJ, 2015, EXPERT OPIN INV DRUG, V24, P659, DOI 10.1517/13543784.2015.1020109; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Song P, 2014, CELL MOL LIFE SCI, V71, P3219, DOI 10.1007/s00018-014-1598-z; Turkseven S, 2005, AM J PHYSIOL-HEART C, V289, pH701, DOI 10.1152/ajpheart.00024.2005; Usui T, 2012, HYPERTENSION, V60, P1031, DOI 10.1161/HYPERTENSIONAHA.112.200337; Virdis A, 2003, CURR OPIN NEPHROL HY, V12, P181, DOI 10.1097/00041552-200303000-00009; Wang BX, 2015, J MOL CELL CARDIOL, V82, P22, DOI 10.1016/j.yjmcc.2015.02.020; Xu H, 2015, PHARMACOLOGY, V96, P1, DOI 10.1159/000430823; Zeng Y, 2013, CNS NEUROL DISORD-DR, V12, P1066, DOI 10.2174/18715273113129990089	33	13	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135345	10.1371/journal.pone.0135345	http://dx.doi.org/10.1371/journal.pone.0135345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266800	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300100
J	Salam, MT; Avoundjian, T; Knight, WM; Gilliland, FD				Salam, Muhammad T.; Avoundjian, Tigran; Knight, Wendy M.; Gilliland, Frank D.			Genetic Ancestry and Asthma and Rhinitis Occurrence in Hispanic Children: Findings from the Southern California Children's Health Study	PLOS ONE			English	Article							ACCULTURATION SCALE; AFRICAN ANCESTRY; RISK-FACTOR; AMERICAN; ASSOCIATIONS; BIRTH; SUSCEPTIBILITY; ALLERGIES; INFERENCE; COUNTRY	Background Asthma and rhinitis are common childhood health conditions. Being an understudied and rapidly growing population in the US, Hispanic children have a varying risk for these conditions that may result from sociocultural (including acculturative factors), exposure and genetic diversities. Hispanic populations have varying contributions from European, Amerindian and African ancestries. While previous literature separately reported associations between genetic ancestry and acculturation factors with asthma, whether Amerindian ancestry and acculturative factors have independent associations with development of early-life asthma and rhinitis in Hispanic children remains unknown. We hypothesized that genetic ancestry is an important determinant of early-life asthma and rhinitis occurrence in Hispanic children independent of sociodemographic, acculturation and environmental factors. Methods Subjects were Hispanic children (5-7 years) who participated in the southern California Children's Health Study. Data from birth certificates and questionnaire provided information on acculturation, sociodemographic and environmental factors. Genetic ancestries (Amerindian, European, African and Asian) were estimated based on 233 ancestry informative markers. Asthma was defined by parental report of doctor-diagnosed asthma. Rhinitis was defined by parental report of a history of chronic sneezing or runny or blocked nose without a cold or flu. Sample sizes were 1,719 and 1,788 for investigating the role of genetic ancestry on asthma and rhinitis, respectively. Results Children had major contributions from Amerindian and European ancestries. After accounting for potential confounders, per 25% increase in Amerindian ancestry was associated with 17.6% (95% confidence interval [CI]: 0.74-0.99) and 13.6% (95% CI: 0.79-0.98) lower odds of asthma and rhinitis, respectively. Acculturation was not associated with either outcome. Conclusions Earlier work documented that Hispanic children with significant contribution from African ancestry are at increased asthma risk; however, in Hispanic children who have little contribution from African ancestry, Amerindian ancestry was independently associated with lower odds for development of early-childhood asthma and rhinitis.	[Salam, Muhammad T.; Gilliland, Frank D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Salam, Muhammad T.] Kern Med Ctr, Dept Psychiat, Bakersfield, CA USA; [Avoundjian, Tigran] US Dept Vet Affairs, Ctr Hlth Care Evaluat, Palo Alto, CA USA; [Knight, Wendy M.] Los Angeles Cty Dept Publ Hlth, Acute Communicable Dis Control Program, Los Angeles, CA USA	University of Southern California; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Los Angeles County Department of Public Health	Salam, MT (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	msalam@usc.edu			National Heart, Lung and Blood Institute [5R01HL61768, 5R01HL76647]; Southern California Environmental Health Sciences Center - National Institute of Environmental Health Sciences [5P30ES007048]; Children's Environmental Health Center - National Institute of Environmental Health Sciences [5P01ES009581, R826708-01, RD831861-01]; U.S. Environmental Protection Agency; National Institute of Environmental Health Sciences [5P01ES011627]; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076647, R01HL061768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048, P01ES011627, P01ES009581] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Southern California Environmental Health Sciences Center - National Institute of Environmental Health Sciences; Children's Environmental Health Center - National Institute of Environmental Health Sciences; U.S. Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Heart, Lung and Blood Institute (grants 5R01HL61768 and 5R01HL76647; URL http://www.nhlbi.nih.gov/); the Southern California Environmental Health Sciences Center (grant 5P30ES007048) funded by the National Institute of Environmental Health Sciences; the Children's Environmental Health Center (grants 5P01ES009581, R826708-01, and RD831861-01) funded by the National Institute of Environmental Health Sciences (URL: http://www.niehs.nih.gov/) and the U.S. Environmental Protection Agency (URL: http://www.epa.gov/); the National Institute of Environmental Health Sciences (grants 5P01ES011627; URL: http://www.niehs.nih.gov); and the Hastings Foundation. The sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; Akinbami LJ, 2005, PEDIATRICS, V115, P1254, DOI 10.1542/peds.2004-0897; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Choudhry S, 2006, AM J RESP CRIT CARE, V174, P1086, DOI [10.1164/RCCM.200605-596OC, 10.1164/rccm.200605-596OC]; CUELLAR I, 1995, HISPANIC J BEHAV SCI, V17, P275, DOI 10.1177/07399863950173001; Davis AM, 2006, PEDIATRICS, V118, pE363, DOI 10.1542/peds.2005-2687; Detjen MG, 2007, AM J PUBLIC HEALTH, V97, P2040, DOI 10.2105/AJPH.2006.095505; Eldeirawi K, 2005, J ALLERGY CLIN IMMUN, V116, P42, DOI 10.1016/j.jaci.2005.03.041; Eldeirawi K, 2014, NUTRIENTS, V6, P1598, DOI 10.3390/nu6041598; Eldeirawi K, 2009, J ASTHMA, V46, P796, DOI 10.3109/02770900903114572; Eldeirawi KM, 2006, J ASTHMA, V43, P279, DOI 10.1080/0277090060022869; Ennis S. R., 2011, HISPANIC POPULATION; Falush D, 2003, GENETICS, V164, P1567; Flores C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026807; Holguin F, 2005, AM J RESP CRIT CARE, V171, P103, DOI 10.1164/rccm.200402-143OC; Hunninghake GM, 2006, AM J RESP CRIT CARE, V173, P143, DOI 10.1164/rccm.200508-1232SO; Kondo KK, 2016, J ETHN SUBST ABUSE, V15, P46, DOI 10.1080/15332640.2014.1002878; Kumar R, 2012, CLIN EXP ALLERGY, V42, P265, DOI 10.1111/j.1365-2222.2011.03873.x; Lara M, 2006, PEDIATRICS, V117, P43, DOI 10.1542/peds.2004-1714; Liu JH, 2012, J NUTR, V142, P298, DOI 10.3945/jn.111.145516; Mannino David M, 2002, MMWR Surveill Summ, V51, P1; Marin G, 1996, HISPANIC J BEHAV SCI, V18, P297, DOI 10.1177/07399863960183002; MARIN G, 1987, HISPANIC J BEHAV SCI, V9, P183, DOI 10.1177/07399863870092005; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; Meltzer EO, 2009, J ALLERGY CLIN IMMUN, V124, pS43, DOI 10.1016/j.jaci.2009.05.013; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P228, DOI 10.1016/j.jaci.2014.07.053; Pritchard JK, 2000, GENETICS, V155, P945; Rumpel JA, 2012, J ALLERGY CLIN IMMUN, V130, P1302, DOI 10.1016/j.jaci.2012.09.001; Salam MT, 2007, AM J RESP CRIT CARE, V176, P1192, DOI 10.1164/rccm.200704-561OC; Skoner DR, 2001, J ALLERGY CLIN IMMUN, V108, pS2, DOI 10.1067/mai.2001.115569; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Thomson MD, 2009, SOC SCI MED, V69, P983, DOI 10.1016/j.socscimed.2009.05.011; Vergara C, 2013, GENET EPIDEMIOL, V37, P393, DOI 10.1002/gepi.21702; Vergara C, 2009, HUM GENET, V125, P565, DOI 10.1007/s00439-009-0649-2; von Mutius E, 2007, IMMUNOBIOLOGY, V212, P433, DOI 10.1016/j.imbio.2007.03.002	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135384	10.1371/journal.pone.0135384	http://dx.doi.org/10.1371/journal.pone.0135384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263549	Green Submitted, gold, Green Published			2022-12-27	WOS:000359353300078
J	Shimomura, A; Patel, D; Wilson, SM; Koehler, KR; Khanna, R; Hashino, E				Shimomura, Atsushi; Patel, Dharmeshkumar; Wilson, Sarah M.; Koehler, Karl R.; Khanna, Rajesh; Hashino, Eri			Tlx3 Promotes Glutamatergic Neuronal Subtype Specification through Direct Interactions with the Chromatin Modifier CBP	PLOS ONE			English	Article							DNA-BINDING; TRANSCRIPTIONAL REGULATION; HISTONE; EXPRESSION; DIFFERENTIATION; TRANSMITTER; COFACTORS; SWITCHES; LANGUAGE; COMPLEX	Nervous system development relies on the generation of precise numbers of excitatory and inhibitory neurons. The homeodomain transcription factor, T-cell leukemia 3 (Tlx3), functions as the master neuronal fate regulator by instructively promoting the specification of glutamatergic excitatory neurons and suppressing the specification of gamma-aminobutyric acid (GABAergic) neurons. However, how Tlx3 promotes glutamatergic neuronal subtype specification is poorly understood. In this study, we found that Tlx3 directly interacts with the epigenetic co-activator cyclic adenosine monophosphate (cAMP)-response element-binding protein (CREB)-binding protein (CBP) and that the Tlx3 homeodomain is essential for this interaction. The interaction between Tlx3 and CBP was enhanced by the three amino acid loop extension (TALE)-class homeodomain transcription factor, pre-B-cell leukemia transcription factor 3 (Pbx3). Using mouse embryonic stem (ES) cells stably expressing Tlx3, we found that the interaction between Tlx3 and CBP became detectable only after these Tlx3-expressing ES cells were committed to a neural lineage, which coincided with increased Pbx3 expression during neural differentiation from ES cells. Forced expression of mutated Tlx3 lacking the homeodomain in ES cells undergoing neural differentiation resulted in significantly reduced expression of glutamatergic neuronal subtype markers, but had little effect on the expression on pan neural markers. Collectively, our results strongly suggest that functional interplay between Tlx3 and CBP plays a critical role in neuronal subtype specification, providing novel insights into the epigenetic regulatory mechanism that modulates the transcriptional efficacy of a selective set of neuronal subtype-specific genes during differentiation.	[Shimomura, Atsushi; Patel, Dharmeshkumar; Wilson, Sarah M.; Koehler, Karl R.; Khanna, Rajesh; Hashino, Eri] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Shimomura, Atsushi; Patel, Dharmeshkumar; Koehler, Karl R.; Hashino, Eri] Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA; [Wilson, Sarah M.; Khanna, Rajesh; Hashino, Eri] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Shimomura, Atsushi] Hlth Sci Univ Hokkaido, Sch Psychol Sci, Sapporo, Hokkaido, Japan; [Khanna, Rajesh] Univ Arizona, Sch Med, Dept Pharmacol, Tucson, AZ USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Health Sciences University of Hokkaido; University of Arizona	Hashino, E (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	ehashino@iupui.edu		Khanna, Rajesh/0000-0002-9066-2969; Koehler, Karl/0000-0002-0685-538X	Japan Society for the Promotion of Science Kakenhi Grant [24592567]; National Institutes of Health [R01DC013294]; Indiana University School of Medicine Biomedical Research Grant; Grants-in-Aid for Scientific Research [24592567] Funding Source: KAKEN; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013294] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science Kakenhi Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University School of Medicine Biomedical Research Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the Japan Society for the Promotion of Science Kakenhi Grant 24592567 to AS (http://www.jsps.go.jp/english/egrants/; this funder had role in preparation of the manuscript), by the National Institutes of Health grant R01DC013294 to EH (http://grants.nih.gov/grants/funding/r01.htm; this funder had role in data collection and analysis) and by the Indiana University School of Medicine Biomedical Research Grant to EH (http://operations.medicine.iu.edu/research-administration/internal-and-local-research-funding/brg/; this funder had role in data collection and analysis).	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Chariot A, 1999, ONCOGENE, V18, P4007, DOI 10.1038/sj.onc.1202776; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Choe SK, 2009, DEV CELL, V17, P561, DOI 10.1016/j.devcel.2009.08.007; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Guo Z, 2012, J NEUROSCI, V32, P8509, DOI 10.1523/JNEUROSCI.6301-11.2012; Hodge RD, 2012, CELL MOL LIFE SCI, V69, P2125, DOI 10.1007/s00018-011-0916-y; Holmqvist PH, 2013, TRANSCR-AUSTIN, V4, P18, DOI 10.4161/trns.22601; Hori K, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/921732; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Ju WN, 2013, TRANSL NEUROSCI, V4, P330, DOI 10.2478/s13380-013-0132-3; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; Kondo T, 2008, P NATL ACAD SCI USA, V105, P5780, DOI 10.1073/pnas.0708704105; Kondo T, 2011, STEM CELLS, V29, P836, DOI 10.1002/stem.624; Ladam F, 2014, DEV DYNAM, V243, P4, DOI 10.1002/dvdy.23997; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Logan C, 1998, J NEUROSCI, V18, P5389, DOI 10.1523/JNEUROSCI.18-14-05389.1998; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Paluszkiewicz SM, 2011, DEV NEUROSCI-BASEL, V33, P349, DOI 10.1159/000329420; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Qian Y, 2001, GENE DEV, V15, P2533, DOI 10.1101/gad.921501; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Shen WF, 2004, J BIOL CHEM, V279, P39895, DOI 10.1074/jbc.M404132200; Shen WF, 2001, MOL CELL BIOL, V21, P7509, DOI 10.1128/MCB.21.21.7509-7522.2001; Shimomura A, 1998, J NEUROCHEM, V70, P1029; Shimomura A., 2013, TRENDS CELL SIGNALIN, P305; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470	40	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135060	10.1371/journal.pone.0135060	http://dx.doi.org/10.1371/journal.pone.0135060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258652	Green Published, gold			2022-12-27	WOS:000359352600037
J	d'Abramo, C; Acker, CM; Jimenez, H; Davies, P				d'Abramo, Cristina; Acker, Christopher M.; Jimenez, Heidy; Davies, Peter			Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies	PLOS ONE			English	Article							NEUROFIBRILLARY TANGLES; MOUSE MODEL; PATHOLOGY; IMMUNOTHERAPY; AGGREGATION; PROPAGATION; TAUOPATHY; DECLINE; PROTEIN	Recent work from our lab and few others have strongly suggested that immunotherapy could be an effective means of preventing the development of tau accumulation in JNPL3 transgenic mice, carrying the human P301L mutation. The aim of this study was to test the efficacy of a variety of specific tau monoclonal antibodies in JNPL3. Starting at 3 months of age, mice were treated for 4 months with weekly intraperitoneal injections of saline or purified tau monoclonal antibodies (10mg/Kg) different in specificity for pathological tau: CP13 (pSer202), RZ3 (pThr231) and PG5 (pSer409). As expected, not all the antibodies tested showed efficacy at preventing the development of tau pathology at the described dose, with some of them even worsening the pathological scenario. Only by targeting the pSer202 epitope with CP13 was a conspicuous reduction of insoluble or soluble tau in cortex and hindbrain obtained. Here we report about the importance of screening in vivo multiple tau antibodies in order to select the antibodies to direct into future clinical studies.	[d'Abramo, Cristina; Acker, Christopher M.; Jimenez, Heidy; Davies, Peter] North Shore LIJ Hlth Syst, Feinstein Inst Med Res, Litwin Zucker Ctr Res Alzheimers Dis, Manhasset, NY 11030 USA	Northwell Health	Davies, P (corresponding author), North Shore LIJ Hlth Syst, Feinstein Inst Med Res, Litwin Zucker Ctr Res Alzheimers Dis, Manhasset, NY 11030 USA.	pdavies@nshs.edu			National Institute on Aging [R37 AG022102]; NATIONAL INSTITUTE ON AGING [R01AG022102, R37AG022102] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institute on Aging R37 AG022102 to PD.	Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2015, ADV ANAT EMBRYOL CEL, V215, P1, DOI 10.1007/978-3-319-12679-1_1; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; d'Abramo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062402; Davies P, 2000, METH MOLEC MED, V32, P361, DOI 10.1385/1-59259-195-7:361; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Forest SK, 2013, J ALZHEIMERS DIS, V33, P463, DOI 10.3233/JAD-2012-121354; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Jicha GA, 1999, J NEUROSCI RES, V55, P713, DOI 10.1002/(SICI)1097-4547(19990315)55:6<713::AID-JNR6>3.0.CO;2-G; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kovacech B, 2010, NEURODEGENER DIS, V7, P24, DOI 10.1159/000283478; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Pedersen JT, 2015, TRENDS MOL MED, V21, P394, DOI 10.1016/j.molmed.2015.03.003; Sankaranarayanan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125614; Theunis C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072301; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; Uchihara T, 2001, ACTA NEUROPATHOL, V101, P535; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yanamandra K, 2015, ANN CLIN TRANSL NEUR, V2, P278, DOI 10.1002/acn3.176; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046	32	38	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135774	10.1371/journal.pone.0135774	http://dx.doi.org/10.1371/journal.pone.0135774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270821	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800110
J	Dollinger, M; Muller-Wille, R; Zeman, F; Halmeri, M; Niessen, C; Beyer, LP; Lang, SA; Teufel, A; Stroszczynski, C; Wiggermann, P				Dollinger, Marco; Mueller-Wille, Rene; Zeman, Florian; Halmeri, Michael; Niessen, Christoph; Beyer, Lukas P.; Lang, Sven A.; Teufel, Andreas; Stroszczynski, Christian; Wiggermann, Philipp			Irreversible Electroporation of Malignant Hepatic Tumors - Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up	PLOS ONE			English	Article							CELLS ABLATION; LIVER	Purpose To evaluate risk factors associated with alterations in venous structures adjacent to an ablation zone after percutaneous irreversible electroporation (IRE) of hepatic malignancies at subacute follow-up (1 to 3 days after IRE) and to describe evolution of these alterations at mid-term follow-up. Materials and Methods 43 patients (men/women, 32/11; mean age, 60.3 years) were identified in whom venous structures were located within a perimeter of 1.0 cm of the ablation zone at subacute follow-up after IRE of 84 hepatic lesions (primary/secondary hepatic tumors, 31/53). These vessels were retrospectively evaluated by means of pre-interventional and post-interventional contrast-enhanced magnetic resonance imaging or computed tomography or both. Any vascular changes in flow, patency, and diameter were documented. Correlations between vascular change (yes/no) and characteristics of patients, lesions, and ablation procedures were assessed by generalized linear models. Results 191 venous structures were located within a perimeter of 1.0 cm of the ablation zone: 55 (29%) were encased by the ablation zone, 78 (41%) abutted the ablation zone, and 58 (30%) were located between 0.1 and 1.0 cm from the border of the ablation zone. At subacute follow-up, vascular changes were found in 19 of the 191 vessels (9.9%), with partial portal vein thrombosis in 2, complete portal vein thrombosis in 3, and lumen narrowing in 14 of 19. At follow-up of patients with subacute vessel alterations (mean, 5.7 months; range, 0 to 14 months) thrombosis had resolved in 2 of 5 cases; vessel narrowing had completely resolved in 8 of 14 cases, and partly resolved in 1 of 14 cases. The encasement of a vessel by ablation zone (OR = 6.36, p<0.001), ablation zone being adjacent to a portal vein (OR = 8.94, p<0.001), and the usage of more than 3 IRE probes (OR = 3.60, p = 0.035) were independently associated with post-IRE vessel alterations. Conclusion Venous structures located in close proximity to an IRE ablation zone remain largely unaffected by this procedure, and thrombosis is rare.	[Dollinger, Marco; Mueller-Wille, Rene; Halmeri, Michael; Niessen, Christoph; Beyer, Lukas P.; Stroszczynski, Christian; Wiggermann, Philipp] Univ Med Ctr Regensburg, Dept Radiol, Regensburg, Germany; [Zeman, Florian] Univ Med Ctr Regensburg, Ctr Clin Studies, Regensburg, Germany; [Lang, Sven A.] Univ Med Ctr Regensburg, Dept Surg, Regensburg, Germany; [Teufel, Andreas] Univ Med Ctr Regensburg, Dept Internal Med 1, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Dollinger, M (corresponding author), Univ Med Ctr Regensburg, Dept Radiol, Regensburg, Germany.	marco.dollinger@ukr.de	WIGGERMANN, Philipp/AAX-6721-2021; Teufel, Andreas/ABD-8000-2021; Beyer, Lukas/B-2496-2019; Beyer, Lukas/AAJ-7242-2020; Zeman, Florian/GNH-3239-2022; Wiggermann, Philipp/AAY-6759-2021	Beyer, Lukas/0000-0002-2498-920X; 				Appelbaum L, 2012, RADIOLOGY, V262, P117, DOI 10.1148/radiol.11110475; Charpentier KP, 2011, HPB, V13, P168, DOI 10.1111/j.1477-2574.2010.00261.x; Goldberg SN, 1998, J VASC INTERV RADIOL, V9, P101, DOI 10.1016/S1051-0443(98)70491-9; Kingham TP, 2012, J AM COLL SURGEONS, V215, P379, DOI 10.1016/j.jamcollsurg.2012.04.029; Lee EW, 2007, TECHNOL CANCER RES T, V6, P287, DOI 10.1177/153303460700600404; Lee EW, 2012, J VASC INTERV RADIOL, V23, P833, DOI 10.1016/j.jvir.2012.02.017; Lee EW, 2010, RADIOLOGY, V255, P426, DOI 10.1148/radiol.10090337; Lee YJ, 2013, J COMPUT ASSIST TOMO, V37, P154, DOI 10.1097/RCT.0b013e31827dbf9b; Lee YJ, 2012, INVEST RADIOL, V47, P671, DOI 10.1097/RLI.0b013e318274b0df; Lu DSK, 2002, AM J ROENTGENOL, V178, P47, DOI 10.2214/ajr.178.1.1780047; Lu DSK, 2005, RADIOLOGY, V234, P954, DOI 10.1148/radiol.2343040153; Maor E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004757; Meloni MF, 2011, J VASC INTERV RADIOL, V22, P947, DOI 10.1016/j.jvir.2011.03.012; Miller L, 2005, TECHNOL CANCER RES T, V4, P699, DOI 10.1177/153303460500400615; Narayanan G, 2014, CARDIOVASC INTER RAD, V37, P1523, DOI 10.1007/s00270-014-0988-9; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Scheffer HJ, 2014, J VASC INTERV RADIOL, V25, P997, DOI 10.1016/j.jvir.2014.01.028	17	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135773	10.1371/journal.pone.0135773	http://dx.doi.org/10.1371/journal.pone.0135773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270651	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800109
J	Song, Y; Liu, LJ; Feng, YJ; Wei, YZ; Yue, XL; He, WL; Zhang, H; An, LZ				Song, Yuan; Liu, Lijun; Feng, Yanhao; Wei, Yunzhu; Yue, Xiule; He, Wenliang; Zhang, Hua; An, Lizhe			Chilling- and Freezing- Induced Alterations in Cytosine Methylation and Its Association with the Cold Tolerance of an Alpine Subnival Plant, Chorispora bungeana	PLOS ONE			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; SUSPENSION-CULTURED CELLS; DNA METHYLATION; STRESS RESPONSES; GENE-EXPRESSION; MOLECULAR-CLONING; LOW-TEMPERATURE; MECHANISMS; ACCLIMATION; INHIBITION	Chilling (0-18 degrees C) and freezing (<0 degrees C) are two distinct types of cold stresses. Epigenetic regulation can play an important role in plant adaptation to abiotic stresses. However, it is not yet clear whether and how epigenetic modification (i.e., DNA methylation) mediates the adaptation to cold stresses in nature (e.g., in alpine regions). Especially, whether the adaptation to chilling and freezing is involved in differential epigenetic regulations in plants is largely unknown. Chorispora bungeana is an alpine subnival plant that is distributed in the freeze-thaw tundra in Asia, where chilling and freezing frequently fluctuate daily (24 h). To disentangle how C. bungeana copes with these intricate cold stresses through epigenetic modifications, plants of C. bungeana were treated at 4 degrees C (chilling) and -4 degrees C (freezing) over five periods of time (0-24 h). Methylation-sensitive amplified fragment-length polymorphism markers were used to investigate the variation in DNA methylation of C. bungeana in response to chilling and freezing. It was found that the alterations in DNA methylation of C. bungeana largely occurred over the period of chilling and freezing. Moreover, chilling and freezing appeared to gradually induce distinct DNA methylation variations, as the treatment went on (e.g., after 12 h). Forty-three cold-induced polymorphic fragments were randomly selected and further analyzed, and three of the cloned fragments were homologous to genes encoding alcohol dehydrogenase, UDP-glucosyltransferase and polygalacturonase-inhibiting protein. These candidate genes verified the existence of different expressive patterns between chilling and freezing. Our results showed that C. bungeana responded to cold stresses rapidly through the alterations of DNA methylation, and that chilling and freezing induced different DNA methylation changes. Therefore, we conclude that epigenetic modifications can potentially serve as a rapid and flexible mechanism for C. bungeana to adapt to the intricate cold stresses in the alpine areas.	[Song, Yuan; Liu, Lijun; Wei, Yunzhu; Yue, Xiule; He, Wenliang; Zhang, Hua; An, Lizhe] Lanzhou Univ, Sch Life Sci, Key Lab Cell Act & Stress Adaptat, Minist Educ, Lanzhou 730000, Peoples R China; [Feng, Yanhao] Univ Konstanz, Dept Biol, Constance, Germany	Lanzhou University; University of Konstanz	Song, Y (corresponding author), Lanzhou Univ, Sch Life Sci, Key Lab Cell Act & Stress Adaptat, Minist Educ, Lanzhou 730000, Peoples R China.	songyuan@lzu.edu.cn; lizhean@lzu.edu.cn	Yang, Xiaoming/GRJ-9483-2022	Yang, Xiaoming/0000-0002-1792-6921	National Basic Research Program of China (973 Program) [2014CB954203]; National Natural Science Foundation of China [31200298]; Key Program National Natural Science Foundation of China [31230014]; Fundamental Research Funds for the Central Universities [lzujbky-2014-99, lzujbky-2014-bt05]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Basic Research Program of China (973 Program) (2014CB954203); The National Natural Science Foundation of China (No. 31200298); The Key Program National Natural Science Foundation of China (No. 31230014); The Fundamental Research Funds for the Central Universities (lzujbky-2014-99 and lzujbky-2014-bt05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers B, 2010, MOL ECOL, V19, P1283, DOI 10.1111/j.1365-294X.2010.04580.x; Becker C, 2012, CURR OPIN PLANT BIOL, V15, P562, DOI 10.1016/j.pbi.2012.08.004; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Chang J, 2005, ENVIRON EXP BOT, V5, P158; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Cortijo S, 2014, SCIENCE, V343, P1145, DOI 10.1126/science.1248127; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Di CX, 2009, PLANTA, V231, P169, DOI 10.1007/s00425-009-1039-7; DOLFERUS R, 1994, PLANT PHYSIOL, V105, P1075, DOI 10.1104/pp.105.4.1075; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Eichten SR, 2013, PLANT CELL, V25, P2783, DOI 10.1105/tpc.113.114793; Eriksson ME, 2011, CURR OPIN PLANT BIOL, V14, P731, DOI 10.1016/j.pbi.2011.08.005; Fan HH, 2013, ACTA PHYSIOL PLANT, V35, P2445, DOI 10.1007/s11738-013-1278-x; Fu XY, 2006, ENVIRON EXP BOT, V55, P282, DOI 10.1016/j.envexpbot.2004.11.009; Fulnecek J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-2; Grativol C, 2012, BBA-GENE REGUL MECH, V1819, P176, DOI 10.1016/j.bbagrm.2011.08.010; Gupta KJ, 2011, NEW PHYTOL, V189, P360, DOI 10.1111/j.1469-8137.2010.03586.x; Guy C, 2008, PHYSIOL PLANTARUM, V132, P220, DOI 10.1111/j.1399-3054.2007.00999.x; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Hirsch S, 2012, Cold Spring Harb Symp Quant Biol, V77, P97, DOI 10.1101/sqb.2013.77.014605; Huff JT, 2012, CURR OPIN GENET DEV, V22, P132, DOI 10.1016/j.gde.2012.01.007; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; JUNGHANS H, 1990, BIOTECHNIQUES, V8, P176; Knight MR, 2012, NEW PHYTOL, V195, P737, DOI 10.1111/j.1469-8137.2012.04239.x; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Liu XC, 2013, PLANT CELL, V25, P1258, DOI 10.1105/tpc.113.109710; Liu YJ, 2011, J PLANT PHYSIOL, V168, P853, DOI 10.1016/j.jplph.2010.09.020; Liu YJ, 2010, PLANT PHYSIOL BIOCH, V48, P936, DOI 10.1016/j.plaphy.2010.09.001; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; McClung CR, 2010, CURR BIOL, V20, pR1086, DOI 10.1016/j.cub.2010.10.035; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Pecinka A, 2012, PLANT CELL PHYSIOL, V53, P801, DOI 10.1093/pcp/pcs044; Peters JS, 2004, PLANT PHYSIOL BIOCH, V42, P841, DOI 10.1016/j.plaphy.2004.10.004; Richards C., 2012, PLANT GENOME DIVERSI, P257, DOI [DOI 10.1007/978-3-7091-1130-7_, DOI 10.1007/978-3-7091-1130-7_16]; Richards CL, 2010, NEW PHYTOL, V187, P562, DOI 10.1111/j.1469-8137.2010.03369.x; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Roberts RJ, 2007, NUCLEIC ACIDS RES, V35, pD269, DOI 10.1093/nar/gkl891; Sahu PP, 2013, PLANT CELL REP, V32, P1151, DOI 10.1007/s00299-013-1462-x; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Scoville AG, 2011, NEW PHYTOL, V191, P251, DOI 10.1111/j.1469-8137.2011.03656.x; Shan XH, 2013, J PLANT BIOL, V56, P32, DOI 10.1007/s12374-012-0251-3; Shi YL, 2008, PROTOPLASMA, V232, P173, DOI 10.1007/s00709-008-0291-1; Si J, 2009, J PLANT BIOL, V52, P593, DOI 10.1007/s12374-009-9077-z; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Sung SB, 2004, CURR OPIN PLANT BIOL, V7, P4, DOI 10.1016/j.pbi.2003.11.010; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Wang JH, 2006, IN VITRO CELL DEV-PL, V42, P148, DOI [10.1079/IVP2006718, 10.1079/IVP2006748]; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wu JM, 2008, CRYOBIOLOGY, V57, P9, DOI 10.1016/j.cryobiol.2008.04.001; Wu JM, 2009, PROTOPLASMA, V235, P27, DOI 10.1007/s00709-008-0026-3; Yang Y, 2014, PLANTA, V240, P369, DOI 10.1007/s00425-014-2091-5; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872; Zhang LJ, 2009, BIOL TRACE ELEM RES, V128, P269, DOI 10.1007/s12011-008-8275-8; Zhang TG, 2006, PLANT PHYSIOL BIOCH, V44, P78, DOI 10.1016/j.plaphy.2006.01.001; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222	67	36	36	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135485	10.1371/journal.pone.0135485	http://dx.doi.org/10.1371/journal.pone.0135485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270551	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800082
J	Yeoh, PL; Hornetz, K; Shauki, NIA; Dahlui, M				Yeoh, Ping Ling; Hornetz, Klaus; Shauki, Nor Izzah Ahmad; Dahlui, Maznah			Assessing the Extent of Adherence to the Recommended Antenatal Care Content in Malaysia: Room for Improvement	PLOS ONE			English	Article							QUALITY; ADEQUACY; BIRTH; TANZANIA; INDEX	Background Recent papers on monitoring of health services affirmed that while antenatal care (ANC) is an effective measure, quality is still a problem. Quality in maternal services " ... involves providing a minimum level of care to all pregnant women ... " Yet adherence to a minimum level of recommended ANC content appears to be unmet. Comprehensive review of ANC content rendered in environments with rapid changes in demographic, socio-economic, lifestyle and morbidity was sparse. Malaysia is such a country that has undergone these transitions with tremendous progress in health. However, recent progress in pregnancy outcomes is stagnating. This study aims to analyse adherence to recommended ANC; specifically, to examine the extent of adherence to recommended ANC content and to determine the factors influencing ANC content score. Methods A retrospective cohort study of 522 randomly selected women who used ANC was conducted. Data were extracted from individual records. The study examined adherence to essential ANC guidelines using weighted scoring for physical examination, health screening, case management, and health education. GLM Univariate analysis procedure was used to determine the factors associated with ANC content score. Binary logistic regression was used to assess ANC content level and pregnancy outcomes, controlled for ANC utilisation. Results Around half of the women had <80% of recommended ANC content documented. Health education had the lowest mean score, at around 35%. The low-risk pregnancies had a higher ANC content score than the high-risk pregnancies (78% vs. 75%; P = 0.002). The smallest clinics had a higher ANC content score than the bigger clinics (78% vs. 74-76%; P<0.001). ANC content score among the women with "adequate" ANC utilisation, as defined by the modified Adequacy of Prenatal Care Utilisation Index, was lower than the women with "adequate-plus" ANC utilisation (75% vs. 78%, P<0.001). Assessment of symphysis-fundal height, foetal presentation and foetal heart auscultation were initiated earlier than recommended. Inadequate ANC content was associated with higher prevalence of preterm birth. Conclusions Our findings indicate the presence of issues related to delivery of recommended ANC content. We advocate for all pregnant women to be ensured of adherence to the recommended ANC content. We also recommend monitoring the delivery of health advice. Conforming to recommended timing of initiation for ANC practices is essential due to resource implication and possible implication on maternal wellbeing. The association of inadequate ANC content and preterm birth may be due to lesser opportunities to receive some of the care because of lower number of ANC visits among preterm birth; this may also indicate the importance of having adequate ANC content.	[Yeoh, Ping Ling; Dahlui, Maznah] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Hornetz, Klaus] German Dev Cooperat, Berlin, Germany; [Shauki, Nor Izzah Ahmad] Selangor State Hlth Dept, Family Hlth Dev, Shah Alam, Malaysia; [Yeoh, Ping Ling] Mediconsult Sdn Bhd, Ampang, Malaysia	Universiti Malaya	Yeoh, PL (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	pingling@mediconsult.com.my	Dahlui, Maznah/F-9665-2010; DAHLUI, MAZNAH/B-8976-2010; PAN, ZEQIANG/X-6341-2018	DAHLUI, MAZNAH/0000-0003-4923-9410; 	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant [E000010-20001]; Mediconsult; Mediconsult S.B. Malaysia	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant; Mediconsult; Mediconsult S.B. Malaysia	This work is part of the STeMM Programme supported by the University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant (Grant number E000010-20001). Mediconsult S.B. Malaysia http://www.mediconsult.com.my/ - support for PhD study of author PLY. The funder Mediconsult provided support in the form of a salary for author PLY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	[AAP/ACOG] American Academy of Pediatrics and American College of Obstetricians and Gynecologists, 2012, GUIDELINES FOR PERIN; [AHMAC] Australian Health Ministers' Advisory Council, 2012, CLINICAL PRACTICE GU; Bloom SS, 1999, HEALTH POLICY PLANN, V14, P38, DOI 10.1093/heapol/14.1.38; Boerma T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001728; Boller C, 2003, B WORLD HEALTH ORGAN, V81, P116; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Chalmers B, 2001, BIRTH-ISS PERINAT C, V28, P202, DOI 10.1046/j.1523-536x.2001.00202.x; Department of Statistics Malaysia, 2011, POPULATION AND HOUSI; Dhar RS, 2010, ARCH GYNECOL OBSTET, V282, P245, DOI 10.1007/s00404-009-1214-x; Graham WJ, 1991, MEASURING MATERNAL H; Gravett MG, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S2; Handler A, 2012, MATERN CHILD HLTH J, V16, P393, DOI 10.1007/s10995-011-0763-3; Jaafar S, 2013, MALAYSIA HEALTH SYST; Koroukian SM, 2002, J CLIN EPIDEMIOL, V55, P296, DOI 10.1016/S0895-4356(01)00471-1; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; LIBBUS MK, 1991, BIRTH-ISS PERINAT C, V18, P78, DOI 10.1111/j.1523-536X.1991.tb00064.x; Lindmark G, 1992, Int J Technol Assess Health Care, V8 Suppl 1, P2; Majrooh MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113390; Ministry of Health, 2010, PERINATAL CARE MANUA; Ministry of Health Malaysia, 2012, ANNUAL REPORT FAMILY; Ministry of Health Malaysia, 1991, ANNUAL REPORT 1990 M; National Institute for Health and Clinical Excellence, 2008, ANTENATAL CARE ROUTI; Pathmanathan I, 2003, INVESTING IN MATERNA; Pembe AB, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-35; Pittrof R, 2002, ACTA OBSTET GYN SCAN, V81, P277, DOI 10.1034/j.1600-0412.2002.810401.x; Ravindran J, 2003, Med J Malaysia, V58, P37; Requejo JH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001416; Trinh LTT, 2006, PUBLIC HEALTH REP, V121, P468, DOI 10.1177/003335490612100417; Victora CG, 2010, HEALTH POLICY PLANN, V25, P253, DOI 10.1093/heapol/czp065; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; White Deborah E, 2006, Health Care Women Int, V27, P777, DOI 10.1080/07399330600880335; World Health Organization, 2014, WORLD HEALTH STATIST; World Health Organization, 2012, WORLD HEALTH STATIST; World Health Organization (WHO), 2009, WHO RECOMMENDED INTE; YOONG AFE, 1992, BMJ-BRIT MED J, V305, P1184, DOI 10.1136/bmj.305.6863.1184	35	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135301	10.1371/journal.pone.0135301	http://dx.doi.org/10.1371/journal.pone.0135301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JX	26270471	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492800053
J	Boloc, D; Castillo-Lara, S; Marfany, G; Gonzalez-Duarte, R; Abril, JF				Boloc, Daniel; Castillo-Lara, Sergio; Marfany, Gemma; Gonzalez-Duarte, Roser; Abril, Josep F.			Distilling a Visual Network of Retinitis Pigmentosa Gene-Protein Interactions to Uncover New Disease Candidates	PLOS ONE			English	Article							GENEMANIA; INSIGHTS; MUTATION	Background Retinitis pigmentosa (RP) is a highly heterogeneous genetic visual disorder with more than 70 known causative genes, some of them shared with other non-syndromic retinal dystrophies (e.g. Leber congenital amaurosis, LCA). The identification of RP genes has increased steadily during the last decade, and the 30% of the cases that still remain unassigned will soon decrease after the advent of exome/genome sequencing. A considerable amount of genetic and functional data on single RD genes and mutations has been gathered, but a comprehensive view of the RP genes and their interacting partners is still very fragmentary. This is the main gap that needs to be filled in order to understand how mutations relate to progressive blinding disorders and devise effective therapies. Methodology We have built an RP-specific network (RPGeNet) by merging data from different sources: high-throughput data from BioGRID and STRING databases, manually curated data for interactions retrieved from iHOP, as well as interactions filtered out by syntactical parsing from up-to-date abstracts and full-text papers related to the RP research field. The paths emerging when known RP genes were used as baits over the whole interactome have been analysed, and the minimal number of connections among the RP genes and their close neighbors were distilled in order to simplify the search space. Conclusions In contrast to the analysis of single isolated genes, finding the networks linking disease genes renders powerful etiopathological insights. We here provide an interactive interface, RPGeNet, for the molecular biologist to explore the network centered on the non-syndromic and syndromic RP and LCA causative genes. By integrating tissue-specific expression levels and phenotypic data on top of that network, a more comprehensive biological view will highlight key molecular players of retinal degeneration and unveil new RP disease candidates.	[Boloc, Daniel; Castillo-Lara, Sergio; Marfany, Gemma; Gonzalez-Duarte, Roser; Abril, Josep F.] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Catalonia, Spain; [Marfany, Gemma; Gonzalez-Duarte, Roser; Abril, Josep F.] Univ Barcelona, Inst Biomed IBUB, Barcelona, Catalonia, Spain; [Marfany, Gemma; Gonzalez-Duarte, Roser] Inst Salud Carlos III, CIBERER, Barcelona, Catalonia, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Gonzalez-Duarte, R (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Catalonia, Spain.	rgonzalez@ub.edu; jabril@ub.edu	Marfany, Gemma/I-5668-2015; Castillo-Lara, Sergio/I-7980-2014; Ferrando, Josep F Abril/B-3877-2014; Boloc, Daniel/I-9044-2014	Marfany, Gemma/0000-0001-7941-983X; Castillo-Lara, Sergio/0000-0003-3904-2948; Ferrando, Josep F Abril/0000-0001-7793-589X; Boloc, Daniel/0000-0002-8045-5392	Ministerio de Ciencia e Innovacion [BFU2010-15656, BFU2009-09102, SAF2013-49069-C2-1-R]; Generalitat de Catalunya [SGR2014-0932, 2009-SGR-001018]; CIBERER; Retina Asturias; ONCE	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); CIBERER; Retina Asturias; ONCE	This work was supported by grants SAF2013-49069-C2-1-R (GM and RGD), BFU2010-15656 (GM) (Ministerio de Ciencia e Innovacion), SGR2014-0932 (RGD and GM) (Generalitat de Catalunya), CIBERER (RGD), Retina Asturias (RGD), ONCE (RGD), BFU2009-09102 (JFA) (Ministerio de Ciencia e Innovacion), and 2009-SGR-001018 (JFA) (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; [Anonymous], 2014, RPGENET RETINITIS PI; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bastian M., 2009, ICWSM, DOI DOI 10.1136/QSHC.2004.010033; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Bettencourt C, 2014, JAMA NEUROL, V71, P831, DOI 10.1001/jamaneurol.2014.756; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Canese K., 2013, NCBI HDB, Vsecond; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Castro-Miro M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088410; De Marneffe M.-C., 2006, P LREC, P449; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Fernandez JM, 2007, NUCLEIC ACIDS RES, V35, pW21, DOI 10.1093/nar/gkm298; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Garanto A, 2011, INVEST OPHTH VIS SCI, V52, P5202, DOI 10.1167/iovs.10-7101; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Hamed M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S5-S2; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hoffmann R, 2005, BIOINFORMATICS, V21, P252, DOI 10.1093/bioinformatics/bti1142; Hoffmann R, 2003, TRENDS GENET, V19, P79, DOI 10.1016/S0168-9525(02)00014-8; Hu Y, 2005, MATH J 10, V10, P37, DOI DOI 10.3402/QHW.V6I2.5918; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Kahle JJ, 2011, HUM MOL GENET, V20, P510, DOI 10.1093/hmg/ddq496; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Khateb S, 2014, J MED GENET, V51, P460, DOI 10.1136/jmedgenet-2014-102287; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; Lotia S, 2013, BIOINFORMATICS, V29, P1350, DOI 10.1093/bioinformatics/btt138; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Podder A, 2014, OMICS, V18, P754, DOI 10.1089/omi.2014.0082; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Riazuddin SA, 2010, AM J HUM GENET, V86, P805, DOI 10.1016/j.ajhg.2010.04.001; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sun J, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008769, 10.1371/journal.pone.0011351]; Uhart M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00010; van Wijk E, 2009, HUM MOL GENET, V18, P51, DOI 10.1093/hmg/ddn312; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yang RD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-314; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	50	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135307	10.1371/journal.pone.0135307	http://dx.doi.org/10.1371/journal.pone.0135307			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267445	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300094
J	Bianchi, M; Dahlgren, S; Massey, J; Dietschi, E; Kierczak, M; Lund-Ziener, M; Sundberg, K; Thoresen, SI; Kampe, O; Andersson, G; Ollier, WER; Hedhammar, A; Leeb, T; Lindblad-Toh, K; Kennedy, LJ; Lingaas, F; Pielberg, GR				Bianchi, Matteo; Dahlgren, Stina; Massey, Jonathan; Dietschi, Elisabeth; Kierczak, Marcin; Lund-Ziener, Martine; Sundberg, Katarina; Thoresen, Stein Istre; Kampe, Olle; Andersson, Goran; Ollier, William E. R.; Hedhammar, Ake; Leeb, Tosso; Lindblad-Toh, Kerstin; Kennedy, Lorna J.; Lingaas, Frode; Pielberg, Gerli Rosengren			A Multi-Breed Genome-Wide Association Analysis for Canine Hypothyroidism Identifies a Shared Major Risk Locus on CFA12	PLOS ONE			English	Article							AUTOIMMUNE LYMPHOCYTIC THYROIDITIS; CONGENITAL HYPOTHYROIDISM; HLA GENES; DISEASE; DOGS; MUTATIONS; GENETICS; REVEALS; METAANALYSIS; PREVALENCE	Hypothyroidism is a complex clinical condition found in both humans and dogs, thought to be caused by a combination of genetic and environmental factors. In this study we present a multi-breed analysis of predisposing genetic risk factors for hypothyroidism in dogs using three high-risk breeds-the Gordon Setter, Hovawart and the Rhodesian Ridgeback. Using a genome-wide association approach and meta-analysis, we identified a major hypothyroidism risk locus shared by these breeds on chromosome 12 (p = 2.1x10(-11)). Further characterisation of the candidate region revealed a shared similar to 167 kb risk haplotype (4,915,018-5,081,823 bp), tagged by two SNPs in almost complete linkage disequilibrium. This breed-shared risk haplotype includes three genes (LHFPL5, SRPK1 and SLC26A8) and does not extend to the dog leukocyte antigen (DLA) class II gene cluster located in the vicinity. These three genes have not been identified as candidate genes for hypothyroid disease previously, but have functions that could potentially contribute to the development of the disease. Our results implicate the potential involvement of novel genes and pathways for the development of canine hypothyroidism, raising new possibilities for screening, breeding programmes and treatments in dogs. This study may also contribute to our understanding of the genetic etiology of human hypothyroid disease, which is one of the most common endocrine disorders in humans.	[Bianchi, Matteo; Kierczak, Marcin; Pielberg, Gerli Rosengren] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Dahlgren, Stina; Lund-Ziener, Martine; Thoresen, Stein Istre; Lingaas, Frode] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Massey, Jonathan; Ollier, William E. R.; Kennedy, Lorna J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Integrated Genom Med Res, Manchester, Lancs, England; [Dietschi, Elisabeth; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Sundberg, Katarina; Andersson, Goran] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Kampe, Olle] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Hedhammar, Ake] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge, MA USA	Uppsala University; Norwegian University of Life Sciences; University of Manchester; University of Bern; Swedish University of Agricultural Sciences; Karolinska Institutet; Swedish University of Agricultural Sciences; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Pielberg, GR (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden.	gerli.pielberg@imbim.uu.se	Andersson, Goran/AAK-6564-2020; Fiumefreddo, Andrea/T-2977-2019; Leeb, Tosso/G-3187-2014; Kennedy, Lorna/AAK-8767-2020	Andersson, Goran/0000-0001-5131-3144; Leeb, Tosso/0000-0003-0553-4880; Kennedy, Lorna/0000-0002-3087-4548; Hedhammar, Ake/0000-0001-7048-3851; Kampe, Olle/0000-0001-6091-9914; Massey, Jonathan/0000-0002-4576-1124; Kierczak, Marcin/0000-0003-2629-5655; Bianchi, Matteo/0000-0003-3394-6495	European Commission (LUPA), FP7 [201370]; Research Council of Norway [207982, 209909/140]; Norwegian English setter Club [ESNVH2010-001]; Norwegian Gordon setter Club [GSNVH2010-001]; Swedish Research Council [2009-3376, 2012-2826]; European Research Council [ERC-2012-StG 310203-K9Genes]; Swedish Research Council Formas [2009-1689, 2010-629]; Agria and Swedish Kennel Club Research, Fund [N2011-0039]; American Kennel Club [2447]; Albert Heim Foundation [105]; Novo Nordisk Fonden [NNF14OC0011003, NNF13OC0005975] Funding Source: researchfish	European Commission (LUPA), FP7; Research Council of Norway(Research Council of Norway); Norwegian English setter Club; Norwegian Gordon setter Club; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Agria and Swedish Kennel Club Research, Fund; American Kennel Club; Albert Heim Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the European Commission (LUPA), FP7 201370, http://ec.europa.eu/ (MB SD JM ED MK MLZ KS OK GA WERO AH TL KLT LJK FL GRP), The Research Council of Norway 207982 and 209909/140, http://www.forskningsradet.no/en/Home_page/1177315753906 (SD MLZ FL), The Norwegian English setter Club, ESNVH2010-001, http://www.nesk.no/ (SD MLZ FL), The Norwegian Gordon setter Club, GSNVH2010-001, http://www.gordonsetter.no/ (SD MLZ FL), The Swedish Research Council, 2009-3376 and 2012-2826, http://www.vr.se/ (MB MK KS OK GA AH KLT GRP), European Research Council, ERC-2012-StG 310203-K9Genes, http://erc.europa.eu/ (KLT), The Swedish Research Council Formas, 2009-1689 and 2010-629, http://www.formas.se/ (MB KLT GRP), Agria and Swedish Kennel Club Research, Fund N2011-0039, http://www.skk.se/ and http://www.agria.se/ (MB GRP), American Kennel Club, No: 2447, http://www.akc.org/ (JM WERO LJK), The Albert Heim Foundation, No: 105, http://www.albert-heim-stiftung.ch/ (ED TL).	Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Azizi F, 1974, Trans Assoc Am Physicians, V87, P111; Ban Y, 2002, CLIN ENDOCRINOL, V57, P81, DOI 10.1046/j.1365-2265.2002.01566.x; Bannasch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009632; BEIERWALTES WH, 1968, ENDOCRINOLOGY, V83, P501, DOI 10.1210/endo-83-3-501; Belonogova NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065395; Benjamin SA, 1996, VET PATHOL, V33, P486, DOI 10.1177/030098589603300502; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Briggs J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017107; DELUCA F, 1982, EUR J PEDIATR, V138, P327, DOI 10.1007/BF00442510; Dirami T, 2013, AM J HUM GENET, V92, P760, DOI 10.1016/j.ajhg.2013.03.016; Dixon R M, 1999, Vet Rec, V145, P481; Dodgson SE, 2012, J VET INTERN MED, V26, P1350, DOI 10.1111/j.1939-1676.2012.01015.x; Dror AA, 2014, MAMM GENOME, V25, P304, DOI 10.1007/s00335-014-9515-1; Egenvall A, 2000, VET REC, V146, P519, DOI 10.1136/vr.146.18.519; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Ferguson DC, 2007, VET CLIN N AM-SMALL, V37, P647, DOI 10.1016/j.cvsm.2007.05.015; Ferm K, 2009, J SMALL ANIM PRACT, V50, P176, DOI 10.1111/j.1748-5827.2008.00696.x; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Fyfe JC, 2003, J VET INTERN MED, V17, P50, DOI 10.1111/j.1939-1676.2003.tb01323.x; Gaitonde DY, 2012, AM FAM PHYSICIAN, V86, P244; Graham PA, 2001, VET CLIN N AM-SMALL, V31, P915, DOI 10.1016/S0195-5616(01)50005-4; Graham PA, 2007, VET CLIN N AM-SMALL, V37, P617, DOI 10.1016/j.cvsm.2007.05.002; Happ GM, 1995, ADV VET SCI COMP MED, V39, P97, DOI 10.1016/S0065-3519(06)80018-2; Hoeppner MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091172; Hoffman GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075707; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Kalay E, 2006, HUM MUTAT, V27, P633, DOI 10.1002/humu.20368; Kamachi M, 2002, J EXP MED, V196, P1213, DOI 10.1084/jem.20021167; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Karlsson EK, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r132; Kennedy LJ, 2006, TISSUE ANTIGENS, V67, P53, DOI 10.1111/j.1399-0039.2005.00518.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P82, DOI 10.1111/j.1399-0039.2006.00614.x; Khandelwal D, 2012, DRUGS, V72, P17, DOI 10.2165/11598070-000000000-00000; Laurberg P, 2010, BEST PRACT RES CL EN, V24, P13, DOI 10.1016/j.beem.2009.08.013; Levin L, 2004, HUM IMMUNOL, V65, P640, DOI 10.1016/j.humimm.2004.02.026; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Longo-Guess CM, 2005, P NATL ACAD SCI USA, V102, P7894, DOI 10.1073/pnas.0500760102; LUCKE VM, 1983, J COMP PATHOL, V93, P415, DOI 10.1016/0021-9975(83)90028-2; Massey JP, 2012, THESIS U MANCHESTER; Menconi F, 2008, P NATL ACAD SCI USA, V105, P14034, DOI 10.1073/pnas.0806584105; MOENS H, 1978, NEW ENGL J MED, V299, P133, DOI 10.1056/NEJM197807202990306; Mooney CT, 2011, NEW ZEAL VET J, V59, P105, DOI 10.1080/00480169.2011.563729; Nachreiner RMF, 2002, J AM VET MED ASSOC, V220, P466, DOI 10.2460/javma.2002.220.466; Nousiainen L, 2013, INNATE IMMUN-LONDON, V19, P516, DOI 10.1177/1753425912473345; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Prescott EL, 2014, J VIROL, V88, P12599, DOI 10.1128/JVI.02029-14; ROMAN SH, 1992, J CLIN ENDOCR METAB, V74, P496, DOI 10.1210/jc.74.3.496; Ronnegard L, 2010, R J, V2, P20; Safra N, 2011, VET J, V189, P220, DOI 10.1016/j.tvjl.2011.06.023; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; SCOTT DW, 1990, CAN VET J, V31, P830; Seddon JM, 2010, TISSUE ANTIGENS, V75, P218, DOI 10.1111/j.1399-0039.2009.01426.x; Shabbir MI, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039834; Sutter NB, 2004, NAT REV GENET, V5, P900, DOI 10.1038/nrg1492; Szinnai G, 2014, BEST PRACT RES CL EN, V28, P133, DOI 10.1016/j.beem.2013.08.005; Tengvall K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003475; Toker A, 2014, MOL CELL, V54, P329, DOI 10.1016/j.molcel.2014.04.020; Toure A, 2001, J BIOL CHEM, V276, P20309, DOI 10.1074/jbc.M011740200; Turner SD, QQMAN R PACKAGE VISU; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Wilbe M, 2010, TISSUE ANTIGENS, V75, P712, DOI 10.1111/j.1399-0039.2010.01449.x; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191	71	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134720	10.1371/journal.pone.0134720	http://dx.doi.org/10.1371/journal.pone.0134720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26261983	Green Published, gold, Green Accepted			2022-12-27	WOS:000359353300039
J	Heikkinen, S; Pitkaniemi, J; Sarkeala, T; Malila, N; Koskenvuo, M				Heikkinen, Sanna; Pitkaniemi, Janne; Sarkeala, Tytti; Malila, Nea; Koskenvuo, Markku			Does Hair Dye Use Increase the Risk of Breast Cancer? A Population-Based Case-Control Study of Finnish Women	PLOS ONE			English	Article							AROMATIC-AMINES; PERSONAL USE	Introduction Role of hair dyes in the etiology of breast cancer has occasionally raised concern but previous research has concluded with mixed results. Remnants of prohibited aromatic amines have been found in many hair dye products, and elevated levels of DNA-adducts of these amines have been detected from breast epithelial cells of hair dye users. However, the IARC working group has concluded that there is inadequate evidence for carcinogenicity of personal hair dye use and limited evidence in experimental animals for carcinogenicity of hair colorants. Material and Methods We investigated whether the use of hair dyes is associated with breast cancer risk in women. The study design was a retrospective population-based case-control study in Finland, with a self-administered questionnaire from 6,567 breast cancer patients, aged 22-60 years and diagnosed in 2000-2007, and their 21,598 matched controls. We report odds ratios (OR) with 95% confidence interval (95% CI) from a conditional logistic regression model applied to the frequency matched sets of cases and controls. Bias-adjusted odds ratios from the sensitivity analysis are also presented. Results After adjusting for potential confounders, the odds of breast cancer increased by 23% (OR: 1.23, 95% CI: 1.11-1.36) among women who used hair dyes compared to those who did not. In women born before 1950 an increase of 28% was noted (OR: 1.28, 95% CI: 1.10-1.48). We also observed a significant trend between the OR and cumulative use of hair dyes (P: 0.005). Bias-adjusted odds ratios varied between 1.04 and 2.50. Conclusions Our results suggest that use of hair dyes is associated with breast cancer incidence. The impact on public health may be substantial due to vast popularity of hair coloring in modern societies. It should be noted that regardless of all efforts, a possibility of bias cannot definitively be ruled out and use of a prospective design is warranted. Based on the present results, it may be concluded however that safety of hair dyes in relation to breast cancer cannot yet be fully acknowledged and lack of external safety assessment within the cosmetics industry is of major concern.	[Heikkinen, Sanna; Pitkaniemi, Janne; Sarkeala, Tytti; Malila, Nea] Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FI-00130 Helsinki, Finland; [Pitkaniemi, Janne; Koskenvuo, Markku] Univ Helsinki, Hjelt Inst, Dept Publ Hlth, FI-00014 Helsinki, Finland; [Malila, Nea] Univ Tampere, Sch Hlth Sci, FI-33014 Tampere, Finland	Finnish Cancer Registry; University of Helsinki; Tampere University	Heikkinen, S (corresponding author), Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, Unioninkatu 22, FI-00130 Helsinki, Finland.	sanna.heikkinen@cancer.fi		Heikkinen, Sanna/0000-0001-9995-5605	ZEG Berlin, Center for Epidemiology and Health Research; Cancer Society of Finland	ZEG Berlin, Center for Epidemiology and Health Research; Cancer Society of Finland	The original data collection was funded by the ZEG Berlin, Center for Epidemiology and Health Research and it produced a study "Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer" by Dinger, Bardenheuer and Do Minh, published in 2010. SH was supported by the Cancer Society of Finland for the present study (Epidemiological Researcher-grant), http://www.cancer.fi/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyuz M, 2008, J PHARMACEUT BIOMED, V47, P68, DOI 10.1016/j.jpba.2007.12.011; Ambrosone CB, 2007, ARCH BIOCHEM BIOPHYS, V464, P169, DOI 10.1016/j.abb.2007.05.018; Baan R, 2008, LANCET ONCOL, V9, P322, DOI 10.1016/S1470-2045(08)70089-5; Bratten T, 2004, INT J CANCER, V110, P579, DOI 10.1002/ijc.20141; Clausen T S-JA, 2006, ULLMANNS ENCY IND CH, P1, DOI [10.1002/14356007.a12_571pub2, DOI 10.1002/14356007.A12_571PUB2]; Cook LS, 1999, CANCER CAUSE CONTROL, V10, P551, DOI 10.1023/A:1008903126798; Dinger J, 2011, CONTRACEPTION, V83, P211, DOI 10.1016/j.contraception.2010.11.009; European Commission, HLTH CONS HAIR DYE P; Green A, 1987, JNCI, V79; Hamblen EL, 2003, CHEMOSPHERE, V52, P1173, DOI 10.1016/S0045-6535(03)00333-3; IARC working group on the evaluation of carcinogenic risks to humans Organisation mondiale de la sante Centre international de recherche sur le cancer, 2008, SOM AR AM ORG DYES R; KOENIG KL, 1991, AM J EPIDEMIOL, V133, P985, DOI 10.1093/oxfordjournals.aje.a115818; Mendelsohn JB, 2009, CANCER SCI, V100, P1088, DOI 10.1111/j.1349-7006.2009.01149.x; NASCA PC, 1980, J NATL CANCER I, V64, P23; National Cancer Insitute at the National Institutes of Health, HAIR DYES CANC RISK; Orsini N, 2008, STATA J, V8, P29, DOI 10.1177/1536867X0800800103; Petro-Nustas W, 2002, J NURS SCHOLARSHIP, V34, P19, DOI 10.1111/j.1547-5069.2002.00019.x; Pukkala E, 2009, ACTA ONCOL, V48, P646, DOI 10.1080/02841860902913546; Rothman KJ, MODERN EPIDEMIOLOGY, P62; SHORE RE, 1979, J NATL CANCER I, V62, P277; Statistics Finland, 2009, OFF STAT FINL OSF PO; Statistics Finland, OFF STAT FINL OSF ED; Takkouche B, 2005, JAMA-J AM MED ASSOC, V293, P2516, DOI 10.1001/jama.293.20.2516; TEPPO L, 1994, ACTA ONCOL, V33, P365, DOI 10.3109/02841869409098430; Turesky RJ, 2003, CHEM RES TOXICOL, V16, P1162, DOI 10.1021/tx030029r; U.S. Food and Drug Administration, GUID IND COL ADD PET; Zanoni TB, 2014, TOXICOL LETT, V227, P139, DOI 10.1016/j.toxlet.2014.03.007; Zheng T, 2002, EUR J CANCER, V38, P1647, DOI 10.1016/S0959-8049(02)00138-7	29	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135190	10.1371/journal.pone.0135190	http://dx.doi.org/10.1371/journal.pone.0135190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263013	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300066
J	Tack, JD; Fedy, BC				Tack, Jason D.; Fedy, Bradley C.			Landscapes for Energy and Wildlife: Conservation Prioritization for Golden Eagles across Large Spatial Scales	PLOS ONE			English	Article							GREATER SAGE-GROUSE; WINTER HABITAT SELECTION; WIND ENERGY; AQUILA-CHRYSAETOS; AVAILABILITY; RAPTORS; IMPACTS; FARMS; OCCUPANCY; MORTALITY	Proactive conservation planning for species requires the identification of important spatial attributes across ecologically relevant scales in a model-based framework. However, it is often difficult to develop predictive models, as the explanatory data required for model development across regional management scales is rarely available. Golden eagles are a large-ranging predator of conservation concern in the United States that may be negatively affected by wind energy development. Thus, identifying landscapes least likely to pose conflict between eagles and wind development via shared space prior to development will be critical for conserving populations in the face of imposing development. We used publically available data on golden eagle nests to generate predictive models of golden eagle nesting sites in Wyoming, USA, using a suite of environmental and anthropogenic variables. By overlaying predictive models of golden eagle nesting habitat with wind energy resource maps, we highlight areas of potential conflict among eagle nesting habitat and wind development. However, our results suggest that wind potential and the relative probability of golden eagle nesting are not necessarily spatially correlated. Indeed, the majority of our sample frame includes areas with disparate predictions between suitable nesting habitat and potential for developing wind energy resources. Map predictions cannot replace on-the-ground monitoring for potential risk of wind turbines on wildlife populations, though they provide industry and managers a useful framework to first assess potential development.	[Tack, Jason D.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Tack, Jason D.; Fedy, Bradley C.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Fedy, Bradley C.] Univ Waterloo, Dept Environm & Resource Studies, Waterloo, ON N2L 3G1, Canada	Colorado State University; United States Department of the Interior; United States Geological Survey; University of Waterloo	Tack, JD (corresponding author), Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA.	Jason.Tack@colostate.edu	Fedy, Bradley C/A-6017-2015	Fedy, Bradley/0000-0003-3933-4043	National Fish and Wildlife Foundation	National Fish and Wildlife Foundation	The authors are grateful to the National Fish and Wildlife Foundation for providing funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; Bayne EM, 2008, CONSERV BIOL, V22, P1186, DOI 10.1111/j.1523-1739.2008.00973.x; BEECHAM JJ, 1975, WILSON BULL, V87, P506; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Bergquist E, 2007, ENVIRON MONIT ASSESS, V128, P381, DOI 10.1007/s10661-006-9321-7; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 2011, ENERGY DEV WILDLIFE, pix; Bright J, 2008, BIOL CONSERV, V141, P2342, DOI 10.1016/j.biocon.2008.06.029; Campagna C, 2011, BIOSCIENCE, V61, P393, DOI 10.1525/bio.2011.61.5.8; Carrete M, 2005, OIKOS, V108, P125, DOI 10.1111/j.0030-1299.2005.12942.x; Carrete M, 2012, BIOL CONSERV, V145, P102, DOI 10.1016/j.biocon.2011.10.017; Cooperation CfE, 2009, EC REG N AM; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Craig T.H., 1984, Raptor Research, V18, P20; de Lucas M, 2008, J APPL ECOL, V45, P1695, DOI 10.1111/j.1365-2664.2008.01549.x; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Fargione J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041468; Fedy BC, 2011, OECOLOGIA, V165, P915, DOI 10.1007/s00442-010-1768-0; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Fielding AH, 2006, BIOL CONSERV, V131, P359, DOI 10.1016/j.biocon.2006.02.011; Fleishman E, 2011, BIOSCIENCE, V61, P290, DOI 10.1525/bio.2011.61.4.9; Garvin JC, 2011, J APPL ECOL, V48, P199, DOI 10.1111/j.1365-2664.2010.01912.x; Gruenspecht H, 2010, INT ENERGY OUTLOOK 2; Hebblewhite M, 2011, BIOL CONSERV, V144, P2403, DOI 10.1016/j.biocon.2011.03.020; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Homer CG, 2012, INT J APPL EARTH OBS, V14, P233, DOI 10.1016/j.jag.2011.09.012; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Hotker H., 2006, IMPACTS BIODIVERSITY; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Jones NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081391; Kiesecker JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017566; Kochert M. N., 2002, GOLDEN EAGLE AQUILA; MACLAREN PA, 1988, GREAT BASIN NAT, V48, P548; Martin J, 2009, BIOL CONSERV, V142, P2726, DOI 10.1016/j.biocon.2009.06.027; Marzluff JM, 1997, AUK, V114, P673, DOI 10.2307/4089287; MCGAHAN J, 1968, AUK, V85, P1; McIntyre CL, 2006, AUK, V123, P877, DOI 10.1642/0004-8038(2006)123[877:PDPOMG]2.0.CO;2; MERRILL EH, 1996, WYOMING GAP ANAL PRO; MORNEAU F, 1994, J RAPTOR RES, V28, P220; Neal MC, 2007, THESIS U WYOMING LAR; Northrup JM, 2013, ECOLOGY; Nygard T, 2010, BOU P CLIMATE CHANGE; Obermeyer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026698; Odden J, 2008, J WILDLIFE MANAGE, V72, P276, DOI 10.2193/2005-537; OLENDORFF RR, 1976, AM MIDL NAT, V95, P231, DOI 10.2307/2424254; Pagel JE, 2013, J RAPTOR RES, V47, P311, DOI 10.3356/JRR-12-00019.1; PHILLIPS RL, 1984, WILDLIFE SOC B, V12, P269; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Postupalsky S, 1974, MANAGEMENT RAPTORS, V2, P21; Pruett CL, 2009, BIOSCIENCE, V59, P257, DOI 10.1525/bio.2009.59.3.10; Reese KP, 2007, MONITORING POPULATIO, V88; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Theobald DM, 2011, ECOL APPL, V21, P2445, DOI 10.1890/10-1701.1; THOMPSON SK, 2002, SAMPLING; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Watson J., 2010, GOLDEN EAGLE, V2; Whitfield DP, 2004, BIOL CONSERV, V119, P319, DOI 10.1016/j.biocon.2003.11.015; WIENS JA, 1987, OIKOS, V48, P132, DOI 10.2307/3565849	63	17	17	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134781	10.1371/journal.pone.0134781	http://dx.doi.org/10.1371/journal.pone.0134781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262876	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300041
J	Li, J; Hettenhausen, C; Sun, GL; Zhuang, HF; Li, JH; Wu, JQ				Li, Juan; Hettenhausen, Christian; Sun, Guiling; Zhuang, Huifu; Li, Jian-Hong; Wu, Jianqiang			The Parasitic Plant Cuscuta australis Is Highly Insensitive to Abscisic Acid-Induced Suppression of Hypocotyl Elongation and Seed Germination	PLOS ONE			English	Article							MESSENGER-RNA; BIOSYNTHESIS; PERCEPTION; RESISTANCE; DISTANCE; DROUGHT; STOMATA; SIGNAL; ABA	Around 1% of angiosperms are parasitic plants. Their growth and development solely or partly depend on host plants from which they extract water, nutrients, and other molecules using a parasitic plant-specific organ, the haustorium. Strong depletion of nutrients can result in serious growth retardation and in some cases, death of the hosts. The genus Cuscuta (dodder) comprises about 200 holoparasitic species occurring on all continents. Their seedlings have no roots and cotyledons but are only string-like hypocotyls. When they contact suitable host plants, haustoria are formed and thereafter seedlings rapidly develop into vigorously growing branches without roots and leaves. This highly specialized lifestyle suggests that Cuscuta plants likely have unique physiology in development and stress responses. Using germination and seedling growth assays, we show that C. australis seeds and seedlings are highly insensitive to abscisic acid (ABA). Transcriptome analysis and protein sequence alignment with Arabidopsis, tomato, and rice homologs revealed that C. australis most likely consists of only four functional ABA receptors. Given that Cuscuta plants are no longer severely challenged by drought stress, we hypothesize that the ABA-mediated drought resistance pathway in Cuscuta spp. might have had degenerated over time during evolution.	[Li, Juan; Li, Jian-Hong] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hunan, Peoples R China; [Li, Juan; Hettenhausen, Christian; Sun, Guiling; Zhuang, Huifu; Wu, Jianqiang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming, Yunnan, Peoples R China; [Wu, Jianqiang] Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Wild Plant Resources, Kunming, Yunnan, Peoples R China	Huazhong Agricultural University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Li, JH (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hunan, Peoples R China.	jianhl@mail.hzau.edu.cn; wujianqiang@mail.kib.ac.cn	Wu, Jianqiang/A-7169-2019	Wu, Jianqiang/0000-0002-7726-6216	Yunnan Recruitment Program of Experts in Sciences from Yunnan Provincial Science and Technology Department [2012HA016]; Natural Science Foundation of China [31301037]	Yunnan Recruitment Program of Experts in Sciences from Yunnan Provincial Science and Technology Department; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by a grant from the Yunnan Recruitment Program of Experts in Sciences (No. 2012HA016) from the Yunnan Provincial Science and Technology Department, a grant from the Natural Science Foundation of China (No. 31301037), and a grant for the Max Planck Partner Group Program.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Alakonya A, 2012, PLANT CELL, V24, P3153, DOI 10.1105/tpc.112.099994; Aly R, 2012, WEED SCI, V60, P290, DOI 10.1614/WS-D-11-00066.1; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; Christmann A, 2006, PLANT BIOLOGY, V8, P314, DOI 10.1055/s-2006-924120; David-Schwartz R, 2008, NEW PHYTOL, V179, P1133, DOI 10.1111/j.1469-8137.2008.02540.x; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; Finkelstein RR, 2006, PLANT CELL, V18, P786, DOI 10.1105/tpc.106.041129; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Gonzalez-Guzman M, 2014, J EXP BOT, V65, P4451, DOI 10.1093/jxb/eru219; Haupt S, 2001, J EXP BOT, V52, P173, DOI 10.1093/jexbot/52.354.173; He Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095246; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kim G, 2014, SCIENCE, V345, P808, DOI 10.1126/science.1253122; Li WQ, 2013, CELL RES, V23, P1369, DOI 10.1038/cr.2013.143; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Okamoto M, 2009, PLANT PHYSIOL, V149, P825, DOI 10.1104/pp.108.130823; Parent B, 2009, PLANT PHYSIOL, V149, P2000, DOI 10.1104/pp.108.130682; Qin XQ, 2008, PLANT PHYSIOL, V147, P816, DOI 10.1104/pp.108.116749; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Ranjan A, 2014, PLANT PHYSIOL, V166, P1186, DOI 10.1104/pp.113.234864; Roney JK, 2007, PLANT PHYSIOL, V143, P1037, DOI 10.1104/pp.106.088369; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Varrelman F A, 1937, Science, V85, P101, DOI 10.1126/science.85.2195.101-b; Westwood JH, 2010, TRENDS PLANT SCI, V15, P227, DOI 10.1016/j.tplants.2010.01.004; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Yu H, 2011, BIOL INVASIONS, V13, P747, DOI 10.1007/s10530-010-9865-x; Zhang X, 2001, CELL RES, V11, P195, DOI 10.1038/sj.cr.7290086; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	31	15	15	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135197	10.1371/journal.pone.0135197	http://dx.doi.org/10.1371/journal.pone.0135197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258814	gold, Green Published, Green Submitted			2022-12-27	WOS:000359352600046
J	Artz, DR; Pitts-Singer, TL				Artz, Derek R.; Pitts-Singer, Theresa L.			Effects of Fungicide and Adjuvant Sprays on Nesting Behavior in Two Managed Solitary Bees, Osmia lignaria and Megachile rotundata	PLOS ONE			English	Article							APIDAE COLONY HEALTH; APIS-MELLIFERA L; HONEY-BEE; NEONICOTINOID INSECTICIDES; HYMENOPTERA APIDAE; PESTICIDE EXPOSURE; RISK-ASSESSMENT; OLFACTORY CUES; BUMBLE BEES; POLLINATORS	There is a growing body of empirical evidence showing that wild and managed bees are negatively impacted by various pesticides that are applied in agroecosystems around the world. The lethal and sublethal effects of two widely used fungicides and one adjuvant were assessed in cage studies in California on blue orchard bees, Osmia lignaria, and in cage studies in Utah on alfalfa leafcutting bees, Megachile rotundata. The fungicides tested were Rovral 4F (iprodione) and Pristine (mixture of pyraclostrobin + boscalid), and the adjuvant tested was N-90, a non-ionic wetting agent (90% polyethoxylated nonylphenol) added to certain tank mixtures of fungicides to improve the distribution and contact of sprays to plants. In separate trials, we erected screened cages and released 20 paint-marked females plus 30-50 males per cage to document the behavior of nesting bees under treated and control conditions. For all females in each cage, we recorded pollen-collecting trip times, nest substrate-collecting trip times (i.e., mud for O. lignaria and cut leaf pieces for M. rotundata), cell production rate, and the number of attempts each female made to enter her own or to enter other nest entrances upon returning from a foraging trip. No lethal effects of treatments were observed on adults, nor were there effects on time spent foraging for pollen and nest substrates and on cell production rate. However, Rovral 4F, Pristine, and N-90 disrupted the nest recognition abilities of O. lignaria females. Pristine, N-90, and Pristine + N-90 disrupted nest recognition ability of M. rotundata females. Electroantennogram responses of antennae of O. lignaria females maintained in the laboratory did not differ significantly between the fungicide-exposed and control bees. Our results provide the first empirical evidence that two commonly used fungicides and a non-ionic adjuvant can disrupt nest recognition in two managed solitary bee species.	[Artz, Derek R.; Pitts-Singer, Theresa L.] ARS, USDA, Pollinating Insect Res Unit, Logan, UT 84341 USA	United States Department of Agriculture (USDA)	Artz, DR (corresponding author), ARS, USDA, Pollinating Insect Res Unit, Logan, UT 84341 USA.	Derek.Artz@ars.usda.gov		Artz, Derek/0000-0003-2082-4974	ARS [ARS-0425663] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		Abbott VA, 2008, J ECON ENTOMOL, V101, P784, DOI 10.1603/0022-0493(2008)101[784:LASEOI]2.0.CO;2; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Alston DG, 2007, ENVIRON ENTOMOL, V36, P811, DOI 10.1603/0046-225X(2007)36[811:EOTIPO]2.0.CO;2; Arena M, 2014, ECOTOXICOLOGY, V23, P324, DOI 10.1007/s10646-014-1190-1; Avenot H, 2008, PLANT PATHOL, V57, P135, DOI 10.1111/j.1365-3059.2007.01701.x; Bartlett DW, 2002, PEST MANAG SCI, V58, P649, DOI 10.1002/ps.520; Bernauer OM, 2015, INSECTS, V6, P478, DOI 10.3390/insects6020478; Biddinger DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072587; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bosch J, 1999, BEE WORLD, V80, P163, DOI 10.1080/0005772X.1999.11099452; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Bosch Jordi, 2008, P83; Brittain C, 2011, BASIC APPL ECOL, V12, P321, DOI 10.1016/j.baae.2010.12.004; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chagnon M, 2015, ENVIRON SCI POLLUT R, V22, P119, DOI 10.1007/s11356-014-3277-x; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Ciarlo TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040848; COLIN ME, 1992, PESTIC SCI, V36, P115, DOI 10.1002/ps.2780360206; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Devillers J, 2003, SAR QSAR ENVIRON RES, V14, P389, DOI 10.1080/10629360310001623980; Fauria K, 1998, J INSECT BEHAV, V11, P649, DOI 10.1023/A:1022394708973; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Fungicide Resistance Action Committee, 2014, FRAC COD LIST 2014; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gill RJ, 2014, FUNCT ECOL, V28, P1459, DOI 10.1111/1365-2435.12292; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Guedot C, 2006, PHYSIOL ENTOMOL, V31, P110, DOI 10.1111/j.1365-3032.2005.00490.x; Guedot C, 2013, ENVIRON ENTOMOL, V42, P779, DOI 10.1603/EN13015; HEFETZ A, 1992, J INSECT BEHAV, V5, P763, DOI 10.1007/BF01047985; HEFETZ A, 1990, ENTOMOL GEN, V15, P103; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Huntzinger CI, 2008, J ECON ENTOMOL, V101, P1088, DOI 10.1603/0022-0493(2008)101[1088:FTOAAL]2.0.CO;2; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Kevan P. G., 1990, American Journal of Alternative Agriculture, V5, P13, DOI 10.1017/S0889189300003179; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Ladurner E, 2008, J ECON ENTOMOL, V101, P647, DOI 10.1603/0022-0493(2008)101[647:FANBOO]2.0.CO;2; Ladurner E, 2005, APIDOLOGIE, V36, P449, DOI 10.1051/apido:2005032; Laycock I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079872; Lu CS, 2014, B INSECTOL, V67, P125; Matsumoto T, 2013, B INSECTOL, V66, P1; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Morandin LA, 2003, ENVIRON ENTOMOL, V32, P555, DOI 10.1603/0046-225X-32.3.555; Noon R., 2004, NEW DEV FUNGICIDES; Peterson SS, 2014, MASS PRODUCTION BENE; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pitts-Singer TL, 2011, ANNU REV ENTOMOL, V56, P221, DOI 10.1146/annurev-ento-120709-144836; Roberts T. R., 1999, METABOLIC PATHWAYS A; Rogers SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097307; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Sandrock C, 2014, AGR FOREST ENTOMOL, V16, P119, DOI 10.1111/afe.12041; Scheper J, 2014, P NATL ACAD SCI USA, V111, P17552, DOI 10.1073/pnas.1412973111; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Scott-Dupree CD, 2009, J ECON ENTOMOL, V102, P177, DOI 10.1603/029.102.0125; Simon-Delso N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103073; STEINMANN E, 1973, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V46, P119; Tasei JN, 2002, HONEY BEES: ESTIMATING THE ENVIRONMENTAL IMPACT OF CHEMICALS, P101, DOI 10.1201/9780203218655.ch7; Thompson Helen, 2003, Bulletin of Insectology, V56, P131; Thompson HM, 2003, ECOTOXICOLOGY, V12, P317, DOI 10.1023/A:1022575315413; Thompson HM, 2001, APIDOLOGIE, V32, P305, DOI 10.1051/apido:2001131; TORCHIO P F, 1976, Journal of the Kansas Entomological Society, V49, P475; Tylianakis JM, 2013, SCIENCE, V339, P1532, DOI 10.1126/science.1235464; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; VANDAME R, 1995, ENVIRON TOXICOL CHEM, V14, P855, DOI 10.1002/etc.5620140517; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; WCISLO WT, 1992, ETHOLOGY, V92, P108, DOI 10.1111/j.1439-0310.1992.tb00952.x; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Yang Chia-Anne, 2010, Int J Alzheimers Dis, V2011, P607861, DOI 10.4061/2011/607861; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Yoder JA, 2013, J TOXICOL ENV HEAL A, V76, P587, DOI 10.1080/15287394.2013.798846; Zhang CQ, 2007, PLANT PATHOL, V56, P646, DOI 10.1111/j.1365-3059.2007.01611.x	79	54	55	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135688	10.1371/journal.pone.0135688	http://dx.doi.org/10.1371/journal.pone.0135688			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274401	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600094
J	Kempf, H; Bleicher, M; Meyer-Hermann, M				Kempf, Harald; Bleicher, Marcus; Meyer-Hermann, Michael			Spatio-Temporal Dynamics of Hypoxia during Radiotherapy	PLOS ONE			English	Article							MULTICELLULAR TUMOR SPHEROIDS; OXYGEN ENHANCEMENT RATIO; SOLID TUMORS; IN-VIVO; RADIATION-THERAPY; CYCLING HYPOXIA; 3 DIMENSIONS; CELLS; MODEL; GROWTH	Tumour hypoxia plays a pivotal role in cancer therapy for most therapeutic approaches from radiotherapy to immunotherapy. The detailed and accurate knowledge of the oxygen distribution in a tumour is necessary in order to determine the right treatment strategy. Still, due to the limited spatial and temporal resolution of imaging methods as well as lacking fundamental understanding of internal oxygenation dynamics in tumours, the precise oxygen distribution map is rarely available for treatment planing. We employ an agent-based in silico tumour spheroid model in order to study the complex, localized and fast oxygen dynamics in tumour micro-regions which are induced by radiotherapy. A lattice-free, 3D, agent-based approach for cell representation is coupled with a high-resolution diffusion solver that includes a tissue density-dependent diffusion coefficient. This allows us to assess the space-and time-resolved reoxygenation response of a small subvolume of tumour tissue in response to radiotherapy. In response to irradiation the tumour nodule exhibits characteristic reoxygenation and re-depletion dynamics which we resolve with high spatio-temporal resolution. The reoxygenation follows specific timings, which should be respected in treatment in order to maximise the use of the oxygen enhancement effects. Oxygen dynamics within the tumour create windows of opportunity for the use of adjuvant chemotherapeutica and hypoxia-activated drugs. Overall, we show that by using modelling it is possible to follow the oxygenation dynamics beyond common resolution limits and predict beneficial strategies for therapy and in vitro verification. Models of cell cycle and oxygen dynamics in tumours should in the future be combined with imaging techniques, to allow for a systematic experimental study of possible improved schedules and to ultimately extend the reach of oxygenation monitoring available in clinical treatment.	[Kempf, Harald; Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Dept Syst Immunol, Braunschweig, Germany; [Kempf, Harald; Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Braunschweig Integrated Ctr Syst Biol, Braunschweig, Germany; [Kempf, Harald; Bleicher, Marcus] Frankfurt Inst Adv Studies, Frankfurt, Germany; [Meyer-Hermann, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Meyer-Hermann, M (corresponding author), Helmholtz Ctr Infect Res, Dept Syst Immunol, Braunschweig, Germany.	michael.meyer-hermann@theoretical-biology.de	Bleicher, Marcus J./A-2758-2010		Human Frontier Science Program [RGP0017/2011]; German Federal Ministry of Education and Research within the GerontoSys initiative (BMBF GerontoSys project GerontoShield) [FKZ 0315890A]; German Federal Ministry of Education and Research within the Measures for the Establishment of Systems Medicine, project SYSIMIT (BMBF eMed project SYSIMIT) [FKZ: 01ZX1308B]; German Federal Ministry of Education and Research within the Measures for the Establishment of Systems Medicine, project SysStomach (BMBF eMed project SysStomach) [FKZ: 01ZX1310C]; Helmholtz Association cross-program activity Metabolic Dysfunction and Human Disease; Helmholtz Initiative on Personalized Medicine (iMed)	Human Frontier Science Program(Human Frontier Science Program); German Federal Ministry of Education and Research within the GerontoSys initiative (BMBF GerontoSys project GerontoShield); German Federal Ministry of Education and Research within the Measures for the Establishment of Systems Medicine, project SYSIMIT (BMBF eMed project SYSIMIT); German Federal Ministry of Education and Research within the Measures for the Establishment of Systems Medicine, project SysStomach (BMBF eMed project SysStomach); Helmholtz Association cross-program activity Metabolic Dysfunction and Human Disease; Helmholtz Initiative on Personalized Medicine (iMed)	This work was supported by the Human Frontier Science Program (RGP0017/2011), by the German Federal Ministry of Education and Research within the GerontoSys initiative (BMBF GerontoSys project GerontoShield, FKZ 0315890A), within the Measures for the Establishment of Systems Medicine, projects SYSIMIT (BMBF eMed project SYSIMIT, FKZ: 01ZX1308B) and SysStomach (BMBF eMed project SysStomach, FKZ: 01ZX1310C), the Helmholtz Association cross-program activity Metabolic Dysfunction and Human Disease, and the Helmholtz Initiative on Personalized Medicine (iMed). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2004, PROG BIOPHYS MOL BIO, V85, P451, DOI 10.1016/j.pbiomolbio.2004.02.004; ALPER T, 1956, NATURE, V178, P978, DOI 10.1038/178978a0; Angus SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114098; Ansari N, 2012, METHOD CELL BIOL, V113, P295, DOI 10.1016/B978-0-12-407239-8.00013-6; AWWAD HK, 1986, INT J RADIAT ONCOL, V12, P1329, DOI 10.1016/0360-3016(86)90165-3; Bache M, 2008, CURR MED CHEM, V15, P322, DOI 10.2174/092986708783497391; Badeer HS, 2001, ADV PHYSIOL EDUC, V25, P44, DOI 10.1152/advances.2001.25.1.44; Bayer C, 2011, INT J RADIAT ONCOL, V80, P965, DOI 10.1016/j.ijrobp.2011.02.049; Bennewith KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-504; Bentzen SM, 2005, LANCET ONCOL, V6, P112, DOI 10.1016/S1470-2045(05)01737-7; Beyer T, 2005, COMPUT PHYS COMMUN, V172, P86, DOI 10.1016/j.cpc.2005.06.009; Beyer T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021929; Brown JM, 1998, CANCER RES, V58, P1408; Buffa FM, 2001, INT J RADIAT ONCOL, V49, P1109, DOI 10.1016/S0360-3016(00)01533-9; Busk M, 2008, ACTA ONCOL, V47, P1201, DOI 10.1080/02841860802307716; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; Carlin S, 2012, J NUCL MED, V53, P1171, DOI 10.2967/jnumed.111.099770; Carlson DJ, 2011, INT J RADIAT ONCOL, V79, P1188, DOI 10.1016/j.ijrobp.2010.10.007; CASCIARI JJ, 1988, CANCER RES, V48, P3905; Chu YS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028102; Cotran RS, 1999, ROBBINS PATHOLOGY SE; Dasu A, 2003, PHYS MED BIOL, V48, P2829, DOI 10.1088/0031-9155/48/17/307; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dionysiou DD, 2004, J THEOR BIOL, V230, P1, DOI 10.1016/j.jtbi.2004.03.024; Fenton BM, 2001, RADIAT RES, V155, P360, DOI 10.1667/0033-7587(2001)155[0360:EOROTI]2.0.CO;2; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; FREYER JP, 1985, J CELL PHYSIOL, V124, P516, DOI 10.1002/jcp.1041240323; Gregoire V, 2007, J NUCL MED, V48, p68S; GROTE J, 1977, PFLUG ARCH EUR J PHY, V372, P37, DOI 10.1007/BF00582204; Hall E.J, 2006, RADIOBIOLOGY RADIOLO, V6, P576; Harada H, 2011, J RADIAT RES, V52, P545, DOI 10.1269/jrr.11056; Harriss W, 2010, AUSTRALAS PHYS ENG S, V33, P251, DOI 10.1007/s13246-010-0032-6; Hatzikirou H, 2015, CANCER THERAPEUTIC P, P1; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Hill AV, 1928, P R SOC LOND B-CONTA, V109, P39; Horing E, 2012, ACTA NEUROPATHOL, V124, P83, DOI 10.1007/s00401-011-0940-x; Horsman MR, 2012, NAT REV CLIN ONCOL, V9, P674, DOI 10.1038/nrclinonc.2012.171; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Kallinowski F, 1989, J CELL PHYSL, V191, P138, DOI DOI 10.1002/JCP.1041380124; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Kelada OJ, 2014, RADIAT RES, V181, P335, DOI 10.1667/RR13590.1; Kempf H, 2010, EUR PHYS J D, V60, P177, DOI 10.1140/epjd/e2010-00178-4; Kempf H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003295; KIM IH, 1994, INT J RADIAT ONCOL, V29, P493, DOI 10.1016/0360-3016(94)90444-8; Krause BJ, 2006, Q J NUCL MED MOL IM, V50, P28; Leschner S, 2010, J MOL MED, V88, P763, DOI 10.1007/s00109-010-0636-z; Lin A, 2012, SEMIN NUCL MED, V42, P343, DOI 10.1053/j.semnuclmed.2012.04.002; Alfonso JCL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089380; Lyng H, 1997, RADIOTHER ONCOL, V44, P163, DOI 10.1016/S0167-8140(97)01920-8; Masunaga SI, 2008, RADIAT MED, V26, P270, DOI 10.1007/s11604-008-0227-x; MASUNAGA SI, 1991, RADIAT RES, V125, P243, DOI 10.2307/3578105; Matsumoto S, 2010, CANCER RES, V70, P10019, DOI 10.1158/0008-5472.CAN-10-2821; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Pampaloni F, 2013, CELL TISSUE RES, V352, P161, DOI 10.1007/s00441-013-1589-7; Powathil G, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/410602; Powathil GG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003120; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; Primeau AJ, 2005, CLIN CANCER RES, V11, P8782, DOI 10.1158/1078-0432.CCR-05-1664; Ryan RM, 2009, GENE THER, V16, P329, DOI 10.1038/gt.2008.188; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Schaller G, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051910; Schaller G, 2004, COMPUT PHYS COMMUN, V162, P9, DOI 10.1016/j.cpc.2004.06.066; Scifoni E, 2013, PHYS MED BIOL, V58, P3871, DOI 10.1088/0031-9155/58/11/3871; SINCLAIR WK, 1968, RADIAT RES, V33, P620, DOI 10.2307/3572419; Staab A, 2004, RADIAT RES, V161, P219, DOI 10.1667/RR3113; Stein W., 1990, CHANNELS CARRIERS PU; Thorwarth D, 2010, RADIOTHER ONCOL, V97, P172, DOI 10.1016/j.radonc.2010.05.012; Titz B, 2008, PHYS MED BIOL, V53, P4471, DOI 10.1088/0031-9155/53/17/001; Toma-Dasu I, 2004, PHYS MED BIOL, V49, P4463, DOI 10.1088/0031-9155/49/19/002; Toma-Dasu I, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/141087; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; VAUPEL P, 1989, CANCER RES, V49, P6449; Verwer EE, 2014, WORLD J CLIN ONCOL, V5, P824, DOI 10.5306/wjco.v5.i5.824; Wehrle JP, 2000, NMR BIOMED, V13, P349, DOI 10.1002/1099-1492(200010)13:6<349::AID-NBM652>3.0.CO;2-X; Wenzl T, 2011, PHYS MED BIOL, V56, P3251, DOI 10.1088/0031-9155/56/11/006; YAES RJ, 1991, INT J RADIAT ONCOL, V20, P1353, DOI 10.1016/0360-3016(91)90249-4; Yahiro T, 2005, J RADIAT RES, V46, P363, DOI 10.1269/jrr.46.363; Yasui H, 2010, CANCER RES, V70, P6427, DOI 10.1158/0008-5472.CAN-10-1350; Zacharaki EI, 2004, COMPUT METH PROG BIO, V76, P193, DOI 10.1016/j.cmpb.2004.07.003; Zheng XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6834	84	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133357	10.1371/journal.pone.0133357	http://dx.doi.org/10.1371/journal.pone.0133357			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26273841	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600012
J	Gennaro, G; Claudino, M; Cestari, TM; Ceolin, D; Germino, P; Garlet, GP; de Assis, GF				Gennaro, Gabriela; Claudino, Marcela; Cestari, Tania Mary; Ceolin, Daniele; Germino, Patricia; Garlet, Gustavo Pompermaier; de Assis, Gerson Francisco			Green Tea Modulates Cytokine Expression in the Periodontium and Attenuates Alveolar Bone Resorption in Type 1 Diabetic Rats	PLOS ONE			English	Article							NF-KAPPA-B; EPIGALLOCATECHIN-GALLATE; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; GENE-EXPRESSION; DISEASE; OSTEOBLAST; MICE; (-)-EPIGALLOCATECHIN-3-GALLATE; LIPOPOLYSACCHARIDE; INTERLEUKIN-1-BETA	Diabetes mellitus comprises a heterogeneous group of disorders with the main feature of hyperglycemia. Chronic hyperglycemia increases the severity of periodontal disease via an exacerbated inflammatory response, activated by advanced glycation end products and their receptor, RAGE. Therefore, anti-inflammatory agents represent potential inhibitors of this pathological interaction. In particular, green tea has been shown to possess anti-inflammatory properties mediated by its polyphenol content. Objectives: This study investigated the mechanisms by which green tea attenuates the spontaneous onset of diabetes-induced periodontitis. Methods: Diabetes was induced in rats via a single intraperitoneal injection of streptozotocin (STZ). Diabetic and control animals were divided into water-treated and green tea-treated subgroups and were analyzed at 15, 30, 60 and 90 days after diabetes induction. Immunohistochemistry was performed to quantitatively evaluate tumor necrosis factor-alpha (TNF-alpha), receptor activator of nuclear factor kappa-B ligand (RANKL), osteoprotegerin (OPG), interleukin-10 (IL-10) and runt-related transcription factor 2 (RUNX-2) expression in serial sections of each hemimaxilla. Morphometric measurements of the distance from the cementum-enamel junction (CEJ) of the superior distal root of the first molar to the alveolar bone crest (ABC) were performed to assess bone loss. Results: Diabetes resulted in significant bone loss and alterations in the number of cells that stained positive for inflammatory mediators. In the diabetic rats treated with green tea, we observed a decreased number of cells expressing RANKL and TNF-alpha compared with that observed in the diabetic rats treated with water. Additionally, green tea increased the numbers of cells that stained positive for OPG, RUNX-2 and IL-10 in the diabetic rats. Conclusion: Green tea intake reduces expression of the pro-inflammatory cytokine TNF-alpha and the osteoclastogenic mediator RANKL to normal levels while increasing expression of the anti-inflammatory cytokine IL-10, the osteogenesis-related factor RUNX-2 and the anti-osteoclastogenic factor OPG. Therefore, green tea represents a potential therapeutic agent for the treatment of diabetesrelated periodontal disease.	[Gennaro, Gabriela; Claudino, Marcela; Cestari, Tania Mary; Ceolin, Daniele; Germino, Patricia; Garlet, Gustavo Pompermaier; de Assis, Gerson Francisco] Univ Sao Paulo, Sch Dent Bauru, Dept Biol Sci, Sao Paulo, Brazil	Universidade de Sao Paulo	Gennaro, G (corresponding author), Univ Sao Paulo, Sch Dent Bauru, Dept Biol Sci, Div Histol, Sao Paulo, Brazil.	gabigennaro@hotmail.com	Assis, Gerson Francisco/E-5871-2012; Garlet, Gustavo Pompermaier/E-6762-2012; Cestari, Tania Mary/E-7060-2012	Assis, Gerson Francisco/0000-0001-8225-3164; Garlet, Gustavo Pompermaier/0000-0002-5071-8382; Cestari, Tania Mary/0000-0003-1287-5974; Gronthos, Stan/0000-0002-6225-3084	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berletch JB, 2008, J CELL BIOCHEM, V103, P509, DOI 10.1002/jcb.21417; Braga SMG, 2011, EUR J ORAL SCI, V119, P7, DOI 10.1111/j.1600-0722.2010.00793.x; Chen CH, 2005, OSTEOPOROSIS INT, V16, P2039, DOI 10.1007/s00198-005-1995-0; Claudino M, 2012, EXP DIABETES RES, DOI 10.1155/2012/356841; Claudino M, 2010, EUR J ORAL SCI, V118, P19, DOI 10.1111/j.1600-0722.2009.00706.x; Claudino M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001320; Daroux M, 2010, DIABETES METAB, V36, P1, DOI 10.1016/j.diabet.2009.06.005; Dona M, 2003, J IMMUNOL, V170, P4335, DOI 10.4049/jimmunol.170.8.4335; Ebersole JL, 2008, J PERIODONTOL, V79, P637, DOI 10.1902/jop.2008.070455 ; Engebretson SP, 2004, J PERIODONTOL, V75, P1203, DOI 10.1902/jop.2004.75.9.1203; Fang MZ, 2003, CANCER RES, V63, P7563; Ferreira SB, 2008, INFECT IMMUN, V76, P3725, DOI 10.1128/IAI.00546-08; Fu Z, 2011, BRIT J NUTR, V105, P1218, DOI 10.1017/S0007114510004824; Garcia-Hernandez A, 2012, BONE, V50, P276, DOI 10.1016/j.bone.2011.10.032; Garlet GP, 2006, ORAL MICROBIOL IMMUN, V21, P12, DOI 10.1111/j.1399-302X.2005.00245.x; Garlet GP, 2005, MICROBES INFECT, V7, P738, DOI 10.1016/j.micinf.2005.01.012; Garlet GP, 2004, J CLIN PERIODONTOL, V31, P671, DOI 10.1111/j.1600-051X.2004.00545.x; Golub LM, 2006, J DENT RES, V85, P102, DOI 10.1177/154405910608500201; Graves DT, 2008, FRONT BIOSCI-LANDMRK, V13, P1227, DOI 10.2741/2757; Gurav A, 2011, J DIABETES, V3, P21, DOI 10.1111/j.1753-0407.2010.00098.x; Haqqi TM, 1999, P NATL ACAD SCI USA, V96, P4524, DOI 10.1073/pnas.96.8.4524; Ishida I, 2007, J MED MICROBIOL, V56, P1042, DOI 10.1099/jmm.0.47029-0; Jagannathan M, 2010, DIABETOLOGIA, V53, P1461, DOI 10.1007/s00125-010-1730-z; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Kloting N, 2005, DIABETES-METAB RES, V21, P281, DOI 10.1002/dmrr.526; Kushiyama M, 2009, J PERIODONTOL, V80, P372, DOI 10.1902/jop.2009.080510 ; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Lee JH, 2010, MOL PHARMACOL, V77, P17, DOI 10.1124/mol.109.057877; Liu R, 2006, J DENT RES, V85, P510, DOI 10.1177/154405910608500606; LOE H, 1993, DIABETES CARE, V16, P329, DOI 10.2337/diacare.16.1.329; McKay DL, 2002, J AM COLL NUTR, V21, P1; Motyl K, 2009, BIOL PROCED ONLINE, V11, P296, DOI 10.1007/s12575-009-9000-5; Naguib G, 2004, J INVEST DERMATOL, V123, P87, DOI 10.1111/j.0022-202X.2004.22711.x; Nakagawa H, 2002, BIOCHEM BIOPH RES CO, V292, P94, DOI 10.1006/bbrc.2002.6622; Nakamura H, 2010, J PERIODONTAL RES, V45, P23, DOI 10.1111/j.1600-0765.2008.01198.x; Osada K, 2001, COMP BIOCHEM PHYS C, V128, P153, DOI 10.1016/S1532-0456(00)00192-7; Palmqvist P, 2008, J DENT RES, V87, P558, DOI 10.1177/154405910808700614; Purwata Thomas Eko, 2011, J Pain Res, V4, P169, DOI 10.2147/JPR.S21751; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Renno WM, 2008, NUTR NEUROSCI, V11, P32, DOI 10.1179/147683008X301405; Roccaro AS, 2004, ANTIMICROB AGENTS CH, V48, P1968, DOI 10.1128/AAC.48.6.1968-1973.2004; Rogers J, 2005, EXP BIOL MED, V230, P645; Salvi GE, 1998, J PERIODONTAL RES, V33, P212, DOI 10.1111/j.1600-0765.1998.tb02193.x; Shen CL, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-76; Shen CL, 2010, J NUTR BIOCHEM, V21, P968, DOI 10.1016/j.jnutbio.2009.08.002; Takai S, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/291808; Trombone AP, 2010, GENES IMMUN, V11, P479, DOI 10.1038/gene.2010.13; Venza I, 2010, J PERIODONTOL, V81, P99, DOI 10.1902/jop.2009.090358; Wong CP, 2011, IMMUNOL LETT, V139, P7, DOI 10.1016/j.imlet.2011.04.009; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yang FJ, 1998, J NUTR, V128, P2334, DOI 10.1093/jn/128.12.2334; Yun JM, 2010, BRIT J NUTR, V103, P1771, DOI 10.1017/S000711451000005X	52	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134784	10.1371/journal.pone.0134784	http://dx.doi.org/10.1371/journal.pone.0134784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270535	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492800018
J	Khan, IS; Park, CY; Mavropoulos, A; Shariat, N; Pollack, JL; Barczak, AJ; Erle, DJ; McManus, MT; Anderson, MS; Jeker, LT				Khan, Imran S.; Park, Chong Y.; Mavropoulos, Anastasia; Shariat, Nikki; Pollack, Joshua L.; Barczak, Andrea J.; Erle, David J.; McManus, Michael T.; Anderson, Mark S.; Jeker, Lukas T.			Identification of MiR-205 As a MicroRNA That Is Highly Expressed in Medullary Thymic Epithelial Cells	PLOS ONE			English	Article							PROMISCUOUS GENE-EXPRESSION; KERATINOCYTE GROWTH-FACTOR; DIFFERENTIATION PROGRAM; NEGATIVE SELECTION; AIRE CONTROLS; TOLERANCE; ABLATION; BIOGENESIS; SKIN; RECONSTITUTION	Thymic epithelial cells (TECs) support T cell development in the thymus. Cortical thymic epithelial cells (cTECs) facilitate positive selection of developing thymocytes whereas medullary thymic epithelial cells (mTECs) facilitate the deletion of self-reactive thymocytes in order to prevent autoimmunity. The mTEC compartment is highly dynamic with continuous maturation and turnover, but the genetic regulation of these processes remains poorly understood. MicroRNAs (miRNAs) are important regulators of TEC genetic programs since miRNA-deficient TECs are severely defective. However, the individual miRNAs important for TEC maintenance and function and their mechanisms of action remain unknown. Here, we demonstrate that miR-205 is highly and preferentially expressed in mTECs during both thymic ontogeny and in the postnatal thymus. This distinct expression is suggestive of functional importance for TEC biology. Genetic ablation of miR-205 in TECs, however, neither revealed a role for miR-205 in TEC function during homeostatic conditions nor during recovery from thymic stress conditions. Thus, despite its distinct expression, miR-205 on its own is largely dispensable for mTEC biology.	[Khan, Imran S.; Park, Chong Y.; Mavropoulos, Anastasia; Shariat, Nikki; McManus, Michael T.; Anderson, Mark S.; Jeker, Lukas T.] Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA; [Park, Chong Y.; Shariat, Nikki; McManus, Michael T.] Univ Calif San Francisco, WM Keck Ctr Noncoding RNAs, San Francisco, CA 94143 USA; [Mavropoulos, Anastasia; Pollack, Joshua L.; Barczak, Andrea J.; Erle, David J.; Jeker, Lukas T.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Shariat, Nikki; McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Jeker, Lukas T.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Anderson, MS (corresponding author), Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA.	manderson@diabetes.ucsf.edu; lukas.jeker@unibas.ch	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Erle, David/0000-0002-2171-0648; Jeker, Lukas/0000-0002-3359-8796; Shariat, Nikki/0000-0003-3943-4829; Khan, Imran/0000-0003-4570-4143	UCSF Program for Breakthrough Biomedical Research - Sandler Foundation, M.S.A.; Swiss Foundation for Grants in Biology and Medicine [PASMP3-124274/1]; UCSF Medical Scientist Training Program; Diabetes and Endocrinology Research Center (DERC) grant; National Institute Of Allergy And Infectious Diseases of the National Institutes of Health [AI097457, R56AI106923]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106923, R01AI097457, R56AI106923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	UCSF Program for Breakthrough Biomedical Research - Sandler Foundation, M.S.A.; Swiss Foundation for Grants in Biology and Medicine; UCSF Medical Scientist Training Program; Diabetes and Endocrinology Research Center (DERC) grant; National Institute Of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the UCSF Program for Breakthrough Biomedical Research (funded in part by the Sandler Foundation, M.S.A.), the Swiss Foundation for Grants in Biology and Medicine (PASMP3-124274/1, L. T. J), and the UCSF Medical Scientist Training Program (I. S. K). Flow Cytometry data were generated in the UCSF Parnassus Flow Cytometry Core which is supported by the Diabetes and Endocrinology Research Center (DERC) grant, NIH P30 DK063720. Microarray analysis was supported by the Sandler Asthma Basic Research (SABRE) Center Functional Genomics Core Facility. Research reported in this publication was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Numbers AI097457 to M. S. A. and R56AI106923 to L. T. J. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funding bodies.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Alpdogan O, 2006, BLOOD, V107, P2453, DOI 10.1182/blood-2005-07-2831; Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Anz D, 2009, J IMMUNOL, V182, P6044, DOI 10.4049/jimmunol.0803809; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Billard MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017940; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; de Kouchkovsky D, 2013, J IMMUNOL, V191, P1594, DOI 10.4049/jimmunol.1203567; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Dumont-Lagace M, 2014, J IMMUNOL, V192, P2219, DOI 10.4049/jimmunol.1302961; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Farmer DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076634; Fletcher AL, 2009, J IMMUNOL, V183, P823, DOI 10.4049/jimmunol.0900225; Gabler J, 2007, EUR J IMMUNOL, V37, P3363, DOI 10.1002/eji.200737131; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Goldberg GL, 2010, J IMMUNOL, V184, P6014, DOI 10.4049/jimmunol.0802445; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Hanahan D, 1998, CURR OPIN IMMUNOL, V10, P656, DOI 10.1016/S0952-7915(98)80085-X; Heng TSP, 2005, J IMMUNOL, V175, P2982, DOI 10.4049/jimmunol.175.5.2982; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jeker LT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036684; Khan IS, 2014, J EXP MED, V211, P761, DOI 10.1084/jem.20131889; Khan IS, 2014, EUR J IMMUNOL, V44, P1313, DOI 10.1002/eji.201344079; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Macedo C, 2015, IMMUNOBIOLOGY, V220, P93, DOI 10.1016/j.imbio.2014.08.015; Macedo C, 2013, IMMUNOBIOLOGY, V218, P554, DOI 10.1016/j.imbio.2012.06.013; Matsumoto M, 2011, EUR J IMMUNOL, V41, P12, DOI 10.1002/eji.201041024; Matsushima K, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-30; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Metzger TC, 2013, CELL REP, V5, P166, DOI 10.1016/j.celrep.2013.08.038; Min DL, 2002, BLOOD, V99, P4592, DOI 10.1182/blood.V99.12.4592; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nishikawa Y, 2014, J IMMUNOL, V192, P2585, DOI 10.4049/jimmunol.1302786; Nitta T, 2011, CURR OPIN IMMUNOL, V23, P190, DOI 10.1016/j.coi.2010.12.002; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Osada M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083024; Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193; Parent AV, 2013, CELL STEM CELL, V13, P219, DOI 10.1016/j.stem.2013.04.004; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq367; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Purton JF, 2004, J IMMUNOL, V173, P3816, DOI 10.4049/jimmunol.173.6.3816; Rode I, 2012, P NATL ACAD SCI USA, V109, P3463, DOI 10.1073/pnas.1118823109; Ross EA, 2012, J IMMUNOL, V189, P4266, DOI 10.4049/jimmunol.1200070; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Ryan D, 2006, MOL VIS, V12, P1175; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Seach N, 2012, J IMMUNOL METHODS, V385, P23, DOI 10.1016/j.jim.2012.07.023; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Sleeman JP, 2011, CELL, V145, DOI 10.1016/j.cell.2011.03.029; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Ucar O, 2013, EUR J IMMUNOL, V43, P1769, DOI 10.1002/eji.201343343; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Wang DM, 2013, NAT CELL BIOL, V15, P1153, DOI 10.1038/ncb2827; Waterfield M, 2010, ANN NY ACAD SCI, V1214, P138, DOI 10.1111/j.1749-6632.2010.05818.x; Xie H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046990; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zuklys S, 2012, J IMMUNOL, V189, P3894, DOI 10.4049/jimmunol.1200783	80	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135440	10.1371/journal.pone.0135440	http://dx.doi.org/10.1371/journal.pone.0135440			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270036	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800069
J	Lanig, H; Reisen, F; Whitley, D; Schneider, G; Banting, L; Clark, T				Lanig, Harald; Reisen, Felix; Whitley, David; Schneider, Gisbert; Banting, Lee; Clark, Timothy			In Silico Adoption of an Orphan Nuclear Receptor NR4A1	PLOS ONE			English	Article							ALLOSTERIC MECHANISMS; STRUCTURAL BASIS; BINDING-SITES; NGFI-B; NUR77; DNA; APOPTOSIS; SIGNAL; NURR1; IDENTIFICATION	A 4.1 mu s molecular dynamics simulation of the NR4A1 (hNur77) apo-protein has been undertaken and a previously undetected druggable pocket has become apparent that is located remotely from the 'traditional' nuclear receptor ligand-binding site. A NR4A1/bisindole ligand complex at this novel site has been found to be stable over 1 mu s of simulation and to result in an interesting conformational transmission to a remote loop that has the capacity to communicate with a NBRE within a RXR-alpha/NR4A1 heterodimer. Several features of the simulations undertaken indicate how NR4A1 can be affected by alternate-site modulators.	[Lanig, Harald; Clark, Timothy] Univ Erlangen Nurnberg, Comp Chem Ctr, D-91052 Erlangen, Germany; [Reisen, Felix; Schneider, Gisbert] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland; [Whitley, David; Clark, Timothy] Univ Portsmouth, Sch Pharm & Biomol Sci, Ctr Mol Design, Portsmouth PO1 2DY, Hants, England; [Banting, Lee] Univ Portsmouth, Sch Pharm & Biomol Sci, Portsmouth PO1 2DT, Hants, England	University of Erlangen Nuremberg; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Portsmouth; University of Portsmouth	Banting, L (corresponding author), Univ Portsmouth, Sch Pharm & Biomol Sci, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.	Lee.Banting@port.ac.uk; Tim.Clark@fau.de		Schneider, Gisbert/0000-0001-6706-1084; Lanig, Harald/0000-0003-1593-5557; Banting, Lee/0000-0002-3623-3629				Brelivet Y, 2012, MOL CELL ENDOCRINOL, V348, P466, DOI 10.1016/j.mce.2011.08.015; Brenner C, 2000, SCIENCE, V289, P1150, DOI 10.1126/science.289.5482.1150; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; CHANGEUX JEAN-PIERRE, 1964, BROOKHAVEN SYMP BIOL, V17, P232; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; Chintharlapalli S, 2005, J BIOL CHEM, V280, P24903, DOI 10.1074/jbc.M500107200; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Darragh J, 2005, BIOCHEM J, V390, P749, DOI 10.1042/BJ20050196; Diaz MB, 2006, CELL METAB, V4, P339, DOI 10.1016/j.cmet.2006.10.005; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Flaig R, 2005, J BIOL CHEM, V280, P19250, DOI 10.1074/jbc.M413175200; Gross M, 2011, CHEM WORLD-UK, V8, P42; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Haberl F, 2009, PROTEINS, V77, P857, DOI 10.1002/prot.22505; Hall DA, 2000, MOL PHARMACOL, V58, P1412, DOI 10.1124/mol.58.6.1412; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hsu Hui-Chen, 2004, Current Drug Targets - Inflammation and Allergy, V3, P413, DOI 10.2174/1568010042634523; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Kale S, 2009, J BIOL CHEM, V284, P33122, DOI 10.1074/jbc.M109.065508; Kellenberger E, 2006, J CHEM INF MODEL, V46, P717, DOI 10.1021/ci050372x; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Lee SO, 2012, ONCOGENE, V31, P3265, DOI 10.1038/onc.2011.504; Lee SO, 2014, MOL ENDOCRINOL, V28, P1729, DOI 10.1210/me.2014-1102; Lee SO, 2014, MOL CANCER RES, V12, P527, DOI 10.1158/1541-7786.MCR-13-0567; Lee SO, 2011, EXPERT OPIN THER TAR, V15, P195, DOI 10.1517/14728222.2011.547481; Lefebvre P, 1998, J BIOL CHEM, V273, P12288, DOI 10.1074/jbc.273.20.12288; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Michiels P, 2010, BIOMOL NMR ASSIGN, V4, P101, DOI 10.1007/s12104-010-9210-4; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moore TW, 2010, MOL ENDOCRINOL, V24, P683, DOI 10.1210/me.2009-0362; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; Okabe T, 1998, J ENDOCRINOL, V156, P169, DOI 10.1677/joe.0.1560169; Osz J, 2012, P NATL ACAD SCI USA, V109, pE588, DOI 10.1073/pnas.1118192109; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Reisen F, 2010, J PROTEOME RES, V9, P6498, DOI 10.1021/pr100719n; Rochel N, 2011, NAT STRUCT MOL BIOL, V18, P564, DOI 10.1038/nsmb.2054; Safe S, 2016, J STEROID BIOCHEM, V157, P48, DOI 10.1016/j.jsbmb.2015.04.016; Salt DW, 2005, J MED CHEM, V48, P3214, DOI 10.1021/jm049216s; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; Tanrikulu Y, 2009, CHEMMEDCHEM, V4, P820, DOI 10.1002/cmdc.200800443; Thompson J, 2010, EUR J IMMUNOL, V40, P2041, DOI 10.1002/eji.200940231; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; Vanni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001053; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101; Wang AB, 2009, J IMMUNOL, V183, P3268, DOI 10.4049/jimmunol.0900894; Wang CG, 2011, METHODS MOL BIOL, V776, P169, DOI 10.1007/978-1-61779-243-4_11; Wang WJ, 2014, NAT CHEM BIOL, V10, P133, DOI [10.1038/nchembio.1406, 10.1038/NCHEMBIO.1406]; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; Watson LC, 2013, NAT STRUCT MOL BIOL, V20, P876, DOI 10.1038/nsmb.2595; Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656; Zhan YY, 2012, NAT CHEM BIOL, V8, P897, DOI [10.1038/NCHEMBIO.1069, 10.1038/nchembio.1069]; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhang XK, 2007, EXPERT OPIN THER TAR, V11, P69, DOI 10.1517/14728222.11.1.69	57	4	4	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135246	10.1371/journal.pone.0135246	http://dx.doi.org/10.1371/journal.pone.0135246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270486	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800044
J	Vieira, MF; Sacco, IDN; Nora, FGDA; Rosenbaum, D; da Costa, PHL				Vieira, Marcus Fraga; Neves Sacco, Isabel de Camargo; da Silva Azevedo Nora, Fernanda Grazielle; Rosenbaum, Dieter; Lobo da Costa, Paula Hentschel			Footwear and Foam Surface Alter Gait Initiation of Typical Subjects	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; LOWER-LIMB AMPUTEES; DYNAMIC BALANCE CONTROL; PARKINSONS-DISEASE; OLDER-ADULTS; STEP INITIATION; SUBTHALAMIC STIMULATION; PLANTAR SENSATION; CHILDREN; WALKING	Gait initiation is the task commonly used to investigate the anticipatory postural adjustments necessary to begin a new gait cycle from the standing position. In this study, we analyzed whether and how foot-floor interface characteristics influence the gait initiation process. For this purpose, 25 undergraduate students were evaluated while performing a gait initiation task in three experimental conditions: barefoot on a hard surface (barefoot condition), barefoot on a soft surface (foam condition), and shod on a hard surface (shod condition). Two force plates were used to acquire ground reaction forces and moments for each foot separately. A statistical parametric mapping (SPM) analysis was performed in COP time series. We compared the anterior-posterior (AP) and medial-lateral (ML) resultant center of pressure (COP) paths and average velocities, the force peaks under the right and left foot, and the COP integral x force impulse for three different phases: the anticipatory postural adjustment (APA) phase (Phase 1), the swing-foot unloading phase (Phase 2), and the support-foot unloading phase (Phase 3). In Phase 1, significantly smaller ML COP paths and velocities were found for the shod condition compared to the barefoot and foam conditions. Significantly smaller ML COP paths were also found in Phase 2 for the shod condition compared to the barefoot and foam conditions. In Phase 3, increased AP COP velocities were found for the shod condition compared to the barefoot and foam conditions. SPM analysis revealed significant differences for vector COP time series in the shod condition compared to the barefoot and foam conditions. The foam condition limited the impulse-generating capacity of COP shift and produced smaller ML force peaks, resulting in limitations to body-weight transfer from the swing to the support foot. The results suggest that footwear and a soft surface affect COP and impose certain features of gait initiation, especially in the ML direction of Phase 1.	[Vieira, Marcus Fraga; da Silva Azevedo Nora, Fernanda Grazielle] Univ Fed Goias, Bioengn & Biomech Lab, Goiania, Go, Brazil; [Neves Sacco, Isabel de Camargo] Univ Sao Paulo, Sch Med, Phys Therapy Speech & Occupat Therapy Dept, Sao Paulo, Brazil; [Rosenbaum, Dieter] Univ Hosp, Inst Expt Musculoskeletal Med, Movement Anal Lab, Munster, Germany; [Lobo da Costa, Paula Hentschel] Univ Fed Sao Carlos, Dept Phys Educ, BR-13560 Sao Carlos, SP, Brazil	Universidade Federal de Goias; Universidade de Sao Paulo; University of Munster; Universidade Federal de Sao Carlos	Vieira, MF (corresponding author), Univ Fed Goias, Bioengn & Biomech Lab, Goiania, Go, Brazil.	marcus@ufg.br	Sacco, Isabel/D-7172-2011; Rosenbaum, Dieter/U-6089-2019; da Costa, Paula Hentschel Lobo/AAQ-3498-2021; Vieira, Marcus Fraga/G-4840-2012; Sacco, Isabel/T-2630-2019	Sacco, Isabel/0000-0003-1254-0007; da Costa, Paula Hentschel Lobo/0000-0003-2117-0423; Vieira, Marcus Fraga/0000-0001-9096-1603; Sacco, Isabel/0000-0003-1254-0007; Silva Azevedo Nora, Fernanda Grazielle da/0000-0002-0880-1326	Deutsche Forschungsgemeinschaft [444 BRA 113/21/0-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	MFV, ICNS, FGSAN and PHC received no specific funding for this work. DR received partial financial support given by Deutsche Forschungsgemeinschaft under the number 444 BRA 113/21/0-1. They funded the travel expenses for the visits to Brazil for DR. There was no additional external funding received for this study.	Andrew PD, 2002, PHYS THER, V82, P1264, DOI 10.1093/ptj/82.12.1264; [Anonymous], GAIT POSTURE; Aruin AS, 2001, EXP BRAIN RES, V138, P458; Bouisset S, 2008, NEUROPHYSIOL CLIN, V38, P345, DOI 10.1016/j.neucli.2008.10.001; Buckley TA, 2008, MOVEMENT DISORD, V23, P1274, DOI 10.1002/mds.22079; Caderby T, 2013, GAIT POSTURE, V37, P144, DOI 10.1016/j.gaitpost.2012.06.012; Chang HA, 1999, ARCH PHYS MED REHAB, V80, P490; Chastan N, 2009, MOVEMENT DISORD, V24, P188, DOI 10.1002/mds.22269; Couillandre A, 2000, NEUROSCI LETT, V285, P150, DOI 10.1016/S0304-3940(00)01015-6; CRENNA P, 1991, J PHYSIOL-LONDON, V437, P635, DOI 10.1113/jphysiol.1991.sp018616; Demura S., 2013, ADV AGING RES, V2, P57; Dibble LE, 2004, GAIT POSTURE, V19, P215, DOI 10.1016/S0966-6362(03)00065-1; Eils E, 2004, GAIT POSTURE, V20, P54, DOI 10.1016/S0966-6362(03)00095-X; Eils E, 2002, J BIOMECH, V35, P1307, DOI 10.1016/S0021-9290(02)00168-9; Freychat P, 1996, MED SCI SPORT EXER, V28, P225, DOI 10.1097/00005768-199602000-00011; Halliday SE, 1998, GAIT POSTURE, V8, P8, DOI 10.1016/S0966-6362(98)00020-4; Hansen AH, 2010, GAIT POSTURE, V31, P13, DOI 10.1016/j.gaitpost.2009.08.237; Hass CJ, 2008, CLIN BIOMECH, V23, P743, DOI 10.1016/j.clinbiomech.2008.02.012; Hass CJ, 2012, GAIT POSTURE, V35, P669, DOI 10.1016/j.gaitpost.2011.12.022; Hass CJ, 2005, ARCH PHYS MED REHAB, V86, P2172, DOI 10.1016/j.apmr.2005.05.013; Hass CJ, 2004, ARCH PHYS MED REHAB, V85, P1593, DOI 10.1016/j.apmr.2004.01.020; Henriksson M, 2005, GAIT POSTURE, V21, P289, DOI 10.1016/j.gaitpost.2004.03.001; Hillstrom HJ, 2013, J AM PODIAT MED ASSN, V103, P297, DOI 10.7547/1030297; Isaias IU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092736; Jones SF, 2005, CLIN BIOMECH, V20, P405, DOI 10.1016/j.clinbiomech.2004.11.018; KATOH Y, 1983, CLIN ORTHOP RELAT R, P23; Kurz MJ, 2004, J AM PODIAT MED ASSN, V94, P53, DOI 10.7547/87507315-94-1-53; Ledebt A, 1998, EXP BRAIN RES, V120, P9, DOI 10.1007/s002210050372; Lin SI, 2011, GAIT POSTURE, V34, P451, DOI 10.1016/j.gaitpost.2011.06.016; Liu W, 2006, GAIT POSTURE, V23, P492, DOI 10.1016/j.gaitpost.2005.06.012; Malouin F, 2000, GAIT POSTURE, V11, P239, DOI 10.1016/S0966-6362(00)00051-5; Melzer I, 2007, AGE AGEING, V36, P532, DOI 10.1093/ageing/afm068; Menant JC, 2008, GERONTOLOGY, V54, P18, DOI 10.1159/000115850; Menant JC, 2009, GAIT POSTURE, V29, P392, DOI 10.1016/j.gaitpost.2008.10.057; Morio C, 2009, J BIOMECH, V42, P2081, DOI 10.1016/j.jbiomech.2009.06.015; Mouchnino L, 2012, GAIT POSTURE, V35, P616, DOI 10.1016/j.gaitpost.2011.12.009; Muniz AMS, 2010, INT J NEUROSCI, V120, P609, DOI 10.3109/00207454.2010.504904; Najafi B, 2010, GAIT POSTURE, V32, P29, DOI 10.1016/j.gaitpost.2010.02.016; NISSAN M, 1991, J REHABIL RES DEV, V28, P1, DOI 10.1682/JRRD.1991.04.0001; Nurse MA, 2001, CLIN BIOMECH, V16, P719, DOI 10.1016/S0268-0033(01)00090-0; Okada Y, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/202937; Pataky T, 2015, J STAT SOFT IN PRESS; Pataky TC, 2014, GAIT POSTURE, V40, P255, DOI 10.1016/j.gaitpost.2014.01.023; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Patel M, 2011, EXP BRAIN RES, V208, P519, DOI 10.1007/s00221-010-2498-6; Polcyn AF, 1998, ARCH PHYS MED REHAB, V79, P1582, DOI 10.1016/S0003-9993(98)90425-7; Robbins S, 1992, J AM GERIATRICS SOC; ROBBINS SE, 1988, MED SCI SPORT EXER, V20, P85, DOI 10.1249/00005768-198802000-00013; Ruget H, 2008, NEUROSCIENCE, V155, P640, DOI 10.1016/j.neuroscience.2008.06.021; Sacco ICN, 2009, CLIN BIOMECH, V24, P687, DOI 10.1016/j.clinbiomech.2009.05.003; Shakoor N, 2004, BEST PRACT RES CL RH, V18, P173, DOI 10.1016/j.berh.2004.02.005; Stackhouse C, 2007, GAIT POSTURE, V26, P301, DOI 10.1016/j.gaitpost.2006.09.076; STACOFF A, 1991, MED SCI SPORT EXER, V23, P482; Tokuno CD, 2003, GAIT POSTURE, V18, P158, DOI 10.1016/S0966-6362(03)00004-3; Uemura K, 2012, GAIT POSTURE, V35, P282, DOI 10.1016/j.gaitpost.2011.09.100; van Schie C H M, 2005, Int J Low Extrem Wounds, V4, P160; Vrieling AH, 2008, GAIT POSTURE, V27, P423, DOI 10.1016/j.gaitpost.2007.05.013; Welter ML, 2007, GAIT POSTURE, V26, P393, DOI 10.1016/j.gaitpost.2006.10.005; Wicart P, 2003, NEUROSCI LETT, V351, P67, DOI 10.1016/S0304-3940(03)00619-0; Wicart P, 2006, J ELECTROMYOGR KINES, V16, P650, DOI 10.1016/j.jelekin.2005.11.005; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Witherington DC, 2002, INFANCY, V3, P495, DOI 10.1207/S15327078IN0304_05; Xu DL, 2004, J MOTOR BEHAV, V36, P316, DOI 10.3200/JMBR.36.3.316-326; Yiou E, 2011, J ELECTROMYOGR KINES, V21, P727, DOI 10.1016/j.jelekin.2011.04.008; Yiou E, 2011, MOTOR CONTROL, V15, P507, DOI 10.1123/mcj.15.4.507	65	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135821	10.1371/journal.pone.0135821	http://dx.doi.org/10.1371/journal.pone.0135821			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270323	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800115
J	Deditius, JA; Felgner, S; Sporing, I; Kuhne, C; Frahm, M; Rohde, M; Weiss, S; Erhardt, M				Deditius, Julia Andrea; Felgner, Sebastian; Spoering, Imke; Kuehne, Caroline; Frahm, Michael; Rohde, Manfred; Weiss, Siegfried; Erhardt, Marc			Characterization of Novel Factors Involved in Swimming and Swarming Motility in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							SIGMA FACTOR FLGM; ESCHERICHIA-COLI; FLAGELLAR GENES; PROTEIN; REGULATOR; SURFACE; TRANSCRIPTION; COMPLEX; FLHDC; YDIV	Salmonella enterica utilizes flagellar motility to swim through liquid environments and on surfaces. The biosynthesis of the flagellum is regulated on various levels, including transcriptional and posttranscriptional mechanisms. Here, we investigated the motility phenotype of 24 selected single gene deletions that were previously described to display swimming and swarming motility effects. Mutations in flgE, fliH, ydiV, rfaG, yjcC, STM1267 and STM3363 showed an altered motility phenotype. Deletions of flgE and fliH displayed a non-motile phenotype in both swimming and swarming motility assays as expected. The deletions of STM1267, STM3363, ydiV, rfaG and yjcC were further analyzed in detail for flagellar and fimbrial gene expression and filament formation. A Delta ydiV mutant showed increased swimming motility, but a decrease in swarming motility, which coincided with derepression of curli fimbriae. A deletion of yjcC, encoding for an EAL domain-containing protein, increased swimming motility independent on flagellar gene expression. A Delta STM1267 mutant displayed a hypermotile phenotype on swarm agar plates and was found to have increased numbers of flagella. In contrast, a knockout of STM3363 did also display an increase in swarming motility, but did not alter flagella numbers. Finally, a deletion of the LPS biosynthesis-related protein RfaG reduced swimming and swarming motility, associated with a decrease in transcription from flagellar class II and class III promoters and a lack of flagellar filaments.	[Deditius, Julia Andrea; Spoering, Imke; Kuehne, Caroline; Erhardt, Marc] Helmholtz Ctr Infect Res, Jr Res Grp Infect Biol Salmonella, D-38124 Braunschweig, Germany; [Felgner, Sebastian; Frahm, Michael; Weiss, Siegfried] Helmholtz Ctr Infect Res, Dept Mol Immunol, D-38124 Braunschweig, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res, Cent Facil Microscopy, D-38124 Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research	Erhardt, M (corresponding author), Helmholtz Ctr Infect Res, Jr Res Grp Infect Biol Salmonella, Inhoffenstr 7, D-38124 Braunschweig, Germany.	marc.erhardt@helmholtz-hzi.de		Erhardt, Marc/0000-0001-6292-619X	Helmholtz Association Young Investigator grant [VH-NG-932]; People Programme (Marie Curie Actions) of the European Unions's Seventh Framework Programme grant [334030]; Helmholtz Association of German Research Centers (HGF) [VH-GS-202]; Niedersachsiche Ministerium fur Wissenschaft und Kultur (MWK)	Helmholtz Association Young Investigator grant; People Programme (Marie Curie Actions) of the European Unions's Seventh Framework Programme grant; Helmholtz Association of German Research Centers (HGF)(Helmholtz Association); Niedersachsiche Ministerium fur Wissenschaft und Kultur (MWK)	This work was supported by Helmholtz Association Young Investigator grant number VH-NG-932 and the People Programme (Marie Curie Actions) of the European Unions's Seventh Framework Programme grant number 334030 (to ME). JAD, IS and CK acknowledge support by the President's Initiative and Networking Funds of the Helmholtz Association of German Research Centers (HGF) under contract number VH-GS-202. SF was funded in the Zoonosis PhD program via a Lichtenberg Fellowship from the Niedersachsiche Ministerium fur Wissenschaft und Kultur (MWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1967, J GEN MICROBIOL, V46, P175, DOI 10.1099/00221287-46-2-175; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Anwar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106095; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BLAIR DF, 1990, CELL, V60, P439, DOI 10.1016/0092-8674(90)90595-6; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Bogomolnaya LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111513; Chadsey MS, 1998, GENE DEV, V12, P3123, DOI 10.1101/gad.12.19.3123; Chadsey MS, 2001, J MOL BIOL, V306, P915, DOI 10.1006/jmbi.2001.4438; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Duan QD, 2013, J BASIC MICROB, V53, P1, DOI [10.1002/jobm.201100335, 10.1002/jobm.201370001]; Ellermeier CD, 2003, J BACTERIOL, V185, P5096, DOI 10.1128/JB.185.17.5096-5108.2003; Erhardt M, 2011, EMBO J, V30, P2948, DOI 10.1038/emboj.2011.185; Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GYGI D, 1995, MOL MICROBIOL, V17, P1167, DOI 10.1111/j.1365-2958.1995.mmi_17061167.x; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; HARTLEY RW, 1973, J BIOL CHEM, V248, P5624; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Kisiela DI, 2011, J BIOL CHEM, V286, P38136, DOI 10.1074/jbc.M111.237511; Ko M, 2000, J BACTERIOL, V182, P4670, DOI 10.1128/JB.182.16.4670-4672.2000; Kong QK, 2011, INFECT IMMUN, V79, P4227, DOI 10.1128/IAI.05398-11; Lee J, 2007, J MOL BIOL, V373, P11, DOI 10.1016/j.jmb.2007.07.037; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; LIBBY SJ, 1994, P NATL ACAD SCI USA, V91, P489, DOI 10.1073/pnas.91.2.489; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Minamino T, 2003, J BACTERIOL, V185, P3983, DOI 10.1128/JB.185.13.3983-3988.2003; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Mireles JR, 2001, J BACTERIOL, V183, P5848, DOI 10.1128/JB.183.20.5848-5854.2001; Park SY, 2015, P NATL ACAD SCI USA, V112, P1850, DOI 10.1073/pnas.1422938112; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rubin RH., 1977, SALMONELLOSIS MICROB; Saini S, 2008, J BACTERIOL, V190, P4979, DOI 10.1128/JB.01996-07; SANDERSON KE, 1983, MICROBIOL REV, V47, P410, DOI 10.1128/MMBR.47.3.410-453.1983; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Simm R, 2007, J BACTERIOL, V189, P3613, DOI 10.1128/JB.01719-06; Singer HM, 2014, J BACTERIOL, V196, P1448, DOI 10.1128/JB.01438-13; Singer HM, 2013, J BACTERIOL, V195, P4274, DOI 10.1128/JB.00728-13; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; Spory A, 2002, J BACTERIOL, V184, P3549, DOI 10.1128/JB.184.13.3549-3559.2002; Spurbeck RR, 2013, J BACTERIOL, V195, P3156, DOI 10.1128/JB.02254-12; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; Takaya A, 2012, MOL MICROBIOL, V83, P1268, DOI 10.1111/j.1365-2958.2012.08007.x; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wada T, 2011, J BACTERIOL, V193, P5191, DOI 10.1128/JB.05441-11; Wada T, 2011, J BACTERIOL, V193, P1600, DOI 10.1128/JB.01494-10; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; Wang SY, 2006, J MOL BIOL, V355, P798, DOI 10.1016/j.jmb.2005.11.020; Wozniak CE, 2009, J BACTERIOL, V191, P1498, DOI 10.1128/JB.01177-08	61	21	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135351	10.1371/journal.pone.0135351	http://dx.doi.org/10.1371/journal.pone.0135351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267246	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300103
J	Gan, SR; Ni, W; Dong, Y; Wang, N; Wu, ZY				Gan, Shi-Rui; Ni, Wang; Dong, Yi; Wang, Ning; Wu, Zhi-Ying			Population Genetics and New Insight into Range of CAG Repeats of Spinocerebellar Ataxia Type 3 in the Han Chinese Population	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; 2 INTRAGENIC POLYMORPHISMS; DOMINANT SPINOCEREBELLAR; INTERMEDIATE ALLELES; HUNTINGTONS-DISEASE; MOLECULAR ANALYSIS; INDIAN POPULATION; EXPANDED ALLELE; MJD1 GENE; EXPANSIONS	Spinocerebellar ataxia type 3 (SCA3), also called Machado-Joseph disease (MJD), is one of the most common SCAs worldwide and caused by a CAG repeat expansion located in ATXN3 gene. Based on the CAG repeat numbers, alleles of ATXN3 can be divided into normal alleles (ANs), intermediate alleles (AIs) and expanded alleles (AEs). It was controversial whether the frequency of large normal alleles (large ANs) is related to the prevalence of SCA3 or not. And there were huge chaos in the comprehension of the specific numbers of the range of CAG repeats which is fundamental for genetic analysis of SCA3. To illustrate these issues, we made a novel CAG repeat ladder to detect CAG repeats of ATXN3 in 1003 unrelated Chinese normal individuals and studied haplotypes defined by three single nucleotide polymorphisms (SNPs) closed to ATXN3. We found that the number of CAG repeats ranged from 13 to 49, among them, 14 was the most common number. Positive skew, the highest frequency of large ANs and 4 AIs which had never been reported before were found. Also, AEs and large ANs shared the same haplotypes defined by the SNPs. Based on these data and other related studies, we presumed that de novo mutations of ATXN3 emerging from large ANs are at least one survival mechanisms of mutational ATXN3 and we can redefine the range of CAG repeats as: ANs <= 44, 45 <= AIs <= 49 and AEs >= 50.	[Gan, Shi-Rui; Ni, Wang; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou, Zhejiang, Peoples R China; [Gan, Shi-Rui; Ni, Wang; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Res Ctr Neurol, Hangzhou, Zhejiang, Peoples R China; [Gan, Shi-Rui; Ni, Wang; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Collaborat Innovat Ctr Brain Sci, Hangzhou, Zhejiang, Peoples R China; [Gan, Shi-Rui; Wang, Ning] Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Peoples R China; [Gan, Shi-Rui; Wang, Ning] Fujian Med Univ, Affiliated Hosp 1, Inst Neurol, Fuzhou, Peoples R China; [Dong, Yi; Wu, Zhi-Ying] Fudan Univ, Huashan Hosp, Inst Brain Sci, Dept Neurol, Shanghai 200433, Peoples R China; [Dong, Yi; Wu, Zhi-Ying] Fudan Univ, Huashan Hosp, Inst Brain Sci, Inst Neurol, Shanghai 200433, Peoples R China; [Dong, Yi; Wu, Zhi-Ying] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Fujian Medical University; Fujian Medical University; Fudan University; Fudan University; Fudan University	Wu, ZY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou, Zhejiang, Peoples R China.	zhiyingwu@zju.edu.cn			National Natural Science Foundation of China (Beijing) [81125009, 81100851]; national key clinical specialty discipline construction program	National Natural Science Foundation of China (Beijing)(National Natural Science Foundation of China (NSFC)); national key clinical specialty discipline construction program	This work was supported by The National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to Z-Y Wu (81125009, Beijing) and S-R Gan (81100851, Beijing). This work was also supported by national key clinical specialty discipline construction program. The funding agencies played no role in the design and conduct of the study, collection, management, analysis and interpretation of the data, preparation, review, or approval of the manuscript and decision to submit the manuscript for publication.	Bauer PO, 2005, EUR J NEUROL, V12, P851, DOI 10.1111/j.1468-1331.2005.01090.x; Bettencourt C, 2008, J HUM GENET, V53, P920, DOI 10.1007/s10038-008-0330-y; Chattopadhyay B, 2003, ACTA NEUROL SCAND, V108, P407, DOI 10.1034/j.1600-0404.2003.00167.x; Costa MD, 2013, MOL THER, V21, P1898, DOI 10.1038/mt.2013.144; Dorschner MO, 2002, J MOL DIAGN, V4, P108, DOI 10.1016/S1525-1578(10)60689-7; Egan RA, 2000, EUR NEUROL, V44, P189, DOI 10.1159/000008218; Evers MM, 2013, NEUROBIOL DIS, V58, P49, DOI 10.1016/j.nbd.2013.04.019; Futamura N, 1998, ACTA NEUROL SCAND, V98, P55, DOI 10.1111/j.1600-0404.1998.tb07378.x; Gan SR, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-47; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; Gu WH, 2004, EUR NEUROL, V52, P107, DOI 10.1159/000080221; Hsieh ML, 1997, HUM GENET, V100, P155, DOI 10.1007/s004390050483; Jakupciak JP, 2000, IUBMB LIFE, V50, P355, DOI 10.1080/152165400300089358; Jiang H, 2005, CHINESE MED J-PEKING, V118, P837; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; Lima M, 2005, HUM HERED, V60, P156, DOI 10.1159/000090035; Limprasert P, 1996, HUM MOL GENET, V5, P207, DOI 10.1093/hmg/5.2.207; Long Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117488; Maciel P, 2001, ARCH NEUROL-CHICAGO, V58, P1821, DOI 10.1001/archneur.58.11.1821; Maciel P, 1999, EUR J HUM GENET, V7, P147, DOI 10.1038/sj.ejhg.5200264; Maruyama H, 2002, AM J MED GENET, V114, P578, DOI 10.1002/ajmg.10514; Matsumura R, 2003, ACTA NEUROL SCAND, V107, P38, DOI 10.1034/j.1600-0404.2003.01347.x; Mendonca LS, 2015, BRAIN, V138, P320, DOI 10.1093/brain/awu352; Mittal U, 2005, ARCH NEUROL-CHICAGO, V62, P637, DOI 10.1001/archneur.62.4.637; Moseley ML, 1998, NEUROLOGY, V51, P1666, DOI 10.1212/WNL.51.6.1666; Nance MA, 1998, AM J HUM GENET, V62, P1243, DOI 10.1086/301846; Pacheco LS, 2013, MUTAT RES-GEN TOX EN, V757, P99, DOI 10.1016/j.mrgentox.2013.06.023; Padiath QS, 2005, AM J MED GENET B, V133B, P124, DOI 10.1002/ajmg.b.30088; Raposo M, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-17; RUBINSZTEIN DC, 1994, NAT GENET, V7, P525, DOI 10.1038/ng0894-525; Saleem Q, 2000, HUM GENET, V106, P179, DOI 10.1007/s004390051026; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Seneca S, 2008, EUR J HUM GENET, V16, P913, DOI 10.1038/ejhg.2008.29; SEQUEIROS J, 1993, ADV NEUROL, V61, P139; Sequeiros J, 2010, EUR J HUM GENET, V18, P1173, DOI 10.1038/ejhg.2010.8; Sequeiros J, 2010, EUR J HUM GENET, V18, P1188, DOI 10.1038/ejhg.2010.10; Stevanin G, 1998, HUM MOL GENET, V7, P1809, DOI 10.1093/hmg/7.11.1809; Stevanin G, 1997, AM J HUM GENET, V60, P1548; Storey E, 2000, AM J MED GENET, V95, P351, DOI 10.1002/1096-8628(20001211)95:4<351::AID-AJMG10>3.0.CO;2-R; Takano H, 1998, AM J HUM GENET, V63, P1060, DOI 10.1086/302067; Takiyama Y, 1997, NEUROLOGY, V49, P604, DOI 10.1212/WNL.49.2.604; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; TAKIYAMA Y, 1994, NEUROLOGY, V44, P1302, DOI 10.1212/WNL.44.7.1302; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; TUITE PJ, 1995, ANN NEUROL, V38, P684, DOI 10.1002/ana.410380422; van Alfen N, 2001, ANN NEUROL, V49, P805, DOI 10.1002/ana.1089; vanSchaik IN, 1997, J NEUROL NEUROSUR PS, V63, P534, DOI 10.1136/jnnp.63.4.534; Wu YR, 2004, CLIN GENET, V65, P209, DOI 10.1111/j.0009-9163.2004.00213.x; Wu ZY, 2006, J MOL MED, V84, P438, DOI 10.1007/s00109-005-0036-y; [郑巧娟 Zheng Qiaojuan], 2010, [中华神经科杂志, Chinese Journal of Neurology], V43, P659	51	21	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134405	10.1371/journal.pone.0134405	http://dx.doi.org/10.1371/journal.pone.0134405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266536	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492300044
J	Huang, HW				Huang, Hsiang-Wen			Conservation Hotspots for the Turtles on the High Seas of the Atlantic Ocean	PLOS ONE			English	Article							PELAGIC LONGLINE FISHERY; DERMOCHELYS-CORIACEA; LEPIDOCHELYS-OLIVACEA; GLOBAL PATTERNS; BYCATCH; LOGGERHEAD; SEABIRD; MORTALITY; PACIFIC	Understanding the distribution of bycaught sea turtles could inform conservation strategies and priorities. This research analyses the distribution of turtles caught as longline fisheries bycatch on the high seas of the Atlantic Ocean. This research collected 18,142 bycatch observations and 47.1 million hooks from large-scale Taiwanese longline vessels in the Atlantic Ocean from June 2002 to December 2013. The coverage rates were ranged from 0.48% to 17.54% by year. Seven hundred and sixty-seven turtles were caught, and the major species were leatherback (59.8%), olive ridley (27.1%) and loggerhead turtles (8.7%). Most olive ridley (81.7%) and loggerhead (82.1%) turtles were hooked, while the leatherbacks were both hooked (44.0%) and entangled (31.8%). Depending on the species, 21.4% to 57.7% were dead when brought onboard. Most of the turtles were caught in tropical areas, especially in the Gulf of Guinea (15 degrees N-10 degrees S, 30 degrees W-10 degrees E), but loggerheads were caught in the south Atlantic Ocean (25 degrees S-35 degrees S, 40 degrees W-10 degrees E and 30 degrees S-40 degrees S, 55 degrees W-45 degrees W). The bycatch rate was the highest at 0.030 per 1000 hooks for leatherbacks in the tropical area. The bycatch rates of olive ridley ranged from 0 to 0.010 per thousand hooks. The loggerhead bycatch rates were higher in the northern and southern Atlantic Ocean and ranged from 0.0128 to 0.0239 per thousand hooks. Due to the characteristics of the Taiwanese deep-set longline fleet, bycatch rates were lower than those of coastal longline fisheries, but mortality rates were higher because of the long hours of operation. Gear and bait modification should be considered to reduce sea turtle bycatch and increase survival rates while reducing the use of shallow hooks would also be helpful.	Natl Taiwan Ocean Univ, Inst Marine Affairs & Resource Management, Keelung, Taiwan	National Taiwan Ocean University	Huang, HW (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Affairs & Resource Management, Keelung, Taiwan.	Julia@ntou.edu.tw			Fisheries Agency of the Council of Agriculture, Taiwan [102AS-10.1.1-FA-F6(2)]	Fisheries Agency of the Council of Agriculture, Taiwan	The study was sponsored by grants from Fisheries Agency of the Council of Agriculture, Taiwan (102AS-10.1.1-FA-F6(2)). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Babcock E.A., 2003, MUCH OBSERVER COVERA; Barcelo C, 2013, MAR ECOL PROG SER, V479, P235, DOI 10.3354/meps10222; Cochran WG., 1963, SAMPLING TECHNIQUES; Coelho R, 2013, INT COMM CONS ATL CO, V69, P1788; Curran D, 2011, FISH RES, V109, P265, DOI 10.1016/j.fishres.2011.02.013; Dodge KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091726; Donoso M, 2010, BIOL CONSERV, V143, P2672, DOI 10.1016/j.biocon.2010.07.011; Dutton DL, 2005, BIOL CONSERV, V126, P186, DOI 10.1016/j.biocon.2005.05.013; Eckert SA, 2002, MAR ECOL PROG SER, V230, P289, DOI 10.3354/meps230289; ECKERT SA, 1986, HERPETOLOGICA, V42, P381; Finkbeiner EM, 2011, BIOL CONSERV, V144, P2719, DOI 10.1016/j.biocon.2011.07.033; Food and Agriculture Organization [FAO], 2009, GUID RED SEA TURTL M; Fossette S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3065; Gardner B, 2008, CAN J FISH AQUAT SCI, V65, P2461, DOI 10.1139/F08-152; Garson G. D., 2015, MULTIVARIATE GLM MAN; Gilman Eric, 2008, Endangered Species Research, V5, P309, DOI 10.3354/esr00133; Hall MA, 1999, INTERNATIONAL CONFERENCE ON INTEGRATED FISHERIES MONITORING, PROCEEDINGS, P175; Halpin PN, 2009, OCEANOGRAPHY, V22, P104, DOI 10.5670/oceanog.2009.42; Hawkes LA, 2007, DIVERS DISTRIB, V13, P447, DOI 10.1111/j.1472-4642.2007.00354.x; Hawkes LA, 2011, DIVERS DISTRIB, V17, P624, DOI 10.1111/j.1472-4642.2011.00768.x; Hays GC, 2010, CONSERV BIOL, V24, P1636, DOI 10.1111/j.1523-1739.2010.01531.x; Honig M.B., 2008, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V62, P1757; Huang HW, 2011, MAR POLICY, V35, P712, DOI 10.1016/j.marpol.2011.02.012; Huang HW, 2010, FISH RES, V106, P261, DOI 10.1016/j.fishres.2010.08.005; Humber F, 2014, DIVERS DISTRIB, V20, P579, DOI 10.1111/ddi.12183; ICCAT, 2006, REC 06 01 ICCAT REG; ICCAT, 2012, REP BIENN PER 2012 2; ICCAT, 2004, REP BIENN PER 2002 2; ICCAT, 2005, REC 05 02 ICCAT REG; ICCAT, 1960, STAT B, V42; International Commission for the Conservation of Atlantic Tunas ( ICCAT), TASK 2 CATC EFF DAT; James MC, 2007, MAR ECOL PROG SER, V337, P245, DOI 10.3354/meps337245; Julian F, 1998, FISH B-NOAA, V96, P271; Kot C. Y., 2015, STATE WORLDS SEA TUR; Lewison R, 2015, BIOSCIENCE; Lewison RL, 2014, P NATL ACAD SCI USA, V111, P5271, DOI 10.1073/pnas.1318960111; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Lewison RL, 2003, ECOL APPL, V13, P743, DOI 10.1890/1051-0761(2003)013[0743:EFBAEO]2.0.CO;2; Marine Turtle Specialist Group, 1996, IUCN RED LIST THREAT; Mast R., 2005, MARINE TURTLE NEWSLE, V110, P13; Maxwell SM, 2015, MAR POLICY, V58, P42, DOI 10.1016/j.marpol.2015.03.014; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; Minami H, 2013, INT COMM CONS ATL CO, V69, P1901; Minami M, 2007, FISH RES, V84, P210, DOI 10.1016/j.fishres.2006.10.019; Motimer, 2008, ERETMOCHELYS IMBRICA; Pacheco JC, 2011, FISH RES, V107, P39, DOI 10.1016/j.fishres.2010.10.003; Petersen SL, 2009, AFR J MAR SCI, V31, P87, DOI 10.2989/AJMS.2009.31.1.8.779; Pikesley SK, 2013, DIVERS DISTRIB, V19, P1518, DOI 10.1111/ddi.12118; Piovano S, 2009, AQUAT CONSERV, V19, P779, DOI 10.1002/aqc.1021; Polovina JJ, 2003, FISH B-NOAA, V101, P189; Pons Maite, 2009, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V64, P2443; Read AJ, 2007, BIOL CONSERV, V135, P155, DOI 10.1016/j.biocon.2006.10.030; Roberts C., 2000, WWF ENDANGERED SEAS; Seminoff JASFSC, 2004, IUCN RED LIST THREAT; Swimmer Y, 2006, MAR ECOL PROG SER, V323, P253, DOI 10.3354/meps323253; Tiwari M., 2013, IUCN RED LIST THREAT, pT46967817A46967821; Turtle Expert Working Group, 2007, ASS LEATH TURTL POP; Wallace BP, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00388.1; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Witt MJ, 2009, BIOL CONSERV, V142, P1719, DOI 10.1016/j.biocon.2009.03.009	63	14	14	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133614	10.1371/journal.pone.0133614	http://dx.doi.org/10.1371/journal.pone.0133614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267796	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300019
J	Mubiru, D; Byabasheija, R; Bwanika, JB; Meier, JE; Magumba, G; Kaggwa, FM; Abusu, JO; Opio, AC; Lodda, CC; Patel, J; Diaz, T				Mubiru, Denis; Byabasheija, Robert; Bwanika, John Baptist; Meier, Joslyn Edelstein; Magumba, Godfrey; Kaggwa, Flavia Mpanga; Abusu, Jackson Ojera; Opio, Alex Chono; Lodda, Charles Clarke; Patel, Jaanki; Diaz, Theresa			Evaluation of Integrated Community Case Management in Eight Districts of Central Uganda	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; CHILDHOOD MORTALITY; PNEUMONIA; CHILDREN; MALARIA; IMPLEMENTATION; STRATEGY; QUALITY; ILLNESS; IMPACT	Objective Evidence is limited on whether Integrated Community Case Management (iCCM) improves treatment coverage of the top causes of childhood mortality (acute respiratory illnesses (ARI), diarrhoea and malaria). The coverage impact of iCCM in Central Uganda was evaluated. Methods Between July 2010 and December 2012 a pre-post quasi-experimental study in eight districts with iCCM was conducted; 3 districts without iCCM served as controls. A two-stage household cluster survey at baseline (n = 1036 and 1042) and end line (n = 3890 and 3844) was done in the intervention and comparison groups respectively. Changes in treatment coverage and timeliness were assessed using difference in differences analysis (DID). Mortality impact was modelled using the Lives Saved Tool. Findings 5,586 Village Health Team members delivered 1,907,746 treatments to children under age five. Use of oral rehydration solution (ORS) and zinc treatment of diarrhoea increased in the intervention area, while there was a decrease in the comparison area (DID = 22.9, p = 0.001). Due to national stock-outs of amoxicillin, there was a decrease in antibiotic treatment for ARI in both areas; however, the decrease was significantly greater in the comparison area (DID = 5.18; p<0.001). There was a greater increase in Artemisinin Combination Therapy treatment for fever in the intervention areas than in the comparison area but this was not significant (DID = 1.57, p = 0.105). In the intervention area, timeliness of treatments for fever and ARI increased significantly higher in the intervention area than in the comparison area (DID = 2.12, p = 0.029 and 7.95, p<0.001, respectively). An estimated 106 lives were saved in the intervention area while 611 lives were lost in the comparison area. Conclusion iCCM significantly increased treatment coverage for diarrhoea and fever, mitigated the effect of national stock outs of amoxicillin on ARI treatment, improved timeliness of treatments for fever and ARI and saved lives.	[Mubiru, Denis; Bwanika, John Baptist; Meier, Joslyn Edelstein; Magumba, Godfrey] Malaria Consortium, Kampala, Uganda; [Byabasheija, Robert; Kaggwa, Flavia Mpanga; Abusu, Jackson Ojera; Opio, Alex Chono; Lodda, Charles Clarke] UNICEF Uganda, Keeping Children & Mothers Alive, Kampala, Uganda; [Patel, Jaanki] Columbia Univ, Mailman Sch Publ Hlth, Epidemiol & Hlth Policy & Practice, New York, NY USA; [Diaz, Theresa] UNICEF Headquarters, Hlth Sect, Programme Div, New York, NY 10017 USA	Columbia University; UNICEF	Diaz, T (corresponding author), UNICEF Headquarters, Hlth Sect, Programme Div, New York, NY 10017 USA.	tdiaz@unicef.org		Diaz, Theresa/0000-0001-5063-8078	Department of Foreign Affairs Trade and Development Canada	Department of Foreign Affairs Trade and Development Canada	This study was supported by the Department of Foreign Affairs Trade and Development Canada, and administered through UNICEF to Malaria Consortium.	Amouzou A, 2014, J GLOB HEALTH, V4, P177, DOI 10.7189/jogh.04.020411; [Anonymous], 2012, UG DEM HLTH SURV 201; [Anonymous], 2012, REC MAN COMM CHILDH; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Awor P, 2012, AM J TROP MED HYG, V87, P92, DOI 10.4269/ajtmh.2012.11-0791; Byakika-Kibwika P, 2009, Afr Health Sci, V9, P206; Chanda P, 2011, MALARIA J, V10, P1475; Chinbuah MA, 2012, AM J TROP MED HYG, V87, P11, DOI 10.4269/ajtmh.2012.12-0078; Diaz T, 2014, J GLOB HEALTH, V4, P150, DOI [10.7189/jogh.04.020409, 10.7189/jogh.04.020101]; Druetz T, 2015, HEALTH POLICY PLANN, V30, P253, DOI 10.1093/heapol/czt104; Friberg IK, 2014, J GLOB HEALTH, V4, P186, DOI 10.7189/jogh.04.020412; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Ghimire M, 2010, B WORLD HEALTH ORGAN, V88, P216, DOI 10.2471/BLT.09.065649; Hamer DH, 2012, PATHOG GLOB HEALTH, V106, P32, DOI 10.1179/1364859411Y.0000000042; Kalyango JN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060481, DOI 10.1371/J0URNAL.P0NE.0060481]; Kalyango JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-340; Lainez YB, 2012, AM J TROP MED HYG, V87, P144, DOI 10.4269/ajtmh.2012.12-0106; Lauritsen JM, 2000, EPIDATA DATA ENTRY D; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Marsh DR, 2012, AM J TROP MED HYG, V87, P2, DOI 10.4269/ajtmh.2012.12-0504; Miller NP, 2014, AM J TROP MED HYG, V91, P424, DOI 10.4269/ajtmh.13-0751; Mubi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019753; Mukanga D, 2012, AM J TROP MED HYG, V87, P21, DOI 10.4269/ajtmh.2012.11-0816; Rutebemberwa E, 2012, AM J TROP MED HYG, V87, P30, DOI 10.4269/ajtmh.2012.11-0732; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; STATA, 2011, STAT STAT SOFTW REL; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P155, DOI 10.1093/ije/dyq032; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; [WHO UNICEF], FULF HLTH AG WOM CHI; WHO/UNICEF, 2012, INT COMM CAS MAN EQ; Yansaneh AI, 2014, TROP MED INT HEALTH, V19, P1466, DOI 10.1111/tmi.12383	31	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134767	10.1371/journal.pone.0134767	http://dx.doi.org/10.1371/journal.pone.0134767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267141	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300058
J	Radic, T; Al-Qaisi, O; Jungenitz, T; Beining, M; Schwarzacher, SW				Radic, Tijana; Al-Qaisi, Omar; Jungenitz, Tassilo; Beining, Marcel; Schwarzacher, Stephan W.			Differential Structural Development of Adult-Born Septal Hippocampal Granule Cells in the Thy1-GFP Mouse, Nuclear Size as a New Index of Maturation	PLOS ONE			English	Article							NEWLY GENERATED NEURONS; DENTATE GYRUS; PATTERN SEPARATION; FASCIA-DENTATA; NEUROGENESIS; BRAIN; DOUBLECORTIN; EXPRESSION; PROX1; PROLIFERATION	Adult neurogenesis is frequently studied in the mouse hippocampus. We examined the morphological development of adult-born, immature granule cells in the suprapyramidal blade of the septal dentate gyrus over the period of 7-77 days after mitosis with BrdU-labeling in 6-weeks-old male Thy1-GFP mice. As Thy1-GFP expression was restricted to maturated granule cells, it was combined with doublecortin-immunolabeling of immature granule cells. We developed a novel classification system that is easily applicable and enables objective and direct categorization of newborn granule cells based on the degree of dendritic development in relation to the layer specificity of the dentate gyrus. The structural development of adult-generated granule cells was correlated with age, albeit with notable differences in the time course of development between individual cells. In addition, the size of the nucleus, immunolabeled with the granule cell specific marker Prospero-related homeobox 1 gene, was a stable indicator of the degree of a cell's structural maturation and could be used as a straightforward parameter of granule cell development. Therefore, further studies could employ our doublecortin-staging system and nuclear size measurement to perform investigations of morphological development in combination with functional studies of adult-born granule cells. Furthermore, the Thy1-GFP transgenic mouse model can be used as an additional investigation tool because the reporter gene labels granule cells that are 4 weeks or older, while very young cells could be visualized through the immature marker doublecortin. This will enable comparison studies regarding the structure and function between young immature and older matured granule cells.	[Radic, Tijana; Al-Qaisi, Omar; Jungenitz, Tassilo; Beining, Marcel; Schwarzacher, Stephan W.] Goethe Univ Frankfurt, Inst Clin Neuroanat, NeuroSci Ctr, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Schwarzacher, SW (corresponding author), Goethe Univ Frankfurt, Inst Clin Neuroanat, NeuroSci Ctr, D-60054 Frankfurt, Germany.	schwarzacher@em.uni-frankfurt.de	Beining, Marcel/P-3897-2019; Beining, Marcel/Q-3840-2016	Beining, Marcel/0000-0002-6577-2648; Beining, Marcel/0000-0002-6577-2648; Jungenitz, Tassilo/0000-0001-7291-8548	deutsche Forschungsgemeinschaft (collaborative research center 1080)	deutsche Forschungsgemeinschaft (collaborative research center 1080)(German Research Foundation (DFG))	This study and TR were funded by the deutsche Forschungsgemeinschaft (www.dfg.de, collaborative research center 1080. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2010, TRENDS COG SCI, P1; ALTMAN J, 1967, NATURE, V214, P1098, DOI 10.1038/2141098a0; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008; Braun SMG, 2014, NEUROPATH APPL NEURO, V40, P3, DOI 10.1111/nan.12107; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chancey JH, 2014, J NEUROSCI, V34, P2349, DOI 10.1523/JNEUROSCI.3620-13.2014; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dieni CV, 2013, J NEUROSCI, V33, P19131, DOI 10.1523/JNEUROSCI.2289-13.2013; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Franklin K, 1997, THE MOUSE BRAIN IN S; Galeeva A, 2007, NEUROSCIENCE, V146, P604, DOI 10.1016/j.neuroscience.2007.02.002; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Iwano T, 2012, DEVELOPMENT, V139, P3051, DOI 10.1242/dev.080002; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jungenitz T, 2013, CEREB CORTEX; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim WR, 2012, BEHAV BRAIN RES, V227, P470, DOI 10.1016/j.bbr.2011.07.012; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lavado A, 2007, DEV DYNAM, V236, P518, DOI 10.1002/dvdy.21024; Lavado A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000460; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Marin-Burgin A, 2012, SCIENCE, V335, P1238, DOI 10.1126/science.1214956; Martinez-Canabal A, 2013, HIPPOCAMPUS, V23, P66, DOI 10.1002/hipo.22054; Mathews EA, 2010, J COMP NEUROL, V518, P4479, DOI 10.1002/cne.22489; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Muramatsu R, 2007, NEUROSCIENCE, V148, P593, DOI 10.1016/j.neuroscience.2007.06.040; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048757; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vivar C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00015; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Vukovic J, 2013, J NEUROSCI, V33, P6603, DOI 10.1523/JNEUROSCI.3064-12.2013; Vuksic M, 2008, HIPPOCAMPUS, V18, P364, DOI 10.1002/hipo.20398; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	63	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135493	10.1371/journal.pone.0135493	http://dx.doi.org/10.1371/journal.pone.0135493			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267362	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300126
J	Schwieger, J; Warnecke, A; Lenarz, T; Esser, KH; Scheper, V				Schwieger, Jana; Warnecke, Athanasia; Lenarz, Thomas; Esser, Karl-Heinz; Scheper, Verena			Neuronal Survival, Morphology and Outgrowth of Spiral Ganglion Neurons Using a Defined Growth Factor Combination	PLOS ONE			English	Article							DEAFENED GUINEA-PIG; CILIARY NEUROTROPHIC FACTOR; TRIPARTITE CNTF RECEPTOR; TGF-BETA SUPERFAMILY; ELECTRICAL-STIMULATION; IN-VITRO; NEURITE OUTGROWTH; SIGNALING PATHWAYS; AUDITORY NEURONS; CYTOKINE RECEPTORS	Objectives The functionality of cochlear implants (CI) depends, among others, on the number and excitability of surviving spiral ganglion neurons (SGN). The spatial separation between the SGN, located in the bony axis of the inner ear, and the CI, which is inserted in the scala tympani, results in suboptimal performance of CI patients and may be decreased by attracting the SGN neurites towards the electrode contacts. Neurotrophic factors (NTFs) can support neuronal survival and neurite outgrowth. Methods Since brain-derived neurotrophic factor (BDNF) is well known for its neuroprotective effect and ciliary neurotrophic factor (CNTF) increases neurite outgrowth, we evaluated if the combination of BDNF and CNTF leads to an enhanced neuronal survival with extended neurite outgrowth. Both NTFs were added in effective high concentrations (BDNF 50ng/ml, CNTF 100ng/ml), alone and in combination, to cultured dissociated SGN of neonatal rats for 48 hours. Results The neuronal survival and neurite outgrowth were significantly higher in SGN treated with the combination of the two NTFs compared to treatment with each factor alone. Additionally, with respect to the morphology, the combination of BDNF and CNTF leads to a significantly higher number of bipolar neurons and a decreased number of neurons without neurites in culture. Conclusion The combination of BDNF and CNTF shows a great potential to increase the neuronal survival and the number of bipolar neurons in vitro and to regenerate retracted nerve fibers.	[Schwieger, Jana; Warnecke, Athanasia; Lenarz, Thomas; Scheper, Verena] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Schwieger, Jana; Esser, Karl-Heinz] Univ Vet Med Hannover, Inst Zool, Hannover, Germany; [Scheper, Verena] Hannover Med Sch, Inst Audioneurotechnol, Hannover, Germany; [Warnecke, Athanasia; Lenarz, Thomas] German Res Fdn, Cluster Excellence Hearing4all, Hannover, Germany	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School; German Research Foundation (DFG)	Schwieger, J (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	Schwieger.Jana@mh-hannover.de	Warnecke, Athanasia/HHC-6174-2022; Scheper, Verena/J-4298-2019	Scheper, Verena/0000-0001-8618-8793; Forsythe, John/0000-0003-2849-229X	DFG (German Research Foundation, "Deutsche Forschungsgemeinschaft") project D2 [SFB599]; cluster of excellence "Hearing4all"; EC project NeuEar: Neurotrophic Cochlea Implant for Severe Hearing Loss [304930]	DFG (German Research Foundation, "Deutsche Forschungsgemeinschaft") project D2(German Research Foundation (DFG)); cluster of excellence "Hearing4all"; EC project NeuEar: Neurotrophic Cochlea Implant for Severe Hearing Loss	The work was supported by the DFG (German Research Foundation, "Deutsche Forschungsgemeinschaft") SFB599 project D2 (http://www.sfb599.de/) (JS) and the cluster of excellence "Hearing4all" (http://hearing4all.eu/EN/) (AW), and by the EC project (project number: 304930) NeuEar: Neurotrophic Cochlea Implant for Severe Hearing Loss (http://www.neuear.eu/) (VS, JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzi T, 2001, MOL CELL NEUROSCI, V18, P270, DOI 10.1006/mcne.2001.1018; Bailey EM, 2014, J NEUROSCI, V34, P13110, DOI 10.1523/JNEUROSCI.1014-14.2014; Battmer RD, 1999, ANN OTO RHINOL LARYN, V108, P69, DOI 10.1177/00034894991080S414; Berkingali N, 2008, HEARING RES, V243, P121, DOI 10.1016/j.heares.2008.07.003; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; Brand Y, 2013, J MOL NEUROSCI, V51, P663, DOI 10.1007/s12031-013-0040-6; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; Dolcet X, 2001, MOL CELL NEUROSCI, V18, P619, DOI 10.1006/mcne.2001.1058; Gillespie LN, 2001, NEUROREPORT, V12, P275, DOI 10.1097/00001756-200102120-00019; Glueckert R, 2008, J COMP NEUROL, V507, P1602, DOI 10.1002/cne.21619; Green SH, 2012, ANAT REC, V295, P1877, DOI 10.1002/ar.22587; Hafidi A, 2004, HEARING RES, V194, P14, DOI 10.1016/j.heares.2004.04.004; Hartnick CJ, 1996, J NEUROBIOL, V30, P246, DOI 10.1002/(SICI)1097-4695(199606)30:2<246::AID-NEU6>3.0.CO;2-5; HARTSHORN DO, 1991, OTOLARYNG HEAD NECK, V104, P311, DOI 10.1177/019459989110400305; Hirano Toshio, 1997, Cytokine and Growth Factor Reviews, V8, P241, DOI 10.1016/S1359-6101(98)80005-1; Ip Nancy Y., 1992, Progress in Growth Factor Research, V4, P139, DOI 10.1016/0955-2235(92)90028-G; Ip Nancy Y., 1994, Current Opinion in Neurobiology, V4, P400, DOI 10.1016/0959-4388(94)90102-3; Ip NY, 1996, ANNU REV NEUROSCI, V19, P491; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; Jin YL, 2013, CELL TISSUE RES, V351, P15, DOI 10.1007/s00441-012-1526-1; Kaiser O, 2013, NEUROPHARMACOLOGY, V75, P416, DOI 10.1016/j.neuropharm.2013.08.008; Kranz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092157; Landry TG, 2013, J COMP NEUROL, V521, P2818, DOI 10.1002/cne.23318; Leake PA, 1999, J COMP NEUROL, V412, P543, DOI 10.1002/(SICI)1096-9861(19991004)412:4<543::AID-CNE1>3.0.CO;2-3; LEAKE PA, 1991, HEARING RES, V54, P251, DOI 10.1016/0378-5955(91)90120-X; Leake PA, 2011, J COMP NEUROL, V519, P1526, DOI 10.1002/cne.22582; Lie M, 2010, NEUROSCIENCE, V169, P855, DOI 10.1016/j.neuroscience.2010.05.020; Liu W, 2015, NEUROSCIENCE, V284, P470, DOI 10.1016/j.neuroscience.2014.09.059; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; LOUSTEAU RJ, 1987, LARYNGOSCOPE, V97, P836; Malgrange B, 1998, NEUROCHEM RES, V23, P1133, DOI 10.1023/A:1020724506337; Marzella PL, 1999, HEARING RES, V138, P73, DOI 10.1016/S0378-5955(99)00152-5; Mitchell A, 1997, HEARING RES, V105, P30, DOI 10.1016/S0378-5955(96)00202-X; Nakaizumi T, 2004, AUDIOL NEURO-OTOL, V9, P135, DOI 10.1159/000077264; Nayagam BA, 2011, HEARING RES, V278, P2, DOI 10.1016/j.heares.2011.04.003; Ogilvie JM, 2000, EXP NEUROL, V161, P676, DOI 10.1006/exnr.1999.7291; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Scheper V, 2009, J NEUROSCI RES, V87, P1389, DOI 10.1002/jnr.21964; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SHEPHERD RK, 1993, HEARING RES, V66, P108, DOI 10.1016/0378-5955(93)90265-3; Shibata SB, 2010, EXP NEUROL, V223, P464, DOI 10.1016/j.expneurol.2010.01.011; Shinohara T, 2002, P NATL ACAD SCI USA, V99, P1657, DOI 10.1073/pnas.032677999; Sleeman M W, 2000, Pharm Acta Helv, V74, P265, DOI 10.1016/S0031-6865(99)00050-3; Staecker H, 1996, DEV BRAIN RES, V92, P49, DOI 10.1016/0165-3806(95)00198-0; STAECKER H, 1995, NEUROREPORT, V6, P1533, DOI 10.1097/00001756-199507310-00017; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1994, J NEUROBIOL, V25, P1454, DOI 10.1002/neu.480251111; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Turnley AM, 2000, J NEUROCHEM, V74, P889, DOI 10.1046/j.1471-4159.2000.0740889.x; Vieira M, 2007, HEARING RES, V230, P17, DOI 10.1016/j.heares.2007.03.005; Warnecke A, 2007, NEUROREPORT, V18, P1683, DOI 10.1097/WNR.0b013e3282f0b5d7; Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008; Whitlon DS, 2007, NEUROSCIENCE, V146, P833, DOI 10.1016/j.neuroscience.2007.01.036; Whitlon DS, 2006, NEUROSCIENCE, V138, P653, DOI 10.1016/j.neuroscience.2005.11.030; Wise AK, 2005, J COMP NEUROL, V487, P147, DOI 10.1002/cne.20563; Wise AK, 2010, MOL THER, V18, P1111, DOI 10.1038/mt.2010.28; Yamagata T, 2004, J NEUROSCI RES, V78, P75, DOI 10.1002/jnr.20239	60	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0133680	10.1371/journal.pone.0133680	http://dx.doi.org/10.1371/journal.pone.0133680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263175	Green Submitted, Green Published, gold			2022-12-27	WOS:000359353300011
J	Hodge, G; Upham, JW; Chang, AB; Baines, KJ; Yerkovich, ST; Pizzutto, SJ; Hodge, S				Hodge, G.; Upham, J. W.; Chang, A. B.; Baines, K. J.; Yerkovich, S. T.; Pizzutto, S. J.; Hodge, S.			Increased Peripheral Blood Pro-Inflammatory/Cytotoxic Lymphocytes in Children with Bronchiectasis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SYSTEMIC INFLAMMATION; NATURAL-KILLER; GRANZYME-B; T-CELLS; ATHEROSCLEROSIS; INFECTIONS	Objective Bronchiectasis (BE) in children is common in some communities including Indigenous children in Australia. Relatively little is known about the nature of systemic inflammation in these children, especially the contribution of specific pro-inflammatory and cytotoxic lymphocyte subsets: T-cells, natural killer (NK) cells and NKT-like cells. We have shown that these cells produce increased cytotoxic (granzyme b and perforin) and inflammatory (IFN gamma and TNF alpha) mediators in several adult chronic lung diseases and hypothesised that similar changes would be evident in children with BE. Methods Intracellular cytotoxic mediators perforin and granzyme b and pro-inflammatory cytokines were measured in T cell subsets, NKT-like and NK cells from blood and bronchoalveolar samples from 12 children with BE and 10 aged-matched control children using flow cytometry. Results There was a significant increase in the percentage of CD8+ T cells and T and NKT-like subsets expressing perforin/granzyme and IFN gamma and TNF alpha in blood in BE compared with controls. There was a further increase in the percentage of pro-inflammatory cytotoxic T cells in Indigenous compared with non-Indigenous children. There was no change in any of these mediators in BAL. Conclusions Childhood bronchiectasis is associated with increased systemic pro-inflammatory/cytotoxic lymphocytes in the peripheral blood. Future studies need to examine the extent to which elevated levels of pro-inflammatory cytotoxic cells predict future co-morbidities.	[Hodge, G.; Hodge, S.] Royal Adelaide Hosp, Hanson Inst, Lung Res, Adelaide, SA 5000, Australia; [Hodge, G.; Hodge, S.] Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA 5000, Australia; [Upham, J. W.] Univ Queensland, Sch Med, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Chang, A. B.; Pizzutto, S. J.] Menzies Sch Hlth Res, Child Hlth Div, Darwin, NT, Australia; [Chang, A. B.] Queensland Univ Technol, Childrens Hlth Queensland, Lady Cilento Childrens Hosp, Dept Resp & Sleep Med, South Brisbane, Qld, Australia; [Baines, K. J.] Hunter Med Res Inst, Dept Resp & Sleep Med, Newcastle, NSW, Australia; [Baines, K. J.] Univ Newcastle, Callaghan, NSW 2308, Australia; [Yerkovich, S. T.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Yerkovich, S. T.] Prince Charles Hosp, Brisbane, Qld 4032, Australia	Hanson Institute; Royal Adelaide Hospital; Royal Adelaide Hospital; University of Queensland; Charles Darwin University; Menzies School of Health Research; Queensland University of Technology (QUT); Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Queensland; Prince Charles Hospital	Hodge, G (corresponding author), Royal Adelaide Hosp, Hanson Inst, Lung Res, Adelaide, SA 5000, Australia.	greg.hodge@health.sa.gov.au	Upham, John/F-4420-2010; Chang, Anne/F-2066-2013; BAINES, KATHERINE JOANNE/G-7654-2013	Upham, John/0000-0002-0017-3433; Chang, Anne/0000-0002-1331-3706; BAINES, KATHERINE JOANNE/0000-0002-4240-6581; Yerkovich, Stephanie/0000-0003-4163-4782	Channel 7 grant [13688]; NHMRC project grant [1042601]; NHMRC CRE for Lung Health of Aboriginal and Torres Strait Islander children grant [1040830]; NHMRC [1058552, 1058213]; NHMRC post-graduate scholarship [1038415]	Channel 7 grant; NHMRC project grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC CRE for Lung Health of Aboriginal and Torres Strait Islander children grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC post-graduate scholarship(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a Channel 7 grant (13688), NHMRC project grant 1042601 and supported by NHMRC CRE for Lung Health of Aboriginal and Torres Strait Islander children grant 1040830. PG (grant 1058552) and AC (grant 1058213) are supported by NHMRC fellowships, SP by a NHMRC post-graduate scholarship (1038415). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez-Garcia MA, 2008, ARCH BRONCONEUMOL, V44, P8, DOI 10.1016/S1579-2129(08)60003-8; Arsava BE, 2011, TUBERK TORAK, V59, P340, DOI 10.5578/tt.2934; Australian Institute of Health and Welfare, 2011, AUSTR I HLTH WELF AR, V15; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Chalmers JD, 2012, AM J RESP CRIT CARE, V186, P657, DOI 10.1164/rccm.201203-0487OC; Chang AB, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-3; Chang AB, 2003, PEDIATR PULM, V35, P477, DOI 10.1002/ppul.10289; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Hodge G, 2007, CLIN EXP IMMUNOL, V150, P22, DOI 10.1111/j.1365-2249.2007.03451.x; Hodge G, 2010, CLIN EXP IMMUNOL, V161, P584, DOI 10.1111/j.1365-2249.2010.04186.x; Hodge G, 2013, RESPIROLOGY, V18, P369, DOI 10.1111/j.1440-1843.2012.02287.x; Hodge Sandra, 2006, COPD, V3, P179, DOI 10.1080/15412550600976868; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Kyaw T, 2013, CIRCULATION, V127, P1028, DOI 10.1161/CIRCULATIONAHA.112.001347; Liao KP, 2014, CIRC-CARDIOVASC IMAG, V7, P575, DOI 10.1161/CIRCIMAGING.114.002235; Pizzutto SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104236; Selathurai A, 2014, CARDIOVASC RES, V102, P128, DOI 10.1093/cvr/cvu016; Sevenoaks MJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-70; SILVA JRLE, 1989, THORAX, V44, P668, DOI 10.1136/thx.44.8.668; Simpson JL, 2014, RESPIROLOGY, V19, P280, DOI 10.1111/resp.12213; Singleton RJ, 2014, PEDIATR PULM, V49, P189, DOI 10.1002/ppul.22763; Steinfort DP, 2008, RESP MED, V102, P574, DOI 10.1016/j.rmed.2007.11.007; Wilson CB, 1998, EUR RESPIR J, V12, P820, DOI 10.1183/09031936.98.12040820; Zhao W, 2009, INT J CLIN EXP PATHO, V2, P544	26	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0133695	10.1371/journal.pone.0133695	http://dx.doi.org/10.1371/journal.pone.0133695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258716	gold, Green Published, Green Submitted			2022-12-27	WOS:000359352600006
J	Ereskovsky, AV; Borisenko, IE; Lapebie, P; Gazave, E; Tokina, DB; Borchiellini, C				Ereskovsky, Alexander V.; Borisenko, Ilya E.; Lapebie, Pascal; Gazave, Eve; Tokina, Daria B.; Borchiellini, Carole			Oscarella lobularis (Homoscleromorpha, Porifera) Regeneration: Epithelial Morphogenesis and Metaplasia	PLOS ONE			English	Article							STEM-CELLS; SPONGE OSCARELLA; DEVELOPMENTAL BIOLOGY; CALCAREOUS SPONGE; MODEL SYSTEM; TRANSDIFFERENTIATION; GASTRULATION; EVOLUTION; EMBRYOGENESIS; INVAGINATION	Sponges are known to possess remarkable reconstitutive and regenerative abilities ranging from common wounding or body part regeneration to more impressive re-building of a functional body from dissociated cells. Among the four sponge classes, Homoscleromorpha is notably the only sponge group to possess morphologically distinct basement membrane and specialized cell-junctions, and is therefore considered to possess true epithelia. The consequence of this peculiar organization is the predominance of epithelial morphogenesis during ontogenesis of these sponges. In this work we reveal the underlying cellular mechanisms used during morphogenesis accompanying ectosome regeneration in the homoscleromorph sponge model: Oscarella lobularis. We identified three main sources of novel exopinacoderm during the processes of its regeneration and the restoration of functional peripheral parts of the aquiferous system in O. lobularis: (1) intact exopinacoderm surrounding the wound surface, (2) the endopinacoderm from peripheral exhalant and inhalant canals, and (3) the intact choanoderm found on the wound surface. The basic morphogenetic processes during regeneration are the spreading and fusion of epithelial sheets that merge into one continuous epithelium. Transdifferentiation of choanocytes into exopinacocytes is also present. Epithelial-mesenchymal transition is absent during regeneration. Moreover, we cannot reveal any other morphologically distinct pluripotent cells. In Oscarella, neither blastema formation nor local dedifferentiation and proliferation have been detected, which is probably due to the high morphogenetic plasticity of the tissue. Regeneration in O. lobularis goes through cell transdifferentiation and through the processes, when lost body parts are replaced by the remodeling of the remaining tissue. Morphogenesis during ectosome regeneration in O. lobularis is correlated with its true epithelial organization. Knowledge of the morphological basis of morphogenesis during Oscarella regeneration could have important implications for our understanding of the diversity and evolution of regeneration mechanisms in metazoans, and is a strong basis for future investigations with molecular-biological approaches.	[Ereskovsky, Alexander V.; Tokina, Daria B.; Borchiellini, Carole] Avignon Univ, Aix Marseille Univ, Inst Mediterraneen Biodivers & Ecol Marine & Cont, CNRS,IRD,Stn Marine Endoume, Marseille, France; [Ereskovsky, Alexander V.; Borisenko, Ilya E.] St Petersburg State Univ, Dept Embryol, Fac Biol, St Petersburg 199034, Russia; [Lapebie, Pascal] UPMC, CNRS, Observ Oceanol Quai Darse, Lab Biol Dev Villefranche Mer,UMR7009, Villefranche Sur Mer, France; [Gazave, Eve] Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS,UMR 7592, Paris, France	Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Saint Petersburg State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Ereskovsky, AV (corresponding author), Avignon Univ, Aix Marseille Univ, Inst Mediterraneen Biodivers & Ecol Marine & Cont, CNRS,IRD,Stn Marine Endoume, Marseille, France.	alexander.ereskovsky@imbe.fr	Ereskovsky, Alexander/B-3136-2013; Ereskovsky, Alexander/W-1504-2019; Borisenko, Ilya E/G-1428-2015	Ereskovsky, Alexander/0000-0003-1079-7204; Borisenko, Ilya E/0000-0002-5575-7639; Gazave, Eve/0000-0002-4647-6640; Lapebie, Pascal/0000-0003-4073-0633	Russian Foundation for Basic Research [13-04-01084]; Saint-Petersburg State University [1.38.209.2014]; French Government A*MIDEX project [ANR-ll-IDEX-DOOI-02]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Saint-Petersburg State University; French Government A*MIDEX project(French National Research Agency (ANR))	This work was supported by 13-04-01084 Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng/about) to AVE, IEB, and DBT for data collection and analysis; 1.38.209.2014 Saint-Petersburg State University grants (http://spbu.ru/images/orders/2015/496_1.pdf) to AVE and IEB for data collection and analysis; and ANR-ll-IDEX-DOOI-02 French Government A*MIDEX project (http://amidex.univ-amu.fr/) to AVE and CB for preparation of the manuscript.	Agata K, 2007, DEV GROWTH DIFFER, V49, P73, DOI 10.1111/j.1440-169x.2007.00919.x; Alvarado AS, 2000, BIOESSAYS, V22, P578, DOI 10.1002/(SICI)1521-1878(200006)22:6<578::AID-BIES11>3.0.CO;2-#; [Anonymous], 1969, VESTNIK LENINGR STAT; Borisenko IE, 2015, PEERJ, V3, DOI 10.7717/peerj.1211; Borojevid R., 1970, Symp. zool. Soc. Lond., VNo. 25, P467; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Brockes JP, 2001, J ANAT, V199, P3; Carlson B. M., 2007, PRINCIPLES REGENERAT; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Diaz J.-P., 1977, Bulletin Mus Natn Hist Nat Paris (Zool), VNo. 308, P373; Duboscq O, 1935, CR HEBD ACAD SCI, V200, P1788; Eerkes-Medrano DI, 2006, INVERTEBR BIOL, V125, P177, DOI 10.1111/j.1744-7410.2006.00051.x; Ereskovsky AV, 2007, J MORPHOL, V268, P518, DOI 10.1002/jmor.10506; Ereskovsky AV, 2007, MAR BIOL, V151, P425, DOI 10.1007/s00227-006-0439-5; Ereskovsky AV, 2006, ZOOTAXA, P37, DOI 10.11646/zootaxa.1376.1.2; Ereskovsky AV, 2013, DEV GENES EVOL, V223, P5, DOI 10.1007/s00427-012-0399-3; Ereskovsky AV, 2010, ZOOMORPHOLOGY, V129, P21, DOI 10.1007/s00435-009-0097-5; Ereskovsky AV, 2009, CAH BIOL MAR, V50, P369; Ereskovsky AV, 2009, BIOESSAYS, V31, P89, DOI 10.1002/bies.080058; Ereskovsky Alexander V., 2000, Zoosystema, V22, P355; Ereskovsky AV, 2010, COMPARATIVE EMBRYOLOGY OF SPONGES, P1, DOI 10.1007/978-90-481-8575-7; Ereskovsky AV, 2002, J NAT HIST, V36, P1761, DOI 10.1080/00222930110069050; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Funayama N, 2013, DEV GENES EVOL, V223, P23, DOI 10.1007/s00427-012-0417-5; Funayama N, 2010, DEV GROWTH DIFFER, V52, P1, DOI 10.1111/j.1440-169X.2009.01162.x; Gaino Elda, 1995, Animal Biology, V4, P31; Galliot B, 2012, INT J DEV BIOL, V56, P411, DOI 10.1387/ijdb.120086bg; Galliot B, 2010, MOL REPROD DEV, V77, P837, DOI 10.1002/mrd.21206; Gazave E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063976; Gazave E, 2012, HYDROBIOLOGIA, V687, P3, DOI 10.1007/s10750-011-0842-x; Gonobobleva EL, 2004, B MUS I BIOL U GEN, V68, P349; Gonobobleva Elisaveta L., 2004, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V74, P101; Holstein TW, 2003, DEV DYNAM, V226, P257, DOI 10.1002/dvdy.10227; Isaeva VV, 2011, RUSS J MAR BIOL+, V37, P209, DOI 10.1134/S1063074011030059; Isaeva V, 2009, RUSS J DEV BIOL+, V40, P57, DOI 10.1134/S1062360409020015; Kaneto S, 2011, J EXP ZOOL PART B, V316B, P409, DOI 10.1002/jez.b.21411; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Kimberly EL, 1998, DEV BIOL, V204, P235, DOI 10.1006/dbio.1998.9075; KOROTKO GP, 1961, ACTA BIOL ACAD SCI H, V11, P315; Korotkova G., 1997, REGENERATION ANIMALS; KOROTKOVA G P, 1972, Trudy Leningradskogo Obshchestva Estestvoispytatelei, V78, P74; Korotkova G. P., 1970, Symp. zool. Soc. Lond., VNo. 25, P423; Korotkova G. P., 1963, Vestnik Leningrad Univ, V3, P34; KOROTKOVA G. P., 1963, CAHIERS BIOL MAR, V4, P47; Korotkova GP, 1969, MORPHOLOGICAL INVEST, P9; Korotkova GP, 1979, BIOL SPONGIAURES, V291, P53; Kraus Y, 2006, DEV GENES EVOL, V216, P119, DOI 10.1007/s00427-005-0038-3; Lapebie P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005823; Laplante M., 2014, 5 M EUR SOC EV DEV B, P374, DOI [10.1016/S0092-8674(00)81280-5, DOI 10.1016/S0092-8674(00)81280-5]; Leys SP, 2006, CAN J ZOOL, V84, P262, DOI 10.1139/Z05-170; Leys SP, 2005, INTEGR COMP BIOL, V45, P342, DOI 10.1093/icb/45.2.342; Mochii M, 1998, DEV BIOL, V196, P145, DOI 10.1006/dbio.1998.8864; Morgan T.H., 1901, REGENERATION; Muller WEG, 2006, SEMIN CELL DEV BIOL, V17, P481, DOI 10.1016/j.semcdb.2006.05.006; Okada LS, 1991, TRANSDIFFERENTIATION; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rinkevich B, 2013, CELLS, V2, P1, DOI DOI 10.3390/CELLS2010001; Salvenmoser W, 2001, BELG J ZOOL, V131, P105; SCHMID V, 1992, INT REV CYTOL, V142, P213, DOI 10.1016/S0074-7696(08)62077-X; Simpson T., 1984, CELL BIOL SPONGES; Slack JMW, 2001, CURR OPIN GENET DEV, V11, P581, DOI 10.1016/S0959-437X(00)00236-7; Somorjai IML, 2012, P NATL ACAD SCI USA, V109, P517, DOI 10.1073/pnas.1100045109; Sukhodolskaya A.N., 1973, P127; Thowfeequ S, 2007, DEV DYNAM, V236, P3208, DOI 10.1002/dvdy.21336; Tsonis PA, 2004, INT J DEV BIOL, V48, P975, DOI 10.1387/ijdb.041867pt; Vervoort Michel, 2011, Biology Theory, V6, P25, DOI 10.1007/s13752-011-0005-3; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Worheide G, 2012, ADV MAR BIOL, V61, P1, DOI 10.1016/B978-0-12-387787-1.00007-6; Wolpert L., 1998, PRINCIPLES DEV	69	26	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134566	10.1371/journal.pone.0134566	http://dx.doi.org/10.1371/journal.pone.0134566			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270639	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800010
J	Maurer, C; Stief, F; Jonas, A; Kovac, A; Groneberg, DA; Meurer, A; Ohlendorf, D				Maurer, Christian; Stief, Felix; Jonas, Alexander; Kovac, Andrej; Groneberg, David Alexander; Meurer, Andrea; Ohlendorf, Daniela			Influence of the Lower Jaw Position on the Running Pattern	PLOS ONE			English	Article							UNILATERAL POSTERIOR CROSSBITE; DENTAL OCCLUSION; POSTURAL STABILITY; MOVEMENT PATTERNS; GAIT PATTERNS; BODY POSTURE; FORCE; HEAD; APPARATUS; MUSCLES	Introduction The effects of manipulated dental occlusion on body posture has been investigated quite often and discussed controversially in the literature. Far less attention has been paid to the influence of dental occlusion position on human movement. If human movement was analysed, it was mostly while walking and not while running. This study was therefore designed to identify the effect of lower jaw positions on running behaviour according to different dental occlusion positions. Methods Twenty healthy young recreational runners (mean age = 33.9 +/- 5.8 years) participated in this study. Kinematic data were collected using an eight-camera Vicon motion capture system (VICON Motion Systems, Oxford, UK). Subjects were consecutively prepared with four different dental occlusion conditions in random order and performed five running trials per test condition on a level walkway with their preferred running shoes. Vector based pattern recognition methods, in particular cluster analysis and support vector machines (SVM) were used for movement pattern identification. Results Subjects exhibited unique movement patterns leading to 18 clusters for the 20 subjects. No overall classification of the splint condition could be observed. Within individual subjects different running patterns could be identified for the four splint conditions. The splint conditions lead to a more symmetrical running pattern than the control condition. Discussion The influence of an occlusal splint on running pattern can be confirmed in this study. Wearing a splint increases the symmetry of the running pattern. A more symmetrical running pattern might help to reduce the risk of injuries or help in performance. The change of the movement pattern between the neutral condition and any of the three splint conditions was significant within subjects but not across subjects. Therefore the dental splint has a measureable influence on the running pattern of subjects, however subjects individuality has to be considered when choosing the optimal splint condition for a specific subject.	[Maurer, Christian; Kovac, Andrej] Move Funct, Salzburg, Austria; [Stief, Felix; Meurer, Andrea] Orthopaed Univ Hosp Friedrichsheim gGmbH, Frankfurt, Germany; [Jonas, Alexander] Goethe Univ Frankfurt, Inst Sport Sci, Dept Movement & Exercise Sci, D-60054 Frankfurt, Germany; [Groneberg, David Alexander; Ohlendorf, Daniela] Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Ohlendorf, D (corresponding author), Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, D-60054 Frankfurt, Germany.	occup-med@uni-frankfurt.de	Mickel, Christoph/U-2400-2017; Groneberg, David/A-5132-2018; Maurer, Christian/AAS-9688-2020; Stief, Felix/AAC-3138-2019	Mickel, Christoph/0000-0002-0202-5100; Groneberg, David/0000-0001-8551-6556; Maurer, Christian/0000-0002-8426-813X; Stief, Felix/0000-0001-7088-3927; Meurer, Andrea M./0000-0002-1878-9551	Move functional, Salzburg	Move functional, Salzburg	Author Christian Maurer is affiliated with Move functional, Salzburg. Move functional, Salzburg provided support in the form of salary for Christian Maurer, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alaqtash M, 2011, IEEE ENG MED BIO, P453, DOI 10.1109/IEMBS.2011.6090063; Baldini A, 2013, CLINICS, V68, P45, DOI 10.6061/clinics/2013(01)OA07; Begg R, 2005, J BIOMECH, V38, P401, DOI 10.1016/j.jbiomech.2004.05.002; Bracco P, 2004, NEUROSCI LETT, V356, P228, DOI 10.1016/j.neulet.2003.11.055; Bumann A., 2002, TMJ DISORDERS OROFAC; Cerna M, 2015, J ORAL REHABIL, V42, P544, DOI 10.1111/joor.12284; Cuccia AM, 2011, J BODYW MOV THER, V15, P242, DOI 10.1016/j.jbmt.2010.10.007; D'Ermes Vittorio, 2012, Ann Stomatol (Roma), V3, P113; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Duda R.O., 2000, PATTERN CLASSIFICATI; Duddy FA, 2012, DENT TRAUMATOL, V28, P263, DOI 10.1111/j.1600-9657.2011.01106.x; Eble O S, 2000, J Orofac Orthop, V61, P100, DOI 10.1007/BF01300352; Ferrario VF, 1996, J PROSTHET DENT, V76, P302, DOI 10.1016/S0022-3913(96)90176-6; Francis K T, 1991, Br J Sports Med, V25, P227; Fujimoto Mariko, 2001, Journal of Medical and Dental Sciences, V48, P131; FUNAKOSHI M, 1976, J DENT RES, V55, P684, DOI 10.1177/00220345760550042401; GOLE DR, 1993, CRANIO, V11, P55, DOI 10.1080/08869634.1993.11677941; Havel SC, 2003, J BIOMECH, V36, P759, DOI 10.1016/S0021-9290(03)00009-5; HERZOG W, 1989, MED SCI SPORT EXER, V21, P110, DOI 10.1249/00005768-198902000-00020; Janssen D, 2011, HUM MOVEMENT SCI, V30, P966, DOI 10.1016/j.humov.2010.08.010; Jordan K, 2006, GAIT POSTURE, V24, P120, DOI 10.1016/j.gaitpost.2005.08.003; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kopp S., 2005, OKKLUSALE KLINISCH F; Lee YK, 2012, MED HYPOTHESES, V79, P761, DOI 10.1016/j.mehy.2012.08.023; Maeda Y, 2009, DENT TRAUMATOL, V25, P556, DOI 10.1111/j.1600-9657.2009.00822.x; Manfredini D, 2012, J ORAL REHABIL, V39, P463, DOI 10.1111/j.1365-2842.2012.02291.x; MANNI E, 1975, EXP NEUROL, V47, P330, DOI 10.1016/0014-4886(75)90261-7; Maurer C, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.49; Maurer C, 2012, GAIT POSTURE, V36, P40, DOI 10.1016/j.gaitpost.2011.12.023; Michelotti A, 2006, NEUROSCI LETT, V392, P140, DOI 10.1016/j.neulet.2005.09.008; Michelotti A, 1999, Minerva Stomatol, V48, P525; Michelotti A, 2007, EUR J ORTHODONT, V29, P622, DOI 10.1093/ejo/cjm071; Michelotti Ambra, 2011, Prog Orthod, V12, P53, DOI 10.1016/j.pio.2010.09.010; Miles TS, 2004, HUM MOVEMENT SCI, V23, P337, DOI 10.1016/j.humov.2004.08.010; MILES TS, 1993, J NEUROSCI METH, V46, P197, DOI 10.1016/0165-0270(93)90067-2; Miles TS, 2004, J PHYSIOL-LONDON, V554, P216, DOI 10.1113/jphysiol.2003.050443; Miles TS, 2002, ADV EXP MED BIOL, V508, P443; Nigg S, 2013, GAIT POSTURE, V38, P115, DOI 10.1016/j.gaitpost.2012.10.024; Nobili A, 1996, CRANIO, V14, P274, DOI 10.1080/08869634.1996.11745978; Ohlendorf D, 2013, Minerva Stomatol, V62, P409; Ohlendorf D, 2011, D Z SPORTMED, V12, P16; Ohlendorf D, 2014, SPINE J, V14, P2384, DOI 10.1016/j.spinee.2014.01.045; Ohlendorf D, 2012, PRAVENT GESUNDHEIT, V7, P256, DOI 10.1007/s11553-012-0360-3; Perinetti G, 2006, GAIT POSTURE, V24, P165, DOI 10.1016/j.gaitpost.2005.07.012; Perinetti Giuseppe, 2007, J Contemp Dent Pract, V8, P60; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saccucci M, 2011, SCOLIOSIS SPINAL DIS, V6, DOI 10.1186/1748-7161-6-15; Solow B, 1998, EUR J ORTHODONT, V20, P685, DOI 10.1093/ejo/20.6.685; SZENTAGOTHAI J, 1958, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V197, P335, DOI 10.1007/BF00345842; SZENTAGOTHAI J, 1983, REV PHYSIOL BIOCH P, V98, P11, DOI 10.1007/BFb0033866; Tardieu C, 2009, NEUROSCI LETT, V450, P221, DOI 10.1016/j.neulet.2008.12.005; Tecco S, 2008, Minerva Stomatol, V57, P399; Tecco Simona, 2010, BMC Res Notes, V3, P141, DOI 10.1186/1756-0500-3-141; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; URBANOWICZ M, 1991, CRANIO, V9, P174, DOI 10.1080/08869634.1991.11678365; von Arx T, 2008, INT J SPORTS MED, V29, P435, DOI 10.1055/s-2007-965341; von Tscharner V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065063; Watanabe I, 1999, Kokubyo Gakkai Zasshi, V66, P8; Wollny R, 2007, BEWEGUNGSWISSENSCHAF; WOLTRING HJ, 1991, HUM MOVEMENT SCI, V10, P603, DOI 10.1016/0167-9457(91)90048-3; Yurchenko M, 2014, INT DENT J, V64, P12, DOI 10.1111/idj.12057	61	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135712	10.1371/journal.pone.0135712	http://dx.doi.org/10.1371/journal.pone.0135712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270961	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800103
J	Spietz, RL; Williams, CM; Rocap, G; Horner-Devine, MC				Spietz, Rachel L.; Williams, Cheryl M.; Rocap, Gabrielle; Horner-Devine, M. Claire			A Dissolved Oxygen Threshold for Shifts in Bacterial Community Structure in a Seasonally Hypoxic Estuary	PLOS ONE			English	Article							PUGET-SOUND; BLACK-SEA; MICROBIAL ECOLOGY; WATER COLUMN; DIVERSITY; DEOXYGENATION; ASSEMBLAGES; ABUNDANCE; DYNAMICS; EUTROPHICATION	Pelagic ecosystems can become depleted of dissolved oxygen as a result of both natura processes and anthropogenic effects. As dissolved oxygen concentration decreases, energy shifts from macrofauna to microorganisms, which persist in these hypoxic zones. Oxygen-limited regions are rapidly expanding globally; however, patterns of microbial communities associated with dissolved oxygen gradients are not yet well understood. To assess the effects of decreasing dissolved oxygen on bacteria, we examined shifts in bacterial community structure over space and time in Hood Canal, Washington, USA-a glacial fjord-like water body that experiences seasonal low dissolved oxygen levels known to be detrimental to fish and other marine organisms. We found a strong negative association between bacterial richness and dissolved oxygen. Bacterial community composition across all samples was also strongly associated with the dissolved oxygen gradient, and significant changes in bacterial community composition occurred at a dissolved oxygen concentration between 5.18 and 7.12 mg O2L-1. This threshold value of dissolved oxygen is higher than classic definitions of hypoxia (<2.0 mg O2L-1), suggesting that changes in bacterial communities may precede the detrimental effects on ecologically and economically important macrofauna. Furthermore, bacterial taxa responsible for driving whole community changes across the oxygen gradient are commonly detected in other oxygen-stressed ecosystems, suggesting that the patterns we uncovered in Hood Canal may be relevant in other low oxygen ecosystems.	[Spietz, Rachel L.; Horner-Devine, M. Claire] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Spietz, Rachel L.; Williams, Cheryl M.; Rocap, Gabrielle] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Spietz, RL (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	rklange@u.washington.edu		Horner-Devine, Claire/0000-0002-0783-3406; Spietz, Rachel/0000-0001-5277-0734; Rocap, Gabrielle/0000-0001-7253-611X	U.S. Navy, Naval Sea Systems Command [N0024-02-D-6602/50]; W.M. Keck Foundation; NOAA [NA07NOS4730203]; National Science Foundation Graduate Research Fellowship Program; School of Aquatic and Fishery Sciences at the University of Washington	U.S. Navy, Naval Sea Systems Command; W.M. Keck Foundation(W.M. Keck Foundation); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); School of Aquatic and Fishery Sciences at the University of Washington(University of Washington)	Sampling was accomplished through a Hood Canal Dissolved Oxygen Program Integrated Assessment and Modeling (HCDOP-IAM) program award to GR and MCHD funded through the U.S. Navy, Naval Sea Systems Command (N0024-02-D-6602/50). Sequencing was performed as part of the International Census of Marine Microbes (ICoMM) supported by a W.M. Keck Foundation award to the Marine Biological Laboratory at Woods Hole. Collection and maintenance of ORCA buoy data provided by NANOOS, part of the U.S. IOOS, was funded by NOAA (NA07NOS4730203). RLS acknowledges support from the National Science Foundation Graduate Research Fellowship Program and the School of Aquatic and Fishery Sciences at the University of Washington.	Allison SD, 2008, PNAS, V105; Amaral-Zettler Linda, 2010, P223; Babson AL, 2006, ATMOS OCEAN, V44, P29, DOI 10.3137/ao.440103; Baird D, 2004, ECOL APPL, V14, P805, DOI 10.1890/02-5094; Baker ME, 2010, METHODS ECOL EVOL, V1, P25, DOI 10.1111/j.2041-210X.2009.00007.x; Beman JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3705; Bouvy M, 2011, ENVIRON MICROBIOL, V13, P1842, DOI 10.1111/j.1462-2920.2011.02498.x; Brewer PG, 2014, DEEP SEA RES 1; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; CARPENTER JAMES H., 1965, LIMNOL OCEANOGR, V10, P141; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Cheng W, 2002, FISH SHELLFISH IMMUN, V13, P351, DOI 10.1006/fsim.2001.0411; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; Devol AH, 2007, ENV RES ENG MANAGEME, V1, P19; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Eby LA, 2002, CAN J FISH AQUAT SCI, V59, P952, DOI 10.1139/F02-067; Froehlich HE, 2014, ESTUAR COAST, V37, P449, DOI 10.1007/s12237-013-9676-2; Fuchs BM, 2005, AQUAT MICROB ECOL, V39, P145, DOI 10.3354/ame039145; Fuchsman CA, 2011, FEMS MICROBIOL ECOL, V78, P586, DOI 10.1111/j.1574-6941.2011.01189.x; Hofmann AF, 2011, DEEP-SEA RES PT I, V58, P1212, DOI 10.1016/j.dsr.2011.09.004; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Horner-Devine MC, 2003, ECOL LETT, V6, P613; Howarth R, 2011, FRONT ECOL ENVIRON, V9, P18, DOI 10.1890/100008; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; JORGENSEN BB, 1980, OIKOS, V34, P68, DOI 10.2307/3544551; Judd KE, 2006, ECOLOGY, V87, P2068, DOI 10.1890/0012-9658(2006)87[2068:VIDOMC]2.0.CO;2; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Keister JE, 2013, LIMNOL OCEANOGR, V58, P667, DOI 10.4319/lo.2013.58.2.0667; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Labrenz M, 2007, AQUAT MICROB ECOL, V46, P177, DOI 10.3354/ame046177; Legendre P., 2012, NUMERICAL ECOLOGY; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lin XJ, 2006, APPL ENVIRON MICROB, V72, P2679, DOI 10.1128/AEM.72.4.2679-2690.2006; Madrid VM, 2001, APPL ENVIRON MICROB, V67, P1663, DOI 10.1128/AEM.67.4.1663-1674.2001; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Moore SK, 2008, ESTUAR COAST SHELF S, V80, P545, DOI 10.1016/j.ecss.2008.09.016; Newton J, 2009, DECIS ANAL, V2, P5; Newton J. A., 2011, HOOD CANAL DISSOLVED; Palsson WA, 2008, AM FISH S S, V64, P255; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rabalais NN, 2014, OCEANOGRAPHY, V27, P172, DOI 10.5670/oceanog.2014.21; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Steinberg PD, 2011, BIOGEOCHEMISTRY, V106, P415, DOI 10.1007/s10533-010-9521-7; Stevens H, 2008, ENVIRON MICROBIOL, V10, P1244, DOI 10.1111/j.1462-2920.2007.01539.x; Stolper DA, 2010, P NATL ACAD SCI USA, V107, P18755, DOI 10.1073/pnas.1013435107; UNESCO, 1994, PROT JOINT GLOB OC F, V29; Urakawa H, 2010, APPL ENVIRON MICROB, V76, P2129, DOI 10.1128/AEM.02692-09; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Vergin KL, 2013, ISME J, V7, P1322, DOI 10.1038/ismej.2013.32; Vetriani C, 2003, APPL ENVIRON MICROB, V69, P6481, DOI 10.1128/AEM.69.11.6481-6488.2003; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Wakeham SG, 2007, ORG GEOCHEM, V38, P2070, DOI 10.1016/j.orggeochem.2007.08.003; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778; Zaikova E, 2010, ENVIRON MICROBIOL, V12, P172, DOI 10.1111/j.1462-2920.2009.02058.x; Zubkov MV, 2006, AQUAT MICROB ECOL, V43, P23, DOI 10.3354/ame043023	61	55	58	9	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135731	10.1371/journal.pone.0135731	http://dx.doi.org/10.1371/journal.pone.0135731			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270047	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800105
J	Tille, JC; Ho, L; Shah, J; Seyde, O; McKee, TA; Citi, S				Tille, Jean-Christophe; Ho, Liza; Shah, Jimit; Seyde, Olivia; McKee, Thomas A.; Citi, Sandra			The Expression of the Zonula Adhaerens Protein PLEKHA7 Is Strongly Decreased in High Grade Ductal and Lobular Breast Carcinomas	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; E-CADHERIN; ADHERENS JUNCTIONS; TIGHT JUNCTIONS; CANCER PROGRESSION; MAMMARY-CARCINOMA; EPITHELIAL-CELLS; SUPPRESSOR GENE; P120 CATENIN; P120-CATENIN	PLEKHA7 is a junctional protein, which participates in a complex that stabilizes E-cadherin at the zonula adhaerens. Since E-cadherin is involved in epithelial morphogenesis, signaling, and tumor progression, we explored PLEKHA7 expression in cancer. PLEKHA7 expression was assessed in invasive ductal and lobular carcinomas of the breast by immunohistochemistry, immunofluorescence and quantitative RT-PCR. PLEKHA7 was detected at epithelial junctions of normal mammary ducts and lobules, and of tubular and micropapillary structures within G1 and G2 ductal carcinomas. At these junctions, the localization of PLEKHA7 was along the circumferential belt (zonula adhaerens), and only partially overlapping with that of E-cadherin, p120ctn and ZO-1, as shown previously in rodent tissues. PLEKHA7 immunolabeling was strongly decreased in G3 ductal carcinomas and undetectable in lobular carcinomas. PLEKHA7 mRNA was detected in both ductal and lobular carcinomas, with no observed correlation between mRNA levels and tumor type or grade. In summary, PLEKHA7 is a junctional marker of epithelial cells within tubular structures both in normal breast tissue and ductal carcinomas, and since PLEKHA7 protein but not mRNA expression is strongly decreased or lost in high grade ductal carcinomas and in lobular carcinomas, loss of PLEKHA7 is a newly characterized feature of these carcinomas.	[Tille, Jean-Christophe; Ho, Liza; Seyde, Olivia; McKee, Thomas A.] Univ Hosp Geneva, Div Clin Pathol, Geneva, Switzerland; [Shah, Jimit; Citi, Sandra] Univ Geneva, Dept Cell Biol, Geneva, Switzerland; [Shah, Jimit; Citi, Sandra] Univ Geneva, Inst Genom & Genet Geneva iGE3, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Citi, S (corresponding author), Univ Geneva, Dept Cell Biol, Geneva, Switzerland.	sandra.citi@unige.ch	tille, jc/HII-7658-2022	McKee, Thomas/0000-0002-2147-3136; Citi, Sandra/0000-0002-6537-4818	Swiss Cancer League [KFS-2813-08-2011]; Swiss Fond National [3100_135730]; Ligue Genevoise contre le Cancer Project [1013]	Swiss Cancer League; Swiss Fond National; Ligue Genevoise contre le Cancer Project	This work was supported by the Swiss Cancer League, KFS-2813-08-2011 (http://www.krebsliga.ch) (SC); Swiss Fond National, 3100_135730 (http://www.snf.ch) (SC); and Ligue Genevoise contre le Cancer Project n. 1013 (http://www.lgc.ch) (JCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Cardellini P, 1996, DEV DYNAM, V207, P104, DOI 10.1002/(SICI)1097-0177(199609)207:1<104::AID-AJA10>3.0.CO;2-0; Castellana B, 2012, HUM PATHOL, V43, P1902, DOI 10.1016/j.humpath.2012.01.017; CITI S, 1991, AM J PATHOL, V138, P781; Citi Sandra, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.973760; Dabbs DJ, 2013, AM J SURG PATHOL, V37, pE1, DOI 10.1097/PAS.0b013e3182918a2b; DeLeeuw WJF, 1997, J PATHOL, V183, P404, DOI 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Dillon DA, 1998, AM J PATHOL, V152, P75; Droufakou S, 2001, INT J CANCER, V92, P404, DOI 10.1002/ijc.1208; Elloul S, 2014, MOL CANCER RES, V12, P464, DOI 10.1158/1541-7786.MCR-13-0398; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Endres BT, 2014, P NATL ACAD SCI USA, V111, P12817, DOI 10.1073/pnas.1410745111; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fournier G, 2011, ONCOGENE, V30, P3862, DOI 10.1038/onc.2011.106; Geiger T, 2012, CANCER RES, V72, P2428, DOI 10.1158/0008-5472.CAN-11-3711; Gonzalez-Mariscal L, 2007, PROG HISTOCHEM CYTO, V42, P1, DOI 10.1016/j.proghi.2007.01.001; Gruel N, 2010, EUR J CANCER, V46, P2399, DOI 10.1016/j.ejca.2010.05.013; Guillemot L, 2014, MOL BIOL CELL, V25, P1995, DOI 10.1091/mbc.E13-11-0680; Kourtidis A, 2013, PROG MOL BIOL TRANSL, V116, P409, DOI 10.1016/B978-0-12-394311-8.00018-2; Kurita S, 2013, J BIOL CHEM, V288, P29356, DOI 10.1074/jbc.M113.453464; Lakhani SR, 2012, WHO CLASSIFICATION T; Letessier A, 2007, ONCOGENE, V26, P298, DOI 10.1038/sj.onc.1209772; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; LUNAMORE S, 1994, PATHOL RES PRACT, V190, P668, DOI 10.1016/S0344-0338(11)80745-4; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Paschoud S, 2007, MODERN PATHOL, V20, P947, DOI 10.1038/modpathol.3800835; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Shibata T, 2004, AM J PATHOL, V164, P2269, DOI 10.1016/S0002-9440(10)63783-2; Spadaro D, 2014, J BIOL CHEM, V289, P22500, DOI 10.1074/jbc.M114.556449; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Weigelt B, 2010, J PATHOL, V220, P45, DOI 10.1002/path.2629; Wythe JD, 2011, DIS MODEL MECH, V4, P607, DOI 10.1242/dmm.002204; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	44	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135442	10.1371/journal.pone.0135442	http://dx.doi.org/10.1371/journal.pone.0135442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270346	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800070
J	Bastian, B; Zhang, AR; Moffat, K				Bastian, Brock; Zhang, Airong; Moffat, Kieren			The Interaction of Economic Rewards and Moral Convictions in Predicting Attitudes toward Resource Use	PLOS ONE			English	Article							CLIMATE-CHANGE; SOCIAL LICENSE; ACCEPTANCE; IMPACTS; MONEY; GOVERNANCE; CONFIDENCE; DISHONESTY; OPERATE; BOOM	When people are morally convicted regarding a specific issue, these convictions exert a powerful influence on their attitudes and behavior. In the current research we examined whether there are boundary conditions to the influence of this effect. Specifically, whether in the context of salient economic rewards, moral convictions may become weaker predictors of attitudes regarding resource use. Focusing on the issue of mining we gathered large-scale samples across three different continents (Australia, Chile, and China). We found that moral convictions against mining were related to a reduced acceptance of mining in each country, while perceived economic rewards from mining increased acceptance. These two motivations interacted, however, such that when perceived economic benefit from mining was high, the influence of moral conviction was weaker. The results highlight the importance of understanding the roles of both moral conviction and financial gain in motivating attitudes towards resource use.	[Bastian, Brock] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Zhang, Airong; Moffat, Kieren] CSIRO Mineral Resources Flagship, Resources Soc Grp, Pullenvale, Qld, Australia	University of New South Wales Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Bastian, B (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	b.bastian@unsw.edu.au	Zhang, Airong/I-8581-2015; Moffat, Kieren/O-9088-2014	Moffat, Kieren/0000-0002-5823-3056; Bastian, Brock/0000-0003-4619-3322	Australian Research Council [FT130101177]; Australia-China Council, Department of Foreign Affairs and Trade Australia; CSIRO	Australian Research Council(Australian Research Council); Australia-China Council, Department of Foreign Affairs and Trade Australia; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This research was supported by an Australian Research Council grant awarded to Brock Bastian (FT130101177), the Australia-China Council, Department of Foreign Affairs and Trade Australia and the CSIRO.	Aiken L. S., 1991, MULTIPLE REGRESSION; [Anonymous], 2010, CUMULATIVE IMPACTS G; Becker G., 1976, EC APPROACH HUMAN BE; Bolderdijk JW, 2013, NAT CLIM CHANGE, V3, P413, DOI [10.1038/NCLIMATE1767, 10.1038/nclimate1767]; Bratanova B, 2012, EUR J SOC PSYCHOL, V42, P539, DOI 10.1002/ejsp.1871; Cardenas JC, 2000, WORLD DEV, V28, P1719, DOI 10.1016/S0305-750X(00)00055-3; Cardenas JC, 2002, ECOL ECON, V40, P379, DOI 10.1016/S0921-8009(01)00285-3; Contestabile M., 2012, NAT CLIM CHANG, V2, P231; Cronin T, 2012, BASIC APPL SOC PSYCH, V34, P322, DOI 10.1080/01973533.2012.693347; Davis R, 2011, P 1 INT SEM SOC RESP, V30; DePaulo BM, 1996, J PERS SOC PSYCHOL, V70, P979, DOI 10.1037/0022-3514.70.5.979; Dunlap RE, 1997, SOC SCI QUART, V78, P24; Dunlap RE, 1995, J SOC ISSUES, V51, P121, DOI 10.1111/j.1540-4560.1995.tb01351.x; Evans L, 2013, NAT CLIM CHANGE, V3, P122, DOI [10.1038/NCLIMATE1662, 10.1038/nclimate1662]; Fargher JD, 2003, RANGELAND J, V25, P140, DOI 10.1071/RJ03012; Farrell J, 2013, ENVIRON BEHAV, V45, P399, DOI 10.1177/0013916511422445; Feinberg M, 2013, PSYCHOL SCI, V24, P56, DOI 10.1177/0956797612449177; Fleming DA, 2015, AUST J AGR RESOUR EC, V59, P78, DOI 10.1111/1467-8489.12043; Foer Jonathan Safran, 2009, EATING ANIMALS; Franzen A, 2010, EUR SOCIOL REV, V26, P219, DOI 10.1093/esr/jcp018; Furnham A., 1986, EC MIND SOCIAL PSYCH; Gino F, 2014, PSYCHOL SCI, V25, P973, DOI 10.1177/0956797614520714; Gino F, 2014, PSYCHOL SCI, V25, P414, DOI 10.1177/0956797613506438; Gino F, 2009, ORGAN BEHAV HUM DEC, V109, P142, DOI 10.1016/j.obhdp.2009.03.003; Gino F, 2009, PSYCHOL SCI, V20, P393, DOI 10.1111/j.1467-9280.2009.02306.x; Hornsey M. J., 2007, SOC INFLUENCE, V2, P244, DOI [10.1080/15534510701476500, DOI 10.1080/15534510701476500]; Hornsey MJ, 2003, BRIT J SOC PSYCHOL, V42, P319, DOI 10.1348/014466603322438189; Kortenkamp KV, 2001, J ENVIRON PSYCHOL, V21, P261, DOI 10.1006/jevp.2001.0205; Markowitz EM, 2012, CLIMATIC CHANGE, V114, P479, DOI 10.1007/s10584-012-0422-8; Markowitz EM, 2012, NAT CLIM CHANGE, V2, P243, DOI [10.1038/NCLIMATE1378, 10.1038/nclimate1378]; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; Moffat K, 2014, RESOUR POLICY, V39, P61, DOI 10.1016/j.resourpol.2013.11.003; Morgan GS, 2012, ANAL SOC ISS PUB POL, V10, P307; Mullen E, 2008, J EXP SOC PSYCHOL, V44, P1239, DOI 10.1016/j.jesp.2008.04.001; Pini B, 2010, SOC CULT GEOGR, V11, P559, DOI 10.1080/14649365.2010.497850; Prno J, 2012, RESOUR POLICY, V37, P346, DOI 10.1016/j.resourpol.2012.04.002; Rolfe J, 2007, AUSTRALAS J REG STUD, V13, P134; Sacchi S, 2014, J ENVIRON PSYCHOL, V38, P252, DOI 10.1016/j.jenvp.2014.03.001; Siegrist M, 2012, RISK ANAL, V32, P1394, DOI 10.1111/j.1539-6924.2011.01739.x; Singer P, 1981, THE EXPANDING CIRCLE; Skitka LJ, 2008, POLIT PSYCHOL, V29, P29, DOI 10.1111/j.1467-9221.2007.00611.x; Skitka LJ, 2009, J PERS SOC PSYCHOL, V97, P567, DOI 10.1037/a0015998; Skitka LJ, 2005, J PERS SOC PSYCHOL, V88, P895, DOI 10.1037/0022-3514.88.6.895; STERN PC, 1986, POPUL ENVIRON, V8, P204; Thomson I., 2011, SME MINING ENG HDB, P673; Vohs KD, 2008, CURR DIR PSYCHOL SCI, V17, P208, DOI 10.1111/j.1467-8721.2008.00576.x; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Yang Q, 2013, J PERS SOC PSYCHOL, V104, P473, DOI 10.1037/a0030596; Zhang AR, 2015, RESOUR POLICY, V44, P25, DOI 10.1016/j.resourpol.2015.01.001	49	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134863	10.1371/journal.pone.0134863	http://dx.doi.org/10.1371/journal.pone.0134863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267904	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492300065
J	Huang, JX; An, JD; Wu, J; Williams, PH				Huang, Jiaxing; An, Jiandong; Wu, Jie; Williams, Paul H.			Extreme Food-Plant Specialisation in Megabombus Bumblebees as a Product of Long Tongues Combined with Short Nesting Seasons	PLOS ONE			English	Article							YULE-COALESCENT MODEL; SPECIES DELIMITATION; HISTORICAL BIOGEOGRAPHY; HYMENOPTERA APIDAE; TIBETAN PLATEAU; DIET BREADTH; RARITY; BOMBUS; BEES; LOCUS	Megabombus bumblebees have unusually long tongues and are generally more specialised than other bumblebees in their choice of food plants. The phylogeny of Megabombus bumblebees shows that speciation was concentrated in two periods. Speciation in the first period (ca 4.25-1.5 Ma) is associated with the late rise of the Hengduan Mountains at the eastern end of the Qinghai-Tibetan plateau. Speciation in the second period (1.2-0.3 Ma) is associated with climatic cooling in the northern forests. The most extreme food-specialist species belong to the second period, which may point to climate as a factor in specialisation. These extreme specialist species occur either in the far north (Bombus consobrinus), or at high elevations (Bombus gerstaeckeri), in situations where long tongues coincide with the shortest nesting seasons. Species with the longest tongues but occurring further south (even at high elevations) use a broader range of food plants.	[Huang, Jiaxing; An, Jiandong; Wu, Jie; Williams, Paul H.] Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Insect Pollinator Biol, Beijing 100093, Peoples R China; [Williams, Paul H.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs; Natural History Museum London	An, JD (corresponding author), Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Insect Pollinator Biol, Beijing 100093, Peoples R China.	anjiandong@caas.cn; apis@vip.sina.com			China Agriculture Research System [CARS-45]; Special Fund for Agro-scientific Research in the Public Interest [201203080-4]; SAFEA High-end Foreign Experts Program [GDJ20140326002]; International Exchange and Cooperation Program in Agricultural Science [A6950]; CAAS Agricultural Science and Technology Innovation Program [CAAS-ASTIP-2015-IAR]; CAAS Fundamental Research Funds [201422021]	China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest; SAFEA High-end Foreign Experts Program; International Exchange and Cooperation Program in Agricultural Science; CAAS Agricultural Science and Technology Innovation Program; CAAS Fundamental Research Funds	This work was supported financially by the China Agriculture Research System (CARS-45), the Special Fund for Agro-scientific Research in the Public Interest (201203080-4), the SAFEA High-end Foreign Experts Program (GDJ20140326002), the International Exchange and Cooperation Program in Agricultural Science (A6950), the CAAS Agricultural Science and Technology Innovation Program (CAAS-ASTIP-2015-IAR), the CAAS Fundamental Research Funds (201422021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JD, 2011, ZOOTAXA, P1; An JD, 2014, ZOOTAXA, V3830, P1, DOI 10.11646/zootaxa.3830.1.1; Aytekin A. Murat, 2003, Turkish Journal of Zoology, V27, P195; Camargo A, 2012, SYST BIOL, V61, P272, DOI 10.1093/sysbio/syr105; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DELMAS R, 1976, ANN SOC ENTOMOL FR, V12, P247; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson D, 2004, APIDOLOGIE, V35, P55, DOI 10.1051/apido:2003062; Goulson D, 2006, J INSECT CONSERV, V10, P95, DOI 10.1007/s10841-006-6286-3; Goulson D, 2008, BIODIVERS CONSERV, V17, P3269, DOI 10.1007/s10531-008-9428-y; Harris N, 2006, PALAEOGEOGR PALAEOCL, V241, P4, DOI 10.1016/j.palaeo.2006.07.009; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hines HM, 2012, ZOOL J LINN SOC-LOND, V166, P805, DOI 10.1111/j.1096-3642.2012.00861.x; Huang JX, 2015, APIDOLOGIE, V46, P250, DOI 10.1007/s13592-014-0319-9; ITO M, 1985, Folia Entomologica Hungarica, V46, P5; Kawakita A, 2004, MOL PHYLOGENET EVOL, V31, P799, DOI 10.1016/j.ympev.2003.12.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee Seung-Hwan, 1999, Insecta Koreana, V16, P77; LOKEN A, 1973, Norsk Entomologisk Tidsskrift, V20, P1; Loken A, 1961, P 11 INT C ENT, V1, P598; MJELDE A, 1983, Acta Entomologica Fennica, V42, P51; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Papadopoulou A, 2009, SYST BIOL, V58, P442, DOI 10.1093/sysbio/syp038; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Potapov P, 2008, REMOTE SENS ENVIRON, V112, P3708, DOI 10.1016/j.rse.2008.05.006; Prys-Jones O. E., 1982, Ecological studies of foraging and life history in bumblebees.; RASMONT P, 1988, ANN SOC ROY ZOOL BEL, V118, P141; Rasmont P., 2005, SURVEY WILD BEES HYM; Rasmont P., 1983, NOTES FAUNIQUES GEMB, V7, P1; Sithaldeen R, 2009, MOL PHYLOGENET EVOL, V53, P1042, DOI 10.1016/j.ympev.2009.07.038; Skorikov A. S, 1923, IZVESTIYA SEVERNOI O, V4, P1; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x; Williams P, 2005, BIOL CONSERV, V122, P33, DOI 10.1016/j.biocon.2004.06.019; Williams P.H., 1991, Bulletin of the British Museum (Natural History) Entomology, V60, P1; Williams P, 2009, SYST BIODIVERS, V7, P101, DOI 10.1017/S1477200008002843; Williams PH, 2008, APIDOLOGIE, V39, P46, DOI 10.1051/apido:2007052; Williams PH, 2012, SYST BIODIVERS, V10, P21, DOI 10.1080/14772000.2012.664574; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Williams Paul H., 1998, Bulletin of the Natural History Museum Entomology Series, V67, P79; WILLIAMS PH, 1989, BOT J LINN SOC, V101, P31, DOI 10.1111/j.1095-8339.1989.tb00134.x; Xie ZH, 2008, J INSECT CONSERV, V12, P695, DOI 10.1007/s10841-008-9180-3; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	51	30	33	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0132358	10.1371/journal.pone.0132358	http://dx.doi.org/10.1371/journal.pone.0132358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267382	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300005
J	Chen, YY; Lee, PC; Wu, YL; Liu, LY				Chen, Yung-Yi; Lee, Pei-Chi; Wu, Yi-Long; Liu, Li-Yun			In Vivo Effects of Free Form Astaxanthin Powder on Anti-Oxidation and Lipid Metabolism with High-Cholesterol Diet	PLOS ONE			English	Article							OXIDATIVE STRESS; ALPHA-TOCOPHEROL; BETA-CAROTENE; FREE-RADICALS; MICE; CANTHAXANTHIN; EXTRACTION; INCREASES; TISSUES; ASSAY	Astaxanthin extracted from Pomacea canaliculata eggs was made into free-form astaxanthin powder (FFAP) and its effects on lipid metabolism, liver function, antioxidants activities and astaxanthin absorption rate were investigated. 45 hamsters were split into 5 groups and fed with normal diet, high-cholesterol control (0.2% cholesterol), 1.6FFAP (control+1.6% FFAP), 3.2FFAP (control+3.2% FFAP) and 8.0FFAP (control+8.0% FFAP), respectively, for 6 weeks. FFAP diets significantly decreased the liver total cholesterol, triglyceride levels and increased liver fatty acids (C20:5n3;C22:6n3) compositions. It decreased plasma alanine aminotransferase and aspartate aminotransferase. In terms of anti-oxidative activities, we found 8.0 FFAP diet significantly decreased plasma and liver malonaldehyde (4.96 +/- 1.96 mu g TEP eq./mL and 1.56 +/- 0.38 mu g TEP eq./g liver) and liver 8-isoprostane levels (41.48 +/- 13.69 mu g 8-ISOP/g liver). On the other hand, it significantly increased liver catalase activity (149.10 +/- 10.76 mu mol/min/g liver), Vitamin C (2082.97 +/- 142.23 mu g/g liver), Vitamin E (411.32 +/- 81.67 mu g/g liver) contents, and glutathione levels (2.13 +/- 0.42 mg GSH eq./g liver). Furthermore, 80% of astaxanthin absorption rates in all FFAP diet groups suggest FFAP is an effective form in astaxanthin absorption. Finally, astaxanthin was found to redistribute to the liver and eyes in a dose dependent manner. Taken together, our results suggested that the appropriate addition of FFAP into high cholesterol diets increases liver anti-oxidative activity and reduces the concentration of lipid peroxidase and therefore, it may be beneficial as a material in developing healthy food.	[Chen, Yung-Yi] Univ Birmingham, Dept Immun & Infect, Liver Res Unit, Birmingham, W Midlands, England; [Lee, Pei-Chi; Liu, Li-Yun] Shih Chien Univ, Dept Food Sci Nutr & Nutraceut Biotechnol, Taipei, Taiwan; [Wu, Yi-Long] Bioptik Technol Inc, Dept Res & Dev, Hsin Tzu, Taiwan	University of Birmingham; Shih Chien University	Liu, LY (corresponding author), Shih Chien Univ, Dept Food Sci Nutr & Nutraceut Biotechnol, Taipei, Taiwan.	liyun@g2.usc.edu.tw	Wu, Yi-Long/AAB-9137-2022; Wu, Yi-Long/GRJ-9238-2022	Wu, Yi-Long/0000-0002-3611-0258; Chen, Yung-Yi/0000-0003-2999-3715	Jin Chang Yang, Bioptik Technnology Inc. [VSC-102-03-02010]; Bioptik Technology Inc. through Industry-University Cooperative Research framework in Taiwan; Bioptik Technology Inc.	Jin Chang Yang, Bioptik Technnology Inc.; Bioptik Technology Inc. through Industry-University Cooperative Research framework in Taiwan; Bioptik Technology Inc.	This research was supported by Jin Chang Yang, Bioptik Technnology Inc., grant number: VSC-102-03-02010. This study was supported and funded by Bioptik Technology Inc. through Industry-University Cooperative Research framework in Taiwan. Bioptik Technology Inc. provided support in the form of salaries for author YW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the Author Contributions section.	Ambati RR, 2014, MAR DRUGS, V12, P128, DOI 10.3390/md12010128; Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Augusti PR, 2012, J CLIN BIOCHEM NUTR, V51, P42, DOI 10.3164/jcbn.11-74; Bell JG, 2000, J NUTR, V130, P1800, DOI 10.1093/jn/130.7.1800; Bhuvaneswari SAE, 2010, PROCESS BIOCHEM, V45, P8; Choi HD, 2011, PLANT FOOD HUM NUTR, V66, P363, DOI 10.1007/s11130-011-0258-9; Ciccone MM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/782137; COHN VH, 1966, ANAL BIOCHEM, V14, P434, DOI 10.1016/0003-2697(66)90286-7; Curek GD, 2010, TOXICOLOGY, V267, P147, DOI 10.1016/j.tox.2009.11.003; Del Rio JC, 1998, ORG GEOCHEM, V29, P10; Dong LY, 2013, MAR DRUGS, V11, P960, DOI 10.3390/md11030960; Dreon MS, 2004, MOL REPROD DEV, V68, P359, DOI 10.1002/mrd.20078; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Hochgraf E, 1997, J NUTR, V127, P681, DOI 10.1093/jn/127.5.681; Hussein G, 2005, BIOL PHARM BULL, V28, P47, DOI 10.1248/bpb.28.47; Hussein G, 2006, J NAT PROD, V69, P443, DOI 10.1021/np050354+; Ikeuchi M, 2007, BIOSCI BIOTECH BIOCH, V71, P893, DOI 10.1271/bbb.60521; Iwamoto T, 2000, J Atheroscler Thromb, V7, P216; JAGOTA SK, 1982, ANAL BIOCHEM, V127, P178, DOI 10.1016/0003-2697(82)90162-2; Kang CD, 2007, BIOTECHNOL PROGR, V23, P866, DOI 10.1021/bp0700354; Karppi J, 2007, INT J VITAM NUTR RES, V77, P3, DOI 10.1024/0300-9831.77.1.3; Katalinic V, 2005, COMP BIOCHEM PHYS C, V140, P47, DOI 10.1016/j.cca.2005.01.005; Kim JH, 2011, J MED FOOD, V14, P1469, DOI 10.1089/jmf.2011.1626; Kurihara H, 2002, LIFE SCI, V70, P2509, DOI 10.1016/S0024-3205(02)01522-9; Leite MF, 2010, INT ENDOD J, V43, P959, DOI 10.1111/j.1365-2591.2010.01707.x; Maxwell SRJ, 1997, BRIT J CLIN PHARMACO, V44, P307, DOI 10.1046/j.1365-2125.1997.t01-1-00594.x; MIKI W, 1998, Patent No. 10155459; MILLER KW, 1984, ANAL BIOCHEM, V138, P340, DOI 10.1016/0003-2697(84)90819-4; Mimic-Oka J., 1999, MED BIOL, V6, P11; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Nishida Y, 2007, CAROTENOID SCI, V11, P4; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Osada K, 1998, LIPIDS, V33, P757, DOI 10.1007/s11745-998-0267-x; PALOZZA P, 1992, ARCH BIOCHEM BIOPHYS, V297, P291, DOI 10.1016/0003-9861(92)90675-M; Park JS, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-18; Pratico D, 2001, TRENDS ENDOCRIN MET, V12, P243, DOI 10.1016/S1043-2760(01)00411-8; Shen M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/954502; Shih CK, 2008, BRIT J NUTR, V99, P59, DOI 10.1017/S0007114507781497; TERAO J, 1989, LIPIDS, V24, P659, DOI 10.1007/BF02535085; Yang Y, 2015, BBA-GEN SUBJECTS, V1850, P178, DOI 10.1016/j.bbagen.2014.10.014; Yoshida H, 2010, ATHEROSCLEROSIS, V209, P520, DOI 10.1016/j.atherosclerosis.2009.10.012; [No title captured]	43	19	24	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134733	10.1371/journal.pone.0134733	http://dx.doi.org/10.1371/journal.pone.0134733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262684	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300040
J	Huang, G; Mouraux, A				Huang, Gan; Mouraux, Andre			MEP Latencies Predict the Neuromodulatory Effect of cTBS Delivered to the Ipsilateral and Contralateral Sensorimotor Cortex	PLOS ONE			English	Article							THETA-BURST-STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; PRIMARY MOTOR CORTEX; CORTICAL EXCITABILITY; EVOKED-POTENTIALS; TMS; RTMS; PLASTICITY; EEG; REPRODUCIBILITY	Background Recently, it was shown that the highly variable after-effect of continuous theta-burst stimulation (cTBS) of the primary motor cortex (M1) can be predicted by the latency of motorevoked potentials (MEPs) recorded before cTBS. This suggests that at least part of this inter-individual variability is driven by differences in the neuronal populations preferentially activated by transcranial magnetic stimulation (TMS). Methods Here, we recorded MEPs, TMS-evoked brain potentials (TEPs) and somatosensory-evoked potentials (SEPs) to investigate the effects of cTBS delivered over the primary sensorimotor cortex on both the ipsilateral and contralateral M1, and the ipsilateral and contralateral primary somatosensory cortex (S1). Results We confirm that the after-effects of cTBS can be predicted by the latency of MEPs recorded before cTBS. Over the hemisphere onto which cTBS was delivered, short-latency MEPs at baseline were associated with an increase of MEP magnitude (i.e. an excitatory effect of cTBS) whereas late-latency MEPs were associated with reduced MEPs (i.e. an inhibitory effect of cTBS). This relationship was reversed over the contralateral hemisphere, indicating opposite effects of cTBS on the responsiveness of the ipsilateral and contralateral M1. Baseline MEP latencies also predicted changes in the magnitude of the N100 wave of TEPs elicited by stimulation of the ipsilateral and contralateral hemisphere, indicating that this TEP component is specifically dependent on the state of M1. Finally, there was a reverse relationship between MEP latency and the effects of cTBS on the SEP waveforms (50-130 ms), indicating that after-effects of cTBS on S1 are opposite to those on M1. Conclusion Taken together, our results confirm that the variable after-effects of cTBS can be explained by differences in the neuronal populations activated by TMS. Furthermore, our results show that this variability also determines remote effects of cTBS in S1 and the contralateral hemisphere, compatible with inter-hemispheric and sensorimotor interactions.	[Huang, Gan; Mouraux, Andre] Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium	Universite Catholique Louvain	Huang, G (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium.	gan.huang@uclouvain.be	Mouraux, Andre/F-3724-2012	Mouraux, Andre/0000-0003-1056-5980	Belgian National Foundation for Scientific Research (Mandat d'impulsion scientifique FNRS) [14613969]; ERC Starting Grant [PROBING-PAIN 336130]	Belgian National Foundation for Scientific Research (Mandat d'impulsion scientifique FNRS)(Fonds de la Recherche Scientifique - FNRS); ERC Starting Grant(European Research Council (ERC))	GH and AM received support from the Belgian National Foundation for Scientific Research (Mandat d'impulsion scientifique FNRS 14613969). AM received support from an ERC Starting Grant (PROBING-PAIN 336130).	Blankenburg F, 2008, J NEUROSCI, V28, P13202, DOI 10.1523/JNEUROSCI.3043-08.2008; Bonato C, 2006, CLIN NEUROPHYSIOL, V117, P1699, DOI 10.1016/j.clinph.2006.05.006; BUCHNER H, 1995, EXP BRAIN RES, V104, P511; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P3871, DOI 10.1113/jphysiol.2008.152736; Di Lazzaro V, 2008, CLIN NEUROPHYSIOL, V119, P715, DOI 10.1016/j.clinph.2007.11.049; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V565, P945, DOI 10.1113/jphysiol.2005.087288; Di Lazzaro V, 2011, J NEUROPHYSIOL, V105, P2150, DOI 10.1152/jn.00781.2010; Di Lazzaro V, 2008, BRAIN STIMUL, V1, P345, DOI 10.1016/j.brs.2008.07.004; Duque J, 2012, J NEUROSCI, V32, P806, DOI 10.1523/JNEUROSCI.4299-12.2012; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Fox P, 1997, NEUROREPORT, V8, P2787, DOI 10.1097/00001756-199708180-00027; Gilio F, 2003, J PHYSIOL-LONDON, V551, P563, DOI 10.1113/jphysiol.2003.044313; Goldsworthy M, 2002, CLIN NEURIPHYSIOL, V123, P2256; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Hinder MR, 2014, BRAIN STIMUL, V7, P365, DOI 10.1016/j.brs.2014.01.004; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Ishikawa S, 2007, CLIN NEUROPHYSIOL, V118, P1033, DOI 10.1016/j.clinph.2007.02.003; Katayama T, 2010, CLIN NEUROPHYSIOL, V121, P2097, DOI 10.1016/j.clinph.2010.05.014; Komssi S, 2004, HUM BRAIN MAPP, V21, P154, DOI 10.1002/hbm.10159; Komssi S, 2002, CLIN NEUROPHYSIOL, V113, P175, DOI 10.1016/S1388-2457(01)00721-0; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Lioumis P, 2009, HUM BRAIN MAPP, V30, P1387, DOI 10.1002/hbm.20608; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; Nikouline V, 1999, CLIN NEUROPHYSIOL, V110, P1325, DOI 10.1016/S1388-2457(99)00070-X; Paus T, 2001, J NEUROPHYSIOL, V86, P1983, DOI 10.1152/jn.2001.86.4.1983; Perez MA, 2009, J PHYSIOL-LONDON, V587, P725, DOI 10.1113/jphysiol.2008.166926; Plewnia C, 2003, NEUROREPORT, V14, P609, DOI 10.1097/00001756-200303240-00017; Rocco MM, 2007, J NEUROSCI METH, V162, P139, DOI 10.1016/j.jneumeth.2007.01.002; Rogasch NC, 2013, BRAIN STIMUL, V6, P868, DOI 10.1016/j.brs.2013.04.004; Sekiguchi H, 2011, CLIN NEUROPHYSIOL, V122, P984, DOI 10.1016/j.clinph.2010.09.004; Sommer M, 2006, CLIN NEUROPHYSIOL, V117, P838, DOI 10.1016/j.clinph.2005.10.029; Stefan K, 2008, NEUROIMAGE, V40, P265, DOI 10.1016/j.neuroimage.2007.11.037; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Suppa A, 2008, J PHYSIOL-LONDON, V586, P4489, DOI 10.1113/jphysiol.2008.156596; Talelli P, 2007, CLIN NEUROPHYSIOL, V118, P1815, DOI 10.1016/j.clinph.2007.05.062; Tiitinen H, 1999, CLIN NEUROPHYSIOL, V110, P982, DOI 10.1016/S1388-2457(99)00038-3; Torta DME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073263; Veniero D, 2009, CLIN NEUROPHYSIOL, V120, P1392, DOI 10.1016/j.clinph.2009.04.023; Vernet M, 2014, CLIN NEUROPHYSIOL, V125, P320, DOI 10.1016/j.clinph.2013.07.004; Vernet M, 2013, EUR J NEUROSCI, V37, P598, DOI 10.1111/ejn.12069; Young-Bernier M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00182	41	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0133893	10.1371/journal.pone.0133893	http://dx.doi.org/10.1371/journal.pone.0133893			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263505	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300013
J	Wang, C; Jia, ZF; Cao, DH; You, LL; Jin, MS; Wu, X; Wen, SM; Cao, XY; Jiang, J				Wang, Chuan; Jia, Zhifang; Cao, Donghui; You, Lili; Jin, Meishan; Wu, Xing; Wen, Simin; Cao, Xueyuan; Jiang, Jing			Polymorphism of DNA Methyltransferase 3b and Association with Development and Prognosis in Gastric Cancer	PLOS ONE			English	Article							PROMOTER POLYMORPHISMS; DNMT3B POLYMORPHISMS; BREAST-CANCER; RISK; METHYLATION; EXPRESSION; VARIANTS; CARCINOMA; MUCOSA	Objective DNA methyltransferase 3b (DNMT3b) plays an important role in abnormal methylation during tumorigenesis. Polymorphism of the DNMT3b gene may influence DNMT3b activity and be associated with cancer risk. This study aimed to investigate the association between single nucleotide polymorphisms (SNPs) of the DNMT3b gene and susceptibility and prognosis of gastric cancer. Methods Four hundred and forty-seven histologically-confirmed gastric cancer cases, 111 gastric atrophy cases and 961 tumor-free controls were enrolled into the study. Five tag SNPs (rs6119954, rs1569686, rs4911107, rs4911259 and rs8118663) of the DNMT3b gene were genotyped by TaqMan assay. DNMT3b expression was evaluated in 104 cancer tissues by immunohistochemistry method. Results The median follow-up time for 422 gastric patients with prognosis information was 55.1 (51.8-58.5) month. We found that individuals with the rs1569686 variant genotype (TG/GG) were significantly associated with poor prognosis in gastric cancer compared to those carrying the TT genotype (HR = 1.43, 95%CI: 1.02-1.99). This trend was more evident in the long-term survival of gastric cancer. Similar results were observed for the G allele carriers of rs4911107 and T allele carriers of rs4911259 as these two sites were in complete linkage disequilibrium with rs1569686. The rs8118663 GG carriers tended to live shorter than AA/AG genotype (HR = 2.72, 95%CI: 1.45-5.12) in patients living longer than 2.0 years. None of the five SNPs was associated with the risks of gastric cancer or gastric atrophy. And no relationship was found between each of the five SNPs and DNMT3b expression. Conclusions This study provides evidence that DNMT3b polymorphisms may predict long-term survival of gastric cancer. However, further studies are needed to reveal the underlying biological roles of DNMT3b polymorphism.	[Wang, Chuan; Jia, Zhifang; Cao, Donghui; You, Lili; Wu, Xing; Wen, Simin; Jiang, Jing] Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130021, Jilin, Peoples R China; [Jin, Meishan] Jilin Univ, Hosp 1, Div Pathol, Changchun 130021, Jilin, Peoples R China; [Cao, Xueyuan] Jilin Univ, Hosp 1, Dept Gastr & Colorectal Surg, Changchun 130021, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Cao, XY (corresponding author), Jilin Univ, Hosp 1, Dept Gastr & Colorectal Surg, Changchun 130021, Jilin, Peoples R China.	jiangjing19702000@jlu.edu.cn; caoxy@aliyun.com		Cao, Xueyuan/0000-0002-1982-1672	National Natural Science Foundation of China [81072369, 81373084, 81273065]; Norman Bethune Program of Jilin University [2013025]; Youth Foundation of The First Hospital of Jilin University [JDYY42013014, JDYY42013018]; Science and Technology Development Program of Jilin Province [20150414014GH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Norman Bethune Program of Jilin University; Youth Foundation of The First Hospital of Jilin University; Science and Technology Development Program of Jilin Province	This work was supported by the National Natural Science Foundation of China (81072369, JJ), National Natural Science Foundation of China (81373084, JJ), National Natural Science Foundation of China (81273065, XYC), Norman Bethune Program of Jilin University (2013025, JJ), the Youth Foundation of The First Hospital of Jilin University (JDYY42013014, ZFJ), the Youth Foundation of The First Hospital of Jilin University (JDYY42013018, DHC), and Science and Technology Development Program of Jilin Province (20150414014GH, JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuli A, 2013, CARCINOGENESIS, V34, P2286, DOI 10.1093/carcin/bgt179; Amara K, 2010, CANCER SCI, V101, P1722, DOI 10.1111/j.1349-7006.2010.01569.x; Azad AK, 2012, CANCER-AM CANCER SOC, V118, P1554, DOI 10.1002/cncr.26446; Bai XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040024; Bao Q, 2011, INT J COLORECTAL DIS, V26, P1107, DOI 10.1007/s00384-011-1199-3; Cao Q, 2007, J DIGEST DIS, V8, P15, DOI 10.1111/j.1443-9573.2007.00271.x; Cao XY, 2014, WORLD J GASTROENTERO, V20, P8201, DOI 10.3748/wjg.v20.i25.8201; Cebrian A, 2006, CARCINOGENESIS, V27, P1661, DOI 10.1093/carcin/bgi375; Chang KP, 2008, ONCOL REP, V19, P217; Chuah SK, 2011, WORLD J GASTROENTERO, V17, P3971, DOI 10.3748/wjg.v17.i35.3971; De La Vega Francisco M, 2007, Methods Mol Biol, V376, P177; Fan H, 2008, WORLD J GASTROENTERO, V14, P2230, DOI 10.3748/wjg.14.2230; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao J, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-86; Girault I, 2003, CLIN CANCER RES, V9, P4415; Guo XQ, 2010, MOL BIOL REP, V37, P219, DOI 10.1007/s11033-009-9626-z; Hayette S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051527; Hu JB, 2010, DIGEST DIS SCI, V55, P1011, DOI 10.1007/s10620-009-0831-3; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1994, SCHISTOSOMES LIVER F, V61, P1; Jones JS, 2006, CANCER EPIDEM BIOMAR, V15, P886, DOI 10.1158/1055-9965.EPI-05-0644; Kanai Y, 2010, CANCER SCI, V101, P36, DOI 10.1111/j.1349-7006.2009.01383.x; Kawakami K, 2006, BRIT J CANCER, V94, P593, DOI 10.1038/sj.bjc.6602940; Lao YB, 2013, BIOMED REP, V1, P771, DOI 10.3892/br.2013.142; Lee SJ, 2005, CARCINOGENESIS, V26, P403, DOI 10.1093/carcin/bgh307; Lehours P, 2003, AM J GASTROENTEROL, V98, P291, DOI 10.1111/j.1572-0241.2003.t01-1-07264.x; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Montgomery KG, 2004, BREAST CANCER RES, V6, pR390, DOI 10.1186/bcr807; Oh BK, 2007, INT J MOL MED, V20, P65; Samudio-Ruiz SL, 2012, EPIGENETICS-US, V7, P216, DOI 10.4161/epi.7.3.19273; Shen HB, 2002, CANCER RES, V62, P4992; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Yang XX, 2012, INT J MOL SCI, V13, P8364, DOI 10.3390/ijms13078364; Zhu SM, 2012, MOL BIOL REP, V39, P4429, DOI 10.1007/s11033-011-1231-2	36	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134059	10.1371/journal.pone.0134059	http://dx.doi.org/10.1371/journal.pone.0134059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262893	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300017
J	Zhang, Z; Li, JW; Muhammad, J; Cai, J; Jia, F; Shi, YZ; Gong, JW; Shang, HH; Liu, AY; Chen, TT; Ge, Q; Palanga, KK; Lu, QW; Deng, XY; Tan, YN; Li, W; Sun, LY; Gong, WK; Yuan, YL				Zhang, Zhen; Li, Junwen; Muhammad, Jamshed; Cai, Juan; Jia, Fei; Shi, Yuzhen; Gong, Juwu; Shang, Haihong; Liu, Aiying; Chen, Tingting; Ge, Qun; Palanga, Koffi Kibalou; Lu, Quanwei; Deng, Xiaoying; Tan, Yunna; Li, Wei; Sun, Linyang; Gong, Wankui; Yuan, Youlu			High Resolution Consensus Mapping of Quantitative Trait Loci for Fiber Strength, Length and Micronaire on Chromosome 25 of the Upland Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							BLAST RESISTANCE GENES; QTL ANALYSIS; QUALITY TRAITS; GENOME SEQUENCE; RIL POPULATION; LINKAGE MAP; SNP MARKERS; BARBADENSE; YIELD; IDENTIFICATION	Cotton (Gossypium hirsutum L.) is an important agricultural crop that provides renewable natural fiber resources for the global textile industry. Technological developments in the textile industry and improvements in human living standards have increased the requirement for supplies and better quality cotton. Upland cotton 0-153 is an elite cultivar harboring strong fiber strength genes. To conduct quantitative trait locus (QTL) mapping for fiber quality in 0-153, we developed a population of 196 recombinant inbred lines (RILs) from a cross between 0-153 and sGK9708. The fiber quality traits in 11 environments were measured and a genetic linkage map of chromosome 25 comprising 210 loci was constructed using this RIL population, mainly using simple sequence repeat markers and single nucleotide polymorphism markers. QTLs were identified across diverse environments using the composite interval mapping method. A total of 37 QTLs for fiber quality traits were identified on chromosome 25, of which 17 were stably expressed in at least in two environments. A stable fiber strength QTL, qFS-chr25-4, which was detected in seven environments and was located in the marker interval between CRI-SNP120491 and BNL2572, could explain 6.53%-11.83% of the observed phenotypic variations. Meta-analysis also confirmed the above QTLs with previous reports. Application of these QTLs could contribute to improving fiber quality and provide information for marker-assisted selection.	[Zhang, Zhen; Li, Junwen; Muhammad, Jamshed; Cai, Juan; Jia, Fei; Shi, Yuzhen; Gong, Juwu; Shang, Haihong; Liu, Aiying; Chen, Tingting; Ge, Qun; Palanga, Koffi Kibalou; Deng, Xiaoying; Tan, Yunna; Gong, Wankui; Yuan, Youlu] Chinese Acad Agr Sci, Inst Cotton Res, Minist Agr, State Key Lab Cotton Biol,Key Lab Biol & Genet Br, Anyang 455000, Henan, Peoples R China; [Lu, Quanwei; Li, Wei; Sun, Linyang] Anyang Collage Technol, Anyang 455000, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs	Gong, WK (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, Minist Agr, State Key Lab Cotton Biol,Key Lab Biol & Genet Br, Anyang 455000, Henan, Peoples R China.	wkgong@aliyun.com; youluyuan@hotmail.com	Jamshed, Muhammad/AAY-7037-2020; Gǒng, Wànkuí/AAL-5622-2020	Jamshed, Muhammad/0000-0002-6084-2766; Gǒng, Wànkuí/0000-0002-8556-0669	National Natural Science Foundation of China [31371668, 31471538]; National High Technology Research and Development Program of China [2012AA101108]; National Agricultural Science and technology innovation project for CAAS; Henan province foundation [142300413202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Agricultural Science and technology innovation project for CAAS; Henan province foundation	This work was funded by the National Natural Science Foundation of China (31371668, 31471538), the National High Technology Research and Development Program of China (2012AA101108), the National Agricultural Science and technology innovation project for CAAS and the Henan province foundation with cutting-edge technology research projects (142300413202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Chen W, 2014, PLANT BREEDING, V133, P256, DOI 10.1111/pbr.12144; Drenkard E, 2000, PLANT PHYSIOL, V124, P1483, DOI 10.1104/pp.124.4.1483; Fang H, 2014, MOL BREEDING, V33, P709, DOI 10.1007/s11032-013-9987-9; Hayashi K, 2006, THEOR APPL GENET, V113, P251, DOI 10.1007/s00122-006-0290-6; Hayashi K, 2004, THEOR APPL GENET, V108, P1212, DOI 10.1007/s00122-003-1553-0; He DH, 2007, EUPHYTICA, V153, P181, DOI 10.1007/s10681-006-9254-9; Islam MS, 2014, MOL BREEDING, V34, P373, DOI 10.1007/s11032-014-0040-4; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KNAPP SJ, 1990, GENETICS, V126, P769; Kohel RJ, 2001, EUPHYTICA, V121, P163, DOI 10.1023/A:1012263413418; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Lacape JM, 2013, FIELD CROP RES, V144, P256, DOI 10.1016/j.fcr.2013.01.001; Lacape JM, 2009, THEOR APPL GENET, V119, P281, DOI 10.1007/s00122-009-1037-y; Lacape JM, 2005, CROP SCI, V45, P123, DOI 10.2135/cropsci2005.0123a; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Liang QZ, 2013, CHINESE SCI BULL, V58, P3233, DOI 10.1007/s11434-013-5807-1; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; Ning ZY, 2014, EUPHYTICA, V195, P143, DOI 10.1007/s10681-013-0990-3; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2003, THEOR APPL GENET, V106, P384, DOI 10.1007/s00122-002-1025-y; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Said JI, 2015, MOL GENET GENOMICS, V290, P1003, DOI [10.1007/s00438-015-1021-y, 10.1007/s00438-014-0963-9]; Shao QS, 2014, EUPHYTICA, V198, P43, DOI 10.1007/s10681-014-1082-8; Shappley Z. W., 1998, Journal of Cotton Science, V2, P153; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; Shi YZ, 2014, J INTEGR PLANT BIOL; Sun FD, 2012, MOL BREEDING, V30, P569, DOI 10.1007/s11032-011-9645-z; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Tang SY, 2015, EUPHYTICA, V201, P195, DOI [10.1007/s10681-014-1189-y, 10.1007/s10681-]; Ulloa M, 2005, J HERED, V96, P132, DOI 10.1093/jhered/esi020; Ulloa M., 2000, Journal of Cotton Science, V4, P161; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; VOORRIPS RE, 2006, MAPCHART 2 2 SOFTWAR; Wang BH, 2006, EUPHYTICA, V152, P367, DOI 10.1007/s10681-006-9224-2; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang S., 2001, WINDOWS QTL CARTOGRA; Wu JX, 2009, EUPHYTICA, V165, P231, DOI 10.1007/s10681-008-9748-8; Yang XL, 2015, EUPHYTICA, V201, P215, DOI 10.1007/s10681-014-1194-1; Yu JW, 2013, EUPHYTICA, V191, P375, DOI 10.1007/s10681-013-0875-5; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang J, 2002, THEOR APPL GENET, V105, P1166, DOI 10.1007/s00122-002-1100-4; Zhang K, 2012, MOL BREEDING, V29, P335, DOI 10.1007/s11032-011-9549-y; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang ZS, 2009, MOL BREEDING, V24, P49, DOI 10.1007/s11032-009-9271-1; Zhang ZS, 2005, EUPHYTICA, V144, P91, DOI 10.1007/s10681-005-4629-x	50	40	45	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135430	10.1371/journal.pone.0135430	http://dx.doi.org/10.1371/journal.pone.0135430			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262992	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300082
J	Katsuda, Y; Niwano, Y; Nakashima, T; Mokudai, T; Nakamura, K; Oizumi, S; Kanno, T; Kanetaka, H; Egusa, H				Katsuda, Yusuke; Niwano, Yoshimi; Nakashima, Takuji; Mokudai, Takayuki; Nakamura, Keisuke; Oizumi, Satomi; Kanno, Taro; Kanetaka, Hiroyasu; Egusa, Hiroshi			Cytoprotective Effects of Grape Seed Extract on Human Gingival Fibroblasts in Relation to Its Antioxidant Potential	PLOS ONE			English	Article							POLYMERIC PROCYANIDIN FRACTIONS; RAPID COLORIMETRIC ASSAY; SCAVENGING ACTIVITY; SUPEROXIDE ANIONS; HYDROGEN-PEROXIDE; OXIDATIVE DAMAGE; HERBAL EXTRACTS; SINGLET OXYGEN; CELLS; MICE	Cytoprotective effects of short-term treatment with grape seed extract (GSE) upon human gingival fibroblasts (hGFs) were evaluated in relation to its antioxidant properties and compared with those of a water-soluble analog of vitamin E: trolox (Tx). GSE and Tx showed comparable antioxidant potential in vitro against di(phenyl)-(2,4,6-trinitrophenyl) iminoazanium (DPPH; a stable radical), hydroxyl radical ((OH)-O-center dot), singlet oxygen (O-1(2)), and hydrogen peroxide (H2O2). Pretreatment or concomitant treatment with GSE for 1 min protected hGFs from oxidative stressors, including H2O2, acid-electrolyzed water (AEW), and O-1(2), and attenuated the intracellular formation of reactive oxygen species induced by H2O2 and AEW. Tx also reduced the H2O2-and AEW-induced intracellular formation of reactive oxygen species, but showed no cytoprotective effects on hGFs exposed to H2O2, AEW, or O-1(2). These results suggest that the cytoprotective effects of GSE are likely exerted independently of its antioxidant potential.	[Katsuda, Yusuke; Niwano, Yoshimi; Mokudai, Takayuki; Nakamura, Keisuke; Oizumi, Satomi; Kanno, Taro; Kanetaka, Hiroyasu; Egusa, Hiroshi] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan; [Nakashima, Takuji] Kitasato Univ, Kiasato Inst Life Sci, Minato Ku, Tokyo, Japan	Tohoku University; Kitasato University	Niwano, Y (corresponding author), Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan.	niwano@m.tohoku.ac.jp	Nakashima, Takuji/Q-4166-2019; Niwnao, Yoshimi/Z-3593-2019; Mokudai, Takayuki/M-1029-2018; MOKUDAI, TAKAYUKI/AAK-1541-2020; Nakashima, Takuji/AAK-1075-2021; Egusa, Hiroshi/AFT-9694-2022	Mokudai, Takayuki/0000-0003-4628-6908; MOKUDAI, TAKAYUKI/0000-0003-4628-6908; Nakashima, Takuji/0000-0001-6324-0472; Egusa, Hiroshi/0000-0002-0200-8132; Kanetaka, Hiroyasu/0000-0001-7744-3879	Ministry of Education, Culture, Sports, Science and Technology Japan [26460116]	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Ministry of Education, Culture, Sports, Science and Technology Japan, Grant-in-Aid for Scientific Research (C), 26460116, 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1970, METHODS FOOD ANAL; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Campos J, 2014, FOOD CHEM, V151, P175, DOI 10.1016/j.foodchem.2013.11.018; Cheah KY, 2013, DIGEST DIS SCI, V58, P970, DOI 10.1007/s10620-012-2464-1; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Gertzberg N, 2004, AM J PHYSIOL-LUNG C, V286, pL37, DOI 10.1152/ajplung.00116.2003; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Hogan S, 2011, J AGR FOOD CHEM, V59, P3035, DOI 10.1021/jf1042773; Ishiyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037871; JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N; Kalaiselvi P, 2013, FOOD CHEM TOXICOL, V56, P110, DOI 10.1016/j.fct.2013.01.042; Kim YS, 2013, BIOL PHARM BULL, V36, P609, DOI 10.1248/bpb.b12-00990; Kim Y, 2013, FOOD CHEM, V137, P136, DOI 10.1016/j.foodchem.2012.10.006; Kurauchi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113403; Mokudai T, 2015, J TOXICOL SCI, V40, P13, DOI 10.2131/jts.40.13; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura K, 2011, J CLIN BIOCHEM NUTR, V49, P87, DOI 10.3164/jcbn.10-125; Niwano Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1145, DOI 10.1271/bbb.60593; Nuttall SL, 1998, J CLIN PHARM THER, V23, P385, DOI 10.1046/j.1365-2710.1998.00180.x; Ohyama K, 2011, ANN NUTR METAB, V58, P250, DOI 10.1159/000330444; Padilla C, 2006, J PERIODONTAL RES, V41, P350, DOI 10.1111/j.1600-0765.2006.00882.x; Park HJ, 2009, ARCH PHARM RES, V32, P583, DOI 10.1007/s12272-009-1415-7; PRIEUR C, 1994, PHYTOCHEMISTRY, V36, P781, DOI 10.1016/S0031-9422(00)89817-9; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rzeppa S, 2012, MOL NUTR FOOD RES, V56, P653, DOI 10.1002/mnfr.201100471; Saito K, 2008, J SCI FOOD AGR, V88, P2707, DOI 10.1002/jsfa.3397; Saito K, 2008, PLANT FOOD HUM NUTR, V63, P65, DOI 10.1007/s11130-008-0071-2; Spranger I, 2008, FOOD CHEM, V108, P519, DOI 10.1016/j.foodchem.2007.11.004; Sun Y, 2010, J PERIODONTOL, V81, P1488, DOI 10.1902/jop.2010.100004; Tada M, 2010, J CLIN BIOCHEM NUTR, V46, P224, DOI 10.3164/jcbn.09-84; Terra X, 2009, J NUTR BIOCHEM, V20, P210, DOI 10.1016/j.jnutbio.2008.02.005; Velmurugan B, 2010, NEOPLASIA, V12, P95, DOI 10.1593/neo.91718; Vislocky LM, 2010, NUTR REV, V68, P656, DOI 10.1111/j.1753-4887.2010.00335.x; Wang H, 2013, MOL NUTR FOOD RES, V57, P2253, DOI 10.1002/mnfr.201300146; Wang YH, 2011, INT IMMUNOPHARMACOL, V11, P1620, DOI 10.1016/j.intimp.2011.05.024; WATTS RWE, 1965, J LAB CLIN MED, V66, P688; Wei C, 2015, INFLAMMATION, V38, P896, DOI 10.1007/s10753-014-0051-7; Yamaguchi F, 1999, J AGR FOOD CHEM, V47, P2544, DOI 10.1021/jf9806762	41	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134704	10.1371/journal.pone.0134704	http://dx.doi.org/10.1371/journal.pone.0134704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258747	gold, Green Submitted, Green Published			2022-12-27	WOS:000359352600021
J	Kreitz, C; Furley, P; Memmert, D; Simons, DJ				Kreitz, Carina; Furley, Philip; Memmert, Daniel; Simons, Daniel J.			Inattentional Blindness and Individual Differences in Cognitive Abilities	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; EYE-MOVEMENTS; ATTENTION; TASK; LOAD; SEE; DISTRACTORS; PERCEPTION; FAILURES; CAPTURE	People sometimes fail to notice salient unexpected objects when their attention is otherwise occupied, a phenomenon known as inattentional blindness. To explore individual differences in inattentional blindness, we employed both static and dynamic tasks that either presented the unexpected object away from the focus of attention (spatial) or near the focus of attention (central). We hypothesized that noticing in central tasks might be driven by the availability of cognitive resources like working memory, and that noticing in spatial tasks might be driven by the limits on spatial attention like attention breadth. However, none of the cognitive measures predicted noticing in the dynamic central task or in either the static or dynamic spatial task. Only in the central static task did working memory capacity predict noticing, and that relationship was fairly weak. Furthermore, whether or not participants noticed an unexpected object in a static task was only weakly associated with their odds of noticing an unexpected object in a dynamic task. Taken together, our results are largely consistent with the notion that noticing unexpected objects is driven more by stochastic processes common to all people than by stable individual differences in cognitive abilities.	[Kreitz, Carina; Furley, Philip; Memmert, Daniel] German Sport Univ Cologne, Inst Cognit & Team, Racket Sport Res, Cologne, Germany; [Simons, Daniel J.] Univ Illinois Champaign Urbana, Dept Psychol, Champaign, IL USA	German Sport University Cologne; University of Illinois System; University of Illinois Urbana-Champaign	Kreitz, C (corresponding author), German Sport Univ Cologne, Inst Cognit & Team, Racket Sport Res, Cologne, Germany.	c.kreitz@dshs-koeln.de	Furley, Philip/V-2921-2019; Simons, Daniel J./P-3625-2019	Furley, Philip/0000-0002-1230-2220	German Research Council (Deutsche Forschungsgemeinschaft) [ME 2678/11.1]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The presented research was funded by the German Research Council (Deutsche Forschungsgemeinschaft, www.dfg.de) to DM, ME 2678/11.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Beanland V., 2010, ASCS09, P12, DOI DOI 10.5096/ASCS20093; Beanland V, 2011, CONSCIOUS COGN, V20, P1282, DOI 10.1016/j.concog.2011.04.009; Becker MW, 2011, EMOTION, V11, P1248, DOI 10.1037/a0023524; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Bredemeier K, 2014, PSYCHOL CONSCIOUSNES, V1, P370, DOI [10.1037/cns0000032, DOI 10.1037/CNS0000032]; Bredemeier K, 2012, PSYCHON B REV, V19, P239, DOI 10.3758/s13423-011-0204-8; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Calvillo DP, 2014, PSYCHON B REV, V21, P670, DOI 10.3758/s13423-013-0543-8; Chabris CF, 2011, I-PERCEPTION, V2, P150, DOI 10.1068/i0436; Clifasefi SL, 2006, APPL COGNITIVE PSYCH, V20, P697, DOI 10.1002/acp.1222; Colflesh GJH, 2007, PSYCHON B REV, V14, P699, DOI 10.3758/BF03196824; Dale G, 2015, PSYCHOL RES-PSYCH FO, V79, P534, DOI 10.1007/s00426-014-0591-3; Dale G, 2010, ATTEN PERCEPT PSYCHO, V72, P602, DOI 10.3758/APP.72.3.602; Davies AMA, 2013, CONSCIOUS COGN, V22, P221, DOI 10.1016/j.concog.2012.11.015; Drew T, 2013, PSYCHOL SCI, V24, P1848, DOI 10.1177/0956797613479386; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Forster J, 2005, PSYCHOL SCI, V16, P631, DOI 10.1111/j.1467-9280.2005.01586.x; Fougnie D, 2007, PSYCHON B REV, V14, P142, DOI 10.3758/BF03194041; French, 2014, PSYCHOL CONSCIOUSNES, V1, P60, DOI [10.1037/css0000003, DOI 10.1037/CSS0000003]; Graham ER, 2011, PSYCHOL AGING, V26, P162, DOI 10.1037/a0020647; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; HAINES RF, 1991, PERSP VIS R, P171; Hannon EM, 2010, PERCEPTION, V39, P309, DOI 10.1068/p6379; Huttermann S, 2014, J EXP PSYCHOL-APPL, V20, P147, DOI 10.1037/xap0000012; Huttermann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065673; Huttermann S, 2012, PERCEPTION, V41, P963, DOI 10.1068/p7294; Huttermann S., 2012, AGEING RES, V4, pe10, DOI [10.4081/ar.2012.e10, DOI 10.4081/AR.2012.E10]; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; KLUMB PL, 1995, ERGONOMICS, V38, P1456, DOI 10.1080/00140139508925202; Koivisto M, 2004, VISION RES, V44, P3211, DOI 10.1016/j.visres.2004.07.026; Koivisto M, 2008, PSYCHOL RES-PSYCH FO, V72, P39, DOI 10.1007/s00426-006-0072-4; Kreitz C, 2015, PSYCHOL RES-PSYCH FO, V79, P1034, DOI 10.1007/s00426-014-0633-x; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Mack A, 2002, CONSCIOUS COGN, V11, P488, DOI 10.1016/S1053-8100(02)00028-4; Mack A., 1998, INATTENTIONAL BLINDN; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; Memmert D, 2006, CONSCIOUS COGN, V15, P620, DOI 10.1016/j.concog.2006.01.001; Memmert D, 2010, CONSCIOUS COGN, V19, P1107, DOI 10.1016/j.concog.2010.06.005; Most S. B., 2000, PSYCHE, V6, P14; Most SB, 2005, PSYCHOL REV, V112, P217, DOI 10.1037/0033-295X.112.1.217; Most SB, 2001, PSYCHOL SCI, V12, P9, DOI 10.1111/1467-9280.00303; Most SB., 2001, ATTRACTION DISTRACTI, P151, DOI 10.1016/S0166-4115(01)80009-1; Most SB, 2010, CONSCIOUS COGN, V19, P1102, DOI 10.1016/j.concog.2010.01.011; Navon D., 1969, PERCEPT PSYCHOPHYS, V5, P197; NEISSER U, 1975, COGNITIVE PSYCHOL, V7, P480, DOI 10.1016/0010-0285(75)90019-5; Newby EA, 1998, PERCEPTION, V27, P1025, DOI 10.1068/p271025; O'Shea DM, 2015, PSYCHOL RES-PSYCH FO, V79, P570, DOI 10.1007/s00426-014-0594-0; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pringle HL, 2001, PSYCHON B REV, V8, P89, DOI 10.3758/BF03196143; Redick TS, 2013, PSYCHON B REV, V20, P1102, DOI 10.3758/s13423-013-0453-9; Richards A, 2012, CONSCIOUS COGN, V21, P170, DOI 10.1016/j.concog.2011.09.013; Richards A, 2010, PSYCHOL RES-PSYCH FO, V74, P513, DOI 10.1007/s00426-009-0273-8; SALTHOUSE TA, 1991, PSYCHOL SCI, V2, P179, DOI 10.1111/j.1467-9280.1991.tb00127.x; Seegmiller JK, 2011, J EXP PSYCHOL LEARN, V37, P785, DOI 10.1037/a0022474; Simons DJ, 2009, PSYCHON B REV, V16, P398, DOI 10.3758/PBR.16.2.398; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Swettenham J, 2014, NEUROPSYCHOLOGY, V28, P563, DOI 10.1037/neu0000042; Todd JJ, 2005, PSYCHOL SCI, V16, P965, DOI 10.1111/j.1467-9280.2005.01645.x; Tombu M, 2008, COGNITION, V108, P1, DOI 10.1016/j.cognition.2007.12.014; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Ward EJ, 2015, PSYCHON B REV, V22, P722, DOI 10.3758/s13423-014-0745-8; WINGFIELD A, 1988, EXP AGING RES, V14, P103, DOI 10.1080/03610738808259731	67	42	43	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134675	10.1371/journal.pone.0134675	http://dx.doi.org/10.1371/journal.pone.0134675			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO7PJ	26258545	Green Submitted, Green Published, gold			2022-12-27	WOS:000359352600019
J	Li, J; Lei, H; Xu, Y; Tao, ZZ				Li, Jun; Lei, Han; Xu, Yong; Tao, Ze-Zhang			miR-512-5p Suppresses Tumor Growth by Targeting hTERT in Telomerase Positive Head and Neck Squamous Cell Carcinoma In Vitro and In Vivo	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; CLINICAL-USEFULNESS; DOWN-REGULATION; KAPPA-B; CANCER; INHIBITION; EXPRESSION; RNA; ACTIVATION	Telomerase activation has very important implications for head and neck squamous cell carcinoma (HNSCC), but the regulatory mechanisms of telomerase in HNSCC remain unclear. In our present study, we found that miR-512-5P was markedly downregulated in telomerase-positive HNSCC cell lines. Both in vitro and in vivo assays revealed that miR-512-5P mimic attenuated HNSCC cell proliferation, and tumor growth in nude mice, which exerts its tumor suppressor function through elevated apoptosis, inhibition of the telomerase activity, decrease of telomere-binding proteins and shortening of telomere length by human telomerase reverse transcriptase (hTERT) downregulation. Furthermore, the dual-luciferase reporter gene assay results demonstrated that hTERT was a direct target of miR-5125P. We conclude that the frequently miR-512-5P overexpression can regulate hTERT and function as a tumor suppressor in HNSCC. Therefore, miR-512-5P may serve as a potential therapeutic agent for miR-based HNSCC therapy.	[Li, Jun] Wuhan Univ, Dept Otolaryngol Head & Neck Surg, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Li, Jun; Xu, Yong; Tao, Ze-Zhang] Renmin Hosp Wuhan Univ, Dept Otolaryngol Head & Neck Surg, Wuhan 430060, Peoples R China; [Lei, Han] Wuhan Univ, Hubei key Lab Tumor Biol Behav, Zhongnan Hosp, Wuhan 430071, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Tao, ZZ (corresponding author), Renmin Hosp Wuhan Univ, Dept Otolaryngol Head & Neck Surg, Wuhan 430060, Peoples R China.	tao_zezhang@163.com			National Natural Science Foundation of China [30872851, 30901662]; Science and Technology Department of Hubei Province [2007AA302B08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Hubei Province	This study was supported by grants from the National Natural Science Foundation of China (No. 30872851 and 30901662), and the Science and Technology Department of Hubei Province (No. 2007AA302B08).	Aggarwal S, 2004, INT J CANCER, V111, P679, DOI 10.1002/ijc.20333; Akiyama M, 2011, LEUKEMIA RES, V35, P416, DOI 10.1016/j.leukres.2010.11.002; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Capraro V, 2011, EXP HEMATOL, V39, P195, DOI 10.1016/j.exphem.2010.10.008; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen SM, 2007, CANCER INVEST, V25, P691, DOI 10.1080/07357900701561065; Chen SM, 2006, ARCH OTOLARYNGOL, V132, P200, DOI 10.1001/archotol.132.2.200; Cong YS, 2008, CELL RES, V18, P725, DOI 10.1038/cr.2008.74; Friedman JM, 2014, WORLD J CLIN ONCOL, V5, P781, DOI 10.5306/wjco.v5.i4.781; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; John K, 2013, INT J DENT, V2013, DOI 10.1155/2013/650218; Mabruk MJEMF, 2005, EXPERT REV MOL DIAGN, V5, P907, DOI 10.1586/14737159.5.6.907; Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x; Miura N, 2006, CANCER SCI, V97, P1366, DOI 10.1111/j.1349-7006.2006.00342.x; Mizumoto Y, 2011, CLIN CANCER RES, V17, P1341, DOI 10.1158/1078-0432.CCR-10-2291; Moon DO, 2008, FEBS LETT, V582, P3367, DOI 10.1016/j.febslet.2008.08.029; Nagadia R, 2013, CELL ONCOL, V36, P1, DOI 10.1007/s13402-012-0122-4; Osterhage JL, 2009, J BIOL CHEM, V284, P16061, DOI 10.1074/jbc.R900011200; Patel MM, 2002, HEAD NECK-J SCI SPEC, V24, P1060, DOI 10.1002/hed.10169; Saito Y, 2009, ONCOGENE, V28, P2738, DOI 10.1038/onc.2009.140; Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Sitaram RT, 2009, INT J CANCER, V125, P783, DOI 10.1002/ijc.24335; Tao ZZ, 2005, J LARYNGOL OTOL, V119, P92, DOI 10.1258/0022215053419943; Won YS, 2015, CANCER LETT, V356, P918, DOI 10.1016/j.canlet.2014.11.006	27	30	30	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135265	10.1371/journal.pone.0135265	http://dx.doi.org/10.1371/journal.pone.0135265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258591	Green Published, Green Submitted, gold			2022-12-27	WOS:000359352600052
J	Wolf, SJ; Reske, AP; Hammermuller, S; Costa, ELV; Spieth, PM; Hepp, P; Carvalho, AR; Krassler, J; Wrigge, H; Amato, MBP; Reske, AW				Wolf, Samuel J.; Reske, Alexander P.; Hammermueller, Soeren; Costa, Eduardo L. V.; Spieth, Peter M.; Hepp, Pierre; Carvalho, Alysson R.; Krassler, Jens; Wrigge, Hermann; Amato, Marcelo B. P.; Reske, Andreas W.			Correlation of Lung Collapse and Gas Exchange - A Computer Tomographic Study in Sheep and Pigs with Atelectasis in Otherwise Normal Lungs	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; HYPOXIC PULMONARY VASOCONSTRICTION; RESPIRATORY-DISTRESS-SYNDROME; ALVEOLAR RECRUITMENT; GENERAL-ANESTHESIA; VENOUS ADMIXTURE; AERATION; VENTILATION; EXTRAPOLATION; OXYGENATION	Background Atelectasis can provoke pulmonary and non-pulmonary complications after general anaesthesia. Unfortunately, there is no instrument to estimate atelectasis and prompt changes of mechanical ventilation during general anaesthesia. Although arterial partial pressure of oxygen (PaO2) and intrapulmonary shunt have both been suggested to correlate with atelectasis, studies yielded inconsistent results. Therefore, we investigated these correlations. Methods Shunt, PaO2 and atelectasis were measured in 11 sheep and 23 pigs with otherwise normal lungs. In pigs, contrasting measurements were available 12 hours after induction of acute respiratory distress syndrome (ARDS). Atelectasis was calculated by computed tomography relative to total lung mass (M-total). We logarithmically transformed PaO2 (lnPaO(2)) to linearize its relationships with shunt and atelectasis. Data are given as median (interquartile range). Results M-total was 768 (715-884) g in sheep and 543 (503-583) g in pigs. Atelectasis was 26 (16-47)% in sheep and 18 (13-23) % in pigs. PaO2 (FiO(2) = 1.0) was 242 (106-414) mmHg in sheep and 480 (437-514) mmHg in pigs. Shunt was 39 (29-51)% in sheep and 15 (11-20) % in pigs. Atelectasis correlated closely with lnPaO(2) (R-2 = 0.78) and shunt (R-2 = 0.79) in sheep (P-values<0.0001). The correlation of atelectasis with lnPaO(2) (R-2 = 0.63) and shunt (R-2 = 0.34) was weaker in pigs, but R-2 increased to 0.71 for lnPaO(2) and 0.72 for shunt 12 hours after induction of ARDS. In both, sheep and pigs, changes in atelectasis correlated strongly with corresponding changes in lnPaO(2) and shunt. Discussion and Conclusion In lung-healthy sheep, atelectasis correlates closely with lnPaO(2) and shunt, when blood gases are measured during ventilation with pure oxygen. In lung-healthy pigs, these correlations were significantly weaker, likely because pigs have stronger hypoxic pulmonary vasoconstriction (HPV) than sheep and humans. Nevertheless, correlations improved also in pigs after blunting of HPV during ARDS. In humans, the observed relationships may aid in assessing anaesthesia-related atelectasis.	[Wolf, Samuel J.; Hammermueller, Soeren; Wrigge, Hermann; Reske, Andreas W.] Univ Hosp Leipzig, Dept Anaesthesiol & Intens Care Med, Leipzig, Germany; [Reske, Alexander P.; Krassler, Jens] Fachkrankenhaus Coswig, Anaesthesiol & Intens Care Med, Coswig Meissen, Germany; [Costa, Eduardo L. V.; Amato, Marcelo B. P.] Univ Sao Paulo, Cardio Pulm Dept, Div Pulm, Hosp Clin, Sao Paulo, Brazil; [Costa, Eduardo L. V.] Hosp Sirio Libanes, Res & Educ Inst, Sao Paulo, Brazil; [Spieth, Peter M.] Univ Hosp Carl Gustav Carus, Dept Anaesthesiol & Intens Care Med, Dresden, Germany; [Hepp, Pierre] Univ Hosp Leipzig, Dept Orthoped Trauma & Plast Surg, Leipzig, Germany; [Carvalho, Alysson R.] Univ Fed Rio de Janeiro, Carlos Chagas Biophys Inst, Rio De Janeiro, Brazil	Leipzig University; Universidade de Sao Paulo; Hospital Sirio Libanes; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Leipzig University; Universidade Federal do Rio de Janeiro	Reske, AW (corresponding author), Univ Hosp Leipzig, Dept Anaesthesiol & Intens Care Med, Leipzig, Germany.	andreas.reske@medizin.uni-leipzig.de	Reske, Andreas W/E-8141-2010; Costa, Eduardo/K-5841-2012; Carvalho, Alysson/AAF-1022-2019; Spieth, Peter/C-2928-2011; amato, Marcelo Britto Passo/L-5001-2016; Wrigge, Hermann/AAJ-8985-2021	Reske, Andreas W/0000-0002-2759-0245; Costa, Eduardo/0000-0002-6941-3626; amato, Marcelo Britto Passo/0000-0003-3525-8282; Wrigge, Hermann/0000-0002-9035-6822; Carvalho, Alysson/0000-0003-2708-7735; Spieth, Peter/0000-0003-3953-3253	Deutsche Forschungsgemeinschaft [DFG WR 47/1-1]; German Research Foundation (DFG); Universitat Leipzig [SCHU 1672/3-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig	This work was supported by Deutsche Forschungsgemeinschaft to Hermann Wrigge, www.dfg.de, Grant Number DFG WR 47/1-1. The authors acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing (grant number SCHU 1672/3-2). No individuals employed or contracted by the funders (other than the named authors) played any role in study design. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araos JD, 2012, AM J VET RES, V73, P2013, DOI 10.2460/ajvr.73.12.2013; Asadi AK, 2014, J APPL PHYSL; Berggren SM, 1942, ACTA PHYSIOL SCAND, V4, P1, DOI DOI 10.1111/J.1365-201X.1942.TB11002.X; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Borges JB, 2006, AM J RESP CRIT CARE, V174, P268, DOI 10.1164/rccm.200506-976OC; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Caironi P, 2010, AM J RESP CRIT CARE, V181, P578, DOI 10.1164/rccm.200905-0787OC; Cressoni M, 2008, CRIT CARE MED, V36, P669, DOI 10.1097/01.CCM.0000300276.12074.E1; Dewitte K, 2002, CLIN CHEM, V48, P799; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; Edmark L, 2003, ANESTHESIOLOGY, V98, P28, DOI 10.1097/00000542-200301000-00008; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Gattinoni L, 2001, AM J RESP CRIT CARE, V164, P1701, DOI 10.1164/ajrccm.164.9.2103121; GATTINONI L, 1988, ANESTHESIOLOGY, V69, P824, DOI 10.1097/00000542-198812000-00005; HACHENBERG T, 1992, ACTA ANAESTH SCAND, V36, P800, DOI 10.1111/j.1399-6576.1992.tb03568.x; HEDENSTIERNA G, 1986, ACTA ANAESTH SCAND, V30, P183, DOI 10.1111/j.1399-6576.1986.tb02393.x; Hemmes SNT, 2014, LANCET, V384, P495, DOI 10.1016/S0140-6736(14)60416-5; Henzler D, 2005, CRIT CARE, V9, pR471, DOI 10.1186/cc3772; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim H, 2005, PROC INT C TOOLS ART, P607; LACHMANN B, 1992, INTENS CARE MED, V18, P319, DOI 10.1007/BF01694358; Li G, 2009, PHYS MED BIOL, V54, P4113, DOI 10.1088/0031-9155/54/13/010; Li RJ, 2009, PHYS MED BIOL, V54, P4821, DOI 10.1088/0031-9155/54/15/012; LUNDQUIST H, 1995, ACTA RADIOL, V36, P626, DOI 10.3109/02841859509176761; Malbouisson LM, 2001, AM J RESP CRIT CARE, V163, P1444, DOI 10.1164/ajrccm.163.6.2005001; Markstaller K, 2003, BRIT J ANAESTH, V91, P699, DOI 10.1093/bja/aeg246; MARSHALL BE, 1994, INTENS CARE MED, V20, P291, DOI 10.1007/BF01708968; MORRELL NW, 1995, RESP PHYSIOL, V100, P271, DOI 10.1016/0034-5687(95)00002-U; Muders T, 2012, CRIT CARE MED, V40, P903, DOI 10.1097/CCM.0b013e318236f452; Nagendran J, 2006, CURR OPIN ANESTHESIO, V19, P34, DOI 10.1097/01.aco.0000192777.09527.9e; Nakayama M, 1999, ANESTHESIOLOGY, V91, P760, DOI 10.1097/00000542-199909000-00029; Neumann P, 1999, ACTA ANAESTH SCAND, V43, P295, DOI 10.1034/j.1399-6576.1999.430309.x; NUNN JF, 1965, BRIT J ANAESTH, V37, P898, DOI 10.1093/bja/37.12.898; ONEILL M, 1995, BRIT J ANAESTH, V75, P603, DOI 10.1093/bja/75.5.603; PEAKE MD, 1981, J APPL PHYSIOL, V51, P1214, DOI 10.1152/jappl.1981.51.5.1214; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reske AW, 2010, INTENS CARE MED, V36, P1836, DOI 10.1007/s00134-010-2014-2; Reske AW, 2013, CRIT CARE MED, V41, P732, DOI 10.1097/CCM.0b013e3182711b6e; Reske AW, 2011, CRIT CARE, V15, DOI 10.1186/cc10563; Reske AW, 2011, CRIT CARE, V15, DOI 10.1186/cc10060; Richard JC, 2004, CRIT CARE, V8, P163, DOI 10.1186/cc2391; Rothen HU, 1999, BRIT J ANAESTH, V82, P551, DOI 10.1093/bja/82.4.551; Rouby JJ, 2000, INTENS CARE MED, V26, P1046, DOI 10.1007/s001340051317; Schreiter D, 2004, CRIT CARE MED, V32, P968, DOI 10.1097/01.CCM.0000120050.85798.38; Serpa Neto A, 2015, ANESTHESIOLOGY; Strumper D, 2005, FETAL DIAGN THER, V20, P377, DOI 10.1159/000086816; Suarez-Sipmann F, 2007, CRIT CARE MED, V35, P214, DOI 10.1097/01.CCM.0000251131.40301.E2; Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010; Tenling A, 1998, ANESTHESIOLOGY, V89, P371, DOI 10.1097/00000542-199808000-00013; TERRY PB, 1987, J APPL PHYSIOL, V62, P1028, DOI 10.1152/jappl.1987.62.3.1028	51	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135272	10.1371/journal.pone.0135272	http://dx.doi.org/10.1371/journal.pone.0135272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258686	Green Published, gold, Green Submitted			2022-12-27	WOS:000359352600053
J	Ge, HY; Han, ZJ; Tian, P; Sun, WJ; Xue, DX; Bi, Y; Yang, ZH; Liu, P				Ge, Hong-yan; Han, Zhong-jing; Tian, Pei; Sun, Wen-jie; Xue, Da-xi; Bi, Yu; Yang, Zhang-hui; Liu, Ping			VEGFA Expression Is Inhibited by Arsenic Trioxide in HUVECs through the Upregulation of Ets-2 and miRNA-126	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ENDOTHELIAL GROWTH-FACTOR; GASTRIC-CANCER; BREAST-CANCER; NUDE-MICE; ANGIOGENESIS; CELLS; MICRORNAS; THERAPY; DISEASE	Arsenic trioxide (ATO) has been used to treat patients with acute promyelocytic leukemia. Recently, studies have shown that ATO can induce apoptosis in leukemic cells and blood vessel endothelial cells in a time- and dose-dependent manner through the inhibition of vascular endothelial growth factor A (VEGFA) production. VEGFA is a key factor in angiogenesis initiation. Targeted inhibition of VEGF or VEGFA expression can suppress angiogenesis; however, little is known about the mechanism by which ATO inhibits VEGFA expression. In this study, we investigated the role of miRNA-126 in the mechanism of action of ATO in human umbilical vein endothelial cells (HUVECs). ATO significantly decreased the viability and proliferation of HUVECs and decreased their migration at 48 h. Cell proliferation was inhibited by 50% (IC50) when 5.0 mu mol/L ATO was used. ATO treatment induced miR-126 upregulation and HUVEC apoptosis. Transfection with a miR-126 mimic significantly downregulated VEGFA mRNA levels, and transfection with a miR-126 inhibitor significantly upregulated VEGFA mRNA levels. Finally, we showed that ATO treatment upregulated Ets-2 and miR-126 expression in HUVECs. These results demonstrate that ATO inhibits the growth of HUVECs and induces apoptosis by downregulating VEGFA. One mechanism by which this occurs is Ets-2 upregulation, which results in an increase in miR-126 levels and downregulation of VEGFA expression.	[Ge, Hong-yan; Tian, Pei; Sun, Wen-jie; Xue, Da-xi; Bi, Yu; Yang, Zhang-hui; Liu, Ping] Harbin Med Univ, Affiliated Hosp 1, Hosp Eye, Key Lab,Eye Ctr, Harbin, Peoples R China; [Han, Zhong-jing] Daqing Oilfield Gen Hosp, Saertu Dist Daqing, Peoples R China; [Han, Zhong-jing] Harbin Med Univ, Dept Biochem & Mol Biol, Harbin, Peoples R China; [Sun, Wen-jie] Harbin Med Univ, Affiliated Hosp 2, Key Lab Myocardial Ischemia Mech & Treatment, Dept Cardiol,Minist Educ, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Liu, P (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Hosp Eye, Key Lab,Eye Ctr, 23 Youzheng St, Harbin, Peoples R China.	ping_liu53@hotmail.com			Special Fund for the Doctoral Program of Higher Education (New Teacher category) [20132307120035]; Natural Science Foundation of China [81300728]	Special Fund for the Doctoral Program of Higher Education (New Teacher category); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Special Fund for the Doctoral Program of Higher Education (New Teacher category: 20132307120035), and the Natural Science Foundation of China (Project No. 81300728).	Agis H, 1999, ANN HEMATOL, V78, P329, DOI 10.1007/s002770050523; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Deshpande RG, 1998, INFECT IMMUN, V66, P5337, DOI 10.1128/IAI.66.11.5337-5343.1998; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Galimberti S, 1999, BONE MARROW TRANSPL, V24, P345, DOI 10.1038/sj.bmt.1701875; Griffioen AW, 1999, INT J CANCER, V80, P315, DOI 10.1002/(SICI)1097-0215(19990118)80:2<315::AID-IJC23>3.0.CO;2-L; Hamma-Kourbali Y, 2003, BRIT J CANCER, V89, P215, DOI 10.1038/sj.bjc.6601029; Harris TA, 2010, ARTERIOSCL THROM VAS, V30, P1990, DOI 10.1161/ATVBAHA.110.211706; Hirooka T, 2013, J TOXICOL SCI, V38, P837; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Kong HL, 1998, J NATL CANCER I, V90, P273, DOI 10.1093/jnci/90.4.273; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Oettgen P, 2006, CIRC RES, V99, P1159, DOI 10.1161/01.RES.0000251056.85990.db; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Roboz GJ, 2000, BLOOD, V96, P1525, DOI 10.1182/blood.V96.4.1525.h8001525_1525_1530; Sato Y, 2001, CELL STRUCT FUNCT, V26, P19, DOI 10.1247/csf.26.19; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Soucy NV, 2003, TOXICOL SCI, V76, P271, DOI 10.1093/toxsci/kfg231; Sun Y, 2009, ANAL BIOCHEM, V391, P85, DOI 10.1016/j.ab.2009.05.010; Turner DP, 2007, J CELL BIOCHEM, V102, P549, DOI 10.1002/jcb.21494; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang ZS, 2013, TOXICOL APPL PHARM, V271, P20, DOI 10.1016/j.taap.2013.04.018; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Xiao YF, 2007, WORLD J GASTROENTERO, V13, P6498, DOI 10.3748/wjg.13.6498; Xiao YF, 2006, WORLD J GASTROENTERO, V12, P5780, DOI 10.3748/wjg.v12.i36.5780; Yao Q, 2003, TOXICOL LETT, V222, P72; Yu W, 2012, TOXICOL APPL PHARM, V264, P73, DOI 10.1016/j.taap.2012.07.019	33	19	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135795	10.1371/journal.pone.0135795	http://dx.doi.org/10.1371/journal.pone.0135795			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274316	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600113
J	Ma, X; Li, DD; Sun, XM; Guo, YQ; Xiang, JY; Wang, WH; Zhang, LX; Gu, QJ; Duan, ZJ				Ma, Xin; Li, Dan-di; Sun, Xiao-man; Guo, Yan-qing; Xiang, Jing-yao; Wang, Wei-huan; Zhang, Li-xia; Gu, Qing-jiu; Duan, Zhao-jun			Binding Patterns of Rotavirus Genotypes P[4], P[6], and P[8] in China with Histo-Blood Group Antigens	PLOS ONE			English	Article							SIALIC-ACID; NOROVIRUS; STRAIN; VP4; SUSCEPTIBILITY; IDENTIFICATION; VP8-ASTERISK; VP5-ASTERISK; POLYMORPHISM; RESISTANCE	Rotaviruses (RVs) are an important cause of severe gastroenteritis in children. It has been found that RV may recognize the histo-blood group antigens (HBGAs) as ligands or receptors and bind HBGAs in a type-dependent manner. In this study, we investigated the binding specificity of VP8* proteins from human rotaviruses (RV) that are prevalent in China including genotypes P[4], P[6], and P[8]. Through the saliva-and oligosaccharide-based binding assays, we found that the VP8* proteins of P[4] and P[8] RV showed similar reactivity with the Le(b) and H type 1 antigens, while P[6] RV weakly bound the Le(b) antigen. These findings may facilitate further research into RV host specificity and vaccine development.	[Ma, Xin; Zhang, Li-xia; Gu, Qing-jiu] Beijing Tiejian Hosp, China Railway Construct Corp, Beijing 100039, Peoples R China; [Ma, Xin; Li, Dan-di; Sun, Xiao-man; Guo, Yan-qing; Xiang, Jing-yao; Duan, Zhao-jun] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China; [Wang, Wei-huan] Beijing Railway Ctr Dis Control & Prevent, Beijing 100038, Peoples R China	China Railway Construction Corporation; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Li, DD (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.	dandili@126.com; zhaojund@126.com			National Nature Science Foundation of China (NSFC) [81472003]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The research was supported by the National Nature Science Foundation of China (NSFC Grant no. 81472003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo EC, 2007, J PEDIAT-BRAZIL, V83, P217, DOI [10.2223/JPED.1600, 10.1590/S0021-75572007000400006]; Arias CF, 2002, ARCH MED RES, V33, P356, DOI 10.1016/S0188-4409(02)00374-0; Bohm R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6907; Breiman RF, 2012, VACCINE, V30, pA24, DOI 10.1016/j.vaccine.2011.08.124; Ciarlet M, 1999, J GEN VIROL, V80, P943, DOI 10.1099/0022-1317-80-4-943; Dormitzer PR, 2002, EMBO J, V21, P885, DOI 10.1093/emboj/21.5.885; Esteban LE, 2010, J MED VIROL, V82, P1083, DOI 10.1002/jmv.21745; ESTES MK, 1989, MICROBIOL REV, V53, P410, DOI 10.1128/MMBR.53.4.410-449.1989; Estes MK, 2007, FIELDS VIROLOGY, V2, P1918; FIORE L, 1991, VIROLOGY, V181, P553, DOI 10.1016/0042-6822(91)90888-I; Frenck R, 2012, J INFECT DIS, V206, P1386, DOI 10.1093/infdis/jis514; Hu LY, 2012, NATURE, V485, P256, DOI 10.1038/nature10996; Huang PW, 2012, J VIROL, V86, P4833, DOI 10.1128/JVI.05507-11; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Imbert-Marcille BM, 2014, J INFECT DIS, V209, P1227, DOI 10.1093/infdis/jit655; Isa P, 2006, GLYCOCONJUGATE J, V23, P27, DOI 10.1007/s10719-006-5435-y; Le Pendu J, 2004, ADV EXP MED BIOL, V554, P135; Le Pendu J, 2006, SEMIN IMMUNOL, V18, P375, DOI 10.1016/j.smim.2006.07.009; Liu YH, 2013, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2013-8; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI [10.2217/fmb.09.96, 10.2217/FMB.09.96]; Monnier N, 2006, J VIROL, V80, P1513, DOI 10.1128/JVI.80.3.1513-1523.2006; Trang NV, 2014, J CLIN MICROBIOL, V52, P1366, DOI 10.1128/JCM.02927-13; Nordgren J, 2014, CLIN INFECT DIS, V59, P1567, DOI 10.1093/cid/ciu633; PADILLANORIEGA L, 1995, VIROLOGY, V206, P148, DOI 10.1016/S0042-6822(95)80029-8; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; PATTON JT, 1993, J VIROL, V67, P4848, DOI 10.1128/JVI.67.8.4848-4855.1993; Ramani S, 2013, J VIROL, V87, P7255, DOI 10.1128/JVI.03518-12; Tan M, 2008, J MED VIROL, V80, P1296, DOI 10.1002/jmv.21200; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; YOLKEN RH, 1987, J CLIN INVEST, V79, P148, DOI 10.1172/JCI112775	32	24	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134584	10.1371/journal.pone.0134584	http://dx.doi.org/10.1371/journal.pone.0134584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274396	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600034
J	Men, YQ; Zhang, AZ; Li, HX; Zhang, TT; Jin, YC; Li, HS; Zhang, J; Gao, JG				Men, Yuqin; Zhang, Aizhen; Li, Haixiang; Zhang, Tingting; Jin, Yecheng; Li, Huashun; Zhang, Jian; Gao, Jiangang			LKB1 Is Required for the Development and Maintenance of Stereocilia in Inner Ear Hair Cells in Mice	PLOS ONE			English	Article							PEUTZ-JEGHERS-SYNDROME; ACTIN-BUNDLING PROTEINS; HEARING-LOSS; COCHLEAR STEREOCILIA; CANCER; EZRIN/RADIXIN/MOESIN; MOUSE; GENE; DEGENERATION; DEFICIENCY	The LKB1 gene, which encodes a serine/threonine kinase, was discovered to play crucial roles in cell differentiation, proliferation, and the establishment of cell polarity. In our study, LKB1 conditional knockout mice (Atoh1-LKB1(-/-) mice) were generated to investigate LKB1 function in the inner ear. Tests of auditory brainstem response and distortion product otoacoustic emissions revealed significant decreases in the hearing sensitivities of the Atoh1-LKB1(-/-) mice. In Atoh1-LKB1(-/-) mice, malformations of hair cell stereocilliary bundles were present as early as postnatal day 1 (P1), a time long before the maturation of the hair cell bundles. In addition, we also observed outer hair cell (OHC) loss starting at P14. The impaired stereocilliary bundles occurred long before the presence of hair cell loss. Stereociliary cytoskeletal structure depends on the core actin-based cytoskeleton and several actin-binding proteins. By Western blot, we examined actin-binding proteins, specifically ERM (ezrin/radixin/moesin) proteins involved in the regulation of the actin cytoskeleton of hair cell stereocilia. Our results revealed that the phosphorylation of ERM proteins (pERM) was significantly decreased in mutant mice. Thus, we propose that the decreased pERM may be a key factor for the impaired stereocillia function, and the damaged stereocillia may induce hair cell loss and hearing impairments. Taken together, our data indicates that LKB1 is required for the development and maintenance of stereocilia in the inner ear.	[Men, Yuqin; Zhang, Aizhen; Li, Haixiang; Zhang, Tingting; Jin, Yecheng; Zhang, Jian; Gao, Jiangang] Shandong Univ, Inst Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Li, Huashun] Tongji Univ, SARITEX Ctr Stem Cell, Engn Translat Med, Shanghai East Hosp,Adv Inst Translat Med,Sch Med, Shanghai 200092, Peoples R China; [Li, Huashun] Chinese Acad Sci, Shanghai Adv Res Inst, Ctr Stem Cell & Nanomed, Shanghai, Peoples R China; [Li, Huashun] Chinese Acad Sci, Shenzhen Key Lab Mol Biol Neural Dev, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China	Shandong University; Tongji University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Zhang, J (corresponding author), Shandong Univ, Inst Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	zhj8226@sdu.edu.cn; jggao@sdu.edu.cn		Zhang, Jian/0000-0001-6231-0301	National Basic Research Program (973) of China [2014CB541703]; National Natural Science Foundation of China [30871436, 30973297, 31171194]; Shandong Provincial Science and Technology Key Program [2009GG10002039]; Shandong Provincial Natural Science Foundation of China Grants [ZR2013CQ041]; Independent Innovation Foundation of Shandong University Grants, IIFSDU [2013GN011]; Shenzhen Committee for Technological Renovation [ZDSY20120617112838879]	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Science and Technology Key Program; Shandong Provincial Natural Science Foundation of China Grants; Independent Innovation Foundation of Shandong University Grants, IIFSDU; Shenzhen Committee for Technological Renovation	This work was supported by the National Basic Research Program (973) of China (2014CB541703), http://www.most.gov.cn/; the National Natural Science Foundation of China (30871436, 30973297, and 31171194), http://www.nsfc.gov.cn/; the Shandong Provincial Science and Technology Key Program (2009GG10002039); the Shandong Provincial Natural Science Foundation of China Grants, ZR2013CQ041, http://www.sdnsf.gov.cn/; Independent Innovation Foundation of Shandong University Grants, IIFSDU (2013GN011), http://www.sdu.edu.cn/; and Shenzhen Committee for Technological Renovation (ZDSY20120617112838879), http://www.szsti.gov.sdu.edu.cn/	Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; CORWIN JT, 1991, ANNU REV NEUROSCI, V14, P301, DOI 10.1146/annurev.neuro.14.1.301; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Fidalgo M, 2012, J BIOL CHEM, V287, P11556, DOI 10.1074/jbc.M111.320259; Francis SP, 2015, J NEUROSCI, V35, P1999, DOI 10.1523/JNEUROSCI.3449-14.2015; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Furness DN, 2013, P NATL ACAD SCI USA, V110, P13898, DOI 10.1073/pnas.1304644110; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Gloerich M, 2012, NAT CELL BIOL, V14, P793, DOI 10.1038/ncb2537; Goodyear RJ, 2014, J COMP NEUROL, V522, P3281, DOI 10.1002/cne.23597; Holley MC, 2005, DRUG DISCOV TODAY, V10, P1269, DOI 10.1016/S1359-6446(05)03595-6; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; Kersigo J, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00033; Kitajiri S, 2004, J CELL BIOL, V166, P559, DOI 10.1083/jcb.200402007; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Kolb CA, 2001, PLANT PHYSIOL, V127, P863, DOI 10.1104/pp.010373; Kopecky B, 2011, PHARMACEUTICALS, V4, P848, DOI 10.3390/ph4060848; Kopecky D, 2001, STUD HEALTH TECHNOL, V84, P484; Makary CA, 2011, JARO-J ASSOC RES OTO, V12, P711, DOI 10.1007/s10162-011-0283-2; Mangeat P, 1999, TRENDS CELL BIOL, V9, P289, DOI 10.1016/S0962-8924(99)01607-4; Meshikhes AWN, 2000, ANN SAUDI MED, V20, P413, DOI 10.5144/0256-4947.2000.413; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Ohashi K, 2010, J BIOL CHEM, V285, P22291, DOI 10.1074/jbc.M110.123794; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Perrin BJ, 2013, J NEUROSCI, V33, P8114, DOI 10.1523/JNEUROSCI.0238-13.2013; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Rivolta MN, 2013, BRIT MED BULL, V105, P69, DOI 10.1093/bmb/lds035; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; Shi ZB, 2013, STRUCTURE, V21, P449, DOI 10.1016/j.str.2013.01.007; Smith DP, 1999, HUM MOL GENET, V8, P1479, DOI 10.1093/hmg/8.8.1479; Steigelman KA, 2011, J NEUROSCI, V31, P12241, DOI 10.1523/JNEUROSCI.6531-10.2011; Sun C, 2014, NEUROREPORT, V25, P177, DOI 10.1097/WNR.0000000000000069; Sun G, 2011, DIS MODEL MECH, V4, P193, DOI 10.1242/dmm.006833; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Ueyama T, 2014, J CELL SCI, V127, P2040, DOI 10.1242/jcs.143602; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Yang H, 2010, GENESIS, V48, P407, DOI 10.1002/dvg.20633; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	50	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135841	10.1371/journal.pone.0135841	http://dx.doi.org/10.1371/journal.pone.0135841			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274331	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600123
J	Ahn, JK; Kim, S; Kim, J; Hwang, J; Kim, KH; Cha, HS				Ahn, Joong Kyong; Kim, Sooah; Kim, Jungyeon; Hwang, Jiwon; Kim, Kyoung Heon; Cha, Hoon-Suk			A Comparative Metabolomic Evaluation of Behcet's Disease with Arthritis and Seronegative Arthritis Using Synovial Fluid	PLOS ONE			English	Article							AMINO-ACIDS; METHIONINE; OXIDATION	Behcet's disease (BD) with arthritis is often confused with seronegative arthritis (SNA) because of shared clinical symptoms and the lack of definitive biomarkers for BD. To investigate possible metabolic patterns and potential biomarkers of BD with arthritis, metabolomic profiling of synovial fluid (SF) from 6 patients with BD with arthritis and 18 patients with SNA was performed using gas chromatography/time-of-flight mass spectrometry in conjunction with univariate and multivariate statistical analyses. A total of 123 metabolites were identified from samples. Orthogonal partial least square-discriminant analysis showed clear discrimination between BD with arthritis and SNA. A set of 11 metabolites were identified as potential biomarkers for BD using variable importance for projection values and the Wilcoxon-Mann-Whitney test. Compared with SNA, BD with arthritis exhibited relatively high levels of glutamate, valine, citramalate, leucine, methionine sulfoxide, glycerate, phosphate, lysine, isoleucine, urea, and citrulline. There were two markers identified, elevated methionine sulfoxide and citrulline, that were associated with increased oxidative stress, providing a potential link to BD-associated neutrophil hyperactivity. Glutamate, citramalate, and valine were selected and validated as putative biomarkers for BD with arthritis (sensitivity, 100%; specificity, 61.1%). This is the first report to present potential biomarkers from SF for discriminating BD with arthritis from SNA. The metabolomics of SF may be helpful in searching for potential biomarkers and elucidating the clinicopathogenesis of BD with arthritis.	[Ahn, Joong Kyong; Hwang, Jiwon] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med,Div Rheumatol, Seoul, South Korea; [Kim, Sooah; Kim, Jungyeon; Kim, Kyoung Heon] Korea Univ, Dept Biotechnol, Grad Sch, Seoul, South Korea; [Cha, Hoon-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Rheumatol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, KH (corresponding author), Korea Univ, Dept Biotechnol, Grad Sch, Seoul, South Korea.	khekim@korea.ac.kr; hoonsuk.cha@samsung.com	Kim, Kyoung Heon/F-1059-2013	Kim, Kyoung Heon/0000-0003-4600-8668	Advanced Biomass R&D Center of Korea [2011-0031353]; National Research Foundation of Korea - Ministry of Education [NRF-2013R1A1A2059103]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health Welfare [HI14C2285]; Korean Government	Advanced Biomass R&D Center of Korea; National Research Foundation of Korea - Ministry of Education; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health Welfare; Korean Government(Korean Government)	This work was supported by the Advanced Biomass R&D Center of Korea (http://www.biomass.re.kr/en, 2011-0031353) to KHK, the National Research Foundation of Korea funded by the Ministry of Education (http://www.nrf.re.kr/nrf_eng_cms/, NRF-2013R1A1A2059103) to HSC, and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare (http://www.khidi.or.kr/kps, HI14C2285) to HSC, which are funded by the Korean Government. Experiments were performed using facilities of the Institute of Biomedical Science and Food Safety at the Korea University Food Safety Hall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JK, 2011, J KOREAN MED SCI, V26, P697, DOI 10.3346/jkms.2011.26.5.697; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bassit RA, 2002, NUTRITION, V18, P376, DOI 10.1016/S0899-9007(02)00753-0; Bicer Ali, 2012, Patholog Res Int, V2012, P653806, DOI 10.1155/2012/653806; Bonanno G, 2007, INT REV NEUROBIOL, V82, P73, DOI 10.1016/S0074-7742(07)-82004-6; de Chambrun MP, 2012, AUTOIMMUN REV, V11, P687, DOI 10.1016/j.autrev.2011.11.026; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Fitzpatrick MA, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13743; FREUND HR, 1978, ANN SURG, V188, P423, DOI 10.1097/00000658-197809000-00017; Frikha F, 2009, INT J RHEUM DIS, V12, P250, DOI 10.1111/j.1756-185X.2009.01419.x; GIBSON T, 1981, ANN RHEUM DIS, V40, P376, DOI 10.1136/ard.40.4.376; Hatemi G, 2008, ARTHRITIS RHEUM-US, V58, P1539, DOI 10.1002/art.23450; International Study Group for Beh~et's Disease, 1990, LANCET, V335, P1078, DOI DOI 10.1016/0140-; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097501; Kim S, 2013, ANAL CHEM, V85, P2169, DOI 10.1021/ac302881e; Lauridsen MB, 2010, J PROTEOME RES, V9, P4545, DOI 10.1021/pr1002774; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; McNearney T, 2004, CLIN EXP IMMUNOL, V137, P621, DOI 10.1111/j.1365-2249.2004.02563.x; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; PERLMAN S, 1984, CLIN CHEM, V30, P1209; Priori R, 2013, AUTOIMMUN REV, V12, P1022, DOI 10.1016/j.autrev.2013.04.002; Qi Y, 2014, J CHROMATOGR B, V953, P11, DOI 10.1016/j.jchromb.2014.01.044; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Scrivo R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0445-5; Taysi S, 2008, CLIN RHEUMATOL, V27, P1529, DOI 10.1007/s10067-008-0963-4; TRANG LE, 1985, SCAND J RHEUMATOL, V14, P393, DOI 10.3109/03009748509102044; TSAN MF, 1980, J CLIN INVEST, V65, P1041, DOI 10.1172/JCI109756; Umetrics A.B., 2005, US GUID SIMCA P SIMC; VERNONROBERTS B, 1978, ANN RHEUM DIS, V37, P139, DOI 10.1136/ard.37.2.139; YURDAKUL S, 1983, ANN RHEUM DIS, V42, P505, DOI 10.1136/ard.42.5.505	34	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135856	10.1371/journal.pone.0135856	http://dx.doi.org/10.1371/journal.pone.0135856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270538	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800118
J	Hendrickson, RC; Lee, AYH; Song, QH; Liaw, A; Wiener, M; Paweletz, CP; Seeburger, JL; Li, J; Meng, FY; Deyanova, EG; Mazur, MT; Settlage, RE; Zhao, XM; Southwick, K; Du, Y; Holder, D; Sachs, JR; Laterza, OF; Dallob, A; Chappell, DL; Snyder, K; Modur, V; King, E; Joachim, C; Bondarenko, AY; Shearman, M; Soper, KA; Smith, D; Potter, WZ; Koblan, KS; Sachs, AB; Yates, NA				Hendrickson, Ronald C.; Lee, Anita Y. H.; Song, Qinghua; Liaw, Andy; Wiener, Matt; Paweletz, Cloud P.; Seeburger, Jeffrey L.; Li, Jenny; Meng, Fanyu; Deyanova, Ekaterina G.; Mazur, Matthew T.; Settlage, Robert E.; Zhao, Xuemei; Southwick, Katie; Du, Yi; Holder, Dan; Sachs, Jeffrey R.; Laterza, Omar F.; Dallob, Aimee; Chappell, Derek L.; Snyder, Karen; Modur, Vijay; King, Elizabeth; Joachim, Catharine; Bondarenko, Andrey Y.; Shearman, Mark; Soper, Keith A.; Smith, David; Potter, William Z.; Koblan, Ken S.; Sachs, Alan B.; Yates, Nathan A.			High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid	PLOS ONE			English	Article							DIFFERENTIAL MASS-SPECTROMETRY; NEURONAL PENTRAXIN RECEPTOR; BINDING PROTEIN 49; QUANTITATIVE-ANALYSIS; STATISTICAL-MODEL; PEPTIDE PRECURSOR; ELDERLY SUBJECTS; COMPLEX PEPTIDE; CSF BIOMARKERS; VGF	Disease modifying treatments for Alzheimer's disease (AD) constitute a major goal in medicine. Current trends suggest that biomarkers reflective of AD neuropathology and modifiable by treatment would provide supportive evidence for disease modification. Nevertheless, a lack of quantitative tools to assess disease modifying treatment effects remains a major hurdle. Cerebrospinal fluid (CSF) biochemical markers such as total tau, ptau and Ab42 are well established markers of AD; however, global quantitative biochemical changes in CSF in AD disease progression remain largely uncharacterized. Here we applied a high resolution open discovery platform, dMS, to profile a cross-sectional cohort of lumbar CSF from post-mortem diagnosed AD patients versus those from non-AD/non-demented (control) patients. Multiple markers were identified to be statistically significant in the cohort tested. We selected two markers SME-1 (p<0.0001) and SME-2 (p = 0.0004) for evaluation in a second independent longitudinal cohort of human CSF from post-mortem diagnosed AD patients and age-matched and case-matched control patients. In cohort-2, SME-1, identified as neuronal secretory protein VGF, and SME-2, identified as neuronal pentraxin receptor-1 (NPTXR), in AD were 21% (p = 0.039) and 17% (p = 0.026) lower, at baseline, respectively, than in controls. Linear mixed model analysis in the longitudinal cohort estimate a decrease in the levels of VGF and NPTXR at the rate of 10.9% and 6.9% per year in the AD patients, whereas both markers increased in controls. Because these markers are detected by mass spectrometry without the need for antibody reagents, targeted MS based assays provide a clear translation path for evaluating selected AD disease-progression markers with high analytical precision in the clinic.	[Hendrickson, Ronald C.; Lee, Anita Y. H.; Paweletz, Cloud P.; Li, Jenny; Meng, Fanyu; Deyanova, Ekaterina G.; Mazur, Matthew T.; Settlage, Robert E.; Zhao, Xuemei; Southwick, Katie; Du, Yi; Sachs, Alan B.; Yates, Nathan A.] Merck & Co Inc, Dept Exploratory Sci, Rahway, NJ 07065 USA; [Hendrickson, Ronald C.; Lee, Anita Y. H.; Paweletz, Cloud P.; Li, Jenny; Meng, Fanyu; Deyanova, Ekaterina G.; Mazur, Matthew T.; Settlage, Robert E.; Zhao, Xuemei; Southwick, Katie; Du, Yi; Sachs, Alan B.; Yates, Nathan A.] Merck & Co Inc, Dept Translat Sci, Rahway, NJ 07065 USA; [Song, Qinghua; Liaw, Andy] Merck & Co Inc, Biometr, Rahway, NJ 07065 USA; [Wiener, Matt; Sachs, Jeffrey R.] Merck & Co Inc, Appl Comp Sci & Math, Rahway, NJ 07065 USA; [Seeburger, Jeffrey L.; Potter, William Z.] Merck & Co Inc, Clin Neurosci & Ophthalmol, West Point, PA USA; [Holder, Dan; Soper, Keith A.] Merck & Co Inc, Biometr, West Point, PA USA; [Laterza, Omar F.; Dallob, Aimee; Chappell, Derek L.; Snyder, Karen] Merck & Co Inc, Clin Dev Lab, Rahway, NJ 07065 USA; [Modur, Vijay; Shearman, Mark; Koblan, Ken S.] Merck & Co Inc, Neurosci Basic Res, West Point, PA USA; [King, Elizabeth; Joachim, Catharine; Smith, David] Univ Oxford, Dept Pharmacol, OPTIMA, Oxford OX1 3QT, England; [Bondarenko, Andrey Y.] Rosetta Biosoftware, Seattle, WA USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; University of Oxford	Hendrickson, RC (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	hendricr@mskcc.org	Liu, Zhanqiang/HGC-0565-2022; liu, wen/HGE-3071-2022; Smith, David/GQQ-8257-2022; Smith, Anthony D./A-4233-2010	Smith, Anthony D./0000-0002-1095-6722	Merck Co.	Merck Co.(Merck & Company)	This discovery proteomics and analysis work was supported by Merck & Co. The manuscript was reviewed and approved for publication by Merck. The funders had no other role in the study design, data collection and analysis or preparation of the manuscript. The specific roles of the authors are articulated in the "author contribution" section.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Alder J, 2003, J NEUROSCI, V23, P10800; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Beckett LA, 2010, ALZHEIMERS DEMENT, V6, P257, DOI 10.1016/j.jalz.2010.03.002; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; BLASCHKO H, 1967, NATURE, V215, P58, DOI 10.1038/215058a0; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Breteler MMB, 2011, JAMA-J AM MED ASSOC, V305, P304, DOI 10.1001/jama.2010.2017; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Canu N, 1997, GENOMICS, V45, P443, DOI 10.1006/geno.1997.4945; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Choi YS, 2013, J CHROMATOGR B, V930, P129, DOI 10.1016/j.jchromb.2013.05.003; Choi YS, 2010, EXPERT REV PROTEOMIC, V7, P919, DOI 10.1586/EPR.10.75; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Davidsson P, 2002, NEUROREPORT, V13, P611, DOI 10.1097/00001756-200204160-00015; Dodds DC, 1997, J BIOL CHEM, V272, P21488, DOI 10.1074/jbc.272.34.21488; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; FCaL Lam, 1983, BIOMETRIKA, V70, P3; Finehout EJ, 2007, ANN NEUROL, V61, P120, DOI 10.1002/ana.21038; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; HINDLEY NJ, 1995, ACTA NEUROL SCAND, V91, P405, DOI 10.1111/j.1600-0404.1995.tb07029.x; Hu Y, 2007, PROTEOM CLIN APPL, V1, P1373, DOI 10.1002/prca.200600999; Jahn H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026540; Jobst K A, 1998, Int Psychogeriatr, V10, P271, DOI 10.1017/S1041610298005389; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kirkpatrick LL, 2000, J BIOL CHEM, V275, P17786, DOI 10.1074/jbc.M002254200; Lee AYH, 2008, J PROTEOME RES, V7, P5177, DOI 10.1021/pr800510p; Levi A, 2004, CELL MOL NEUROBIOL, V24, P517, DOI 10.1023/B:CEMN.0000023627.79947.22; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Mattsson N, 2012, J ALZHEIMERS DIS, V30, P767, DOI 10.3233/JAD-2012-120019; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meng FY, 2007, J AM SOC MASS SPECTR, V18, P226, DOI 10.1016/j.jasms.2006.09.014; Mount C, 2006, NAT MED, V12, P780, DOI 10.1038/nm0706-780; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Paweletz CP, 2010, J PROTEOME RES, V9, P1392, DOI 10.1021/pr900925d; Percy AJ, 2014, J PROTEOME RES, V13, P3733, DOI 10.1021/pr500317d; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Ringman JM, 2012, ARCH NEUROL-CHICAGO, V69, P96, DOI 10.1001/archneurol.2011.642; Sadygov RG, 2004, ANAL CHEM, V76, P1664, DOI 10.1021/ac035112y; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Simonsen AH, 2008, NEUROBIOL AGING, V29, P961, DOI 10.1016/j.neurobiolaging.2007.01.011; Smith AD, 2002, P NATL ACAD SCI USA, V99, P4135, DOI 10.1073/pnas.082107399; SOMOGYI P, 1984, BRAIN RES REV, V8, P193, DOI 10.1016/0165-0173(84)90007-9; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Thakker-Varia S, 2007, J NEUROSCI, V27, P12156, DOI 10.1523/JNEUROSCI.1898-07.2007; Vemuri P, 2009, NEUROLOGY, V73, P287, DOI 10.1212/WNL.0b013e3181af79e5; Wagner JA, 2008, ANNU REV PHARMACOL, V48, P631, DOI 10.1146/annurev.pharmtox.48.113006.094611; Wiener MC, 2004, ANAL CHEM, V76, P6085, DOI 10.1021/ac0493875; Wildsmith KR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-22; Williams JH, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt64; Yin GN, 2009, BRAIN RES, V1265, P158, DOI 10.1016/j.brainres.2009.01.058; Zhao XM, 2008, J PROTEOME RES, V7, P4373, DOI 10.1021/pr800309z	61	43	43	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135365	10.1371/journal.pone.0135365	http://dx.doi.org/10.1371/journal.pone.0135365			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270474	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800062
J	Huang, JH; Shen, ZQ; Lien, SP; Hsiao, KN; Leng, CH; Chen, CC; Siu, LK; Chong, PCS				Huang, Jui-Hsin; Shen, Zhe-Qing; Lien, Shu-Pei; Hsiao, Kuang-Nan; Leng, Chih-Hsiang; Chen, Chi-Chang; Siu, Leung-Kei; Chong, Pele Choi-Sing			Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE; PROTECTIVE IMMUNITY; MONOCLONAL-ANTIBODY; MUCOSAL ADJUVANT; TERMINAL REPEATS; DENDRITIC CELLS; IMMUNIZATION; EXPRESSION; INFECTION; CHEMOKINE	Clostridium difficile is an emerging pathogen responsible for opportunistic infections in hospitals worldwide and is the main cause of antibiotic-associated pseudo-membranous colitis and diarrhea in humans. Clostridial toxins A and B (TcdA and TcdB) specifically bind to unknown glycoprotein(s) on the surface of epithelial cells in the host intestine, disrupting the intestinal barrier and ultimately leading to acute inflammation and diarrhea. The C-terminal receptor-binding domain (RBD) of TcdA, which is responsible for the initial binding of the toxin to host glycoproteins, has been predicted to contain 7 potential oligosaccharide-binding sites. To study the specific roles and functions of these 7 putative lectin-like binding regions, a consensus sequence of TcdA RBD derived from different C. difficile strains deposited in the NCBI protein database and three truncated fragments corresponding to the N-terminal (residues 1-411), middle (residues 296-701), and C-terminal portions (residues 524-911) of the RBD (F1, F2 and F3, respectively) were designed and expressed in Escherichia coli. In this study, the recombinant RBD (rRBD) and its truncated fragments were purified, characterized biologically and found to have the following similar properties: (a) are capable of binding to the cell surface of both Vero and Caco-2 cells; (b) possess Toll-like receptor agonist-like adjuvant activities that can activate dendritic cell maturation and increase the secretion of pro-inflammatory cytokines; and (c) function as potent adjuvants in the intramuscular immunization route to enhance immune responses against weak immunogens. Although F1, F2 and F3 have similar repetitive amino acid sequences and putative oligosaccharide-binding domains, they do not possess the same biological and immunological properties: (i) TcdA rRBD and its fragments bind to the cell surface, but only TcdA rRBD and F3 internalize into Vero cells within 15 min; (ii) the fragments exhibit various levels of hemagglutinin (HA) activity, with the exception of the F1 fragment, which demonstrates no HA activity; and (iii) in the presence of alum, all fragments elicit various levels of anti-toxin A-neutralizing antibody responses, but those neutralizing antibodies elicited by F2 did not protect mice against a TcdA challenge. Because TcdA rRBD, F1 and F3 formulated with alum can elicit immune protective responses against the cytotoxicity of TcdA, they represent potential components of future candidate vaccines against C. difficile-associated diseases.	[Huang, Jui-Hsin; Shen, Zhe-Qing; Lien, Shu-Pei; Hsiao, Kuang-Nan; Leng, Chih-Hsiang; Chen, Chi-Chang; Siu, Leung-Kei; Chong, Pele Choi-Sing] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Vaccine R&D Ctr, Zhunan Town, Miaoli County, Taiwan; [Huang, Jui-Hsin; Chong, Pele Choi-Sing] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chong, Pele Choi-Sing] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Defense Medical Center; China Medical University Taiwan	Chong, PCS (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Vaccine R&D Ctr, Zhunan Town, Miaoli County, Taiwan.	pelechong@nhri.org.tw			National Science Council [NSC 101-2320-B-400-012, NSC 101-2923-B-400-001-MY3]; National Health Research Institutes, Taiwan, ROC	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan, ROC(National Health Research Institutes - Taiwan)	This work was supported by the grants from National Science Council (NSC 101-2320-B-400-012 and NSC 101-2923-B-400-001-MY3) and National Health Research Institutes, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albesa-Jove D, 2010, J MOL BIOL, V396, P1260, DOI 10.1016/j.jmb.2010.01.012; ARONSSON B, 1985, INFECTION, V13, P97, DOI 10.1007/BF01642866; Brun P, 2008, J MED MICROBIOL, V57, P725, DOI 10.1099/jmm.0.47736-0; Burger S, 2003, BIOCHEM BIOPH RES CO, V307, P584, DOI 10.1016/S0006-291X(03)01234-8; Castagliuolo I, 2004, INFECT IMMUN, V72, P2827, DOI 10.1128/IAI.72.5.2827-2836.2004; Davies AH, 2011, BIOCHEM J, V436, P517, DOI 10.1042/BJ20110106; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; DOVE CH, 1990, INFECT IMMUN, V58, P480, DOI 10.1128/IAI.58.2.480-488.1990; FERNIE DS, 1982, DEV BIOLOGICALS, V53, P325; FLEGEL WA, 1991, INFECT IMMUN, V59, P3659, DOI 10.1128/IAI.59.10.3659-3666.1991; FREY SM, 1992, INFECT IMMUN, V60, P2488, DOI 10.1128/IAI.60.6.2488-2492.1992; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; Gardiner DF, 2009, VACCINE, V27, P3598, DOI 10.1016/j.vaccine.2009.03.058; Gerhard R, 2013, J MED MICROBIOL, V62, P1414, DOI 10.1099/jmm.0.057828-0; Giannasca PJ, 1999, INFECT IMMUN, V67, P527, DOI 10.1128/IAI.67.2.527-538.1999; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Huang JH, 2015, J VACCINES VACCIN, V6, P276; Humphreys DP, 2014, CLIN VACCINE IMMUNOL, V21, P913, DOI 10.1128/CVI.00116-14; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kim JM, 2006, SCAND J IMMUNOL, V63, P453, DOI 10.1111/j.1365-3083.2006.001756.x; Kink JA, 1998, INFECT IMMUN, V66, P2018, DOI 10.1128/IAI.66.5.2018-2025.1998; KNOOP FC, 1993, CLIN MICROBIOL REV, V6, P251, DOI 10.1128/CMR.6.3.251-265.1993; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Lavelle EC, 2001, IMMUNOLOGY, V102, P77, DOI 10.1046/j.1365-2567.2001.01157.x; Lee JY, 2009, J MOL MED, V87, P169, DOI 10.1007/s00109-008-0415-2; Leuzzi R, 2013, INFECT IMMUN, V81, P2851, DOI 10.1128/IAI.01341-12; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; LYERLY D M, 1988, Clinical Microbiology Reviews, V1, P1; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Monaghan TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074452; Olling A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017623; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Permpoonpattana P, 2011, INFECT IMMUN, V79, P2295, DOI 10.1128/IAI.00130-11; Pruitt RN, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00028; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Ryan ET, 1997, INFECT IMMUN, V65, P2941, DOI 10.1128/IAI.65.7.2941-2949.1997; Sauerborn M, 1997, FEMS MICROBIOL LETT, V155, P45, DOI 10.1016/S0378-1097(97)00365-0; Seregin SS, 2012, VACCINE, V30, P1492, DOI 10.1016/j.vaccine.2011.12.064; Shen A, 2012, J INNATE IMMUN, V4, P149, DOI 10.1159/000332946; Stabler RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031559; Sun XM, 2010, TOXINS, V2, P1848, DOI 10.3390/toxins2071848; Taylor CP, 2008, VACCINE, V26, P3404, DOI 10.1016/j.vaccine.2008.04.042; Tian JH, 2012, VACCINE, V30, P4249, DOI 10.1016/j.vaccine.2012.04.045; TORRES JF, 1995, INFECT IMMUN, V63, P4619, DOI 10.1128/IAI.63.12.4619-4627.1995; Ward SJ, 1999, INFECT IMMUN, V67, P2145, DOI 10.1128/IAI.67.5.2145-2152.1999; Ward SJ, 1999, INFECT IMMUN, V67, P5124, DOI 10.1128/IAI.67.10.5124-5132.1999; WREN BW, 1991, INFECT IMMUN, V59, P3151, DOI 10.1128/IAI.59.9.3151-3155.1991; Wullt M, 2012, CLIN VACCINE IMMUNOL, V19, P1552, DOI 10.1128/CVI.00210-12; Yeh CY, 2008, INFECT IMMUN, V76, P1170, DOI 10.1128/IAI.01340-07	55	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135045	10.1371/journal.pone.0135045	http://dx.doi.org/10.1371/journal.pone.0135045			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271033	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800031
J	Ju, B; Qian, YT; Ye, MC; Ni, R; Zhu, CX				Ju, Bin; Qian, Yuntao; Ye, Minchao; Ni, Rong; Zhu, Chenxi			Using Dynamic Multi-Task Non-Negative Matrix Factorization to Detect the Evolution of User Preferences in Collaborative Filtering	PLOS ONE			English	Article								Predicting what items will be selected by a target user in the future is an important function for recommendation systems. Matrix factorization techniques have been shown to achieve good performance on temporal rating-type data, but little is known about temporal item selection data. In this paper, we developed a unified model that combines Multi-task Non-negative Matrix Factorization and Linear Dynamical Systems to capture the evolution of user preferences. Specifically, user and item features are projected into latent factor space by factoring co-occurrence matrices into a common basis item-factor matrix and multiple factor-user matrices. Moreover, we represented both within and between relationships of multiple factor-user matrices using a state transition matrix to capture the changes in user preferences over time. The experiments show that our proposed algorithm outperforms the other algorithms on two real datasets, which were extracted from Netflix movies and Last.fm music. Furthermore, our model provides a novel dynamic topic model for tracking the evolution of the behavior of a user over time.	[Ju, Bin; Ye, Minchao] Zhejiang Univ, Coll Comp Sci, Inst Artificial Intelligence, Hangzhou 310003, Zhejiang, Peoples R China; [Ju, Bin; Qian, Yuntao; Ni, Rong; Zhu, Chenxi] Hlth Informat Ctr Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Qian, YT (corresponding author), Hlth Informat Ctr Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.	ytqian@zju.edu.cn			Natural Science Foundation of Zhejiang Province of China [Y1101359]; National Basic Research Program of China [2012CB316400]; Major Projects of Zhejiang Provincial Science and Technology Program for Traditional Chinese Medicine [2015ZZ005]	Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); National Basic Research Program of China(National Basic Research Program of China); Major Projects of Zhejiang Provincial Science and Technology Program for Traditional Chinese Medicine	The work described in this paper was supported by the following funding: 1) the Natural Science Foundation of Zhejiang Province of China (no. Y1101359); 2) the National Basic Research Program of China (no. 2012CB316400); and 3) the Major Projects of Zhejiang Provincial Science and Technology Program for Traditional Chinese Medicine (no. 2015ZZ005).	Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Argyriou A., 2007, ADV NEURAL INFORM PR, V19, DOI DOI 10.2139/SSRN.1031158; Badea L, 2008, PACIFIC S BIOCOMPUTI, V13, P279; Bennett J., 2007, P KDD CUP WORKSH NEW, P3; Blei D.M., 2006, ICML, V25-29, P113; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Chen G, 2009, INFORM PROCESS MANAG, V45, P368, DOI 10.1016/j.ipm.2008.12.004; Chu M, 2004, SIAM J MATRIX ANAL; Chua FCT, 2013, IEEE DATA MINING, P91, DOI 10.1109/ICDM.2013.25; Cichocki A, 2006, BMFLAB SIGNAL PROCES; Cichocki A., 2009, NONNEGATIVE MATRIX T, DOI DOI 10.1002/9780470747278; Devarajan K, 2014, UNIFIED STAT APPROAC, P1; Ding C., 2006, P 21 NATL C ARTIFICI, V1, P342; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gaussier E., 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P601, DOI 10.1145/1076034.1076148; Gu Q., 2010, SIAM INT C DATA MIN, P199, DOI 10.1137/1.9781611972801.18; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Herrada OCC., 2009, MUSIC RECOMMENDATION; Hofmann T, 1999, IJCAI-99: PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 & 2, P688; Hofmann T, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P289; Jiang Y, 2014, MULTITASK TSK FUZZY; Jiang YZ, 2015, INFORM SCIENCES, V298, P512, DOI 10.1016/j.ins.2014.12.007; Koren Y, 2010, COMMUN ACM, V53, P89, DOI 10.1145/1721654.1721677; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Lathia N, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P796, DOI 10.1145/1571941.1572133; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Li R, 2011, AAAI; Lin CJ, 2007, NEURAL COMPUT, V19, P2756, DOI 10.1162/neco.2007.19.10.2756; Macskassy S, 2004, P 1 WORKSH ROC AN AI, P61; Sahoo N, 2012, MIS QUART, V36, P1329; Salakhutdinov R, 2008, P INT C MACH LEARN, P880, DOI DOI 10.1145/1390156.1390267; Salakhutdinov Ruslan, 2007, ADV NEURAL INFORM PR, P1257; Si L., 2003, MACHINE LEARNING INT, V20, P704; Su X., 2009, ADV ARTIF INTELL, V2009, P19, DOI [10.1155/2009/421425, DOI 10.1155/2009/421425]; Sun J, 2012, COLLABORATIVE KALMAN; Sun JZ, 2012, INT CONF ACOUST SPEE, P1897, DOI 10.1109/ICASSP.2012.6288274; Xie SN, 2012, INT C PATT RECOG, P2954; Xiong L., 2010, P SDM COL OH, P211; Zhang S, 2006, SIAM PROC S, P549	43	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135090	10.1371/journal.pone.0135090	http://dx.doi.org/10.1371/journal.pone.0135090			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270539	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800036
J	Kaiser, M; Maser, P; Tadoori, LP; Ioset, JR; Brun, R				Kaiser, Marcel; Maser, Pascal; Tadoori, Leela Pavan; Ioset, Jean-Robert; Brun, Reto			Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI; CHAGAS-DISEASE; RIMANTADINE HYDROCHLORIDE; AMANTADINE HYDROCHLORIDE; TRYPANOTHIONE REDUCTASE; PLASMODIUM-FALCIPARUM; CLINICAL DEVELOPMENT; LEISHMANIA-DONOVANI; SLEEPING SICKNESS; EXISTING DRUGS	Neglected tropical diseases cause significant morbidity and mortality and are a source of poverty in endemic countries. Only a few drugs are available to treat diseases such as leishmaniasis, Chagas' disease, human African trypanosomiasis and malaria. Since drug development is lengthy and expensive, a drug repurposing strategy offers an attractive fast-track approach to speed up the process. A set of 100 registered drugs with drug repositioning potential for neglected diseases was assembled and tested in vitro against four protozoan parasites associated with the aforementioned diseases. Several drugs and drug classes showed in vitro activity in those screening assays. The results are critically reviewed and discussed in the perspective of a follow-up drug repositioning strategy where R&D has to be addressed with limited resources.	[Kaiser, Marcel; Maser, Pascal; Brun, Reto] Swiss Trop & Publ Hlth Inst, Parasite Chemotherapy, Basel, Switzerland; [Kaiser, Marcel; Maser, Pascal; Brun, Reto] Univ Basel, Basel, Switzerland; [Tadoori, Leela Pavan; Ioset, Jean-Robert] Drugs Neglected Dis Initiat, Geneva, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Kaiser, M (corresponding author), Swiss Trop & Publ Hlth Inst, Parasite Chemotherapy, Basel, Switzerland.	marcel.kaiser@unibas.ch		Maser, Pascal/0000-0003-3122-1941; Kaiser, Marcel/0000-0003-1785-7302	Department for International Development (UK); Reconstruction Credit Institution-Federal Ministry of Education and Research (KfW-BMBF; Germany); Bill & Melinda Gates Foundation (United States); Medecins Sans Frontieres	Department for International Development (UK); Reconstruction Credit Institution-Federal Ministry of Education and Research (KfW-BMBF; Germany); Bill & Melinda Gates Foundation (United States); Medecins Sans Frontieres	The Drugs for Neglected Diseases initiative received financial support from the following donors: Department for International Development (UK), Reconstruction Credit Institution-Federal Ministry of Education and Research (KfW-BMBF; Germany), Bill & Melinda Gates Foundation (United States), and Medecins Sans Frontieres. The donors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaki M, 2002, PARASITOL RES, V88, P1044, DOI 10.1007/s00436-002-0690-8; ALGER NE, 1970, NATURE, V227, P381, DOI 10.1038/227381b0; ARBISER JL, 1995, J AM ACAD DERMATOL, V32, P241, DOI 10.1016/0190-9622(95)90134-5; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Baginski M, 2009, CURR DRUG METAB, V10, P459, DOI 10.2174/138920009788898019; Bahia MT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001870; Baik J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047494; BITONTI AJ, 1988, SCIENCE, V242, P1301, DOI 10.1126/science.3057629; Boiani M, 2010, BIOCHEM PHARMACOL, V79, P1736, DOI 10.1016/j.bcp.2010.02.009; Chibale K, 2000, BIOORG MED CHEM LETT, V10, P1147, DOI 10.1016/S0960-894X(00)00154-2; Cholo MC, 2012, J ANTIMICROB CHEMOTH, V67, P290, DOI 10.1093/jac/dkr444; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Davis DA, 2012, ANTIMICROB AGENTS CH, V56, P3620, DOI 10.1128/AAC.00055-12; De Rycker M, 2013, ANTIMICROB AGENTS CH, V57, P2913, DOI 10.1128/AAC.02398-12; Debnath A, 2012, NAT MED, V18, P956, DOI 10.1038/nm.2758; DNDi, 2013, TARG PROD PROF; Don R, 2014, PARASITOLOGY, V141, P140, DOI 10.1017/S003118201300142X; Eastman RT, 2013, ANTIMICROB AGENTS CH, V57, P425, DOI 10.1128/AAC.00920-12; EVANS AT, 1989, ANN TROP MED PARASIT, V83, P447, DOI 10.1080/00034983.1989.11812371; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Hall BS, 2011, J BIOL CHEM, V286, P13088, DOI 10.1074/jbc.M111.230847; HAYDEN FG, 1985, ANTIMICROB AGENTS CH, V28, P216, DOI 10.1128/AAC.28.2.216; HAYDEN FG, 1981, ANTIMICROB AGENTS CH, V19, P226, DOI 10.1128/AAC.19.2.226; Hotez P, 2006, ADV EXP MED BIOL, V582, P23; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; INTOCCIA AP, 1982, J RHEUMATOL, V9, P90; Jansen C, 2013, J MED CHEM, V56, P2087, DOI 10.1021/jm3017877; Jeon KI, 2003, EXP MOL MED, V35, P61, DOI 10.1038/emm.2003.9; Jin GX, 2014, DRUG DISCOV TODAY, V19, P637, DOI 10.1016/j.drudis.2013.11.005; Kelly JM, 1999, ANTIMICROB AGENTS CH, V43, P985, DOI 10.1128/AAC.43.4.985; Kelly JM, 2001, ANTIMICROB AGENTS CH, V45, P1360, DOI 10.1128/AAC.45.5.1360-1366.2001; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023852; Lobanov AV, 2006, NUCLEIC ACIDS RES, V34, P4012, DOI 10.1093/nar/gkl541; Loiseau PM, 2011, PARASITE, V18, P115, DOI 10.1051/parasite/2011182115; Mahmoudi N, 2008, ANTIMICROB AGENTS CH, V52, P1215, DOI 10.1128/AAC.01043-07; Mathis AM, 2006, ANTIMICROB AGENTS CH, V50, P2185, DOI 10.1128/AAC.00192-06; MMV, 2013, TARG PROD PROF; MMV, 2008, COMP PROGR CRIT; Molina I, 2014, NEW ENGL J MED, V370, P1899, DOI 10.1056/NEJMoa1313122; Moraes CB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04703; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nzila A, 2011, FUTURE MED CHEM, V3, P1413, DOI [10.4155/fmc.11.95, 10.4155/FMC.11.95]; Orhan I, 2010, MAR DRUGS, V8, P47, DOI 10.3390/md8010047; Padhy BM, 2011, J POSTGRAD MED, V57, P153, DOI 10.4103/0022-3859.81870; Penna-Coutinho J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021237; PINTO LH, 1995, TRENDS MICROBIOL, V3, P271, DOI 10.1016/S0966-842X(00)88942-8; Richardson JL, 2009, CHEMMEDCHEM, V4, P1333, DOI 10.1002/cmdc.200900097; Royle KE, 2013, DRUG DISCOV TODAY, V18, P1250, DOI 10.1016/j.drudis.2013.07.002; Seebeck T, 2011, FUTURE MED CHEM, V3, P1289, DOI [10.4155/fmc.11.77, 10.4155/FMC.11.77]; Sharlow ER, 2014, ACS CHEM BIOL, V9, P663, DOI 10.1021/cb400800q; SPECTOR R, 1988, J PHARMACOL EXP THER, V244, P516; STRATH M, 1993, T ROY SOC TROP MED H, V87, P211, DOI 10.1016/0035-9203(93)90497-E; Sun T, 2008, NUCLEIC ACIDS RES, V36, P1654, DOI 10.1093/nar/gkm1180; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Torreele E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000923; Tweats D, 2012, MUTAGENESIS, V27, P523, DOI 10.1093/mutage/ges015; Wang HC, 2012, J BIOL CHEM, V287, P11788, DOI 10.1074/jbc.M111.326777; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; Wilkinson SR, 2008, P NATL ACAD SCI USA, V105, P5022, DOI 10.1073/pnas.0711014105; WILLS RJ, 1987, ANTIMICROB AGENTS CH, V31, P826, DOI 10.1128/AAC.31.5.826; Zoidis G, 2008, ORG BIOMOL CHEM, V6, P3177, DOI 10.1039/b804907f	63	53	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135556	10.1371/journal.pone.0135556	http://dx.doi.org/10.1371/journal.pone.0135556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270335	gold, Green Published, Green Accepted			2022-12-27	WOS:000359492800088
J	Mushemi-Blake, S; Melikian, N; Drasar, E; Bhan, A; Lunt, A; Desai, SR; Greenough, A; Monaghan, MJ; Thein, SL; Shah, AM				Mushemi-Blake, Sitali; Melikian, Narbeh; Drasar, Emma; Bhan, Amit; Lunt, Alan; Desai, Sujal R.; Greenough, Anne; Monaghan, Mark J.; Thein, Swee Lay; Shah, Ajay M.			Pulmonary Haemodynamics in Sickle Cell Disease Are Driven Predominantly by a High-Output State Rather Than Elevated Pulmonary Vascular Resistance: A Prospective 3-Dimensional Echocardiography/Doppler Study	PLOS ONE			English	Article							UNITED-STATES; HYPERTENSION; HEART; RECOMMENDATIONS; ANEMIA	Aims Patients with sickle cell disease have significant morbidity and mortality. Pulmonary hypertension is suggested to be an important contributor but its nature and severity in these patients and how best to non-invasively assess it are controversial. We hypothesised that a high-output state rather than primary pulmonary vascular pathology may be the major abnormality in sickle cell disease. This study aimed to evaluate the characteristics and severity of pulmonary hypertension in patients with sickle cell disease using detailed echocardiography. Methods and Results We undertook a prospective study in 122 consecutive stable outpatients with sickle cell disease and 30 age, gender and ethnicity-matched healthy controls. Echocardiographic evaluation included 3D ventricular volumes, sphericity, tissue Doppler, and non-invasive estimation of pulmonary vascular resistance. 36% of patients had a tricuspid regurgitant velocity >= 2.5 m.s(-1) but only 2% had elevated pulmonary vascular resistance and the prevalence of right ventricular dysfunction was very low. Patients with raised tricuspid regurgitant velocity had significantly elevated biventricular volumes and globular left ventricular remodelling, related primarily to anaemia. In a subgroup of patients who underwent cardiac catheterization, invasive pulmonary haemodynamics confirmed the echocardiographic findings. Conclusions Elevated cardiac output and left ventricular volume overload secondary to chronic anaemia may be the dominant factor responsible for abnormal cardiopulmonary haemodynamics in patients with sickle cell disease. 3D echocardiography with non-invasive estimation of pulmonary vascular resistance represents a valuable approach for initial evaluation of cardiopulmonary haemodynamics in sickle cell disease.	[Mushemi-Blake, Sitali; Melikian, Narbeh; Monaghan, Mark J.; Shah, Ajay M.] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, London WC2R 2LS, England; [Mushemi-Blake, Sitali; Melikian, Narbeh; Bhan, Amit; Monaghan, Mark J.; Shah, Ajay M.] Kings Coll Hosp London, Dept Cardiol, London, England; [Drasar, Emma; Thein, Swee Lay] Kings Coll Hosp London, Dept Haematol Med, London, England; [Lunt, Alan; Greenough, Anne] Kings Coll Hosp London, Dept Paediat, London, England; [Desai, Sujal R.] Kings Coll Hosp London, Dept Radiol, London, England; [Thein, Swee Lay] Natl Inst Heart Lung & Blood Dis, NIH, Sickle Cell Branch, Bethesda, MD USA	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Shah, AM (corresponding author), Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, London WC2R 2LS, England.	ajay.shah@kcl.ac.uk		Desai, Sujal/0000-0002-5237-3613; Shah, Ajay/0000-0002-6547-0631; Greenough, Anne/0000-0002-8672-5349; Lunt, Alan/0000-0002-4585-9180	Department of Health via a National Institute for Health Research (NIHR) Biomedical Research Centre; British Heart Foundation [RE/13/2/30182]	Department of Health via a National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	SMB was funded by the Department of Health via a National Institute for Health Research (NIHR) Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. AMS is supported by research grants from the British Heart Foundation (RE/13/2/30182). The funders had no role in study design, data collection, decision to publish, or preparation off the manuscript.	Abbas AE, 2003, J AM COLL CARDIOL, V41, P1021, DOI 10.1016/S0735-1097(02)02973-X; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Barst RJ, 2010, BRIT J HAEMATOL, V149, P426, DOI 10.1111/j.1365-2141.2010.08097.x; Bech-Hanssen O, 2013, J AM SOC ECHOCARDIOG, V26, P469, DOI 10.1016/j.echo.2013.02.011; Bunn HF, 2010, BLOOD, V116, P687, DOI 10.1182/blood-2010-02-268193; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; COVITZ W, 1995, CHEST, V108, P1214, DOI 10.1378/chest.108.5.1214; De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058; De Castro S, 2007, HEART, V93, P205, DOI 10.1136/hrt.2006.093997; Fonseca GHH, 2012, EUR RESPIR J, V39, P112, DOI 10.1183/09031936.00134410; GERRY JL, 1976, AM J MED, V60, P968, DOI 10.1016/0002-9343(76)90568-4; Gladwin MT, 2012, J AM COLL CARDIOL, V59, P1123, DOI 10.1016/j.jacc.2011.10.900; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Jenkins C, 2004, J AM COLL CARDIOL, V44, P878, DOI 10.1016/j.jacc.2004.05.050; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Laszlo G, 2006, THORAX, V61, P744, DOI 10.1136/thx.2006.061648; Machado RF, 2011, BLOOD, V118, P855, DOI 10.1182/blood-2010-09-306167; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Mor-Avi V, 2011, EUR J ECHOCARDIOGR, V12, P167, DOI 10.1093/ejechocard/jer021; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Prabhakar H, 2010, AM J HEMATOL, V85, P346, DOI 10.1002/ajh.21676; Sachdev V, 2011, CIRCULATION, V124, P1452, DOI 10.1161/CIRCULATIONAHA.111.032920; Saxena N, 2006, ECHOCARDIOGR-J CARD, V23, P750, DOI 10.1111/j.1540-8175.2006.00305.x; SUTTON LL, 1994, AM J CARDIOL, V74, P626, DOI 10.1016/0002-9149(94)90760-9	25	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135472	10.1371/journal.pone.0135472	http://dx.doi.org/10.1371/journal.pone.0135472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270484	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800080
J	Leite, LAC; Filho, AAP; Ferreira, RDD; da Fonseca, CSM; dos Santos, BS; Montenegro, SML; Lopes, EPD; Domingues, ALC; Owen, JS; Lima, VLD				Calheiros Leite, Luiz Arthur; Pimenta Filho, Adenor Almeida; dos Santos Ferreira, Rita de Cassia; Martins da Fonseca, Caique Silveira; dos Santos, Bianka Santana; Lucena Montenegro, Silvia Maria; de Almeida Lopes, Edmundo Pessoa; Coutinho Domingues, Ana Lucia; Owen, James Stuart; de Menezes Lima, Vera Lucia			Splenectomy Improves Hemostatic and Liver Functions in Hepatosplenic Schistosomiasis Mansoni	PLOS ONE			English	Article							LECITHIN; DYSFUNCTION; LCAT	Background Schistosomiasis mansoni is a chronic liver disease, in which some patients (5-10%) progress to the most severe form, hepatosplenic schistosomiasis. This form is associated with portal hypertension and splenomegaly, and often episodes of gastrointestinal bleeding, even with liver function preserved. Splenectomy is a validated procedure to reduce portal hypertension following digestive bleeding. Here, we evaluate beneficial effects of splenectomy on blood coagulation factors and liver function tests in hepatosplenic schistosomiasis mansoni compared to non-operated patients. Methodology/Principal Findings Forty-five patients who had undergone splenectomy surgery were assessed by laboratory analyses and ultrasound examination and compared to a non-operated group (n = 55). Blood samples were obtained for liver function tests, platelet count and prothrombin time. Coagulation factors (II, VII, VIII, IX and X), protein C and antithrombin IIa, plasminogen activator inhibitor-1 were measured by routine photometric, chromogenic or enzyme-linked immunosorbent assays, while hyperfibrinolysis was defined by plasminogen activator inhibitor-1 levels. Both groups had similar age, gender and pattern of periportal fibrosis. Splenectomized patients showed significant reductions in portal vein diameter, alkaline phosphatase and bilirubin levels compared to non-operated patients, while for coagulation factors there were significant improvement in prothrombin, partial thromboplastin times and higher levels of factor VII, VIII, IX, X, protein C and plasminogen activator inhibitor-1. Conclusion/Significance This study shows that the decrease of flow pressure in portal circulation after splenectomy restores the capacity of hepatocyte synthesis, especially on the factor VII and protein C levels, and these findings suggest that portal hypertension in patients with hepatosplenic schistosomiasis influences liver functioning and the blood coagulation status.	[Calheiros Leite, Luiz Arthur; Pimenta Filho, Adenor Almeida; Martins da Fonseca, Caique Silveira; dos Santos, Bianka Santana; de Menezes Lima, Vera Lucia] Univ Fed Pernambuco, Dept Bioquim, Ctr Ciencias Biol, Recife, PE, Brazil; [Calheiros Leite, Luiz Arthur] Univ Fed Pernambuco, Dept Biofis & Radiobiol, Recife, PE, Brazil; [dos Santos Ferreira, Rita de Cassia] Univ Fed Pernambuco, Dept Med Trop, Ctr Ciencias Saude, Recife, PE, Brazil; [Lucena Montenegro, Silvia Maria] Ctr Pesquisa Aggeu Magalhaes CPqAM FIOCRUZ, Dept Imunol, Recife, PE, Brazil; [de Almeida Lopes, Edmundo Pessoa; Coutinho Domingues, Ana Lucia] Univ Fed Pernambuco, Hosp Clin, Dept Med Clin, Ctr Ciencias Saude, Recife, PE, Brazil; [Owen, James Stuart] UCL, Sch Med, Inst Liver & Digest Hlth, Div Med, London W1N 8AA, England	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Fundacao Oswaldo Cruz; Universidade Federal de Pernambuco; University of London; University College London; UCL Medical School	Lopes, EPD (corresponding author), Univ Fed Pernambuco, Hosp Clin, Dept Med Clin, Ctr Ciencias Saude, Recife, PE, Brazil.	epalopes@uol.com.br; lima.vera.ufpe@gmail.com	montenegro, silvia/AAD-9090-2020; Fonseca, Caique S M/G-1564-2013; Lopes, Edmundo/R-5159-2017; Owen, James S./AAP-8628-2020	Lopes, Edmundo/0000-0002-3470-1564; Lima, Vera/0000-0003-2581-9218	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Fundacao de Amparo a Ciencia do Estado de Pernambuco - FACEPE [FACEPE-PPSUS-PE APQ-1369-4.00/08]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Ciencia do Estado de Pernambuco - FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, and Fundacao de Amparo a Ciencia do Estado de Pernambuco - FACEPE (Grant: FACEPE-PPSUS-PE APQ-1369-4.00/08) for financial support to carry out this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves Jr. Antonio, 2003, Arq. Gastroenterol., V40, P203, DOI [10.1590/S0004-28032003000400002, 10.1590/S0004-28032003000400006]; Amaral ACC, 2002, ARQ GASTROENTEROL, V39, P27, DOI [10.1590/S0004-28032002000100006, DOI 10.1590/S0004-28032002000100006]; Andrade ZA, 2004, MEM I OSWALDO CRUZ, V99, P51, DOI 10.1590/S0074-02762004000900009; BARRETO VST, 1971, ANN INTERN MED, V74, P450, DOI 10.7326/0003-4819-74-3-450_2; Leite LAC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002314; Camacho-Lobato L, 1998, J HEPATOL, V29, P233, DOI 10.1016/S0168-8278(98)80008-1; Correia MCB, 2009, T ROY SOC TROP MED H, V103, P1053, DOI 10.1016/j.trstmh.2008.11.017; de Cleva R, 2007, WORLD J GASTROENTERO, V13, P5471, DOI 10.3748/wjg.v13.i41.5471; de Toledo CF, 2009, DIGEST DIS SCI, V54, P1331, DOI 10.1007/s10620-008-0475-8; Denie C, 1996, LIVER, V16, P309, DOI 10.1111/j.1600-0676.1996.tb00751.x; Dias HS, 2013, ACTA TROP, V126, P240, DOI 10.1016/j.actatropica.2013.02.011; ElBassiouni NE, 1996, J CLIN PATHOL, V49, P990, DOI 10.1136/jcp.49.12.990; Ferraz A A, 2001, Arq Gastroenterol, V38, P84; Ferraz AAB, 2001, INT SURG, V86, P1; Ferraz Álvaro Antônio Bandeira, 2003, Arq. Gastroenterol., V40, P4, DOI 10.1590/S0004-28032003000100002; Fonseca C. S. M., 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.01019, DOI 10.1371/J0URNAL.P0NE.01019]; FUJII S, 1992, THROMB HAEMOSTASIS, V67, P233; Gryseels B, 2012, INFECT DIS CLIN N AM, V26, P383, DOI 10.1016/j.idc.2012.03.004; HORTON RC, 1990, LANCET, V336, P249, DOI 10.1016/0140-6736(90)91777-8; Katz N, 2000, Rev Soc Bras Med Trop, V33, P303, DOI 10.1590/S0037-86822000000300009; Leite Luiz Arthur Calheiros, 2013, Rev. Bras. Hematol. Hemoter., V35, P332, DOI 10.5581/1516-8484.20130098; Lima VLM, 2004, CARBOHYD POLYM, V55, P179, DOI 10.1016/j.carbpol.2003.09.005; de Morais CNL, 2008, MEM I OSWALDO CRUZ, V103, P561, DOI 10.1590/S0074-02762008000600009; Maia MD, 2007, ACTA TROP, V101, P183, DOI 10.1016/j.actatropica.2007.01.004; Makdissi Fábio Ferrari, 2009, Arq. Gastroenterol., V46, P50, DOI 10.1590/S0004-28032009000100014; Negrao-Correa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088042; OMRAN SA, 1990, J CLIN PATHOL, V43, P476, DOI 10.1136/jcp.43.6.476; OMRAN SA, 1994, J CLIN PATHOL, V47, P502, DOI 10.1136/jcp.47.6.502; OWEN JS, 1978, SCAND J CLIN LAB INV, V38, P194, DOI 10.3109/00365517809104925; Scholte RGC, 2014, ACTA TROP, V132, P57, DOI 10.1016/j.actatropica.2013.12.007; SHIMADA M, 1989, TRANSPLANTATION, V48, P600; Silva CA, 2002, ACTA CIR BRAS, V17, P28, DOI DOI 10.1590/50102-86502002000700008; SPRENGERS ED, 1985, J LAB CLIN MED, V105, P751; Tanabe M, 2003, PARASITOL INT, V52, P351, DOI 10.1016/S1383-5769(03)00051-5	34	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135370	10.1371/journal.pone.0135370	http://dx.doi.org/10.1371/journal.pone.0135370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267788	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300107
J	Chong, W; Shi, XG; Shan, ZY; Teng, XC; Teng, D; Guan, HX; Li, YS; Jin, Y; Yu, XH; Fan, CL; Yang, F; Dai, H; Yu, Y; Li, J; Chen, YY; Zhao, D; Hu, FN; Mao, JY; Gu, XL; Yang, R; Tong, YJ; Wang, WB; Gao, TS; Li, CY; Teng, WP				Chong, Wei; Shi, Xiaoguang; Shan, Zhongyan; Teng, Xiaochun; Teng, Di; Guan, Haixia; Li, Yushu; Jin, Ying; Yu, Xiaohui; Fan, Chenling; Yang, Fan; Dai, Hong; Yu, Yang; Li, Jia; Chen, Yanyan; Zhao, Dong; Hu, Fengnan; Mao, Jinyuan; Gu, Xiaolan; Yang, Rong; Tong, Yajie; Wang, Weibo; Gao, Tianshu; Li, Chenyang; Teng, Weiping			Tg in Adults as a Sensitive Biomarker of Iodine Status: A 5-Year Follow up Population Study in Different Levels of Iodine Intake Regions	PLOS ONE			English	Article							THYROGLOBULIN MEASUREMENT; MARKER	This study was to evaluate the usefulness of serum thymoglobulin (Tg) in adults to assess iodine status through a 5-year cohort study which was conducted in three regions with different levels of iodine intake: mild deficiency, more than adequate, and excess, from 1999 to 2004 in China. A total of 3099 subjects over 14 years old with normal serum levels of Tg in 1999 were eligible, of whom 2448 were followed in 2004. Serum levels of thyroid hormones and thyroid autoantibodies as well as urine iodine were measured, and B-mode ultrasonography of the thyroid was performed. A general linear model was performed to determine the determinant factors of serum Tg. Among subjects with mildly deficient iodine intake, those with more than adequate intake, and those with excessive intake, the baseline levels of serum Tg were substantially different (7.5 mu g/L, 5.9 mu g/L, and 6.8 mu g/L respectively, P<0.01), which were associated with age, sex, the rate of positive TgAb, abnormal thyroid volume, abnormal TSH, and positive personal history of thyroid diseases. The data from 1856 subjects with normal range of thyroid parameters but no personal history of thyroid diseases were analyzed to clarify the effect of iodine intake on Tg. Among these three regions, the serum Tg levels were substantially different in both 1999 and 2004, with a similar pattern for increased Tg (Delta Tg) (3.1 mu g/L, 2.5 mu g/L and 3.5 mu g/L respectively, P<0.01). The general linear model analysis revealed that age, Tg, and baseline TSH levels were the determinants of Delta Tg besides iodine intake. In conclusion, serum Tg in adults, resulting from a time-accumulative effect of iodine exposure, is a useful biomarker of regional iodine intake.	[Chong, Wei] China Med Univ, Affiliated Hosp 1, Dept Emergency, Shenyang, Liaoning, Peoples R China; [Shi, Xiaoguang; Shan, Zhongyan; Teng, Xiaochun; Teng, Di; Guan, Haixia; Li, Yushu; Jin, Ying; Yu, Xiaohui; Fan, Chenling; Yang, Fan; Dai, Hong; Yu, Yang; Li, Jia; Chen, Yanyan; Zhao, Dong; Hu, Fengnan; Mao, Jinyuan; Gu, Xiaolan; Yang, Rong; Tong, Yajie; Wang, Weibo; Gao, Tianshu; Li, Chenyang; Teng, Weiping] China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Inst Endocrinol,Liaoning Prov Key Lab Endocrine D, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University	Teng, WP (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Inst Endocrinol,Liaoning Prov Key Lab Endocrine D, Shenyang, Liaoning Provin, Peoples R China.	twp@vip.163.com			Important Platform of Science and Technology for Universities in Liaoning Province [16010]	Important Platform of Science and Technology for Universities in Liaoning Province	This study was supported by Important Platform of Science and Technology for Universities in Liaoning Province (Project Number: 16010) to WT, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; [Anonymous], 2007, ASS IOD DEF DIS MON; BRUNN J, 1981, DEUT MED WOCHENSCHR, V106, P1338, DOI 10.1055/s-2008-1070506; Gao T, 2001, Zhonghua Yi Xue Za Zhi, V81, P453; Knudsen N, 2001, J CLIN ENDOCR METAB, V86, P3599, DOI 10.1210/jc.86.8.3599; Li Chen-yang, 2003, Zhonghua Nei Ke Za Zhi, V42, P316; Liberman CS, 1998, J CLIN ENDOCR METAB, V83, P3545, DOI 10.1210/jc.83.10.3545; SPENCER CA, 1995, ENDOCRIN METAB CLIN, V24, P841, DOI 10.1016/S0889-8529(18)30023-9; Spencer CA, 2003, THYROID, V13, P2, DOI 10.1089/105072503321086953; Sun X, 2014, ENDOCRINOL METAB, V29, P240, DOI 10.3803/EnM.2014.29.3.240; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; Torrens JI, 2001, ENDOCRIN METAB CLIN, V30, P429, DOI 10.1016/S0889-8529(05)70194-8; Vejbjerg P, 2009, EUR J ENDOCRINOL, V161, P475, DOI 10.1530/EJE-09-0262; Wang RY, 1996, CHINESE J CONTROL EN, V11, P27; World Health Organization; United Nations Children's Fund; International Council for the Control of Iodine Deficiency Disorders, 1993, IND ASS IOD DEF DIS; Zimmermann MB, 2003, AM J CLIN NUTR, V77, P663, DOI 10.1093/ajcn/77.3.663; Zimmermann MB, 2008, BRIT J NUTR, V99, pS2, DOI 10.1017/S000711450800679X; Zimmermann MB, 2013, J CLIN ENDOCR METAB, V98, P1271, DOI 10.1210/jc.2012-3952	18	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135553	10.1371/journal.pone.0135553	http://dx.doi.org/10.1371/journal.pone.0135553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266530	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300132
J	Clawson, GA; Matters, GL; Xin, P; Imamura-Kawasawa, Y; Du, Z; Thiboutot, DM; Helm, KF; Neves, RI; Abraham, T				Clawson, Gary A.; Matters, Gail L.; Xin, Ping; Imamura-Kawasawa, Yuka; Du, Zhen; Thiboutot, Diane M.; Helm, Klaus F.; Neves, Rogerio I.; Abraham, Thomas			Macrophage-Tumor Cell Fusions from Peripheral Blood of Melanoma Patients	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; SENTINEL LYMPH-NODES; FATTY-ACID SYNTHASE; PANCREATIC-CANCER; DNA-PLOIDY; STEM-CELLS; FACTOR MIF; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC-FACTORS	Background While the morbidity and mortality from cancer are largely attributable to its metastatic dissemination, the integral features of the cascade are not well understood. The widely accepted hypothesis is that the primary tumor microenvironment induces the epithelial-to-mesenchymal transition in cancer cells, facilitating their escape into the bloodstream, possibly accompanied by cancer stem cells. An alternative theory for metastasis involves fusion of macrophages with tumor cells (MTFs). Here we culture and characterize apparent MTFs from blood of melanoma patients. Methods We isolated enriched CTC populations from peripheral blood samples from melanoma patients, and cultured them. We interrogated these cultured cells for characteristic BRAF mutations, and used confocal microscopy for immunophenotyping, motility, DNA content and chromatin texture analyses, and then conducted xenograft studies using nude mice. Findings Morphologically, the cultured MTFs were generally large with many pseudopod extensions and lamellipodia. Ultrastructurally, the cultured MTFs appeared to be macrophages. They were rich in mitochondria and lysosomes, as well as apparent melanosomes. The cultured MTF populations were all heterogeneous with regard to DNA content, containing aneuploid and/or high-ploidy cells, and they typically showed large sheets (and/or clumps) of cytoplasmic chromatin. This cytoplasmic DNA was found within heterogeneously-sized autophagic vacuoles, which prominently contained chromatin and micronuclei. Cultured MTFs uniformly expressed pan-macrophage markers (CD14, CD68) and macrophage markers indicative of M2 polarization (CD163, CD204, CD206). They also expressed melanocyte-specific markers (ALCAM, MLANA), epithelial biomarkers (KRT, EpCAM), as well as the pro-carcinogenic cytokine MIF along with functionally related stem cell markers (CXCR4, CD44). MTF cultures from individual patients (5 of 8) contained melanoma-specific BRAF activating mutations. Chromatin texture analysis of deconvoluted images showed condensed DNA (DAPI-intense) regions similar to focal regions described in stem cell fusions. MTFs were readily apparent in vivo in all human melanomas examined, often exhibiting even higher DNA content than the cultured MTFs. When cultured MTFs were transplanted subcutaneously in nude mice, they disseminated and produced metastatic lesions at distant sites. Conclusions and Hypothesis Apparent MTFs are present in peripheral blood of patients with cutaneous melanomas, and they possess the ability to form metastatic lesions when transplanted into mice. We hypothesize that these MTFs arise at the periphery of primary tumors in vivo, that they readily enter the bloodstream and invade distant tissues, secreting cytokines (such as MIF) to prepare "niches" for colonization by metastasis initiating cells.	[Clawson, Gary A.; Xin, Ping; Du, Zhen] Penn State Univ, Dept Pathol, Hershey, PA 17033 USA; [Clawson, Gary A.; Xin, Ping; Du, Zhen] Penn State Univ, Milton S Hershey Med Ctr, Gittlen Canc Res Labs, Hershey, PA 17033 USA; [Matters, Gail L.] Penn State Univ, Milton S Hershey Med Ctr, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Imamura-Kawasawa, Yuka] Penn State Univ, Dept Pharmacol, Hershey, PA USA; [Imamura-Kawasawa, Yuka] Penn State Univ, Milton S Hershey Med Ctr, Inst Personalized Med, Hershey, PA 17033 USA; [Thiboutot, Diane M.] Penn State Univ, Milton S Hershey Med Ctr, Dept Dermatol, Div Hlth Sci Res, Hershey, PA 17033 USA; [Helm, Klaus F.] Penn State Univ, Milton S Hershey Med Ctr, Dept Dermatopathol, Hershey, PA 17033 USA; [Neves, Rogerio I.] Penn State Univ, Dept Surg, Hershey, PA USA; [Neves, Rogerio I.] Penn State Univ, Milton S Hershey Med Ctr, Melanoma Ctr, Hershey, PA 17033 USA; [Abraham, Thomas] Penn State Univ, Dept Neural & Behav Sci, Hershey, PA USA; [Abraham, Thomas] Penn State Univ, Milton S Hershey Med Ctr, Microscopy Imaging Facil, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Clawson, GA (corresponding author), Penn State Univ, Dept Pathol, Hershey, PA 17033 USA.	gac4@psu.edu	Neves, Rogerio Izar/AAV-5842-2020; Abraham, Thomas/AAJ-7950-2020; Abraham, Thomas/J-7080-2014	Neves, Rogerio Izar/0000-0003-4866-5215; Matters, Gail/0000-0001-8613-8649; Abraham, Thomas/0000-0003-0750-8774	National Institutes of Health [SIG S10D010756]; Penn State Hershey Cancer Institute; Gittlen Cancer Research Laboratories	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn State Hershey Cancer Institute; Gittlen Cancer Research Laboratories	This work was supported with funds from the National Institutes of Health (SIG S10D010756), the Penn State Hershey Cancer Institute, and funds from the Gittlen Cancer Research Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi DJ, 2007, STEM CELLS, V25, P1104, DOI 10.1634/stemcells.2006-0532; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Brown KE, 2013, CELL CYCLE, V12, P3253, DOI 10.4161/cc.26223; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Clawson GA, 2013, SCIENCE, V342, P699, DOI 10.1126/science.1244270; Clawson GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041052; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cristofanilli M, 2004, NEW ENGL J MED, V351, P2453; Cui YZ, 2009, CANCER INVEST, V27, P747, DOI 10.1080/07357900802672746; de Andrade BAB, 2011, ORAL DIS, V17, P808, DOI 10.1111/j.1601-0825.2011.01841.x; Denz A, 2010, J SURG RES, V160, P29, DOI 10.1016/j.jss.2009.03.048; Ding JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041942; Drabeni M, 2013, AM J DERMATOPATH, V35, P56, DOI 10.1097/DAD.0b013e31825ba933; Erenpreisa J, 2012, AUTOPHAGY, V8, P1877, DOI 10.4161/auto.21610; Erenpreisa J, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-92; Erenpreisa J, 2011, CELL BIOL INT, V35, P687, DOI 10.1042/CBI20100762; ESKELINEN M, 1992, SCAND J GASTROENTERO, V27, P39, DOI 10.3109/00365529209011164; ESKELINEN M, 1991, PANCREAS, V6, P90, DOI 10.1097/00006676-199101000-00012; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Friedlander TW, 2014, PHARMACOL THERAPEUT, V142, P271, DOI 10.1016/j.pharmthera.2013.12.011; Friedlander TW, 2014, INT J CANCER, V134, P2284, DOI 10.1002/ijc.28561; Funamizu N, 2012, INT J CANC; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Gandarillas A, 2014, EXP DERMATOL, V23, P87, DOI 10.1111/exd.12287; Girard E, 2012, BRIT J CANCER, V107, P1498, DOI 10.1038/bjc.2012.392; Goldenberg DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107927; Grimaldi AM, 2014, CANCER TREAT RES, V159, P443, DOI 10.1007/978-3-642-38007-5_25; Grover PK, 2014, ANN ONCOL; Haq R, 2014, CLIN CANCER RES, V20, P2257, DOI 10.1158/1078-0432.CCR-13-0898; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Huisman A, 2007, PROSTATE, V67, P248, DOI 10.1002/pros.20507; Itakura E, 2011, AM J SURG PATHOL, V35, P1657, DOI 10.1097/PAS.0b013e3182322cf7; Jannie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039330; Jung H, 2008, J BIOL CHEM, V283, P32669, DOI 10.1074/jbc.M806225200; Kamphues C, 2013, PANCREAS, V42, P807, DOI 10.1097/MPA.0b013e3182773eb6; Kanno H, 2013, NEURO-ONCOLOGY, V15, P853, DOI 10.1093/neuonc/not028; Karamitopoulou E, 2013, EUR J CANCER, V49, P1032, DOI 10.1016/j.ejca.2012.10.022; Karamitopoulou E, 2013, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00209; Kindt N, 2012, ANTICANCER RES, V32, P4499; Koong AC, 2000, CANCER RES, V60, P883; Kumeta M, 2013, EXP CELL RES, V319, P3226, DOI 10.1016/j.yexcr.2013.07.021; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Kyriakis JM, 2009, J BIOL CHEM, V284, P10993, DOI 10.1074/jbc.R800085200; Lan CY, 2013, TECHNOL CANCER RES T, V12, P259, DOI 10.7785/tcrt.2012.500312; Lazebnik Y, 2014, CELL CYCLE, V13, P2323, DOI 10.4161/cc.29704; Lazova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066731; Li YM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.347; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Lo MC, 2013, CANC LETT; Long J, 2012, INT J ONCOL, V41, P1662, DOI 10.3892/ijo.2012.1613; Losick VP, 2013, CURR BIOL, V23, P2224, DOI 10.1016/j.cub.2013.09.029; Ma X, 2014, TUMOUR BIOL; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Markiewicz Aleksandra, 2013, Cancers (Basel), V5, P1485, DOI 10.3390/cancers5041485; Matsumura Y, 2012, CANCER SCI, V103, P1342, DOI 10.1111/j.1349-7006.2012.02275.x; MAUL GG, 1970, CANCER RES, V30, P2782; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Mijaljica D, 2013, J CELL SCI, V126, P4325, DOI 10.1242/jcs.133090; Mitchem JB, 2013, CANC RES, V73, P31128; Ohlund D, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-154; Pandey V, 2012, INT J CANCER, V130, P497, DOI 10.1002/ijc.26048; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Pathania AS, 2015, MOL CANCER, V14, DOI 10.1186/1476-4598-14-6; Pawelek JM, 2005, LANCET ONCOL, V6, P988, DOI 10.1016/S1470-2045(05)70466-6; Pawelek JM, 2000, MELANOMA RES, V10, P507, DOI 10.1097/00008390-200012000-00001; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pawelek JM, 2008, ADV CANCER RES, V101, P397, DOI 10.1016/S0065-230X(08)00410-7; Ploeger LS, 2008, BIOTECH HISTOCHEM, V83, P63, DOI 10.1080/10520290802127586; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Rello-Varona S, 2012, CELL CYCLE, V11, P170, DOI 10.4161/cc.11.1.18564; Salmi M, 2013, CIRC RES, V112, P1577, DOI 10.1161/CIRCRESAHA.111.300476; Schouppe E, 2013, CANC RES; Schramm HM, 2014, J CANCER, V5, P125, DOI 10.7150/jca.8242; Schulz R, 2014, CURR OPIN ONCOL, V26, P108, DOI 10.1097/CCO.0000000000000036; Schulz R, 2012, J EXP MED, V209, P275, DOI 10.1084/jem.20111117; Schwarz-Finsterle J, 2013, MUTAT RES-GEN TOX EN, V756, P56, DOI 10.1016/j.mrgentox.2013.05.004; Seguin F, 2012, BRIT J CANCER, V107, P077; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Shabo I, 2011, ADV EXP MED BIOL, V714, P141, DOI 10.1007/978-94-007-0782-5_7; Shabo I, 2009, INT J CANCER, V125, P1826, DOI 10.1002/ijc.24506; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Silk AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055572; Swierczynski J, 2014, WORLD J GASTROENTERO, V20, P2279, DOI 10.3748/wjg.v20.i9.2279; Tekola P, 1996, J PATHOL, V180, P214; Tsavaris N, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-264; Tsubouchi T, 2013, CELL, V152, P873, DOI 10.1016/j.cell.2013.01.012; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Wang D, 2014, ONCOL REP, V31, P1199, DOI 10.3892/or.2013.2946; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P231; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292; Xynos Ioannis D, 2013, ISRN Gastroenterol, V2013, P490578, DOI 10.1155/2013/490578; Yaddanapudi K, 2013, J IMMUNOL, V190, P2984, DOI 10.4049/jimmunol.1201650; Yoshikawa K, 2012, CANCER SCI, V103, P2012, DOI 10.1111/j.1349-7006.2012.02411.x; Zecchin KG, 2011, LAB INVEST, V91, P232, DOI 10.1038/labinvest.2010.157; Zhang L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-60; Zhang LX, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005109	106	55	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134320	10.1371/journal.pone.0134320	http://dx.doi.org/10.1371/journal.pone.0134320			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267609	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300040
J	Oghaz, MM; Maarof, MA; Zainal, A; Rohani, MF; Yaghoubyan, SH				Oghaz, Mahdi Maktabdar; Maarof, Mohd Aizaini; Zainal, Anazida; Rohani, Mohd Foad; Yaghoubyan, S. Hadi			A Hybrid Color Space for Skin Detection Using Genetic Algorithm Heuristic Search and Principal Component Analysis Technique	PLOS ONE			English	Article							FACE DETECTION; SEGMENTATION; RECOGNITION	Color is one of the most prominent features of an image and used in many skin and face detection applications. Color space transformation is widely used by researchers to improve face and skin detection performance. Despite the substantial research efforts in this area, choosing a proper color space in terms of skin and face classification performance which can address issues like illumination variations, various camera characteristics and diversity in skin color tones has remained an open issue. This research proposes a new three-dimensional hybrid color space termed SKN by employing the Genetic Algorithm heuristic and Principal Component Analysis to find the optimal representation of human skin color in over seventeen existing color spaces. Genetic Algorithm heuristic is used to find the optimal color component combination setup in terms of skin detection accuracy while the Principal Component Analysis projects the optimal Genetic Algorithm solution to a less complex dimension. Pixel wise skin detection was used to evaluate the performance of the proposed color space. We have employed four classifiers including Random Forest, Naive Bayes, Support Vector Machine and Multilayer Perceptron in order to generate the human skin color predictive model. The proposed color space was compared to some existing color spaces and shows superior results in terms of pixel-wise skin detection accuracy. Experimental results show that by using Random Forest classifier, the proposed SKN color space obtained an average F-score and True Positive Rate of 0.953 and False Positive Rate of 0.0482 which outperformed the existing color spaces in terms of pixel wise skin detection accuracy. The results also indicate that among the classifiers used in this study, Random Forest is the most suitable classifier for pixel wise skin detection applications.	[Oghaz, Mahdi Maktabdar; Maarof, Mohd Aizaini; Zainal, Anazida; Rohani, Mohd Foad; Yaghoubyan, S. Hadi] Univ Teknol Malaysia, Fac Comp, Johor Baharu, Malaysia	Universiti Teknologi Malaysia	Oghaz, MM (corresponding author), Univ Teknol Malaysia, Fac Comp, Johor Baharu, Malaysia.	Mahdi_mak2000@yahoo.com	Maktabdar/AAN-1324-2020	Maktabdar/0000-0003-2697-8288	Universiti Teknologi Malaysia's Research University Grant [PY/2014/02479]; UTM Flagship Research University Grant [PY/2014/03405]	Universiti Teknologi Malaysia's Research University Grant; UTM Flagship Research University Grant	The research is funded by Universiti Teknologi Malaysia's Research University Grant (PY/2014/02479) and UTM Flagship Research University Grant Vote Number (PY/2014/03405).	Aibinu AM, 2012, PROCEDIA ENGINEER, V41, P1183, DOI 10.1016/j.proeng.2012.07.299; Bergasa LM, 2000, IMAGE VISION COMPUT, V18, P987, DOI 10.1016/S0262-8856(00)00042-1; Bin Ghazali KH, 2012, PHYSCS PROC, V25, P2116, DOI 10.1016/j.phpro.2012.03.358; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown D., 2001, BMVC, V2, P491; Casiraghi E, 2003, LECT NOTES COMPUT SC, V2859, P113; Chai D., 2000, TENCON P INT SYST TE, V2, P421; Chaves-Gonzalez JM, 2010, DIGIT SIGNAL PROCESS, V20, P806, DOI 10.1016/j.dsp.2009.10.008; Chen C, 1997, IEE P-VIS IMAGE SIGN, V144, P384, DOI 10.1049/ip-vis:19971414; Choi JY, 2009, IEEE T SYST MAN CY B, V39, P1217, DOI 10.1109/TSMCB.2009.2014245; Colantoni P, 2004, COLOR SPACE TRANSFOR; de Dios JJ, 2004, IEEE IMAGE PROC, P191; De Dios JJ, 2003, IM PROC ICIP 2003 P, P919; Gammerman A., 1996, COMPUTATIONAL LEARNI; Ghazali KHB, 2011, INT J COMPUTER APPL, V34, P6; Gomez G., 2002, MICAI 2002: Advances in Artificial Intelligence.Second Mexican International Conference on Artificial Intelligence. Proceedings (Lecture Notes in Artificial Intelligence Vol. 2313), P69; Gonzalez R. C., 2007, DIGITAL IMAGE PROCES; Haykin S., 2008, NEURAL NETWORKS LEAR; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Juang CF, 2008, NEUROCOMPUTING, V71, P3409, DOI 10.1016/j.neucom.2007.11.007; Kawulok M, 2014, PATTERN RECOGN LETT, V41, P3, DOI 10.1016/j.patrec.2013.08.028; Kemp R, 1996, PERCEPTION, V25, P37, DOI 10.1068/p250037; Khan R, 2012, PATTERN RECOGN LETT, V33, P157, DOI 10.1016/j.patrec.2011.09.032; Khan R, 2010, IEEE IMAGE PROC, P4613, DOI 10.1109/ICIP.2010.5651638; Kim C, 2008, PATTERN RECOGN, V41, P22, DOI 10.1016/j.patcog.2007.04.011; Kovac J, 2003, IEEE REGION 8 EUROCON 2003, VOL B, PROCEEDINGS, P144; Lee JS, 2007, PATTERN RECOGN, V40, P2261, DOI 10.1016/j.patcog.2006.11.016; Lin C., 2005, P IEEE INT C INF ACQ, P518, DOI 10.1109/icia.2005.1635143; Liu ZM, 2008, IEEE T IMAGE PROCESS, V17, P1975, DOI 10.1109/TIP.2008.2002837; Martinez, 1998, 24 CVC; Oghaz MM, 2014, J APPL ENV BIOL SCI, P82; Oliveira V., 2009, WORKSHOPS SIBGRAPI, P1; Oliver N, 1997, PROC CVPR IEEE, P123, DOI 10.1109/CVPR.1997.609309; OSUNA E, 1997, PROC CVPR IEEE, P130, DOI DOI 10.1109/CVPR.1997.609310; Pascale D., 2003, BABEL COLOR, V18, P136; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Phung SL, 2005, IEEE T PATTERN ANAL, V27, P148, DOI 10.1109/TPAMI.2005.17; Polpinij J, 2006, IEEE SYS MAN CYBERN, P1481, DOI 10.1109/ICSMC.2006.384926; Schettini R, 2003, P SPIE; Schmugge SJ, 2007, COMPUT VIS IMAGE UND, V108, P41, DOI 10.1016/j.cviu.2006.10.009; Shih PC, 2005, INT J PATTERN RECOGN, V19, P873, DOI 10.1142/S0218001405004381; Shih PC, 2006, IEEE IMAGE PROC, P1001, DOI 10.1109/ICIP.2006.312668; Shin MC, 2002, 6 IEEE WORKSH APPL C, P1; Shlens J, 2009, TUTORIAL PRINCIPAL C, P1; Singh S., 2003, TAMKANG J SCI ENG, V6, P227; Subban R, 2013, INT C ADV REC TECHN, P68; Tan WR, 2012, IEEE T IND INFORM, V8, P138, DOI 10.1109/TII.2011.2172451; Tao LM, 2001, CHINESE SCI BULL, V46, P1411, DOI 10.1007/BF03187020; Terrillon J.-C., 2000, Proceedings Fourth IEEE International Conference on Automatic Face and Gesture Recognition (Cat. No. PR00580), P54, DOI 10.1109/AFGR.2000.840612; Terrillon JC, 1998, AUTOMATIC FACE AND GESTURE RECOGNITION - THIRD IEEE INTERNATIONAL CONFERENCE PROCEEDINGS, P112, DOI 10.1109/AFGR.1998.670934; Tomaz F, 2004, 1ST CANADIAN CONFERENCE ON COMPUTER AND ROBOT VISION, PROCEEDINGS, P180, DOI 10.1109/CCCRV.2004.1301442; Torres L., 1999, IEEE INT C IM PROC, V3, P627; Vezhnevets V., 2003, P GRAPHICON, V3, P85; Wang JG, 1999, PATTERN RECOGN LETT, V20, P1053, DOI 10.1016/S0167-8655(99)00072-0; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Yang J, 1996, THIRD IEEE WORKSHOP ON APPLICATIONS OF COMPUTER VISION - WACV '96, PROCEEDINGS, P142, DOI 10.1109/ACV.1996.572043; Yang MH, 2002, IEEE T PATTERN ANAL, V24, P34, DOI 10.1109/34.982883; Zaidan AA, 2014, ENG APPL ARTIF INTEL, V32, P136, DOI 10.1016/j.engappai.2014.03.002; Zainuddin R, 2010, LECT NOTES COMPUT SC, V6485, P136, DOI 10.1007/978-3-642-17569-5_15; Zarit B. D., 1999, Proceedings International Workshop on Recognition, Analysis, and Tracking of Faces and Gestures in Real-Time Systems. In Conjunction with ICCV'99 (Cat. No.PR00378), P58, DOI 10.1109/RATFG.1999.799224; Zhang ZZ, 2009, ITCS: 2009 INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY AND COMPUTER SCIENCE, PROCEEDINGS, VOL 2, PROCEEDINGS, P410, DOI 10.1109/ITCS.2009.222	61	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134828	10.1371/journal.pone.0134828	http://dx.doi.org/10.1371/journal.pone.0134828			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267377	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000359492300060
J	Principi, N; Piralla, A; Zampiero, A; Bianchini, S; Umbrello, G; Scala, A; Bosis, S; Fossali, E; Baldanti, F; Esposito, S				Principi, Nicola; Piralla, Antonio; Zampiero, Alberto; Bianchini, Sonia; Umbrello, Giulia; Scala, Alessia; Bosis, Samantha; Fossali, Emilio; Baldanti, Fausto; Esposito, Susanna			Bocavirus Infection in Otherwise Healthy Children with Respiratory Disease	PLOS ONE			English	Article							HIGH VIRAL LOAD; HOSPITALIZED CHILDREN; PHYLOGENETIC ANALYSIS; MOLECULAR EVOLUTION; TRACT INFECTIONS; YOUNG-CHILDREN; PANEL FAST; VIRUSES; PARVOVIRUS; IMPACT	To evaluate the role of human bocavirus (hBoV) as a causative agent of respiratory disease, the importance of the viral load in respiratory disease type and severity and the pathogenicity of the different hBoV species, we studied all hBoV-positive nasopharyngeal samples collected from children who attended an emergency room for a respiratory tract infection during three winters (2009-2010, 2011-2012, and 2013-2014). Human bocavirus was detected using the respiratory virus panel fast assay and real-time PCR. Of the 1,823 nasopharyngeal samples, 104 (5.7%) were positive for hBoV; a similar prevalence was observed in all three periods studied. Among hBoV-infected children, 53.8% were between 1-2 years old, and hBoV was detected alone in 57/104 (54.8%) cases. All of the detected hBoV strains belonged to genotype 1. The median hBoV load was significantly higher in samples containing strains with both the N546H and T590S mutations compared to other samples (p<0.05). Children with a single hBoV-1 infection more frequently had upper respiratory tract infections (URTIs) than those who were co-infected (37.0% vs 17.8%, respectively, p = 0.04). The duration of hospitalization was longer among children with high viral loads than that observed among children with low viral loads (8.0 +/- 2.2 days vs 5.0 +/- 1.5 days, respectively, p = 0.03), and the use of aerosol therapy was more frequent among children with high viral loads than among those with low viral loads (77.1% vs 55.7%, respectively, p = 0.04). This study shows that hBoV is a relatively uncommon but stable infectious agent in children and that hBoV1 seems to be the only strain detected in Italy in respiratory samples. From a clinical point of view, hBoV1 seems to have in the majority of healthy children relatively low clinical relevance. Moreover, the viral load influences only the duration of hospitalization and the use of aerosol therapy without any association with the site of the respiratory disease.	[Piralla, Antonio; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Mol Virol Unit, Microbiol & Virol Dept, Pavia, Italy; [Fossali, Emilio] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Milan, Italy; [Baldanti, Fausto] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Microbiol Sect, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Pavia	Esposito, S (corresponding author), Univ Milan, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Pediat Highly Intens Care Unit,Dept Pathophysiol, Milan, Italy.	susanna.esposito@unimi.it	Esposito, Susanna/K-3475-2016; Piralla, Antonio/K-4756-2018; Fossali, Emilio/K-2200-2015; Bosis, Samantha/K-2754-2016; Baldanti, Fausto/J-4924-2018	Esposito, Susanna/0000-0003-4103-2837; Piralla, Antonio/0000-0002-6062-2579; Fossali, Emilio/0000-0002-3197-062X; Bosis, Samantha/0000-0003-2288-2633; Baldanti, Fausto/0000-0002-3358-8969	Italian Ministry of Health (Bando Giovani Ricercatori)	Italian Ministry of Health (Bando Giovani Ricercatori)(Ministry of Health, Italy)	The study was supported by a grant from the Italian Ministry of Health (Bando Giovani Ricercatori 2009). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Antunes H, 2010, J CLIN VIROL, V48, P134, DOI 10.1016/j.jcv.2010.03.002; Arnott A, 2013, INFLUENZA OTHER RESP, V7, P201, DOI 10.1111/j.1750-2659.2012.00369.x; Calvo C, 2008, PEDIATR INFECT DIS J, V27, P677, DOI 10.1097/INF.0b013e31816be052; Chieochansin T, 2007, VIRUS RES, V129, P54, DOI 10.1016/j.virusres.2007.04.022; Christensen A, 2010, J CLIN VIROL, V49, P158, DOI 10.1016/j.jcv.2010.07.016; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dina J, 2009, J PAEDIATR CHILD H, V45, P149, DOI 10.1111/j.1440-1754.2008.01442.x; Endo R, 2007, J CLIN MICROBIOL, V45, P3218, DOI 10.1128/JCM.02140-06; Esposito S, 2008, J CLIN MICROBIOL, V46, P1337, DOI 10.1128/JCM.02160-07; Esposito S, 2013, INFLUENZA OTHER RESP, V7, P18, DOI 10.1111/j.1750-2659.2012.00340.x; Esposito S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-271; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Gadsby NJ, 2010, J CLIN MICROBIOL, V48, P2213, DOI 10.1128/JCM.02446-09; Garcia-Garcia ML, 2010, PEDIATR PULM, V45, P585, DOI 10.1002/ppul.21225; Garcia-Garcia ML, 2008, PEDIATR INFECT DIS J, V27, P358, DOI 10.1097/INF.0b013e3181626d2a; Gerna G, 2007, NEW MICROBIOL, V30, P383; Gurda BL, 2010, J VIROL, V84, P5880, DOI 10.1128/JVI.02719-09; Hao R, 2013, J GEN VIROL, V94, P1079, DOI 10.1099/vir.0.047472-0; Hustedt JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038206; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kim JS, 2011, KOREAN J LAB MED, V31, P179, DOI 10.3343/kjlm.2011.31.3.179; Knapp K.M., 2009, FEIGIN CHERRYS TXB P, P2741; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Longtin J, 2008, EMERG INFECT DIS, V14, P217, DOI 10.3201/eid1402.070851; Lu QB, 2015, EUR J CLIN MICROBIOL, V34, P75, DOI 10.1007/s10096-014-2215-7; Lukashov VV, 2001, J VIROL, V75, P2729, DOI 10.1128/JVI.75.6.2729-2740.2001; Ghietto LM, 2015, ARCH VIROL, V160, P117, DOI 10.1007/s00705-014-2238-5; Martin ET, 2012, INFLUENZA OTHER RESP, V6, P71, DOI 10.1111/j.1750-2659.2011.00265.x; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Martin ET, 2009, J CLIN MICROBIOL, V47, P4131, DOI 10.1128/JCM.01508-09; Martin ET, 2015, J INFECT DIS, V28; Miyakis S, 2009, J CLIN VIROL, V44, P179, DOI 10.1016/j.jcv.2008.10.010; Monavari HR, 2013, J AIDS CLIN RES, V4; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Pabbaraju K, 2011, J CLIN MICROBIOL, V49, P1738, DOI 10.1128/JCM.02090-10; Peltola V, 2013, PEDIATR INFECT DIS J, V32, P178, DOI 10.1097/INF.0b013e31827fef67; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Qu XW, 2008, BIOCHEM BIOPH RES CO, V365, P158, DOI 10.1016/j.bbrc.2007.10.164; Ringshausen Felix C, 2009, Int J Chron Obstruct Pulmon Dis, V4, P111; Smuts H, 2008, J MED VIROL, V80, P906, DOI 10.1002/jmv.21135; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terrosi C, 2007, J CLIN VIROL, V40, P43, DOI 10.1016/j.jcv.2007.06.011; Zehender G, 2010, INFECT GENET EVOL, V10, P215, DOI 10.1016/j.meegid.2009.11.011; Zhang LL, 2008, CHINESE MED J-PEKING, V121, P1607, DOI 10.1097/00029330-200809010-00002; Zhou LL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-424	46	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135640	10.1371/journal.pone.0135640	http://dx.doi.org/10.1371/journal.pone.0135640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267139	Green Published, gold			2022-12-27	WOS:000359492300146
J	Xiao, YY; Qiao, YJ; Pan, L; Liu, J; Zhang, T; Li, N; Liu, EQ; Wang, Y; Liu, HY; Liu, GS; Huang, GW; Hu, G				Xiao, Yanyu; Qiao, Yijuan; Pan, Lei; Liu, Jin; Zhang, Tao; Li, Nan; Liu, Enqing; Wang, Yue; Liu, Hongyan; Liu, Gongshu; Huang, Guowei; Hu, Gang			Trends in the Prevalence of Overweight and Obesity among Chinese Preschool Children from 2006 to 2014	PLOS ONE			English	Article							NUTRITION TRANSITION; BIRTH-WEIGHT; GROWTH; RISK; ADOLESCENTS; SIZE	Objective To examine the trends in the prevalence of overweight and obesity among preschool children from 2006 to 2014. Methods A total of 145,078 children aged 3-6 years from 46 kindergartens finished the annual health examination in Tianjin, China. Height, weight and other information were obtained using standardized methods. Z-scores for weight, height, and BMI were calculated based on the standards for the World Health Organization (WHO) child growth standards. Results From 2006 to 2014, mean values of height z-scores significantly increased from 0.34 to 0.54, mean values of weight z-scores kept constant, and mean values of BMI z-scores significantly decreased from 0.40 to 0.23. Mean values of height z-scores, weight z-scores, and BMI z-scores slightly decreased among children from 3 to 4 years old, and then increased among children from 4 to 6 years old. Between 2006 and 2014, there were no significant changes in prevalence of overweight (BMI z-scores >2 SD) and obesity (BMI z-scores >3 SD) among 3-4 years children. However, prevalence of obesity (BMI z-scores >2 SD) increased from 8.8% in 2006 to 10.1% in 2010, and then kept stable until 2014 among 5-6 years children. Boys had higher prevalence of obesity than girls. Conclusions Mean values of BMI z-scores decreased from 2006 to 2014 among Chinese children aged 3-6 years old due to the significant increase of height z-scores. Prevalence of obesity increased from 2006 to 2010, and then kept stable until 2014 among children aged 5-6 years. The prevalence of obesity was higher in boys than in girls.	[Xiao, Yanyu; Huang, Guowei] Tianjin Med Univ, Sch Publ Hlth, Dept Nutr & Food Sci, Tianjin, Peoples R China; [Qiao, Yijuan; Pan, Lei; Liu, Jin; Zhang, Tao; Li, Nan; Liu, Enqing; Wang, Yue; Liu, Hongyan; Liu, Gongshu] Tianjin Womens & Childrens Hlth Ctr, Tianjin, Peoples R China; [Qiao, Yijuan; Hu, Gang] Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, Baton Rouge, LA 70808 USA	Tianjin Medical University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Huang, GW (corresponding author), Tianjin Med Univ, Sch Publ Hlth, Dept Nutr & Food Sci, Tianjin, Peoples R China.	huangguowei@tmu.edu.cn; gang.hu@pbrc.edu	Hu, Gang/N-1971-2017; Hu, Gang/V-7947-2019	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017	Tianjin Women's and Children's Health Center; National Institute Of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK100790]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100790] Funding Source: NIH RePORTER	Tianjin Women's and Children's Health Center; National Institute Of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Tianjin Women's and Children's Health Center, and the National Institute Of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number R01DK100790.	Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Belfort MB, 2007, J PEDIATR-US, V151, P670, DOI 10.1016/j.jpeds.2007.05.010; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cui ZH, 2012, BRIT J NUTR, V108, P1292, DOI 10.1017/S0007114511006891; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Ji CY, 2008, OBES REV, V9, P78, DOI 10.1111/j.1467-789X.2007.00443.x; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; Jiang JX, 2006, INT J PEDIATR OBES, V1, P103, DOI 10.1080/17477160600699391; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Li HA, 2008, ZHONGHUA ER KE ZA ZH, V46, P174; Li N, 2014, AM J HUM BIOL, V26, P331, DOI 10.1002/ajhb.22506; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077809; Li YP, 2008, ASIA PAC J CLIN NUTR, V17, P131; Lyu Y, 2013, PUBLIC HEALTH, V127, P1082, DOI 10.1016/j.puhe.2013.09.001; Ma YN, 2011, ARCH MED RES, V42, P633, DOI 10.1016/j.arcmed.2011.10.011; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Skouteris H, 2010, OBES REV, V11, P757, DOI 10.1111/j.1467-789X.2010.00806.x; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053069; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; WHO, WHO CHILD GROWTH STA; WHO, 2006, WHO CHILD GROWTH STA; Wu S, 2009, CHIN J SCH HLTH, V30, P4; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Yu ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051949; Zhai FY, 2009, NUTR REV, V67, pS56, DOI 10.1111/j.1753-4887.2009.00160.x; Zhang X, 2009, PREV MED, V49, P172, DOI 10.1016/j.ypmed.2009.07.013; Zong XN, 2014, B WORLD HEALTH ORGAN, V92, P555, DOI 10.2471/BLT.13.126243; Zong XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046942	34	28	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134466	10.1371/journal.pone.0134466	http://dx.doi.org/10.1371/journal.pone.0134466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267264	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300048
J	Zhang, L; Sun, ZX; Ren, PP; Lee, RJ; Xiang, GY; Lv, Q; Han, W; Wang, J; Ge, SP; Xie, MX				Zhang, Li; Sun, Zhenxing; Ren, Pingping; Lee, Robert J.; Xiang, Guangya; Lv, Qing; Han, Wei; Wang, Jing; Ge, Shuping; Xie, Mingxing			Ultrasound-Targeted Microbubble Destruction (UTMD) Assisted Delivery of shRNA against PHD2 into H9C2 Cells	PLOS ONE			English	Article							EFFICIENT GENE DELIVERY; IN-VITRO; THERAPEUTIC ULTRASOUND; DNA TRANSFECTION; SKELETAL-MUSCLE; POLYETHYLENIMINE; PEI; SONOPORATION; EXPRESSION; SURVIVIN	Gene therapy has great potential for human diseases. Development of efficient delivery systems is critical to its clinical translation. Recent studies have shown that microbubbles in combination with ultrasound (US) can be used to facilitate gene delivery. An aim of this study is to investigate whether the combination of US-targeted microbubble destruction (UTMD) and polyethylenimine (PEI) (UTMD/PEI) can mediate even greater gene transfection efficiency than UTMD alone and to optimize ultrasonic irradiation parameters. Another aim of this study is to investigate the biological effects of PHD2-shRNA after its transfection into H9C2 cells. pEGFP-N1 or eukaryotic shPHD2-EGFP plasmid was mixed with albumin-coated microbubbles and PEI to form complexes for transfection. After these were added into H9C2 cells, the cells were exposed to US with various sets of parameters. The cells were then harvested and analyzed for gene expression. UTMD/PEI was shown to be highly efficient in gene transfection. An US intensity of 1.5 W/cm(2), a microbubble concentration of 300 mu l/ml, an exposure time of 45s, and a plasmid concentration of 15 mu g/ml were found to be optimal for transfection. UTMD/PEI-mediated PHD2-shRNA transfection in H9C2 cells significantly down regulated the expression of PHD2 and increased expression of HIF-1 alpha and downstream angiogenesis factors VEGF, TGF-beta and bFGF. UTMD/PEI, combined with albumin-coated microbubbles, warrants further investigation for therapeutic gene delivery.	[Zhang, Li; Sun, Zhenxing; Ren, Pingping; Lv, Qing; Han, Wei; Wang, Jing; Xie, Mingxing] Huazhong Univ Sci & Technol, Union Hosp, Hubei Prov Key Lab Mol Imaging, Dept Ultrasound,Tongji Med Coll, Wuhan 430022, Peoples R China; [Lee, Robert J.] Ohio State Univ, Div Pharmaceut, Coll Pharm, Columbus, OH 43210 USA; [Xiang, Guangya] Huazhong Univ Sci & Technol, Sch Pharm, Tongji Med Coll, Wuhan 430022, Peoples R China; [Ge, Shuping] Drexel Univ, Coll Med, St Christophers Hosp Children, Ctr Heart, Philadelphia, PA 19104 USA	Huazhong University of Science & Technology; University System of Ohio; Ohio State University; Huazhong University of Science & Technology; Drexel University	Ge, SP (corresponding author), Drexel Univ, Coll Med, St Christophers Hosp Children, Ctr Heart, Philadelphia, PA 19104 USA.	shuping.ge@drexelmed.edu; xiemx64@126.com	guangya, xiang/F-2551-2013; Zhang, L/ABG-4378-2020; Zhang, L/A-8465-2019	Zhang, L/0000-0003-1620-1512; Zhang, L/0000-0003-1620-1512; Xie, Mingxing/0000-0003-4984-1567	National Natural Science Foundation of China [81471678, 81271582, 81071280, 81301235]; National Natural Science Foundation of Hubei [2014CFB148]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Hubei	Funding was received from the National Natural Science Foundation of China (Grant Nos. 81471678, 81271582, 81071280 to MXX; 81301235 to LZ) and by the National Natural Science Foundation of Hubei (Grant No. 2014CFB148 to LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile PG, 2001, J AM COLL CARDIOL, V37, P1975, DOI 10.1016/S0735-1097(01)01253-0; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Chen SY, 2006, P NATL ACAD SCI USA, V103, P8469, DOI 10.1073/pnas.0602921103; Chen ZY, 2008, J HUAZHONG U SCI-MED, V28, P613, DOI 10.1007/s11596-008-0528-4; Deshpande MC, 2007, J CONTROL RELEASE, V118, P126, DOI 10.1016/j.jconrel.2006.12.010; Duvshani-Eshet M, 2006, J CONTROL RELEASE, V112, P156, DOI 10.1016/j.jconrel.2006.02.013; Hacker DL, 2013, PROTEIN EXPRES PURIF, V92, P67, DOI 10.1016/j.pep.2013.09.001; Hinnis AR, 2007, BRIT J CANCER, V96, P639, DOI 10.1038/sj.bjc.6603616; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Jiang Yong-nan, 2010, Yaoxue Xuebao, V45, P659; Jin QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076544; Kodama T, 2005, ULTRASOUND MED BIOL, V31, P1683, DOI 10.1016/j.ultrasmedbio.2005.08.002; Krasovitski B, 2001, J ACOUST SOC AM, V109, P891, DOI 10.1121/1.1346683; Larina IV, 2005, ANTICANCER RES, V25, P149; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Li PJ, 2013, CELL BIOCHEM BIOPHYS, V66, P775, DOI 10.1007/s12013-013-9523-x; Liang HD, 2004, ULTRASOUND MED BIOL, V30, P1523, DOI 10.1016/j.ultrasmedbio.2004.08.021; Liu YY, 2006, J CONTROL RELEASE, V114, P89, DOI 10.1016/j.jconrel.2006.05.018; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Oberle V, 2004, BBA-GENE STRUCT EXPR, V1676, P223, DOI 10.1016/j.bbaexp.2003.12.003; Ogris M, 2003, J CONTROL RELEASE, V91, P173, DOI 10.1016/S0168-3659(03)00230-X; Paproski RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056423; Pedro GS, 2014, J CONTROL RELEASE, V195, P130, DOI 10.1016/j.jconrel.2014.06.033; Rahim A, 2006, ULTRASOUND MED BIOL, V32, P1269, DOI 10.1016/j.ultrasmedbio.2006.04.014; Raisinghani A, 2002, AM J CARDIOL, V90, p3J; Shariat SF, 2005, J UROLOGY, V174, P2046, DOI 10.1097/01.ju.0000176459.79180.d1; Sutton JT, 2014, INT J NANOMED, V9, P4671, DOI 10.2147/IJN.S63850; Tomizawa Minoru, 2013, World J Methodol, V3, P39, DOI 10.5662/wjm.v3.i4.39; Wang LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096586; Wang XH, 2005, RADIOLOGY, V237, P224, DOI 10.1148/radiol.2371040805; Ward M, 2000, ULTRASOUND MED BIOL, V26, P1169, DOI 10.1016/S0301-5629(00)00260-X; Wu SZ, 2014, INT J NANOMED, V9, P5639, DOI 10.2147/IJN.S73950; Yang H, 2011, INT J NANOMED, V6, P2043, DOI 10.2147/IJN.S24808	34	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134629	10.1371/journal.pone.0134629	http://dx.doi.org/10.1371/journal.pone.0134629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267649	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300051
J	Bleckmann, M; Fritz, MHY; Bhuju, S; Jarek, M; Schurig, M; Geffers, R; Benes, V; Besir, H; van den Heuvel, J				Bleckmann, Maren; Fritz, Markus H. -Y.; Bhuju, Sabin; Jarek, Michael; Schuerig, Margitta; Geffers, Robert; Benes, Vladimir; Besir, Hueseyin; van den Heuvel, Joop			Genomic Analysis and Isolation of RNA Polymerase II Dependent Promoters from Spodoptera frugiperda	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; INSECT-CELL-LINES; BACULOVIRUS EXPRESSION SYSTEM; TISSUE-PLASMINOGEN-ACTIVATOR; MEDIATED CASSETTE EXCHANGE; GENE-EXPRESSION; HIGH-LEVEL; TRANSIENT TRANSFECTION; PROTEIN-PRODUCTION; IE-2 GENE	The Baculoviral Expression Vector System (BEVS) is the most commonly used method for high expression of recombinant protein in insect cells. Nevertheless, expression of some target proteins-especially those entering the secretory pathway-provides a severe challenge for the baculovirus infected insect cells, due to the reorganisation of intracellular compounds upon viral infection. Therefore, alternative strategies for recombinant protein production in insect cells like transient plasmid-based expression or stable expression cell lines are becoming more popular. However, the major bottleneck of these systems is the lack of strong endogenous polymerase II dependent promoters, as the strong baculoviral p10 and polH promoters used in BEVS are only functional in presence of the viral transcription machinery during the late phase of infection. In this work we present a draft genome and a transcriptome analysis of Sf21 cells for the identification of the first known endogenous Spodoptera frugiperda promoters. Therefore, putative promoter sequences were identified and selected because of high mRNA level or in analogy to other strong promoters in other eukaryotic organism. The chosen endogenous Sf21 promoters were compared to early viral promoters for their efficiency to trigger eGFP expression using transient plasmid based transfection in a BioLector Microfermentation system. Furthermore, promoter activity was not only shown in Sf21 cells but also in Hi5 cells. The novel endogenous Sf21 promoters were ranked according to their activity and expand the small pool of available promoters for stable insect cell line development and transient plasmid expression in insect cells. The best promoter was used to improve plasmid based transient transfection in insect cells substantially.	[Bleckmann, Maren; Schuerig, Margitta; van den Heuvel, Joop] Helmholtz Ctr Infect Res, Res Grp Recombinant Prot Express, Dept Struct & Funct Prot, Braunschweig, Germany; [Fritz, Markus H. -Y.; Benes, Vladimir; Besir, Hueseyin] EMBL Heidelberg, Dept Prot Express, Heidelberg, Germany; [Fritz, Markus H. -Y.; Benes, Vladimir; Besir, Hueseyin] EMBL Heidelberg, Purificat Core Facil, Heidelberg, Germany; [Fritz, Markus H. -Y.; Benes, Vladimir; Besir, Hueseyin] EMBL Heidelberg, Genom Core Facil, Heidelberg, Germany; [Bhuju, Sabin; Jarek, Michael; Geffers, Robert] Helmholtz Ctr Infect Res, Dept Genome Analyt, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Helmholtz-Center for Infection Research	van den Heuvel, J (corresponding author), Helmholtz Ctr Infect Res, Res Grp Recombinant Prot Express, Dept Struct & Funct Prot, Braunschweig, Germany.	Joop.vandenHeuvel@helmholtz-hzi.de		Schubert, Maren/0000-0002-7041-9056; Besir, Huseyin/0000-0002-7249-4762	Helmholtz Protein Sample Production Facility; Instruct, European Strategy Forum on Research Infrastructures (ESFRI); European Community's Seventh Framework Programme (FP7) for the ComplexInc Project [270089]; President's Initiative and Networking Funds of the Helmholtz Association of German Research Centres (HGF) [VH-GS-202]	Helmholtz Protein Sample Production Facility; Instruct, European Strategy Forum on Research Infrastructures (ESFRI); European Community's Seventh Framework Programme (FP7) for the ComplexInc Project; President's Initiative and Networking Funds of the Helmholtz Association of German Research Centres (HGF)	This work was supported by the Helmholtz Protein Sample Production Facility and by Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI), MB, JH. The research leading to these results also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) for the ComplexInc Project under grant agreement No 270089, MB, MS, JH. This research project has been supported by the President's Initiative and Networking Funds of the Helmholtz Association of German Research Centres (HGF) under contract number VH-GS-202, MB, MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN JK, 1992, HUM GENE THER, V3, P487, DOI 10.1089/hum.1992.3.5-487; Andersson HA, 2014, VACCINES-BASEL, V2, P216, DOI 10.3390/vaccines2020216; Aronesty E ea-utils, 2011, COMMAND LINE TOOLS P; Benslimane C, 2005, BIOTECHNOL PROGR, V21, P78, DOI 10.1021/bp049800u; BITTER GA, 1984, GENE, V32, P263, DOI 10.1016/0378-1119(84)90002-7; Bollin F, 2011, PROTEIN EXPRES PURIF, V78, P61, DOI 10.1016/j.pep.2011.02.008; Douris V, 2006, ADV VIRUS RES, V68, P113, DOI 10.1016/S0065-3527(06)68004-4; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Farrell PJ, 1998, BIOTECHNOL BIOENG, V60, P656, DOI 10.1002/(SICI)1097-0290(19981220)60:6<656::AID-BIT2>3.0.CO;2-9; Fernandes F, 2012, BIOTECHNOL BIOENG, V109, P2836, DOI 10.1002/bit.24542; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GUARINO LA, 1986, J VIROL, V60, P224, DOI 10.1128/JVI.60.1.224-229.1986; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; HANAOKA K, 1991, DIFFERENTIATION, V48, P183, DOI 10.1111/j.1432-0436.1991.tb00256.x; Jager V, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-52; Jarvis DL, 1996, PROTEIN EXPRES PURIF, V8, P191, DOI 10.1006/prep.1996.0092; JARVIS DL, 1993, J BIOL CHEM, V268, P16754; JARVIS DL, 1989, MOL CELL BIOL, V9, P214, DOI 10.1128/MCB.9.1.214; JOHNSON R, 1992, VIROLOGY, V190, P815, DOI 10.1016/0042-6822(92)90919-G; Jones G, 1996, GENE, V173, P209, DOI 10.1016/0378-1119(96)00100-X; Kakumani PK, 2014, GENOMICS, V104, P134, DOI 10.1016/j.ygeno.2014.06.005; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lopez-Vidal J, 2013, J BIOTECHNOL, V165, P201, DOI 10.1016/j.jbiotec.2013.03.012; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Meyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068674; MORRIS TD, 1992, J VIROL, V66, P7397, DOI 10.1128/JVI.66.12.7397-7405.1992; Negrete A, 2007, J GENE MED, V9, P938, DOI 10.1002/jgm.1092; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Radner S, 2012, J STRUCT BIOL, V179, P46, DOI 10.1016/j.jsb.2012.04.013; Shen X, 2014, J BIOTECHNOL, V171, P61, DOI 10.1016/j.jbiotec.2013.11.018; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; THEILMANN DA, 1992, VIROLOGY, V187, P97, DOI 10.1016/0042-6822(92)90298-4; THEILMANN DA, 1991, VIROLOGY, V180, P492, DOI 10.1016/0042-6822(91)90063-H; THEILMANN DA, 1992, VIROLOGY, V187, P84, DOI 10.1016/0042-6822(92)90297-3; TING LP, 1986, BIOCHEM BIOPH RES CO, V136, P1063, DOI 10.1016/0006-291X(86)90441-9; Vidigal J, 2014, METHODS MOL BIOL, V1104, P15, DOI 10.1007/978-1-62703-733-4_2; WICKHAM TJ, 1992, BIOTECHNOL PROGR, V8, P391, DOI 10.1021/bp00017a003	40	21	22	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0132898	10.1371/journal.pone.0132898	http://dx.doi.org/10.1371/journal.pone.0132898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263512	gold, Green Submitted, Green Published			2022-12-27	WOS:000359353300005
J	Keeratijarut, A; Lohnoo, T; Rujirawat, T; Yingyong, W; Kalambaheti, T; Miller, S; Phuntumart, V; Krajaejun, T				Keeratijarut, Angsana; Lohnoo, Tassanee; Rujirawat, Thidarat; Yingyong, Wanta; Kalambaheti, Thareerat; Miller, Shannon; Phuntumart, Vipaporn; Krajaejun, Theerapong			The Immunoreactive Exo-1,3-beta-Glucanase from the Pathogenic Oomycete Pythium insidiosum Is Temperature Regulated and Exhibits Glycoside Hydrolase Activity	PLOS ONE			English	Article							74-KILODALTON IMMUNODOMINANT ANTIGEN; PHYTOPHTHORA-INFESTANS; PHYLOGENETIC ANALYSIS; CANDIDA-ALBICANS; HUMAN PYTHIOSIS; GENOMIC DNA; DATABASE; IMMUNOTHERAPY; MANNOPROTEIN; PERFORMANCE	The oomycete organism, Pythium insidiosum, is the etiologic agent of the life-threatening infectious disease called "pythiosis". Diagnosis and treatment of pythiosis is difficult and challenging. Novel methods for early diagnosis and effective treatment are urgently needed. Recently, we reported a 74-kDa immunodominant protein of P. insidiosum, which could be a diagnostic target, vaccine candidate, and virulence factor. The protein was identified as a putative exo-1,3-beta-glucanase (Exo1). This study reports on genetic, immunological, and biochemical characteristics of Exo1. The full-length exo1 coding sequence (2,229 bases) was cloned. Phylogenetic analysis showed that exo1 is grouped with glucanase-encoding genes of other oomycetes, and is far different from glucanase-encoding genes of fungi. exo1 was up-regulated upon exposure to body temperature, and its gene product is predicted to contain BglC and X8 domains, which are involved in carbohydrate transport, binding, and metabolism. Based on its sequence, Exo1 belongs to the Glycoside Hydrolase family 5 (GH5). Exo1, expressed in E. coli, exhibited beta-glucanase and cellulase activities. Exo1 is a major intracellular immunoreactive protein that can trigger host immune responses during infection. Since GH5 enzyme-encoding genes are not present in human genomes, Exo1 could be a useful target for drug and vaccine development against this pathogen.	[Keeratijarut, Angsana; Krajaejun, Theerapong] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok 10700, Thailand; [Lohnoo, Tassanee; Rujirawat, Thidarat; Yingyong, Wanta] Mahidol Univ, Ramathibodi Hosp, Fac Med, Res Ctr, Bangkok 10700, Thailand; [Keeratijarut, Angsana] Mahidol Univ, Fac Sci, Multidisciplinary Unit, Program Mol Med, Bangkok 10400, Thailand; [Kalambaheti, Thareerat] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Miller, Shannon; Phuntumart, Vipaporn] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA	Mahidol University; Mahidol University; Mahidol University; Mahidol University; University System of Ohio; Bowling Green State University	Krajaejun, T (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok 10700, Thailand.	mr_en@hotmail.com	Krajaejun, Theerapong/P-2550-2017	Krajaejun, Theerapong/0000-0003-0545-3765; Rujirawat, Thidarat/0000-0003-1256-7330	Thailand Research Fund [RMU5380047]; Mahidol University [E01/2557]; Royal Golden Jubilee Ph.D. Scholarship [PHD/0199/2551]	Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Royal Golden Jubilee Ph.D. Scholarship	This work is supported by the Thailand Research Fund (TKr; Grant number, RMU5380047; URL, http://www.trf.or.th), a Research Fund from Mahidol University (TKr; Grant number, E01/2557; URL, http://www.op.mahidol.ac.th/orra), and the Royal Golden Jubilee Ph.D. Scholarship (AK; Grant number, PHD/0199/2551; URL, http://rgj.trf.or.th). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; Biondo C, 2005, INFECT IMMUN, V73, P7348, DOI 10.1128/IAI.73.11.7348-7355.2005; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chareonsirisuthigul T, 2013, DIAGN MICR INFEC DIS, V76, P42, DOI 10.1016/j.diagmicrobio.2013.02.025; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gaastra W, 2010, VET MICROBIOL, V146, P1, DOI 10.1016/j.vetmic.2010.07.019; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; Kasana RC, 2008, CURR MICROBIOL, V57, P503, DOI 10.1007/s00284-008-9276-8; Keeratijarut A, 2015, J MED MICROBIOL; Keeratijarut A, 2014, ASIAN BIOMED, V8, P637, DOI 10.5372/1905-7415.0805.338; Keeratijarut A, 2013, SE ASIAN J TROP MED, V44, P672; Klein BS, 2000, CURR OPIN MICROBIOL, V3, P339, DOI 10.1016/S1369-5274(00)00100-4; Krajaejun T, 2006, CLIN INFECT DIS, V43, P569, DOI 10.1086/506353; Krajaejun T, 2006, J CLIN MICROBIOL, V44, P1674, DOI 10.1128/JCM.44.5.1674-1680.2006; Krajaejun T, 2014, FUNGAL BIOL-UK, V118, P640, DOI 10.1016/j.funbio.2014.01.009; Krajaejun T, 2010, CLIN VACCINE IMMUNOL, V17, P1203, DOI 10.1128/CVI.00515-09; KWONCHUNG KJ, 1994, CLIN INFECT DIS, V19, pS1, DOI 10.1093/clinids/19.Supplement_1.S1; La Valle R, 2000, INFECT IMMUN, V68, P6777, DOI 10.1128/IAI.68.12.6777-6784.2000; Lohnoo Tassanee, 2014, Journal of the Medical Association of Thailand, V97, P342; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Martin K, 2007, FEMS MICROBIOL REV, V31, P168, DOI 10.1111/j.1574-6976.2006.00055.x; McLeod A, 2003, FUNGAL GENET BIOL, V38, P250, DOI 10.1016/S1087-1845(02)00523-6; McLeod A, 2004, EUKARYOT CELL, V3, P91, DOI 10.1128/EC.3.1.91-99.2004; Mendoza L, 2005, MED MYCOL, V43, P477, DOI 10.1080/13693780500279882; Mendoza L, 1996, J MYCOL MED, V6, P151; PELLEQUER JL, 1993, J MOL GRAPH MODEL, V11, P204, DOI 10.1016/0263-7855(93)80074-2; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Rujirawat T, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00574-15; Sandini S, 2007, CELL MICROBIOL, V9, P1223, DOI 10.1111/j.1462-5822.2006.00862.x; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Stajich JE, 2012, NUCLEIC ACIDS RES, V40, pD675, DOI 10.1093/nar/gkr918; Wanachiwanawin W, 2004, VACCINE, V22, P3613, DOI 10.1016/j.vaccine.2004.03.031; Zerillo MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072572	42	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135239	10.1371/journal.pone.0135239	http://dx.doi.org/10.1371/journal.pone.0135239			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263509	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300069
J	Mento, G; Tarantino, V				Mento, Giovanni; Tarantino, Vincenza			Developmental Trajectories of Internally and Externally Driven Temporal Prediction	PLOS ONE			English	Article							LEFT INTRAPARIETAL SULCUS; ORIENTING ATTENTION; TIME; FOREPERIOD; FMRI; DISSOCIATIONS; UNCERTAINTY; EXPECTANCY; MODULATION; INTERVALS	The ability to generate temporal prediction (TP) is fundamental to our survival since it allows us to selectively orient our attention in time in order to prioritize relevant environmental information. Studies on adult participants showed that externally and internally driven mechanisms can be engaged to establish TP, both resulting in better behavioural performance. However, few studies on children have investigated the ability to engage internally and externally driven TP, especially in relation to how these mechanisms change across development. In this study, 111 participants (88 children between six and eleven years of age, and 23 adults) were tested by means of a simple reaction time paradigm, in which temporal cueing and neutral conditions were orthogonally manipulated to induce externally and internally driven TP mechanisms, as well as an interaction between the two. Sequential effects (SEs) relative to both tasks were also investigated. Results showed that all children participating in the study were able to implement both external and internal TP in an independent fashion. However, children younger than eight years were not able to combine both strategies. Furthermore, in the temporal cueing blocks they did not show the typically-observed asymmetric SE pattern. These results suggest that children can flexibly use both external and internal TP mechanisms to optimise their behaviour, although their successful combined use develops only after eight years of age.	[Mento, Giovanni; Tarantino, Vincenza] Univ Padua, Dept Gen Psychol, I-35131 Padua, Italy; [Tarantino, Vincenza] Univ Padua, SNPSRR, Dept Neurosci, I-35128 Padua, PD, Italy	University of Padua; University of Padua	Mento, G (corresponding author), Univ Padua, Dept Gen Psychol, Via Venezia 8, I-35131 Padua, Italy.	giovanni.mento@unipd.it	Mento, Giovanni/L-7924-2017	Mento, Giovanni/0000-0002-1529-2056; Tarantino, Vincenza/0000-0002-5836-3811	grant 'Progetto Giovani Studiosi' from the University of Padua [1682/2012]	grant 'Progetto Giovani Studiosi' from the University of Padua	This work was supported by the grant 'Progetto Giovani Studiosi' from the University of Padua (prot. 1682/2012) to GM. http://www.unipd.it/en/home-page.	Barnes R, 2000, COGNITIVE PSYCHOL, V41, P254, DOI 10.1006/cogp.2000.0738; Brannon EM, 2008, J COGNITIVE NEUROSCI, V20, P193, DOI 10.1162/jocn.2008.20016; Brannon EM, 2004, COGNITIVE BRAIN RES, V21, P227, DOI 10.1016/j.cogbrainres.2004.04.007; Capizzi M, 2015, COGNITION, V134, P39, DOI 10.1016/j.cognition.2014.09.002; Capizzi M, 2013, NEUROPSYCHOLOGIA, V51, P326, DOI 10.1016/j.neuropsychologia.2012.10.005; Capizzi M, 2012, COGNITION, V123, P293, DOI 10.1016/j.cognition.2012.02.005; Colombo J, 2002, PSYCHOL SCI, V13, P475, DOI 10.1111/1467-9280.00484; Correa A, 2006, EXP BRAIN RES, V169, P58, DOI 10.1007/s00221-005-0131-x; Correa A., 2012, ATTENTION TIME, P359, DOI [10.1093/acprof:oso/9780199563456.003.0026, DOI 10.1093/ACPR0T0S0/9780199563456.003.0026]; Correa A, 2008, J NEUROPHYSIOL, V100, P1649, DOI 10.1152/jn.90656.2008; Cotti J, 2011, NEUROIMAGE, V54, P1221, DOI 10.1016/j.neuroimage.2010.09.038; Coull J, 2010, ATTENTION TO TIME; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2011, ATTENTION PERFORM, P87, DOI 10.1016/B978-0-12-385948-8.00007-4; Coull JT, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000166; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Czudner G, 1972, AGE DIFFERENCES IRRE, P516; Davranche K, 2011, J COGNITIVE NEUROSCI, V23, P3318, DOI 10.1162/jocn_a_00030; de la Rosa MD, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00308; Elithorn A, 1955, Q J EXP PSYCHOL, V7, P116, DOI 10.1080/17470215508416684; Elliot R, 1970, J EXP CHILD PSYCHOL, P9; Feng Changyong, 2014, Shanghai Arch Psychiatry, V26, P105, DOI 10.3969/j.issn.1002-0829.2014.02.009; Johnson KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123625; KARLIN L, 1959, J EXP PSYCHOL, V58, P185, DOI 10.1037/h0049152; Los S.A., 2010, ATTENTION TIME, P289, DOI [10.1093/acprof:oso/9780199563456.003.0021, DOI 10.1093/ACPROF:OSO/9780199563456.001.0001]; Luce RD, 1986, RESPONSE TIMES THEIR; Mento G, 2015, J COGNITIVE NEUROSCI, V27, P425, DOI 10.1162/jocn_a_00715; Mento Giovanni, 2013, Front Hum Neurosci, V7, P827, DOI 10.3389/fnhum.2013.00827; Mento G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062896; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobre AC, 2001, NEUROPSYCHOLOGIA, V39, P1317; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Olesen PJ, 2003, COGNITIVE BRAIN RES, V18, P48, DOI 10.1016/j.cogbrainres.2003.09.003; Olivier I, 2002, NEUROSCI LETT, V319, P125, DOI 10.1016/S0304-3940(01)02510-1; OZMUN JC, 1989, PERCEPT MOTOR SKILL, V68, P931, DOI 10.2466/pms.1989.68.3.931; Puccioni O, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00327; Rohenkohl G, 2014, J VISION, V14, DOI 10.1167/14.4.8; Rohenkohl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014620; Sanabria D, 2011, J EXP PSYCHOL HUMAN, V37, P236, DOI 10.1037/a0019956; Smulders SFA, 2005, J EXP CHILD PSYCHOL, V90, P208, DOI 10.1016/j.jecp.2004.10.003; Steinborn MB, 2008, ACTA PSYCHOL, V129, P297, DOI 10.1016/j.actpsy.2008.08.005; Trillenberg P, 2000, CLIN NEUROPHYSIOL, V111, P1216, DOI 10.1016/S1388-2457(00)00274-1; Vallesi A., 2010, ATTENTION TIME, P303, DOI [DOI 10.1093/ACPROF:OSO/9780199563456.003.0022, 10.1093/acprof:oso/9780199563456.003.0022]; Vallesi A, 2007, J EXP PSYCHOL HUMAN, V33, P1377, DOI 10.1037/0096-1523.33.6.1377; Vallesi A, 2007, NEUROPSYCHOLOGIA, V45, P2755, DOI 10.1016/j.neuropsychologia.2007.04.017; Vallesi A, 2007, CEREB CORTEX, V17, P466, DOI 10.1093/cercor/bhj163; Vallesi A, 2014, COGNITION, V130, P141, DOI 10.1016/j.cognition.2013.10.006; Vallesi A, 2009, J COGNITIVE NEUROSCI, V21, P1116, DOI 10.1162/jocn.2009.21098; Vanmarle K, 2006, DEVELOPMENTAL SCI, V9, pF41, DOI 10.1111/j.1467-7687.2006.00508.x; Werner LA, 2009, J ACOUST SOC AM, V125, P1040, DOI 10.1121/1.3050254; Wiener M, 2010, NEUROPSYCHOLOGIA, V48, P3967, DOI 10.1016/j.neuropsychologia.2010.09.014; Woodrow H, 1914, PSYCHOL MONOGR, V17, P1	54	23	23	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135098	10.1371/journal.pone.0135098	http://dx.doi.org/10.1371/journal.pone.0135098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262878	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300057
J	Koes, DR; Pabon, NA; Deng, XY; Phillips, MA; Camacho, CJ				Koes, David Ryan; Pabon, Nicolas A.; Deng, Xiaoyi; Phillips, Margaret A.; Camacho, Carlos J.			A Teach-Discover-Treat Application of ZincPharmer: An Online Interactive Pharmacophore Modeling and Virtual Screening Tool	PLOS ONE			English	Article							FALCIPARUM DIHYDROOROTATE DEHYDROGENASE; ANTIMALARIAL ACTIVITY; LEAD OPTIMIZATION; INHIBITORS; POTENT; EFFICIENT; SEARCH; ZINC	The 2012 Teach-Discover-Treat (TDT) community-wide experiment provided a unique opportunity to test prospective virtual screening protocols targeting the anti-malarial target dihydroorotate dehydrogenase (DHODH). Facilitated by ZincPharmer, an open access online interactive pharmacophore search of the ZINC database, the experience resulted in the development of a novel classification scheme that successfully predicted the bound structure of a non-triazolopyrimidine inhibitor, as well as an overall hit rate of 27% of tested active compounds from multiple novel chemical scaffolds. The general approach entailed exhaustively building and screening sparse pharmacophore models comprising of a minimum of three features for each bound ligand in all available DHODH co-crystals and iteratively adding features that increased the number of known binders returned by the query. Collectively, the TDT experiment provided a unique opportunity to teach computational methods of drug discovery, develop innovative methodologies and prospectively discover new compounds active against DHODH.	[Koes, David Ryan; Pabon, Nicolas A.; Camacho, Carlos J.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Deng, Xiaoyi; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas	Koes, DR (corresponding author), Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA.	dkoes@pitt.edu; ccamacho@pitt.edu	Koes, David Ryan/M-4523-2018	Koes, David Ryan/0000-0002-6892-6614	National Institute of Health [R01GM097082, R01AI103947]; Commonwealth of Pennsylvania Department of Health [SAP 4100062224]; National Science Foundation [CNS1229064]; Welch Foundation [I-1257]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097082] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania Department of Health; National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health [R01GM097082] (to CJC), [R01GM097082] and R01AI103947 (to MAP), Commonwealth of Pennsylvania Department of Health Grant SAP 4100062224 (to CJC), and National Science Foundation CNS1229064. MAP acknowledges the support of the Welch Foundation (I-1257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Booker ML, 2010, J BIOL CHEM, V285, P33054, DOI 10.1074/jbc.M110.162081; Coteron JM, 2011, J MED CHEM, V54, P5540, DOI 10.1021/jm200592f; Deng XY, 2014, J MED CHEM, V57, P5381, DOI 10.1021/jm500481t; Deng XY, 2009, J BIOL CHEM, V284, P26999, DOI 10.1074/jbc.M109.028589; Dunbar JB, 2011, J CHEM INF MODEL, V51, P2036, DOI 10.1021/ci200082t; GERO AM, 1990, BLOOD CELLS, V16, P467; Gujjar R, 2011, J MED CHEM, V54, P3935, DOI 10.1021/jm200265b; Gujjar R, 2009, J MED CHEM, V52, P1864, DOI 10.1021/jm801343r; Haigh JA, 2005, J CHEM INF MODEL, V45, P673, DOI 10.1021/ci049651v; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378; Koes DR, 2011, J CHEM INF MODEL, V51, P1307, DOI 10.1021/ci200097m; Norman TC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002678; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; Schrodinger L. L. C., 2014, PYMOL MOL GRAPHICS S; Sheridan RP, 2002, DRUG DISCOV TODAY, V7, P903, DOI 10.1016/S1359-6446(02)02411-X; Shim J, 2011, MEDCHEMCOMM, V2, P356, DOI 10.1039/c1md00044f; Smith RD, 2011, J CHEM INF MODEL, V51, P2115, DOI 10.1021/ci200269q; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334	22	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134697	10.1371/journal.pone.0134697	http://dx.doi.org/10.1371/journal.pone.0134697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258606	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000359352600020
J	Mahnert, A; Vaishampayan, P; Probst, AJ; Auerbach, A; Moissl-Eichinger, C; Venkateswaran, K; Berg, G				Mahnert, Alexander; Vaishampayan, Parag; Probst, Alexander J.; Auerbach, Anna; Moissl-Eichinger, Christine; Venkateswaran, Kasthuri; Berg, Gabriele			Cleanroom Maintenance Significantly Reduces Abundance but Not Diversity of Indoor Microbiomes	PLOS ONE			English	Article							PROPIDIUM MONOAZIDE; GENE-SEQUENCES; SPACECRAFT; ENVIRONMENT; BACTERIAL; COMMUNITIES; PRIMERS; ROOM; MICROORGANISMS; COLLECTION	Cleanrooms have been considered microbially-reduced environments and are used to protect human health and industrial product assembly. However, recent analyses have deciphered a rather broad diversity of microbes in cleanrooms, whose origin as well as physiological status has not been fully understood. Here, we examined the input of intact microbial cells from a surrounding built environment into a spacecraft assembly cleanroom by applying a molecular viability assay based on propidium monoazide (PMA). The controlled cleanroom (CCR) was characterized by similar to 6.2*10(3) 16S rRNA gene copies of intact bacterial cells per m(2) floor surface, which only represented 1% of the total community that could be captured via molecular assays without viability marker. This was in contrast to the uncontrolled adjoining facility (UAF) that had 12 times more living bacteria. Regarding diversity measures retrieved from 16S rRNA Illumina-tag analyzes, we observed, however, only a minor drop in the cleanroom facility allowing the conclusion that the number but not the diversity of microbes is strongly affected by cleaning procedures. Network analyses allowed tracking a substantial input of living microbes to the cleanroom and a potential enrichment of survival specialists like bacterial spore formers and archaeal halophiles and mesophiles. Moreover, the cleanroom harbored a unique community including 11 exclusive genera, e.g., Haloferax and Sporosarcina, which are herein suggested as indicators of cleanroom environments. In sum, our findings provide evidence that archaea are alive in cleanrooms and that cleaning efforts and cleanroom maintenance substantially decrease the number but not the diversity of indoor microbiomes.	[Mahnert, Alexander; Berg, Gabriele] Graz Univ Technol, Inst Environm Biotechnol, A-8010 Graz, Austria; [Mahnert, Alexander; Vaishampayan, Parag; Venkateswaran, Kasthuri] CALTECH, Jet Prop Lab, Biotechnol & Planetary Protect Grp, Pasadena, CA USA; [Probst, Alexander J.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Auerbach, Anna; Moissl-Eichinger, Christine] Univ Regensburg, Inst Microbiol, D-93053 Regensburg, Germany; [Auerbach, Anna; Moissl-Eichinger, Christine] Univ Regensburg, Archaea Ctr, D-93053 Regensburg, Germany; [Moissl-Eichinger, Christine] Med Univ Graz, Dept Internal Med, Graz, Austria; [Moissl-Eichinger, Christine] BioTechMed Graz, Graz, Austria	Graz University of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Berkeley; University of Regensburg; University of Regensburg; Medical University of Graz	Berg, G (corresponding author), Graz Univ Technol, Inst Environm Biotechnol, A-8010 Graz, Austria.	gabriele.berg@tugraz.at	Moissl-Eichinger, Christine/A-6682-2015; Probst, Alexander J/K-2813-2016	Moissl-Eichinger, Christine/0000-0001-6755-6263; Probst, Alexander/0000-0002-9392-6544; Berg, Gabriele/0000-0001-9423-3101	BioTechMed-Graz	BioTechMed-Graz	The study was funded by BioTechMed-Graz.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2014, R LANG ENV STAT COMP; Arnold C, 2014, ENVIRON HEALTH PERSP, V122, pA182, DOI 10.1289/ehp.122-A182; Barth VC, 2012, ANAL BIOCHEM, V428, P108, DOI 10.1016/j.ab.2012.06.012; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Berg G, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00015; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cooper M, 2011, APPL ENVIRON MICROB, V77, P5438, DOI 10.1128/AEM.00192-11; Curtis TP, 2005, SCIENCE, V309, P1331, DOI 10.1126/science.1118176; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Kelley ST, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-202; Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kwan K, 2011, APPL ENVIRON MICROB, V77, P2943, DOI 10.1128/AEM.02978-10; La Duc MT, 2004, MICROB ECOL, V47, P150, DOI 10.1007/s00248-003-1012-0; La Duc MT, 2007, APPL ENVIRON MICROB, V73, P2600, DOI 10.1128/AEM.03007-06; La Duc MT, 2014, ASTROBIOLOGY, V14, P15, DOI 10.1089/ast.2013.0966; La Duc MT, 2012, APPL ENVIRON MICROB, V78, P5912, DOI 10.1128/AEM.01435-12; La Duc MT, 2009, APPL ENVIRON MICROB, V75, P6559, DOI 10.1128/AEM.01073-09; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Moissl-Eichinger C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09156; Moissl-Eichinger C, 2013, ASTROBIOLOGY, V13, P1125, DOI 10.1089/ast.2013.1024; Moissl-Eichinger C, 2012, ASTROBIOLOGY, V12, P1024, DOI 10.1089/ast.2012.0906; Nocker A, 2006, APPL ENVIRON MICROB, V72, P1997, DOI 10.1128/AEM.72.3.1997-2004.2006; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Oxley APA, 2010, ENVIRON MICROBIOL, V12, P2398, DOI 10.1111/j.1462-2920.2010.02212.x; Pitkaranta M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-235; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Probst A, 2012, INT J ASTROBIOL, V11, P117, DOI 10.1017/S1473550411000425; Probst A, 2010, APPL ENVIRON MICROB, V76, P2837, DOI 10.1128/AEM.02167-09; Probst AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065388; PULEO JR, 1977, APPL ENVIRON MICROB, V33, P379, DOI 10.1128/AEM.33.2.379-384.1977; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Rawsthorne H, 2009, APPL ENVIRON MICROB, V75, P2936, DOI 10.1128/AEM.02524-08; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Rummel J D, 1992, Adv Space Res, V12, P129; Rummel J D, 1989, Adv Space Res, V9, P181, DOI 10.1016/0273-1177(89)90227-5; Rummel JD, 2004, SPACE POLICY, V20, P49, DOI 10.1016/j.spacepol.2003.11.005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045; Vaishampayan P, 2013, ISME J, V7, P312, DOI 10.1038/ismej.2012.114; Vaishampayan P, 2010, ASTROBIOLOGY, V10, P499, DOI 10.1089/ast.2009.0443; Venkateswaran K, 2003, J MICROBIOL METH, V52, P367, DOI 10.1016/S0167-7012(02)00192-6; Venkateswaran K, 2014, MICROBES ENVIRON, V29, P243, DOI 10.1264/jsme2.ME14032; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186	58	39	39	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134848	10.1371/journal.pone.0134848	http://dx.doi.org/10.1371/journal.pone.0134848			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26273838	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600042
J	Sullivan, MJP; Davies, RG; Mossman, HL; Franco, AMA				Sullivan, Martin J. P.; Davies, Richard G.; Mossman, Hannah L.; Franco, Aldina M. A.			An Anthropogenic Habitat Facilitates the Establishment of Non-Native Birds by Providing Underexploited Resources	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; LAND-USE; COMMUNITIES; DISPERSAL; PATTERNS; INVASION; NONRANDOM; FRAMEWORK; IMPACTS; RISK	Anthropogenic modification of habitats may reduce the resources available for native species, leading to population declines and extinction. These same habitats often have the highest richness of non-native species. This pattern may be explained if recently human-modified habitats provide novel resources that are more accessible to non-native species than native species. Using non-native birds in the Iberian Peninsula as a case study, we conduct a large-scale study to investigate whether non-native species are positively associated with human modified habitats, and to investigate whether this positive association may be driven by the presence of resources that are not fully exploited by native species. We do this by comparing the functional diversity and resource use of native and non-native bird communities in a recently human-modified habitat ( rice fields) and in more traditional habitats in the Iberian Peninsula. The functional diversity of native bird communities was lower in rice fields, but non-native birds were positively associated with rice fields and plugged this gap. Differences in resource use between native and non-native species allowed non-native species to exploit resources that were plentiful in rice fields, supporting the role of underexploited resources in driving the positive association of non-native birds with rice fields. Our results provide a potential mechanism explaining the positive association of non-native species with anthropogenic habitats, and further work is needed to test if this applies more generally.	[Sullivan, Martin J. P.; Franco, Aldina M. A.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TY, Norfolk, England; [Sullivan, Martin J. P.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Davies, Richard G.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TY, Norfolk, England; [Mossman, Hannah L.] Manchester Metropolitan Univ, Sch Sci & Environm, Manchester M1 5GD, Lancs, England	University of East Anglia; University of Leeds; University of East Anglia; Manchester Metropolitan University	Sullivan, MJP (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich Res Pk, Norwich NR4 7TY, Norfolk, England.	m.j.sullivan@leeds.ac.uk	Franco, Aldina M/G-2144-2010; Davies, Richard/H-7447-2019	Franco, Aldina M/0000-0001-6055-7378; Mossman, Hannah/0000-0001-5958-5320; Sullivan, Martin/0000-0002-5955-0483	Natural Environment Research Council; British Ornithologists' Union small research grant; European Research Council grant [291585]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Ornithologists' Union small research grant; European Research Council grant(European Research Council (ERC))	This work was funded by a Natural Environment Research Council PhD studentship and British Ornithologists' Union small research grant awarded to MS. MS is currently supported by European Research Council grant 291585 (Tropical forests in the changing earth system). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard P, 1997, THE ATLAS OF SOUTHER, P612; Batalha HR, 2013, ACTA OECOL, V49, P92, DOI 10.1016/j.actao.2013.03.003; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blackburn TM, 2009, AVIAN INVASIONS THE; Cassey P, 2004, P ROY SOC B-BIOL SCI, V271, pS405, DOI 10.1098/rsbl.2004.0199; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Crawley MJ, 2005, SCIENCE, V310, P623, DOI 10.1126/science.1118216; del Hoyo J, 2009, HANDBOOK OF THE BIRD; del Hoyo J, 2010, HANDBOOK OF THE BIRD; Diaz S, 2013, ECOL EVOL, V3, P2958, DOI 10.1002/ece3.601; Dolman PM, 2012, J APPL ECOL, V49, P986, DOI 10.1111/j.1365-2664.2012.02174.x; Edwards FA, 2013, IBIS, V155, P313, DOI 10.1111/ibi.12027; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Garcia D, 2014, J ANIM ECOL, V83, P1441, DOI 10.1111/1365-2656.12237; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Joffre R, 1999, AGROFOREST SYST, V45, P57, DOI 10.1023/A:1006259402496; Kirmer A, 2008, J APPL ECOL, V45, P1523, DOI 10.1111/j.1365-2664.2008.01529.x; Laake J, 2014, R PACKAGE VERSION 2; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Lima A., 1997, CAHIERS OPTIONS MEDI, V15, P29; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; Maskell LC, 2006, J ECOL, V94, P1052, DOI 10.1111/j.1365-2745.2006.01172.x; Matias R, 2002, AVES EXOPTICAS QUE N; Mendez V, 2012, DIVERS DISTRIB, V18, P356, DOI 10.1111/j.1472-4642.2011.00868.x; Moles AT, 2012, J ECOL, V100, P116, DOI 10.1111/j.1365-2745.2011.01915.x; Pejchar L, 2008, BIOL CONSERV, V141, P536, DOI 10.1016/j.biocon.2007.11.008; Perrins C, 1994, HANDBOOK OF THE BIRD; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; R Core Team (n.d.), R A LANGUAGE AND ENV; Rader R, 2014, DIVERS DISTRIB, V20, P908, DOI 10.1111/ddi.12221; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Seabloom EW, 2002, P NATL ACAD SCI USA, V99, P11229, DOI 10.1073/pnas.162064899; Siriwardena GM, 2000, ECOGRAPHY, V23, P702, DOI 10.1034/j.1600-0587.2000.230608.x; Smart SM, 2006, J APPL ECOL, V43, P1128, DOI 10.1111/j.1365-2664.2006.01231.x; Stohigren TJ, 2008, ECOL LETT, V11, P313, DOI 10.1111/j.1461-0248.2008.01153.x; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Sullivan MJP, 2014, IBIS, V156, P231, DOI 10.1111/ibi.12104; Sullivan MJP, 2012, METHODS ECOL EVOL, V3, P870, DOI 10.1111/j.2041-210X.2012.00219.x; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Vaz-Pinto F, 2013, BIOL INVASIONS, V15, P1833, DOI 10.1007/s10530-013-0412-4; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003; Whittingham MJ, 2004, IBIS, V146, P210, DOI 10.1111/j.1474-919X.2004.00370.x	48	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135833	10.1371/journal.pone.0135833	http://dx.doi.org/10.1371/journal.pone.0135833			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26273825	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600122
J	Abualrous, ET; Saini, SK; Ramnarayan, VR; Ilca, FT; Zacharias, M; Springer, S				Abualrous, Esam Tolba; Saini, Sunil Kumar; Ramnarayan, Venkat Raman; Ilca, Florin Tudor; Zacharias, Martin; Springer, Sebastian			The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2K(b): A Combined Molecular Dynamics and Experimental Study	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; T-CELL RESPONSES; CONFORMATIONAL FLEXIBILITY; ANTIGEN PRESENTATION; TAPASIN DEPENDENCE; CRYSTAL-STRUCTURE; BINDING GROOVE; SELF-PEPTIDES; COMPLEX; PROTEINS	Major histocompatibility complex (MHC) class I molecules (proteins) bind peptides of eight to ten amino acids to present them at the cell surface to cytotoxic T cells. The class I binding groove binds the peptide via hydrogen bonds with the peptide termini and via diverse interactions with the anchor residue side chains of the peptide. To elucidate which of these interactions is most important for the thermodynamic and kinetic stability of the peptide-bound state, we have combined molecular dynamics simulations and experimental approaches in an investigation of the conformational dynamics and binding parameters of a murine class I molecule (H-2K(b)) with optimal and truncated natural peptide epitopes. We show that the F pocket region dominates the conformational and thermodynamic properties of the binding groove, and that therefore the binding of the C terminus of the peptide to the F pocket region plays a crucial role in bringing about the peptide-bound state of MHC class I.	[Abualrous, Esam Tolba; Saini, Sunil Kumar; Ramnarayan, Venkat Raman; Ilca, Florin Tudor; Springer, Sebastian] Jacobs Univ Bremen, Dept Chem & Life Sci, D-28759 Bremen, Germany; [Abualrous, Esam Tolba] Ain Shams Univ, Fac Sci, Dept Phys, Cairo, Egypt; [Zacharias, Martin] Tech Univ Munich, Phys Dept T38, D-85748 Garching, Germany	Jacobs University; Egyptian Knowledge Bank (EKB); Ain Shams University; Technical University of Munich	Springer, S (corresponding author), Jacobs Univ Bremen, Dept Chem & Life Sci, Campus Ring 1, D-28759 Bremen, Germany.	sebastian.springer@queens.oxon.org	Abualrous, Esam T/E-1698-2018; Springer, Sebastian/AAJ-7036-2021	Abualrous, Esam T/0000-0001-9582-9089; Springer, Sebastian/0000-0002-5527-6149; Saini, Sunil Kumar/0000-0003-3382-9432; Ramnarayan, Venkat Raman/0000-0003-2781-8729	Jacobs University; DAAD (German Academic Exchange Service)	Jacobs University; DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Jacobs University and by the DAAD (German Academic Exchange Service) to ETA.	Bailey A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089657; BARBER LD, 1993, ANNU REV CELL BIOL, V9, P163; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; Bouvier M, 1998, NAT STRUCT BIOL, V5, P377, DOI 10.1038/nsb0598-377; Chefalo PJ, 2001, J IMMUNOL, V167, P1274, DOI 10.4049/jimmunol.167.3.1274; Chen L, 2004, SCAND J IMMUNOL, V59, P545, DOI 10.1111/j.1365-3083.2004.01426.x; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Christensen O, 2009, J IMMUNOTHER, V32, P613, DOI 10.1097/CJI.0b013e3181a95198; Dedier S, 2001, J IMMUNOL METHODS, V255, P57, DOI 10.1016/S0022-1759(01)00423-9; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Donini OAT, 2000, J MED CHEM, V43, P4180, DOI 10.1021/jm000040d; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Elliott T, 1997, IMMUNOL TODAY, V18, P375, DOI 10.1016/S0167-5699(97)01097-9; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Fenley AT, 2012, P NATL ACAD SCI USA, V109, P20006, DOI 10.1073/pnas.1213180109; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; Garstka M, 2007, J BIOL CHEM, V282, P30680, DOI 10.1074/jbc.M701721200; Garstka MA, 2011, FASEB J, V25, P3989, DOI 10.1096/fj.11-190249; Glithero A, 2006, J BIOL CHEM, V281, P12699, DOI 10.1074/jbc.M511683200; Harndahl M, 2012, EUR J IMMUNOL, V42, P1405, DOI 10.1002/eji.201141774; Hein Z, 2014, J CELL SCI, V127, P2885, DOI 10.1242/jcs.145334; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Johansen TE, 1997, SCAND J IMMUNOL, V46, P137, DOI 10.1046/j.1365-3083.1997.d01-102.x; Kienast A, 2007, NAT IMMUNOL, V8, P864, DOI 10.1038/ni1483; Koch CP, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003088; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; Kumar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059711; Kurimoto E, 2013, MOL IMMUNOL, V55, P393, DOI 10.1016/j.molimm.2013.03.014; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Mage MG, 2012, J IMMUNOL, V189, P1391, DOI 10.4049/jimmunol.1200831; MIYAMOTO S, 1993, PROTEINS, V16, P226, DOI 10.1002/prot.340160303; Narzi D, 2012, J MOL BIOL, V415, P429, DOI 10.1016/j.jmb.2011.11.021; Natarajan K, 1999, Rev Immunogenet, V1, P32; Page CS, 2006, J COMPUT CHEM, V27, P1990, DOI 10.1002/jcc.20534; Pearlman DA, 2005, J MED CHEM, V48, P7796, DOI 10.1021/jm050306m; Persson Karina, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P135; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; Reboul CF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002404; Reichen C, 2014, J STRUCT BIOL, V185, P147, DOI 10.1016/j.jsb.2013.07.012; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Rupp B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018662; Saini SK, 2013, P NATL ACAD SCI USA, V110, P15383, DOI 10.1073/pnas.1308672110; Saini SK, 2013, MOL IMMUNOL, V54, P386, DOI 10.1016/j.molimm.2013.01.004; Sharp K, 2001, PROTEIN SCI, V10, P661, DOI 10.1110/ps.37801; Sieker F, 2008, MOL IMMUNOL, V45, P3714, DOI 10.1016/j.molimm.2008.06.009; Sieker F, 2007, PROTEIN SCI, V16, P299, DOI 10.1110/ps.062568407; Sieker F, 2009, CURR PROTEIN PEPT SC, V10, P286, DOI 10.2174/138920309788452191; Simone LC, 2012, MOL IMMUNOL, V49, P628, DOI 10.1016/j.molimm.2011.11.002; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Springer S, 1998, BIOCHEMISTRY-US, V37, P3001, DOI 10.1021/bi9717441; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Sun HY, 2014, PHYS CHEM CHEM PHYS, V16, P16719, DOI 10.1039/c4cp01388c; TOWNSEND A, 1989, COLD SH Q B, V54, P299; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang W, 2000, J MOL BIOL, V303, P567, DOI 10.1006/jmbi.2000.4057; Wright CA, 2004, BIOL CHEM, V385, P763, DOI 10.1515/BC.2004.100; Yanaka S, 2014, J BIOL CHEM, V289, P24680, DOI 10.1074/jbc.M114.566174; Yaneva R, 2010, MOL IMMUNOL, V47, P649, DOI 10.1016/j.molimm.2009.10.008; Yaneva R, 2009, BIOPOLYMERS, V91, P14, DOI 10.1002/bip.21078; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; YOUNG ACM, 1995, FASEB J, V9, P26, DOI 10.1096/fasebj.9.1.7821756; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743; Zernich D, 2004, J EXP MED, V200, P13, DOI 10.1084/jem.20031680	73	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135421	10.1371/journal.pone.0135421	http://dx.doi.org/10.1371/journal.pone.0135421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270965	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800067
J	Chapelain, A; Pimbert, P; Aube, L; Perrocheau, O; Debunne, G; Bellido, A; Blois-Heulin, C				Chapelain, Amandine; Pimbert, Pauline; Aube, Lydiane; Perrocheau, Oceane; Debunne, Gilles; Bellido, Alain; Blois-Heulin, Catherine			Can Population-Level Laterality Stem from Social Pressures? Evidence from Cheek Kissing in Humans	PLOS ONE			English	Article							BRAIN LATERALIZATION; CEREBRAL LATERALIZATION; SPATIAL AUTOCORRELATION; RIGHT-HANDEDNESS; HEAD POSITION; ASYMMETRY; PREFERENCE; BEHAVIOR; ORIGINS; PERFORMANCE	Despite extensive research, the origins and functions of behavioural laterality remain largely unclear. One of the most striking unresolved issues is the fact that laterality generally occurs at the population-level. Why would the majority of the individuals of a population exhibit the same laterality, while individual-level laterality would yet provide the advantages in terms of improving behavioural efficiency? Are social pressures the key factor? Can social pressures induce alignment of laterality between the individuals of a population? Can the effect of social pressures overpass the effect of other possible determining factors (e.g. genes)? We tested this important new hypothesis in humans, for the first time. We asked whether population-level laterality could stem from social pressures. Namely, we assessed social pressures on laterality in an interactive social behaviour: kissing on the cheek as a greeting. We performed observations in 10 cities of France. The observations took place in spots where people of the city meet and greet each other. We showed that: a) there is a population-level laterality for cheek kissing, with the majority of individuals being aligned in each city, and b) there is a variation between populations, with a laterality that depends on the city. These results were confirmed by our complementary data from questionnaires and internet surveys. These findings show that social pressures are involved in determining laterality. They demonstrate that population-level laterality can stem from social pressures.	[Chapelain, Amandine; Pimbert, Pauline; Aube, Lydiane; Perrocheau, Oceane; Blois-Heulin, Catherine] Univ Rennes 1, CNRS, UMR 6552, Stn Biol, F-35380 Paimpont, France; [Bellido, Alain] Univ Rennes 1, CNRS, UMR 6553, Stn Biol, F-35380 Paimpont, France; [Debunne, Gilles] QDC, Dept R&D, F-31000 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes	Chapelain, A (corresponding author), Univ Rennes 1, CNRS, UMR 6552, Stn Biol, F-35380 Paimpont, France.	chapelain_amandine@yahoo.fr		Aube, Lydiane/0000-0002-6174-3743				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Annett M, 2009, LANGUAGE LATERALIZATION AND PSYCHOSIS, P73, DOI 10.1017/CBO9780511576744.006; Barrett D, 2006, LATERALITY, V11, P573, DOI 10.1080/13576500600886614; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; Bisazza A, 2005, P ROY SOC B-BIOL SCI, V272, P1677, DOI 10.1098/rspb.2005.3145; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Bisazza A, 2002, BEHAV BRAIN RES, V134, P417, DOI 10.1016/S0166-4328(02)00055-4; Blois-Heulin C, MANUAL PODAL V UNPUB; Casperd JM, 1996, BEHAV PROCESS, V37, P57, DOI 10.1016/0376-6357(95)00075-5; Christensen R. H. B., 2014, ORDINAL REGRESSION M, P12; Collins RL, 1977, LATERALIZATION NERVO, P137; COREN S, 1977, SCIENCE, V198, P631, DOI 10.1126/science.335510; Dadda M, 2003, PHYSIOL BEHAV, V78, P337, DOI 10.1016/S0031-9384(02)01001-6; Dahmen R, 2005, CORTEX, V6, P739; Damerose E., 2002, P306, DOI 10.1017/CBO9780511546372.011; Donnot J., 2005, NEUROPSYCHIATR ENFAN, V53, P413, DOI [DOI 10.1016/J.NEURENF.2005.09.019, 10.1016/j.neurenf.2005.09.019]; FABRETHORPE M, 1993, CORTEX, V29, P15, DOI 10.1016/S0010-9452(13)80208-0; Fagard J, 2004, LATERALITY, V9, P67, DOI 10.1080/13576500342000167; FAGARD J, 2004, DROITIERS GAUCHERS A; Faurie C, 2005, CURR ANTHROPOL, V46, P142, DOI 10.1086/427101; Faurie C, 2004, THESIS U MONTPELLIER; Faurie C, 2004, P R SOC LOND, V271, P43, DOI DOI 10.1098/RSBL.2003.0092); Fox J., 2019, R COMPANION APPL REG, V.; FRAGASZY DM, 1990, J COMP PSYCHOL, V104, P275, DOI 10.1037/0735-7036.104.3.275; GABRIEL KR, 1969, SYST ZOOL, V18, P259, DOI 10.2307/2412323; Ghirlanda S, 2004, P ROY SOC B-BIOL SCI, V271, P853, DOI 10.1098/rspb.2003.2669; Ghirlanda S, 2009, PHILOS T R SOC B, V364, P861, DOI 10.1098/rstb.2008.0227; Gunturkun O, 2003, NATURE, V421, P711, DOI 10.1038/421711a; Gunturkun O, 2000, CURR BIOL, V10, P1079, DOI 10.1016/S0960-9822(00)00671-0; Herve M., 2014, RVAIDEMEMOIRE DIVER; HOPKINS B, 1987, HUM NEUROBIOL, V6, P153; Hopkins WD, 2006, PSYCHOL BULL, V132, P538, DOI 10.1037/0033-2909.132.4.538; KONISHI Y, 1986, DEV MED CHILD NEUROL, V28, P450; Laland KN, 2008, PHILOS T R SOC B, V363, P3577, DOI 10.1098/rstb.2008.0132; Lenth RV, 2014, LSMEANS LEAST SQUARE; MacManus C, 2002, RIGHT HAND LEFT HAND; MacNeilage PF, 2009, SCI AM, V301, P60, DOI 10.1038/scientificamerican0709-60; MANNING JT, 1991, ETHOL SOCIOBIOL, V12, P237, DOI 10.1016/0162-3095(91)90006-C; MARCHANT LF, 1995, ETHOLOGY, V101, P239; McGrew WC, 1999, PRIMATES, V40, P509, DOI 10.1007/BF02557586; MCGREW WC, 1992, CURR ANTHROPOL, V33, P114; MICHEL GF, 1981, SCIENCE, V212, P685, DOI 10.1126/science.7221558; Nicholls MER, 2002, BRAIN COGNITION, V48, P480, DOI 10.1006/brcg.2001.1402; Nicholls MER, 1999, P ROY SOC B-BIOL SCI, V266, P1517, DOI 10.1098/rspb.1999.0809; Ocklenburg S, 2014, FRONT PSYCHOL, V5, DOI [10.3389/fpsyg.2014.01300, 10.3389/fpsyg.2014.01143]; Ocklenburg S, 2009, LATERALITY, V14, P79, DOI 10.1080/13576500802243689; PREVIC FH, 1991, PSYCHOL REV, V98, P299, DOI 10.1037/0033-295X.98.3.299; Provins KA, 1997, PSYCHOL REV, V104, P554, DOI 10.1037/0033-295X.104.3.554; Rankin B, 2014, ECONOMIST; Rogers L.J., 2013, DIVIDED BRAINS BIOL; Rogers Lesley J., 2002, P126, DOI 10.1017/CBO9780511546372.006; Rogers Lesley J., 1989, INT J COMP PSYCHOL, V3, P5; ROGERS LJ, 1989, APPL ANIM BEHAV SCI, V23, P187, DOI 10.1016/0168-1591(89)90109-3; Rogers LJ, 2000, BRAIN LANG, V73, P236, DOI 10.1006/brln.2000.2305; Rogers LJ, 2004, P ROY SOC B-BIOL SCI, V271, pS420, DOI 10.1098/rsbl.2004.0200; Rogers LJ, 2002, COMP VERTEBRATE LATE; Ronnqvist L, 1998, CHILD DEV, V69, P13, DOI 10.2307/1132066; Schirillo JA, 2000, NEUROPSYCHOLOGIA, V38, P1593, DOI 10.1016/S0028-3932(00)00063-4; Shaki S, 2013, J NONVERBAL BEHAV, V37, P43, DOI 10.1007/s10919-012-0141-x; Shaki S, 2012, J EXP CHILD PSYCHOL, V112, P275, DOI 10.1016/j.jecp.2011.12.005; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Singh M, 2001, CORTEX, V37, P231, DOI 10.1016/S0010-9452(08)70570-7; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Sokal RR, 1997, BIOL J LINN SOC, V60, P73, DOI 10.1111/j.1095-8312.1997.tb01484.x; Sovrano VA, 1999, BEHAV BRAIN RES, V106, P175, DOI 10.1016/S0166-4328(99)00105-9; Sovrano VA, 2005, BEHAV BRAIN RES, V163, P122, DOI 10.1016/j.bbr.2005.04.012; TURKEWITZ G, 1965, J GENET PSYCHOL, V107, P143, DOI 10.1080/00221325.1965.10532772; TURNBULL OH, 1995, J GENET PSYCHOL, V156, P17, DOI 10.1080/00221325.1995.9914802; Vallortigara G, 1999, BRAIN RES REV, V30, P164, DOI 10.1016/S0165-0173(99)00012-0; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2006, DEV PSYCHOBIOL, V48, P418, DOI 10.1002/dev.20166; Vallortigara G, 2011, WIRES COGN SCI, V2, P146, DOI 10.1002/wcs.100; Vallortigara Giorgio, 2002, P9, DOI 10.1017/CBO9780511546372.003; van der Kamp J, 2011, LATERALITY, V16, P257, DOI 10.1080/13576500903530778; Vauclair J, 2005, NEUROPSYCHOLOGIA, V43, P564, DOI 10.1016/j.neuropsychologia.2004.07.005; VERVERS IAP, 1994, EARLY HUM DEV, V39, P83, DOI 10.1016/0378-3782(94)90157-0	76	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0124477	10.1371/journal.pone.0124477	http://dx.doi.org/10.1371/journal.pone.0124477			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JX	26270648	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800002
J	Jiang, SS; Yan, H; Chen, Q; Tian, L; Lu, TL; Tan, HY; Yan, J; Zhang, D				Jiang, Sisi; Yan, Hao; Chen, Qiang; Tian, Lin; Lu, Tianlan; Tan, Hao-Yang; Yan, Jun; Zhang, Dai			Cerebral Inefficient Activation in Schizophrenia Patients and Their Unaffected Parents during the N-Back Working Memory Task: A Family fMRI Study	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; COGNITIVE DEFICITS; 1ST-EPISODE SCHIZOPHRENIA; INTERMEDIATE PHENOTYPES; NONPSYCHOTIC RELATIVES; BRAIN ACTIVATION; GENE-EXPRESSION; METAANALYSIS; DYSFUNCTION; RISK	Background It has been suggested that working memory deficits is a core feature of symptomatology of schizophrenia, which can be detected in patients and their unaffected relatives. The impairment of working memory has been found related to the abnormal activity of human brain regions in many functional magnetic resonance imaging (fMRI) studies. This study investigated how brain region activation was altered in schizophrenia and how it was inherited independently from performance deficits. Method The authors used fMRI method during N-back task to assess working memory related cortical activation in four groups (N = 20 in each group, matching task performance, age, gender and education): schizophrenic patients, their unaffected biological parents, young healthy controls for the patients and older healthy controls for their parents. Results Compared to healthy controls, patients showed an exaggerated response in the right dorsolateral prefrontal cortex (brodmann area [BA] 46) and bilateral ventrolateral prefrontal cortex, and had reduced activation in bilateral dorsolateral prefrontal cortex (BA 9). In the conjunction analysis, the effect of genetic risk (parents versus older control) shared significantly overlapped activation with effect of disease (patients versus young control) in the right middle frontal gyrus (BA 46) and left inferior parietal gyrus (BA 40). Conclusions Physiological inefficiency of dorsal prefrontal cortex and compensation involvement of ventral prefrontal cortex in working memory function may one physiological characteristics of schizophrenia. And relatively inefficient activation in dorsolateral prefrontal cortex probably can be a promising intermediate phenotype for schizophrenia.	[Jiang, Sisi; Yan, Hao; Tian, Lin; Lu, Tianlan; Yan, Jun; Zhang, Dai] Peking Univ, Hosp 6, Beijing 100191, Peoples R China; [Jiang, Sisi; Yan, Hao; Tian, Lin; Lu, Tianlan; Yan, Jun; Zhang, Dai] Peking Univ, Inst Mental Hlth, Beijing 100191, Peoples R China; [Jiang, Sisi; Yan, Hao; Tian, Lin; Lu, Tianlan; Yan, Jun; Zhang, Dai] Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100191, Peoples R China; [Chen, Qiang; Tan, Hao-Yang] Lieber Inst Brain Dev, Baltimore, MD USA; [Tan, Hao-Yang] Johns Hopkins Univ, Sch Med, Psychiat & Behav Sci, Baltimore, MD USA; [Zhang, Dai] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Zhang, Dai] Peking Univ Tsinghua Univ Joint Ctr Life Sci, Beijing 100871, Peoples R China; [Zhang, Dai] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Johns Hopkins University; Tsinghua University; Tsinghua University; Peking University	Zhang, D (corresponding author), Peking Univ, Hosp 6, Beijing 100191, Peoples R China.	daizhang@bjmu.edu.cn	chen, qiang/GWZ-7308-2022; chen, qiang/HGU-5418-2022; Yan, Hao/U-1330-2017	Yan, Hao/0000-0003-0376-9037	National Basic Research Program of China [2011CB707805]; National Natural Science Foundation of China [81370032, 91232305, 81361120395, 91432304]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (http://www.973.gov.cn/English/Index.aspx) (2011CB707805) and the National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/) (81370032, 91232305, 81361120395, 91432304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Bakshi N, 2011, J PSYCHIATR RES, V45, P1067, DOI 10.1016/j.jpsychires.2011.01.002; Barch DM, 2007, AM J PSYCHIAT, V164, P1090, DOI 10.1176/appi.ajp.164.7.1090; Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959; Bienvenu OJ, 2011, PSYCHOL MED, V41, P33, DOI 10.1017/S003329171000084X; Blokland GAM, 2011, J NEUROSCI, V31, P10882, DOI 10.1523/JNEUROSCI.5334-10.2011; Callicott JH, 1998, NEUROPSYCHOPHARMACOL, V18, P186, DOI 10.1016/S0893-133X(97)00096-1; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Cieslik EC, 2013, CEREB CORTEX, V23, P2677, DOI 10.1093/cercor/bhs256; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; de Leeuw M, 2013, SCHIZOPHR RES, V150, P555, DOI 10.1016/j.schres.2013.08.016; Diwadkar VA, 2011, NEUROIMAGE, V58, P234, DOI 10.1016/j.neuroimage.2011.06.033; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fioravanti M, 2005, NEUROPSYCHOL REV, V15, P73, DOI 10.1007/s11065-005-6254-9; Forbes NF, 2009, PSYCHOL MED, V39, P889, DOI 10.1017/S0033291708004558; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Guillozet-Bongaarts AL, 2014, MOL PSYCHIATR, V19, P478, DOI 10.1038/mp.2013.30; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Kim JH, 2004, SCHIZOPHR RES, V68, P173, DOI 10.1016/S0920-9964(03)00150-6; Kumari V, 2006, NEUROIMAGE, V29, P545, DOI 10.1016/j.neuroimage.2005.08.013; Kumari V, 2009, BIOL PSYCHIAT, V66, P594, DOI 10.1016/j.biopsych.2009.04.036; Lee J, 2010, BIOL PSYCHIAT, V68, P78, DOI 10.1016/j.biopsych.2010.03.028; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; MacDonald AW, 2009, SCHIZOPHRENIA BULL, V35, P1142, DOI 10.1093/schbul/sbn053; MENDELSON MD, 1987, J AM ACAD PSYCHOAN, V15, P293, DOI 10.1521/jaap.1.1987.15.3.293; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Mitchell RLC, 2001, TRENDS COGN SCI, V5, P71, DOI 10.1016/S1364-6613(00)01599-0; Nejad AB, 2011, WORLD J BIOL PSYCHIA, V12, P271, DOI 10.3109/15622975.2010.556199; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Rasetti R, 2009, AM J PSYCHIAT, V166, P216, DOI 10.1176/appi.ajp.2008.08020261; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seidman LJ, 2006, SCHIZOPHR RES, V85, P58, DOI 10.1016/j.schres.2006.03.019; Silver H, 2003, AM J PSYCHIAT, V160, P1809, DOI 10.1176/appi.ajp.160.10.1809; Sitskoom MM, 2004, SCHIZOPHR RES, V71, P285, DOI 10.1016/j.schres.2004.03.007; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tan HY, 2008, MOL PSYCHIATR, V13, P233, DOI 10.1038/sj.mp.4002145; Tan HY, 2007, CEREB CORTEX, V17, pI171, DOI [10.1093/cercor/bhm069, 10.1093/cercor/hhm069]; Tan HY, 2006, AM J PSYCHIAT, V163, P1969, DOI 10.1176/appi.ajp.163.11.1969; Tan HY, 2005, AM J PSYCHIAT, V162, P1849, DOI 10.1176/appi.ajp.162.10.1849; Thermenos HW, 2005, SCHIZOPHR RES, V74, P179, DOI 10.1016/j.schres.2004.07.021; Thermenos HW, 2004, BIOL PSYCHIAT, V55, P490, DOI 10.1016/j.biopsych.2003.11.014; Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Whalley HC, 2004, BRAIN, V127, P478, DOI 10.1093/brain/awh070; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910	51	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135468	10.1371/journal.pone.0135468	http://dx.doi.org/10.1371/journal.pone.0135468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270056	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800078
J	Lim, KS; Tan, AH; Lim, CS; Chua, KH; Lee, PC; Ramli, N; Rajahram, GS; Hussin, FT; Wong, KT; Bhattacharjee, MB; Ng, CC				Lim, Kheng-Seang; Tan, Ai-Huey; Lim, Chun-Shen; Chua, Kek-Heng; Lee, Ping-Chin; Ramli, Norlisah; Rajahram, Giri Shan; Hussin, Fatimah Tina; Wong, Kum-Thong; Bhattacharjee, Meenakshi B.; Ng, Ching-Ching			R54C Mutation of NOTCH3 Gene in the First Rungus Family with CADASIL	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT ARTERIOPATHY; LEUKOENCEPHALOPATHY CADASIL; SUBCORTICAL INFARCTS; DIAGNOSTIC STRATEGIES; SPECTRUM; HYPERINTENSITIES; FEATURES	Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a rare hereditary stroke caused by mutations in NOTCH3 gene. We report the first case of CADASIL in an indigenous Rungus (Kadazan-Dusun) family in Kudat, Sabah, Malaysia confirmed by a R54C (c. 160C> T, p. Arg54Cys) mutation in the NOTCH3. This mutation was previously reported in a Caucasian and two Korean cases of CADASIL. We recruited two generations of the affected Rungus family (n = 9) and found a missense mutation (c. 160C> T) in exon 2 of NOTCH3 in three siblings. Two of the three siblings had severe white matter abnormalities in their brain MRI (Scheltens score 33 and 50 respectively), one of whom had a young stroke at the age of 38. The remaining sibling, however, did not show any clinical features of CADASIL and had only minimal changes in her brain MRI (Scheltens score 17). This further emphasized the phenotype variability among family members with the same mutation in CADASIL. This is the first reported family with CADASIL in Rungus subtribe of Kadazan-Dusun ethnicity with a known mutation at exon 2 of NOTCH3. The penetrance of this mutation was not complete during the course of this study.	[Lim, Kheng-Seang; Tan, Ai-Huey] Univ Malaya, Fac Med, Div Neurol, Kuala Lumpur, Malaysia; [Lim, Chun-Shen; Lee, Ping-Chin; Ng, Ching-Ching] Univ Malaya, Fac Sci, Inst Biol Sci, Genet & Mol Biol Unit, Kuala Lumpur, Malaysia; [Chua, Kek-Heng] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Ramli, Norlisah] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur, Malaysia; [Rajahram, Giri Shan] Queen Elizabeth Hosp, Dept Med, Sabah, Malaysia; [Hussin, Fatimah Tina] Queen Elizabeth Hosp, Dept Radiol, Sabah, Malaysia; [Wong, Kum-Thong] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia; [Bhattacharjee, Meenakshi B.] UT Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX USA	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Lim, KS (corresponding author), Univ Malaya, Fac Med, Div Neurol, Kuala Lumpur, Malaysia.	kslimum@gmail.com	LIM, KHENG SEANG/B-8863-2010; CHUA, KEK HENG/B-5261-2010; RAMLI, NORLISAH MOHD/G-5209-2010; NG, CHING CHING/B-9221-2010; Lee, Ping Chin/AGV-4612-2022; Tan, Ai Huey/G-5264-2016; Wong, Kum Thong/B-2788-2010; Lim, Chun Shen/H-6604-2015	LIM, KHENG SEANG/0000-0002-2787-2365; CHUA, KEK HENG/0000-0002-0452-9994; RAMLI, NORLISAH MOHD/0000-0001-7497-8093; Lee, Ping Chin/0000-0002-4280-0829; Lim, Chun Shen/0000-0001-7015-0125	University of Malaya [RG517-13HTM, UM-MOHE UM.C/625/1/HIR/MOHE/CHAN-02H-50001-A000023]	University of Malaya(Universiti Malaya)	This work was supported by University of Malaya Research Grant (RG517-13HTM), University of Malaya, to K-S Lim (http://umresearch.um.edu.my/mainpage.php?module=Maklumat & and High Impact Research Grant (UM-MOHE UM.C/625/1/HIR/MOHE/CHAN-02H-50001-A000023), University of Malaya, to K-S Lim (http://hir.um.edu.my/).	Adib-Samii P, 2010, STROKE, V41, P630, DOI 10.1161/STROKEAHA.109.568402; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bianchi S, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.03.005; Cappelli A, 2009, NEUROSCI LETT, V462, P176, DOI 10.1016/j.neulet.2009.06.087; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; Coulthard A, 2000, BRIT J RADIOL, V73, P256, DOI 10.1259/bjr.73.867.10817040; Dichgans M, 1998, ANN NEUROL, V44, P731, DOI 10.1002/ana.410440506; Escary JL, 2000, HUM MUTAT, V16, P518; Fan WM, 2013, J CLIN NEUROSCI, V20, P316, DOI 10.1016/j.jocn.2012.02.026; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kim YE, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.004; Markus HS, 2002, NEUROLOGY, V59, P1134, DOI 10.1212/WNL.59.8.1134; Monet-Lepretre M, 2013, BRAIN, V136, P1830, DOI 10.1093/brain/awt092; Oberstein SAJL, 1999, NEUROLOGY, V52, P1913, DOI 10.1212/WNL.52.9.1913; Opherk C, 2004, BRAIN, V127, P2533, DOI 10.1093/brain/awh282; Pavlovic A, 2013, ACTA NEUROL BELG, V113, P299, DOI 10.1007/s13760-012-0174-2; Peisker T, 2013, BIOMEDICAL PAPERS ME; Peters N, 2005, ARCH NEUROL-CHICAGO, V62, P1091, DOI 10.1001/archneur.62.7.1091; Ross OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075035; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Schmidt H, 2011, BRAIN, V134, P3384, DOI 10.1093/brain/awr252; Tan ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036590; Tikka S, 2009, BRAIN, V132, P933, DOI 10.1093/brain/awn364; Ueda A, 2015, J NEUROLOGY; Ungaro C, 2009, J NEUROSCI RES, V87, P1162, DOI 10.1002/jnr.21935; van den Boom R, 2003, J CEREBR BLOOD F MET, V23, P599, DOI 10.1097/01.WCB.0000062341.61367.D3; VERIN M, 1995, J NEUROL NEUROSUR PS, V59, P579, DOI 10.1136/jnnp.59.6.579; Vlachakis D, 2014, J MOL BIOCH     1206; Wang ZX, 2011, J NEUROL NEUROSUR PS, V82, P534, DOI 10.1136/jnnp.2010.209247; Wilder-Smith E, 2004, J CLIN NEUROSCI, V11, P304, DOI 10.1016/j.jocn.2003.05.007; Yadav S, 2013, J STROKE CEREBROVASC, V22, P28, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.023	33	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135470	10.1371/journal.pone.0135470	http://dx.doi.org/10.1371/journal.pone.0135470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270344	Green Published, gold			2022-12-27	WOS:000359492800079
J	Sadler, B; Haller, G; Edenberg, H; Tischfield, J; Brooks, A; Kramer, J; Schuckit, M; Nurnberger, J; Goate, A				Sadler, Brooke; Haller, Gabe; Edenberg, Howard; Tischfield, Jay; Brooks, Andy; Kramer, John; Schuckit, Marc; Nurnberger, John; Goate, Alison			Positive Selection on Loci Associated with Drug and Alcohol Dependence	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR KNOCKOUT MICE; NICOTINE DEPENDENCE; DNA POLYMORPHISM; LUNG-CANCER; RISK; VARIANTS; ALLELE; POPULATIONS; PERFORMANCE	Much of the evolution of human behavior remains a mystery, including how certain disadvantageous behaviors are so prevalent. Nicotine addiction is one such phenotype. Several loci have been implicated in nicotine related phenotypes including the nicotinic receptor gene clusters (CHRNs) on chromosomes 8 and 15. Here we use 1000 Genomes sequence data from 3 populations (Africans, Asians and Europeans) to examine whether natural selection has occurred at these loci. We used Tajima's D and the integrated haplotype score (iHS) to test for evidence of natural selection. Our results provide evidence for strong selection in the nicotinic receptor gene cluster on chromosome 8, previously found to be significantly associated with both nicotine and cocaine dependence, as well as evidence selection acting on the region containing the CHRNA5 nicotinic receptor gene on chromosome 15, that is genome wide significant for risk for nicotine dependence. To examine the possibility that this selection is related to memory and learning, we utilized genetic data from the Collaborative Studies on the Genetics of Alcoholism (COGA) to test variants within these regions with three tests of memory and learning, the Wechsler Adult Intelligence Scale (WAIS) Block Design, WAIS Digit Symbol and WAIS Information tests. Of the 17 SNPs genotyped in COGA in this region, we find one significantly associated with WAIS digit symbol test results. This test captures aspects of reaction time and memory, suggesting that a phenotype relating to memory and learning may have been the driving force behind selection at these loci. This study could begin to explain why these seemingly deleterious SNPs are present at their current frequencies.	[Sadler, Brooke] Washington Univ, Dept Psychiat, St Louis, MO USA; [Haller, Gabe] Washington Univ, Dept Orthoped Surg, St Louis, MO USA; [Edenberg, Howard] Indiana Univ, Dept Mol Biol, Indianapolis, IN 46204 USA; [Tischfield, Jay; Brooks, Andy] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Kramer, John] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Schuckit, Marc] Univ San Diego, Dept Psychiat, La Jolla, CA USA; [Nurnberger, John] Indiana Univ, Dept Psychiat, Indianapolis, IN USA; [Goate, Alison] Mt Sinai, Dept Neurosci, New York, NY 10029 USA	Washington University (WUSTL); Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis; Rutgers State University New Brunswick; University of Iowa; University of San Diego; Indiana University System; Indiana University-Purdue University Indianapolis; Icahn School of Medicine at Mount Sinai	Goate, A (corresponding author), Mt Sinai, Dept Neurosci, New York, NY 10029 USA.	alison.goate@mssm.edu		Nurnberger, John/0000-0002-7674-1767; Edenberg, Howard/0000-0003-0344-9690; Tischfield, Jay/0000-0003-3217-8287; Haller, Gabriel/0000-0002-3884-5776; Goate, Alison/0000-0002-0576-2472	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001108] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bierut LJ, 2009, DRUG ALCOHOL DEPEN, V104, pS64, DOI 10.1016/j.drugalcdep.2009.06.003; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Drago J, 2003, CELL MOL LIFE SCI, V60, P1267, DOI 10.1007/s00018-003-2259-9; Garrett B, 2009, CDC MORBIDITY AND MO, V60, P109; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Grucza RA, 2008, BIOL PSYCHIAT, V64, P922, DOI 10.1016/j.biopsych.2008.04.018; Haller G, 2013, HUM MOL GENET; Hoyle E, 2006, PSYCHOPHARMACOLOGY, V189, P211, DOI 10.1007/s00213-006-0549-2; Hutter S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-409; Jobling MA, 2004, HUMAN EVOUTIONARY GE; Jones BL, 2013, AM J HUM GENET, V93, P538, DOI 10.1016/j.ajhg.2013.07.008; Kumari V, 2003, NEUROIMAGE, V19, P1002, DOI 10.1016/S1053-8119(03)00110-1; Lichtenberger, 1998, INTELLECTUAL ASSESSM; Liu XY, 2013, AM J HUM GENET, V92, P866, DOI 10.1016/j.ajhg.2013.04.021; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Preller KH, 2014, P NATL ACAD SCI USA, V111, P2842, DOI 10.1073/pnas.1317090111; Rice JP, 2012, ADDICTION, V107, P2019, DOI 10.1111/j.1360-0443.2012.03922.x; Rigbi A, 2008, GENES BRAIN BEHAV, V7, P164, DOI 10.1111/j.1601-183X.2007.00329.x; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sadler B, 2014, SCI REP-UK, V4, DOI 10.1038/srep04497; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; TAJIMA F, 1989, GENETICS, V123, P585; Thiel CM, 2005, NEUROPSYCHOPHARMACOL, V30, P810, DOI 10.1038/sj.npp.1300633; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang JC, 2009, HUM MOL GENET, V18, P3125, DOI 10.1093/hmg/ddp231; Wang JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080204; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Winterer G, 2010, AM J MED GENET B, V153B, P1448, DOI 10.1002/ajmg.b.31126; Young JW, 2011, GENES BRAIN BEHAV, V10, P720, DOI 10.1111/j.1601-183X.2011.00711.x	39	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134393	10.1371/journal.pone.0134393	http://dx.doi.org/10.1371/journal.pone.0134393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270548	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800009
J	Schmid, S; Studer, D; Hasler, CC; Romkes, J; Taylor, WR; Brunner, R; Lorenzetti, S				Schmid, Stefan; Studer, Daniel; Hasler, Carol-Claudius; Romkes, Jacqueline; Taylor, William R.; Brunner, Reinald; Lorenzetti, Silvio			Using Skin Markers for Spinal Curvature Quantification in Main Thoracic Adolescent Idiopathic Scoliosis: An Explorative Radiographic Study	PLOS ONE			English	Article							LEG LENGTH DISCREPANCY; UPPER-BODY MOVEMENTS; SPINOUS PROCESSES; TRUNK KINEMATICS; SPASTIC DIPLEGIA; CEREBRAL-PALSY; WALKING; GAIT; PALPATION; CHILDREN	Background and Purpose Although the relevance of understanding spinal kinematics during functional activities in patients with complex spinal deformities is undisputed among researchers and clinicians, evidence using skin marker-based motion capture systems is still limited to a handful of studies, mostly conducted on healthy subjects and using non-validated marker configurations. The current study therefore aimed to explore the validity of a previously developed enhanced trunk marker set for the static measurement of spinal curvature angles in patients with main thoracic adolescent idiopathic scoliosis. In addition, the impact of inaccurate marker placement on curvature angle calculation was investigated. Methods Ten patients (Cobb angle: 44.4 +/- 17.7 degrees) were equipped with radio-opaque markers on selected spinous processes and underwent a standard biplanar radiographic examination. Subsequently, radio-opaque markers were replaced with retro-reflective markers and the patients were measured statically using a Vicon motion capture system. Thoracolumbar /lumbar and thoracic curvature angles in the sagittal and frontal planes were calculated based on the centers of area of the vertebral bodies and radio-opaque markers as well as the three-dimensional position of the retro-reflective markers. To investigate curvature angle estimation accuracy, linear regression analyses among the respective parameters were used. The impact of inaccurate marker placement was explored using linear regression analyses among the radio-opaque marker-and spinous process-derived curvature angles. Results and Discussion The results demonstrate that curvatures angles in the sagittal plane can be measured with reasonable accuracy, whereas in the frontal plane, angles were systematically underestimated, mainly due to the positional and structural deformities of the scoliotic vertebrae. Inaccuracy of marker placement had a greater impact on thoracolumbar / lumbar than thoracic curvature angles. It is suggested that spinal curvature measurements are included in marker-based clinical gait analysis protocols in order to enable a deeper understanding of the biomechanical behavior of the healthy and pathological spine in dynamic situations as well as to comprehensively evaluate treatment effects.	[Schmid, Stefan; Taylor, William R.; Lorenzetti, Silvio] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Schmid, Stefan] Bern Univ Appl Sci, Hlth Div, Bern, Switzerland; [Studer, Daniel; Hasler, Carol-Claudius; Brunner, Reinald] Univ Basel, Childrens Hosp, Dept Orthopaed, Basel, Switzerland; [Romkes, Jacqueline; Brunner, Reinald] Univ Basel, Childrens Hosp, Lab Movement Anal, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; University of Basel	Schmid, S (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	stefanschmid79@gmail.com	Schmid, Stefan/E-8534-2010; Lorenzetti, Silvio Rene/B-1188-2009; Taylor, William R./F-8692-2010	Schmid, Stefan/0000-0001-5138-9800; Lorenzetti, Silvio Rene/0000-0002-8339-8960; Taylor, William R./0000-0003-4060-4098	Health Division at Bern University of Applied Sciences, Switzerland; Swiss Physiotherapy Association (physioswiss)	Health Division at Bern University of Applied Sciences, Switzerland; Swiss Physiotherapy Association (physioswiss)	SS was supported by the Health Division at Bern University of Applied Sciences, Switzerland and the Swiss Physiotherapy Association (physioswiss). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRYANT JT, 1989, SPINE, V14, P258, DOI 10.1097/00007632-198903000-00004; Chan PY, 2006, GAIT POSTURE, V24, P219, DOI 10.1016/j.gaitpost.2005.09.003; Crosbie J, 1997, GAIT POSTURE, V5, P13, DOI 10.1016/S0966-6362(96)01068-5; Crosbie J, 1997, GAIT POSTURE, V5, P6, DOI 10.1016/S0966-6362(96)01066-1; Ernst Markus J, 2013, BMC Res Notes, V6, P58, DOI 10.1186/1756-0500-6-58; Frigo C, 2003, CLIN BIOMECH, V18, P419, DOI 10.1016/S0268-0033(03)00028-7; Harlick JC, 2007, MANUAL THER, V12, P56, DOI 10.1016/j.math.2006.02.008; Hashemirad F, 2013, J BODYW MOV THER, V17, P46, DOI 10.1016/j.jbmt.2012.04.010; HERZENBERG JE, 1990, SPINE, V15, P874, DOI 10.1097/00007632-199009000-00007; Heyrman L, 2013, GAIT POSTURE, V38, P770, DOI 10.1016/j.gaitpost.2013.03.019; Heyrman L, 2013, GAIT POSTURE, V37, P424, DOI 10.1016/j.gaitpost.2012.08.021; Heyrman L, 2014, RES DEV DISABIL, V35, P2044, DOI 10.1016/j.ridd.2014.04.031; Hong JY, 2013, SPINE J, V13, P1510, DOI 10.1016/j.spinee.2013.06.047; Kakushima M, 2003, SPINE, V28, P2472, DOI 10.1097/01.BRS.0000090829.82231.4A; Konz RJ, 2006, SPINE, V31, pE898, DOI 10.1097/01.brs.0000245939.97637.ae; KREBS DE, 1992, PHYS THER, V72, P505, DOI 10.1093/ptj/72.7.505; Leardini A, 2011, CLIN BIOMECH, V26, P562, DOI 10.1016/j.clinbiomech.2011.01.015; Lenke LG, 2001, J BONE JOINT SURG AM, V83A, P1169, DOI 10.2106/00004623-200108000-00006; Liljenqvist UR, 2002, J BONE JOINT SURG AM, V84A, P359, DOI 10.2106/00004623-200203000-00005; List R, 2013, J STRENGTH COND RES, V27, P1529, DOI 10.1519/JSC.0b013e3182736034; Masaracchio M, 2014, CLIN GUIDE MUSCULOSK; Merz O, 2013, MANUAL THER, V18, P333, DOI 10.1016/j.math.2012.12.003; Morl F, 2006, EUR SPINE J, V15, P742, DOI 10.1007/s00586-005-0960-0; Needham R, 2012, STUD HEALTH TECHNOL, V176, P104, DOI 10.3233/978-1-61499-067-3-104; Rigo Manuel, 2011, Physiotherapy Theory and Practice, V27, P7, DOI 10.3109/09593985.2010.503990; Robinson R, 2009, MANUAL THER, V14, P409, DOI 10.1016/j.math.2008.06.002; Romkes J, 2007, J PEDIATR ORTHOP B, V16, P175, DOI 10.1097/BPB.0b013e32801405bf; Schmid S, 2013, GAIT POSTURE, V37, P480, DOI 10.1016/j.gaitpost.2012.09.006; Schweizer K, 2014, CLIN BIOMECH, V29, P387, DOI 10.1016/j.clinbiomech.2014.02.005; Shin S, 2011, ANESTH ANALG, V112, P1232, DOI 10.1213/ANE.0b013e3182110f9f; Snider KT, 2011, J MANIP PHYSIOL THER, V34, P306, DOI 10.1016/j.jmpt.2011.04.006; Studer D, 2013, J CHILD ORTHOP, V7, P29, DOI 10.1007/s11832-012-0461-8; TAUBIN G, 1991, IEEE T PATTERN ANAL, V13, P1115, DOI 10.1109/34.103273; Zemp R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095426	34	38	40	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135689	10.1371/journal.pone.0135689	http://dx.doi.org/10.1371/journal.pone.0135689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270557	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800100
J	Sureban, SM; May, R; Qu, DF; Chandrakesan, P; Weygant, N; Ali, N; Lightfoot, SA; Ding, K; Umar, S; Schlosser, MJ; Houchen, CW				Sureban, Sripathi M.; May, Randal; Qu, Dongfeng; Chandrakesan, Parthasarathy; Weygant, Nathaniel; Ali, Naushad; Lightfoot, Stan A.; Ding, Kai; Umar, Shahid; Schlosser, Michael J.; Houchen, Courtney W.			Dietary Pectin Increases Intestinal Crypt Stem Cell Survival following Radiation Injury	PLOS ONE			English	Article							KAPPA-B ACTIVITY; TUFT CELLS; GROWTH; IDENTIFICATION; IRRADIATION; INHIBITION; MUSASHI-1; MARKER; MICE	Gastrointestinal (GI) mucosal damage is a devastating adverse effect of radiation therapy. We have recently reported that expression of Dclk1, a Tuft cell and tumor stem cell (TSC) marker, 24h after high dose total-body gamma-IR (TBI) can be used as a surrogate marker for crypt survival. Dietary pectin has been demonstrated to possess chemopreventive properties, whereas its radioprotective property has not been studied. The aim of this study was to determine the effects of dietary pectin on ionizing radiation (IR)-induced intestinal stem cell (ISC) deletion, crypt and overall survival following lethal TBI. C57BL/6 mice received a 6% pectin diet and 0.5% pectin drinking water (pre-IR mice received pectin one week before TBI until death; post-IR mice received pectin after TBI until death). Animals were exposed to TBI (14 Gy) and euthanized at 24 and 84h post-IR to assess ISC deletion and crypt survival respectively. Animals were also subjected to overall survival studies following TBI. In pre-IR treatment group, we observed a three-fold increase in ISC/crypt survival, a two-fold increase in Dclk1+stem cells, increased overall survival (median 10d vs. 7d), and increased expression of Dclk1, Msi1, Lgr5, Bmi1, and Notch1 (in small intestine) post-TBI in pectin treated mice compared to controls. We also observed increased survival of mice treated with pectin (post-IR) compared to controls. Dietary pectin is a radioprotective agent; prevents IR-induced deletion of potential reserve ISCs; facilitates crypt regeneration; and ultimately promotes overall survival. Given the anti-cancer activity of pectin, our data support a potential role for dietary pectin as an agent that can be administered to patients receiving radiation therapy to protect against radiation-induces mucositis.	[Sureban, Sripathi M.; May, Randal; Qu, Dongfeng; Chandrakesan, Parthasarathy; Weygant, Nathaniel; Ali, Naushad; Houchen, Courtney W.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73106 USA; [Lightfoot, Stan A.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Ding, Kai] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Coll Publ Hlth, Oklahoma City, OK USA; [Sureban, Sripathi M.; May, Randal; Houchen, Courtney W.] Dept Vet Affairs Med Ctr, Oklahoma City, OK USA; [Sureban, Sripathi M.; Ali, Naushad; Houchen, Courtney W.] Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK USA; [Umar, Shahid] Univ Kansas, Dept Mol & Integrat Physiol, Kansas City, KS USA; [Schlosser, Michael J.] COARE Biotechnol Inc, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Kansas	Sureban, SM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73106 USA.	sripathi-sureban@ouhsc.edu; courtney-houchen@ouhsc.edu	Chandrakesan, Parthasarathy/AAB-9136-2020	Ali, Naushad/0000-0002-0058-7396; Weygant, Nathaniel/0000-0001-7861-6532; Chandrakesan, Parthasarathy/0000-0002-7587-9553; Sureban, Sripathi/0000-0001-5476-9593	National Institute of Diabetes and Digestive and Kidney Diseases [NIH U01 DK-085508]; Oklahoma Center for the Advancement of Science and Technology; COARE Biotechnology Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085508] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Oklahoma Center for the Advancement of Science and Technology; COARE Biotechnology Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was performed as a project of the Intestinal Stem Cell Consortium, a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIH U01 DK-085508 to CWH), and a grant from Oklahoma Center for the Advancement of Science and Technology to CWH. COARE Biotechnology Inc. provided support in the form of salaries for authors [MJS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Avritscher Elenir B C, 2004, Semin Oncol Nurs, V20, P3; Chandrakesan P, 2012, INFECT IMMUN, V80, P753, DOI 10.1128/IAI.06101-11; Chandrakesan P, 2010, J BIOL CHEM, V285, P33485, DOI 10.1074/jbc.M110.129353; Citrin D, 2010, ONCOLOGIST, V15, P360, DOI 10.1634/theoncologist.2009-S104; Dekaney CM, 2005, GASTROENTEROLOGY, V129, P1567, DOI 10.1053/j.gastro.2005.08.011; DIRKS P, 1987, CLIN INVEST MED, V10, P32; George RJ, 2009, AM J PHYSIOL-GASTR L, V296, pG245, DOI 10.1152/ajpgi.00021.2008; Gerbe F, 2012, CELL MOL LIFE SCI, V69, P2907, DOI 10.1007/s00018-012-0984-7; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; Jagetia GC, 2007, J CLIN BIOCHEM NUTR, V40, P74, DOI 10.3164/jcbn.40.74; Jagetia GC, 2003, NAHRUNG, V47, P181, DOI 10.1002/food.200390042; Keefe Dorothy M K, 2004, Semin Oncol Nurs, V20, P38; Koukourakis MI, 2012, BRIT J RADIOL, V85, P313, DOI 10.1259/bjr/16386034; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; May R, 2014, STEM CELLS, V32, P822, DOI 10.1002/stem.1566; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Qu DF, 2014, AM J PHYSIOL-GASTR L, V306, pG404, DOI 10.1152/ajpgi.00088.2013; Short B., 2011, J CELL BIOL, V192, P706, DOI [10.1083/jcb.1925iti2, DOI 10.1083/JCB.1925ITI2]; Stringer Andrea M, 2007, J Support Oncol, V5, P259; Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057; Sureban SM, 2014, CANCER LETT, V351, P151, DOI 10.1016/j.canlet.2014.05.011; Sureban SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073940; Sureban SM, 2009, GASTROENTEROLOGY, V137, P649, DOI 10.1053/j.gastro.2009.05.004; Umar S, 2003, CELL PROLIFERAT, V36, P361, DOI 10.1046/j.1365-2184.2003.00291.x; Voragen AGJ, 2009, STRUCT CHEM, V20, P263, DOI 10.1007/s11224-009-9442-z; Xiao M, 2007, MOL PHARMACOL, V72, P370, DOI 10.1124/mol.107.035394; YEOH E, 1993, AM J MED, V95, P397, DOI 10.1016/0002-9343(93)90309-D; Yeoh EK, 1998, GUT, V43, P123, DOI 10.1136/gut.43.1.123; Yu T, 2010, MED SCI MONITOR, V16, pBR68	32	21	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135561	10.1371/journal.pone.0135561	http://dx.doi.org/10.1371/journal.pone.0135561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270561	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492800091
J	Agajanian, M; Campeau, A; Hoover, M; Hou, A; Brambilla, D; La Kim, S; Klemke, RL; Kelber, JA				Agajanian, Megan; Campeau, Anaamika; Hoover, Malachia; Hou, Alexander; Brambilla, Daniel; La Kim, Sa; Klemke, Richard L.; Kelber, Jonathan A.			PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGF beta Responses in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; NEOADJUVANT CHEMOTHERAPY; CELL-PROLIFERATION; PANCREATIC-CANCER; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; METASTASIS; EXPRESSION; RECEPTOR	Transforming Growth Factor beta (TGF beta) has dual functions as both a tumor suppressor and a promoter of cancer progression within the tumor microenvironment, but the molecular mechanisms by which TGF beta signaling switches between these outcomes and the contexts in which this switch occurs remain to be fully elucidated. We previously identified PEAK1 as a new non-receptor tyrosine kinase that associates with the cytoskeleton, and facilitates signaling of HER2/Src complexes. We also showed PEAK1 functions downstream of KRas to promote tumor growth, metastasis and therapy resistance using preclinical in vivo models of human tumor progression. In the current study, we analyzed PEAK1 expression in human breast cancer samples and found PEAK1 levels correlate with mesenchymal gene expression, poor cellular differentiation and disease relapse. At the cellular level, we also observed that PEAK1 expression was highest in mesenchymal breast cancer cells, correlated with migration potential and increased in response to TGF beta-induced epithelial-mesenchymal transition (EMT). Thus, we sought to evaluate the role of PEAK1 in the switching of TGF beta from a tumor suppressing to tumor promoting factor. Notably, we discovered that high PEAK1 expression causes TGF beta to lose its anti-proliferative effects, and potentiates TGF beta-induced proliferation, EMT, cell migration and tumor metastasis in a fibronectin-dependent fashion. In the presence of fibronectin, PEAK1 caused a switching of TGF beta signaling from its canonical Smad2/3 pathway to non-canonical Src and MAPK signaling. This report is the first to provide evidence that PEAK1 mediates signaling cross talk between TGF beta receptors and integrin/Src/MAPK pathways and that PEAK1 is an important molecular regulator of TGF beta-induced tumor progression and metastasis in breast cancer. Finally, PEAK1 overexpression/upregulation cooperates with TGF beta to reduce breast cancer sensitivity to Src kinase inhibition. These findings provide a rational basis to develop therapeutic agents to target PEAK1 expression/function or upstream/downstream pathways to abrogate breast cancer progression.	[Agajanian, Megan; Campeau, Anaamika; Hoover, Malachia; Hou, Alexander; Brambilla, Daniel; La Kim, Sa; Kelber, Jonathan A.] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA; [Hou, Alexander] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Klemke, Richard L.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Klemke, Richard L.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	California State University System; California State University Northridge; Georgetown University; University of California System; University of California San Diego; University of California System; University of California San Diego	Kelber, JA (corresponding author), Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA.	jonathan.kelber@csun.edu		Agajanian, Megan/0000-0002-1296-5665; Kelber, Jonathan/0000-0002-4606-1445	California State University Northridge College of Science and Mathematics; National Institutes of Health [5R01CA097022]; California State University Program for Education and Research in Biotechnology New Investigator; California State University Northridge Research Scholarship and Creative Works Award; NATIONAL CANCER INSTITUTE [R01CA097022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008395, R25GM063787] Funding Source: NIH RePORTER	California State University Northridge College of Science and Mathematics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California State University Program for Education and Research in Biotechnology New Investigator; California State University Northridge Research Scholarship and Creative Works Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by resources from the California State University Northridge College of Science and Mathematics (to JAK), California State University Program for Education and Research in Biotechnology New Investigator and California State University Northridge Research Scholarship and Creative Works Award (to JAK) and National Institutes of Health 5R01CA097022 Grant (to RLK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bristow JM, 2013, J BIOL CHEM, V288, P123, DOI 10.1074/jbc.M112.410910; Croucher DR, 2013, CANCER RES, V73, P1969, DOI 10.1158/0008-5472.CAN-12-1472; Dawson PJ, 1996, AM J PATHOL, V148, P313; Eswaran J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00264; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fujimura K., 2014, CANC RES; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; Gray PC, 2006, MOL CELL BIOL, V26, P9268, DOI 10.1128/MCB.01168-06; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Kelber JA, 2012, CANCER RES, V72, P2554, DOI 10.1158/0008-5472.CAN-11-3552; Kelber JA, 2010, ONCOTARGET, V1, P219, DOI 10.18632/oncotarget.128; Loi S, 2008, EUR J CANCER, V44, P2813, DOI 10.1016/j.ejca.2008.09.012; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Massague J, 2012, FEBS LETT, V586, P1833, DOI 10.1016/j.febslet.2012.05.030; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Matsuura I, 2010, BIOCHEM J, V426, P327, DOI 10.1042/BJ20090990; Miyake T, 2012, CANCER SCI, V103, P913, DOI 10.1111/j.1349-7006.2012.02231.x; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Rivera LB, 2011, J CELL BIOL, V193, P1305, DOI 10.1083/jcb.201011143; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stickeler E, 2011, ONCOL REP, V26, P1037, DOI 10.3892/or.2011.1392; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Taylor MA, 2013, BREAST CANCER RES TR, V142, P341, DOI 10.1007/s10549-013-2753-1; Thiery JP, 2013, CANCER CELL, V23, P272, DOI 10.1016/j.ccr.2013.03.004; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang YC, 2010, P NATL ACAD SCI USA, V107, P10920, DOI 10.1073/pnas.0914776107; Weir SJ, 2011, J CLIN PHARM THER, V36, P128, DOI 10.1111/j.1365-2710.2010.01172.x; Wendt MK, 2012, CELL TISSUE RES, V347, P85, DOI 10.1007/s00441-011-1199-1; Wendt MK, 2009, J BIOL CHEM, V284, P34145, DOI 10.1074/jbc.M109.023614; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Xu J, 2015, CANCER CELL, V27, P177, DOI 10.1016/j.ccell.2014.11.025; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yalcin B., 2013, Experimental Oncology, V35, P238; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang SY, 2013, CANCER RES, V73, P5764, DOI 10.1158/0008-5472.CAN-12-1803; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308; Zijlstra A, 2002, CANCER RES, V62, P7083	51	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135748	10.1371/journal.pone.0135748	http://dx.doi.org/10.1371/journal.pone.0135748			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267863	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300152
J	Nadon, MO; Ault, JS; Williams, ID; Smith, SG; DiNardo, GT				Nadon, Marc O.; Ault, Jerald S.; Williams, Ivor D.; Smith, Steven G.; DiNardo, Gerard T.			Length-Based Assessment of Coral Reef Fish Populations in the Main and Northwestern Hawaiian Islands	PLOS ONE			English	Article							FLORIDA; MORTALITY; SUSTAINABILITY; SERRANIDAE; FISHERIES; GROUPER	The coral reef fish community of Hawaii is composed of hundreds of species, supports a multimillion dollar fishing and tourism industry, and is of great cultural importance to the local population. However, a major stock assessment of Hawaiian coral reef fish populations has not yet been conducted. Here we used the robust indicator variable "average length in the exploited phase of the population ((L) over bar)", estimated from size composition data from commercial fisheries trip reports and fishery-independent diver surveys, to evaluate exploitation rates for 19 Hawaiian reef fishes. By and large, the average lengths obtained from diver surveys agreed well with those from commercial data. We used the estimated exploitation rates coupled with life history parameters synthesized from the literature to parameterize a numerical population model and generate stock sustainability metrics such as spawning potential ratios (SPR). We found good agreement between predicted average lengths in an unfished population (from our population model) and those observed from diver surveys in the largely unexploited Northwestern Hawaiian Islands. Of 19 exploited reef fish species assessed in the main Hawaiian Islands, 9 had SPRs close to or below the 30% overfishing threshold. In general, longer-lived species such as surgeonfishes, the redlip parrotfish (Scarus rubroviolaceus), and the gray snapper (Aprion virescens) had the lowest SPRs, while short-lived species such as goatfishes and jacks, as well as two invasive species (Lutjanus kasmira and Cephalopholis argus), had SPRs above the 30% threshold.	[Nadon, Marc O.; Ault, Jerald S.; Smith, Steven G.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Nadon, Marc O.] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Nadon, Marc O.; Williams, Ivor D.; DiNardo, Gerard T.] NOAA Fisheries, Pacific Isl Fisheries Sci Ctr, Honolulu, HI 96818 USA	University of Miami; University of Hawaii System; National Oceanic Atmospheric Admin (NOAA) - USA	Nadon, MO (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	marc.nadon@noaa.gov	Ault, Jerald S/A-5241-2008	Ault, Jerald S/0000-0001-9657-8007; Williams, Ivor/0000-0002-9444-1020	National Atmospheric and Oceanic Administration (NOAA) Pacific Islands Fisheries Science Center (PIFSC) iREEF [WE-133F-12-SE-2099]; NOAA Papahanaumokea Marine National Monument Grant [RA133C11SE2851]; NOAA Coral Reef Ecosystem Division, Pacific Reef Assessment and Monitoring Program, NOAA Fisheries; NOAA National Marine Sanctuaries	National Atmospheric and Oceanic Administration (NOAA) Pacific Islands Fisheries Science Center (PIFSC) iREEF; NOAA Papahanaumokea Marine National Monument Grant; NOAA Coral Reef Ecosystem Division, Pacific Reef Assessment and Monitoring Program, NOAA Fisheries; NOAA National Marine Sanctuaries	The research was partially supported by the National Atmospheric and Oceanic Administration (NOAA) Pacific Islands Fisheries Science Center (PIFSC) iREEF Contract No. WE-133F-12-SE-2099 and the NOAA Papahanaumokea Marine National Monument Grant No. RA133C11SE2851. Funding for the reef fish surveys was provided by the NOAA Coral Reef Ecosystem Division as part of the Pacific Reef Assessment and Monitoring Program, NOAA Fisheries, and NOAA National Marine Sanctuaries.	ALAGARAJA K, 1984, Indian Journal of Fisheries, V31, P177; [Anonymous], QUANTITATIVE FISHERI; Ault JS, 2008, ENVIRON CONSERV, V35, P221, DOI 10.1017/S0376892908005043; Ault JS, 2005, B MAR SCI, V76, P595; Ault JS, 2005, ICES J MAR SCI, V62, P417, DOI 10.1016/j.icesjms.2004.12.001; Ault JS, 1998, FISH B-NOAA, V96, P395; Babcock EA, 2013, FISH RES, V147, P434, DOI 10.1016/j.fishres.2013.03.011; Beverton R.J.H., 1957, FISH INVEST SER, P19; Beverton R.J.H., 1956, J CONS INT EXPLOR ME, V14, P67; Brandt ME, 2009, NATURAL RESOURCE REP; Cesar Herman S. J., 2004, Pacific Science, V58, P231, DOI 10.1353/psc.2004.0014; Chiappone M, 2000, MAR ECOL PROG SER, V198, P261, DOI 10.3354/meps198261; Clark WG, 2002, N AM J FISH MANAGE, V22, P251, DOI 10.1577/1548-8675(2002)022<0251:FRTYL>2.0.CO;2; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; DeMello JD, 2004, P 2001 FISH S HAW; Donovan MK, 2013, ENVIRON BIOL FISH, V96, P981, DOI 10.1007/s10641-012-0095-1; Eble JA, 2009, GROWTH REPROD HAWAII; EHRHARDT NM, 1992, T AM FISH SOC, V121, P115, DOI 10.1577/1548-8659(1992)121<0115:AOTLMM>2.3.CO;2; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 1997, FISH RES, V32, P33, DOI 10.1016/S0165-7836(97)00038-6; Gabriel W.L., 1989, North American Journal of Fisheries Management, V9, P383, DOI 10.1577/1548-8675(1989)009<0383:AOSSBP>2.3.CO;2; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Gedamke T, 2006, T AM FISH SOC, V135, P476, DOI 10.1577/T05-153.1; Goodyear C. Philip, 1993, Canadian Special Publication of Fisheries and Aquatic Sciences, V120, P67; Gulko D, 2002, STATUS CORAL REEFS H, P155; Haddon M., 2010, MODELLING QUANTITATI; Hamnett M, 2006, FISHING OCEAN RECREA; Hewitt DA, 2005, FISH B-NOAA, V103, P433; HOENIG JM, 1983, FISH B US, V82, P898, DOI DOI 10.1890/04-0594; Kenchington TJ, 2014, FISH FISH, V15, P533, DOI 10.1111/faf.12027; Kittinger JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025460; Kleiber P, 2013, IMPROVING SPECIFICAT, P24; McClanahan TR, 2001, ECOL APPL, V11, P559, DOI 10.2307/3060909; Meyer CG, 2007, MAR ECOL PROG SER, V333, P13, DOI 10.3354/meps333013; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Pardee C, 2014, THESIS HAWAII PACIFI; Restrepo VR, 1998, NMFSFSPO031 NOAA; Rivera MAJ, 2004, BIOL J LINN SOC, V81, P449, DOI 10.1111/j.1095-8312.2003.00304.x; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Smith SG, 2011, FISH RES, V109, P25, DOI 10.1016/j.fishres.2011.01.012; Then AY, 2015, ICES J MAR SCI, V72, P82, DOI 10.1093/icesjms/fsu136; Williams I, 2013, H1304 NOAA PAC ISL F, P61; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Williams I. D., 2011, J MAR BIOL, V2011, P14, DOI DOI 10.1155/2011/826234; Williams ID, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0120516, DOI 10.1371/J0URNAL.P0NE.0120516]; Zeller D, 2005, RECONSTRUCTION CORAL; [No title captured]; [No title captured]; [No title captured]; [No title captured]	52	63	63	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133960	10.1371/journal.pone.0133960	http://dx.doi.org/10.1371/journal.pone.0133960			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267473	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492300028
J	Ciarroni, S; Gallipoli, L; Taratufolo, MC; Butler, MI; Poulter, RTM; Pourcel, C; Vergnaud, G; Balestra, GM; Mazzaglia, A				Ciarroni, Serena; Gallipoli, Lorenzo; Taratufolo, Maria C.; Butler, Margi I.; Poulter, Russell T. M.; Pourcel, Christine; Vergnaud, Gilles; Balestra, Giorgio M.; Mazzaglia, Angelo			Development of a Multiple Loci Variable Number of Tandem Repeats Analysis (MLVA) to Unravel the Intra-Pathovar Structure of Pseudomonas syringae pv. actinidiae Populations Worldwide	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; BACTERIAL CANKER; CAUSAL AGENT; 1ST REPORT; HIGH-RESOLUTION; YERSINIA-PESTIS; PCR ASSAY; KIWIFRUIT; STRAINS; INFERENCE	The bacterial canker of kiwifruit by Pseudomonas syringae pv. actinidiae is an emblematic example of a catastrophic disease of fruit crops. In 2008 a new, extremely virulent form of the pathogen emerged and rapidly devastated many Actinidia spp. orchards all over the world. In order to understand differences in populations within this pathovar and to elucidate their diffusion and movements on world scale, it is necessary to be able to quickly and on a routine basis compare new isolates with previous records. In this report a worldwide collection of 142 strains was analyzed by MLVA, chosen as investigative technique for its efficacy, reproducibility, simplicity and low cost. A panel of 13 Variable Number of Tandem Repeats (VNTR) loci was identified and used to describe the pathogen population. The MLVA clustering is highly congruent with the population structure as previously established by other molecular approaches including whole genome sequencing and correlates with geographic origin, time of isolation and virulence. For convenience, we divided the VNTR loci in two panels. Panel 1 assay, using six loci, recognizes 23 different haplotypes, clustered into ten complexes with highest congruence with previous classifications. Panel 2, with seven VNTR loci, provides discriminatory power. Using the total set of 13 VNTR loci, 58 haplotypes can be distinguished. The recent hypervirulent type shows very limited diversity and includes, beside the strains from Europe, New Zealand and Chile, a few strains from Shaanxi, China. A broad genetic variability is observed in China, but different types are also retrievable in Japan and Korea. The low virulent strains cluster together and are very different from the other MLVA genotypes. Data were used to generate a public database in MLVAbank. MLVA represents a very promising first-line assay for large-scale routine genotyping, prior to whole genome sequencing of only the most relevant samples.	[Ciarroni, Serena; Gallipoli, Lorenzo; Taratufolo, Maria C.; Balestra, Giorgio M.; Mazzaglia, Angelo] Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy; [Butler, Margi I.; Poulter, Russell T. M.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Pourcel, Christine; Vergnaud, Gilles] Univ Paris Saclay, Univ Paris 11, CNRS, Inst Integrat Biol Cell, Orsay, France; [Vergnaud, Gilles] Univ Paris Saclay, ENSTA ParisTech, Palaiseau, France	Tuscia University; University of Otago; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay	Mazzaglia, A (corresponding author), Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy.	angmazza@unitus.it	Pourcel, Christine/E-4949-2017; Vergnaud, Gilles/P-1304-2015; Vergnaud, Gilles/AAC-1162-2020; Mazzaglia, Angelo/I-4336-2012	Pourcel, Christine/0000-0002-8951-466X; Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X; Mazzaglia, Angelo/0000-0002-1295-2565; Poulter, Russell/0000-0001-5848-646X; Butler, Margi/0000-0001-6863-3961	Italian Minister of Agriculture and Food Polices [247]; Direction Generale de l'Armement (DGA) [14- ASMA-0002-02]; Agence Nationale de la Recherche	Italian Minister of Agriculture and Food Polices; Direction Generale de l'Armement (DGA)(General Electric); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Italian Minister of Agriculture and Food Polices, www.politicheagricole.it, grant OIGA n. 247, GMB, AM; Direction Generale de l'Armement (DGA), http://www.defense.gouv.fr/dga, grant Microtype 14- ASMA-0002-02, GV, CP; and Agence Nationale de la Recherche, www.agence-nationale-recherche.fr, grant program ASTRID Maturation, GV, CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BACTERIAL CANKER KIW; [Anonymous], 2011, EPPO REP SERV, P168; Balestra GM, 2013, PLANT DIS, V97, P472, DOI 10.1094/PDIS-06-12-0590-RE; Balestra G. M., 2010, New Disease Reports, V22, P10, DOI 10.5197/j.2044-0588.2010.022.010; Balestra GM, 2009, AUSTRALAS PLANT DIS, V4, P34, DOI 10.1071/DN09014; Balestra G. M., 2011, NEW DIS REPORTS, V24, P10, DOI DOI 10.5197/J.2044-0588.2011.024.010; Balestra G. M., 2008, INFORM AGRARIO, V38, P75; Bastas KK, 2012, PLANT DIS, V96, P452, DOI 10.1094/PDIS-08-11-0675; Bergsma-Vlami M, 2012, J PLANT PATHOL, V94, DOI 10.4454/jpp.v94i1sup.006; Biondi E, 2013, ANN APPL BIOL, V162, P60, DOI 10.1111/aab.12001; Blouin Y, 2014, EMERG INFECT DIS, V20, P21, DOI 10.3201/eid2001.130652; Blouin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052841; Buhlmann A, 2014, ENVIRON MICROBIOL, V16, P2112, DOI 10.1111/1462-2920.12289; Butler MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057464; Chapman JR, 2012, PHYTOPATHOLOGY, V102, P1034, DOI 10.1094/PHYTO-03-12-0064-R; Cheng H.Y., 1995, J ANHUI AGR U, V22, P219; Ciammaruconi A, 2009, DIAGN MICR INFEC DIS, V65, P7, DOI 10.1016/j.diagmicrobio.2009.04.015; Cunty A, 2015, PLANT PATHOL, V64, P582, DOI 10.1111/ppa.12297; Della Coletta H, 2001, APPL ENVIRON MICROB, V67, P4091, DOI 10.1128/AEM.67.9.4091-4095.2001; Dreo T, 2014, PLANT DIS, V98, P1578, DOI 10.1094/PDIS-05-14-0513-PDN; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Everett KR, 2011, AUSTRALAS PLANT DIS, V6, P67, DOI 10.1007/s13314-011-0023-9; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fang Y., 1990, SICHUAN FRUIT SCI TE, V18, P28; Ferrante P, 2015, EUR J PLANT PATHOL, V142, P677, DOI 10.1007/s10658-015-0643-6; Ferrante P, 2010, PLANT PATHOL, V59, P954, DOI 10.1111/j.1365-3059.2010.02304.x; Gallelli A, 2011, PHYTOPATHOL MEDITERR, V50, P462; Gascuel O., 1997, DIMACS SERIES DISCRE, P149, DOI 10.1090/dimacs/037/09; Gironde S, 2012, APPL ENVIRON MICROB, V78, P3266, DOI 10.1128/AEM.06655-11; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Holeva MC, 2015, PLANT DIS, V99, P723, DOI 10.1094/PDIS-07-14-0738-PDN; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IPPC website. Detection of the Asian strain of bacterial canker of kiwifruit in Victoria, AUS453 IPPC; Koh HS, 2014, PLANT PATHOLOGY J, V30, P96, DOI 10.5423/PPJ.NT.09.2013.0095; Koh Y., 1994, KOREAN J PLANT PATHO, V10, P68; Koh YJ, 2010, NEW ZEAL J CROP HORT, V38, P275, DOI 10.1080/01140671.2010.512624; Koh YJ, 2012, PLANT PATHOLOGY J, V28, P423, DOI 10.5423/PPJ.NT.05.2012.0061; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Lee Jae Hong, 2005, The Plant Pathology Journal, V21, P119; Liang Y, 2000, J NW FORESTRY COLL, V15, P37; Lindstedt BA, 2013, EUROSURVEILLANCE, V18, P7; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Maquart M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-145; Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297; Mazzaglia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036518; Mazzaglia A, 2011, CAN J PLANT PATHOL, V33, P8, DOI 10.1080/07060661.2010.538556; McCann HC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003503; N'Guessan CA, 2013, J MICROBIOL METH, V92, P366, DOI 10.1016/j.mimet.2013.01.012; Ngoc LBT, 2009, APPL ENVIRON MICROB, V75, P1173, DOI 10.1128/AEM.02245-08; Perrier X., 2006, DARWIN SOFTWARE; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Pourcel C, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-22; Pourcel C, 2011, MOLECULAR MICROBIOLOGY: DIAGNOSTIC PRINCIPLES AND PRACTICE, SECOND EDITION, P179; Pourcel C, 2011, J CLIN MICROBIOL, V49, P539, DOI 10.1128/JCM.02003-10; Pritchard JK, 2000, GENETICS, V155, P945; Pruvost O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098129; Renzi M, 2014, FRUTTICOLTURA, V12, P84; Renzi M, 2012, PHYTOPATHOLOGY, V102, P827, DOI 10.1094/PHYTO-02-12-0019-R; Sawada H., 2014, Japanese Journal of Phytopathology, V80, P171, DOI 10.3186/jjphytopath.80.171; SCORTICHINI M, 1994, PLANT PATHOL, V43, P1035, DOI 10.1111/j.1365-3059.1994.tb01654.x; [申哲 SHEN Zhe], 2009, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V18, P191; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sobral D, 2012, EUR J CLIN MICROBIOL, V31, P2247, DOI 10.1007/s10096-012-1562-5; Sobral D, 2011, APPL ENVIRON MICROB, V77, P6899, DOI 10.1128/AEM.05556-11; Sobral D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033967; Stefani E, 2011, PHYTOPATHOL MEDITERR, V50, P489; TAKIKAWA Y, 1989, Annals of the Phytopathological Society of Japan, V55, P437, DOI 10.3186/jjphytopath.55.437; Tu X, 2011, J ANHUI AGR SCI, V39, P6433; Vanneste JL, 2011, PLANT DIS, V95, P1311, DOI 10.1094/PDIS-03-11-0195; Vanneste J. L., 2011, New Zealand Plant Protection, V64, P241; Vanneste J. L., 2011, New Zealand Plant Protection, V64, P246; Vergnaud G, 2006, MOL IDENTIFICATION S, P83; Vergnaud G, 2009, METHODS MOL BIOL, V551, P141, DOI 10.1007/978-1-60327-999-4_12; Verniere C, 2014, ENVIRON MICROBIOL, V16, P2226, DOI 10.1111/1462-2920.12369; Wang Z., 1992, J SW AGR U; Whatmore AM, 2014, INT J SYST EVOL MICR, V64, P4120, DOI 10.1099/ijs.0.065482-0; Young JM, 2010, J PLANT PATHOL, V92, pS5; YOUNG JM, 1978, NEW ZEAL J AGR RES, V21, P153, DOI 10.1080/00288233.1978.10427397; Zaluga J, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-126; Zhao S, 2012, PHYTOPATHOLOGY, V102, P948, DOI 10.1094/PHYTO-04-12-0078-R; Zhao ZB, 2013, J PLANT PATHOL, V95, P155; Zhu XX, 1993, AGR SCI TECHNOLOGY, V6, P31	83	26	30	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135310	10.1371/journal.pone.0135310	http://dx.doi.org/10.1371/journal.pone.0135310			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262683	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300072
J	Karthikeyan, B; Kadhiravan, T; Deepanjali, S; Swaminathan, RP				Karthikeyan, Balasubramanian; Kadhiravan, Tamilarasu; Deepanjali, Surendran; Swaminathan, Rathinam Palamalai			Case-Mix, Care Processes, and Outcomes in Medically-Ill Patients Receiving Mechanical Ventilation in a Low-Resource Setting from Southern India: A Prospective Clinical Case Series	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM RISK; UNPLANNED EXTUBATION; CRITICALLY-ILL; MORTALITY; PROPHYLAXIS; PREDICTORS; PNEUMONIA; ENDORSE; SCORE; UNITS	Background Mechanical ventilation is a resource intensive organ support treatment, and historical studies from low-resource settings had reported a high mortality. We aimed to study the outcomes in patients receiving mechanical ventilation in a contemporary low-resource setting. Methods We prospectively studied the characteristics and outcomes (disease-related, mechanical ventilation-related, and process of care-related) in 237 adults mechanically ventilated for a medical illness at a teaching hospital in southern India during February 2011 to August 2012. Vital status of patients discharged from hospital was ascertained on Day 90 or later. Results Mean age of the patients was 40 +/- 17 years; 140 (51%) were men. Poisoning and envenomation accounted for 98 (41%) of 237 admissions. In total, 87 (37%) patients died in-hospital; 16 (7%) died after discharge; 115 (49%) were alive at 90-day assessment; and 19 (8%) were lost to follow-up. Weaning was attempted in 171 (72%) patients; most patients (78 of 99 [79%]) failing the first attempt could be weaned off. Prolonged mechanical ventilation was required in 20 (8%) patients. Adherence to head-end elevation and deep vein thrombosis prophylaxis were 164 (69%) and 147 (62%) respectively. Risk of nosocomial infections particularly ventilator-associated pneumonia was high (57.2 per 1,000 ventilator-days). Higher APACHE II score quartiles (adjusted HR [95% CI] quartile 2, 2.65 [1.19-5.89]; quartile 3, 2.98 [1.24-7.15]; quartile 4, 5.78 [2.45-13.60]), and new-onset organ failure (2.98 [1.94-4.56]) were independently associated with the risk of death. Patients with poisoning had higher risk of reintubation (43% vs. 20%; P = 0.001) and ventilator-associated pneumonia (75% vs. 53%; P = 0.001). But, their mortality was significantly lower compared to the rest (24% vs. 44%; P = 0.002). Conclusions The case-mix considerably differs from other settings. Mortality in this low-resource setting is similar to high-resource settings. But, further improvements in care processes and prevention of nosocomial infections are required.	[Karthikeyan, Balasubramanian; Kadhiravan, Tamilarasu; Deepanjali, Surendran; Swaminathan, Rathinam Palamalai] Jawaharlal Inst Postgrad Med Educ & Res, Dept Med, Dhanvantri Nagar, Puducherry, India	Jawaharlal Institute of Postgraduate Medical Education & Research	Kadhiravan, T (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res, Dept Med, Dhanvantri Nagar, Puducherry, India.	kadhir@jipmer.edu.in	Kadhiravan, Tamilarasu/AAU-8104-2020; Deepanjali, Surendran/AAR-6341-2021; Deepanjali, Surendran/GQP-5858-2022	Deepanjali, Surendran/0000-0003-2151-4273; Kadhiravan, Tamilarasu/0000-0002-4676-743X				Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Azevedo LCP, 2013, CRIT CARE, V17, DOI 10.1186/cc12594; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Chevron V, 1998, CRIT CARE MED, V26, P1049, DOI 10.1097/00003246-199806000-00026; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Dudeck MA, 2013, AM J INFECT CONTROL, V41, P1148, DOI 10.1016/j.ajic.2013.09.002; Dunser MW, 2006, CRIT CARE MED, V34, P1234, DOI 10.1097/01.CCM.0000208360.70835.87; Eber MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025298; Epstein SK, 2000, AM J RESP CRIT CARE, V161, P1912, DOI 10.1164/ajrccm.161.6.9908068; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Esteban A, 2013, AM J RESP CRIT CARE, V188, P220, DOI 10.1164/rccm.201212-2169OC; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Gupta R, 2004, INDIAN J MED RES, V119, P273; Indira M, 2013, CLIN TOXICOL, V51, P838, DOI 10.3109/15563650.2013.837915; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; Luna CM, 2004, CRIT CARE, V8, P425, DOI 10.1186/cc2988; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Murthy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116949; Murthy Srinivas, 2013, Ann Am Thorac Soc, V10, P509, DOI 10.1513/AnnalsATS.201307-246OT; Pinjala R, 2012, INDIAN J MED RES, V136, P60; POTGIETER PD, 1985, CRIT CARE MED, V13, P798, DOI 10.1097/00003246-198510000-00005; RAJAPAKSE VPH, 1989, ANN ROY COLL SURG, V71, P344; Riviello ED, 2011, CRIT CARE MED, V39, P860, DOI 10.1097/CCM.0b013e318206d6d5; Rosenthal VD, 2006, ANN INTERN MED, V145, P582, DOI 10.7326/0003-4819-145-8-200610170-00007; Scotland Health Protection, 2011, INT CAR UN ASS INF N; SINCLAIR JR, 1988, ANN ROY COLL SURG, V70, P76; Sudarsanam TD, 2005, POSTGRAD MED J, V81, P780, DOI 10.1136/pgmj.2005.033076; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135336	10.1371/journal.pone.0135336	http://dx.doi.org/10.1371/journal.pone.0135336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262995	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300074
J	Liu, CJ; Huang, SS; Toullec, JY; Chang, CY; Chen, YR; Huang, WS; Lee, CY				Liu, Chun-Jing; Huang, Shiau-Shan; Toullec, Jean-Yves; Chang, Cheng-Yen; Chen, Yun-Ru; Huang, Wen-San; Lee, Chi-Ying			Functional Assessment of Residues in the Amino- and Carboxyl-Termini of Crustacean Hyperglycemic Hormone (CHH) in the Mud Crab Scylla olivacea Using Point-Mutated Peptides	PLOS ONE			English	Article							CRAYFISH PROCAMBARUS-CLARKII; MOLT-INHIBITING HORMONE; ION-TRANSPORT; KURUMA PRAWN; ACID-SEQUENCE; MACROBRACHIUM-ROSENBERGII; STRUCTURAL VARIANTS; MUTATIONAL ANALYSIS; CHIRAL ISOFORMS; LOBSTER	To assess functional importance of the residues in the amino- and carboxyl-termini of crustacean hyperglycemic hormone in the mud crab Scylla olivacea (Sco-CHH), both wild-type and point-mutated CHH peptides were produced with an amidated C-terminal end. Spectral analyses of circular dichroism, chromatographic retention time, and mass spectrometric analysis of the recombinant peptides indicate that they were close in conformation to native CHH and were produced with the intended substitutions. The recombinant peptides were subsequently used for an in vivo hyperglycemic assay. Two mutants (R13A and I69A rSco-CHH) completely lacked hyperglycemic activity, with temporal profiles similar to that of vehicle control. Temporal profiles of hyperglycemic responses elicited by 4 mutants (I2A, F3A, D12A, and D60A Sco-CHH) were different from that elicited by wild-type Sco-CHH; I2A was unique in that it exhibited significantly higher hyperglycemic activity, whereas the remaining 3 mutants showed lower activity. Four mutants (D4A, Q51A, E54A, and V72A rSco-CHH) elicited hyperglycemic responses with temporal profiles similar to those evoked by wild-type Sco-CHH. In contrast, the glycine-extended version of V72A rSco-CHH (V72A rSco-CHH-Gly) completely lost hyperglycemic activity. By comparing our study with previous ones of ion-transport peptide (ITP) and molt-inhibiting hormone (MIH) using deleted or point-mutated mutants, detail discussion is made regarding functionally important residues that are shared by both CHH and ITP (members of Group I of the CHH family), and those that discriminate CHH from ITP, and Group-I from Group-II peptides. Conclusions summarized in the present study provide insights into understanding of how functional diversification occurred within a peptide family of multifunctional members.	[Liu, Chun-Jing; Huang, Shiau-Shan; Chang, Cheng-Yen; Lee, Chi-Ying] Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan; [Toullec, Jean-Yves] Univ Paris 06, Univ Sorbonne, CNRS, UMR 7144,Equipe ABICE,Stn Biol Roscoff, Roscoff, France; [Toullec, Jean-Yves] CNRS, UMR 7144, Adaptat & Diversite Milieu Marin, Stn Biolog Roscoff, Roscoff, France; [Chen, Yun-Ru] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Huang, Wen-San] Natl Museum Nat Sci, Dept Biol, Taichung, Taiwan; [Huang, Wen-San] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan	National Changhua University of Education; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; National Tsing Hua University; National Chung Hsing University	Huang, WS (corresponding author), Natl Museum Nat Sci, Dept Biol, Taichung, Taiwan.	wshuang@mail.nmns.edu.tw; bicylee@cc.ncue.edu.tw		Huang, Wen-San/0000-0003-0073-3557	Ministry of Science and Technology, Taiwan [103-2311-B-018-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by 103-2311-B-018-001, Ministry of Science and Technology (http://www.most.gov.tw/mp.aspx), Taiwan to C-YL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR MB, 1995, PEPTIDES, V16, P1375, DOI 10.1016/0196-9781(95)02024-1; Bulau P, 2003, PEPTIDES, V24, P1871, DOI 10.1016/j.peptides.2003.10.002; Chan SM, 2003, GEN COMP ENDOCR, V134, P214, DOI 10.1016/S0016-6480(03)00263-6; Chang CC, 2010, GEN COMP ENDOCR, V167, P68, DOI 10.1016/j.ygcen.2010.02.013; Chang ES, 1998, GEN COMP ENDOCR, V111, P359, DOI 10.1006/gcen.1998.7120; Chang ES, 1999, J COMP NEUROL, V414, P50; CHANG ES, 1990, BIOCHEM BIOPH RES CO, V171, P818, DOI 10.1016/0006-291X(90)91219-I; Chen SH, 2004, MAR BIOTECHNOL, V6, P83, DOI 10.1007/s10126-003-0014-8; Chen SH, 2005, MAR BIOTECHNOL, V7, P193, DOI 10.1007/s10126-004-0020-5; Christie AE, 2008, GEN COMP ENDOCR, V157, P174, DOI 10.1016/j.ygcen.2008.03.027; Christie AE, 2011, GEN COMP ENDOCR, V170, P480, DOI 10.1016/j.ygcen.2010.11.002; Chung JS, 2008, FEBS J, V275, P693, DOI 10.1111/j.1742-4658.2007.06231.x; Chung JS, 1999, P NATL ACAD SCI USA, V96, P13103, DOI 10.1073/pnas.96.23.13103; Cooke I.M., 1982, BIOL CRUSTACEA VOL 3, P206; DeKleijn DPV, 1995, COMP BIOCHEM PHYS B, V112, P573, DOI 10.1016/0305-0491(95)00126-3; Dircksen H, 2001, BIOCHEM J, V356, P159, DOI 10.1042/0264-6021:3560159; DRACH P, 1967, VIE MILIEU A BIOL MA, V18, P595; Hsiao NW, 2003, BIOCHEMISTRY-US, V42, P11183, DOI 10.1021/bi034678d; Katayama H, 2002, PEPTIDES, V23, P1537, DOI 10.1016/S0196-9781(02)00094-3; Katayama H, 2004, BIOCHEMISTRY-US, V43, P9629, DOI 10.1021/bi049433v; Katayama H, 2003, J BIOL CHEM, V278, P9620, DOI 10.1074/jbc.M212962200; KEGEL G, 1991, PEPTIDES, V12, P909, DOI 10.1016/0196-9781(91)90036-O; KELLER R, 1992, EXPERIENTIA, V48, P439, DOI 10.1007/BF01928162; Khayat M, 1998, GEN COMP ENDOCR, V110, P307, DOI 10.1006/gcen.1998.7078; Kung PC, 2013, GEN COMP ENDOCR, V186, P80, DOI 10.1016/j.ygcen.2013.03.010; Lacombe C, 1999, NEUROPEPTIDES, V33, P71, DOI 10.1054/npep.1999.0016; Lebaupain F, 2012, PEPTIDES, V34, P65, DOI 10.1016/j.peptides.2012.01.019; Lee CY, 2014, J MAR SCI TECH-TAIW, V22, P75, DOI 10.6119/JMST-013-0308-1; Lorenzon S, 2004, J EXP BIOL, V207, P4205, DOI 10.1242/jeb.01264; Marco HG, 2000, PEPTIDES, V21, P19, DOI 10.1016/S0196-9781(99)00171-0; McCowan C, 2014, GENE, V536, P366, DOI 10.1016/j.gene.2013.11.054; Meredith J, 1996, J EXP BIOL, V199, P1053; Mettulio R, 2004, REGUL PEPTIDES, V119, P189, DOI 10.1016/j.regpep.2004.02.002; Montagne N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-62; Mosco A, 2012, PLOS ONE, V7, P1; Mosco A, 2008, REGUL PEPTIDES, V147, P88, DOI 10.1016/j.regpep.2008.01.005; Mosco A, 2015, J EXP ZOOL PART A, V323, P121, DOI 10.1002/jez.1909; Mosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030052; Nagai C, 2009, ANN NY ACAD SCI, V1163, P478, DOI 10.1111/j.1749-6632.2009.04452.x; Ohira T, 2006, ZOOL SCI, V23, P383, DOI 10.2108/zsj.23.383; Phillips J, 2001, PERSPECTIVE IN COMPARATIVE ENDOCRINOLOGY: UNITY AND DIVERSITY, P745; SANTOS EA, 1993, COMP BIOCHEM PHYS A, V106, P405, DOI 10.1016/0300-9629(93)90234-U; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Serrano L, 2003, J EXP BIOL, V206, P979, DOI 10.1242/jeb.00178; Soyez D, 1998, NEUROSCIENCE, V82, P935; Soyez D, 1997, ANN NY ACAD SCI, V814, P319, DOI 10.1111/j.1749-6632.1997.tb46174.x; SOYEZ D, 1994, J BIOL CHEM, V269, P18295; Spanings-Pierrot C, 2000, GEN COMP ENDOCR, V119, P340, DOI 10.1006/gcen.2000.7527; Toullec JY, 2006, PEPTIDES, V27, P1269, DOI 10.1016/j.peptides.2005.12.001; Tsai KW, 2008, GEN COMP ENDOCR, V159, P16, DOI 10.1016/j.ygcen.2008.07.014; Wang YJ, 2000, ARCH INSECT BIOCHEM, V45, P129, DOI 10.1002/1520-6327(200011)45:3&lt;129::AID-ARCH4&gt;3.0.CO;2-L; Wanlem S, 2011, FISH SHELLFISH IMMUN, V30, P877, DOI 10.1016/j.fsi.2011.01.014; Webster SG, 1996, J EXP BIOL, V199, P1579; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Wu HJ, 2012, ZOOL STUD, V51, P288; Wu SH, 2012, COMP BIOCHEM PHYS A, V161, P463, DOI 10.1016/j.cbpa.2012.01.007; Yang WJ, 1997, PEPTIDES, V18, P479, DOI 10.1016/S0196-9781(96)00332-4; YASUDA A, 1994, GEN COMP ENDOCR, V95, P387, DOI 10.1006/gcen.1994.1138; Zhao Y, 2005, ARCH INSECT BIOCHEM, V58, P27, DOI 10.1002/arch.20028; Zou HS, 2003, J EXP ZOOL PART A, V298A, P44, DOI 10.1002/jez.a.10273	60	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134983	10.1371/journal.pone.0134983	http://dx.doi.org/10.1371/journal.pone.0134983			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26261986	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300047
J	Wolff, G; Truse, R; Decking, U				Wolff, Georg; Truse, Richard; Decking, Ulrich			Extracellular Adenosine Formation by Ecto-5 '-Nucleotidase (CD73) Is No Essential Trigger for Early Phase Ischemic Preconditioning	PLOS ONE			English	Article							NONSPECIFIC ALKALINE-PHOSPHATASE; ACUTE MYOCARDIAL-INFARCTION; STUNNED MYOCARDIUM; REPERFUSION INJURY; RECEPTORS; HEART; PROTECTS; SIZE; CARDIOPROTECTION; METABOLISM	Background Adenosine is a powerful trigger for ischemic preconditioning (IPC). Myocardial ischemia induces intracellular and extracellular ATP degradation to adenosine, which then activates adenosine receptors and elicits cardioprotection. Conventionally extracellular adenosine formation by ecto-5'-nucleotidase (CD73) during ischemia was thought to be negligible compared to the massive intracellular production, but controversial reports in the past demand further evaluation. In this study we evaluated the relevance of ecto-5'-nucleotidase (CD73) for infarct size reduction by ischemic preconditioning in in vitro and in vivo mouse models of myocardial infarction, comparing CD73(-/-) and wild type (WT) mice. Methods and Results 3x5 minutes of IPC induced equal cardioprotection in isolated saline perfused hearts of wild type (WT) and CD73(-/-) mice, reducing control infarct sizes after 20 minutes of ischemia and 90 minutes of reperfusion from 46 +/- 6.3% (WT) and 56.1 +/- 7.6% (CD73(-/-)) to 26.8 +/- 4.7% (WT) and 25.6 +/- 4.7% (CD73(-/-)). Coronary venous adenosine levels measured after IPC stimuli by high-pressure liquid chromatography showed no differences between WT and CD73(-/-) hearts. Pharmacological preconditioning of WT hearts with adenosine, given at the measured venous concentration, was evenly cardioprotective as conventional IPC. In vivo, 4x5 minutes of IPC reduced control infarct sizes of 45.3 +/- 8.9% (WT) and 40.5 +/- 8% (CD73(-/-)) to 26.3 +/- 8% (WT) and 22.6 +/- 6.6% (CD73(-/-)) respectively, eliciting again equal cardioprotection. The extent of IPC-induced cardioprotection in male and female mice was identical. Conclusion The infarct size limiting effects of IPC in the mouse heart in vitro and in vivo are not significantly affected by genetic inactivation of CD73. The ecto-5'-nucleotidase derived extracellular formation of adenosine does not contribute substantially to adenosine's well known cardioprotective effect in early phase ischemic preconditioning.	[Wolff, Georg; Truse, Richard; Decking, Ulrich] Univ Dusseldorf, Dept Cardiovasc Physiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Wolff, G (corresponding author), Univ Hosp Dusseldorf, Dept Cardiol Pneumol & Angiol, Dusseldorf, Germany.	georg.wolff@uni-duesseldorf.de	Wolff, Georg/J-8597-2019	Wolff, Georg/0000-0002-1734-6177; Truse, Richard/0000-0001-6650-5800				Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; Bonner F, 2013, CIRC RES, V113, P301, DOI 10.1161/CIRCRESAHA.113.300180; BORST MM, 1991, CIRC RES, V68, P797, DOI 10.1161/01.RES.68.3.797; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; BRAUNWALD E, 1982, CIRCULATION, V66, P1146, DOI 10.1161/01.CIR.66.6.1146; Buehler PW, 2004, ANTIOXID REDOX SIGN, V6, P1000, DOI 10.1089/ars.2004.6.1000; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Cohen MV, 2008, BASIC RES CARDIOL, V103, P203, DOI 10.1007/s00395-007-0687-7; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Decking UKM, 1997, CIRC RES, V81, P154, DOI 10.1161/01.RES.81.2.154; Deussen A, 1999, CIRCULATION, V99, P2041, DOI 10.1161/01.CIR.99.15.2041; Downey JM, 2009, CIRC J, V73, P1171, DOI 10.1253/circj.CJ-09-0338; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Flaherty MP, 2007, CARDIOVASC TOXICOL, V7, P165, DOI 10.1007/s12012-007-0028-y; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gelpi RJ, 2002, BASIC RES CARDIOL, V97, P40, DOI 10.1007/s395-002-8386-0; GOTO M, 1995, CIRC RES, V77, P611, DOI 10.1161/01.RES.77.3.611; Hasegawa T, 2008, CIRC RES, V103, P1410, DOI 10.1161/CIRCRESAHA.108.180059; HEADRICK JP, 1992, J MOL CELL CARDIOL, V24, P295, DOI 10.1016/0022-2828(92)93166-H; Huang DY, 2006, AM J PHYSIOL-RENAL, V291, pF282, DOI 10.1152/ajprenal.00113.2005; Jackson EK, 2014, AM J PHYSIOL-RENAL, V307, pF680, DOI 10.1152/ajprenal.00312.2014; Jagger JE, 2001, AM J PHYSIOL-HEART C, V280, pH2833, DOI 10.1152/ajpheart.2001.280.6.H2833; JENKINS DP, 1995, J MOL CELL CARDIOL, V27, P1623, DOI 10.1016/S0022-2828(95)90590-1; KITAKAZE M, 1994, CIRCULATION, V89, P1237, DOI 10.1161/01.CIR.89.3.1237; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; KUSUOKA H, 1987, J CLIN INVEST, V79, P950, DOI 10.1172/JCI112906; Lennon PF, 1998, J EXP MED, V188, P1433, DOI 10.1084/jem.188.8.1433; Li W, 2004, J MOL CELL CARDIOL, V37, P671, DOI 10.1016/j.yjmcc.2004.05.005; Methner C, 2011, J MOL CELL CARDIOL, V50, P582, DOI 10.1016/j.yjmcc.2010.10.031; Methner C, 2010, AM J PHYSIOL-HEART C, V299, pH1262, DOI 10.1152/ajpheart.00181.2010; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Miki T, 1998, AM J PHYSIOL-HEART C, V275, pH1329, DOI 10.1152/ajpheart.1998.275.4.H1329; Miki T, 1998, MOL CELL BIOCHEM, V186, P3, DOI 10.1023/A:1006856124501; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Napoli C, 1998, EUR HEART J, V19, P411, DOI 10.1053/euhj.1997.0748; Newby AC, 1987, TOPICS PERSPECTIVES, P155; Ozuyaman B, 2006, PFLUG ARCH EUR J PHY, V452, P324, DOI 10.1007/s00424-006-0045-x; Peart J, 2003, CARDIOVASC RES, V58, P589, DOI 10.1016/S0008-6363(03)00259-1; Picher M, 2003, J BIOL CHEM, V278, P13468, DOI 10.1074/jbc.M300569200; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Romio M, 2011, AM J PHYSIOL-CELL PH, V301, pC530, DOI 10.1152/ajpcell.00385.2010; SANDHU R, 1993, CARDIOVASC RES, V27, P602, DOI 10.1093/cvr/27.4.602; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schmidt K, 2010, EUR HEART J, V31, P1655, DOI 10.1093/eurheartj/ehp555; Schrader J, 1998, MOL B INT U, P39; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; SCHULTZ JEJ, 1995, AM J PHYSIOL-HEART C, V268, pH2157, DOI 10.1152/ajpheart.1995.268.5.H2157; Schulz R, 1998, CIRCULATION, V98, P1022, DOI 10.1161/01.CIR.98.10.1022; SCHUTZ W, 1981, AM J PHYSIOL, V240, pH963, DOI 10.1152/ajpheart.1981.240.6.H963; Solenkova NV, 2006, AM J PHYSIOL-HEART C, V290, pH441, DOI 10.1152/ajpheart.00589.2005; Song X, 2003, ACTA PHYSIOL SCAND, V177, P459, DOI 10.1046/j.1365-201X.2003.01068.x; Strohmeier GR, 1997, J CLIN INVEST, V99, P2588, DOI 10.1172/JCI119447; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Turcato S, 2006, BASIC RES CARDIOL, V101, P235, DOI 10.1007/s00395-006-0585-4; Vessey DA, 2011, AM J PHYSIOL-HEART C, V301, pH881, DOI 10.1152/ajpheart.00305.2011; WALL TM, 1994, J PHARMACOL EXP THER, V270, P681; Xi L, 1998, MOL CELL BIOCHEM, V186, P69, DOI 10.1023/A:1006811128561; Yang XL, 2010, CARDIOVASC DRUG THER, V24, P225, DOI 10.1007/s10557-010-6236-x; Zernecke A, 2006, CIRCULATION, V113, P2120, DOI 10.1161/CIRCULATIONAHA.105.595249; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	65	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135086	10.1371/journal.pone.0135086	http://dx.doi.org/10.1371/journal.pone.0135086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26261991	Green Submitted, gold, Green Published			2022-12-27	WOS:000359353300055
J	Yegneswaran, S; Banerjee, Y; Fernandez, JA; Deguchi, H; Griffin, JH				Yegneswaran, Subramanian; Banerjee, Yajnavalka; Fernandez, Jose A.; Deguchi, Hiroshi; Griffin, John H.			Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex	PLOS ONE			English	Article							FACTOR-VA; BLOOD-COAGULATION; FACTOR-XII; SPHINGOSINE 1-PHOSPHATE; MEMBRANE-COMPOSITION; PROCOAGULANT LIPIDS; CATALYTIC-ACTIVITY; PROTEIN-C; ACTIVATION; PHOSPHATIDYLSERINE	Blood coagulation reactions are strongly influenced by phospholipids, but little is known about the influence of sphingolipids on coagulation mechanisms. Lysosulfatide (lyso-SF) (sulfogalactosyl sphingosine) prolonged factor Xa (fXa) 1-stage plasma clotting assays, showing it had robust anticoagulant activity. In studies using purified clotting factors, lyso-SF inhibited >90% of prothrombin (II) activation for reaction mixtures containing fXa/factor Va (fVa)/II, and also inhibited II activation generation by fXa/phospholipids and by Gla-domainless-fXa/fVa/phospholipids. When lyso-SF analogs were tested, results showed that N-acetyl-sulfatide was not anticoagulant, implying that the free amine group was essential for the anticoagulant effects of lyso-SF. Lyso-SF did not inhibit fXa enzymatic hydrolysis of small peptide substrates, showing it did not directly inhibit the fXa activity. In surface plasmon resonance studies, lyso-SF bound to immobilized inactivated fXa as well as inactivated Gla-domainless-fXa. Confirming this lyso-SF: fXa interaction, fluorescence studies showed that fluorescently-labeled-fXa in solution bound to lyso-SF. Thus, lyso-SF is an anticoagulant lipid that inhibits fXa when this enzyme is bound to either phospholipids or to fVa. Mechanisms for inhibition of procoagulant activity are likely to involve lyso-SF binding to fXa domain(s) that are distinct from the fXa Gla domain. This suggests that certain sphingolipids, including lyso-SF and some of its analogs, may down-regulate fXa activity without inhibiting the enzyme's active site or binding to the fXa Gla domain.	[Yegneswaran, Subramanian; Banerjee, Yajnavalka; Fernandez, Jose A.; Deguchi, Hiroshi; Griffin, John H.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Griffin, JH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jgriffin@scripps.edu	Banerjee, Yajnavalka/J-5890-2019; Fernandez, Jose A/A-3211-2008	Banerjee, Yajnavalka/0000-0002-7546-8893; Fernandez, Jose A/0000-0002-0804-1865; Deguchi, Hiroshi/0000-0002-7721-1207; Griffin, John/0000-0002-4302-2547	NIH [RO1 HL021544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021544] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH RO1 HL021544 (J.H.G.).	Banerjee M, 2002, BIOCHEMISTRY-US, V41, P7751, DOI 10.1021/bi020017p; Banerjee M, 2002, BIOCHEMISTRY-US, V41, P950, DOI 10.1021/bi0116902; Becattini Cecilia, 2012, Curr Drug Discov Technol, V9, P119; Blomqvist M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-28; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Charlton B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4681; Deguchi H, 2004, J BIOL CHEM, V279, P12036, DOI 10.1074/jbc.M302531200; Deguchi H, 2001, BLOOD, V97, P1907, DOI 10.1182/blood.V97.7.1907; DELL VA, 1990, BIOCHEMISTRY-US, V29, P1757, DOI 10.1021/bi00459a014; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GERADS I, 1990, BIOCHEMISTRY-US, V29, P7967, DOI 10.1021/bi00486a027; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Hans M, 2009, NEUROCHEM RES, V34, P508, DOI 10.1007/s11064-008-9813-7; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; Koppaka V, 1996, BIOCHEMISTRY-US, V35, P7482, DOI 10.1021/bi952063d; KRISHNASWAMY S, 1993, METHOD ENZYMOL, V222, P260; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Levigne S, 2007, J BIOL CHEM, V282, P31569, DOI 10.1074/jbc.M704837200; Li SC, 1986, ENZYMES LIPID METABO, P307; Majumder R, 2005, BIOCHEMISTRY-US, V44, P16998, DOI 10.1021/bi051469f; Majumder R, 2011, J BIOL CHEM, V286, P35535, DOI 10.1074/jbc.M111.260141; MANN KG, 1990, BLOOD, V76, P1; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mirzaian M, 2015, J LIPID RES, V56, P936, DOI 10.1194/jlr.M057232; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; Nofer JR, 2001, J BIOL CHEM, V276, P34480, DOI 10.1074/jbc.M103782200; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Nofer JR, 2003, BIOCHEM BIOPH RES CO, V310, P98, DOI 10.1016/j.bbrc.2003.08.126; Nofer JR, 2000, BIOCHEMISTRY-US, V39, P15199, DOI 10.1021/bi001162a; Prandoni P, 2014, NAT REV CARDIOL, V11, P70, DOI 10.1038/nrcardio.2013.210; Qureshi SH, 2007, BIOCHEM J, V407, P427, DOI 10.1042/BJ20070735; Qureshi SH, 2009, BIOCHEMISTRY-US, V48, P5034, DOI 10.1021/bi900240g; Rauch BH, 2014, CELL PHYSIOL BIOCHEM, V34, P185, DOI 10.1159/000362994; Rezaie AR, 2004, J BIOL CHEM, V279, P48262, DOI 10.1074/jbc.M409964200; ROSING J, 1986, J BIOL CHEM, V261, P4224; ROSING J, 1980, J BIOL CHEM, V255, P274; SHIMADA T, 1985, J BIOCHEM-TOKYO, V97, P1637, DOI 10.1093/oxfordjournals.jbchem.a135221; Smirnov MD, 1999, BIOCHEMISTRY-US, V38, P3591, DOI 10.1021/bi982538b; Srivasatava KR, 2014, BIOCHEM J, V459, P229, DOI 10.1042/BJ20131099; Srivastava A, 2002, J BIOL CHEM, V277, P1855, DOI 10.1074/jbc.M105697200; TANS G, 1982, BLOOD, V59, P69; TANS G, 1983, J BIOL CHEM, V258, P8215; Tavoosi N, 2014, THROMB HAEMOSTASIS, V111, P770, DOI 10.1160/TH13-07-0628; Tavoosi N, 2013, BIOCHEMISTRY-US, V52, P5545, DOI 10.1021/bi4006368; TODA K, 1990, J NEUROCHEM, V55, P1585, DOI 10.1111/j.1471-4159.1990.tb04942.x; Toso R, 2008, J BIOL CHEM, V283, P18627, DOI 10.1074/jbc.M802205200; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Wu JR, 2002, BIOCHEMISTRY-US, V41, P935, DOI 10.1021/bi0116893; Yegneswaran S, 2002, CHEM BIOL, V9, P485, DOI 10.1016/S1074-5521(02)00132-1; Yegneswaran S, 2004, J BIOL CHEM, V279, P49019, DOI 10.1074/jbc.M406645200; Young MM, 2013, J LIPID RES, V54, P5, DOI 10.1194/jlr.R031278	53	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135025	10.1371/journal.pone.0135025	http://dx.doi.org/10.1371/journal.pone.0135025			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263376	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300052
J	Hirashima, T; Adachi, T				Hirashima, Tsuyoshi; Adachi, Taiji			Procedures for the Quantification of Whole-Tissue Immunofluorescence Images Obtained at Single-Cell Resolution during Murine Tubular Organ Development	PLOS ONE			English	Article							MORPHOGENESIS; EXPRESSION	Whole-tissue quantification at single-cell resolution has become an inevitable approach for further quantitative understanding of morphogenesis in organ development. The feasibility of the approach has been dramatically increased by recent technological improvements in optical tissue clearing and microscopy. However, the series of procedures required for this approach to lead to successful whole-tissue quantification is far from developed. To provide the appropriate procedure, we here show tips for each critical step of the entire process, including fixation for immunofluorescence, optical clearing, and digital image processing, using developing murine internal organs such as epididymis, kidney, and lung as an example. Through comparison of fixative solutions and of clearing methods, we found optimal conditions to achieve clearer deep-tissue imaging of specific immunolabeled targets and explain what methods result in vivid volume imaging. In addition, we demonstrated that three-dimensional digital image processing after optical clearing produces objective quantitative data for the whole-tissue analysis, focusing on the spatial distribution of mitotic cells in the epididymal tubule. The procedure for the whole-tissue quantification shown in this article should contribute to systematic measurements of cellular processes in developing organs, accelerating the further understanding of morphogenesis at the single cell level.	[Hirashima, Tsuyoshi; Adachi, Taiji] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan	Kyoto University	Hirashima, T (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan.	hirashima@frontier.kyoto-u.ac.jp	Adachi, Taiji/P-8981-2016	Adachi, Taiji/0000-0001-5280-4156; Hirashima, Tsuyoshi/0000-0001-7323-9627	Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Agency for Medical Research and Development (AMED); Grant for Basic Science Research Projects from Sumitomo Foundation	Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grant for Basic Science Research Projects from Sumitomo Foundation	The work was supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, the Japan Agency for Medical Research and Development (AMED), and by a Grant for Basic Science Research Projects from the Sumitomo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Cho EA, 1998, DEVELOPMENT, V125, P803; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; DENT JA, 1989, DEVELOPMENT, V105, P61; Gonzalez R.C., 2007, DIGITAL IMAGE PROCES, V607, DOI [10.1007/3-540-27563-0, DOI 10.1007/3-540-27563-0]; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hayashi K, 1999, J CELL SCI, V112, P1149; Hirashima T, 2014, CELL REP, V9, P866, DOI 10.1016/j.celrep.2014.09.041; Jackson M, 2010, METHOD MOL BIOL, V633, P29; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Keller PJ, 2013, SCIENCE, V340, P1184, DOI 10.1126/science.1234168; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Lin CY, 2012, MICROSC MICROANAL, V18, P493, DOI 10.1017/S1431927612000141; Long FH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002519; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Michael L, 2005, KIDNEY INT, V68, P2010, DOI 10.1111/j.1523-1755.2005.00655.x; Packard A, 2013, DEV CELL, V27, P319, DOI 10.1016/j.devcel.2013.09.001; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rosenberg P, 1997, DEV BIOL, V187, P55, DOI 10.1006/dbio.1997.8602; Shindo A, 2014, SCIENCE, V343, P649, DOI 10.1126/science.1243126; Short K, 2013, DEVELOPMENT, V140, P471, DOI 10.1242/dev.088500; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Yokomizo T, 2012, NAT PROTOC, V7, P421, DOI 10.1038/nprot.2011.441	31	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135343	10.1371/journal.pone.0135343	http://dx.doi.org/10.1371/journal.pone.0135343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258587	Green Submitted, Green Published, gold			2022-12-27	WOS:000359352600060
J	Sun, Y; Jiang, CQ; Cheng, KK; Zhang, WS; Leung, GM; Lam, TH; Schooling, CM				Sun, Yangbo; Jiang, Chao Qiang; Cheng, Kar Keung; Zhang, Wei Sen; Leung, Gabriel M.; Lam, Tai Hing; Schooling, C. Mary			Fruit and Vegetable Consumption and Cardiovascular Risk Factors in Older Chinese: The Guangzhou Biobank Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; TYPE-2 DIABETES-MELLITUS; BLOOD-PRESSURE; MEDITERRANEAN DIET; VITAMIN-D; HEALTH; METAANALYSIS; STROKE; CHOLESTEROL; PATTERNS	Objective To examine the adjusted associations of fruit consumption and vegetable consumption with the Framingham score and its components in the non-Western setting of Southern China, considering health status. Method Linear regression was used to assess the cross-sectional associations of fruit and vegetable consumption with the Framingham score and its components, among 19,518 older Chinese (>= 50 years) from the Guangzhou Biobank Cohort Study in Southern China (20032006), and whether these differed by health status. Results The association of fruit consumption with the Framingham score varied by health status (P-value<0.001), but not vegetable consumption (P-value 0.51). Fruit consumption was associated with a lower Framingham score (-0.04 per portions/day, 95% confidence interval (CI) -0.08 to -0.004) among participants in poor health, adjusted for age, sex, recruitment phase, socio-economic position and lifestyle. However, similarly adjusted, fruit consumption was associated with a higher Framingham score (0.05, 95% CI 0.02 to 0.09) among participants in good health, perhaps due to a positive association of fruit consumption with fasting glucose. Similarly adjusted, vegetable consumption was associated with a higher Framingham score (0.03, 95% CI 0.01 to 0.05) among all participants, with no difference by health status. Conclusion This large study from a non-western setting found that fruit and vegetable consumption was barely associated with the Framingham score, or major CVD risk factors.	[Sun, Yangbo; Leung, Gabriel M.; Lam, Tai Hing; Schooling, C. Mary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Jiang, Chao Qiang; Zhang, Wei Sen] Guangzhou 12 Hosp, Guangzhou, Guangdong, Peoples R China; [Cheng, Kar Keung] Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham, W Midlands, England; [Schooling, C. Mary] CUNY, Sch Publ Hlth, New York, NY 10021 USA	University of Hong Kong; University of Birmingham; City University of New York (CUNY) System	Lam, TH (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hkucc.hku.hk	Cheng, Kar/AAL-8899-2021; Lam, Tai Hing/C-4317-2009	Cheng, Kar/0000-0002-1516-1857; Leung, Gabriel/0000-0002-2503-6283; Schooling, Mary/0000-0001-9933-5887; Lam, Tai Hing/0000-0002-2033-9971	University of Hong Kong Foundation for Development and Research; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Bureau, Guangzhou, China; University of Birmingham, UK	University of Hong Kong Foundation for Development and Research; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Bureau, Guangzhou, China; University of Birmingham, UK	This work was supported by The University of Hong Kong Foundation for Development and Research, and the University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Bureau, Guangzhou, China; and The University of Birmingham, UK. The funding sources had no role in any of the following: study design; the collection, analysis, and interpretation of data; the writing of the report; and the decision to submit the paper for publication.	Agudo A, 1999, PUBLIC HEALTH NUTR, V2, P263, DOI 10.1017/S136898009900035X; [Anonymous], 2007, DIET GUID CHIN RES 2; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Azagba S, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-118; Bazzano LA, 2002, AM J CLIN NUTR, V76, P93; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Brion MJA, 2011, INT J EPIDEMIOL, V40, P670, DOI 10.1093/ije/dyr020; Broekmans WMR, 2001, EUR J CLIN NUTR, V55, P636, DOI 10.1038/sj.ejcn.1601192; Carter Patrice, 2010, BMJ, V341, pc4229, DOI 10.1136/bmj.c4229; Chandalia M, 2000, NEW ENGL J MED, V342, P1392, DOI 10.1056/NEJM200005113421903; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Elhayany A, 2010, DIABETES OBES METAB, V12, P204, DOI 10.1111/j.1463-1326.2009.01151.x; Elwell-Sutton T, 2011, J EPIDEMIOL COMMUN H, V65, pA331, DOI 10.1136/jech.2011.142976l.25; Goff Jr DC, 2013, J AM COLL CARDIOL, V63, P2935, DOI DOI 10.1016/J.JACC.2013.11.005; Hajifathalian K, 2015, LANCET DIABETES ENDO, V3, P339, DOI 10.1016/S2213-8587(15)00081-9; Hartley L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009874.pub2; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; Heraclides A, 2012, EUR J NUTR, V51, P583, DOI 10.1007/s00394-011-0242-z; Hsu-Hage B H, 1992, Asia Pac J Clin Nutr, V1, P211; Ioannidis JPA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6698; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; Leppala JM, 1999, STROKE, V30, P2535, DOI 10.1161/01.STR.30.12.2535; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Macready AL, 2014, AM J CLIN NUTR, V99, P479, DOI 10.3945/ajcn.113.074237; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; National Bureau of Statistics of China, 2013, AV PRIC FOOD 50 CIT; Okada S, 2012, J DIABETES INVEST, V3, P36, DOI 10.1111/j.2040-1124.2011.00161.x; Paterson E, 2006, J NUTR, V136, P2849, DOI 10.1093/jn/136.11.2849; Riboli E, 2003, AM J CLIN NUTR, V78, p559S, DOI 10.1093/ajcn/78.3.559S; Rickman JC, 2007, J SCI FOOD AGR, V87, P1185, DOI 10.1002/jsfa.2824; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2006, ARCH INTERN MED, V166, P1498, DOI 10.1001/archinte.166.14.1498; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Svetkey LP, 1999, ARCH INTERN MED, V159, P285, DOI 10.1001/archinte.159.3.285; Takachi R, 2010, AM J CLIN NUTR, V91, P456, DOI 10.3945/ajcn.2009.28587; Van Duyn MS, 2000, J AM DIET ASSOC, V100, P1511, DOI 10.1016/S0002-8223(00)00420-X; Wallace IR, 2012, IRISH J MED SCI, V181, pS345; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yu D, 2013, BR J NUTR, V19, P1; Zhang Ji-Guo, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P310; Zhang YH, 2013, J NUTR, V143, P1391, DOI 10.3945/jn.113.175323	44	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135380	10.1371/journal.pone.0135380	http://dx.doi.org/10.1371/journal.pone.0135380			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258947	Green Published, gold			2022-12-27	WOS:000359352600063
J	Lamarche, J; Potvin, A; Pelletier, G; Stewart, D; Feau, N; Alayon, DIO; Dale, AL; Coelho, A; Uzunovic, A; Bilodeau, GJ; Briere, SC; Hamelin, RC; Tanguay, P				Lamarche, Josyanne; Potvin, Amelie; Pelletier, Gervais; Stewart, Don; Feau, Nicolas; Alayon, Dario I. O.; Dale, Angela L.; Coelho, Aaron; Uzunovic, Adnan; Bilodeau, Guillaume J.; Briere, Stephan C.; Hamelin, Richard C.; Tanguay, Philippe			Molecular Detection of 10 of the Most Unwanted Alien Forest Pathogens in Canada Using Real-Time PCR	PLOS ONE			English	Article							PHYTOPHTHORA-RAMORUM; QUANTITATIVE PCR; FUSARIUM-CIRCINATUM; DNA EXTRACTION; CAUSAL AGENT; ROSELLINIA-NECATRIX; PITCH CANKER; PRIMER SETS; SP-NOV.; ASSAY	Invasive alien tree pathogens can cause significant economic losses as well as large-scale damage to natural ecosystems. Early detection to prevent their establishment and spread is an important approach used by several national plant protection organizations (NPPOs). Molecular detection tools targeting 10 of the most unwanted alien forest pathogens in Canada were developed as part of the TAIGA project (http://taigaforesthealth.com/). Forest pathogens were selected following an independent prioritization. Specific TaqMan real-time PCR detection assays were designed to function under homogeneous conditions so that they may be used in 96- or 384-well plate format arrays for high-throughput testing of large numbers of samples against multiple targets. Assays were validated for 1) specificity, 2) sensitivity, 3) precision, and 4) robustness on environmental samples. All assays were highly specific when evaluated against a panel of pure cultures of target and phylogenetically closely-related species. Sensitivity, evaluated by assessing the limit of detection (with a threshold of 95% of positive samples), was found to be between one and ten target gene region copies. Precision or repeatability of each assay revealed a mean coefficient of variation of 3.4%. All assays successfully allowed detection of target pathogen on positive environmental samples, without any non-specific amplification. These molecular detection tools will allow for rapid and reliable detection of 10 of the most unwanted alien forest pathogens in Canada.	[Lamarche, Josyanne; Potvin, Amelie; Pelletier, Gervais; Stewart, Don; Hamelin, Richard C.; Tanguay, Philippe] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ, Canada; [Feau, Nicolas; Alayon, Dario I. O.; Dale, Angela L.; Hamelin, Richard C.] Univ British Columbia, Fac Forestry, Dept Forest & Conservat Sci, Vancouver, BC V6T 1W5, Canada; [Dale, Angela L.; Coelho, Aaron; Uzunovic, Adnan] FPInnovations, Vancouver, BC, Canada; [Bilodeau, Guillaume J.] Canadian Food Inspect Agcy, PIRL, Ottawa, ON, Canada; [Briere, Stephan C.] Canadian Food Inspect Agcy, PPL, Ottawa, ON, Canada	Natural Resources Canada; Canadian Forest Service; University of British Columbia; Canadian Food Inspection Agency; Canadian Food Inspection Agency	Lamarche, J (corresponding author), Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ, Canada.	Josyanne.Lamarche@RNCan-NRCan.gc.ca	Alayon, Dario Isidro Ojeda/I-2520-2013; Bilodeau, Guillaume/AAH-3625-2019; Hamelin, Richard/F-7006-2010	Alayon, Dario Isidro Ojeda/0000-0001-8181-4804; Bilodeau, Guillaume/0000-0003-1766-229X; Potvin, Amelie/0000-0002-9558-5886; Hamelin, Richard/0000-0003-4006-532X	Genome Canada; Genome British Columbia (Large-Scale Applied Research Program) [164]; Genomics Research and Development Initiative (GRDI) of Natural Resources Canada; FPInnovations; Canadian Food and Inspection Agency (CFIA)	Genome Canada(Genome Canada); Genome British Columbia (Large-Scale Applied Research Program); Genomics Research and Development Initiative (GRDI) of Natural Resources Canada(Natural Resources Canada); FPInnovations(German Research Foundation (DFG)); Canadian Food and Inspection Agency (CFIA)	This work was supported by grants from Genome Canada and Genome British Columbia (Large-Scale Applied Research Program, Grant #164) as well as by the Genomics Research and Development Initiative (GRDI) of Natural Resources Canada, FPInnovations and its government and industry members, and the Canadian Food and Inspection Agency (CFIA).	Andrew M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029943; Belbahri L, 2007, FOREST PATHOL, V37, P403, DOI 10.1111/j.1439-0329.2007.00517.x; Berdal KG, 2001, EUR FOOD RES TECHNOL, V213, P432, DOI 10.1007/s002170100403; Bilodeau GJ, 2007, PHYTOPATHOLOGY, V97, P632, DOI 10.1094/PHYTO-97-5-0632; Bilodeau G, 2009, CAN J PLANT PATHOL, V31, P195, DOI 10.1080/07060660909507593; Bilodeau GJ, 2014, PHYTOPATHOLOGY, V104, P733, DOI 10.1094/PHYTO-09-13-0263-R; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Borja I, 2006, PHYTOPATHOLOGY, V96, P1305, DOI 10.1094/PHYTO-96-1305; Brasier CM, 2005, MYCOL RES, V109, P853, DOI 10.1017/S0953756205003357; Busby PE, 2012, THESIS STANDFORD U S; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calderon-Cortes N, 2010, INT J MOL SCI, V11, P5057, DOI 10.3390/ijms11125056; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Chandelier A., 2006, Bulletin OEPP, V36, P409; Charlton S, 2000, PCR VALIDATION PERFO; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; DEMEKE T, 1992, BIOTECHNIQUES, V12, P332; Desprez-Loustau Marie-Laure, 2009, V3, P15; Dreaden TJ, 2012, FOREST PATHOL, V42, P405, DOI 10.1111/j.1439-0329.2012.00774.x; Ederveen J, 2010, PROGRESS REPORT NO 0; Ellison SLR, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-33; Gallup JM, 2011, PCR TROUBLESHOOTING AND OPTIMIZATION: THE ESSENTIAL GUIDE, P23; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamelin RC, 1998, PHYTOPATHOLOGY, V88, P582, DOI 10.1094/PHYTO.1998.88.6.582; Hantula J, 2000, MYCOL RES, V104, P1062, DOI 10.1017/S0953756200002999; Harrington TC, 2009, GENUS CERATOCYSTIS D; Hawksworth DL, 1997, PHYTOPATHOLOGY, V87, P888, DOI 10.1094/PHYTO.1997.87.9.888; Hayden KJ, 2004, PHYTOPATHOLOGY, V94, P1075, DOI 10.1094/PHYTO.2004.94.10.1075; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Holden MJ, 2003, J AGR FOOD CHEM, V51, P2468, DOI 10.1021/jf0211130; Hubner P, 2001, J AOAC INT, V84, P1855; Hughes KJD, 2006, PHYTOPATHOLOGY, V96, P975, DOI 10.1094/PHYTO-96-0975; Hughes KJD, 2011, EUR J PLANT PATHOL, V131, P695, DOI 10.1007/s10658-011-9843-x; Ibrahim MS, 2003, J CLIN MICROBIOL, V41, P3835, DOI 10.1128/JCM.41.8.3835-3839.2003; Ioos R, 2009, PHYTOPATHOLOGY, V99, P582, DOI 10.1094/PHYTO-99-5-0582; Ippolito A, 2004, EUR J PLANT PATHOL, V110, P833, DOI 10.1007/s10658-004-5571-9; Jacobs K, 2004, MYCOL RES, V108, P411, DOI 10.1017/S0953756204009748; Juen A, 2006, SOIL BIOL BIOCHEM, V38, P1872, DOI 10.1016/j.soilbio.2005.11.034; Kolarik M, 2011, MYCOLOGIA, V103, P325, DOI 10.3852/10-124; Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004; Lamarche J, 2014, CAN J FOREST RES, V44, P1103, DOI 10.1139/cjfr-2014-0082; Lopez-Fabuel I, 2013, J VIROL METHODS, V188, P21, DOI 10.1016/j.jviromet.2012.11.034; Loppnau PA, 2003, FEMS MICROBIOL LETT, V222, P143, DOI 10.1016/S0378-1097(03)00256-8; Margam VM, 2010, MOL BIOL REP, V37, P3631, DOI 10.1007/s11033-010-0014-5; Marin M, 2005, MYCOL RES, V109, P1137, DOI 10.1017/S095375620500362X; Mbofung GY, 2007, PHYTOPATHOLOGY, V97, P87, DOI 10.1094/PHYTO-97-0087; McDowell DG, 1998, NUCLEIC ACIDS RES, V26, P3340, DOI 10.1093/nar/26.14.3340; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Nielsen CR, 2004, EUR FOOD RES TECHNOL, V219, P421, DOI 10.1007/s00217-004-0964-8; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; O'Donnell Kerry, 2000, Mycoscience, V41, P61, DOI 10.1007/BF02464387; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Palacio-Bielsa A, 2011, APPL ENVIRON MICROB, V77, P89, DOI 10.1128/AEM.01593-10; Qu XS, 2011, J APPL MICROBIOL, V110, P769, DOI 10.1111/j.1365-2672.2010.04930.x; Rohn S, 2002, J AGR FOOD CHEM, V50, P3566, DOI 10.1021/jf011714b; Ronning SB, 2003, EUR FOOD RES TECHNOL, V216, P347, DOI 10.1007/s00217-002-0653-4; Rutledge RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017636; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Schena L, 2008, PLANT PATHOL, V57, P64, DOI 10.1111/j.1365-3059.2007.01689.x; Schena L, 2002, EUR J PLANT PATHOL, V108, P355, DOI 10.1023/A:1015697813352; Schena L, 2003, J PLANT PATHOL, V108, P355; Schena L, 2006, MOL PLANT PATHOL, V7, P365, DOI 10.1111/j.1364-3703.2006.00345.x; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schweigkofler W, 2004, APPL ENVIRON MICROB, V70, P3512, DOI 10.1128/AEM.70.6.3512-3520.2004; Shishido M, 2012, J GEN PLANT PATHOL, V78, P115, DOI 10.1007/s10327-012-0366-x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomlinson JA, 2010, PHYTOPATHOLOGY, V100, P143, DOI 10.1094/PHYTO-100-2-0143; Tomlinson JA, 2005, APPL ENVIRON MICROB, V71, P6702, DOI 10.1128/AEM.71.11.6702-6710.2005; Tooley PW, 2006, PHYTOPATHOLOGY, V96, P336, DOI 10.1094/PHYTO-96-0336; Veal C, 2012, BMC GENOMICS, V13, P1; Vettraino AM, 2005, MYCOL RES, V109, P96, DOI 10.1017/S0953756204001583; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Witthuhn RC, 2000, MYCOLOGIA, V92, P447, DOI 10.2307/3761503; Wu CP, 2011, FOREST PATHOL, V41, P15, DOI 10.1111/j.1439-0329.2009.00628.x; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235; ZOLAN ME, 1986, MOL CELL BIOL, V6, P195, DOI 10.1128/MCB.6.1.195	81	35	37	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134265	10.1371/journal.pone.0134265	http://dx.doi.org/10.1371/journal.pone.0134265			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274489	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600024
J	Liu, ZY; Song, XH; Seger, CA				Liu, Zhiya; Song, Xiaohong; Seger, Carol A.			An Eye-Tracking Study of Multiple Feature Value Category Structure Learning: The Role of Unique Features	PLOS ONE			English	Article							SELECTIVE ATTENTION; CLASSIFICATION; CATEGORIZATION; MODELS; SYSTEMS; EYETRACKING; ALLOCATION; COMPLEXITY; INFERENCE; FRUGAL	We examined whether the degree to which a feature is uniquely characteristic of a category can affect categorization above and beyond the typicality of the feature. We developed a multiple feature value category structure with different dimensions within which feature uniqueness and typicality could be manipulated independently. Using eye tracking, we found that the highest attentional weighting (operationalized as number of fixations, mean fixation time, and the first fixation of the trial) was given to a dimension that included a feature that was both unique and highly typical of the category. Dimensions that included features that were highly typical but not unique, or were unique but not highly typical, received less attention. A dimension with neither a unique nor a highly typical feature received least attention. On the basis of these results we hypothesized that subjects categorized via a rule learning procedure in which they performed an ordered evaluation of dimensions, beginning with unique and strongly typical dimensions, and in which earlier dimensions received higher weighting in the decision. This hypothesis accounted for performance on transfer stimuli better than simple implementations of two other common theories of category learning, exemplar models and prototype models, in which all dimensions were evaluated in parallel and received equal weighting.	[Liu, Zhiya; Song, Xiaohong; Seger, Carol A.] S China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Seger, Carol A.] Colorado State Univ, Cognit Psychol Mol Cellular & Integrat Neurosci, Ft Collins, CO 80523 USA	South China Normal University; Colorado State University	Liu, ZY (corresponding author), S China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	zhiyaliu@scnu.edu.cn; seger@lamar.colostate.edu			National Natural Science Foundation of China, China [31371050]; National Institutes of Health, USA [R01 MH079182]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079182] Funding Source: NIH RePORTER	National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Natural Science Foundation of China, China, (31371050); National Institutes of Health, USA, (R01 MH079182).	Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Beach L.R., 1978, ACAD MANAGE REV, V3, P439, DOI [10.5465/AMR.1978.4305717, DOI 10.5465/AMR.1978.4305717]; Bergert FB, 2007, J EXP PSYCHOL LEARN, V33, P107, DOI 10.1037/0278-7393.33.1.107; Blair MR, 2009, J EXP PSYCHOL LEARN, V35, P1196, DOI 10.1037/a0016272; Bruner J., 1967, STUDY THINKING; Chen LH, 2013, ATTEN PERCEPT PSYCHO, V75, P244, DOI [10.3758/s13414-012-0395-8, 10.3758/s13414-013-0475-4]; Chin-Parker S, 2004, J EXP PSYCHOL LEARN, V30, P216, DOI 10.1037/0278-7393.30.1.216; Coutinho MVC, 2010, BRAIN COGNITION, V74, P88, DOI 10.1016/j.bandc.2010.07.001; Feldman J, 2000, NATURE, V407, P630, DOI 10.1038/35036586; Fific M, 2010, PSYCHOL REV, V117, P309, DOI 10.1037/a0018526; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; Goodman ND, 2008, COGNITIVE SCI, V32, P108, DOI 10.1080/03640210701802071; Juslin P, 2003, J EXP PSYCHOL GEN, V132, P133, DOI 10.1037/0096-3445.132.1.133; KRUSCHKE JK, 1992, PSYCHOL REV, V99, P22, DOI 10.1037/0033-295X.99.1.22; Little DR, 2013, J EXP PSYCHOL LEARN, V39, P801, DOI 10.1037/a0029667; Little DR, 2011, J EXP PSYCHOL LEARN, V37, P1, DOI 10.1037/a0021330; Markman AB, 2003, J EXP PSYCHOL LEARN, V29, P107, DOI 10.1037/0278-7393.29.1.107; Martignon L, 2002, THEOR DECIS, V52, P29, DOI 10.1023/A:1015516217425; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; Meier KM, 2013, COGNITION, V126, P319, DOI 10.1016/j.cognition.2012.09.014; Minda JP, 2002, J EXP PSYCHOL LEARN, V28, P275, DOI 10.1037//0278-7393.28.2.275; Minda JP, 2001, J EXP PSYCHOL LEARN, V27, P775, DOI 10.1037//0278-7393.27.3.775; Nosofsky R. M., 1992, ESSAYS HONOR WK ESTE, V1, P149; NOSOFSKY RM, 1994, PSYCHOL REV, V101, P53, DOI 10.1037/0033-295X.101.1.53; Rehder B, 2005, J EXP PSYCHOL LEARN, V31, P811, DOI 10.1037/0278-7393.31.5.811; Rehder B, 2005, COGNITIVE PSYCHOL, V51, P1, DOI 10.1016/j.cogpsych.2004.11.001; Rieskamp J, 2006, J EXP PSYCHOL GEN, V135, P207, DOI 10.1037/0096-3445.135.2.207; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Seger CA, 2006, CEREB CORTEX, V16, P1546, DOI 10.1093/cercor/bhj092; Smith EE, 2008, NEUROSCI BIOBEHAV R, V32, P249, DOI 10.1016/j.neubiorev.2007.07.009; Smith JD, 2000, J EXP PSYCHOL LEARN, V26, P3, DOI 10.1037/0278-7393.26.1.3; TVERSKY A, 1969, PSYCHOL REV, V76, P31, DOI 10.1037/h0026750; Yamauchi T, 2002, J EXP PSYCHOL LEARN, V28, P585, DOI 10.1037//0278-7393.28.3.585	34	0	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135729	10.1371/journal.pone.0135729	http://dx.doi.org/10.1371/journal.pone.0135729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26274332	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600103
J	Sun, WT; Fang, JJ; Yong, Q; Li, SF; Xie, QP; Yin, JB; Cui, L				Sun, Wentao; Fang, Jianjun; Yong, Qi; Li, Sufang; Xie, Qingping; Yin, Jingbo; Cui, Lei			Subcutaneous Construction of Engineered Adipose Tissue with Fat Lobule-Like Structure Using Injectable Poly-Benzyl-L-Glutamate Microspheres Loaded with Adipose-Derived Stem Cells	PLOS ONE			English	Article							IN-VITRO; SCAFFOLD; DIFFERENTIATION; CONVERSION; 3T3-CELLS; VIVO	Porous microcarriers were fabricated from synthesized poly(gamma-benzyl-L-glutamate) (PBLG) polymer to engineer adipose tissue with lobule-like structure via the injectable approach. The adipogenic differentiation of human adipose-derived stem cells (hASCs) seeded on porous PBLG microcarriers was determined by adipogenic gene expression and glycerol-3-phosphate dehydrogenase enzyme activity. In vitro adipogenic cultivation was performed for 7 days, and induced hASC/PBLG complex (Adi-ASC/PBLG group) was subcutaneously injected into nude mice. Injections of PBLG microcarriers alone (PBLG group) and non-induced hASC/PBLG complex (ASC/PBLG group) served as controls. Newly formed tissues were harvested after 4 and 8 weeks. Generation of subcutaneous adipose tissue with typical lobule-like structure separated by fibrous septa was observed upon injection of adipogenic-induced hASC/microsphere complex. Adipogenesis significantly increased in the Adi-ASC/PBLG group compared with the control groups. The angiogenesis in the engineered adipose tissue was comparable to that in normal tissue as determined by capillary density and luminal diameter. Cell tracking assay demonstrated that labeled hASCs remained detectable in the neo-generated tissues 8 weeks post-injection using green fluorescence protein-labeled hASCs. These results indicate that adipose tissue with typical lobule-like structure could be engineered using injectable porous PBLG microspheres loaded with adipogenic-induced hASCs.	[Sun, Wentao; Yong, Qi; Cui, Lei] Shanghai Jiao Tong Univ, Sch Med, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China; [Fang, Jianjun; Yin, Jingbo] Shanghai Univ, Dept Polymer Mat, Shanghai, Peoples R China; [Li, Sufang] Hunan Univ, Coll Chem & Chem Engn, Changsha 410082, Hunan, Peoples R China; [Xie, Qingping] Zhejiang Prov Peoples Hosp, Dept Hand Surg, Hangzhou, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Shanghai University; Hunan University; Zhejiang Provincial People's Hospital	Xie, QP (corresponding author), Zhejiang Prov Peoples Hosp, Dept Hand Surg, Hangzhou, Zhejiang, Peoples R China.	xqp1376@hotmail.com; jbyin@shu.edu.cn; leicuite@163.com	li, sufang/ABC-6767-2020		National Natural Science Foundation of China [81271724]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (Grant No. 81271724), L. Cui.	Ayhan M, 2001, AESTHET PLAST SURG, V25, P338, DOI 10.1007/s002660010145; Brandl FP, 2010, BIOMATERIALS, V31, P3957, DOI 10.1016/j.biomaterials.2010.01.128; Choi BG, 2010, BIOMATERIALS, V31, P9266, DOI 10.1016/j.biomaterials.2010.08.067; Choi YS, 2006, BIOCHEM BIOPH RES CO, V345, P631, DOI 10.1016/j.bbrc.2006.04.128; Coe NR, 1998, BBA-LIPID LIPID MET, V1391, P287, DOI 10.1016/S0005-2760(97)00205-1; Cui L, 2007, BIOMATERIALS, V28, P5477, DOI 10.1016/j.biomaterials.2007.08.042; de Miguel L, 2014, INT J PHARMACEUT, V460, P73, DOI 10.1016/j.ijpharm.2013.10.048; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Fang JJ, 2015, J MATER CHEM B, V3, P1020, DOI 10.1039/c4tb01333f; Huang CC, 2012, BIOMATERIALS, V33, P4069, DOI 10.1016/j.biomaterials.2012.02.024; Janigan D T, 1993, Obes Res, V1, P384; Khadka DB, 2012, NANOMED-NANOTECHNOL, V8, P1242, DOI 10.1016/j.nano.2012.02.013; Kumar P, 2011, INDIAN J PLAST SURG, V44, P478, DOI 10.4103/0970-0358.90828; KURIHARCUCH W, 1978, CELL, V14, P53, DOI 10.1016/0092-8674(78)90300-8; Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z; Li YZ, 2008, NEUROUROL URODYNAM, V27, P254, DOI 10.1002/nau.20489; Liu QH, 2009, TISSUE ENG PT A, V15, P3487, DOI 10.1089/ten.TEA.2009.0175; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017; Mertsching H, 2005, BIOMATERIALS, V26, P6610, DOI 10.1016/j.biomaterials.2005.04.048; NICHOLS MG, 1994, PHYS MED BIOL, V39, P2161, DOI 10.1088/0031-9155/39/12/003; Patrick CW, 2004, ANNU REV BIOMED ENG, V6, P109, DOI 10.1146/annurev.bioeng.6.040803.140032; Phull MK, 2013, J MATER SCI-MATER M, V24, P461, DOI 10.1007/s10856-012-4806-0; POISSONNET CM, 1983, EARLY HUM DEV, V8, P1, DOI 10.1016/0378-3782(83)90028-2; Qian JM, 2013, MAT SCI ENG C-MATER, V33, P4587, DOI 10.1016/j.msec.2013.07.016; Ravichandran R, 2012, BIOMATERIALS, V33, P846, DOI 10.1016/j.biomaterials.2011.10.030; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Ullah M, 2013, MATRIX BIOL, V32, P452, DOI 10.1016/j.matbio.2013.07.001; Verseijden F, 2012, CELL TRANSPLANT, V21, P2283, DOI 10.3727/096368912X653129; WISE LS, 1979, J BIOL CHEM, V254, P273; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yao R, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/4/045003; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	34	6	6	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135611	10.1371/journal.pone.0135611	http://dx.doi.org/10.1371/journal.pone.0135611			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274326	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600083
J	Cross, BD; Kohfeld, KE; Bailey, J; Cooper, AB				Cross, Benjamin D.; Kohfeld, Karen E.; Bailey, Joseph; Cooper, Andrew B.			The Impacts of Wind Speed Trends and 30-Year Variability in Relation to Hydroelectric Reservoir Inflows on Wind Power in the Pacific Northwest	PLOS ONE			English	Article							BRITISH-COLUMBIA; CLIMATE-CHANGE; UNITED-STATES; ENERGY; ELECTRICITY; SYSTEM; COAST; EVENTS; TIME	In hydroelectric dominated systems, the value and benefits of energy are higher during extended dry periods and lower during extended or extreme wet periods. By accounting for regional and temporal differences in the relationship between wind speed and reservoir inflow behavior during wind farm site selection, the benefits of energy diversification can be maximized. The goal of this work was to help maximize the value of wind power by quantifying the long-term (30-year) relationships between wind speed and streamflow behavior, using British Columbia (BC) and the Pacific Northwest (PNW) as a case study. Clean energy and self-sufficiency policies in British BC make the benefits of increased generation during low streamflow periods particularly large. Wind density (WD) estimates from a height of 10m (North American Regional Reanalysis, NARR) were correlated with cumulative usable inflows (CUI) for BC (collected from BC Hydro) for 1979-2010. The strongest WD-CUI correlations were found along the US coast (r similar to 0.55), whereas generally weaker correlations were found in northern regions, with negative correlations (r similar to -0.25) along BC's North Coast. Furthermore, during the lowest inflow years, WD anomalies increased by up to 40% above average values for the North Coast. Seasonally, high flows during the spring freshet were coincident with widespread negative WD anomalies, with a similar but opposite pattern for low inflow winter months. These poorly or negatively correlated sites could have a moderating influence on climate related variability in provincial electricity supply, by producing greater than average generation in low inflow years and reduced generation in wet years. Wind speed and WD trends were also analyzed for all NARR grid locations, which showed statistically significant positive trends for most of the PNW and the largest increases along the Pacific Coast.	[Cross, Benjamin D.; Kohfeld, Karen E.; Bailey, Joseph; Cooper, Andrew B.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Cross, BD (corresponding author), Simon Fraser Univ, Sch Resource & Environm Management, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	bcross@sfu.ca		Kohfeld, Karen/0000-0001-7241-1624	Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada Canada Research Chair; Natural Sciences and Engineering Research Council of Canada Discovery Grant [342251]	Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada Canada Research Chair(Natural Sciences and Engineering Research Council of Canada (NSERC)Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship received by BC, http://www.nserc-crsng. gc.ca/Students-Etudiants/PG-CS/CGSM-BESCM_eng.asp; the Natural Sciences and Engineering Research Council of Canada Canada Research Chair received by KEK, http://www.chairs-chaires.gc.ca/program-programme/admin_guide-eng.aspx; and a Natural Sciences and Engineering Research Council of Canada Discovery Grant received by KEK, Grant Number: 342251, http://www.nserc-crsng.gc. ca/Professors-Professeurs/Grants-Subs/DGIGPPSIGP_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysirigunawardena DS, 2009, ATMOS OCEAN, V47, P41, DOI 10.3137/AO1003.2009; AWEA, 2013, STAT WIND EN STAT WA; BC Hydro, 2013, BC HYR ANN REP; Belanger C, 2002, ENERG POLICY, V30, P1279, DOI 10.1016/S0301-4215(02)00089-7; Benitez LE, 2008, ENERG ECON, V30, P1973, DOI 10.1016/j.eneco.2007.01.017; Bonneville Power Administration, 2011, INT ENV RED NEG PRIC; Bradbury K, 2014, APPL ENERG, V114, P512, DOI 10.1016/j.apenergy.2013.10.010; Brekken TKA, 2011, IEEE T SUSTAIN ENERG, V2, P69, DOI 10.1109/TSTE.2010.2066294; Bye T, 2008, ENERG ECON, V30, P1693, DOI 10.1016/j.eneco.2007.11.009; Bylhouwer B, 2013, J GEOPHYS RES-OCEANS, V118, P2565, DOI 10.1002/jgrc.20194; Chakrabarti BB, 2011, 2011 IEEE POW EN SOC, P1, DOI [10.1109/PES.2011.6039133, DOI 10.1109/PES.2011.6039133]; Chang EKM, 2002, J CLIMATE, V15, P2163, DOI 10.1175/1520-0442(2002)015<02163:STD>2.0.CO;2; Chang EKM, 2002, J CLIMATE, V15, P642, DOI 10.1175/1520-0442(2002)015<0642:IVINHW>2.0.CO;2; Chang MK, 2013, APPL ENERG, V112, P1, DOI 10.1016/j.apenergy.2013.04.092; Curry CL, 2012, CLIM DYNAM, V38, P1281, DOI 10.1007/s00382-011-1173-3; Denault M, 2009, ENERG POLICY, V37, P5376, DOI 10.1016/j.enpol.2009.07.064; DETTINGER MD, 2001, INTERHEMISPHERIC CLI, P1, DOI DOI 10.1016/B978-012472670-3/50004-5; Enloe J, 2004, J CLIMATE, V17, P1728, DOI 10.1175/1520-0442(2004)017<1728:EIOPWG>2.0.CO;2; Frankfurt School-UNEP Centre, 2014, GLOB TRENDS REN EN; Fripp M, 2008, IEEE T POWER SYST, V23, P477, DOI 10.1109/TPWRS.2008.919427; Gower JFR, 2002, J CLIMATE, V15, P3709, DOI 10.1175/1520-0442(2002)015<3709:TWAWCA>2.0.CO;2; Griffin BJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045052; Hamlet AF, 1999, J AM WATER RESOUR AS, V35, P1597, DOI 10.1111/j.1752-1688.1999.tb04240.x; Holt E, 2012, J APPL METEOROL CLIM, V51, P2188, DOI 10.1175/JAMC-D-11-0205.1; Hydro BC, 2013, INT RES PLAN APP 3A; Hydro BC, 2010, CLEAN POWER CALL REQ; Hydro BC, 2013, INT RES PLAN M BCS F; Hydro BC, 2010, 2010 RES OPT REP; Hydro-Quebec, 2012, ANN REP 2012; International Energy Agency, 2011, EN POL IEA COUNTR NO; Joskow PL, 2011, AM ECON REV, V101, P238, DOI 10.1257/aer.101.3.238; Karki R, 2010, IEEE T POWER SYST, V25, P685, DOI 10.1109/TPWRS.2009.2032758; Kiani B, 2013, ENERG POLICY, V54, P311, DOI 10.1016/j.enpol.2012.11.040; Kiviluoma J, 2006, P EUR WIND EN C EXH; Klink K, 1999, CLIMATE RES, V13, P193, DOI 10.3354/cr013193; Klink K, 2002, J CLIMATE, V15, P3311, DOI 10.1175/1520-0442(2002)015&lt;3311:TAIVOW&gt;2.0.CO;2; Lamont AD, 2008, ENERG ECON, V30, P1208, DOI 10.1016/j.eneco.2007.02.007; Lee AHI, 2009, RENEW ENERG, V34, P120, DOI 10.1016/j.renene.2008.04.013; Li X, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013415; Lorenz DJ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008087; Lu J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028443; Lynch AH, 2004, B AM METEOROL SOC, V85, P209, DOI 10.1175/BAMS-85-2-209; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Matevosyan J, 2009, ELECTR POW SYST RES, V79, P39, DOI 10.1016/j.epsr.2008.05.019; McCabe GJ, 2001, J CLIMATE, V14, P2763, DOI 10.1175/1520-0442(2001)014<2763:TINHSC>2.0.CO;2; McVicar TR, 2012, J HYDROL, V416, P182, DOI 10.1016/j.jhydrol.2011.10.024; McVicar TR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035627; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Neuhoff K, 2008, ENERG ECON, V30, P1990, DOI 10.1016/j.eneco.2007.07.009; New Zealand Ministry of Business Innovation & Employment, 2013, EN NZ; Pryor SC, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013281; Pryor SC, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011416; Rauscher SA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034424; Robinson PJ, 1997, INT J CLIMATOL, V17, P983, DOI [10.1002/(SICI)1097-0088(199707)17:9<983::AID-JOC174>3.0.CO;2-I, 10.1002/(SICI)1097-0088(199707)17:9<983::AID-JOC174>3.3.CO;2-9]; Rood SB, 2005, J HYDROL, V306, P215, DOI 10.1016/j.jhydrol.2004.09.010; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Sopinka A, 2013, ELECT J ELSEVIER INC, V26, P81, DOI [10.1016/j.tej.2013.03.003, DOI 10.1016/J.TEJ.2013.03.003]; Sopinka A, 2013, ENERG POLICY, V61, P223, DOI 10.1016/j.enpol.2013.05.068; Stewart IT, 2004, CLIMATIC CHANGE, P217; Tuller SE, 2004, INT J CLIMATOL, V24, P1359, DOI 10.1002/joc.1073; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Vautard R, 2010, NAT GEOSCI, V3, P756, DOI [10.1038/ngeo979, 10.1038/NGEO979]; Voisin N, 2006, J APPL METEOROL CLIM, V45, P653, DOI 10.1175/JAM2361.1; Wan H, 2010, J CLIMATE, V23, P1209, DOI 10.1175/2009JCLI3200.1; Wang J. Y., 2006, Canadian Water Resources Journal, V31, P25; Warner MD, 2012, MON WEATHER REV, V140, P2021, DOI 10.1175/MWR-D-11-00197.1; Woo CK, 2013, IEEE T POWER SYST, V28, P4245, DOI 10.1109/TPWRS.2013.2265238; Woo CK, 2011, MANAG DECIS ECON, V32, P265, DOI 10.1002/mde.1533; Yin JH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023684	69	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135730	10.1371/journal.pone.0135730	http://dx.doi.org/10.1371/journal.pone.0135730			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271035	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800104
J	Estepa, A; Coll, J				Estepa, Amparo; Coll, Julio			Innate Multigene Family Memories Are Implicated in the Viral-Survivor Zebrafish Phenotype	PLOS ONE			English	Article							HEMORRHAGIC SEPTICEMIA VIRUS; TROUT ONCORHYNCHUS-MYKISS; C-REACTIVE PROTEIN; UBIQUITIN-PROTEASOME SYSTEM; RAINBOW-TROUT; IN-VITRO; PARALICHTHYS-OLIVACEUS; JAPANESE FLOUNDER; CANDIDA-ALBICANS; IMMUNE-RESPONSE	Since adaptive features such as memory were discovered in mammalian innate immunity, interest in the immunological status of primitive vertebrates after infections has grown. In this context, we used zebrafish (Danio rerio), a primitive vertebrate species suited to molecular and genetic studies to explore transcriptional memories of the immune system in long-term survivors of viral haemorrhagic septicemia virus infections. Immune-gene targeted microarrays designed in-house, multipath genes, gene set enrichment, and leading-edge analysis, reveal unexpected consistent correlations between the viral-survivor phenotype and several innate multigene families. Thus, here we describe in survivors of infections the upregulation of the multigene family of proteasome subunit macropains, zebrafish-specific novel gene sets, mitogen activated protein kinases, and epidermal growth factor. We also describe the downregulation of the multigene families of c-reactive proteins, myxovirus-induced proteins and novel immunoglobulin-type receptors. The strength of those immunological memories was reflected by the exceptional similarity of the transcriptional profiles of survivors before and after re-infection compared with primary infected fish. On the other hand, the high levels of neutralizing antibodies in the blood plasma of survivors contrasted with the depletion of transcripts specific for most cell types present in lymphoid organs. Therefore, long-term survivors maintained unexpected molecular/cellular memories of previous viral encounters by modulating the expression levels of innate multigene families as well as having specific adaptive antibodies. The implications of the so-called "trained immunity" for future research in this field are also discussed.	[Coll, Julio] Inst Nacl Invest Agr, Dept Biotechnol, Madrid, Spain; [Estepa, Amparo] Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Miguel Hernandez de Elche	Coll, J (corresponding author), Inst Nacl Invest Agr, Dept Biotechnol, Madrid, Spain.	juliocoll@inia.es	Coll, julio/M-6071-2019	Coll, julio/0000-0001-8496-3493	Instituto nacional de Investigacion y Tecnologia Agraria y Alimentaria [RTA2013-00008-00-00]; Comision Interministerial de Ciencia y Tecnologia (CICYT) [AGL2014-51773-C3-1-R, AGL2014-51773-C3-2-R, AGL2014-53190 REDC]	Instituto nacional de Investigacion y Tecnologia Agraria y Alimentaria(Instituto de Investigacion Agropecuaria (INIA)); Comision Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT))	This work was supported by RTA2013-00008-00-00 from Instituto nacional de Investigacion y Tecnologia Agraria y Alimentaria www.inia.es, AGL2014-51773-C3-1-R and 2-R, and AGL2014-53190 REDC from Comision Interministerial de Ciencia y Tecnologia (CICYT), www.cicyt.mincyt.gob.ar.	Acosta F, 2005, FISH SHELLFISH IMMUN, V18, P81, DOI 10.1016/j.fsi.2004.06.005; Ballesteros NA, 2012, FISH SHELLFISH IMMUN, V33, P174, DOI 10.1016/j.fsi.2012.03.016; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Caipang CMA, 2005, FISH SHELLFISH IMMUN, V19, P79, DOI 10.1016/j.fsi.2004.12.008; Caipang CMA, 2003, VIROLOGY, V317, P373, DOI 10.1016/j.virol.2003.08.040; Chinchilla B, 2015, APPL MICROBIOL BIOT, V99, P1827, DOI 10.1007/s00253-014-6366-3; Chinchilla B, 2013, J VIROL METHODS, V193, P627, DOI 10.1016/j.jviromet.2013.07.049; Chinchilla B, 2013, ZEBRAFISH, V10, P43, DOI 10.1089/zeb.2012.0805; Desai S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-177; Encinas P, 2011, FISH SHELLFISH IMMUN, V30, P929, DOI 10.1016/j.fsi.2011.01.021; Encinas P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073553; Encinas P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-518; Falco A, 2012, DEV COMP IMMUNOL, V37, P127, DOI 10.1016/j.dci.2011.10.005; Fernandez-Trujillo MA, 2013, MOL IMMUNOL, V56, P630, DOI 10.1016/j.molimm.2013.06.018; Forlenza M, 2008, MOL IMMUNOL, V45, P3178, DOI 10.1016/j.molimm.2008.02.025; Forlenza M, 2011, DEV COMP IMMUNOL, V35, P1246, DOI 10.1016/j.dci.2011.03.008; Goody MF, 2014, DEV COMP IMMUNOL, V46, P84, DOI 10.1016/j.dci.2014.03.025; Hawke NA, 2001, P NATL ACAD SCI USA, V98, P13832, DOI 10.1073/pnas.231418598; Hohn C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044451; Horst D, 2012, J VIROL, V86, P9175, DOI 10.1128/JVI.00309-12; Kniepert A, 2014, TRENDS BIOCHEM SCI, V39, P17, DOI 10.1016/j.tibs.2013.10.004; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Korom M, 2008, J VIROL, V82, P3642, DOI 10.1128/JVI.02409-07; le Berre M, 1977, Bulletin Off int Epizoot, V87, P391; Leong JAC, 1998, IMMUNOL REV, V166, P349, DOI 10.1111/j.1600-065X.1998.tb01275.x; Levy O, 2014, PEDIATR RES, V75, P184, DOI 10.1038/pr.2013.214; Litman GW, 2001, IMMUNOL REV, V181, P250, DOI 10.1034/j.1600-065X.2001.1810121.x; Lopez-Munoz A, 2010, DEV COMP IMMUNOL, V34, P546, DOI 10.1016/j.dci.2009.12.015; Lorenzen N, 1997, DEV BIOLOGICALS, V90, P201; Lorenzen N, 2005, REV SCI TECH OIE, V24, P201, DOI 10.20506/rst.24.1.1565; LORENZEN N, 1993, FISH SHELLFISH IMMUN, V3, P461, DOI 10.1006/fsim.1993.1045; Lorenzen N, 1999, AQUACULTURE, V172, P41, DOI 10.1016/S0044-8486(98)00443-8; Lutfalla G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-29; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Martinez-Lopez A, 2014, VACCINE, V32, P6012, DOI 10.1016/j.vaccine.2014.07.111; Mas V, 2004, J VIROL, V78, P1936, DOI 10.1128/JVI.78.4.1936-1944.2004; Murray BW, 1999, J IMMUNOL, V163, P2657; NAKANISHI Y, 1991, AM J VET RES, V52, P397; Naujokat C, 2007, STEM CELLS, V25, P2408, DOI 10.1634/stemcells.2007-0255; Netea MG, 2014, J INNATE IMMUN, V6, P117, DOI 10.1159/000357283; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Novoa B, 2006, VACCINE, V24, P5806, DOI 10.1016/j.vaccine.2006.05.015; Page HG, 2010, J VIROL, V84, P6886, DOI 10.1128/JVI.00166-10; Pionnier N, 2014, DIS AQUAT ORGAN, V109, P187, DOI 10.3354/dao02727; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; Purcell MK, 2012, VIRUSES-BASEL, V4, P140, DOI 10.3390/v4010140; Purcell MK, 2004, FISH SHELLFISH IMMUN, V17, P447, DOI 10.1016/j.fsi.2004.04.017; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rogers N, 2010, NEUROPATH APPL NEURO, V36, P113, DOI [10.1111/j.1365-2990.2009.01063.x, 10.1111/j.1365-2990.2010.01063.x]; Romero A, 2011, VET IMMUNOL IMMUNOP, V140, P119, DOI 10.1016/j.vetimm.2010.12.001; Roumenina LT, 2006, BIOCHEMISTRY-US, V45, P4093, DOI 10.1021/bi052646f; SANCHEZ C, 1993, FISH SHELLFISH IMMUN, V3, P237, DOI 10.1006/fsim.1993.1024; SANCHEZ C, 1991, MOL IMMUNOL, V28, P1271, DOI 10.1016/0161-5890(91)90014-B; SANCHEZ C, 1993, VET IMMUNOL IMMUNOP, V36, P65, DOI 10.1016/0165-2427(93)90006-P; SANCHEZ C, 1991, VET IMMUNOL IMMUNOP, V27, P383, DOI 10.1016/0165-2427(91)90033-9; Sandlund N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108529; Sanz F., 1992, Bulletin of the European Association of Fish Pathologists, V12, P116; Sepulcre MP, 2007, MOL IMMUNOL, V44, P3751, DOI 10.1016/j.molimm.2007.03.021; Sepulcre MP, 2010, DEV COMP IMMUNOL, V34, P603, DOI 10.1016/j.dci.2010.01.010; Shen LL, 2004, DEV COMP IMMUNOL, V28, P139, DOI 10.1016/S0145-305X(03)00119-8; Sommerset I, 2003, VACCINE, V21, P4661, DOI 10.1016/S0264-410X(03)00526-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sun JC, 2014, EMBO J, V33, P1295, DOI 10.1002/embj.201387651; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Sun Z, 2010, J CELL PHYSIOL, V223, P798, DOI 10.1002/jcp.22100; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Trobridge GD, 1997, DIS AQUAT ORGAN, V30, P91, DOI 10.3354/dao030091; Trobridge GD, 1997, J VIROL, V71, P5304, DOI 10.1128/JVI.71.7.5304-5311.1997; Trobridge GD, 2000, DIS AQUAT ORGAN, V40, P1, DOI 10.3354/dao040001; VECCHIARELLI A, 1989, CELL IMMUNOL, V124, P334, DOI 10.1016/0008-8749(89)90135-4; VerburgvanKemenade BML, 1996, VET IMMUNOL IMMUNOP, V51, P189, DOI 10.1016/0165-2427(95)05506-1; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Yao XD, 2011, J GEN VIROL, V92, P1981, DOI 10.1099/vir.0.030296-0; Yoder JA, 2004, P NATL ACAD SCI USA, V101, P15706, DOI 10.1073/pnas.0405242101	78	19	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135483	10.1371/journal.pone.0135483	http://dx.doi.org/10.1371/journal.pone.0135483			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270536	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800081
J	Sun, ZQ; Yu, ZY; Yu, SF; Chen, JH; Wang, JQ; Yang, C; Jin, MM; Yan, S; Zhang, ML; Zhang, M; Zheng, SS				Sun, Zhongquan; Yu, Zhiyong; Yu, Songfeng; Chen, Jihao; Wang, Jingqiao; Yang, Cheng; Jin, Mengmeng; Yan, Sheng; Zhang, Mangli; Zhang, Min; Zheng, Shusen			Post-Operative Complications in Living Liver Donors: A Single-Center Experience in China	PLOS ONE			English	Article							RIGHT HEPATECTOMY; TRANSPLANTATION; MORBIDITY; RESECTION; SAFETY; VOLUME	The gap between the growing demand for available organs and the cadaveric organs facilitates the adoption of living donor liver transplantation. We retrospectively identified and evaluated the post-operative complications as per the modified Clavien classification system in 152 living liver donors at at the First Affiliated Hospital, College of Medicine, Zhejiang University between December, 2006 and June, 2014. Post-operative complications were observed in 61 patients (40.1%) in the present study, but no mortality was reported. Complications developed in 58 (40.0%) right, 1 (33.3%) left, and 2 (66.7%) lateral left hepatectomy donors. The prevalence of re-operation was 1.3%. Grade I and II complications were observed in 38 (25.0%) and 11 (7.2%) donors, respectively. Grade IIIa complications developed in 9 (5.9%) donors and only 3 (2.0%) patients reported grade IIIb complications. The most common complication was pleural effusion that occurred in 31 (20.4%) donors. No significant prognostic baseline factor was identified in this study. In conclusion, living donors experienced various complications, which were usually mild and had a good prognosis.	[Sun, Zhongquan; Yu, Zhiyong; Yu, Songfeng; Chen, Jihao; Wang, Jingqiao; Yang, Cheng; Jin, Mengmeng; Yan, Sheng; Zhang, Mangli; Zhang, Min; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Zhongquan; Yu, Zhiyong; Yu, Songfeng; Yan, Sheng; Zhang, Mangli; Zhang, Min; Zheng, Shusen] Minist Publ Hlth, Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China; [Sun, Zhongquan; Yu, Zhiyong; Yu, Songfeng; Yan, Sheng; Zhang, Mangli; Zhang, Min; Zheng, Shusen] Key Lab Organ Transplantat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China.	sunzq@zju.edu.cn			Science and Technology Planning Project of Zhejiang Province, China [2013C33226]; Health Bureau of Zhejiang Province Foundation, China [2014KYA085]; Natural Science Foundation of Zhejiang Province, China [LY14H030003]	Science and Technology Planning Project of Zhejiang Province, China; Health Bureau of Zhejiang Province Foundation, China; Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This work was supported by Science and Technology Planning Project of Zhejiang Province, China (2013C33226, http://www.zjkjt.gov.cn/), Health Bureau of Zhejiang Province Foundation, China (2014KYA085, http://www.zjwst.gov.cn/), and Natural Science Foundation of Zhejiang Province, China (LY14H030003, http://www.zjnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Barr ML, 2006, TRANSPLANTATION, V81, P1373, DOI 10.1097/01.tp.0000216825.56841.cd; Broering DC, 2004, ANN SURG, V240, P1013, DOI 10.1097/01.sla.0000146146.97485.6c; Brown RS, 2003, NEW ENGL J MED, V348, P818, DOI 10.1056/NEJMsa021345; Chan SC, 2006, LIVER TRANSPLANT, V12, P259, DOI 10.1002/lt.20565; CLAVIEN PA, 1992, SURGERY, V111, P518; Fan ST, 2006, TRANSPLANTATION, V82, P723, DOI 10.1097/01.tp.0000235171.17287.f2; Fan ST, 2000, ARCH SURG-CHICAGO, V135, P336, DOI 10.1001/archsurg.135.3.336; Grewal HP, 1998, ANN SURG, V228, P214, DOI 10.1097/00000658-199808000-00011; Hashikura Y, 2009, TRANSPLANTATION, V88, P110, DOI 10.1097/TP.0b013e3181aaccb0; Kubota K, 1997, HEPATOLOGY, V26, P1176; Liu CL, 2005, LIVER TRANSPLANT, V11, P314, DOI 10.1002/lt.20359; RAIA S, 1989, LANCET, V2, P497; Reddy SK, 2012, HEPATOLOGY, V56, P2221, DOI 10.1002/hep.25935; Renz JF, 2000, LIVER TRANSPLANT, V6, pS73, DOI 10.1053/jlts.2000.18686; Shoup M, 2003, J GASTROINTEST SURG, V7, P325, DOI 10.1016/S1091-255X(02)00370-0; Song GW, 2014, CURR OPIN ORGAN TRAN, V19, P217, DOI 10.1097/MOT.0000000000000088; STRONG RW, 1990, NEW ENGL J MED, V322, P1505, DOI 10.1056/NEJM199005243222106; Tamura S, 2008, GASTROENTEROLOGY, V135, P1804, DOI 10.1053/j.gastro.2008.09.050; Tanaka K, 2004, YONSEI MED J, V45, P1089, DOI 10.3349/ymj.2004.45.6.1089; Trotter JF, 2006, LIVER TRANSPLANT, V12, P1485, DOI 10.1002/lt.20875; Truant S, 2007, J AM COLL SURGEONS, V204, P22, DOI 10.1016/j.jamcollsurg.2006.09.007; Umeshita K, 2003, LANCET, V362, P687, DOI 10.1016/S0140-6736(03)14230-4; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Yi NJ, 2007, LIVER TRANSPLANT, V13, P797, DOI 10.1002/lt.21030; Yuan D, 2011, HEPATOB PANCREAT DIS, V10, P480, DOI 10.1016/S1499-3872(11)60082-9	26	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135557	10.1371/journal.pone.0135557	http://dx.doi.org/10.1371/journal.pone.0135557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270475	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800089
J	Black, LJ; Anderson, D; Clarke, MW; Ponsonby, AL; Lucas, RM				Black, Lucinda J.; Anderson, Denise; Clarke, Michael W.; Ponsonby, Anne-Louise; Lucas, Robyn M.		Ausimmune Investigator Grp	Analytical Bias in the Measurement of Serum 25-Hydroxyvitamin D Concentrations Impairs Assessment of Vitamin D Status in Clinical and Research Settings	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; D ASSAYS; ADULTS; 25-HYDROXYCHOLECALCIFEROL; STANDARDIZATION; CHROMATOGRAPHY; METABOLITES; PREVALENCE; NUTRITION; ACCURACY	Measured serum 25-hydroxyvitamin D concentrations vary depending on the type of assay used and the specific laboratory undertaking the analysis, impairing the accurate assessment of vitamin D status. We investigated differences in serum 25-hydroxyvitamin D concentrations measured at three laboratories (laboratories A and B using an assay based on liquid chromatography-tandem mass spectrometry and laboratory C using a DiaSorin Liaison assay), against a laboratory using an assay based on liquid chromatography-tandem mass spectrometry that is certified to the standard reference method developed by the National Institute of Standards and Technology and Ghent University (referred to as the 'certified laboratory'). Separate aliquots from the same original serum sample for a subset of 50 participants from the Ausimmune Study were analysed at the four laboratories. Bland-Altman plots were used to visually check agreement between each laboratory against the certified laboratory. Compared with the certified laboratory, serum 25-hydroxyvitamin D concentrations were on average 12.4 nmol/L higher at laboratory A (95% limits of agreement: -17.8,42.6); 12.8 nmol/L higher at laboratory B (95% limits of agreement: 0.8,24.8); and 10.6 nmol/L lower at laboratory C (95% limits of agreement: -48.4,27.1). The prevalence of vitamin D deficiency (defined here as 25-hydroxyvitamin D <50 nmol/L) was 24%, 16%, 12% and 41% at the certified laboratory, and laboratories A, B, and C, respectively. Our results demonstrate considerable differences in the measurement of 25-hydroxyvitamin D concentrations compared with a certified laboratory, even between laboratories using assays based on liquid chromatography-tandem mass spectrometry, which is often considered the gold-standard assay. To ensure accurate and reliable measurement of serum 25-hydroxyvitamin D concentrations, all laboratories should use an accuracy-based quality assurance system and, ideally, comply with international standardisation efforts.	[Black, Lucinda J.; Anderson, Denise; Lucas, Robyn M.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Clarke, Michael W.] Univ Western Australia, Metabol Australia, Ctr Metabol, Perth, WA 6009, Australia; [Ponsonby, Anne-Louise] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Lucas, Robyn M.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; Murdoch Children's Research Institute; University of Melbourne; Australian National University	Black, LJ (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.	lucinda.black@telethonkids.org.au	Clarke, Michael W/H-8997-2014; Ponsonby, Anne-Louise/AAE-4351-2019; van der Mei, Ingrid/J-7457-2014	Clarke, Michael W/0000-0002-9639-5670; Kilpatrick, Trevor/0000-0003-3999-085X; Anderson, Denise/0000-0003-0643-4136; Ponsonby, Anne-Louise/0000-0002-6581-3657; Lucas, Robyn/0000-0003-2736-3541; van der Mei, Ingrid/0000-0001-9009-7472; Black, Lucinda/0000-0003-4727-4773	National Multiple Sclerosis Society of the USA [RG3364A1/2]; National Health and Medical Research Council (NHMRC) of Australia; Multiple Sclerosis Research Australia; Telethon Kids Institute; Bioplatforms Australia (NCRIS); Western Australian Government Innovation Co-investment Program (ICP); NHMRC Fellowships	National Multiple Sclerosis Society of the USA(National Multiple Sclerosis Society); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Multiple Sclerosis Research Australia; Telethon Kids Institute; Bioplatforms Australia (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science); Western Australian Government Innovation Co-investment Program (ICP); NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from the National Multiple Sclerosis Society of the USA (RG3364A1/2), the National Health and Medical Research Council (NHMRC) of Australia, and Multiple Sclerosis Research Australia. LJB and DA were supported by the Telethon Kids Institute; MWC was supported by Bioplatforms Australia (NCRIS) and the Western Australian Government Innovation Co-investment Program (ICP); A-LP and RML were supported by NHMRC Fellowships.	[Anonymous], 2009, R LANG ENV STAT COMP; [Anonymous], 2011, NAT DIET NUTR SURV H; Ashwell M, 2010, BRIT J NUTR, V104, P603, DOI 10.1017/S0007114510002138; Australian Bureau of Statistics, 2014, AUSTR HLTH SURV BIOM; Australian Government Department of Health, 2014, MBS REV VIT D TESTIN; Bailey D, 2013, CLIN BIOCHEM, V46, P190, DOI 10.1016/j.clinbiochem.2012.10.037; BELSEY RE, 1974, J CLIN ENDOCR METAB, V38, P1046, DOI 10.1210/jcem-38-6-1046; Bilinski K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002955; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Carter GD, 2011, CURR DRUG TARGETS, V12, P19; Carter GD, 2009, CLIN CHEM, V55, P1300, DOI 10.1373/clinchem.2009.125906; Cashman KD, 2015, CLIN CHEM, V61, P636, DOI 10.1373/clinchem.2014.234955; Cashman KD, 2014, J NUTR, V144, P1050, DOI 10.3945/jn.114.192419; Cashman KD, 2013, AM J CLIN NUTR, V97, P1235, DOI 10.3945/ajcn.112.057182; Cashman KD, 2013, BRIT J NUTR, V109, P1248, DOI 10.1017/S0007114512003212; Clarke MW, 2013, METABOLOMICS, V9, P1031, DOI 10.1007/s11306-013-0518-9; EISMAN JA, 1977, ANAL BIOCHEM, V80, P298, DOI 10.1016/0003-2697(77)90648-0; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; HADDAD JG, 1971, J CLIN ENDOCR METAB, V33, P992, DOI 10.1210/jcem-33-6-992; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; HOLLIS BW, 1985, CLIN CHEM, V31, P1815; HOLLIS BW, 1985, J CHROMATOGR, V343, P43, DOI 10.1016/S0378-4347(00)84566-1; Lai JK, 2001, INTERN MED J, V42, P43; Lind C, 1997, CLIN CHEM, V43, P943; LINNET K, 1990, STAT MED, V9, P1463, DOI 10.1002/sim.4780091210; Lucas RM, 2007, MULT SCLER J, V13, P827, DOI 10.1177/1352458507077174; Manuilova E, 2012, MCR METHOD COMP REGR; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Sempos CT, 2012, SCAND J CLIN LAB INV, V72, P32, DOI 10.3109/00365513.2012.681935; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P1132, DOI 10.1136/jnnp.2011.240432; Wagner D, 2011, J STEROID BIOCHEM, V126, P72, DOI 10.1016/j.jsbmb.2011.05.003; Whiting SJ, 2011, AM J CLIN NUTR, V94, P128, DOI 10.3945/ajcn.111.013268	33	45	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135478	10.1371/journal.pone.0135478	http://dx.doi.org/10.1371/journal.pone.0135478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266807	Green Published, gold			2022-12-27	WOS:000359492300122
J	Chang, CT; Hsiang, CY; Ho, TY; Wu, CZ; Hong, HH; Huang, YF				Chang, Chung-Ta; Hsiang, Chien-Yun; Ho, Tin-Yun; Wu, Ching-Zong; Hong, Hsiang-Hsi; Huang, Yi-Fang			Comprehensive Assessment of Host Responses to 5-Fluorouracil-Induced Oral Mucositis through Transcriptomic Analysis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; COLONY-STIMULATING FACTOR; DOUBLE-BLIND; ECONOMIC OUTCOMES; GENE-EXPRESSION; KAPPA-B; CHEMOTHERAPY; CANCER; INTERLEUKIN-1; RADIOTHERAPY	Background Chemotherapy plays an important role in current cancer therapy; however, several problems remain unsolved on the issue of host-therapeutics interaction. The purpose of this study was to investigate the host responses after 5-flurouracil (5-FU) administration and to find the target genes and their relationship with other cytokines in the 5-FU-induced oral mucositis (OM) mouse model through transcriptomic analysis. Materials and Methods Thirty-six 6 to 8 week-old male BALB/c mice were randomly divided into the control group and 5-FU-treated group. In the 5-FU group, mice received 5-FU (100 mg/kg, intraperitoneally) on day 1, day 8, day 15, day 22, and day 29, respectively. We evaluated the oral mucosal change under macroanalysis and histological examination at indicated periods, and then applied transcriptomic analysis of gene expression profile and Immunohistochemical stain to identify the target molecules related to 5-FU-induced OM. Results The most prominent histological change in this model was observed in the fifth week. The gene expression of Bone gamma-carboxyglutamate protein, related sequence 1 (Bglap-rs1) (-12.69-fold) and Chitinase 3-like 4 (Chi3l4) (-6.35-fold) were significantly down-regulated in this phase. The quantitative real-time PCR results also revealed the expression levels were 0.62-fold in Bglap-rs1 and 0.13-fold in Chi3l4 compared with the control group. Immunohistochemical stain showed significant expression of cluster of differentiation 11b (p<0.01), interleukin-1 beta (p<0.001) and tumor necrosis factor-alpha (p<0.05), and down-regulation of Bglap-rs1 (p<0.01) compared with the control group. By Kyoto Encyclopedia of Genes and Genomes pathway analysis, there were twenty-three pathways significantly participated in this study (p<0.05). Conclusions Through comprehensively transcriptomic analysis and IHC stain, we discovered several valuable pathways, verified the main pro-inflammatory cytokines, and revealed two significantly down-regulated genes in the 5-FU-induced OM model. These findings highlighted the way of seeking effective therapeutic agents for chemotherapy-induced OM in future.	[Chang, Chung-Ta] Far Eastern Mem Hosp, Dept Emergency Med, Taipei 22056, Taiwan; [Chang, Chung-Ta; Wu, Ching-Zong; Huang, Yi-Fang] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei 11031, Taiwan; [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung 40402, Taiwan; [Ho, Tin-Yun] China Med Univ, Grad Inst Chinese Med, Taichung 40402, Taiwan; [Wu, Ching-Zong] Taipei Med Univ Hosp, Dept Dent, Taipei 11031, Taiwan; [Wu, Ching-Zong] Lotung Poh Ai Hosp, Dept Dent, Yilan 26546, Taiwan; [Hong, Hsiang-Hsi] Chang Gung Mem Hosp, Dept Periodont, Linkou 33305, Taiwan; [Hong, Hsiang-Hsi] Chang Gung Univ, Grad Inst Dent & Craniofacial Sci, Taoyuan 33302, Taiwan; [Huang, Yi-Fang] Chang Gung Mem Hosp, Dept Gen Dent, Linkou 33305, Taiwan	Far Eastern Memorial Hospital; Taipei Medical University; China Medical University Taiwan; China Medical University Taiwan; Taipei Medical University; Taipei Medical University Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, YF (corresponding author), Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei 11031, Taiwan.	chungta.yifang@msa.hinet.net	Hsiang, Chien-Yun/O-3853-2015; Chang, Chung-Ta/ABB-5600-2021; Huang, Yi-Fang/ABB-5777-2021; Ho, Tin-Yun/O-3889-2015	Chang, Chung-Ta/0000-0002-9211-1407; Huang, Yi-Fang/0000-0003-2569-999X	Ministry of Science and Technology [NSC101-2320-B-039-034-MY3, NSC102-2632-B-039-001-MY3, MOST103-2815-C-039-044-B]; Far Eastern Memorial Hospital [FEMH-2015-C-020]; China Medical University [CMU102-NSC-04, CMU103-SR-44]; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Far Eastern Memorial Hospital; China Medical University(China Medical University); CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This work was supported by grants from Ministry of Science and Technology (NSC101-2320-B-039-034-MY3, NSC102-2632-B-039-001-MY3, and MOST103-2815-C-039-044-B), Far Eastern Memorial Hospital (FEMH-2015-C-020), China Medical University (CMU102-NSC-04 and CMU103-SR-44), and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031808; Chang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023682; Campos MID, 2014, MOL CLIN ONCOL, V2, P337, DOI 10.3892/mco.2014.253; DESBOIS C, 1994, J BIOL CHEM, V269, P1183; DINARELLO CA, 1991, BLOOD, V77, P1627; DREIZEN S, 1982, POSTGRAD MED, V71, P133, DOI 10.1080/00325481.1982.11716097; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Duncan GG, 2005, HEAD NECK-J SCI SPEC, V27, P421, DOI 10.1002/hed.20162; Elting LS, 2003, CANCER, V98, P1531, DOI 10.1002/cncr.11671; Epstein JB, 1997, ORAL ONCOL, V33, P359; Epstein JB, 2000, CANCER-AM CANCER SOC, V89, P2258, DOI 10.1002/1097-0142(20001201)89:11<2258::AID-CNCR14>3.0.CO;2-Z; Farrell CL, 2002, CELL PROLIFERAT, V35, P78, DOI 10.1046/j.1365-2184.35.s1.8.x; Foncuberta MC, 2001, J IMMUNOTHER, V24, P384, DOI 10.1097/00002371-200107000-00014; GRADISHAR WJ, 1990, ANN ONCOL, V1, P409, DOI 10.1093/oxfordjournals.annonc.a057793; Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016; Hunter A, 2009, BONE MARROW TRANSPL, V43, P563, DOI 10.1038/bmt.2008.363; Jones JA, 2006, SUPPORT CARE CANCER, V14, P505, DOI 10.1007/s00520-006-0055-4; Koeneman KS, 1999, PROSTATE, V39, P246; Leitao RFC, 2007, CANCER CHEMOTH PHARM, V59, P603, DOI 10.1007/s00280-006-0301-y; LOCKHART PB, 1981, J DERMATOL SURG ONC, V7, P1019, DOI 10.1111/j.1524-4725.1981.tb00208.x; Logan RM, 2007, ORAL ONCOL, V43, P395, DOI 10.1016/j.oraloncology.2006.04.011; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lundahl J, 2012, SCAND J IMMUNOL, V75, P419, DOI 10.1111/j.1365-3083.2012.02679.x; Matsuda C, 2015, CANCER CHEMOTH PHARM, V76, P97, DOI 10.1007/s00280-015-2767-y; MAURER D, 1991, ANN HEMATOL, V62, P135, DOI 10.1007/BF01702927; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Minegaki T, 2014, INT J MED SCI, V11, P321, DOI 10.7150/ijms.7654; Motoori M, 2010, INT J ONCOL, V37, P1113, DOI 10.3892/ijo_00000763; Mougeot JLC, 2013, OR SURG OR MED OR PA, V115, P630, DOI 10.1016/j.oooo.2013.01.003; Mougeot JLC, 2011, ORAL SURG ORAL MED O, V112, P446, DOI 10.1016/j.tripleo.2011.05.009; NEUMAN E, 1990, J IMMUNOL, V145, P3325; NOGUCHI S, 1991, AM J PHYSIOL, V260, pE620, DOI 10.1152/ajpendo.1991.260.4.E620; Ohno M, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-23; PITTELKOW MR, 1988, ANN NY ACAD SCI, V548, P211, DOI 10.1111/j.1749-6632.1988.tb18809.x; PUCHACZ E, 1989, ENDOCRINOLOGY, V124, P2648, DOI 10.1210/endo-124-5-2648; Qureshi Asif M, 2011, Genes Cancer, V2, P74, DOI 10.1177/1947601911402681; Raber-Durlacher JE, 2013, SUPPORT CARE CANCER, V21, P343, DOI 10.1007/s00520-012-1594-5; Skeff MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113378; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sonis ST, 1997, ORAL ONCOL, V33B, P47, DOI 10.1016/S0964-1955(96)00043-7; Sonis ST, 2001, J CLIN ONCOL, V19, P2201, DOI 10.1200/JCO.2001.19.8.2201; Sonis ST, 2011, ANTI-CANCER DRUG, V22, P607, DOI 10.1097/CAD.0b013e3283462086; Sonis ST, 2009, ORAL ONCOL, V45, P1015, DOI 10.1016/j.oraloncology.2009.08.006; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200; Williams PD, 2009, CANCER RES, V69, P8302, DOI 10.1158/0008-5472.CAN-09-0798; Won JH, 2013, BIOL PHARM BULL, V36, P425, DOI 10.1248/bpb.b12-00869; Wu HG, 2009, CANCER-AM CANCER SOC, V115, P3699, DOI 10.1002/cncr.24414; ZAGHLOUL MS, 1994, INT J RADIAT ONCOL, V29, P805, DOI 10.1016/0360-3016(94)90569-X; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106	50	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135102	10.1371/journal.pone.0135102	http://dx.doi.org/10.1371/journal.pone.0135102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266941	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300079
J	Cusack, R; Wild, C; Linke, AC; Arichi, T; Lee, DSC; Han, VK				Cusack, Rhodri; Wild, Conor; Linke, Annika C.; Arichi, Tomoki; Lee, David S. C.; Han, Victor K.			Optimizing Stimulation and Analysis Protocols for Neonatal fMRI	PLOS ONE			English	Article							FUNCTIONAL MRI; ACTIVATION; CHILDREN; PRETERM; BRAIN; RESPONSES; OUTCOMES; NEWBORN; DESIGN	The development of brain function in young infants is poorly understood. The core challenge is that infants have a limited behavioral repertoire through which brain function can be expressed. Neuroimaging with fMRI has great potential as a way of characterizing typical development, and detecting abnormal development early. But, a number of methodological challenges must first be tackled to improve the robustness and sensitivity of neonatal fMRI. A critical one of these, addressed here, is that the hemodynamic response function (HRF) in pre-term and term neonates differs from that in adults, which has a number of implications for fMRI. We created a realistic model of noise in fMRI data, using resting-state fMRI data from infants and adults, and then conducted simulations to assess the effect of HRF of the power of different stimulation protocols and analysis assumptions (HRF modeling). We found that neonatal fMRI is most powerful if block-durations are kept at the lower range of those typically used in adults (full on/off cycle duration 25-30s). Furthermore, we show that it is important to use the age-appropriate HRF during analysis, as mismatches can lead to reduced power or even inverted signal. Where the appropriate HRF is not known (for example due to potential developmental delay), a flexible basis set performs well, and allows accurate post-hoc estimation of the HRF.	[Cusack, Rhodri; Wild, Conor; Linke, Annika C.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Cusack, Rhodri; Lee, David S. C.; Han, Victor K.] Childrens Hlth Res Inst, London, ON, Canada; [Arichi, Tomoki] Kings Coll London, Dept Perinatal Imaging & Hlth, London WC2R 2LS, England; [Arichi, Tomoki] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	Western University (University of Western Ontario); University of London; King's College London; Imperial College London	Cusack, R (corresponding author), Univ Western Ontario, Brain & Mind Inst, London, ON, Canada.	rhodri@cusacklab.org	Linke, Annika/AAR-2639-2021; Arichi, Tomoki/AFR-9798-2022; Cusack, Rhodri/A-2231-2010	Arichi, Tomoki/0000-0002-3550-1644; Cusack, Rhodri/0000-0002-5234-7415; Wild, Conor/0000-0002-4303-3537	Canadian Institutes of Health Research/National Science and Engineering Research Council Collaborative Health Research Programme [414500-2012]; National Institute for Health Research [ACF-2006-21-028, CL-2012-17-006] Funding Source: researchfish	Canadian Institutes of Health Research/National Science and Engineering Research Council Collaborative Health Research Programme(Canadian Institutes of Health Research (CIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors gratefully acknowledge financial support from the Canadian Institutes of Health Research/National Science and Engineering Research Council Collaborative Health Research Programme 414500-2012 (R.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Allen MC, 2008, CURR OPIN NEUROL, V21, P123, DOI 10.1097/WCO.0b013e3282f88bb4; Altman NR, 2001, RADIOLOGY, V221, P56, DOI 10.1148/radiol.2211010074; Anderson AW, 2001, MAGN RESON IMAGING, V19, P1, DOI 10.1016/S0730-725X(00)00231-9; Arichi T, 2010, NEUROIMAGE, V49, P2063, DOI 10.1016/j.neuroimage.2009.10.038; Arichi T, 2012, NEUROIMAGE, V63, P663, DOI 10.1016/j.neuroimage.2012.06.054; Arichi T, 2012, DEV MED CHILD NEUROL, V54, P680, DOI 10.1111/j.1469-8749.2012.04355.x; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Born P, 1998, PEDIATR RES, V44, P578, DOI 10.1203/00006450-199810000-00018; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Carter CS, 2008, BIOL PSYCHIAT, V64, P842, DOI 10.1016/j.biopsych.2008.06.014; Chen C-C, 2008, NOVEL TRENDS BRAIN S; Colonnese MT, 2008, NAT NEUROSCI, V11, P72, DOI 10.1038/nn2017; Cusack R, 2015, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00090; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; de Zwart JA, 2005, NEUROIMAGE, V24, P667, DOI 10.1016/j.neuroimage.2004.09.013; Dehaene-Lambertz G, 2010, BRAIN LANG, V114, P53, DOI 10.1016/j.bandl.2009.09.003; Dehaene-Lambertz G, 2002, SCIENCE, V298, P2013, DOI 10.1126/science.1077066; Erberich SG, 2003, NEUROIMAGE, V20, P683, DOI 10.1016/S1053-8119(03)00370-7; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Howseman A, 1997, SPECIAL ISSUES FUNCT; Kozberg MG, 2013, P NATL ACAD SCI USA, V110, P4380, DOI 10.1073/pnas.1212785110; Lee W, 2012, DEV MED CHILD NEUROL, V54, P724, DOI 10.1111/j.1469-8749.2012.04342.x; Liao SM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3369809; Perani D, 2011, P NATL ACAD SCI USA, V108, P16056, DOI 10.1073/pnas.1102991108; Rivkin MJ, 2004, MAGNET RESON MED, V51, P1287, DOI 10.1002/mrm.20098; Sato H., 2011, HUM BRAIN MAPP, P1; Skudlarski P, 1999, NEUROIMAGE, V9, P311, DOI 10.1006/nimg.1999.0402; Telkemeyer S, 2009, J NEUROSCI, V29, P14726, DOI 10.1523/JNEUROSCI.1246-09.2009; Yamada H, 2000, NEUROLOGY, V55, P218, DOI 10.1212/WNL.55.2.218; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263	32	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0120202	10.1371/journal.pone.0120202	http://dx.doi.org/10.1371/journal.pone.0120202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266954	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300002
J	Hogg, RT; Godfrey, LR; Schwartz, GT; Dirks, W; Bromage, TG				Hogg, Russell T.; Godfrey, Laurie R.; Schwartz, Gary T.; Dirks, Wendy; Bromage, Timothy G.			Lemur Biorhythms and Life History Evolution	PLOS ONE			English	Article							SEMICIRCULAR CANAL SYSTEM; DENTAL DEVELOPMENT; METABOLIC-RATES; BRAIN SIZE; BODY-SIZE; ENAMEL; EXTINCT; ENERGETICS; TISSUE	Skeletal histology supports the hypothesis that primate life histories are regulated by a neuroendocrine rhythm, the Havers-Halberg Oscillation (HHO). Interestingly, subfossil lemurs are outliers in HHO scaling relationships that have been discovered for haplorhine primates and other mammals. We present new data to determine whether these species represent the general lemur or strepsirrhine condition and to inform models about neuroendocrinemediated life history evolution. We gathered the largest sample to date of HHO data from histological sections of primate teeth (including the subfossil lemurs) to assess the relationship of these chronobiological measures with life history-related variables including body mass, brain size, age at first female reproduction, and activity level. For anthropoids, these variables show strong correlations with HHO conforming to predictions, though body mass and endocranial volume are strongly correlated with HHO periodicity in this group. However, lemurs (possibly excepting Daubentonia) do not follow this pattern and show markedly less variability in HHO periodicity and lower correlation coefficients and slopes. Moreover, body mass is uncorrelated, and brain size and activity levels are more strongly correlated with HHO periodicity in these animals. We argue that lemurs evolved this pattern due to selection for risk-averse life histories driven by the unpredictability of the environment in Madagascar. These results reinforce the idea that HHO influences life history evolution differently in response to specific ecological selection regimes.	[Hogg, Russell T.] Florida Gulf Coast Univ, Dept Rehabil Sci, Ft Myers, FL 33965 USA; [Godfrey, Laurie R.] Univ Massachusetts, Dept Anthropol, Amherst, MA 01003 USA; [Schwartz, Gary T.] Arizona State Univ, Inst Human Origins, Tempe, AZ USA; [Schwartz, Gary T.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Dirks, Wendy] Univ Durham, Dept Anthropol, Durham, England; [Bromage, Timothy G.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA; [Bromage, Timothy G.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY USA	State University System of Florida; Florida Gulf Coast University; University of Massachusetts System; University of Massachusetts Amherst; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Durham University; New York University; New York University	Hogg, RT (corresponding author), Florida Gulf Coast Univ, Dept Rehabil Sci, Ft Myers, FL 33965 USA.	rhogg@fgcu.edu	bromage, timothy/H-8621-2015	bromage, timothy/0000-0002-9843-7993	National Science Foundation [BCS-0622479, BCS-0237338, BCS-0503988, BCS-1062680]; Natural History Collections at the University of Massachusetts; Royal Society of London; Institute of Human Origins; Max Planck Research Award; Division Of Behavioral and Cognitive Sci [1062680] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Natural History Collections at the University of Massachusetts; Royal Society of London(Royal Society of London); Institute of Human Origins; Max Planck Research Award(Max Planck Society); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by National Science Foundation (http://www.nsf.gov) grants BCS-0622479 (RTH), BCS-0237338, BCS-0503988 (LRG and GTS), and BCS-1062680 (TGB); The Natural History Collections at the University of Massachusetts (http://bcrc.bio.umass.edu/ummnh/) (LRG); The Royal Society of London (http://www.royalsociety.org) (WD); The Institute of Human Origins (https://iho.asu.edu) (GTS); and the Max Planck Research Award (http://www.mpg.de/en), which is endowed by the German Federal Ministry of Education and Research to the Max Planck Society and the Alexander von Humboldt Foundation in respect of the Hard Tissue Research Program in Human Paleobiomics (TGB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asper H, 1916, VIERTELJAHRSCHRIFT Z, V26, P277; Barrickman NL, 2010, AM J PHYS ANTHROPOL, V143, P579, DOI 10.1002/ajpa.21354; Bromage TG, 2014, BIOL J LINN SOC, V112, P649, DOI 10.1111/bij.12269; Bromage TG, 2012, J THEOR BIOL, V305, P131, DOI 10.1016/j.jtbi.2012.04.007; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown MF, 2007, AM J PHYSIOL-REG I, V292, pR2115, DOI 10.1152/ajpregu.00568.2006; Burnham K P, 2003, MODEL SELECT MULTIMO; Catlett KK, 2010, AM J PHYS ANTHROPOL, V142, P391, DOI 10.1002/ajpa.21236; Clift PD, 2006, EARTH PLANET SC LETT, V241, P571, DOI 10.1016/j.epsl.2005.11.028; Crowley BE, 2013, S AFR J SCI, V109, P70, DOI 10.1590/sajs.2013/1346; Delson Eric, 2000, Anthropological Papers of the American Museum of Natural History, V83, P1; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Dirks W, 2007, J HUM EVOL, V53, P309, DOI 10.1016/j.jhevol.2007.04.007; Elgar MA, 1987, FUNCT ECOL, V1, P25, DOI 10.2307/2389354; FitzGerald CM, 1998, J HUM EVOL, V35, P371, DOI 10.1006/jhev.1998.0232; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Genoud M, 2002, EVOL ANTHROPOL, V11, P108, DOI 10.1002/evan.10070; Glenn ME, 1997, AM J PRIMATOL, V43, P167; Godfrey Laurie R., 2006, P41, DOI 10.1007/978-0-387-34586-4_3; Godfrey Laurie R., 2013, P51; Godfrey LR, 2005, INT J PRIMATOL, V26, P825, DOI 10.1007/s10764-005-5325-3; Godfrey LR, 2004, AM J PHYS ANTHROPOL, V123, P250, DOI 10.1002/ajpa.10315; Godfrey LR, 2001, AM J PHYS ANTHROPOL, V114, P192, DOI 10.1002/1096-8644(200103)114:3<192::AID-AJPA1020>3.0.CO;2-Q; Goodman S.M., 2014, EXTINCT MADAGASCAR P; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hartwig WC, 1996, AM J PRIMATOL, V40, P99, DOI 10.1002/(SICI)1098-2345(1996)40:2<99::AID-AJP1>3.0.CO;2-V; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; Hogg RT, 2010, THESIS CITY U NEW YO; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; Ivany LC, 2000, NATURE, V407, P887, DOI 10.1038/35038044; Janson Charles H., 1993, P57; Jungers WL, 2008, DEV PRIMATOL-PROG PR, P343, DOI 10.1007/978-0-387-73896-3_23; Kelley J, 2012, INT J PRIMATOL, V33, P1332, DOI 10.1007/s10764-012-9607-2; Kistler L, 2015, J HUM EVOL, V79, P45, DOI 10.1016/j.jhevol.2014.06.016; Lindenfors P, 2002, J EVOLUTION BIOL, V15, P595, DOI 10.1046/j.1420-9101.2002.00422.x; Macho GA, 1996, J HUM EVOL, V30, P57, DOI 10.1006/jhev.1996.0004; Martin R.D., 1990, PRIMATE ORIGINS EVOL; MARTIN RD, 1972, PHILOS T ROY SOC B, V264, P295, DOI 10.1098/rstb.1972.0013; Masters JC, 2007, J BIOGEOGR, V34, P21, DOI 10.1111/j.1365-2699.2006.01569.x; Nakagawa N, 2000, AM J PRIMATOL, V52, P169, DOI 10.1002/1098-2345(200012)52:4<169::AID-AJP2>3.0.CO;2-B; Pearson PN, 2008, GEOLOGY, V36, P179, DOI 10.1130/G24308A.1; Perry GH, 2012, GENOME BIOL EVOL, V4, P126, DOI 10.1093/gbe/evr132; PROTHERO DR, 1994, ANNU REV EARTH PL SC, V22, P145, DOI 10.1146/annurev.ea.22.050194.001045; Samonds KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062086; Schmid J, 1996, AM J PRIMATOL, V38, P169, DOI 10.1002/(SICI)1098-2345(1996)38:2<169::AID-AJP5>3.0.CO;2-X; Schwartz GT, 2005, J HUM EVOL, V49, P702, DOI 10.1016/j.jhevol.2005.08.006; Schwartz GT, 2002, P NATL ACAD SCI USA, V99, P6124, DOI 10.1073/pnas.092685099; Shellis RP, 1998, J HUM EVOL, V35, P387, DOI 10.1006/jhev.1998.0260; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; Spoor F, 2007, P NATL ACAD SCI USA, V104, P10808, DOI 10.1073/pnas.0704250104; Sterling Eleanor J., 2006, P159, DOI 10.1007/978-0-387-34586-4_8; Tafforeau P., 2004, THESIS U MONTPELLIER; van Woerden JT, 2010, AM NAT, V176, P758, DOI 10.1086/657045; WALKER A, 1983, NATURE, V305, P525, DOI 10.1038/305525a0; Walker A, 2008, EVOL ANTHROPOL, V17, P135, DOI 10.1002/evan.20165; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100	58	17	17	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134210	10.1371/journal.pone.0134210	http://dx.doi.org/10.1371/journal.pone.0134210			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267241	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000359492300037
J	Hoile, SP; Grenfell, LM; Hanson, MA; Lillycrop, KA; Burdge, GC				Hoile, Samuel P.; Grenfell, Leonie M.; Hanson, Mark A.; Lillycrop, Karen A.; Burdge, Graham C.			Fat and Carbohydrate Intake over Three Generations Modify Growth, Metabolism and Cardiovascular Phenotype in Female Mice in an Age-Related Manner	PLOS ONE			English	Article							IN-UTERO; RATS; DIET; WOMEN; ASSOCIATION; HYPOSPADIAS; DYSFUNCTION; PREGNANCY; EXPOSURE	Environmental challenges such as a high fat diet during pregnancy can induce changes in offspring growth, metabolism and cardiovascular function. However, challenges that are sustained over several generations can induce progressive compensatory metabolic adjustments in young adults. It is not known if such effects persist during ageing. We investigated whether diets with different fat and carbohydrate contents over three generations modifies markers of ageing. Female C57BL/6 F0 mice were fed diets containing 5% or 21% fat (w/w) throughout pregnancy and lactation. Female offspring were fed the same diet as their dams until the F3 generation. In each generation, body weight, 24-hour food intake were recorded weekly, and plasma metabolites were measured by colorimetric assays, blood pressure by tail cuff plethysmography and vasoconstriction by myography on postnatal day 90 or 456. There was little effect of diet or generation on phenotypic markers in day 90 adults. There was a significant increase in whole body, liver and heart weight with ageing (d456) in the F3 21% fat group compared to the F1 and F3 5% groups. Fasting plasma glucose concentration was significantly increased with ageing in the 5% group in the F3 generation and in the 21% group in both generations. There was a significant effect of diet and generation on ex-vivo vasoconstriction in ageing females. Differences in dietary fat may induce metabolic compensation in young adults that persist over three generations. However, such compensatory effects decline during ageing.	[Hoile, Samuel P.; Grenfell, Leonie M.; Hanson, Mark A.; Burdge, Graham C.] Univ Southampton, Fac Med, Acad Unit Human Dev & Hlth, Southampton SO9 5NH, Hants, England; [Lillycrop, Karen A.] Univ Southampton, Fac Environm & Nat Sci, Ctr Biol Sci, Southampton, Hants, England	University of Southampton; University of Southampton	Lillycrop, KA (corresponding author), Univ Southampton, Fac Environm & Nat Sci, Ctr Biol Sci, Southampton, Hants, England.	k.a.lillycrop@soton.ac.uk	Hanson, Mark/AAE-8236-2019; Burdge, Graham/A-2370-2014	Hanson, Mark/0000-0002-6907-613X; Burdge, Graham/0000-0002-7665-2967; Price, Leonie/0000-0002-8547-3549; Lillycrop, Karen/0000-0001-7350-5489	European Union 7th Framework award IDEAL [259679]	European Union 7th Framework award IDEAL	SPH and LRG receive salary support from European Union 7th Framework award IDEAL (259679).	ADOLPH EF, 1947, AM J PHYSIOL, V151, P110, DOI 10.1152/ajplegacy.1947.151.1.110; Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P171, DOI 10.1113/jphysiol.2005.084947; Armitage JA, 2007, EXP PHYSIOL, V92, P583, DOI 10.1113/expphysiol.2006.036202; BAILEY CJ, 1982, METABOLISM, V31, P238, DOI 10.1016/0026-0495(82)90059-2; Bengmark S, 2006, CURR OPIN CLIN NUTR, V9, P2, DOI 10.1097/01.mco.0000171129.29278.26; BOOTH DA, 1972, PHYSIOL BEHAV, V8, P891, DOI 10.1016/0031-9384(72)90302-2; Brouwers MM, 2006, HUM REPROD, V21, P666, DOI 10.1093/humrep/dei398; Bruce KD, 2009, HEPATOLOGY; Burdge GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028282; Das M, 2004, Obes Rev, V5, P13, DOI 10.1111/j.1467-789X.2004.00115.x; DEPUE RH, 1983, J NATL CANCER I, V71, P1151; Drake AJ, 2005, AMJPHYSIOL REGULINTE, V288; GILL WB, 1979, J UROLOGY, V122, P36, DOI 10.1016/S0022-5347(17)56240-0; HANSEN BC, 1981, PHYSIOL BEHAV, V26, P479, DOI 10.1016/0031-9384(81)90177-3; Herbst AL, 1999, AM J OBSTET GYNECOL, V181, P1574, DOI 10.1016/S0002-9378(99)70411-4; Hoile SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021668; JANOWITZ HD, 1949, AM J PHYSIOL, V158, P184, DOI 10.1152/ajplegacy.1949.158.2.184; Kaufman RH, 2002, OBSTET GYNECOL, V99, P197, DOI 10.1016/S0029-7844(01)01682-9; Kelsall CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034492; Khan IY, 2005, AM J PHYSIOL-REG I, V288, pR127, DOI 10.1152/ajpregu.00354.2004; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Klip H, 2002, LANCET, V359, P1102, DOI 10.1016/S0140-6736(02)08152-7; LangleyEvans SC, 1996, INT J FOOD SCI NUTR, V47, P417, DOI 10.3109/09637489609006955; Laurent S, 2012, J HYPERTENS, V30, pS3, DOI 10.1097/HJH.0b013e328353e501; MCHUGH PR, 1979, AM J PHYSIOL, V236, pR254, DOI 10.1152/ajpregu.1979.236.5.R254; MCHUGH PR, 1978, AM J PHYSIOL, V235, pR29, DOI 10.1152/ajpregu.1978.235.1.R29; Meyer JH, 2001, PHYSIOL BEHAV, V72, P325, DOI 10.1016/S0031-9384(00)00419-4; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Plagemann A, 2009, JPHYSIOL, V587; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Slater-Jefferies JL, 2011, J DEV ORIG HLTH DIS, V2, P250, DOI 10.1017/S2040174410000425; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Stevens A, 2011, EUR J PHARMACOL, V660, P194, DOI 10.1016/j.ejphar.2010.10.111; Taylor PD, 2004, J PHYSIOL-LONDON, V558, P943, DOI 10.1113/jphysiol.2002.018879; Taylor PD, 2003, EXP PHYSIOL, V88, P389, DOI 10.1113/eph8802495; Vafeiadou K, 2012, BRIT J NUTR, V107, P303, DOI 10.1017/S0007114511004764; WILCOX AJ, 1995, AM J OBSTET GYNECOL, V173, P835, DOI 10.1016/0002-9378(95)90350-X; Zambrano E, 2005, JPHYSIOL, V566	42	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134664	10.1371/journal.pone.0134664	http://dx.doi.org/10.1371/journal.pone.0134664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266533	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000359492300055
J	Kelehear, C; Jones, HI; Wood, BA; Shine, R				Kelehear, Crystal; Jones, Hugh I.; Wood, Benjamin A.; Shine, Richard			Wild Cane Toads (Rhinella marina) Expel Foreign Matter from the Coelom via the Urinary Bladder in Response to Internal Injury, Endoparasites and Disease	PLOS ONE			English	Article							IMPLANTED DUMMY TRANSMITTERS; BUFO-MARINUS; RHABDIAS-PSEUDOSPHAEROCEPHALA; TRANSINTESTINAL EXPULSION; TROPICAL AUSTRALIA; FROGS; BUFONIDAE; DYNAMICS; ANURA; ACANTHOCEPHALA	Dissections of > 1,200 wild-caught cane toads (Rhinella marina) in tropical Australia confirm a laboratory report that anurans can expel foreign objects from the coelom by incorporating them into the urinary bladder. The foreign objects that we found inside bladders included a diverse array of items (e.g., grass seeds, twigs, insect prey, parasites), many of which may have entered the coelom via rupture of the gut wall. In some cases, the urinary bladder was fused to other organs including liver, fat bodies, ovaries, Bidder's organs, lungs, mesentery, stomach wall, gall bladder, and the abdominal wall. Acanthocephalan parasites (of a range of developmental stages) were identified from the walls of the urinary bladders of three cane toads. This organ may play a significant role in destroying or excreting metazoan parasites, as well as inanimate objects.	[Kelehear, Crystal; Shine, Richard] Univ Sydney, Sch Biol Sci, Camperdown, NSW, Australia; [Jones, Hugh I.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia; [Wood, Benjamin A.] Queen Elizabeth Med Ctr, PathWest Lab Med, Nedlands, WA, Australia	University of Sydney; University of Western Australia; University of Western Australia	Kelehear, C (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	crystal.kelehear@hotmail.com	Kelehear, Crystal/G-7625-2011	Kelehear, Crystal/0000-0003-3343-131X	Australian Research Council [FL120100074]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council (http://www.arc.gov.au) Grant FL120100074 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo NJ, 2009, FOLIA PARASIT, V56, P295, DOI 10.14411/fp.2009.034; Baras E, 1999, T AM FISH SOC, V128, P737, DOI 10.1577/1548-8659(1999)128&lt;0737:TEOSIT&gt;2.0.CO;2; Barton D.P., 1994, REC S AUST MUS, V27, P13; Barton DP, 1999, PARASITE, V6, P269, DOI 10.1051/parasite/1999063269; Brown GP, 2006, BIOL CONSERV, V133, P88, DOI 10.1016/j.biocon.2006.05.020; Brown LJ, 1997, J HERPETOL, V31, P410, DOI 10.2307/1565670; Drake MC, 2014, J PARASITOL, V100, P608, DOI 10.1645/13-470.1; EDMONDS S J, 1989, Records of the South Australian Museum (Adelaide), V23, P127; Espinola-Novelo JF, 2008, J PARASITOL, V94, P672, DOI 10.1645/GE-1384.1; Essner RL, 2010, NATURWISSENSCHAFTEN, V97, P935, DOI 10.1007/s00114-010-0697-4; FREELAND WJ, 1986, AUST WILDLIFE RES, V13, P489; Galicia-Guerrero S, 2000, COMP PARASITOL, V67, P129; Glorioso Brad M., 2012, Herpetological Review, V43, P627; GOODCHILD CG, 1956, J EXP ZOOL, V131, P301, DOI 10.1002/jez.1401310307; Kelehear C, 2013, OIKOS, V122, P1317, DOI 10.1111/j.1600-0706.2013.00292.x; Kelehear C, 2010, J WILDLIFE DIS, V46, P1126, DOI 10.7589/0090-3558-46.4.1126; Lane M, 2015, MICROCHIP IDENTIFICA; MARTY GD, 1986, T AM FISH SOC, V115, P577, DOI 10.1577/1548-8659(1986)115<577:PAMFEO>2.0.CO;2; Meyer CG, 2005, T AM FISH SOC, V134, P602, DOI 10.1577/T04-082.1; Nauwelaerts S, 2006, J EXP BIOL, V209, P66, DOI 10.1242/jeb.01969; Nordick Andrew W., 2015, Herpetological Review, V46, P18; Pearson David J., 2002, Herpetological Review, V33, P261; Pizzatto L, 2013, INT J PARASITOL, V43, P753, DOI 10.1016/j.ijpara.2013.05.002; Pizzatto L, 2010, J WILDLIFE DIS, V46, P1152, DOI 10.7589/0090-3558-46.4.1152; Roark AW, 2000, J HERPETOL, V34, P481, DOI 10.2307/1565378; Roberts LS, 2012, FDN PARASITOLOGY; SPEARE R, 1990, AUST WILDLIFE RES, V17, P387; SUMMERFELT RC, 1984, T AM FISH SOC, V113, P760, DOI 10.1577/1548-8659(1984)113<760:TEOSID>2.0.CO;2; Tracy CR, 2011, BIOL LETTERS, V7, P465, DOI 10.1098/rsbl.2010.0877	29	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134036	10.1371/journal.pone.0134036	http://dx.doi.org/10.1371/journal.pone.0134036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267862	Green Published, gold			2022-12-27	WOS:000359492300031
J	Knight, L; Todd, G; Muloiwa, R; Matjila, M; Lehloenya, RJ				Knight, Lauren; Todd, Gail; Muloiwa, Rudzani; Matjila, Mushi; Lehloenya, Rannakoe J.			Stevens Johnson Syndrome and Toxic Epidermal Necrolysis: Maternal and Foetal Outcomes in Twenty-Two Consecutive Pregnant HIV Infected Women	PLOS ONE			English	Article							COHORT; AFRICA; RISK	Introduction Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) form a spectrum of a rare and life-threatening cutaneous drug reaction. SJS/TEN in pregnancy poses largely unknown risk factors and outcomes for both the mother and foetus compared to the general population. Methods We conducted a study of consecutive pregnant women admitted to single tertiary referral centre in South Africa with SJS/TEN over a 3 year period. They were all managed by the same medical team using the same protocols. We evaluated their underlying illnesses, offending drugs and the course of pregnancy and outcomes to determine factors influencing maternal and foetal outcomes. Results We identified twenty-two women who developed SJS/TEN while pregnant, all of them HIV-infected. Their median age was 29 years. The majority 16/22 (73%) had SJS, the milder variant of the disease affecting < 10% body surface area. Nevirapine was the offending drug in 21/22 (95%) cases. All 22 of the mothers survived with 3/22 (14%) developing postpartum sepsis. Pregnancy outcomes were known in 18/22 women and 9/18 (50%) babies were delivered by caesarean section. There were 2 foetal deaths at 21 and 31 weeks respectively and both were associated with post-partum sepsis. Postnatal complications occurred in 5 cases, 3 involving the respiratory system and the other two being low birth weight deliveries. Eight placentae and one foetus were sent for histology and none showed macroscopic or microscopic features of SJS/TEN. On follow-up, only weeks post-delivery and none of them were HIV-infected. All had received prophylactic ARVs including nevirapine. Conclusions TEN, the severe form of the disease, was associated with poorer foetal outcomes. SJS/TEN-associated mortality is not increased in HIV-infected pregnant women. Maternal SJS/TEN does not seem to commonly manifest in the foetus.	[Knight, Lauren; Todd, Gail; Lehloenya, Rannakoe J.] Univ Cape Town, Dept Med, Div Dermatol, ZA-7925 Cape Town, South Africa; [Muloiwa, Rudzani] Univ Cape Town, Dept Paediat & Child Hlth, ZA-7925 Cape Town, South Africa; [Matjila, Mushi] Univ Cape Town, Dept Obstet & Gynaecol, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Lehloenya, RJ (corresponding author), Univ Cape Town, Dept Med, Div Dermatol, ZA-7925 Cape Town, South Africa.	rannakoe.lehloenya@uct.ac.za	Muloiwa, Rudzani/AAY-7338-2020; Muloiwa, Rudzani/AAG-8139-2021; Todd, Gail/AAI-8952-2020; Lehloenya, Rannakoe J/C-5672-2012	Muloiwa, Rudzani/0000-0002-4527-0827; Lehloenya, Rannakoe J/0000-0002-1281-1789				[Anonymous], 2011, MID POP EST; Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Dube N, 2013, SAMJ S AFR MED J, V103, P322, DOI 10.7196/SAMJ.6077; Fellahi A, 2011, ANN DERMATOL VENER, V138, P88, DOI 10.1016/j.annder.2010.10.029; Finkelstein Y, 2011, PEDIATRICS, V128, P723, DOI 10.1542/peds.2010-3322; Garcia-Doval I, 2000, ARCH DERMATOL, V136, P323, DOI 10.1001/archderm.136.3.323; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; George SMC, 2008, CRIT CARE, V12, DOI 10.1186/cc6141; Kannenberg SMH, 2012, QJM-INT J MED, V105, P839, DOI 10.1093/qjmed/hcs078; Knight L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093543; Koh MJA, 2010, J AM ACAD DERMATOL, V62, P54, DOI 10.1016/j.jaad.2009.06.085; Kourouma S, 2014, MED SANTE TROP, V24, P94, DOI 10.1684/mst.2013.0272; KRATZERT K, 1988, OBSTET GYNECOL, V72, P447; Limpawattana P, 2014, J DERMATOL, V41, P634, DOI 10.1111/1346-8138.12499; Macdonald EM, 2014, INT J PEDIAT, V2014, DOI 10.1155/2014/291846; Mittmann N, 2012, AM J CLIN DERMATOL, V13, P49, DOI 10.2165/11593240-000000000-00000; Niemeijer IC, 2009, ARCH GYNECOL OBSTET, V280, P851, DOI 10.1007/s00404-009-1008-1; Oplatek A, 2006, J BURN CARE RES, V27, P26, DOI 10.1097/01.bcr.0000194268.01514.f8; PERRY IJ, 1995, BMJ-BRIT MED J, V310, P436, DOI 10.1136/bmj.310.6977.436; Pliskow S, 2013, J REPROD MED, V58, P354; REVUZ J, 1987, ARCH DERMATOL, V123, P1160, DOI 10.1001/archderm.123.9.1160; Rodriguez G, 2006, J AM ACAD DERMATOL, V55, pS96, DOI 10.1016/j.jaad.2005.09.021; Roujeau Jean-Claude, 1997, Journal of Dermatology (Tokyo), V24, P726; Rowan DM, 2010, J LOW GENIT TRACT DI, V14, P390, DOI 10.1097/LGT.0b013e3181ddf5da; Saka B, 2010, Med Trop (Mars), V70, P255; Saka B, 2013, INT J DERMATOL, V52, P575, DOI 10.1111/j.1365-4632.2012.05743.x; Sekula P, 2013, J INVEST DERMATOL, V133, P1197, DOI 10.1038/jid.2012.510; Struck MF, 2010, J BURN CARE RES, V31, P816, DOI 10.1097/BCR.0b013e3181eed441; Wetter DA, 2010, MAYO CLIN PROC, V85, P131, DOI 10.4065/mcp.2009.0379; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864	31	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135501	10.1371/journal.pone.0135501	http://dx.doi.org/10.1371/journal.pone.0135501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267659	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300128
J	Prevato, M; Cozzi, R; Pezzicoli, A; Taddei, AR; Ferlenghi, I; Nandi, A; Montomoli, E; Settembre, EC; Bertholet, S; Bonci, A; Legay, F				Prevato, Marua; Cozzi, Roberta; Pezzicoli, Alfredo; Taddei, Anna Rita; Ferlenghi, Ilaria; Nandi, Avishek; Montomoli, Emanuele; Settembre, Ethan C.; Bertholet, Sylvie; Bonci, Alessandra; Legay, Francois			An Innovative Pseudotypes-Based Enzyme-Linked Lectin Assay for the Measurement of Functional Anti-Neuraminidase Antibodies	PLOS ONE			English	Article							INFLUENZA VIRAL NEURAMINIDASE; VIRUS; VACCINE; HEMAGGLUTININ; PROTECTION; PARTICLES	Antibodies (Ab) to neuraminidase (NA) play a role in limiting influenza infection and might help reduce the disease impact. The most widely used serological assay to measure functional anti-NA immune responses is the Enzyme-Linked Lectin Assay (ELLA) which relies on hemagglutinin (HA) mismatched virus reassortants, or detergent treated viruses as the NA source to overcome interference associated with steric hindrance of anti-HA Ab present in sera. The difficulty in producing and handling these reagents, which are not easily adapted for screening large numbers of samples, limits the routine analysis of functional anti-NA Ab in clinical trials. In this study, we produced influenza lentiviral pseudoparticles (PPs) containing only the NA antigen (NA-PPs) with a simple two-plasmid co-transfection system. NA-PPs were characterized and tested as an innovative source of NA in the NA inhibition (NI) assay. Both swine A/California/07/2009 (H1N1) and avian A/turkey/Turkey/01/2005 (H5N1) N1s within NA-PPs retained their sialidase activity and were specifically inhibited by homologous and N1 subtype-specific, heterologous sheep sera. Moreover, A/California/07/2009 N1-PPs were a better source of NA compared to whole live and detergent treated H1N1 viruses in ELLA, likely due to lack of interference by anti-HA Ab, and absence of possible structural modifications caused by treatment with detergent. This innovative assay is safer and applicable to all NAs. Taken together, these results highlight the potential of NA-PPs-based NI assays to be developed as sensitive, flexible, easy to handle and scalable serological tests for routine NA immune response analysis.	[Prevato, Marua] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Cozzi, Roberta; Pezzicoli, Alfredo; Ferlenghi, Ilaria; Bertholet, Sylvie; Bonci, Alessandra; Legay, Francois] GSK, Res Ctr, I-53100 Siena, Italy; [Taddei, Anna Rita] Univ Tuscia, Great Equipment Ctr, Sect Electron Microscopy, I-01100 Viterbo, Italy; [Nandi, Avishek] GSK, Vaccine Res, Holly Springs, NC 27540 USA; [Nandi, Avishek; Settembre, Ethan C.] GSK, Vaccine Res, Cambridge, MA 02139 USA; [Montomoli, Emanuele] Univ Siena, Dept Mol & Dev Med, I-53100 Siena, Italy; [Legay, Francois] GSK, CH-4056 Basel, Switzerland	University of Siena; GlaxoSmithKline; Tuscia University; GlaxoSmithKline; GlaxoSmithKline; University of Siena; GlaxoSmithKline	Legay, F (corresponding author), GSK, Res Ctr, Via Fiorentina 1, I-53100 Siena, Italy.	francois.legay@novartis.com	MONTOMOLI, EMANUELE/Q-2122-2015	MONTOMOLI, EMANUELE/0000-0001-7595-4974	GSK	GSK(GlaxoSmithKline)	GSK provided support in the form of salaries for authors RC, AP, IF, AN, ECS, SB, AB and FL but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alberini I, 2009, VACCINE, V27, P5998, DOI 10.1016/j.vaccine.2009.07.079; Aymard M, 2003, Dev Biol (Basel), V115, P75; Cate TR, 2010, VACCINE, V28, P2076, DOI 10.1016/j.vaccine.2009.12.041; Chen ZY, 2012, VACCINE, V30, P2516, DOI 10.1016/j.vaccine.2012.01.090; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; Eichelberger MC, 2015, CURR TOP MICROBIOL, V386, P275, DOI 10.1007/82_2014_398; Fritz R, 2012, J INFECT DIS, V205, P28, DOI 10.1093/infdis/jir711; Garcia JM, 2011, EXPERT REV ANTI-INFE, V9, P443, DOI [10.1586/eri.11.25, 10.1586/ERI.11.25]; Gavrilov V, 2011, J VIROL METHODS, V173, P364, DOI 10.1016/j.jviromet.2011.03.011; Johansson BE, 2007, VACCINE, V25, P3062, DOI 10.1016/j.vaccine.2007.01.030; Johansson BE, 2011, EXPERT REV VACCINES, V10, P1683, DOI [10.1586/erv.11.130, 10.1586/ERV.11.130]; Jonges M, 2010, J CLIN MICROBIOL, V48, P928, DOI 10.1128/JCM.02045-09; LAMBRE CR, 1990, J IMMUNOL METHODS, V135, P49, DOI 10.1016/0022-1759(90)90255-T; Marcelin G, 2012, REV MED VIROL, V22, P267, DOI 10.1002/rmv.1713; Mather ST, 2014, J VIROL METHODS, V210, P51, DOI 10.1016/j.jviromet.2014.09.021; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Molesti E, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/457932; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Sandbulte MR, 2009, INFLUENZA OTHER RESP, V3, P233, DOI 10.1111/j.1750-2659.2009.00094.x; SCHULMAN JL, 1969, P NATL ACAD SCI USA, V63, P326, DOI 10.1073/pnas.63.2.326; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Sylte MJ, 2009, CURR TOP MICROBIOL, V333, P227, DOI 10.1007/978-3-540-92165-3_12; Temperton NJ, 2007, INFLUENZA OTHER RESP, V1, P105, DOI 10.1111/j.1750-2659.2007.00016.x; WEBSTER RG, 1988, VIROLOGY, V164, P230, DOI 10.1016/0042-6822(88)90640-X; Wohlbold TJ, 2014, VIRUSES-BASEL, V6, P2465, DOI 10.3390/v6062465; World Health Organization, 2014, INFL SEAS FACT SHEET; Wright E, 2009, ENCICLOPEDIA LIFE SC, P1	28	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135383	10.1371/journal.pone.0135383	http://dx.doi.org/10.1371/journal.pone.0135383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267900	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300109
J	Raina, D; Agarwal, P; Lee, J; Bharti, A; McKnight, CJ; Sharma, P; Kharbanda, S; Kufe, D				Raina, Deepak; Agarwal, Praveen; Lee, James; Bharti, Ajit; McKnight, C. James; Sharma, Pankaj; Kharbanda, Surender; Kufe, Donald			Characterization of the MUC1-C Cytoplasmic Domain as a Cancer Target	PLOS ONE			English	Article							INTRINSIC DISORDER; ONCOPROTEIN; ACTIVATION; PREDICTION; SURVIVAL	Mucin 1 (MUC1) is a heterodimeric protein that is aberrantly expressed in diverse human carcinomas and certain hematologic malignancies. The oncogenic MUC1 transmembrane C-terminal subunit (MUC1-C) functions in part by transducing growth and survival signals from cell surface receptors. However, little is known about the structure of the MUC1-C cytoplasmic domain as a potential drug target. Using methods for structural predictions, our results indicate that a highly conserved CQCRRK sequence, which is adjacent to the cell membrane, forms a small pocket that exposes the two cysteine residues for forming disulfide bonds. By contrast, the remainder of the MUC1-C cytoplasmic domain has no apparent structure, consistent with an intrinsically disordered protein. Our studies thus focused on targeting the MUC1 CQCRRK region. The results show that L-and D-amino acid CQCRRK-containing peptides bind directly to the CQC motif. We further show that the D-amino acid peptide, designated GO-203, blocks homodimerization of the MUC1-C cytoplasmic domain in vitro and in transfected cells. Moreover, GO-203 binds directly to endogenous MUC1-C in breast and lung cancer cells. Colocalization studies further demonstrate that GO-203 predominantly binds to MUC1-C at the cell membrane. These findings support the further development of agents that target the MUC1-C cytoplasmic domain CQC motif and thereby MUC1-C function in cancer cells.	[Raina, Deepak; Lee, James; Kharbanda, Surender; Kufe, Donald] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Raina, Deepak; Kharbanda, Surender] Genus Oncol, Boston, MA 02118 USA; [Agarwal, Praveen; Sharma, Pankaj] LeadInvent, New Delhi, India; [Bharti, Ajit] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [McKnight, C. James] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Boston University; Boston University	Kufe, D (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA.	donald_kufe@dfci.harvard.edu		McKnight, Christopher/0000-0002-3237-0896; Bharti, Ajit/0000-0001-7972-6688	National Cancer Institute of the National Institutes of Health [CA097098, CA166480]; Genus Oncology; LeadInvent; NATIONAL CANCER INSTITUTE [R01CA097098, R01CA042802, R01CA166480] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genus Oncology; LeadInvent; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under awards CA097098 and CA166480, http://www.cancer.gov (D.K.). Genus Oncology provided support in the form of salaries for authors D.R. and S.K. LeadInvent provided support in the form of salaries for authors P.A. and P.S. The specific roles of these authors are articulated in the "authors contributions section". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Case D.A., 2022, AMBER; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Hao JH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000138; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Kharbanda A, 2014, CLIN CANCER RES, V20, P5423, DOI 10.1158/1078-0432.CCR-13-3168; Khodarev N, 2010, ONCOGENE, V29, P920, DOI 10.1038/onc.2009.391; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; KUFE D, 2009, CANCER BIOL THER, V8, P1201; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Malaney P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02035; McEwan IJ, 2012, MOL BIOSYST, V8, P82, DOI 10.1039/c1mb05249g; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Raina D, 2012, INT J ONCOL, V40, P1644, DOI 10.3892/ijo.2011.1308; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Rajabi H, 2012, J BIOL CHEM, V287, P10703, DOI 10.1074/jbc.M111.323311; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren J, 2006, ONCOGENE, V25, P20, DOI 10.1038/sj.onc.1209012; Shah A, 2010, CURR PROTEOMICS, V7, P49, DOI 10.2174/157016410790979635; Smirnov SL, 2007, BIOCHEMISTRY-US, V46, P7488, DOI 10.1021/bi700110v; Stroopinsky D, 2013, CANCER RES, V73, P5569, DOI 10.1158/0008-5472.CAN-13-0677; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Zhou YC, 2011, MOL PHARMACOL, V79, P886, DOI 10.1124/mol.110.070797	32	45	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135156	10.1371/journal.pone.0135156	http://dx.doi.org/10.1371/journal.pone.0135156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267657	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300084
J	Sae-Lim, P; Mulder, H; Gjerde, B; Koskinen, H; Lillehammer, M; Kause, A				Sae-Lim, Panya; Mulder, Han; Gjerde, Bjarne; Koskinen, Heikki; Lillehammer, Marie; Kause, Antti			Genetics of Growth Reaction Norms in Farmed Rainbow Trout	PLOS ONE			English	Article							PLANT-BASED DIETS; ENVIRONMENT INTERACTION; PHENOTYPIC PLASTICITY; ONCORHYNCHUS-MYKISS; BODY-WEIGHT; QUANTITATIVE GENETICS; SEXUAL-MATURITY; LIFE-HISTORY; GENOTYPE; SELECTION	Rainbow trout is farmed globally under diverse uncontrollable environments. Fish with low macroenvironmental sensitivity (ES) of growth is important to thrive and grow under these uncontrollable environments. The ES may evolve as a correlated response to selection for growth in one environment when the genetic correlation between ES and growth is nonzero. The aims of this study were to quantify additive genetic variance for ES of body weight (BW), defined as the slope of reaction norm across breeding environment (BE) and production environment (PE), and to estimate the genetic correlation (r(g(int, sl))) between BW and ES. To estimate heritable variance of ES, the coheritability of ES was derived using selection index theory. The BW records from 43,040 rainbow trout performing either in freshwater or seawater were analysed using a reaction norm model. High additive genetic variance for ES (9584) was observed, inferring that genetic changes in ES can be expected. The coheritability for ES was either -0.06 (intercept at PE) or -0.08 (intercept at BE), suggesting that BW observation in either PE or BE results in low accuracy of selection for ES. Yet, the r(g(int, sl)) was negative (-0.41 to -0.33) indicating that selection for BW in one environment is expected to result in more sensitive fish. To avoid an increase of ES while selecting for BW, it is possible to have equal genetic gain in BW in both environments so that ES is maintained stable.	[Sae-Lim, Panya; Gjerde, Bjarne; Lillehammer, Marie] Nofima, Aquaculture & Genet, As, Norway; [Mulder, Han] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands; [Koskinen, Heikki] Nat Resources Inst Finland, Aquaculture Unit, Tervo, Finland; [Kause, Antti] Nat Resources Inst Finland, Biometr Genet, Jokioinen, Finland	Nofima; Wageningen University & Research; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke)	Sae-Lim, P (corresponding author), Nofima, Aquaculture & Genet, Osloveien 1, As, Norway.	panya.sae-lim@nofima.no	Mulder, Han A/E-4303-2012	Mulder, Han A/0000-0003-2124-4787; Lillehammer, Marie/0000-0001-5092-1105	Norwegian Research Council [NRC: 234144/E40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study is funded by Norwegian Research Council (NRC: 234144/E40), http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashey F, 2006, EVOLUTION, V60, P348, DOI 10.1554/05-087.1; Brascamp E. W., 1984, Animal Breeding Abstracts, V52, P645; Castillo-Juarez H, 2007, AQUACULTURE, V273, P42, DOI 10.1016/j.aquaculture.2007.09.023; Charo-Karisa H, 2006, AQUACULTURE, V255, P586, DOI 10.1016/j.aquaculture.2005.11.041; de Jong G, 2002, LIVEST PROD SCI, V78, P195, DOI 10.1016/S0301-6226(02)00096-9; DEJONG G, 1990, J EVOLUTION BIOL, V3, P447, DOI 10.1046/j.1420-9101.1990.3050447.x; Dupont-Nivet M, 2008, AQUACULTURE, V275, P81, DOI 10.1016/j.aquaculture.2007.12.032; Ellen E. D., 2009, Breeding for robustness in cattle, P45; Falconer D. S., 1996, INTRO QUANTITATIVE G; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; FINLAY KW, 1963, AUST J AGR RES, V14, P742, DOI 10.1071/AR9630742; Fischer TM, 2004, GENET SEL EVOL, V36, P363, DOI 10.1051/gse:2004006; Fishback AG, 2002, AQUACULTURE, V206, P137, DOI 10.1016/S0044-8486(01)00707-4; Flaherty M, 2000, AMBIO, V29, P174, DOI 10.1639/0044-7447(2000)029[0174:LSISFI]2.0.CO;2; Gilmour AR, 2009, ASREML USER GUIDE RE; Hill WG, 2010, GENET RES, V92, P381, DOI 10.1017/S0016672310000546; Hutchings JA, 2011, HEREDITY, V106, P421, DOI 10.1038/hdy.2010.166; Janhunen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038766; JANSSENS MJJ, 1979, EUPHYTICA, V28, P601, DOI 10.1007/BF00038926; JINKS JL, 1973, HEREDITY, V30, P33, DOI 10.1038/hdy.1973.4; Kause A, 2005, AQUACULTURE, V247, P177, DOI 10.1016/j.aquaculture.2005.02.023; Kause A, 2004, AQUAC RES, V35, P924, DOI 10.1111/j.1365-2109.2004.01085.x; Kause A, 2003, AQUACULTURE, V228, P53, DOI 10.1016/S0044-8486(03)00244-8; Khaw HL, 2012, AQUACULTURE, V326, P53, DOI 10.1016/j.aquaculture.2011.11.016; Kolmodin R, 2004, GENET SEL EVOL, V36, P435, DOI 10.1051/gse:2004010; Kolmodin R, 2003, ANIM SCI, V76, P375, DOI 10.1017/S1357729800058604; Kolstad K, 2006, AQUACULTURE, V259, P66, DOI 10.1016/j.aquaculture.2005.12.022; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; Le Boucher R, 2011, AQUACULTURE, V321, P41, DOI 10.1016/j.aquaculture.2011.08.010; Lema S, 2008, AM SCI, V96, P28, DOI 10.1511/2008.69.28; Maluwa AO, 2006, AQUACULTURE, V259, P47, DOI 10.1016/j.aquaculture.2006.06.033; Mulder HA, 2007, GENETICS, V175, P1895, DOI 10.1534/genetics.106.063743; Ninh NH, 2011, AQUACULTURE, V322, P39, DOI 10.1016/j.aquaculture.2011.09.031; NILSSON J, 1990, AQUACULTURE, V84, P211, DOI 10.1016/0044-8486(90)90087-4; Pierce LR, 2008, AQUACULTURE, V278, P37, DOI 10.1016/j.aquaculture.2008.03.017; Quinton CD, 2007, GENET SEL EVOL, V39, P431, DOI 10.1051/gse:2007013; Reznick DN, 1996, AM NAT, V147, P319, DOI 10.1086/285854; ROSIELLE AA, 1981, CROP SCI, V21, P943, DOI 10.2135/cropsci1981.0011183X002100060033x; Sae-Lim P, 2013, J ANIM SCI, V91, P5572, DOI 10.2527/jas.2012-5949; Sae-Lim P, 2015, REV AQUACUL IN PRESS; Sae-Lim P, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0122-8; Sae-Lim P, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-16; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; SCHEINER SM, 1989, J EVOLUTION BIOL, V2, P95, DOI 10.1046/j.1420-9101.1989.2020095.x; Schmalhausen II, 1949, FACTORS EVOLUTION TH; SPITZE K, 1992, AM NAT, V139, P229, DOI 10.1086/285325; SYLVEN S, 1991, LIVEST PROD SCI, V28, P253, DOI 10.1016/0301-6226(91)90146-H; Tobin D, 2006, AQUACULTURE, V261, P510, DOI 10.1016/j.aquaculture.2006.07.023; VANTIENDEREN PH, 1994, GENET RES, V64, P115, DOI 10.1017/S0016672300032729; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Walsh B, 2013, EVOLUTION SELECTION	51	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135133	10.1371/journal.pone.0135133	http://dx.doi.org/10.1371/journal.pone.0135133			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267268	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300081
J	Shin, JH; Park, H; Ehm, GH; Lee, WW; Yun, JY; Kim, YE; Lee, JY; Kim, HJ; Kim, JM; Jeon, BS; Park, SS				Shin, Jung Hwan; Park, Hyeyoung; Ehm, Gwan Hee; Lee, Woong Woo; Yun, Ji Young; Kim, Young Eun; Lee, Jee-Young; Kim, Han-Joon; Kim, Jong-Min; Jeon, Beom Seok; Park, Sung-Sup			The Pathogenic Role of Low Range Repeats in SCA17	PLOS ONE			English	Article							SPINOCEREBELLAR ATAXIA; DIAGNOSIS; EXPANSION; CRITERIA; ALLELE; ONSET; GENE	Introduction SCA17 is an autosomal dominant cerebellar ataxia with expansion of the CAG/CAA trinucleotide repeats in the TATA-binding protein (TBP) gene. SCA17 can have various clinical presentations including parkinsonism, ataxia, chorea and dystonia. SCA17 is diagnosed by detecting the expanded CAG repeats in the TBP gene; however, in the literature, pathologic repeat numbers as low as 41 overlap with normal repeat numbers. Methods The subjects in this study included patients with involuntary movement disorders such as cerebellar ataxia, parkinsonism, chorea and dystonia who visited Seoul National University Hospital between Jan. 2006 and Apr. 2014 and were screened for SCA17. Those who were diagnosed with other genetic diseases or nondegenerative diseases were excluded. DNA from healthy subjects who did not have a family history of parkinsonism, ataxia, psychiatric symptoms, chorea or dystonia served as the control. In total, 5242 chromosomes from 2099 patients and 522 normal controls were analyzed. Results The total number of patients included in the analysis was 2099 (parkinsonism, 1706; ataxia, 345; chorea, 37; and dystonia, 11). In the normal control, up to 44 repeats were found. In the 44 repeat group, there were 7 (0.3%) patients and 1 (0.2%) normal control. In 43 repeat group, there were 8 (0.4%) patients and 2 (0.4%) normal controls. In the 42 repeat group, there were 16 (0.8%) patients and 3 (0.6%) normal controls. In 41 repeat group, there were 48 (2.3%) patients and 8 (1.5%) normal controls. Considering the overlaps and non-significant differences in allelic frequencies between the patients and the normal controls with low-expansions, we could not determine a definitive cutoff value for the pathologic CAG repeat number of SCA17. Conclusion Because the statistical analysis between the normal controls and patients with low range expansions failed to show any differences so far, we must consider that clinical cases with low range expansions could be idiopathic movement disorders showing coincidental CAG/CAA expansions. Thus, we need to reconsider the pathologic role of low range expansions (41-42). Long term follow up and comprehensive investigations using autopsy and imaging studies in patients and controls with low range expansions are necessary to determine the cutoff value for the pathologic CAG repeat number of SCA17.	[Shin, Jung Hwan; Park, Hyeyoung; Kim, Han-Joon; Jeon, Beom Seok] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Park, Sung-Sup] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Lab Med, Seoul, South Korea; [Kim, Jong-Min] Seoul Natl Univ, Dept Neurol, Coll Med, Bundang Hosp, Songnam, South Korea; [Kim, Young Eun] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Neurol, Anyang, South Korea; [Ehm, Gwan Hee] Myongi Hosp, Dept Neurol, Goyang, South Korea; [Yun, Ji Young] Ewha Womans Univ, Sch Med, Dept Neurol, Seoul, South Korea; [Yun, Ji Young] Ewha Med Res Inst, Seoul, South Korea; [Lee, Jee-Young] Seoul Natl Univ, Boramae Hosp, Dept Neurol, Seoul, South Korea; [Lee, Woong Woo] Eulji Univ, Eulji Gen Hosp, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Hallym University; Ewha Womans University; Ewha Womans University; Seoul National University (SNU); Seoul National University Hospital; Eulji University	Jeon, BS (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea.	brain@snu.ac.kr		Shin, Jung Hwan/0000-0003-4182-3612; Lee, Jee-Young/0000-0002-9120-2075; Kim, Han-Joon/0000-0001-8219-9663; Park, Sung Sup/0000-0003-3754-4848	Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A101273]	Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A101273).	Alibardi A, 2014, PARKINSONISM RELAT D, V20, P678, DOI 10.1016/j.parkreldis.2014.03.007; Armstrong MJ, 2013, NEUROLOGY, V80, P496, DOI 10.1212/WNL.0b013e31827f0fd1; Bauer P, 2004, J MED; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Gu WH, 2004, EUR NEUROL, V52, P107, DOI 10.1159/000080221; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JANKOVIC J, 1995, J MED GENET, V32, P516, DOI 10.1136/jmg.32.7.516; Jeong S, 2001, HUMAN MOL; Kenney C, 2007, MOVEMENT DISORD, V22, P127, DOI 10.1002/mds.21195; Kim Han-Joon, 2014, Exp Neurobiol, V23, P271, DOI 10.5607/en.2014.23.4.271; Kim J, 2009, NEUROLOGY; Kim JM, 2007, ARCH NEUROL-CHICAGO, V64, P1510, DOI 10.1001/archneur.64.10.1510; Kim JY, 2001, MOL CELLS, V12, P336; Kobayashi S, 1999, HUMAN MOL; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Mariotti C, 2001, NEUROLOGY, V57, P1502, DOI 10.1212/WNL.57.8.1502; Marks MP, 2014, STROKE, V45, P1035, DOI 10.1161/STROKEAHA.113.004085; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Nanda A, 2007, MOVEMENT DISORD, V22, P436, DOI 10.1002/mds.21275; Nielsen TT, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-73; Nolte D, 2010, J NEUROLOGY; Oda M, 2004, ARCHIVES; Perandones C, 2014, PARKINSONISM RELAT D, V20, P558, DOI [10.1016/j.parkreldis.2013.11.014, 10.1016/j.Parkreldis.2013.11.014]; Potter Nicholas T, 2004, Genet Med, V6, P61, DOI 10.1097/01.GIM.0000106165.74751.15; Rolfs A, 2003, ANN NEUROL, V54, P367, DOI 10.1002/ana.10676; Stevanin G, 1998, HUM MOL GENET, V7, P1809, DOI 10.1093/hmg/7.11.1809; Stevanin G, 2008, CEREBELLUM, V7, P170, DOI 10.1007/s12311-008-0016-1; Toyoshima Y, 1993, GENEREVIEWS; Wu YR, 2004, CLIN GENET, V65, P209, DOI 10.1111/j.0009-9163.2004.00213.x; Yamashita C, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.022; Yun JY, 2011, PARKINSONISM RELAT D, V17, P338, DOI 10.1016/j.parkreldis.2011.01.015	31	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135275	10.1371/journal.pone.0135275	http://dx.doi.org/10.1371/journal.pone.0135275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267067	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300091
J	Zhou, JQ; Hao, Z; Irwin, N; Berthoud, HR; Ye, JP				Zhou, Jiaqiang; Hao, Zheng; Irwin, Nigel; Berthoud, Hans-Rudolf; Ye, Jianping			Gastric Inhibitory Polypeptide (GIP) Is Selectively Decreased in the Roux-Limb of Dietary Obese Mice after RYGB Surgery	PLOS ONE			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; BETA-CELL FUNCTION; ENERGY-EXPENDITURE; BYPASS-SURGERY; WEIGHT-LOSS; GLUCOSTATIC PARAMETERS; BARIATRIC SURGERIES; INCRETIN; GUT; MECHANISMS	Gastric inhibitory polypeptide (GIP, glucose-dependent insulinotropic polypeptide) is expressed by intestinal K cells to regulate glucose-induced insulin secretion. The impact of Roux-en Y bypass (RYGB) surgery on blood GIP is highly contraversial. This study was conducted to address the mechanism of controversy. GIP mRNA was examined in the intestine, and serum GIP was determined using Luminex and ELISA in diet-induced obese (DIO) mice. The assays were conducted in RYGB mice in fasting and fed conditions. Food preference, weight loss and insulin sensitivity were monitored in RYGB mice. In DIO mice, GIP mRNA was increased by 80% in all sections of the small intestine over the lean control. The increase was observed in both fasting and fed conditions. After RYGB surgery, the food-induced GIP expression was selectively reduced in the Roux-limb, but not in the biliopancreatic and common limbs of intestine in fed condition. Lack of stimulation by glucose or cholesterol contributed to the reduction. Jejunal mucosa of Roux-limb exhibited hypertrophy, but villous surface was decreased by the undigested food. Serum GIP (total) was significantly higher in the fasting condition, but not in the fed condition due to attenuated GIP response to food intake in RYGB mice. The GIP alteration was associated with chow diet preference, sustained weight loss and insulin sensitization in RYGB mice. RYGB increased serum GIP in the fasting, but not in the fed conditions. The loss of food-induced GIP response in Roux-limb of intestine likely contributes to the attenuated serum GIP response to feeding.	[Zhou, Jiaqiang] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Jiaqiang; Hao, Zheng; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, Baton Rouge, LA 70803 USA; [Irwin, Nigel] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Berthoud, Hans-Rudolf] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Neurobiol Nutr Lab, Baton Rouge, LA USA	Zhejiang University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Ulster University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Ye, JP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, Baton Rouge, LA 70803 USA.	yej@pbrc.edu	Berthoud, Hans-Rudolf/N-1950-2017; Ye, Jianping/N-1998-2017; Irwin, Nigel/H-9696-2019	Ye, Jianping/0000-0003-3875-365X; Irwin, Nigel/0000-0003-4855-964X	NIH grant [DK068036, DK085495]; NORC center from the National Institutes of Health [NIH 2P30DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068036, P30DK072476, R56DK068036, R01DK085495] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC center from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors appreciate technical support from Ms. Xin Ye in qRT-PCR and GIP ELISA assays. This work was supported by NIH grant (DK068036 and DK085495) to JY. qRT-PCR was conducted in the Genetic Core that was supported in part by NORC (NIH 2P30DK072476) center grants from the National Institutes of Health.	Berghofer P, 1997, METABOLISM, V46, P261, DOI 10.1016/S0026-0495(97)90251-1; Berthoud HR, 2011, PHYSIOL BEHAV, V105, P106, DOI 10.1016/j.physbeh.2011.01.023; BUCHAN AMJ, 1983, REGUL PEPTIDES, V7, P221, DOI 10.1016/0167-0115(83)90015-0; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Chandarana K, 2012, NAT MED, V18, P668, DOI 10.1038/nm.2748; Chandarana K, 2011, DIABETES, V60, P810, DOI 10.2337/db10-0566; Cho YM, 2010, VITAM HORM, V84, P111, DOI [10.1016/S0083-6729(10)84002-6, 10.1016/B978-0-12-381517-0.00004-7]; Clements RH, 2004, AM SURGEON, V70, P1; Deacon CF, 2000, J CLIN ENDOCR METAB, V85, P3575, DOI 10.1210/jc.85.10.3575; Foo J, 2011, OBES SURG, V21, P1914, DOI 10.1007/s11695-011-0527-6; Fujita Y, 2010, GASTROENTEROLOGY, V138, P1966, DOI 10.1053/j.gastro.2010.01.049; Goldfine AB, 2007, J CLIN ENDOCR METAB, V92, P4678, DOI 10.1210/jc.2007-0918; Hao Z, 2015, INT J OBESITY, V39, P798, DOI 10.1038/ijo.2014.189; Hao Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052922; Irwin N, 2010, EXPERT OPIN INV DRUG, V19, P1039, DOI 10.1517/13543784.2010.513381; Jackness C, 2013, DIABETES, V62, P3027, DOI 10.2337/db12-1762; Karra E, 2010, TRENDS ENDOCRIN MET, V21, P337, DOI 10.1016/j.tem.2010.01.006; Kashyap S. R., 2010, International Journal of Obesity, V34, P462, DOI 10.1038/ijo.2009.254; Kim MK, 2012, DIABETES-METAB RES, V28, P439, DOI 10.1002/dmrr.2297; KLAPDOR R, 1982, RES EXP MED, V181, P11, DOI 10.1007/BF01850985; Korner J, 2007, SURG OBES RELAT DIS, V3, P597, DOI 10.1016/j.soard.2007.08.004; Laferrere B, 2007, DIABETES CARE, V30, P1709, DOI 10.2337/dc06-1549; le Roux CW, 2007, ANN SURG, V246, P780, DOI 10.1097/SLA.0b013e3180caa3e3; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Lingvay I, 2013, DIABETES CARE, V36, P2741, DOI 10.2337/dc12-2316; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Mokadem M, 2014, MOL METAB, V3, P191, DOI 10.1016/j.molmet.2013.11.010; MORGAN LM, 1988, BRIT J NUTR, V60, P29, DOI 10.1079/BJN19880073; Mortensen K, 2003, REGUL PEPTIDES, V114, P189, DOI 10.1016/S0167-0115(03)00125-3; Nestoridi E, 2012, ENDOCRINOLOGY, V153, P2234, DOI 10.1210/en.2011-2041; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Parker HE, 2009, DIABETOLOGIA, V52, P289, DOI 10.1007/s00125-008-1202-x; Paschetta E, 2011, OBES REV, V12, P813, DOI 10.1111/j.1467-789X.2011.00897.x; Plum L, 2011, OBESITY, V19, P2149, DOI 10.1038/oby.2011.134; Rodieux F, 2008, OBESITY, V16, P298, DOI 10.1038/oby.2007.83; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Shin AC, 2010, ENDOCRINOLOGY, V151, P1588, DOI 10.1210/en.2009-1332; Spak E, 2010, HISTOPATHOLOGY, V57, P680, DOI 10.1111/j.1365-2559.2010.03677.x; Stefater MA, 2012, ENDOCR REV, V33, P595, DOI 10.1210/er.2011-1044; Stemmer K, 2013, ENDOCRINOLOGY, V154, P2015, DOI 10.1210/en.2012-2130; Stylopoulos N, 2009, OBESITY, V17, P1839, DOI 10.1038/oby.2009.207; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Thomas JR, 2008, OBES SURG, V18, P282, DOI 10.1007/s11695-007-9336-3; Whitson BA, 2007, J SURG RES, V141, P31, DOI 10.1016/j.jss.2007.02.022; Ye JP, 2014, AM J PHYSIOL-REG I, V306, pR352, DOI 10.1152/ajpregu.00491.2013; Yin DP, 2011, ANN SURG, V254, P73, DOI 10.1097/SLA.0b013e3182197035; YOSHIDOME K, 1995, SCAND J GASTROENTERO, V30, P586, DOI 10.3109/00365529509089794	48	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134728	10.1371/journal.pone.0134728	http://dx.doi.org/10.1371/journal.pone.0134728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266950	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300057
J	Chang, CC; Chiou, CS; Lin, HL; Wang, LH; Chang, YS; Lin, HC				Chang, Chi Ching; Chiou, Chi Sheng; Lin, Hsiu Li; Wang, Li Hsuan; Chang, Yu Sheng; Lin, Hsiu-Chen			Increased Risk of Acute Pancreatitis in Patients with Rheumatoid Arthritis: A Population-Based Cohort Study	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; AMYLOIDOSIS; ETIOLOGY; THERAPY	The study was conducted to determine whether patients with rheumatoid arthritis (RA) are at increased risk of acute pancreatitis compared with those without RA and to determine if the risk of acute pancreatitis varied by anti-RA drug use. We used the large population-based dataset from the National Health Insurance (NHI) program in Taiwan to conduct a retrospective cohort study. Patients newly diagnosed with RA between 2000 and 2011 were referred to as the RA group. The comparator non-RA group was matched with propensity score, using age and sex, in the same time period. We presented the incidence density by 100,000 person-years. The propensity score and all variables were analyzed in fully adjusted Cox proportional hazard regression. The cumulative incidence of acute pancreatitis was assessed by Kaplan-Meier analysis, with significance based on the log-rank test. From claims data of one million enrollees randomly sampled from the Taiwan NHI database, 29,755 adults with RA were identified and 119,020 non-RA persons were matched as a comparison group. The RA cohort had higher incidence density of acute pancreatitis (185.7 versus 119.0 per 100,000 person-years) than the non-RA cohort. The adjusted hazard ratio (HR) was 1.62 (95% CI [confidence interval] 1.43-1.83) for patients with RA to develop acute pancreatitis. Oral corticosteroid use decreased the risk of acute pancreatitis (adjusted HR 0.83, 95% CI 0.73-0.94) but without a dose-dependent effect. Current use of disease modifying anti-rheumatic drugs or tumor necrosis factor blockers did not decrease the risk of acute pancreatitis. In conclusion, patients with RA are at an elevated risk of acute pancreatitis. Use of oral corticosteroids may reduce the risk of acute pancreatitis.	[Chang, Chi Ching] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Chang, Chi Ching; Chiou, Chi Sheng] Taipei Med Univ Hosp, Dept Internal Med, Div Rheumatol Immunol & Allergy, Taipei, Taiwan; [Lin, Hsiu Li] Gen Cathay Hosp, Dept Neurol, Sijhih Branch, New Taipei City, Taiwan; [Lin, Hsiu Li] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Wang, Li Hsuan] Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei, Taiwan; [Wang, Li Hsuan] Taipei Med Univ Hosp, Dept Pharm, Taipei, Taiwan; [Chang, Yu Sheng] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, New Taipei City, Taiwan; [Lin, Hsiu-Chen] Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan; [Lin, Hsiu-Chen] Taipei Med Univ Hosp, Dept Lab Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Cathay General Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lin, HC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan.	jane2@tmu.edu.tw	Wang, Li-Hsuan/AAU-3257-2021	Lin, Hsiu-Li/0000-0001-9316-8504				Aparisi L, 2005, GUT, V54, P703, DOI 10.1136/gut.2004.047142; Avina-Zubieta JA, 2013, RHEUMATOLOGY, V52, P68, DOI 10.1093/rheumatology/kes353; Bely M, 1989, Morphol Igazsagugyi Orv Sz, V29, P213; Bely M, 2008, PATHOL ONCOL RES, V14, P473, DOI 10.1007/s12253-008-9026-z; Chang MC, 2003, HEPATO-GASTROENTEROL, V50, P1655; Chaudhari S, 2004, DIGEST DIS SCI, V49, P1000, DOI 10.1023/B:DDAS.0000034562.17003.50; Chen CH, 2006, J FORMOS MED ASSOC, V105, P550, DOI 10.1016/S0929-6646(09)60149-2; Davidson TS, 2005, AM J PATHOL, V166, P729, DOI 10.1016/S0002-9440(10)62294-8; Dixon WG, 2012, ANN RHEUM DIS, V71, P1128, DOI 10.1136/annrheumdis-2011-200702; EISEMANN AD, 1989, ANN INTERN MED, V111, P860, DOI 10.7326/0003-4819-111-10-860_2; Eland IA, 2000, GASTROENTEROLOGY, V119, P230, DOI 10.1053/gast.2000.8528; Fagenholz PJ, 2007, ANN EPIDEMIOL, V17, P491, DOI 10.1016/j.annepidem.2007.02.002; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fu CY, 2007, WORLD J GASTROENTERO, V13, P1966, DOI 10.3748/wjg.v13.i13.1966; Ghazale A, 2007, GUT, V56, P1650, DOI 10.1136/gut.2007.129833; Girman CJ, 2010, DIABETES OBES METAB, V12, P766, DOI 10.1111/j.1463-1326.2010.01231.x; HAMED I, 1978, AM J MED SCI, V276, P211, DOI 10.1097/00000441-197809000-00009; Ichikawa T, 2005, WORLD J GASTROENTERO, V11, P2032; Jain P, 2007, WORLD J GASTROENTERO, V13, P5741, DOI 10.3748/wjg.v13.i43.5741; Kim KP, 2004, AM J GASTROENTEROL, V99, P1605, DOI 10.1111/j.1572-0241.2004.30336.x; KOLK A, 1995, CLIN EXP RHEUMATOL, V13, P399; Kuroda T, 2011, INTERNAL MED, V50, P739, DOI 10.2169/internalmedicine.50.4876; Lai CH, 2012, CLIN EXP RHEUMATOL, V30, P358; Lanehart Rheta, 2012, SAS GLOBAL FORUM STA, P314; Lowenfels Albert B, 2009, Curr Gastroenterol Rep, V11, P97; McKeown E, 2012, RHEUMATOLOGY, V51, P1662, DOI 10.1093/rheumatology/kes079; Michaud K, 2007, BEST PRACT RES CL RH, V21, P885, DOI 10.1016/j.berh.2007.06.002; Oishi Kazuhiro, 2000, Journal of Medicine (Westbury), V31, P303; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; PALOYAN D, 1977, AM J DIG DIS, V22, P839, DOI 10.1007/BF01694518; Rodriguez-Rodriguez L, 2012, RHEUMATOL INT, V32, P3097, DOI 10.1007/s00296-011-2090-9; Uchida K, 2002, LAB INVEST, V82, P411, DOI 10.1038/labinvest.3780435; Uzan KN, 2005, CLIN GASTROENTEROL H, V3, P903, DOI 10.1053/S1542-3565(05)00540-9; Vonlaufen A, 2008, J GASTROEN HEPATOL, V23, P1339, DOI 10.1111/j.1440-1746.2008.05520.x; Wu CY, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0449-5	35	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135187	10.1371/journal.pone.0135187	http://dx.doi.org/10.1371/journal.pone.0135187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262880	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300065
J	Chen, YL; Chang, S; Chen, TT; Lee, CK				Chen, Yi-Ling; Chang, Shiun; Chen, Ting-Ting; Lee, Chien-Kuo			Efficient Generation of Plasmacytoid Dendritic Cell from Common Lymphoid Progenitors by Flt3 Ligand	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E2-2; MOUSE BONE-MARROW; IN-VIVO; AUTOIMMUNE-DISEASES; LINEAGE COMMITMENT; HEMATOPOIETIC STEM; ANTIVIRAL RESPONSE; CUTTING EDGE; EXPRESSION; VITRO	Dendritic cells (DCs), including conventional DCs (cDCs) and plasmacytoid DCs (pDCs) are critical for initiating and controlling the immune response. However, study of DC, particularly pDC, function is hampered by their low frequency in lymphoid organs, and existing methods for in vitro DC generation preferentially favor the production of cDCs over pDCs. Here, we demonstrated that pDCs could be efficiently generated in vitro from common lymphoid progenitors (CLPs) using Flt3 ligand (FL) in three different culture systems, namely feeder-free, BM-feeder and AC-6-feeder. This was in stark contrast to common DC progenitors (CDPs), in which cDCs were prominently generated under the same conditions. Moreover, the efficiency and function of pDCs generated from these three systems varied. While AC-6 system showed the greatest ability to support pDC development from CLPs, BM-feeder system was able to develop pDCs with better functionality. pDCs could also be expanded in vivo using hydrodynamic gene transfer of FL, which was further enhanced by the combined treatment of FL and IFN-alpha. Interestingly, IFN-alpha selectively promoted the proliferation of CLPs and not CDPs, which might contribute to enhanced pDC development. Together, we have defined conditions for in vitro and in vivo generation of pDCs, which may be useful for investigating the biology of pDCs.	[Chen, Yi-Ling; Chang, Shiun; Chen, Ting-Ting; Lee, Chien-Kuo] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan	National Taiwan University	Lee, CK (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.	leeck@ntu.edu.tw	Lee, Chien-Kuo/AAZ-1039-2020	Lee, Chien-Kuo/0000-0001-8189-6045; Chen, Yi-Ling/0000-0003-3758-0638	National Health Research Institutes, Taiwan [NHRI-EX103-10256SI]; Ministry of Science and Technology, Taiwan (MOST) [102-2320-B-002-030-MY3]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	This work was supported by the National Health Research Institutes, Taiwan (NHRI-EX103-10256SI) and the Ministry of Science and Technology, Taiwan (MOST 102-2320-B-002-030-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcanjo K, 2002, J CELL BIOCHEM, V87, P160, DOI 10.1002/jcb.10293; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bao MS, 2013, PROTEIN CELL, V4, P40, DOI 10.1007/s13238-012-2104-8; Bock TA, 1997, STEM CELLS, V15, P185, DOI 10.1002/stem.5530150824; Chen LS, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-22; Chen YL, 2013, J EXP MED, V210, P2515, DOI 10.1084/jem.20130536; Chou WC, 2006, BLOOD, V108, P3005, DOI 10.1182/blood-2006-05-024430; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Contractor N, 2007, J IMMUNOL, V179, P2690, DOI 10.4049/jimmunol.179.5.2690; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fancke B, 2008, BLOOD, V111, P150, DOI 10.1182/blood-2007-05-089292; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Li HYS, 2012, BLOOD, V120, P4363, DOI 10.1182/blood-2012-07-441311; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; O'Neill HC, 2004, J LEUKOCYTE BIOL, V75, P600, DOI 10.1189/jlb.0903446; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; Shortman K, 2013, ADV IMMUNOL, V120, P105, DOI 10.1016/B978-0-12-417028-5.00004-1; Stanley ER, 2009, CELL STEM CELL, V5, P234, DOI 10.1016/j.stem.2009.08.015; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Szilvassy SJ, 1996, BLOOD, V87, P4618, DOI 10.1182/blood.V87.11.4618.bloodjournal87114618; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Wan H, 2005, CELL MOL IMMUNOL, V2, P28; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Watowich SS, 2010, IMMUNOL REV, V238, P76, DOI 10.1111/j.1600-065X.2010.00949.x; WHITLOCK CA, 1987, CELL, V48, P1009, DOI 10.1016/0092-8674(87)90709-4	42	3	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135217	10.1371/journal.pone.0135217	http://dx.doi.org/10.1371/journal.pone.0135217			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263178	gold, Green Submitted, Green Published			2022-12-27	WOS:000359353300067
J	Teshima, T; Matsumoto, H; Okusa, T; Nakamura, Y; Koyama, H				Teshima, Takahiro; Matsumoto, Hirotaka; Okusa, Tomoko; Nakamura, Yumi; Koyama, Hidekazu			Effects of Carbenoxolone on the Canine Pituitary-Adrenal Axis	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; DEPENDENT HYPERADRENOCORTICISM; CUSHINGS-DISEASE; MEDICAL-TREATMENT; ADRENOCORTICOTROPIC HORMONE; DOGS; TRILOSTANE; MITOTANE; EXPRESSION; CORTISOL	Cushing's disease caused by pituitary corticotroph adenoma is a common endocrine disease in dogs. A characteristic biochemical feature of corticotroph adenomas is their relative resistance to suppressive negative feedback by glucocorticoids. The abnormal expression of 11beta-hydroxysteroid dehydrogenase (11HSD), which is a cortisol metabolic enzyme, is found in human and murine corticotroph adenomas. Our recent studies demonstrated that canine corticotroph adenomas also have abnormal expression of 11HSD. 11HSD has two isoforms in dogs, 11HSD type1 (HSD11B1), which converts cortisone into active cortisol, and 11HSD type2 (HSD11B2), which converts cortisol into inactive cortisone. It has been suggested that glucocorticoid resistance in corticotroph tumors is related to the overexpression of HSD11B2. Therefore it was our aim to investigate the effects of carbenoxolone (CBX), an 11HSD inhibitor, on the healthy dog's pituitary-adrenal axis. Dogs were administered 50 mg/kg of CBX twice each day for 15 days. During CBX administration, no adverse effects were observed in any dogs. The plasma adrenocorticotropic hormone (ACTH), and serum cortisol and cortisone concentrations were significantly lower at day 7 and 15 following corticotropin releasing hormone stimulation. After completion of CBX administration, the HSD11B1 mRNA expression was higher, and HSD11B2 mRNA expression was significantly lower in the pituitaries. Moreover, proopiomelanocortin mRNA expression was lower, and the ratio of ACTH-positive cells in the anterior pituitary was also significantly lower after CBX treatment. In adrenal glands treated with CBX, HSD11B1 and HSD11B2 mRNA expression were both lower compared to normal canine adrenal glands. The results of this study suggested that CBX inhibits ACTH secretion from pituitary due to altered 11HSD expressions, and is potentially useful for the treatment of canine Cushing's disease.	[Teshima, Takahiro; Matsumoto, Hirotaka; Okusa, Tomoko; Nakamura, Yumi; Koyama, Hidekazu] Nippon Vet & Life Sci Univ, Fac Vet Sci, Sch Vet Med, Div Therapeut Sci 1,Dept Vet Clin Med, Musashino, Tokyo 1808602, Japan	Nippon Veterinary & Life Science University	Teshima, T (corresponding author), Nippon Vet & Life Sci Univ, Fac Vet Sci, Sch Vet Med, Div Therapeut Sci 1,Dept Vet Clin Med, 1-7-1 Kyonan Cho, Musashino, Tokyo 1808602, Japan.	teshima63@nvlu.ac.jp			Japan Society for the Promotion of Science KAKENHI Grant [24780315]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TT received Japan Society for the Promotion of Science KAKENHI Grant Number 24780315, http://www.jsps.go.jp/english/index.html.	Alenza DP, 2006, J AM ANIM HOSP ASSOC, V42, P269, DOI 10.5326/0420269; ARMANINI D, 1989, J ENDOCRINOL INVEST, V12, P337, DOI 10.1007/BF03350002; Atkinson AB, 2005, CLIN ENDOCRINOL, V63, P549, DOI 10.1111/j.1365-2265.2005.02380.x; Barker EN, 2005, J VET INTERN MED, V19, P810, DOI 10.1892/0891-6640(2005)19[810:ACOTST]2.0.CO;2; Bell R, 2006, VET REC, V159, P277, DOI 10.1136/vr.159.9.277; Braddock JA, 2003, AUST VET J, V81, P600, DOI 10.1111/j.1751-0813.2003.tb12498.x; Castillo V, 2006, ENDOCRINOLOGY, V147, P4438, DOI 10.1210/en.2006-0414; Castillo V, 2011, NEUROENDOCRINOLOGY, V94, P124, DOI 10.1159/000327429; Dhanesha N, 2012, CLIN EXP PHARMACOL P, V39, P69, DOI 10.1111/j.1440-1681.2011.05640.x; Fracassi F, 2007, DOMEST ANIM ENDOCRIN, V32, P43, DOI 10.1016/j.domaniend.2005.12.009; Fukuoka H, 2011, J CLIN INVEST, V121, P4712, DOI 10.1172/JCI60417; Gadelha MR, 2014, CLIN ENDOCRINOL, V80, P1, DOI 10.1111/cen.12345; Goossens MMC, 1998, J AM VET MED ASSOC, V212, P374; Hammer GD, 2004, J CLIN ENDOCR METAB, V89, P6348, DOI 10.1210/jc.2003-032180; HAYES MJ, 1977, GUT, V18, P1054, DOI 10.1136/gut.18.12.1054; KEMPPAINEN RJ, 1984, J ENDOCRINOL, V103, P219, DOI 10.1677/joe.0.1030219; Kooistra HS, 1997, J ENDOCRINOL, V152, P113, DOI 10.1677/joe.0.1520113; Korbonits M, 2001, J CLIN ENDOCR METAB, V86, P2728, DOI 10.1210/jc.86.6.2728; Ma X, 2011, TOXICOLOGY, V285, P83, DOI 10.1016/j.tox.2011.04.007; McKeage K, 2013, DRUGS, V73, P563, DOI 10.1007/s40265-013-0052-0; Meij B, 2002, MOL CELL ENDOCRINOL, V197, P89, DOI 10.1016/S0303-7207(02)00283-6; NELSON RW, 1985, AM J VET RES, V46, P1534; Nigawara T, 2006, ENDOCRINOLOGY, V147, P769, DOI 10.1210/en.2005-0544; Peterson ME, 1997, VET CLIN N AM-SMALL, V27, P255, DOI 10.1016/S0195-5616(97)50030-1; Petrossians P, 2010, NEUROENDOCRINOLOGY, V92, P116, DOI 10.1159/000317716; Pineiro MIR, 2009, J VET INTERN MED, V23, P850, DOI 10.1111/j.1939-1676.2009.0328.x; Rabbitt E, 2003, ONCOGENE, V22, P1663, DOI 10.1038/sj.onc.1206293; Ramsey IK, 2010, VET CLIN N AM-SMALL, V40, P269, DOI 10.1016/j.cvsm.2009.10.008; Reine NJ, 2007, CLIN TECH SMALL AN P, V22, P18, DOI 10.1053/j.ctsap.2007.02.003; Reine NJ, 2012, TOP COMPANION ANIM M, V27, P25, DOI 10.1053/j.tcam.2012.06.002; Sandeep TC, 2005, DIABETES, V54, P872, DOI 10.2337/diabetes.54.3.872; Sano S, 2012, HORM METAB RES, V44, P15, DOI 10.1055/s-0031-1297990; SARFATY D, 1988, J AM VET MED ASSOC, V193, P854; Sieber-Ruckstuhl NS, 2007, HORM METAB RES, V39, P548, DOI 10.1055/s-2007-985142; SIMONS MA, 1976, GASTROENTEROLOGY, V71, P603; Taoda T, 2006, AM J VET RES, V67, P1385, DOI 10.2460/ajvr.67.8.1385; Teshima T, 2009, DOMEST ANIM ENDOCRIN, V36, P32, DOI 10.1016/j.domaniend.2008.10.002; Teshima T, 2009, DOMEST ANIM ENDOCRIN, V36, P3, DOI 10.1016/j.domaniend.2008.08.002; Teshima T, 2014, VET J, V200, P452, DOI 10.1016/j.tvjl.2014.03.022; van der Pas R, 2013, DRUGS, V73, P907, DOI 10.1007/s40265-013-0067-6	40	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135516	10.1371/journal.pone.0135516	http://dx.doi.org/10.1371/journal.pone.0135516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262685	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300088
J	Ong, HS; Rahim, MS; Firdaus-Raih, M; Ramlan, EI				Ong, Hui San; Rahim, Mohd Syafiq; Firdaus-Raih, Mohd; Ramlan, Effirul Ikhwan			DNA Tetrominoes: The Construction of DNA Nanostructures Using Self-Organised Heterogeneous Deoxyribonucleic Acids Shapes	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; NUCLEIC-ACID; ORIGAMI; DESIGN; OLIGONUCLEOTIDES; NANOTECHNOLOGY; STABILITY; SOFTWARE; MOTIFS	The unique programmability of nucleic acids offers alternative in constructing excitable and functional nanostructures. This work introduces an autonomous protocol to construct DNA Tetris shapes (L-Shape, B-Shape, T-Shape and I-Shape) using modular DNA blocks. The protocol exploits the rich number of sequence combinations available from the nucleic acid alphabets, thus allowing for diversity to be applied in designing various DNA nanostructures. Instead of a deterministic set of sequences corresponding to a particular design, the protocol promotes a large pool of DNA shapes that can assemble to conform to any desired structures. By utilising evolutionary programming in the design stage, DNA blocks are subjected to processes such as sequence insertion, deletion and base shifting in order to enrich the diversity of the resulting shapes based on a set of cascading filters. The optimisation algorithm allows mutation to be exerted indefinitely on the candidate sequences until these sequences complied with all the four fitness criteria. Generated candidates from the protocol are in agreement with the filter cascades and thermodynamic simulation. Further validation using gel electrophoresis indicated the formation of the designed shapes. Thus, supporting the plausibility of constructing DNA nanostructures in a more hierarchical, modular, and interchangeable manner.	[Ong, Hui San; Ramlan, Effirul Ikhwan] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Artificial Intelligence, Nat Comp Lab, Kuala Lumpur 50603, Malaysia; [Rahim, Mohd Syafiq; Firdaus-Raih, Mohd] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Malaysia; [Rahim, Mohd Syafiq; Firdaus-Raih, Mohd] Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi 43600, Malaysia	Universiti Malaya; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Ramlan, EI (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Dept Artificial Intelligence, Nat Comp Lab, Kuala Lumpur 50603, Malaysia.	effirul@um.edu.my	Ramlan, Effirul I/B-5264-2010; Firdaus-Raih, Mohd/H-3286-2019; Firdaus-Raih, Mohd/A-9217-2011	Ramlan, Effirul I/0000-0002-8150-4782; Firdaus-Raih, Mohd/0000-0003-4275-4663; Firdaus-Raih, Mohd/0000-0003-4275-4663	High Impact Research Grant jointly - Ministry of Education (Malaysia); University of Malaya [UM.C/625/1/HIR/MOE/FCSIT/002 - H-22001-00-B0002]	High Impact Research Grant jointly - Ministry of Education (Malaysia); University of Malaya(Universiti Malaya)	The research is supported by the High Impact Research Grant jointly funded by the Ministry of Education (Malaysia) and University of Malaya (UM.C/625/1/HIR/MOE/FCSIT/002 - H-22001-00-B0002).	Aldaye FA, 2008, SCIENCE, V321, P1795, DOI 10.1126/science.1154533; Aldaye FA, 2007, J AM CHEM SOC, V129, P13376, DOI 10.1021/ja075966q; Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/NNANO.2014.58, 10.1038/nnano.2014.58]; Andersen ES, 2008, ACS NANO, V2, P1213, DOI 10.1021/nn800215j; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Dirks RM, 2004, NUCLEIC ACIDS RES, V32, P1392, DOI 10.1093/nar/gkh291; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Feldkamp U., 2003, Genetic Programming and Evolvable Machines, V4, P153, DOI 10.1023/A:1023985029398; Feldkamp U., 2002, LNCS, V2340, P23; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Gothelf KV, 2005, ORG BIOMOL CHEM, V3, P4023, DOI 10.1039/b510551j; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Kuzuya A, 2010, NANOSCALE, V2, P310, DOI 10.1039/b9nr00246d; Li J, 2011, ACS NANO, V5, P8783, DOI 10.1021/nn202774x; Lin CX, 2006, CHEMPHYSCHEM, V7, P1641, DOI 10.1002/cphc.200600260; Lin CX, 2012, NAT CHEM, V4, P832, DOI 10.1038/NCHEM.1451; Lubin AA, 2006, ANAL CHEM, V78, P5671, DOI 10.1021/ac0601819; Mei QA, 2011, NANO LETT, V11, P1477, DOI 10.1021/nl1040836; Ousterhout J. K., 1990, Proceedings of the Winter 1990 USENIX Conference, P133; Ousterhout J. K., 2009, TCL TK TOOLKIT; Ousterhout J. K., 1994, TCL TK TOOLKIT; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; Seeman NC, 2007, MOL BIOTECHNOL, V37, P246, DOI 10.1007/s12033-007-0059-4; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Seifferf J, 2008, J BIOMOL STRUCT DYN, V25, P453, DOI 10.1080/07391102.2008.10507193; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Shen XB, 2012, CHEM COMMUN, V48, P11301, DOI 10.1039/c2cc36185j; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Subramanian HKK, 2011, NANO LETT, V11, P910, DOI 10.1021/nl104555t; Team RDC, 2005, R LANG ENV STAT COMP; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Wei B, 2007, J COMPUT THEOR NANOS, V4, P133; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Williams S, 2008, 14 INT M DNA COMP P; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Winfree E., 1996, DNA BASED COMPUTERS, P199; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zauner KP, 2005, LECT NOTES COMPUT SC, V3566, P47; Zhang Z, 2010, SMALL, V6, P1854, DOI 10.1002/smll.201000908; Zhang Z, 2010, ADV MATER, V22, P2672, DOI 10.1002/adma.201000151	52	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134520	10.1371/journal.pone.0134520	http://dx.doi.org/10.1371/journal.pone.0134520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258940	Green Published, gold, Green Submitted			2022-12-27	WOS:000359352600015
J	Sagui, E; Montigon, C; Abriat, A; Jouvion, A; Duron-Martinaud, S; Canini, F; Zagnoli, F; Bendahan, D; Figarella-Branger, D; Bregigeon, M; Brosset, C				Sagui, Emmanuel; Montigon, Coline; Abriat, Amandine; Jouvion, Arnaud; Duron-Martinaud, Sandrine; Canini, Frederic; Zagnoli, Fabien; Bendahan, David; Figarella-Branger, Dominique; Bregigeon, Michel; Brosset, Christian			Is There a Link between Exertional Heat Stroke and Susceptibility to Malignant Hyperthermia?	PLOS ONE			English	Article							CONTRACTURE TEST; MUSCLE; DIAGNOSIS; EXERCISE; ILLNESS; RHABDOMYOLYSIS; HEATSTROKE; HALOTHANE; CAFFEINE; SPECTROSCOPY	Objective The identification of a predisposition toward malignant hyperthermia (MH) as a risk factor for exertional heat stroke (EHS) remains a matter of debate. Such a predisposition indicates a causal role for MH susceptibility (MHS) after EHS in certain national recommendations and has led to the use of an in vitro contracture test (IVCT) to identify the MHS trait in selected or unselected EHS patients. The aim of this study was to determine whether the MHS trait is associated with EHS. Methods EHS subjects in the French Armed Forces were routinely examined for MHS after experiencing an EHS episode. This retrospective study compared the features of IVCT-diagnosed MHS (iMHS) EHS subjects with those of MH-normal EHS patients and MH patients during the 2004-2010 period. MHS status was assessed using the European protocol. Results During the study period, 466 subjects (median age 25 years; 31 women) underwent MHS status investigation following an EHS episode. None of the subjects reported previous MH events. An IVCT was performed in 454 cases and was diagnostic of MHS in 45.6% of the study population, of MH susceptibility to halothane in 18.5%, of MH susceptibility to caffeine in 9.9%, and of MH susceptibility to halothane and caffeine in 17.2%. There were no differences in the clinical features, biological features or outcomes of iMHS EHS subjects compared with those of MH-normal or caffeine or halothane MHS subjects without known prior EHS episode. The recurrence rate was 12.7% and was not associated with MH status or any clinical or biological features. iMHS EHS patients exhibited a significantly less informative IVCT response than MH patients. Conclusions The unexpected high prevalence of the MHS trait after EHS suggested a latent disturbance of calcium homeostasis that accounted for the positive IVCT results. This study did not determine whether EHS patients have an increased risk of MH, and it could not determine whether MH susceptibility is a risk factor for EHS.	[Sagui, Emmanuel; Montigon, Coline; Jouvion, Arnaud; Bregigeon, Michel; Brosset, Christian] French Mil Hosp Laveran, Marseille, France; [Sagui, Emmanuel; Montigon, Coline; Canini, Frederic; Zagnoli, Fabien] Val de Grace Mil Sch, Paris, France; [Sagui, Emmanuel] Aix Marseille Univ, Lab Neurosci Cognit, Unite Mixte Rech 7291, Marseille, France; [Abriat, Amandine] French Fire Brigade Hlth Serv, Courbevoie, France; [Duron-Martinaud, Sandrine] Armed Forces Epidemiol & Publ Hlth Ctr, Marseille, France; [Canini, Frederic] Armed Forces Biomed Res Inst, Bretigny Sur Orge, France; [Zagnoli, Fabien] French Mil Hosp Clermont Tonnerre, Brest, France; [Bendahan, David] Aix Marseille Univ, Ctr Magnet Resonance Biol & Med, Unite Mixte Rech 7339, Marseille, France; [Figarella-Branger, Dominique] Timone Hosp, AP HM, Serv Anat Pathol & Neuropathol, Marseille, France	Val-de-Grace Hospital; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Sagui, E (corresponding author), French Mil Hosp Laveran, Marseille, France.	emlsmg@gmail.com	Bendahan, David/AAU-1420-2020		French Ministry of Defence	French Ministry of Defence	This work was funded by the French Ministry of Defence (no grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriat A, 2014, MIL MED, V179, P309, DOI 10.7205/MILMED-D-13-00315; Armstrong LE, 2007, MED SCI SPORT EXER, V39, P556, DOI 10.1249/MSS.0b013e31802fa199; Bendahan D, 1998, ANESTHESIOLOGY, V88, P96, DOI 10.1097/00000542-199801000-00017; Bendahan D, 2004, ACTA ANAESTH SCAND, V48, P1019, DOI 10.1111/j.0001-5172.2004.00461.x; BENDAHAN D, 1990, FEBS LETT, V272, P155, DOI 10.1016/0014-5793(90)80472-U; Bendahan D, 2001, ANESTH ANALG, V93, P683, DOI 10.1097/00000539-200109000-00030; Berger F, 2004, EXERTIONAL HEAT STRO; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; BOURDON L, 1995, MED HYPOTHESES, V45, P268, DOI 10.1016/0306-9877(95)90116-7; Clarkson PM, 2006, MED SCI SPORT EXER, V38, P623, DOI 10.1249/01.mss.0000210192.49210.fc; COOPER KH, 1968, J AMER MED ASSOC, V203, P201, DOI 10.1001/jama.203.3.201; Denborough M, 1998, LANCET, V352, P1131, DOI 10.1016/S0140-6736(98)03078-5; Duron-Martinaud S, 2012, EXERTIONAL HEAT STRO, P1; ELLIS FR, 1984, BRIT J ANAESTH, V56, P1267; Epstein Y, 1999, MED SCI SPORT EXER, V31, P224, DOI 10.1097/00005768-199902000-00004; FIGARELLABRANGER D, 1993, NEUROMUSCULAR DISORD, V3, P553, DOI 10.1016/0960-8966(93)90114-Y; Fiszer D, 2015, ANESTHESIOLOGY; Gardner JW, 1996, MED SCI SPORT EXER, V28, P939, DOI 10.1097/00005768-199608000-00001; Grogan H, 2002, BRIT J ANAESTH, V88, P700, DOI 10.1093/bja/88.5.700; HACKL W, 1991, BRIT J ANAESTH, V66, P138, DOI 10.1093/bja/66.1.138; HEIMANPATTERSON TD, 1988, MUSCLE NERVE, V11, P453, DOI 10.1002/mus.880110507; HOPKINS PM, 1991, LANCET, V338, P1491, DOI 10.1016/0140-6736(91)92304-K; KNOCHEL JP, 1972, NEW ENGL J MED, V287, P927, DOI 10.1056/NEJM197211022871810; Kochling A, 1998, ANAESTH INTENS CARE, V26, P315, DOI 10.1177/0310057X9802600317; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; LARACH MG, 1989, ANESTH ANALG, V69, P511; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Monnier N, 2002, ANESTHESIOLOGY, V97, P1067, DOI 10.1097/00000542-200211000-00007; Muldoon S, 2004, EXERC SPORT SCI REV, V32, P174; O'Connor FG, 2010, CURR SPORT MED REP, V9, P314, DOI 10.1249/JSR.0b013e3181f1d183; Ording H, 1997, ACTA ANAESTH SCAND, V41, P955, DOI 10.1111/j.1399-6576.1997.tb04820.x; Porter AMW, 2003, MIL MED, V168, P76, DOI 10.1093/milmed/168.1.76; Rosenberg H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-21; Sanchez H, 2013, EUROPEAN J SPORTS ME, V1, P18; Tobin JR, 2001, JAMA-J AM MED ASSOC, V286, P168, DOI 10.1001/jama.286.2.168; Touze J, 2004, 848DEFDCSSAASTTECMDA, P2; Wappler F, 2001, ANESTHESIOLOGY, V94, P95, DOI 10.1097/00000542-200101000-00019; Wingard D, 1978, 2ND INT S MAL HYP, P363	38	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135496	10.1371/journal.pone.0135496	http://dx.doi.org/10.1371/journal.pone.0135496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258863	Green Published, Green Submitted, gold			2022-12-27	WOS:000359352600070
J	Tenorio, MJ; Luchsinger, C; Mardones, GA				Tenorio, Maria J.; Luchsinger, Charlotte; Mardones, Gonzalo A.			Protein Kinase A Activity Is Necessary for Fission and Fusion of Golgi to Endoplasmic Reticulum Retrograde Tubules	PLOS ONE			English	Article							EPIDIDYMAL CLEAR CELLS; BREFELDIN-A; LIVING CELLS; MEMBRANE-TRANSPORT; MATRIX PROTEINS; PKA ACTIVITY; COMPLEX; ER; DYNAMICS; VESICLE	It is becoming increasingly accepted that together with vesicles, tubules play a major role in the transfer of cargo between different cellular compartments. In contrast to our understanding of the molecular mechanisms of vesicular transport, little is known about tubular transport. How signal transduction molecules regulate these two modes of membrane transport processes is also poorly understood. In this study we investigated whether protein kinase A (PKA) activity regulates the retrograde, tubular transport of Golgi matrix proteins from the Golgi to the endoplasmic reticulum (ER). We found that Golgi-to-ER retrograde transport of the Golgi matrix proteins giantin, GM130, GRASP55, GRASP65, and p115 was impaired in the presence of PKA inhibitors. In addition, we unexpectedly found accumulation of tubules containing both Golgi matrix proteins and resident Golgi transmembrane proteins. These tubules were still attached to the Golgi and were highly dynamic. Our data suggest that both fission and fusion of retrograde tubules are mechanisms regulated by PKA activity.	[Mardones, Gonzalo A.] Univ Austral Chile, Inst Fisiol, Fac Med, Valdivia, Chile; Univ Austral Chile, Ctr Interdisciplinario Estudios Sistema Nervis, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile	Mardones, GA (corresponding author), Univ Austral Chile, Inst Fisiol, Fac Med, Valdivia, Chile.	gonzalo.mardones@uach.cl			FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico de Chile) [1130710]; DID-UACh (Direccion de Investigacion y Desarrollo, Universidad Austral de Chile)	FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico de Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DID-UACh (Direccion de Investigacion y Desarrollo, Universidad Austral de Chile)	This work was funded by FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico de Chile; http://www.conicyt.cl/fondecyt) Grant 1130710 (G. A. M.), and DID-UACh (Direccion de Investigacion y Desarrollo, Universidad Austral de Chile; http://investigacion.uach.cl) (G. A. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; BARROSO M, 1995, P NATL ACAD SCI USA, V92, P527, DOI 10.1073/pnas.92.2.527; Bejarano E, 2006, J CELL SCI, V119, P3764, DOI 10.1242/jcs.03146; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brandon E, 2006, MOL BIOL CELL, V17, P2996, DOI 10.1091/mbc.e05-09-0862; Cabrera M, 2003, MOL BIOL CELL, V14, P4114, DOI 10.1091/mbc.E03-04-0194; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Cancino J, 2014, DEV CELL, V30, P280, DOI 10.1016/j.devcel.2014.06.018; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Ha KD, 2012, BBA-MOL CELL BIOL L, V1821, P1078, DOI 10.1016/j.bbalip.2012.04.004; Hallows KR, 2009, AM J PHYSIOL-CELL PH, V296, pC672, DOI 10.1152/ajpcell.00004.2009; HANSEN SH, 1994, J CELL BIOL, V126, P677, DOI 10.1083/jcb.126.3.677; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lee TH, 2000, MOL BIOL CELL, V11, P2577, DOI 10.1091/mbc.11.8.2577; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Loebrich S, 2013, P NATL ACAD SCI USA, V110, pE4548, DOI 10.1073/pnas.1318860110; Luini A, 2005, CURR OPIN CELL BIOL, V17, P353, DOI 10.1016/j.ceb.2005.06.012; Luini Alberto, 2014, F1000Prime Rep, V6, P88, DOI 10.12703/P6-88; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; Mardones GA, 2006, MOL BIOL CELL, V17, P525, DOI 10.1091/mbc.E05-05-0447; Mardones GA, 2007, MOL BIOL CELL, V18, P3486, DOI 10.1091/mbc.E07-02-0190; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Martin ME, 1999, J CELL SCI, V112, P3869; Martinez-Alonso E, 2007, TRAFFIC, V8, P359, DOI 10.1111/j.1600-0854.2006.00533.x; Martinez-Alonso E, 2013, HISTOCHEM CELL BIOL, V140, P327, DOI 10.1007/s00418-013-1114-9; Martinez-Martinez N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111685; Muniz M, 1997, P NATL ACAD SCI USA, V94, P14461, DOI 10.1073/pnas.94.26.14461; Muniz M, 1996, J BIOL CHEM, V271, P30935, DOI 10.1074/jbc.271.48.30935; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Pastor-Soler NM, 2008, AM J PHYSIOL-CELL PH, V294, pC488, DOI 10.1152/ajpcell.00537.2007; Ramakrishnan N, 2013, BIOPHYS J, V104, P1018, DOI 10.1016/j.bpj.2012.12.045; Ross BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088147; Rothman JE, 2002, NAT MED, V8, P1059, DOI 10.1038/nm770; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Salazar G, 2002, MOL BIOL CELL, V13, P1677, DOI 10.1091/mbc.01-08-0403; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Sohda M, 1998, J BIOL CHEM, V273, P5385, DOI 10.1074/jbc.273.9.5385; Storrie B, 2000, TRENDS CELL BIOL, V10, P385, DOI 10.1016/S0962-8924(00)01818-3; Valente C, 2013, HISTOCHEM CELL BIOL, V140, P407, DOI 10.1007/s00418-013-1138-1; Vinke FP, 2011, BIOCHEM J, V433, P423, DOI 10.1042/BJ20101540; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Wong M, 2014, SCIENCE, V346, P601, DOI 10.1126/science.1256898; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2; Zegers MMP, 1997, J CELL BIOL, V138, P307, DOI 10.1083/jcb.138.2.307	57	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135260	10.1371/journal.pone.0135260	http://dx.doi.org/10.1371/journal.pone.0135260			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258546	gold, Green Submitted, Green Published			2022-12-27	WOS:000359352600051
J	Haddad, L; Cassenote, AJF; Andraus, W; de Martino, RB; Ortega, NRD; Abe, JM; D'Albuquerque, LAC				Haddad, Luciana; Flores Cassenote, Alex Jones; Andraus, Wellington; de Martino, Rodrigo Bronze; de Siqueira Ortega, Neli Regina; Abe, Jair Minoro; Carneiro D'Albuquerque, Luiz Augusto			Factors Associated with Mortality and Graft Failure in Liver Transplants: A Hierarchical Approach	PLOS ONE			English	Article							MELD SCORE; SURVIVAL BENEFIT; DISEASE MELD; DONOR; MODEL; ALLOCATION; PREDICT	Background Liver transplantation has received increased attention in the medical field since the 1980s following the introduction of new immunosuppressants and improved surgical techniques. Currently, transplantation is the treatment of choice for patients with end-stage liver disease, and it has been expanded for other indications. Liver transplantation outcomes depend on donor factors, operating conditions, and the disease stage of the recipient. A retrospective cohort was studied to identify mortality and graft failure rates and their associated factors. All adult liver transplants performed in the state of Sao Paulo, Brazil, between 2006 and 2012 were studied. Methods and Findings A hierarchical Poisson multiple regression model was used to analyze factors related to mortality and graft failure in liver transplants. A total of 2,666 patients, 18 years or older, (1,482 males; 1,184 females) were investigated. Outcome variables included mortality and graft failure rates, which were grouped into a single binary variable called negative outcome rate. Additionally, donor clinical, laboratory, intensive care, and organ characteristics and recipient clinical data were analyzed. The mortality rate was 16.2 per 100 person-years (py) (95% CI: 15.1-17.3), and the graft failure rate was 1.8 per 100 py (95% CI: 1.5-2.2). Thus, the negative outcome rate was 18.0 per 100 py (95% CI: 16.9-19.2). The best risk model demonstrated that recipient creatinine >= 2.11 mg/dl [RR = 1.80 (95% CI: 1.56-2.08)], total bilirubin >= 2.11 mg/dl [RR = 1.48 (95% CI: 1.27-1.72)], Na+ >= 141.01 mg/dl [RR = 1.70 (95% CI: 1.47-1.97)], RNI >= 2.71 [RR = 1.64 (95% CI: 1.41-1.90)], body surface >= 1.98 [RR = 0.81 (95% CI: 0.68-0.97)] and donor age >= 54 years [RR = 1.28 (95% CI: 1.11-1.48)], male gender [RR = 1.19(95% CI: 1.03-1.37)], dobutamine use [RR = 0.54 (95% CI: 0.36-0.82)] and intubation >= 6 days [RR = 1.16 (95% CI: 1.10-1.34)] affected the negative outcome rate. Conclusions The current study confirms that both donor and recipient characteristics must be considered in post-transplant outcomes and prognostic scores. Our data demonstrated that recipient characteristics have a greater impact on post-transplant outcomes than donor characteristics. This new concept makes liver transplant teams to rethink about the limits in a MELD allocation system, with many teams competing with each other. The results suggest that although we have some concerns about the donors features, the recipient factors were heaviest predictors for bad outcomes.	[Haddad, Luciana; Andraus, Wellington; de Martino, Rodrigo Bronze; Carneiro D'Albuquerque, Luiz Augusto] Univ Sao Paulo, Dept Gastroenterol, Digest Transplant Unit, Sao Paulo, Brazil; [Flores Cassenote, Alex Jones] Univ Sao Paulo, Fac Med, Postgrad Program Infect & Parasit Dis, Sao Paulo, Brazil; [Flores Cassenote, Alex Jones; de Siqueira Ortega, Neli Regina] Univ Sao Paulo, Fac Med, Ctr Fuzzy Syst Hlth, Sao Paulo, Brazil; [Abe, Jair Minoro] Univ Sao Paulo, Inst Adv Studies, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Haddad, L (corresponding author), Univ Sao Paulo, Dept Gastroenterol, Digest Transplant Unit, Sao Paulo, Brazil.	luciana.haddad@hc.fm.usp.br	Haddad, Luciana B P/G-1797-2012; Haddad, Luciana/S-2436-2019; Abe, Jair Minoro/C-6997-2013; Cassenote, Alex/C-4220-2013; Andraus, Wellington/G-1860-2012; D'Albuquerque, Luiz A Carneiro/I-4011-2012	Haddad, Luciana B P/0000-0003-0202-9037; Haddad, Luciana/0000-0003-0202-9037; Abe, Jair Minoro/0000-0003-2088-9065; Andraus, Wellington/0000-0002-5162-138X; D'Albuquerque, Luiz A Carneiro/0000-0001-7607-7168	Paulo State Research Foundation - Fapesp [2013/05300-2]; Sao Paulo State Research Foundation (FAPESP) [2013/18158-0]	Paulo State Research Foundation - Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Paulo State Research Foundation - Fapesp (protocol number #2013/05300-2). AJFC received a scholarship from the Sao Paulo State Research Foundation (FAPESP: protocol number #2013/18158-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbad Gardênia, 2002, Estud. psicol. (Natal), V7, P19, DOI 10.1590/S1413-294X2002000300004; Aberg F, 2011, SCAND J SURG, V100, P14, DOI 10.1177/145749691110000104; ABTO, 2014, DIM TRANSPL BRAS CAD; Atkinson A., 2000, SPR S STAT, DOI 10.1007/978-1-4612-1160-0; Blok JJ, 2012, LIVER TRANSPLANT, V18, P113, DOI 10.1002/lt.22447; Bonney GK, 2009, TRANSPLANTATION, V87, P1858, DOI 10.1097/TP.0b013e3181a75b37; Botelho F, 2009, ACTA UROL, V26, P33; Briceno J, 2008, TRANSPL P, V40, P2952, DOI 10.1016/j.transproceed.2008.09.023; Cameron AM, 2006, ANN SURG, V243, P748, DOI 10.1097/01.sla.0000219669.84192.b3; Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea; Campos ACL, 2002, CURR OPIN CLIN NUTR, V5, P297, DOI 10.1097/00075197-200205000-00010; Daniel W., 2009, BIOSTATISTICS FDN AN, V9; Dutkowski P, 2011, ANN SURG, V254, P745, DOI 10.1097/SLA.0b013e3182365081; Fay MP, EXACT P VALUES MATCH; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Fleiss J., STAT METHODS RATES P; Fleming TR, 2011, COUNTING PROCESSES S; Freeman RB, 2004, AM J TRANSPLANT, V4, P114, DOI 10.1111/j.1600-6135.2004.00403.x; Geyer JC, GEN LINEAR MODELS R; Ghobrial RM, 2002, ANN SURG, V236, P315, DOI 10.1097/00000658-200209000-00008; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Hair J., 2010, MULTIVARIATE DATA AN, V7; Halldorson JB, 2009, AM J TRANSPLANT, V9, P318, DOI 10.1111/j.1600-6143.2008.02491.x; Hoofnagle JH, 1996, HEPATOLOGY, V24, P89, DOI 10.1002/hep.510240116; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Lucey MR, 2008, AM J TRANSPLANT, V8, P196, DOI 10.1111/j.1600-6143.2007.02086.x; Merion RM, 2005, AM J TRANSPLANT, V5, P307, DOI 10.1111/j.1600-6143.2004.00703.x; MORABIA A, 1991, EPIDEMIOLOGY, V2, P367, DOI 10.1097/00001648-199109000-00010; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Quante M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/264015; Rana A, 2008, AM J TRANSPLANT, V8, P2537, DOI 10.1111/j.1600-6143.2008.02400.x; Ravaioli M, 2009, TRANSPLANTATION, V88, P826, DOI 10.1097/TP.0b013e3181b26807; Reddy MS, 2013, WORLD J HEPATOL, V5, P603, DOI 10.4254/wjh.v5.i11.603; Roberts MS, 2004, LIVER TRANSPLANT, V10, P886, DOI 10.1002/lt.20137; Saab S, 2003, LIVER TRANSPLANT, V9, P473, DOI 10.1053/jlts.2003.50090; Santori G, 2008, TRANSPL P, V40, P1903, DOI 10.1016/j.transproceed.2008.05.016; Siciliano Maria, 2012, World J Gastrointest Pharmacol Ther, V3, P49, DOI 10.4292/wjgpt.v3.i4.49; TUTTLE RR, 1975, CIRC RES, V36, P185, DOI 10.1161/01.RES.36.1.185; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wang ZX, 2007, TRANSPL P, V39, P1501, DOI 10.1016/j.transproceed.2007.02.070; Weismuller TJ, 2008, SCAND J GASTROENTERO, V43, P736, DOI 10.1080/00365520801932944; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Zeier M, 2002, J AM SOC NEPHROL, V13, P2570, DOI 10.1097/01.ASN.0000030078.74889.69	43	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134874	10.1371/journal.pone.0134874	http://dx.doi.org/10.1371/journal.pone.0134874			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274497	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600044
J	Zacarias De Azevedo, P; Sylvestre, TF; Cavalcante, RD; de Carvalho, LR; Moris, DV; de Oliveira, MLCS; Mendes, RP				de Azevedo, Priscila Zacarias; Sylvestre, Tatiane Fernanda; Cavalcante, Ricardo de Souza; de Carvalho, Lidia Raquel; Moris, Daniela Vanessa; Cotrim Sartor de Oliveira, Maria Luiza; Mendes, Rinaldo Poncio			Evaluation of the Double Agar Gel Immunodiffusion Test and of the Enzyme-Linked Immunosorbent Assay in the Diagnosis and Follow-Up of Patients with Chronic Pulmonary Aspergillosis	PLOS ONE			English	Article							CROSS-REACTIVITY; GALACTOMANNAN; ANTIBODIES; FUMIGATUS; GALACTOXYLOMANNAN; ELISA	The diagnosis of chronic pulmonary aspergillosis (CPA) depends on the radiologic image and the identification of specific antibodies. The present study aimed to evaluate accuracy parameters of enzyme-linked immunosorbent assay (ELISA) and of the determination of serum galactomannan level in the diagnosis of patients with CPA, comparing these results with the double agar gel immunodiffusion (DID) test. In addition, the prevalence of cross-reactivity and the serological progression after treatment were evaluated by comparing DID and ELISA. Six study groups were formed: G1:22 patients with CPA, 17 of whom had Aspergillus fungus ball, one chronic cavitary pulmonary aspergillosis (CCPA) and four chronic fibrosing pulmonary aspergillosis (CFPA); G2:28 patients with pulmonary tuberculosis (TB); G3:23 patients with histoplasmosis (HST); G4:50 patients with paracoccidioidomycosis (PCM); G5:20 patients with cryptococcosis (CRC); and G6:200 healthy controls. Serum antibodies were measured by DID and ELISA, with two antigen preparations-Aspergillus fumigatus (DID1, ELISA(1)) and a pool of A. fumigatus, A. flavus and A. niger antigens (DID2, ELISA(2)). The Platelia Aspergillus Enzyme Immunoassay (EIA) kit was used to measure galactomannan. The cut-off points of ELISA were determined for each antigen preparation and for the 95% and 99% confidence intervals. Despite the low sensitivity, DID was the technique of choice due to its specificity, positive and negative predictive values and positive likelihood ratio-especially with the antigen pool and due to the low frequency of cross-reactivity. ELISA(1) and a 0.090 cut-off showed high sensitivity, specificity and negative predictive value, but a high frequency of cross-reactivity with CRC. The best degree of agreement was observed between ELISA(1) and ELISA(2). The detection of serum galactomannan showed high sensitivity, comparable to ELISA(2). The immunodiffusion test showed an excellent relationship with the progression after treatment, which made it the reaction of choice for patient follow-up.	[de Azevedo, Priscila Zacarias; Sylvestre, Tatiane Fernanda; Cavalcante, Ricardo de Souza; Mendes, Rinaldo Poncio] Univ Estadual Paulista UNESP, Fac Med Botucatu, Dept Trop Dis, Botucatu, SP, Brazil; [de Carvalho, Lidia Raquel] UNESP, Inst Biociencias Botucatu, Botucatu, SP, Brazil; [Moris, Daniela Vanessa] Univ Oeste Paulista, UNOESTE, Presidente Prudente, Sao Paulo State, Brazil; [Cotrim Sartor de Oliveira, Maria Luiza] Univ Estadual Paulista UNESP, Fac Med Botucatu, Dept Pathol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Universidade do Oeste Paulista; Universidade Estadual Paulista	Zacarias De Azevedo, P (corresponding author), Univ Estadual Paulista UNESP, Fac Med Botucatu, Dept Trop Dis, Botucatu, SP, Brazil.	priscilaazeve@gmail.com	Carvalho, L.R./C-2973-2013; de Souza Cavalcante, Ricardo/D-2058-2013; Moris, Daniela Vanessa/T-5821-2019; Sylvestre, Tatiane/AAV-4449-2021; Moris, Daniela V/G-1956-2014	Carvalho, L.R./0000-0003-0575-2263; de Souza Cavalcante, Ricardo/0000-0001-6382-2675; Cotrim Sartor de Oliveira, Maria Luiza/0000-0002-8830-1267; Sylvestre, Tatiane Fernanda/0000-0002-0023-964X; Moris, Daniela Vanessa/0000-0002-0267-3589	Coordenation for the Improvement of Higher Level Personnel - CAPES	Coordenation for the Improvement of Higher Level Personnel - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was partially sponsored by the Coordenation for the Improvement of Higher Level Personnel - CAPES. No additional funding sources for this study.	Ahmed Hossain, 2009, Journal of Medicine, V10, P149; Aquino VR, 2007, MYCOPATHOLOGIA, V163, P191, DOI 10.1007/s11046-007-9010-2; BRASIL. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2014, B EPIDEMIOL, V45, P2; CAMPBELL MJ, 1964, AM REV RESPIR DIS, V89, P186; Camuset J, 2007, CHEST, V131, P1435, DOI 10.1378/chest.06-2441; COLEMAN RM, 1972, APPL MICROBIOL, V23, P301, DOI 10.1128/AEM.23.2.301-308.1972; Curi PR, 1997, METODOLOGIA ANALISE, P220; Dalle F, 2005, J CLIN MICROBIOL, V43, P2929, DOI 10.1128/JCM.43.6.2929-2931.2005; DALY RC, 1986, J THORAC CARDIOV SUR, V92, P981; De Jesus M, 2007, CLIN VACCINE IMMUNOL, V14, P624, DOI 10.1128/CVI.00368-06; DEBEULE K, 1988, MYCOSES, V31, P476, DOI 10.1111/j.1439-0507.1988.tb03653.x; Denning DW, 2011, B WORLD HEALTH ORGAN, V89, P864, DOI 10.2471/BLT.11.089441; DENNING DW, 1989, AM J MED, V86, P791, DOI 10.1016/0002-9343(89)90475-0; Denning DW, 2003, CLIN INFECT DIS, V37, pS265, DOI 10.1086/376526; DENNING DW, 1991, NEW ENGL J MED, V324, P654, DOI 10.1056/NEJM199103073241003; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; FERREIRA-DA-CRUZ M F, 1988, Memorias do Instituto Oswaldo Cruz, V83, P357, DOI 10.1590/S0074-02761988000300013; Fletcher RH, 2006, EPIDEMIOLOGIA CLIN E, P56; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; FROUDIST JH, 1989, J CLIN PATHOL, V42, P1215, DOI 10.1136/jcp.42.11.1215; Giacchino M, 2006, J CLIN MICROBIOL, V44, P3432, DOI 10.1128/JCM.00856-06; Halweg H, 1968, Tubercle, V49, P404, DOI 10.1016/S0041-3879(68)80021-2; Huang YT, 2007, J CLIN MICROBIOL, V45, P2858, DOI 10.1128/JCM.00050-07; JEWKES J, 1983, THORAX, V38, P572, DOI 10.1136/thx.38.8.572; KAUFFMAN HF, 1983, J ALLERGY CLIN IMMUN, V72, P255, DOI 10.1016/0091-6749(83)90029-5; Kawamura S, 2000, INTERNAL MED, V39, P209, DOI 10.2169/internalmedicine.39.209; KILMAN JW, 1969, J THORAC CARDIOV SUR, V57, P642, DOI 10.1016/S0022-5223(19)42677-9; Landis J. R., 1977, BIOMETRICS; LONGBOTTOM JL, 1964, J PATHOL BACTERIOL, V88, P141, DOI 10.1002/path.1700880119; LONGBOTTOM JL, 1964, LANCET, V1, P588; Maia Filho HS, 2001, MED BASEADA EVIDENCI, P81; MANTYJARVI RA, 1980, CLIN ALLERGY, V10, P187, DOI 10.1111/j.1365-2222.1980.tb02096.x; MASSARD G, 1992, ANN THORAC SURG, V54, P1159, DOI 10.1016/0003-4975(92)90086-J; Narreddy S, 2008, J INFECTION, V56, P80, DOI 10.1016/j.jinf.2007.09.013; Pedroso RS, 2006, NEWSLAB, V77, P94; Restrepo A., 1988, Aspergillus and aspergillosis. Proceedings of the Second International Symposium on Topics in Mycology, held June 28-July 1, 1987, at the University of Antwerp, Antwerp, Belgium., P253; RESTREPO A, 1966, SABOURAUDIA, V4, P223; RICHARDSON MD, 1982, J CLIN PATHOL, V35, P1134, DOI 10.1136/jcp.35.10.1134; SEPULVEDA R, 1979, CLIN ALLERGY, V9, P359, DOI 10.1111/j.1365-2222.1979.tb02494.x; SHALE DJ, 1985, J IMMUNOL METHODS, V77, P197, DOI 10.1016/0022-1759(85)90032-8; Siegel S, 1975, ESTATISTICA NAO PARA, P69; SLAVIN RG, 1970, J ALLERGY, V46, P150, DOI 10.1016/0021-8707(70)90093-6; Smith NL, 2001, EUR RESPIR J, V37, P865; STALLYBRASS F C, 1963, Mycopathol Mycol Appl, V21, P272, DOI 10.1007/BF02052580; STYNEN D, 1995, J CLIN MICROBIOL, V33, P497, DOI 10.1128/JCM.33.2.497-500.1995; Swanink CMA, 1997, J CLIN MICROBIOL, V35, P257, DOI 10.1128/JCM.35.1.257-260.1997; Thoracic British and Association Tuberculosis, 1970, TUBERCLE, P227; Tsubura E, 1997, Kekkaku, V72, P557; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; WALTER JE, 1968, DIS CHEST, V53, P729; Wheat LJ, 2007, CLIN VACCINE IMMUNOL, V14, P638, DOI 10.1128/CVI.00479-06; Xavier MO, 2009, CLIN VACCINE IMMUNOL, V16, P132, DOI 10.1128/CVI.00310-08; Zmeili OS, 2007, QJM-INT J MED, V100, P317, DOI 10.1093/qjmed/hcm035	53	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134841	10.1371/journal.pone.0134841	http://dx.doi.org/10.1371/journal.pone.0134841			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271000	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800022
J	Khan, WA; Saha, D; Ahmed, S; Salam, MA; Bennish, ML				Khan, Wasif Ali; Saha, Debasish; Ahmed, Sabeena; Salam, Mohammed Abdus; Bennish, Michael Louis			Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1	PLOS ONE			English	Article							SINGLE-DOSE CIPROFLOXACIN; SALMONELLA-TYPHI; RESISTANCE; VIBRIO-CHOLERAE-01; STRAINS; TRIAL	Objective We identified a poor clinical response to treatment of cholera with a single 1 g dose of ciprofloxacin, a standard treatment for cholera. Methods To determine reasons for the poor response and better therapeutic approaches we examined the minimal inhibitor concentration (MIC, n = 275) and disc-diffusion zone sizes (n = 205) for ciprofloxacin and nalidixic acid of V. cholerae O1 strains isolated in Bangladesh from 1994 to 2012, and reexamined data from 161patients infected with Vibrio cholerae O1 recruited in four clinical trials who received single-or multiple-dose ciprofloxacin for treatment of cholera and compared their clinical response to the V. cholerae O1 susceptibility. Results Although all 275 isolates of V. cholerae O1 remained susceptible to ciprofloxacin using standard MIC and disc-diffusion thresholds, the MIC90 to ciprofloxacin increased from 0.010 in 1994 to 0.475 mu gm/ml in 2012. Isolates became frankly resistant to nalidixic with the MIC90 increasing from 21 mu gm/ml in 1994 to >256 mu gm/ml and 166 of 205 isolates from 1994 to 2005 being frankly resistant using disc-diffusion testing. Isolates resistant to nalidixic acid by disc-diffusion testing had a median ciprofloxacin MIC of 0.190 mu gm/ml (10th-90th centiles 0.022 to 0.380); nalidixic acid-susceptible isolates had a median ciprofloxacin MIC of 0.002 (0.002 to 0.012). The rate of clinical success with single-dose ciprofloxacin treatment for nalidixic acid-susceptible strains was 94% (61 of 65 patients) and bacteriologic success 97% (63/65) compared to 18% (12/67) and 8% (5/67) respectively with nalidixic acid-resistant strains (P<0.001 for both comparisons). Multiple-dose treatment with ciprofloxacin had 86% and 100% clinical and bacteriologic success rates respectively in patients infected with nalidixic acid-susceptible strains of V. cholerae O1 compared to clinical success 67% and bacteriologic success 60% with nalidixic acid-resistant strains. Conclusions Single-dose ciprofloxacin is not effective for treating cholera caused by V. cholerae O1 with diminished susceptibility to ciprofloxacin, and nalidixic acid disc-diffusion testing effectively screens for such isolates.	[Khan, Wasif Ali; Saha, Debasish; Ahmed, Sabeena; Salam, Mohammed Abdus] Icddr, B Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Saha, Debasish] Univ Otago, Sch Med, Ctr Int Hlth, Dept Prevent & Social Med, Dunedin, New Zealand; [Bennish, Michael Louis] Mpilonhle, Mtubatuba, South Africa	International Centre for Diarrhoeal Disease Research (ICDDR); University of Otago	Khan, WA (corresponding author), Icddr, B Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.	wakhan@icddrb.org		Zhou, Dongsheng/0000-0003-3827-5969	Australian Agency for International Development (AusAID); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This study was funded by core donors which provide unrestricted support to icddr,b for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors received any specific funding for this work.	[Anonymous], 2005, HSB (Health Science Bulletin), V3, P1; [Anonymous], 2021, STAND PERF STAND ANT; Baranwal S, 2002, ANTIMICROB AGENTS CH, V46, P2676, DOI 10.1128/AAC.46.8.2676-2678.2002; Bennish M.L., 2008, ANTIMICROBIAL DRUG R; Bennish M.L., 2003, QUINOLONE ANTIMICROB, P193; Bennish M.L., 2003, OXFORD TXB MED, P515; Bennish Michael L., 1994, P229; Bhattacharya M K, 2000, J Indian Med Assoc, V98, P389; CALIA KE, 1994, INFECT IMMUN, V62, P1504, DOI 10.1128/IAI.62.4.1504-1506.1994; Chandel DS, 2001, EMERG INFECT DIS, V7, P762; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; Crump JA, 2003, CLIN INFECT DIS, V37, P75, DOI 10.1086/375602; Dutta P, 2001, J TROP PEDIATRICS, V47, P252, DOI 10.1093/tropej/47.4.252; GOTUZZO E, 1995, CLIN INFECT DIS, V20, P1485, DOI 10.1093/clinids/20.6.1485; Hakanen A, 1999, J CLIN MICROBIOL, V37, P3572, DOI 10.1128/JCM.37.11.3572-3577.1999; HORIUCHI S, 1993, ANTIMICROB AGENTS CH, V37, P2486, DOI 10.1128/AAC.37.11.2486; Huang DB, 2005, J INFECTION, V50, P97, DOI 10.1016/j.jinf.2004.05.019; Islam MS, 2009, JAMA-J AM MED ASSOC, V302, P2321, DOI 10.1001/jama.2009.1750; Jacoby GA, 2005, CLIN INFECT DIS, V41, pS120, DOI 10.1086/428052; Jesudason MV, 1997, INDIAN J MED RES, V105, P153; Jesudason MV, 2002, INDIAN J MED RES, V116, P96; Kadhiravan T, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-37; KHAN WA, 1995, T ROY SOC TROP MED H, V89, P103, DOI 10.1016/0035-9203(95)90675-4; Khan WA, 1996, LANCET, V348, P296, DOI 10.1016/S0140-6736(96)01180-4; KNAPP JS, 1995, ANTIMICROB AGENTS CH, V39, P2442, DOI 10.1128/AAC.39.11.2442; Kumar P, 2014, CLIN MICROBIOL INFEC, V20, pO292, DOI 10.1111/1469-0691.12393; Launay Odile, 1997, Clin Microbiol Infect, V3, P541, DOI 10.1111/j.1469-0691.1997.tb00304.x; NCCLS (National Committee for Clinical Laboratory Standards), 1997, M100A6 NCCLS; Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771; Ng LK, 2003, ANTIMICROB AGENTS CH, V47, P1479, DOI 10.1128/AAC.47.4.1479-1480.2003; Saha D, 2005, LANCET, V366, P1085, DOI 10.1016/S0140-6736(05)67290-X; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493; Salam M.A., 2005, 40 US JAP CHOL M BOS; Thwaites RT, 1999, J CLIN PATHOL, V52, P812, DOI 10.1136/jcp.52.11.812; Van JCN, 2000, CLIN MICROBIOL INFEC, V6, P231, DOI 10.1046/j.1469-0691.2000.00060-3.x; Wain J, 1997, CLIN INFECT DIS, V25, P1404, DOI 10.1086/516128; Wells J. G., 2003, MANUAL LAB IDENTIFIC	37	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134921	10.1371/journal.pone.0134921	http://dx.doi.org/10.1371/journal.pone.0134921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271050	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800023
J	Oladosu, FA; Conrad, MS; O'Buckley, SC; Rashid, NU; Slade, GD; Nackley, AG				Oladosu, Folabomi A.; Conrad, Matthew S.; O'Buckley, Sandra C.; Rashid, Naim U.; Slade, Gary D.; Nackley, Andrea G.			Mu Opioid Splice Variant MOR-1K Contributes to the Development of Opioid-Induced Hyperalgesia	PLOS ONE			English	Article							RECEPTOR GENE; DIFFERENTIAL EXPRESSION; PAIN HYPERSENSITIVITY; MORPHINE; MICE; REMIFENTANIL; CATHETERIZATION; TOLERANCE; ISOFORM; STRAINS	Background A subset of the population receiving opioids for the treatment of acute and chronic clinical pain develops a paradoxical increase in pain sensitivity known as opioid-induced hyperalgesia. Given that opioid analgesics are one of few treatments available against clinical pain, it is critical to determine the key molecular mechanisms that drive opioid-induced hyperalgesia in order to reduce its prevalence. Recent evidence implicates a splice variant of the mu opioid receptor known as MOR-1K in the emergence of opioid-induced hyperalgesia. Results from human genetic association and cell signaling studies demonstrate that MOR-1K contributes to decreased opioid analgesic responses and produces increased cellular activity via Gs signaling. Here, we conducted the first study to directly test the role of MOR-1K in opioid-induced hyperalgesia. Methods and Results In order to examine the role of MOR-1K in opioid-induced hyperalgesia, we first assessed pain responses to mechanical and thermal stimuli prior to, during, and following chronic morphine administration. Results show that genetically diverse mouse strains (C57BL/6J, 129S6, and CXB7/ByJ) exhibited different morphine response profiles with corresponding changes in MOR-1K gene expression patterns. The 129S6 mice exhibited an analgesic response correlating to a measured decrease in MOR-1K gene expression levels, while CXB7/ByJ mice exhibited a hyperalgesic response correlating to a measured increase in MOR-1K gene expression levels. Furthermore, knockdown of MOR-1K in CXB7/ByJ mice via chronic intrathecal siRNA administration not only prevented the development of opioid-induced hyperalgesia, but also unmasked morphine analgesia. Conclusions These findings suggest that MOR-1K is likely a necessary contributor to the development of opioid-induced hyperalgesia. With further research, MOR-1K could be exploited as a target for antagonists that reduce or prevent opioid-induced hyperalgesia.	[Oladosu, Folabomi A.; O'Buckley, Sandra C.; Slade, Gary D.; Nackley, Andrea G.] Univ N Carolina, Ctr Pain Res & Innovat, Chapel Hill, NC 27515 USA; [Conrad, Matthew S.] Univ Illinois, Neurosci Program, Urbana, IL USA; [Rashid, Naim U.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; University of North Carolina Chapel Hill	Nackley, AG (corresponding author), Univ N Carolina, Ctr Pain Res & Innovat, Chapel Hill, NC 27515 USA.	anackley@unc.edu		O'Buckley, Sandra/0000-0001-6683-5295; Oladosu, Folabomi/0000-0001-9077-9799	National Institute of Neurological Disorders and Stroke [R01 NS072205, P01 NS045685]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072205, P01NS045685] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support was provided by National Institute of Neurological Disorders and Stroke R01 NS072205 and National Institute of) Neurological Disorders and Stroke (P01 NS045685.	Angst MS, 2003, PAIN, V106, P49, DOI 10.1016/S0304-3959(03)00276-8; Arout CA, 2015, PHYSIOL BEHAV, V147, P364, DOI 10.1016/j.physbeh.2015.05.006; Butt MT, 2011, TOXICOL PATHOL, V39, P213, DOI 10.1177/0192623310391679; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cho KJ, 2013, BIOCHEM BIOPH RES CO, V441, P280, DOI 10.1016/j.bbrc.2013.08.103; Chu LF, 2012, PAIN, V153, P974, DOI 10.1016/j.pain.2012.01.014; Convertino M, 2014, STUDY MULTIDISCIPLIN, V2014; Dever SM, 2014, AIDS, V28, P19, DOI 10.1097/QAD.0000000000000113; Diatchenko Luda, 2011, Eur J Pain Suppl, V5, P433; Doherty MM, 2006, J PHARMACOL EXP THER, V317, P890, DOI 10.1124/jpet.105.100446; Drossman Douglas, 2014, Am J Gastroenterol Suppl, V2, P22, DOI 10.1038/ajgsup.2014.6; Gris P, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-33; IWAMOTO K, 1978, J PHARMACOL EXP THER, V206, P181; Joly V, 2005, ANESTHESIOLOGY, V103, P147, DOI 10.1097/00000542-200507000-00022; Kolesnikov Y, 1998, J PHARMACOL EXP THER, V284, P455; Laboureyras E, 2014, PAIN RES MANAG, V19, P191, DOI 10.1155/2014/285308; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lee PW, 2004, MOL PHARMACOL, V66, P1580, DOI 10.1124/mol.66.6.; Liang DY, 2011, ANESTHESIOLOGY, V114, P1180, DOI 10.1097/ALN.0b013e31820efb19; Liang DY, 2006, ANESTHESIOLOGY, V104, P1054, DOI 10.1097/00000542-200605000-00023; Liu XY, 2011, CELL, V147, P447, DOI 10.1016/j.cell.2011.08.043; Lu ZG, 2014, MOL PHARMACOL, V85, P368, DOI 10.1124/mol.113.089292; Majumdar S, 2011, P NATL ACAD SCI USA, V108, P19778, DOI 10.1073/pnas.1115231108; Mattioli TA, 2012, ANESTH ANALG, V114, P690, DOI 10.1213/ANE.0b013e31823fad94; McDonald DC, 2012, J PAIN, V13, P988, DOI 10.1016/j.jpain.2012.07.007; Menendez L, 2002, J NEUROSCI METH, V113, P91, DOI 10.1016/S0165-0270(01)00483-6; Oertel BG, 2012, HUM MOL GENET, V21, P4751, DOI 10.1093/hmg/dds314; Pasternak GW, 2013, PHARMACOL REV, V65, P1257, DOI 10.1124/pr.112.007138; Raffa R, 2011, PAIN MANAGEMENT NURS, P1; Schmid CW, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-4; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Shabalina SA, 2009, HUM MOL GENET, V18, P1037, DOI 10.1093/hmg/ddn439; Shigeta Y, 2008, PHARMACOGENET GENOM, V18, P927, DOI 10.1097/FPC.0b013e32830d0b9e; Tan MS, 2014, J ALZHEIMERS DIS; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Xu J, 2013, J BIOL CHEM, V288, P21211, DOI 10.1074/jbc.M113.458687; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002	38	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135711	10.1371/journal.pone.0135711	http://dx.doi.org/10.1371/journal.pone.0135711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270813	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800102
J	Pan, JM; Yang, YF; Yang, B; Dai, WH; Yu, YH				Pan, Jinming; Yang, Yefeng; Yang, Bo; Dai, Wenhua; Yu, Yonghua			Human-Friendly Light-Emitting Diode Source Stimulates Broiler Growth	PLOS ONE			English	Article							SHORT-WAVELENGTH LIGHT; MONOCHROMATIC LIGHT; NONVISUAL RESPONSES; HIGH-SENSITIVITY; BRAIN RESPONSES; JAPANESE-QUAIL; MALE CHICKS; PERFORMANCE; BEHAVIOR; BLUE	Previous study and our laboratory have reported that short-wavelength (blue and green) light and combination stimulate broiler growth. However, short-wavelength stimuli could have negative effects on poultry husbandry workers. The present study was conducted to evaluate the effects of human-friendly yellow LED light, which is acceptable to humans and close to green light, on broiler growth. We also aimed to investigate the potential quantitative relationship between the wavelengths of light used for artificial illumination and growth parameters in broilers. After hatching, 360 female chicks ("Meihuang" were evenly divided into six lighting treatment groups: white LED strips (400-700 nm, WL); red LED strips (620 nm, RL); yellow LED strips (580 nm, YL); green LED strips (514 nm, GL); blue LED strips (455 nm, BL); and fluorescent strips (400-700 nm, FL). From 30 to 72 days of age, broilers reared under YL and GL were heavier than broilers treated with FL (P < 0.05). Broilers reared under YL obtained the similar growth parameters with the broilers reared under GL and BL (P > 0.05). Moreover, YL significantly improved feeding efficiency when compared with GL and BL at 45 and 60 days of age (P < 0.05). In addition, we found an age-dependent effect of light spectra on broiler growth and a quantitative relationship between LED light spectra (455 to 620 nm) and the live body weights of broilers. The wavelength of light (455 to 620 nm) was found to be negatively related (R-2 = 0.876) to live body weight at an early stage of development, whereas the wavelength of light (455 to 620 nm) was found to be positively correlated with live body weight (R-2 = 0.925) in older chickens. Our results demonstrated that human-friendly yellow LED light (YL), which is friendly to the human, can be applied to the broilers production.	[Pan, Jinming; Yang, Yefeng; Yang, Bo; Yu, Yonghua] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Dai, Wenhua] Agr Machinery Tech Extending Stn, Jiaxing 31400, Peoples R China	Zhejiang University	Yu, YH (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China.	yhyu@zju.edu.cn	Yang, Yefeng/AAB-8118-2022; Pan, Jinming/A-7377-2018	Yang, Yefeng/0000-0002-8610-4016; Pan, Jinming/0000-0003-0228-4564	Opening Fund of the State Key Laboratory of Soil and Plant Machinery System Technology [2014SKL02]	Opening Fund of the State Key Laboratory of Soil and Plant Machinery System Technology	Founding: The Opening Fund of the State Key Laboratory of Soil and Plant Machinery System Technology (Project number: 2014SKL02). Authors who received the funding: J. M. Pan. URLs of funders: (http://www.caams.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby M.C., 2004, POULTRY BEHAV WELFAR; BALTHAZART J, 1978, J ENDOCRINOL, V77, P149, DOI 10.1677/joe.0.0770149; BENOIT J, 1964, ANN NY ACAD SCI, V117, P204, DOI 10.1111/j.1749-6632.1964.tb48175.x; Blatchford RA, 2009, POULTRY SCI, V88, P20, DOI 10.3382/ps.2008-00177; Buyse J, 1996, WORLD POULTRY SCI J, V52, P121, DOI 10.1079/WPS19960012; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Chang AM, 2014, P NATL ACAD SCI USA; CHARLES RG, 1992, POULTRY SCI, V71, P1595, DOI 10.3382/ps.0711595; Chellappa S. L, 2011, PLOS ONE, V6; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Chen L, 2014, INT J OPHTHALMOL-CHI, V7, P163, DOI 10.3980/j.issn.2222-3959.2014.01.30; COLEMAN MA, 1977, POULTRY SCI, V56, P1421, DOI 10.3382/ps.0561421; Deep A., 2010, IMPACT LIGHT INTENSI; Dijk DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000145; Falchi F, 2011, J ENVIRON MANAGE, V92, P2714, DOI 10.1016/j.jenvman.2011.06.029; FOSS DC, 1972, POULTRY SCI, V51, P1922, DOI 10.3382/ps.0511922; FOSTER RG, 1985, J COMP PHYSIOL A, V157, P519, DOI 10.1007/BF00615153; HOGAN JA, 1973, J COMP PHYSIOL PSYCH, V83, P355, DOI 10.1037/h0034669; Karakaya M, 2009, BRIT POULTRY SCI, V50, P76, DOI 10.1080/00071660802629571; Lauber J, 1961, FED P; LAUBER JK, 1975, COMP BIOCHEM PHYS A, V51, P903, DOI 10.1016/0300-9629(75)90073-0; LEVENICK CK, 1988, POULTRY SCI, V67, P1505, DOI 10.3382/ps.0671505; Lockley SW, 2006, SLEEP, V29, P161; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Lougheed T, 2014, ENVIRON HEALTH PERSP, V122, pA81, DOI 10.1289/ehp.122-A81; Marples NM, 1996, ANIM BEHAV, V51, P1417, DOI 10.1006/anbe.1996.0145; Olanrewaju H. A., 2006, International Journal of Poultry Science, V5, P301; OOKAWA T, 1970, POULTRY SCI, V49, P333, DOI 10.3382/ps.0490333; Pallant J., 2010, SPSS SURVIVAL MANUAL, DOI DOI 10.1108/jacpr.2011.55003baa.002; Pan JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113595; Papamichael C, 2012, J BIOL RHYTHM, V27, P70, DOI 10.1177/0748730411431447; Perrin F, 2004, CURR BIOL, V14, P1842, DOI 10.1016/j.cub.2004.09.082; Prayitno DS, 1997, POULTRY SCI, V76, P452, DOI 10.1093/ps/76.3.452; PROUDFOOT FG, 1978, POULTRY SCI, V57, P408, DOI 10.3382/ps.0570408; PYRZAK R, 1986, POULTRY SCI, V65, P1262, DOI 10.3382/ps.0651262; Rodenboog H., 2001, WORLD POULTRY SCI J, V17, P22; Rozenboim I, 1999, BRIT POULTRY SCI, V40, P452, DOI 10.1080/00071669987197; SMITH LT, 1959, POULTRY SCI, V38, P1248; TAMIMIE HS, 1967, COMP BIOCHEM PHYSIOL, V21, P59, DOI 10.1016/0010-406X(67)90114-4; van der Lely S, 2015, J ADOLESCENT HEALTH, V56, P113, DOI 10.1016/j.jadohealth.2014.08.002; Vandewalle G, 2010, P NATL ACAD SCI USA, V107, P19549, DOI 10.1073/pnas.1010180107; Vandewalle G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001247; WABECK CJ, 1974, POULTRY SCI, V53, P2055, DOI 10.3382/ps.0532055; WELLS RG, 1971, BRIT POULTRY SCI, V12, P313, DOI 10.1080/00071667108415887; WOODARD AE, 1969, POULTRY SCI, V48, P118, DOI 10.3382/ps.0480118; Wyszecki G, 1982, COLOR SCI, Vsecond; ZELLER FJ, 1973, J REPROD FERTIL, V34, P147, DOI 10.1530/jrf.0.0340147	47	16	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135330	10.1371/journal.pone.0135330	http://dx.doi.org/10.1371/journal.pone.0135330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270988	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492800058
J	Ren, FH; Tang, RX; Zhang, X; Madushi, WM; Luo, DZ; Dang, YW; Li, ZY; Wei, KL; Chen, G				Ren, Fanghui; Tang, Ruixue; Zhang, Xin; Madushi, Wickramaarachchi Mihiranganee; Luo, Dianzhong; Dang, Yiwu; Li, Zuyun; Wei, Kanglai; Chen, Gang			Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-2 MMP-2; INVASIVE DUCTAL CARCINOMA; PREOPERATIVE SERUM-LEVELS; MATRIX-METALLOPROTEINASE-9 MMP-9; POOR-PROGNOSIS; EXPRESSION; SURVIVAL; LEVEL; TUMOR; RISK	Background Matrix metalloproteinases (MMPs) are regarded to be relevant to the prognosis of breast cancer. Numerous studies have confirmed the association between MMPs and tumor growth, invasion and metastasis in breast cancer. However, their prognostic values for survival in patients with breast cancer remain controversial. Hence, a meta-analysis was performed to clarify a more accurate estimation of the role of MMPs on prognosis of breast cancer patients. Method A systemic electronic search was conducted in PubMed, Embase and Web of science databases to identify eligible studies, which were associated with the relationship between MMPs and prognosis of breast cancer. The correlation in random-effect model was evaluated by using the hazard ratios (HRs) and 95% confidence intervals (CIs). Results A total of 28 studies covering 4944 patients were included for meta-analysis. A summary hazard ratio (HR) of all studies was calculated, as well as the sub-group HRs. The combined HRs calculated by either univariate or multivariate analysis both suggested that overexpression of MMPs had an unfavorable impact on overall survival (OS) (HR = 1.694, 95% CI: 1.347-2.129, P < 0.001; HR = 1.611, 95% CI: 1.419-1.830, P < 0.001, respectively). And the univariate analysis showed that patients with overexpression of MMPs had worse relapse-free survival (RFS) (HR = 1.969, 95% CI: 1.460-2.655, P < 0.001) in all eligible studies. In the sub-group analyses, HRs of MMP-9 positivity with poor OS were 1.794 (95% CI: 1.330-2.420, P < 0.001) and 1.709 (95% CI: 1.157-2.526, P = 0.007) which were separately evaluated by univariate and multivariate analysis. A small number of articles demonstrated that MMP-2 overexpression was not related with shorter OS (HR = 1.400, 95% CI: 0.610-3.029, P = 0.427). Four studies included in the OS analysis of MMPs expression in serum suggested that positive expression of serum MMPs may be an unfavorable factor (HR = 1.630, 95% CI: 1.065-2.494) for breast cancer patients. No publication bias was observed in the current meta-analysis. Conclusions Our findings suggested that MMPs overexpression (especially MMP-9, MMP-2, MMPs overexpression in serum) might indicate a higher risk of poor prognosis in breast cancer. Larger prospective studies are further needed to estimate the prognostic values of MMPs overexpression.	[Ren, Fanghui; Tang, Ruixue; Zhang, Xin; Madushi, Wickramaarachchi Mihiranganee; Luo, Dianzhong; Dang, Yiwu; Li, Zuyun; Wei, Kanglai; Chen, Gang] Guangxi Med Univ, Dept Pathol, Affiliated Hosp 1, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University	Chen, G (corresponding author), Guangxi Med Univ, Dept Pathol, Affiliated Hosp 1, Nanning, Guangxi Zhuang, Peoples R China.	chen_gang_triones@163.com	Zhang, Daniel Xin/L-5143-2019	Zhang, Daniel Xin/0000-0001-8561-6928	Fund of Guangxi Natural Scientific Research [2011GXNSFA018212]	Fund of Guangxi Natural Scientific Research	The study was supported partially by the Fund of Guangxi Natural Scientific Research (No. 2011GXNSFA018212). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1998, AM J PATHOL, V152, P721; Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; Bostrom P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-348; Bottino J, 2014, ACTA HISTOCHEM, V116, P1367, DOI 10.1016/j.acthis.2014.08.009; Chen Pin-Shern, 2011, PLoS One, V6, pe20164, DOI 10.1371/journal.pone.0020164; Chen YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121404; Chenard MP, 1996, INT J CANCER, V69, P448, DOI 10.1002/(SICI)1097-0215(19961220)69:6<448::AID-IJC5>3.3.CO;2-4; ENGEL G, 1994, INT J CANCER, V58, P830, DOI 10.1002/ijc.2910580614; Fernandez-Guinea O, 2013, INT J CLIN ONCOL, V18, P629, DOI 10.1007/s10147-012-0428-2; Folgueira MA, 2013, BIOSCIENCE REP, P33; Gonzalez-Arriaga P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-121; Hirvonen R, 2003, BREAST CANCER RES TR, V77, P85, DOI 10.1023/A:1021152910976; Kulic A, 2012, BIOMARKERS, V17, P416, DOI 10.3109/1354750X.2012.678885; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Leppa S, 2004, CLIN CANCER RES, V10, P1057, DOI 10.1158/1078-0432.CCR-03-0047; Li HC, 2004, BREAST CANCER RES TR, V88, P75, DOI 10.1007/s10549-004-1200-8; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; McGowan PM, 2008, ANN ONCOL, V19, P1566, DOI 10.1093/annonc/mdn180; Merdad A, 2014, ANTICANCER RES, V34, P1355; Min KW, 2014, APMIS, V122, P1196, DOI 10.1111/apm.12285; Mylona E, 2007, HISTOPATHOLOGY, V50, P338, DOI 10.1111/j.1365-2559.2007.02615.x; Park HI, 2000, J BIOL CHEM, V275, P20540, DOI 10.1074/jbc.M002349200; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pellikainen JM, 2004, CLIN CANCER RES, V10, P7621, DOI 10.1158/1078-0432.CCR-04-1061; Przybylowska K, 2006, BREAST CANCER RES TR, V95, P65, DOI 10.1007/s10549-005-9042-6; Rahko E, 2004, ANTICANCER RES, V24, P4247; Ranogajec I, 2012, MED ONCOL, V29, P561, DOI 10.1007/s12032-011-9984-y; Savinov AY, 2006, CANCER RES, V66, P2716, DOI 10.1158/0008-5472.CAN-05-3592; Scorilas A, 2001, BRIT J CANCER, V84, P1488, DOI 10.1054/bjoc.2001.1810; Sivula A, 2005, BREAST CANCER RES TR, V89, P215, DOI 10.1007/s10549-004-0714-4; Song J, 2013, ASIAN PAC J CANCER P, V14, P1615, DOI 10.7314/APJCP.2013.14.3.1615; Song N, 2012, CANCER EPIDEM BIOMAR, V21, P1371, DOI 10.1158/1055-9965.EPI-12-0293; Sullu Y, 2011, PATHOL RES PRACT, V207, P747, DOI 10.1016/j.prp.2011.09.010; Sung H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-193; Talvensaari-Mattila A, 2003, BRIT J CANCER, V89, P1270, DOI 10.1038/sj.bjc.6601238; Talvensaari-Mattila A, 2001, BREAST CANCER RES TR, V65, P55, DOI 10.1023/A:1006458601568; Talvensaari-Mattila A, 1999, BREAST CANCER RES TR, V58, P287; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wadowska-Jaszczynska K, 2011, NEUROENDOCRINOL LETT, V32, P821; Wu ZS, 2008, INT J CANCER, V122, P2050, DOI 10.1002/ijc.23337; Zeng Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0562-3; Zhang B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-83; Zhao S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0335-4	43	124	129	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135544	10.1371/journal.pone.0135544	http://dx.doi.org/10.1371/journal.pone.0135544			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270045	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800087
J	Bono, MS; Garcia, RD; Sri-Jayantha, DV; Ahner, BA; Kirby, BJ				Bono, Michael S., Jr.; Garcia, Ravi D.; Sri-Jayantha, Dylan V.; Ahner, Beth A.; Kirby, Brian J.			Measurement of Lipid Accumulation in Chlorella vulgaris via Flow Cytometry and Liquid-State H-1 NMR Spectroscopy for Development of an NMR-Traceable Flow Cytometry Protocol	PLOS ONE			English	Article							HIGH-RESOLUTION; VISIBLE LIPIDS; MICROALGAE; CHLAMYDOMONAS; CELLS; VALIDATION; LIMITATION; FREQUENCY	In this study, we cultured Chlorella vulgaris cells with a range of lipid contents, induced via nitrogen starvation, and characterized them via flow cytometry, with BODIPY 505/515 as a fluorescent lipid label, and liquid-state H-1 NMR spectroscopy. In doing so, we demonstrate the utility of calibrating flow cytometric measurements of algal lipid content using triacylglyceride (TAG, also known as triacylglycerol or triglyceride) content per cell as measured via quantitative H-1 NMR. Ensemble-averaged fluorescence of BODIPY-labeled cells was highly correlated with average TAG content per cell measured by bulk NMR, with a linear regression yielding a linear fit with r(2) = 0.9974. This correlation compares favorably to previous calibrations of flow cytometry protocols to lipid content measured via extraction, and calibration by NMR avoids the time and complexity that is generally required for lipid quantitation via extraction. Flow cytometry calibrated to a direct measurement of TAG content can be used to investigate the distribution of lipid contents for cells within a culture. Our flow cytometry measurements showed that Chlorella vulgaris cells subjected to nitrogen limitation exhibited higher mean lipid content but a wider distribution of lipid content that overlapped the relatively narrow distribution of lipid content for replete cells, suggesting that nitrogen limitation induces lipid accumulation in only a subset of cells. Calibration of flow cytometry protocols using direct in situ measurement of TAG content via NMR will facilitate rapid development of more precise flow cytometry protocols, enabling investigation of algal lipid accumulation for development of more productive algal biofuel feedstocks and cultivation protocols.	[Bono, Michael S., Jr.; Kirby, Brian J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Garcia, Ravi D.; Sri-Jayantha, Dylan V.; Ahner, Beth A.] Cornell Univ, Biol & Environm Engn, Ithaca, NY 14853 USA; [Kirby, Brian J.] Weill Cornell Med Coll, Div Hematol & Med Oncol, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University	Kirby, BJ (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	kirby@cornell.edu	Kirby, Brian/D-4139-2012	Kirby, Brian/0000-0002-7479-9738	Empire State Stem Cell Fund through New York State Department of Health Contract [C026718]; US Department of Defense (US DoD) through the National Defense Science and Engineering Graduate (NDSEG) Fellowship program; National Institutes of Health (NIH) via the Physical Sciences-Oncology Center at Cornell University [U54CA143876]; NATIONAL CANCER INSTITUTE [U54CA143876] Funding Source: NIH RePORTER	Empire State Stem Cell Fund through New York State Department of Health Contract; US Department of Defense (US DoD) through the National Defense Science and Engineering Graduate (NDSEG) Fellowship program; National Institutes of Health (NIH) via the Physical Sciences-Oncology Center at Cornell University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work made use of the Cornell University NMR Facility and the Cornell University Flow Cytometry Core Laboratory. The Flow Cytometry Core Laboratory acknowledges support by the Empire State Stem Cell Fund (stemcell.ny.gov) through New York State Department of Health Contract #C026718. Opinions expressed here are solely those of the authors and do not necessarily reflect those of the Empire State Stem Cell Board, the New York State Department of Health, or the State of New York. MSB was supported by the US Department of Defense (US DoD) through the National Defense Science and Engineering Graduate (NDSEG) Fellowship program (ndseg.asee.org) and received partial support from the National Institutes of Health (NIH) via the Physical Sciences-Oncology Center at Cornell University (Award U54CA143876, physics.cancer.gov).	Axelsson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089643; Barba I, 1999, CANCER RES, V59, P1861; Beal CM, 2010, BIOTECHNOL BIOENG, V106, P573, DOI 10.1002/bit.22701; Bearden DW, 2012, ENCYCLOPEDIA OF MAGN; Bittar TB, 2013, J PHYCOL, V124, P217; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bondu S, 2008, J APPL PHYCOL, V20, P673, DOI 10.1007/s10811-007-9231-2; Bono MS, 2013, BIORESOURCE TECHNOL, V143, P623, DOI 10.1016/j.biortech.2013.06.040; Cai HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086422; Chandler GT, 2004, MAR BIOTECHNOL, V6, P128, DOI 10.1007/s10126-002-0105-y; Chauton MS, 2003, J APPL PHYCOL, V15, P533, DOI 10.1023/B:JAPH.0000004355.11837.1d; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; Chia MA, 2013, EUR J PHYCOL, V48, P1, DOI 10.1080/09670262.2012.750687; Chioccioli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097269; Cirulis JT, 2012, CYTOM PART A, V81A, P618, DOI 10.1002/cyto.a.22066; Cooper MS, 2010, J BIOSCI BIOENG, V109, P198, DOI 10.1016/j.jbiosc.2009.08.004; Davey PT, 2012, ALGAL RES, V1, P166, DOI 10.1016/j.algal.2012.07.003; Davis RW, 2012, BIOTECHNOL BIOENG, V109, P2503, DOI 10.1002/bit.24517; de la Jara A, 2003, J APPL PHYCOL, V15, P433, DOI 10.1023/A:1026007902078; Dean AP, 2010, BIORESOURCE TECHNOL, V101, P4499, DOI 10.1016/j.biortech.2010.01.065; Deng XD, 2011, AFR J MICROBIOL RES, V5, P260; Deng Y., 2014, ADV MECH ENG, V2014, P8, DOI DOI 10.1063/1.4903942; Deng YL, 2013, BIORESOURCE TECHNOL, V135, P137, DOI 10.1016/j.biortech.2012.11.046; Gao CF, 2008, J MICROBIOL METH, V75, P437, DOI 10.1016/j.mimet.2008.07.019; GARDNER WS, 1985, LIMNOL OCEANOGR, V30, P1099, DOI 10.4319/lo.1985.30.5.1099; Gimpel JA, 2013, CURR OPIN CHEM BIOL, V17, P489, DOI 10.1016/j.cbpa.2013.03.038; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Govender T, 2012, BIORESOURCE TECHNOL, V114, P507, DOI 10.1016/j.biortech.2012.03.024; Hadady H, 2014, ELECTROPHORESIS, V35, P3533, DOI 10.1002/elps.201400306; Hakumaki JM, 2000, TRENDS BIOCHEM SCI, V25, P357, DOI 10.1016/S0968-0004(00)01614-5; Henderson TJ, 2002, ANAL CHEM, V74, P191, DOI 10.1021/ac010809+; Holland SL, 2014, ENVIRON MICROBIOL, V16, P1729, DOI 10.1111/1462-2920.12243; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hyka P, 2013, BIOTECHNOL ADV, V31, P2, DOI 10.1016/j.biotechadv.2012.04.007; Lee DH, 2013, ANAL CHEM, V85, P8749, DOI 10.1021/ac401836j; Lee J.Y., 2010, BIORESOURCE TECHN S1, V101, P575, DOI DOI 10.1016/j.biortech.2009.03.058; Lee TH, 2013, BIOTECHNOL J, V8, P1301, DOI 10.1002/biot.201200391; Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Merkley N, 2012, J APPL PHYCOL, V24, P535, DOI 10.1007/s10811-011-9731-y; Michael KA, 2014, ALGAL RES, V6, P17, DOI 10.1016/j.algal.2014.08.004; Millis KK, 1997, MAGNET RESON MED, V38, P399, DOI 10.1002/mrm.1910380307; Montero MF, 2011, J APPL PHYCOL, V23, P1053, DOI 10.1007/s10811-010-9623-6; Na JG, 2011, BIOTECHNOL LETT, V33, P957, DOI 10.1007/s10529-011-0522-y; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Pan X, 2013, LIPIDS AND METABOLIT; Quintero M, 2007, BBA-MOL CELL BIOL L, V1771, P31, DOI 10.1016/j.bbalip.2006.10.003; Schmollinger S, 2014, PLANT CELL, V26, P1410, DOI 10.1105/tpc.113.122523; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Vigeolas H, 2012, J BIOTECHNOL, V162, P3, DOI 10.1016/j.jbiotec.2012.03.017; Wang TT, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-58; Wensel P, 2014, ALGAL RES, V4, P2, DOI 10.1016/j.algal.2013.12.005; Weyer KM, 2010, BIOENERG RES, V3, P204, DOI 10.1007/s12155-009-9046-x	54	14	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134846	10.1371/journal.pone.0134846	http://dx.doi.org/10.1371/journal.pone.0134846			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267664	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300062
J	Buffum, B; McGreevy, TJ; Gottfried, AE; Sullivan, ME; Husband, TP				Buffum, Bill; McGreevy, Thomas J., Jr.; Gottfried, Amy E.; Sullivan, Mary E.; Husband, Thomas P.			An Analysis of Overstory Tree Canopy Cover in Sites Occupied by Native and Introduced Cottontails in the Northeastern United States with Recommendations for Habitat Management for New England Cottontail	PLOS ONE			English	Article							FOREST; LAGOMORPHS; SUCCESS; SIZE	The New England cottontail (Sylvilagus transitionalis) is a high conservation priority in the Northeastern United States and has been listed as a candidate species under the Endangered Species Act. Loss of early successional habitat is the most common explanation for the decline of the species, which is considered to require habitat with dense low vegetation and limited overstory tree canopy. Federal and state wildlife agencies actively encourage landowners to create this habitat type by clearcutting blocks of forest. However, there are recent indications that the species also occupies sites with moderate overstory tree canopy cover. This is important because many landowners have negative views about clearcutting and are more willing to adopt silvicultural approaches that retain some overstory trees. Furthermore, it is possible that clearcuts with no overstory canopy cover may attract the eastern cottontail (S. floridanus), an introduced species with an expanding range. The objective of our study was to provide guidance for future efforts to create habitat that would be more favorable for New England cottontail than eastern cottontail in areas where the two species are sympatric. We analyzed canopy cover at 336 cottontail locations in five states using maximum entropy modelling and other statistical methods. We found that New England cottontail occupied sites with a mean overstory tree canopy cover of 58% (SE +/- 1.36), and was less likely than eastern cottontail to occupy sites with lower overstory canopy cover and more likely to occupy sites with higher overstory canopy cover. Our findings suggest that silvicultural approaches that retain some overstory canopy cover may be appropriate for creating habitat for New England cottontail. We believe that our results will help inform critical management decisions for the conservation of New England cottontail, and that our methodology can be applied to analyses of habitat use of other critical wildlife species.	[Buffum, Bill; McGreevy, Thomas J., Jr.; Gottfried, Amy E.; Sullivan, Mary E.; Husband, Thomas P.] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA	University of Rhode Island	Buffum, B (corresponding author), Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA.	buffum@uri.edu	Buffum, Bill/M-2756-2013		Rhode Island Department of Environmental Management, Division of Fish and Wildlife/Pittman-Robertson Federal Aid in Wildlife Restoration Act [S000182, S000109]; Rhode Island Resource Conservation and Development Area Council/National Fish and Wildlife Foundation [4157]; University of Rhode Island	Rhode Island Department of Environmental Management, Division of Fish and Wildlife/Pittman-Robertson Federal Aid in Wildlife Restoration Act; Rhode Island Resource Conservation and Development Area Council/National Fish and Wildlife Foundation; University of Rhode Island	This research was funded by the Rhode Island Department of Environmental Management, Division of Fish and Wildlife/Pittman-Robertson Federal Aid in Wildlife Restoration Act (#S000182 (BB) and #S000109 (TJM, AEG, MES)); the Rhode Island Resource Conservation and Development Area Council/National Fish and Wildlife Foundation (#4157 (BB)); and the University of Rhode Island (TPH). This is contribution #5428 of the University of Rhode Island Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi MK, 2005, ACTA AGR SCAND B-S P, V55, P221, DOI 10.1080/09064710510008720; [Anonymous], 1987, NE603 USDA FOR SERV; Arbuthnot M, 2008, LANDOWNERSS GUIDE NE; Askins RA, 2007, FOREST ECOL MANAG, V250, P137, DOI 10.1016/j.foreco.2007.05.009; Baasch DM, 2010, ECOL MODEL, V221, P565, DOI 10.1016/j.ecolmodel.2009.10.033; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Berlick MM, 2002, 26 HARV U HARV FOR; Brubaker DR, 2014, WILDLIFE SOC B, V38, P513, DOI 10.1002/wsb.416; Buffum B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089972; Buffum B, 2011, FOREST ECOL MANAG, V262, P1775, DOI 10.1016/j.foreco.2011.07.024; Crawford HS, 1976, NE349 USDA FOR SERV; DeGraaf RM, 2003, FOREST ECOL MANAG, V185, P179, DOI 10.1016/S0378-1127(03)00254-8; Evangelista P., 2011, MAXENT MODEL V3 3 3E; Farrell SL, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-000352.1; FAY F. H., 1955, JOUR MAMMAL, V36, P415, DOI 10.2307/1375684; Fenderson LE, 2014, ECOL EVOL, V4, P1853, DOI 10.1002/ece3.1068; Fenderson LE, 2011, CONSERV GENET, V12, P943, DOI 10.1007/s10592-011-0197-x; Field A, 2005, DISCROVERING STAT US; Foster D.R., 2004, FORESTS TIME ENV CON; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Fuller S., 2012, CONSERVATION STRATEG; Fuller S., CONSERVATION STRATEG; Gottfried A, 2013, THESIS U RHODE ISLAN; Jennings SB, 1999, FORESTRY, V72, P59, DOI 10.1093/forestry/72.1.59; King DI, 2000, FOREST ECOL MANAG, V129, P227, DOI 10.1016/S0378-1127(99)00167-X; Litvaitis JA, 2006, WILDLIFE SOC B, V34, P1190, DOI 10.2193/0091-7648(2006)34[1190:ARSTDT]2.0.CO;2; Litvaitis John A., 2008, P167, DOI 10.1007/978-3-540-72446-9_12; Lorimer CG, 2001, WILDLIFE SOC B, V29, P425; Maynard C, 2013, EVALUATING COASTAL I; McKinney RA, 2014, INT J FORESTRY RES, V2014, P9, DOI [10.1155/2014/329836, DOI 10.1155/2014/329836]; NEC Regional Technical Committee, 2013, BEST MAN PRACT MAKE; Niebels M, 2013, THESIS U RHODE ISLAN; NRCS, 2014, NEW ENGL COTT NAT RE; Nyland R., 2002, SILVICULTURE CONCEPT; Paletto A, 2009, EUR J FOREST RES, V128, P265, DOI 10.1007/s10342-009-0262-x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Probert BL, 1996, BIOL CONSERV, V76, P289, DOI 10.1016/0006-3207(95)00127-1; Scharine PD, 2011, J MAMMAL, V92, P880, DOI 10.1644/10-MAMM-A-078.1; Schlossberg S, 2010, J WILDLIFE MANAGE, V74, P1513, DOI 10.2193/2008-601; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith Douglas F., 1999, Northeast Wildlife, V54, P55; Stokland JN, 2011, ECOL MODEL, V222, P1800, DOI 10.1016/j.ecolmodel.2011.02.025; Trani MK, 2001, WILDLIFE SOC B, V29, P413; [USDI USDA], EX VEG COV EVC DAT L; USFWS, 2011, FED REGISTER, V71, P53756; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Walters RS, 1986, NE581 USDA FOR SERV; [No title captured]	49	8	8	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135067	10.1371/journal.pone.0135067	http://dx.doi.org/10.1371/journal.pone.0135067			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267857	Green Published, gold			2022-12-27	WOS:000359492300075
J	Calabrese, M; Reynolds, R; Magliozzi, R; Castellaro, M; Morra, A; Scalfari, A; Farina, G; Romualdi, C; Gajofatto, A; Pitteri, M; Benedetti, MD; Monaco, S				Calabrese, Massimiliano; Reynolds, Richard; Magliozzi, Roberta; Castellaro, Marco; Morra, Aldo; Scalfari, Antonio; Farina, Gabriele; Romualdi, Chiara; Gajofatto, Alberto; Pitteri, Marco; Benedetti, Maria Donata; Monaco, Salvatore			Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients	PLOS ONE			English	Article							LONG-TERM DISABILITY; GREY-MATTER; CORTICAL PATHOLOGY; MENINGEAL INFLAMMATION; COGNITIVE IMPAIRMENT; AXONAL DEGENERATION; LESION DETECTION; ATROPHY; ONSET; PROGRESSION	Background Both gray-matter (GM) atrophy and lesions occur from the earliest stages of Multiple Sclerosis (MS) and are one of the major determinants of long-term clinical outcomes. Nevertheless, the relationship between focal and diffuse GM damage has not been clarified yet. Here we investigate the regional distribution and temporal evolution of cortical thinning and how it is influenced by the local appearance of new GM lesions at different stages of the disease in different populations of MS patients. Methods We studied twenty MS patients with clinically isolated syndrome (CIS), 27 with early relapsing-remitting MS (RRMS, disease duration <5 years), 29 with late RRMS (disease duration >= 5 years) and 20 with secondary-progressive MS (SPMS). The distribution and evolution of regional cortical thickness and GM lesions were assessed during 5-year follow-up. Results The results showed that new lesions appeared more frequently in hippocampus and para-hippocampal gyri (9.1%), insula (8.9%), cingulate cortex (8.3%), superior frontal gyrus (8.1%), and cerebellum (6.5%). The aforementioned regions showed the greatest reduction in thickness/volume, although (several) differences were observed across subgroups. The correlation between the appearance of new cortical lesions and cortical thinning was stronger in CIS (r(2) = 50.0, p<0.001) and in early RRMS (r(2) = 52.3, p<0.001), compared to late RRMS (r(2) = 25.5, p<0.001) and SPMS (r(2) = 6.3, p = 0.133). Conclusions We conclude that GM atrophy and lesions appear to be different signatures of cortical disease in MS having in common overlapping spatio-temporal distribution patterns. However, the correlation between focal and diffuse damage is only moderate and more evident in the early phase of the disease.	[Calabrese, Massimiliano; Farina, Gabriele; Gajofatto, Alberto; Pitteri, Marco; Benedetti, Maria Donata; Monaco, Salvatore] Univ Verona, Neurol Sect, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Calabrese, Massimiliano; Morra, Aldo] Euganea Med, Neuroimaging Unit, Padua, Italy; [Reynolds, Richard; Magliozzi, Roberta] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Div Brain Sci, London, England; [Magliozzi, Roberta] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Castellaro, Marco] Univ Padua, Dept Informat Engn, Padua, Italy; [Scalfari, Antonio] Univ London Imperial Coll Sci Technol & Med, Wolfson Neurosci Labs, Ctr Neurosci, Dept Med,Div Brain Sci, London, England; [Farina, Gabriele] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Romualdi, Chiara] Univ Padua, Dept Biol, Padua, Italy	University of Verona; Imperial College London; Istituto Superiore di Sanita (ISS); University of Padua; Imperial College London; University of Sassari; University of Padua	Calabrese, M (corresponding author), Univ Verona, Neurol Sect, Dept Neurol & Movement Sci, I-37100 Verona, Italy.	calabresem@hotmail.it	Pitteri, Marco/M-3695-2015; Romualdi, Chiara/K-1132-2016; Monaco, Salvatore/K-4659-2018; Castellaro, Marco/AAE-2937-2019; Calabrese, Massimiliano/AAB-7082-2022	Pitteri, Marco/0000-0001-8093-4548; Romualdi, Chiara/0000-0003-4792-9047; Monaco, Salvatore/0000-0003-3191-8597; Castellaro, Marco/0000-0002-1203-2670; Calabrese, Massimiliano/0000-0002-3362-7403; Reynolds, Richard/0000-0003-4622-4694; Gajofatto, Alberto/0000-0001-6539-0458; Morra, Aldo/0000-0002-2771-9803; Benedetti, Maria Donata/0000-0002-8340-2915	Biogen Idec; Genzyme; Novartis Pharma; Teva Pharmaceutical Industries; EMD Serono; Parkinson&quot;s UK [J-1402] Funding Source: researchfish	Biogen Idec(Biogen); Genzyme(Sanofi-AventisGenzyme Corporation); Novartis Pharma; Teva Pharmaceutical Industries(Teva Pharmaceutical Industries); EMD Serono; Parkinson&quot;s UK(Parkinson&apos;s UK)	M. Calabrese received consultancy fees from Biogen Idec, Genzyme, Novartis Pharma, and Teva Pharmaceutical Industries. R. Reynolds received consultancy fees from EMD Serono. R. Magliozzi, M. Castellaro, M. Morra, A. Scalfari, G. Farina, C. Romualdi, A. Gajofatto, M. Pitteri, M.D. Benedetti, and S. Monaco have nothing to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding is not specifically related to this study.	Bendfeldt K, 2010, BRAIN RES, V1325, P174, DOI 10.1016/j.brainres.2010.02.035; Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; Calabrese M, 2011, NEUROLOGY, V77, P257, DOI 10.1212/WNL.0b013e318220abd4; Calabrese M, 2010, NEUROLOGY, V75, P1234, DOI 10.1212/WNL.0b013e3181f5d4da; Calabrese M, 2009, MULT SCLER J, V15, P933, DOI 10.1177/1352458509106510; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Calabrese M, 2007, J NEUROL, V254, P1212, DOI 10.1007/s00415-006-0503-6; Calabrese M, 2012, BRAIN, V135, P2952, DOI 10.1093/brain/aws246; Calabrese M, 2011, RADIOLOGY, V261, P891, DOI 10.1148/radiol.11110195; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; de Graaf WL, 2013, EUR RADIOL, V23, P528, DOI 10.1007/s00330-012-2619-7; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Evangelou N, 2000, BRAIN, V123, P1845, DOI 10.1093/brain/123.9.1845; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423; Gabilondo I, 2014, ANN NEUROL, V75, P98, DOI 10.1002/ana.24030; Geurts JJG, 2011, NEUROLOGY, V76, P418, DOI 10.1212/WNL.0b013e31820a0cc4; Geurts JJG, 2012, LANCET NEUROL, V11, P1082, DOI 10.1016/S1474-4422(12)70230-2; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Hulst HE, 2013, NEUROLOGY, V80, P1025, DOI 10.1212/WNL.0b013e31828726cc; Kilsdonk ID, 2013, AM J NEURORADIOL, V34, P791, DOI 10.3174/ajnr.A3289; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Llufriu S, 2014, MULT SCLER J, V20, P424, DOI 10.1177/1352458513503722; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Magliozzi R, 2010, ANN NEUROL, V68, P477, DOI 10.1002/ana.22230; MILLER DH, 1991, J NEUROL NEUROSUR PS, V54, P683, DOI 10.1136/jnnp.54.8.683; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Parisi L, 2014, J NEUROL, V261, P1715, DOI 10.1007/s00415-014-7409-5; Pirko I, 2007, NEUROLOGY, V68, P634, DOI 10.1212/01.wnl.0000250267.85698.7a; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rinaldi F, 2012, MULT SCLER J, V18, P1760, DOI 10.1177/1352458512447704; Sbardella E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063250; Scalfari A, 2013, JAMA NEUROL, V70, P214, DOI 10.1001/jamaneurol.2013.599; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Seewann A, 2011, MULT SCLER J, V17, P1202, DOI 10.1177/1352458511406575; Sepulcre J, 2009, ARCH NEUROL-CHICAGO, V66, P173, DOI 10.1001/archneurol.2008.562; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steenwijk MD, 2015, HUM BRAIN MAPP; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tur C, 2011, J NEUROL NEUROSUR PS, V82, P423, DOI 10.1136/jnnp.2010.209890; Vercellino M, 2005, J NEUROPATH EXP NEUR, V64, P1101, DOI 10.1097/01.jnen.0000190067.20935.42; Wegner C, 2006, NEUROLOGY, V67, P960, DOI 10.1212/01.wnl.0000237551.26858.39	44	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135428	10.1371/journal.pone.0135428	http://dx.doi.org/10.1371/journal.pone.0135428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267665	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300117
J	Darmon, D; Omodei, E; Garland, J				Darmon, David; Omodei, Elisa; Garland, Joshua			Followers Are Not Enough: A Multifaceted Approach to Community Detection in Online Social Networks	PLOS ONE			English	Article							COMPLEX NETWORKS	In online social media networks, individuals often have hundreds or even thousands of connections, which link these users not only to friends, associates, and colleagues, but also to news outlets, celebrities, and organizations. In these complex social networks, a 'community' as studied in the social network literature, can have very different meaning depending on the property of the network under study. Taking into account the multifaceted nature of these networks, we claim that community detection in online social networks should also be multifaceted in order to capture all of the different and valuable viewpoints of 'community.' In this paper we focus on three types of communities beyond follower-based structural communities: activity-based, topic-based, and interaction-based. We analyze a Twitter dataset using three different weightings of the structural network meant to highlight these three community types, and then infer the communities associated with these weightings. We show that interesting insights can be obtained about the complex community structure present in social networks by studying when and how these four community types give rise to similar as well as completely distinct community structure.	[Darmon, David] Univ Maryland, Dept Math, College Pk, MD 20742 USA; [Omodei, Elisa] ISC PIF, LaTTiCe CNRS, Paris, France; [Omodei, Elisa] Univ Rovira & Virgili, Dept Engn Informat & Matemat, E-43007 Tarragona, Spain; [Garland, Joshua] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA	University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); Universitat Rovira i Virgili; University of Colorado System; University of Colorado Boulder	Darmon, D (corresponding author), Univ Maryland, Dept Math, College Pk, MD 20742 USA.	ddarmon@math.umd.edu		Omodei, Elisa/0000-0002-6748-5124	Region Ile-de-France (DIM); French National Agency of Research [ANR-12-CORD-0018]	Region Ile-de-France (DIM)(Region Ile-de-France); French National Agency of Research(French National Research Agency (ANR))	This work was partially supported by the Region Ile-de-France (http://www.iledefrance.fr, DIM 2011 to EO), and by the French National Agency of Research (http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/, ANR-12-CORD-0018 to EO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher C, 2014, J COMPL NET IN PRESS; [Anonymous], 2009, NETWORKS INTRO; Baumes J., 2005, IADIS AC, V5, P97; Becker H., 2011, ICWSM, V11, P438; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Cazabet R, 2012, P 4 WI C; Conover M. D., 2011, 5 INT AAAI C WEBL SO, DOI DOI 10.1021/JA202932E; Darmon D, 2013, P CSSS; Darmon D, 2013, 2013 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM), P102, DOI 10.1109/SocialCom.2013.22; Deitrick W, 2013, J DATA ANAL INFORM P, V1, P19, DOI [10.4236/jdaip.2013.13004, DOI 10.4236/JDAIP.2013.13004]; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; GRANGER CWJ, 1963, INFORM CONTROL, V6, P28, DOI 10.1016/S0019-9958(63)90092-5; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gregory S, 2007, LECT NOTES ARTIF INT, V4702, P91; HOLLAND PW, 1983, SOC NETWORKS, V5, P109, DOI 10.1016/0378-8733(83)90021-7; Java A, 2009, LECT NOTES ARTIF INT, V5439, P118, DOI 10.1145/1348549.1348556; Kao A, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS: BIG DATA, EMERGENT THREATS, AND DECISION-MAKING IN SECURITY INFORMATICS, P137, DOI 10.1109/ISI.2013.6578803; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lim KH, 2012, P 23 ACM C HYP SOC M, P317, DOI [10.1145/2309996.2310052, DOI 10.1145/2309996.2310052]; Lim KH, 2012, 2012 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE AND INTELLIGENT AGENT TECHNOLOGY (WI-IAT 2012), VOL 1, P214, DOI 10.1109/WI-IAT.2012.53; Meila M, 2003, LECT NOTES ARTIF INT, V2777, P173, DOI 10.1007/978-3-540-45167-9_14; Michelson M., 2010, P 4 WORKSH AN NOIS U, P73, DOI DOI 10.1145/1871840.1871852; Nepusz T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016107; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nguyen NP, 2011, IEEE INFOCOM SER, P2282, DOI 10.1109/INFCOM.2011.5935045; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Romero DM, 2011, LECT NOTES ARTIF INT, V6913, P18, DOI 10.1007/978-3-642-23808-6_2; Rossi L, 2012, P 6 INT AAAI C WEBL, P563; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Salton G, 1983, INTRO MODERN INFORM; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Tsur O, 2012, P 5 ACM INT C WEB SE, P643, DOI [10.1145/2124295.2124320, DOI 10.1145/2124295.2124320]; Ver Steeg G., 2012, P 21 INT C WORLD WID, P509, DOI DOI 10.1145/2187836.2187906; Yin ZJ, 2012, ACM T INTEL SYST TEC, V3, DOI 10.1145/2337542.2337548; Zhang SH, 2007, PHYSICA A, V374, P483, DOI 10.1016/j.physa.2006.07.023; Zhao WNX, 2011, LECT NOTES COMPUT SC, V6611, P338, DOI 10.1007/978-3-642-20161-5_34	43	22	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134860	10.1371/journal.pone.0134860	http://dx.doi.org/10.1371/journal.pone.0134860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267868	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300064
J	Greer, T; Hao, L; Nechyporenko, A; Lee, S; Vezina, CM; Ricke, WA; Marker, PC; Bjorling, DE; Bushman, W; Li, LJ				Greer, Tyler; Hao, Ling; Nechyporenko, Anatoliy; Lee, Sanghee; Vezina, Chad M.; Ricke, Will A.; Marker, Paul C.; Bjorling, Dale E.; Bushman, Wade; Li, Lingjun			Custom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS)	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; MASS TAG QUANTIFICATION; TRANSFORMING GROWTH-FACTOR-BETA-1; ABSOLUTE QUANTIFICATION; QUANTITATIVE PROTEOMICS; CEREBROSPINAL-FLUID; SODIUM-CHANNEL; FIBROSIS; EXPRESSION; INFLAMMATION	The relative quantification of proteins using liquid chromatography mass spectrometry (LC-MS) has allowed researchers to compile lists of potential disease markers. These complex quantitative workflows often include isobaric labeling of enzymatically-produced peptides to analyze their relative abundances across multiple samples in a single LC-MS run. Recent efforts by our lab have provided scientists with cost-effective alternatives to expensive commercial labels. Although the quantitative performance of these dimethyl leucine (DiLeu) labels has been reported using known ratios of complex protein and peptide standards, their potential in large-scale proteomics studies using a clinically relevant system has never been investigated. Our work rectifies this oversight by implementing 4-plex DiLeu to quantify proteins in the urine of aging human males who suffer from lower urinary tract symptoms (LUTS). Protein abundances in 25 LUTS and 15 control patients were compared, revealing that of the 836 proteins quantified, 50 were found to be differentially expressed (>20% change) and statistically significant (p-value <0.05). Gene ontology (GO) analysis of the differentiated proteins showed that many were involved in inflammatory responses and implicated in fibrosis. While confirmation of individual protein abundance changes would be required to verify protein expression, this study represents the first report using the custom isobaric label, 4-plex DiLeu, to quantify protein abundances in a clinically relevant system.	[Greer, Tyler; Li, Lingjun] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Hao, Ling; Nechyporenko, Anatoliy; Marker, Paul C.; Li, Lingjun] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Lee, Sanghee; Ricke, Will A.; Bushman, Wade] Univ Wisconsin, Dept Urol, Madison, WI USA; [Vezina, Chad M.; Bjorling, Dale E.] Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Li, LJ (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	lingjun.li@wisc.edu	Vezina, Chad/GRO-2299-2022	Ricke, William/0000-0002-9807-2090; Vezina, Chad/0000-0001-7058-5399; Lee, Sanghee/0000-0002-6574-8656; hao, ling/0000-0002-0106-5266	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant [P20 DK097826]; NIH shared instrument grant [NIH-NCRR S10RR029531]; undergraduate Hilldale Fellowship; H. I. Romnes Faculty Research Fellowship;  [DK091193]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P20DK097826, U54DK104310, R01DK091193] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant; NIH shared instrument grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); undergraduate Hilldale Fellowship; H. I. Romnes Faculty Research Fellowship; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge support for this work by the National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant (P20 DK097826). The Q-Exactive Orbitrap instrument was purchased through the support of an NIH shared instrument grant (NIH-NCRR S10RR029531). A. N. acknowledges an undergraduate Hilldale Fellowship. P. C. M. acknowledges grant DK091193. L. L. acknowledges an H. I. Romnes Faculty Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; AUMULLER G, 1982, PROSTATE, V3, P361, DOI 10.1002/pros.2990030406; Azad AK, 2009, HUM MUTAT, V30, P1093, DOI 10.1002/humu.21011; Bauman TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109102; BELANGER A, 1994, J CLIN ENDOCR METAB, V79, P1086; Bercovich E, 1999, Arch Ital Urol Androl, V71, P287; Betancourt A, 2014, J PROTEOME RES, V13, P1502, DOI 10.1021/pr401027q; Bierhoff E, 1996, EUR UROL, V29, P345; Boeker KHW, 2002, CLIN CHIM ACTA, V316, P71, DOI 10.1016/S0009-8981(01)00730-6; Boersema PJ, 2008, PROTEOMICS, V8, P4624, DOI 10.1002/pmic.200800297; Bushman W, 2009, UROL CLIN N AM, V36, P403, DOI 10.1016/j.ucl.2009.07.003; Cairo ER, 2008, BBA-BIOMEMBRANES, V1778, P398, DOI 10.1016/j.bbamem.2007.10.009; Cannon GW, 2007, J UROLOGY, V177, P610, DOI 10.1016/j.juro.2006.09.023; Cantiello F, 2013, UROLOGY, V81, P1018, DOI 10.1016/j.urology.2013.01.053; Cantiello HF, 1996, EXP PHYSIOL, V81, P505, DOI 10.1113/expphysiol.1996.sp003953; CASINI A, 1994, BIOCHEM BIOPH RES CO, V199, P1019, DOI 10.1006/bbrc.1994.1331; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Clozel M, 2005, ANN MED, V37, P2, DOI 10.1080/07853890410018925; Constantinou CE, 1996, NEUROUROL URODYNAM, V15, P85, DOI 10.1002/(SICI)1520-6777(1996)15:1<85::AID-NAU9>3.0.CO;2-B; Cunningham R, 2013, J PROTEOME RES, V12, P719, DOI 10.1021/pr300785h; Darrah R, 2010, PHYSIOL GENOMICS, V41, P71, DOI 10.1152/physiolgenomics.00185.2009; De Lisle RC, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01418.x; de Oliveira BM, 2014, MOL CELL PROTEOMICS, V13, P3001, DOI 10.1074/mcp.M113.032276; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; DeLisle RC, 1997, GASTROENTEROLOGY, V113, P521, DOI 10.1053/gast.1997.v113.pm9247472; Delongchamps NB, 2008, J UROLOGY, V179, P1736, DOI 10.1016/j.juro.2008.01.034; Dephoure N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002548; DeSouza L, 2005, J PROTEOME RES, V4, P377, DOI 10.1021/pr049821j; DeSouza LV, 2008, J PROTEOME RES, V7, P3525, DOI 10.1021/pr800312m; Dihazi H, 2011, J PROTEOMICS, V74, P304, DOI 10.1016/j.jprot.2010.11.007; Eltoweissy M, 2011, MOL BIOSYST, V7, P1277, DOI 10.1039/c0mb00116c; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Engstrom G, 2005, BJU INT, V95, P810, DOI 10.1111/j.1464-410X.2005.05406.x; Evans AR, 2013, PROTEOMICS, V13, P3267, DOI 10.1002/pmic.201300198; Frost DC, 2015, ANAL CHEM, V87, P1646, DOI 10.1021/ac503276z; Greer T, 2015, J AM SOC MASS SPECTR, V26, P107, DOI 10.1007/s13361-014-1012-y; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hammarsten J, 2001, EUR UROL, V39, P151, DOI 10.1159/000052430; Hebert AS, 2013, MOL CELL PROTEOMICS, V12, P3360, DOI 10.1074/mcp.M113.032011; Hebert AS, 2013, NAT METHODS, V10, P332, DOI [10.1038/NMETH.2378, 10.1038/nmeth.2378]; Hellstrom WJG, 2009, UROLOGY, V74, P15, DOI 10.1016/j.urology.2008.06.048; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hui LM, 2012, PEPTIDES, V36, P230, DOI 10.1016/j.peptides.2012.05.007; Hwang CY, 2014, PROTEOMICS, V14, P121, DOI 10.1002/pmic.201200497; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Jablonska E, 2010, J BIOL CHEM, V285, P11638, DOI 10.1074/jbc.M109.045963; Jeanson L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108671; Ji CJ, 2005, J PROTEOME RES, V4, P2099, DOI 10.1021/pr050215d; Kalantari S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080830, DOI 10.1371/J0URNAL.P0NE.0080830]; Kalantari S, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-141; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kanno Y, 2007, J THROMB HAEMOST, V5, P2266, DOI 10.1111/j.1538-7836.2007.02745.x; Kitamura H, 2013, MODERN PATHOL, V26, P117, DOI 10.1038/modpathol.2012.139; Kitsberg DI, 1996, ONCOGENE, V13, P2507; KOHNEN PW, 1979, J UROLOGY, V121, P755, DOI 10.1016/S0022-5347(17)56980-3; Kramer G, 2007, EUR UROL, V51, P1202, DOI 10.1016/j.eururo.2006.12.011; Lavallee-Adam M, 2014, J PROTEOME RES, V13, P5496, DOI 10.1021/pr500473n; Lee S, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/939053; Ma JJ, 2012, J UROLOGY, V188, P1375, DOI 10.1016/j.juro.2012.06.007; Mahapokai W, 2000, PROSTATE, V44, P40; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; MCNEAL J, 1990, UROL CLIN N AM, V17, P477; MCNEAL JE, 1978, INVEST UROL, V15, P340; Meigs JB, 2001, J CLIN EPIDEMIOL, V54, P935, DOI 10.1016/S0895-4356(01)00351-1; Merl J, 2012, PROTEOMICS, V12, P1902, DOI 10.1002/pmic.201100549; Mertins P, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014423; Michel M, 2009, EUR UROL SUPPL, V8, P496, DOI 10.1016/j.eursup.2009.02.001; Milner KL, 2009, HEPATOLOGY, V49, P1926, DOI 10.1002/hep.22896; Mirtti T, 2003, PROSTATE, V54, P290, DOI 10.1002/pros.10196; Muramatsu T, 2011, CURR PHARM DESIGN, V17, P410, DOI 10.2174/138161211795164167; Nangaku M, 1999, J AM SOC NEPHROL, V10, P2323; Nicholson TM, 2012, ENDOCRINOLOGY, V153, P5556, DOI 10.1210/en.2012-1522; Nickel JC, 1999, BJU INT, V84, P976; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; OMACINI S, 1992, EUR UROL, V21, P108; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Prat AG, 1999, AM J PHYSIOL-CELL PH, V277, pC1160, DOI 10.1152/ajpcell.1999.277.6.C1160; Raju R, 2013, CYTOKINE, V61, P724, DOI 10.1016/j.cyto.2012.12.019; Ranganathan K, 2006, J ORAL PATHOL MED, V35, P25, DOI 10.1111/j.1600-0714.2005.00366.x; Richards AL, 2013, MOL CELL PROTEOMICS, V12, P3812, DOI 10.1074/mcp.M113.028951; Roehrborn Claus G, 2005, Rev Urol, V7 Suppl 9, pS3; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Saban Marcia R, 2006, BMC Physiol, V6, P1, DOI 10.1186/1472-6793-6-1; Saigal CS, 2005, J UROLOGY, V173, P1309, DOI 10.1097/01.ju.0000152318.79184.6f; Sanchez-Nino MD, 2012, LAB INVEST, V92, P32, DOI 10.1038/labinvest.2011.138; Savitski MM, 2013, J PROTEOME RES, V12, P3586, DOI 10.1021/pr400098r; Savitski MM, 2011, ANAL CHEM, V83, P8959, DOI 10.1021/ac201760x; Schneider M, 2008, J MOL MED, V86, P507, DOI 10.1007/s00109-007-0301-3; Shadforth IP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-145; Sinclair J, 2011, METHODS, V54, P361, DOI 10.1016/j.ymeth.2011.03.004; Sousa MM, 2000, J BIOL CHEM, V275, P38176, DOI 10.1074/jbc.M002886200; Southey BR, 2014, ANAL CHEM, V86, P443, DOI 10.1021/ac4023378; Stanke F, 2006, HUM GENET, V119, P331, DOI 10.1007/s00439-006-0140-2; Stebbing J, 2014, ONCOGENE, V33, P939, DOI 10.1038/onc.2013.80; STEINER G, 1994, J UROLOGY, V151, P480, DOI 10.1016/S0022-5347(17)34998-4; Sturm RM, 2014, RAPID COMMUN MASS SP, V28, P1051, DOI 10.1002/rcm.6875; Sulyok S, 2004, MOL CELL ENDOCRINOL, V225, P127, DOI 10.1016/j.mce.2004.07.011; THEYER G, 1992, LAB INVEST, V66, P96; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Titulaer Mark K, 2011, BMC Res Notes, V4, P21, DOI 10.1186/1756-0500-4-21; Tzortzaki EG, 2003, ANAT REC PART A, V275A, P1073, DOI 10.1002/ar.a.10120; Ulbrich A, 2014, J AM SOC MASS SPECTR, V25, P6, DOI 10.1007/s13361-013-0765-z; Verhamme KMC, 2002, EUR UROL, V42, P323, DOI 10.1016/S0302-2838(02)00354-8; WALSH PC, 1976, J CLIN INVEST, V57, P1093, DOI 10.1172/JCI108353; Wenger CD, 2011, NAT METHODS, V8, P933, DOI [10.1038/NMETH.1716, 10.1038/nmeth.1716]; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079; WINTER ML, 1995, PROSTATE, V26, P325, DOI 10.1002/pros.2990260608; Wong L, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100770, DOI 10.1371/J0URNAL.P0NE.0100770]; Wong L, 2015, PROSTATE, V75, P23, DOI 10.1002/pros.22886; Xiang F, 2010, ANAL CHEM, V82, P2817, DOI 10.1021/ac902778d; Zhang RJ, 2001, ANAL CHEM, V73, P5142, DOI 10.1021/ac010583a; Zhang SG, 2014, INSECT BIOCHEM MOLEC, V47, P46, DOI 10.1016/j.ibmb.2014.02.002; Zhou L, 2013, PROTEOMICS, V13, P2469, DOI 10.1002/pmic.201200230; Zhou Y, 2009, ASIAN J ANDROL, V11, P451, DOI 10.1038/aja.2009.28	117	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135415	10.1371/journal.pone.0135415	http://dx.doi.org/10.1371/journal.pone.0135415			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267142	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300113
J	Kuai, P; Li, W; Liu, NF				Kuai, Peng; Li, Wei; Liu, Nianfeng			Evaluating the Effects of Land Use Planning for Non-Point Source Pollution Based on a System Dynamics Approach in China	PLOS ONE			English	Article							WATER-QUALITY; STORM RUNOFF; MODEL; LOADS; MANAGEMENT; IMPACTS; AREA	Urbanization is proceeding rapidly in several developing countries such as China. This accelerating urbanization alters the existing land use types in a way that results in more Non-Point Source (NPS) pollution to local surface waters. Reasonable land use planning is necessary. This paper compares seven planning scenarios of a case study area, namely Wulijie, China, from the perspective of NPS pollution. A System Dynamics (SD) model was built for the comparison to adequately capture the planning complexity. These planning scenarios, which were developed by combining different land use intensities (LUIs) and construction speeds (CSs), were then simulated. The results show that compared to scenario S1 (business as usual) all other scenarios will introduce more NPS pollution (with an incremental rate of 22%-70%) to Wulijie. Scenario S6 was selected as the best because it induced relatively less NPS pollution while simultaneously maintaining a considerable development rate. Although LUIs represent a more critical factor compared to CSs, we conclude that both LUIs and CSs need to be taken into account to make the planning more environmentally friendly. Considering the power of SD in decision support, it is recommended that land use planning should take into consideration findings acquired from SD simulations.	[Kuai, Peng; Li, Wei] Beijing Normal Univ, Sch Environm, Beijing 100875, Peoples R China; [Liu, Nianfeng] Huazhong Univ Sci & Technol, Sch Environm, Wuhan 430074, Peoples R China	Beijing Normal University; Huazhong University of Science & Technology	Li, W (corresponding author), Beijing Normal Univ, Sch Environm, Beijing 100875, Peoples R China.	weili@bnu.edu.cn			Ministry of Environmental Protection, China [2013467042]; Public Welfare Research Project of Critical Environmental Assessment Techniques for Watershed General Planning	Ministry of Environmental Protection, China; Public Welfare Research Project of Critical Environmental Assessment Techniques for Watershed General Planning	This study was supported by Funding institution: Ministry of Environmental Protection, China. Grant numbers: 2013467042. Funding project: The Public Welfare Research Project of Critical Environmental Assessment Techniques for Watershed General Planning. PK and WL received the funding. (URLs:http://www.zhb.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, DES MAN WAT SUPPL DR, V5; Araujo-Pradere E. A., 2002, Radio Science, V37, P4; Barbosa AE, 2012, WATER RES, V46, P6787, DOI 10.1016/j.watres.2012.05.029; Bei, 2005, WATER RESOURCE PROTE, V21, P63; Brun S. E., 2000, Computers, Environment and Urban Systems, V24, P5, DOI 10.1016/S0198-9715(99)00040-X; Buhaug H, 2013, GLOBAL ENVIRON CHANG, V23, P1, DOI 10.1016/j.gloenvcha.2012.10.016; Chen S, 1991, ACTA OCEANOL SIN, V3, P6; [程炯 CHENG Jong], 2006, [生态环境, Ecology and Environment], V15, P641; Cheng M.-l., 2003, OPERATIONS RES MANAG, V12, P85, DOI [10.1088/1009-1963/12/3/307, DOI 10.1088/1009-1963/12/3/307]; China State Council, 2011, 12 5 YEAR PLAN NAT E; Cohen B, 2006, TECHNOL SOC, V28, P63, DOI 10.1016/j.techsoc.2005.10.005; Eisakhani M, 2009, GIS BASED NONPOINT S; Ellis JB, 2012, SCI TOTAL ENVIRON, V416, P172, DOI 10.1016/j.scitotenv.2011.12.003; Ellis K. V., 1989, SURFACE WATER POLLUT; Ford A., 1999, MODELING ENV INTRO S; Forrester JW, 2007, SYST DYNAM REV, V23, P345, DOI 10.1002/sdr.382; Forrester JW, 2007, SYST DYNAM REV, V23, P359, DOI 10.1002/sdr.381; FORRESTER JW, 1994, SYST DYNAM REV, V10, P245, DOI 10.1002/sdr.4260100211; Gil K, 2014, J ENVIRON SCI-CHINA, V26, P1321, DOI 10.1016/S1001-0742(13)60606-3; Goonetilleke A, 2005, J ENVIRON MANAGE, V74, P31, DOI 10.1016/j.jenvman.2004.08.006; Guan DJ, 2011, ECOL INDIC, V11, P1333, DOI 10.1016/j.ecolind.2011.02.007; Hou P, 2009, WATER WASTEWATER ENG, V35, P188; Jeon JH, 2007, AGR WATER MANAGE, V90, P75, DOI 10.1016/j.agwat.2007.02.006; Jeong SJ, 2009, ENERG POLICY, V37, P2630, DOI 10.1016/j.enpol.2009.02.034; Ji M., 1999, OCEANOLOGIA LIMNOLOG, V30, P731; Lee JH, 2002, SCI TOTAL ENVIRON, V293, P163, DOI 10.1016/S0048-9697(02)00006-2; Li G, 2013, RES POLLUTANT DEGRAD; Li J, 2013, RES APPL QUANTITATIV; [马蔚纯 Ma Weichun], 2003, [地球科学进展, Advance in Earth Sciences], V18, P358; Maillard P, 2008, J ENVIRON MANAGE, V86, P158, DOI 10.1016/j.jenvman.2006.12.009; MEP (Ministry of Environmental Protection P.R. China), 2002, Environmental Quality Standards for Surface Water, Patent No. 38382002; Miller JD, 2014, J HYDROL, V515, P59, DOI 10.1016/j.jhydrol.2014.04.011; Ministry of Environmental Protection of the Peoples Republic of China, 1989, REG POLL PREV CONTR; Mitchell G, 2005, J ENVIRON MANAGE, V74, P1, DOI 10.1016/j.jenvman.2004.08.002; Nakicenovic N., 2000, IPCC SPECIAL REPORT; National Bureau of Statistics of the Peoples Republic of China, 2012, TAB 2010 POP CENS PP; Qin M, 2013, RES AGR NONPOINT SOU; Richardson G.P., 1981, INTRO SYSTEM DYNAMIC; Rossman L. A., 2010, STORM WATER MANAGEME; Sanders I, 2008, COMPLEX SYSTEMS THIN, P275; Shen QP, 2009, HABITAT INT, V33, P15, DOI 10.1016/j.habitatint.2008.02.004; Shen ZY, 2010, SCI TOTAL ENVIRON, V408, P1971, DOI 10.1016/j.scitotenv.2009.12.007; Shen ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071194; STERMAN JD, 1994, SYST DYNAM REV, V10, P291, DOI 10.1002/sdr.4260100214; Su M., 1988, SYST ENG, V6, P7; [孙兆刚 Sun Zhaogang], 2012, [生态环境学报, Ecology and Environmental Sciences], V21, P590; Susnik J, 2012, SCI TOTAL ENVIRON, V440, P290, DOI 10.1016/j.scitotenv.2012.05.085; Tang H, 2010, J SHANGHAI JIAOTONG, P426; The Chinese Academy for Environmental Planning, 2004, TECHN KEY POINTS SUR; The Chinese State Council, 2014, NAT NEW URB PLANN 20; Tong STY, 2002, J ENVIRON MANAGE, V66, P377, DOI 10.1006/jema.2002.0593; Wang SM, 2013, J ENVIRON SCI-CHINA, V25, P502, DOI 10.1016/S1001-0742(11)61032-2; Wang Y, 2005, ENVIRON MANAGE, V35, P194, DOI 10.1007/s00267-003-0315-8; Wei SK, 2012, EUR J OPER RES, V221, P248, DOI 10.1016/j.ejor.2012.03.014; Wu YP, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024025; Wu YP, 2013, ECOL INDIC, V32, P294, DOI 10.1016/j.ecolind.2013.04.002; [夏军 Xia Jun], 2012, [地理科学进展, Progress in Geography], V31, P941; Xu Z, 2012, BUILD ENVIRON, V47, P272, DOI 10.1016/j.buildenv.2011.07.012; Yin C, 2010, THEORIES TECHNOLOGIE; Zang S, 2008, TERRITORY NATURAL RE, P35	60	7	7	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135572	10.1371/journal.pone.0135572	http://dx.doi.org/10.1371/journal.pone.0135572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267482	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300138
J	Thomann, M; Schlothauer, T; Dashivets, T; Malik, S; Avenal, C; Bulau, P; Ruger, P; Reusch, D				Thomann, Marco; Schlothauer, Tilman; Dashivets, Tetyana; Malik, Sebastian; Avenal, Cecile; Bulau, Patrick; Rueger, Petra; Reusch, Dietmar			In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity	PLOS ONE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; IMMUNOGLOBULIN-G; ANTIINFLAMMATORY ACTIVITY; N-ACETYLGLUCOSAMINE; GAMMA-RIIIA; SIALIC-ACID; ANTIBODIES; GLYCOSYLATION; SIALYLATION; GLYCOFORMS	The importance and effect of Fc glycosylation of monoclonal antibodies with regard to biological activity is widely discussed and has been investigated in numerous studies. Fc glycosylation of monoclonal antibodies from current production systems is subject to batch-to-batch variability. If there are glycosylation changes between different batches, these changes are observed not only for one but multiple glycan species. Therefore, studying the effect of distinct Fc glycan species such as galactosylated and sialylated structures is challenging due to the lack of well-defined differences in glycan patterns of samples used. In this study, the influence of IgG1 Fc galactosylation and sialylation on its effector functions has been investigated using five different samples which were produced from one single drug substance batch by in vitro glycoengineering. This sample set comprises preparations with minimal and maximal galactosylation and different levels of sialylation of fully galactosylated Fc glycans. Among others, Roche developed the glycosyltransferase enzyme sialyltransferase which was used for the in vitro glycoengineering activities at medium scale. A variety of analytical assays, including Surface Plasmon Resonance and recently developed Fc gamma R affinity chromatography, as well as an optimized cell-based ADCC assay were applied to investigate the effect of Fc galactosylation and sialylation on the in vitro Fc gamma RI, IIa, and IIIa receptor binding and ADCC activity of IgG1. The results of our studies do not show an impact, neither positive nor negative, of sialic acid-containing Fc glycans of IgG1 on ADCC activity, Fc gamma RI, and RIIIa receptors, but a slightly improved binding to Fc gamma RIIa. Furthermore, we demonstrate a galactosylation-induced positive impact on the binding activity of the IgG1 to Fc gamma RIIa and Fc gamma RIIIa receptors and ADCC activity.	[Thomann, Marco; Malik, Sebastian; Bulau, Patrick; Reusch, Dietmar] Roche Diagnost GmbH, Pharma Tech Dev Penzberg, Penzberg, Germany; [Schlothauer, Tilman; Dashivets, Tetyana; Rueger, Petra] Roche Innovat Ctr, Biochem & Analyt Res, Large Mol Res, Pharma Res & Early Dev pRED, Penzberg, Germany; [Avenal, Cecile] F Hoffmann La Roche Ltd, Pharma Tech Dev Basel, Basel, Switzerland; [Dashivets, Tetyana] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, Garching, Germany	Roche Holding; Roche Holding; Technical University of Munich	Thomann, M (corresponding author), Roche Diagnost GmbH, Pharma Tech Dev Penzberg, Penzberg, Germany.	marco.thomann@roche.com		Bulau, Patrick/0000-0002-7121-2954	Pharma Technical Development Penzberg; Roche Diagnostics GmbH; Roche Innovation Center Penzberg; Pharma Technical Development Basel; F. Hoffmann-La Roche Ltd	Pharma Technical Development Penzberg; Roche Diagnostics GmbH; Roche Innovation Center Penzberg; Pharma Technical Development Basel; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche)	Pharma Technical Development Penzberg; Roche Diagnostics GmbH, Roche Innovation Center Penzberg and Pharma Technical Development Basel; F. Hoffmann-La Roche Ltd provided support in the form of salaries for authors MT, TS, TD, SM, CA, PB, PR, and DR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahn WS, 2008, BIOTECHNOL BIOENG, V101, P1234, DOI 10.1002/bit.22006; Barb AW, 2009, BIOCHEMISTRY-US, V48, P9705, DOI 10.1021/bi901430h; Bohm S, 2012, SEMIN IMMUNOPATHOL, V34, P443, DOI 10.1007/s00281-012-0308-x; Boyd PN, 1995, MOL IMMUNOL, V32, P1311, DOI 10.1016/0161-5890(95)00118-2; Chung S, 2012, MABS-AUSTIN, V4, P326, DOI 10.4161/mabs.19941; Diepold K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030295; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; FUJII S, 1990, J BIOL CHEM, V265, P6009; Gottschalk PG, 2005, J BIOPHARM STAT, V15, P437, DOI 10.1081/BIP-200056532; Hodoniczky J, 2005, BIOTECHNOL PROGR, V21, P1644, DOI 10.1021/bp050228w; Houde D, 2010, MOL CELL PROTEOMICS, V9, P1716, DOI 10.1074/mcp.M900540-MCP200; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Jefferis R, 2009, TRENDS PHARMACOL SCI, V30, P356, DOI 10.1016/j.tips.2009.04.007; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kapur R, 2014, IMMUNOL LETT, V160, P139, DOI 10.1016/j.imlet.2014.01.015; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Kumpel Belinda M., 1995, Human Antibodies and Hybridomas, V6, P82; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; Naso MF, 2010, MABS-AUSTIN, V2, P519, DOI 10.4161/mabs.2.5.13078; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Niwa R, 2005, CLIN CANCER RES, V11, P2327, DOI 10.1158/1078-0432.CCR-04-2263; Pacis E, 2011, BIOTECHNOL BIOENG; Raju TS, 2012, MABS-AUSTIN, V4, P385, DOI 10.4161/mabs.19868; Raju TS, 2001, BIOCHEMISTRY-US, V40, P8868, DOI 10.1021/bi010475i; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; Schiestl M, 2011, NAT BIOTECHNOL, V29, P310, DOI 10.1038/nbt.1839; Schlothauer T, 2013, MABS-AUSTIN, V5, P576, DOI 10.4161/mabs.24981; Schnueriger A, 2011, MOL IMMUNOL, V48, P1512, DOI 10.1016/j.molimm.2011.04.010; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Smith KGC, 2010, NAT REV IMMUNOL, V10, P674, DOI 10.1038/nri2762; Sondermann P, 2001, J MOL BIOL, V309, P737, DOI 10.1006/jmbi.2001.4670; Stadlmann J, 2010, J CLIN IMMUNOLOGY; Warnock D, 2005, BIOTECHNOL BIOENG, V92, P831, DOI 10.1002/bit.20658; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Zeck A, 2011, J PROTEOME RES, V10, P3031, DOI 10.1021/pr1012653	36	79	82	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134949	10.1371/journal.pone.0134949	http://dx.doi.org/10.1371/journal.pone.0134949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266936	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300068
J	Islam, SKH; Khan, MK; Li, X				Islam, S. K. Hafizul; Khan, Muhammad Khurram; Li, Xiong			Security Analysis and Improvement of 'a More Secure Anonymous User Authentication Scheme for the Integrated EPR Information System'	PLOS ONE			English	Article							KEY AGREEMENT SCHEME; EFFICIENT AUTHENTICATION; MUTUAL AUTHENTICATION; SMART-CARDS; CRYPTANALYSIS; EXTREMALITY; PROTOCOL	Over the past few years, secure and privacy-preserving user authentication scheme has become an integral part of the applications of the healthcare systems. Recently, Wen has designed an improved user authentication system over the Lee et al.'s scheme for integrated electronic patient record (EPR) information system, which has been analyzed in this study. We have found that Wen's scheme still has the following inefficiencies: (1) the correctness of identity and password are not verified during the login and password change phases; (2) it is vulnerable to impersonation attack and privileged-insider attack; (3) it is designed without the revocation of lost/stolen smart card; (4) the explicit key confirmation and the no key control properties are absent, and (5) user cannot update his/her password without the help of server and secure channel. Then we aimed to propose an enhanced two-factor user authentication system based on the intractable assumption of the quadratic residue problem (QRP) in the multiplicative group. Our scheme bears more securities and functionalities than other schemes found in the literature.	[Islam, S. K. Hafizul] Birla Inst Technol & Sci, Dept Comp Sci & Informat Syst, Pilani 333031, Rajasthan, India; [Khan, Muhammad Khurram] King Saud Univ, Ctr Excellence Informat Assurance, Riyadh, Saudi Arabia; [Li, Xiong] Hunan Univ Sci & Technol, Sch Comp Sci & Engn, Xiangtan 411201, Hunan, Peoples R China	Birla Institute of Technology & Science Pilani (BITS Pilani); King Saud University; Hunan University of Science & Technology	Islam, SKH (corresponding author), Birla Inst Technol & Sci, Dept Comp Sci & Informat Syst, Pilani 333031, Rajasthan, India.	hafi786@gmail.com	Islam, SK Hafizul/K-5724-2017; KHAN, MUHAMMAD KHURRAM/E-4836-2014; Li, Xiong/K-7233-2012	Islam, SK Hafizul/0000-0002-2703-0213; KHAN, MUHAMMAD KHURRAM/0000-0001-6636-0533; Li, Xiong/0000-0001-6619-554X	Outstanding Potential for Excellence in Research and Academics (OPERA) award; King Saud University [PRG-1436-16]; Birla Institute of Technology and Science (BITS) Pilani, Pilani Campus, Rajasthan, India	Outstanding Potential for Excellence in Research and Academics (OPERA) award; King Saud University(King Saud University); Birla Institute of Technology and Science (BITS) Pilani, Pilani Campus, Rajasthan, India	The first author is supported by the Outstanding Potential for Excellence in Research and Academics (OPERA) award, Birla Institute of Technology and Science (BITS) Pilani, Pilani Campus, Rajasthan, India. The authors also extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this Prolific Research Group (PRG-1436-16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured], DOI [10.12785/amis/090156, DOI 10.12785/amis/090156]; Blake-Wilson S, 1997, LECT NOTES COMPUT SC, V1355, P30, DOI 10.1007/BFb0024447; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chen HM, 2012, J MED SYST, V36, P3907, DOI 10.1007/s10916-012-9862-y; Chen YL, 2008, COMPUT NETW, V52, P2373, DOI 10.1016/j.comnet.2008.04.016; Das AK, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9969-9; Das AK, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9948-1; Dehmer M, 2013, MATCH-COMMUN MATH CO, V69, P785; Ding S, 2015, CHAOS SOLITON FRACT, V71, P91, DOI 10.1016/j.chaos.2014.12.014; Ding S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097762; Ding S, 2014, KNOWL-BASED SYST, V56, P216, DOI 10.1016/j.knosys.2013.11.014; DOLEV D, 1983, IEEE T INFORM THEORY, V29, P198, DOI 10.1109/TIT.1983.1056650; Fan CI, 2005, COMPUT SECUR, V24, P619, DOI 10.1016/j.cose.2005.03.006; Hafizul Islam S. K., 2014, Journal of Electronics (China), V31, P473, DOI 10.1007/s11767-014-4002-0; He DB, 2015, MULTIMEDIA SYST, V21, P49, DOI 10.1007/s00530-013-0346-9; He DB, 2015, INFORM SCIENCES, V321, P263, DOI 10.1016/j.ins.2015.02.010; He DB, 2015, IEEE COMMUN MAG, V53, P71, DOI 10.1109/MCOM.2015.7010518; He DB, 2012, J MED SYST, V36, P1989, DOI 10.1007/s10916-011-9658-5; Islam S. K. H., 2011, 2011 International Conference on Recent Trends in Information Technology (ICRTIT 2011), P1221, DOI 10.1109/ICRTIT.2011.5972366; Islam SKH, 2016, INT J COMMUN SYST, V29, P1708, DOI 10.1002/dac.2793; Islam SKH, 2015, J KING SAUD UNIV-COM, V27, P211, DOI 10.1016/j.jksuci.2014.03.018; Islam SKH, 2014, WIRELESS PERS COMMUN, V79, P1975, DOI 10.1007/s11277-014-1968-8; Islam SKH, 2014, NONLINEAR DYNAM, V78, P2261, DOI 10.1007/s11071-014-1584-x; Islam SKH, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0135-9; Islam SKH, 2012, ANN TELECOMMUN, V67, P547, DOI 10.1007/s12243-012-0296-9; Islam SKH, 2013, MATH COMPUT MODEL, V57, P2703, DOI 10.1016/j.mcm.2011.07.001; Islam SKH, 2011, J SYST SOFTWARE, V84, P1892, DOI 10.1016/j.jss.2011.06.061; Islam S. K. Hafizul, 2014, INT J INFORM SCI, V3, P35, DOI DOI 10.12785/ISL/030105; Islam SH, 2012, THEOR APPL INFORM, V24, P293, DOI [10.2478/v10179-012-0018-z, DOI 10.2478/V10179-012-0018-Z]; Jiang Q, 2013, J MED SYST, V37, DOI 10.1007/s10916-012-9897-0; Joye M., 2005, ENCY CRYPTOGRAPHY SE, P571; Khan MK, 2011, COMPUT COMMUN, V34, P305, DOI 10.1016/j.comcom.2010.02.011; Kocher P., 1999, Advances in Cryptology - CRYPTO'99. 19th Annual International Cryptology Conference. Proceedings, P388; Kraus V, 2013, MATCH-COMMUN MATH CO, V70, P885; Kumari S, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9952-5; Lee TF, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9985-9; Lee TF, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9941-8; Li SH, 2012, J MED SYST, V36, P1629, DOI 10.1007/s10916-010-9625-6; Li XX, 2010, IEEE T IND ELECTRON, V57, P793, DOI 10.1109/TIE.2009.2028351; Li X, 2013, J NETW COMPUT APPL, V36, P1365, DOI 10.1016/j.jnca.2013.02.034; Li X, 2013, MATH COMPUT MODEL, V58, P85, DOI 10.1016/j.mcm.2012.06.033; Li X, 2012, J NETW COMPUT APPL, V35, P763, DOI 10.1016/j.jnca.2011.11.009; Li X, 2011, J NETW COMPUT APPL, V34, P73, DOI 10.1016/j.jnca.2010.09.003; Li XL, 2013, MATCH-COMMUN MATH CO, V70, P85; Messerges TS, 2002, IEEE T COMPUT, V51, P541, DOI 10.1109/TC.2002.1004593; Pu Q, 2012, J MED SYST, V36, P2609, DOI 10.1007/s10916-011-9735-9; Rosen K, 2008, ELEMENTARY NUMBER TH; Tzong-Sun Wu, 2011, Journal of Digital Information Management, V9, P51; Wei JH, 2012, J MED SYST, V36, P3597, DOI 10.1007/s10916-012-9835-1; Wen FT, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0042-0; Wen FT, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9980-1; Wu SH, 2012, SECUR COMMUN NETW, V5, P236, DOI 10.1002/sec.315; Wu ZY, 2012, J MED SYST, V36, P1529, DOI 10.1007/s10916-010-9614-9; Wu ZY, 2012, J MED SYST, V36, P631, DOI 10.1007/s10916-010-9527-7; Xu X, 2014, J MED SYST, V38, DOI 10.1007/s10916-013-9994-8; Yau WC, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9993-9; Yoon E-J, 2014, CONT ENG SCI, V7, P1467; Zhu ZA, 2012, J MED SYST, V36, P3833, DOI 10.1007/s10916-012-9856-9; Zi-Yao Cheng, 2013, International Journal of Information and Electronics Engineering, V3, P419, DOI 10.7763/IJIEE.2013.V3.348	59	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0131368	10.1371/journal.pone.0131368	http://dx.doi.org/10.1371/journal.pone.0131368			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263401	Green Submitted, gold, Green Published			2022-12-27	WOS:000359353300004
J	Liang, S; Zhao, MH; Choi, JW; Kim, NH; Cui, XS				Liang, Shuang; Zhao, Ming-Hui; Choi, Jeong-woo; Kim, Nam-Hyung; Cui, Xiang-Shun			Scriptaid Treatment Decreases DNA Methyltransferase 1 Expression by Induction of MicroRNA-152 Expression in Porcine Somatic Cell Nuclear Transfer Embryos	PLOS ONE			English	Article							IN-VITRO DEVELOPMENT; HISTONE ACETYLATION; GENE-EXPRESSION; METHYLATION PATTERNS; MOUSE; APOPTOSIS; CLONING; PIG; FERTILIZATION; IMPROVEMENT	Abnormal epigenetic reprogramming of donor nuclei after somatic cell nuclear transfer (SCNT) is thought to be the main cause of low cloning efficiencies. A growing body of evidence has demonstrated a positive role of Scriptaid, a histone deacetylase inhibitor (HDACi) that belongs to an existing class of hydroxamic acid-containing HDACis, on the development competence of cloned embryos in many species. The present study investigated the effects of Scriptaid on the development of porcine SCNT embryos in vitro and its mechanism. Treatment with 300 or 500 nM Scriptaid for 20 h after activation significantly increased the percentage of SCNT embryos that developed to the blastocyst stage and the total number of cells per blastocyst and significantly decreased the percentage of apoptotic cells in blastocysts. Scriptaid treatment significantly increased the level of histone H3 acetylated at K9 and the conversion of 5-methylcytosine into 5-hydroxymethylcytosine and significantly decreased the level of histone H3 trimethylated at K9 at the pronuclear stage. As a potential mechanism for the DNA methylation changes, our results showed that the expression of DNA methyltransferase 1 was frequently down-regulated in Scriptaid-treated embryos in comparison with untreated embryos and was inversely correlated to endogenous microRNA-152 (miR-152). Taken together, these findings illustrated a crucial functional crosstalk between miR-152 and DNMT1. Meanwhile, mRNA and protein levels of POU5F1 and CDX2 were increased in Scriptaid-treated embryos. mRNA levels of Caspase3, and Bax were significantly decreased and that of Bcl-xL was significantly increased in Scriptaid-treated embryos. In conclusion, these observations would contribute to uncover the nuclear reprogramming mechanisms underlying the effects of Scriptaid on the improvement of porcine SCNT embryos.	[Liang, Shuang; Zhao, Ming-Hui; Choi, Jeong-woo; Kim, Nam-Hyung; Cui, Xiang-Shun] Chungbuk Natl Univ, Dept Anim Sci, Cheongju 361763, Chungbuk, South Korea; [Liang, Shuang; Zhao, Ming-Hui; Choi, Jeong-woo; Kim, Nam-Hyung; Cui, Xiang-Shun] Brain Korea 21 Ctr Bioresource Dev, Cheongju 361763, Chungbuk, South Korea	Chungbuk National University	Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju 361763, Chungbuk, South Korea.	nhkim@cbnu.ac.kr; xscui@cbnu.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ011126, PJ01104103]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by Next-Generation BioGreen 21 Program (PJ011126 and PJ01104103), Rural Development Administration, Republic of Korea.	Azizi M, 2014, CANCER BIOL THER, V15, P419, DOI 10.4161/cbt.27630; Blackwell L, 2008, LIFE SCI, V82, P1050, DOI 10.1016/j.lfs.2008.03.004; Bonsch D, 2006, J NEURAL TRANSM, V113, P1299, DOI 10.1007/s00702-005-0413-2; Bourassa MW, 2014, NEUROCHEMIS IN PRESS; Bourc'his D, 2001, CURR BIOL, V11, P1542, DOI 10.1016/S0960-9822(01)00480-8; Brill A, 1999, J ASSIST REPROD GEN, V16, P512, DOI 10.1023/A:1020541019347; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Chung Y, 2009, CLONING STEM CELLS, V11, P213, DOI 10.1089/clo.2009.0004; Cui XS, 2011, CELL REPROGRAM, V13, P179, DOI 10.1089/cell.2010.0060; Cui XS, 2009, BIOCHEM BIOPH RES CO, V379, P390, DOI 10.1016/j.bbrc.2008.12.148; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Funahashi H, 2003, REPROD FERT DEVELOP, V15, P167, DOI 10.1071/RD02076; Geiman TM, 2002, J CELL BIOCHEM, V87, P117, DOI 10.1002/jcb.10286; Glaser KB, 2003, MOL CANCER THER, V2, P151; Hao YH, 2003, BIOL REPROD, V69, P501, DOI 10.1095/biolreprod.103.016170; Haouzi D, 2009, CURR MED CHEM, V16, P1905, DOI 10.2174/092986709788186075; Bui HT, 2011, BIOL REPROD, V85, P1048, DOI 10.1095/biolreprod.110.089474; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Luczak MW, 2006, FOLIA HISTOCHEM CYTO, V44, P143; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; NAGAI T, 1988, J REPROD FERTIL, V84, P585, DOI 10.1530/jrf.0.0840585; Ohgane J, 2004, GENES CELLS, V9, P253, DOI 10.1111/j.1356-9597.2004.00720.x; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Pandey M, 2014, EXP MOL PATHOL, V96, P61, DOI 10.1016/j.yexmp.2013.12.001; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Qin HH, 2013, J DERMATOL SCI, V69, P61, DOI 10.1016/j.jdermsci.2012.10.011; Rizos D, 2002, MOL REPROD DEV, V62, P320, DOI 10.1002/mrd.10138; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun X, 2013, CELL SIGNAL, V25, P1870, DOI 10.1016/j.cellsig.2013.05.013; Tung EWY, 2011, MOL PHARMACOL, V80, P979, DOI 10.1124/mol.111.072314; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wang LJ, 2011, CELL REPROGRAM, V13, P431, DOI 10.1089/cell.2011.0024; Whitworth KM, 2011, CELL REPROGRAM, V13, P191, DOI 10.1089/cell.2010.0087; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xiong XR, 2013, CELL REPROGRAM, V15, P293, DOI 10.1089/cell.2012.0092; Xu Q, 2012, J IND ENG ENG MANAGE, P1; Yang FK, 2007, REPRODUCTION, V133, P219, DOI 10.1530/rep.1.01206; Yokomine T, 2006, CYTOGENET GENOME RES, V113, P75, DOI 10.1159/000090817; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016; Zhao MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102097; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131; Zhou Y, 2013, CHINESE SCI BULL, V58, P2044, DOI 10.1007/s11434-013-5827-x	52	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134567	10.1371/journal.pone.0134567	http://dx.doi.org/10.1371/journal.pone.0134567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26261994	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300031
J	McDonnell, MD; Tissera, MD; Vladusich, T; van Schaik, A; Tapson, J				McDonnell, Mark D.; Tissera, Migel D.; Vladusich, Tony; van Schaik, Andre; Tapson, Jonathan			Fast, Simple and Accurate Handwritten Digit Classification by Training Shallow Neural Network Classifiers with the 'Extreme Learning Machine' Algorithm	PLOS ONE			English	Article							REGRESSION; ONLINE; DEEP; BIG	Recent advances in training deep (multi-layer) architectures have inspired a renaissance in neural network use. For example, deep convolutional networks are becoming the default option for difficult tasks on large datasets, such as image and speech recognition. However, here we show that error rates below 1% on the MNIST handwritten digit benchmark can be replicated with shallow non-convolutional neural networks. This is achieved by training such networks using the 'Extreme Learning Machine' (ELM) approach, which also enables a very rapid training time (similar to 10 minutes). Adding distortions, as is common practise for MNIST, reduces error rates even further. Our methods are also shown to be capable of achieving less than 5.5% error rates on the NORB image database. To achieve these results, we introduce several enhancements to the standard ELM algorithm, which individually and in combination can significantly improve performance. The main innovation is to ensure each hidden-unit operates only on a randomly sized and positioned patch of each image. This form of random 'receptive field' sampling of the input ensures the input weight matrix is sparse, with about 90% of weights equal to zero. Furthermore, combining our methods with a small number of iterations of a single-batch backpropagation method can significantly reduce the number of hidden-units required to achieve a particular performance. Our close to state-of-the-art results for MNIST and NORB suggest that the ease of use and accuracy of the ELM algorithm for designing a single-hidden-layer neural network classifier should cause it to be given greater consideration either as a standalone method for simpler problems, or as the final classification stage in deep neural networks applied to more difficult problems.	[McDonnell, Mark D.; Tissera, Migel D.; Vladusich, Tony] Univ S Australia, Inst Telecommun Res, Sch Informat Technol & Math Sci, Computat & Theoret Neurosci Lab, Mawson Lakes, SA 5095, Australia; [van Schaik, Andre; Tapson, Jonathan] Univ Western Sydney, MARCS Inst, Biomed Engn & Neurosci Grp, Penrith, NSW 2751, Australia	University of South Australia; Western Sydney University	McDonnell, MD (corresponding author), Univ S Australia, Inst Telecommun Res, Sch Informat Technol & Math Sci, Computat & Theoret Neurosci Lab, Mawson Lakes, SA 5095, Australia.	mark.mcdonnell@unisa.edu.au	McDonnell, Mark/A-8374-2008	McDonnell, Mark/0000-0002-7009-3869; van Schaik, Andre/0000-0001-6140-017X	Australian Research Council [DP1093425, DP140103001]	Australian Research Council(Australian Research Council)	Mark D. McDonnell's contribution was supported by an Australian Research Fellowship from the Australian Research Council (www.arc.gov.au, Discovery Project DP1093425). Andre van Schaik's contribution was supported by the Australian Research Council (www.arc.gov.au, Discovery Project DP140103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, NEURAL ENG COMPUTATI; Chen CLP, 1996, IEEE T NEURAL NETWOR, V7, P1220, DOI 10.1109/72.536316; Cires D. C., 2011, PROC 22 INT JOINT C, V22, P1237; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; Ciresan DC, 2010, NEURAL COMPUT, V22, P3207, DOI 10.1162/NECO_a_00052; Coates A, 2011, JMLR W CP; Eliasmith C, 1999, NEUROCOMPUTING, V26-7, P1013, DOI 10.1016/S0925-2312(99)00098-3; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Goodfellow I. J., 2013, JMLR W CP, V28; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2014, COGN COMPUT, V6, P376, DOI 10.1007/s12559-014-9255-2; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Jarrett K, 2009, P IEEE 12 INT C COMP; Kasun LLC, 2013, IEEE INTELL SYST, V28, P31; LeCun Y, 2004, PROC CVPR IEEE, P97; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; LeCun Y., 2014, MNIST DATABASE HANDW; Lee CY, 2014, DEEP LEARN REPR LEAM; Liang NY, 2006, IEEE T NEURAL NETWOR, V17, P1411, DOI 10.1109/TNN.2006.880583; Lim MH, 2013, NEURAL NETWORKS, V48, P59, DOI 10.1016/j.neunet.2013.07.004; MARQUARDT DW, 1975, AM STAT, V29, P3, DOI 10.2307/2683673; Nair V., 2010, P 27 INT C MACH LEAR, DOI DOI 10.5555/3104322.3104425; Press W. H., 1992, ART SCI COMPUTING; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; SCHMIDT WF, 1992, 11TH IAPR INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION, PROCEEDINGS, VOL II, P1, DOI 10.1109/ICPR.1992.201708; Simard P., 2003, P 7 INT C DOC AN REC; Stewart TC, 2014, P IEEE, V102, P881, DOI 10.1109/JPROC.2014.2306061; Tapson J, 2013, NEURAL NETWORKS, V45, P94, DOI 10.1016/j.neunet.2013.02.008; Tapson J, 2014, P ELM2014 C IN PRESS; van Schaik A, 2015, NEUROCOMPUTING, V149, P233, DOI 10.1016/j.neucom.2014.01.071; Wan L, 2013, JMLR W CP, V28; Widrow B, 2013, NEURAL NETWORKS, V48, P204, DOI 10.1016/j.neunet.2013.11.003; Widrow B, 2013, NEURAL NETWORKS, V37, P180, DOI 10.1016/j.neunet.2012.09.020; Yu D, 2012, PATTERN RECOGN LETT, V33, P554, DOI 10.1016/j.patrec.2011.12.002; Zelier MD, 2013, P INT C LEARN REPR S, P2013; Zhu W, 2015, COMPUTER SCI	37	55	57	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134254	10.1371/journal.pone.0134254	http://dx.doi.org/10.1371/journal.pone.0134254			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262687	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000359353300024
J	Zetterstrom, K; Voss, M; Alexanderson, K; Ivert, T; Pehrsson, K; Hammar, N; Vaez, M				Zetterstrom, Katharina; Voss, Margaretha; Alexanderson, Kristina; Ivert, Torbjorn; Pehrsson, Kenneth; Hammar, Niklas; Vaez, Marjan			Disability Pension at the Time of Coronary Revascularisation Is Associated with Higher Five-Year Mortality; A Swedish Nationwide, Register-Based Prospective Cohort Study	PLOS ONE			English	Article							ARTERY-BYPASS GRAFT; POPULATION-BASED COHORT; LONG-TERM OUTCOMES; MYOCARDIAL-INFARCTION; SICKNESS ABSENCE; ALL-CAUSE; WOMEN; SURGERY; SURVIVAL; DISEASE	Background Although coronary revascularisation by coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are common procedures, little is known regarding disability pension (DP) at the time of coronary revascularisation and its association with mortality. The aim was to investigate the five-year mortality following a first coronary revascularisation among women and men on DP, compared with those not on DP at the time of intervention, accounting for socio-demographic and medical factors. Material and Methods A nationwide prospective population-based cohort study was conducted, using national registers including 70,040 patients (80% men), aged 30-64 years, with a first CABG (n = 24,987; 36%) or PCI (n = 45,053; 64%) during 1994-2006 in Sweden, who were alive 30 days after the intervention. The main outcome was all-cause and cause-specific mortality within five years or through 31 December 2006, following CABG and PCI, and the exposure was DP at the time of a first coronary revascularisation. Information on DP, patient characteristics, date and cause of death was obtained from nationwide registers. Hazard ratios (HR) with 95% confidence intervals (CI) for the outcome were estimated, using Cox proportional hazard regression analyses. All analyses were stratified by type of intervention and gender. Findings Four percent died following coronary revascularisation. Cardiovascular disease was the most common cause of death (54%), followed by neoplasms (25%). Regardless of type of intervention, gender and after multivariable adjustments, patients on DP had a higher HR for five-year mortality compared with those not on DP at time of revascularisation (CABG: women HR 2.14; 95% CI 1.59-2.89, men HR 2.09; 1.84-2.38, PCI: women HR 2.25; 1.78-2.83, men HR 1.95; 1.72-2.21). Young women on DP at the time of PCI had a substantially higher HR (HR 4.10; 95% CI: 2.25-7.48). Conclusion Patients on DP at the time of first coronary revascularisation had a higher five-year risk of mortality compared with those not on DP.	[Zetterstrom, Katharina; Voss, Margaretha; Alexanderson, Kristina; Vaez, Marjan] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden; [Voss, Margaretha] Swedish Social Insurance Agcy, Dept Anal & Forecasts, Stockholm, Sweden; [Ivert, Torbjorn] Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, Stockholm, Sweden; [Ivert, Torbjorn] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Pehrsson, Kenneth] Karolinska Inst, Dept Med, Stockholm, Sweden; [Hammar, Niklas] AstraZeneca R&D, Molndal, Sweden; [Hammar, Niklas] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Vaez, Marjan] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; AstraZeneca; Karolinska Institutet; Stockholm County Council	Zetterstrom, K (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden.	katharina.zetterstrom@ki.se			Swedish Research Council for Health, Working Life and Welfare [2007-0728 + 1762]; National School of Research in Caring Science, Karolinska Institutet	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); National School of Research in Caring Science, Karolinska Institutet	This work was supported by the Swedish Research Council for Health, Working Life and Welfare (grant number 2007-0728 + 1762; www.forte.se) and the National School of Research in Caring Science, Karolinska Institutet (www.ki.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AstraZeneca provided support in the form of salary for author Niklas Hammar, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808; [Anonymous], 2013, SOC INS FIG 2012; [Anonymous], 2009, ARSR SWEDHEART 2008; Bjorkenstam C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1247; Blackledge HM, 2009, HEART, V95, P304, DOI 10.1136/hrt.2007.127928; Bravata DM, 2007, ANN INTERN MED, V147, P703, DOI 10.7326/0003-4819-147-10-200711200-00185; Funakoshi S, 2011, CIRC J, V75, P1358, DOI 10.1253/circj.CJ-10-0718; Giesdal S, 2008, SCAND J WORK ENV HEA, V34, P479, DOI 10.5271/sjweh.1286; Gjesdal S, 2009, SCAND J PUBLIC HEALT, V37, P387, DOI 10.1177/1403494809103994; Gjesdal S, 2009, SCAND J PUBLIC HEALT, V37, P168, DOI 10.1177/1403494808100937; Hamalainen H, 2004, EUR J PUBLIC HEALTH, V14, P350, DOI 10.1093/eurpub/14.4.350; Hammar N, 1997, J AM COLL CARDIOL, V29, P659, DOI 10.1016/S0735-1097(96)00531-1; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Jonsson U, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002286; Karlsson NE, 2007, SCAND J PUBLIC HEALT, V35, P341, DOI 10.1080/14034940601159229; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Norheim A, 2011, SCAND CARDIOVASC J, V45, P247, DOI 10.3109/14017431.2011.582139; OECD, 2009, SICKN DIS WORK BREAK; Ortolani P, 2013, J CARDIOVASC MED, V14, P421, DOI 10.2459/JCM.0b013e328357bb04; Perk J, 2004, SCAND J PUBLIC HEALT, V32, P181, DOI 10.1080/14034950410021880; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; Sato H, 2011, J CARDIOL, V58, P158, DOI 10.1016/j.jjcc.2011.03.003; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Wallman T, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-103; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; Zetterstrom K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115540	27	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135277	10.1371/journal.pone.0135277	http://dx.doi.org/10.1371/journal.pone.0135277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26261990	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300071
J	Mueller, KE; Fields, KA				Mueller, Konrad E.; Fields, Kenneth A.			Application of beta-Lactamase Reporter Fusions as an Indicator of Effector Protein Secretion during Infections with the Obligate Intracellular Pathogen Chlamydia trachomatis	PLOS ONE			English	Article							III SECRETION; TRANSCRIPTIONAL REPRESSOR; TRANSLOCATED PROTEIN; BACTERIAL PATHOGENS; IDENTIFICATION; MEMBRANE; EXPRESSION; CYCLE; RECRUITMENT; INHIBITORS	Chlamydia spp. utilize multiple secretion systems, including the type III secretion system (T3SS), to deploy host-interactive effector proteins into infected host cells. Elucidation of secreted proteins has traditionally required ectopic expression in a surrogate T3SS followed by immunolocalization of endogenous candidate effectors to confirm secretion by chlamydiae. The ability to transform Chlamydia and achieve stable expression of recombinant gene products has enabled a more direct assessment of secretion. We adapted TEM-1 beta-lactamase as a reporter system for assessment of chlamydial protein secretion. We provide evidence that this system facilitates visualization of secretion in the context of infection. Specifically, our findings provide definitive evidence that C. trachomatis CT695 is secreted during infection. Follow-up indirect immunofluorescence studies confirmed CT695 secretion and indicate that this effector can be secreted at multiple points during the chlamydial developmental cycle. Our results indicate that the BlaM-fusion reporter assay will allow efficacious identification of novel secreted proteins. Moreover, this approach can easily be adapted to enable more sophisticated studies of the secretion process in Chlamydia.	[Mueller, Konrad E.; Fields, Kenneth A.] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Coll Med, Lexington, KY 40506 USA	University of Kentucky	Fields, KA (corresponding author), Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Coll Med, Lexington, KY 40506 USA.	Ken.fields@uky.edu			NIAID [AI065530]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065530] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by a grant from NIAID: AI065530.	Agaisse H, 2014, INFECT IMMUN, V82, P2037, DOI 10.1128/IAI.01530-14; Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; BAEHR W, 1988, P NATL ACAD SCI USA, V85, P4000, DOI 10.1073/pnas.85.11.4000; Bauler LD, 2014, J BACTERIOL, V196, P1325, DOI 10.1128/JB.01290-13; Beare P, 2011, FRONTIERS MICROBIOLO, V2; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Betts-Hampikian HJ, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00114; Bullock HD, 2012, J BIOL CHEM, V287, P28078, DOI 10.1074/jbc.M112.386904; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Campbell-Valois FX, 2014, FEBS LETT, V588, P2428, DOI 10.1016/j.febslet.2014.05.022; Carabeo RA, 2004, TRAFFIC, V5, P418, DOI 10.1111/j.1398-9219.2004.00184.x; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Chellas-Gery B, 2007, CELL MICROBIOL, V9, P2417, DOI 10.1111/j.1462-5822.2007.00970.x; Chen YS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003954; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Copenhaver AM, 2014, INFECT IMMUN, V82, P4325, DOI 10.1128/IAI.01891-14; da Cunha M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-40; Engstrom P, 2013, J BACTERIOLOGY; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x; Fields KA, 2000, MOL MICROBIOL, V38, P1048, DOI 10.1046/j.1365-2958.2000.02212.x; Fields KA, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P192, DOI 10.1128/9781555817329.ch9; Gauliard E, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00013; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Hefty PS, 2007, J BACTERIOL, V189, P198, DOI 10.1128/JB.01034-06; Heinzen RA, 1997, INFECT IMMUN, V65, P1088, DOI 10.1128/IAI.65.3.1088-1094.1997; Hovis KM, 2013, PATHOG DIS, V0, P1; Hower S, 2009, MOL MICROBIOL, V72, P1423, DOI 10.1111/j.1365-2958.2009.06732.x; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Jamison WP, 2008, MICROB PATHOGENESIS, V45, P435, DOI 10.1016/j.micpath.2008.10.002; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Keyser P, 2008, J INTERN MED, V264, P17, DOI 10.1111/j.1365-2796.2008.01941.x; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mills E, 2008, CELL HOST MICROBE, V3, P104, DOI 10.1016/j.chom.2007.11.007; Moore ER, 2011, MICROBIOL-SGM, V157, P830, DOI 10.1099/mic.0.045856-0; Mueller KE, 2014, INFECT IMMUN, V82, P2, DOI 10.1128/IAI.00917-13; Nunes A, 2014, INFECT GENET EVOL, V23, P49, DOI 10.1016/j.meegid.2014.01.029; Pais SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056292; Rosario CJ, 2014, MOL MICROBIOL, V94, P888, DOI 10.1111/mmi.12804; Rosario CJ, 2012, MOL MICROBIOL, V84, P1097, DOI 10.1111/j.1365-2958.2012.08077.x; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Schachter J, 1999, CHLAMYDIA, P139; Scidmore-Carlson MA, 1999, MOL MICROBIOL, V33, P753, DOI 10.1046/j.1365-2958.1999.01523.x; Sharma J, 2006, INFECT IMMUN, V74, P1490, DOI 10.1128/IAI.74.3.1490-1499.2006; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Subtil A, 2005, MOL MICROBIOL, V56, P1636, DOI 10.1111/j.1365-2958.2005.04647.x; Voth DE, 2011, J BACTERIOL, V193, P1493, DOI 10.1128/JB.01359-10; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743	57	56	57	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135295	10.1371/journal.pone.0135295	http://dx.doi.org/10.1371/journal.pone.0135295			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258949	Green Published, gold, Green Submitted			2022-12-27	WOS:000359352600055
J	Fleta-Soriano, E; Pinto-Marijuan, M; Munne-Bosch, S				Fleta-Soriano, Eva; Pinto-Marijuan, Marta; Munne-Bosch, Sergi			Evidence of Drought Stress Memory in the Facultative CAM, Aptenia cordifolia: Possible Role of Phytohormones	PLOS ONE			English	Article							CRASSULACEAN ACID METABOLISM; ABSCISIC-ACID; WATER-DEFICIT; TRANSCRIPTIONAL MEMORY; ARABIDOPSIS-THALIANA; PLANT; BIOSYNTHESIS; ABA; TOCOPHEROLS; CAROTENOIDS	Although plant responses to drought stress have been studied in detail in several plant species, including CAM plants, the occurrence of stress memory and possible mechanisms for its regulation are still very poorly understood. In an attempt to better understand the occurrence and possible mechanisms of regulation of stress memory in plants, we measured the concentrations of phytohormones in Aptenia cordifolia exposed to reiterated drought, together with various stress indicators, including leaf water contents, photosynthesis and mechanisms of photo- and antioxidant protection. Results showed that plants exposed to drought stress responded differently if previously challenged with a first drought. Gibberellin levels decreased upon exposure to the first drought and remained lower in double-stressed plants compared with those exposed to stress for the first time. In contrast, abscisic acid levels were higher in double-than single-stressed plants. This occurred in parallel with alterations in hydroperoxide levels, but not with malondialdehyde levels, thus suggesting an increased oxidation state that did not result in oxidative damage in double-stressed plants. It is concluded that (i) drought stress memory occurs in double-stressed A. cordifolia plants, (ii) both gibberellins and abscisic acid may play a role in plant response to repeated periods of drought, and (iii) changes in abscisic acid levels in double-stressed plants may have a positive effect by modulating changes in the cellular redox state with a role in signalling, rather than cause oxidative damage to the cell.	[Fleta-Soriano, Eva; Pinto-Marijuan, Marta; Munne-Bosch, Sergi] Univ Barcelona, Fac Biol, Dept Biol Vegetal, E-08028 Barcelona, Spain	University of Barcelona	Munne-Bosch, S (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Vegetal, Avinguda Diagonal 643, E-08028 Barcelona, Spain.	smunne@ub.edu	Bosch, Sergi Munne/N-3302-2014	Bosch, Sergi Munne/0000-0001-6523-6848; Pinto-Marijuan, Marta/0000-0002-9865-8438	Generalitat de Catalunya under the ICREA Academia award; Generalitat de Catalunya [2013 BP-B 00235]	Generalitat de Catalunya under the ICREA Academia award(ICREA); Generalitat de Catalunya(Generalitat de Catalunya)	The research was fully funded by the Generalitat de Catalunya under the ICREA Academia award given to SMB. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. MPM was supported by a postdoctoral fellowship from Generalitat de Catalunya (2013 BP-B 00235).	Alonso R, 2015, PLANT PHYSIOL BIOCH, V91, P56, DOI 10.1016/j.plaphy.2015.03.011; Amaral JS, 2005, ANAL SCI, V21, P1545, DOI 10.2116/analsci.21.1545; Bao GG, 2016, PLANT BIOTECHNOL J, V14, P206, DOI 10.1111/pbi.12374; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; Cela J, 2009, PLANT SCI, V177, P404, DOI 10.1016/j.plantsci.2009.07.001; Chaudhary N, 2009, PLANT SCI, V177, P479, DOI 10.1016/j.plantsci.2009.07.014; Coudray C., 1995, P185; CROZIER A, 1991, GIBBERELLINS, P83; Cushman JC, 2001, PLANT PHYSIOL, V127, P1439, DOI 10.1104/pp.010818; DeLong JM, 2002, J AGR FOOD CHEM, V50, P248, DOI 10.1021/jf0106695; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1732; El Kayal W, 2006, PHYSIOL PLANTARUM, V126, P212, DOI 10.1111/j.1399-3054.2006.00614.x; Herrera A, 2009, ANN BOT-LONDON, V103, P645, DOI 10.1093/aob/mcn145; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Mioto PT, 2013, J PLANT PHYSIOL, V170, P996, DOI 10.1016/j.jplph.2013.02.004; Morales M, 2015, TREE PHYSIOL, V35, P253, DOI 10.1093/treephys/tpv012; Muller M, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-37; Munne-Bosch S, 2000, PLANTA, V210, P925, DOI 10.1007/s004250050699; Munne-Bosch S, 2009, J PLANT PHYSIOL, V166, P136, DOI 10.1016/j.jplph.2008.02.011; Peckmann K, 1997, J PLANT PHYSL, V150, P141; Pinto-Marijuan M, 2014, J EXP BOT, V65, P3845, DOI 10.1093/jxb/eru086; RAYDER L, 1983, PHOTOSYNTH RES, V4, P203, DOI 10.1007/BF00041816; Sharp RE, 2002, J EXP BOT, V53, P33, DOI 10.1093/jexbot/53.366.33; Songling B, 2013, PLANT CELL PHYSL, V54, P1132, DOI [10.1093/pcp/pct067, DOI 10.1093/PCP/PCT067]; Thomas SG, 1991, PLANT HORMONES VITAM, V72, P289; TREICHEL S, 1975, PLANT SCI LETT, V4, P141, DOI 10.1016/0304-4211(75)90086-3; Trewavas A, 2005, TRENDS PLANT SCI, V10, P413, DOI 10.1016/j.tplants.2005.07.005; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Verslues PE, 2006, J EXP BOT, V57, P201, DOI 10.1093/jxb/erj026; Virlouvet L, 2015, NEW PHYTOL, V205, P596, DOI 10.1111/nph.13080; Virlouvet L, 2014, PLANT J, V79, P150, DOI 10.1111/tpj.12548; Winter K, 2011, J EXP BOT, V62, P4037, DOI 10.1093/jxb/err106; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395	34	41	42	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135391	10.1371/journal.pone.0135391	http://dx.doi.org/10.1371/journal.pone.0135391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274325	gold, Green Submitted, Green Published			2022-12-27	WOS:000359493600063
J	Kang, KY; Kim, IJ; Yoon, MA; Hong, YS; Park, SH; Ju, JH				Kang, Kwi Young; Kim, In Je; Yoon, Min A.; Hong, Yeon Sik; Park, Sung-Hwan; Ju, Ji Hyeon			Fat Metaplasia on Sacroiliac Joint Magnetic Resonance Imaging at Baseline Is Associated with Spinal Radiographic Progression in Patients with Axial Spondyloarthritis	PLOS ONE			English	Article							ANKYLOSING-SPONDYLITIS; BONE-FORMATION; INFLAMMATORY LESIONS; RESEARCH CONSORTIUM; SYNDESMOPHYTES; SPONDYLARTHRITIS; PREDICT; CLASSIFICATION; RESOLUTION; CRITERIA	Objective To study the relationship between inflammatory and structural lesions in the sacroiliac joints (SIJs) on MRI and spinal progression observed on conventional radiographs in patients with axial spondyloarthritis (axSpA). Methods One hundred and ten patients who fulfilled the ASAS axSpA criteria were enrolled. All underwent SIJ MRI at baseline and lumbar spine radiographs at baseline and after 2 years. Inflammatory and structural lesions on SIJ MRI were scored using the SPondyloArthritis Research Consortium of Canada (SPARCC) method. Spinal radiographs were scored using the Stoke AS Spinal Score (SASSS). Multivariate logistic regression analysis was performed to identify predictors of spinal progression. Results Among the 110 patients, 25 (23%) showed significant radiographic progression (change of SASSS >= 2) over 2 years. There was no change in the SASSS over 2 years according to the type of inflammatory lesion. Patients with fat metaplasia or ankyloses on baseline MRI showed a significantly higher SASSS at 2 years than those without (p<0.001). According to univariate logistic regression analysis, age at diagnosis, HLA-B27 positivity, the presence of fat metaplasia, erosion, and ankyloses on SIJ MRI, increased baseline CRP levels, and the presence of syndesmophytes at baseline were associated with spinal progression over 2 years. Multivariate analysis identified syndesmophytes and severe fat metaplasia on baseline SIJ MRI as predictive of spinal radiographic progression (OR, 14.74 and 5.66, respectively). Conclusion Inflammatory lesions in the SIJs on baseline MRI were not associated with spinal radiographic progression. However, fat metaplasia at baseline was significantly associated with spinal progression after 2 years.	[Kang, Kwi Young; Hong, Yeon Sik; Park, Sung-Hwan; Ju, Ji Hyeon] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Kang, Kwi Young; Hong, Yeon Sik] Catholic Univ Korea, Incheon St Marys Hosp, Div Rheumatol, Dept Internal Med, Inchon, South Korea; [Kim, In Je] Ewha Womans Univ, Div Rheumatol, Dept Internal Med, Coll Med, Seoul, South Korea; [Yoon, Min A.] Korea Univ, Coll Med, Korea Univ Guro Hosp, Dept Radiol, Seoul 136705, South Korea	Catholic University of Korea; Catholic University of Korea; Ewha Womans University; Korea University; Korea University Medicine (KU Medicine)	Ju, JH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea.	juji@catholic.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2014R1A1006695]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (NRF-2014R1A1006695) [http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averns HL, 1996, BRIT J RHEUMATOL, V35, P373; Baraliakos X, 2007, ANN RHEUM DIS, V66, P910, DOI 10.1136/ard.2006.066415; Baraliakos X, 2014, ANN RHEUM DIS, V73, P1819, DOI 10.1136/annrheumdis-2013-203425; Baraliakos X, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2496; Chiowchanwisawakit P, 2011, ARTHRITIS RHEUM-US, V63, P2215, DOI 10.1002/art.30393; Dragojevic J, 2013, J BONE MINER METAB, V31, P512, DOI 10.1007/s00774-013-0445-x; Kang KY, 2015, SCAND J RHEUMATOL, V44, P125, DOI 10.3109/03009742.2014.938693; Lories RJU, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2642; Maksymowych WP, 2015, J RHEUMATOL, V42, P79, DOI 10.3899/jrheum.140519; Maksymowych WP, 2014, ARTHRITIS RHEUMATOL, V66, P2958, DOI 10.1002/art.38792; Maksymowych WP, 2009, ARTHRITIS RHEUM-US, V60, P93, DOI 10.1002/art.24132; Maksymowych WP, 2005, ARTHRIT RHEUM-ARTHR, V53, P703, DOI 10.1002/art.21445; Pedersen SJ, 2011, J RHEUMATOL, V38, P1349, DOI 10.3899/jrheum.100925; Pedersen SJ, 2011, ARTHRITIS RHEUM-US, V63, P3789, DOI 10.1002/art.30627; Pedersen SJ, 2010, ANN RHEUM DIS, V69, P1065, DOI 10.1136/ard.2009.111187; Poddubnyy D, 2012, CURR OPIN RHEUMATOL, V24, P363, DOI 10.1097/BOR.0b013e328352b7bd; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Rudwaleit M, 2005, ARTHRITIS RHEUM, V52, P1000, DOI 10.1002/art.20990; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P1520, DOI 10.1136/ard.2009.110767; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P770, DOI 10.1136/ard.2009.108217; Song IH, 2011, ANN RHEUM DIS, V70, P1257, DOI 10.1136/ard.2010.147033; van der Heijde D, 2012, ANN RHEUM DIS, V71, P369, DOI 10.1136/annrheumdis-2011-200208; Van Praet L, 2014, ANN RHEUM DIS, V73, P1186, DOI 10.1136/annrheumdis-2013-203854; van Tubergen A, 2012, ANN RHEUM DIS, V71, P518, DOI 10.1136/annrheumdis-2011-200411; Wanders A, 2005, ARTHRITIS RHEUM-US, V52, P1756, DOI 10.1002/art.21054; Weber U, 2015, ANN RHEUM DIS, V74, P985, DOI 10.1136/annrheumdis-2013-203887	26	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135206	10.1371/journal.pone.0135206	http://dx.doi.org/10.1371/journal.pone.0135206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271099	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492800041
J	Li, MW; Zhou, L; Lam, HM				Li, Man-Wah; Zhou, Liang; Lam, Hon-Ming			Paraformaldehyde Fixation May Lead to Misinterpretation of the Subcellular Localization of Plant High Mobility Group Box Proteins	PLOS ONE			English	Article							HMGB1 PROTEIN; DNA-BINDING; ARABIDOPSIS; CELLS; EXPRESSION; TOLERANCE; SEEDLINGS; MODULATE; TOBACCO	Arabidopsis High Mobility Group Box (HMBG) proteins were previously found associated with the interphase chromatin but not the metaphase chromosome. However, these studies are usually based on immunolocalization analysis involving paraformaldehyde fixation. Paraformaldehyde fixation has been widely adapted to preserved cell morphology before immunofluorescence staining. On one hand, the processed cells are no longer living. On the other hand, the processing may lead to misinterpretation of localization. HMGBs from Arabidopsis were fused with enhanced green fluorescence protein (EGFP) and transformed into tobacco BY-2 cells. Basically, the localization of these HMGB proteins detected with EGFP fluorescence in interphase agreed with previous publications. Upon 4% paraformaldehyde fixation, AtHMGB1 was found associated with interphase but not the metaphase chromosomes as previously reported. However, when EGFP fluorescence signal was directly observed under confocal microscope without fixation, association of AtHMGB1 with metaphase chromosomes can be detected. Paraformaldehyde fixation led to dissociation of EGFP tagged AtHMBG1 protein from metaphase chromosomes. This kind of pre-processing of live specimen may lead to dissociation of protein-protein or protein-nucleic acid interaction. Therefore, using of EGFP fusion proteins in live specimen is a better way to determine the correct localization and interaction of proteins.	[Li, Man-Wah; Zhou, Liang; Lam, Hon-Ming] Chinese Univ Hong Kong, Ctr Soybean Res Partner, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Li, Man-Wah; Zhou, Liang; Lam, Hon-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Zhou, Liang] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Radiat Med, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Southern Medical University - China	Lam, HM (corresponding author), Chinese Univ Hong Kong, Ctr Soybean Res Partner, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China.	honming@cuhk.edu.hk	Li, Man-Wah/AAZ-5631-2021; Li, Man-Wah/AAZ-5724-2021; Lam, Hon-Ming/A-9866-2008; Zhou, Liang/P-4174-2015	Li, Man-Wah/0000-0003-4859-5683; Lam, Hon-Ming/0000-0002-6673-8740; Zhou, Liang/0000-0001-5973-7873	Hong Kong Research Grant Council General Research Fund [468013]; Hong Kong University Grants Committee Area of Excellence [AoE/M-05/12]	Hong Kong Research Grant Council General Research Fund(Hong Kong Research Grants Council); Hong Kong University Grants Committee Area of Excellence	This work is supported by the Hong Kong Research Grant Council General Research Fund (468013) (http://www.ugc.edu.hk/eng/rgc/fund/fund.htm) and Hong Kong University Grants Committee Area of Excellence (AoE/M-05/12) (http://www.ugc.edu.hk/eng/ugc/activity/aoes/aoes.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antosch M, 2012, PLANT PHYSIOL, V159, P875, DOI 10.1104/pp.112.198283; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; BREARS T, 1993, PLANT PHYSIOL, V103, P1285, DOI 10.1104/pp.103.4.1285; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Grasser M, 2006, J MOL BIOL, V358, P654, DOI 10.1016/j.jmb.2006.02.068; Grasser M, 2007, BIOCHEMISTRY-US, V46, P6375, DOI 10.1021/bi6024947; Hu LS, 2011, PLANT BIOTECHNOL J, V9, P1038, DOI 10.1111/j.1467-7652.2011.00617.x; Jaouen S, 2005, J MOL BIOL, V353, P822, DOI 10.1016/j.jmb.2005.08.073; Kolotuev I, 2014, MICROSC MICROANAL, V20, P1392, DOI 10.1017/S1431927614012999; Launholt D, 2006, PLANT CELL, V18, P2904, DOI 10.1105/tpc.106.047274; Li WYF, 2006, PLANT CELL ENVIRON, V29, P1122, DOI 10.1111/j.1365-3040.2005.01487.x; Lichota J, 2004, BIOCHEM BIOPH RES CO, V318, P317, DOI 10.1016/j.bbrc.2004.03.193; Lildballe DL, 2008, J MOL BIOL, V384, P9, DOI 10.1016/j.jmb.2008.09.014; Manzanero S, 2000, CHROMOSOMA, V109, P308, DOI 10.1007/s004120000087; McDonald KL, 2006, BIOTECHNIQUES, V41, P137, DOI 10.2144/000112226; Nagata T, 1992, INT REV CYTOL, V131, P1; Pallier C, 2003, MOL BIOL CELL, V14, P3414, DOI 10.1091/mbc.E02-09-0581; Park S, 2011, BIOCHEMISTRY-US, V50, P2567, DOI 10.1021/bi2000214; Pedersen DS, 2010, PLANT PHYSIOL, V154, P1831, DOI 10.1104/pp.110.163055; Ugrinova I, 2009, MOL BIOL REP, V36, P1399, DOI 10.1007/s11033-008-9327-z; Wilson SM, 2012, NAT PROTOC, V7, P1716, DOI 10.1038/nprot.2012.096; Wu Q, 2003, ARCH BIOCHEM BIOPHYS, V411, P105, DOI 10.1016/S0003-9861(02)00721-X; Xiong HQ, 2014, NAT COMMUN, V5	23	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135033	10.1371/journal.pone.0135033	http://dx.doi.org/10.1371/journal.pone.0135033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270959	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492800030
J	Luk, AOY; Fu, WC; Li, X; Ozaki, R; Chung, HHY; Wong, RYM; So, WY; Chow, FCC; Chan, JCN				Luk, Andrea O. Y.; Fu, Wai-Chi; Li, Xue; Ozaki, Risa; Chung, Harriet H. Y.; Wong, Rebecca Y. M.; So, Wing-Yee; Chow, Francis C. C.; Chan, Juliana C. N.			The Clinical Utility of SUDOSCAN in Chronic Kidney Disease in Chinese Patients with Type 2 Diabetes	PLOS ONE			English	Article							EVALUATION JADE PROGRAM; RISK; TOOL; DYSFUNCTION; NEUROPATHY; MORTALITY; MELLITUS; EZSCAN	There are gaps between recommendations on regular screening for diabetic kidney disease (DKD) and clinical practice especially in busy and low resource settings. SUDOSCAN (Impeto Medical, Paris, France) is a non-invasive technology for assessing sudomotor function using reverse iontophoresis and chronoamperometry which detects abnormal sweat gland function. Vasculopathy and neuropathy share common risk factors and we hypothesized that SUDOSCAN may be used to detect chronic kidney disease (CKD). Between 2012 and 2013, SUDOSCAN was performed in a consecutive cohort of 2833 Hong Kong Chinese adults with type 2 diabetes. Chronic kidney disease was defined as estimated glomerular filtration rate <60 ml/min/1.73m(2). In this cross-sectional cohort (mean age 58.6 +/- 9.5 years, 55.7% male, median disease duration 8 [interquartile range 3-14] years), 5.8% had CKD. At a cut-off SUDOSCAN-DKD score of 53, the test had sensitivity of 76.7%, specificity of 63.4% and positive likelihood ratio of 2.1 to detect CKD. The area under receiver operating characteristic curve for CKD was 0.75 (95% confidence interval 0.72-0.79). Patients without CKD but low score had worse risk factors and complications than those with high score. We conclude that SUDOSCAN may be used to detect patients at risk of impaired renal function as part of a screening program in Chinese population, especially in outreach or low resource settings.	[Luk, Andrea O. Y.; Fu, Wai-Chi; Li, Xue; Chan, Juliana C. N.] Prince Wales Hosp, Asia Diabet Fdn, Hong Kong, Hong Kong, Peoples R China; [Luk, Andrea O. Y.; Ozaki, Risa; Chung, Harriet H. Y.; Chan, Juliana C. N.] Prince Wales Hosp, Hong Kong Inst Diabet & Obes, Hong Kong, Hong Kong, Peoples R China; [Luk, Andrea O. Y.; Ozaki, Risa; Wong, Rebecca Y. M.; So, Wing-Yee; Chow, Francis C. C.; Chan, Juliana C. N.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Luk, Andrea O. Y.; Ozaki, Risa; Wong, Rebecca Y. M.; So, Wing-Yee; Chow, Francis C. C.; Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Int Diabet Ctr Educ, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Luk, AOY (corresponding author), Prince Wales Hosp, Asia Diabet Fdn, Hong Kong, Hong Kong, Peoples R China.	andrealuk@cuhk.edu.hk	Chan, Juliana/B-7918-2016; Luk, Andrea/B-5766-2016	Chan, Juliana/0000-0003-1325-1194; Li, Xue/0000-0003-4836-7808	Impeto, Paris, France; Liao Wun Yuk Diabetes Research Memorial Fund under the Chinese University of Hong Kong; Merck Limited; Liao Wun Yuk Diabetes Research Memorial Fund	Impeto, Paris, France; Liao Wun Yuk Diabetes Research Memorial Fund under the Chinese University of Hong Kong; Merck Limited; Liao Wun Yuk Diabetes Research Memorial Fund	The study was supported by a research grant by Impeto, Paris, France, and the Liao Wun Yuk Diabetes Research Memorial Fund under the Chinese University of Hong Kong. The Joint Asia Diabetes Evaluation program was partly supported by Merck Limited. Impeto, Paris, France, had input in study design, manuscript revision and decision to publish, but they had no role in data collection, data analysis, and data interpretation. The other funders including the Liao Wun Yuk Diabetes Research Memorial Fund and Merck Limited had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Calvet J. H., 2011, BR J DIABETES VASC D, V11, P204, DOI DOI 10.1177/1474651411402629; Casellini CM, 2013, DIABETES TECHNOL THE, V15, P948, DOI 10.1089/dia.2013.0129; Chan J, 2009, DIABETIC MED, V26, P693, DOI 10.1111/j.1464-5491.2009.02751.x; Chen LZ, 2013, DIABETES RES CLIN PR, V100, P210, DOI 10.1016/j.diabres.2013.03.001; FEALEY RD, 1989, MAYO CLIN PROC, V64, P617, DOI 10.1016/S0025-6196(12)65338-5; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Frazee Lawrence A, 2006, Am J Ther, V13, P18, DOI 10.1097/01.mjt.0000174345.59177.9b; Freedman BI, 2014, J DIABETES COMPLICAT, V28, P56, DOI 10.1016/j.jdiacomp.2013.09.006; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Illigens BMW, 2009, CLIN AUTON RES, V19, P79, DOI 10.1007/s10286-008-0506-8; Ko GT, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-26; Kreyden OP, 2004, CLIN DERMATOL, V22, P40, DOI 10.1016/j.clindermatol.2003.12.029; Luo KR, 2012, DIABETES CARE, V35, P612, DOI 10.2337/dc11-1607; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Maclsaac RJ, 2014, KIDNEY INT, V86, P50, DOI 10.1038/ki.2014.98; Mayaudon H, 2010, DIABETES METAB, V36, P450, DOI 10.1016/j.diabet.2010.05.004; Mueller G, 2013, PRIM CARE DIABETES, V7, P269, DOI 10.1016/j.pcd.2013.08.001; Ozaki R, 2011, DIABETES TECHNOL THE, V13, P937, DOI 10.1089/dia.2011.0023; Ramachandran A, 2010, DIABETES RES CLIN PR, V88, P302, DOI 10.1016/j.diabres.2010.01.023; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043449; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Whaley-Connell A, 2009, AM J KIDNEY DIS, V53, pS11, DOI 10.1053/j.ajkd.2009.01.004; Yajnik Chittaranjan S, 2012, ISRN Endocrinol, V2012, P103714, DOI 10.5402/2012/103714; Yang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056480	28	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134981	10.1371/journal.pone.0134981	http://dx.doi.org/10.1371/journal.pone.0134981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270544	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800027
J	Meillere, A; Brischoux, F; Parenteau, C; Angelier, F				Meillere, Alizee; Brischoux, Francois; Parenteau, Charline; Angelier, Frederic			Influence of Urbanization on Body Size, Condition, and Physiology in an Urban Exploiter: A Multi-Component Approach	PLOS ONE			English	Article							SPARROW PASSER-DOMESTICUS; JAYS APHELOCOMA-COERULESCENS; BASE-LINE CORTICOSTERONE; LONG-LIVED BIRD; HOUSE SPARROW; REPRODUCTIVE SUCCESS; STRESS-RESPONSE; FOOD SUPPLEMENTATION; GREAT TITS; ENERGY MANAGEMENT	Consistent expanding urbanization dramatically transforms natural habitats and exposes organisms to novel environmental challenges, often leading to reduced species richness and diversity in cities. However, it remains unclear how individuals are affected by the urban environment and how they can or cannot adjust to the specific characteristics of urban life (e.g. food availability). In this study, we used an integrative multi-component approach to investigate the effects of urbanization on the nutritional status of house sparrows (Passer domesticus). We assessed several morphological and physiological indices of body condition in both juveniles (early post-fledging) and breeding adults from four sites with different levels of urbanization in France, Western Europe. We found that sparrows in more urbanized habitats have reduced body size and body mass compared to their rural conspecifics. However, we did not find any consistent differences in a number of complementary indices of condition (scaled mass index, muscle score, hematocrit, baseline and stress-induced corticosterone levels) between urban and rural birds, indicating that urban sparrows may not be suffering nutritional stress. Our results suggest that the urban environment is unlikely to energetically constrain adult sparrows, although other urban-related variables may constrain them. On the other hand, we found significant difference in juvenile fat scores, suggesting that food types provided to young sparrows differed highly between habitats. In addition to the observed smaller size of urban sparrows, these results suggest that the urban environment is inadequate to satisfy early-life sparrows' nutritional requirements, growth, and development. The urban environment may therefore have life-long consequences for developing birds.	[Meillere, Alizee; Brischoux, Francois; Parenteau, Charline; Angelier, Frederic] Univ La Rochelle, CEBC, CNRS, UMR 7372, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Meillere, A (corresponding author), Univ La Rochelle, CEBC, CNRS, UMR 7372, Villiers En Bois, France.	alizee.meillere@gmail.com	Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Meillere, Alizee/A-8185-2011	Meillere, Alizee/0000-0002-1323-1954	Fondation Fyssen; Centre National de la Recherche Scientifique; Region Poitou-Charentes; Conseil General des Deux-Sevres	Fondation Fyssen; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Region Poitou-Charentes(Region Nouvelle-Aquitaine); Conseil General des Deux-Sevres(Region Nouvelle-Aquitaine)	This work was funded by the Fondation Fyssen (grant to FA) and by the Centre National de la Recherche Scientifique. AM was supported by a grant from the Region Poitou-Charentes and the Conseil General des Deux-Sevres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR., 2006, BIOL UBIQUITOUS HOUS; Angelier F, 2007, PHYSIOL BIOCHEM ZOOL, V80, P283, DOI 10.1086/512585; Angelier F, 2015, HORM BEHAV, V67, P28, DOI 10.1016/j.yhbeh.2014.11.009; Angelier F, 2010, BIOL LETTERS, V6, P846, DOI 10.1098/rsbl.2010.0376; Angelier F, 2010, J ORNITHOL, V151, P415, DOI 10.1007/s10336-009-0471-6; Angelier F, 2009, J EXP BIOL, V212, P2824, DOI 10.1242/jeb.027722; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; [Anonymous], 2014, R LANG ENV STAT COMP; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Bichet C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053866; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bokony V, 2012, LANDSCAPE URBAN PLAN, V104, P75, DOI 10.1016/j.landurbplan.2011.10.006; Bokony V, 2010, OIKOS, V119, P437, DOI 10.1111/j.1600-0706.2009.17848.x; Bonier F, 2012, HORM BEHAV, V61, P763, DOI 10.1016/j.yhbeh.2012.03.016; Bonier F, 2007, BEHAV ECOL, V18, P121, DOI 10.1093/beheco/arl050; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Bowers EK, 2014, ECOLOGY, V95, P3027; Breuner CW, 2008, GEN COMP ENDOCR, V157, P288, DOI 10.1016/j.ygcen.2008.05.017; Brodin A, 2007, PHILOS T R SOC B, V362, P1857, DOI 10.1098/rstb.2006.1812; Brotons L, 2003, ECOSCIENCE, V10, P273, DOI 10.1080/11956860.2003.11682774; Brown Margaret E., 1996, Current Ornithology, V13, P67; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chamberlain DE, 2009, IBIS, V151, P1, DOI 10.1111/j.1474-919X.2008.00899.x; Chavez-Zichinelli CA, 2013, CONDOR, V115, P84, DOI 10.1525/cond.2013.110201; Chavez-Zichinelli CA, 2010, LANDSCAPE URBAN PLAN, V98, P183, DOI 10.1016/j.landurbplan.2010.08.001; CHEREL Y, 1992, J COMP PHYSIOL B, V162, P305, DOI 10.1007/BF00260757; CHEREL Y, 1988, AM J PHYSIOL, V254, pR170, DOI 10.1152/ajpregu.1988.254.2.R170; Clergeau P, 2006, BIOL CONSERV, V127, P336, DOI 10.1016/j.biocon.2005.06.035; Costantini D, 2014, J EXP BIOL, V217, P2994, DOI 10.1242/jeb.106450; Crino OL, 2013, J EXP BIOL, V216, P2055, DOI 10.1242/jeb.081109; Croci S, 2008, LANDSCAPE ECOL, V23, P1171, DOI 10.1007/s10980-008-9257-0; Cuthill IC, 2000, BEHAV ECOL, V11, P189, DOI 10.1093/beheco/11.2.189; Dantzer B, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou023; De Coster G, 2015, LANDSCAPE URBAN PLAN, V134, P139, DOI 10.1016/j.landurbplan.2014.10.020; De Laet J, 2007, J ORNITHOL, V148, pS275, DOI 10.1007/s10336-007-0154-0; DuRant SE, 2013, HORM BEHAV, V63, P385, DOI 10.1016/j.yhbeh.2012.12.001; Eeva T, 1996, OECOLOGIA, V108, P631, DOI 10.1007/BF00329036; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Evans KL, 2009, OIKOS, V118, P774, DOI 10.1111/j.1600-0706.2008.17226.x; Evans KL, 2009, OIKOS, V118, P251, DOI 10.1111/j.1600-0706.2008.17092.x; Fair J, 2007, IBIS, V149, P535, DOI 10.1111/j.1474-919X.2007.00680.x; Fokidis HB, 2008, J AVIAN BIOL, V39, P300, DOI [10.1111/j.0908-8857.2008.04248.x, 10.1111/j.2008.0908-8857.04248.x]; Fokidis HB, 2009, GEN COMP ENDOCR, V160, P259, DOI 10.1016/j.ygcen.2008.12.005; Foltz SL, 2015, J EXP ZOOL PART A, V323, P109, DOI 10.1002/jez.1906; French SS, 2008, J COMP PHYSIOL B, V178, P997, DOI 10.1007/s00360-008-0290-8; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gebhardt-Henrich Sabine, 1998, Oxford Ornithology Series, V8, P324; Gering JC, 1999, ECOGRAPHY, V22, P532, DOI 10.1111/j.1600-0587.1999.tb00542.x; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Giraudeau M, 2014, INTEGR COMP BIOL, V54, P622, DOI 10.1093/icb/icu024; Giraudeau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086747; Gosler AG, 1996, J ANIM ECOL, V65, P1, DOI 10.2307/5695; Goutte A, 2010, GEN COMP ENDOCR, V167, P246, DOI 10.1016/j.ygcen.2010.03.018; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grunst ML, 2014, J AVIAN BIOL, V45, P574, DOI 10.1111/jav.00459; Hamer AJ, 2010, AUSTRAL ECOL, V35, P568, DOI 10.1111/j.1442-9993.2009.02068.x; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; Heidinger BJ, 2006, P ROY SOC B-BIOL SCI, V273, P2227, DOI 10.1098/rspb.2006.3557; Heiss RS, 2009, ECOL APPL, V19, P829, DOI 10.1890/08-0140.1; Herrera-Duenas A, 2014, ECOL INDIC, V42, P6, DOI 10.1016/j.ecolind.2013.08.014; Horak P, 1998, FUNCT ECOL, V12, P750, DOI 10.1046/j.1365-2435.1998.00244.x; Jenni L, 1998, J AVIAN BIOL, V29, P521, DOI 10.2307/3677171; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; Kempenaers B, 2010, CURR BIOL, V20, P1735, DOI 10.1016/j.cub.2010.08.028; Khalilieh A, 2012, AM J PHYSIOL-REG I, V303, pR551, DOI 10.1152/ajpregu.00076.2012; Kitaysky AS, 2001, J COMP PHYSIOL B, V171, P701, DOI 10.1007/s003600100230; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Krams I, 2010, FUNCT ECOL, V24, P172, DOI 10.1111/j.1365-2435.2009.01628.x; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Leloutre C, 2014, CURR ZOOL, V60, P449, DOI 10.1093/czoolo/60.4.449; Lendvai AZ, 2007, P ROY SOC B-BIOL SCI, V274, P391, DOI 10.1098/rspb.2006.3735; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lormee H, 2003, IBIS, V145, P212, DOI 10.1046/j.1474-919X.2003.00106.x; Lucas LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049895; Lynn SE, 2003, HORM BEHAV, V43, P150, DOI 10.1016/S0018-506X(02)00023-5; MacLeod R, 2006, BIOL LETT-UK, V2, P43, DOI 10.1098/rsbl.2005.0421; Marzluff John M., 2001, P19; Mccleery RA, 2009, LANDSCAPE ECOL, V24, P483, DOI 10.1007/s10980-009-9323-2; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Meillere A, 2015, BEHAV ECOL, V26, P569, DOI 10.1093/beheco/aru232; Mennechez Gwenaelle, 2001, P275; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Moller AP, 2010, OECOLOGIA, V163, P35, DOI 10.1007/s00442-009-1525-4; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Pap PL, 2008, CAN J ZOOL, V86, P834, DOI 10.1139/Z08-060; Partecke J, 2006, ECOLOGY, V87, P1945, DOI 10.1890/0012-9658(2006)87[1945:SATCUA]2.0.CO;2; Partecke J, 2005, J AVIAN BIOL, V36, P295, DOI 10.1111/j.0908-8857.2005.03344.x; Peach WJ, 2008, ANIM CONSERV, V11, P493, DOI 10.1111/j.1469-1795.2008.00209.x; Peach WJ, 2014, BIRD STUDY, V61, P378, DOI 10.1080/00063657.2014.918577; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Perrig M, 2014, IBIS, V156, P755, DOI 10.1111/ibi.12171; Plummer KE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02002; Prange S, 2004, J MAMMAL, V85, P483, DOI 10.1644/BOS-121; Pravosudov VV, 1997, CURR ORNITHOL, V14, P189; Rasner CA, 2004, MOL ECOL, V13, P671, DOI 10.1046/j.1365-294X.2004.02104.x; RICHNER H, 1989, J ANIM ECOL, V58, P427, DOI 10.2307/4840; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Romero LM, 2000, GEN COMP ENDOCR, V118, P113, DOI 10.1006/gcen.1999.7446; Ruiz G, 2002, CONDOR, V104, P162, DOI 10.1650/0010-5422(2002)104[0162:HPASII]2.0.CO;2; Sauter A, 2006, BEHAV ECOL SOCIOBIOL, V60, P465, DOI 10.1007/s00265-006-0187-z; Schlesinger MD, 2008, ECOLOGY, V89, P2302, DOI 10.1890/07-0256.1; Schoech SJ, 2007, GEN COMP ENDOCR, V154, P150, DOI 10.1016/j.ygcen.2007.05.027; Seebohm H., 1901, BIRDS OF SIBERIA; Seress G, 2012, J AVIAN BIOL, V43, P403, DOI 10.1111/j.1600-048X.2012.05527.x; Shaw LM, 2008, J ORNITHOL, V149, P293, DOI 10.1007/s10336-008-0285-y; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shochat E, 2004, OIKOS, V106, P622, DOI 10.1111/j.0030-1299.2004.13159.x; Sol D, 1998, CONDOR, V100, P298, DOI 10.2307/1370270; Sol D, 2013, ANIM BEHAV, V85, P1101, DOI 10.1016/j.anbehav.2013.01.023; Spee M, 2010, HORM BEHAV, V58, P762, DOI 10.1016/j.yhbeh.2010.07.011; Swanson DL, 2010, CURR ORNITHOL, V17, P75, DOI 10.1007/978-1-4419-6421-2_3; Tartu S, 2014, SCI TOTAL ENVIRON, V476, P553, DOI 10.1016/j.scitotenv.2014.01.060; Vitousek MN, 2014, HORM BEHAV, V66, P812, DOI 10.1016/j.yhbeh.2014.11.004; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walker BG, 2005, INTEGR COMP BIOL, V45, P12, DOI 10.1093/icb/45.1.12; Wellicome TI, 2013, ECOL EVOL, V3, P2684, DOI 10.1002/ece3.616; Williams TD, 2004, FUNCT ECOL, V18, P330, DOI 10.1111/j.0269-8463.2004.00829.x; WINGFIELD JC, 1994, PERSPECTIVES IN COMPARATIVE ENDOCRINOLOGY, P520; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; Zhang SP, 2011, J ORNITHOL, V152, P801, DOI 10.1007/s10336-011-0663-8	130	89	91	1	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135685	10.1371/journal.pone.0135685	http://dx.doi.org/10.1371/journal.pone.0135685			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270531	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800099
J	Ullah, F; Khan, T; Ali, N; Malik, FA; Kayani, MA; Shah, STA; Saeed, M				Ullah, Farman; Khan, Taimoor; Ali, Nawab; Malik, Faraz Arshad; Kayani, Mahmood Akhtar; Shah, Syed Tahir Abbas; Saeed, Muhammad			Promoter Methylation Status Modulate the Expression of Tumor Suppressor (RbL2/p130) Gene in Breast Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LUNG-CANCER; RETINOBLASTOMA FAMILY; DIFFERENTIAL EXPRESSION; POCKET PROTEINS; DOWN-REGULATION; GASTRIC-CANCER; CYCLE CONTROL; RB2/P130; P107	Background Aberrant expression of tumor suppressor genes may correspond to the abnormal cell development and tumorigenesis. Rbl2/p130, a member of retinoblastoma family of proteins, has growth suppressive properties. Numerous studies reported de-regulation of Rbl2/p130 in various types of cancer as a consequence of a number of genetic alterations. However, role of epigenetic mechanisms like DNA methylation in Rbl2/p130 expression remains elusive. Methods In the current study, 76 breast cancer tumors along with normal tissues (n = 76), blood (n = 76) of respective individuals and control blood (n = 50) were analyzed. Rbl2/p130 expression was analyzed by quantitative real time PCR (syber green method). Promoter methylation status was studied through methylation specific PCR of bisulfite converted genomic DNA. Data was analyzed using various statistical tests. Results We report significantly reduced Rbl2/p130 expression (P = 0.001) in tumors tissues as compared to control samples. Similarly, Rbl2/p130 expression varies with age and disease stages (P = 0.022), which suggest its involvement in tumor progression. Aberrant promotermethylation (Delta meth) was found in almost all the diseased samples and that was significantly different (P<0.001) with control samples. Similarly, methylation status varies significantly with tumor progression stages (P = 0.022). Hyper-methylation was observed at -1, +3, +15 and +75 of Rbl2/p130 promoter flanking around the TSS. Statistical analysis revealed that Rbl2/p130 expression negatively correlates to its promoter methylation (r = -0.412) in tumor tissues. Our results reflect an epigenetic regulation of Rbl2/p130 expression in breast cancer. This highlights the importance of Rbl2/p130 promoter methylation in breast cancer pathogenesis.	[Ullah, Farman; Khan, Taimoor; Malik, Faraz Arshad; Kayani, Mahmood Akhtar; Shah, Syed Tahir Abbas; Saeed, Muhammad] COMSATS Inst Informat Technol CIIT, Dept Biosci, Canc Genet & Epigenet Lab, Islamabad, Pakistan; [Ali, Nawab] Kohat Univ Sci & Technol KUST, Dept Biotechnol & Genet Engn, Kohat, Pakistan	COMSATS University Islamabad (CUI); Kohat University of Science & Technology	Saeed, M (corresponding author), COMSATS Inst Informat Technol CIIT, Dept Biosci, Canc Genet & Epigenet Lab, Islamabad, Pakistan.	muhammad.saeed@comsats.edu.pk	Shah, Syed Tahir Abbas/K-4637-2015; malik, Faraz./AFQ-1839-2022; Kayani, Mahmood/I-7760-2015	Shah, Syed Tahir Abbas/0000-0001-9151-9374; Kayani, Mahmood/0000-0001-9886-180X	Higher Education Commission (HEC); COMSATS Research Grant Program (CRGP); CIIT	Higher Education Commission (HEC)(Higher Education Commission of Pakistan); COMSATS Research Grant Program (CRGP); CIIT	The author specially acknowledge the Higher Education Commission (HEC), COMSATS Research Grant Program (CRGP), and CIIT for their research grant for supporting this study.	Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; Baldi A, 1996, P NATL ACAD SCI USA, V93, P4629, DOI 10.1073/pnas.93.10.4629; Baldi A, 1996, CLIN CANCER RES, V2, P1239; Baldi A, 1997, CLIN CANCER RES, V3, P1691; Baxter E, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-45; Bozkurt C, 2011, TURK J MED SCI, V41, P8; Campioni M, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-38; Cenci M, 2005, ANTICANCER RES, V25, P2187; Cherkasova E, 2011, ONCOGENE, V30, P4697, DOI 10.1038/onc.2011.179; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; Claudio P, 2002, GENOME BIOL, V3; CLAUDIO PP, 1994, CANCER RES, V54, P5556; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Colozza M, 2005, ANN ONCOL, V16, P1723, DOI 10.1093/annonc/mdi352; D'Andrilli G, 2004, CLIN CANCER RES, V10, P3098, DOI 10.1158/1078-0432.CCR-03-0524; De Falco G, 2007, BLOOD, V110, P1301, DOI 10.1182/blood-2006-12-064865; Dong SW, 2012, WORLD J GASTROENTERO, V18, P576, DOI 10.3748/wjg.v18.i6.576; Feng L, 2011, BIOCHEM BIOPH RES CO, V406, P534, DOI 10.1016/j.bbrc.2011.02.081; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Guo XB, 2011, BIOCHEM BIOPH RES CO, V404, P622, DOI 10.1016/j.bbrc.2010.12.026; Hatzimichael E, 2009, CLIN LYMPHOMA MYELOM, V9, P239, DOI 10.3816/CLM.2009.n.047; Jovanovic J, 2010, MOL ONCOL, V4, P242, DOI 10.1016/j.molonc.2010.04.002; Khan ZN, 2013, ASIAN PAC J CANCER P, V14, P2255, DOI 10.7314/APJCP.2013.14.3.2255; Lacy S, 1997, ONCOGENE, V14, P2395, DOI 10.1038/sj.onc.1201085; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li QY, 2015, ONCOL LETT, V9, P1807, DOI 10.3892/ol.2015.2908; Ling YQ, 2014, BIOCHEM BIOPH RES CO, V444, P147, DOI 10.1016/j.bbrc.2014.01.012; Lu F, 2011, ANAT REC, V294, P1787, DOI 10.1002/ar.21471; Macaluso M, 2007, CANCER RES, V67, P7731, DOI 10.1158/0008-5472.CAN-07-1476; Masciullo V, 2008, CLIN CANCER RES, V14, P4775, DOI 10.1158/1078-0432.CCR-07-4055; McDonald ER, 2000, INT J ONCOL, V16, P871; Milde-Langosch K, 2001, BRIT J CANCER, V85, P546, DOI 10.1054/bjoc.2001.1923; Obata Y, 2015, IMMUNOL CELL BIOL, V93, P226, DOI 10.1038/icb.2014.114; Paggi MG, 2001, CANCER RES, V61, P4651; Rocha-Sanchez SMS, 2007, INT J DEV BIOL, V51, P585, DOI 10.1387/ijdb.072387sr; Sabir M, 2014, CELL ONCOL, V37, P203, DOI 10.1007/s13402-014-0173-9; Scambia G, 2006, ONCOGENE, V25, P5302, DOI 10.1038/sj.onc.1209620; Smith EJ, 1996, MOL CELL BIOL, V16, P6965; Smith L, 2008, BIOCHEM SOC T, V36, P708, DOI 10.1042/BST0360708; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Strauss W M, 2001, Curr Protoc Mol Biol, VChapter 2, DOI 10.1002/0471142727.mb0202s42; Susini T, 2001, HUM PATHOL, V32, P360, DOI 10.1053/hupa.2001.23514; Suzuki M, 2010, SURG TODAY, V40, P602, DOI 10.1007/s00595-009-4094-6; Tsz J, 2011, J BIOMATERIALS NANOB, V2, p[41, 8]; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	45	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134687	10.1371/journal.pone.0134687	http://dx.doi.org/10.1371/journal.pone.0134687			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271034	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800013
J	Khan, NA; Ahmad, F; Khan, SA				Khan, Naeem Akhtar; Ahmad, Farooq; Khan, Sher Afzal			SHER: A Colored Petri Net Based Random Mobility Model for Wireless Communications	PLOS ONE			English	Article							EXTREMALITY; NETWORKS	In wireless network research, simulation is the most imperative technique to investigate the network's behavior and validation. Wireless networks typically consist of mobile hosts; therefore, the degree of validation is influenced by the underlying mobility model, and synthetic models are implemented in simulators because real life traces are not widely available. In wireless communications, mobility is an integral part while the key role of a mobility model is to mimic the real life traveling patterns to study. The performance of routing protocols and mobility management strategies e.g. paging, registration and handoff is highly dependent to the selected mobility model. In this paper, we devise and evaluate the Show Home and Exclusive Regions (SHER), a novel two-dimensional (2-D) Colored Petri net (CPN) based formal random mobility model, which exhibits sociological behavior of a user. The model captures hotspots where a user frequently visits and spends time. Our solution eliminates six key issues of the random mobility models, i.e., sudden stops, memoryless movements, border effect, temporal dependency of velocity, pause time dependency, and speed decay in a single model. The proposed model is able to predict the future location of a mobile user and ultimately improves the performance of wireless communication networks. The model follows a uniform nodal distribution and is a mini simulator, which exhibits interesting mobility patterns. The model is also helpful to those who are not familiar with the formal modeling, and users can extract meaningful information with a single mouse-click. It is noteworthy that capturing dynamic mobility patterns through CPN is the most challenging and virulent activity of the presented research. Statistical and reachability analysis techniques are presented to elucidate and validate the performance of our proposed mobility model. The state space methods allow us to algorithmically derive the system behavior and rectify the errors of our proposed model.	[Khan, Naeem Akhtar] Univ Cent Punjab, Fac Informat Technol, Lahore, Pakistan; [Ahmad, Farooq] COMSATS Inst Informat Technol, Dept Comp Sci, Lahore, Pakistan; [Khan, Sher Afzal] Abdul Wali Khan Univ, Dept Comp Sci, Mardan, Pakistan; [Khan, Sher Afzal] King Abdulaziz Univ, Fac Comp & Informat Technol Rabigh, Jeddah 21413, Saudi Arabia	University of Central Punjab; COMSATS University Islamabad (CUI); Abdul Wali Khan University; King Abdulaziz University	Ahmad, F (corresponding author), COMSATS Inst Informat Technol, Dept Comp Sci, Lahore, Pakistan.	farooqahmad@ciitlahore.edu.pk	Khan, Sher Afzal/H-2958-2012	Khan, Sher Afzal/0000-0003-0273-1248				Abdullah S. J., 2011, P WORLD C ENG COMP S, P19; Agrahari S, 2012, P 2 INT C COMP SCI E, P65; Akyildiz IF, 2005, COMPUT NETW, V47, P445, DOI 10.1016/j.comnet.2004.12.001; Alparslan DN, 2007, IEEE ACM T NETWORK, V15, P602, DOI 10.1109/TNET.2007.893235; Aschenbruck N, 2011, COMPUT COMMUN, V34, P704, DOI 10.1016/j.comcom.2010.11.002; Camp T, 2002, WIREL COMMUN MOB COM, V2, P483, DOI 10.1002/wcm.72; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Clarke EM, 1996, ACM COMPUT SURV, V28, P626, DOI 10.1145/242223.242257; Dehmer M, 2013, MATCH-COMMUN MATH CO, V69, P785; Desel J., 1998, LNCS, V1491, P122, DOI [10.1007/3-540-65306-615, DOI 10.1007/3-540-65306-615, DOI 10.1007/3-540-65306-6]; Gyarmati M, 2008, P IEEE GLOB TEL C GL, P404; Hasan O, 2013, ABS13114303 CORR, V17, P256; Holzmann G.J., 1991, DESIGN VALIDATION CO, V512; HOLZMANN GJ, 1988, SOFTWARE PRACT EXPER, V18, P137, DOI 10.1002/spe.4380180203; HOLZMANN GJ, 1993, COMPUT NETWORKS ISDN, V25, P981, DOI 10.1016/0169-7552(93)90095-L; Jensen K., 1997, MONOGRAPHS THEORETIC, V1-3; Jensen K, 2009, COLOURED PETRI NETS: MODELLING AND VALIDATION OF CONCURRENT SYSTEMS, P1, DOI 10.1007/b95112; Johnson D.B., 1996, MOBILE COMPUTING, P153, DOI DOI 10.1007/978-0-585-29603-6_5; Khan NA, 2014, INT BHURBAN C APPL S, P436, DOI 10.1109/IBCAST.2014.6778183; Khan NA, 2014, IEEE SYS MAN CYBERN, P139, DOI 10.1109/SMC.2014.6973897; Khan NA, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/798927; Kim D. S., 2007, J UBIQUITOUS CONVERG, V1; Kraus V, 2013, MATCH-COMMUN MATH CO, V70, P885; Kristensen L. M., 1998, International Journal on Software Tools for Technology Transfer, V2, P98, DOI 10.1007/s100090050021; Kristensen L.M, 2003, LECT NOTES COMPUTER, P626; Kurkowski S., 2005, ACM SIGMOBILE MOBILE, V9, P50, DOI DOI 10.1145/1096166.1096174; Li XL, 2013, MATCH-COMMUN MATH CO, V70, P85; Macintosh A, 2014, INT J RES WIRELESS S, V3, P9; Meghanathan N, 2012, INFORM-J COMPUT INFO, V36, P185; Pazand B, 2007, 6TH IEEE/ACIS INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION SCIENCE, PROCEEDINGS, P141, DOI 10.1109/ICIS.2007.15; Resta G, 2000, P 2 ACM INT WORKSH P, P44; Roy RR, 2011, HANDBOOK OF MOBILE AD HOC NETWORKS FOR MOBILITY MODELS, P1, DOI 10.1007/978-1-4419-6050-4; Royer EM, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS, VOLS 1-10, CONFERENCE RECORD, P857, DOI 10.1109/ICC.2001.937360; Sanchez M, 2001, FUTURE GENER COMP SY, V17, P573, DOI 10.1016/S0167-739X(00)00040-6; Ullman J., 1998, ELEMENTS ML PROGRAMM; Xia CY, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500567; Xia CY, 2009, FRONT COMPUT SCI CHI, V3, P361, DOI 10.1007/s11704-009-0057-8; Xiong C., 2002, RES PRACTICE INFORMA, V12, P145; Yoon J, 2003, IEEE INFOCOM SER, P1312; Zheng Q., 2004, P 42 ANN SE REG C, P70, DOI [DOI 10.1145/986537.986554, 10.1145/986537.986554]	40	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133634	10.1371/journal.pone.0133634	http://dx.doi.org/10.1371/journal.pone.0133634			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267860	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300020
J	Maag, D; Erb, M; Bernal, JS; Wolfender, JL; Turlings, TCJ; Glauser, G				Maag, Daniel; Erb, Matthias; Bernal, Julio S.; Wolfender, Jean-Luc; Turlings, Ted C. J.; Glauser, Gaetan			Maize Domestication and Anti-Herbivore Defences: Leaf-Specific Dynamics during Early Ontogeny of Maize and Its Wild Ancestors	PLOS ONE			English	Article							CORN-BORER LEPIDOPTERA; FALL ARMYWORM LEPIDOPTERA; LIFE-HISTORY EVOLUTION; PLANT DEFENSE; ZEA-MAYS; BETA-GLUCOSIDASES; INNATE IMMUNITY; RESISTANCE; INSECT; BRASSICA	As a consequence of artificial selection for specific traits, crop plants underwent considerable genotypic and phenotypic changes during the process of domestication. These changes may have led to reduced resistance in the cultivated plant due to shifts in resource allocation from defensive traits to increased growth rates and yield. Modern maize (Zea mays ssp. mays) was domesticated from its ancestor Balsas teosinte (Z. mays ssp. parviglumis) approximately 9000 years ago. Although maize displays a high genetic overlap with its direct ancestor and other annual teosintes, several studies show that maize and its ancestors differ in their resistance phenotypes with teosintes being less susceptible to herbivore damage. However, the underlying mechanisms are poorly understood. Here we addressed the question to what extent maize domestication has affected two crucial chemical and one physical defence traits and whether differences in their expression may explain the differences in herbivore resistance levels. The ontogenetic trajectories of 1,4-benzoxazin-3-ones, maysin and leaf toughness were monitored for different leaf types across several maize cultivars and teosinte accessions during early vegetative growth stages. We found significant quantitative and qualitative differences in 1,4-benzoxazin-3-one accumulation in an initial pairwise comparison, but we did not find consistent differences between wild and cultivated genotypes during a more thorough examination employing several cultivars/accessions. Yet, 1,4-benzoxazin-3-one levels tended to decline more rapidly with plant age in the modern maize cultivars. Foliar maysin levels and leaf toughness increased with plant age in a leaf-specific manner, but were also unaffected by domestication. Based on our findings we suggest that defence traits other than the ones that were investigated are responsible for the observed differences in herbivore resistance between teosinte and maize. Furthermore, our results indicate that single pairwise comparisons may lead to false conclusions regarding the effects of domestication on defensive and possibly other traits.	[Maag, Daniel; Turlings, Ted C. J.; Glauser, Gaetan] Univ Neuchatel, Lab Fundamental & Appl Res Chem Ecol, CH-2000 Neuchatel, Switzerland; [Maag, Daniel; Wolfender, Jean-Luc] Univ Lausanne, Lab Phytochem & Bioact Nat Prod, Sch Pharmaceut Sci, Univ Geneva, CH-1211 Geneva, Switzerland; [Erb, Matthias] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; [Bernal, Julio S.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Glauser, Gaetan] Univ Neuchatel, Neuchatel Platform Analyt Chem, CH-2000 Neuchatel, Switzerland	University of Neuchatel; University of Geneva; University of Lausanne; University of Bern; Texas A&M University System; Texas A&M University College Station; University of Neuchatel	Maag, D (corresponding author), Univ Neuchatel, Lab Fundamental & Appl Res Chem Ecol, Rue Emile Argand 11, CH-2000 Neuchatel, Switzerland.	daniel.maag@unine.ch	Jean-Luc, Wolfender JLW/O-2163-2018; Glauser, Gaetan/K-7574-2017; Turlings, Ted CJ/E-8671-2012; Jean-Luc, Wolfender JLW/EWV-1043-2022; Bernal, Julio S./N-1290-2013; Erb, Matthias/H-6886-2019	Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Glauser, Gaetan/0000-0002-0983-8614; Turlings, Ted CJ/0000-0002-8315-785X; Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Bernal, Julio S./0000-0003-4615-2213; Erb, Matthias/0000-0002-4446-9834; Maag, Daniel/0000-0002-5961-1506	Swiss National Science Foundation [CRSII3_136184]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by CRSII3_136184, Swiss National Science Foundation, http://www.snf.ch/en/Pages/default.aspx, DM ME JLW TCJT GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, PLANT PHYSIOL, V157, P317, DOI 10.1104/pp.111.180224; BARRY D, 1994, ENVIRON ENTOMOL, V23, P177, DOI 10.1093/ee/23.1.177; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; Bellota E, 2013, ENTOMOL EXP APPL, V149, P185, DOI 10.1111/eea.12122; Benrey B, 1998, BIOL CONTROL, V11, P130, DOI 10.1006/bcon.1997.0590; BERGVINSON DJ, 1994, J ECON ENTOMOL, V87, P1743, DOI 10.1093/jee/87.6.1743; Brooks TD, 2007, J ECON ENTOMOL, V100, P1470, DOI 10.1603/0022-0493(2007)100[1470:GBORTF]2.0.CO;2; Buckler ES., 2006, DARWINS HARVEST NEW, V67, P90, DOI [DOI 10.7312/MOTL13316-005/HTML, 10.7312/motl13316-005]; Cambier V, 2000, PHYTOCHEMISTRY, V53, P223, DOI 10.1016/S0031-9422(99)00498-7; Chaudhary Bhupendra, 2013, Int J Plant Genomics, V2013, P572784, DOI 10.1155/2013/572784; Chen YH, 2015, ANNU REV ENTOMOL, V60, P35, DOI 10.1146/annurev-ento-010814-020601; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; Davila-Flores AM, 2013, OECOLOGIA, V173, P1425, DOI 10.1007/s00442-013-2728-2; de Lange ES, 2014, NEW PHYTOL, V204, P329, DOI 10.1111/nph.13005; Degen T, 2004, PLANT PHYSIOL, V135, P1928, DOI 10.1104/pp.104.039891; Degenhardt J, 2009, PLANT PHYSIOL, V149, P96, DOI 10.1104/pp.108.128975; DICKE M, 1988, NETH J ZOOL, V38, P148, DOI 10.1163/156854288X00111; Doebley J, 2001, GENETICS, V158, P487; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; ELLIGER CA, 1980, NATURWISSENSCHAFTEN, V67, P358, DOI 10.1007/BF01106595; ELLIGER CA, 1980, PHYTOCHEMISTRY, V19, P293, DOI 10.1016/S0031-9422(00)81977-9; Ellstrand NC, 2007, J HERED, V98, P183, DOI 10.1093/jhered/esm002; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Erb M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7273; Frost CJ, 2007, ECOL LETT, V10, P490, DOI 10.1111/j.1461-0248.2007.01043.x; Glauser G, 2011, PLANT J, V68, P901, DOI 10.1111/j.1365-313X.2011.04740.x; Gols R, 2008, J CHEM ECOL, V34, P132, DOI 10.1007/s10886-008-9429-z; Gouinguene S, 2001, CHEMOECOLOGY, V11, P9, DOI 10.1007/PL00001832; Hammack L, 2001, J CHEM ECOL, V27, P1373, DOI 10.1023/A:1010365225957; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hufford MB, 2012, TRENDS GENET, V28, P606, DOI 10.1016/j.tig.2012.08.004; Karban R, 2003, OIKOS, V100, P325, DOI 10.1034/j.1600-0706.2003.12075.x; Kim J., 2014, J ELECT MAT, V2014, P1, DOI DOI 10.1167/14.7.1.[; Kohler A, 2015, PLANT CELL ENVIRON, V38, P1081, DOI 10.1111/pce.12464; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Lee EA, 1998, GENETICS, V149, P1997; Maag D, 2014, PHYTOCHEMISTRY, V102, P97, DOI 10.1016/j.phytochem.2014.03.018; Maresh J, 2006, ACS CHEM BIOL, V1, P165, DOI 10.1021/cb600051w; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; McCormick AC, 2012, TRENDS PLANT SCI, V17, P303, DOI 10.1016/j.tplants.2012.03.012; McMullen MD, 1998, P NATL ACAD SCI USA, V95, P1996, DOI 10.1073/pnas.95.5.1996; Meihls LN, 2013, PLANT CELL, V25, P2341, DOI 10.1105/tpc.113.112409; Miller N, 2014, JOURNAL OF APPLIED E; MITHEN RF, 1987, PHYTOCHEMISTRY, V26, P1969, DOI 10.1016/S0031-9422(00)81740-9; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Niemeyer H, 1982, CHEMISTRY AND BIOLOG; Niemeyer HM, 2009, J AGR FOOD CHEM, V57, P1677, DOI 10.1021/jf8034034; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Robert CAM, 2012, FUNCT ECOL, V26, P1429, DOI 10.1111/j.1365-2435.2012.02030.x; Robert CAM, 2012, ECOL LETT, V15, P55, DOI 10.1111/j.1461-0248.2011.01708.x; Robert CAM, 2013, PLANT BIOTECHNOL J, V11, P628, DOI 10.1111/pbi.12053; Rosenthal JP, 1997, EVOL ECOL, V11, P337, DOI 10.1023/A:1018420504439; Sasai H, 2009, BIOSCI BIOTECH BIOCH, V73, P1333, DOI 10.1271/bbb.80903; Schnee C, 2006, P NATL ACAD SCI USA, V103, P1129, DOI 10.1073/pnas.0508027103; Shahid M., 1998, Maize Genetics Cooperation Newsletter, P23; Snook ME, 1994, PROCEEDINGS OF AN IN; Szczepaniec A, 2013, ENTOMOL EXP APPL, V146, P242, DOI 10.1111/eea.12014; Takahashi CG, 2012, ENTOMOL EXP APPL, V145, P191, DOI 10.1111/eea.12004; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Turcotte MM, 2014, NEW PHYTOL, V204, P671, DOI 10.1111/nph.12935; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; Velasco P, 2007, J AGR FOOD CHEM, V55, P955, DOI 10.1021/jf0624897; Wallace SK, 2002, J CHEM ECOL, V28, P243, DOI 10.1023/A:1017973005994; Williams WP, 1998, J ECON ENTOMOL, V91, P1471, DOI 10.1093/jee/91.6.1471; WISEMAN BR, 1992, J ECON ENTOMOL, V85, P2473, DOI 10.1093/jee/85.6.2473; Wouters FC, 2014, ANGEW CHEM INT EDIT, V53, P11320, DOI 10.1002/anie.201406643; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891	73	33	33	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135722	10.1371/journal.pone.0135722	http://dx.doi.org/10.1371/journal.pone.0135722			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267478	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300149
J	Xiang, YF; Kim, KY; Gelernter, J; Park, IH; Zhang, HP				Xiang, Yangfei; Kim, Kun-Yong; Gelernter, Joel; Park, In-Hyun; Zhang, Huiping			Ethanol Upregulates NMDA Receptor Subunit Gene Expression in Human Embryonic Stem Cell-Derived Cortical Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTORS; GLUTAMATE RECEPTORS; MESSENGER-RNA; NEURAL CELLS; CYCLIN D2; ALCOHOL; DEPENDENCE; PROTEIN; BLOOD	Chronic alcohol consumption may result in sustained gene expression alterations in the brain, leading to alcohol abuse or dependence. Because of ethical concerns of using live human brain cells in research, this hypothesis cannot be tested directly in live human brains. In the present study, we used human embryonic stem cell (hESC)-derived cortical neurons as in vitro cellular models to investigate alcohol-induced expression changes of genes involved in alcohol metabolism (ALDH2), anti-apoptosis (BCL2 and CCND2), neurotransmission (NMDA receptor subunit genes: GRIN1, GRIN2A, GRIN2B, and GRIN2D), calcium channel activity (ITPR2), or transcriptional repression (JARID2). hESCs were differentiated into cortical neurons, which were characterized by immunostaining using antibodies against cortical neuron-specific biomarkers. Ethanol-induced gene expression changes were determined by reverse-transcription quantitative polymerase chain reaction (RT-qPCR). After a 7-day ethanol (50 mM) exposure followed by a 24-hour ethanol withdrawal treatment, five of the above nine genes (including all four NMDA receptor subunit genes) were highly upregulated (GRIN1: 1.93-fold, P = 0.003; GRIN2A: 1.40-fold, P = 0.003; GRIN2B: 1.75-fold, P = 0.002; GRIN2D: 1.86-fold, P = 0.048; BCL2: 1.34-fold, P = 0.031), and the results of GRIN1, GRIN2A, and GRIN2B survived multiple comparison correction. Our findings suggest that alcohol responsive genes, particularly NMDA receptor genes, play an important role in regulating neuronal function and mediating chronic alcohol consumption-induced neuroadaptations.	[Xiang, Yangfei; Kim, Kun-Yong; Gelernter, Joel; Park, In-Hyun] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Gelernter, Joel; Zhang, Huiping] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Gelernter, Joel] Yale Univ, Dept Neurobiol, Sch Med, New Haven, CT USA; [Gelernter, Joel; Zhang, Huiping] VA Connecticut Healthcare Syst, VA Med Ctr, West Haven, CT USA	Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Park, IH (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	inhyun.park@yale.edu; huiping.zhang@yale.edu	; Xiang, Yangfei/K-5094-2015	Zhang, Huiping/0000-0002-4902-0104; Xiang, Yangfei/0000-0002-6256-6312; Gelernter, Joel/0000-0002-4067-1859	National Institutes of Health (NIH) [P50 AA12870, R01 GM111667, R21 AA023068]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA023068, P50AA012870] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The work was supported by the National Institutes of Health (NIH) Grants P50 AA12870 (JG and HZ), R01 GM111667 (IP), and R21 AA023068 (HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JM, 2014, EUR J NEUROSCI, V39, P999, DOI 10.1111/ejn.12477; Barker JM, 2013, ALCOHOL CLIN EXP RES, V37, pE101, DOI 10.1111/j.1530-0277.2012.01906.x; Bigge CF, 1999, CURR OPIN CHEM BIOL, V3, P441, DOI 10.1016/S1367-5931(99)80065-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHANDLER LJ, 1993, J NEUROCHEM, V60, P1578, DOI 10.1111/j.1471-4159.1993.tb03326.x; Chandler LJ, 1999, ALCOHOL CLIN EXP RES, V23, P363, DOI 10.1111/j.1530-0277.1999.tb04123.x; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Ding X, 2014, AM J PHYSIOL-GASTR L, V306, pG37, DOI 10.1152/ajpgi.00085.2013; Edenberg HJ, 2013, NAT REV GASTRO HEPAT, V10, P487, DOI 10.1038/nrgastro.2013.86; Escobar TM, 2014, IMMUNITY, V40, P865, DOI 10.1016/j.immuni.2014.03.014; Floyd DW, 2003, J PHARMACOL EXP THER, V307, P1020, DOI 10.1124/jpet.103.057505; FOLLESA P, 1995, MOL BRAIN RES, V29, P99, DOI 10.1016/0169-328X(94)00235-7; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Guo WT, 1997, ONCOGENE, V15, P1143, DOI 10.1038/sj.onc.1201287; HAMLYN AN, 1975, LANCET, V2, P345; Hansson AC, 2008, EUR J NEUROSCI, V27, P1912, DOI 10.1111/j.1460-9568.2008.06159.x; Harlaar N, 2013, DRUG ALCOHOL DEPEN, V133, P305, DOI 10.1016/j.drugalcdep.2013.07.026; Hicklin TR, 2011, P NATL ACAD SCI USA, V108, P6650, DOI 10.1073/pnas.1017856108; Hui K, 2008, CELL DEATH DIFFER, V15, P691, DOI 10.1038/sj.cdd.4402294; JONES AW, 1988, FORENSIC SCI INT, V37, P277, DOI 10.1016/0379-0738(88)90236-8; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; Kimura Y, 2009, ALCOHOL ALCOHOLISM, V44, P261, DOI 10.1093/alcalc/agn123; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Krystal JH, 2003, PHARMACOL THERAPEUT, V99, P79, DOI 10.1016/S0163-7258(03)00054-8; LANCASTER FE, 1992, ALCOHOL CLIN EXP RES, V16, P539, DOI 10.1111/j.1530-0277.1992.tb01413.x; Li DW, 2012, HUM GENET, V131, P725, DOI 10.1007/s00439-011-1116-4; Li SY, 2004, J BIOL CHEM, V279, P11244, DOI 10.1074/jbc.M308011200; Lieberman R, 2012, ALCOHOL CLIN EXP RES, V36, P1678, DOI 10.1111/j.1530-0277.2012.01792.x; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Maler JM, 2005, BRAIN RES, V1052, P156, DOI 10.1016/j.brainres.2005.06.017; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; MELGAARD B, 1983, ACTA NEUROL SCAND, V67, P131, DOI 10.1111/j.1600-0404.1983.tb04556.x; MESSING RO, 1986, P NATL ACAD SCI USA, V83, P6213, DOI 10.1073/pnas.83.16.6213; Mishra D, 2012, ALCOHOL CLIN EXP RES, V36, P2117, DOI 10.1111/j.1530-0277.2012.01824.x; Nagy J, 2008, CURR NEUROPHARMACOL, V6, P39, DOI 10.2174/157015908783769662; NIE ZG, 1994, J PHARMACOL EXP THER, V271, P1566; Puglia MP, 2010, ALCOHOL CLIN EXP RES, V34, P594, DOI 10.1111/j.1530-0277.2009.01128.x; Puttonen HAJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00102; Quillen EE, 2014, AM J MED GENET B, V165, P103, DOI 10.1002/ajmg.b.32213; Ridge JP, 2008, ANN NY ACAD SCI, V1139, P10, DOI 10.1196/annals.1432.053; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Starkman BG, 2012, ALCOHOL RES-CURR REV, V34, P293; TRUJILLO KA, 1995, DRUG ALCOHOL DEPEN, V38, P139, DOI 10.1016/0376-8716(95)01119-J; van Es MA, 2007, LANCET NEUROL, V6, P869, DOI 10.1016/S1474-4422(07)70222-3; Wang F, 2013, J ADDICT RES THER, V4; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Yadav S, 2011, J BIOL CHEM, V286, P37347, DOI 10.1074/jbc.M111.235531; Zhang HP, 2014, HUM GENET, V133, P1383, DOI 10.1007/s00439-014-1473-x; Zhang KZ, 1996, P NATL ACAD SCI USA, V93, P4504, DOI 10.1073/pnas.93.9.4504	50	21	21	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134907	10.1371/journal.pone.0134907	http://dx.doi.org/10.1371/journal.pone.0134907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266540	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300066
J	Zeng, QW; Chen, HY; Zhang, C; Han, MJ; Li, T; Qi, XW; Xiang, ZH; He, NJ				Zeng, Qiwei; Chen, Hongyu; Zhang, Chao; Han, Minjing; Li, Tian; Qi, Xiwu; Xiang, Zhonghuai; He, Ningjia			Definition of Eight Mulberry Species in the Genus Morus by Internal Transcribed Spacer-Based Phylogeny	PLOS ONE			English	Article							GENETIC DIVERSITY; SEQUENCES; MORACEAE; ALBA; L.; WILD	Mulberry, belonging to the order Rosales, family Moraceae, and genus Morus, has received attention because of both its economic and medicinal value, as well as for its important ecological function. The genus Morus has a worldwide distribution, however, its taxonomy remains complex and disputed. Many studies have attempted to classify Morus species, resulting in varied numbers of designated Morus spp. To address this issue, we used information from internal transcribed spacer (ITS) genetic sequences to study the taxonomy of all the members of generally accepted genus Morus. We found that intraspecific 5.8S rRNA sequences were identical but that interspecific 5.8S sequences were diverse. M. alba and M. notabilis showed the shortest (215 bp) and the longest (233 bp) ITS1 sequence length, respectively. With the completion of the mulberry genome, we could identify single nucleotide polymorphisms within the ITS locus in the M. notabilis genome. From reconstruction of a phylogenetic tree based on the complete ITS data, we propose that the Morus genus should be classified into eight species, including M. alba, M. nigra, M. notabilis, M. serrata, M. celtidifolia, M. insignis, M. rubra, and M. mesozygia. Furthermore, the classification of the ITS sequences of known interspecific hybrid clones into both paternal and maternal clades indicated that ITS variation was sufficient to distinguish interspecific hybrids in the genus Morus.	[Zeng, Qiwei; Chen, Hongyu; Zhang, Chao; Han, Minjing; Li, Tian; Qi, Xiwu; Xiang, Zhonghuai; He, Ningjia] Southwest Univ, Inst Sericulture & Syst Biol, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China	Southwest University - China	He, NJ (corresponding author), Southwest Univ, Inst Sericulture & Syst Biol, State Key Lab Silkworm Genome Biol, 216 Tiansheng Rd, Chongqing 400716, Peoples R China.	hejia@swu.edu.cn	chen, hongyu/HHS-4314-2022		National Natural Science Foundation of China [31201005]; Scientific and Technical Assistance Project in Xingjiang [2013911102]; Scientific Research Fund for Doctor of Southwest University [swu1111080]; Fundamental Research Funds for the Central Universities [XDJK2014C050]; National Hi-Tech Research and Development Program of China [2013AA100605-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technical Assistance Project in Xingjiang; Scientific Research Fund for Doctor of Southwest University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	The National Natural Science Foundation of China (31201005), Scientific and Technical Assistance Project in Xingjiang (2013911102) and Scientific Research Fund for Doctor of Southwest University (swu1111080) for data collection and analysis, the Fundamental Research Funds for the Central Universities (XDJK2014C050) for data analysis, National Hi-Tech Research and Development Program of China (2013AA100605-3) for decision to publish.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; [Anonymous], [No title captured]; BASAVAIAH, 1989, CYTOLOGIA, V54, P747, DOI 10.1508/cytologia.54.747; Berg C. C., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P423; Berg CC, 2001, MOREAE ARTOCARPEAE D, V7; Buckley SB, 1863, MORUS MICROPHYLLA BU, P8; Bureau L.E., 1873, PRODROMUS SYSTEMATIS, P211; Burgess KS, 2005, MOL ECOL, V14, P3471, DOI 10.1111/j.1365-294X.2005.02670.x; Butt MS, 2008, TRENDS FOOD SCI TECH, V19, P505, DOI 10.1016/j.tifs.2008.06.002; CHEMERIS A V, 1989, Molekulyarnaya Biologiya (Moscow), V23, P320; [陈仁芳 Chen Renfang], 2012, [蚕业科学, Acta Sericologica Sinica], V38, P2; Chen RenFang, 2010, Scientia Agricultura Sinica, V43, P1771; [赵卫国 Diao Weiguo], 2004, [蚕业科学, Acta Sericologica Sinica], V30, P11; GRAY E, 1987, CASTANEA, V52, P216; He NJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3445; Hotta T, 1954, KINUGASA SANPO, V390, P13; Kafkas S, 2008, J AM SOC HORTIC SCI, V133, P593, DOI 10.21273/JASHS.133.4.593; Kapche GDWF, 2009, PHYTOCHEMISTRY, V70, P216, DOI 10.1016/j.phytochem.2008.12.014; Kiss L, 2012, P NATL ACAD SCI USA, V109, pE1811, DOI 10.1073/pnas.1207143109; Koidzumi G, 1917, B SERIC EXP STATION, V3, P1; LeRoy J. F., 1949, Revue Internationale de Botanique Appliquee et d'Agriculture Tropicale, V29, P481; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li W, 2014, CURR GENET, V60, P1, DOI 10.1007/s00294-013-0397-7; Linnaeus C, 1753, MORUS SPECIES PLANTA, P968; Nepal MP, 2012, SYST BOT, V37, P442, DOI 10.1600/036364412X635485; Pawlowska AM, 2008, J AGR FOOD CHEM, V56, P3377, DOI 10.1021/jf703709r; [秦俭 Qin Jian], 2010, [蚕业科学, Acta Sericologica Sinica], V36, P984; Rao AA, 2011, J HORTIC SCI BIOTECH, V86, P291; Robinson JP, 2001, PLANT SYST EVOL, V226, P35, DOI 10.1007/s006060170072; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saar D, 2011, RED WHITE MULBERRIES; Sanchez MD, 2000, MULBERRY ANIMAL PROD; Sanjappa M, 1989, GEOGRAPHICAL DISTRIB, P4; Sargent CS, 1917, PLANTAE WILSONIANAE, P293; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sharma A, 2000, THEOR APPL GENET, V101, P1049, DOI 10.1007/s001220051579; Simon UK, 2008, MOL BIOL EVOL, V25, P2251, DOI 10.1093/molbev/msn188; SUH YB, 1992, NUCLEIC ACIDS RES, V20, P6101, DOI 10.1093/nar/20.22.6101; Sukrong S, 2007, BIOL PHARM BULL, V30, P1284, DOI 10.1248/bpb.30.1284; Sulochana Priya, 2012, Journal of Pharmacy Research, V5, P3588; Sun W, 2012, SCI CHINA LIFE SCI, V55, P483, DOI 10.1007/s11427-012-4334-7; TOJYO I, 1985, JARQ-JPN AGR RES Q, V18, P222; Tutin GT, 1996, FLORA EUROPA; VAKHITOV V A, 1989, Molekulyarnaya Biologiya (Moscow), V23, P431; Vijayan K, 2004, GENOME, V47, P439, DOI 10.1139/G03-147; Vijayan K, 2011, SCI HORTIC-AMSTERDAM, V128, P371, DOI 10.1016/j.scienta.2010.11.012; Vollmer SV, 2004, MOL ECOL, V13, P2763, DOI 10.1111/j.1365-294X.2004.02265.x; West C, 2014, SYST BIOL, V63, P543, DOI 10.1093/sysbio/syu019; Wikipedia, 2015, MOR PLANT; Yang ZY, 2007, PHYTOMEDICINE, V14, P416, DOI 10.1016/j.phymed.2007.04.009; Zerega NJC, 2005, MOL PHYLOGENET EVOL, V37, P402, DOI 10.1016/j.ympev.2005.07.004; Zhang SD, 2011, MOL PHYLOGENET EVOL, V60, P21, DOI [10.1016/j.ympev.2011.04.008, 10.1016/j.ympev.2011.09.018]; Zhao WG, 2007, BIODIVERS CONSERV, V16, P275, DOI 10.1007/s10531-005-6973-5; Zhao WG, 2006, CAN J PLANT SCI, V86, P251, DOI 10.4141/P04-110; Zhao WG, 2009, AFR J BIOTECHNOL, V8, P2604; Zhao WG, 2005, AFR J BIOTECHNOL, V4, P563; Zhao WG, 2005, PLANT SCI, V168, P519, DOI 10.1016/j.plantsci.2004.09.020; Zhou Z., 2003, FLORA CHINA, P22	59	21	26	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135411	10.1371/journal.pone.0135411	http://dx.doi.org/10.1371/journal.pone.0135411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266951	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300112
J	Kloss-Brandstatter, A; Weissensteiner, H; Erhart, G; Schafer, G; Forer, L; Schonherr, S; Pacher, D; Seifarth, C; Stockl, A; Fendt, L; Sottsas, I; Klocker, H; Huck, CW; Rasse, M; Kronenberg, F; Kloss, FR				Kloss-Brandstaetter, Anita; Weissensteiner, Hansi; Erhart, Gertraud; Schaefer, Georg; Forer, Lukas; Schoenherr, Sebastian; Pacher, Dominic; Seifarth, Christof; Stoeckl, Andrea; Fendt, Liane; Sottsas, Irma; Klocker, Helmut; Huck, Christian W.; Rasse, Michael; Kronenberg, Florian; Kloss, Frank R.			Validation of Next-Generation Sequencing of Entire Mitochondrial Genomes and the Diversity of Mitochondrial DNA Mutations in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; NON-SYNONYMOUS VARIANTS; POLYMERASE-GAMMA; MTDNA HETEROPLASMY; SOMATIC MUTATIONS; NECK-CANCER; DISEASE; HEAD; CANCERIZATION; ALIGNMENT	Background Oral squamous cell carcinoma (OSCC) is mainly caused by smoking and alcohol abuse and shows a five-year survival rate of similar to 50%. We aimed to explore the variation of somatic mitochondrial DNA (mtDNA) mutations in primary oral tumors, recurrences and metastases. Methods We performed an in-depth validation of mtDNA next-generation sequencing (NGS) on an Illumina HiSeq 2500 platform for its application to cancer tissues, with the goal to detect low-level heteroplasmies and to avoid artifacts. Therefore we genotyped the mitochondrial genome (16.6 kb) from 85 tissue samples (tumors, recurrences, resection edges, metastases and blood) collected from 28 prospectively recruited OSCC patients applying both Sanger sequencing and high-coverage NGS (similar to 35,000 reads per base). Results We observed a strong correlation between Sanger sequencing and NGS in estimating the mixture ratio of heteroplasmies (r = 0.99; p<0.001). Non-synonymous heteroplasmic variants were enriched among cancerous tissues. The proportions of somatic and inherited variants in a given gene region were strongly correlated (r = 0.85; p<0.001). Half of the patients shared mutations between benign and cancerous tissue samples. Low level heteroplasmies (<10%) were more frequent in benign samples compared to tumor samples, where heteroplasmies >10% were predominant. Four out of six patients who developed a local tumor recurrence showed mutations in the recurrence that had also been observed in the primary tumor. Three out of five patients, who had tumor metastases in the lymph nodes of their necks, shared mtDNA mutations between primary tumors and lymph node metastases. The percentage of mutation heteroplasmy increased from the primary tumor to lymph node metastases. Conclusions We conclude that Sanger sequencing is valid for heteroplasmy quantification for heteroplasmies >= 10% and that NGS is capable of reliably detecting and quantifying heteroplasmies down to the 1%-level. The finding of shared mutations between primary tumors, recurrences and metastasis indicates a clonal origin of malignant cells in oral cancer.	[Kloss-Brandstaetter, Anita; Weissensteiner, Hansi; Erhart, Gertraud; Forer, Lukas; Schoenherr, Sebastian; Pacher, Dominic; Stoeckl, Andrea; Fendt, Liane; Kronenberg, Florian] Med Univ Innsbruck, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Weissensteiner, Hansi; Forer, Lukas; Schoenherr, Sebastian; Pacher, Dominic] Leopold Franzens Univ Innsbruck, Dept Database & Informat Syst, Inst Comp Sci, Innsbruck, Austria; [Schaefer, Georg; Seifarth, Christof; Sottsas, Irma; Klocker, Helmut] Med Univ Innsbruck, Dept Urol, A-6020 Innsbruck, Austria; [Huck, Christian W.] Leopold Franzens Univ Innsbruck, Inst Analyt Chem & Radiochem, Innsbruck, Austria; [Rasse, Michael; Kloss, Frank R.] Med Univ Innsbruck, Dept Craniomaxillofacial & Oral Surg, A-6020 Innsbruck, Austria	Medical University of Innsbruck; University of Innsbruck; Medical University of Innsbruck; University of Innsbruck; Medical University of Innsbruck	Kloss-Brandstatter, A (corresponding author), Med Univ Innsbruck, Div Genet Epidemiol, A-6020 Innsbruck, Austria.	anita.kloss@i-med.ac.at	Weissensteiner, Hansi/AAT-1789-2021; Forer, Lukas/ABE-6007-2020; Forer, Lukas/AAX-9577-2021; Kronenberg, Florian/B-1736-2008; Schoenherr, Sebastian/ABB-3366-2020; Klocker, Helmut/AAI-7130-2020; Schoenherr, Sebastian/W-8761-2019	Weissensteiner, Hansi/0000-0002-2871-8669; Forer, Lukas/0000-0003-2139-7329; Kronenberg, Florian/0000-0003-2229-1120; Schoenherr, Sebastian/0000-0001-5909-9226; Kloss-Brandstatter, Anita/0000-0002-0873-6704; Huck, Christian/0000-0002-6272-3242	Austrian Cancer Society/Tirol; Tiroler Wissenschaftsfond; Tiroler Standortagentur	Austrian Cancer Society/Tirol; Tiroler Wissenschaftsfond; Tiroler Standortagentur	The project was supported by grants of the Austrian Cancer Society/Tirol and the Tiroler Wissenschaftsfond, and Tiroler Standortagentur, which were awarded to A. Kloss-Brandstatter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Avital G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/hmg/dds245; Aydin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106301; Bailey CM, 2010, BBA-PROTEINS PROTEOM, V1804, P1213, DOI 10.1016/j.bbapap.2010.01.007; Bedi GC, 1996, CANCER RES, V56, P2484; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801; Brandstatter A, 2005, ELECTROPHORESIS, V26, P3414, DOI 10.1002/elps.200500307; Carr IM, 2009, BIOINFORMATICS, V25, P3244, DOI 10.1093/bioinformatics/btp583; Castellana S, 2015, HUM MUTAT, V36, pE2413, DOI 10.1002/humu.22720; Challen C, 2011, BRIT J CANCER, V104, P1319, DOI 10.1038/bjc.2011.96; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Croghan CW, 2003, METHODS OF DEALING W; Fan L, 2011, MITOCHONDRION, V11, P351, DOI 10.1016/j.mito.2010.09.013; Fendt L, 2011, BREAST CANCER RES TR, V128, P327, DOI 10.1007/s10549-010-1092-8; Foschini MP, 2011, HISTOPATHOLOGY, V58, P361, DOI 10.1111/j.1365-2559.2011.03754.x; Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427; Gardner K, 2015, EUR J HUM GENET, V23, P413, DOI 10.1038/ejhg.2014.96; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Heck JE, 2010, INT J EPIDEMIOL, V39, P166, DOI 10.1093/ije/dyp350; Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233; Irwin JA, 2009, J MOL EVOL, V68, P516, DOI 10.1007/s00239-009-9227-4; Izumchenko E, 2015, CANCER PREV RES, V8, P277, DOI 10.1158/1940-6207.CAPR-14-0257; Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kloss-Brandstatter A, 2010, AM J HUM GENET, V87, P802, DOI 10.1016/j.ajhg.2010.11.001; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Krjutskov K, 2014, CURR GENET, V60, P11, DOI 10.1007/s00294-013-0398-6; KUNKEL TA, 1988, J BIOL CHEM, V263, P4450; Lai CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065578; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112; Li MK, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks499; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Lopes MC, 2012, HUM HERED, V73, P47, DOI 10.1159/000334984; McMahon S, 2014, CARCINOGENESIS, V35, P1046, DOI 10.1093/carcin/bgu012; Miller CS, 2003, ORAL SURG ORAL MED O, V95, P570, DOI 10.1067/moe.2003.108; Mondal R, 2013, MITOCHONDR DNA, V24, P432, DOI 10.3109/19401736.2012.760551; Mondal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057771; Montebugnoli L, 2014, HEAD NECK-J SCI SPEC, V36, P94, DOI 10.1002/hed.23259; Naue J, 2015, MITOCHONDRION, V20, P82, DOI 10.1016/j.mito.2014.12.002; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Perez-Sayans M, 2009, ONCOL REP, V22, P1277, DOI 10.3892/or_00000565; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ramos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074636; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Rock AW, 2013, FORENSIC SCI INT-GEN, V7, P601, DOI 10.1016/j.fsigen.2013.07.005; Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929; Santos C, 2008, CURR TOP MED CHEM, V8, P1351, DOI 10.2174/156802608786141151; Schonberg A, 2011, EUR J HUM GENET, V19, P988, DOI 10.1038/ejhg.2011.62; Schonherr S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-200; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Shutt TE, 2010, ENVIRON MOL MUTAGEN, V51, P360, DOI 10.1002/em.20571; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307; van Oven M, 2010, P NATL ACAD SCI USA, V107, pE38, DOI 10.1073/pnas.0915120107; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Weissensteiner H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-122; Wolff D, 2004, J CRANIO MAXILL SURG, V32, P318, DOI 10.1016/j.jcms.2004.05.005; Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438; Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012	69	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135643	10.1371/journal.pone.0135643	http://dx.doi.org/10.1371/journal.pone.0135643			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262956	gold, Green Submitted, Green Published			2022-12-27	WOS:000359353300098
J	Yu, P; Zhang, J; Yu, SC; Luo, ZZ; Hua, FZ; Yuan, LH; Zhou, ZD; Liu, Q; Du, XH; Chen, SS; Zhang, LL; Xu, GH				Yu, Peng; Zhang, Jing; Yu, Shuchun; Luo, Zhenzhong; Hua, Fuzhou; Yuan, Linhui; Zhou, Zhidong; Liu, Qin; Du, Xiaohong; Chen, Sisi; Zhang, Lieliang; Xu, Guohai			Protective Effect of Sevoflurane Postconditioning against Cardiac Ischemia/Reperfusion Injury via Ameliorating Mitochondrial Impairment, Oxidative Stress and Rescuing Autophagic Clearance	PLOS ONE			English	Article							MYOCARDIAL REPERFUSION INJURY; CARDIOMYOCYTE DEATH; UP-REGULATION; CELL-DEATH; RAT HEARTS; IN-VIVO; ISCHEMIA; ATP; ACTIVATION; EXPRESSION	Background and Purpose Myocardial infarction leads to heart failure. Autophagy is excessively activated in myocardial ischemia/reperfusion (I/R) in rats. The aim of this study is to investigate whether the protection of sevoflurane postconditioning (SPC) in myocardial I/R is through restored impaired autophagic flux. Methods Except for the sham control (SHAM) group, each rat underwent 30 min occlusion of the left anterior descending coronary (LAD) followed by 2 h reperfusion. Cardiac infarction was determined by 2,3,5-triphenyltetrazolium chloride triazole (TTC) staining. Cardiac function was examined by hemodynamics and echocardiography. The activation of autophagy was evaluated by autophagosome accumulation, LC3 conversion and p62 degradation. Potential molecular mechanisms were investigated by immunoblotting, real-time PCR and immunofluorescence staining. Results SPC improved the hemodynamic parameters, cardiac dysfunction, histopathological and ultrastructural damages, and decreased myocardial infarction size after myocardial I/R injury (P < 0.05 vs. I/R group). Compared with the cases in I/R group, myocardial ATP and NAD(+) content, mitochondrial function related genes and proteins, and the expressions of SOD2 and HO-1 were increased, while the expressions of ROS and Vimentin were decreased in the SPC group (P < 0.05 vs. I/R group). SPC significantly activated Akt/mTOR signaling, and inhibited the formation of Vps34/Beclin1 complex via increasing expression of Bcl2 protein (P < 0.05 vs. I/R group). SPC suppressed elevated expressions of LC3 II/I ratio, Beclin1, Atg5 and Atg7 in I/R rat, which indicated that SPC inhibited over-activation of autophagy, and promoted autophagosome clearance. Meanwhile, SPC significantly suppressed the decline of Opa1 and increases of Drp1 and Parkin induced by I/R injury (P < 0.05 vs. I/R group). Moreover, SPC maintained the contents of ATP by reducing impaired mitochondria. Conclusion SPC protects rat hearts against I/R injury via ameliorating mitochondrial impairment, oxidative stress and rescuing autophagic clearance.	[Zhang, Jing; Yu, Shuchun; Luo, Zhenzhong; Hua, Fuzhou; Yuan, Linhui; Zhou, Zhidong; Liu, Qin; Du, Xiaohong; Zhang, Lieliang; Xu, Guohai] Nanchang Univ, Dept Anesthesiol, Affiliated Hosp 2, Nanchang 330000, Peoples R China; [Yu, Peng; Chen, Sisi] Nanchang Univ, Dept Cardiol, Affiliated Hosp 2, Nanchang 330000, Peoples R China	Nanchang University; Nanchang University	Xu, GH (corresponding author), Nanchang Univ, Dept Anesthesiol, Affiliated Hosp 2, Nanchang 330000, Peoples R China.	xuguohai@sina.com	Hua, Fuzhou/ABB-5380-2021	peng, yu/0000-0002-9405-7686	Chinese National Natural Science Foundation [81360285]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research was supported by the Chinese National Natural Science Foundation Grant (Grant No. 81360285). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; BROWN GC, 1992, BIOCHEM J, V284, P1; Carreira RS, 2011, CURR PHARM DESIGN, V17, P2017; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cheng BC, 2013, INT J CARDIOL, V168, P2064, DOI 10.1016/j.ijcard.2013.01.162; Cuadrado I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.113; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Ha TZ, 2006, AM J PHYSIOL-HEART C, V290, pH985, DOI 10.1152/ajpheart.00720.2005; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Han Y, 2013, CIRC J, V77, P1807, DOI 10.1253/circj.CJ-12-1211; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Joubert PE, 2012, AUTOPHAGY, V8, P1261, DOI 10.4161/auto.20751; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003722; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kofidis T, 2005, CIRCULATION, V111, P2486, DOI 10.1161/01.CIR.0000165063.09283.A8; Kordas KS, 2004, PANCREAS, V29, P53, DOI 10.1097/00006676-200407000-00056; Li C, J MOL CELL CARDIOL, V997, P2571; Li H, 2008, CLIN EXP PHARMACOL P, V35, P1043, DOI 10.1111/j.1440-1681.2008.04952.x; Li JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070331; Li J, 2011, J CLIN INVEST, V121, P3689, DOI 10.1172/JCI45709; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Luedde M, 2014, CARDIOVASC RES, V103, P206, DOI 10.1093/cvr/cvu146; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Melo LG, 2002, CIRCULATION, V105, P602, DOI 10.1161/hc0502.103363; Mital R, 2011, AM J PHYSIOL-HEART C, V300, pH1960, DOI 10.1152/ajpheart.01285.2010; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Neubauer S, 1997, CIRCULATION, V96, P2190; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Obal D, 2005, ANESTH ANALG, V101, P1252, DOI 10.1213/01.ANE.0000181336.96511.32; PAGEL PS, 1995, ANESTHESIOLOGY, V83, P1021, DOI 10.1097/00000542-199511000-00016; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Qiao SG, 2013, J ANESTH, V27, P251, DOI 10.1007/s00540-012-1494-3; Ruiz-Meana M, 2007, BASIC RES CARDIOL, V102, P542, DOI 10.1007/s00395-007-0675-y; Sadagurski M, 2011, J CLIN INVEST, V121, P4070, DOI 10.1172/JCI46305; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; SCHELLENS JPM, 1991, HISTOCHEM J, V23, P460, DOI 10.1007/BF01041376; Shiomi M, 2014, EUR J PHARMACOL, V724, P58, DOI 10.1016/j.ejphar.2013.12.027; Soltysinska E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103402; Steinberg SF, 2013, CIRC RES, V112, P393, DOI 10.1161/CIRCRESAHA.111.300496; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Pham T, 2014, AM J PHYSIOL-CELL PH, V307, pC499, DOI 10.1152/ajpcell.00006.2014; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; WALLIN RF, 1975, ANESTH ANALG, V54, P758; Wang C, 2006, ANESTH ANALG, V103, P281, DOI 10.1213/01.ane.0000226094.94877.98; Xu J, 2015, BBA-MOL BASIS DIS, V1852, P262, DOI 10.1016/j.bbadis.2014.05.012; Yao YT, 2010, MOL BIOL REP, V37, P2439, DOI 10.1007/s11033-009-9755-4; Yao YT, 2009, BIOL PHARM BULL, V32, P1854, DOI 10.1248/bpb.32.1854; Ye Z, 2012, BRAIN RES, V1463, P63, DOI 10.1016/j.brainres.2012.04.050; Yu LN, 2010, J ZHEJIANG UNIV-SC B, V11, P661, DOI 10.1631/jzus.B1000155; Zhang YM, 2014, CIRCULATION, V129, P1088, DOI 10.1161/CIRCULATIONAHA.113.008115; Zheng JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094732; Zheng ZP, 2011, J SURG RES, V170, pE3, DOI 10.1016/j.jss.2011.04.035	55	75	94	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134666	10.1371/journal.pone.0134666	http://dx.doi.org/10.1371/journal.pone.0134666			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263161	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300035
J	Molenaar, FM; La Rocca, SA; Khatri, M; Lopez, J; Steinbach, F; Dastjerdi, A				Molenaar, Fieke M.; La Rocca, S. Anna; Khatri, Meenakshi; Lopez, Javier; Steinbach, Falko; Dastjerdi, Akbar			Exposure of Asian Elephants and Other Exotic Ungulates to Schmallenberg Virus	PLOS ONE			English	Article							BITING MIDGES; INFECTION; SEROPREVALENCE; NETHERLANDS; CATTLE; SPP.	Schmallenberg virus (SBV) is an emerging Orthobunyavirus, first described in 2011 in cattle in Germany and subsequently spread throughout Europe, affecting mainly ruminant livestock through the induction of foetal malformations. To gain a better understanding of the spectrum of susceptible species and to assess the value of current SBV serological assays, screening of serum samples from exotic artiodactyls and perissodactyls collected at the Living Collections from the Zoological Society of London (Whipsnade and London Zoos) and Chester Zoo was carried out. There was compelling evidence of SBV infection in both zoological collections. The competitive ELISA has proved to be applicable for the detection of SBV in exotic Bovidae, Cervidae, Suidae, Giraffidae and most notably in endangered Asian elephants (Elephas maximus), but unreliable for the screening of Camelidae, for which the plaque reduction neutralisation test was considered the assay of choice.	[Molenaar, Fieke M.] Zool Soc London, ZSL Whipsnade Zoo, London, Beds, England; [La Rocca, S. Anna; Khatri, Meenakshi; Steinbach, Falko; Dastjerdi, Akbar] Anim & Plant Hlth Agcy APHA Weybridge, Dept Virol, Addlestone, Surrey, England; [Lopez, Javier] Chester Zoo, Upton By Chester, Cheshire, England	Zoological Society of London; Animal & Plant Health Agency UK	Dastjerdi, A (corresponding author), Anim & Plant Hlth Agcy APHA Weybridge, Dept Virol, Woodham Lane, Addlestone, Surrey, England.	akbar.dastjerdi@apha.gsi.gov.uk	Dastjerdi, Akbar/E-1803-2011; la rocca, severina anna/D-8028-2011; Molenaar, Fieke/AGN-3794-2022; Steinbach, Falko/V-1682-2019	Steinbach, Falko/0000-0003-1236-2837; Molenaar, Fieke/0000-0001-9943-7381	Department for Environment, Food and Rural Affairs (DEFRA) [SE0541]; Zoological Society of London (ZSL) Whipsnade zoo	Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Zoological Society of London (ZSL) Whipsnade zoo	This work was funded by Department for Environment, Food and Rural Affairs (DEFRA) project SE0541, www.defra.gov.uk, and Zoological Society of London (ZSL) Whipsnade zoo, www.zsl.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso A, 2014, PREVENTIVE VET MED; [Anonymous], 2012, VET REC, V170, P89, DOI 10.1136/vr.e621; Barlow A, 2013, VET REC, V172, P429, DOI 10.1136/vr.f2438; Chiari M, 2014, TRANSBOUND EMERG DIS, V61, P1, DOI 10.1111/tbed.12158; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; DEFRA, 2013, SCHMALL VIR; Elbers ARW, 2015, TRANSBOUND EMERG DIS, V62, P339, DOI 10.1111/tbed.12128; Elbers ARW, 2013, EMERG INFECT DIS, V19, P106, DOI 10.3201/eid1901.121054; European Food Safety Authority (EFSA), SCHMALL VIR AN EP DA; Glover M, 2013, VET REC, V173, DOI 10.1136/vr.f5810; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; IUCN, 2015, IUCN RED LIST; Jack Corin, 2012, Vet Rec, V170, P603, DOI 10.1136/vr.e3939; Laloy E, 2014, EMERG INFECT DIS, V20, P131, DOI 10.3201/eid2001.130411; Larska M, 2013, TRANSBOUND EMERG DIS, V60, P97, DOI 10.1111/tbed.12057; Larska M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0307-3; Larska M, 2013, VET J, V198, P279, DOI 10.1016/j.tvjl.2013.08.013; Linden A, 2012, EMERG INFECT DIS, V18, P2006, DOI 10.3201/eid1812.121067; Mansfield KL, 2013, J VIROL METHODS, V188, P139, DOI 10.1016/j.jviromet.2012.11.031; Meroc E, 2015, TRANSBOUND EMERG DIS, V62, pE80, DOI 10.1111/tbed.12202; Meroc E, 2013, TRANSBOUND EMERG DIS, V60, P4, DOI 10.1111/tbed.12042; Middlemiss C, 2012, UPDATE 11 SCHMALLENB; Muskens J, 2012, TIJDSCHR DIERGENEESK, V137, P112; Pioz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043360; Rasmussen LD, 2012, EMERG INFECT DIS, V18, P1204, DOI 10.3201/eid1807.120385; Simmons Alick, 2012, Vet Rec, V171, P651, DOI 10.1136/vr.e8629; van den Brom R, 2012, TIJDSCHR DIERGENEESK, V137, P106; Veronesi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057747	28	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135532	10.1371/journal.pone.0135532	http://dx.doi.org/10.1371/journal.pone.0135532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274399	Green Submitted, gold, Green Published			2022-12-27	WOS:000359493600074
J	Ngamwong, Y; Tangamornsuksan, W; Lohitnavy, O; Chaiyakunapruk, N; Scholfield, CN; Reisfeld, B; Lohitnavy, M				Ngamwong, Yuwadee; Tangamornsuksan, Wimonchat; Lohitnavy, Ornrat; Chaiyakunapruk, Nathorn; Scholfield, C. Norman; Reisfeld, Brad; Lohitnavy, Manupat			Additive Synergism between Asbestos and Smoking in Lung Cancer Risk: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CASE-REFERENT; OCCUPATIONAL EXPOSURES; PLEURAL MESOTHELIOMA; CHRYSOTILE ASBESTOS; CIGARETTE-SMOKING; DUST EXPOSURE; MORTALITY; EPIDEMIOLOGY; TOBACCO; INFLAMMATION	Smoking and asbestos exposure are important risks for lung cancer. Several epidemiological studies have linked asbestos exposure and smoking to lung cancer. To reconcile and unify these results, we conducted a systematic review and meta-analysis to provide a quantitative estimate of the increased risk of lung cancer associated with asbestos exposure and cigarette smoking and to classify their interaction. Five electronic databases were searched from inception to May, 2015 for observational studies on lung cancer. All case-control (N = 10) and cohort (N = 7) studies were included in the analysis. We calculated pooled odds ratios (ORs), relative risks (RRs) and 95% confidence intervals (CIs) using a random-effects model for the association of asbestos exposure and smoking with lung cancer. Lung cancer patients who were not exposed to asbestos and non-smoking (A-S-) were compared with; (i) asbestos-exposed and non-smoking (A+S-), (ii) non-exposure to asbestos and smoking (A-S+), and (iii) asbestos-exposed and smoking (A+S+). Our meta-analysis showed a significant difference in risk of developing lung cancer among asbestos exposed and/or smoking workers compared to controls (A-S-), odds ratios for the disease (95% CI) were (i) 1.70 (A+S-, 1.31-2.21), (ii) 5.65; (A-S+, 3.38-9.42), (iii) 8.70 (A+S+, 5.8-13.10). The additive interaction index of synergy was 1.44 (95% CI = 1.26-1.77) and the multiplicative index = 0.91 (95% CI = 0.63-1.30). Corresponding values for cohort studies were 1.11 (95% CI = 1.00-1.28) and 0.51 (95% CI = 0.31-0.85). Our results point to an additive synergism for lung cancer with co-exposure of asbestos and cigarette smoking. Assessments of industrial health risks should take smoking and other airborne health risks when setting occupational asbestos exposure limits.	[Ngamwong, Yuwadee; Tangamornsuksan, Wimonchat; Lohitnavy, Ornrat; Chaiyakunapruk, Nathorn; Scholfield, C. Norman; Reisfeld, Brad; Lohitnavy, Manupat] Naresuan Univ, Fac Pharmaceut Sci, Ctr Excellence Environm Hlth & Toxicol, Phitsanulok, Thailand; [Ngamwong, Yuwadee; Tangamornsuksan, Wimonchat; Lohitnavy, Ornrat; Lohitnavy, Manupat] Naresuan Univ, Fac Pharmaceut Sci, Pharmacokinet Res Unit, Phitsanulok, Thailand; [Lohitnavy, Ornrat; Chaiyakunapruk, Nathorn; Scholfield, C. Norman; Lohitnavy, Manupat] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Phitsanulok, Thailand; [Chaiyakunapruk, Nathorn] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Ctr Pharmaceut Outcomes Res, Phitsanulok, Thailand; [Chaiyakunapruk, Nathorn] Monash Univ Malaysia, Sch Pharm, Selangor, Malaysia; [Chaiyakunapruk, Nathorn] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Chaiyakunapruk, Nathorn] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Reisfeld, Brad] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA	Naresuan University; Naresuan University; Naresuan University; Naresuan University; Monash University; Monash University Sunway; University of Wisconsin System; University of Wisconsin Madison; University of Queensland; Colorado State University	Lohitnavy, M (corresponding author), Naresuan Univ, Fac Pharmaceut Sci, Ctr Excellence Environm Hlth & Toxicol, Phitsanulok, Thailand.	manupatl@gmail.com	Tangamornsuksan, Wimonchat Tae/X-4150-2018; Tangamornsuksan, Wimonchat/N-8467-2019; Lohitnavy, Manupat/A-6621-2008; Reisfeld, Brad/A-1319-2016	Tangamornsuksan, Wimonchat Tae/0000-0003-3473-6000; Tangamornsuksan, Wimonchat/0000-0003-3473-6000; Lohitnavy, Manupat/0000-0002-4439-0560; Scholfield, Charles Norman/0000-0001-7288-590X; Reisfeld, Brad/0000-0003-1310-1495	Opa Tangpitukkul's scholarship; Center of Excellence for Innovation in Chemistry (PERCH-CIC)	Opa Tangpitukkul's scholarship; Center of Excellence for Innovation in Chemistry (PERCH-CIC)	Yuwadee Ngamwong was financially supported by the Opa Tangpitukkul's scholarship and Center of Excellence for Innovation in Chemistry (PERCH-CIC).	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; BEGG CB, 1989, J NATL CANCER I, V81, P107, DOI 10.1093/jnci/81.2.107; Bernstein D, 2013, CRIT REV TOXICOL, V43, P154, DOI 10.3109/10408444.2012.756454; BERRY G, 1972, LANCET, V2, P476; BERRY G, 1985, BRIT J IND MED, V42, P12; BLOT WJ, 1980, J NATL CANCER I, V65, P571; BLOT WJ, 1982, CANCER-AM CANCER SOC, V50, P364, DOI 10.1002/1097-0142(19820715)50:2<364::AID-CNCR2820500234>3.0.CO;2-Q; BLOT WJ, 1978, NEW ENGL J MED, V299, P620, DOI 10.1056/NEJM197809212991202; Bovenzi M, 1992, Med Lav, V83, P338; BOVENZI M, 1993, INT ARCH OCC ENV HEA, V65, P35, DOI 10.1007/BF00586056; DAVE SK, 1988, BRIT J IND MED, V45, P790; DEKLERK NH, 1991, BRIT J IND MED, V48, P412; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Donaldson K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-5; EASTMAN A, 1983, CANCER RES, V43, P1251; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Elsa Nielsen, 2008, TOXICOLOGICAL RISK A; Erren TC, 1999, EPIDEMIOLOGY, V10, P405, DOI 10.1097/00001648-199907000-00011; FERGUSON DA, 1987, MED J AUSTRALIA, V147, P166, DOI 10.5694/j.1326-5377.1987.tb133348.x; Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ijc.23033; Gustavsson P, 2002, AM J EPIDEMIOL, V155, P1016, DOI 10.1093/aje/155.11.1016; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashim D, 2014, ANN GLOB HEALTH, V80, P393, DOI 10.1016/j.aogh.2014.10.002; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HILT B, 1986, SCAND J WORK ENV HEA, V12, P561, DOI 10.5271/sjweh.2106; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Hubaux R, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-89; IARC, 1977, ASBESTOS, V14, P1; International Agency for Research on Cancer, 1986, IARC SCI PUBL, V38, P1; International Agency for Research on Cancer, 2004, IARC MONOGR EVAL CAR, V83, P1; International Agency for Research on Cancer (IARC), 2012, IARC MONOGRAPHS EVAL, p100C; Jung M, 2000, FREE RADICAL BIO MED, V28, P1295, DOI 10.1016/S0891-5849(00)00211-2; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; KJUUS H, 1986, SCAND J WORK ENV HEA, V12, P193, DOI 10.5271/sjweh.2158; KJUUS H, 1986, SCAND J WORK ENV HEA, V12, P210, DOI 10.5271/sjweh.2156; KJUUS H, 1986, SCAND J WORK ENV HEA, V12, P203, DOI 10.5271/sjweh.2157; LAW MR, 1983, THORAX, V38, P744, DOI 10.1136/thx.38.10.744; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lee PN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-385; Lee PN, 2001, OCCUP ENVIRON MED, V58, P145, DOI 10.1136/oem.58.3.145; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liddell F D, 1984, Ann Acad Med Singap, V13, P340; Liddell FDK, 1998, ANN OCCUP HYG, V42, P7, DOI 10.1016/S0003-4878(97)00053-7; Liu G, 2013, ANNU REV PATHOL-MECH, V8, P161, DOI 10.1146/annurev-pathol-020712-163942; Luce D, 2000, AM J EPIDEMIOL, V151, P259, DOI 10.1093/oxfordjournals.aje.a010201; Markowitz SB, 2013, AM J RESP CRIT CARE, V188, P90, DOI 10.1164/rccm.201302-0257OC; MARTISCHNIG KM, 1977, BRIT MED J, V1, P746, DOI 10.1136/bmj.1.6063.746; Matsuzaki H, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/492608; MCDONALD JC, 1980, BRIT J IND MED, V37, P11; MORABIA A, 1992, BRIT J IND MED, V49, P721; MUSCAT JE, 1991, CANCER RES, V51, P2263; Nelson HH, 2002, ONCOGENE, V21, P7284, DOI 10.1038/sj.onc.1205804; Neumann V, 2013, DTSCH ARZTEBL INT, V110, P319, DOI 10.3238/arztebl.2013.0319; Niklinski J, 2004, LUNG CANCER, V45, pS7, DOI 10.1016/j.lungcan.2004.04.008; Nishimura Y, 2013, ENVIRON HEALTH PREV, V18, P198, DOI 10.1007/s12199-013-0333-y; Olsen NJ, 2011, MED J AUSTRALIA, V195, P271, DOI 10.5694/mja11.10125; PASTORINO U, 1984, INT J CANCER, V33, P231, DOI 10.1002/ijc.2910330211; Rake C, 2009, BRIT J CANCER, V100, P1175, DOI 10.1038/sj.bjc.6604879; Reid A, 2006, OCCUP ENVIRON MED, V63, P509, DOI 10.1136/oem.2005.025379; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; RUBINO GF, 1979, BRIT J IND MED, V36, P187; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Sekhon H, 1995, INT J EXP PATHOL, V76, P411; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; (US) Office on Smoking and Health, 2006, THE HEALTH CONSEQUEN; VAINIO H, 1994, SCAND J WORK ENV HEA, V20, P235, DOI 10.5271/sjweh.1402; Valavanidis A, 2013, INT J ENV RES PUB HE, V10, P3886, DOI 10.3390/ijerph10093886; Villeneuve PJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-595; Wang XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071899; Wells G., 2013, OTTAWA HOSP RES I; Wong O, 1996, OCCUP ENVIRON MED, V53, P793, DOI 10.1136/oem.53.12.793; Yang M, 2011, J ENVIRON SCI HEAL C, V29, P223, DOI 10.1080/10590501.2011.601848; Yano E, 2010, OCCUP ENVIRON MED, V67, P867, DOI 10.1136/oem.2009.051615	76	42	49	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135798	10.1371/journal.pone.0135798	http://dx.doi.org/10.1371/journal.pone.0135798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274395	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600114
J	Aberle, D; Oetter, KM; Meyers, G				Aberle, Daniel; Oetter, Kay-Marcus; Meyers, Gregor			Lipid Binding of the Amphipathic Helix Serving as Membrane Anchor of Pestivirus Glycoprotein E-rns	PLOS ONE			English	Article							SWINE-FEVER VIRUS; HEPATITIS-C VIRUS; INTERFERON REGULATORY FACTOR-3; N-PRO PRODUCT; RNASE E-RNS; PROTEIN; ASSOCIATION; IDENTIFICATION; EXPRESSION; INHIBITION	Pestiviruses express a peculiar protein named Erns representing envelope glycoprotein and RNase, which is important for control of the innate immune response and persistent infection. The latter functions are connected with secretion of a certain amount of Erns from the infected cell. Retention/secretion of Erns is most likely controlled by its unusual membrane anchor, a long amphipathic helix attached in plane to the membrane. Here we present results of experiments conducted with a lipid vesicle sedimentation assay able to separate lipid-bound from unbound protein dissolved in the water phase. Using this technique we show that a protein composed of tag sequences and the carboxyterminal 65 residues of Erns binds specifically to membrane vesicles with a clear preference for compositions containing negatively charged lipids. Mutations disturbing the helical folding and/or amphipathic character of the anchor as well as diverse truncations and exchange of amino acids important for intracellular retention of Erns had no or only small effects on the proteins membrane binding. This result contrasts the dramatically increased secretion rates observed for Erns proteins with equivalent mutations within cells. Accordingly, the ratio of secreted versus cell retained Erns is not determined by the lipid affinity of the membrane anchor.	[Aberle, Daniel; Oetter, Kay-Marcus; Meyers, Gregor] Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany	Friedrich Loeffler Institute	Meyers, G (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany.	gregor.meyers@fli.bund.de			Deutsche Forschungsgemeinschaft [DFG-ME1367/4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (grant number DFG-ME1367/4), www.dfg.de/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003973; Arnold RS, 1997, BIOCHEMISTRY-US, V36, P6149, DOI 10.1021/bi970023z; Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; Bogomolovas J, 2009, PROTEIN EXPRES PURIF, V64, P16, DOI 10.1016/j.pep.2008.10.003; Brass V, 2007, J VIROL, V81, P2745, DOI 10.1128/JVI.01279-06; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Burrack S, 2012, FASEB J, V26, P3292, DOI 10.1096/fj.12-207191; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Deshpande RA, 2002, CRIT REV MICROBIOL, V28, P79, DOI 10.1080/1040-840291046704; Doceul V, 2008, J GEN VIROL, V89, P1881, DOI 10.1099/vir.0.83643-0; Dubuisson J, 2002, TRENDS CELL BIOL, V12, P517, DOI 10.1016/S0962-8924(02)02383-8; Einav S, 2004, J VIROL, V78, P11288, DOI 10.1128/JVI.78.20.11288-11295.2004; Fetzer C, 2005, J VIROL, V79, P11901, DOI 10.1128/JVI.79.18.11901-11913.2005; Gil LHVG, 2006, J VIROL, V80, P900, DOI 10.1128/JVI.80.2.900-911.2006; Gouttenoire Jerome, 2006, Hepatology, V44, P1690, DOI 10.1002/hep.21449; Gouttenoire J, 2010, J VIROL, V84, P12529, DOI 10.1128/JVI.01798-10; Gouttenoire J, 2010, REV MED VIROL, V20, P117, DOI 10.1002/rmv.640; Gouttenoire J, 2009, J VIROL, V83, P11378, DOI 10.1128/JVI.01122-09; Gouttenoire J, 2009, J VIROL, V83, P6257, DOI 10.1128/JVI.02663-08; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Hulst MM, 1997, J GEN VIROL, V78, P2779, DOI 10.1099/0022-1317-78-11-2779; HULST MM, 1994, VIROLOGY, V200, P558, DOI 10.1006/viro.1994.1218; Hulst MM, 1998, J VIROL, V72, P151, DOI 10.1128/JVI.72.1.151-157.1998; Hulst MM, 2001, METHOD ENZYMOL, V342, P431, DOI 10.1016/S0076-6879(01)42564-X; Huth JR, 1997, PROTEIN SCI, V6, P2359; Iqbal M, 2004, J VIROL, V78, P136, DOI 10.1128/JVI.78.1.136-145.2004; Irie M, 2001, METHOD ENZYMOL, V341, P42, DOI 10.1016/S0076-6879(01)41144-X; Krey T, 2012, STRUCTURE, V20, P862, DOI 10.1016/j.str.2012.03.018; La Rocca SA, 2005, J VIROL, V79, P7239, DOI 10.1128/JVI.79.11.7239-7247.2005; Lampio A, 2000, J BIOL CHEM, V275, P37853, DOI 10.1074/jbc.M004865200; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Liu L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000351; Magkouras I, 2008, J GEN VIROL, V89, P2501, DOI 10.1099/vir.0.2008/003749-0; Matzener P, 2009, VIRUS RES, V140, P15, DOI 10.1016/j.virusres.2008.10.015; Meyer C, 2002, J VIROL, V76, P8494, DOI 10.1128/JVI.76.16.8494-8503.2002; Meyers G, 1999, J VIROL, V73, P10224, DOI 10.1128/JVI.73.12.10224-10235.1999; Meyers G, 2007, JVIROL; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Moradpour Darius, 2005, Hepatology, V42, P732, DOI 10.1002/hep.20851; Morissey JH., MORRISSEY LAB PROTOC; Mouritsen OG, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004622; PELHAM HRB, 1993, CELL, V75, P603, DOI 10.1016/0092-8674(93)90479-A; Python S, 2013, PLOS PATHOG, V9, DOI [10.1371/journal.ppat.1003412, 10.1371/annotation/4290dfee-64fd-4157-89e3-8edbba912420]; Ruggli N, 2005, VIROLOGY, V340, P265, DOI 10.1016/j.virol.2005.06.033; Ruggli N, 2003, J VIROL, V77, P7645, DOI 10.1128/JVI.77.13.7645-7654.2003; Ruggli N, 2009, J VIROL, V83, P817, DOI 10.1128/JVI.01509-08; RUMENAPF T, 1993, J VIROL, V67, P3288; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; SCHNEIDER R, 1993, SCIENCE, V261, P1169, DOI 10.1126/science.8356450; Seago J, 2007, J GEN VIROL, V88, P3002, DOI 10.1099/vir.0.82934-0; Simmonds P., 2012, VIRUS TAXONOMY, P1003, DOI [10.1016/B978-0-12-384684-6.00086-0, DOI 10.1016/B978-0-12-384684-6.00086-0]; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Spuul P, 2007, J VIROL, V81, P872, DOI 10.1128/JVI.01785-06; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Tautz N, 1996, J VIROL, V70, P7851, DOI 10.1128/JVI.70.11.7851-7858.1996; Tews BA, 2007, J BIOL CHEM, V282, P32730, DOI 10.1074/jbc.M706803200; Tews BA, 2009, J VIROL, V83, P4823, DOI 10.1128/JVI.01710-08; Thiel H.J., 1996, FIELDS VIROLOGY, V1, P1059; THIEL HJ, 1991, J VIROL, V65, P4705, DOI 10.1128/JVI.65.9.4705-4712.1991; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; WEILAND E, 1992, J VIROL, V66, P3677, DOI 10.1128/JVI.66.6.3677-3682.1992; Windisch JM, 1996, J VIROL, V70, P352, DOI 10.1128/JVI.70.1.352-358.1996; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; Zhou H, 2003, J BACTERIOL, V185, P4326, DOI 10.1128/JB.185.15.4326-4335.2003; Zurcher C, 2014, J VIROL, V88, P7235, DOI 10.1128/JVI.00672-14	68	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135680	10.1371/journal.pone.0135680	http://dx.doi.org/10.1371/journal.pone.0135680			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270479	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800098
J	Gyarmati, P; Kjellander, C; Aust, C; Kalin, M; Ohrmalm, L; Giske, CG				Gyarmati, Peter; Kjellander, Christian; Aust, Carl; Kalin, Mats; Ohrmalm, Lars; Giske, Christian G.			Bacterial Landscape of Bloodstream Infections in Neutropenic Patients via High Throughput Sequencing	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; SHEWANELLA-ALGAE; NUCLEOTIDE-SEQUENCES; FEBRILE NEUTROPENIA; SKIN MICROBIOTA; ORAL MICROBIOME; BACTEREMIA; COMMUNITY; GUT; PSEUDOMONAS	Background Bloodstream infection (BSI) is a common and potentially life-threatening complication in patients with hematological malignancies and therapy-induced neutropenia. Administration of broad spectrum antibiotics has substantially decreased the mortality rate in febrile neutropenia, but bacterial infection is documented in only one-third or fewer of the cases. BSI is typically diagnosed by blood culture; however, this method can detect only culturable pathogens. Methods In the present study, a total of 130 blood samples from hematological patients receiving dose-intensive antitumoural treatment were subjected to 16S rRNA PCR and 62 of them were cultured. PCR positive samples were processed to high throughput sequencing by amplifying the V1-V3 regions of the 16S rRNA gene to obtain a full spectrum of bacteria present in BSI. Results Five phyla and 30 genera were identified with sequencing compared to 2 phyla and 4 genera with culture. The largest proportion of bacteria detected by sequencing belonged to Proteobacteria (55.2%), Firmicutes (33.4%) and Actinobacteria (8.6%), while Fusobacteria (0.4%) and Bacteroidetes (0.1%) were also detected. Ninety-eight percent of the bacteria identified by sequencing were opportunistic human pathogens and 65% belonged to the normal human microbiota. Conclusions The present study indicates that BSIs in neutropenic hosts contain a much broader diversity of bacteria, likely with host origin, than previously realized. The elevated ratio of Proteobacteria in BSI corroborates the results found in other systemic inflammatory diseases, such as inflammatory bowel disease or mucosal infections. This knowledge may become of value for tailoring antimicrobial drug administration.	[Gyarmati, Peter; Giske, Christian G.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Gyarmati, Peter; Giske, Christian G.] Karolinska Univ Hosp, Dept Clin Microbiol L2 02, Stockholm, Sweden; [Kjellander, Christian] Karolinska Inst, Dept Med, Div Hematol, Stockholm, Sweden; [Aust, Carl; Ohrmalm, Lars] Karolinska Inst, Dept Med, Solna, Sweden; [Aust, Carl; Ohrmalm, Lars] Karolinska Univ Hosp, Infect Dis Unit, Ctr Mol Med, Stockholm, Sweden; [Kalin, Mats] Karolinska Inst, Dept Infect Dis, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Gyarmati, P (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Nobels Vag 16, Stockholm, Sweden.	peter.gyarmati@ki.se	Gyarmati, Peter/F-4887-2013	Gyarmati, Peter/0000-0001-7362-316X	Swedish Research Council (vr.se Vetenskapsradet) [2012-3291]; Swedish Society of Medicine [sls. se SLS-408571]; Cathrine Everts Research Foundation; Blodcancerfonden	Swedish Research Council (vr.se Vetenskapsradet); Swedish Society of Medicine; Cathrine Everts Research Foundation; Blodcancerfonden	This work was supported by the Swedish Research Council (vr.se Vetenskapsradet, 2012-3291) to PG, The Swedish Society of Medicine (sls. se SLS-408571) to LO, Cathrine Everts Research Foundation (http://cathrinesstiftelse.se/), Blodcancerfonden (www.blodcancerforbundet.se) to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amir A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1070; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Beck JM, 2012, TRANSL RES, V160, P258, DOI 10.1016/j.trsl.2012.02.005; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; de Naurois J, 2010, ANN ONCOL, V21, pv252, DOI 10.1093/annonc/mdq196; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dominguez H, 1996, CLIN INFECT DIS, V22, P1036, DOI 10.1093/clinids/22.6.1036; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gomila M, 2007, INT J SYST EVOL MICR, V57, P2629, DOI 10.1099/ijs.0.65149-0; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Holt HM, 2005, CLIN MICROBIOL INFEC, V11, P347, DOI 10.1111/j.1469-0691.2005.01108.x; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Jacob-Kokura S, 2014, ANN PHARMACOTHER, V48, P128, DOI 10.1177/1060028013517630; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; Kjellander C, 2012, EUR J HAEMATOL, V88, P422, DOI 10.1111/j.1600-0609.2012.01768.x; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kommedal O, 2014, J CLIN MICROBIOL, V52, P1990, DOI 10.1128/JCM.00346-14; Kuderer NM, 2006, CANCER-AM CANCER SOC, V106, P2258, DOI 10.1002/cncr.21847; Lecuit M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00025; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Molloy MJ, 2013, CELL HOST MICROBE, V14, P318, DOI 10.1016/j.chom.2013.08.003; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Murillo N, 2013, FUTURE MICROBIOL, V8, P209, DOI [10.2217/FMB.12.141, 10.2217/fmb.12.141]; Myung DS, 2009, J KOREAN MED SCI, V24, P1192, DOI 10.3346/jkms.2009.24.6.1192; Ni JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01968; Ortega M, 2014, EPIDEMIOL INFECT, V30, P1; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sartor RB, 2012, AM J GASTROENTEROL S, V1, P15, DOI DOI 10.1038/AJGSUP.2012.4; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sze MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111228; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wunderink RG, 2014, AM J RESP CRIT CARE, V190, P25, DOI 10.1164/rccm.201403-0577UP; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385	55	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135756	10.1371/journal.pone.0135756	http://dx.doi.org/10.1371/journal.pone.0135756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270467	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800107
J	Iredahl, F; Lofberg, A; Sjoberg, F; Farnebo, S; Tesselaar, E				Iredahl, Fredrik; Lofberg, Andreas; Sjoberg, Folke; Farnebo, Simon; Tesselaar, Erik			Non-Invasive Measurement of Skin Microvascular Response during Pharmacological and Physiological Provocations	PLOS ONE			English	Article							POLARIZED-LIGHT SPECTROSCOPY; LASER-DOPPLER FLOWMETRY; REACTIVE HYPEREMIA; NITRIC-OXIDE; BLOOD-FLOW; SODIUM-NITROPRUSSIDE; ENDOTHELIAL FUNCTION; IN-VIVO; VASOCONSTRICTION; HUMANS	Introduction Microvascular changes in the skin due to pharmacological and physiological provocations can be used as a marker for vascular function. While laser Doppler flowmetry (LDF) has been used extensively for measurement of skin microvascular responses, Laser Speckle Contrast Imaging (LSCI) and Tissue Viability Imaging (TiVi) are novel imaging techniques. TiVi measures red blood cell concentration, while LDF and LSCI measure perfusion. Therefore, the aim of this study was to compare responses to provocations in the skin using these different techniques. Method Changes in skin microcirculation were measured in healthy subjects during (1) iontophoresis of sodium nitroprusside (SNP) and noradrenaline (NA), (2) local heating and (3) post-occlusive reactive hyperemia (PORH) using LDF, LSCI and TiVi. Results Iontophoresis of SNP increased perfusion (LSCI: baseline 40.9 +/- 6.2 PU; 10-min 100 +/- 25 PU; p<0.001) and RBC concentration (TiVi: baseline 119 +/- 18; 10-min 150 +/- 41 AU; p = 0.011). No change in perfusion (LSCI) was observed after iontophoresis of NA (baseline 38.0 +/- 4.4 PU; 10-min 38.9 +/- 5.0 PU; p = 0.64), while RBC concentration decreased (TiVi: baseline 59.6 +/- 11.8 AU; 10-min 54.4 +/- 13.3 AU; p = 0.021). Local heating increased perfusion (LDF: baseline 8.8 +/- 3.6 PU; max 112 +/- 55 PU; p<0.001, LSCI: baseline 50.8 +/- 8.0 PU; max 151 +/- 22 PU; p<0.001) and RBC concentration (TiVi: baseline 49.2 +/- 32.9 AU; max 99.3 +/- 28.3 AU; p<0.001). After 5 minutes of forearm occlusion with prior exsanguination, a decrease was seen in perfusion (LDF: p = 0.027; LSCI: p<0.001) and in RBC concentration (p = 0.045). Only LSCI showed a significant decrease in perfusion after 5 minutes of occlusion without prior exsanguination (p<0.001). Coefficients of variation were lower for LSCI and TiVi compared to LDF for most responses. Conclusion LSCI is more sensitive than TiVi for measuring microvascular changes during SNP-induced vasodilatation and forearm occlusion. TiVi is more sensitive to noradrenaline-induced vasoconstriction. LSCI and TiVi show lower inter-subject variability than LDF. These findings are important to consider when choosing measurement techniques for studying skin microvascular responses.	[Iredahl, Fredrik; Lofberg, Andreas; Sjoberg, Folke; Farnebo, Simon; Tesselaar, Erik] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Sjoberg, Folke; Farnebo, Simon] Linkoping Univ, Dept Plast Surg Hand Surg & Burns, Linkoping, Sweden; [Tesselaar, Erik] Linkoping Univ, Dept Radiat Phys, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Iredahl, F (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	fredrik.iredahl@liu.se	Iredahl, Fredrik/AAT-7968-2021					Angus JA, 2000, J PHARMACOL TOX MET, V44, P395, DOI 10.1016/S1056-8719(00)00121-0; Briers D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.066018; Brown H, 2003, BRIT J ANAESTH, V90, P446, DOI 10.1093/bja/aeg099; Cordovil I, 2012, MICROVASC RES, V83, P376, DOI 10.1016/j.mvr.2012.01.004; Cracowski JL, 2010, MICROCIRCULATION, V17, P79, DOI 10.1111/j.1549-8719.2009.00018.x; de Jongh RT, 2008, MICROVASC RES, V75, P256, DOI 10.1016/j.mvr.2007.08.001; Droog EJ, 2004, MICROVASC RES, V67, P197, DOI 10.1016/j.mvr.2003.12.003; Drummond PD, 2002, BRIT J CLIN PHARMACO, V54, P45, DOI 10.1046/j.1365-2125.2002.01597.x; EKENVALL L, 1988, AM J PHYSIOL, V255, pH1000, DOI 10.1152/ajpheart.1988.255.5.H1000; Farnebo S, 2011, MICROCIRCULATION, V18, P198, DOI 10.1111/j.1549-8719.2010.00077.x; Farnebo S, 2010, MICROVASC RES, V80, P412, DOI 10.1016/j.mvr.2010.07.008; Fredriksson I, 2009, MICROVASC RES, V78, P4, DOI 10.1016/j.mvr.2009.02.008; Henricson J, 2007, MICROVASC RES, V73, P143, DOI 10.1016/j.mvr.2006.10.004; Henricson J, 2011, MICROCIRCULATION, V18, P214, DOI 10.1111/j.1549-8719.2010.00079.x; Hodges GJ, 2008, J APPL PHYSIOL, V105, P233, DOI 10.1152/japplphysiol.90412.2008; Holowatz LA, 2008, J APPL PHYSIOL, V105, P370, DOI 10.1152/japplphysiol.00858.2007; IJzerman RG, 2003, EUR J CLIN INVEST, V33, P536, DOI 10.1046/j.1365-2362.2003.01179.x; Iredahl F, 2013, MICROCIRCULATION, V20, P717, DOI 10.1111/micc.12071; Kellogg DL, 2008, AM J PHYSIOL-HEART C, V295, pH123, DOI 10.1152/ajpheart.00082.2008; Kellogg DL, 2006, J APPL PHYSIOL, V100, P1709, DOI 10.1152/japplphysiol.01071.2005; Khan F, 2000, DIABETES CARE, V23, P215, DOI 10.2337/diacare.23.2.215; Khan F, 2008, CLIN SCI, V115, P295, DOI 10.1042/CS20070431; Kvandal P, 2006, MICROVASC RES, V72, P120, DOI 10.1016/j.mvr.2006.05.006; Lipnicki DM, 2001, CLIN AUTON RES, V11, P93, DOI 10.1007/BF02322052; Lorenzo S, 2007, J PHYSIOL-LONDON, V585, P295, DOI 10.1113/jphysiol.2007.143867; Mahe G, 2012, CIRC-CARDIOVASC IMAG, V5, P155, DOI 10.1161/CIRCIMAGING.111.970418; Minson CT, 2001, J APPL PHYSIOL, V91, P1619, DOI 10.1152/jappl.2001.91.4.1619; Newton DJ, 2001, CLIN SCI, V101, P567, DOI 10.1042/CS20010128; O'Doherty J, 2007, SKIN RES TECHNOL, V13, P472, DOI 10.1111/j.1600-0846.2007.00253.x; O'Doherty J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149863; Petersen LJ, 2010, MICROVASC RES, V80, P499, DOI 10.1016/j.mvr.2010.07.011; Puissant C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061320; Rossi M, 2005, MICROVASC RES, V70, P17, DOI 10.1016/j.mvr.2005.05.001; Rousseau A, 2010, J VASC RES, V47, P441, DOI 10.1159/000282667; Roustit M, 2010, MICROVASC RES, V80, P505, DOI 10.1016/j.mvr.2010.05.012; Roustit M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040792; Roustit M, 2012, MICROCIRCULATION, V19, P47, DOI 10.1111/j.1549-8719.2011.00129.x; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Tee Get Bee Yvonne, 2004, Journal of Pharmacological and Toxicological Methods, V50, P73, DOI 10.1016/j.vascn.2004.02.002; TENLAND T, 1983, INT J MICROCIRC, V2, P81; Tesselaar E, 2012, MICROCIRCULATION, V19, P705, DOI 10.1111/j.1549-8719.2012.00203.x; Tesselaar E, 2011, MICROVASC RES, V81, P88, DOI 10.1016/j.mvr.2010.11.002; Toth A, 2007, AM J PHYSIOL-HEART C, V292, pH2643, DOI 10.1152/ajpheart.00207.2006; Vuilleumier P, 2002, J HYPERTENS, V20, P1753, DOI 10.1097/00004872-200209000-00018	44	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0133760	10.1371/journal.pone.0133760	http://dx.doi.org/10.1371/journal.pone.0133760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270037	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800006
J	Tan, S; Xiao, XJ; Ma, HY; Zhang, ZH; Chen, JB; Ding, L; Yu, SP; Xu, RL; Yang, SL; Huang, XY; Hong, H				Tan, Shuai; Xiao, Xiaojuan; Ma, Hanyu; Zhang, Zhaohui; Chen, Jiangbo; Ding, Lei; Yu, Shenping; Xu, Rulin; Yang, Shiliang; Huang, Xinyi; Hong, Hua			Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; CEREBRAL INFARCTION; RECURRENCE; RISK; SURVIVAL	Background and Purpose Antiplatelet therapy is widely used for the primary or secondary prevention of stroke. Drugs like clopidogrel have emerged as alternatives for traditional antiplatelet therapy, and dual therapy with clopidogrel and aspirin is of particular interest. We conducted this meta-analysis to systematically review studies about dual therapy comparing monotherapy with aspirin alone. Methods Randomized controlled trials were searched in PubMed (1966-May, 2015), EMBASE (1947-May, 2015), the Cochrane Central Register of Controlled Trials (CENTRAL) (1948-May, 2015), WHO International Clinical Trial (ICTRP) (2004-May, 2015), China Biology Medicine disc (CBM disc) (1978-May, 2015) and were included into the final analysis according to the definite inclusion criteria mentioned in the study selection section. Risk ratio (RR) was pooled with 95% confidence interval (CI) for dichotomous data. The heterogeneity was considered significant if the chi(2) test was significant (P value < 0.10) or the I-2 > 50.00%. Subgroup analyses were carried out on the long and short time periods, the race and region. Results We included 5 studies involving 24,084 patients. A pooled analysis showed that dual therapy with clopidogrel and aspirin had a lower stroke incidence than monotherapy in both the short term and long term (RR = 0.69, 95% CI: 0.59-0.82, P <0.05; RR = 0.84, 95% CI: 0.72-0.98, P = 0.03, respectively). With regard to safety, dual therapy had a higher risk of bleeding than monotherapy for both periods (RR = 1.51, 95% CI: 1.03-2.23, P = 0.04; RR = 1.54, 95% CI: 1.32-1.79, P<0.05, respectively). Conclusions Dual therapy with clopidogrel and aspirin could be a preferable choice to prevent stroke in patients who have had a previous stroke or transient ischemic attack, as well as those who are at high risk for stroke. And the effect of dual therapy seems to be more obvious for short-term. However, it is associated with a higher risk of bleeding.	[Tan, Shuai; Yang, Shiliang; Huang, Xinyi; Hong, Hua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China; [Xiao, Xiaojuan; Yu, Shenping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510080, Guangdong, Peoples R China; [Ma, Hanyu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Zhaohui] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pancreatobiliary Surg, Guangzhou 510080, Guangdong, Peoples R China; [Chen, Jiangbo] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Radiol, Guangzhou 510080, Guangdong, Peoples R China; [Ding, Lei] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou 510080, Guangdong, Peoples R China; [Xu, Rulin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Hong, H (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China.	hhsums@126.com	zhang, zh/GWV-4677-2022		Natural Science Foundation of Guangdong Province, China [S2012010008539]	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the Natural Science Foundation of Guangdong Province, China; S2012010008539.	BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Epstein FH, 1955, J GERONTOL, V10, P331, DOI 10.1093/geronj/10.3.331; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Hachinski V, 2008, STROKE, V39, P2407, DOI 10.1161/STROKEAHA.108.531681; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Lee M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006672; Petty GW, 1998, NEUROLOGY, V50, P208, DOI 10.1212/WNL.50.1.208; Rother J, 2008, CEREBROVASC DIS, V25, P366, DOI 10.1159/000120687; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626; SACCO RL, 1982, STROKE, V13, P290, DOI 10.1161/01.STR.13.3.290; Schunemann HJ, 2011, COCHRANE HDB SYSTEMA; Uyttenboogaart M, 2005, STROKE, V36, P1984, DOI 10.1161/01.STR.0000177872.87960.61; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Yang Wanyong, 2008, CHINESE J NERVOUS ME, V11, P658	22	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135372	10.1371/journal.pone.0135372	http://dx.doi.org/10.1371/journal.pone.0135372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270530	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800063
J	Ai, SM; Gao, JJ; Liu, SQ; Fu, YX				Ai, Shi-Meng; Gao, Jian-Jun; Liu, Shu-Qun; Fu, Yun-Xin			Efficient Estimation of Mutation Rates during Individual Development by Minimization of Chi-Square	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; GERMLINE MUTATION; MOUSE	Mutation primarily occurs when cells divide and it is highly desirable to have knowledge of the rate of mutations for each of the cell divisions during individual development. Recently, recessive lethal or nearly lethal mutations which were observed in a large mutation accumulation experiment using Drosophila melanogaster suggested that mutation rates vary significantly during the germline development of male Drosophila melanogaster. The analysis of the data was based on a combination of the maximum likelihood framework with numerical assistance from a newly developed coalescent algorithm. Although powerful, the likelihood based framework is computationally highly demanding which limited the scope of the inference. This paper presents a new estimation approach by minimizing chi-square statistics which is asymptotically consistent with the maximum likelihood method. When only at most one mutation in a family is considered the minimization of chi-square is simplified to a constrained weighted minimum least square method which can be solved easily by optimization theory. The new methods effectively eliminates the computational bottleneck of the likelihood. Reanalysis of the published Drosophila melanogaster mutation data results in similar estimates of mutation rates. The new method is also expected to be applicable to the analysis of mutation data generated by next-generation sequencing technology.	[Ai, Shi-Meng; Gao, Jian-Jun; Liu, Shu-Qun; Fu, Yun-Xin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China; [Ai, Shi-Meng] Yunnan Agr Univ, Dept Appl Math, Kunming 650201, Peoples R China; [Fu, Yun-Xin] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Fu, Yun-Xin] Univ Texas Hlth Sci Ctr Houston, Div Biostat, Sch Publ Hlth, Houston, TX 77030 USA	Yunnan University; Yunnan Agricultural University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Fu, YX (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China.	yunxin.fu@uth.tmc.edu			Chinese National Science Foundation (CNSF) [91231120]; University of Texas Health Science Center at Houston; program for Excellent Young Talents of Yunnan University	Chinese National Science Foundation (CNSF)(National Natural Science Foundation of China (NSFC)); University of Texas Health Science Center at Houston; program for Excellent Young Talents of Yunnan University	This work was supported by a grant (91231120 YF) from the Chinese National Science Foundation (CNSF). An endowment (YF) from University of Texas Health Science Center at Houston and an award (SQL) from program for Excellent Young Talents of Yunnan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKSON J, 1980, ANN STAT, V8, P457, DOI 10.1214/aos/1176345003; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P1040, DOI 10.1137/S1052623494240456; Cottle R. W., 1992, COMPUTER SCI SCI COM; Drost JB, 1998, GENETICA, V102-3, P421, DOI 10.1023/A:1017002221520; DROST JB, 1995, ENVIRON MOL MUTAGEN, V25, P48, DOI 10.1002/em.2850250609; Fletcher R., 1987, PRACTICAL METHODS OP; Fu YX, 2013, GENETICS, V194, P927, DOI 10.1534/genetics.113.151571; Gao JJ, 2014, G3-GENES GENOM GENET, V4, P1503, DOI 10.1534/g3.114.011056; Gao JJ, 2011, P NATL ACAD SCI USA, V108, P15914, DOI 10.1073/pnas.1100233108; Gilbert S.F., 2003, DEV BIOL, V7th Edn; Hudson RR, 1991, OXF SURV EVOL BIOL, V7, P1; Karush W, 1939, THESIS U CHICAGO; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kuhn H. W., 1951, P 2 BERK S MATH STAT, P481, DOI DOI 10.1007/BF01582292; LEMKE CE, 1965, MANAGE SCI, V11, P681, DOI 10.1287/mnsc.11.7.681; Muller HJ, 1928, GENETICS, V13, P279; Muller HJ, 1928, METHODOLOGY BASIC GE, P249; Murty KG., 1988, LINEAR COMPLEMENTARI, V1, P62; WATERMAN MS, 1974, TECHNOMETRICS, V16, P135, DOI 10.2307/1267503; Woodruff RC, 1996, GENETICA, V98, P149, DOI 10.1007/BF00121363; YE YY, 1989, MATH PROGRAM, V44, P157, DOI 10.1007/BF01587086	21	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135398	10.1371/journal.pone.0135398	http://dx.doi.org/10.1371/journal.pone.0135398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266814	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300111
J	Albert, AYK; Chaban, B; Wagner, EC; Schellenberg, JJ; Links, MG; van Schalkwyk, J; Reid, G; Hemmingsen, SM; Hill, JE; Money, D				Albert, Arianne Y. K.; Chaban, Bonnie; Wagner, Emily C.; Schellenberg, John J.; Links, Matthew G.; van Schalkwyk, Julie; Reid, Gregor; Hemmingsen, Sean M.; Hill, Janet E.; Money, Deborah		VOGUE Res Grp	A Study of the Vaginal Microbiome in Healthy Canadian Women Utilizing cpn60-Based Molecular Profiling Reveals Distinct Gardnerella Subgroup Community State Types	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; UREAPLASMA-UREALYTICUM; HYDROGEN-PEROXIDE; IDENTIFICATION; ASSOCIATION; VALIDATION; MICROFLORA; QUANTIFICATION; REPRESENTATION; LACTOBACILLI	The vaginal microbiota is important in women's reproductive and overall health. However, the relationships between the structure, function and dynamics of this complex microbial community and health outcomes remain elusive. The objective of this study was to determine the phylogenetic range and abundance of prokaryotes in the vaginal microbiota of healthy, non-pregnant, ethnically diverse, reproductive-aged Canadian women. Sociodemographic, behavioural and clinical data were collected and vaginal swabs were analyzed from 310 women. Detailed profiles of their vaginal microbiomes were generated by pyrosequencing of the chaperonin-60 universal target. Six community state types (CST) were delineated by hierarchical clustering, including three Lactobacillus-dominated CST (L. crispatus, L. iners, L. jensenii), two Gardnerella-dominated (subgroups A and C) and an "intermediate" CST which included a small number of women with microbiomes dominated by seven other species or with no dominant species but minority populations of Streptococcus, Staphylococcus, Peptoniphilus, E. coli and various Proteobacteria in co-dominant communities. The striking correspondence between Nugent score and deep sequencing CST continues to reinforce the basic premise provided by the simpler Gram stain method, while additional analyses reveal detailed cpn60-based phylogeny and estimated abundance in microbial communities from vaginal samples. Ethnicity was the only demographic or clinical characteristic predicting CST, with differences in Asian and White women p = 0.05). In conclusion, this study confirms previous work describing four cpn60-based subgroups of Gardnerella, revealing previously undescribed CST. The data describe the range of bacterial communities seen in Canadian women presenting with no specific vaginal health concerns, and provides an important baseline for future investigations of clinically important cohorts.	[Albert, Arianne Y. K.; Wagner, Emily C.; van Schalkwyk, Julie; Money, Deborah] Womens Hlth Res Inst, Vancouver, BC, Canada; [Chaban, Bonnie; Schellenberg, John J.; Links, Matthew G.] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Links, Matthew G.] Agr & AgriFood Canada, Saskatoon, SK, Canada; [van Schalkwyk, Julie; Money, Deborah] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Reid, Gregor] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Reid, Gregor] Lawson Hlth Res Inst, London, ON, Canada; [Hemmingsen, Sean M.] Natl Res Council Canada, Saskatoon, SK, Canada; [Hemmingsen, Sean M.] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada; [Chaban, Bonnie] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Fac Nat Sci, London, England	University of Saskatchewan; Agriculture & Agri Food Canada; University of British Columbia; Western University (University of Western Ontario); Western University (University of Western Ontario); National Research Council Canada; University of Saskatchewan; Imperial College London	Money, D (corresponding author), Womens Hlth Res Inst, Vancouver, BC, Canada.	dmoney@cw.bc.ca	Hill, Janet E./B-5001-2011; Reid, Gregor/ABE-8327-2020; Albert, Arianne/AAG-7518-2019; Links, Matthew G./P-4949-2019	Hill, Janet E./0000-0002-2187-6277; Reid, Gregor/0000-0001-9658-5696; Albert, Arianne/0000-0002-3050-0888; Links, Matthew G./0000-0003-1917-6789; Quigley, Bonnie/0000-0003-3787-0993; Schellenberg, John/0000-0003-3970-1608; Tang, Patrick/0000-0003-1583-5484	Canadian Institutes of Health Research (CIHR) Emerging Team Grant; Genome British Columbia (GBC) grant [108030]	Canadian Institutes of Health Research (CIHR) Emerging Team Grant(Canadian Institutes of Health Research (CIHR)); Genome British Columbia (GBC) grant	Financial support for this study was provided by a joint Canadian Institutes of Health Research (CIHR) Emerging Team Grant and a Genome British Columbia (GBC) grant awarded to DM, SMH, GR and JEH (grant reference #108030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; Balashov SV, 2014, J MED MICROBIOL, V63, P162, DOI 10.1099/jmm.0.066407-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradshaw CS, 2014, J INFECT DIS, V209, P1562, DOI 10.1093/infdis/jit664; Bradshaw CS, 2013, CLIN INFECT DIS, V56, P777, DOI 10.1093/cid/cis1030; Brousseau R, 2001, APPL ENVIRON MICROB, V67, P4828, DOI 10.1128/AEM.67.10.4828-4833.2001; Cadieux PA, 2009, J PHYSIOL PHARMACOL, V60, P13; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaban B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-23; Chaban B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069559; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Drell T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054379; Dunn J.C., 1974, J CYBERNETICS, V4, P95, DOI 10.1080/01969727408546059; Endres DM, 2003, IEEE T INFORM THEORY, V49, P1858, DOI 10.1109/TIT.2003.813506; Eschenbach DA, 2000, CLIN INFECT DIS, V30, P901, DOI 10.1086/313818; Fashemi Bisiayo, 2013, Microb Ecol Health Dis, V24, DOI 10.3402/mehd.v24i0.19703; Fernandes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067019; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Hennig C., FPC FLEXIBLE PROCEDU; Hickey RJ, 2013, BJOG-INT J OBSTET GY, V120, P695, DOI 10.1111/1471-0528.12151; Hickey RJ, 2012, TRANSL RES, V160, P267, DOI 10.1016/j.trsl.2012.02.008; Hill JE, 2010, APPL ENVIRON MICROB, V76, P4550, DOI 10.1128/AEM.01510-09; Hill JE, 2006, J MED MICROBIOL, V55, P393, DOI 10.1099/jmm.0.46282-0; Hill JE, 2006, ENVIRON MICROBIOL, V8, P741, DOI 10.1111/j.1462-2920.2005.00944.x; Hill JE, 2005, AM J OBSTET GYNECOL, V193, P682, DOI 10.1016/j.ajog.2005.02.094; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; HILLIER SL, 1992, OBSTET GYNECOL, V79, P369, DOI 10.1097/00006250-199203000-00008; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Jayaprakash TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043009; Johnson Lisa A, 2015, BMC Res Notes, V8, P253, DOI 10.1186/s13104-015-1170-4; Keane FEA, 1997, INT J STD AIDS, V8, P489, DOI 10.1258/0956462971920631; Links MG, 2014, NEW PHYTOL, V202, P542, DOI 10.1111/nph.12693; Links MG, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-23; Links MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049755; Lopes dos Santos Santiago G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028180; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Macklaim JM, 2012, REPROD SCI, V19, P1154, DOI 10.1177/1933719112446075; Matu MN, 2010, ANAEROBE, V16, P210, DOI 10.1016/j.anaerobe.2009.11.002; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Patel Meghan Arvind, 2010, Curr Infect Dis Rep, V12, P417, DOI 10.1007/s11908-010-0136-x; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reid G, 1996, FEMS IMMUNOL MED MIC, V15, P23, DOI 10.1111/j.1574-695X.1996.tb00354.x; Riggs M, 2007, SEX TRANSM DIS, V34, P954, DOI 10.1097/OLQ.0b013e31811ed0e4; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schellenberg J, 2008, J MICROBIOL METH, V73, P216, DOI 10.1016/j.mimet.2008.03.004; Schellenberg J, 2011, METHODS MOL BIOL, V733, P143, DOI 10.1007/978-1-61779-089-8_10; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Schwebke JR, 1999, J INFECT DIS, V180, P1632, DOI 10.1086/315065; Sobel, 1999, Curr Infect Dis Rep, V1, P379, DOI 10.1007/s11908-999-0045-z; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Statistics Canada, 2006, PROF ETHN OR VIS MIN; Strus M, 2006, FEMS IMMUNOL MED MIC, V48, P56, DOI 10.1111/j.1574-695X.2006.00120.x; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TENG LJ, 1995, J FORMOS MED ASSOC, V94, P396; TENG LJ, 1994, J CLIN MICROBIOL, V32, P1464, DOI 10.1128/JCM.32.6.1464-1469.1994; VANKUPPEVELD FJM, 1993, APPL ENVIRON MICROB, V59, P655, DOI 10.1128/AEM.59.2.655-.1993; Velraeds MMC, 1996, COLLOID SURFACE B, V8, P51, DOI 10.1016/S0927-7765(96)01297-0; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Vermette CJ, 2010, MICROB ECOL, V59, P14, DOI 10.1007/s00248-009-9601-1; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Yamamoto T, 2009, J PEDIATR ADOL GYNEC, V22, P11, DOI 10.1016/j.jpag.2008.01.073; Yoshida T, 2002, J CLIN MICROBIOL, V40, P105, DOI 10.1128/JCM.40.1.105-110.2002; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12; Zhou X, 2010, FEMS IMMUNOL MED MIC, V58, P169, DOI 10.1111/j.1574-695X.2009.00618.x	77	65	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135620	10.1371/journal.pone.0135620	http://dx.doi.org/10.1371/journal.pone.0135620			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266808	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300144
J	Panozzo, S; Colauzzi, M; Scarabel, L; Collavo, A; Rosan, V; Sattin, M				Panozzo, Silvia; Colauzzi, Michele; Scarabel, Laura; Collavo, Alberto; Rosan, Valentina; Sattin, Maurizio			iMAR: An Interactive Web-Based Application for Mapping Herbicide Resistant Weeds	PLOS ONE			English	Article							ALS-INHIBITORS; GLYPHOSATE; MANAGEMENT; FUTURE; ACCASE; CROPS; L.	Herbicides are the major weed control tool in most cropping systems worldwide. However, the high reliance on herbicides has led to environmental issues as well as to the evolution of herbicide-resistant biotypes. Resistance is a major concern in modern agriculture and early detection of resistant biotypes is therefore crucial for its management and prevention. In this context, a timely update of resistance biotypes distribution is fundamental to devise and implement efficient resistance management strategies. Here we present an innovative web-based application called iMAR (interactive MApping of Resistance) for the mapping of herbicide resistant biotypes. It is based on open source software tools and translates into maps the data reported in the GIRE (Italian herbicide resistance working group) database of herbicide resistance at national level. iMAR allows an automatic, easy and cost-effective updating of the maps a nd provides two different systems, "static" and "dynamic". In the first one, the user choices are guided by a hierarchical tree menu, whereas the latter is more flexible and includes a multiple choice criteria (type of resistance, weed species, region, cropping systems) that permits customized maps to be created. The generated information can be useful to various stakeholders who are involved in weed resistance management: farmers, advisors, national and local decision makers as well as the agrochemical industry. iMAR is freely available, and the system has the potential to handle large datasets and to be used for other purposes with geographical implications, such as the mapping of invasive plants or pests.	[Panozzo, Silvia; Scarabel, Laura; Collavo, Alberto; Rosan, Valentina; Sattin, Maurizio] Natl Res Council CNR, Inst Agroenvironm & Forest Biol IBAF, Legnaro, PD, Italy; [Colauzzi, Michele] Free Iance Webmaster, Padua, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Agroambientale e Forestale (IBAF-CNR)	Sattin, M (corresponding author), Natl Res Council CNR, Inst Agroenvironm & Forest Biol IBAF, Legnaro, PD, Italy.	maurizio.sattin@ibaf.cnr.it	Panozzo, Silvia/ABC-3350-2020; Scarabel, Laura/AAO-4970-2021; Sattin, Maurizio/I-9783-2014	Scarabel, Laura/0000-0002-2584-3069; Sattin, Maurizio/0000-0001-9144-3816	Italian herbicide resistance working group (GIRE); National Research Council of Italy (CNR)	Italian herbicide resistance working group (GIRE); National Research Council of Italy (CNR)(Consiglio Nazionale delle Ricerche (CNR))	This work was jointly supported by the Italian herbicide resistance working group (GIRE) and the National Research Council of Italy (CNR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzman MS, 2014, INTEGRATED PEST MANA, V4, P415; Bukowski R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033047, 10.1371/journal.pone.0047149]; Cantele A, 1985, INFORM AGRARIO, V41, P153; Collavo A, 2014, WEED RES, V54, P325, DOI 10.1111/wre.12082; Collavo A, 2012, WEED RES, V52, P16, DOI 10.1111/j.1365-3180.2011.00883.x; Collavo A, 2013, PEST MANAG SCI, V69, P200, DOI 10.1002/ps.3449; Cook T, 2013, P 17 NSW WEEDS C 9 1, P48; Galassi T., 2014, INTEGRATED PEST MANA, P487; GIRE, 2014, DAT HERB RES IT; Hardy Q., 2012, NY TIMES; HEAP I, 2000, INT SURVEY HERBICIDE; Heap I, 2014, INT SURVEY HERBICIDE; Heap I, 2014, PEST MANAG SCI, V70, P1306, DOI 10.1002/ps.3696; Hess M, 2012, P 25 GERM C WEED BIO, DOI [10.5073/jka.2012.434.019, DOI 10.5073/JKA.2012.434.019]; Hyvonen T, 2011, P 2 WORKSH EWRS WORK; Kremer RJ, 2014, WEED SCI, V62, P415, DOI 10.1614/WS-D-13-00114.1; Lawrence RL, 2006, REMOTE SENS ENVIRON, V100, P356, DOI 10.1016/j.rse.2005.10.014; LUTMAN PJW, 2013, ALOPECURUS MYOSUROID, V53, P299, DOI DOI 10.1111/WRE.12024; Pena JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077151; Massa D, 2013, AGRONOMY-BASEL, V3, P13, DOI 10.3390/agronomy3010013; Melville NP, 2010, MIS QUART, V34, P1; Menchari Y, 2006, NEW PHYTOL, V171, P861, DOI 10.1111/j.1469-8137.2006.01788.x; Neve P, 2014, PEST MANAG SCI, V70, P1385, DOI 10.1002/ps.3757; Neve P, 2009, NEW PHYTOL, V184, P783, DOI 10.1111/j.1469-8137.2009.03034.x; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Panozzo S, 2013, PESTIC BIOCHEM PHYS, V105, P93, DOI 10.1016/j.pestbp.2012.12.003; Panozzo S, 2015, JOVE-J VIS EXP, DOI 10.3791/52923; Porceddu E., 1997, Agricoltura Mediterranea, V127, P97; Powles S.B., 2001, HERBICIDES RESISTANC, P308; Rew LJ, 2001, WEED RES, V41, P1, DOI 10.1046/j.1365-3180.2001.00215.x; Ruiz-Santaella JP, 2011, P 2 WORKSH EWRS WORK, P16; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Sattin M, 2001, BCPC CONFERENCE - WEEDS 2001, VOLS 1 AND 2, P755; Sattin M, 1999, 1999 BRIGHTON CONFERENCE: WEEDS, VOLS 1-3, P783; Sattin M, 2014, DIFESA FITOSANITARIA, P362; Scarabel L, 2007, WEED RES, V47, P527, DOI 10.1111/j.1365-3180.2007.00600.x; Scarabel L, 2004, PLANT SCI, V166, P703, DOI 10.1016/j.plantsci.2003.11.006; Scarabel L, 2012, AGRONOMY-BASEL, V2, P371, DOI 10.3390/agronomy2040371; Scarabel L, 2011, PEST MANAG SCI, V67, P932, DOI 10.1002/ps.2133; Senseman SA, 2014, WEED SCI, V62, P382, DOI 10.1614/WS-D-13-00082.1; Shaner DL, 2014, PEST MANAG SCI, V70, P1329, DOI 10.1002/ps.3706; Steiniger S, 2013, COMPUT ENVIRON URBAN, V39, P136, DOI 10.1016/j.compenvurbsys.2012.10.003; Yu Q, 2014, PEST MANAG SCI, V70, P1340, DOI 10.1002/ps.3710; Zanin G, 1998, WEED RES, V38, P107, DOI 10.1046/j.1365-3180.1998.00074.x; Zijlstra C, 2011, PEST MANAG SCI, V67, P616, DOI 10.1002/ps.2134	45	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135328	10.1371/journal.pone.0135328	http://dx.doi.org/10.1371/journal.pone.0135328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266545	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300099
J	Koo, KA; Kong, WS; Nibbelink, NP; Hopkinson, CS; Lee, JH				Koo, Kyung Ah; Kong, Woo-Seok; Nibbelink, Nathan P.; Hopkinson, Charles S.; Lee, Joon Ho			Potential Effects of Climate Change on the Distribution of Cold-Tolerant Evergreen Broadleaved Woody Plants in the Korean Peninsula	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; VEGETATION CHANGE; RANGE SHIFTS; TEMPERATURE; ALPINE; RESPIRATION; POPULATIONS; ALPS; PHOTOSYNTHESIS; PRECIPITATION	Climate change has caused shifts in species' ranges and extinctions of high-latitude and altitude species. Most cold-tolerant evergreen broadleaved woody plants (shortened to cold-evergreens below) are rare species occurring in a few sites in the alpine and subalpine zones in the Korean Peninsula. The aim of this research is to 1) identify climate factors controlling the range of cold-evergreens in the Korean Peninsula; and 2) predict the climate change effects on the range of cold-evergreens. We used multimodel inference based on combinations of climate variables to develop distribution models of cold-evergreens at a physiognomic-level. Presence/absence data of 12 species at 204 sites and 6 climatic factors, selected from among 23 candidate variables, were used for modeling. Model uncertainty was estimated by mapping a total variance calculated by adding the weighted average of within-model variation to the between-model variation. The range of cold-evergreens and model performance were validated by true skill statistics, the receiver operating characteristic curve and the kappa statistic. Climate change effects on the cold-evergreens were predicted according to the RCP 4.5 and RCP 8.5 scenarios. Multimodel inference approach excellently projected the spatial distribution of cold-evergreens (AUC = 0.95, kappa = 0.62 and TSS = 0.77). Temperature was a dominant factor in model-average estimates, while precipitation was minor. The climatic suitability increased from the southwest, lowland areas, to the northeast, high mountains. The range of cold-evergreens declined under climate change. Mountain-tops in the south and most of the area in the north remained suitable in 2050 and 2070 under the RCP 4.5 projection and 2050 under the RCP 8.5 projection. Only high-elevations in the northeastern Peninsula remained suitable under the RCP 8.5 projection. A northward and upper-elevational range shift indicates change in species composition at the alpine and subalpine ecosystems in the Korean Peninsula.	[Koo, Kyung Ah] Natl Inst Ecol, Seocheon Gun, Chungnam, South Korea; [Kong, Woo-Seok; Lee, Joon Ho] Kyung Hee Univ, Seoul, South Korea; [Nibbelink, Nathan P.; Hopkinson, Charles S.] Univ Georgia, Athens, GA 30602 USA	National Institute of Ecology; Kyung Hee University; University System of Georgia; University of Georgia	Koo, KA (corresponding author), Natl Inst Ecol, Seocheon Gun, Chungnam, South Korea.	kyungah.koo@gmail.com		hopkinson, charles/0000-0002-7331-8322	"Climate Change Response Technology Project" of the Ministry of Environment, Republic of Korea [2014001310009]	"Climate Change Response Technology Project" of the Ministry of Environment, Republic of Korea	This work was supported by "Climate Change Response Technology Project" of the Ministry of Environment, the Republic of Korea (2014001310009).	Diaz-Varela RA, 2010, ECOL MODEL, V221, P621, DOI 10.1016/j.ecolmodel.2009.11.010; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2008, 74 HCTN MET OFF HALD; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Atkin OK, 2006, GLOBAL CHANGE BIOL, V12, P500, DOI 10.1111/j.1365-2486.2006.01114.x; Bauert MR, 1998, MOL ECOL, V7, P1519, DOI 10.1046/j.1365-294x.1998.00470.x; Briggs D., 1997, PLANT VARIATION EVOL; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carlson BZ, 2014, DIVERS DISTRIB, V20, P1379, DOI 10.1111/ddi.12238; Carpenter S. R., 2006, MILLENNIUM ECOSYSTEM; Chung TH., 1965, J SUNGKYUNKWAN U, V10, P329; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Dullinger S, 2012, NAT CLIM CHANGE, V2, P619, DOI 10.1038/NCLIMATE1514; Dumais D, 2007, FOREST CHRON, V83, P378, DOI 10.5558/tfc83378-3; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Ernakovich JG, 2014, GLOBAL CHANGE BIOL, V20, P3256, DOI 10.1111/gcb.12568; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P2636, DOI 10.1111/j.1365-2486.2012.02719.x; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P1335, DOI 10.1111/j.1365-2486.2011.02602.x; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Flagmeier M, 2014, PLANT ECOL DIVERS, V7, P457, DOI 10.1080/17550874.2013.817487; Freeman EA, 2008, J STAT SOFTW, V23, P1; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; Hartley S, 2006, ECOL LETT, V9, P1068, DOI 10.1111/j.1461-0248.2006.00954.x; Heide OM, 2003, TREE PHYSIOL, V23, P931, DOI 10.1093/treephys/23.13.931; Heskel MA, 2014, FUNCT PLANT BIOL, V41, P287, DOI 10.1071/FP13137; Higgins SI, 2003, J ECOL, V91, P341, DOI 10.1046/j.1365-2745.2003.00781.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holden J, 2007, EARTH-SCI REV, V82, P75, DOI 10.1016/j.earscirev.2007.01.003; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jones MM, 2006, J ECOL, V94, P181, DOI 10.1111/j.1365-2745.2005.01071.x; Jung HS, 2002, INT J CLIMATOL, V22, P1327, DOI 10.1002/joc.797; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Kiviniemi K, 1999, OIKOS, V86, P241, DOI 10.2307/3546442; Kong W.-S., 1993, PLANT GEOGRAPHY KORE; Kong Wooseok, 2002, [Journal of the Korean Geographical Society, 대한지리학회지], V37, P357; Koo K., 2001, J KOREAN GEOGR SOC, V36, P247; Koo K, 2000, THESIS KYUNG HEE U S; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LARIGAUDERIE A, 1995, ANN BOT-LONDON, V76, P245, DOI 10.1006/anbo.1995.1093; Lee W, 1978, KOREAN J PLANT TAXON; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238; Martin GM, 2011, GEOSCI MODEL DEV, V4, P723, DOI 10.5194/gmd-4-723-2011; Matteodo M, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024043; Mazerolle M. C., 2013, AICCMODAVG MODEL SEL; Mazerolle MJ, 2014, PACKAGE AICCMODAVG; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; MOONEY HA, 1961, ECOL MONOGR, V31, P1, DOI 10.2307/1950744; MYKING T, 1995, TREE PHYSIOL, V15, P697, DOI 10.1093/treephys/15.11.697; Neuner G, 1999, PLANT CELL ENVIRON, V22, P1539, DOI 10.1046/j.1365-3040.1999.00508.x; Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x; Pachauri R.K., 2007, P 27 SESS INT PAN CL, P12; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pauli H, 2012, SCIENCE, V336, P353, DOI 10.1126/science.1219033; Pearson RG, 2007, SYNTH AM MUS NAT HIS, V50; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Rixen C, 2012, OIKOS, V121, P1532, DOI 10.1111/j.1600-0706.2011.20031.x; Rocchini D, 2012, COMPUT GEOSCI-UK, V39, P145, DOI 10.1016/j.cageo.2011.06.002; Ross LC, 2012, J VEG SCI, V23, P755, DOI 10.1111/j.1654-1103.2012.01390.x; Sevanto S, 2006, TREE PHYSIOL, V26, P749, DOI 10.1093/treephys/26.6.749; Slot M., 2014, OECOLOGIA, P1; Sproull GJ, 2015, J VEG SCI, V26, P552, DOI 10.1111/jvs.12264; Stockli V, 2011, PLANT ECOL DIVERS, V4, P415, DOI 10.1080/17550874.2011.651504; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Theurillat JP, 1998, POLIT SCI ENVIRONM, P225; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Vittoz P, 2008, J VEG SCI, V19, P671, DOI 10.3170/2008-8-18434; Wipf S, 2013, PLANT ECOL DIVERS, V6, P447, DOI 10.1080/17550874.2013.764943	79	22	30	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134043	10.1371/journal.pone.0134043	http://dx.doi.org/10.1371/journal.pone.0134043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262755	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300016
J	Li, YT; Ko, HY; Lee, CCD; Lai, CY; Kao, CL; Yang, C; Wang, WB; King, CC				Li, Yao-Tsun; Ko, Hui-Ying; Lee, Chang-Chun David; Lai, Ching-Yu; Kao, Chuan-Liang; Yang, Chinglai; Wang, Won-Bo; King, Chwan-Chuen			Phenotypic and Genetic Characterization of Avian Influenza H5N2 Viruses with Intra- and Inter-Duck Variations in Taiwan	PLOS ONE			English	Article							14-DAY-OLD EMBRYONATED EGGS; T-CELL RESPONSES; A VIRUSES; RECEPTOR SPECIFICITY; DOMESTIC DUCKS; WET MARKETS; AMINO-ACID; HONG-KONG; NEURAMINIDASE; HEMAGGLUTININ	Background Human infections with avian influenza viruses (AIVs) have frequently raised global concerns of emerging, interspecies-transmissible viruses with pandemic potential. Waterfowl, the predominant reservoir of influenza viruses in nature, harbor precursors of different genetic lineages that have contributed to novel pandemic influenza viruses in the past. Methods Two duck influenza H5N2 viruses, DV518 and DV413, isolated through virological surveillance at a live-poultry market in Taiwan, showed phylogenetic relatedness but exhibited different replication capabilities in mammalian Madin-Darby Canine Kidney (MDCK) cells. This study characterizes the replication properties of the two duck H5N2 viruses and the determinants involved. Results The DV518 virus replicated more efficiently than DV413 in both MDCK and chicken DF1 cells. Interestingly, the infection of MDCK cells by DV518 formed heterogeneous plaques with great differences in size [large (L) and small (S)], and the two viral strains (p518-L and p518-S) obtained from plaque purification exhibited distinguishable replication kinetics in MDCK cells. Nonetheless, both plaque-purified DV518 strains still maintained their growth advantages over the plaque-purified p413 strain. Moreover, three amino acid substitutions in PA (P224S), PB2 (E72D), and M1 (A128T) were identified in intra-duck variations (p518-L vs p518-S), whereas other changes in HA (N170D), NA (I56T), and NP (Y289H) were present in inter-duck variations (DV518 vs DV413). Both p518-L and p518-S strains had the N170D substitution in HA, which might be related to their greater binding to MDCK cells. Additionally, polymerase activity assays on 293T cells demonstrated the role of vRNP in modulating the replication capability of the duck p518-L viruses in mammalian cells. Conclusion These results demonstrate that intra-host phenotypic variation occurs even within an individual duck. In view of recent human infections by low pathogenic AIVs, this study suggests possible determinants involved in the stepwise selection of virus variants from the duck influenza virus population which may facilitate inter-species transmission.	[Li, Yao-Tsun; Ko, Hui-Ying; Lee, Chang-Chun David; Kao, Chuan-Liang; King, Chwan-Chuen] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lai, Ching-Yu; Wang, Won-Bo] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan; [Yang, Chinglai] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	National Taiwan University; National Taiwan University; Emory University	Wang, WB (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan.	wbwang@ntu.edu.tw; chwanchuen@gmail.com		KAO, CHUAN-LIANG/0000-0002-1020-2605	NIH in USA [NIAID contract grants for Center of Excellence for InfluenzaResearch and Surveillance (CEIRS)] [HHSN266200700006C]; NSC in Taiwan [102-2621-M-002-002]	NIH in USA [NIAID contract grants for Center of Excellence for InfluenzaResearch and Surveillance (CEIRS)]; NSC in Taiwan	The funders - both the National Institute of Health (NIH) in the USA and the National Science Council (NSC) in the Republic of China in Taiwan) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study design, decision to publish and preparation of the manuscript were all carried out by the two corresponding authors (Dr. CC King and Dr. WB Wang) teaching at National Taiwan University. The grant supported by NIH in USA [NIAID contract grants for Center of Excellence for InfluenzaResearch and Surveillance (CEIRS): HHSN266200700006C] and NSC in Taiwan [NSC Grant #102-2621-M-002-002] were approved through peer-review process for the study. Both of these two grants were research grants with the roles of scientific study only. Therefore, the two funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ashour J, 2015, J VIROL, V89, P2792, DOI 10.1128/JVI.02693-14; Bourret V, 2013, INFECT GENET EVOL, V18, P31, DOI 10.1016/j.meegid.2013.04.034; Chan RWY, 2013, VIRUS RES, V178, P133, DOI 10.1016/j.virusres.2013.03.003; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Chen L, 2014, J VIROL, V88, P11760, DOI 10.1128/JVI.01631-14; Chen WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038794; Cheung PPH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5794; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Costa TP, 2011, AVIAN PATHOL, V40, P119, DOI 10.1080/03079457.2010.540002; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Driskell EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038067; ELS MC, 1985, VIROLOGY, V142, P241, DOI 10.1016/0042-6822(85)90332-0; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; HORIMOTO T, 1995, VIROLOGY, V206, P755, DOI 10.1016/S0042-6822(95)80004-2; Horimoto T, 1998, J VET MED SCI, V60, P273, DOI 10.1292/jvms.60.273; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Hsu WB, 2013, J VIROL, V87, P110, DOI 10.1128/JVI.00939-12; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jeong J, 2014, VET MICROBIOL, V173, P249, DOI 10.1016/j.vetmic.2014.08.002; Kao CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031162; Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638; Kaverin NV, 2000, VIRUS RES, V66, P123, DOI 10.1016/S0168-1702(99)00131-8; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Lang V, 2011, ARCH VIROL, V156, P987, DOI 10.1007/s00705-011-0933-z; Lee CW, 2008, J VIROL METHODS, V153, P22, DOI 10.1016/j.jviromet.2008.06.019; Lee C-K, 2008, THESIS; Lee SS, 2013, LANCET, V381, P1815, DOI 10.1016/S0140-6736(13)60949-6; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li Z, 2009, J VIROL, V83, P4153, DOI 10.1128/JVI.02642-08; Lim KL, 2013, RES VET SCI, V95, P1224, DOI 10.1016/j.rvsc.2013.07.013; Lin H., 2007, THESIS; Manz B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003279; Marjuki H, 2015, J INFECT DIS, V211, P249, DOI 10.1093/infdis/jiu447; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Mok CK, 2015, J MICROBIOL IMMUNOL, V48, P465, DOI 10.1016/j.jmii.2013.09.010; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; REED L. J., 1938, AMER JOUR HYG, V27, P493; Russell RJ, 2013, TEXTBOOK OF INFLUENZA, 2ND EDITION, P67, DOI 10.1079/9781780640372.0067; Song JS, 2011, J VIROL, V85, P2180, DOI 10.1128/JVI.01975-10; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Su B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008495; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Varble A, 2014, CELL HOST MICROBE, V16, P691, DOI 10.1016/j.chom.2014.09.020; Webster R.G., 2002, WHO MAN AN INFL DIAG; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Wei SH, 2013, LANCET RESP MED, V1, P771, DOI 10.1016/S2213-2600(13)70221-2; Wong KK, 2012, EMERG INFECT DIS, V18, P1937, DOI 10.3201/eid1812.121097; World Health Organization, CUM NUMB CONF HUM CA; Wu HB, 2014, EMERG INFECT DIS, V20, P1315, DOI 10.3201/eid2008.140339; Wu HS, 2014, EMERG INFECT DIS, V20, P857, DOI 10.3201/eid2005.131393; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yamada S, 2012, J VIROL, V86, P1411, DOI 10.1128/JVI.06100-11; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108; Zaraket H, 2013, J VIROL, V87, P4826, DOI 10.1128/JVI.03110-12; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11	74	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0133910	10.1371/journal.pone.0133910	http://dx.doi.org/10.1371/journal.pone.0133910			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263554	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300014
J	Sanderson, M; Sadie-Van Gijsen, H; Hough, S; Ferris, WF				Sanderson, Micheline; Sadie-Van Gijsen, Hanel; Hough, Stephen; Ferris, William F.			The Role of MKP-1 in the Anti-Proliferative Effects of Glucocorticoids in Primary Rat Pre-Osteoblasts	PLOS ONE			English	Article							PROTEIN-KINASE PHOSPHATASE-1; SIGNAL-REGULATED KINASE; INDUCED OSTEOPOROSIS; MAPK PHOSPHATASE-1; SPECIFICITY PHOSPHATASE-1; CELL-DIFFERENTIATION; GENE-EXPRESSION; ADIPOSE-TISSUE; IN-VITRO; PROLIFERATION	Glucocorticoid (GC)-induced osteoporosis has been attributed to a GC-induced suppression of pre-osteoblast proliferation. Our previous work identified a critical role for mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) in mediating the anti-proliferative effects of GCs in immortalized pre-osteoblasts, but we subsequently found that MKP-1 null mice were not protected against the pathological effects of GCs on bone. In order to reconcile this discrepancy, we have assessed the effects of GCs on proliferation, activation of the MAPK ERK1/2 and MKP-1 expression in primary adipose-derived stromal cells (ADSCs) and ADSC-derived pre-osteoblasts (ADSC-OBs). ADSCs were isolated by means of collagenase digestion from adipose tissue biopsies harvested from adult male Wistar rats. ADSC-OBs were prepared by treating ADSCs with osteoblast differentiation media for 7 days. The effects of increasing concentrations of the GC dexamethasone on basal and mitogen-stimulated cell proliferation were quantified by tritiated thymidine incorporation. ERK1/2 activity was measured by Western blotting, while MKP-1 expression was quantified on both RNA and protein levels, using semi-quantitative real-time PCR and Western blotting, respectively. GCs were strongly anti-proliferative in both naive ADSCs and ADSC-OBs, but had very little effect on mitogen-induced ERK1/2 activation and did not upregulate MKP-1 protein expression. These findings suggest that the anti-proliferative effects of GCs in primary ADSCs and ADSC-OBs in vitro do not require the inhibition of ERK1/2 activation by MKP-1, which is consistent with our in vivo findings in MKP-1 null mice.	[Sanderson, Micheline; Sadie-Van Gijsen, Hanel; Hough, Stephen; Ferris, William F.] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Med, Div Endocrinol, Parow, South Africa	Stellenbosch University	Ferris, WF (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Dept Med, Div Endocrinol, Tygerberg Campus, Parow, South Africa.	wferris@sun.ac.za	Ferris, William/AAF-9435-2020	Sadie-Van Gijsen, Hanel/0000-0002-1745-563X; Ferris, William/0000-0002-4515-5239	South African Medical Research Council (SAMRC); National Research Foundation of South Africa (NRF)	South African Medical Research Council (SAMRC); National Research Foundation of South Africa (NRF)(National Research Foundation - South Africa)	This work was funded by the South African Medical Research Council (SAMRC) (www.mrc.ac.za) to WFF (no grant number issued), and National Research Foundation of South Africa (NRF) (www.nrf.ac.za) to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Beloti Márcio Mateus, 2005, Braz. Dent. J., V16, P156, DOI 10.1590/S0103-64402005000200013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Canalis E, 2007, OSTEOPOROSIS INT, V18, P1319, DOI 10.1007/s00198-007-0394-0; Canalis E, 1996, J CLIN ENDOCR METAB, V81, P3441, DOI 10.1210/jc.81.10.3441; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Conradie MM, 2011, CALCIFIED TISSUE INT, V89, P221, DOI 10.1007/s00223-011-9509-x; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Dorfman K, 1996, ONCOGENE, V13, P925; Engelbrecht Y, 2003, ENDOCRINOLOGY, V144, P412, DOI 10.1210/en.2002-220769; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Furst R, 2007, FASEB J, V21, P74, DOI 10.1096/fj.06-6752com; Gijsen HSV, 2012, MOL CELL ENDOCRINOL, V348, P55, DOI 10.1016/j.mce.2011.07.030; HAHN TJ, 1979, J CLIN INVEST, V64, P655, DOI 10.1172/JCI109506; Horsch K, 2007, MOL ENDOCRINOL, V21, P2929, DOI 10.1210/me.2007-0153; Huang JI, 2002, PLAST RECONSTR SURG, V109, P1033, DOI 10.1097/00006534-200203000-00037; Hulley PA, 1998, ENDOCRINOLOGY, V139, P2423, DOI 10.1210/en.139.5.2423; Ishida Y, 1998, J BONE MINER RES, V13, P1822, DOI 10.1359/jbmr.1998.13.12.1822; Kim CH, 1999, J ENDOCRINOL, V162, P371, DOI 10.1677/joe.0.1620371; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pereira RC, 2002, BONE, V30, P685, DOI 10.1016/S8756-3282(02)00687-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POCKWINSE SM, 1995, EXP CELL RES, V216, P244, DOI 10.1006/excr.1995.1031; Price DM, 2004, FEBS LETT, V577, P220, DOI 10.1016/j.febslet.2004.09.083; Sadie-Van Gijsen H, 2010, MOL CELL ENDOCRINOL, V328, P22, DOI 10.1016/j.mce.2010.06.009; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; van Wijngaarden P, 2007, MOL VIS, V13, P1508; Walsh S, 2001, RHEUMATOLOGY, V40, P74, DOI 10.1093/rheumatology/40.1.74; Yin L, 2006, CHINESE MED J-PEKING, V119, P581, DOI 10.1097/00029330-200604010-00012; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	40	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135358	10.1371/journal.pone.0135358	http://dx.doi.org/10.1371/journal.pone.0135358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263165	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300075
J	Iqbal, E; Mallah, R; Jackson, RG; Ball, M; Ibrahim, ZM; Broadbent, M; Dzahini, O; Stewart, R; Johnston, C; Dobson, RJB				Iqbal, Ehtesham; Mallah, Robbie; Jackson, Richard George; Ball, Michael; Ibrahim, Zina M.; Broadbent, Matthew; Dzahini, Olubanke; Stewart, Robert; Johnston, Caroline; Dobson, Richard J. B.			Identification of Adverse Drug Events from Free Text Electronic Patient Records and Information in a Large Mental Health Case Register	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; MEDICAL-RECORD; ACUTE DYSTONIA; SCHIZOPHRENIA; LONDON; ETHNICITY; ILLNESS; PEOPLE; CARE	Objectives Electronic healthcare records (EHRs) are a rich source of information, with huge potential for secondary research use. The aim of this study was to develop an application to identify instances of Adverse Drug Events (ADEs) from free text psychiatric EHRs. Methods We used the GATE Natural Language Processing (NLP) software to mine instances of ADEs from free text content within the Clinical Record Interactive Search (CRIS) system, a de-identified psychiatric case register developed at the South London and Maudsley NHS Foundation Trust, UK. The tool was built around a set of four movement disorders (extrapyramidal side effects [EPSEs]) related to antipsychotic therapy and rules were then generalised such that the tool could be applied to additional ADEs. We report the frequencies of recorded EPSEs in patients diagnosed with a Severe Mental Illness (SMI) and then report performance in identifying eight other unrelated ADEs. Results The tool identified EPSEs with >0.85 precision and >0.86 recall during testing. Akathisia was found to be the most prevalent EPSE overall and occurred in the Asian ethnic group with a frequency of 8.13%. The tool performed well when applied to most of the non-EPSEs but least well when applied to rare conditions such as myocarditis, a condition that appears frequently in the text as a side effect warning to patients. Conclusions The developed tool allows us to accurately identify instances of a potential ADE from psychiatric EHRs. As such, we were able to study the prevalence of ADEs within subgroups of patients stratified by SMI diagnosis, gender, age and ethnicity. In addition we demonstrated the generalisability of the application to other ADE types by producing a high precision rate on a non-EPSE related set of ADE containing documents.	[Iqbal, Ehtesham; Ibrahim, Zina M.; Johnston, Caroline; Dobson, Richard J. B.] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr SGDP, London WC2R 2LS, England; [Mallah, Robbie; Dzahini, Olubanke] South London & Maudsley NHS Fdn Trust, Dept Pharm, London, England; [Jackson, Richard George; Ball, Michael; Stewart, Robert] Kings Coll London, Inst Psychiat, Dept Hlth Serv & Populat Res, London WC2R 2LS, England; [Jackson, Richard George; Ball, Michael; Broadbent, Matthew; Stewart, Robert; Dobson, Richard J. B.] South London & Maudsley NHS Fdn, NIHR Biomed Res Ctr Mental Hlth, London, England; [Jackson, Richard George; Ball, Michael; Broadbent, Matthew; Stewart, Robert; Dobson, Richard J. B.] South London & Maudsley NHS Fdn, Biomed Res Unit Dementia, London, England	University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London	Dobson, RJB (corresponding author), Kings Coll London, MRC Social Genet & Dev Psychiat Ctr SGDP, London WC2R 2LS, England.	richard.j.dobson@kcl.ac.uk	Stewart, Robert/B-1667-2010; Dzahini, Olubanke/HDM-6742-2022; dobson, richard/C-9269-2011	Stewart, Robert/0000-0002-4435-6397; Dzahini, Olubanke/0000-0003-3878-2143; dobson, richard/0000-0003-4224-9245; Ibrahim, Zina/0000-0001-6203-2727; Jackson, Richard/0000-0002-3278-8547; Iqbal, Ehtesham/0000-0001-9477-9745	NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at the South London and Maudsley NHS Foundation Trust; Kings College London; Guy's and St Thomas' Charity; Maudsley Charity; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre	NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at the South London and Maudsley NHS Foundation Trust; Kings College London(General Electric); Guy's and St Thomas' Charity; Maudsley Charity; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre	This work was supported by the NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at the South London and Maudsley NHS Foundation Trust and Kings College London and a joint infrastructure grant from Guy's and St Thomas' Charity and the Maudsley Charity. This study was part funded by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre.	Alvarez E, 2003, EUR NEUROPSYCHOPHARM, V13, P39, DOI 10.1016/S0924-977X(02)00079-2; Berna F, 2013, J ANESTH, V27, P803, DOI 10.1007/s00540-013-1612-x; Cascade Elisa, 2009, Psychiatry (Edgmont), V6, P15; Chang CK, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-77; Connolly A, 2007, J PSYCHOPHARMACOL, V21, P191, DOI 10.1177/0269881107065899; Connolly A, 2010, PSYCHIATR BULL, V34, P169, DOI 10.1192/pb.bp.109.026435; Cunningham H, 2002, PROCEEDINGS OF THE 4; Cunningham H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002854; Dauner A, 1990, J Psychosoc Nurs Ment Health Serv, V28, P13; Eriksson R, 2013, J AM MED INFORM ASSN, V20, P947, DOI 10.1136/amiajnl-2013-001708; Fernandes AC, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-71; Field TS, 2004, J AM MED INFORM ASSN, V11, P492, DOI 10.1197/jamia.M1586; GERLACH J, 1988, ACTA PSYCHIAT SCAND, V77, P369, DOI 10.1111/j.1600-0447.1988.tb05138.x; Haerian K, 2010, DRUG SAFETY; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Hazlehurst B, 2005, J AM MED INFORM ASSN, V12, P517, DOI 10.1197/jamia.M1771; Hazlehurst B, 2009, VACCINE, V27, P2077, DOI 10.1016/j.vaccine.2009.01.105; Honigman B, 2001, J AM MED INFORM ASSN, V8, P254, DOI 10.1136/jamia.2001.0080254; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Johnson DL, 1997, CLIN PSYCHOL REV, V17, P247, DOI 10.1016/S0272-7358(97)00017-2; Kakar Puneet, 2006, Int J Cardiol, V112, pe5, DOI 10.1016/j.ijcard.2006.01.033; KEEPERS GA, 1987, J CLIN PSYCHOPHARM, V7, P342; Kerwin R, 2007, EUR PSYCHIAT, V22, P433, DOI 10.1016/j.eurpsy.2007.03.002; LLOYD K, 1992, SOC PSYCH PSYCH EPID, V27, P95, DOI 10.1007/BF00788512; MCDOWELL F, 1970, ANN INTERN MED, V72, P29, DOI 10.7326/0003-4819-72-1-29; Misdrahi D, 2001, LENCEPHALE, V28, P266; MITCHELL PB, 1991, MED J AUSTRALIA, V155, P488, DOI 10.5694/j.1326-5377.1991.tb93849.x; Murff HJ, 2003, J AM MED INFORM ASSN, V10, P339, DOI 10.1197/jamia.M1201; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Sanger TD, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e89; Shepherd G, 2012, ANN PHARMACOTHER, V46, P169, DOI 10.1345/aph.1P592; Somers A, 2003, EUR J CLIN PHARMACOL, V58, P707, DOI 10.1007/s00228-002-0535-5; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; Thanvi B, 2009, POSTGRAD MED J, V85, P322, DOI 10.1136/pgmj.2008.073312; van Harten PN, 1999, BMJ-BRIT MED J, V319, P623, DOI 10.1136/bmj.319.7210.623; Wang XY, 2010, J BIOMED INFORM, V43, P595, DOI 10.1016/j.jbi.2010.03.011; Wang XY, 2009, J AM MED INFORM ASSN, V16, P328, DOI 10.1197/jamia.M3028; Wu CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074262	39	44	45	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134208	10.1371/journal.pone.0134208	http://dx.doi.org/10.1371/journal.pone.0134208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26273830	Green Submitted, gold, Green Published			2022-12-27	WOS:000359493600022
J	Lawrence, AJ; Brookes, RL; Zeestraten, EA; Barrick, TR; Morris, RG; Markus, HS				Lawrence, Andrew J.; Brookes, Rebecca L.; Zeestraten, Eva A.; Barrick, Thomas R.; Morris, Robin G.; Markus, Hugh S.			Pattern and Rate of Cognitive Decline in Cerebral Small Vessel Disease: A Prospective Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NATURAL-HISTORY; IMPAIRMENT; PROGRESSION; PROFILES; DEMENTIA; CADASIL; MRI	Objectives Cognitive impairment, predominantly affecting processing speed and executive function, is an important consequence of cerebral small vessel disease (SVD). To date, few longitudinal studies of cognition in SVD have been conducted. We determined the pattern and rate of cognitive decline in SVD and used the results to determine sample size calculations for clinical trials of interventions reducing cognitive decline. Methods 121 patients with MRI confirmed lacunar stroke and leukoaraiosis were enrolled into the prospective St George's Cognition And Neuroimaging in Stroke (SCANS) study. Patients attended one baseline and three annual cognitive assessments providing 36 month follow-up data. Neuropsychological assessment comprised a battery of tests assessing working memory, long-term (episodic) memory, processing speed and executive function. We calculated annualized change in cognition for the 98 patients who completed at least two time-points. Results Task performance was heterogeneous, but significant cognitive decline was found for the executive function index (p<0.007). Working memory and processing speed decreased numerically, but not significantly. The executive function composite score would require the smallest samples sizes for a treatment trial with an aim of halting decline, but this would still require over 2,000 patients per arm to detect a 30% difference with power of 0.8 over a three year follow-up. Conclusions The pattern of cognitive decline seen in SVD over three years is consistent with the pattern of impairments at baseline. Rates of decline were slow and sample sizes would need to be large for clinical trials aimed at halting decline beyond initial diagnosis using cognitive scores as an outcome measure. This emphasizes the importance of more sensitive surrogate markers in this disease.	[Lawrence, Andrew J.; Brookes, Rebecca L.; Markus, Hugh S.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Zeestraten, Eva A.; Barrick, Thomas R.] St Georges Univ London, Cardiovasc & Cell Sci Res Inst, Neurosci Res Ctr, London, England; [Morris, Robin G.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London WC2R 2LS, England	University of Cambridge; St Georges University London; University of London; King's College London; University of London; King's College London	Lawrence, AJ (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.	ajl54@medschl.cam.ac.uk		Barrick, Thomas/0000-0003-1783-3650; Lawrence, Andrew/0000-0002-1420-3381	Wellcome Trust [081589]; Alzheimer's Research UK [ARUK-PG2013-2]; Alzheimers Research UK [ARUK-PG2013-2] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10019] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); National Institute for Health Research(National Institute for Health Research (NIHR))	A Wellcome Trust #081589 (http://www.wellcome.ac.uk/) project grant was awarded to HSM. Dr. Lawrence (AJL) is supported by Alzheimer's Research UK - ARUK-PG2013-2 (http://www.alzheimersresearchuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Charlton RA, 2006, NEUROLOGY, V66, P1523, DOI 10.1212/01.wnl.0000216270.02610.7e; Charlton RA, 2006, NEUROLOGY, V66, P217, DOI 10.1212/01.wnl.0000194256.15247.83; Coughlan AK, 2007, THE BIRT MEMORY AND; Crawford J. R., 2003, CLIN NEUROPSYCHOLOGY, P121; Dawson JD, 2010, J AM GERIATR SOC, V58, P1090, DOI 10.1111/j.1532-5415.2010.02872.x; Delis DC, 2001, DELIS KAPLAN EXECUTI; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Garde E, 2005, J NEUROL NEUROSUR PS, V76, P1289, DOI 10.1136/jnnp.2004.055905; HAXBY JV, 1992, J CLIN EXP NEUROPSYC, V14, P575, DOI 10.1080/01688639208402846; Hothorn T, 2008, J STAT SOFTW, V28, P1; Jokinen H, 2009, CEREBROVASC DIS, V27, P384, DOI 10.1159/000207442; Jouvent E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.013; Lawrence AJ, 2014, NEUROLOGY, V83, P304, DOI 10.1212/WNL.0000000000000612; Lawrence AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061014; Liem MK, 2009, NEUROLOGY, V72, P143, DOI 10.1212/01.wnl.0000339038.65508.96; Lim YY, 2014, ALZHEIMERS DEMENT, V10, P743, DOI 10.1016/j.jalz.2013.11.005; Matthews C, 1964, INSTRUCTION MANUAL F; Mitrushina M, 2005, HANDBOOK OF NORMATIV; Mok VCT, 2004, J NEUROL NEUROSUR PS, V75, P560, DOI 10.1136/jnnp.2003.015107; Mura T, 2014, J NEUROL NEUROSUR PS, V85, P363, DOI 10.1136/jnnp-2013-305078; Nagahama Y, 2003, DEMENT GERIATR COGN, V16, P103, DOI 10.1159/000070683; Nelson H E, 1991, NATL ADULT READING T, V2nd; Nitkunan A, 2008, STROKE, V39, P1999, DOI 10.1161/STROKEAHA.107.507475; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Patel B, 2013, STROKE, V44, P356, DOI 10.1161/STROKEAHA.112.670216; Patel B, 2011, INT J STROKE, V6, P47, DOI 10.1111/j.1747-4949.2010.00552.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RANKIN J, 1957, Scott Med J, V2, P200; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Sachdev PS, 2004, NEUROLOGY, V63, P1618, DOI 10.1212/01.WNL.0000142964.83484.DE; Schmidt R, 2012, STROKE, V43, P2643, DOI 10.1161/STROKEAHA.112.662593; van den Heuvel DMJ, 2006, J NEUROL NEUROSUR PS, V77, P149, DOI 10.1136/jnnp.2005.070193; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Wechsler D., 1997, ADMINISTRATION AND S; Wechsler D., 1997, WECHSLER ADULT INTEL; Wilson RS, 2012, PSYCHOL AGING, V27, P1008, DOI 10.1037/a0029857; Zhou AH, 2009, J INT NEUROPSYCH SOC, V15, P898, DOI 10.1017/S1355617709990816	42	34	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135523	10.1371/journal.pone.0135523	http://dx.doi.org/10.1371/journal.pone.0135523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26273828	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000359493600072
J	Warneke, AM; Long, JD				Warneke, Alexandria M.; Long, Jeremy D.			Copper Contamination Impairs Herbivore Initiation of Seaweed Inducible Defenses and Decreases Their Effectiveness	PLOS ONE			English	Article							BROWN SEAWEED; INDUCED RESISTANCE; MORPHOLOGICAL RESPONSES; DAPHNIA-PULEX; INDUCTION; METAL; HISTORY; STRESS; PLANTS; SUSCEPTIBILITY	Seaweed-herbivore interactions are often mediated by environmental conditions, yet the roles of emerging anthropogenic stressors on these interactions are poorly understood. For example, chemical contaminants have unknown consequences on seaweed inducible resistance and herbivore response to these defenses despite known deleterious effects of contaminants on animal inducible defenses. Here, we investigated the effect of copper contamination on the interactions between a snail herbivore and a brown seaweed that displays inducible resistance to grazing. We examined seaweed inducible resistance and its effectiveness for organisms exposed to copper at two time points, either during induction or after herbivores had already induced seaweed defenses. Under ambient conditions, non-grazed tissues were more palatable than grazed tissues. However, copper additions negated the preference for non-grazed tissues regardless of the timing of copper exposure, suggesting that copper decreased both how herbivores initiated these inducible defenses and their subsequent effectiveness. Copper decreased stimulation of defenses, at least in part, by suppressing snail grazing pressure-the cue that turns inducible defenses on. Copper decreased effectiveness of defenses by preventing snails from preferentially consuming non-grazed seaweed. Thus, contaminants can potentially stress communities by changing seaweed-herbivore interactions mediated via inducible defenses. Given the ubiquity of seaweed inducible resistance and their potential influence on herbivores, we hypothesize that copper contamination may change the impact of these resistant traits on herbivores.	[Warneke, Alexandria M.; Long, Jeremy D.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University	Long, JD (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	jlong@mail.sdsu.edu			Inamori Foundation; Women's Environmental Council Scholarship; SDSU's Ecology Program Area; Honors Society of Phi Kappa Phi; CSU Council on Ocean Affairs, Science, and Technology Student Fellowship; SciFund Challenge	Inamori Foundation; Women's Environmental Council Scholarship; SDSU's Ecology Program Area; Honors Society of Phi Kappa Phi; CSU Council on Ocean Affairs, Science, and Technology Student Fellowship; SciFund Challenge	Generous financial support for this project provided to AW by the Inamori Foundation (http://www.inamori-f.or.jp/index_e.html), Women's Environmental Council Scholarship (http://www.wecweb.org), SDSU's Ecology Program Area (http://www.bio.sdsu.edu/ecology/), the Honors Society of Phi Kappa Phi (http://www.phikappaphi.org), the CSU Council on Ocean Affairs, Science, and Technology Student Fellowship (http://www.calstate.edu/coast/), and the #SciFund Challenge (http://scifundchallenge.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, 2363 CRG LAB INC; Barry MJ, 1998, J PLANKTON RES, V20, P1219, DOI 10.1093/plankt/20.7.1219; Bolser RC, 1996, ECOLOGY, V77, P2269, DOI 10.2307/2265730; Boyd RS, 2010, J CHEM ECOL, V36, P46, DOI 10.1007/s10886-009-9730-5; BRYAN GW, 1973, J MAR BIOL ASSOC UK, V53, P705, DOI 10.1017/S0025315400058902; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Cronin G, 1996, ECOLOGY, V77, P1531, DOI 10.2307/2265549; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; Deal MS, 2003, OECOLOGIA, V136, P107, DOI 10.1007/s00442-003-1242-3; Dethier MN, 2005, ECOL MONOGR, V75, P403, DOI 10.1890/03-4108; Dixson DL, 2015, GLOBAL CHANGE BIOL, V21, P1454, DOI 10.1111/gcb.12678; Edwards MS, 2011, ALGAE, V26, P1; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Flothe CR, 2014, J PHYCOL, V50, P564, DOI 10.1111/jpy.12186; Geisler RS, 1975, THESIS TEXAS A M U, P133; Haavisto F, 2010, OECOLOGIA, V162, P685, DOI 10.1007/s00442-009-1494-7; HALL WS, 1988, ENVIRON MONIT ASSESS, V11, P33, DOI 10.1007/BF00394510; HANAZATO T, 1993, J PLANKTON RES, V15, P1087, DOI 10.1093/plankt/15.9.1087; HASSALL M, 1982, OECOLOGIA, V53, P374, DOI 10.1007/BF00389017; Hunter K, 2004, ENVIRON TOXICOL CHEM, V23, P1311, DOI 10.1897/03-369; Jhee EM, 2006, J CHEM ECOL, V32, P239, DOI 10.1007/s10886-005-9000-0; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kubanek J, 1997, MAR ECOL PROG SER, V157, P139; Kubicek A, 2011, J EXP MAR BIOL ECOL, V397, P208, DOI 10.1016/j.jembe.2010.11.025; Kwan CK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133329; Long JD, 2007, ECOLOGY, V88, P1232, DOI 10.1890/06-1585; Lurling M, 2007, TRENDS ECOL EVOL, V22, P374, DOI 10.1016/j.tree.2007.04.002; Lurling M, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P250; Martens SN, 2002, AM J BOT, V89, P998, DOI 10.3732/ajb.89.6.998; McIntyre JK, 2012, ECOL APPL, V22, P1460, DOI 10.1890/11-2001.1; Mirza RS, 2009, FRESHWATER BIOL, V54, P1016, DOI 10.1111/j.1365-2427.2008.02148.x; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nykanen H, 2004, OIKOS, V104, P247, DOI 10.1111/j.0030-1299.2004.12768.x; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Pavia H, 2000, MAR ECOL PROG SER, V193, P285, DOI 10.3354/meps193285; Pavia H, 2000, ECOLOGY, V81, P3212; PETERSON CH, 1989, OECOLOGIA, V80, P82, DOI 10.1007/BF00789935; Rainbow PS, 2007, ENVIRON INT, V33, P576, DOI 10.1016/j.envint.2006.05.007; RENAUD PE, 1990, OECOLOGIA, V82, P217, DOI 10.1007/BF00323538; Roberts DA, 2008, MAR POLLUT BULL, V56, P1057, DOI 10.1016/j.marpolbul.2008.03.003; Roberts DA, 2006, ENVIRON TOXICOL CHEM, V25, P2470, DOI 10.1897/05-661R.1; Schiff K, 2007, MAR POLLUT BULL, V54, P322, DOI 10.1016/j.marpolbul.2006.10.013; Schulte EE, 1987, 6U WISC MAD SOIL TES; Scott GR, 2003, J EXP BIOL, V206, P1779, DOI 10.1242/jeb.00353; Taylor RB, 2002, OECOLOGIA, V132, P68, DOI 10.1007/s00442-002-0944-2; Toth G, 2000, MAR ECOL PROG SER, V192, P119, DOI 10.3354/meps192119; Toth GB, 2000, P NATL ACAD SCI USA, V97, P14418, DOI 10.1073/pnas.250226997; Toth GB, 2005, ECOLOGY, V86, P612, DOI 10.1890/04-0484; Toth GB, 2007, J ECOL, V95, P425, DOI 10.1111/j.1365-2745.2007.01224.x; United States Environmental Protection Agency, 2002, EPA821R02012; WEEKS JM, 1993, B ENVIRON CONTAM TOX, V50, P883; Weidner K, 2004, MAR ECOL PROG SER, V283, P113, DOI 10.3354/meps283113; Weinberger F, 2011, MAR ECOL PROG SER, V427, P83, DOI 10.3354/meps09044; YATES JL, 1993, ECOLOGY, V74, P1757, DOI 10.2307/1939934	54	6	6	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135395	10.1371/journal.pone.0135395	http://dx.doi.org/10.1371/journal.pone.0135395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274491	gold, Green Submitted, Green Published			2022-12-27	WOS:000359493600064
J	Bao, RY; Hernandez, K; Huang, L; Kang, WJ; Bartom, E; Onel, K; Volchenboum, S; Andrade, J				Bao, Riyue; Hernandez, Kyle; Huang, Lei; Kang, Wenjun; Bartom, Elizabeth; Onel, Kenan; Volchenboum, Samuel; Andrade, Jorge			ExScalibur: A High-Performance Cloud-Enabled Suite for Whole Exome Germline and Somatic Mutation Identification	PLOS ONE			English	Article							INTEGRATIVE GENOMICS VIEWER; VARIANT-CALLING PIPELINES; SEQUENCING DATA; GENETIC-VARIANTS; POINT MUTATIONS; CANCER; DISCOVERY; FRAMEWORK; SAMPLES	Whole exome sequencing has facilitated the discovery of causal genetic variants associated with human diseases at deep coverage and low cost. In particular, the detection of somatic mutations from tumor/normal pairs has provided insights into the cancer genome. Although there is an abundance of publicly-available software for the detection of germline and somatic variants, concordance is generally limited among variant callers and alignment algorithms. Successful integration of variants detected by multiple methods requires in-depth knowledge of the software, access to high-performance computing resources, and advanced programming techniques. We present ExScalibur, a set of fully automated, highly scalable and modulated pipelines for whole exome data analysis. The suite integrates multiple alignment and variant calling algorithms for the accurate detection of germline and somatic mutations with close to 99% sensitivity and specificity. ExScalibur implements streamlined execution of analytical modules, real-time monitoring of pipeline progress, robust handling of errors and intuitive documentation that allows for increased reproducibility and sharing of results and workflows. It runs on local computers, high-performance computing clusters and cloud environments. In addition, we provide a data analysis report utility to facilitate visualization of the results that offers interactive exploration of quality control files, read alignment and variant calls, assisting downstream customization of potential disease-causing mutations. ExScalibur is open-source and is also available as a public image on Amazon cloud.	[Bao, Riyue; Hernandez, Kyle; Huang, Lei; Kang, Wenjun; Bartom, Elizabeth; Volchenboum, Samuel; Andrade, Jorge] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA; [Onel, Kenan; Volchenboum, Samuel] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Volchenboum, Samuel] Univ Chicago, Computat Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Volchenboum, S (corresponding author), Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA.	svolchen@peds.bsd.uchicago.edu; jandrade@bsd.uchicago.edu	Hernandez, Kyle/K-2536-2019; Andrade, Jorge/H-3104-2019; Bartom, Elizabeth/S-4475-2017	Hernandez, Kyle/0000-0001-8267-644X; Andrade, Jorge/0000-0003-3210-2186; Bartom, Elizabeth/0000-0002-5618-2582	Biological Sciences Division; Institute for Translational Medicine/CTSA at the University of Chicago [NIH UL1 RR024999]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER	Biological Sciences Division; Institute for Translational Medicine/CTSA at the University of Chicago; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The Center for Research Informatics is funded by the Biological Sciences Division, including the Institute for Translational Medicine/CTSA (NIH UL1 RR024999) at the University of Chicago (http://itm.uchicago.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andrews S, 2012, FASTQC QUALITY APPL; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cingolani P, 2015, BIOINFORMATICS, V31, P10, DOI 10.1093/bioinformatics/btu595; D'Antonio M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S11; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Exome Variant Server, NHLBI GO EXOM SEQ PR; Fischer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041948; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Garrison E, 2012, VCFILB C LIB PARSING; Garrison E, 2012, ARXIV12073907GBIOGN; Hansen NF, 2013, BIOINFORMATICS, V29, P1498, DOI 10.1093/bioinformatics/btt183; John J.S., 2011, SEQPREP TOOL STRIPPI; Kim S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r90; Kim SY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-189; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095217; Mutarelli M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S3-S5; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Pirooznia M, 2014, HUM GENOMICS, V8, DOI 10.1186/1479-7364-8-14; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Roberts ND, 2013, BIOINFORMATICS, V29, P2223, DOI 10.1093/bioinformatics/btt375; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tan A, 2015, BIOINFORMATICS, V31, P2202, DOI 10.1093/bioinformatics/btv112; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; VdAuwera G, 2013, PRIMER PARALLELISM G; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	44	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135800	10.1371/journal.pone.0135800	http://dx.doi.org/10.1371/journal.pone.0135800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271043	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800112
J	Liddell, BJ; Das, P; Battaglini, E; Malhi, GS; Felmingham, KL; Whitford, TJ; Bryant, RA				Liddell, Belinda J.; Das, Pritha; Battaglini, Eva; Malhi, Gin S.; Felmingham, Kim L.; Whitford, Thomas J.; Bryant, Richard A.			Self-Orientation Modulates the Neural Correlates of Global and Local Processing	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; TOP-DOWN; HUMAN BRAIN; CULTURE; ATTENTION; OBJECT; CONFLICT; INDIVIDUALISM; ALLOCATION; SELECTION	Differences in self-orientation (or "self-construal") may affect how the visual environment is attended, but the neural and cultural mechanisms that drive this remain unclear. Behavioral studies have demonstrated that people from Western backgrounds with predominant individualistic values are perceptually biased towards local-level information; whereas people from non-Western backgrounds that support collectivist values are preferentially focused on contextual and global-level information. In this study, we compared two groups differing in predominant individualistic (N = 15) vs collectivistic (N = 15) self-orientation. Participants completed a global/local perceptual conflict task whilst undergoing functional Magnetic Resonance Imaging (fMRI) scanning. When participants high in individualistic values attended to the global level (ignoring the local level), greater activity was observed in the frontoparietal and cingulo-opercular networks that underpin attentional control, compared to the match (congruent) baseline. Participants high in collectivistic values activated similar attentional control networks o only when directly compared with global processing. This suggests that global interference was stronger than local interference in the conflict task in the collectivistic group. Both groups showed increased activity in dorsolateral prefrontal regions involved in resolving perceptual conflict during heightened distractor interference. The findings suggest that self-orientation may play an important role in driving attention networks to facilitate interaction with the visual environment.	[Liddell, Belinda J.; Battaglini, Eva; Whitford, Thomas J.; Bryant, Richard A.] UNSW Australia, Sch Psychol, Sydney, NSW 2052, Australia; [Das, Pritha; Malhi, Gin S.] Northern Sydney Local Hlth Dist, Kolling Inst, Acad Dept Psychiat, St Leonards, NSW 2065, Australia; [Das, Pritha; Malhi, Gin S.] Univ Sydney, Sydney Med Sch Northern, ARCHI, Sydney, NSW 2006, Australia; [Das, Pritha; Malhi, Gin S.] Northern Sydney Local Hlth Dist, Royal N Shore Hosp, CADE Clin, St Leonards, NSW 2065, Australia; [Felmingham, Kim L.] Univ Tasmania, Sch Psychol, Hobart, Tas 7001, Australia	University of New South Wales Sydney; University of Sydney; Kolling Institute of Medical Research; University of Sydney; Royal North Shore Hospital; University of Tasmania	Liddell, BJ (corresponding author), UNSW Australia, Sch Psychol, Sydney, NSW 2052, Australia.	b.liddell@unsw.edu.au	Bryant, Richard/AAA-6479-2019; Malhi, Gin/Z-2418-2019	Bryant, Richard/0000-0002-9607-819X; Malhi, Gin/0000-0002-4524-9091; Battaglini, Eva/0000-0001-9591-9930; Liddell, Belinda/0000-0002-8036-5864	Australian Research Council (ARC) [LP120200284]	Australian Research Council (ARC)(Australian Research Council)	This study was funded by an Australian Research Council (ARC) Grant (LP120200284) received by RAB, KLF, and GSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Billington J, 2008, NEUROPSYCHOLOGIA, V46, P511, DOI 10.1016/j.neuropsychologia.2007.09.003; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Caparos S, 2013, PSYCHOL SCI, V24, P206, DOI 10.1177/0956797612452569; Chiao JY, 2009, HUM BRAIN MAPP, V30, P2813, DOI 10.1002/hbm.20707; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Flevaris AV, 2010, PSYCHOL SCI, V21, P424, DOI 10.1177/0956797609359909; Goh JOS, 2004, J NEUROSCI, V24, P10223, DOI 10.1523/JNEUROSCI.3373-04.2004; Goh JO, 2007, COGN AFFECT BEHAV NE, V7, P44, DOI 10.3758/CABN.7.1.44; Goh JO, 2009, PROG BRAIN RES, V178, P95, DOI 10.1016/S0079-6123(09)17807-X; Goh JO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008238; Goh JOS, 2010, SOC COGN AFFECT NEUR, V5, P227, DOI 10.1093/scan/nsq060; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gutchess AH, 2006, COGN AFFECT BEHAV NE, V6, P102, DOI 10.3758/CABN.6.2.102; Han SH, 2004, HUM BRAIN MAPP, V22, P321, DOI 10.1002/hbm.20044; Han SH, 2008, NAT REV NEUROSCI, V9, P646, DOI 10.1038/nrn2456; Han SH, 2013, ANNU REV PSYCHOL, V64, P335, DOI 10.1146/annurev-psych-071112-054629; Hedden T, 2008, PSYCHOL SCI, V19, P12, DOI 10.1111/j.1467-9280.2008.02038.x; Kitayama S, 2011, ANNU REV PSYCHOL, V62, P419, DOI 10.1146/annurev-psych-120709-145357; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kristjansson A, 2002, COGNITION, V85, P37, DOI 10.1016/S0010-0277(02)00074-4; Lewis RS, 2008, PERS SOC PSYCHOL B, V34, P623, DOI 10.1177/0146167207313731; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lin ZC, 2008, BIOL PSYCHOL, V77, P93, DOI 10.1016/j.biopsycho.2007.08.002; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Markus HR, 2010, PERSPECT PSYCHOL SCI, V5, P420, DOI 10.1177/1745691610375557; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; McKone E, 2010, VISION RES, V50, P1540, DOI 10.1016/j.visres.2010.05.010; Mesquita B, 2001, J PERS SOC PSYCHOL, V80, P68, DOI 10.1037/0022-3514.80.1.68; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Oyserman D, 2008, PSYCHOL BULL, V134, P311, DOI 10.1037/0033-2909.134.2.311; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Spielberger C. D., 1973, MANUAL STATE TRAIT I; STOFFER TH, 1993, PSYCHOL RES-PSYCH FO, V56, P14, DOI 10.1007/BF00572129; STOFFER TH, 1994, PSYCHOL RES-PSYCH FO, V56, P83, DOI 10.1007/BF00419715; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Weissman DH, 2002, NEUROIMAGE, V17, P1266, DOI 10.1006/nimg.2002.1284; Wilkinson DT, 2001, NEUROIMAGE, V13, P56, DOI 10.1006/nimg.2000.0678; Yamaguchi S, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-09-j0002.2000	47	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135453	10.1371/journal.pone.0135453	http://dx.doi.org/10.1371/journal.pone.0135453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JX	26270820	Green Published, gold			2022-12-27	WOS:000359492800075
J	Caldwell, RL; Ross, R; Rodaniche, A; Huffard, CL				Caldwell, Roy L.; Ross, Richard; Rodaniche, Arcadio; Huffard, Christine L.			Behavior and Body Patterns of the Larger Pacific Striped Octopus	PLOS ONE			English	Article							ABDOPUS-ACULEATUS DORBIGNY; WUNDERPUS-PHOTOGENICUS; VULCANOCTOPUS-HYDROTHERMALIS; CEPHALOPODA OCTOPODIDAE; MATING-BEHAVIOR; CYANEA GRAY; N.-GEN.; VULGARIS; WILD; CUTTLEFISH	Over thirty years ago anecdotal accounts of the undescribed Larger Pacific Striped Octopus suggested behaviors previously unknown for octopuses. Beak-to-beak mating, dens shared by mating pairs, inking during mating and extended spawning were mentioned in publications, and enticed generations of cephalopod biologists. In 2012-2014 we were able to obtain several live specimens of this species, which remains without a formal description. All of the unique behaviors listed above were observed for animals in aquaria and are discussed here. We describe the behavior, body color patterns, and postures of 24 adults maintained in captivity. Chromatophore patterns of hatchlings are also shown.	[Caldwell, Roy L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Caldwell, Roy L.; Ross, Richard; Huffard, Christine L.] Calif Acad Sci, San Francisco, CA 94118 USA; [Rodaniche, Arcadio] Smithsonian Trop Res Inst, Panama City, Panama; [Huffard, Christine L.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA	University of California System; University of California Berkeley; California Academy of Sciences; Smithsonian Institution; Smithsonian Tropical Research Institute; Monterey Bay Aquarium Research Institute	Caldwell, RL (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	rlcaldwell@berkeley.edu			University of California Museum of Paleontology	University of California Museum of Paleontology	Funding was provided to RLC by the University of California Museum of Paleontology. This funding group had no influence on the authors' study design, interpretation, or communication.	Anderson Roland C., 2002, Journal of Applied Animal Welfare Science, V5, P275, DOI 10.1207/S15327604JAWS0504_02; Boletzky S. v., 2003, Berliner Palaeobiologische Abhandlungen, V3, P19; Boyle PR, 2000, MAR BIOL, V137, P317, DOI 10.1007/s002270000351; CIGLIANO JA, 1993, ANIM BEHAV, V46, P677, DOI 10.1006/anbe.1993.1244; Forsythe JW, 1997, J EXP MAR BIOL ECOL, V209, P15, DOI 10.1016/S0022-0981(96)00057-3; FORSYTHE JW, 1988, MALACOLOGIA, V29, P41; FROESCH D, 1975, PROC R SOC SER B-BIO, V188, P95, DOI 10.1098/rspb.1975.0005; Gilly WF, 2006, MAR ECOL PROG SER, V313, P125, DOI 10.3354/meps313125; Godfrey-Smith P., 2012, MAR FRESHW BEHAV PHY, V45, P1, DOI DOI 10.1080/10236244.2012.727617; GUERRA A, 1981, J ZOOL, V195, P133; Guerra A, 2014, SCI MAR, V78, P405, DOI 10.3989/scimar.04071.28F; Hanlon R.T., 1977, Proceedings of the Annual Meeting of the World Mariculture Society, V8, P471; Hanlon R. T., 1998, CEPHALOPOD BEHAV; Hanlon RT, 2008, MAR FRESHW BEHAV PHY, V41, P19, DOI 10.1080/10236240701661123; HANLON RT, 1989, AM MALACOL BULL, V7, P21; HANLON RT, 1980, B MAR SCI, V30, P749; HANLON RT, 1988, MALACOLOGIA, V29, P247; HANLON RT, 1988, PHILOS T ROY SOC B, V320, P437, DOI 10.1098/rstb.1988.0087; Hernandez-Urcera J, 2014, J COMP PSYCHOL, V128, P427, DOI 10.1037/a0036883; Hochberg FG, 2006, MOLLUSCAN RES, V26, P128; Huffard CL, 2008, MAR BIOL, V154, P353, DOI 10.1007/s00227-008-0930-2; Huffard CL, 2007, J MOLLUS STUD, V73, P185, DOI 10.1093/mollus/eym015; Huffard CL, 2006, J EXP BIOL, V209, P3697, DOI 10.1242/jeb.02435; Huffard Christine L., 2005, Molluscan Research, V25, P113; Huffard CL, 2015, MOLLUSCAN RES, V35, P12, DOI 10.1080/13235818.2014.909558; Huffard CL, 2010, BIOL J LINN SOC, V101, P68, DOI 10.1111/j.1095-8312.2010.01484.x; Huffard CL, 2010, J COMP PSYCHOL, V124, P38, DOI 10.1037/a0017230; Huffard CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003732; Jantzen TM, 2003, BIOL BULL-US, V204, P305, DOI 10.2307/1543601; Jereb P, 2014, FAO SPECIES CATALOGU, V4, P370; Leite TS, 2009, FISH RES, V98, P85, DOI 10.1016/j.fishres.2009.04.001; Mangold K., 1987, P157; Messenger JB, 2001, BIOL REV, V76, P473, DOI 10.1017/S1464793101005772; Moynihan M., 1985, COMMUNICATION NONCOM; Naud MJ, 2004, ANIM BEHAV, V67, P1043, DOI 10.1016/j.anbehav.2003.10.005; Norman M.D., 2005, Phuket Marine Biological Center Research Bulletin, V66, P127; Norman Mark D., 2005, Molluscan Research, V25, P57; Norman MD, 2001, INVERTEBR TAXON, V15, P13, DOI 10.1071/IT99018; Norman MD, 1997, INVERTEBR TAXON, V11, P89, DOI 10.1071/IT95026; NORMAN MD, 1991, B MAR SCI, V49, P20; Norman MD, 2000, CEPHALOPODS WORLD GU; Packard A., 1977, Symposia of the Zoological Society of London, P191; PACKARD A, 1971, ANIM BEHAV, V19, P780, DOI 10.1016/S0003-3472(71)80181-1; Robson GC, 1929, MONOGRAPH RECENT CEP; Rocha F, 2002, CAH BIOL MAR, V43, P299; Rocha F, 2001, BIOL REV, V76, P291, DOI 10.1017/S1464793101005681; RODANICHE A F, 1991, Bulletin of Marine Science, V49, P667; RODANICHE AF, 1984, B MAR SCI, V35, P99; Rodaniche AF, 1977, ANIMALS COMMUNICATE, P293; Rodaniche AF, 1982, J COMP ETHOLOGY S, V25; Squires ZE, 2013, J MOLLUS STUD, V79, P263, DOI 10.1093/mollus/eyt025; Sreeja V., 2013, Journal of Threatened Taxa, V5, P4492, DOI 10.11609/JoTT.o3256.4492-7; Steer MA, 2003, J EXP MAR BIOL ECOL, V290, P165, DOI 10.1016/S0022-0981(03)00076-5; Tricarico E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018710; Tsuchiya K., 1997, JPN J MALAC TOKYO, V56, P177; VILLANUEVA R, 1992, MAR BIOL, V114, P265, DOI 10.1007/BF00349529; Voight JR, 2005, J MAR BIOL ASSOC UK, V85, P985, DOI 10.1017/S0025315405011999; VOSS GL, 1968, B MAR SCI, V18, P645; Wada T, 2005, J ETHOL, V23, P85, DOI 10.1007/s10164-005-0146-6; WELLS MJ, 1972, ANIM BEHAV, V20, P293, DOI 10.1016/S0003-3472(72)80051-4	60	35	35	17	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134152	10.1371/journal.pone.0134152	http://dx.doi.org/10.1371/journal.pone.0134152			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266543	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300033
J	Cosmo, C; Baptista, AF; de Araujo, AN; do Rosario, RS; Miranda, JGV; Montoya, P; de Sena, EP				Cosmo, Camila; Baptista, Abrahao Fontes; de Araujo, Arao Nogueira; do Rosario, Raphael Silva; Vivas Miranda, Jose Garcia; Montoya, Pedro; de Sena, Eduardo Ponde			A Randomized, Double-Blind, Sham-Controlled Trial of Transcranial Direct Current Stimulation in Attention-Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; MINI-MENTAL-STATE; PREFRONTAL CORTEX; DC-STIMULATION; EXECUTIVE FUNCTIONS; BRAIN-STIMULATION; WORKING-MEMORY; TDCS; DEPRESSION; ADHD	Background Current standardized treatments for cognitive impairment in attention-deficit/hyperactivity disorder remain limited and their efficacy restricted. Transcranial direct current stimulation (tDCS) is a promising tool for enhancing cognitive performance in several neuropsychiatric disorders. Nevertheless, the effects of tDCS in reducing cognitive impairment in patients with attention-deficit/hyperactivity disorder (ADHD) have not yet been investigated. Methods A parallel, randomized, double-blind, sham-controlled trial was conducted to examine the efficacy of tDCS on the modulation of inhibitory control in adults with ADHD. Thirty patients were randomly allocated to each group and performed a go/no-go task before and after a single session of either anodal stimulation (1 mA) over the left dorsolateral prefrontal cortex or sham stimulation. Results A nonparametric two-sample Wilcoxon rank-sum (Mann-Whitney) test revealed no significant differences between the two groups of individuals with ADHD (tDCS vs. sham) in regard to behavioral performance in the go/no go tasks. Furthermore, the effect sizes of group differences after treatment for the primary outcome measures-correct responses, impulsivity and omission errors-were small. No adverse events resulting from stimulation were reported. Conclusion According to these findings, there is no evidence in support of the use of anodal stimulation over the left dorsolateral prefrontal cortex as an approach for improving inhibitory control in ADHD patients. To the best of our knowledge, this is the first clinical study to assess the cognitive effects of tDCS in individuals with ADHD. Further research is needed to assess the clinical efficacy of tDCS in this population.	[Cosmo, Camila; de Araujo, Arao Nogueira; de Sena, Eduardo Ponde] Univ Fed Bahia, Interact Proc Organs & Syst, Postgrad Program, Salvador, BA, Brazil; [Cosmo, Camila] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Spaulding Neuromodulat Ctr, Boston, MA USA; [Cosmo, Camila] Bahia State Hlth Dept SESAB, Salvador, BA, Brazil; [Cosmo, Camila; Baptista, Abrahao Fontes] Univ Fed Bahia, Funct Electrostimulat Lab, Biomorphol Dept, Salvador, BA, Brazil; [Baptista, Abrahao Fontes] Univ Fed Bahia, Sch Med, Postgrad Program Med & Human Hlth, Salvador, BA, Brazil; [do Rosario, Raphael Silva; Vivas Miranda, Jose Garcia] Univ Fed Bahia, Inst Phys, Salvador, BA, Brazil; [Montoya, Pedro] Univ Balearic Isl, Res Inst Hlth Sci IUNICS IdisPa, Palma De Mallorca, Spain	Universidade Federal da Bahia; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Institut Investigacio Sanitaria Illes Balears (IdISBa); Universitat de les Illes Balears	Cosmo, C (corresponding author), Univ Fed Bahia, Interact Proc Organs & Syst, Postgrad Program, Salvador, BA, Brazil.	ccosmo@ufba.br	Montoya, Pedro/A-4666-2009; Miranda, Jose/HCI-6099-2022; de Sena, Eduardo Pondé/D-2481-2010; Baptista, Abrahão F/N-8036-2018	Montoya, Pedro/0000-0001-8652-948X; de Sena, Eduardo Pondé/0000-0002-6166-8093; Baptista, Abrahão F/0000-0001-7870-3820; de Araujo, Arao/0000-0001-5861-6818	CAPES/Brazil	CAPES/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors received no specific funding for this trial. CC and PM received scholarship from CAPES/Brazil.	Accornero N, 2014, J NEUROPHYSIOL, V112, P1367, DOI 10.1152/jn.00088.2014; Agarwal Rashi, 2012, Innov Clin Neurosci, V9, P10; Ambrus GG, 2012, BRAIN STIMUL, V5, P499, DOI 10.1016/j.brs.2011.12.001; Antshel KM, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-72; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Berman SM, 2009, MOL PSYCHIATR, V14, P123, DOI 10.1038/mp.2008.90; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Boggio PS, 2007, J AFFECT DISORDERS, V101, P91, DOI 10.1016/j.jad.2006.10.026; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690; Carlson RV, 2004, BRIT J CLIN PHARMACO, V57, P695, DOI 10.1111/j.1365-2125.2004.02103.x; Cubillo A, 2011, PSYCHIAT RES-NEUROIM, V193, P17, DOI 10.1016/j.pscychresns.2010.12.014; Demirtas-Tatlidede A, 2013, NEUROPHARMACOLOGY, V64, P566, DOI 10.1016/j.neuropharm.2012.06.020; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; Ditye T, 2012, EXP BRAIN RES, V219, P363, DOI 10.1007/s00221-012-3098-4; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Doyle AE, 2006, J CLIN PSYCHIAT, V67, P21; Durston S, 2011, BIOL PSYCHIAT, V69, P1178, DOI 10.1016/j.biopsych.2010.07.037; Fecteau S, 2007, J NEUROSCI, V27, P12500, DOI 10.1523/JNEUROSCI.3283-07.2007; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jacobson L, 2012, CLIN NEUROPHYSIOL, V123, P979, DOI 10.1016/j.clinph.2011.09.016; Kang EK, 2009, RESTOR NEUROL NEUROS, V27, P645, DOI 10.3233/RNN-2009-0514; Keeser D, 2011, J NEUROSCI, V31, P15284, DOI 10.1523/JNEUROSCI.0542-11.2011; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Lange KW, 2010, ADHD-ATTEND DEFICIT, V2, P241, DOI 10.1007/s12402-010-0045-8; Lapenta OM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00256; Lauro LJR, 2014, CORTEX, V58, P99, DOI 10.1016/j.cortex.2014.05.003; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Loo CK, 2012, BRIT J PSYCHIAT, V200, P52, DOI 10.1192/bjp.bp.111.097634; Loo CK, 2010, INT J NEUROPSYCHOPH, V13, P61, DOI 10.1017/S1461145709990411; Lundervold AJ, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-27; Martin DM, 2014, EXP BRAIN RES, V232, P3345, DOI 10.1007/s00221-014-4022-x; McGough JJ, 2015, BRAIN STIMUL, V8, P299, DOI 10.1016/j.brs.2014.11.013; Neuling Toralf, 2012, Front Psychiatry, V3, P83; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Noetscher GM, 2014, IEEE T BIO-MED ENG, V61, P2488, DOI 10.1109/TBME.2014.2322774; O'Connell NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047514; Oliveira JF, 2013, NEUROSCI LETT, V537, P60, DOI 10.1016/j.neulet.2013.01.023; Polania R, 2012, HUM BRAIN MAPP, V33, P2499, DOI 10.1002/hbm.21380; Ranby KW, 2012, J CLIN CHILD ADOLESC, V41, P261, DOI 10.1080/15374416.2012.654465; Rubia K, 2014, REV NEUROLOGIA, V58, pS3, DOI 10.33588/rn.58S01.2013570; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Turi Z, 2015, CORTEX, V63, P145, DOI 10.1016/j.cortex.2014.08.026; Wirth M, 2011, NEUROPSYCHOLOGIA, V49, P3989, DOI 10.1016/j.neuropsychologia.2011.10.015; Wolkenstein L, 2013, BIOL PSYCHIAT, V73, P646, DOI 10.1016/j.biopsych.2012.10.010	54	49	54	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135371	10.1371/journal.pone.0135371	http://dx.doi.org/10.1371/journal.pone.0135371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267861	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492300108
J	Huang, BY; Zhan, YP; Zong, WJ; Yu, CJ; Li, JF; Qu, YM; Han, S				Huang, Bo Yuan; Zhan, Yi Ping; Zong, Wen Jing; Yu, Chun Jiang; Li, Jun Fa; Qu, Yan Ming; Han, Song			The PD-1/B7-H1 Pathway Modulates the Natural Killer Cells versus Mouse Glioma Stem Cells	PLOS ONE			English	Article							NK CELLS; PROGRAMMED DEATH-1; T-CELLS; PD-1; EXPRESSION; ANTIBODY; CANCER; SAFETY; GLIOBLASTOMA; RADIOTHERAPY	Purpose Glioblastoma multiforme (GBM) is the most malignant primary type of brain tumor in adults. There has been increased focus on the immunotherapies to treat GBM patients, the therapeutic value of natural killer (NK) cells is still unknown. Programmed death-1 (PD-1) is a major immunological checkpoint that can negatively regulate the T-cell-mediated immune response. We tested the combination of the inhibiting the PD-1/B7H1 pathway with a NK-cell mediated immune response in an orthotopic mouse model of GBM. Methods and Materials Mouse glioma stem cells (GL261GSCs) and mouse NK cells were isolated and identified. A lactate dehydrogenase (LDH) assay was perfomed to detect the cytotoxicity of NK cells against GL261GSCs. GL261GSCs were intracranially implanted into mice, and the mice were stratified into 3 treatment groups: 1) control, 2) NK cells treatment, and 3) PD-1 inhibited NK cells treatment group. Overall survival was quantified, and animal magnetic resonance imaging (MRI) was performed to determine tumor growth. The brains were harvested after the mice were euthanized, and immunohistochemistry against CD45 and PCNA was performed. Results The mouse NK cells were identified as 90% CD3(-)NK1.1(+)CD335(+) by flow cytometric analysis. In the LDH assay, the ratios of the damaged GL261GSCs, with the E:T ratios of 2.5:1, 5: 1, and 10: 1, were as follows: 1) non-inhibited group: 7.42%, 11.31%, and 15.1%, 2) B7H1 inhibited group: 14.75%, 18.25% and 29.1%, 3) PD-1 inhibited group: 15.53%, 19.21% and 29.93%, 4) double inhibited group: 33.24%, 42.86% and 54.91%. In the in vivo experiments, the mice in the PD-1 inhibited NK cells treatment group and IL-2-stimulated-NK cells treatment group displayed a slowest tumor growth (F = 308.5, P<0.01) and a slower tumor growth compared with control group (F = 118.9, P<0.01), respectively. The median survival of the mice in the three groups were as follows: 1) conrol group: 29 days, 2) NK cells treatment group: 35 days (P = 0.0012), 3) PD-1 inhibited NK cells treatment group: 44 days (P = 0.0024). Immunologic data of PCNA-positive cell ratios and CD45-positive cell ratios of the tumor specimens in the three groups were as follows: 1) control group: 65.72% (PCNA) and 0.92% (CD45), 2) NK treatment group: 27.66% (PCNA) and 13.46% (CD45), and 3) PD-1 inhibited NK cells treatment group: 13.66% (PCNA) and 23.66% (CD45) (P<0.001). Conclusion The results demonstrated that blockade of PD-1/B7H1 pathway could promote mouse NK cells to kill the GL261GSCs, and the PD-1-inhibited NK cells could be a feasible immune therapeutic approach against GBM.	[Huang, Bo Yuan; Zhan, Yi Ping; Yu, Chun Jiang; Qu, Yan Ming] Capital Med Univ, Beijing San Bo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China; [Zong, Wen Jing] Capital Med Univ, Coll Tradit Chinese Med, Beijing, Peoples R China; [Li, Jun Fa; Han, Song] Capital Med Univ, Brain Sci Inst Beijing, Dept Neurosurg, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Yu, CJ (corresponding author), Capital Med Univ, Beijing San Bo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China.	cjyu1955@sina.com; junfali@ccmu.edu.cn	Li, Junfa/H-8707-2013	Li, Junfa/0000-0002-1930-9724	National Nature Fundation of China [81372694]	National Nature Fundation of China	This research was funded by National Natural Science Foundation of China. The author Chun Jiang Yu received the funding. This research is funded by the National Nature Fundation of China. Project name: Role played by the PD-1/B7-HI pathway modulates the natural killer cells against human glioma stem cells. Project number: 81372694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez IB, 2010, J INFECT DIS, V202, P524, DOI 10.1086/654932; Ansell SM, 2014, N ENGL J MED; Arase H, 2001, J IMMUNOL, V167, P1141, DOI 10.4049/jimmunol.167.3.1141; Avril T, 2012, BRAIN PATHOL, V22, P159, DOI 10.1111/j.1750-3639.2011.00515.x; Baker J, 2001, BLOOD, V97, P2923, DOI 10.1182/blood.V97.10.2923; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Cheng XX, 2013, J BIOL CHEM, V288, P11771, DOI 10.1074/jbc.M112.448126; Cunha LL, 2013, FUTURE ONCOL, V9, P1417, DOI 10.2217/fon.13.89; Demaria S, 2005, CLIN CANCER RES, V11, P728; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Dillman RO, 2004, J IMMUNOTHER, V27, P398, DOI 10.1097/00002371-200409000-00009; Engel JB, 2014, ARCH GYNECOL OBSTET, V289, P141, DOI 10.1007/s00404-013-2922-9; French AR, 2004, ARTHRITIS RES THER, V6, P8, DOI 10.1186/ar1034; HAYES RL, 1995, CANCER-AM CANCER SOC, V76, P840, DOI 10.1002/1097-0142(19950901)76:5<840::AID-CNCR2820760519>3.0.CO;2-R; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Ishikawa E, 2004, ANTICANCER RES, V24, P1861; Jin J, 2011, ONCOL REP, V25, P33, DOI 10.3892/or_00001038; Kedmi M, 2015, ACTA HAEMATOL-BASEL, V133, P129, DOI 10.1159/000362151; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; LU PH, 1994, J IMMUNOL, V153, P1687; Marcus A, 2011, ONCOTARGET, V2, P525; Meinhardt K, 2012, J IMMUNOL METHODS, V378, P1, DOI 10.1016/j.jim.2012.01.008; Miller JS, 2002, CANCER INVEST, V20, P405, DOI 10.1081/CNV-120001185; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Mou X, 2014, SCI REP-UK, V4, DOI 10.1038/srep06138; Nam DH, 2004, ONCOL REP, V11, P263; Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9; Ogbomo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066825; Pak-Wittel MA, 2014, CURR PROTOC IMMUNOL, V105, P221; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Poli A, 2013, ONCOTARGET, V4, P1527, DOI 10.18632/oncotarget.1291; Riella LV, 2012, AM J TRANSPLANT, V12, P2575, DOI 10.1111/j.1600-6143.2012.04224.x; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Weber J, 2010, SEMIN ONCOL, V37, P430, DOI 10.1053/j.seminoncol.2010.09.005; Wu A, 2007, J IMMUNOTHER, V30, P789, DOI 10.1097/CJI.0b013e318155a0f6; Zhang SJ, 2013, ONCOL LETT, V6, P1649, DOI 10.3892/ol.2013.1623	42	87	92	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134715	10.1371/journal.pone.0134715	http://dx.doi.org/10.1371/journal.pone.0134715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266810	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492300056
J	Jelbert, SA; Singh, PJ; Gray, RD; Taylor, AH				Jelbert, Sarah A.; Singh, Puja J.; Gray, Russell D.; Taylor, Alex H.			New Caledonian Crows Rapidly Solve a Collaborative Problem without Cooperative Cognition	PLOS ONE			English	Article							INEQUITY AVERSION; SOCIAL-STRUCTURE; HOOK-TOOLS; ET-AL.; WILD; BEHAVIOR; MANUFACTURE; CHIMPANZEES; EVOLUTION; ELEPHANTS	There is growing comparative evidence that the cognitive bases of cooperation are not unique to humans. However, the selective pressures that lead to the evolution of these mechanisms remain unclear. Here we show that while tool-making New Caledonian crows can produce collaborative behavior, they do not understand the causality of cooperation nor show sensitivity to inequity. Instead, the collaborative behavior produced appears to have been underpinned by the transfer of prior experience. These results suggest that a number of possible selective pressures, including tool manufacture and mobbing behaviours, have not led to the evolution of cooperative cognition in this species. They show that causal cognition can evolve in a domain specific manner-understanding the properties and flexible uses of physical tools does not necessarily enable animals to grasp that a conspecific can be used as a social tool.	[Jelbert, Sarah A.; Singh, Puja J.; Gray, Russell D.; Taylor, Alex H.] Univ Auckland, Sch Psychol, Auckland 1, New Zealand; [Singh, Puja J.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of Auckland; University of St Andrews	Jelbert, SA (corresponding author), Univ Auckland, Sch Psychol, Private Bag 92019, Auckland 1, New Zealand.	s.jelbert@auckland.ac.nz	Taylor, Alex H/D-6428-2012	Taylor, Alex/0000-0003-3492-7667; Jelbert, Sarah/0000-0002-7503-0648	University of Auckland Doctoral Scholarship; University of Auckland Master's Scholarship; Corpus Christi college, University of Cambridge; Cogito Foundation grant; Rutherford Discovery Fellowship; New Zealand Marsden Fund	University of Auckland Doctoral Scholarship; University of Auckland Master's Scholarship; Corpus Christi college, University of Cambridge; Cogito Foundation grant; Rutherford Discovery Fellowship; New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by a University of Auckland Doctoral Scholarship (S.A.J.), a University of Auckland Master's Scholarship (P.J.S.), a Research Fellowship (Corpus Christi college, University of Cambridge), Cogito Foundation grant and a Rutherford Discovery Fellowship (A.H.T.), and a grant from the New Zealand Marsden Fund (A.H.T. and R.D.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie EA, 2006, P ROY SOC B-BIOL SCI, V273, P513, DOI 10.1098/rspb.2005.3361; Barrett L, 2012, PHILOS T R SOC B, V367, P2108, DOI 10.1098/rstb.2012.0113; Barton RA, 2012, PHILOS T R SOC B, V367, P2097, DOI 10.1098/rstb.2012.0112; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Boogert NJ, 2013, P NATL ACAD SCI USA, V110, pE273, DOI 10.1073/pnas.1219664110; Brauer J, 2009, AM J PRIMATOL, V71, P175, DOI 10.1002/ajp.20639; Brosnan S.F., 2006, SOC JUSTICE RES, V19, P153, DOI [10.1007/s11211-006-0002-z, DOI 10.1007/S11211-006-0002-Z]; Brosnan SF, 2006, AM J PRIMATOL, V68, P713, DOI 10.1002/ajp.20261; Brosnan SF, 2014, SCIENCE, V346, P314, DOI 10.1126/science.1251776; Brosnan SF, 2013, P NATL ACAD SCI USA, V110, P10416, DOI 10.1073/pnas.1301194110; Brosnan SF, 2011, FOLIA PRIMATOL, V82, P56, DOI 10.1159/000328142; Brosnan SF, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00043; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Buchsbaum D, 2012, PHILOS T R SOC B, V367, P2202, DOI 10.1098/rstb.2012.0122; Byrne R, 1989, MACHIAVELLIAN INTELL; Chalmeau R, 1997, INT J PRIMATOL, V18, P23, DOI 10.1023/A:1026337006136; CHEVALIERSKOLNIKOFF S, 1993, ANIM BEHAV, V46, P209, DOI 10.1006/anbe.1993.1183; Cronin KA, 2005, ANIM BEHAV, V69, P133, DOI 10.1016/j.anbehav.2004.02.024; Drea CM, 2009, ANIM BEHAV, V78, P967, DOI 10.1016/j.anbehav.2009.06.030; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Durand E, 2007, J THEOR BIOL, V249, P262, DOI 10.1016/j.jtbi.2007.07.012; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fletcher GE, 2008, AM J PRIMATOL, V70, P901, DOI 10.1002/ajp.20576; Freeman HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076297; Frith CD, 2012, PHILOS T R SOC B, V367, P2213, DOI 10.1098/rstb.2012.0123; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; Hart BL, 2001, ANIM BEHAV, V62, P839, DOI 10.1006/anbe.2001.1815; Heyes C, 2012, PHILOS T R SOC B, V367, P2181, DOI 10.1098/rstb.2012.0120; Heyes C, 2012, PHILOS T R SOC B, V367, P2091, DOI 10.1098/rstb.2012.0111; Holzhaider JC, 2011, ANIM BEHAV, V81, P83, DOI 10.1016/j.anbehav.2010.09.015; Holzhaider JC, 2010, LEARN BEHAV, V38, P206, DOI 10.3758/LB.38.3.206; Hunt GR, 2012, ETHOLOGY, V118, P423, DOI 10.1111/j.1439-0310.2012.02027.x; Hunt GR, 2000, P ROY SOC B-BIOL SCI, V267, P403, DOI 10.1098/rspb.2000.1015; Hunt GR, 2004, P ROY SOC B-BIOL SCI, V271, pS88, DOI 10.1098/rsbl.2003.0085; Hunt GR, 2004, ANIM COGN, V7, P114, DOI 10.1007/s10071-003-0200-0; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Jablonka E, 2012, PHILOS T R SOC B, V367, P2152, DOI 10.1098/rstb.2012.0117; Jelbert SA, 2015, J COMP PSYCHOL, V129, P283, DOI 10.1037/a0039313; Jelbert SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092895; Logan CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103049; Martin-Ordas G., 2009, INT J COMP PSYCHOL, V22, P43; Martin-Ordas G, 2008, ANIM COGN, V11, P423, DOI 10.1007/s10071-007-0132-1; Massen JJM, 2012, AM J PRIMATOL, V74, P145, DOI 10.1002/ajp.21014; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; McGrew WC, 2010, SCIENCE, V328, P579, DOI 10.1126/science.1187921; Melis AP, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0009; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Mendres KA, 2000, ANIM BEHAV, V60, P523, DOI 10.1006/anbe.2000.1512; Neiworth JJ, 2009, J COMP PSYCHOL, V123, P10, DOI 10.1037/a0012662; Nishida T., 1979, Perspectives on Human Evolution, V5, P73; Ostojic L, 2014, ANIM COGN, V17, P445, DOI 10.1007/s10071-013-0676-1; Peron F, 2011, ANIM COGN, V14, P545, DOI 10.1007/s10071-011-0389-2; Plotnik JM, 2011, P NATL ACAD SCI USA, V108, P5116, DOI 10.1073/pnas.1101765108; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; Rutz C, 2012, CURR BIOL, V22, pR669, DOI 10.1016/j.cub.2012.06.037; Scheid C, 2010, ANIM COGN, V13, P545, DOI 10.1007/s10071-009-0305-1; Schulte BA, 2000, ZOO BIOL, V19, P447, DOI 10.1002/1098-2361(2000)19:5&lt;447::AID-ZOO12&gt;3.0.CO;2-#; Seed AM, 2008, P ROY SOC B-BIOL SCI, V275, P1421, DOI 10.1098/rspb.2008.0111; Silk J.B., 2005, MORAL SENTIMENTS MAT, P43; Sterelny K, 2007, PHILOS T R SOC B, V362, P719, DOI 10.1098/rstb.2006.2006; Sterelny K, 2012, PHILOS T R SOC B, V367, P2141, DOI 10.1098/rstb.2012.0116; Sukumar R., 1993, ASIAN ELEPHANT ECOLO; Takimoto A, 2010, ANIM COGN, V13, P249, DOI 10.1007/s10071-009-0262-8; Talbot CF, 2011, BIOL LETTERS, V7, P680, DOI 10.1098/rsbl.2011.0211; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Taylor AH, 2011, BIOL LETT; Taylor Alex, 2009, Communicative & Integrative Biology, V2, P311; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; Taylor AH, 2013, P NATL ACAD SCI USA, V110, pE337, DOI 10.1073/pnas.1219586110; Taylor AH, 2013, P NATL ACAD SCI USA, V110, pE274, DOI 10.1073/pnas.1220564110; Taylor AH, 2012, P NATL ACAD SCI USA, V109, P16389, DOI 10.1073/pnas.1208724109; Taylor AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026887; Taylor AH, 2010, P ROY SOC B-BIOL SCI, V277, P2637, DOI 10.1098/rspb.2010.0285; Vail AL, 2014, CURR BIOL, V24, pR791, DOI 10.1016/j.cub.2014.07.033; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; van Wolkenten M, 2007, P NATL ACAD SCI USA, V104, P18854, DOI 10.1073/pnas.0707182104; Volter CJ, 2015, ANIM BEHAV, V100, P126, DOI 10.1016/j.anbehav.2014.11.025; Wascher CAF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056885; Whiten A., 1997, MACHIAVELLIAN INTELL, DOI [10.1017/CBO9780511525636, DOI 10.1017/CBO9780511525636]; Wich S. A., 2009, ORANGUTANS GEOGRAPHI	84	18	19	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133253	10.1371/journal.pone.0133253	http://dx.doi.org/10.1371/journal.pone.0133253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266937	Green Published, Green Accepted, gold			2022-12-27	WOS:000359492300013
J	Ledee, D; Smith, L; Bruce, M; Kajimoto, M; Isern, N; Portman, MA; Olson, AK				Ledee, Dolena; Smith, Lincoln; Bruce, Margaret; Kajimoto, Masaki; Isern, Nancy; Portman, Michael A.; Olson, Aaron K.			c-Myc Alters Substrate Utilization and O-GlcNAc Protein Posttranslational Modifications without Altering Cardiac Function during Early Aortic Constriction	PLOS ONE			English	Article							PRESSURE-OVERLOAD; HEART-FAILURE; MYOCYTE HYPERTROPHY; GENE-EXPRESSION; METABOLISM; GROWTH; CARDIOMYOPATHY; DEFICIENCY; TRANSITION; PREVENTS	Hypertrophic stimuli cause transcription of the proto-oncogene c-Myc (Myc). Prior work showed that myocardial knockout of c-Myc (Myc) attenuated hypertrophy and decreased expression of metabolic genes after aortic constriction. Accordingly, we assessed the interplay between Myc, substrate oxidation and cardiac function during early pressure overload hypertrophy. Mice with cardiac specific, inducible Myc knockout (MycKO-TAC) and non-transgenic littermates (Cont-TAC) were subjected to transverse aortic constriction (TAC; n = 7/group). Additional groups underwent sham surgery (Cont-Sham and MycKO-Sham, n = 5 per group). After two weeks, function was measured in isolated working hearts along with substrate fractional contributions to the citric acid cycle by using perfusate with C-13 labeled mixed fatty acids, lactate, ketone bodies and unlabeled glucose and insulin. Cardiac function was similar between groups after TAC although + dP/dT and -dP/dT trended towards improvement in MycKO-TAC versus Cont-TAC. In sham hearts, Myc knockout did not affect cardiac function or substrate preferences for the citric acid cycle. However, Myc knockout altered fractional contributions during TAC. The unlabeled fractional contribution increased in MycKO-TAC versus Cont-TAC, whereas ketone and free fatty acid fractional contributions decreased. Additionally, protein posttranslational modifications by O-GlcNAc were significantly greater in Cont-TAC versus both Cont-Sham and MycKO-TAC. In conclusion, Myc alters substrate preferences for the citric acid cycle during early pressure overload hypertrophy without negatively affecting cardiac function. Myc also affects protein posttranslational modifications by O-GlcNAc during hypertrophy, which may regulate Myc-induced metabolic changes.	[Ledee, Dolena; Bruce, Margaret; Kajimoto, Masaki; Portman, Michael A.; Olson, Aaron K.] Seattle Childrens Res Inst, Seattle, WA 98105 USA; [Smith, Lincoln] Univ Washington, Dept Pediat, Div Crit Care Med, Seattle, WA 98195 USA; [Isern, Nancy] Pacific NW Natl Lab, EMSL, Richland, WA 99352 USA; [Portman, Michael A.; Olson, Aaron K.] Univ Washington, Dept Pediat, Div Cardiol, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Washington; University of Washington Seattle	Olson, AK (corresponding author), Seattle Childrens Res Inst, Seattle, WA 98105 USA.	Aaron.olson@seattlechildrens.org	Kajimoto, Masaki/GPJ-9489-2022	Kajimoto, Masaki/0000-0001-9377-1354; Ledee, Dolena/0000-0003-1041-4795; Olson, Aaron/0000-0002-5237-400X	National Heart, Lung, and Blood Institute [K08-HL-092333]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122546, K08HL092333, T32HL007828] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute, Grant K08-HL-092333 to A. K. Olson.	Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331; Ardehali H, 2012, EUR J HEART FAIL, V14, P120, DOI 10.1093/eurjhf/hfr173; Darley-Usmar VM, 2012, J MOL CELL CARDIOL, V52, P538, DOI 10.1016/j.yjmcc.2011.08.009; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; de Almeida A.C., 2010, J VIS EXP; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Dzimiri N, 2004, FUND CLIN PHARMACOL, V18, P39, DOI 10.1046/j.0767-3981.2003.00212.x; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Gao ZH, 2013, P NATL ACAD SCI USA, V110, P13570, DOI 10.1073/pnas.1308806110; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095; Kolwicz SC, 2012, CIRC RES, V111, P728, DOI 10.1161/CIRCRESAHA.112.268128; KORNFELD R, 1967, J BIOL CHEM, V242, P3135; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Krueger JJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE983, DOI 10.1152/ajpendo.2001.281.5.E983; Laczy B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018417; Ledee D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065532; Lee HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007172; Liao RL, 2002, CIRCULATION, V106, P2125, DOI 10.1161/01.CIR.0000034049.61181.F3; Malloy CR, 1996, MAGN RESON MATER PHY, V4, P35, DOI 10.1007/BF01759778; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Olson AK, 2013, J MOL CELL CARDIOL, V55, P156, DOI 10.1016/j.yjmcc.2012.07.005; Pereira RO, 2014, FASEB J, V28, P3691, DOI 10.1096/fj.14-253823; Pereira RO, 2014, J MOL CELL CARDIOL, V72, P95, DOI 10.1016/j.yjmcc.2014.02.011; Pereira RO, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000301; Rees ML, 2015, BIOCHEM BIOPH RES CO, V459, P430, DOI 10.1016/j.bbrc.2015.02.122; Riehle C, 2011, CIRC RES, V109, P783, DOI 10.1161/CIRCRESAHA.111.243964; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; STARKSEN NF, 1986, P NATL ACAD SCI USA, V83, P8348, DOI 10.1073/pnas.83.21.8348; Taketani S, 1997, CIRCULATION, V96, P83; Taketani S, 2001, ANN THORAC SURG, V71, P1154, DOI 10.1016/S0003-4975(00)02656-4; Xiao GS, 2001, CIRC RES, V89, P1122, DOI 10.1161/hh2401.100742; Zhabyeyev P, 2013, CARDIOVASC RES, V97, P676, DOI 10.1093/cvr/cvs424; Zhong WG, 2006, EMBO J, V25, P3869, DOI 10.1038/sj.emboj.7601252	38	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135262	10.1371/journal.pone.0135262	http://dx.doi.org/10.1371/journal.pone.0135262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266538	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300088
J	Lee, YH; Wu, ZY				Lee, Yu-Hsiang; Wu, Zhen-Yu			Enhancing Macrophage Drug Delivery Efficiency via Co-Localization of Cells and Drug-Loaded Microcarriers in 3D Resonant Ultrasound Field	PLOS ONE			English	Article							STANDING-WAVE; IN-VITRO; GENE DELIVERY; MOUSE MODEL; MANIPULATION; MICROPARTICLES; PLGA; VIVO; MICROSPHERES; FABRICATION	In this study, a novel synthetic 3D molecular transfer system which involved the use of model drug calcein-AM-encapsulated poly(lactic-co-glycolic acid) microspheres (CAPMs) and resonant ultrasound field (RUF) with frequency of 1 MHz and output intensity of 0.5W/cm(2) for macrophage drug delivery was explored. We hypothesized that the efficiency of CAPMs-mediated drug delivery aided by RUF can be promoted by increasing the contact opportunities between cells and the micrometer-sized drug carriers due to effects of acoustic radiation forces generated by RUF. Through the fluoromicroscopic and flow cytometric analyses, our results showed that both DH82 macrophages and CAPMs can be quickly brought to acoustic pressure nodes within 20 sec under RUF exposure, and were consequently aggregated throughout the time course. The efficacy of cellular uptake of CAPMs was enhanced with increased RUF exposure time where a 3-fold augmentation (P < 0.05) was obtained after 15 min of RUF exposure. We further demonstrated that the enhanced CAPM delivery efficiency was mainly contributed by the co-localization of cells and CAPMs resulting from the application of the RUF, rather than from sonoporation. In summary, the developed molecular delivery approach provides a feasible means for macrophage drug delivery.	[Lee, Yu-Hsiang; Wu, Zhen-Yu] Natl Cent Univ, Grad Inst Biomed Engn, Taoyuan, Taiwan	National Central University	Lee, YH (corresponding author), Natl Cent Univ, Grad Inst Biomed Engn, Taoyuan, Taiwan.	yuhsianl@ncu.edu.tw			National Central University - Cathay General Hospital Joint Research Center [104CGH-NCU-A1]	National Central University - Cathay General Hospital Joint Research Center	This work was financially supported by the National Central University - Cathay General Hospital Joint Research Center (104CGH-NCU-A1 to Y.-H. Lee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHNSON AB, 1995, J VIROL METHODS, V54, P131, DOI 10.1016/0166-0934(95)00035-S; Bruus H, 2011, LAB CHIP, V11, P3579, DOI 10.1039/c1lc90058g; Burke B, 2002, J LEUKOCYTE BIOL, V72, P417; Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y; Cioni Chiara, 2012, Front Psychiatry, V3, P47, DOI 10.3389/fpsyt.2012.00047; Clifford AB, 2013, ONCOL REP, V30, P890, DOI 10.3892/or.2013.2508; Courtney CRP, 2010, J ACOUST SOC AM, V128, pE195, DOI 10.1121/1.3479976; Fong D, 2015, ACTA BIOMATER, V12, P183, DOI 10.1016/j.actbio.2014.10.026; Freedman BD, 2003, IMMUNOL RES, V27, P261, DOI 10.1385/IR:27:2-3:261; Gao JM, 2013, BIOCONJUGATE CHEM, V24, P1332, DOI 10.1021/bc400011v; Glucksam-Galnoy Y, 2012, J CONTROL RELEASE, V160, P388, DOI 10.1016/j.jconrel.2011.10.008; Hawkes JJ, 1998, ULTRASONICS, V36, P925, DOI 10.1016/S0041-624X(98)00019-5; Hawkes JJ, 1998, ULTRASONICS, V36, P901, DOI 10.1016/S0041-624X(98)00018-3; Hirota K, 2011, COLLOID SURFACE B, V87, P293, DOI 10.1016/j.colsurfb.2011.05.032; Holmes CA, 2013, ACS APPL MATER INTER, V5, P524, DOI 10.1021/am303029k; Hosta-Rigau L, 2012, ADV HEALTHC MATER, V1, P791, DOI 10.1002/adhm.201200092; Hultstrom J, 2007, ULTRASOUND MED BIOL, V33, P145, DOI 10.1016/j.ultrasmedbio.2006.07.024; Kelly C, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/727241; Lemmon JCM, 2011, J IMMUNOL METHODS, V371, P152, DOI 10.1016/j.jim.2011.06.001; Li J, 2012, CURR RHEUMATOL REP, V14, P445, DOI 10.1007/s11926-012-0272-4; Montes-Fonseca SL, 2012, NANOMED-NANOTECHNOL, V8, P853, DOI 10.1016/j.nano.2011.10.002; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Marino S, 2015, INFECT IMMUN, V83, P324, DOI 10.1128/IAI.02494-14; Nahar M, 2009, PHARM RES-DORDR, V26, P2588, DOI 10.1007/s11095-009-9973-4; Obeid E, 2013, INT J ONCOL, V43, P5, DOI 10.3892/ijo.2013.1938; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj.gt.3301624; Sebastiaan MB, 2011, FUTURE VIROL, V6, P187; Spengler J, 2000, ULTRASONICS, V38, P624, DOI 10.1016/S0041-624X(99)00145-6; Spengler JF, 2003, AICHE J, V49, P2773, DOI 10.1002/aic.690491110; van Noort JM, 2013, BIOMATERIALS, V34, P831, DOI 10.1016/j.biomaterials.2012.10.028; Voigt A, 1999, IND ENG CHEM RES, V38, P4037, DOI 10.1021/ie9900925; Wiese M, 2010, J IMMUNOL METHODS, V353, P102, DOI 10.1016/j.jim.2009.12.002	33	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135321	10.1371/journal.pone.0135321	http://dx.doi.org/10.1371/journal.pone.0135321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267789	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300096
J	Levy, JW; Simasathien, S; Watanaveeradej, V; Bhoomiboonchoo, P; Fernandez, S; Jarman, RG; Klungthong, C; Gibbons, RV; Kerdpanich, P; Piboonbanakit, D; Chirabandhu, T; Yoon, IK				Levy, Jens W.; Simasathien, Sriluck; Watanaveeradej, Veerachai; Bhoomiboonchoo, Piraya; Fernandez, Stefan; Jarman, Richard G.; Klungthong, Chonticha; Gibbons, Robert V.; Kerdpanich, Phirangkool; Piboonbanakit, Danaband; Chirabandhu, Tundorn; Yoon, In-Kyu			Influenza Vaccine Effectiveness in the Tropics: Moderate Protection in a Case Test-Negative Analysis of a Hospital-Based Surveillance Population in Bangkok between August 2009 and January 2013	PLOS ONE			English	Article							SEASONAL INFLUENZA; CIRCULATION	Influenza in the tropics occurs year round with peaks that correspond variably to temperate regions. However, data on influenza vaccine effectiveness (VE) in the tropics is sparse. We report on the effectiveness of influenza vaccine to prevent medically attended laboratory confirmed influenza from sentinel surveillance conducted at a Thai military medical facility in Bangkok, Thailand from August 2009 to January 2013. Patients >= 6 months old presenting with influenza-like illness underwent combined nasal/throat swabs which were tested by influenza RT-PCR. A case test-negative study design was used to evaluate VE. Of 2999 samples available for analysis, 1059 (35.3%) were PCR-positive (cases) and 1940 (64.6%) were PCR-negative (test-negative controls). Five hundred and seven (16.9%) of these patients reported being vaccinated within the previous 12 months. Periods of high and low influenza activity were defined based on publicly available Thai Ministry of Public Health data. Overall VE adjusted for age and epiweek was found to be 50.1% (95% CI: 35.0, 61.9%). The May to April adjusted VE for year 2010, 2011 and 2012 was 57.7% (95% CI: 33.7, 73.8%), 57.1% (95% CI: 35.2, 68.3%) and 37.6% (95% CI: 3.5, 62.9%). During high influenza activity in years with the same vaccine formulation, the adjusted VE was 54.9% (95% CI: 38.9, 66.9%). VE appeared to be much higher during high versus low influenza activity periods. The adjusted point estimate for VE was highest in the 18-49 year age group (76.6%) followed by 6-23 months (58.1%) and 2-17 years (52.5%). Adjusted estimates were not done for those >= 50 years of age due to small numbers. VE in patients with underlying disease was 75.5% compared to 48.0% in those without. Our findings demonstrate moderate protection by influenza vaccination and support the utility of influenza vaccination in the tropics including in very young children and those with underlying disease.	[Levy, Jens W.; Bhoomiboonchoo, Piraya; Fernandez, Stefan; Klungthong, Chonticha; Gibbons, Robert V.; Yoon, In-Kyu] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand; [Simasathien, Sriluck; Watanaveeradej, Veerachai; Kerdpanich, Phirangkool; Piboonbanakit, Danaband; Chirabandhu, Tundorn] Phramongkutklao Hosp, Bangkok, Thailand; [Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Phramongkutklao Hospital; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Levy, JW (corresponding author), Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand.	jenslevy@gmail.com			Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance and Response System (AFHSC-GEIS)	Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance and Response System (AFHSC-GEIS)	The funding was provided by Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance and Response System (AFHSC-GEIS with no specific grant number). The funding source had no role in the study design, data collection, analysis and interpretation, manuscript writing or manuscript submission for publication.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P201; Belongia EA, 2011, VACCINE, V29, P6558, DOI 10.1016/j.vaccine.2011.07.002; Blyth CC, 2014, PEDIATRICS, V133, pE1218, DOI 10.1542/peds.2013-3707; Castilla J, 2012, VACCINE, V30, P195, DOI 10.1016/j.vaccine.2011.11.024; CDC, 2009, CDC PROT REALT RTPCR; Chittaganpitch M, 2012, INFLUENZA OTHER RESP, V6, P276, DOI 10.1111/j.1750-2659.2011.00302.x; Dawood FS, 2014, INFLUENZA OTHER RESP, V8, P463, DOI 10.1111/irv.12233; Fielding JE, 2012, EUROSURVEILLANCE, V17, P8; Foppa IM, 2013, VACCINE, V31, P3104, DOI 10.1016/j.vaccine.2013.04.026; Gupta V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052842; Kelly HA, 2013, INFLUENZA OTHER RESP, V7, P729, DOI 10.1111/irv.12018; Kissling E, 2011, EUROSURVEILLANCE, V16, P11; Kosasih H, 2013, INFLUENZA OTHER RESP, V7, P312, DOI 10.1111/j.1750-2659.2012.00403.x; Ohmit SE, 2013, CLIN INFECT DIS, V56, P1363, DOI 10.1093/cid/cit060; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Prachayangprecha S, 2013, J INFECT DEV COUNTR, V7, P734, DOI 10.3855/jidc.2929; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Thailand Ministry of Public Health, 2014, NAT INFL CTR WEEKL R; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wanitchaya Kittikraisak PS, 2014, INFLUENZA OTHER RESP, DOI [10.1111/irv.12302, DOI 10.1111/IRV.12302]; WHO, 2014, INFL SEAS 2014; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315	26	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134318	10.1371/journal.pone.0134318	http://dx.doi.org/10.1371/journal.pone.0134318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267430	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300039
J	McClure, ML; Burdett, CL; Farnsworth, ML; Lutman, MW; Theobald, DM; Riggs, PD; Grear, DA; Miller, RS				McClure, Meredith L.; Burdett, Christopher L.; Farnsworth, Matthew L.; Lutman, Mark W.; Theobald, David M.; Riggs, Philip D.; Grear, Daniel A.; Miller, Ryan S.			Modeling and Mapping the Probability of Occurrence of Invasive Wild Pigs across the Contiguous United States	PLOS ONE			English	Article							BOAR SUS-SCROFA; MULTIMODEL INFERENCE; POPULATION-DENSITY; BEHAVIORAL ECOLOGY; RESOURCE SELECTION; HABITAT SELECTION; RANGE EXPANSION; HOME-RANGE; ABUNDANCE; DEER	Wild pigs (Sus scrofa), also known as wild swine, feral pigs, or feral hogs, are one of the most widespread and successful invasive species around the world. Wild pigs have been linked to extensive and costly agricultural damage and present a serious threat to plant and animal communities due to their rooting behavior and omnivorous diet. We modeled the current distribution of wild pigs in the United States to better understand the physiological and ecological factors that may determine their invasive potential and to guide future study and eradication efforts. Using national-scale wild pig occurrence data reported between 1982 and 2012 by wildlife management professionals, we estimated the probability of wild pig occurrence across the United States using a logistic discrimination function and environmental covariates hypothesized to influence the distribution of the species. Our results suggest the distribution of wild pigs in the U.S. was most strongly limited by cold temperatures and availability of water, and that they were most likely to occur where potential home ranges had higher habitat heterogeneity, providing access to multiple key resources including water, forage, and cover. High probability of occurrence was also associated with frequent high temperatures, up to a high threshold. However, this pattern is driven by pigs' historic distribution in warm climates of the southern U.S. Further study of pigs' ability to persist in cold northern climates is needed to better understand whether low temperatures actually limit their distribution. Our model highlights areas at risk of invasion as those with habitat conditions similar to those found in pigs' current range that are also near current populations. This study provides a macro-scale approach to generalist species distribution modeling that is applicable to other generalist and invasive species.	[McClure, Meredith L.; Farnsworth, Matthew L.; Theobald, David M.] Conservat Sci Partners, Truckee, CA 96161 USA; [Burdett, Christopher L.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Riggs, Philip D.; Grear, Daniel A.; Miller, Ryan S.] US Anim & Plant Hlth Inspect Serv, Ctr Epidemiol & Anim Hlth, USDA, Ft Collins, CO USA; [Lutman, Mark W.] US Anim & Plant Hlth Inspect Serv, Natl Wildlife Dis Program, USDA, Ft Collins, CO USA	Colorado State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	McClure, ML (corresponding author), Conservat Sci Partners, Truckee, CA 96161 USA.	meredith@csp-inc.org; Ryan.S.Miller@aphis.usda.gov	Miller, Ryan/H-9848-2019	Miller, Ryan/0000-0003-3892-0251; Grear, Daniel/0000-0002-5478-1549	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services, Center for Epidemiology and Animal Health (USDA APHIS) [12-9208-0301, 13-9208-0352]; Food and Drug Administration, Center for Food Safety and Applied Nutrition [12-9208-0301]; USDA APHIS	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services, Center for Epidemiology and Animal Health (USDA APHIS); Food and Drug Administration, Center for Food Safety and Applied Nutrition; USDA APHIS(United States Department of Agriculture (USDA))	Funding for this study was provided by U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services, Center for Epidemiology and Animal Health (USDA APHIS; Agreements #12-9208-0301, #13-9208-0352 to CLB). Additional funding at the onset of the project was provided by the Food and Drug Administration, Center for Food Safety and Applied Nutrition (Agreement #12-9208-0301 to CLB). MWL, PDR, DAG, and RSM are affiliated with the funding source (USDA APHIS) and contributed as detailed in 'Author Contributions' to study design, data collection and analysis, and preparation of the manuscript.	Acevedo P, 2006, ACTA THERIOL, V51, P327, DOI 10.1007/BF03192685; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Anderson DP, 2005, J WILDLIFE MANAGE, V69, P298, DOI 10.2193/0022-541X(2005)069&lt;0298:SSRSBR&gt;2.0.CO;2; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P618; [Anonymous], 2003, SWIN CAR HDB; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; Barrett A.P., 2003, NATL OPERATIONAL HYD; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Barton K., 2014, MUMIN MULTIMODEL INF; Belsley D. A., 1991, CONDITIONING DIAGNOS; Bevins SN, 2014, BIOSCIENCE, V64, P291, DOI 10.1093/biosci/biu015; Booth G. D., 1994, IDENTIFYING PROXY SE; Boughton EH, 2014, BIOL INVASIONS, V16, P2105, DOI 10.1007/s10530-014-0650-0; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brook RK, 2014, WILDLIFE SOC B, V38, P486, DOI 10.1002/wsb.424; Brunt D., 1933, Q J ROY METEOR SOC, V59, P351, DOI [10.1002/qj.49705925204, DOI 10.1002/QJ.49705925204]; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Choquenot D, 1996, FRONTIERS OF POPULATION ECOLOGY, P531; Choquenot D, 2003, J ANIM ECOL, V72, P14, DOI 10.1046/j.1365-2656.2003.00676.x; COLLINS SL, 1990, AM NAT, V135, P633, DOI 10.1086/285066; Danilov PI, 2012, RUSS J ECOL+, V43, P45, DOI 10.1134/S1067413612010043; Dexter N, 1998, WILDLIFE RES, V25, P547, DOI 10.1071/WR97119; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fernandez-Llario P, 2004, ACTA THERIOL, V49, P383, DOI 10.1007/BF03192536; Fitzpatrick MC, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00066.1; Forsyth DM, 2006, ECOLOGY, V87, P297, DOI 10.1890/05-0709; Franklin J, 2009, MAPPING SPECIES DIST, DOI [10.1007/s10980-011-9603-5, DOI 10.1007/S10980-011-9603-5]; FRASER D, 1989, APPL ANIM BEHAV SCI, V24, P13, DOI 10.1016/0168-1591(89)90121-4; Geisser H, 2005, J ZOOL, V267, P89, DOI 10.1017/S095283690500734X; Gipson PS, 1998, WILDLIFE SOC B, V26, P279; Hansen MH, 2002, STAT SCI, V17, P2, DOI 10.1214/ss/1023798997; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Honda T, 2009, MAMM STUDY, V34, P107, DOI 10.3106/041.034.0206; Huberty C.J., 1994, APPL DISCRIMINANT AN; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763; Jeschke JM, 2005, P NATL ACAD SCI USA, V102, P7198, DOI 10.1073/pnas.0501271102; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; Li WK, 2013, ECOGRAPHY, V36, P788, DOI 10.1111/j.1600-0587.2013.07585.x; Li WK, 2011, ECOGRAPHY, V34, P1096, DOI 10.1111/j.1600-0587.2011.06888.x; Long JL, 2003, INTRO MAMMALS WORLD; Lukacs PM, 2010, ANN I STAT MATH, V62, P117, DOI 10.1007/s10463-009-0234-4; Manly B.F.J., 2002, RESOURCE SELECTION A; Maselli V, 2014, EVOL BIOL, V41, P229, DOI 10.1007/s11692-013-9262-3; Mayer J., 1991, WILD PIGS US THEIR L; Mccann BE, 2014, J WILDLIFE MANAGE, V78, P202, DOI 10.1002/jwmg.651; McKnight TL, 1964, FERAL LIVESTOCK ANGL; Melis C, 2006, J BIOGEOGR, V33, P803, DOI 10.1111/j.1365-2699.2006.01434.x; Meng XJ, 2009, PHILOS T R SOC B, V364, P2697, DOI 10.1098/rstb.2009.0086; Merrill A, 2012, COMMENTS ON STATISTI; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Miller RS, 2013, EPIDEMIOL INFECT, V141, P1357, DOI 10.1017/S0950268813000976; Miller RS, 2013, PREV VET MED, V110, P119, DOI 10.1016/j.prevetmed.2012.11.021; MONTGOMERY DR, 1995, WATER RESOUR BULL, V31, P369; Morelle K, 2015, EUR J WILDLIFE RES, V61, P45, DOI 10.1007/s10344-014-0872-6; Morellet N, 2011, LANDSCAPE ECOL, V26, P999, DOI 10.1007/s10980-011-9624-0; ODUM E P, 1971, P574; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Phillips S., 2011, P 25 AAAI C ART INT, P1384; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2013, ECOLOGY, V94, P1409, DOI 10.1890/12-1520.1; Pimental D, 2007, MAN VERT INV SPEC P, P1; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Said S, 2005, LANDSCAPE ECOL, V20, P1003, DOI 10.1007/s10980-005-7518-8; SCHAUSS ME, 1990, CALIF FISH GAME, V76, P68; Seward N. W., 2004, Sheep & Goat Research Journal, V19, P34; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Sol D, 2008, BIOL INVASIONS, V10, P1119, DOI 10.1007/s10530-007-9189-7; Southeastern Cooperative Wildlife Disease Study (SCWDS), 2013, NAT FER SWIN MAPP SY; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Turner MG, 1997, WILDLIFE AND LANDSCAPE ECOLOGY, P331; United States Environmental Protection Agency, 2012, NAT HYDR DAT PLUS NH; United States Geological Survey Gap Analysis Program (USGS GAP), 2011, NAT GAP LAND COV DAT; Wasserman L, 2000, J MATH PSYCHOL, V44, P92, DOI 10.1006/jmps.1999.1278; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wu J., 2012, ECOLOGICAL SYSTEMS, DOI [10.1007/978-1-4614-5755-8_11, DOI 10.1007/978-1-4614-5755-8_11]; Ziska LH, 2011, CLIMATIC CHANGE, V105, P13, DOI 10.1007/s10584-010-9879-5	88	72	75	3	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133771	10.1371/journal.pone.0133771	http://dx.doi.org/10.1371/journal.pone.0133771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267266	Green Published, gold			2022-12-27	WOS:000359492300026
J	Rashidi, MM; Freidoonimehr, N; Momoniat, E; Rostami, B				Rashidi, Mohammad Mehdi; Freidoonimehr, Navid; Momoniat, Ebrahim; Rostami, Behnam			Study of Nonlinear MHD Tribological Squeeze Film at Generalized Magnetic Reynolds Numbers Using DTM	PLOS ONE			English	Article							2 ROTATING-DISKS; FERROFLUID LUBRICATION; JOURNAL BEARING; HEAT-TRANSFER; POROUS-MEDIUM; FLUID; FLOW; RADIATION; FIELD	In the current article, a combination of the differential transform method (DTM) and Pade approximation method are implemented to solve a system of nonlinear differential equations modelling the flow of a Newtonian magnetic lubricant squeeze film with magnetic induction effects incorporated. Solutions for the transformed radial and tangential momentum as well as solutions for the radial and tangential induced magnetic field conservation equations are determined. The DTM-Pade combined method is observed to demonstrate excellent convergence, stability and versatility in simulating the magnetic squeeze film problem. The effects of involved parameters, i.e. squeeze Reynolds number (N-1), dimensionless axial magnetic force strength parameter (N-2), dimensionless tangential magnetic force strength parameter (N-3), and magnetic Reynolds number (Re-m) are illustrated graphically and discussed in detail. Applications of the study include automotive magneto-rheological shock absorbers, novel aircraft landing gear systems and biological prosthetics.	[Rashidi, Mohammad Mehdi] Ali Sina Univ, Dept Mech Engn, Fac Engn, Hamadan, Iran; [Rashidi, Mohammad Mehdi] Shanghai Jiao Tong Univ, Univ Michigan, Joint Inst, Shanghai 200030, Peoples R China; [Freidoonimehr, Navid; Rostami, Behnam] Islamic Azad Univ, Hamedan Branch, Young Researchers & Elite Club, Hamadan, Iran; [Momoniat, Ebrahim] Univ Witwatersrand, Sch Comp Sci & Appl Math, DST NRF Ctr Excellence Math & Stat Sci, ZA-2050 Johannesburg, South Africa	Shanghai Jiao Tong University; Islamic Azad University; University of Witwatersrand	Rashidi, MM (corresponding author), Ali Sina Univ, Dept Mech Engn, Fac Engn, Hamadan, Iran.	mm_rashidi@sjtu.edu.cn	Momoniat, Ebrahim/Y-9783-2019; Freidoonimehr, Navid/I-2308-2014; Rashidi, Mohammad Mehdi/P-2692-2014; Momoniat, Ebrahim/A-5532-2009; Momoniat, Ebrahim/N-2782-2014	Freidoonimehr, Navid/0000-0002-2850-7861; Rashidi, Mohammad Mehdi/0000-0002-6309-8688; Rostami, Behnam/0000-0002-3038-248X; Momoniat, Ebrahim/0000-0001-7762-2690	National Research foundation of South Africa	National Research foundation of South Africa(National Research Foundation - South Africa)	EM acknowledges support from the National Research foundation of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C G, 1983, MAGNETIC SQUEEZE FIL; ANWAR MI, 1972, J LUBRIC TECH-T ASME, V94, P101, DOI 10.1115/1.3451626; Asadi M, 2012, J MECH MED BIOL, V12; Ayaz F, 2004, APPL MATH COMPUT, V152, P649, DOI 10.1016/S0096-3003(03)00581-2; Ayaz F, 2004, APPL MATH COMPUT, V147, P547, DOI 10.1016/S0096-3003(02)00794-4; Baker G., 1981, PADE APPROXIMANTS BA; Baker G. A., 1975, ESSENTIAL PADE APPRO; CHANDRA P, 1992, TRIBOL T, V35, P163, DOI 10.1080/10402009208982104; Chernyakova YM, 2011, J FRICT WEAR+, V32, P54, DOI 10.3103/S1068366611010028; Davidson PA., 2001, INTRO MAGNETOHYDRODY; Dehghan M, 2015, RENEW ENERG, V74, P448, DOI 10.1016/j.renene.2014.08.044; Duran JDG, 2008, TRIBOL T, V51, P271, DOI 10.1080/10402000701793963; Elshekh SS, 1996, INT J ENG SCI, V34, P1183, DOI 10.1016/0020-7225(96)00010-9; Gertzos KP, 2008, TRIBOL INT, V41, P1190, DOI 10.1016/j.triboint.2008.03.002; Gul T, ENG SCI TECHNOLOGY I; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103843; HAMZA EA, 1991, J PHYS D APPL PHYS, V24, P547, DOI 10.1088/0022-3727/24/4/005; HAMZA EA, 1981, J FLUID MECH, V109, P147, DOI 10.1017/S0022112081000980; Huang W, 2011, TRIBOL LETT, V41, P145, DOI 10.1007/s11249-010-9693-2; HUGHES WF, 1962, J FLUID MECH, V13, P21, DOI 10.1017/S0022112062000464; Hussanan A, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14046-x; IBRAHIM FN, 1991, J PHYS D APPL PHYS, V24, P1293, DOI 10.1088/0022-3727/24/8/010; Kargulewicz M, 2012, J TRIBOL-T ASME, V134, DOI 10.1115/1.4006021; Khalid A, ENG SCI TECHNOLOGY I; Khan A, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/861708; Khan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090280; Liao S., 2003, PERTURBATION INTRO H, DOI 10.1201/9780203491164; Liao S.J., 2014, ADV HOMOTOPY ANAL ME; Liu B, 2006, SMART MATER STRUCT, V15, P1960, DOI 10.1088/0964-1726/15/6/052; Moghani T, 2007, COMPUT STRUCT, V85, P1114, DOI 10.1016/j.compstruc.2006.08.026; Park E, 2010, J INTEL MAT SYST STR, V21, P1831, DOI 10.1177/1045389X10390253; Rashidi MM, 2010, HEAT TRANSF-ASIAN RE, V39, P575, DOI 10.1002/htj.20317; Rashidi MM, 2009, COMPUT PHYS COMMUN, V180, P2210, DOI 10.1016/j.cpc.2009.06.029; Rashidi M. M., 2012, THERM SCI, V18, pS527; Rashidi MM, 2014, AIN SHAMS ENG J, V5, P901, DOI 10.1016/j.asej.2014.02.007; Rashidi MM, 2011, COMPUT FLUIDS, V40, P172, DOI 10.1016/j.compfluid.2010.08.021; Samiulhaq, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088766; Sheikholeslami M, 2012, APPL MATH MECH-ENGL, V33, P25, DOI 10.1007/s10483-012-1531-7; Song WL, 2011, TRIBOL T, V54, P616, DOI 10.1080/10402004.2011.584365; Stolarski TA, 2012, TRIBOL LETT, V46, P113, DOI 10.1007/s11249-012-9926-7; Zhu GD, 2009, ENG ANAL BOUND ELEM, V33, P467, DOI 10.1016/j.enganabound.2008.08.017; Zueco J, 2010, TRIBOL INT, V43, P532, DOI 10.1016/j.triboint.2009.09.002	42	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135004	10.1371/journal.pone.0135004	http://dx.doi.org/10.1371/journal.pone.0135004			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267247	Green Published, gold			2022-12-27	WOS:000359492300070
J	Robineau, O; Frange, P; Barin, F; Cazein, F; Girard, PM; Chaix, ML; Kreplak, G; Boelle, PY; Morand-Joubert, L				Robineau, Olivier; Frange, Pierre; Barin, Francis; Cazein, Francoise; Girard, Pierre-Marie; Chaix, Marie-Laure; Kreplak, Georges; Boelle, Pierre-Yves; Morand-Joubert, Laurence			Combining the Estimated Date of HIV Infection with a Phylogenetic Cluster Study to Better Understand HIV Spread: Application in a Paris Neighbourhood	PLOS ONE			English	Article							TRANSMISSION EVENTS; DRUG-RESISTANCE; SEXUAL RISK; MEN; EPIDEMIC; RECONSTRUCTION; IMMUNOASSAY	Objectives To relate socio-demographic and virological information to phylogenetic clustering in HIV infected patients in a limited geographical area and to evaluate the role of recently infected individuals in the spread of HIV. Methods HIV-1 pol sequences from newly diagnosed and treatment-naive patients receiving follow-up between 2008 and 2011 by physicians belonging to a health network in Paris were used to build a phylogenetic tree using neighbour-joining analysis. Time since infection was estimated by immunoassay to define recently infected patients (very early infected presenters, VEP). Data on socio-demographic, clinical and biological features in clustered and non-clustered patients were compared. Chains of infection structure was also analysed. Results 547 patients were included, 49 chains of infection containing 108 (20%) patients were identified by phylogenetic analysis. analysis. Eighty individuals formed pairs and 28 individuals were belonging to larger clusters. The median time between two successive HIV diagnoses in the same chain of infection was 248 days [CI = 176-320]. 34.7% of individuals were considered as VEP, and 27% of them were included in chains of infection. Multivariable analysis showed that belonging to a cluster was more frequent in VEP and those under 30 years old (OR: 3.65, 95 CI 1.49-8.95, p = 0.005 and OR: 2.42, 95% CI 1.05-5.85, p = 0.04 respectively). The prevalence of drug resistance was not associated with belonging to a pair or a cluster. Within chains, VEP were not grouped together more than chance predicted (p = 0.97). Conclusions Most newly diagnosed patients did not belong to a chain of infection, confirming the importance of undiagnosed or untreated HIV infected individuals in transmission. Furthermore, clusters involving both recently infected individuals and longstanding infected individuals support a substantial role in transmission of the latter before diagnosis.	[Robineau, Olivier] Ctr Hosp Tourcoing, Serv Univ Reg Malad Infect & Trop, Tourcoing, France; [Robineau, Olivier; Girard, Pierre-Marie; Boelle, Pierre-Yves] Inst Pierre Louis Epidemiol & Sante Publ, INSERM, UMR S 1136, Paris, France; [Frange, Pierre; Chaix, Marie-Laure] Univ Paris 05, EA 3620, Sorbonne Paris Cite, Paris, France; [Frange, Pierre] Hop Necker Enfants Malad, AP HP, Lab Microbiol & Unite Immunol, Hematol & Rhumatol Pediat, Paris, France; [Barin, Francis] CHU Bretonneau, Ctr Natl Reference VIH, F-37044 Tours, France; [Barin, Francis] CHU Bretonneau, INSERM U966, F-37044 Tours, France; [Barin, Francis] Univ Tours, Tours, France; [Cazein, Francoise] Inst Veille Sanitaire, St Maurice, France; [Girard, Pierre-Marie] Hop St Antoine, AP HP, Serv Malad Infect & Trop, F-75571 Paris, France; [Chaix, Marie-Laure] Hop St Louis, AP HP, Virol Lab, Paris, France; [Kreplak, Georges] Lab Chemin Vert, Paris, France; [Boelle, Pierre-Yves] Univ Paris 06, Sorbonne Univ, UMR S 943, Paris, France; [Boelle, Pierre-Yves] Hop St Antoine, AP HP, Serv Sante Publ, F-75571 Paris, France; [Morand-Joubert, Laurence] INSERM, UMR S 943, Paris, France; [Morand-Joubert, Laurence] Hop St Antoine, AP HP, Virol Lab, F-75571 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Robineau, O (corresponding author), Ctr Hosp Tourcoing, Serv Univ Reg Malad Infect & Trop, Tourcoing, France.	olivier.robineau82@gmail.com; laurence.morand-joubert@sat.aphp.fr	Frange, Pierre/O-6311-2017		ANRS (Agence Nationale de recherche sur le SIDA et les hepatites); STOP SIDA	ANRS (Agence Nationale de recherche sur le SIDA et les hepatites)(ANRS); STOP SIDA	This study have been supported by grants from ANRS (Agence Nationale de recherche sur le SIDA et les hepatites) and STOP SIDA.	Ambrosioni J, 2012, AIDS, V26, P2079, DOI 10.1097/QAD.0b013e32835805b6; [Anonymous], HIV 1 GEN DRUG RES I; Barin F, 2005, J CLIN MICROBIOL, V43, P4441, DOI 10.1128/JCM.43.9.4441-4447.2005; Bezemer D, 2010, EPIDEMICS-NETH, V2, P66, DOI 10.1016/j.epidem.2010.04.001; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown AE, 2009, J INFECT DIS, V199, P427, DOI 10.1086/596049; Dennis AM, 2012, AIDS, V26, P1813, DOI 10.1097/QAD.0b013e3283573244; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Fisher M, 2010, AIDS, V24, P1739, DOI 10.1097/QAD.0b013e32833ac9e6; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2005, AIDS, V19, P449, DOI 10.1097/01.aids.0000161778.15568.a1; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Le Vu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039872; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Le Vu S, 2009, AIDS, V23, P1771, DOI 10.1097/QAD.0b013e32832d8754; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Pilcher CD, 2010, J INFECT DIS, V201, pS7, DOI 10.1086/650393; Poon AFY, 2011, AIDS, V25, P2019, DOI 10.1097/QAD.0b013e32834b643c; R Core Team, 2021, R LANGUAGE ENV STAT; Ragonnet-Cronin M, 2010, JAIDS-J ACQ IMM DEF, V55, P102, DOI 10.1097/QAI.0b013e3181e8c7b0; Recordon-Pinson P, 2009, ANTIVIR THER, V14, P551; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Stall R, 2009, AIDS BEHAV, V13, P615, DOI 10.1007/s10461-008-9509-7; Supervie V, 2013, 20 CROI C ATL; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Velter A, 2013, AIDS BEHAV, V17, P1266, DOI 10.1007/s10461-012-0303-1; Volz EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001568; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081; Yeni P, 2010, PRISE CHARGE MED PER	37	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135367	10.1371/journal.pone.0135367	http://dx.doi.org/10.1371/journal.pone.0135367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267615	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492300106
J	Salto, R; Vilchez, JD; Giron, MD; Cabrera, E; Campos, N; Manzano, M; Rueda, R; Lopez-Pedrosa, JM				Salto, Rafael; Vilchez, Jose D.; Giron, Maria D.; Cabrera, Elena; Campos, Nefertiti; Manzano, Manuel; Rueda, Ricardo; Lopez-Pedrosa, Jose M.			beta-Hydroxy-beta-Methylbutyrate (HMB) Promotes Neurite Outgrowth in Neuro2a Cells	PLOS ONE			English	Article							MEF2 TRANSCRIPTION FACTORS; MYOCYTE-ENHANCER FACTOR-2; NEUROPROTECTIVE ACTIVITY; SIGNALING PATHWAY; CORTICAL-NEURONS; DIFFERENTIATION; BRAIN; GROWTH; ACETYLCHOLINESTERASE; PROLIFERATION	beta-Hydroxy-beta-methylbutyrate (HMB) has been shown to enhance cell survival, differentiation and protein turnover in muscle, mainly activating phosphoinositide-3-kinase/protein kinase B (PI3K/Akt) and mitogen-activated protein kinases/extracellular-signal-regulated kinases (MAPK/ERK) signaling pathways. Since these two pathways are related to neuronal survival and differentiation, in this study, we have investigated the neurotrophic effects of HMB in mouse neuroblastoma Neuro2a cells. In Neuro2a cells, HMB promotes differentiation to neurites independent from any effects on proliferation. These effects are mediated by activation of both the PI3K/Akt and the extracellular-signal-regulated kinases (ERK1/2) signaling as demonstrated by the use of specific inhibitors of these two pathways. As myocyte-enhancer factor 2 (MEF2) family of transcription factors are involved in neuronal survival and plasticity, the transcriptional activity and protein levels of MEF2 were also evaluated. HMB promoted MEF2-dependent transcriptional activity mediated by the activation of Akt and ERK1/2 pathways. Furthermore, HMB increases the expression of brain glucose transporters 1 (GLUT1) and 3 (GLUT3), and mTOR phosphorylation, which translates in a higher protein synthesis in Neuro2a cells. Furthermore, Torin1 and rapamycin effects on MEF2 transcriptional activity and HMB-dependent neurite outgrowth support that HMB acts through mTORC2. Together, these findings provide clear evidence to support an important role of HMB in neurite outgrowth.	[Salto, Rafael; Vilchez, Jose D.; Giron, Maria D.; Cabrera, Elena] Univ Granada, Sch Pharm, Dept Biochem & Mol Biol 2, Granada, Spain; [Campos, Nefertiti; Manzano, Manuel; Rueda, Ricardo; Lopez-Pedrosa, Jose M.] Abbott Nutr R&D, Granada, Spain	University of Granada	Salto, R (corresponding author), Univ Granada, Sch Pharm, Dept Biochem & Mol Biol 2, Granada, Spain.	rsalto@ugr.es	Giron, Maria D/K-2487-2014; Vílchez, Dámaso/E-9823-2016; Salto, Rafael/A-6486-2011	Giron, Maria D/0000-0001-9638-988X; Vílchez, Dámaso/0000-0003-3256-8525; Salto, Rafael/0000-0002-7044-3611; Manzano, Manuel/0000-0003-2856-6295	Abbott Nutrition RD	Abbott Nutrition RD	This project has been funded by Abbott Nutrition R&D. Authors MM, NC, RR and JMLP are employees of the funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alway SE, 2013, EXP GERONTOL, V48, P973, DOI 10.1016/j.exger.2013.06.005; Arsenault J, 2014, J NEUROCHEM, V129, P781, DOI 10.1111/jnc.12645; Bigbee JW, 2000, BRAIN RES, V861, P354, DOI 10.1016/S0006-8993(00)02046-1; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; Chan SF, 2015, GENOM DATA, V3, P24, DOI 10.1016/j.gdata.2014.10.022; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chong ZZ, 2012, FUTUR NEUROL, V7, P733, DOI 10.2217/FNL.12.72; Dickey CA, 2004, NEUROSCI LETT, V366, P10, DOI 10.1016/j.neulet.2004.04.089; Giron MD, 2009, CLIN NUTR, V28, P565, DOI 10.1016/j.clnu.2009.04.018; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Giron MD, 2008, DIABETOLOGIA, V51, P1285, DOI 10.1007/s00125-008-1003-2; Giron MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117520; Giron MD, 2015, JOURNAL OF CACHEXIA; Hrvoj-Mihic B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00707; Jin Y, 2012, ACTA PHARMACOL SIN, V33, P861, DOI 10.1038/aps.2012.59; Jurcovicova J, 2014, Endocr Regul, V48, P35; Kornasio R, 2009, BBA-MOL CELL RES, V1793, P755, DOI 10.1016/j.bbamcr.2008.12.017; Kovarik M, 2010, J PHYSIOL BIOCHEM, V66, P311, DOI 10.1007/s13105-010-0037-3; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; Maiese K, 2009, OXID MED CELL LONGEV, V2, P279, DOI 10.4161/oxim.2.5.9990; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Park SJ, 2015, NEUROSCI LETT, V588, P101, DOI 10.1016/j.neulet.2015.01.001; RASBAND WS, 1995, MICROBEAM ANAL, V4, P137; Rashid AJ, 2014, GENES BRAIN BEHAV, V13, P118, DOI 10.1111/gbb.12058; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Schiwy N, 2009, EUR J NEUROSCI, V30, P1544, DOI 10.1111/j.1460-9568.2009.06929.x; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tata AM, 2014, CNS NEUROL DISORD-DR, V13, P1294, DOI 10.2174/1871527313666140917121132; Wang XH, 2011, BBA-MOL CELL RES, V1813, P827, DOI 10.1016/j.bbamcr.2011.01.027; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; Wang YP, 2007, J NEUROCHEM, V102, P957, DOI 10.1111/j.1471-4159.2007.04606.x; Wang ZY, 2011, INT J DEV NEUROSCI, V29, P415, DOI 10.1016/j.ijdevneu.2011.03.001; Wiedmann M, 2005, J NEUROSCI RES, V81, P226, DOI 10.1002/jnr.20556; Wilson JM, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-18; Wu PY, 2009, CELL SIGNAL, V21, P881, DOI 10.1016/j.cellsig.2009.01.036; Yanaka N, 2007, FEBS LETT, V581, P712, DOI 10.1016/j.febslet.2007.01.035	44	41	41	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135614	10.1371/journal.pone.0135614	http://dx.doi.org/10.1371/journal.pone.0135614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267903	Green Published, gold			2022-12-27	WOS:000359492300142
J	Zininga, T; Makumire, S; Gitau, GW; Njunge, JM; Pooe, OJ; Klimek, H; Scheurr, R; Raifer, H; Prinsloo, E; Przyborski, JM; Hoppe, H; Shonhai, A				Zininga, Tawanda; Makumire, Stanely; Gitau, Grace Wairimu; Njunge, James M.; Pooe, Ofentse Jacob; Klimek, Hanna; Scheurr, Robina; Raifer, Hartmann; Prinsloo, Earl; Przyborski, Jude M.; Hoppe, Heinrich; Shonhai, Addmore			Plasmodium falciparum Hop (PfHop) Interacts with the Hsp70 Chaperone in a Nucleotide-Dependent Fashion and Exhibits Ligand Selectivity	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; PARASITES; DYNAMICS; DOMAIN; HEAT-SHOCK-PROTEIN-70; EXPRESSION; COMPLEXES; GROWTH	Heat shock proteins (Hsps) play an important role in the development and pathogenicity of malaria parasites. One of the most prominent functions of Hsps is to facilitate the folding of other proteins. Hsps are thought to play a crucial role when malaria parasites invade their host cells and during their subsequent development in hepatocytes and red blood cells. It is thought that Hsps maintain proteostasis under the unfavourable conditions that malaria parasites encounter in the host environment. Although heat shock protein 70 (Hsp70) is capable of independent folding of some proteins, its functional cooperation with heat shock protein 90 (Hsp90) facilitates folding of some proteins such as kinases and steroid hormone receptors into their fully functional forms. The cooperation of Hsp70 and Hsp90 occurs through an adaptor protein called Hsp70-Hsp90 organising protein (Hop). We previously characterised the Hop protein from Plasmodium falciparum (PfHop). We observed that the protein co-localised with the cytosol-localised chaperones, PfHsp70-1 and PfHsp90 at the blood stages of the malaria parasite. In the current study, we demonstrated that PfHop is a stress-inducible protein. We further explored the direct interaction between PfHop and PfHsp70-1 using far Western and surface plasmon resonance (SPR) analyses. The interaction of the two proteins was further validated by co-immunoprecipitation studies. We observed that PfHop and PfHsp70-1 associate in the absence and presence of either ATP or ADP. However, ADP appears to promote the association of the two proteins better than ATP. In addition, we investigated the specific interaction between PfHop TPR subdomains and PfHsp70-1/PfHsp90, using a split-GFP approach. This method allowed us to observe that TPR1 and TPR2B subdomains of PfHop bind preferentially to the C-terminus of PfHsp70-1 compared to PfHsp90. Conversely, the TPR2A motif preferentially interacted with the C-terminus of PfHsp90. Finally, we observed that recombinant PfHop occasionally eluted as a protein species of twice its predicted size, suggesting that it may occur as a dimer. We conducted SPR analysis which suggested that PfHop is capable of self-association in presence or absence of ATP/ADP. Overall, our findings suggest that PfHop is a stress-inducible protein that directly associates with PfHsp70-1 and PfHsp90. In addition, the protein is capable of self-association. The findings suggest that PfHop serves as a module that brings these two prominent chaperones (PfHsp70-1 and PfHsp90) into a functional complex. Since PfHsp70-1 and PfHsp90 are essential for parasite growth, findings from this study are important towards the development of possible antimalarial inhibitors targeting the cooperation of these two chaperones.	[Zininga, Tawanda; Makumire, Stanely; Shonhai, Addmore] Univ Venda, Sch Math & Nat Sci, Dept Biochem, ZA-0950 Thohoyandou, South Africa; [Gitau, Grace Wairimu; Pooe, Ofentse Jacob] Univ Zululand, Dept Biochem & Microbiol, ZA-3886 Kwa Dlangezwa, South Africa; [Njunge, James M.; Hoppe, Heinrich] Rhodes, Dept Biochem & Microbiol, ZA-6140 Grahamstown, South Africa; [Raifer, Hartmann] Univ Clin Marburg, Inst Med Microbiol, Flow Cytometry Core Facil, Marburg, Germany; [Klimek, Hanna; Scheurr, Robina; Przyborski, Jude M.] Univ Marburg, Parasitol, FB Biol, D-35043 Marburg, Germany; [Prinsloo, Earl] Rhodes Univ, Biotechnol Innovat Ctr, ZA-6140 Grahamstown, South Africa	University of Venda; University of Zululand; Philipps University Marburg; Rhodes University	Shonhai, A (corresponding author), Univ Venda, Sch Math & Nat Sci, Dept Biochem, ZA-0950 Thohoyandou, South Africa.	addmore.shonhai@univen.ac.za	Zininga, Tawanda/Q-4131-2019; Pooe, Ofentse Jacob/AAF-6720-2019; Shonhai, Addmore/AAS-4506-2021; Przyborski, Jude/ABC-9498-2021; Prinsloo, Earl/F-9737-2012	Zininga, Tawanda/0000-0001-8689-0152; Pooe, Ofentse Jacob/0000-0002-2967-7846; Przyborski, Jude/0000-0002-3494-7767; Prinsloo, Earl/0000-0002-3048-4304; njunge, james/0000-0002-8524-9133; Hoppe, Heinrich/0000-0003-4409-1955; Makumire, Stanley/0000-0003-4355-1382	Deutsche Foschungsgemeinschaft (DFG) grant [L1/402/ 14-1]; Alexander von Humboldt, Germany; National Research Foundation (NRF) of South Africa [92742, 75464, 97534]; NRF of South Africa	Deutsche Foschungsgemeinschaft (DFG) grant(German Research Foundation (DFG)); Alexander von Humboldt, Germany; National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); NRF of South Africa	This research was supported by Deutsche Foschungsgemeinschaft (DFG) grant, L1/402/ 14-1 awarded jointly to HH, JMP, AS. AS is the recipient of a Georg Foster Fellowship (awarded by the Alexander von Humboldt, Germany). The research was further supported through an equipment grant provided by the National Research Foundation (NRF) of South Africa, grant numbers, 92742,75464, 97534, 97534. OJP is a recipient of a scholarship from the NRF of South Africa. The funders had no role in the study design, execution and analysis of data, or preparation of the manuscript.	An WG, 2000, CELL GROWTH DIFFER, V11, P355; Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; Chiang AN, 2009, BIOORGAN MED CHEM, V17, P1527, DOI 10.1016/j.bmc.2009.01.024; Cockburn IL, 2014, BIOL CHEM, V395, P1353, DOI 10.1515/hsz-2014-0138; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Ebong IO, 2011, P NATL ACAD SCI USA, V108, P17939, DOI 10.1073/pnas.1106261108; Famin O, 2003, PARASITE, V10, P39, DOI 10.1051/parasite/2003101p39; Fitch C D, 1989, Prog Clin Biol Res, V313, P45; Gaiser AM, 2009, J MOL BIOL, V391, P621, DOI 10.1016/j.jmb.2009.06.051; Galigniana MD, 2010, NUCLEUS-PHILA, V1, P299, DOI 10.4161/nucl.1.4.11743; Gitau GW, 2012, CELL STRESS CHAPERON, V17, P191, DOI 10.1007/s12192-011-0299-x; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; JOSHI B, 1992, FEBS LETT, V312, P91, DOI 10.1016/0014-5793(92)81417-K; Lassle M, 1997, J BIOL CHEM, V272, P1876, DOI 10.1074/jbc.272.3.1876; Marcion G, 2015, CELL STRESS CHAPERON, V20, P61, DOI 10.1007/s12192-014-0526-3; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Nicolai A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003379; NICOLET CM, 1989, MOL CELL BIOL, V9, P3638, DOI 10.1128/MCB.9.9.3638; Pallavi R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-236; Pesce ER, 2008, INT J BIOCHEM CELL B, V40, P2914, DOI 10.1016/j.biocel.2008.06.011; Rohl A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7655; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Shahinas D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075446; Shonhai A., 2014, HEAT SHOCK PROTEINS, P47, DOI [10.1007/978-94-007-7438-4_3, DOI 10.1007/978-94-007-7438-4_3]; Shonhai A, 2008, PROTEIN PEPTIDE LETT, V15, P1117, DOI 10.2174/092986608786071067; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; Shonhai A, 2011, PROTEIN PEPTIDE LETT, V18, P143, DOI 10.2174/092986611794475002; Shonhai A, 2010, FEMS IMMUNOL MED MIC, V58, P61, DOI 10.1111/j.1574-695X.2009.00639.x; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wang T, 2014, J MED CHEM, V57, P2524, DOI 10.1021/jm401801t; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Yamamoto S, 2014, J BIOL CHEM, V289, P9880, DOI 10.1074/jbc.M114.553255; Zininga T, 2015, PLOS ONE, V10	36	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135326	10.1371/journal.pone.0135326	http://dx.doi.org/10.1371/journal.pone.0135326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267894	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300098
J	Graham, RB; Wachowiak, MP; Gurd, BJ				Graham, Ryan B.; Wachowiak, Mark P.; Gurd, Brendon J.			The Assessment of Muscular Effort, Fatigue, and Physiological Adaptation Using EMG and Wavelet Analysis	PLOS ONE			English	Article							UNIT RECRUITMENT STRATEGIES; INTENSITY ANALYSIS; SURFACE EMG; MECHANOMYOGRAPHIC SIGNALS; SPECTRAL PROPERTIES; SKELETAL-MUSCLE; ACTIVATION; FREQUENCY; EXERCISE; ELECTROMYOGRAM	Peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) is a transcription factor co-activator that helps coordinate mitochondrial biogenesis within skeletal muscle following exercise. While evidence gleaned from submaximal exercise suggests that intracellular pathways associated with the activation of PGC-1 alpha, as well as the expression of PGC-1 alpha itself are activated to a greater extent following higher intensities of exercise, we have recently shown that this effect does not extend to supramaximal exercise, despite corresponding increases in muscle activation amplitude measured with electromyography (EMG). Spectral analyses of EMG data may provide a more in-depth assessment of changes in muscle electrophysiology occurring across different exercise intensities, and therefore the goal of the present study was to apply continuous wavelet transforms (CWTs) to our previous data to comprehensively evaluate: 1) differences in muscle electrophysiological properties at different exercise intensities (i.e. 73%, 100%, and 133% of peak aerobic power), and 2) muscular effort and fatigue across a single interval of exercise at each intensity, in an attempt to shed mechanistic insight into our previous observations that the increase in PGC-1 alpha is dissociated from exercise intensity following supramaximal exercise. In general, the CWTs revealed that localized muscle fatigue was only greater than the 73% condition in the 133% exercise intensity condition, which directly matched the work rate results. Specifically, there were greater drop-offs in frequency, larger changes in burst power, as well as greater changes in burst area under this intensity, which were already observable during the first interval. As a whole, the results from the present study suggest that supramaximal exercise causes extreme localized muscular fatigue, and it is possible that the blunted PGC-1 alpha effects observed in our previous study are the result of fatigue-associated increases in muscle acidosis. This should be explored in future research using further combinations of EMG and muscle biochemistry and histology.	[Graham, Ryan B.] Nipissing Univ, Sch Phys & Hlth Educ, North Bay, ON, Canada; [Graham, Ryan B.; Gurd, Brendon J.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Wachowiak, Mark P.] Nipissing Univ, Dept Comp Sci & Math, North Bay, ON, Canada	Nipissing University; Queens University - Canada; Nipissing University	Gurd, BJ (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	gurdb@queensu.ca			NSERC [402635-2011, 386586-2011]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by NSERC (402635-2011 [BJG] and 386586-2011 [MPW]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison PS, 2005, PHYSIOL MEAS, V26, pR155, DOI 10.1088/0967-3334/26/5/R01; Armstrong WJ, 2014, EUR J APPL PHYSIOL, V114, P2571, DOI 10.1007/s00421-014-2975-x; Armstrong WJ, 2011, J ELECTROMYOGR KINES, V21, P803, DOI 10.1016/j.jelekin.2011.05.011; Beck TW, 2012, ISOKINET EXERC SCI, V20, P5, DOI 10.3233/IES-2011-0433; Beck TW, 2008, BIOMED SIGNAL PROCES, V3, P255, DOI 10.1016/j.bspc.2008.01.005; Beck TW, 2005, J ELECTROMYOGR KINES, V15, P190, DOI 10.1016/j.jelekin.2004.08.007; Bishop DJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE225, DOI 10.1152/ajpendo.00738.2009; Borg F., 2003, FILTER BANKS INTENSI; Croce R, 2014, MUSCLE NERV IN PRESS, P1; Edge J, 2006, J APPL PHYSIOL, V101, P918, DOI 10.1152/japplphysiol.01534.2005; Edgett BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071623; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Fee JW, 2012, EMG METHODS EVALUATI, P1; Frere J, 2012, COMPUT METHOD BIOMEC, V15, P111, DOI 10.1080/10255842.2010.517199; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Howlett RA, 1998, AM J PHYSIOL, V275, P418; Huber C, 2010, J STRENGTH COND RES, V24, P1527, DOI 10.1519/JSC.0b013e3181dc42f6; Hug F, 2010, J APPL PHYSIOL, V108, P1727, DOI 10.1152/japplphysiol.01305.2009; Karlsson JS, 2009, PHILOS T R SOC A, V367, P337, DOI 10.1098/rsta.2008.0214; Karlsson S, 2001, J ELECTROMYOGR KINES, V11, P131, DOI 10.1016/S1050-6411(00)00046-8; Legarreta IR, 2005, INT J WAVELETS MULTI, V3, P19, DOI 10.1142/S0219691305000774; METZGER JM, 1987, J APPL PHYSIOL, V62, P1392, DOI 10.1152/jappl.1987.62.4.1392; Mummidisetty CK, 2012, J NEUROSCI METH, V204, P35, DOI 10.1016/j.jneumeth.2011.10.017; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Pincivero DM, 2001, J APPL PHYSIOL, V90, P804, DOI 10.1152/jappl.2001.90.3.804; Prosser LA, 2010, J ELECTROMYOGR KINES, V20, P851, DOI 10.1016/j.jelekin.2010.04.005; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Scribbans TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098119; Toledo E, 2003, AM J PHYSIOL-REG I, V284, pR1079, DOI 10.1152/ajpregu.00287.2002; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vitor-Costa Marcelo, 2012, Rev. bras. cineantropom. desempenho hum., V14, P660, DOI 10.5007/1980-0037.2012v14n6p660; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4; von Tscharner V, 2008, J APPL PHYSIOL, V105, P1682, DOI 10.1152/japplphysiol.91181.2008; von Tscharner V, 2008, J APPL PHYSIOL, V105, P1671, DOI 10.1152/japplphysiol.90598.2008; Wakeling JM, 2004, J EXP BIOL, V207, P3883, DOI 10.1242/jeb.01223; WEYTJENS JLF, 1984, BIOL CYBERN, V51, P71, DOI 10.1007/BF00357919; Williams CB, 2012, APPL CLIN GENET, V5, P81, DOI 10.2147/TACG.S31276	39	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135069	10.1371/journal.pone.0135069	http://dx.doi.org/10.1371/journal.pone.0135069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263548	Green Submitted, Green Published, gold			2022-12-27	WOS:000359353300054
J	Moura, MCP; Smith, SJ; Belzer, DB				Moura, Maria Cecilia P.; Smith, Steven J.; Belzer, David B.			120 Years of US Residential Housing Stock and Floor Space	PLOS ONE			English	Article							ENERGY-CONSUMPTION; BUILDING CHARACTERISTICS; SECTOR; HOUSEHOLD	Residential buildings are a key driver of energy consumption and also impact transportation and land-use. Energy consumption in the residential sector accounts for one-fifth of total U.S. energy consumption and energy-related CO2 emissions, with floor space a major driver of building energy demands. In this work a consistent, vintage-disaggregated, annual long-term series of U.S. housing stock and residential floor space for 1891-2010 is presented. An attempt was made to minimize the effects of the incompleteness and inconsistencies present in the national housing survey data. Over the 1891-2010 period, floor space increased almost tenfold, from approximately 24,700 to 235,150 million square feet, corresponding to a doubling of floor space per capita from approximately 400 to 800 square feet. While population increased five times over the period, a 50% decrease in household size contributed towards a tenfold increase in the number of housing units and floor space, while average floor space per unit remains surprisingly constant, as a result of housing retirement dynamics. In the last 30 years, however, these trends appear to be changing, as household size shows signs of leveling off, or even increasing again, while average floor space per unit has been increasing. GDP and total floor space show a remarkably constant growth trend over the period and total residential sector primary energy consumption and floor space show a similar growth trend over the last 60 years, decoupling only within the last decade.	[Moura, Maria Cecilia P.; Smith, Steven J.] Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Smith, Steven J.] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA; [Belzer, David B.] Pacific NW Natl Lab, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Moura, MCP (corresponding author), Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA.	cecilia.moura@pnnl.gov	Smith, Steven/HDM-9496-2022; Smith, Steven/F-4502-2010	Smith, Steven/0000-0003-3248-5607	Office of Science of the U.S. Department of Energy, Integrated Assessment Research Program; DOE [DE-AC05-76RL01830]	Office of Science of the U.S. Department of Energy, Integrated Assessment Research Program(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	This research was supported by the Office of Science of the U.S. Department of Energy as part of the Integrated Assessment Research Program http://science.energy.gov/. The Pacific Northwest National Laboratory is operated for DOE by Battelle Memorial Institute under contract DE-AC05-76RL01830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belzer D.B., 2014, COMPREHENSIVE SYSTEM; BLS, 2012, COMP 25 YEARS CONS E, V1; Bolt J, 2014, EC HIST REV; Brennan M, 2013, ANN LOOK HOUSING AFF; Chen WQ, 2015, P NATL ACAD SCI USA; Clune S, 2012, ENERG POLICY, V48, P657, DOI 10.1016/j.enpol.2012.05.072; Energy Information Administration, 2013, RES EN CONS SURV REC; Energy Information Administration, 2014, COMM DEM MOD NAT EN; Energy Information Administration, 2014, MONTHL EN REV JUN 20; Estiri H, 2014, ENERG ECON, V43, P178, DOI 10.1016/j.eneco.2014.02.013; Ewing R, 2008, HOUS POLICY DEBATE, V19, P1, DOI 10.1080/10511482.2008.9521624; Fouquet R, 2014, REV ENV EC POLIC JUN; Harvey LDD, 2014, ENERG BUILDINGS, V76, P488, DOI 10.1016/j.enbuild.2014.03.011; Higgins A, 2011, TECHNOL FORECAST SOC, V78, P621, DOI 10.1016/j.techfore.2010.12.003; JCHS, 2014, MILL KEY STRONG HOUS; Kavousian A, 2013, ENERGY, V55, P184, DOI 10.1016/j.energy.2013.03.086; Kelly S, 2011, ENERGY, V36, P5610, DOI 10.1016/j.energy.2011.07.009; Kialashaki A, 2013, APPL ENERG, V108, P271, DOI 10.1016/j.apenergy.2013.03.034; Levine M., 2007, CLIMATE CHANGE 2007; Perez-Lombard L, 2008, ENERG BUILDINGS, V40, P394, DOI 10.1016/j.enbuild.2007.03.007; Swan LG, 2009, RENEW SUST ENERG REV, V13, P1819, DOI 10.1016/j.rser.2008.09.033; Tso GKF, 2014, ENERGY, V66, P722, DOI 10.1016/j.energy.2014.01.056; U.S. Census Bureau, 2010, AM FAM LIV ARR 2010; U.S. Department of Housing and Urban Development, 2011, AM HOUS SURV DAT SET; United States Department of Agriculture, EC RES SERV INT MACR	25	38	38	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134135	10.1371/journal.pone.0134135	http://dx.doi.org/10.1371/journal.pone.0134135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263391	Green Submitted, gold, Green Published			2022-12-27	WOS:000359353300020
J	Jin, HS; Kim, J; Park, S; Park, E; Kim, Y; Choi, VN; Yoo, YH; Kim, BT; Jeong, SY				Jin, Hyun-Seok; Kim, Jeonghyun; Park, Sangwook; Park, Eunkuk; Kim, Young; Choi, Vit-Na; Yoo, Young- Hyun; Kim, Bom-Teack; Jeong, Seon-Yong			Association of the I264T Variant in the Sulfide Quinone Reductase-Like (SQRDL) Gene with Osteoporosis in Korean Postmenopausal Women	PLOS ONE			English	Article							BONE-MINERAL DENSITY; GENOME-WIDE ASSOCIATION; PROGENITOR CELLS; DIFFERENTIATION; TRAITS; IDENTIFICATION; MASS; POLYMORPHISMS; ULTRASOUND; CHALLENGES	To identify novel susceptibility variants for osteoporosis in Korean postmenopausal women, we performed a genome-wide association analysis of 1180 nonsynonymous single nucleotide polymorphisms (nsSNPs) in 405 individuals with osteoporosis and 722 normal controls of the Korean Association Resource cohort. A logistic regression analysis revealed 72 nsSNPs that showed a significant association with osteoporosis (p<0.05). The top 10 nsSNPs showing the lowest p-values (p = 5.2x10(-4)-8.5x10(-3)) were further studied to investigate their effects at the protein level. Based on the results of an in silico prediction of the protein's functional effect based on amino acid alterations and a sequence conservation evaluation of the amino acid residues at the positions of the nsSNPs among orthologues, we selected one nsSNP in the SQRDL gene (rs1044032, SQRDL I264T) as a meaningful genetic variant associated with postmenopausal osteoporosis. To assess whether the SQRDL I264T variant played a functional role in the pathogenesis of osteoporosis, we examined the in vitro effect of the nsSNP on bone remodeling. Overexpression of the SQRDL I264T variant in the preosteoblast MC3T3-E1 cells significantly increased alkaline phosphatase activity, mineralization, and the mRNA expression of osteoblastogenesis markers, Runx2, Sp7, and Bglap genes, whereas the SQRDL wild type had no effect or a negative effect on osteoblast differentiation. Overexpression of the SQRDL I264T variant did not affect osteoclast differentiation of the primary-cultured monocytes. The known effects of hydrogen sulfide (H2S) on bone remodeling may explain the findings of the current study, which demonstrated the functional role of the H2S-catalyzing enzyme SQRDL I264T variant in osteoblast differentiation. In conclusion, the results of the statistical and experimental analyses indicate that the SQRDL I264T nsSNP may be a significant susceptibility variant for osteoporosis in Korean postmenopausal women that is involved in osteoblast differentiation.	[Jin, Hyun-Seok] Hoseo Univ, Dept Biomed Lab Sci, Coll Life & Hlth Sci, Asan, South Korea; [Kim, Jeonghyun; Park, Eunkuk; Choi, Vit-Na; Jeong, Seon-Yong] Ajou Univ, Dept Med Genet, Sch Med, Suwon 441749, South Korea; [Kim, Jeonghyun; Kim, Young; Choi, Vit-Na; Jeong, Seon-Yong] Ajou Univ, Dept Biomed Sci, Grad Sch Med, Suwon 441749, South Korea; [Park, Eunkuk] Kyungwoon Univ, Dept Biomed Lab Sci, Coll Hlth, Gumi, South Korea; [Kim, Bom-Teack] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Div Intractable Dis, Ctr Biomed Sci, Cheongju, South Korea; [Yoo, Young- Hyun] Dong A Univ, Dept Anat & Cell Biol, Busan, South Korea; [Yoo, Young- Hyun] Dong A Univ, Mitochondria Hub Regulat Ctr, Coll Med, Busan, South Korea; [Kim, Bom-Teack] Ajou Univ, Dept Family Practice & Community Hlth, Sch Med, Suwon 441749, South Korea	Hoseo University; Ajou University; Ajou University; Kyungwoon University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Dong A University; Dong A University; Ajou University	Kim, BT (corresponding author), Ajou Univ, Dept Family Practice & Community Hlth, Sch Med, Suwon 441749, South Korea.	lovesong@ajou.ac.kr; jeongsy@ajou.ac.kr		Jin, Hyun-Seok/0000-0002-3673-9806	National Research Foundation of Korea (NRF) - Korea government [2015 008728, 2012R1A1A2009459, 2013R1A1A2010123]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea)	This work was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korea government (2015 008728, 2012R1A1A2009459, and 2013R1A1A2010123).	Ackermann M, 2014, CELL TISSUE RES, V358, P779, DOI 10.1007/s00441-014-1983-9; Babu LR, 2005, BONE, V36, P555, DOI 10.1016/j.bone.2004.12.005; Balint E, 2001, BONE, V28, P21, DOI 10.1016/S8756-3282(00)00426-9; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Clark GR, 2015, BRIT MED BULL, V113, P73, DOI 10.1093/bmb/ldu042; Croteau-Chonka DC, 2011, OBESITY, V19, P1019, DOI 10.1038/oby.2010.256; Farber CR, 2012, CURR OSTEOPOROS REP, V10, P228, DOI 10.1007/s11914-012-0112-5; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Ferrari S, 2008, BEST PRACT RES CL EN, V22, P723, DOI 10.1016/j.beem.2008.08.007; Gambari L, 2014, PHARMACOL RES, V87, P99, DOI 10.1016/j.phrs.2014.06.014; GUEGUEN R, 1995, J BONE MINER RES, V10, P2017; Hong KW, 2010, J HUM HYPERTENS, V24, P763, DOI 10.1038/jhh.2010.9; Itou T, 2014, ARTERIOSCL THROM VAS, V34, P626, DOI 10.1161/ATVBAHA.113.302576; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; Jin HS, 2013, MOL GENET METAB, V108, P95, DOI 10.1016/j.ymgme.2012.10.017; Johnell O, 2005, OSTEOPOROSIS INT, V16, pS3, DOI 10.1007/s00198-004-1702-6; Kim SM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.799; Kinoshita H, 2007, BONE, V40, P451, DOI 10.1016/j.bone.2006.08.007; Knapp KM, 2004, OSTEOPOROSIS INT, V15, P367, DOI 10.1007/s00198-003-1555-4; Kolluru GK, 2013, REDOX BIOL, V1, P313, DOI 10.1016/j.redox.2013.05.001; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Li WF, 2010, HUM GENET, V127, P249, DOI 10.1007/s00439-009-0773-z; Lin YF, 2008, CELL PROLIFERAT, V41, P803, DOI 10.1111/j.1365-2184.2008.00542.x; Liu J, 2012, J BONE MINER RES, V27, P331, DOI 10.1002/jbmr.549; Liu Yong-Jun, 2014, J Bone Metab, V21, P99, DOI 10.11005/jbm.2014.21.2.99; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Ming Y, 2014, BIOCHEM BIOPH RES CO, V454, P42, DOI 10.1016/j.bbrc.2014.10.033; Neve A, 2013, J CELL PHYSIOL, V228, P1149, DOI 10.1002/jcp.24278; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Pineda B, 2008, CALCIFIED TISSUE INT, V82, P348, DOI 10.1007/s00223-008-9135-4; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Ralston SH, 2010, ENDOCR REV, V31, P629, DOI 10.1210/er.2009-0044; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Sigurdsson G, 2008, J BONE MINER RES, V23, P1584, DOI 10.1359/JBMR.080507; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Tang PLF, 2009, J BONE MINER RES, V24, P1013, DOI [10.1359/jbmr.081258, 10.1359/JBMR.081258]; Theissen U, 2008, FEBS J, V275, P1131, DOI 10.1111/j.1742-4658.2008.06273.x; Torgerson DJ, 1996, J BONE MINER RES, V11, P293; Urano T, 2014, BIOCHEM BIOPH RES CO, V452, P287, DOI 10.1016/j.bbrc.2014.07.141; Urano T, 2010, BONE, V47, P636, DOI 10.1016/j.bone.2010.06.017; Vande Weghe JG, 1999, J BIOL CHEM, V274, P13250, DOI 10.1074/jbc.274.19.13250; Veeranki S, 2015, NITRIC OXIDE-BIOL CH, V46, P66, DOI 10.1016/j.niox.2014.11.012; Weiss M, 2000, OSTEOPOROSIS INT, V11, P688, DOI 10.1007/s001980070067; Wu SY, 2013, GENOME MED, V5, DOI 10.1186/gm448; Zavaczki E, 2011, KIDNEY INT, V80, P731, DOI 10.1038/ki.2011.212; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572; Zheng HF, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001980	56	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135285	10.1371/journal.pone.0135285	http://dx.doi.org/10.1371/journal.pone.0135285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258864	Green Published, gold, Green Submitted			2022-12-27	WOS:000359352600054
J	Mulcahy, MJ; Blattman, SB; Barrantes, FJ; Lukas, RJ; Hawrot, E				Mulcahy, Matthew J.; Blattman, Sydney B.; Barrantes, Francisco J.; Lukas, Ronald J.; Hawrot, Edward			Resistance to Inhibitors of Cholinesterase 3 (Ric-3) Expression Promotes Selective Protein Associations with the Human alpha 7-Nicotinic Acetylcholine Receptor Interactome	PLOS ONE			English	Article								The alpha 7-nicotinic acetylcholine receptor (alpha 7-nAChR) is a ligand-gated ion channel widely expressed in vertebrates and is associated with numerous physiological functions. As transmembrane ion channels, alpha 7-nAChRs need to be expressed on the surface of the plasma membrane to function. The receptor has been reported to associate with proteins involved with receptor biogenesis, modulation of receptor properties, as well as intracellular signaling cascades and some of these associated proteins may affect surface expression of alpha 7-nAChRs. The putative chaperone resistance to inhibitors of cholinesterase 3 (Ric-3) has been reported to interact with, and enhance the surface expression of, alpha 7-nAChRs. In this study, we identified proteins that associate with alpha 7-nAChRs when Ric-3 is expressed. Using alpha-bungarotoxin (alpha-bgtx), we isolated and compared alpha 7-nAChR-associated proteins from two stably transfected, human tumor-derived cell lines: SH-EP1-h alpha 7 expressing human alpha 7-nAChRs and the same cell line further transfected to express Ric-3, SH-EP1-h alpha 7-Ric-3. Mass spectrometric analysis of peptides identified thirty-nine proteins that are associated with alpha 7-nAChRs only when Ric-3 was expressed. Significantly, and consistent with reports of Ric-3 function in the literature, several of the identified proteins are involved in biological processes that may affect nAChR surface expression such as post-translational processing of proteins, protein trafficking, and protein transport. Additionally, proteins affecting the cell cycle, the cytoskeleton, stress responses, as well as cyclic AMP- and inositol triphosphate-dependent signaling cascades were identified. These results illuminate how alpha-bgtx may be used to isolate and identify alpha 7-nAChRs as well as how the expression of chaperones such as Ric-3 can influence proteins associating with alpha 7-nAChRs. These associating proteins may alter activities of alpha 7-nAChRs to expand their functionally-relevant repertoire as well as to affect biogenesis and membrane trafficking of alpha 7-nAChRs.	[Mulcahy, Matthew J.; Blattman, Sydney B.; Hawrot, Edward] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Barrantes, Francisco J.] UCA CONICET, Inst Biomed Res, Mol Neurobiol Lab, Buenos Aires, DF, Argentina; [Lukas, Ronald J.] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA	Brown University; Barrow Neurological Institute	Hawrot, E (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	Edward_Hawrot@brown.edu	; Barrantes, Francisco J./HCH-0258-2022	Mulcahy, Matthew/0000-0001-5588-8762; Barrantes, Francisco J./0000-0002-4745-681X	National Institutes of Health [1R21AG038774, 1S10RR027027, 5T32GM077995, DA015389, NS040417]; National Science Foundation [EPS-1004057]; National Agency for Scientific Research, Ministry of Science and Technology [PICT 2011-0604]; Scientific Research Council of Argentina (CONICET) PIP [112-201101-01023]; Barrow Neurological Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM077995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG038774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Agency for Scientific Research, Ministry of Science and Technology; Scientific Research Council of Argentina (CONICET) PIP; Barrow Neurological Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes of Health 1R21AG038774 (to EH), 1S10RR027027 (to EH), 5T32GM077995 (to EH, MJM), DA015389 (to RJL), NS040417 (to RJL); the National Science Foundation EPS-1004057 (to EH, MJM); the National Agency for Scientific Research, Ministry of Science and Technology PICT 2011-0604 (to FJB); the Scientific Research Council of Argentina (CONICET) PIP No. No 112-201101-01023 (to FJB); the Barrow Neurological Foundation (to RJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134409	10.1371/journal.pone.0134409	http://dx.doi.org/10.1371/journal.pone.0134409			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258666	Green Published, Green Submitted, gold			2022-12-27	WOS:000359352600013
J	Chettab, K; Roux, S; Mathe, D; Cros-Perrial, E; Lafond, M; Lafon, C; Dumontet, C; Mestas, JL				Chettab, Kamel; Roux, Stephanie; Mathe, Doriane; Cros-Perrial, Emeline; Lafond, Maxime; Lafon, Cyril; Dumontet, Charles; Mestas, Jean-Louis			Spatial and Temporal Control of Cavitation Allows High In Vitro Transfection Efficiency in the Absence of Transfection Reagents or Contrast Agents	PLOS ONE			English	Article							MEDIATED GENE TRANSFECTION; VIRAL VECTORS; ULTRASOUND; DELIVERY; CELLS; SONOPORATION; EXPRESSION; MICROBUBBLES; THERAPY; WAVE	Sonoporation using low-frequency high-pressure ultrasound (US) is a non-viral approach for in vitro and in vivo gene delivery. In this study, we developed a new sonoporation device designed for spatial and temporal control of ultrasound cavitation. The regulation system incorporated in the device allowed a real-time control of the cavitation level during sonoporation. This device was evaluated for the in vitro transfection efficiency of a plasmid coding for Green Fluorescent Protein (pEGFP-C1) in adherent and non-adherent cell lines. The transfection efficiency of the device was compared to those observed with lipofection and nucleofection methods. In both adherent and non-adherent cell lines, the sonoporation device allowed high rate of transfection of pEGFP-C1 (40-80%), as determined by flow cytometry analysis of GFP expression, along with a low rate of mortality assessed by propidium iodide staining. The transfection efficiency and toxicity of sonoporation on the non-adherent cell lines Jurkat and K562 were similar to those of nucleofection, while these two cell lines were resistant to transfection by lipofection. Moreover, sonoporation was used to produce three stably transfected human lymphoma and leukemia lines. Significant transfection efficiency was also observed in two fresh samples of human acute myeloid leukemia cells. In conclusion, we developed a user-friendly and cost-effective ultrasound device, well adapted for routine in vitro high-yield transfection experiments and which does not require the use of any transfection reagent or gas micro-bubbles.	[Chettab, Kamel; Roux, Stephanie; Mathe, Doriane; Cros-Perrial, Emeline; Lafond, Maxime; Lafon, Cyril; Dumontet, Charles; Mestas, Jean-Louis] Univ Lyon, F-69000 Lyon, France; [Chettab, Kamel; Roux, Stephanie; Mathe, Doriane; Cros-Perrial, Emeline; Lafond, Maxime; Lafon, Cyril; Dumontet, Charles; Mestas, Jean-Louis] Univ Lyon 1, F-69000 Lyon, France; [Chettab, Kamel; Roux, Stephanie; Mathe, Doriane; Cros-Perrial, Emeline; Dumontet, Charles] Ctr Rech Cancerol Lyon, INSERM, U1052, F-69008 Lyon, France; [Chettab, Kamel; Roux, Stephanie; Mathe, Doriane; Cros-Perrial, Emeline; Dumontet, Charles] Ctr Rech Cancerol Lyon, CNRS, UMR 5286, F-69008 Lyon, France; [Chettab, Kamel; Lafon, Cyril; Mestas, Jean-Louis] Caviskills SAS, Vaulx En Velin, France; [Lafond, Maxime; Lafon, Cyril; Mestas, Jean-Louis] INSERM, U1032, LabTau, F-69003 Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chettab, K (corresponding author), Univ Lyon, F-69000 Lyon, France.	kchettab@yahoo.fr	Lafon, Cyril/W-8107-2019; Lafon, Cyril/E-4152-2016; Mestas, Jean-Louis/A-6358-2008	Lafon, Cyril/0000-0003-1550-970X; Lafon, Cyril/0000-0003-1550-970X; Mestas, Jean-Louis/0000-0002-4684-6082; Lafond, Maxime/0000-0001-8954-9099; chettab, kamel/0000-0002-5311-3792; Dumontet, Charles/0000-0003-1875-134X	French National Research Agency ANR project "SonInCaRe" [2010-TECS-003-01]; Lyric grant [INCa-DGOS-4664]; European Project Eurostars "Oncoson" [E! 6173]; Caviskills SAS	French National Research Agency ANR project "SonInCaRe"(French National Research Agency (ANR)); Lyric grant; European Project Eurostars "Oncoson"; Caviskills SAS	This work was supported by the French National Research Agency ANR project "SonInCaRe" (2010-TECS-003-01), the Lyric grant INCa-DGOS-4664 and the European Project Eurostars E! 6173 named "Oncoson". It was performed within the framework of the LabEx DevWeCan (ANR-10-LABX-0061) and CeLyA (ANR-10-LABX-0060) of Universite de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR). Caviskills SAS provided support in the form of salaries for authors KC, CL and JLM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum C, 2006, HUM GENE THER, V17, P253, DOI 10.1089/hum.2006.17.253; Bouard D, 2009, BRIT J PHARMACOL, V157, P153, DOI 10.1038/bjp.2008.349; Cao F, 2010, MOL IMAGING BIOL, V12, P15, DOI 10.1007/s11307-009-0236-x; Cochran M, 2013, ULTRASOUND MED BIOL, V39, P1102, DOI 10.1016/j.ultrasmedbio.2013.01.013; Dalecki D, 2004, ANNU REV BIOMED ENG, V6, P229, DOI 10.1146/annurev.bioeng.6.040803.140126; de Queiroz FM, 2012, MOL BIOL REP, V39, P2187, DOI 10.1007/s11033-011-0967-z; Escoffre JM, 2011, MOL PHARMACEUT, V8, P799, DOI 10.1021/mp100397p; Escoffre JM, 2010, ULTRASOUND MED BIOL, V36, P1746, DOI 10.1016/j.ultrasmedbio.2010.06.019; Frohly J, 2000, J ACOUST SOC AM, V108, P2012, DOI 10.1121/1.1312360; Grzesik BA, 2013, AM J PHYSIOL-LUNG C, V305, pL786, DOI 10.1152/ajplung.00191.2013; Hahn P, 2010, TOP CURR CHEM, V296, P1, DOI 10.1007/128_2010_71; Jordheim LP, 2015, ANAL BIOANAL CHEM, V22; Keller H, 1999, GENE THER, V6, P931, DOI 10.1038/sj.gt.3300896; Kinoshita M, 2007, BIOCHEM BIOPH RES CO, V359, P860, DOI 10.1016/j.bbrc.2007.05.153; Lee JL, 2012, J CONTROL RELEASE, V160, P64, DOI 10.1016/j.jconrel.2012.03.007; Li FP, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106260; Li YS, 2008, CANCER LETT, V266, P156, DOI 10.1016/j.canlet.2008.02.041; Li YS, 2009, CANCER LETT, V273, P62, DOI 10.1016/j.canlet.2008.07.030; Lin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012582; Lo CW, 2014, ULTRASON SONOCHEM, V21, P833, DOI 10.1016/j.ultsonch.2013.10.017; Marmottant P, 2003, NATURE, V423, P153, DOI 10.1038/nature01613; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244; Mehier-Humbert S, 2005, J CONTROL RELEASE, V104, P203, DOI 10.1016/j.jconrel.2005.01.011; Mehier-Humbert S, 2005, J CONTROL RELEASE, V104, P213, DOI 10.1016/j.jconrel.2005.01.007; Mestas JL, 2014, J DRUG TARGET, V22, P688, DOI 10.3109/1061186X.2014.906604; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Phillips LC, 2010, ULTRASOUND MED BIOL, V36, P1470, DOI 10.1016/j.ultrasmedbio.2010.06.010; Prentice P, 2005, NAT PHYS, V1, P107, DOI 10.1038/nphys148; Putnam D, 2009, NAT MATER, V6, P439; Reslan L, 2010, J CONTROL RELEASE, V142, P251, DOI 10.1016/j.jconrel.2009.10.029; Robenek H, 2009, J CELL MOL MED, V13, P1381, DOI 10.1111/j.1582-4934.2008.00407.x; Song YZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm710; Sun RR, 2014, J CONTROL RELEASE, V182, P111, DOI 10.1016/j.jconrel.2014.03.002; Suzuki R, 2010, J CONTROL RELEASE, V142, P245, DOI 10.1016/j.jconrel.2009.10.027; Togtema M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050730; Un K, 2012, HEPATOLOGY, V56, P259, DOI 10.1002/hep.25607; Villeneuve L, 2009, ULTRASON SONOCHEM, V16, P339, DOI 10.1016/j.ultsonch.2008.09.007; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Wang P, 2012, J ULTRAS MED, V31, P1977; Zeghimi A, 2014, J DRUG TARGET, V22, P748, DOI 10.3109/1061186X.2014.921922; Zhang M, 2014, J IMMUNOL METHODS, V408, P123, DOI 10.1016/j.jim.2014.05.014; Zhang YW, 2012, INT J HYPERTHER, V28, P290, DOI 10.3109/02656736.2012.665568	43	18	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134247	10.1371/journal.pone.0134247	http://dx.doi.org/10.1371/journal.pone.0134247			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274324	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600023
J	Liu, YQ; Wei, XM; Kong, XD; Guo, XQ; Sun, Y; Man, JF; Du, LQ; Zhu, H; Qu, Z; Tian, P; Mao, B; Yang, Y				Liu, Yanqiu; Wei, Xiaoming; Kong, Xiangdong; Guo, Xueqin; Sun, Yan; Man, Jianfen; Du, Lique; Zhu, Hui; Qu, Zelan; Tian, Ping; Mao, Bing; Yang, Yun			Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases	PLOS ONE			English	Article							MUTATIONS; GENE; ENRICHMENT; VARIANTS	Background Targeted next-generation sequencing (NGS) is a cost-effective approach for rapid and accurate detection of genetic mutations in patients with suspected genetic disorders, which can facilitate effective diagnosis. Methodology/Principal Findings We designed a capture array to mainly capture all the coding sequence (CDS) of 2,181 genes associated with 561 Mendelian diseases and conducted NGS to detect mutations. The accuracy of NGS was 99.95%, which was obtained by comparing the genotypes of selected loci between our method and SNP Array in four samples from normal human adults. We also tested the stability of the method using a sample from normal human adults. The results showed that an average of 97.79% and 96.72% of single-nucleotide variants (SNVs) in the sample could be detected stably in a batch and different batches respectively. In addition, the method could detect various types of mutations. Some disease-causing mutations were detected in 69 clinical cases, including 62 SNVs, 14 insertions and deletions (Indels), 1 copy number variant (CNV), 1 microdeletion and 2 microduplications of chromosomes, of which 35 mutations were novel. Mutations were confirmed by Sanger sequencing or real-time polymerase chain reaction (PCR). Conclusions/Significance Results of the evaluation showed that targeted NGS enabled to detect disease-causing mutations with high accuracy, stability, speed and throughput. Thus, the technology can be used for the clinical diagnosis of 561 Mendelian diseases.	[Liu, Yanqiu] Jiangxi Prov Women & Children Hosp, Dept Genet, Nanchang 330006, Peoples R China; [Wei, Xiaoming; Guo, Xueqin; Sun, Yan; Man, Jianfen; Du, Lique; Zhu, Hui; Yang, Yun] BGI Wuhan, Wuhan 430075, Peoples R China; [Wei, Xiaoming; Guo, Xueqin; Sun, Yan; Man, Jianfen; Du, Lique; Zhu, Hui; Qu, Zelan; Yang, Yun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Kong, Xiangdong] Zhengzhou Univ, Affiliated Hosp 1, Prenatal Diag Ctr, Zhengzhou 450052, Peoples R China; [Tian, Ping] Wuhan Med & Hlth Ctr Women & Children, Dept Obstet & Gynecol, Wuhan 430022, Peoples R China; [Mao, Bing] Wuhan Med & Hlth Ctr Women & Children, Dept Neurol, Wuhan 430022, Peoples R China	Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Zhengzhou University	Yang, Y (corresponding author), BGI Wuhan, Wuhan 430075, Peoples R China.	yangyun@genomics.cn	Guo, Xueqin/AAZ-9936-2020					Alkorta-Aranburu G, 2014, MOL GENET METAB, V113, P315, DOI 10.1016/j.ymgme.2014.09.007; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Bragin E, 2014, NUCLEIC ACIDS RES, V42, pD993, DOI 10.1093/nar/gkt937; Brinkman RR, 2006, NAT REV GENET, V7, P249, DOI 10.1038/nrg1828; Cappellano G, 2008, GENES IMMUN, V9, P438, DOI 10.1038/gene.2008.35; CARTER CO, 1977, J MED GENET, V14, P316, DOI 10.1136/jmg.14.5.316; Choudhary A, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0062-0; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Demina A, 1998, BLOOD, V92, P647, DOI 10.1182/blood.V92.2.647.414k13_647_652; Fermo E, 2005, BRIT J HAEMATOL, V129, P839, DOI 10.1111/j.1365-2141.2005.05520.x; Guan YF, 2015, FAM CANCER, V14, P9, DOI 10.1007/s10689-014-9749-9; Hodapp JA, 2006, ARCH NEUROL-CHICAGO, V63, P112, DOI 10.1001/archneur.63.1.112; Huang J, 2010, J NEUROL, V257, P735, DOI 10.1007/s00415-009-5401-2; Janssen EAM, 1997, HUM GENET, V99, P501, DOI 10.1007/s004390050396; Johnson DB, 2014, ONCOLOGIST, V19, P616, DOI 10.1634/theoncologist.2014-0011; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; Magi A, 2012, BIOINFORMATICS, V28, P470, DOI 10.1093/bioinformatics/btr707; Meder B, 2011, CIRC-CARDIOVASC GENE, V4, P110, DOI 10.1161/CIRCGENETICS.110.958322; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Otomo T, 2009, J HUM GENET, V54, P145, DOI 10.1038/jhg.2009.3; Qing J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109178; Sheppard DN, 1996, J BIOL CHEM, V271, P14995, DOI 10.1074/jbc.271.25.14995; Sikkema-Raddatz B, 2013, HUM MUTAT, V34, P1035, DOI 10.1002/humu.22332; Wagner JA, 1999, HUM GENET, V104, P511, DOI 10.1007/s004390050996; Weaver JMJ, 2011, GENOME MED, V3, DOI 10.1186/gm274; Wei XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029500; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yohe S, 2015, ARCH PATHOL LAB MED, V139, P204, DOI 10.5858/arpa.2013-0625-OA; Zhang F, 2010, AM J HUM GENET, V86, P892, DOI 10.1016/j.ajhg.2010.05.001	30	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133636	10.1371/journal.pone.0133636	http://dx.doi.org/10.1371/journal.pone.0133636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274329	gold, Green Published			2022-12-27	WOS:000359493600013
J	Machado, TS; Macabelli, CH; Sangalli, JR; Rodrigues, TB; Smith, LC; Meirelles, FV; Chiaratti, MR				Machado, Thiago Simoes; Macabelli, Carolina Habermann; Sangalli, Juliano Rodrigues; Rodrigues, Thiago Bittencourt; Smith, Lawrence Charles; Meirelles, Flavio Vieira; Chiaratti, Marcos Roberto			Real-Time PCR Quantification of Heteroplasmy in a Mouse Model with Mitochondrial DNA of C57BL/6 and NZB/BINJ Strains	PLOS ONE			English	Article							QUANTITATIVE PCR; RAPID SEGREGATION; COPY NUMBER; MTDNA; MUTATION; CENTRIFUGATION; REDUCTION; EXPLAINS; OOCYTES; TISSUES	Mouse models are widely employed to study mitochondrial inheritance, which have implications to several human diseases caused by mutations in the mitochondrial genome (mtDNA). These mouse models take advantage of polymorphisms between the mtDNA of the NZB/BINJ and the mtDNA of common inbred laboratory (i.e., C57BL/6) strains to generate mice with two mtDNA haplotypes (heteroplasmy). Based on PCR followed by restriction fragment length polymorphism (PCR-RFLP), these studies determine the level of heteroplasmy across generations and in different cell types aiming to understand the mechanisms underlying mitochondrial inheritance. However, PCR-RFLP is a time-consuming method of low sensitivity and accuracy that dependents on the use of restriction enzyme digestions. A more robust method to measure heteroplasmy has been provided by the use of real-time quantitative PCR (qPCR) based on allelic refractory mutation detection system (ARMS-qPCR). Herein, we report an ARMS-qPCR assay for quantification of heteroplasmy using heteroplasmic mice with mtDNA of NZB/BINJ and C57BL/6 origin. Heteroplasmy and mtDNA copy number were estimated in germline and somatic tissues, providing evidence of the reliability of the approach. Furthermore, it enabled single-step quantification of heteroplasmy, with sensitivity to detect as low as 0.1% of either NZB/BINJ or C57BL/6 mtDNA. These findings are relevant as the ARMS-qPCR assay reported here is fully compatible with similar heteroplasmic mouse models used to study mitochondrial inheritance in mammals.	[Machado, Thiago Simoes; Macabelli, Carolina Habermann; Rodrigues, Thiago Bittencourt; Chiaratti, Marcos Roberto] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, BR-13565905 Sao Carlos, SP, Brazil; [Machado, Thiago Simoes; Sangalli, Juliano Rodrigues; Smith, Lawrence Charles; Meirelles, Flavio Vieira; Chiaratti, Marcos Roberto] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Cirurgia, BR-05508270 Sao Paulo, SP, Brazil; [Machado, Thiago Simoes; Macabelli, Carolina Habermann; Sangalli, Juliano Rodrigues; Meirelles, Flavio Vieira; Chiaratti, Marcos Roberto] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Dept Med Vet, BR-13635900 Pirassununga, SP, Brazil; [Smith, Lawrence Charles] Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade de Sao Paulo; Universite de Montreal	Chiaratti, MR (corresponding author), Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, BR-13565905 Sao Carlos, SP, Brazil.	chiarattimr@gmail.com	Smith, Lawrence/AAP-4321-2021; Chiaratti, Marcos R/C-2727-2012; Smith, Lawrence C/K-4658-2012; Meirelles, Flavio V/B-5048-2010; Sangalli, Juliano Rodrigues/C-1834-2013; Macabelli, Carolina/G-5355-2016; CTC USP, CEPID 13 18/J-8951-2014	Smith, Lawrence/0000-0001-8766-0148; Chiaratti, Marcos R/0000-0001-8805-9469; Meirelles, Flavio V/0000-0003-0372-4920; CTC USP, CEPID 13 18/0000-0002-7123-9524	Sao Paulo Research Foundation (FAPESP) [2013/23408-5, 2012/50231-6, 2012/12951-7, 2010/09561-7, 2010/13384-3]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was granted by Sao Paulo Research Foundation (FAPESP; www.fapesp.br). Grant numbers 2013/23408-5 (MRC), 2012/50231-6 (MRC), 2012/12951-7 (MRC), 2010/09561-7 (FVM), 2010/13384-3 (FVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CEM, 2008, REPROD BIOMED ONLINE, V17, P806, DOI 10.1016/S1472-6483(10)60409-9; Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153; Battersby BJ, 2005, HUM MOL GENET, V14, P2587, DOI 10.1093/hmg/ddi293; Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073; Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739; Biffi S, 2011, DIAGN MOL PATHOL, V20, P117, DOI 10.1097/PDM.0b013e3181efe2c6; Bouma GJ, 2004, GENE EXPR PATTERNS, V5, P141, DOI 10.1016/j.modgep.2004.05.001; Burgstaller JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-141; Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chiaratti MR, 2011, REPROD BIOMED ONLINE, V22, P172, DOI 10.1016/j.rbmo.2010.10.011; CRAN DG, 1987, GAMETE RES, V18, P67, DOI 10.1002/mrd.1120180108; Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Ferreira CR, 2010, BIOL REPROD, V82, P563, DOI 10.1095/biolreprod.109.080564; Green MR, 2012, MOL CLONING LAB MANU, V1; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Jokinen R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001161; Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; May-Panloup P, 2007, CURR TOP DEV BIOL, V77, P51, DOI 10.1016/S0070-2153(06)77003-X; Meirelles FV, 1997, GENETICS, V145, P445; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; MORAES CT, 1992, AM J HUM GENET, V50, P934; Nagy A., 2003, MANIPULATING MOUSE E; NAKAMURA K, 1986, GAMETE RES, V15, P83, DOI 10.1002/mrd.1120150109; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Shitara H, 2000, GENETICS, V156, P1277; Steinborn R, 2000, NAT GENET, V25, P255, DOI 10.1038/77000; Stewart JB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004670; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tatham BG, 1996, HUM REPROD, V11, P1499; Venegas V, 2012, METHODS MOL BIOL, V837, P313, DOI 10.1007/978-1-61779-504-6_21; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wang Jing, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1906s68	41	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133650	10.1371/journal.pone.0133650	http://dx.doi.org/10.1371/journal.pone.0133650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274500	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600014
J	Gangwani, MR; Kumar, A				Gangwani, Mohitkumar R.; Kumar, Anil			Multiple Protein Kinases via Activation of Transcription Factors NF-kappa B, AP-1 and C/EBP-delta Regulate the IL-6/IL-8 Production by HIV-1 Vpr in Astrocytes	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD-BRAIN-BARRIER; INTERLEUKIN-8 GENE-EXPRESSION; CELL-DEATH; NEUROCOGNITIVE DISORDERS; SIGNALING PATHWAYS; IL-6 PRODUCTION; INFECTION; P38; MECHANISMS	Neurocognitive impairments affect a substantial population of HIV-1 infected individuals despite the success of anti-retroviral therapy in controlling viral replication. Astrocytes are emerging as a crucial cell type that might be playing a very important role in the persistence of neuroinflammation seen in patients suffering from HIV-1 associated neurocognitive disorders. HIV-1 viral proteins including Vpr exert neurotoxicity through direct and indirect mechanisms. Induction of IL-8 in microglial cells has been shown as one of the indirect mechanism through which Vpr reduces neuronal survival. We show that HIV-1 Vpr induces IL-6 and IL-8 in astrocytes in a time-dependent manner. Additional experiments utilizing chemical inhibitors and siRNA revealed that HIV-1 Vpr activates transcription factors NF-kappa B, AP-1 and C/EBP-delta via upstream protein kinases PI3K/Akt, p38-MAPK and Jnk-MAPK leading to the induction of IL-6 and IL-8 in astrocytes. We demonstrate that one of the mechanism for neuroinflammation seen in HIV-1 infected individuals involves induction of IL-6 and IL-8 by Vpr in astrocytes. Understanding the molecular pathways involved in the HIV-1 neuroinflammation would be helpful in the design of adjunct therapy to ameliorate some of the symptoms associated with HIV-1 neuropathogenesis.	[Gangwani, Mohitkumar R.; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Kumar, A (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA.	kumaran@umkc.edu	KUMAR, ANIL/ACD-8340-2022; Gangwani, Mohitkumar Rajkumar/HHM-6719-2022; Boothapati, Anil Kumar/HHS-1813-2022	Gangwani, Mohitkumar/0000-0002-1432-4984; Buch, Shilpa/0000-0002-3103-6685	NIDA [DA 025528, DA025011]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025011, R01DA025528] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was funded by NIDA grants number DA 025528 and DA025011. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Burdo TH, 2013, IMMUNOL REV, V254, P102, DOI 10.1111/imr.12068; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Carroll-Anzinger D, 2006, J VIROL, V80, P541, DOI 10.1128/JVI.80.1.541-544.2006; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Das M, 2011, GENE DEV, V25, P634, DOI 10.1101/gad.1989311; Davidson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051793; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Duverger A, 2013, J VIROL, V87, P2264, DOI 10.1128/JVI.01594-12; Eugenin EA, 2011, J NEUROSCI, V31, P9456, DOI 10.1523/JNEUROSCI.1460-11.2011; Faggioli L, 2004, BBA-MOL CELL RES, V1692, P17, DOI 10.1016/j.bbamcr.2004.03.001; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Ferrucci A, 2013, J NEUROVIROL, V19, P239, DOI 10.1007/s13365-013-0170-1; GANCHI PA, 1993, MOL CELL BIOL, V13, P7826, DOI 10.1128/MCB.13.12.7826; Gangwani MR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-136; Gardner J, 2006, J NEUROSCI RES, V83, P1281, DOI 10.1002/jnr.20823; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; Guha D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-138; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Holloway G, 2006, J VIROL, V80, P10624, DOI 10.1128/JVI.00390-06; Hoshino S, 2010, J LEUKOCYTE BIOL, V87, P1133, DOI 10.1189/jlb.0809547; Hungness ES, 2002, J CELL PHYSIOL, V192, P64, DOI 10.1002/jcp.10116; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kondo A, 2013, ARCH BIOCHEM BIOPHYS, V535, P227, DOI 10.1016/j.abb.2013.04.007; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; LEVY DN, 1994, P NATL ACAD SCI USA, V91, P10873, DOI 10.1073/pnas.91.23.10873; Li W, 2005, NEUROTOX RES, V8, P119, DOI 10.1007/BF03033824; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Liu RK, 2013, VIROLOGY, V439, P47, DOI 10.1016/j.virol.2013.01.020; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Messam CA, 2000, J NEUROVIROL, V6, pS90; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; Mukerjee R, 2011, J BIOL CHEM, V286, P34976, DOI 10.1074/jbc.M111.241547; Patel CA, 2000, J VIROL, V74, P9717, DOI 10.1128/JVI.74.20.9717-9726.2000; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Piao CS, 2002, MOL BRAIN RES, V107, P137, DOI 10.1016/S0169-328X(02)00456-4; Popov S, 1998, J BIOL CHEM, V273, P13347, DOI 10.1074/jbc.273.21.13347; Roux P, 2000, J VIROL, V74, P4658, DOI 10.1128/JVI.74.10.4658-4665.2000; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Shah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052060; Shah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021261; Shah A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-96; Strazza M, 2011, BRAIN RES, V1399, P96, DOI 10.1016/j.brainres.2011.05.015; Thirumangalakudi L, 2007, J ALZHEIMERS DIS, V11, P305; Ton Hoai, 2013, J AIDS Clin Res, V4, P255; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; Valente T, 2013, NEUROBIOL AGING, V34, P2110, DOI 10.1016/j.neurobiolaging.2013.02.007; Yan CG, 2013, AM J PATHOL, V182, P420, DOI 10.1016/j.ajpath.2012.10.013	54	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135633	10.1371/journal.pone.0135633	http://dx.doi.org/10.1371/journal.pone.0135633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270987	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800094
J	Siriwut, W; Edgecombe, GD; Sutcharit, C; Panha, S				Siriwut, Warut; Edgecombe, Gregory D.; Sutcharit, Chirasak; Panha, Somsak			The Centipede Genus Scolopendra in Mainland Southeast Asia: Molecular Phylogenetics, Geometric Morphometrics and External Morphology as Tools for Species Delimitation	PLOS ONE			English	Article							COLOR-CHANGE; SEA LEVELS; HISTORICAL BIOGEOGRAPHY; MYRIAPODA CHILOPODA; DIGITIPES ATTEMS; SUNDA SHELF; EVOLUTION; DIVERSIFICATION; PHYLOGEOGRAPHY; DIVERSITY	Seven Scolopendra species from the Southeast Asian mainland delimited based on standard external morphological characters represent monophyletic groups in phylogenetic trees inferred from concatenated sequences of three gene fragments (cytochrome c oxidase subunit 1, 16S rRNA and 28S rRNA) using Maximum likelihood and Bayesian inference. Geometric morphometric description of shape variation in the cephalic plate, forcipular coxosternite, and tergite of the ultimate leg-bearing segment provides additional criteria for distinguishing species. Colouration patterns in some Scolopendra species show a high degree of fit to phylogenetic trees at the population level. The most densely sampled species, Scolopendra dehaani Brandt, 1840, has three subclades with allopatric distributions in mainland SE Asia. The molecular phylogeny of S. pinguis Pocock, 1891, indicated ontogenetic colour variation among its populations. The taxonomic validation of S. dawy-doffi Kronmuller, 2012, S. japonica Koch, 1878, and S. dehaani Brandt, 1840, each a former subspecies of S. subspinipes Leach, 1814 sensu Lewis, 2010, as full species was supported by molecular information and additional morphological data. Species delimitation in these taxonomically challenging animals is facilitated by an integrative approach that draws on both morphology and molecular phylogeny.	[Siriwut, Warut] Chulalongkorn Univ, Fac Sci, Biol Sci Program, Bangkok, Thailand; [Siriwut, Warut; Sutcharit, Chirasak; Panha, Somsak] Chulalongkorn Univ, Dept Biol, Anim Systemat Res Unit, Bangkok, Thailand; [Edgecombe, Gregory D.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	Chulalongkorn University; Chulalongkorn University; Natural History Museum London	Panha, S (corresponding author), Chulalongkorn Univ, Dept Biol, Anim Systemat Res Unit, Bangkok, Thailand.	somsak.pan@chula.ac.th		Edgecombe, Gregory/0000-0002-9591-8011	Thailand Research Fund (TRF); Ratchadapisek Sompoch Endowment Fund; Chulalongkorn University [CU-57-017-FW]; Plant Genetic Conservation Project under the Initiative of Her Royal Highness Princess Maha Chakri Sirindhorn; Thai Royal Navy; Department of National Parks, Wildlife and Conservation; TRF Royal Golden Jubilee Ph.D. Program [PHD/0066/2553]; RGJ Newton Fund	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Ratchadapisek Sompoch Endowment Fund; Chulalongkorn University(Chulalongkorn University); Plant Genetic Conservation Project under the Initiative of Her Royal Highness Princess Maha Chakri Sirindhorn; Thai Royal Navy; Department of National Parks, Wildlife and Conservation; TRF Royal Golden Jubilee Ph.D. Program; RGJ Newton Fund	This project received major funding from The Thailand Research Fund (TRF) under TRF Senior Research Scholar to SP, Ratchadapisek Sompoch Endowment Fund (2014), Chulalongkorn University (CU-57-017-FW). Accommodation and travel expenses during field surveys in almost all islands in the Gulf of Thailand and the Andaman Sea were supported by The Plant Genetic Conservation Project under the Initiative of Her Royal Highness Princess Maha Chakri Sirindhorn, The Thai Royal Navy, and The Department of National Parks, Wildlife and Conservation. Additional support came from the TRF Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0066/2553) and the RGJ Newton Fund 2015 to SP and WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; [Anonymous], 2006, CHILOBASE WEB RESOUR; [Anonymous], 2011, MESQUITE MODULAR SYS; ATTEMS C., 1930, REV ZOOL ET BOT AFRICAINES, V19, P287; Attems C., 1953, Memoires Museum Histoire Nat Paris NS, V5A, P133; Attems C, 1930, MYRIAPODA, V2; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Bolton SJ, 2009, ZOOL J LINN SOC-LOND, V156, P239, DOI 10.1111/j.1096-3642.2009.00564.x; Bonato L, 2010, ZOOKEYS, P17, DOI 10.3897/zookeys.69.737; Bookstein F., 1996, IMAGE FUSION SHAPE V, P79; Bookstein FL, 1997, MED IMAGE ANAL, V1, P225, DOI DOI 10.1016/S1361-8415(97)85012-8; Brandt J. F., 1840, B SCI ACAD IMPERIALE, V7, P148; Brolemann Henry W., 1902, Revista do Museu Paulista, Vv, P35; Brown RM, 2012, BIOTIC EVOLUTION ENV, P349; Buecherl W., 1946, MEM INST BUTANLAN, V19, P135; Cannon CH, 2009, P NATL ACAD SCI USA, V106, P11188, DOI 10.1073/pnas.0809865106; Chamberlin Ralph V., 1912, Annals of the Entomological Society of America, V5; Chao J., 2008, SCOLOPENDROMORPHA CH; Chao JL, 2011, P 15 INT C MYR; Chen G, 2011, MOL ECOL, V20, P2425, DOI 10.1111/j.1365-294X.2011.05079.x; Chia OKS, 2006, RAFFLES B ZOOL, V54, P381; Clouse RM, 2010, J BIOGEOGR, V37, P1114, DOI 10.1111/j.1365-2699.2010.02274.x; Cuvier Latreille., 1829, REGNE ANIMAL, V2; DAVIS BL, 1974, SYST ZOOL, V23, P26, DOI 10.2307/2412237; de Bruyn M, 2005, HEREDITY, V94, P370, DOI 10.1038/sj.hdy.6800613; de Bruyn M, 2014, SYST BIOL, V63, P879, DOI 10.1093/sysbio/syu047; Decker P., 2013, ANNOTATED CHECKLIST; Dryden IL, 1998, STAT SHAPE ANAL; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgecombe GD, 2007, ANNU REV ENTOMOL, V52, P70; Edgecombe GD, 2008, INVERTEBR SYST, V22, P1, DOI 10.1071/IS07036; Edgecombe GD, 2007, ZOOTAXA, P327, DOI 10.11646/zootaxa.1668.1.17; Edgecombe GD, 2015, ZOOKEYS, P65, DOI 10.3897/zookeys.510.8573; Edgecombe GD, 2009, CLADISTICS, V25, P406, DOI 10.1111/j.1096-0031.2009.00253.x; Emerson SB, 2000, MOL PHYLOGENET EVOL, V16, P131, DOI 10.1006/mpev.2000.0778; FIELD KG, 1988, SCIENCE, V239, P748, DOI 10.1126/science.3277277; Flower S. S., 1901, Journal Straits Asiatic Society Singapore, VNo. 36, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gervais P, 1847, HIST NATURELLE INSEC, V4, P1; Giribet G, 2013, INVERTEBR SYST, V27, P485, DOI 10.1071/IS13019; Giribet G, 2012, ANNU REV ENTOMOL, V57, P167, DOI 10.1146/annurev-ento-120710-100659; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Gorog AJ, 2004, BIOL J LINN SOC, V81, P91, DOI 10.1111/j.1095-8312.2004.00281.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez BL, 2011, ZOOKEYS, P49, DOI 10.3897/zookeys.156.1997; Haase E., 1887, ABHANDLUNGEN BERICHT, V4, P1; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; Hanebuth TJJ, 2009, GLOBAL PLANET CHANGE, V66, P76, DOI 10.1016/j.gloplacha.2008.03.011; Heiser M, 2013, J BIOGEOGR, V40, P2047, DOI 10.1111/jbi.12133; Horton BP, 2005, HOLOCENE, V15, P1199, DOI 10.1191/0959683605hl891rp; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humbert A, 1870, REV MAGASIN ZOOLOGIE, V22, P202; JANGI BS, 1984, J SCI IND RES INDIA, V43, P27; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Joshi J, 2013, ZOOTAXA, V3626, P99, DOI 10.11646/zootaxa.3626.1.5; Joshi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042225; Joshi J, 2011, MOL PHYLOGENET EVOL, V60, P287, DOI 10.1016/j.ympev.2011.04.024; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; KOCH LE, 1982, ZOOL J LINN SOC-LOND, V76, P125, DOI 10.1111/j.1096-3642.1982.tb01497.x; KOCH LE, 1983, AUST J ZOOL, V31, P799, DOI 10.1071/ZO9830799; Koh LP, 2013, ENCY BIODIVERSITY, V1, P509, DOI DOI 10.1016/B978-0-12-384719-5.00357-9; Kraepelin K., 1903, REVISION SCOLOPENDRI; Kronmuller C, 2012, SPIXIANA, V35, P19; Kronmueller Christian, 2009, Arthropoda, V17, P48; Laakmann S, 2013, MOL ECOL RESOUR, V13, P862, DOI 10.1111/1755-0998.12139; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Langkilde T, 2012, J HERPETOL, V46, P461, DOI 10.1670/11-292; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lewis JGE, 2006, ZOOTAXA, P35; LEWIS JGE, 1982, J NAT HIST, V16, P389, DOI 10.1080/00222938200770321; Lewis JGE, 2000, J NAT HIST, V34, P433, DOI 10.1080/002229300299552; Lewis JGE, 1972, ENTOMOLOGISTS MONTHL, P16; Lewis JGE., 1968, ZOOLOGICAL J LINNEAN, V48, P49; Lewis JGE, 1978, ABHANDLUNGEN VERHAND, V21, P51; Lewis John G.E., 2001, Historia Naturalis Bulgarica, V13, P5; Lewis John G. E., 2010, International Journal of Myriapodology, V3, P83, DOI 10.1163/187525410X12578602960380; Linnaeus C, 1758, SYSTEMA NATURAE; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; LOHMANN GP, 1983, J INT ASS MATH GEOL, V15, P659, DOI 10.1007/BF01033230; Lourenco WR, 2015, ZOOKEYS, P73, DOI 10.3897/zookeys.500.9421; Lourie SA, 2004, J BIOGEOGR, V31, P1975, DOI 10.1111/j.1365-2699.2004.01153.x; Lovatt Smith P.F., 1996, GEOL SOC SPEC PUBL, V106, P233, DOI [10.1144/GSL.SP.1996.106.01.15, DOI 10.1144/GSL.SP.1996.106.01.15]; Lucas H, 1853, REV MAGASIN ZOOLOGIE, V5, P514; Lucas H, 1853, REV MAGASIN ZOOLOGIE, V5, P418; Lucas H, 1853, REV MAGASIN ZOOLOGIE, V5, P65; Lucas H, 1853, REV MAGASIN ZOOLOGIE, V5, P61; Lukoschek V, 2011, ECOL EVOL, V1, P330, DOI 10.1002/ece3.29; Luo SJ, 2014, MOL ECOL, V23, P2072, DOI 10.1111/mec.12716; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Metcalfe I, 2013, J ASIAN EARTH SCI, V66, P1, DOI 10.1016/j.jseaes.2012.12.020; Metcalfe I, 2011, GONDWANA RES, V19, P3, DOI 10.1016/j.gr.2010.02.016; MONGENAJERA J, 1995, ZOOL J LINN SOC-LOND, V114, P21, DOI 10.1111/j.1096-3642.1995.tb00111.x; Monod L, 2015, CLADISTICS, V31, P71, DOI 10.1111/cla.12067; Morgan JAT, 2002, MOL PHYLOGENET EVOL, V25, P477, DOI 10.1016/S1055-7903(02)00280-4; Morley CK, 2012, EARTH-SCI REV, V115, P37, DOI 10.1016/j.earscirev.2012.08.002; Mosimann J., 1979, J AM STAT ASSOC, V63, P930; Moyle RG, 2011, AUK, V128, P777, DOI 10.1525/auk.2011.11019; Muadsub S, 2014, ZOOTAXA, V3869, P53, DOI 10.11646/zootaxa.3869.1.5; Murienne J, 2013, P ROY SOC LOND B BIO, V281; Murienne J, 2011, ORG DIVERS EVOL, V11, P61, DOI 10.1007/s13127-011-0041-7; Murienne J, 2010, MOL PHYLOGENET EVOL, V57, P301, DOI 10.1016/j.ympev.2010.06.022; Myriopoden Attems C., 1898, DENKSCHRIFTEN MED NA, V8, P505; Nantarat N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109785; Nantarat N, 2014, MOL PHYLOGENET EVOL, V70, P99, DOI 10.1016/j.ympev.2013.09.013; Newport G., 1844, ANN MAGAZINE NATURAL, V13, P94, DOI DOI 10.1080/03745484409442576; Newport G., 1844, P LINNEAN SOC LONDON, V1, P191; Niedermeyer EM, 2014, P NATL ACAD SCI USA, V111, P9402, DOI 10.1073/pnas.1323585111; Nishikawa K, 2012, MOL PHYLOGENET EVOL, V63, P714, DOI 10.1016/j.ympev.2012.02.017; Oeyen JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108650; Ohler Annemarie, 2005, Herpetozoa, V18, P99; Outlaw DC, 2008, J BIOGEOGR, V35, P739, DOI 10.1111/j.1365-2699.2007.01821.x; Parker S R, 1997, Methods Mol Biol, V70, P145; Perez SI, 2006, J ANAT, V208, P769, DOI 10.1111/j.1469-7580.2006.00576.x; Pimvichai P, 2014, MOL PHYLOGENET EVOL, V71, P170, DOI 10.1016/j.ympev.2013.11.006; Pocock R. I., 1891, Anu Mus Genova, V(2), P401; Pocock RI., 1891, ANN MAGAZINE NATUR 6, V7, P51, DOI DOI 10.1080/00222939109460598; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Puillandre N, 2010, J MOLLUS STUD, V76, P11, DOI 10.1093/mollus/eyp042; Purcell S, 2006, SPC BECHE DE MER INF, V23, P29; Quek SP, 2007, MOL ECOL, V16, P2045, DOI 10.1111/j.1365-294X.2007.03294.x; Racey A, 2009, GEOL SOC SPEC PUBL, V315, P41, DOI 10.1144/SP315.5; Rambaut A., 2007, FIGTREE V 1 4 2; Rohlf F, 2002, TPS SOFTWARE SERIES; Rohlf F., 2001, TPSDIG C V 1 31 FREE; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; RUDMAN WB, 1991, J MOLLUS STUD, V57, P5, DOI 10.1093/mollus/57.Supplement_Part_4.5; Rust J, 2010, P NATL ACAD SCI USA, V107, P18360, DOI 10.1073/pnas.1007407107; Schileyko Arkadiy A., 2007, Arthropoda Selecta, V16, P71; Schileyko Arkadiy A., 1992, Arthropoda Selecta, V1, P5; Schileyko Arkady A., 1995, Arthropoda Selecta, V4, P73; Schilthuizen M, 2013, HEREDITY, V110, P247, DOI 10.1038/hdy.2012.74; Schwendinger PJ, 2005, INVERTEBR SYST, V19, P297, DOI 10.1071/IS05023; Sheets HD, 2004, MORPHOMETRICS: APPLICATIONS IN BIOLOGY AND PALEONTOLOGY, P67; Shelley RM, 2005, ENTOMOL NEWS, V116, P39; Shelley RM, 2005, SYNOPSIS N AM CENTIP; Simaiakis SM, 2012, BIOL J LINN SOC, V105, P507, DOI 10.1111/j.1095-8312.2011.01813.x; Simaiakis SM, 2011, ZOOL ANZ, V250, P67, DOI 10.1016/j.jcz.2010.11.006; Siriwut W, 2015, ZOOTAXA, V3931, P71, DOI 10.11646/zootaxa.3931.1.5; Siriwut W, 2014, RAFFLES B ZOOL, V62, P339; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Stuart-Fox D, 2006, BIOL J LINN SOC, V88, P437, DOI 10.1111/j.1095-8312.2006.00631.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Menezes RST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119151; Thoma M, 2014, ZOOTAXA, V3798, P1, DOI 10.11646/zootaxa.3798.1.1; Vahtera V, 2013, INVERTEBR SYST, V27, P578, DOI 10.1071/IS13035; Vahtera V, 2012, CLADISTICS, V28, P4, DOI 10.1111/j.1096-0031.2011.00361.x; Vanhooydonck B, 2009, BIOL J LINN SOC, V98, P129, DOI 10.1111/j.1095-8312.2009.01269.x; VERHOEFF KW, 1937, B RAFFLES MUSEUM, V13, P198; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wilson D, 2007, BIOL LETT-UK, V3, P40, DOI 10.1098/rsbl.2006.0574; Wood HC, 1862, J ACAD NATURAL SCI 2, V5, P2; Woodruff DS, 2010, BIODIVERS CONSERV, V19, P919, DOI 10.1007/s10531-010-9783-3; Woodruff DS, 2009, J BIOGEOGR, V36, P803, DOI 10.1111/j.1365-2699.2008.02071.x; Woodruff DS, 2003, J BIOGEOGR, V30, P551, DOI 10.1046/j.1365-2699.2003.00846.x; XIONG B, 1991, GENOME, V34, P306, DOI 10.1139/g91-050; Yodthong S, 2015, ASIAN HERPETOL RES, V5, P18; Zhan S, 2014, NATURE, V514, P317, DOI 10.1038/nature13812	165	29	29	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135355	10.1371/journal.pone.0135355	http://dx.doi.org/10.1371/journal.pone.0135355			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270342	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800061
J	Yang, G; Wang, XJ; Huang, LJ; Zhou, YA; Tian, F; Zhao, JB; Chen, P; Liu, BY; Wen, MM; Li, XF; Zhang, ZP				Yang, Guang; Wang, Xue-Jiao; Huang, Li-Jun; Zhou, Yong-An; Tian, Feng; Zhao, Jin-Bo; Chen, Peng; Liu, Bo-Ya; Wen, Miao-Miao; Li, Xiao-Fei; Zhang, Zhi-Pei			High ABCG4 Expression Is Associated with Poor Prognosis in Non-Small-Cell Lung Cancer Patients Treated with Cisplatin-Based Chemotherapy	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTERS; RESISTANCE PROTEIN; CHOLESTEROL EFFLUX; DRUG-RESISTANCE; SURVIVAL; EXCRETION; ERCC1; ABCC1; GENE; BCRP	ATP-binding cassette (ABC) transporters are associated with poor response to chemotherapy, and confer a poor prognosis in various malignancies. However, the association between the expression of the ABC sub-family G member 4 (ABCG4) and prognosis in patients with non-small-cell lung cancer (NSCLC) remains unclear. NSCLC tissue samples (n = 140) and normal lung tissue samples (n = 90) were resected from patients with stage II to IV NSCLC between May 2004 and May 2009. ABCG4 mRNA and protein expressions were detected by RT-PCR, western blot, and immunohistochemistry. Patients received four cycles of cisplatin-based post-surgery chemotherapy and were followed up until May 31st, 2014. ABCG4 positivity rate was higher in NSCLC than in normal lung tissues (48.6% vs. 0%, P<0.001) and ABCG4 expression was significantly associated with poor differentiation, higher tumor node metastasis (TNM) stage, and adenocarcinoma histological type (all P<0.001). Univariate (HR = 2.284, 95% CI: 1.570-3.324, P<0.001) and multivariate (HR = 2.236, 95% CI: 1.505-3.321, P<0.001) analyses showed that ABCG4 expression was an independent factor associated with a poor prognosis in NSCLC. Patients with ABCG4-positive NSCLC had shorter median survival than ABCG4-negative NSCLC (20.1 vs. 43.2 months, P<0.001). The prognostic significance of ABCG4 expression was apparent in stages III and IV NSCLC. In conclusion, high ABCG4 expression was associated with a poor prognosis in patients with NSCLC treated with cisplatin-based chemotherapy.	[Yang, Guang; Wang, Xue-Jiao; Huang, Li-Jun; Zhou, Yong-An; Tian, Feng; Zhao, Jin-Bo; Chen, Peng; Liu, Bo-Ya; Wen, Miao-Miao; Li, Xiao-Fei; Zhang, Zhi-Pei] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710038, Peoples R China	Air Force Military Medical University	Li, XF (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710038, Peoples R China.	lixiaofeits@126.com; zzpzyy@fmmu.edu.cn	Li, xiaofei/GXF-7187-2022		National Natural Science Foundation of China [81172224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant No. 81172224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annilo T, 2001, CYTOGENET CELL GENET, V94, P196, DOI 10.1159/000048816; Arrieta O, 2010, J CLIN ONCOL, V28, P3463, DOI 10.1200/JCO.2009.26.6452; Askoxylakis V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-105; Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Burdett S, 2014, LANCET, V383, P1561, DOI 10.1016/S0140-6736(13)62159-5; Castanys-Munoz E, 2007, MOL MICROBIOL, V64, P1141, DOI 10.1111/j.1365-2958.2007.05653.x; Cserepes J, 2004, BIOCHEM BIOPH RES CO, V320, P860, DOI 10.1016/j.bbrc.2004.06.037; de Jonge-Peeters SDPWM, 2007, CRIT REV ONCOL HEMAT, V62, P214, DOI 10.1016/j.critrevonc.2007.02.003; Falasca M, 2012, EXPERT OPIN INV DRUG, V21, P657, DOI 10.1517/13543784.2012.679339; Feng XJ, 2014, PAK J MED SCI, V30, P488, DOI 10.12669/pjms.303.4187; Fujiyoshi M, 2007, J NEUROCHEM, V100, P968, DOI 10.1111/j.1471-4159.2006.04240.x; Fukuda Y, 2012, BIOCHEM PHARMACOL, V83, P1073, DOI 10.1016/j.bcp.2011.12.042; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Hall MD, 2014, J BIOL CHEM, V289, P21473, DOI 10.1074/jbc.M114.581702; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Kerr ID, 2011, BRIT J PHARMACOL, V164, P1767, DOI 10.1111/j.1476-5381.2010.01177.x; Kim YH, 2009, LUNG CANCER, V65, P105, DOI 10.1016/j.lungcan.2008.10.008; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Koshiba S, 2007, J EXP THER ONCOL, V6, P321; Kunicka T, 2014, DRUG METAB REV, V46, P325, DOI 10.3109/03602532.2014.901348; Langheim S, 2005, J LIPID RES, V46, P1732, DOI 10.1194/jlr.M500115-JLR200; Li J, 2009, CLIN LUNG CANCER, V10, P414, DOI 10.3816/CLC.2009.n.078; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Oldfield S, 2002, BBA-MOL CELL RES, V1591, P175, DOI 10.1016/S0167-4889(02)00269-0; Ota S, 2009, LUNG CANCER, V64, P98, DOI 10.1016/j.lungcan.2008.07.014; Pohl A, 2005, BBA-MOL CELL BIOL L, V1733, P29, DOI 10.1016/j.bbalip.2004.12.007; Prochazka L, 2013, APOPTOSIS, V18, P286, DOI 10.1007/s10495-012-0795-1; Reungwetwattana T, 2012, CLIN LUNG CANCER, V13, P252, DOI 10.1016/j.cllc.2011.09.004; Ross DD, 1999, J NATL CANCER I, V91, P429, DOI 10.1093/jnci/91.5.429; Ruiz JLM, 2013, BIOCHEM PHARMACOL, V86, P80, DOI 10.1016/j.bcp.2013.02.033; Silverton Latoya, 2011, Drug Metabolism and Drug Interactions, V26, P169, DOI 10.1515/DMDI.2011.027; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Tamaki A, 2011, ESSAYS BIOCHEM, V50, P209, DOI [10.1042/BSE0500209, 10.1042/bse0500209]; Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zhao JB, 2010, CANCER LETT, V290, P238, DOI 10.1016/j.canlet.2009.09.013	38	13	13	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135576	10.1371/journal.pone.0135576	http://dx.doi.org/10.1371/journal.pone.0135576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270652	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800092
J	Dryden-Peterson, S; Medhin, H; Kebabonye-Pusoentsi, M; Seage, GR; Suneja, G; Kayembe, MKA; Mmalane, M; Rebbeck, T; Rider, JR; Essex, M; Lockman, S				Dryden-Peterson, Scott; Medhin, Heluf; Kebabonye-Pusoentsi, Malebogo; Seage, George R., III; Suneja, Gita; Kayembe, Mukendi K. A.; Mmalane, Mompati; Rebbeck, Timothy; Rider, Jennifer R.; Essex, Myron; Lockman, Shahin			Cancer Incidence following Expansion of HIV Treatment in Botswana	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TRENDS; POPULATION; INFECTION; PEOPLE; BURDEN; AIDS; RISK	Background The expansion of combination antiretroviral treatment (ART) in southern Africa has dramatically reduced mortality due to AIDS-related infections, but the impact of ART on cancer incidence in the region is unknown. We sought to describe trends in cancer incidence in Botswana during implementation of the first public ART program in Africa. Methods We included 8479 incident cases from the Botswana National Cancer Registry during a period of significant ART expansion in Botswana, 2003-2008, when ART coverage increased from 7.3% to 82.3%. We fit Poisson models of age-adjusted cancer incidence and counts in the total population, and in an inverse probability weighted population with known HIV status, over time and estimated ART coverage. Findings During this period 61.6% of cancers were diagnosed in HIV-infected individuals and 45.4% of all cancers in men and 36.4% of all cancers in women were attributable to HIV. Age-adjusted cancer incidence decreased in the HIV infected population by 8.3% per year (95% CI -14.1 to -2.1%). However, with a progressively larger and older HIV population the annual number of cancers diagnosed remained constant (0.0% annually, 95% CI -4.3 to +4.6%). In the overall population, incidence of Kaposi's sarcoma decreased (4.6% annually, 95% CI -6.9 to -2.2), but incidence of non-Hodgkin lymphoma (+11.5% annually, 95% CI +6.3 to +17.0%) and HPV-associated cancers increased (+3.9% annually, 95% CI +1.4 to +6.5%). Age-adjusted cancer incidence among individuals without HIV increased 7.5% per year (95% CI +1.4 to +15.2%). Interpretation Expansion of ART in Botswana was associated with decreased age-specific cancer risk. However, an expanding and aging population contributed to continued high numbers of incident cancers in the HIV population. Increased capacity for early detection and treatment of HIV-associated cancer needs to be a new priority for programs in Africa.	[Dryden-Peterson, Scott; Lockman, Shahin] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Dryden-Peterson, Scott; Mmalane, Mompati; Lockman, Shahin] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Dryden-Peterson, Scott; Essex, Myron; Lockman, Shahin] Harvard Sch TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Dryden-Peterson, Scott; Lockman, Shahin] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Medhin, Heluf; Kebabonye-Pusoentsi, Malebogo] Botswana Minist Hlth, Dept Publ Hlth, Gaborone, Botswana; [Seage, George R., III; Rider, Jennifer R.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Suneja, Gita] Univ Utah, Sch Med, Dept Radiat Oncol, Salt Lake City, UT USA; [Kayembe, Mukendi K. A.] Botswana Minist Hlth, Natl Hlth Lab, Gaborone, Botswana; [Rebbeck, Timothy] Univ Penn, Dept Epidemiol, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Utah System of Higher Education; University of Utah; University of Pennsylvania	Dryden-Peterson, S (corresponding author), Brigham & Womens Hosp, Dept Med, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	scott_peterson@post.harvard.edu	Rider, Jennifer/T-1272-2019; Rebbeck, Timothy/GLU-8348-2022	Rider, Jennifer/0000-0002-2637-6036; Rebbeck, Timothy/0000-0002-4799-1900; Dryden-Peterson, Scott/0000-0002-8487-9731	grants from the National Institutes of Health [P30AI060354, P30AI045008, K23AI091434]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI091434, P30AI045008, P30AI060354] Funding Source: NIH RePORTER	grants from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was funded by grants from the National Institutes of Health (P30AI060354, P30AI045008, K23AI091434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blitz S, 2013, J INFECT DIS, V208, P454, DOI 10.1093/infdis/jit181; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; Central Statistics Office, 2006, POPULATION AND HOUSI; Dryden-Peterson S, 2012, 19TH CONFERENCE ON R; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; [International Agency for Research on Cancer International Association of Cancer Registries International Union against Cancer], 1966, IARC SCIENTIFIC PUBL, V3; Martin J, 2012, 19TH CONFERENCE ON R; Ministry of Health, 2002, BOTSWANA GUIDELINES; Ministry of Health, 2005, BOTSWANA GUIDELINES; Ministry of Health, 2012, NATIONAL CERVICAL CA; Ministry of Health, 2010, CHRONIC DISEASE RISK; Mutyaba I, 2015, JAIDS-J ACQ IMM DEF, V69, P481, DOI 10.1097/QAI.0000000000000620; Naimi AI, 2014, EPIDEMIOLOGY, V25, P292, DOI 10.1097/EDE.0000000000000053; National AIDS Coordinating Agency, 2004, BOTSWANA AIDS IMPACT; National AIDS Coordinating Agency, 2010, PROGRESS REPORT OF T; National AIDS Coordinating Agency, 2013, BOTSWANA AIDS IMPACT; National AIDS Coordinating Agency, 2008, BOTSWANA AIDS IMPACT; Paramsothy P, 2009, OBSTET GYNECOL, V113, P26, DOI 10.1097/AOG.0b013e31819225cb; Parkin DM, 2009, EUR J CANCER, V45, P756, DOI 10.1016/j.ejca.2008.11.033; Parkin DM, 2014, CANCER EPIDEM BIOMAR, V23, P953, DOI 10.1158/1055-9965.EPI-14-0281; Parkin DM, 2013, FINDINGS AND RECOMME; Ramogola-Masire D, 2010, THREE SHOTS AT PREVE; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Suneja G, 2013, LANCET ONCOL, V14, pE290, DOI 10.1016/S1470-2045(13)70283-3; Tunstall-Pedoe H., 2006, WHO GLOBAL REPORT, V35, P1107, DOI [10.1093/ije/dyl098, DOI 10.1093/ije/dyl098, DOI 10.1093/IJE/DYL098]; Wester CW, 2006, CLIN INFECT DIS, V43, P1612, DOI 10.1086/508865	30	59	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135602	10.1371/journal.pone.0135602	http://dx.doi.org/10.1371/journal.pone.0135602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267867	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300141
J	Du, LY; Chang, LYL; Ardiles, AO; Tapia-Rojas, C; Araya, J; Inestrosa, NC; Palacios, AG; Acosta, ML				Du, Lucia Y.; Chang, Lily Y-L.; Ardiles, Alvaro O.; Tapia-Rojas, Cheril; Araya, Joaquin; Inestrosa, Nibaldo C.; Palacios, Adrian G.; Acosta, Monica L.			Alzheimer's Disease-Related Protein Expression in the Retina of Octodon degus	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSGENIC MICE; MOUSE MODEL; COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E; BETA-PEPTIDE; RAT-BRAIN; IN-VIVO; TAU; PATHOLOGY	New studies show that the retina also undergoes pathological changes during the development of Alzheimer's disease (AD). While transgenic mouse models used in these previous studies have offered insight into this phenomenon, they do not model human sporadic AD, which is the most common form. Recently, the Octodon degus has been established as a sporadic model of AD. Degus display age-related cognitive impairment associated with A beta aggregates and phosphorylated tau in the brain. Our aim for this study was to examine the expression of AD-related proteins in young, adult and old degus retina using enzyme-linked or fluorescence immunohistochemistry and to quantify the expression using slot blot and western blot assays. A beta 4G8 and A beta 6E10 detected A beta peptides in some of the young animals but the expression was higher in the adults. A beta peptides were observed in the inner and outer segment of the photoreceptors, the nerve fiber layer (NFL) and ganglion cell layer (GCL). Expression was higher in the central retinal region than in the retinal periphery. Using an anti-oligomer antibody we detected A beta oligomer expression in the young, adult and old retina. Immunohistochemical labeling showed small discrete labeling of oligomers in the GCL that did not resemble plaques. Congo red staining did not result in green birefringence in any of the animals analyzed except for one old (84 months) animal. We also investigated expression of tau and phosphorylated tau. Expression was seen at all ages studied and in adults it was more consistently observed in the NFL-GCL. Hyperphosphorylated tau detected with AT8 antibody was significantly higher in the adult retina and it was localized to the GCL. We confirm for the first time that A beta peptides and phosphorylated tau are expressed in the retina of degus. This is consistent with the proposal that AD biomarkers are present in the eye.	[Du, Lucia Y.; Chang, Lily Y-L.; Acosta, Monica L.] Univ Auckland, Sch Optometry & Vis Sci, Auckland 1, New Zealand; [Acosta, Monica L.] Univ Auckland, New Zealand Natl Eye Ctr, Auckland 1, New Zealand; [Ardiles, Alvaro O.; Araya, Joaquin; Palacios, Adrian G.] Univ Valparaiso, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile; [Tapia-Rojas, Cheril; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Cell & Mol Biol, Ctr Aging & Regenerat CARE, Santiago, Chile	University of Auckland; University of Auckland; Universidad de Valparaiso; Pontificia Universidad Catolica de Chile	Acosta, ML (corresponding author), Univ Auckland, Sch Optometry & Vis Sci, Auckland 1, New Zealand.	m.acosta@auckland.ac.nz	Palacios, Adrian G/E-9846-2015; Acosta, Monica/H-2700-2019; Ardiles, Alvaro/ABB-1565-2020	Palacios, Adrian G/0000-0003-1532-7527; Acosta, Monica/0000-0002-5018-339X; Du, Lucia/0000-0003-0151-3783; Ardiles, Alvaro/0000-0001-8295-2133; Tapia Rojas, Cheril/0000-0002-7084-0318; A. Arriagada, Joaquin Alberto/0000-0002-4698-6149	Dicks Robert Community trust through the Neurological Foundation of New Zealand [1229-SPG]; University of Auckland Faculty Research Development grant [3624490]; HOPE-Selwyn Foundation Scholarship for aging research; Chile ICM- Chilean Science Millennium Institute grant [P09-022-F]; Conicyt [PFB12/2007]; FONDECYT [1120156]; CONICYT	Dicks Robert Community trust through the Neurological Foundation of New Zealand; University of Auckland Faculty Research Development grant; HOPE-Selwyn Foundation Scholarship for aging research; Chile ICM- Chilean Science Millennium Institute grant; Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by the Dicks Robert Community trust through the Neurological Foundation of New Zealand (1229-SPG), http://www.neurological.org.nz; University of Auckland Faculty Research Development grant to MLA (3624490); HOPE-Selwyn Foundation Scholarship for aging research to LYLC, http://www.hopefoundation.org.nz; grants from Chile ICM- Chilean Science Millennium Institute grant #P09-022-F; Conicyt PFB12/2007, http://www.conicyt.cl; and FONDECYT No 1120156 and Pre-doctoral Fellowship from CONICYT to CTR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta ML, 2005, AM J PHYSIOL-CELL PH, V289, pC1015, DOI 10.1152/ajpcell.00137.2005; Alzheimer A, 1995, Clin Anat, V8, P429; Ardiles Alvaro O, 2013, Cold Spring Harb Protoc, V2013, P312, DOI 10.1101/pdb.emo071357; Ardiles AO, 2012, P NATL ACAD SCI USA, V109, P13835, DOI 10.1073/pnas.1201209109; Atamna H, 2009, ARCH BIOCHEM BIOPHYS, V487, P59, DOI 10.1016/j.abb.2009.05.003; Beck JA, 2004, HUM MOL GENET, V13, P1219, DOI 10.1093/hmg/ddh134; Bitel CL, 2012, J ALZHEIMERS DIS, V32, P291, DOI 10.3233/JAD-2012-120571; BLANKS JC, 1989, BRAIN RES, V501, P364, DOI 10.1016/0006-8993(89)90653-7; Blanks JC, 1996, NEUROBIOL AGING, V17, P377, DOI 10.1016/0197-4580(96)00010-3; Blanks JC, 1996, NEUROBIOL AGING, V17, P385, DOI 10.1016/0197-4580(96)00009-7; Blard O, 2007, HUM MOL GENET, V16, P555, DOI 10.1093/hmg/ddm011; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braidy N, 2012, J NEURAL TRANSM, V119, P173, DOI 10.1007/s00702-011-0731-5; Chang LYL, 2014, ALZHEIMERS DEMENT, V10, P251, DOI 10.1016/j.jalz.2013.06.004; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Danesh-Meyer HV, 2006, NEUROLOGY, V67, P1852, DOI 10.1212/01.wnl.0000244490.07925.8b; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dunlop SA, 1984, DEV AREA CENTRALIS V; Dutescu RM, 2009, GRAEF ARCH CLIN EXP, V247, P1213, DOI 10.1007/s00417-009-1060-3; Edwards MM, 2014, EXP EYE RES, V127, P252, DOI 10.1016/j.exer.2014.08.006; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; Frost S, 2010, J ALZHEIMERS DIS, V22, P1, DOI 10.3233/JAD-2010-100819; Fryer JD, 2003, J NEUROSCI, V23, P7889; GEULA C, 1995, EXP NEUROL, V134, P157, DOI 10.1006/exnr.1995.1046; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Ho CY, 2014, BRAIN PATHOL, V24, P25, DOI 10.1111/bpa.12070; Ho T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029892; Inestrosa NC, 2005, NEUROBIOL AGING, V26, P1023, DOI 10.1016/j.neurobiolaging.2004.09.016; Janus C, 2001, PHYSIOL BEHAV, V73, P873, DOI 10.1016/S0031-9384(01)00524-8; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; Liu BQ, 2009, AM J PATHOL, V175, P2099, DOI 10.2353/ajpath.2009.090159; LOFFLER KU, 1995, INVEST OPHTH VIS SCI, V36, P24; Martins IJ, 2006, MOL PSYCHIATR, V11, P721, DOI 10.1038/sj.mp.4001854; MESULAM MM, 1988, ANN NEUROL, V24, P765, DOI 10.1002/ana.410240611; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; Nolan JM, 2014, J ALZHEIMERS DIS, V42, P1191, DOI 10.3233/JAD-140507; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Pennanen L, 2004, NEUROBIOL DIS, V15, P500, DOI 10.1016/j.nbd.2003.11.020; Rios J.A, 2014, BRAIN PATHOL; Rocchi A, 2009, CURR ALZHEIMER RES, V6, P224, DOI 10.2174/156720509788486644; Schon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053547; Tarragon E, 2013, CNS NEUROSCI THER, V19, P643, DOI 10.1111/cns.12125; Trojanowski JQ, 1995, FASEB J, V9, P1570, DOI 10.1096/fasebj.9.15.8529836; van Groen T, 2011, NEUROBIOL AGING, V32, P1651, DOI 10.1016/j.neurobiolaging.2009.10.008; Vega-Zuniga T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084199; Walsh DT, 2002, NEUROBIOL DIS, V10, P20, DOI 10.1006/nbdi.2002.0485; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Yamamoto R, 2004, NEUROSCI LETT, V370, P61, DOI 10.1016/j.neulet.2004.07.087; Yin HB, 2008, MED HYPOTHESES, V71, P77, DOI 10.1016/j.mehy.2008.01.030	54	39	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135499	10.1371/journal.pone.0135499	http://dx.doi.org/10.1371/journal.pone.0135499			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267479	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300127
J	Johannsen, A; Fored, MC; Hakansson, J; Ekbom, A; Gustafsson, A				Johannsen, Annsofi; Fored, Michael C.; Hakansson, Jan; Ekbom, Anders; Gustafsson, Anders			Consumption of Dental Treatment in Patients with Inflammatory Bowel Disease, a Register Study	PLOS ONE			English	Article							CROHNS-DISEASE; PERIODONTAL-DISEASE; RISK-FACTORS; SMOKING; PREVALENCE; POPULATION; HEALTH; CARIES	Objective The aim of this study was to compare the consumption of dental treatment among patients with Crohn's disease (CD) or ulcerative colitis (UC) compared to age and gender matched control groups. Design The study group comprised 2085 patients with CD and 3161 with UC from the Uppsala-Orebro region and from the Stockholm region. The patients in the cohort were diagnosed between 1960 and 1989. Patients up to 70 years of age were included in the study. The two patients groups were compared to age- and gender-matched, randomly selected control groups from the same geographic area comprising a corresponding number of participants. Results CD patients had significantly higher total number of procedures registered (p < 0.000). The difference was most pronounced for removable dentures (+65%), fillings in front teeth (+52%) and endodontic treatment (+46%) when Crohn's patients were compared to controls (p<0.001). The corresponding figures for UC patients were also a significantly higher total number of procedures (p < 0.005), more clinical examinations (p<0.000), fillings in canines and incisors (p < 0.001) and fillings in bicuspids and molars (p < 0.000). Conclusion This study demonstrate that CD and UC individuals use more dental treatment compared to an age-gender matched control group, and more caries-related treatments. The difference was most pronounced for restorative treatment in patients with Crohn's.	[Johannsen, Annsofi] Karolinska Inst, Dept Dent Med, Div Periodontol, Huddinge, Sweden; [Fored, Michael C.; Ekbom, Anders; Gustafsson, Anders] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit T2, Stockholm, Sweden; [Hakansson, Jan] Univ Gothenburg, Dept Periodontol, Inst Odontol, Sahlgrenska Acad, Gothenburg, Sweden	Karolinska Institutet; Karolinska Institutet; University of Gothenburg	Gustafsson, A (corresponding author), Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit T2, Stockholm, Sweden.	Anders.Gustafsson@ki.se			Stockholm county council (SLL.se) [20120315]	Stockholm county council (SLL.se)	This study was funded by the Stockholm county council (SLL.se), grant number 20120315. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedetti G, 2013, ACTA ODONTOL SCAND, V71, P363, DOI 10.3109/00016357.2012.734409; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brito F, 2008, J CLIN PERIODONTOL, V35, P555, DOI 10.1111/j.1600-051X.2008.01231.x; Buchwald S, 2013, J CLIN PERIODONTOL, V40, P203, DOI 10.1111/jcpe.12056; Burisch J, 2014, J CROHNS COLITIS, V8, P811, DOI 10.1016/j.crohns.2013.12.023; Dahiya Parveen, 2013, J Indian Soc Periodontol, V17, P411, DOI 10.4103/0972-124X.118306; Fatahzadeh M, 2009, ORAL SURG ORAL MED O, V108, pE1, DOI 10.1016/j.tripleo.2009.07.035; FLEMMIG TF, 1991, J CLIN PERIODONTOL, V18, P690, DOI 10.1111/j.1600-051X.1991.tb00111.x; Grossner-Schreiber B, 2006, J CLIN PERIODONTOL, V33, P478, DOI 10.1111/j.1600-051X.2006.00942.x; Habashneh RA, 2012, J PERIODONTAL RES, V47, P293, DOI 10.1111/j.1600-0765.2011.01431.x; Halfvarson J, 2006, INFLAMM BOWEL DIS, V12, P925, DOI 10.1097/01.mib.0000228998.29466.ac; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Johannsen A, 2014, PERIODONTOL 2000, V64, P111, DOI 10.1111/j.1600-0757.2012.00456.x; Karban A, 2007, WORLD J GASTROENTERO, V13, P2150, DOI 10.3748/wjg.v13.i15.2150; KATSCHINSKI B, 1988, GUT, V29, P1202, DOI 10.1136/gut.29.9.1202; Lakatos PL, 2007, WORLD J GASTROENTERO, V13, P6134, DOI 10.3748/wjg.13.6134; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Piechota-Polanczyk A, 2014, N-S ARCH PHARMACOL, V387, P605, DOI 10.1007/s00210-014-0985-1; Rikardsson S, 2009, ORAL HLTH PREV DENT, V7, P277; Ruthruff B, 2007, J AM ACAD NURSE PRAC, V19, P392, DOI 10.1111/j.1745-7599.2007.00242.x; Ryder MI, 2007, PERIODONTOL 2000, V43, P267, DOI 10.1111/j.1600-0757.2006.00163.x; Sandborn WJ, 2007, LANCET, V3, P1590; Soderlund S, 2009, GASTROENTEROLOGY, V136, P1561, DOI 10.1053/j.gastro.2009.01.064; Stabholz A, 2010, PERIODONTOL 2000, V53, P138, DOI 10.1111/j.1600-0757.2010.00340.x; SUNDH B, 1989, ORAL SURG ORAL MED O, V67, P286, DOI 10.1016/0030-4220(89)90356-3; Szymanska S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091059; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; Vavricka SR, 2013, INFLAMM BOWEL DIS, V19, P2768, DOI 10.1097/01.MIB.0000438356.84263.3b; Wu GD, 2013, ANAEROBE, V24, P117, DOI 10.1016/j.anaerobe.2013.03.011	29	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134001	10.1371/journal.pone.0134001	http://dx.doi.org/10.1371/journal.pone.0134001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267797	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492300030
J	Saraiva, L; Reis, AS; Rugani, JMN; Pereira, AAS; Rego, FD; Lima, ACVMD; Gontijo, CMF; Andrade, JD				Saraiva, Lara; Reis, Alanna Silva; Nunes Rugani, Jeronimo Marteleto; Sampaio Pereira, Agnes Antonia; Rego, Felipe Dutra; Mariano da Rocha Lima, Ana Cristina Vianna; Ferreira Gontijo, Celia Maria; Andrade Filho, Jose Dilermando			Survey of Sand Flies (Diptera: Psychodidae) in an Environmentally Protected Area in Brazil	PLOS ONE			English	Article							AMERICAN VISCERAL LEISHMANIASIS; LUTZOMYIA-LONGIPALPIS; MINAS-GERAIS; ENDEMIC AREA; SPATIAL-ANALYSIS; BELO-HORIZONTE; PERIOD GENE; STATE; POPULATIONS; EPIDEMIOLOGY	Brazil is one of the most important endemic areas for leishmaniasis worldwide. Protected areas that are tourist attractions likely present an important risk of transmission of cutaneous leishmaniasis (CL). Furthermore, with the geographical expansion of visceral leishmaniasis (VL), several studies have recorded the occurrence of its vector, Lutzomyia longipalpis, and cases of human and canine VL in such tourist areas. The Parque Estadual do Sumidouro is an environmentally protected area located in the Brazilian Cerrado biome and in an important area endemic for leishmaniasis in the state of Minas Gerais. The purpose of this study was to monitor the sand fly fauna in areas of tourist activity in the park. Sampling was performed every month, from September 2011 to August 2013, using CDC light traps at six sites of differing environmental characteristics. Sampled specimens were identified following Galati (2003), and females were submitted to molecular techniques for the detection and identification of Leishmania DNA. A total of 4,675 sand fly specimens of 25 species belonging to nine genera were collected. The most abundant species were Micropygomyia quinquefer, Lutzomyia renei and Pintomyia pessoai, although only Pi. pessoai is implicated in the transmission of Leishmania braziliensis. The species accumulation curve reached saturation on the 16th sampling event. Species richness, diversity and evenness differed among the sampled areas. The seasonal curve was not determined by a single unique species, and no single species was the most abundant in all environments sampled. The main vector of Leishmania (Leishmania) infantum, Lutzomyia longipalpis, accounted for only 5.35% of the specimens collected. Proven or suspected vectors of Leishmania (Viannia) braziliensis were recorded, and one female of the cortellezzii complex tested positive for Le. braziliensis DNA. Even with a low infection rate (0.62%), these data indicate the circulation of the parasite and reinforce the need for entomological and epidemiological surveillance in the park and its surroundings.	[Saraiva, Lara; Reis, Alanna Silva; Nunes Rugani, Jeronimo Marteleto; Sampaio Pereira, Agnes Antonia; Rego, Felipe Dutra; Mariano da Rocha Lima, Ana Cristina Vianna; Ferreira Gontijo, Celia Maria; Andrade Filho, Jose Dilermando] Fiocruz MS, MINAS, Ctr Pesquisas Rene Rachou, Grp Estudos Leishmanioses, BR-30190002 Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	Saraiva, L (corresponding author), Fiocruz MS, MINAS, Ctr Pesquisas Rene Rachou, Grp Estudos Leishmanioses, Ave Augusto Lima,1715 Barro Preto,CP 1743, BR-30190002 Belo Horizonte, MG, Brazil.	lara@cpqrr.fiocruz.br	Andrade Filho, José Dilermando/B-7852-2013; Gontijo, Célia/K-6120-2016; Rêgo, Felipe Dutra/S-6013-2017; Gontijo, Celia MF/AAU-7736-2020; Rugani, Jeronimo/ABE-4235-2020; Rego, Felipe Dutra/V-4646-2019	Andrade Filho, José Dilermando/0000-0002-9754-8464; Rêgo, Felipe Dutra/0000-0002-2799-8267; Gontijo, Celia MF/0000-0002-7034-535X; Rego, Felipe Dutra/0000-0002-2799-8267	Conselho Nacional de Pesquisa-CNPq [140585/2011-7]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG	Conselho Nacional de Pesquisa-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	We are indebted to the Conselho Nacional de Pesquisa-CNPq (140585/2011-7) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG-for scholarships. Technical and logistical support from Fundacao Oswaldo Cruz - FIOCRUZ-Minas and Instituto Estadual de Florestas do Estado de Minas Gerais - IEF-are gratefully acknowledged.	Andrade JD, 2007, MEM I OSWALDO CRUZ, V102, P481, DOI 10.1590/S0074-02762007005000035; Andrade-Filho Jose Dilermando, 1998, Revista Brasileira de Entomologia, V42, P93; [Anonymous], 2014, BRAS 2014 CERR, P2014; Aparecida E, 2010, PARQUE ESTADUAL INTE, V54, P311; Barrantes G, 2009, REV BIOL TROP, V57, P451; Bauzer LGSR, 2002, INSECT MOL BIOL, V11, P315, DOI 10.1046/j.1365-2583.2002.00340.x; Bauzer LGSR, 2002, MOL BIOL EVOL, V19, P1624, DOI 10.1093/oxfordjournals.molbev.a004224; Bottecchia M, 2004, J MOL EVOL, V58, P754, DOI 10.1007/s00239-004-2586-y; Brasil. Ministerio da Saude, 2006, MANUAL DE VIGILANCIA, P122; Brasil Ministerio da Saude, 2007, INTR EST ESP SAUD PU, P124; Brazil Reginaldo P., 1997, Anais da Sociedade Entomologica do Brasil, V26, P191, DOI 10.1590/S0301-80591997000100026; Carvalho BM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-325; Carvalho GML, 2008, VECTOR-BORNE ZOONOT, V8, P407, DOI 10.1089/vbz.2007.0180; Carvalho GML, 2010, J MED ENTOMOL, V47, P972, DOI 10.1603/ME09127; Antonialli SAC, 2007, J INFECTION, V54, P509, DOI 10.1016/j.jinf.2006.08.004; da Saude M, 2007, INTRO ESTATISTICA ES, P124; de Aguiar GM, 2014, REV INST MED TROP SP, V56, P143, DOI 10.1590/S0036-46652014000200010; Carvalho GMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077158; De Mato E, 2009, STATE MATO GROSSO 20, V42, P488; de Souza CM, 2004, MEM I OSWALDO CRUZ, V99, P795, DOI 10.1590/S0074-02762004000800003; de Souza CF, 2014, ACTA TROP, V134, P72, DOI 10.1016/j.actatropica.2014.02.019; De Vigilancia S, 2010, MANUAL VIGILANCIA LE; Dweik A, 2007, ANN TROP MED PARASIT, V101, P399, DOI 10.1179/136485907X176436; FORATTINI O. P., 1973, Entomologia Medica. Vol. 4. Psychodidae. Phle-botominae. Leishmanioses. Bartonelose.; Gomes A.C., 1998, REV SOC BRAS MED TRO, V31, P553, DOI [10.1590/S0037-86821998000600008, DOI 10.1590/S0037-86821998000600008]; Gomes A.C., 2002, INFORM EPIDEMIOLOGIC, V11, P79; Hooper AM, 2006, GREEN CHEM, V8, P513, DOI 10.1039/b602875f; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; da Silva AVM, 2011, GEOSPATIAL HEALTH, V6, P33, DOI 10.4081/gh.2011.155; Magurran A.E., 2004, MEASURING BIOL DIVER; Margonari C, 2006, MEM I OSWALDO CRUZ, V101, P31, DOI 10.1590/S0074-02762006000100007; Margonari C, 2010, J MED ENTOMOL, V47, P1212, DOI 10.1603/ME09248; MEATYARD B, 2005, BIOL CONSERV, P309, DOI [10.1016/j.biocon.2006.10.034, DOI 10.1016/J.BIOCON.2006.10.034]; Cardim MFM, 2013, REV SAUDE PUBL, V47, P691, DOI 10.1590/S0034-8910.2013047004454; Muto S, 1999, EUR J ORG CHEM, V1999, P2159; Nascimento BWL, 2013, ACTA TROP, V125, P262, DOI 10.1016/j.actatropica.2012.11.005; Perez J, 2014, MEM I OSWALDO CRUZ, V109, P80, DOI 10.1590/0074-0276130224; Pinto ID, 2012, J VECTOR ECOL, V37, P90, DOI 10.1111/j.1948-7134.2012.00204.x; Pugedo H, 2005, REV SOC BRAS MED TRO, V38, P70, DOI 10.1590/S0037-86822005000100017; Rangel E F, 1984, Mem Inst Oswaldo Cruz, V79, P395, DOI 10.1590/S0074-02761984000300020; Rushton G, 2003, ANNU REV PUBL HEALTH, V24, P43, DOI 10.1146/annurev.publhealth.24.012902.140843; Saraiva L, 2006, REV SOC BRAS MED TRO, V39, P56, DOI 10.1590/S0037-86822006000100011; Saraiva L, 2010, MEM I OSWALDO CRUZ, V105, P1033, DOI 10.1590/S0074-02762010000800013; Saraiva L, 2011, ACTA TROP, V117, P137, DOI 10.1016/j.actatropica.2010.11.007; Scarisbrick J J, 2006, Travel Med Infect Dis, V4, P14, DOI 10.1016/j.tmaid.2004.11.002; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Sherlock Italo A., 1996, Revista da Sociedade Brasileira de Medicina Tropical, V29, P207, DOI 10.1590/S0037-86821996000200013; Souza CF, 2009, NEOTROP ENTOMOL, V38, P267, DOI 10.1590/S1519-566X2009000200016; Souza NA, 2008, MEM I OSWALDO CRUZ, V103, P216, DOI 10.1590/S0074-02762008000200017; State SP, 2010, PARQUE ESTADUAL ALTO, V477, P477; TEODORO U, 1993, REV SAUDE PUBL, V27, P190, DOI 10.1590/S0034-89101993000300006; Yin HZ, 1999, MED VET ENTOMOL, V13, P72, DOI 10.1046/j.1365-2915.1999.00139.x	52	11	11	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134845	10.1371/journal.pone.0134845	http://dx.doi.org/10.1371/journal.pone.0134845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267484	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300061
J	Takahashi, Y; Okada, K; Hoshino, T; Anme, T				Takahashi, Yusuke; Okada, Kensuke; Hoshino, Takahiro; Anme, Tokie			Developmental Trajectories of Social Skills during Early Childhood and Links to Parenting Practices in a Japanese Sample	PLOS ONE			English	Article							SCHOOL; BEHAVIOR	This study used data from a nationwide survey in Japan to model the developmental course of social skills during early childhood. The goals of this study were to identify longitudinal profiles of social skills between 2 and 5 years of age using a group-based trajectory approach, and to investigate whether and to what extent parenting practices at 2 years of age predicted developmental trajectories of social skills during the preschool period. A relatively large sample of boys and girls (N > 1,000) was assessed on three social skill dimensions (Cooperation, Self-control, and Assertion) at four time points (ages 2, 3, 4, and 5), and on four parenting practices (cognitive and emotional involvement, avoidance of restriction and punishment, social stimulation, and social support for parenting) at age 2. The results indicated that for each social skill dimension, group-based trajectory models identified three distinct trajectories: low, moderate, and high. Multinomial regression analysis revealed that parenting practice variables showed differential contributions to development of child social skills. Specifically, Cooperation and Assertion were promoted by cognitive and emotional involvement, Self-control by social stimulation, and Assertion by avoidance of restriction and punishment. Abundant social support for parenting was not associated with higher child social skills trajectories. We found heterogeneity in developmental profiles of social skills during the preschool ages, and we identified parenting practices that contributed to different patterns of social skills development. We discussed the implications of higher-quality parenting practices on the improvement of child social skills across early childhood.	[Takahashi, Yusuke] Kyoto Univ, Grad Sch Educ, Kyoto, Japan; [Okada, Kensuke] Senshu Univ, Sch Human Sci, Kawasaki, Kanagawa, Japan; [Hoshino, Takahiro] Keio Univ, Fac Econ, Tokyo, Japan; [Anme, Tokie] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan	Kyoto University; Keio University; University of Tsukuba	Takahashi, Y (corresponding author), Kyoto Univ, Grad Sch Educ, Kyoto, Japan.	takahashi.yusuke.3n@kyoto-u.ac.jp	Hoshino, Takahiro/P-3997-2019	Hoshino, Takahiro/0000-0002-7862-9250; Okada, Kensuke/0000-0003-1663-5812	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST);  [19330126]; Grants-in-Aid for Scientific Research [26118709] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Scientific Research (B: 19330126) to T.A. and was partially supported by the Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST), to T.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allhusen V, 2002, AM EDUC RES J, V39, P133; Allhusen V, 2004, J FAM PSYCHOL, V18, P628, DOI 10.1037/0893-3200.18.4.628; Anme T, 2004, CHILD CARE HLTH DEV, V30, P345, DOI 10.1111/j.1365-2214.2004.00429.x; Anme T, 2007, EARLY CHILD EDUC J, V35, P293, DOI 10.1007/s10643-007-0192-5; Arnold D.S., 1993, PSYCHOL ASSESSMENT, V9, P137, DOI [10.1037/1040-3590.5.2.137, DOI 10.1037/1040-3590.5.2.137]; Arnold DH, 2012, EARLY CHILD RES Q, V27, P376, DOI 10.1016/j.ecresq.2011.12.009; Berry D, 2010, J APPL DEV PSYCHOL, V31, P1, DOI 10.1016/j.appdev.2009.05.001; Brownell CA, 2013, INFANCY, V18, P1, DOI 10.1111/infa.12004; Caplan M., 1993, PRECURSORS CAUSES DE, P169; Chan D, 2000, MULTIVAR BEHAV RES, V35, P169, DOI 10.1207/S15327906MBR3502_2; Cote S, 2002, J CHILD PSYCHOL PSYC, V43, P609, DOI 10.1111/1469-7610.00050; Downey DB, 2015, J FAM ISSUES, V36, P273, DOI 10.1177/0192513X13507569; Dunn J., 2002, BLACKWELL HDB CHILDH, P223, DOI DOI 10.1080/00223980.2010.528073; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Gresham F.M., 1984, SCHOOL PSYCHOL REV, V13, P292; Gresham F.M., 1990, SOCIAL SKILLS RATING; HAY DF, 1994, J CHILD PSYCHOL PSYC, V35, P29, DOI 10.1111/j.1469-7610.1994.tb01132.x; Howe N., 2006, ENCY EARLY CHILDHOOD; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Kanacri BPL, 2013, J PERS, V81, P302, DOI 10.1111/jopy.12001; Kokko K, 2006, J RES ADOLESCENCE, V16, P403, DOI 10.1111/j.1532-7795.2006.00500.x; Krishnakumar A, 2000, FAM RELAT, V49, P25, DOI 10.1111/j.1741-3729.2000.00025.x; Lamont A, 2013, SOC DEV, V22, P384, DOI 10.1111/sode.12023; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Nantel-Vivier A, 2009, J CHILD PSYCHOL PSYC, V50, P590, DOI 10.1111/j.1469-7610.2008.02039.x; Parke, 1998, HDB CHILD PSYCHOL, P463, DOI DOI 10.1002/9780470147658.chpsy0308; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; SHAW DS, 1993, J ABNORM CHILD PSYCH, V21, P493, DOI 10.1007/BF00916316; Stright AD, 2008, CHILD DEV, V79, P186, DOI 10.1111/j.1467-8624.2007.01119.x; Takahashi Y, 2008, JPN J EDUC PSYCHOL, V56, P81, DOI 10.5926/jjep1953.56.1_81; Tichovolsky MH, 2013, J APPL DEV PSYCHOL, V34, P336, DOI 10.1016/j.appdev.2013.09.001; Vazsonyi AT, 2010, DEV PSYCHOL, V46, P245, DOI 10.1037/a0016538; Veenstra R, 2008, INT J BEHAV DEV, V32, P243, DOI 10.1177/0165025408089274; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P1038, DOI 10.1037/0012-1649.28.6.1038	34	24	25	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135357	10.1371/journal.pone.0135357	http://dx.doi.org/10.1371/journal.pone.0135357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267439	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300105
J	Menz, C; Parsi, MK; Adams, JRJ; Sideek, MA; Kopecki, Z; Cowin, AJ; Gibson, MA				Menz, Clementine; Parsi, Mahroo K.; Adams, Julian R. J.; Sideek, Mohamed A.; Kopecki, Zlatko; Cowin, Allison J.; Gibson, Mark A.			LTBP-2 Has a Single High-Affinity Binding Site for FGF-2 and Blocks FGF-2-Induced Cell Proliferation	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; TGF-BETA; EXTRACELLULAR-MATRIX; HYPERTROPHIC SCARS; WEILL-MARCHESANI; PROTEIN 2; FIBRILLIN-1; ASSOCIATION; EXPRESSION; MUTATIONS	Latent transforming growth factor-beta-1 binding protein-2 (LTBP-2) belongs to the fibrillin-LTBP superfamily of extracellular matrix proteins. LTBPs and fibrillins are involved in the sequestration and storage of latent growth factors, particularly transforming growth factor beta (TGF-beta), in tissues. Unlike other LTBPs, LTBP-2 does not covalently bind TGF-beta, and its molecular functions remain unclear. We are screening LTBP-2 for binding to other growth factors and have found very strong saturable binding to fibroblast growth factor-2 (FGF-2) (Kd = 1.1 nM). Using a series of recombinant LTBP-2 fragments a single binding site for FGF-2 was identified in a central region of LTBP-2 consisting of six tandem epidermal growth factor-like (EGF-like) motifs (EGFs 9-14). This region was also shown to contain a heparin/heparan sulphate-binding site. FGF-2 stimulation of fibroblast proliferation was completely negated by the addition of 5-fold molar excess of LTBP-2 to the assay. Confocal microscopy showed strong co-localisation of LTBP-2 and FGF-2 in fibrotic keloid tissue suggesting that the two proteins may interact in vivo. Overall the study indicates that LTBP-2 is a potent inhibitor of FGF-2 that may influence FGF-2 bioactivity during wound repair particularly in fibrotic tissues.	[Menz, Clementine; Parsi, Mahroo K.; Adams, Julian R. J.; Sideek, Mohamed A.; Gibson, Mark A.] Univ Adelaide, Discipline Anat & Pathol, Sch Med, Adelaide, SA 5005, Australia; [Kopecki, Zlatko; Cowin, Allison J.] Univ S Australia, Regenerat Med, Mawson Inst, Adelaide, SA 5095, Australia	University of Adelaide; University of South Australia	Gibson, MA (corresponding author), Univ Adelaide, Discipline Anat & Pathol, Sch Med, Adelaide, SA 5005, Australia.	mark.gibson@adelaide.edu.au	Cowin, Allison/F-4281-2013; Cowin, Allison/AAM-3105-2020; Kopecki, Zlatko/F-3672-2013	Cowin, Allison/0000-0003-2885-2080; Cowin, Allison/0000-0003-2885-2080; Kopecki, Zlatko/0000-0002-8072-4222	National Health and Medical Research Council of Australia project [519211]; Internatinal Islamic University of Malaysia; Malaysian Government	National Health and Medical Research Council of Australia project(National Health and Medical Research Council (NHMRC) of Australia); Internatinal Islamic University of Malaysia; Malaysian Government	This work was supported by the National Health and Medical Research Council of Australia project grant number 519211. Part of the work was supported by a scholarship to MAS from the Internatinal Islamic University of Malaysia and the Malaysian Government.	Agasse F, 2007, EUR J NEUROSCI, V26, P3036, DOI 10.1111/j.1460-9568.2007.05915.x; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Amadeu TP, 2004, WOUND REPAIR REGEN, V12, P169, DOI 10.1111/j.1067-1927.2004.012209.x; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Baldwin AK, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.9; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Breidthardt T, 2012, CLIN SCI, V123, P557, DOI 10.1042/CS20120058; Cain SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048634; Chan SHK, 2011, INT J CANCER, V129, P565, DOI 10.1002/ijc.25698; Charbonneau NL, 2010, J BIOL CHEM, V285, P24943, DOI 10.1074/jbc.M110.130021; Chua CC, 2004, CIRC RES, V94, P316, DOI 10.1161/01.RES.0000112965.70691.AC; Combs MD, 2013, J BIOL CHEM, V288, P28869, DOI 10.1074/jbc.M113.497727; Desir J, 2010, EUR J HUM GENET, V18, P761, DOI 10.1038/ejhg.2010.11; Dhandapani KM, 2007, J NEUROSCI RES, V85, P1033, DOI 10.1002/jnr.21182; Doyle JJ, 2012, FEBS LETT, V586, P2003, DOI 10.1016/j.febslet.2012.05.027; Eto H, 2012, LAB INVEST, V92, P214, DOI 10.1038/labinvest.2011.127; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; GIBSON MA, 1995, MOL CELL BIOL, V15, P6932; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Haji-Seyed-Javadi R, 2012, HUM MUTAT, V33, P1182, DOI 10.1002/humu.22105; Hanssen E, 2004, J BIOL CHEM, V279, P29185, DOI 10.1074/jbc.M313672200; Hayes AJ, 2014, TISSUE CELL, V46, P185, DOI 10.1016/j.tice.2014.04.002; Hayes AJ, 2011, SPINE, V36, pE1365, DOI 10.1097/BRS.0b013e31821fd23e; Hirani R, 2007, MATRIX BIOL, V26, P213, DOI 10.1016/j.matbio.2006.12.006; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Inoue T, 2014, HUM MOL GENET; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Kardami E, 2007, HEART FAIL REV, V12, P267, DOI 10.1007/s10741-007-9027-0; Kaur J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048629; Kielty CM, 2005, ADV PROTEIN CHEM, V70, P405, DOI 10.1016/S0065-3233(04)70012-1; Kopecki Z, 2013, J INVEST DERMATOL, V133, P1008, DOI 10.1038/jid.2012.457; Kumar A, 2010, HUM GENET, V128, P365, DOI 10.1007/s00439-010-0858-8; Mikroulis D, 2007, CURR VASC PHARMACOL, V5, P195; Narooie-Nejad M, 2009, HUM MOL GENET, V18, P3969, DOI 10.1093/hmg/ddp338; Parsi MK, 2010, MATRIX BIOL, V29, P393, DOI 10.1016/j.matbio.2010.03.005; Perez-Magan E, 2012, J NEUROPATH EXP NEUR, V71, P882, DOI 10.1097/NEN.0b013e31826bf704; Phillips AO, 1997, LAB INVEST, V76, P591; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Ribatti D, 2007, CYTOKINE GROWTH F R, V18, P327, DOI 10.1016/j.cytogfr.2007.04.011; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Shi HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059966; Shipley JM, 2000, MOL CELL BIOL, V20, P4879, DOI 10.1128/MCB.20.13.4879-4887.2000; Sideek MA, 2014, MATRIX BIOL, V34, P114, DOI 10.1016/j.matbio.2013.10.007; Sidgwick GP, 2012, J EUR ACAD DERMATOL, V26, P141, DOI 10.1111/j.1468-3083.2011.04200.x; Sinha S, 2002, CARDIOVASC RES, V53, P971, DOI 10.1016/S0008-6363(01)00512-0; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Vehvilainen P, 2009, J CELL PHYSIOL, V221, P586, DOI 10.1002/jcp.21888; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Weinbaum JS, 2010, MACROMOL BIOSCI, V10, P1338, DOI 10.1002/mabi.201000121; Yu PJ, 2007, J CELL BIOCHEM, V100, P1100, DOI 10.1002/jcb.21116; Yun YR, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/218142; Zilberberg L, 2012, J CELL PHYSIOL, V227, P3828, DOI 10.1002/jcp.24094	58	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135577	10.1371/journal.pone.0135577	http://dx.doi.org/10.1371/journal.pone.0135577			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263555	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000359353300094
J	O'Brien, KS; Carr, S; Ferris, J; Room, R; Miller, P; Livingston, M; Kypri, K; Lynott, D				O'Brien, Kerry S.; Carr, Sherilene; Ferris, Jason; Room, Robin; Miller, Peter; Livingston, Michael; Kypri, Kypros; Lynott, Dermot			Alcohol Advertising in Sport and Non-Sport TV in Australia, during Children's Viewing Times	PLOS ONE			English	Article							INDUSTRY SPONSORSHIP; TELEVISION; EXPOSURE; ADOLESCENTS; DRINKING; ADVERTISEMENTS; FREQUENCY; CONTEXT; MEDIA; ADS	Estimate the amount of alcohol advertising in sport vs. non-sport programming in Australian free-to-air TV and identify children's viewing audience composition at different times of the day. Alcohol advertising and TV viewing audience data were purchased for free-to-air sport and non-sport TV in Australia for 2012. We counted alcohol advertisements in sport and non-sport TV in daytime (6am-8.29pm) and evening periods (8.30pm-11.59pm) and estimated viewing audiences for children and young adults (0-4 years, 5-13 years, 14-17 years, 18-29 years). During the daytime, most of the alcohol advertising (87%) was on sport TV. In the evening, most alcohol advertising (86%) was in non-sport TV. There was little difference in the mean number of children (0-17 years) viewing TV in the evening (N = 273,989), compared with the daytime (N = 235,233). In programs containing alcohol advertising, sport TV had a greater mean number of alcohol adverts per hour (mean 1.74, SD = 1.1) than non-sport TV (mean 1.35, SD = .94). Alcohol advertising during the daytime, when large numbers of children are watching TV, is predominantly in free-to-air sport TV. By permitting day-time advertising in sport programs and in any programs from 8.30pm when many children are still watching TV, current regulations are not protecting children from exposure to alcohol advertising.	[O'Brien, Kerry S.; Carr, Sherilene] Monash Univ, Sch Social Sci, Melbourne, Vic 3004, Australia; [Ferris, Jason] Univ Queensland, Social Sci Res Inst, Brisbane, Qld, Australia; [Room, Robin] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Alcohol Policy Res, Melbourne, Vic, Australia; [Miller, Peter] Deakin Univ, Sch Psychol, Melbourne, Vic, Australia; [Livingston, Michael] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Kypri, Kypros] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia; [Lynott, Dermot] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England	Monash University; University of Queensland; University of Melbourne; Deakin University; University of New South Wales Sydney; University of Newcastle; Lancaster University	O'Brien, KS (corresponding author), Monash Univ, Sch Social Sci, Melbourne, Vic 3004, Australia.	kerrykez@gmail.com	Lynott, Dermot/A-9661-2011; Room, Robin/ABH-8505-2020; Room, Robin/ABF-7460-2021; Ferris, Jason/H-7051-2012; Carr, Sherilene/B-4977-2016; O'Brien, Kerry/K-9975-2013; Kypri, Kypros/D-2809-2009	Lynott, Dermot/0000-0001-7338-0567; Room, Robin/0000-0002-5618-385X; Ferris, Jason/0000-0001-7474-0173; Carr, Sherilene/0000-0002-5217-6441; O'Brien, Kerry/0000-0003-3145-6038; Miller, Peter/0000-0002-6896-5437; Livingston, Michael/0000-0002-8995-9386; Kypri, Kypros/0000-0002-9657-9904	Australian Research Council [LP120100689]; VicHealth; Australian Drug Foundation; Australian National Preventive Health Agency [460BR2011]	Australian Research Council(Australian Research Council); VicHealth; Australian Drug Foundation; Australian National Preventive Health Agency	The research was supported by grant funding from the Australian Research Council (LP120100689), VicHealth, Australian Drug Foundation, and the Australian National Preventive Health Agency (460BR2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-473; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; [Anonymous], COMM TEL IND COD PRA; [Anonymous], EXPL NOT REV COMM TE; [Anonymous], 2012, TEL YEAR IN REV; [Anonymous], 2009, INFL DAM EFF ALC MAR; Australian Commonwealth Government, 2009, CHILDR TEL STAND; Australian Communications and Media Authority (ACMA), 2007, CHILDR VIEW PATT COM; Australian Medical Association, 2012, ALC MARK YOUNG PEOPL; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Center on Alcohol Marketing and Youth, 2004, ALC ADV SPORTS TEL 2; Fielder L, 2009, ADDICTION, V104, P1157, DOI 10.1111/j.1360-0443.2009.02592.x; Gantz W, 2006, J BROADCAST ELECTRON, V50, P95, DOI 10.1207/s15506878jobem5001_6; Graham A, 2014, ALCOHOL ALCOHOLISM, V49, P343, DOI 10.1093/alcalc/agt140; GRUBE JW, 1994, AM J PUBLIC HEALTH, V84, P254, DOI 10.2105/AJPH.84.2.254; House of Commons Health Committee, 2010, 1 HOUS COMM HLTH COM; Irish Medical Organisation, 2011, OIR JOINT COMM UNPUB; Jernigan DH, 2013, MMWR-MORBID MORTAL W, V62, P877; Lefton T, 2009, SPORTS BUSINESS J; Lindsay S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-719; MADDEN PA, 1994, AM J PUBLIC HEALTH, V84, P297, DOI 10.2105/AJPH.84.2.297; O'Brien KS, 2014, ADDICTION, V109, P1647, DOI 10.1111/add.12604; O'Brien KS, 2011, ALCOHOL ALCOHOLISM, V46, P210, DOI 10.1093/alcalc/agq095; Office of the Surgeon General (US); National Institute on Alcohol Abuse and Alcoholism (US), 2007, SURG GEN CALL ACT PR; Ozanian MK, 2009, FORBES; Pettigrew S, 2012, DRUG ALCOHOL REV, V31, P797, DOI 10.1111/j.1465-3362.2012.00439.x; Slater MD, 1996, J STUD ALCOHOL, V57, P425, DOI 10.15288/jsa.1996.57.425; Slater MD, 1997, JOURNALISM MASS COMM, V74, P108, DOI 10.1177/107769909707400109; Smith LA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-51; Snyder LB, 2000, J STUD ALCOHOL, V61, P896, DOI 10.15288/jsa.2000.61.896; Stacy AW, 2004, AM J HEALTH BEHAV, V28, P498; Strick M, 2009, J EXP PSYCHOL-APPL, V15, P35, DOI 10.1037/a0014812; Wang Z, 2012, MEDIA PSYCHOL, V15, P68, DOI 10.1080/15213269.2011.649604; Winter MV, 2008, J STUD ALCOHOL DRUGS, V69, P676, DOI 10.15288/jsad.2008.69.676; World Health Organization Regional Committee for Africa, 2010, RED HARMF US ALC STR	35	9	9	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134889	10.1371/journal.pone.0134889	http://dx.doi.org/10.1371/journal.pone.0134889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO7PP	26263170	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000359353300043
J	Pozdeyev, N; Berlinberg, A; Zhou, Q; Wuensch, K; Shibata, H; Wood, WM; Haugen, BR				Pozdeyev, Nikita; Berlinberg, Adam; Zhou, Qiong; Wuensch, Kelsey; Shibata, Hiroyuki; Wood, William M.; Haugen, Bryan R.			Targeting the NF-kappa B Pathway as a Combination Therapy for Advanced Thyroid Cancer	PLOS ONE			English	Article							CELL-LINES; INDUCED APOPTOSIS; CARCINOMA; INHIBITION; ACTIVATION; METASTASIS; MANAGEMENT; DOCETAXEL; EFFICACY; INVASION	NF-kappa B signaling plays an important role in tumor cell proliferation, cell survival, angiogenesis, invasion, metastasis and drug/radiation resistance. Combination therapy involving NF kappa B pathway inhibition is an attractive strategy for the treatment of advanced forms of thyroid cancer. This study was designed to test the efficacy of NF-kappa B pathway inhibition in combination with cytotoxic chemotherapy, using docetaxel and ionizing radiation in in vitro models of thyroid cancer. We found that while both docetaxel and ionizing radiation activated NF-kappa B signaling in thyroid cancer cells, there was no synergistic effect on cell proliferation and/or programmed cell death with either genetic (transduction of a dominant negative mutant form of I kappa B alpha) or pharmacologic (proteasome inhibitor bortezomib and IKK beta inhibitor GO-Y030) inhibition of the NF-kappa B pathway in thyroid cancer cell lines BCPAP, 8505C, THJ16T and SW1736. Docetaxel plus bortezomib synergistically decreased in vitro invasion of 8505C cells, but not in the other cell lines. Screening of a panel of clinically relevant targeted therapies for synergy with genetic NF-kappa B inhibition in a proliferation/ cytotoxicity assay identified the histone deacetylase (HDAC) inhibitor suberoylanilide hydroxamic acid (SAHA) as a potential candidate. However, the synergistic effect was confirmed only in the BCPAP cells. These results indicate that NF-kappa B inhibitors are unlikely to be beneficial as combination therapy with taxane cytotoxic chemotherapy, external radiation therapy or radioiodine therapy. There may be unique circumstances where NF-kappa B inhibitors may be considered in combination with docetaxel to reduce tumor invasion or in combination with HDAC inhibitors to reduce tumor growth, but this does not appear to be a combination therapy that could be broadly applied to patients with advanced thyroid cancer. Further research may identify which subsets of patients/tumors may respond to this therapeutic approach.	[Pozdeyev, Nikita; Berlinberg, Adam; Wuensch, Kelsey; Wood, William M.; Haugen, Bryan R.] Univ Colorado, Dept Med, Div Endocrinol Diabet & Metab, Aurora, CO 80045 USA; [Zhou, Qiong] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO USA; [Shibata, Hiroyuki] Akita Univ, Dept Clin Oncol, Fac Med, Akita 010, Japan; [Haugen, Bryan R.] Univ Colorado, Ctr Canc, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Akita University; University of Colorado System; University of Colorado Anschutz Medical Campus	Haugen, BR (corresponding author), Univ Colorado, Dept Med, Div Endocrinol Diabet & Metab, Anschutz Med Campus, Aurora, CO 80045 USA.	bryan.haugen@ucdenver.edu	Berlinberg, Adam/W-4367-2019	NASSAR, KELSEY/0000-0002-2547-7580; Zhou, Qiong/0000-0002-8240-0440	NIH/NCI research grant [R01 CA100560]; Mary Rossick Kern and Jerome H. Kern Endowment for Endocrine Neoplasms Research; Endocrine Fellow Foundation; NATIONAL CANCER INSTITUTE [R01CA100560] Funding Source: NIH RePORTER	NIH/NCI research grant; Mary Rossick Kern and Jerome H. Kern Endowment for Endocrine Neoplasms Research; Endocrine Fellow Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by NIH/NCI research grant R01 CA100560 (www.nih.gov) to BRH, by the Mary Rossick Kern and Jerome H. Kern Endowment for Endocrine Neoplasms Research to BRH, and by an Endocrine Fellow Foundation research grant (www.endocrinefellows.org) to NP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, SEER STAT FACT SHEET; Bauerle KT, 2014, J CLIN ENDOCR METAB, V99, pE1436, DOI 10.1210/jc.2013-3636; Bauerle KT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-117; Bose P, 2014, PHARMACOL THERAPEUT, V143, P323, DOI 10.1016/j.pharmthera.2014.04.004; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Godwin P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00120; Hong JM, 2014, ENDOCRINOL METAB, V29, P54, DOI 10.3803/EnM.2014.29.1.54; Kim E, 2012, THYROID, V22, P717, DOI 10.1089/thy.2011.0380; Li F, 2015, ARCH TOXICOL; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Li XY, 2013, THYROID, V23, P209, DOI 10.1089/thy.2012.0237; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Liu J, 2012, INT J CLIN EXP PATHO, V5, P216; Marlow LA, 2010, J CLIN ENDOCR METAB, V95, P5338, DOI 10.1210/jc.2010-1421; Meng ZW, 2012, LIFE SCI, V91, P1236, DOI 10.1016/j.lfs.2012.09.026; Meng ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033597; Monks NR, 2004, J CELL BIOCHEM, V92, P646, DOI 10.1002/jcb.20080; Pyo JS, 2013, PATHOL RES PRACT, V209, P228, DOI 10.1016/j.prp.2013.02.004; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Sato A, 2011, CANCER SCI, V102, P1045, DOI 10.1111/j.1349-7006.2011.01886.x; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Sethi Kruttibas, 2011, J Exp Ther Oncol, V9, P187; Smallridge RC, 2012, THYROID, V22, P1104, DOI 10.1089/thy.2012.0302; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; Troch M, 2010, J CLIN ENDOCR METAB, V95, pE54, DOI 10.1210/jc.2009-2827; van Staveren WCG, 2007, CANCER RES, V67, P8113, DOI 10.1158/0008-5472.CAN-06-4026; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Woyach JA, 2009, J CLIN ENDOCR METAB, V94, P164, DOI 10.1210/jc.2008-1631; Zeng W, 2014, EXP MOL PATHOL, V97, P184, DOI 10.1016/j.yexmp.2014.06.012; Zhang YJ, 2014, LIFE SCI, V118, P39, DOI 10.1016/j.lfs.2014.09.025	33	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134901	10.1371/journal.pone.0134901	http://dx.doi.org/10.1371/journal.pone.0134901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263379	Green Published, gold, Green Submitted			2022-12-27	WOS:000359353300044
J	Papas, KK; Bellin, MD; Sutherland, DER; Suszynski, TM; Kitzmann, JP; Avgoustiniatos, ES; Gruessner, AC; Mueller, KR; Beilman, GJ; Balamurugan, AN; Loganathan, G; Colton, CK; Koulmanda, M; Weir, GC; Wilhelm, JJ; Qian, DJ; Niland, JC; Hering, BJ				Papas, Klearchos K.; Bellin, Melena D.; Sutherland, David E. R.; Suszynski, Thomas M.; Kitzmann, Jennifer P.; Avgoustiniatos, Efstathios S.; Gruessner, Angelika C.; Mueller, Kathryn R.; Beilman, Gregory J.; Balamurugan, Appakalai N.; Loganathan, Gopalakrishnan; Colton, Clark K.; Koulmanda, Maria; Weir, Gordon C.; Wilhelm, Josh J.; Qian, Dajun; Niland, Joyce C.; Hering, Bernhard J.			Islet Oxygen Consumption Rate (OCR) Dose Predicts Insulin Independence in Clinical Islet Autotransplantation	PLOS ONE			English	Article							BETA-CELL MASS; TOTAL PANCREATECTOMY; IMMUNOSUPPRESSIVE REGIMEN; CHRONIC-PANCREATITIS; DIABETES-MELLITUS; TRANSPLANTATION; OUTCOMES; REVERSAL	Background Reliable in vitro islet quality assessment assays that can be performed routinely, prospectively, and are able to predict clinical transplant outcomes are needed. In this paper we present data on the utility of an assay based on cellular oxygen consumption rate (OCR) in predicting clinical islet autotransplant (IAT) insulin independence (II). IAT is an attractive model for evaluating characterization assays regarding their utility in predicting II due to an absence of confounding factors such as immune rejection and immunosuppressant toxicity. Methods Membrane integrity staining (FDA/PI), OCR normalized to DNA (OCR/DNA), islet equivalent (IE) and OCR (viable IE) normalized to recipient body weight (IE dose and OCR dose), and OCR/DNA normalized to islet size index (ISI) were used to characterize autoislet preparations (n = 35). Correlation between pre-IAT islet product characteristics and II was determined using receiver operating characteristic analysis. Results Preparations that resulted in II had significantly higher OCR dose and IE dose (p<0.001). These islet characterization methods were highly correlated with II at 6-12 months post-IAT (area-under-the-curve (AUC) = 0.94 for IE dose and 0.96 for OCR dose). FDA/PI AUC = 0.49) and OCR/DNA (AUC = 0.58) did not correlate with II. OCR/DNA/ISI may have some utility in predicting outcome (AUC = 0.72). Conclusions Commonly used assays to determine whether a clinical islet preparation is of high quality prior to transplantation are greatly lacking in sensitivity and specificity. While IE dose is highly predictive, it does not take into account islet cell quality. OCR dose, which takes into consideration both islet cell quality and quantity, may enable a more accurate and prospective evaluation of clinical islet preparations.	[Papas, Klearchos K.; Kitzmann, Jennifer P.; Gruessner, Angelika C.; Mueller, Kathryn R.] Univ Arizona, Dept Surg, Inst Cellular Transplantat, Tucson, AZ 85721 USA; [Papas, Klearchos K.; Bellin, Melena D.; Sutherland, David E. R.; Suszynski, Thomas M.; Kitzmann, Jennifer P.; Avgoustiniatos, Efstathios S.; Mueller, Kathryn R.; Beilman, Gregory J.; Balamurugan, Appakalai N.; Loganathan, Gopalakrishnan; Wilhelm, Josh J.; Hering, Bernhard J.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Papas, Klearchos K.; Bellin, Melena D.; Sutherland, David E. R.; Suszynski, Thomas M.; Kitzmann, Jennifer P.; Avgoustiniatos, Efstathios S.; Mueller, Kathryn R.; Balamurugan, Appakalai N.; Loganathan, Gopalakrishnan; Wilhelm, Josh J.; Hering, Bernhard J.] Schulze Diabet Inst, Minneapolis, MN USA; [Colton, Clark K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Koulmanda, Maria] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Transplant Inst, Boston, MA 02215 USA; [Weir, Gordon C.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Qian, Dajun; Niland, Joyce C.] City Hope Natl Med Ctr, Informat Sci, Duarte, CA USA	University of Arizona; University of Minnesota System; University of Minnesota Twin Cities; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.; City of Hope	Papas, KK (corresponding author), Univ Arizona, Dept Surg, Inst Cellular Transplantat, Tucson, AZ 85721 USA.	kkpapas@surgery.arizona.edu	Wilhelm, Joshua/H-2314-2015	Wilhelm, Joshua/0000-0002-6187-4874; Beilman, Gregory/0000-0001-5036-3027	NIH; Carol Olson Memorial Diabetes Research Fund; Schott Foundation; Iacocca Foundation; NIDDK [K23 DK084315]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000113, KL2TR002492, UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK084315] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carol Olson Memorial Diabetes Research Fund; Schott Foundation; Iacocca Foundation; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the NIH (Clinical Islet Transplantation [CIT] Consortium grant, Iscel Cell Resources [ICR] grant), by the Carol Olson Memorial Diabetes Research Fund, Schott Foundation, Iacocca Foundation, and NIDDK #K23 DK084315. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anazawa T, 2009, AM J TRANSPLANT, V9, P2383, DOI 10.1111/j.1600-6143.2009.02765.x; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Bellin MD, 2012, AM J TRANSPLANT, V12, P1576, DOI 10.1111/j.1600-6143.2011.03977.x; Bellin MD, 2013, PANCREAS, V42, P317, DOI 10.1097/MPA.0b013e3182681182; Bellin MD, 2012, CURR DIABETES REP, V12, P580, DOI 10.1007/s11892-012-0296-1; Bellin MD, 2011, TRANSPLANTATION, V91, P367, DOI 10.1097/TP.0b013e318203fd09; Colton CK, 2007, CELLULAR TRANSPLANTA, DOI [DOI 10.1016/B978-012369415-7/50007-7, 10.1016/B978-012369415-7/50007-7]; Fraker C, 2006, CELL TRANSPLANT, V15, P745, DOI 10.3727/000000006783981440; Froud T, 2008, TRANSPLANTATION, V86, P1695, DOI 10.1097/TP.0b013e31819025e5; Keymeulen B, 2006, P NATL ACAD SCI USA, V103, P17444, DOI 10.1073/pnas.0608141103; Kitzmann JP, 2014, TRANSPL P, V46, P1985, DOI 10.1016/j.transproceed.2014.06.001; Papas KK, 2007, AM J TRANSPLANT, V7, P707, DOI 10.1111/j.1600-6143.2006.01655.x; Papas KK, 2007, BIOTECHNOL BIOENG, V98, P1071, DOI 10.1002/bit.21486; Papas KK, 2010, J INVEST SURG, V23, P28, DOI 10.3109/08941930903410825; Papas KK, 2009, CURR OPIN ORGAN TRAN, V14, P674, DOI 10.1097/MOT.0b013e328332a489; Pepper AR, 2012, CELL TRANSPLANT, V21, P2797, DOI 10.3727/096368912X653273; Posselt AM, 2010, TRANSPLANTATION, V90, P1595, DOI 10.1097/TP.0b013e3181fe1377; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; RICORDI C, 1991, PANCREAS, V6, P242, DOI 10.1097/00006676-199103000-00018; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Suszynski TM, 2008, TRANSPL P, V40, P346, DOI 10.1016/j.transproceed.2008.01.061; Suszynski TM, 2014, J DIABETES SCI TECHN; Suszynski TM, 2014, TRANSPLANTATION; Sutherland DER, 2012, J AM COLL SURGEONS, V214, P409, DOI 10.1016/j.jamcollsurg.2011.12.040; Sutherland DER, 2008, TRANSPLANTATION, V86, P1799, DOI 10.1097/TP.0b013e31819143ec; Sweet IR, 2008, AM J TRANSPLANT, V8, P183, DOI 10.1111/j.1600-6143.2007.02041.x; Turgeon NA, 2010, AM J TRANSPLANT, V10, P2082, DOI 10.1111/j.1600-6143.2010.03212.x; Wilhelm JJ, 2013, AM J TRANSPLANTATION	30	46	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134428	10.1371/journal.pone.0134428	http://dx.doi.org/10.1371/journal.pone.0134428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258815	Green Published, gold, Green Submitted			2022-12-27	WOS:000359352600014
J	Silva, CJD; Moura, ACM; Paiva, PCP; Ferreira, RC; Silvestrini, RA; Vargas, AMD; de Paula, LPP; Naves, MD; Ferreira, EFE				de Paula Silva, Carlos Jose; Mourao Moura, Ana Clara; Pelli Paiva, Paula Cristina; Ferreira, Raquel Conceicao; Silvestrini, Rafaella Almeida; Duarte Vargas, Andrea Maria; Pinto de Paula, Liliam Pacheco; Naves, Marcelo Drummond; Ferreira e Ferreira, Efigenia			Maxillofacial Injuries as Markers of Interpersonal Violence in Belo Horizonte-Brazil: Analysis of the Socio-Spatial Vulnerability of the Location of Victim's Residences	PLOS ONE			English	Article							HOMICIDE RATES; SAO-PAULO; INCOME INEQUALITY; CITY; MORTALITY; HEALTH	The aim of the present study was to analyze the spatial pattern of cases of maxillofacial injuries caused by interpersonal violence, based on the location of the victim's residence, and to investigate the existence of conditions of socio-spatial vulnerability in these areas. This is a cross-sectional study, using the data of victims attended in three emergency hospitals in Belo Horizonte-Brazil between January 2008 and December 2010. Based on the process of spatial signature, the socio-spatial condition of the victims was identified according to data from census tracts. The spatial distribution trends of the addresses of victims were analyzed using Kernel maps and Ripley's K function. Multicriteria analysis was used to analyze the territorial insertion of victims, using a combination of variables to obtain the degree of socio-spatial vulnerability. The residences of the victims were distributed in an aggregated manner in urban areas, with a confidence level of 99%. The highest densities were found in areas of unfavorable socioeconomic conditions and, to a lesser extent, areas with worse residential and neighborhood infrastructure. Spatial clusters of households formed in slums with a significant level of socio-spatial vulnerability. Explanations of the living conditions in segregated urban areas and analysis of the concentration of more vulnerable populations should be a priority in the development of public health and safety policies.	[de Paula Silva, Carlos Jose; Pelli Paiva, Paula Cristina] Fed Univ Jequitinhonha & Mucuri Valleys, Dept Dent, Diamantina, MG, Brazil; [Mourao Moura, Ana Clara] Univ Fed Minas Gerais, Sch Architecture, Lab Geog Informat Syst, Belo Horizonte, MG, Brazil; [Ferreira, Raquel Conceicao; Duarte Vargas, Andrea Maria; Ferreira e Ferreira, Efigenia] Univ Fed Minas Gerais, Sch Dent, Dept Oral Publ Hlth, Belo Horizonte, MG, Brazil; [Silvestrini, Rafaella Almeida] Univ Belo Horizonte, Dept Spatial Stat & Geostat, Belo Horizonte, MG, Brazil; [Pinto de Paula, Liliam Pacheco] Catholic Univ Minas, Dept Psychol, Belo Horizonte, MG, Brazil; [Naves, Marcelo Drummond] Fed Univ Minas, Sch Dent, Dept Oral & Maxillofacial Surg, Belo Horizonte, MG, Brazil	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Centro Universitario de Belo Horizonte	Paiva, PCP (corresponding author), Fed Univ Jequitinhonha & Mucuri Valleys, Dept Dent, Diamantina, MG, Brazil.	paulacpp@ig.com.br	Ferreira, Raquel Conceição/L-5589-2013; Moura, Ana Clara M/M-4354-2014; Moura, Ana Clara Mourao/AAG-4051-2020; Ferreira, Raquel Conceição/J-5236-2015; Ferreira, Efigenia/AAF-5226-2021	Ferreira, Raquel Conceição/0000-0001-8897-9345; Moura, Ana Clara M/0000-0001-6823-1938; Ferreira, Raquel Conceição/0000-0001-8897-9345; Ferreira, Efigenia/0000-0002-0665-211X; VARGAS, ANDREA/0000-0002-4371-9862	Brazilian fostering agency Coordenacao de aperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian fostering agency FAPEMIG	Brazilian fostering agency Coordenacao de aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian fostering agency FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by the Brazilian fostering agencies Coordenacao de aperfeicoamento de Pessoal de Nivel Superior (CAPES) and FAPEMIG. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adorno Sérgio, 2002, Sociologias, P84; [Anonymous], 2001, CAD SAUDE PUBLICA, V17, P1163, DOI [10. 1590/ S0102- 311X2001000500017, DOI 10.1590/S0102-311X2001000500017]; Atkinson A, 2009, INTERPERSONAL VIOLEN, P1; Bailey T, 1995, INTERACTIVE SPATIAL; Barata RB, 1999, REV BRAS EPIDEMIOL, V2, P50, DOI [10.1590/S1415-790X1999000100005, DOI 10.1590/S1415-790X1999000100005]; Barbosa AMF, 2011, EPIDEMIOL SERV SAUDE, V2, P141; Barcellos C, 2000, SEM NAC SAUD AMB PRO, P27; BEATO C, 1998, REV BRASILEIRA CIENC, V13, P74; Bertin J, 1977, NEOGRAFICA TRATAMENT; Caiaffa WT, 2008, CIENC SAUDE COLETIVA, V13, P1785, DOI 10.1590/S1413-81232008000600013; Cardia N, 2002, CIENCIA CULTURA, V54, P25; Cardia Nancy, 2003, Estud. av., V17, P43, DOI 10.1590/S0103-40142003000100004; Carvalho SN, 2007, SAO PAULO PERSPECT, V21, P29; CESARE J, 1990, J TRAUMA, V30, P176, DOI 10.1097/00005373-199002000-00007; Cromley EK., 2002, GIS PUBLIC HLTH; de Lima LP, 2008, REV SAUDE PUBL, V42, P648, DOI 10.1590/S0034-89102008000400010; de Lima MLC, 2005, REV SAUDE PUBL, V39, P176, DOI 10.1590/S0034-89102005000200006; Duff C, 2013, INT J DRUG POLICY, V13, pS0955; FILHO BEATO, 2000, DESIGUALDADE POBREZA, P385; Gawryszewski VP, 2005, REV SAUDE PUBL, V39, P191, DOI 10.1590/S0034-89102005000200008; Gibson M, 2011, HEALTH PLACE, V17, P175, DOI 10.1016/j.healthplace.2010.09.011; IBGE-Censo demografico, 2010, DAD DISTR MG; Ishitani LH, 2001, REV MED MINAS GERAIS, V11, P7; Kelling G, 2003, CRIMINOLOGICAL PERSP; Lotufo PA, 2009, EUR J PUBLIC HEALTH, V19, P602, DOI 10.1093/eurpub/ckp078; Macedo AC, 2001, REV SAUDE PUBL, V35, P515, DOI 10.1590/S0034-89102001000600004; Macedo Jefferson Lessa Soares de, 2008, Rev. Col. Bras. Cir., V35, P9; Maguirre DJ, 1991, GEOGRAPHICAL INFORM; Mascarenhas MDM, 2012, CAD SAUDE PUBLICA, V28, pS124, DOI 10.1590/S0102-311X2012001300013; Minamisava R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-66; Miranda CEA, 2005, PRO-POSICOES, V16, P16; Moura ACM, 2009, REV BRASILEIRA CARTO, V61, P177; Ompad DC, 2007, J URBAN HEALTH, V84, pI42, DOI 10.1007/s11524-007-9168-4; Perez-Heydrich C, 2013, HEALTH PLACE, V19, P45, DOI 10.1016/j.healthplace.2012.10.002; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Santos José Vicente Tavares dos, 2002, Sociologias, P16; Santos S M, 2001, Cad Saude Publica, V17, P1099, DOI 10.1590/S0102-311X2001000500012; Santos SM, 2006, HEALTH PLACE, V12, P38, DOI 10.1016/j.healthplace.2004.08.009; Sudano JJ, 2013, HEALTH PLACE, V19, P80, DOI 10.1016/j.healthplace.2012.09.015; Szwarcwald CL, 1999, AM J PUBLIC HEALTH, V89, P845, DOI 10.2105/AJPH.89.6.845; Peres MFT, 2008, REV PANAM SALUD PUBL, V23, P268; Tucherman I, 2006, LOGOS, V24, P38; Vinther-Larsen M, 2010, HEALTH PLACE, V19, P53; Waiselfisz Julio J., 2013, MAPA VIOLENCIA 2013; Werb D, 2011, INT J DRUG POLICY, V22, P87, DOI 10.1016/j.drugpo.2011.02.002; Xavier-da-Silva J, 2001, GEOPROCESSAMENTO ANA	46	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134577	10.1371/journal.pone.0134577	http://dx.doi.org/10.1371/journal.pone.0134577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26274320	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600033
J	Blaak, H; van Hoek, AHAM; Hamidjaja, RA; van der Plaats, RQJ; Kerkhof-de Heer, L; Husman, AMD; Schets, FM				Blaak, Hetty; van Hoek, Angela H. A. M.; Hamidjaja, Raditijo A.; van der Plaats, Rozemarijn Q. J.; Kerkhof-de Heer, Lianne; Husman, Ana Maria de Roda; Schets, Franciska M.			Distribution, Numbers, and Diversity of ESBL-Producing E. coli in the Poultry Farm Environment	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; COMMENSAL ESCHERICHIA-COLI; R-PLASMID TRANSFER; EXTENDED-SPECTRUM; ANTIBIOTIC-RESISTANCE; SOURCE ATTRIBUTION; GENETIC EXCHANGE; CTX-M; ENTEROBACTERIACEAE; PREVALENCE	This study aimed to discern the contribution of poultry farms to the contamination of the environment with ESBL-producing Escherichia coli and therewith, potentially to the spread of these bacteria to humans and other animals. ESBL-producing E. coli were detected at all investigated laying hen farms (n = 5) and broiler farms (n = 3) in 65% (46/71) and 81% (57/70) of poultry faeces samples, respectively. They were detected in rinse water and runoff water (21/26; 81%), other farm animals (11/14; 79%), dust (21/35; 60%), surface water adjacent to farms (20/35; 57%), soil (48/87; 55%), on flies (11/73; 15%), and in barn air (2/33; 6%). The highest prevalence and concentrations in the outdoor environment were observed in soil of free-range areas at laying hen farms (100% of samples positive, geometric mean concentration 2.4x10(4) cfu/kg), and surface waters adjacent to broiler farms during, or shortly after, cleaning between production rounds (91% of samples positive, geometric mean concentration 1.9x10(2) cfu/l). The diversity of ESBL-producing E. coli variants with respect to sequence type, phylogenetic group, ESBL-genotype and antibiotic resistance profile was high, especially on broiler farms where on average 16 different variants were detected, and the average Simpson's Indices of diversity (SID; 1-D) were 0.93 and 0.94 among flock and environmental isolates respectively. At laying hen farms on average nine variants were detected, with SIDs of 0.63 (flock isolates) and 0.77 (environmental isolates). Sixty percent of environmental isolates were identical to flock isolates at the same farm. The highest proportions of 'flock variants' were observed in dust (94%), run-off gullies (82%), and barn air (67%), followed by surface water (57%), soil (56%), flies (50%) and other farm animals (35%). The introduction of ESBL-producing E. coli from poultry farms to the environment may pose a health risk if these bacteria reach places where people may become exposed.	[Blaak, Hetty; van Hoek, Angela H. A. M.; Hamidjaja, Raditijo A.; van der Plaats, Rozemarijn Q. J.; Kerkhof-de Heer, Lianne; Husman, Ana Maria de Roda; Schets, Franciska M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Zoonoses & Environm Microbiol, Bilthoven, Netherlands; [Husman, Ana Maria de Roda] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University	Blaak, H (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Zoonoses & Environm Microbiol, Bilthoven, Netherlands.	hetty.blaak@rivm.nl		Hamidjaja, Raditijo/0000-0002-5655-2299	Netherlands Food and Consumer Product Safety Authority (nVWA) [V/092326]	Netherlands Food and Consumer Product Safety Authority (nVWA)	The study was financed by the Netherlands Food and Consumer Product Safety Authority (nVWA). Grant number V/092326. The funding was granted to Ana Maria de Roda Husman.	[Anonymous], 2001, 166492 ISO; [Anonymous], 2014, ANT PLUIMV 2013 TREN; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Blaak H, 2014, VET MICROBIOL, V171, P448, DOI 10.1016/j.vetmic.2014.03.007; Blaak H, 2014, APPL ENVIRON MICROB, V80, P239, DOI 10.1128/AEM.02616-13; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chen H, 2010, ENVIRON POLLUT, V158, P2459, DOI 10.1016/j.envpol.2010.03.023; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clinical and Laboratory Standards Institute, 2015, M100S25 CLSI S; Clinical Laboratory Standards Institute, 2010, M100S20 CLIN LAB S S; COUGHTER JP, 1989, A VAN LEEUW J MICROB, V55, P15, DOI 10.1007/BF02309615; CRANE SR, 1986, WATER AIR SOIL POLL, V27, P411, DOI 10.1007/BF00649422; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776; den Heijer CDJ, 2010, J ANTIMICROB CHEMOTH, V65, P2128, DOI 10.1093/jac/dkq286; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P512, DOI 10.1093/jac/dkq472; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Dierikx CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079005; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P970, DOI 10.1017/S0950268811002676; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P959, DOI 10.1017/S0950268811002172; EARSNet, 2011, ANN REP EUR ANT RES; Escobar-Paramo P, 2006, ENVIRON MICROBIOL, V8, P1975, DOI 10.1111/j.1462-2920.2006.01077.x; Evers EG, 2015, RISK ANAL IN PRESS; Frahm E, 2003, J MICROBIOL METH, V52, P123, DOI 10.1016/S0167-7012(02)00150-1; Franz E, 2014, ENVIRON SCI TECHNOL, V48, P6763, DOI 10.1021/es501677c; Gao LL, 2015, INT J ENV RES PUB HE, V12, P4203, DOI 10.3390/ijerph120404203; GREENBERG B., 1973, FLIES DIS, V2; Hartmann A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00083; Hong HG, 2004, MICROB DRUG RESIST, V10, P184, DOI 10.1089/1076629041310145; Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178; Huijbers PMC, 2013, CLIN MICROBIOL INFEC, V19, pE256, DOI 10.1111/1469-0691.12150; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Laube H, 2014, VET MICROBIOL, V172, P519, DOI 10.1016/j.vetmic.2014.06.008; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; LYSYK TJ, 1986, J ECON ENTOMOL, V79, P993, DOI 10.1093/jee/79.4.993; Ma JY, 2012, APPL ENVIRON MICROB, V78, P3668, DOI 10.1128/AEM.07507-11; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Nazni W.A., 2005, Tropical Biomedicine, V22, P53; Njage PMK, 2015, MICROB BIOTECHNOL, V8, P462, DOI 10.1111/1751-7915.12234; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Poirel L, 2008, CLIN MICROBIOL INFEC, V14, P75, DOI 10.1111/j.1469-0691.2007.01865.x; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; SMITH HW, 1969, LANCET, V1, P1174; Sola-Gines M, 2015, APPL ENVIRON MICROB, V81, P3604, DOI 10.1128/AEM.04252-14; Soraas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069581; TREVORS JT, 1987, SYST APPL MICROBIOL, V9, P312; TREVORS JT, 1987, CAN J MICROBIOL, V33, P191, DOI 10.1139/m87-033; TREVORS JT, 1987, WATER AIR SOIL POLL, V34, P409, DOI 10.1007/BF00282741; TREVORS JT, 1986, CAN J MICROBIOL, V32, P610, DOI 10.1139/m86-114; Usui M, 2013, MICROB DRUG RESIST, V19, P415, DOI 10.1089/mdr.2012.0251; von Salviati C, 2015, VET MICROBIOL, V175, P77, DOI 10.1016/j.vetmic.2014.10.010; Wang J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00188; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zurfluh K, 2013, APPL ENVIRON MICROB, V79, P3021, DOI 10.1128/AEM.00054-13	65	78	82	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135402	10.1371/journal.pone.0135402	http://dx.doi.org/10.1371/journal.pone.0135402			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270644	Green Published, gold			2022-12-27	WOS:000359492800065
J	Bratton, BP; Shaevitz, JW				Bratton, Benjamin P.; Shaevitz, Joshua W.			Simple Experimental Methods for Determining the Apparent Focal Shift in a Microscope System	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; LIVE CAULOBACTER-CRESCENTUS; REFRACTIVE-INDEX MISMATCH; CONFOCAL MICROSCOPY; FLUORESCENCE MICROSCOPY; DIFFRACTION-LIMIT; SURFACE	Three-dimensional optical microscopy is often complicated by a refractive index mismatch between the sample and objective lens. This mismatch causes focal shift, a difference between sample motion and focal-plane motion, that hinders the accuracy of 3D reconstructions. We present two methods for measuring focal shift using fluorescent beads of different sizes and ring-stained fluorescent beads. These simple methods are applicable to most situations, including total internal reflection objectives and samples very close to the interface. For distances 0-1.5 mu m into an aqueous environment, our 1.49-NA objective has a relative focal shift of 0.57 +/- 0.02, significantly smaller than the simple n(2)/n(1) approximation of 0.88. We also expand on a previous sub-critical angle theory by means of a simple polynomial extrapolation. We test the validity of this extrapolation by measuring the apparent focal shift in samples where the refractive index is between 1.33 and 1.45 and with objectives with numerical apertures between 1.25 and 1.49.	[Bratton, Benjamin P.; Shaevitz, Joshua W.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Bratton, Benjamin P.; Shaevitz, Joshua W.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University	Shaevitz, JW (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	shaevitz@princeton.edu	Abraham, Thomas/AAJ-7950-2020; Bratton, Benjamin/AAB-9189-2021; Abraham, Thomas/J-7080-2014	Bratton, Benjamin/0000-0003-1128-2560; Abraham, Thomas/0000-0003-0750-8774	National Science Foundation [PHY-0844466]; National Institutes of Health [P50 GM071508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Science Foundation (www.nsf.gov) CAREER PHY-0844466 to JWS. BPB received support through National Institutes of Health (www.nigms.nih.gov) P50 GM071508. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arigovindan M, 2012, OPT EXPRESS, V20, P6527, DOI 10.1364/OE.20.006527; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2012, CHEMPHYSCHEM, V13, P1007, DOI 10.1002/cphc.201100686; BRENNER JF, 1976, J HISTOCHEM CYTOCHEM, V24, P100, DOI 10.1177/24.1.1254907; de Grauw GJ, 1999, APPL OPTICS, V38, P5995, DOI 10.1364/AO.38.005995; Diaspro A, 2002, APPL OPTICS, V41, P685, DOI 10.1364/AO.41.000685; Egner A, 2006, HDB BIOL CONFOCAL MI, P404, DOI DOI 10.1007/978-0-387-45524-2_20; Harris LK, 2014, MOL MICROBIOL, V94, P988, DOI 10.1111/mmi.12811; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hoyt LF, 1934, IND ENG CHEM, V26, P329, DOI 10.1021/ie50291a023; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Khan I, 2012, J APPL CRYSTALLOGR, V45, P936, DOI 10.1107/S002188981203470X; Kuypers LC, 2005, J MICROSC-OXFORD, V218, P68, DOI 10.1111/j.1365-2818.2005.01457.x; Lew MD, 2011, P NATL ACAD SCI USA, V108, pE1102, DOI 10.1073/pnas.1114444108; Main H, 1907, INT SUGAR J, VIX, P481; Neuman KC, 2005, OPT LETT, V30, P1318, DOI 10.1364/OL.30.001318; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sun Y, 2004, MICROSC RES TECHNIQ, V65, P139, DOI 10.1002/jemt.20118; VISSER TD, 1994, SCANNING, V16, P198, DOI 10.1002/sca.4950160403; White NS, 1996, J MICROSC-OXFORD, V181, P99, DOI 10.1046/j.1365-2818.1996.113392.x; Wiersma SH, 1997, J OPT SOC AM A, V14, P1482, DOI 10.1364/JOSAA.14.001482	24	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134616	10.1371/journal.pone.0134616	http://dx.doi.org/10.1371/journal.pone.0134616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270960	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800012
J	Chesnais, Q; Ameline, A; Doury, G; Le Roux, V; Couty, A				Chesnais, Quentin; Ameline, Arnaud; Doury, Geraldine; Le Roux, Vincent; Couty, Aude			Aphid Parasitoid Mothers Don't Always Know Best through the Whole Host Selection Process	PLOS ONE			English	Article							ERVI HALIDAY HYMENOPTERA; INDUCED PLANT VOLATILES; CAMELINA-SATIVA OIL; OVIPOSITION BEHAVIOR; INDIRECT DEFENSE; CHEMICAL CUES; PERFORMANCE; HERBIVORE; PREFERENCE; STRATEGIES	Parasitoid host selection behaviour has been extensively studied in experimentally simplified tritrophic systems formed by one single food chain (one plant, one herbivore and one parasitoid species). The "Mother knows best" hypothesis predicts that the preference for a plant-host complex should be positively correlated with plant quality for offspring performance. We studied the host selection behaviour of the generalist endoparasitoid Aphidius matricariae towards the black bean aphid Aphis fabae in the intercrop system including Vicia faba as a focal plant and its companion plant Camelina sativa. Dual-choice laboratory bioassays revealed that parasitoid females preferred to orientate towards (1) the plantaphid complex over the non-infested plant whatever the complex (2) the C. sativa-A. fabae complex over the V. faba-A. fabae complex. In dual choice attack rate bioassays, parasitoid females showed more interest towards the aphids on C. sativa but paradoxically chose to oviposit more in aphids on V. faba. Ultimately, parasitoids that had developed on the V. faba-A. fabae complex exhibited better fitness parameters. By demonstrating that parasitoid females were able to discriminate the aphid host that offered the highest fitness to their offspring but selected beforehand the least suitable plant-aphid complex, we provide key insight into the disruption in their host selection behaviour potentially triggered by diverse habitats. This suggests that the "Mother knows best" hypothesis could be thwarted by increasing the complexity of the studied systems.	[Chesnais, Quentin; Ameline, Arnaud; Doury, Geraldine; Le Roux, Vincent; Couty, Aude] Univ Picardie Jules Verne, FRE CNRS EDYSAN Ecol & Dynam Syst Anthropises 34, F-80039 Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Couty, A (corresponding author), Univ Picardie Jules Verne, FRE CNRS EDYSAN Ecol & Dynam Syst Anthropises 34, 33 Rue St Leu, F-80039 Amiens, France.	aude.couty@u-picardie.fr	Chesnais, Quentin/L-4453-2019	Chesnais, Quentin/0000-0002-0481-2335	Investments for the Future by the French government [ANR-001-01]	Investments for the Future by the French government	This work was performed in partnership with the SAS PIVERT within the framework of the French Institute for the Energy Transition (Institut pour la Transition Energetique-ITE), P.I.V.E.R.T. (www.institut-pivert.com), selected as an Investment for the Future ("Investissements d'Avenir"). This work was supported as part of the Investments for the Future by the French government under reference ANR-001-01.	Abramovic H, 2007, FOOD CHEM, V104, P903, DOI 10.1016/j.foodchem.2006.12.044; [Anonymous], 2014, R LANG ENV STAT COMP; Battaglia D, 2000, ENTOMOL EXP APPL, V94, P219, DOI 10.1023/A:1003968700811; Berhow MA, 2013, IND CROP PROD, V43, P119, DOI 10.1016/j.indcrop.2012.07.018; Boquel S, 2012, PLANT DIS, V96, P82, DOI 10.1094/PDIS-06-11-0499; BROWNE LM, 1991, TETRAHEDRON, V47, P3909, DOI 10.1016/S0040-4020(01)86431-0; Chesnais Q, 2015, BIOENERG RES, V8, P91, DOI 10.1007/s12155-014-9497-6; DeFarias AMI, 1997, ENVIRON ENTOMOL, V26, P989, DOI 10.1093/ee/26.4.989; Desneux N, 2004, ENTOMOL EXP APPL, V112, P227, DOI 10.1111/j.0013-8703.2004.00198.x; Dicke M, 2003, BASIC APPL ECOL, V4, P27, DOI 10.1078/1439-1791-00131; Dicke M, 1999, ENTOMOL EXP APPL, V91, P131, DOI 10.1023/A:1003608019062; Dicke M, 2009, NAT CHEM BIOL, V5, P317, DOI 10.1038/nchembio.169; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Doury G, 2015, BIOENERG RES, V8, P1275, DOI 10.1007/s12155-015-9589-y; Du YJ, 1998, J CHEM ECOL, V24, P1355, DOI 10.1023/A:1021278816970; DWERNYCHUK LW, 1972, CAN J ZOOLOG, V50, P559, DOI 10.1139/z72-076; Frohlich A, 2005, IND CROP PROD, V21, P25, DOI 10.1016/j.indcrop.2003.12.004; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Gols R, 2009, PHYTOCHEM REV, V8, P187, DOI 10.1007/s11101-008-9104-6; Gols R, 2009, OIKOS, V118, P733, DOI 10.1111/j.1600-0706.2008.17231.x; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Guerrieri E, 1997, BIOL CONTROL, V10, P159, DOI 10.1006/bcon.1997.0556; GUERRIERI E, 1993, EUR J ENTOMOL, V90, P415; Hagvar E.B., 1991, Biocontrol News and Information, V12, P13; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Henry LM, 2005, ENTOMOL EXP APPL, V116, P167, DOI 10.1111/j.1570-7458.2005.00318.x; Holman J., 2009, HOST PLANT CATALOGUE, DOI [10.1007/978-1-4020-8286-3, DOI 10.1007/978-1-4020-8286-3]; Hopkinson JE, 2013, BIOL CONTROL, V64, P283, DOI 10.1016/j.biocontrol.2012.11.016; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; Kettles GJ, 2013, NEW PHYTOL, V198, P1178, DOI 10.1111/nph.12218; LECKSTEIN PM, 1973, J INSECT PHYSIOL, V19, P973, DOI 10.1016/0022-1910(73)90023-1; Mayhew PJ, 1997, OIKOS, V79, P417, DOI 10.2307/3546884; McCormick AC, 2012, TRENDS PLANT SCI, V17, P303, DOI 10.1016/j.tplants.2012.03.012; Neeraj Verma, 1999, Annals of Plant Protection Sciences, V7, P51; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; OFORI F, 1987, ADV AGRON, V41, P41, DOI 10.1016/S0065-2113(08)60802-0; Pareja M, 2007, J CHEM ECOL, V33, P695, DOI 10.1007/s10886-007-9260-y; Pope TW, 2012, J APPL ENTOMOL, V136, P445, DOI 10.1111/j.1439-0418.2011.01667.x; Powell W, 1998, BIOL CONTROL, V11, P104, DOI 10.1006/bcon.1997.0584; REED HC, 1995, J CHEM ECOL, V21, P407, DOI 10.1007/BF02036738; Rehman A., 2010, J PLANT BREEDING CRO, V2, P299, DOI [10.5897/JPBCS.9000077, DOI 10.1016/J.BEPROC.2010.12.002]; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Saucke H, 2006, WEED RES, V46, P453, DOI 10.1111/j.1365-3180.2006.00530.x; Scheirs J, 2000, P ROY SOC B-BIOL SCI, V267, P2065, DOI 10.1098/rspb.2000.1250; Scheirs J, 2002, OIKOS, V96, P187, DOI 10.1034/j.1600-0706.2002.960121.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Seguin-Swartz G, 2009, CAN J PLANT PATHOL, V31, P375, DOI 10.1080/07060660909507612; Shannag H. K., 2007, World Journal of Agricultural Sciences, V3, P344; Soler R, 2007, FUNCT ECOL, V21, P969, DOI 10.1111/j.1365-2435.2007.01309.x; Soler R, 2005, J ANIM ECOL, V74, P1121, DOI 10.1111/j.1365-2656.2005.01006.x; Soler R, 2007, OIKOS, V116, P367, DOI 10.1111/j.0030-1299.2007.15501.x; Soroka J, 2015, CAN ENTOMOL, V147, P193, DOI 10.4039/tce.2014.42; Stoddard FL, 2010, FIELD CROP RES, V115, P308, DOI 10.1016/j.fcr.2009.07.002; Sznajder B, 2003, ENTOMOL EXP APPL, V109, P73, DOI 10.1046/j.1570-7458.2003.00096.x; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; VET LEM, 1994, J ANIM ECOL, V63, P807, DOI 10.2307/5258; Vet Louise E.M., 1995, P65; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; VINSON SB, 1980, ANNU REV ENTOMOL, V25, P397, DOI 10.1146/annurev.en.25.010180.002145; Wajnberg E., 2013, CHEM ECOLOGY INSECT; WICKREMASINGHE MGV, 1992, PHYSIOL ENTOMOL, V17, P297, DOI 10.1111/j.1365-3032.1992.tb01025.x; Yu DSK, 2016, TAXAPAD 2016 ICHNEUM	67	11	12	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135661	10.1371/journal.pone.0135661	http://dx.doi.org/10.1371/journal.pone.0135661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270046	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800096
J	Frickmann, H; Dekker, D; Schwarz, NG; Hahn, A; Boahen, K; Sarpong, N; Adu-Sarkodie, Y; Halbgewachs, E; Marks, F; von Kalckreuth, V; Poppert, S; Loderstaedt, U; May, J; Hagen, RM				Frickmann, Hagen; Dekker, Denise; Schwarz, Norbert Georg; Hahn, Andreas; Boahen, Kennedy; Sarpong, Nimako; Adu-Sarkodie, Yaw; Halbgewachs, Eva; Marks, Florian; von Kalckreuth, Vera; Poppert, Sven; Loderstaedt, Ulrike; May, Juergen; Hagen, Ralf Matthias			16S rRNA Gene Sequence-Based Identification of Bacteria in Automatically Incubated Blood Culture Materials from Tropical Sub-Saharan Africa	PLOS ONE			English	Article							STREAM INFECTIONS; TYPHOID-FEVER; CHILDREN; ACINETOBACTER; DIAGNOSIS; SURVIVAL; PCR	Background The quality of microbiological diagnostic procedures depends on pre-analytic conditions. We compared the results of 16S rRNA gene PCR and sequencing from automatically incubated blood culture materials from tropical Ghana with the results of cultural growth after automated incubation. Methods Real-time 16S rRNA gene PCR and subsequent sequencing were applied to 1500 retained blood culture samples of Ghanaian patients admitted to a hospital with an unknown febrile illness after enrichment by automated culture. Results Out of all 1500 samples, 191 were culture-positive and 98 isolates were considered etiologically relevant. Out of the 191 culture-positive samples, 16S rRNA gene PCR and sequencing led to concordant results in 65 cases at species level and an additional 62 cases at genus level. PCR was positive in further 360 out of 1309 culture-negative samples, sequencing results of which suggested etiologically relevant pathogen detections in 62 instances, detections of uncertain relevance in 50 instances, and DNA contamination due to sample preparation in 248 instances. In two instances, PCR failed to detect contaminants from the skin flora that were culturally detectable. Pre-analytical errors caused many Enterobacteriaceae to be missed by culture. Conclusions Potentially correctable pre-analytical conditions and not the fastidious nature of the bacteria caused most of the discrepancies. Although 16S rRNA gene PCR and sequencing in addition to culture led to an increase in detections of presumably etiologically relevant blood culture pathogens, the application of this procedure to samples from the tropics was hampered by a high contamination rate. Careful interpretation of diagnostic results is required.	[Frickmann, Hagen; Hagen, Ralf Matthias] German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany; [Frickmann, Hagen] Univ Hosp Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Dekker, Denise; Schwarz, Norbert Georg; Hahn, Andreas; May, Juergen] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Boahen, Kennedy; Sarpong, Nimako] Kumasi Ctr Collaborat Res, Kumasi, Ghana; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Halbgewachs, Eva] German Armed Forces Med Serv Kiel, Cent Inst, Lab Dept 1, Berlin, Germany; [Marks, Florian; von Kalckreuth, Vera] IVI, Seoul, South Korea; [Poppert, Sven] Univ Giessen, Dept Med Microbiol, Univ Med Ctr Giessen, D-35390 Giessen, Germany; [Loderstaedt, Ulrike] Univ Med Ctr Goettingen, Dept Clin Chem, Gottingen, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Rostock; Bernhard Nocht Institut fur Tropenmedizin; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; International Vaccine Institute; Justus Liebig University Giessen; University of Gottingen	Frickmann, H (corresponding author), German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany.	Frickmann@bni-hamburg.de	Hahn, Andreas/AAV-3364-2020; Schwarz, Norbert G/C-8797-2012	Hahn, Andreas/0000-0002-5157-8369; Schwarz, Norbert G/0000-0002-8387-2837; May, Jurgen/0000-0001-7831-8420; Marks, Florian/0000-0002-6043-7170	International Vaccine Institute (IVI); German Ministry of Defense (MoD) [13K2-S-451215]	International Vaccine Institute (IVI); German Ministry of Defense (MoD)	The study from which the Ghanaian samples were taken was organized and funded through the International Vaccine Institute (IVI). PCR analysis and consecutive sequencing were funded by the German Ministry of Defense (MoD), scientific project number 13K2-S-451215, "Development/evaluation of diagnostic molecular procedures for the diagnosis of infectious agents and symptom-based diagnostic procedures for tropical infectious diseases." RMH received the grant; no URL is applicable. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHOJA MS, 1979, J CLIN PATHOL, V32, P497, DOI 10.1136/jcp.32.5.497; Andrade SS, 2008, SHOCK, V30, P41, DOI 10.1097/SHK.0b013e3181819f6c; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bernasconi E, 2004, CLIN INFECT DIS, V38, pE27, DOI 10.1086/381436; Chaudhry R, 1997, J CLIN PATHOL, V50, P437, DOI 10.1136/jcp.50.5.437; Christner M, 2010, J CLIN MICROBIOL, V48, P1584, DOI 10.1128/JCM.01831-09; Cilia V, 1996, MOL BIOL EVOL, V13, P451, DOI 10.1093/oxfordjournals.molbev.a025606; Clinical and Laboratory Standards Institute, 2009, MM18A CLIN LAB STAND, P30; COMMEY JOO, 1994, E AFR MED J, V71, P113; Deen J, 2012, LANCET INFECT DIS, V12, P480, DOI 10.1016/S1473-3099(12)70028-2; Doughari HJ, 2011, MICROBES ENVIRON, V26, P101, DOI 10.1264/jsme2.ME10179; Fenollar F, 2007, INT J ANTIMICROB AG, V30, pS7, DOI 10.1016/j.ijantimicag.2007.06.024; Flot JF, 2007, MOL ECOL NOTES, V7, P974, DOI 10.1111/j.1471-8286.2007.01857.x; Frickmann H, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/938721; Frickmann H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/375681; Frickmann H, 2013, SCAND J INFECT DIS, V45, P616, DOI 10.3109/00365548.2013.777777; GEERDES HF, 1992, CLIN INFECT DIS, V15, P991, DOI 10.1093/clind/15.6.991; Hagen RM, 2011, INT J MED MICROBIOL, V301, P585, DOI 10.1016/j.ijmm.2011.04.017; JEFFERSON H, 1975, AM J CLIN PATHOL, V64, P689; Jenkins C, 2012, J MED MICROBIOL, V61, P483, DOI 10.1099/jmm.0.030387-0; Junier P, 2008, APPL ENVIRON MICROB, V74, P5231, DOI 10.1128/AEM.00288-08; Kawamura Y, 1999, MICROBIOL-UK, V145, P2605, DOI 10.1099/00221287-145-9-2605; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Lefevre P C, 1993, Rev Sci Tech, V12, P451; Linow M, 2012, RES MOL MICROBIOL, V2, P1; LUDWIG W, 1994, FEMS MICROBIOL REV, V15, P155, DOI 10.1111/j.1574-6976.1994.tb00132.x; March-Rossello GA, 2013, EUR J CLIN MICROBIOL, V32, P699, DOI 10.1007/s10096-012-1797-1; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; Massi MN, 2005, INT J MED MICROBIOL, V295, P117, DOI 10.1016/j.ijmm.2005.01.003; MAY JR, 1964, J CLIN PATHOL, V17, P254, DOI 10.1136/jcp.17.3.254; MONROE PW, 1969, APPL MICROBIOL, V18, P214, DOI 10.1128/AEM.18.2.214-220.1969; Muhl H, 2010, DIAGN MICR INFEC DIS, V66, P41, DOI 10.1016/j.diagmicrobio.2008.07.011; Nielsen MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044063; Perry JL, 1997, J CLIN MICROBIOL, V35, P1269, DOI 10.1128/JCM.35.5.1269-1271.1997; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Richter SS, 2002, J CLIN MICROBIOL, V40, P2437, DOI 10.1128/JCM.40.7.2437-2444.2002; Rosey AL, 2007, J MICROBIOL METH, V68, P88, DOI 10.1016/j.mimet.2006.06.010; ROSS PW, 1978, J CLIN PATHOL, V31, P430, DOI 10.1136/jcp.31.5.430; Schaberg DR, 1991, AM J MED S3B, V16, P72; Schwarz NG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-319; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	41	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135923	10.1371/journal.pone.0135923	http://dx.doi.org/10.1371/journal.pone.0135923			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270631	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492800119
J	Pellegrini, E; Campanella, A; Paolocci, M; Trivellini, A; Gennai, C; Muganu, M; Nali, C; Lorenzini, G				Pellegrini, Elisa; Campanella, Alessandra; Paolocci, Marco; Trivellini, Alice; Gennai, Clizia; Muganu, Massimo; Nali, Cristina; Lorenzini, Giacomo			Functional Leaf Traits and Diurnal Dynamics of Photosynthetic Parameters Predict the Behavior of Grapevine Varieties Towards Ozone	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE PARAMETERS; HYBRID POPLAR CLONES; PHYSIOLOGICAL-RESPONSES; MELISSA-OFFICINALIS; BACKGROUND OZONE; AIR-POLLUTION; L.; SENSITIVITY; PROLINE; STRESS	A comparative study on functional leaf treats and the diurnal dynamics of photosynthetic processes was conducted on 2-year-old potted plants of two grape (Vitis vinifera L.) varieties (Aleatico, ALE, and Trebbiano giallo, TRE), exposed under controlled conditions to realistic concentrations of the pollutant gas ozone (80 ppb for 5 h day(-1), 8:00-13:00 h, +40 ppb for 5 h day(-1), 13:00-18:00 h). At constitutive levels, the morphological functional traits of TRE improved leaf resistance to gas exchange, suggesting that TRE is characterized by a potential high degree of tolerance to ozone. At the end of the treatment, both varieties showed typical visible injuries on fully expanded leaves and a marked alteration in the diurnal pattern of photosynthetic activity. This was mainly due to a decreased stomatal conductance (-27 and -29% in ALE and TRE, in terms of daily values in comparison to controls) and to a reduced mesophyllic functioning (+33 and +16% of the intercellular carbon dioxide concentration). Although the genotypic variability of grape regulates the response to oxidative stress, similar detoxification processes were activated, such as an increased content of total carotenoids (+64 and +30%, in ALE and TRE), enhanced efficiency of thermal energy dissipation within photosystem II (+32 and +20%) closely correlated with the increased de-epoxidation index (+26 and +22%) and variations in content of some osmolytes. In summary, we can conclude that: the daily photosynthetic performance of grapevine leaves was affected by a realistic exposure to ozone. In addition, the gas exchange and chlorophyll a fluorescence measurements revealed a different quali-quantitative response in the two varieties. The genotypic variability of V. vinifera and the functional leaf traits would seem to regulate the acclimatory response to oxidative stress and the degree of tolerance to ozone. Similar photoprotective mechanisms were activated in the two varieties, though to a different extent.	[Pellegrini, Elisa; Campanella, Alessandra; Trivellini, Alice; Gennai, Clizia; Nali, Cristina; Lorenzini, Giacomo] Univ Pisa, Dept Agr Food & Environm, I-56124 Pisa, Italy; [Paolocci, Marco; Muganu, Massimo] Univ Tuscia, Dept Agr Forests Nat & Energy, I-01100 Viterbo, Italy	University of Pisa; Tuscia University	Nali, C (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.	cristina.nali@unipi.it	Trivellini, Alice/M-9709-2015; MUGANU, MASSIMO/AAA-8172-2020	Trivellini, Alice/0000-0001-8001-4098; PELLEGRINI, ELISA/0000-0001-9237-5341				Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Baroni Fornasiero R, 1990, GIORN BOT ITAL, V124, P652; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Beis A, 2012, ENVIRON EXP BOT, V78, P173, DOI 10.1016/j.envexpbot.2011.12.038; Britvec M, 2001, BIOLOGIA, V56, P417; Bussotti F, 2005, TREE PHYSIOL, V25, P211, DOI 10.1093/treephys/25.2.211; Bussotti F, 2008, GLOBAL CHANGE BIOL, V14, P2727, DOI 10.1111/j.1365-2486.2008.01677.x; Bussotti F, 2015, ECOL INDIC, V52, P219, DOI 10.1016/j.ecolind.2014.12.010; Bussotti F, 2015, ENVIRON EXP BOT, V111, P91, DOI 10.1016/j.envexpbot.2014.11.006; Calatayud V, 2007, WATER AIR SOIL POLL, V185, P239, DOI 10.1007/s11270-007-9446-5; Calatayud V, 2011, ECOTOX ENVIRON SAFE, V74, P1131, DOI 10.1016/j.ecoenv.2011.02.023; Calatayud V, 2010, ENVIRON POLLUT, V158, P3580, DOI 10.1016/j.envpol.2010.08.013; Carvalho LC, 2015, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00020; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; Cornelissen JHC, 1996, J ECOL, V84, P573, DOI 10.2307/2261479; Molinari HBC, 2007, PHYSIOL PLANTARUM, V130, P218, DOI 10.1111/j.1399-3054.2007.00909.x; Crous KY, 2006, ENVIRON EXP BOT, V58, P169, DOI 10.1016/j.envexpbot.2005.07.007; Dalmolin AC, 2013, PHOTOSYNTHETICA, V51, P379, DOI 10.1007/s11099-013-0034-1; Dawnay L, 2009, ENVIRON POLLUT, V157, P503, DOI 10.1016/j.envpol.2008.09.003; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Doring AS, 2014, PLANT PHYSIOL BIOCH, V74, P156, DOI 10.1016/j.plaphy.2013.11.006; Dubois JJB, 2007, NEW PHYTOL, V176, P402, DOI 10.1111/j.1469-8137.2007.02182.x; Dumont J, 2014, PLANT CELL ENVIRON, V37, P2064, DOI 10.1111/pce.12293; Flowers MD, 2007, ENVIRON EXP BOT, V61, P190, DOI 10.1016/j.envexpbot.2007.05.009; Gottardini E, 2014, ECOL INDIC, V39, P65, DOI 10.1016/j.ecolind.2013.11.021; Goumenaki E, 2010, ENVIRON EXP BOT, V69, P259, DOI 10.1016/j.envexpbot.2010.04.011; Grantz DA, 2013, J EXP BOT, V64, P1703, DOI 10.1093/jxb/ert032; Gucci R, 1997, TREE PHYSIOL, V17, P13, DOI 10.1093/treephys/17.1.13; Guidi L, 2009, ENVIRON EXP BOT, V66, P117, DOI 10.1016/j.envexpbot.2008.12.005; Hewitt DKL, 2014, ENVIRON POLLUT, V189, P111, DOI 10.1016/j.envpol.2014.02.033; Iqbal N, 2014, ENVIRON EXP BOT, V100, P34, DOI 10.1016/j.envexpbot.2013.12.006; Leitao L, 2008, ECOTOX ENVIRON SAFE, V69, P531, DOI 10.1016/j.ecoenv.2006.10.010; Lichtenthaler HK, 2004, ADV PHOTO RESPIRAT, V19, P713; Ljubesic N, 2006, BIOLOGIA, V61, P85, DOI 10.2478/s11756-006-0012-1; Lorenzini G., 1985, Vignevini, V12, P29; Lorenzini G., 1984, Revista della Ortoflorofrutticoltura Italiana, V68, P81; Lorenzini G, 1999, TREE PHYSIOL, V19, P607; Makela P, 2003, PHYSIOL PLANTARUM, V117, P58, DOI 10.1034/j.1399-3054.2003.1170107.x; Medeghini Bonatti P, 1990, ATTI SOC NATURALISTI, V120, P73; Munne-Bosch S, 2005, NEW PHYTOL, V166, P363, DOI 10.1111/j.1469-8137.2005.01411.x; Nali C, 2004, ATMOS ENVIRON, V38, P2247, DOI 10.1016/j.atmosenv.2003.11.043; Noormets A, 2001, PLANT CELL ENVIRON, V24, P327, DOI 10.1046/j.1365-3040.2001.00678.x; Paolocci M, 2014, VITIS, V53, P155; Pellegrini E, 2015, ENVIRON SCI POLLUT R, V22, P13083, DOI 10.1007/s11356-015-4569-5; Pellegrini E, 2013, PLANT CELL REP, V32, P1965, DOI 10.1007/s00299-013-1508-0; Richards BL, 1958, AGRON J, V50, P559, DOI DOI 10.2134/AGRONJ1958.00021962005000090019X; Rohacek K, 2002, PHOTOSYNTHETICA, V40, P13, DOI 10.1023/A:1020125719386; Salleras JM, 1989, FRUTICULTURA PROFESI, V26, P127; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; SHARKEY TD, 1985, BOT REV, V51, P53, DOI 10.1007/BF02861058; Soja G, 1997, PHYTON-ANN REI BOT A, V37, P265; Soja G, 2004, ATMOS ENVIRON, V38, P2313, DOI 10.1016/j.atmosenv.2003.12.038; Stroch M, 2010, J PLANT PHYSIOL, V167, P597, DOI 10.1016/j.jplph.2009.11.011; Surabhi GK, 2009, ENVIRON EXP BOT, V66, P160, DOI 10.1016/j.envexpbot.2009.02.004; TENHUNEN JD, 1976, OECOLOGIA, V26, P89, DOI 10.1007/BF00582888; Thameur A, 2011, S AFR J BOT, V77, P222, DOI 10.1016/j.sajb.2010.08.004; Trebst A, 2003, Z NATURFORSCH C, V58, P609; Velissariou D., 1996, CRITICAL LEVELS OZON, P343; Vlachokostas C, 2010, ATMOS ENVIRON, V44, P3352, DOI 10.1016/j.atmosenv.2010.06.023; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Wagg S, 2013, ENVIRON POLLUT, V175, P82, DOI 10.1016/j.envpol.2012.11.027; Walker AP, 2014, ECOL EVOL, V4, P3218, DOI 10.1002/ece3.1173; Walters RG, 2005, J EXP BOT, V56, P435, DOI 10.1093/jxb/eri060; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wei C, 2004, ENVIRON POLLUT, V130, P199, DOI 10.1016/j.envpol.2003.12.010; Wei C, 2004, ENVIRON POLLUT, V130, P215, DOI 10.1016/j.envpol.2003.12.009; WEINSTEIN LH, 1984, VITIS, V23, P274	67	19	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135056	10.1371/journal.pone.0135056	http://dx.doi.org/10.1371/journal.pone.0135056			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270333	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800034
J	Rudorf, S; Lipowsky, R				Rudorf, Sophia; Lipowsky, Reinhard			Protein Synthesis in E. coli: Dependence of Codon-Specific Elongation on tRNA Concentration and Codon Usage	PLOS ONE			English	Article							AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI; TRANSLATION INITIATION; SINGLE RIBOSOMES; DYNAMICS; MECHANISM; SPEED; SITE; OPTIMIZATION; DISTRIBUTIONS	To synthesize a protein, a ribosome moves along a messenger RNA (mRNA), reads it codon by codon, and takes up the corresponding ternary complexes which consist of aminoacylated transfer RNAs (aa-tRNAs), elongation factor Tu (EF-Tu), and GTP. During this process of translation elongation, the ribosome proceeds with a codon-specific rate. Here, we present a general theoretical framework to calculate codon-specific elongation rates and error frequencies based on tRNA concentrations and codon usages. Our theory takes three important aspects of in-vivo translation elongation into account. First, non-cognate, near-cognate and cognate ternary complexes compete for the binding sites on the ribosomes. Second, the corresponding binding rates are determined by the concentrations of free ternary complexes, which must be distinguished from the total tRNA concentrations as measured in vivo. Third, for each tRNA species, the difference between total tRNA and ternary complex concentration depends on the codon usages of the corresponding cognate and near-cognate codons. Furthermore, we apply our theory to two alternative pathways for tRNA release from the ribosomal E site and show how the mechanism of tRNA release influences the concentrations of free ternary complexes and thus the codon-specific elongation rates. Using a recently introduced method to determine kinetic rates of in-vivo translation from in-vitro data, we compute elongation rates for all codons in Escherichia coli. We show that for some tRNA species only a few tRNA molecules are part of ternary complexes and, thus, available for the translating ribosomes. In addition, we find that codon-specific elongation rates strongly depend on the overall codon usage in the cell, which could be altered experimentally by overexpression of individual genes.	[Rudorf, Sophia; Lipowsky, Reinhard] Max Planck Inst Colloids & Interfaces, Theory & Biosyst, Potsdam, Germany	Max Planck Society	Rudorf, S (corresponding author), Max Planck Inst Colloids & Interfaces, Theory & Biosyst, Potsdam, Germany.	Sophia.Rudorf@mpikg.mpg.de; Reinhard.Lipowsky@mpikg.mpg.de		Lipowsky, Reinhard/0000-0001-8417-8567; Rudorf, Sophia/0000-0001-7653-3733	German Science Foundation (Deutsche Forschungsgemeinschaft) via Research Unit FOR [1805]	German Science Foundation (Deutsche Forschungsgemeinschaft) via Research Unit FOR(German Research Foundation (DFG))	This work was funded by the German Science Foundation (Deutsche Forschungsgemeinschaft) via Research Unit FOR 1805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILGIN N, 1988, FEBS LETT, V233, P95, DOI 10.1016/0014-5793(88)81362-0; Brackley CA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002203; Bremer H, 1996, ESCHERICHIA COLI SAL, V1, P1553; Charneski CA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001508; Chen CL, 2013, NAT STRUCT MOL BIOL, V20, P582, DOI 10.1038/nsmb.2544; Chen CL, 2011, P NATL ACAD SCI USA, V108, P16980, DOI 10.1073/pnas.1106999108; Chen J, 2013, NAT STRUCT MOL BIOL, V20, P718, DOI 10.1038/nsmb.2567; Chu D, 2014, BIOSYSTEMS, V119, P1, DOI 10.1016/j.biosystems.2014.02.005; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Fluitt A, 2007, COMPUT BIOL CHEM, V31, P335, DOI 10.1016/j.compbiolchem.2007.07.003; Garai A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011908; Gromadski KB, 2006, MOL CELL, V21, P369, DOI 10.1016/j.molcel.2005.12.018; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; HILL TL, 1988, P NATL ACAD SCI USA, V85, P2879, DOI 10.1073/pnas.85.9.2879; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Johansson M, 2008, MOL CELL, V30, P589, DOI 10.1016/j.molcel.2008.04.010; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Liang ST, 2000, J BACTERIOL, V182, P3037, DOI 10.1128/JB.182.11.3037-3044.2000; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Mitarai N, 2008, J MOL BIOL, V382, P236, DOI 10.1016/j.jmb.2008.06.068; Mittelstaet J, 2013, J AM CHEM SOC, V135, P17031, DOI 10.1021/ja407511q; NEIDHARDT FC, 1977, J BACTERIOL, V129, P378, DOI 10.1128/JB.129.1.378-387.1977; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Petry S, 2008, CURR OPIN STRUC BIOL, V18, P70, DOI 10.1016/j.sbi.2007.11.005; Potapov I, 2012, J THEOR BIOL, V315, P17, DOI 10.1016/j.jtbi.2012.08.029; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; Rodnina MV, 1996, J BIOL CHEM, V271, P646, DOI 10.1074/jbc.271.2.646; Rudorf S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003909; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Semenkov YP, 1996, P NATL ACAD SCI USA, V93, P12183, DOI 10.1073/pnas.93.22.12183; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Spencer PS, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201204006; Tarrant D, 2014, CELL MOL LIFE SCI, V71, P4195, DOI 10.1007/s00018-014-1684-2; TAYLOR H., 1998, INTRO STOCHASTIC MOD; Tomsic J, 2000, EMBO J, V19, P2127, DOI 10.1093/emboj/19.9.2127; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Wilson DN, 2006, CELL MOL LIFE SCI, V63, P2725, DOI 10.1007/s00018-006-6125-4; Wohlgemuth I, 2011, PHILOS T R SOC B, V366, P2979, DOI 10.1098/rstb.2011.0138; Wohlgemuth I, 2010, EMBO J, V29, P3701, DOI 10.1038/emboj.2010.229; Zhang G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks196; Zhang G, 2010, NUCLEIC ACIDS RES, V38, P4778, DOI 10.1093/nar/gkq196; Zhang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005036; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8; Zouridis H, 2008, BIOPHYS J, V95, P1018, DOI 10.1529/biophysj.107.126128; Zouridis H, 2007, BIOPHYS J, V92, P717, DOI 10.1529/biophysj.106.087825	58	27	30	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134994	10.1371/journal.pone.0134994	http://dx.doi.org/10.1371/journal.pone.0134994			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270805	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800029
J	Song, Y; Ma, YN; Song, YS; Fei, X				Song, Yan; Ma, YaNan; Song, YongSheng; Fei, Xiang			Evaluating the Learning Curve for Percutaneous Nephrolithotomy under Total Ultrasound Guidance	PLOS ONE			English	Article							COMPLICATIONS; MANAGEMENT; OUTCOMES; SOCIETY; ACCESS	Objectives To investigate the learning curve of percutaneous nephrolithotomy under total ultrasound guidance. Methods One hundred and twenty consecutive PCNL operations under total ultrasound guidance performed by a novice surgeon in a tertiary referral center were studied. Operations were analyzed in cohorts of 15 to determine when a plateau was reached for the variables such as operation duration, ultrasound screening time, tract dilation time, stone-free rate and complication rate. Comparison was made with the results of a surgeon who had performed more than 1000 PCNLs. Fluoroscopy was not used at all during procedure. Results The mean operation time dropped from 82.5 min for the first 15 patients to a mean of 64.7 min for cases 46 through 60(P = 0.047). The ultrasound screening time was a peak of 6.4 min in the first 15 cases, whereas it dropped to a mean of 3.9 min for cases 46 through 60 (P = 0.01). The tract dilation time dropped from 4.9 min for the first 15 patients to a mean of 3.8 min for cases 46 through 60(P = 0.036). The senior surgeon had a mean operating time, screening time and tract dilation time equivalent to those of the novice surgeon after 60 cases. There was no significant difference in stone free rate and complication rate. Conclusions The competence of ultrasound guided PCNL is reached after 60 cases with good stone free rate and without major complications.	[Song, Yan; Song, YongSheng; Fei, Xiang] China Med Univ, Sheng Jing Hosp, Div Urol, Shenyang, Liaoning Provin, Peoples R China; [Ma, YaNan] China Med Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University	Fei, X (corresponding author), China Med Univ, Sheng Jing Hosp, Div Urol, Shenyang, Liaoning Provin, Peoples R China.	Fei_xiang918@163.com						Allen D, 2005, J ENDOUROL, V19, P279, DOI 10.1089/end.2005.19.279; de la Rosette J, 2011, J ENDOUROL, V25, P11, DOI 10.1089/end.2010.0424; El-Feel A, 2003, EUR UROL, V43, P622, DOI 10.1016/S0302-2838(03)00148-9; Hellawell GO, 2005, J UROLOGY, V174, P948, DOI 10.1097/01.ju.0000170232.58930.8f; Hosseini MM, 2009, J ENDOUROL, V23, P603, DOI 10.1089/end.2007.0213; Kauer PC, 2005, EUR UROL, V48, P182, DOI 10.1016/j.eururo.2005.01.002; Michel MS, 2007, EUR UROL, V51, P899, DOI 10.1016/j.eururo.2006.10.020; Mottrie A, 2010, EUR UROL, V58, P127, DOI 10.1016/j.eururo.2010.03.045; Osman M, 2005, BJU INT, V96, P875, DOI 10.1111/j.1464-410X.2005.05749.x; Rizvi SAH, 2002, BJU INT, V89, P62, DOI 10.1046/j.1465-5101.2001.134.x; Schilling D, 2011, WORLD J UROL, V29, P749, DOI 10.1007/s00345-010-0553-3; Song Y, 2013, BJU INT, V112, P965, DOI 10.1111/bju.12248; Tanriverdi O, 2007, EUR UROL, V52, P206, DOI 10.1016/j.eururo.2007.01.001; Tefekli A, 2008, EUR UROL, V53, P184, DOI 10.1016/j.eururo.2007.06.049; Tzeng BC, 2011, UROLOGY, V78, P535, DOI 10.1016/j.urology.2010.12.037; Watterson JD, 2006, J UROLOGY, V176, P142, DOI 10.1016/S0022-5347(06)00489-7; Ziaee SAM, 2010, UROL J, V7, P226	17	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0132986	10.1371/journal.pone.0132986	http://dx.doi.org/10.1371/journal.pone.0132986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271037	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800005
J	Takeuchi, Y; Morise, J; Morita, I; Takematsu, H; Oka, S				Takeuchi, Yusuke; Morise, Jyoji; Morita, Ippei; Takematsu, Hiromu; Oka, Shogo			Role of Site-Specific N-Glycans Expressed on GluA2 in the Regulation of Cell Surface Expression of AMPA-Type Glutamate Receptors	PLOS ONE			English	Article							KILLER-1 HNK-1 CARBOHYDRATE; FUNCTIONAL EXPRESSION; ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; EPITOPE HNK-1; BIOSYNTHESIS; SUBUNIT; TRAFFICKING; CADHERIN; COMPLEX	The AMPA-type glutamate receptor (AMPAR), which is a tetrameric complex composed of four subunits (GluA1-4) with several combinations, mediates the majority of rapid excitatory synaptic transmissions in the nervous system. Cell surface expression levels of AMPAR modulate synaptic plasticity, which is considered one of the molecular bases for learning and memory formation. To date, a unique trisaccharide (HSO3-3GlcA beta 1-3Gal beta 1-4GlcNAc), human natural killer-1 (HNK-1) carbohydrate, was found expressed specifically on N-linked glycans of GluA2 and regulated the cell surface expression of AMPAR and the spine maturation process. However, evidence that the HNK-1 epitope on N-glycans of GluA2 directly affects these phenomena is lacking. Moreover, it is thought that other N-glycans on GluA2 also have potential roles in the regulation of AMPAR functions. In the present study, using a series of mutants lacking potential N-glycosylation sites (N256, N370, N406, and N413) within GluA2, we demonstrated that the mutant lacking the N-glycan at N370 strongly suppressed the intracellular trafficking of GluA2 from the endoplasmic reticulum (ER) in HEK293 cells. Cell surface expression of GluA1, which is a major subunit of AMPAR in neurons, was also suppressed by co-expression of the GluA2 N370S mutant. The N370S mutant and wild-type GluA2 were co-immunoprecipitated with GluA1, suggesting that N370S was properly associated with GluA1. Moreover, we found that N413 was the main potential site of the HNK-1 epitope that promoted the interaction of GluA2 with N-cadherin, resulting in enhanced cell surface expression of GluA2. The HNK-1 epitope on N-glycan at the N413 of GluA2 was also involved in the cell surface expression of GluA1. Thus, our data suggested that site-specific N-glycans on GluA2 regulate the intracellular trafficking and cell surface expression of AMPAR.	[Takeuchi, Yusuke; Morise, Jyoji; Takematsu, Hiromu; Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Human Hlth Sci, Kyoto, Japan; [Morita, Ippei] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto, Japan	Kyoto University; Kyoto University	Oka, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Biol Chem, Human Hlth Sci, Kyoto, Japan.	shogo@hs.med.kyoto-u.ac.jp		Takematsu, Hiromu/0000-0003-1689-9500	MEXT of Japan [23110006]; Japan Society for the Promotion of Science [26291021, 24590078]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 23110006 to S.O.) from MEXT of Japan and Grants-in-Aid for Scientific Research (B) (No. 26291021 to S. O.) and Scientific Research (C) (No. 24590078 to H. T.) from the Japan Society for the Promotion of Science.	Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kizuka Y, 2012, CELL MOL LIFE SCI, V69, P4135, DOI 10.1007/s00018-012-1036-z; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kouno T, 2011, J BIOL CHEM, V286, P31337, DOI 10.1074/jbc.M111.233353; Lu W, 2014, J BIOL CHEM, V289, P19218, DOI 10.1074/jbc.M113.511246; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Morise J, 2014, GLYCOBIOLOGY, V24, P314, DOI 10.1093/glycob/cwt116; Morita I, 2009, NEUROSCIENCE, V164, P1685, DOI 10.1016/j.neuroscience.2009.09.065; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Pasternack A, 2003, J NEUROCHEM, V84, P1184, DOI 10.1046/j.1471-4159.2003.01611.x; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Uemura K, 2006, NEUROSCI LETT, V402, P278, DOI 10.1016/j.neulet.2006.04.018; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200	22	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135644	10.1371/journal.pone.0135644	http://dx.doi.org/10.1371/journal.pone.0135644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271046	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800095
J	Bastos, LOD; Guerreiro, MM; Lees, AJ; Warner, TT; Silveira-Moriyama, L				Donnabella Bastos, Lais Orrico; Guerreiro, Marilisa Mantovani; Lees, Andrew John; Warner, Thomas T.; Silveira-Moriyama, Laura			Effects of Age and Cognition on a Cross-Cultural Paediatric Adaptation of the Sniffin' Sticks Identification Test	PLOS ONE			English	Article							OLFACTORY FUNCTION; ODOR DISCRIMINATION; PARKINSONS-DISEASE; MAGNITUDE TEST; CHILDREN; PERFORMANCE; BRAZIL; DYSFUNCTION; POPULATION; THRESHOLDS	Objectives To study the effects of age and cognition on the performance of children aged 3 to 18 years on a culturally adapted version of the 16 item smell identification test from Sniffin' Sticks (SS16). Methods A series of pilots were conducted on 29 children aged 3 to 18 years old and 23 adults to produce an adapted version of the SS16 suitable for Brazilian children (SS16-Child). A final version was applied to 51 children alongside a picture identification test (PIT-SS16-Child) to access cognitive abilities involved in the smell identification task. In addition 20 adults performed the same tasks as a comparison group. Results The final adapted SS16-Child was applied to 51 children with a mean age of 9.9 years (range 3-18 years, SD=4.25 years), of which 68.3% were girls. There was an independent effect of age (p<0.05) and PIT-SS16-Child (p<0.001) on the performance on the SS16-Child, and older children reached the ceiling for scoring in the cognitive and olfactory test. Pre-school children had difficulties identifying items of the test. Discussion/Conclusions A cross-culturally adapted version of the SS16 can be used to test olfaction in children but interpretation of the results must take age and cognitive abilities into consideration.	[Donnabella Bastos, Lais Orrico; Silveira-Moriyama, Laura] Univ Estadual Campinas, Dept Neurol, HC FCM, Complex Motor Disorders Serv, Sao Paulo, Brazil; [Donnabella Bastos, Lais Orrico; Silveira-Moriyama, Laura] Univ Estadual Campinas, Phys & Occupat Therapy Dept, HC FCM, Sao Paulo, Brazil; [Donnabella Bastos, Lais Orrico; Guerreiro, Marilisa Mantovani; Silveira-Moriyama, Laura] Univ Estadual Campinas, Dept Neurol, HC FCM, Sao Paulo, Brazil; [Lees, Andrew John; Warner, Thomas T.; Silveira-Moriyama, Laura] UCL Inst Neurol, Reta Lila Weston Inst Neurol Studies, London, England; [Silveira-Moriyama, Laura] Univ Nove Julho, Uninove, Dept Med, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; University of London; University College London; Universidade Nove de Julho	Silveira-Moriyama, L (corresponding author), Univ Estadual Campinas, Dept Neurol, HC FCM, Sao Paulo, Brazil.	laurasilveira@gmail.com	Moriyama, Laura Silveira/G-4592-2014; Warner, Thomas T/A-1454-2013; Lees, Andrew J/A-6605-2009	Moriyama, Laura Silveira/0000-0003-2184-626X; Warner, Thomas T/0000-0001-6195-6995; Lees, Andrew J/0000-0002-2476-4385	CAPES (Coordination of Improvement of Higher Education Personnel); PSP Association; Weston Trust - The Reta Lila Howard Foundation; NHS Innovations; Brain Research Trust; CHDI; Reta Lila Howard Foundation; FAPESP; FAEPEX-UNICAMP; Parkinson's UK; CNPq-CAPES; Genus; Ipsen; Abbott	CAPES (Coordination of Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PSP Association; Weston Trust - The Reta Lila Howard Foundation; NHS Innovations; Brain Research Trust; CHDI; Reta Lila Howard Foundation; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAEPEX-UNICAMP; Parkinson's UK(Parkinson's UK); CNPq-CAPES(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Genus; Ipsen(Ipsen); Abbott(Abbott Laboratories)	Lais O. D. Bastos declares financial disclosure of CAPES (Coordination of Improvement of Higher Education Personnel) as Master's scholarship. Andrew J. Lees is employed at UCL/UCLH. He has received grants from PSP Association, Weston Trust - The Reta Lila Howard Foundation. He declares advisory boards to Novartis, Teva, Meda, Boehringer Ingelheim, GSK, Ipsen, Lundbeck, Allergan, Orion, BIAL, Noscira, Roche and consultancies to Genus. Thomas Warner is employed at UCL/UCLH and declares grants from NHS Innovations, Brain Research Trust, CHDI. Laura Silveira-Moriyama declares employment from Universidade Nove de Julho (Uninove) and from UCL Institute of Neurology. She has received grants from The Reta Lila Howard Foundation, FAPESP, FAEPEX-UNICAMP, Parkinson's UK and CNPq-CAPES, and travel grants from Genus, Ipsen and Abbott.	Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Cameron EL, 2013, INT J PEDIATR OTORHI, V77, P346, DOI 10.1016/j.ijporl.2012.11.022; Dalton P, 2013, NEUROLOGY, V80, pS32, DOI 10.1212/WNL.0b013e3182872eb4; Dalton P, 2011, LARYNGOSCOPE, V121, P1843, DOI 10.1002/lary.21928; Dalton P, 2009, ANN NY ACAD SCI, V1170, P537, DOI 10.1111/j.1749-6632.2009.03919.x; Daniel-Kagbare TE, 2014, DICT EC COMMERCE; Doty RL, 2007, PARKINSONISM RELAT D, V13, pS225, DOI 10.1016/S1353-8020(08)70006-3; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Doty RL, 1995, SMELL IDENTIFICATION, VThird; Doty RL, 2014, FRONT PSYCHOL, V5, P20, DOI [DOI 10.3389/FPSYG.2014.00020, DOI 10.3389/fpsyg.2014.00020]; Dudova I, 2011, EUR CHILD ADOLES PSY, V20, P333, DOI 10.1007/s00787-011-0177-1; Dulay MF, 2008, J CLIN EXP NEUROPSYC, V30, P327, DOI 10.1080/13803390701415892; Dzaman K, 2013, INT J PEDIATR OTORHI, V77, P418, DOI 10.1016/j.ijporl.2012.12.001; Fornazieri MA, 2013, THESIS U SAO PAULO; Fornazieri MA, 2013, CLINICS, V68, P65, DOI 10.6061/clinics/2013(01)OA10; Frank RA, 2004, PHYSIOL BEHAV, V81, P475, DOI 10.1016/j.physbeh.2004.02.020; Frank RA, 2003, PHYSIOL BEHAV, V78, P195, DOI 10.1016/S0031-9384(02)00965-4; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2007, BEHAV BRAIN RES, V180, P133, DOI 10.1016/j.bbr.2007.02.040; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Laing DG, 2008, OTOLARYNG HEAD NECK, V139, P74, DOI 10.1016/j.otohns.2006.11.058; Lotsch J, 2008, CHEM SENSES, V33, P17, DOI 10.1093/chemse/bjm058; Maloney WF, 2004, LAW EMPLOYMENT LESSO, P109; Maria Larsson, 2009, [心理学报, Acta Psychologica Sinica], V41, P1049; Monnery-Patris S, 2009, Dev Psychobiol, V51, P268, DOI 10.1002/dev.20363; RICHMAN RA, 1995, J PEDIATR-US, V127, P421, DOI 10.1016/S0022-3476(95)70074-9; RICHMAN RA, 1992, J PEDIATR-US, V121, P908, DOI 10.1016/S0022-3476(05)80337-3; Schriever VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101086; Silveira-Moriyama L, 2010, ARQ NEURO-PSIQUIAT, V68, P700, DOI 10.1590/S0004-282X2010000500005; Silveira-Moriyama L, 2008, MOVEMENT DISORD, V23, P2328, DOI 10.1002/mds.22241; Sorokowska A, 2014, EUR ARCH OT IN PRESS; Stevenson RJ, 2007, DEV PSYCHOL, V43, P253, DOI 10.1037/0012-1649.43.1.253; VOLLMECKE TA, 1985, CHEM SENSES, V10, P413	38	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0131641	10.1371/journal.pone.0131641	http://dx.doi.org/10.1371/journal.pone.0131641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267145	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492300003
J	Skurdal, MJ; Bjornerud, A; van Osch, MJP; Nordhoy, W; Lagopoulos, J; Groote, IR				Skurdal, Mikjel Johannes; Bjornerud, Atle; van Osch, Matthias J. P.; Nordhoy, Wibeke; Lagopoulos, Jim; Groote, Inge Rasmus			Voxel-Wise Perfusion Assessment in Cerebral White Matter with PCASL at 3T; Is It Possible and How Long Does It Take?	PLOS ONE			English	Article							BLOOD-FLOW; ARTERIAL; INVERSION; ACCURATE; MRI	Purpose To establish whether reliable voxel-wise assessment of perfusion in cerebral white matter (WM) is possible using arterial spin labeling (ASL) at 3T in a cohort of healthy subjects. Materials and Methods Pseudo-continuous ASL (PCASL) with background suppression (BS) optimized for WM measurements was performed at 3T in eight healthy male volunteers aged 25-41. Four different labeling schemes were evaluated by varying the labeling duration (LD) and postlabeling delay (PLD). Eight slices with voxel dimension 3.75x3.75x5 mm(3) were acquired from the anterosuperior aspect of the brain, and 400 image/control pairs were collected for each run. Rigid head immobilization was applied using individually fitted thermoplastic masks. For each voxel in the resulting ASL time series, the time needed to reach a 95% significance level for the ASL signal to be higher than zero (paired t-test), was estimated. Results The four protocols detected between 88% and 95% (after Bonferroni correction: 75% and 88%) of WM voxels at 95% significance level. In the most efficient sequence, 80% was reached after 5 min and 95% after 53 min (after Bonferroni correction 40% and 88% respectively). For all protocols, the fraction of significant WM voxels increased in an asymptotic fashion with increasing scan time. A small subgroup of voxels was shown to not benefit at all from prolonged measurement. Conclusion Acquisition of a significant ASL signal from a majority of WM voxels is possible within clinically acceptable scan times, whereas full coverage needs prohibitively long scan times, as a result of the asymptotic trajectory.	[Skurdal, Mikjel Johannes] Univ Oslo, Akershus Univ Hosp, Fac Div, Dept Neurol, Lorenskog, Norway; [Bjornerud, Atle; Nordhoy, Wibeke; Groote, Inge Rasmus] Oslo Univ Hosp, Rikshosp, Intervent Ctr, Oslo, Norway; [Bjornerud, Atle] Univ Oslo, Dept Phys, Oslo, Norway; [van Osch, Matthias J. P.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [van Osch, Matthias J. P.] CJ Gorter Ctr High Field MRI, Leiden, Netherlands; [Lagopoulos, Jim] Sydney Med Sch, Brain & Mind Res Inst, Sydney, NSW, Australia; [Groote, Inge Rasmus] Univ Oslo, Dept Psychol, Inst Social Sci, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Sydney; University of Oslo	Groote, IR (corresponding author), Oslo Univ Hosp, Rikshosp, Intervent Ctr, Oslo, Norway.	i.r.groote@gmail.com	Van Osch, Matthias/AAV-3876-2021	Van Osch, Matthias/0000-0001-7034-8959				Bjornerud A, 2010, J CEREBR BLOOD F MET, V30, P1066, DOI 10.1038/jcbfm.2010.4; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; De Keyser J, 2008, J CEREBR BLOOD F MET, V28, P1645, DOI 10.1038/jcbfm.2008.72; DETRE JA, 1994, NMR BIOMED, V7, P75, DOI 10.1002/nbm.1940070112; Detre JA, 2012, J MAGN RESON IMAGING, V35, P1026, DOI 10.1002/jmri.23581; DIXON WT, 1991, MAGN RESON MED, V18, P257, DOI 10.1002/mrm.1910180202; Gardener AG, 2015, MAGN RESON MED, V73, P2243, DOI 10.1002/mrm.25333; Ghariq E, 2012, MAGN RESON MATER PHY, V25, P83, DOI 10.1007/s10334-011-0297-0; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Law I, 2000, J CEREBR BLOOD F MET, V20, P1252, DOI 10.1097/00004647-200008000-00010; Macovski A, 1996, MAGNET RESON MED, V36, P494, DOI 10.1002/mrm.1910360327; Michaelis L, 2013, FEBS LETT, V587, P2712, DOI 10.1016/j.febslet.2013.07.015; Momjian S, 2004, BRAIN, V127, P965, DOI 10.1093/brain/awh131; Mutsaerts HJMM, 2014, NEUROIMAGE-CLIN, V4, P139, DOI 10.1016/j.nicl.2013.11.003; Petersen ET, 2006, BRIT J RADIOL, V79, P688, DOI 10.1259/bjr/67705974; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Pinkham A, 2011, PSYCHIAT RES-NEUROIM, V194, P64, DOI 10.1016/j.pscychresns.2011.06.013; Pohmann R, 2010, MAGN RESON MED, V64, P1109, DOI 10.1002/mrm.22476; van Gelderen P, 2008, MAGN RESON MED, V59, P788, DOI 10.1002/mrm.21515; van Osch MJP, 2009, MAGN RESON MED, V62, P165, DOI 10.1002/mrm.22002; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Wu WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082679	24	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135596	10.1371/journal.pone.0135596	http://dx.doi.org/10.1371/journal.pone.0135596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267661	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492300139
J	Tran, KD; Vieira, DP; Sanchez, MA; Valli, J; Gluenz, E; Landfear, SM				Tran, Khoa D.; Vieira, Danielle P.; Sanchez, Marco A.; Valli, Jessica; Gluenz, Eva; Landfear, Scott M.			Kharon1 Null Mutants of Leishmania mexicana Are Avirulent in Mice and Exhibit a Cytokinesis Defect within Macrophages	PLOS ONE			English	Article							GLUCOSE-TRANSPORTER; CELL-CYCLE; FLAGELLAR; GENERATION; VIABILITY; PROTEINS; SEQUENCE; EVENTS; CILIA; BLOOD	In a variety of eukaryotes, flagella play important roles both in motility and as sensory organelles that monitor the extracellular environment. In the parasitic protozoan Leishmania mexicana, one glucose transporter isoform, LmxGT1, is targeted selectively to the flagellar membrane where it appears to play a role in glucose sensing. Trafficking of LmxGT1 to the flagellar membrane is dependent upon interaction with the KHARON1 protein that is located at the base of the flagellar axoneme. Remarkably, while Delta kharon1 null mutants are viable as insect stage promastigotes, they are unable to survive as amastigotes inside host macrophages. Although Delta kharon1 promastigotes enter macrophages and transform into amastigotes, these intracellular parasites are unable to execute cytokinesis and form multinucleate cells before dying. Notably, extracellular axenic amastigotes of Delta kharon1 mutants replicate and divide normally, indicating a defect in the mutants that is only exhibited in the intra-macrophage environment. Although the flagella of Delta kharon1 amastigotes adhere to the phagolysomal membrane of host macrophages, the morphology of the mutant flagella is often distorted. Additionally, these null mutants are completely avirulent following injection into BALB/c mice, underscoring the critical role of the KHARON1 protein for viability of intracellular amastigotes and disease in the animal model of leishmaniasis.	[Tran, Khoa D.; Vieira, Danielle P.; Sanchez, Marco A.; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Valli, Jessica; Gluenz, Eva] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Oregon Health & Science University; University of Oxford	Landfear, SM (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	landfear@ohsu.edu		Gluenz, Eva/0000-0003-4346-8896; Valli, Jessica/0000-0003-4346-0317	Oregon Health & Science University; American Heart Association [11POST7440105]; Conselho Macional de Senenvolvimento Cientifico e Techologico-Brasil; Medical Research Foundation Studentship; SIr William Dunn School of Pathology Studentship; Royal Society University Research Fellowship; Royal Society [RG130155]; National Institutes of Health [AI114822, 1F32AI096854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI114822, F32AI096854] Funding Source: NIH RePORTER; Medical Research Council [1374928] Funding Source: researchfish	Oregon Health & Science University; American Heart Association(American Heart Association); Conselho Macional de Senenvolvimento Cientifico e Techologico-Brasil; Medical Research Foundation Studentship; SIr William Dunn School of Pathology Studentship; Royal Society University Research Fellowship(Royal Society of London); Royal Society(Royal Society of London); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by Oregon Health & Science University, University Professorship-SML; American Heart Association, 11POST7440105-KDT National Institutes of Health, 1F32AI096854-KDT; Conselho Macional de Senenvolvimento Cientifico e Techologico-Brasil-DPV; Medical Research Foundation Studentship-JV; SIr William Dunn School of Pathology Studentship-JV; Royal Society University Research Fellowship-EG; Royal Society, RG130155-EG; Grant AI114822 to Scott M. Landfear (SML) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambit A, 2011, EUKARYOT CELL, V10, P1429, DOI 10.1128/EC.05118-11; Andre J, 2014, J BIOL CHEM, V289, P464, DOI 10.1074/jbc.M113.509521; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bloodgood RA, 2010, J CELL SCI, V123, P505, DOI 10.1242/jcs.066308; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; Chavan HD, 2007, EXP PARASITOL, V116, P320, DOI 10.1016/j.exppara.2007.01.016; Coura JR, 2015, MEM I OSWALDO CRUZ, V110, P277, DOI 10.1590/0074-0276140362; Figarella K, 2007, MOL MICROBIOL, V65, P1006, DOI 10.1111/j.1365-2958.2007.05845.x; Flannery AR, 2011, J BIOL CHEM, V286, P23266, DOI 10.1074/jbc.M111.229674; Gluenz E, 2010, FASEB J, V24, P3117, DOI 10.1096/fj.09-151381; Gluenz E, 2010, CURR OPIN MICROBIOL, V13, P473, DOI 10.1016/j.mib.2010.05.008; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Gull K, 2003, CURR OPIN MICROBIOL, V6, P365, DOI 10.1016/S1369-5274(03)00092-4; Heras SR, 2006, CELL MOL LIFE SCI, V63, P1449, DOI 10.1007/s00018-006-6038-2; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Kar S, 2000, J BIOL CHEM, V275, P37789, DOI 10.1074/jbc.M002149200; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Melby PC, 2001, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1902S28; Mittra B, 2013, J EXP MED, V210, P401, DOI 10.1084/jem.20121368; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Podinovskaia M, 2015, FUTURE MICROBIOL, V10, P111, DOI 10.2217/fmb.14.103; Price HP, 2013, MOL MICROBIOL, V90, P597, DOI 10.1111/mmi.12383; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rochette A, 2009, MOL BIOCHEM PARASIT, V165, P32, DOI 10.1016/j.molbiopara.2008.12.012; Rodriguez-Contreras D, 2015, FASEB J, V29, P11, DOI 10.1096/fj.14-251991; Spath GF, 2003, P NATL ACAD SCI USA, V100, P9536, DOI 10.1073/pnas.1530604100; Stephan A, 2007, TRAFFIC, V8, P1323, DOI 10.1111/j.1600-0854.2007.00611.x; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Tran KD, 2013, J BIOL CHEM, V288, P22721, DOI 10.1074/jbc.M113.483461; Tran KD, 2012, J CELL SCI, V125, P3293, DOI 10.1242/jcs.103028; Wheeler RJ, 2011, MOL MICROBIOL, V79, P647, DOI 10.1111/j.1365-2958.2010.07479.x; WHO, NEGLECTED TROPICAL D	34	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134432	10.1371/journal.pone.0134432	http://dx.doi.org/10.1371/journal.pone.0134432			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266938	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300046
J	van der Berg, JP; Madoori, PK; Komarudin, AG; Thunnissen, AM; Driessen, AJM				van der Berg, Jan Pieter; Madoori, Pramod Kumar; Komarudin, Amalina Ghaisani; Thunnissen, Andy-Mark; Driessen, Arnold J. M.			Binding of the Lactococcal Drug Dependent Transcriptional Regulator LmrR to Its Ligands and Responsive Promoter Regions	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; TRANSPORTER; GENE; REPRESSOR; EXPRESSION; CLONING	The heterodimeric ABC transporter LmrCD from Lactococcus lactis is able to extrude several different toxic compounds from the cell, fulfilling a role in the intrinsic and induced drug resistance. The expression of the lmrCD genes is regulated by the multi-drug binding repressor LmrR, which also binds to its own promoter to autoregulate its own expression. Previously, we reported the crystal structure of LmrR in the presence and absence of the drugs Hoechst 33342 and daunomycin. Analysis of the mechanism how drugs control the repressor activity of LmrR is impeded by the fact that these drugs also bind to DNA. Here we identified, using X-ray crystallography and fluorescence, that riboflavin binds into the drug binding cavity of LmrR, adopting a similar binding mode as Hoechst 33342 and daunomycin. Microscale thermophoresis was employed to quantify the binding affinity of LmrR to its responsive promoter regions and to evaluate the cognate site of LmrR in the lmrCD promoter region. Riboflavin reduces the binding affinity of LmrR for the promoter regions. Our results support a model wherein drug binding to LmrR relieves the LmrR dependent repression of the lmrCD genes.	[van der Berg, Jan Pieter; Komarudin, Amalina Ghaisani; Driessen, Arnold J. M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Microbiol, Groningen, Netherlands; [Madoori, Pramod Kumar; Thunnissen, Andy-Mark] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biophys Chem, Groningen, Netherlands	University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Microbiol, Groningen, Netherlands.	a.j.m.driessen@rug.nl	Driessen, Arnold J.M./D-1876-2012; Thunnissen, Andy-Mark/A-1777-2010	Thunnissen, Andy-Mark/0000-0002-1915-9850; Driessen, Arnold J.M./0000-0001-9258-9104; van der Berg, Jan Pieter/0000-0003-0089-2240	Ubbo Emmius Bursary of the University of Groningen	Ubbo Emmius Bursary of the University of Groningen	Support was provided by Ubbo Emmius Bursary of the University of Groningen to JB and PM.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agustiandari H, 2008, J BACTERIOL, V190, P759, DOI 10.1128/JB.01151-07; Agustiandari H, 2011, MICROBIOL-SGM, V157, P1519, DOI 10.1099/mic.0.048025-0; BOLHUIS H, 1995, J BIOL CHEM, V270, P26092, DOI 10.1074/jbc.270.44.26092; Bos J, 2012, ANGEW CHEM INT EDIT, V51, P7472, DOI 10.1002/anie.201202070; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gury J, 2004, APPL ENVIRON MICROB, V70, P2146, DOI 10.1128/AEM.70.4.2146-2153.2004; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Lubelski J, 2004, J BIOL CHEM, V279, P34449, DOI 10.1074/jbc.M404072200; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Lubelski J, 2006, MOL MICROBIOL, V61, P771, DOI 10.1111/j.1365-2958.2006.05267.x; Madoori PK, 2009, EMBO J, V28, P156, DOI 10.1038/emboj.2008.263; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Takeuchi K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06922; UBUKATA K, 1989, ANTIMICROB AGENTS CH, V33, P1535, DOI 10.1128/AAC.33.9.1535; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219	22	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135467	10.1371/journal.pone.0135467	http://dx.doi.org/10.1371/journal.pone.0135467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267906	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300120
J	Yoon, YB; Yun, JY; Jung, WH; Cho, KIK; Kim, SN; Lee, TY; Park, HY; Kwon, JS				Yoon, Youngwoo Bryan; Yun, Je-Yeon; Jung, Wi Hoon; Cho, Kang Ik K.; Kim, Sung Nyun; Lee, Tae Young; Park, Hye Yoon; Kwon, Jun Soo			Altered Fronto-Temporal Functional Connectivity in Individuals at Ultra-High-Risk of Developing Psychosis	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; AUDITORY VERBAL HALLUCINATIONS; RESTING-STATE FMRI; SPONTANEOUS FLUCTUATIONS; SCHIZOPHRENIA-PATIENTS; STRUCTURED INTERVIEW; MISMATCH NEGATIVITY; SYNAPTIC PLASTICITY; MENTAL STATE; CORTEX	Background The superior temporal gyrus (STG) is one of the key regions implicated in psychosis, given that abnormalities in this region are associated with an increased risk of conversion from an at-risk mental state to psychosis. However, inconsistent results regarding the functional connectivity strength of the STG have been reported, and the regional heterogeneous characteristics of the STG should be considered. Methods To investigate the distinctive functional connection of each subregion in the STG, we parcellated the STG of each hemisphere into three regions: the planum temporale, Heschl's gyrus, and planum polare. Resting-state functional magnetic resonance imaging was obtained from 22 first-episode psychosis (FEP) patients, 41 individuals at ultra-high-risk for psychosis (UHR), and 47 demographically matched healthy controls. Results Significant group differences (in seed-based connectivity) were demonstrated in the left planum temporale and from both the right and left Heschl's gyrus seeds. From the left planum temporale seed, the FEP and UHR groups exhibited increased connectivity to the bilateral dorsolateral prefrontal cortex. In contrast, the FEP and UHR groups demonstrated decreased connectivity from the bilateral Heschl's gyrus seeds to the dorsal anterior cingulate cortex. The enhanced connectivity between the left planum temporale and right dorsolateral prefrontal cortex was positively correlated with positive symptom severity in individuals at UHR (r = .34, p = .03). Conclusions These findings corroborate the fronto-temporal connectivity disruption hypothesis in schizophrenia by providing evidence supporting the altered fronto-temporal intrinsic functional connection at earlier stages of psychosis. Our data indicate that subregion-specific aberrant fronto-temporal interactions exist in the STG at the early stage of psychosis, thus suggesting that these aberrancies are the neural underpinning of proneness to psychosis.	[Yoon, Youngwoo Bryan; Cho, Kang Ik K.; Kwon, Jun Soo] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea; [Yun, Je-Yeon; Kim, Sung Nyun; Park, Hye Yoon; Kwon, Jun Soo] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Jung, Wi Hoon] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Jung, Wi Hoon; Lee, Tae Young; Kwon, Jun Soo] Seoul Natl Univ, Med Res Ctr, Inst Human Behav Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Pennsylvania; Seoul National University (SNU)	Kwon, JS (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea.	kwonjs@snu.ac.kr	Yoon, Youngwoo Bryan/B-8089-2018; Jung, Wi Hoon/J-4033-2019; Lee, Tae Young/C-9990-2011	Yoon, Youngwoo Bryan/0000-0003-3852-681X; Lee, Tae Young/0000-0002-0238-8147; Jung, Wi Hoon/0000-0002-8697-9584	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2013R1A2A1A03071089]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (Grant no. 2013R1A2A1A03071089). The Ministry of Science, ICT and Future Planning had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Allen P, 2010, NEUROIMAGE, V49, P947, DOI 10.1016/j.neuroimage.2009.08.038; BARTA PE, 1990, AM J PSYCHIAT, V147, P1457; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Belger A, 2012, BIOL PSYCHIAT, V71, P94, DOI 10.1016/j.biopsych.2011.11.009; Benetti S, 2015, SCHIZOPHRENIA BULL, V41, P192, DOI 10.1093/schbul/sbt172; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Borgwardt SJ, 2007, BIOL PSYCHIAT, V61, P1148, DOI 10.1016/j.biopsych.2006.08.009; Carettri F, 2012, SCHIZOPHRENIA BULL, V38, P1170, DOI 10.1093/schbul/sbs053; Crossley NA, 2009, HUM BRAIN MAPP, V30, P4129, DOI 10.1002/hbm.20834; Dandash O, 2014, SCHIZOPHRENIA BULL, V40, P904, DOI 10.1093/schbul/sbt093; Dehaene-Lambertz G, 2002, SCIENCE, V298, P2013, DOI 10.1126/science.1077066; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Diederen KMJ, 2013, PSYCHOL MED, V43, P1685, DOI 10.1017/S0033291712002541; First M.B., 2016, STRUCTURED CLIN INTE; Fornito A, 2013, JAMA PSYCHIAT, V70, P1143, DOI 10.1001/jamapsychiatry.2013.1976; Fornito A, 2010, CURR OPIN PSYCHIATR, V23, P239, DOI 10.1097/YCO.0b013e328337d78d; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Fusar-Poli P, 2009, BRIT J PSYCHIAT, V194, P181, DOI 10.1192/bjp.bp.107.047951; Fusar-Poli P, 2012, SCHIZOPHRENIA BULL, V38, P1297, DOI 10.1093/schbul/sbr134; Gaebler AJ, 2015, BRAIN, V138, P1410, DOI 10.1093/brain/awv049; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; GALABURDA AM, 1983, J COMP NEUROL, V221, P169, DOI 10.1002/cne.902210206; Gavrilescu M, 2010, PSYCHOL MED, V40, P1149, DOI 10.1017/S0033291709991632; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hoffman RE, 2011, BIOL PSYCHIAT, V69, P407, DOI 10.1016/j.biopsych.2010.09.050; Jung MH, 2010, PSYCHIAT INVEST, V7, P257, DOI 10.4306/pi.2010.7.4.257; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Kahn RS, 2013, JAMA PSYCHIAT, V70, P1107, DOI 10.1001/jamapsychiatry.2013.155; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kuhn S, 2012, SCHIZOPHRENIA BULL, V38, P779, DOI 10.1093/schbul/sbq152; Kwon JS, 2012, ASIAN J PSYCHIATR, V5, P98, DOI 10.1016/j.ajp.2012.02.007; Lee TY, 2014, SCHIZOPHR RES, V156, P266, DOI 10.1016/j.schres.2014.04.002; MAHER BA, 1974, J INDIV PSYCHOL, V30, P98; Malaspina D, 2004, BIOL PSYCHIAT, V56, P931, DOI 10.1016/j.biopsych.2004.09.013; Mechelli A, 2007, HUM BRAIN MAPP, V28, P1213, DOI 10.1002/hbm.20341; Miller TJ, 1999, PSYCHIAT QUART, V70, P273, DOI 10.1023/A:1022034115078; Miller TJ, 2002, AM J PSYCHIAT, V159, P863, DOI 10.1176/appi.ajp.159.5.863; Morris R, 2013, SCHIZOPHRENIA BULL, V39, P575, DOI 10.1093/schbul/sbr192; Muschelli J, 2014, NEUROIMAGE, V96, P22, DOI 10.1016/j.neuroimage.2014.03.028; Oertel-Knochel V, 2013, SCHIZOPHR RES, V147, P331, DOI 10.1016/j.schres.2013.04.024; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P17, DOI 10.1503/jpn.100176; PANDYA DN, 1995, REV NEUROL, V151, P486; Rajarethinam RP, 2000, SCHIZOPHR RES, V41, P303, DOI 10.1016/S0920-9964(99)00083-3; Reichenberg A, 2010, AM J PSYCHIAT, V167, P160, DOI 10.1176/appi.ajp.2009.09040574; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; Schall U, 2003, NEUROIMAGE, V20, P729, DOI 10.1016/S1053-8119(03)00398-7; SHENTON ME, 1992, NEW ENGL J MED, V327, P604, DOI 10.1056/NEJM199208273270905; Shin KS, 2012, SCHIZOPHRENIA BULL, V38, P1258, DOI 10.1093/schbul/sbr138; Shin KS, 2009, BIOL PSYCHIAT, V65, P1071, DOI 10.1016/j.biopsych.2008.12.024; Shinn AK, 2013, SCHIZOPHR RES, V143, P260, DOI 10.1016/j.schres.2012.11.037; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Takahashi H, 2013, NEUROIMAGE, V66, P594, DOI 10.1016/j.neuroimage.2012.09.074; Takahashi T, 2009, ARCH GEN PSYCHIAT, V66, P366, DOI 10.1001/archgenpsychiatry.2009.12; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Vercammen A, 2010, BIOL PSYCHIAT, V67, P912, DOI 10.1016/j.biopsych.2009.11.017; Waberski TD, 2001, NEUROSCI LETT, V308, P107, DOI 10.1016/S0304-3940(01)01988-7; White TP, 2010, SCHIZOPHR RES, V123, P105, DOI 10.1016/j.schres.2010.07.020; Wolf DH, 2007, PSYCHIAT RES-NEUROIM, V154, P221, DOI 10.1016/j.pscychresns.2006.11.008; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5; Yum T, 1992, MANUAL KOREN WECHSLE; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081	63	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135347	10.1371/journal.pone.0135347	http://dx.doi.org/10.1371/journal.pone.0135347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267069	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300102
J	Devaney, J; Barrett, B; Barrett, F; Redmond, J; O'Halloran, J				Devaney, John; Barrett, Brian; Barrett, Frank; Redmond, John; O'Halloran, John			Forest Cover Estimation in Ireland Using Radar Remote Sensing: A Comparative Analysis of Forest Cover Assessment Methodologies	PLOS ONE			English	Article							LAND-COVER; ALOS-PALSAR; TROPICAL DEFORESTATION; MAPPING DEFORESTATION; BACKSCATTER; CLASSIFICATION; QUEENSLAND; SATELLITES; PREDICTION; BENEFITS	Quantification of spatial and temporal changes in forest cover is an essential component of forest monitoring programs. Due to its cloud free capability, Synthetic Aperture Radar (SAR) is an ideal source of information on forest dynamics in countries with near-constant cloud-cover. However, few studies have investigated the use of SAR for forest cover estimation in landscapes with highly sparse and fragmented forest cover. In this study, the potential use of L-band SAR for forest cover estimation in two regions (Longford and Sligo) in Ireland is investigated and compared to forest cover estimates derived from three national (Forestry2010, Prime2, National Forest Inventory), one pan-European (Forest Map 2006) and one global forest cover (Global Forest Change) product. Two machine-learning approaches (Random Forests and Extremely Randomised Trees) are evaluated. Both Random Forests and Extremely Randomised Trees classification accuracies were high (98.1-98.5%), with differences between the two classifiers being minimal (<0.5%). Increasing levels of post classification filtering led to a decrease in estimated forest area and an increase in overall accuracy of SAR-derived forest cover maps. All forest cover products were evaluated using an independent validation dataset. For the Longford region, the highest overall accuracy was recorded with the Forestry2010 dataset (97.42%) whereas in Sligo, highest overall accuracy was obtained for the Prime2 dataset (97.43%), although accuracies of SAR-derived forest maps were comparable. Our findings indicate that spaceborne radar could aid inventories in regions with low levels of forest cover in fragmented landscapes. The reduced accuracies observed for the global and pan-continental forest cover maps in comparison to national and SAR-derived forest maps indicate that caution should be exercised when applying these datasets for national reporting.	[Devaney, John; O'Halloran, John] Univ Coll Cork UCC, Sch Biol Earth & Environm Sci BEES, Cork, Ireland; [Barrett, Brian] Univ Coll Cork UCC, Sch Geog & Archaeol, Cork, Ireland; [Barrett, Frank; Redmond, John] Dept Agr Food & Marine, Forest Serv, Johnstown Castle, Wexford, Ireland	University College Cork; University College Cork	Devaney, J (corresponding author), Smithsonian Environm Res Ctr, 647 Contees Wharf, Edgewater, MD 21037 USA.	devaneyj@si.edu		Devaney, John/0000-0002-7676-0378; Barrett, Brian/0000-0002-4380-4020	Science, Technology, Research and Innovation for the Environment (STRIVE) Programme [2011-CCRP-FS-1.1]; Irish Government under National Development Plan (NDP)	Science, Technology, Research and Innovation for the Environment (STRIVE) Programme; Irish Government under National Development Plan (NDP)	This study has been prepared as part of the Science, Technology, Research and Innovation for the Environment (STRIVE) Programme (Grant No. 2011-CCRP-FS-1.1). The programme is financed by the Irish Government under the National Development Plan (NDP) 2007-2013 and is administered by the Environmental Protection Agency (www.epa.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Achard F., 2012, GLOBAL FOREST MONITO; Almeida R, 2009, INT J REMOTE SENS, V30, P3735, DOI 10.1080/01431160902777175; Asner GP, 2014, P NATL ACAD SCI USA, V111, P567, DOI 10.1073/pnas.1322557111; Barrett B, 2014, REMOTE SENS ENVIRON, V152, P109, DOI 10.1016/j.rse.2014.05.018; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Black K., 2008, IRISH FORESTRY, V65, P71; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; BOSSARD M, 2000, CORINE LAND COVER TE; Boyd DS, 2005, PROG PHYS GEOG, V29, P1, DOI 10.1191/0309133305pp432ra; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Busch J, 2011, CONSERV LETT, V4, P101, DOI 10.1111/j.1755-263X.2010.00150.x; Caccetta P, 2012, GLOBAL EST MONITO, P243, DOI DOI 10.1201/B13040-14; COFORD, 2009, FOR 2030; Defries RS, 2000, GLOBAL CHANGE BIOL, V6, P247, DOI 10.1046/j.1365-2486.2000.00296.x; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; DOBSON MC, 1992, IEEE T GEOSCI REMOTE, V30, P412, DOI 10.1109/36.134090; Dong J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0082342, 10.1371/journal.pone.0085801]; Dong JW, 2012, REMOTE SENS ENVIRON, V127, P60, DOI 10.1016/j.rse.2012.08.022; Duffy P., 2012, IRELAND NATL INVENTO; FAO, 2020, GLOBAL FOREST RESOUR; FAO, 2001, GLOB FOR RES ASS 200; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Forest Policy Review Group, 2013, IR FOR POL REN VIS; Forest Service, 2013, IR NAT FOR INV 2012; Gallagher G, 2001, IRELANDS FOREST INVE; Gallego J, 2008, INT J APPL EARTH OBS, V10, P467, DOI 10.1016/j.jag.2007.11.001; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Geurts P, 2009, MOL BIOSYST, V5, P1593, DOI 10.1039/b907946g; Gislason PO, 2006, PATTERN RECOGN LETT, V27, P294, DOI 10.1016/j.patrec.2005.08.011; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Herold Martin, 2011, Carbon Balance Manag, V6, P13, DOI 10.1186/1750-0680-6-13; Hoekman DH, 2010, IEEE J-STARS, V3, P605, DOI 10.1109/JSTARS.2010.2070059; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Karjalainen M, 2012, REMOTE SENS ENVIRON, V117, P338, DOI 10.1016/j.rse.2011.10.008; Kempeneers P, 2013, IEEE J SELECTED TOPI; Kempeneers P, 2011, IEEE T GEOSCI REMOTE, V49, P4977, DOI 10.1109/TGRS.2011.2158548; Le Toan T, 2011, REMOTE SENS ENVIRON, V115, P2850, DOI 10.1016/j.rse.2011.03.020; Lu D, 2007, INT J REMOTE SENS, V28, P823, DOI 10.1080/01431160600746456; Lucas R, 2012, GLOBAL FOREST MONITO; Lucas R, 2010, IEEE J-STARS, V3, P576, DOI 10.1109/JSTARS.2010.2086436; Lucas RM, 2006, REMOTE SENS ENVIRON, V100, P388, DOI 10.1016/j.rse.2005.09.020; Lund HG, 2000, FOREST ECOL MANAG, V128, P3, DOI 10.1016/S0378-1127(99)00282-0; Lynch J, 2013, NATURE, V496, P293, DOI 10.1038/496293a; Maree R., 2013, DECISION FORESTCOM, P125, DOI DOI 10.1007/978-1-4471-4929-3_10; Maree R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-S1-S2; Marti-Cardona B, 2013, REMOTE SENS ENVIRON, V139, P171, DOI 10.1016/j.rse.2013.07.028; Mascaro J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085993; Mellor A, 2013, REMOTE SENS-BASEL, V5, P2838, DOI 10.3390/rs5062838; Mitchell F., 2000, Irish Forestry, V57, P38; Morton D., 2011, 1107 COUNTR SURV; O'Donnell A, 2013, LAND USE POLICY, V35, P16, DOI 10.1016/j.landusepol.2013.04.014; Pal M, 2005, INT J REMOTE SENS, V26, P1007, DOI 10.1080/01431160512331314083; Parker C., 2009, THE LITTLE REDD BOOK; Patenaude G, 2005, ENVIRON SCI POLICY, V8, P161, DOI 10.1016/j.envsci.2004.12.010; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perrin P, 2006, NATL SURVEY NATIVE W; Petit C, 2001, INT J REMOTE SENS, V22, P3435, DOI 10.1080/01431160010006881; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; PULLIAINEN JT, 1994, IEEE T GEOSCI REMOTE, V32, P1041, DOI 10.1109/36.312892; Pulliainen JT, 1999, IEEE T GEOSCI REMOTE, V37, P927, DOI 10.1109/36.752211; Quegan S, 2000, IEEE T GEOSCI REMOTE, V38, P741, DOI 10.1109/36.842003; Rignot E, 1997, REMOTE SENS ENVIRON, V59, P167, DOI 10.1016/S0034-4257(96)00150-2; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Rosenqvist A, 2014, OPERATIONAL PERFORMA; Rosenqvist A, 2007, IEEE T GEOSCI REMOTE, V45, P3307, DOI 10.1109/TGRS.2007.901027; Ryan CM, 2012, GLOBAL CHANGE BIOL, V18, P243, DOI 10.1111/j.1365-2486.2011.02551.x; Saatchi SS, 1997, REMOTE SENS ENVIRON, V59, P191, DOI 10.1016/S0034-4257(96)00153-8; Schlund M, 2013, REMOTE SENSING ENV; Seebach LM, 2011, FORESTRY, V84, P285, DOI 10.1093/forestry/cpr013; Thiel CJ, 2009, IEEE T GEOSCI REMOTE, V47, P3993, DOI 10.1109/TGRS.2009.2021469; Tomppo E, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P1, DOI 10.1007/978-90-481-3233-1; Tso B, 2009, CLASSIFICATION METHO, V2nd; Tuohy A, 2009, ENERG POLICY, V37, P3035, DOI 10.1016/j.enpol.2009.03.049; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Tyrrell M.L., 2012, MANAGING EST CARB, P377; UNFCCC, 1997, UN FRAM CLIM CHANG K; Wagner W, 2003, REMOTE SENS ENVIRON, V85, P125, DOI 10.1016/S0034-4257(02)00198-0; Walker WS, 2010, IEEE J-STARS, V3, P594, DOI 10.1109/JSTARS.2010.2076398; Watson RT, 2000, INT PAN CLIM CHANG L; Whittle M, 2012, REMOTE SENS ENVIRON, V124, P83, DOI 10.1016/j.rse.2012.04.027; Wilson MW, 2012, BIRD DIVERSITY AFFOR, P1; Zhang QF, 2005, ENVIRON MONIT ASSESS, V101, P69; Zhao B, 2004, LAND USE POLICY, V21, P139, DOI 10.1016/j.landusepol.2003.10.003	89	8	8	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0133583	10.1371/journal.pone.0133583	http://dx.doi.org/10.1371/journal.pone.0133583			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262681	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000359353300008
J	Pai, PP; Ranjani, SSS; Mondal, S				Pai, Priyadarshini P.; Ranjani, S. S. Shree; Mondal, Sukanta			PINGU: PredIction of eNzyme catalytic residues usinG seqUence information	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT RESIDUES; ACTIVE-SITES; DATABASE; EVOLUTIONARY	Identification of catalytic residues can help unveil interesting attributes of enzyme function for various therapeutic and industrial applications. Based on their biochemical roles, the number of catalytic residues and sequence lengths of enzymes vary. This article describes a prediction approach (PINGU) for such a scenario. It uses models trained using physicochemical properties and evolutionary information of 650 non-redundant enzymes (2136 catalytic residues) in a support vector machines architecture. Independent testing on 200 non-redundant enzymes (683 catalytic residues) in predefined prediction settings, i.e., with noncatalytic per catalytic residue ranging from 1 to 30, suggested that the prediction approach was highly sensitive and specific, i.e., 80% or above, over the incremental challenges. To learn more about the discriminatory power of PINGU in real scenarios, where the prediction challenge is variable and susceptible to high false positives, the best model from independent testing was used on 60 diverse enzymes. Results suggested that PINGU was able to identify most catalytic residues and non-catalytic residues properly with 80% or above accuracy, sensitivity and specificity. The effect of false positives on precision was addressed in this study by application of predicted ligand-binding residue information as a post-processing filter. An overall improvement of 20% in F-measure and 0.138 in Correlation Coefficient with 16% enhanced precision could be achieved. On account of its encouraging performance, PINGU is hoped to have eventual applications in boosting enzyme engineering and novel drug discovery.	[Pai, Priyadarshini P.; Mondal, Sukanta] Birla Inst Technol & Sci Pilani, Dept Biol Sci, Zuarinagar, Goa, India; [Ranjani, S. S. Shree] Birla Inst Technol & Sci Pilani, Dept Comp Sci & Informat Syst, Zuarinagar, Goa, India	Birla Institute of Technology & Science Pilani (BITS Pilani); Birla Institute of Technology & Science Pilani (BITS Pilani)	Mondal, S (corresponding author), Birla Inst Technol & Sci Pilani, Dept Biol Sci, KK Birla Goa Campus, Zuarinagar, Goa, India.	suku@goa.bits-pilani.ac.in						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Bate P, 2004, J MOL BIOL, V340, P263, DOI 10.1016/j.jmb.2004.04.070; Ben-Shimon A, 2005, J MOL BIOL, V351, P309, DOI 10.1016/j.jmb.2005.06.047; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bruha I., 2001, Machine learning and its applications. Advanced lectures, P258; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chien YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047951; Choi KM, 2011, J BIOINF COMPUT BIOL, V9, P597, DOI 10.1142/S0219720011005677; Chou KC, 2004, PROTEINS, V55, P77, DOI 10.1002/prot.10622; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; Dou YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035666; Fajardo JE, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-63; Fleischmann A, 2004, NUCLEIC ACIDS RES, V32, pD434, DOI 10.1093/nar/gkh119; Furnham N, 2014, NUCLEIC ACIDS RES, V42, pD485, DOI 10.1093/nar/gkt1243; Gao YF, 2013, MOL BIOSYST, V9, P61, DOI 10.1039/c2mb25327e; Holliday GL, 2005, BIOINFORMATICS, V21, P4315, DOI 10.1093/bioinformatics/bti693; Izidoro SC, 2015, BIOINFORMATICS, V31, P864, DOI 10.1093/bioinformatics/btu746; Joachims T., 1999, ADV KERNEL METHODS S; Koh KM, 2007, J MACH LEARN RES, V8, P1519; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lu CH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/807839; Meroz Y, 2008, PROTEINS, V72, P606, DOI 10.1002/prot.21951; Nagano N, 2005, NUCLEIC ACIDS RES, V33, pD407, DOI 10.1093/nar/gki080; Ou, 2005, QUICKRBF PACKAGE EFF; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Sankararaman S, 2010, BIOINFORMATICS, V26, P617, DOI 10.1093/bioinformatics/btq008; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Youn E, 2007, PROTEIN SCI, V16, P216, DOI 10.1110/ps.062523907; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhang Z, 2012, CURR BIOINFORM, V4, P197; Zhao SW, 2013, NATURE, V502, P698, DOI 10.1038/nature12576	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135122	10.1371/journal.pone.0135122	http://dx.doi.org/10.1371/journal.pone.0135122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26261982	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300063
J	Scicchitano, F; van Rijn, CM; van Luijtelaar, G				Scicchitano, Francesca; van Rijn, Clementina M.; van Luijtelaar, Gilles			Unilateral and Bilateral Cortical Resection: Effects on Spike-Wave Discharges in a Genetic Absence Epilepsy Model	PLOS ONE			English	Article							RETICULAR THALAMIC NUCLEUS; FUNCTIONAL CONNECTIVITY; SOMATOSENSORY CORTEX; WAG/RIJ RATS; SEIZURES; NEURONS; STIMULATION; FOCUS; ETHOSUXIMIDE; LOCALIZATION	Research Question Recent discoveries have challenged the traditional view that the thalamus is the primary source driving spike-and-wave discharges (SWDs). At odds, SWDs in genetic absence models have a cortical focal origin in the deep layers of the perioral region of the somatosensory cortex. The present study examines the effect of unilateral and bilateral surgical resection of the assumed focal cortical region on the occurrence of SWDs in anesthetized WAG/Rij rats, a well described and validated genetic absence model. Methods Male WAG/Rij rats were used: 9 in the resected and 6 in the control group. EEG recordings were made before and after craniectomy, after unilateral and after bilateral removal of the focal region. Results SWDs decreased after unilateral cortical resection, while SWDs were no longer noticed after bilateral resection. This was also the case when the resected areas were restricted to layers I-IV with layers V and VI intact. Conclusions These results suggest that SWDs are completely abolished after bilateral removal of the focal region, most likely by interference with an intracortical columnar circuit. The evidence suggests that absence epilepsy is a network type of epilepsy since interference with only the local cortical network abolishes all seizures.	[van Rijn, Clementina M.; van Luijtelaar, Gilles] Radboud Univ Nijmegen, Donders Ctr Cognit, Dept Biol Psychol, Donders Inst Brain Cognit & Behav, NL-6500 HE Nijmegen, Netherlands; [Scicchitano, Francesca] Magna Graecia Univ Catanzaro, Sch Med & Surg, Dept Hlth Sci, I-88100 Catanzaro, Italy	Radboud University Nijmegen; Magna Graecia University of Catanzaro	van Luijtelaar, G (corresponding author), Radboud Univ Nijmegen, Donders Ctr Cognit, POB 9104, NL-6500 HE Nijmegen, Netherlands.	g.vanluijtelaar@donders.ru.nl	van Rijn, Clementina/D-5828-2012	van Rijn, Clementina/0000-0002-1103-6338				Abbasova KR, 2010, BRAIN RES, V1366, P257, DOI 10.1016/j.brainres.2010.10.007; Aboitiz F, 2003, BRAZ J MED BIOL RES, V36, P409, DOI 10.1590/S0100-879X2003000400002; Amor F, 2009, NEUROIMAGE, V45, P950, DOI 10.1016/j.neuroimage.2008.12.011; AVANZINI G, 1992, J NEURAL TRANSM-GEN, P85; Avoli M, 2012, EPILEPSIA, V53, P779, DOI 10.1111/j.1528-1167.2012.03421.x; Berdiev RK, 2007, BRAIN RES, V1185, P266, DOI 10.1016/j.brainres.2007.09.010; Berdiev RK, 2009, NEUROSCI LETT, V463, P249, DOI 10.1016/j.neulet.2009.07.068; Berg AT, 2011, EPILEPSIA, V52, P1058, DOI 10.1111/j.1528-1167.2011.03101.x; Berg AT, 2000, NEUROLOGY, V54, P625, DOI 10.1212/WNL.54.3.625; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Carran MA, 1999, EPILEPSIA, V40, P1755, DOI 10.1111/j.1528-1157.1999.tb01594.x; Chahboune H, 2009, NEUROIMAGE, V47, P459, DOI 10.1016/j.neuroimage.2009.04.060; Citraro R, 2006, NEUROPHARMACOLOGY, V51, P1058, DOI 10.1016/j.neuropharm.2006.06.014; Englot DJ, 2012, J NEUROSURG, V116, P1042, DOI 10.3171/2012.1.JNS111620; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Forcelli PA, 2013, SONE, V8; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Fujita I, 1996, J COMP NEUROL, V368, P467, DOI 10.1002/(SICI)1096-9861(19960513)368:4<467::AID-CNE1>3.0.CO;2-2; Gibbs FA, 1935, ARCH NEURO PSYCHIATR, V34, P1133, DOI 10.1001/archneurpsyc.1935.02250240002001; Gupta D, 2011, MED BIOL ENG COMPUT, V49, P555, DOI 10.1007/s11517-011-0778-3; Gurbanova AA, 2006, BRIT J PHARMACOL, V148, P1076, DOI 10.1038/sj.bjp.0706791; Hader WJ, 2013, EPILEPSIA, V54, P840, DOI 10.1111/epi.12161; Holmes MD, 2004, EPILEPSIA, V45, P1568, DOI 10.1111/j.0013-9580.2004.23204.x; Hosking PG, 2003, SEIZURE-EUR J EPILEP, V12, P160, DOI 10.1016/S1059-1311(02)00189-9; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; INOUE M, 1994, PHARMACOL BIOCHEM BE, V48, P547, DOI 10.1016/0091-3057(94)90569-X; JURNA I, 1979, N-S ARCH PHARMACOL, V309, P145, DOI 10.1007/BF00501222; Kandel A, 1997, J NEUROSCI, V17, P6783; Klein JP, 2004, BRAIN RES, V1000, P102, DOI 10.1016/j.brainres.2003.11.051; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; Loiseau P, 2002, CURR PROB E, V17, P285; Luttjohann A, 2011, NEUROSCIENCE, V188, P125, DOI 10.1016/j.neuroscience.2011.04.038; Luttjohann A, 2013, EXP NEUROL, V239, P235, DOI 10.1016/j.expneurol.2012.10.021; Luttjohann A, 2012, NEUROBIOL DIS, V47, P49, DOI 10.1016/j.nbd.2012.03.023; Manning JPA, 2004, NEUROSCIENCE, V123, P5, DOI 10.1016/j.neuroscience.2003.09.026; Marrocco J, 2013, MOL PHARMACOL, V84, P244, DOI 10.1124/mol.113.085530; Martin LBE, 2001, COMPARATIVE MED, V51, P43; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; Meeren HKM, 2009, EXP NEUROL, V217, P25, DOI 10.1016/j.expneurol.2009.01.009; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Midzianovskaia IS, 2001, BRAIN RES, V911, P62, DOI 10.1016/S0006-8993(01)02705-6; Millan E, 2001, EPILEPSY BEHAV, V2, P54, DOI 10.1006/ebeh.2001.0147; Mishra AM, 2013, EPILEPSIA, V54, P1214, DOI 10.1111/epi.12227; Niedermeyer E, 1996, CLIN ELECTROENCEPHAL, V27, P1, DOI 10.1177/155005949602700103; Ovchinnikov A, 2010, J NEUROSCI METH, V194, P172, DOI 10.1016/j.jneumeth.2010.09.017; Panayiotopoulos CP, 2008, EPILEPSIA, V49, P2131, DOI 10.1111/j.1528-1167.2008.01777.x; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pinault D, 2003, J PHYSIOL-LONDON, V552, P881, DOI 10.1113/jphysiol.2003.046573; Polack PO, 2007, J NEUROSCI, V27, P6590, DOI 10.1523/JNEUROSCI.0753-07.2007; Polack PO, 2009, CEREB CORTEX, V19, P2078, DOI 10.1093/cercor/bhn237; Polack PO, 2009, EPILEPSIA, V50, P1816, DOI 10.1111/j.1528-1167.2009.02047.x; Ramey WL, 2013, CLIN NEUROL NEUROSUR, V115, P2411, DOI 10.1016/j.clineuro.2013.09.035; RAOS V, 1993, J COMP NEUROL, V332, P145, DOI 10.1002/cne.903320202; Reeves AL, 1997, EPILEPSIA, V38, P689, DOI 10.1111/j.1528-1157.1997.tb01238.x; Richards DA, 2003, EPILEPSY RES, V54, P97, DOI 10.1016/S0920-1211(03)00060-3; Risse GL, 2006, EPILEPSIA, V47, P87, DOI 10.1111/j.1528-1167.2006.00699.x; Samotaeva IS, 2013, NEUROSCIENCE, V230, P50, DOI 10.1016/j.neuroscience.2012.11.013; Schubert D, 2006, CEREB CORTEX, V16, P223, DOI 10.1093/cercor/bhi100; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Seidenbecher T, 2001, EUR J NEUROSCI, V13, P1537, DOI 10.1046/j.0953-816x.2001.01537.x; Sitnikova E, 2004, BRAIN RES, V1012, P127, DOI 10.1016/j.brainres.2004.03.041; Sitnikova E, 2006, EPILEPSY RES, V71, P159, DOI 10.1016/j.eplepsyres.2006.06.008; So NK, 1998, EPILEPSIA, V39, pS49, DOI 10.1111/j.1528-1157.1998.tb05125.x; Stefan H, 2008, EPILEPSY COMPREHENSI, P573; Stefan H, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00008; STERIADE M, 1993, J NEUROSCI, V13, P3284; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; van der Knaap LJ, 2011, BEHAV BRAIN RES, V223, P211, DOI 10.1016/j.bbr.2011.04.018; van Luijtelaar G, 2006, NEUROSCI BIOBEHAV R, V30, P983, DOI 10.1016/j.neubiorev.2006.03.002; van Luijtelaar G, 2014, ADV EXP MED BIOL, V813, P81, DOI 10.1007/978-94-017-8914-1_7; van Luijtelaar G, 2011, CLIN EEG NEUROSCI, V42, P83, DOI 10.1177/155005941104200209; VANLUIJTELAAR ELJM, 1986, NEUROSCI LETT, V70, P393, DOI 10.1016/0304-3940(86)90586-0; VERGNES M, 1989, EPILEPSY RES, V4, P8, DOI 10.1016/0920-1211(89)90052-1; VERGNES M, 1992, J NEURAL TRANSM-GEN, P71; Westmijse I, 2009, EPILEPSIA, V50, P2538, DOI 10.1111/j.1528-1167.2009.02162.x; Yoshinaga H, 2004, SEIZURE-EUR J EPILEP, V13, P296, DOI 10.1016/S1059-1311(03)00196-1; Zilles Karl, 1995, P649; Zobeiri M, 2013, EPILEPSY BEHAV, V26, P42, DOI 10.1016/j.yebeh.2012.10.018	82	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0133594	10.1371/journal.pone.0133594	http://dx.doi.org/10.1371/journal.pone.0133594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262879	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300009
J	Goindin, D; Delannay, C; Ramdini, C; Gustave, J; Fouque, F				Goindin, Daniella; Delannay, Christelle; Ramdini, Cedric; Gustave, Joel; Fouque, Florence			Parity and Longevity of Aedes aegypti According to Temperatures in Controlled Conditions and Consequences on Dengue Transmission Risks	PLOS ONE			English	Article							L. DIPTERA-CULICIDAE; FRENCH-WEST-INDIES; VIRUS TRANSMISSION; FEEDING PATTERNS; BLOOD; VECTOR; FLUCTUATIONS; OVIPOSITION; BEHAVIOR; CYCLE	Background In Guadeloupe, Aedes aegypti mosquitoes are the only vectors of dengue and chikungunya viruses. For both diseases, vector control is the only tool for preventing epidemics since no vaccine or specific treatment is available. However, to efficiently implement control of mosquitoes vectors, a reliable estimation of the transmission risks is necessary. To become infective an Ae. aegypti female must ingest the virus during a blood meal and will not be able to transmit the virus during another blood-meal until the extrinsic incubation period is completed. Consequently the aged females will carry more infectious risks. The objectives of the present study were to estimate under controlled conditions the expectation of infective life for females and thus the transmission risks in relation with their reproductive cycle and parity status. Methodology/Principal Findings Larvae of Ae. aegypti were collected in central Guadeloupe and breed under laboratory conditions until adult emergence. The experiments were performed at constant temperatures (+/- 1.5 degrees C) of 24 degrees C, 27 degrees C and 30 degrees C on adults females from first generation (F1). Females were kept and fed individually and records of blood-feeding, egg-laying and survival were done daily. Some females were dissected at different physiological stages to observe the ovaries development. The data were analyzed to follow the evolution of parity rates, the number of gonotrophic cycles, the fecundity and to study the mean expectation of life and the mean expectation of infective life for Ae. aegypti females according to temperatures. The expectation of life varies with the parity rates and according to the temperatures, with durations from about 10 days at low parity rates at the higher temperature to an optimal duration of about 35 days when 70% of females are parous at 27 degrees C. Infective life expectancy was found highly variable in the lower parous rates and again the optimal durations were found when more than 50% of females are parous for the mean temperatures of 27 degrees C and 30 degrees C. Conclusion Parity rates can be determined for field collected females and could be a good proxy of the expectation of infective life according to temperatures. However, for the same parity rates, the estimation of infective life expectation is very different between Ae. aegypti and Anopheles gambiae mosquitoes. Correlation of field parity rates with transmission risks requires absolutely to be based on Ae. aegypti models, since available Anopheles sp. models underestimate greatly the females longevity.	[Goindin, Daniella; Delannay, Christelle; Fouque, Florence] Inst Pasteur Guadeloupe, Unit Environm & Hlth, Lab Med Entomol, Les Abymes 97183, Guadeloupe, France; [Ramdini, Cedric; Gustave, Joel] Agence Reg Sante, Serv Lutte Antivectorielle, Dothemare, Guadeloupe, France; [Fouque, Florence] WHO, Special Programme Res & Training Trop Dis TDR, Vector Environm & Soc Unit, CH-1211 Geneva 27, Switzerland	World Health Organization	Goindin, D (corresponding author), Inst Pasteur Guadeloupe, Unit Environm & Hlth, Lab Med Entomol, Les Abymes 97183, Guadeloupe, France.	dgoindin@pasteur-guadeloupe.fr			European funds FEDER [1.4.32932]; French Ministry of Health; European Union; Guadeloupe Region; European funds FEDER [1.4.32932]; French Ministry of Health; European Union; Guadeloupe Region	European funds FEDER(European Commission); French Ministry of Health; European Union(European Commission); Guadeloupe Region; European funds FEDER(European Commission); French Ministry of Health; European Union(European Commission); Guadeloupe Region	Funding for this work was from European funds FEDER 1.4.32932 allocated to the Pasteur Institute of Guadeloupe for the development of the Unit of Environment and Health and from a grant from the French Ministry of Health. Daniella Goindin was supported by a FSE fund from European Union and Guadeloupe Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, BIOL MOSQUITOES DEV; Antilles-Guyane CIRE, 2014, CHIK ANT GUYAN; Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824; Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190; Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242; Cassadou S, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.13.20752; Chadee D D, 2012, Pathog Glob Health, V106, P413, DOI 10.1179/2047773212Y.0000000036; Chadee DD, 2010, ACTA TROP, V116, P212, DOI 10.1016/j.actatropica.2010.08.008; Christophers R., 1960, AEDES AEGYPTI L YELL; COZ J., 1961, BULL SOC PATHOL EXOT, V54, P1353; David MR, 2012, REV SAUDE PUBL, V46, P858, DOI 10.1590/S0034-89102012000500013; DAVIDSON G, 1954, NATURE, V174, P792, DOI 10.1038/174792a0; Detinova TS, 1963, METHODES APPL CLASSE, P49; Farjana T, 2013, J MED ENTOMOL, V50, P838, DOI 10.1603/ME12146; Fouque F, 2006, J VECTOR ECOL, V31, P390, DOI 10.3376/1081-1710(2006)31[390:AASADT]2.0.CO;2; GARRETTJ.C, 1964, B WORLD HEALTH ORGAN, V31, P71; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Gustave J, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/249524; Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2; Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048; Higgs S, 2014, VECTOR-BORNE ZOONOT, V14, P535, DOI 10.1089/vbz.2014.14.8.edit; Hugo LE, 2008, J MED ENTOMOL, V45, P353, DOI 10.1603/0022-2585(2008)45[353:EOMAGT]2.0.CO;2; Joy TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046946; KLOWDEN MJ, 1995, BIOSCIENCE, V45, P326, DOI 10.2307/1312493; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Larrieu S, 2014, ACTA TROP, V131, P37, DOI 10.1016/j.actatropica.2013.11.023; Laughlin CA, 2012, J INFECT DIS, V206, P1121, DOI 10.1093/infdis/jis351; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Lima-Camara TN, 2007, J VECTOR ECOL, V32, P34, DOI DOI 10.3376/1081-1710(2007)32[34:PA0D0A]2.0.C0;2; MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P613; MacDonald G, 1952, P ROY SOC MED, V48, P295; Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004; Morrison AC, 1999, J AM MOSQUITO CONTR, V15, P98; PANT CP, 1973, J MED ENTOMOL, V10, P219, DOI 10.1093/jmedent/10.2.219; Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; Saifur RGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030919; Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94; SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922; Strobel M, 1998, PRESSE MED, V27, P1376; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wong J, 2011, J MED ENTOMOL, V48, P45, DOI 10.1603/ME10149; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040; Zar J.H., 1996, BIOSTAT ANAL	47	43	45	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135489	10.1371/journal.pone.0135489	http://dx.doi.org/10.1371/journal.pone.0135489			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258684	Green Published, gold, Green Submitted			2022-12-27	WOS:000359352600069
J	He, YQ; Dong, YH; Cui, FZ; Chen, XJ; Lin, RQ				He, Yiqun; Dong, Youhai; Cui, Fuzhai; Chen, Xujun; Lin, Rongqiang			Ectopic Osteogenesis and Scaffold Biodegradation of Nano-Hydroxyapatite-Chitosan in a Rat Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TRICALCIUM PHOSPHATE; BONE REGENERATION; OSTEOBLAST DIFFERENTIATION; ARTIFICIAL LAMINAE; IN-VIVO; FABRICATION; BETA; NANOCOMPOSITE; CYTOTOXICITY	The bone-formation and scaffold-biodegradation processes have not been fully characterized. This study aimed to determine the osteogenic ability of nHA-CS osteo-induced bone marrow mesenchymal stem cell (BMSC) composites and to explore the relationship between bone formation and scaffold biodegradation. The nHA-CS osteo-induced BMSC composites (nHA-CS+cells group) and the nHA-CS scaffolds (nHA-CS group) were implanted into the femoral spatium intermusculare of SD rats. At 2, 4, 6, 8, and 12 weeks post-implantation, the rat femurs were scanned using computerized tomography (CT), and the CT values of the implants were measured and comparatively analyzed. The implants were then harvested and subjected to hematoxylin and eosin (HE) and Masson's trichrome staining, and the percentages of bone area, scaffold area and collagen area were compared between the two groups. The CT values of the implants were higher in the nHA-CS+cells group than the nHA-CS group at the same time points (P < 0.05). Histological analysis revealed that de novo bone and collagen formation in the pores of the scaffolds gradually increased from 2 weeks post-implantation in both groups and that the scaffold gradually degraded as bone formation proceeded. However, more de novo bone and collagen formation and scaffold degradation occurred in the nHA-CS+cells group than in the nHA-CS group at the same time points (P < 0.05). In conclusion, nHA-CS osteo-induced BMSC composites are promising bone tissue engineering substitutes, and osteo-induced BMSCs can significantly enhance the osteogenic ability and play an active role in the degradation of nHA-CS scaffolds on par with bone formation.	[He, Yiqun; Dong, Youhai; Chen, Xujun; Lin, Rongqiang] Fudan Univ, Peoples Hosp Shanghai 5, Dept Orthopaed, Shanghai 200433, Peoples R China; [Cui, Fuzhai] Tsinghua Univ, Dept Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China	Fudan University; Tsinghua University	Dong, YH (corresponding author), Fudan Univ, Peoples Hosp Shanghai 5, Dept Orthopaed, Shanghai 200433, Peoples R China.	youhaidong1964@163.com		Chen, Xujun/0000-0002-2162-1020	Science and Technology Development Fund Item of Shanghai [114119b1300]; high-level talents special fund of Minhang District of Shanghai; Graduate Innovation Fund of Fudan University [EZH6281304/001/071]	Science and Technology Development Fund Item of Shanghai; high-level talents special fund of Minhang District of Shanghai; Graduate Innovation Fund of Fudan University	The Science and Technology Development Fund Item of Shanghai (No: 114119b1300) http://www.stcsm.gov.cn/, the high-level talents special fund of Minhang District of Shanghai http://gdrc.shmh.gov.cn/, and the Graduate Innovation Fund of Fudan University (No: EZH6281304/001/071) http://www.gs.fudan.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgawad AM, 2014, CARBOHYD POLYM, V100, P166, DOI 10.1016/j.carbpol.2012.12.043; Akazawa T, 2006, J BIOMED MATER RES A, V76A, P44, DOI 10.1002/jbm.a.30439; Becker ST, 2012, INT J ORAL MAX SURG, V41, P1153, DOI 10.1016/j.ijom.2012.03.031; Biazar E, 2015, ARTIF CELL NANOMED B, V43, P112, DOI 10.3109/21691401.2013.848874; Boonyagul S, 2014, ODONTOLOGY, V102, P310, DOI 10.1007/s10266-012-0101-2; Brun V, 2014, BIO-MED MATER ENG, V24, pS63, DOI 10.3233/BME-140975; Chang C, 2013, CARBOHYD POLYM, V91, P7, DOI 10.1016/j.carbpol.2012.07.070; Chang HW, 2013, J APPL POLYM SCI, V127, P169, DOI 10.1002/app.37855; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Damaraju S, 2014, TISSUE ENG; Danilchenko SN, 2011, J BIOMED MATER RES A, V96A, P639, DOI 10.1002/jbm.a.33017; de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110; Dong YH, 2013, SPINE, V38, pE1300, DOI 10.1097/BRS.0b013e3182a3cbb3; Dong YH, 2012, SPINE, V37, P648, DOI 10.1097/BRS.0b013e31822ecebc; Franca R, 2013, J BIOMED MATER RES B, V101, P1444, DOI 10.1002/jbm.b.32964; Gu QL, 2012, PHARMACOGN MAG, V8, P202, DOI 10.4103/0973-1296.99285; Gunter HM, 2014, J APPL ICHTHYOL, V30, P630, DOI 10.1111/jai.12521; Hartl L, 2012, APPL MICROBIOL BIOT, V93, P533, DOI 10.1007/s00253-011-3723-3; Kim BJ, 2012, OR SURG OR MED OR PA, V113, P583, DOI 10.1016/j.tripleo.2011.04.029; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Liu HH, 2013, BIOMATERIALS, V34, P4404, DOI 10.1016/j.biomaterials.2013.02.048; Liu Y, 2014, TISSUE ENG; Martin JR, 2014, BIOMATERIALS, V35, P3766, DOI 10.1016/j.biomaterials.2014.01.026; Mueller B, 2014, MAT SCI ENG C-MATER, V42, P137, DOI 10.1016/j.msec.2014.05.017; Nikukar H, 2013, ACS NANO, V7, P2758, DOI 10.1021/nn400202j; Rogina A, 2013, MAT SCI ENG C-MATER, V33, P4539, DOI 10.1016/j.msec.2013.07.008; Rolfing JHD, 2014, ACTA ORTHOP, V85, P201, DOI 10.3109/17453674.2014.889981; SONG SH, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/230152; SUN TR, 2014, MATH PROBL ENG, P71276, DOI DOI 10.1155/2014/; Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P258, DOI [10.1089/ten.TEB.2011.0440, 10.1089/ten.teb.2011.0440]; Tamariz E., 2013, BIODEGRADATION LIFE, V14, P1, DOI DOI 10.5772/56220; Tavakol S, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-012-1373-8; Torabinejad B, 2014, MAT SCI ENG C-MATER, V42, P199, DOI 10.1016/j.msec.2014.05.003; Villa MM, 2014, J BIOMEDICAL MAT R B; Wu MY, 2013, CARBON, V51, P335, DOI 10.1016/j.carbon.2012.08.061; Wu SL, 2014, MAT SCI ENG R, V80, P1, DOI 10.1016/j.mser.2014.04.001; Xia ZM, 2013, ACTA BIOMATER, V9, P7308, DOI 10.1016/j.actbio.2013.03.038; Xiao Y, 2010, INT J ORAL SCI, V2, P127, DOI 10.4248/IJOS10045; Ye XH, 2012, TISSUE ENG PART C-ME, V18, P545, DOI [10.1089/ten.TEC.2011.0470, 10.1089/ten.tec.2011.0470]; Yu B, 2013, J NANOMATER, V2013, DOI 10.1155/2013/506593; Zhang CY, 2012, J APPL POLYM SCI, V124, P397, DOI 10.1002/app.35103; Zhou DA, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-239	42	24	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135366	10.1371/journal.pone.0135366	http://dx.doi.org/10.1371/journal.pone.0135366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258851	gold, Green Published, Green Submitted			2022-12-27	WOS:000359352600062
J	Liu, L; Xiong, N; Zhang, P; Chen, CN; Huang, JS; Zhang, GX; Xu, XY; Shen, Y; Lin, ZC; Wang, T				Liu, Ling; Xiong, Nian; Zhang, Ping; Chen, Chunnuan; Huang, Jinsha; Zhang, Guoxin; Xu, Xiaoyun; Shen, Yan; Lin, Zhicheng; Wang, Tao			Genetic Variants in GAPDH Confer Susceptibility to Sporadic Parkinson's Disease in a Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ALZHEIMERS-DISEASE; PROTEIN; LEWY; METAANALYSIS; COMPLEX	Background Accumulating evidence has demonstrated that the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a part of Lewy body inclusions and involves the pathogenesis of Parkinson's disease (PD). However, it remains unknown whether or not genetic variation at the GAPDH locus contributes to the risk for PD. Methods A total of 302 sporadic PD patients and 377 control subjects were recruited in our study for assessing two single nucleotide polymorphisms (rs3741918 and rs1060619) in the GAPDH gene. Both allelic association and additive models were used to analyze association between GAPDH variants and risk for PD. Results Both polymorphisms were significantly associated with risk for PD after correction by Bonferroni multiple testing. The minor allele of rs3741918 was associated with decreased risk of sporadic PD (allelic contrast, OR = 0.74, 95% CI: 0.59-0.93, corrected P = 0.028; additive model, OR = 0.73, 95% CI: 0.58-0.92, corrected P = 0.018). While for the rs1060619 locus, the minor allele conferred increased risk for PD (allelic contrast, OR = 1.41, 95% CI: 1.14-1.75, corrected P = 0.007; additive model, OR = 1.43, 95% CI: 1.15-1.79, corrected P = 0.002). Conclusion Our study indicates that GAPDH variants confer susceptibility to sporadic PD in a Chinese Han population, which is consistent with the role of GAPDH protein in neuronal apoptosis. To our knowledge, this is the first study of genetic association between GAPDH locus and risk for PD in the Chinese population.	[Liu, Ling; Xiong, Nian; Huang, Jinsha; Zhang, Guoxin; Xu, Xiaoyun; Shen, Yan; Wang, Tao] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan 430074, Hubei, Peoples R China; [Zhang, Ping] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Wenzhou, Zhejiang, Peoples R China; [Chen, Chunnuan] Fujian Med Univ, Affiliated Hosp 2, Dept Neurol, Quanzhou, Fujian, Peoples R China; [Lin, Zhicheng] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02178 USA; [Lin, Zhicheng] Harvard Univ, Sch Med, Harvard NeuroDiscovery Ctr, Belmont, MA 02178 USA; [Lin, Zhicheng] McLean Hosp, Div Alcohol & Drug Abuse, Lab Psychiat Neurogen, Belmont, MA 02178 USA	Huazhong University of Science & Technology; Wenzhou Medical University; Fujian Medical University; Harvard University; Harvard University; Harvard University; McLean Hospital	Wang, T (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan 430074, Hubei, Peoples R China.	wangtaowh@hust.edu.cn			National Natural Science Foundation of China [81471305, 31171211, 81200983, 81301082]; China Medical Foundation [2012B09]; Hubei Molecular Imaging Key Laboratory [0203201343]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Medical Foundation(China Medical University); Hubei Molecular Imaging Key Laboratory	This study was supported by the National Natural Science Foundation of China (No. 81471305 and 31171211 to TW, No. 81200983 to NX, No. 81301082 to JH), China Medical Foundation (No. 2012B09 to NX) and Hubei Molecular Imaging Key Laboratory (No. 0203201343 to NX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.002; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; Charlesworth G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.001; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Fukuhara Y, 2001, NEUROREPORT, V12, P2049, DOI 10.1097/00001756-200107030-00051; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang J, 2011, NEUROSCIENCE, V192, P598, DOI 10.1016/j.neuroscience.2011.06.050; Huang JS, 2009, BRAIN RES, V1279, P1, DOI 10.1016/j.brainres.2009.05.011; Hunn BHM, 2015, TRENDS NEUROSCI, V38, P178, DOI 10.1016/j.tins.2014.12.009; Kodama R, 2005, GENES CELLS, V10, P1211, DOI 10.1111/j.1365-2443.2005.00911.x; Lee JH, 2008, NEUROGENETICS, V9, P127, DOI 10.1007/s10048-008-0122-8; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Lin PI, 2006, NEUROLOGY, V67, P64, DOI 10.1212/01.wnl.0000223438.90113.4e; Maruyama W, 2002, NEUROSCI LETT, V321, P29, DOI 10.1016/S0304-3940(01)02490-9; Nakajima H, 2009, BIOCHEM BIOPH RES CO, V390, P1066, DOI 10.1016/j.bbrc.2009.10.118; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Olah J, 2006, FEBS LETT, V580, P5807, DOI 10.1016/j.febslet.2006.09.037; Sutherland GT, 2011, J ALZHEIMERS DIS, V25, P395, DOI 10.3233/JAD-2011-110026; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; Verstraeten A, 2015, TRENDS GENET, V31, P140, DOI 10.1016/j.tig.2015.01.004; Zhang P, 2014, GENOME, V57, P253, DOI 10.1139/gen-2014-0032	26	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135425	10.1371/journal.pone.0135425	http://dx.doi.org/10.1371/journal.pone.0135425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258539	Green Submitted, Green Published, gold			2022-12-27	WOS:000359352600067
J	Kumar, K; Singh, A; Kumar, S; Ram, F; Singh, A; Ram, U; Negin, J; Kowal, PR				Kumar, Kaushalendra; Singh, Ashish; Kumar, Santosh; Ram, Faujdar; Singh, Abhishek; Ram, Usha; Negin, Joel; Kowal, Paul R.			Socio-Economic Differentials in Impoverishment Effects of Out-of-Pocket Health Expenditure in China and India: Evidence from WHO SAGE	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; POLICY IMPLICATIONS; MEDICAL EXPENSES; CARE; POVERTY; PAYMENTS; CHILDREN; ASIA	Background and Objectives The provision of affordable health care is generally considered a fundamental goal of a welfare state. In addition to its role in maintaining and improving the health status of individuals and households, it impacts the economic prosperity of a society through its positive effects on labor productivity. Given this context, this paper assesses socioeconomic-differentials in the impact of out-of-pocket-health-expenditure (OOPHE) on impoverishment in China and India, two of the fastest growing economies of the world. Data and Methods The paper uses data from the World Health Organisation's Study on Global Ageing and Adult Health (WHO SAGE), and Bivariate as well as Multivariate analyses for investigating the socioeconomic-differentials in the impact of out-of-pocket-health-expenditure (OOPHE) on impoverishment in China and India. Results and Conclusions Annually, about 7% and 8% of the population in China and India, respectively, fall in poverty due to OOPHE. Also, the percentage shortfall in income for the population from poverty line due to OOPHE is 2% in China and 1.3% in India. Further, findings from the multivariate analysis indicate that lower wealth status and inpatient as well as outpatient care increase the odds of falling below poverty line significantly (with the extent much higher in the case of inpatient care) due to OOPHE in both China and India. In addition, having at least an under-5 child in the household, living in rural areas and having a household head with no formal education increases the odds of falling below poverty line significantly (compared to a head with college level education) due to OOPHE in China; whereas having at least an under-5 child, not having health insurance and residing in rural areas increases the odds of becoming poor significantly due to OOPHE in India.	[Kumar, Kaushalendra; Ram, Faujdar; Singh, Abhishek; Ram, Usha] Int Inst Populat Sci, Bombay, Maharashtra, India; [Singh, Ashish] Indian Inst Technol, Bombay, Maharashtra, India; [Kumar, Santosh] Sam Houston State Univ, Houston, TX USA; [Negin, Joel] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Kowal, Paul R.] World Hlth Org WHO, Geneva, Switzerland	International Institute for Population Sciences; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Texas State University System; Sam Houston State University; University of Sydney; World Health Organization	Kumar, K (corresponding author), Int Inst Populat Sci, Bombay, Maharashtra, India.	kaushalendra.1983@gmail.com	Kumar, Kaushalendra/ABC-7943-2020; Singh, Abhishek/ABC-7813-2020; Ram, Usha/AAS-4140-2020	Kumar, Kaushalendra/0000-0001-5913-0297; Singh, Abhishek/0000-0001-6263-4410; Ram, Usha/0000-0001-6722-7347; Kowal, Paul/0000-0002-6314-8753	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Alam K, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-21; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Barber SL, 2010, HEALTH INSURANCE SYS; BHASKARAM P, 1987, Indian Journal of Pediatrics, V54, P535, DOI 10.1007/BF02749048; Boing AC, 2014, REV SAUDE PUBL, V48, P797, DOI 10.1590/S0034-8910.2014048005113; Bonu S, 2009, HEALTH POLICY AND PL; Bredenkamp C, 2011, HEALTH POLICY PLANN, V26, P349, DOI 10.1093/heapol/czq070; Buigut S, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0168-9; Cao SX, 2009, J POLICY MODEL, V31, P298, DOI 10.1016/j.jpolmod.2008.09.004; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Ghosh S, 2011, ECONOMIC AND POLITIC, VXLVI; Gustafsson B, 2004, CHINA ECON REV, V15, P292, DOI 10.1016/j.chieco.2003.07.004; Ha N, 2011, HEALTH POLICY PLANN, V26, pi53, DOI 10.1093/heapol/czr028; HAFFNER J, 1987, EUR ARCH PSY CLIN N, V236, P288, DOI 10.1007/BF00380954; Minh VH, 2013, SOC SCI MED, V96, P258, DOI 10.1016/j.socscimed.2012.11.028; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; IIPS & WHO, 2013, STUDY ON GLOBAL AGEI; Kanjilal B, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-19; Kawabata K, 2002, B WORLD HEALTH ORGAN, V80, P612; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kruk ME, 2009, HEALTH AFFAIR, V28, P1056, DOI 10.1377/hlthaff.28.4.1056; Laveesh B, 2010, ECONOMIC AND POLITIC, VXLV; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Li XH, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-506; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093253; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Meng QY, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001694; O'Donnell O., 2008, CATASTROPHIC PAYMENT; Pal R, 2012, INT J HEALTH CARE FI, V12, P63, DOI 10.1007/s10754-012-9103-4; Pathak PK, 2011, SOC SCI MED, V73, P576, DOI 10.1016/j.socscimed.2011.06.024; Raban MZ, 2013, B WORLD HEALTH ORGAN, V91, P726, DOI 10.2471/BLT.12.113100; Roger JP, 2007, AM J PUBLIC HEALTH, V97, P804, DOI 10.2105/AJPH.2005.080184; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; WHO, 2014, HEALTH FINANCING HEA, DOI Geneva; Xu K, 2003, LANCET, V362, P997, DOI 10.1016/S0140-6736(03)14377-2; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2005, DISCUSSION PAPER 2; Xu K, 2009, HEALTH CARE FINANCIN; Zhang L, 2013, HEALTH POLICY AND PL	44	56	56	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135051	10.1371/journal.pone.0135051	http://dx.doi.org/10.1371/journal.pone.0135051			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JX	26270049	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800033
J	Lyberopoulou, A; Chachami, G; Gatselis, NK; Kyratzopoulou, E; Saitis, A; Gabeta, S; Eliades, P; Paraskeva, E; Zachou, K; Koukoulis, GK; Mamalaki, A; Dalekos, GN; Simos, G				Lyberopoulou, Aggeliki; Chachami, Georgia; Gatselis, Nikolaos K.; Kyratzopoulou, Eleni; Saitis, Asterios; Gabeta, Stella; Eliades, Petros; Paraskeva, Efrosini; Zachou, Kalliopi; Koukoulis, George K.; Mamalaki, Avgi; Dalekos, George N.; Simos, George			Low Serum Hepcidin in Patients with Autoimmune Liver Diseases	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; IRON OVERLOAD; GENE-EXPRESSION; PEPTIDE; ANTIBODIES; DISORDERS; SEVERITY; ANEMIA; IGA	Hepcidin, a liver hormone, is important for both innate immunity and iron metabolism regulation. As dysfunction of the hepcidin pathway may contribute to liver pathology, we analysed liver hepcidin mRNA and serum hepcidin in patients with chronic liver diseases. Hepcidin mRNA levels were determined in liver biopsies obtained from 126 patients with HCV (n = 21), HBV (n = 23), autoimmune cholestatic disease (primary biliary cirrhosis and primary sclerosing cholangitis; PBC/PSC; n = 34), autoimmune hepatitis (AIH; n = 16) and non-alcoholic fatty liver disease (NAFLD; n = 32). Sera sampled on the biopsy day from the same patients were investigated for serum hepcidin levels. Hepatic hepcidin mRNA levels correlated positively with ferritin and negatively with serum gamma-GT levels. However, no correlation was found between serum hepcidin and either ferritin or liver hepcidin mRNA. Both serum hepcidin and the serum hepcidin/ferritin ratio were significantly lower in AIH and PBC/PSC patients' sera compared to HBV, HCV or NAFLD (P<0.001 for each comparison) and correlated negatively with serum ALP levels. PBC/PSC and AIH patients maintained low serum hepcidin during the course of their two-year long treatment. In summary, parallel determination of liver hepcidin mRNA and serum hepcidin in patients with chronic liver diseases shows that circulating hepcidin and its respective ratio to ferritin are significantly diminished in patients with autoimmune liver diseases. These novel findings, once confirmed by follow-up studies involving bigger size and better-matched disease subgroups, should be taken into consideration during diagnosis and treatment of autoimmune liver diseases.	[Lyberopoulou, Aggeliki; Chachami, Georgia; Simos, George] Univ Thessaly, Biochem Lab, Fac Med, Larisa, Greece; [Gatselis, Nikolaos K.; Saitis, Asterios; Gabeta, Stella; Zachou, Kalliopi; Dalekos, George N.] Univ Thessaly, Dept Med, Fac Med, Larisa, Greece; [Gatselis, Nikolaos K.; Saitis, Asterios; Gabeta, Stella; Zachou, Kalliopi; Dalekos, George N.] Univ Thessaly, Res Lab Internal Med, Fac Med, Larisa, Greece; [Kyratzopoulou, Eleni; Eliades, Petros; Mamalaki, Avgi] Hellenic Pasteur Inst, Lab Mol Biol & Immunobiotechnol, Athens, Greece; [Paraskeva, Efrosini] Univ Thessaly, Physiol Lab, Fac Med, Larisa, Greece; [Koukoulis, George K.] Univ Thessaly, Dept Pathol, Fac Med, Larisa, Greece; [Lyberopoulou, Aggeliki; Chachami, Georgia; Simos, George] Inst Res & Technol Thessaly IRETETH, Larisa, Greece	University of Thessaly; University of Thessaly; University of Thessaly; University of Thessaly; University of Thessaly	Dalekos, GN (corresponding author), Univ Thessaly, Dept Med, Fac Med, Larisa, Greece.	georgedalekos@gmail.com; simos@med.uth.gr	Paraskeva, Efrosyni/E-6449-2015; Simos, George/AAH-2596-2021	Paraskeva, Efrosyni/0000-0002-1312-0322; Chachami, Georgia/0000-0002-4771-4196; Simos, George/0000-0001-5453-3185	NSRF [09SYN-12-682]; National Range Action "COOPERATION"; Greek Government; European Union - European Regional Development Fund	NSRF; National Range Action "COOPERATION"; Greek Government(Greek Ministry of Development-GSRT); European Union - European Regional Development Fund	This work was supported by program 09SYN-12-682, which is implemented under the auspices of NSRF and the National Range Action "COOPERATION" and co-funded by the Greek Government and the European Union - European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Barisani D, 2008, J HEPATOL, V49, P123, DOI 10.1016/j.jhep.2008.03.011; Camaschella C, 2009, HAEMATOL-HEMATOL J, V94, P307, DOI 10.3324/haematol.2008.005405; Chachami G, 2013, BIOCHEM BIOPH RES CO, V435, P540, DOI 10.1016/j.bbrc.2013.04.085; Chamaillard M, 2011, WORLD J GASTROENTERO, V17, P567, DOI 10.3748/wjg.v17.i5.567; Corengia C, 2005, AM J CLIN PATHOL, V124, P846, DOI 10.1309/X4UH5Q68Q4J3GDNV; Dao MC, 2013, ADV NUTR, V4, P602, DOI 10.3945/an.113.004424; Detivaud L, 2005, BLOOD, V106, P746, DOI 10.1182/blood-2004-12-4855; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fujita N, 2008, J HEPATOL, V49, P702, DOI 10.1016/j.jhep.2008.05.014; Fujita N, 2007, MOL MED, V13, P97, DOI 10.2119/2006-00057.Fujita; Gabeta S, 2007, J CLIN IMMUNOL, V27, P378, DOI 10.1007/s10875-007-9092-0; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Gatselis NK, 2005, WORLD J GASTROENTERO, V11, P482, DOI 10.3748/wjg.v11.i4.482; Gatselis NK, 2013, AUTOIMMUNITY, V46, P471, DOI 10.3109/08916934.2013.801461; Gatselis NK, 2012, CLIN CHIM ACTA, V413, P1683, DOI 10.1016/j.cca.2012.05.015; Girelli D, 2009, J HEPATOL, V51, P845, DOI 10.1016/j.jhep.2009.06.027; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Huang YH, 2009, LAB INVEST, V89, P1128, DOI 10.1038/labinvest.2009.82; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Koliaraki V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004581; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Lang KS, 2007, J AUTOIMMUN, V29, P206, DOI 10.1016/j.jaut.2007.07.018; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Ludwig J, 1997, GASTROENTEROLOGY, V112, P882, DOI 10.1053/gast.1997.v112.pm9041250; Martinelli AL, 2004, J GASTROEN HEPATOL, V19, P1036, DOI 10.1111/j.1440-1746.2004.03410.x; Martinelli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048250; Muckenthaler MU, 2008, CELL METAB, V8, P1, DOI 10.1016/j.cmet.2008.06.009; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pietrangelo A, 2011, J HEPATOL, V54, P173, DOI 10.1016/j.jhep.2010.08.004; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Ravasi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036425; Rigopoulou Eirini I, 2008, Expert Opin Med Diagn, V2, P621, DOI 10.1517/17530059.2.6.621; Rouault TA, 2003, ALCOHOL, V30, P103, DOI 10.1016/S0741-8329(03)00102-2; Ruchala P, 2014, TRENDS PHARMACOL SCI, V35, P155, DOI 10.1016/j.tips.2014.01.004; Silva B, 2015, BBA-MOL BASIS DIS, V1852, P1347, DOI 10.1016/j.bbadis.2015.03.011; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Steinbicker AU, 2013, NUTRIENTS, V5, P3034, DOI 10.3390/nu5083034; Tan TCH, 2012, LIVER INT, V32, P1391, DOI 10.1111/j.1478-3231.2012.02828.x; Trombini P, 2007, J HEPATOL, V46, P549, DOI 10.1016/j.jhep.2007.01.004; Tsochatzis E, 2010, J VIRAL HEPATITIS, V17, P800, DOI 10.1111/j.1365-2893.2009.01244.x; Turlin B, 2001, AM J CLIN PATHOL, V116, P263; Williamson KD, 2014, DIGEST DIS, V32, P438, DOI 10.1159/000358150; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Zhang XL, 2013, BIOL CHEM, V394, P231, DOI 10.1515/hsz-2012-0217	57	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135486	10.1371/journal.pone.0135486	http://dx.doi.org/10.1371/journal.pone.0135486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270641	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800083
J	Puchner, SE; Kutscha-Lissberg, P; Kaider, A; Panotopoulos, J; Puchner, R; Bohler, C; Hobusch, G; Windhager, R; Funovics, PT				Puchner, Stephan E.; Kutscha-Lissberg, Paul; Kaider, Alexandra; Panotopoulos, Joannis; Puchner, Rudolf; Boehler, Christoph; Hobusch, Gerhard; Windhager, Reinhard; Funovics, Philipp T.			Outcome after Reconstruction of the Proximal Tibia - Complications and Competing Risk Analysis	PLOS ONE			English	Article							LIMB SALVAGE SURGERY; BONE-TUMOR RESECTION; ENDOPROSTHETIC REPLACEMENT; EXTENSOR MECHANISM; MALIGNANT-TUMORS; OSTEOARTICULAR ALLOGRAFTS; EXTREMITY OSTEOSARCOMA; FOLLOW-UP; KNEE; PROSTHESIS	Background and Objectives The proximal tibia (pT) is a common site for bone tumors. Improvements in imaging, chemotherapy and surgical technique made limb salvage surgery the treatment of choice. Yet, reconstructions of the pT have been associated with less favorable outcome compared to other parts of the extremities. The aim of this study was to evaluate the outcome of patients with a modular endoprosthetic reconstruction of the pT. Methods Eighty-one consecutive patients with an average age of 29 years underwent endoprosthetic reconstruction of the pT. Postoperative complications were categorized according to the ISOLS classification, and revision-free survival until first complication (any Type 1-5), soft tissue failure (Type 1), aseptic loosening (Type 2), structural failure (Type 3), infection (Type 4), and local tumor progression (Type 5) was estimated by using a Fine-Gray model for competing risk analyses for univariate and multivariable regression with Firth's bias correction. Results A total of 45 patients (56%) had at least one complication. Cumulative incidence for complication Types 1 to 5 at 5 years with death and amputation as competing events revealed a risk of 41% for the first complication, 14% for Type 1, 16% for Type 2, 11% for Type 3, 17% for Type 4, and 1% for Type 5. Conclusion Despite inclusion of amputation and death as strong competing events, pT replacements are still associated with a high risk of postoperative failures. The results suggest that infection and soft tissue failures (Type 1 and 5) seem to depend from each other. Sufficient soft tissue reconstruction and closure allow better function and reduce the risk of infection as the most prominent complication. The use of a rotating hinge design has significantly reduced structural failures over time.	[Puchner, Stephan E.; Kutscha-Lissberg, Paul; Panotopoulos, Joannis; Boehler, Christoph; Hobusch, Gerhard; Windhager, Reinhard; Funovics, Philipp T.] Med Univ Vienna, Vienna Gen Hosp, Dept Orthoped, Vienna, Austria; [Kaider, Alexandra] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Clin Biometr, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Puchner, SE (corresponding author), Med Univ Vienna, Vienna Gen Hosp, Dept Orthoped, Vienna, Austria.	stephan.puchner@meduniwien.ac.at	Hobusch, Gerhard/AAA-6637-2021	Hobusch, Gerhard M/0000-0002-4123-6680; Windhager, Reinhard/0000-0002-6321-1804				AG H, 1979, BONE TUMORS DIAGNOSI; Ahlmann ER, 2006, J BONE JOINT SURG BR, V88B, P790, DOI 10.1302/0301-620X.88B6; Ayerza MA, 2006, CLIN ORTHOP RELAT R, P33, DOI 10.1097/01.blo.0000229291.21722.b5; Biau DJ, 2007, CLIN ORTHOP RELAT R, P211, DOI 10.1097/BLO.0b013e31802ba478; Bickels J, 2001, J ARTHROPLASTY, V16, P856, DOI 10.1054/arth.2001.25502; BRIEN EW, 1994, CLIN ORTHOP RELAT R, P116; CAMPANACCI M, 1979, J BONE JOINT SURG BR, V61, P455, DOI 10.1302/0301-620X.61B4.227909; CLOHISY DR, 1994, J BONE JOINT SURG AM, V76A, P549, DOI 10.2106/00004623-199404000-00009; Dominkus M, 2006, CLIN ORTHOP RELAT R, P328, DOI 10.1097/01.blo.0000229368.42738.b6; Donati D, 2002, CLIN ORTHOP RELAT R, P192; Donati D, 2008, CLIN ORTHOP RELAT R, V466, P459, DOI 10.1007/s11999-007-0055-9; ECKARDT JJ, 1991, ORTHOP CLIN N AM, V22, P149; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GEBHARDT MC, 1991, CLIN ORTHOP RELAT R, P181; Gosheger G, 2001, CLIN ORTHOP RELAT R, P264; Gosheger G, 2006, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000223978.36831.39; GOTTSAUNERWOLF F, 1991, J BONE JOINT SURG AM, V73A, P1365, DOI 10.2106/00004623-199173090-00012; Grimer RJ, 1999, J BONE JOINT SURG BR, V81B, P488, DOI 10.1302/0301-620X.81B3.9234; Henderson ER, 2014, BONE JOINT J, V96B, P1436, DOI 10.1302/0301-620X.96B11.34747; Henderson ER, 2011, J BONE JOINT SURG AM, V93A, P418, DOI 10.2106/JBJS.J.00834; Higuera CA, 2005, J ORTHOP RES, V23, P1091, DOI 10.1016/j.orthres.2005.01.017; Hornicek FJ, 1998, CLIN ORTHOP RELAT R, P179; HOROWITZ SM, 1991, J BONE JOINT SURG AM, V73A, P286, DOI 10.2106/00004623-199173020-00017; HOROWITZ SM, 1993, CLIN ORTHOP RELAT R, P280; Jeys LM, 2005, J BONE JOINT SURG AM, V87A, P842, DOI 10.2106/JBJS.C.01222; Kohl M, 2015, COMPUT METH PROG BIO, V118, P218, DOI 10.1016/j.cmpb.2014.11.009; Kotz R, 1997, SEMIN SURG ONCOL, V13, P34, DOI 10.1002/(SICI)1098-2388(199701/02)13:1<34::AID-SSU6>3.0.CO;2-5; Lee SH, 2002, INT ORTHOP, V26, P179, DOI 10.1007/s00264-001-0328-y; MALAWER MM, 1989, CLIN ORTHOP RELAT R, P231; MALAWER MM, 1995, J BONE JOINT SURG AM, V77A, P1154, DOI 10.2106/00004623-199508000-00003; Mankin HJ, 1996, CLIN ORTHOP RELAT R, P86; Mavrogenis AF, 2013, J SURG ONCOL, V107, P335, DOI 10.1002/jso.23216; Mittermayer F, 2002, J BONE JOINT SURG BR, V84B, P401, DOI 10.1302/0301-620X.84B3.12204; Myers GJC, 2007, J BONE JOINT SURG BR, V89B, P1632, DOI 10.1302/0301-620X.89B12.19481; Orlic D, 2006, INT ORTHOP, V30, P458, DOI 10.1007/s00264-006-0193-9; Pendegrass CJ, 2006, J BONE JOINT SURG BR, V88B, P1245, DOI 10.1302/0301-620X.88B9.17748; PETSCHNIG R, 1995, ACTA ORTHOP SCAND, V66, P266, DOI 10.3109/17453679508995539; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Schuh R, 2015, CLIN ORTHOP RELAT R, V473, P900, DOI 10.1007/s11999-014-3703-x; Shimose S, 2005, CLIN ORTHOP RELAT R, P176, DOI 10.1097/01.blo.0000176150.16509.33; Unwin PS, 1996, J BONE JOINT SURG BR, V78B, P5, DOI 10.1302/0301-620X.78B1.0780005; Wunder JS, 2001, J SURG ONCOL, V77, P89, DOI 10.1002/jso.1076.abs; Yoshida Y, 2010, SURG TODAY, V40, P646, DOI 10.1007/s00595-009-4161-z	43	30	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135736	10.1371/journal.pone.0135736	http://dx.doi.org/10.1371/journal.pone.0135736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270336	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800106
J	Annighofer, P; Beckschafer, P; Vor, T; Ammer, C				Annighoefer, Peter; Beckschaefer, Philip; Vor, Torsten; Ammer, Christian			Regeneration Patterns of European Oak Species (Quercus petraea (Matt.) Liebl., Quercus robur L.) in Dependence of Environment and Neighborhood	PLOS ONE			English	Article							AFFECTING NATURAL REGENERATION; FAGUS-SYLVATICA L.; FOREST MANAGEMENT; OVERSTORY DENSITY; SITE PREPARATION; WATER RELATIONS; CLIMATE-CHANGE; EARLY GROWTH; NORTH WALES; SEEDLINGS	Quercus robur L. (pedunculate oak) and Quercus petraea (Matt.) Liebl. (sessile oak) are two European oak species of great economic and ecological importance. Even though both oaks have wide ecological amplitudes of suitable growing conditions, forests dominated by oaks often fail to regenerate naturally. The regeneration performance of both oak species is assumed to be subject to a variety of variables that interact with one another in complex ways. The novel approach of this research was to study the effect of many ecological variables on the regeneration performance of both oak species together and identify key variables and interactions for different development stages of the oak regeneration on a large scale in the field. For this purpose, overstory and regeneration inventories were conducted in oak dominated forests throughout southern Germany and paired with data on browsing, soil, and light availability. The study was able to verify the assumption that the occurrence of oak regeneration depends on a set of variables and their interactions. Specifically, combinations of site and stand specific variables such as light availability, soil pH and iron content on the one hand, and basal area and species composition of the overstory on the other hand. Also browsing pressure was related to oak abundance. The results also show that the importance of variables and their combinations differs among the development stages of the regeneration. Light availability becomes more important during later development stages, whereas the number of oaks in the overstory is important during early development stages. We conclude that successful natural oak regeneration is more likely to be achieved on sites with lower fertility and requires constantly controlling overstory density. Initially sufficient mature oaks in the overstory should be ensured. In later stages, overstory density should be reduced continuously to meet the increasing light demand of oak seedlings and saplings.	[Annighoefer, Peter; Vor, Torsten; Ammer, Christian] Univ Gottingen, Dept Silviculture & Forest Ecol Temperate Zones, D-37077 Gottingen, Germany; [Beckschaefer, Philip] Univ Gottingen, Chair Forest Inventory & Remote Sensing, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen	Annighofer, P (corresponding author), Univ Gottingen, Dept Silviculture & Forest Ecol Temperate Zones, Busgenweg 1, D-37077 Gottingen, Germany.	peter.annighoefer@forst.uni-goettingen.de	Annighöfer, Peter/AAS-8418-2021; Ammer, Christian/ABG-4629-2020; Ammer, Christian/ABG-7360-2020	Annighöfer, Peter/0000-0001-8126-5307; Ammer, Christian/0000-0002-4235-0135; Beckschafer, Philip/0000-0003-1728-724X	Bavarian Ministry for Food, Agriculture and Forestry	Bavarian Ministry for Food, Agriculture and Forestry	The research was funded by the Bavarian Ministry for Food, Agriculture and Forestry.	Aas G, 1784, HDB ATLAS DENDROLOGI; Aas G, 1998, LIBRI BOT, V19; Abrams MD, 2005, NORTH J APPL FOR, V22, P190, DOI 10.1093/njaf/22.3.190; ABRAMS MD, 1992, BIOSCIENCE, V42, P346, DOI 10.2307/1311781; AkStok, 2003, FORSTL STAND BEGR DE; Alaoui-Sosse B, 2005, ANN FOREST SCI, V62, P593, DOI 10.1051/forest:2005052; Aldrich PR, 2005, FOREST SCI, V51, P406; Ammer C, 2008, TREE PHYSIOL, V28, P721, DOI 10.1093/treephys/28.5.721; Ammer U, 1999, FORSTWISS CENTRALBL, V118, P70, DOI 10.1007/BF02768976; ASKEW RR, 1980, J ANIM ECOL, V49, P817, DOI 10.2307/4229; Bergquist J, 2009, SCAND J FOREST RES, V24, P308, DOI 10.1080/02827580903117420; BMELV, 2002, ZWEIT BUND BWI2 WICH; Bohme J, 2001, PHYTOPHAGE KAFER IHR; Bolte A, 2009, SCAND J FOREST RES, V24, P473, DOI 10.1080/02827580903418224; BOSSEMA I, 1979, BEHAVIOUR, V70, P1, DOI 10.1163/156853979X00016; Bourtsoukidis E, 2014, TREES-STRUCT FUNCT, V28, P193, DOI 10.1007/s00468-013-0942-5; BREDA N, 1993, ANN SCI FOREST, V50, P571, DOI 10.1051/forest:19930606; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cater M, 2006, EUR J FOREST RES, V125, P419, DOI 10.1007/s10342-006-0134-6; Collet C, 1996, CAN J BOT, V74, P1562, DOI 10.1139/b96-189; Crawley M.J., 2007, R BOOK; CROW TR, 1988, FOREST SCI, V34, P19; Dech JP, 2008, FOREST ECOL MANAG, V256, P760, DOI 10.1016/j.foreco.2008.05.033; Dey DC, 2000, FOREST CHRON, V76, P339, DOI 10.5558/tfc76339-2; DREYER E, 1994, ANN SCI FOREST, V51, P417, DOI 10.1051/forest:19940407; EITINGEN GR., 1926, FORSTW CENTRALBL, V48, P849, DOI 10.1007/BF02423252; Ellenberg H, 2001, ZEIGERWERTE PFLANZEN, V3rd ed; GILL RMA, 1992, FORESTRY, V65, P363, DOI 10.1093/forestry/65.4.363-a; Giraudoux P., 2014, PGIRMESS DATA ANAL E; Goldberg D. E., 1990, Perspectives on plant competition., P27; Grundmann, 2008, ARCH FORSTWESEN LAND, V42, P97; HARMER R, 1994, FORESTRY, V67, P275, DOI 10.1093/forestry/67.4.275-a; JARVIS PG, 1964, J ECOL, V52, P545, DOI 10.2307/2257848; Krahl-Urban J, 1959, FORSTLICHE MONOGRAPH; Kuhne C, 2004, VERJUNGUNG STIELEICH; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Larsen DR, 1997, CAN J FOREST RES, V27, P869, DOI 10.1139/cjfr-27-6-869; Ligot G, 2013, FOREST ECOL MANAG, V304, P391, DOI 10.1016/j.foreco.2013.05.050; Lof M, 1998, FOREST ECOL MANAG, V109, P241, DOI 10.1016/S0378-1127(98)00254-0; Lof M, 2000, CAN J FOREST RES, V30, P855, DOI 10.1139/cjfr-30-6-855; Lof M, 2004, ANN FOREST SCI, V61, P781, DOI 10.1051/forest:2004075; LORIMER CG, 1994, J ECOL, V82, P227, DOI 10.2307/2261291; Lupke B. V., 1999, Forst und Holz, V54, P563; Lupke B. von, 2004, Allgemeine Forst- und Jagdzeitung, V175, P61; Major KC, 2013, FOREST ECOL MANAG, V291, P144, DOI 10.1016/j.foreco.2012.12.006; Meyer P, 2006, NATURWALDER NIEDERSA, V1; Muller J, 2007, J APPL ENTOMOL, V131, P613, DOI 10.1111/j.1439-0418.2007.01227.x; Muller J, 2009, FOREST ECOL MANAG, V257, P502, DOI 10.1016/j.foreco.2008.09.023; Nilsson U, 1996, NEW FOREST, V12, P69, DOI 10.1007/BF00029983; Oksanen J., 2020, VEGAN COMMUNITY ECOL; OVINGTON JD, 1960, J ECOL, V48, P549, DOI 10.2307/2257332; Parelle J, 2007, TREE PHYSIOL, V27, P1027, DOI 10.1093/treephys/27.7.1027; Parker WC, 2008, TREE PHYSIOL, V28, P797, DOI 10.1093/treephys/28.5.797; Parrott DL, 2013, NORTH J APPL FOR, V30, P125, DOI 10.5849/njaf.13-002; Pretzsch H, 2001, MODELLIERUNG WALDSWA; R Core Team, 2021, R LANGUAGE ENV STAT; Reif A., 2007, WALDOEKOLOGIE ONLINE, V5, P79; Reif Albert, 2010, Naturschutz und Landschaftsplanung, V42, P261; Rohrig E, 2006, WALDBAU OKOLOGISCHER; Saha S, 2012, FOREST ECOL MANAG, V283, P106, DOI 10.1016/j.foreco.2012.07.021; Schmull M, 2000, PLANT SOIL, V225, P227, DOI 10.1023/A:1026516027096; SHAW MW, 1968, J ECOL, V56, P565, DOI 10.2307/2258251; SHAW MW, 1968, J ECOL, V56, P647, DOI 10.2307/2258097; Shaw MW., 1974, BRIT OAK, P162; SHIMODA K, 1994, ECOL RES, V9, P85, DOI 10.1007/BF02347245; ULRICH B., 1966, Zeitschrift fur Pflanzenernahrung, Dungung und Bodenkunde, V113, P141, DOI 10.1002/jpln.19661130208; Vasic V, 2014, FORESTRY, V87, P407, DOI 10.1093/forestry/cpt060; von Lupke B, 2004, P 7 INT BEECH S IUFR, P128; Wada N, 1997, AM J BOT, V84, P1294, DOI 10.2307/2446055; Watt AS, 1919, J ECOL, V7, P173, DOI 10.2307/2255275; Weber-Blaschke G, 2008, EUR J FOREST RES, V127, P465, DOI 10.1007/s10342-008-0230-x; Wiedemann E, 1927, ALLG FORST JAGDZTG, V103, P433; ZIEGENHAGEN B, 1995, FOREST ECOL MANAG, V72, P97, DOI 10.1016/0378-1127(94)03482-C	73	83	87	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134935	10.1371/journal.pone.0134935	http://dx.doi.org/10.1371/journal.pone.0134935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266803	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300067
J	Gona, JK; Newton, CR; Rimba, K; Mapenzi, R; Kihara, M; Van de Vijver, FJR; Abubakar, A				Gona, Joseph K.; Newton, Charles R.; Rimba, Kenneth; Mapenzi, Rachel; Kihara, Michael; Van de Vijver, Fons J. R.; Abubakar, Amina			Parents' and Professionals' Perceptions on Causes and Treatment Options for Autism Spectrum Disorders (ASD) in a Multicultural Context on the Kenyan Coast	PLOS ONE			English	Article							CHILDREN; FAMILIES	Objective To explore parents' and professionals' perceived causes and treatment of Autism Spectrum Disorders (ASD) on the Kenyan Coast. Methods In-depth interviews and focus group discussions using guiding questions were utilized in data collection. One hundred and three participants, who included parents of children with ASD, special needs teachers, clinicians, and social workers from diverse cultural background, participated in this study. The interviews and focus groups were recorded, transcribed verbatim and then translated to English. Themes were generated using content analysis. Results Preternatural causes were mentioned and included evil spirits, witchcraft, and curses. Biomedical causes comprised infections, drug abuse, birth complications, malnutrition, and genetic related problems. Treatment varied from traditional and spiritual healing to modern treatment in health facilities, and included consultations with traditional healers, offering prayers to God, and visits to hospitals. Conclusions The results suggest that regardless of cultural backgrounds, people on the Kenyan Coast have similar views on perceived causes and treatment of ASD. These findings provide valuable conceptual understanding for professionals when planning and implementing community based rehabilitation interventions targeting children with ASD within a local context.	[Gona, Joseph K.; Newton, Charles R.; Rimba, Kenneth; Mapenzi, Rachel; Kihara, Michael; Abubakar, Amina] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, POB 230-80108, Kilifi, Kenya; [Newton, Charles R.] Univ Oxford, Dept Psychiat, Oxford, England; [Kihara, Michael] US Int Univ Africa, Dept Psychol, Nairobi, Kenya; [Van de Vijver, Fons J. R.; Abubakar, Amina] Tilburg Univ, Dept Culture Studies, NL-5000 LE Tilburg, Netherlands; [Abubakar, Amina] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England	Kenya Medical Research Institute; University of Oxford; United States International University Africa; Tilburg University; Lancaster University	Gona, JK (corresponding author), Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, POB 230-80108, Kilifi, Kenya.	jgona@kemri-wellcome.org	van de Vijver, Fons/A-4317-2012; Newton, Charles/V-7872-2019; Newton, Charles RJC/B-7578-2014; Abubakar, Amina/F-1479-2017; Eapen, Valsamma/N-9608-2017	van de Vijver, Fons/0000-0003-0220-2485; Newton, Charles/0000-0002-6999-5507; Newton, Charles RJC/0000-0002-6999-5507; Abubakar, Amina/0000-0002-3686-7904; Meiring, Deon/0000-0003-3458-2064; Eapen, Valsamma/0000-0001-6296-8306	KEMRI/Wellcome Trust Research Programme in Kenya; Oxford University, in UK; Wellcome Trust, UK	KEMRI/Wellcome Trust Research Programme in Kenya; Oxford University, in UK; Wellcome Trust, UK(Wellcome Trust)	This work was supported by KEMRI/Wellcome Trust Research Programme in Kenya and Oxford University, in UK. Professor Charles Newton is supported by Wellcome Trust, UK and an endowment from Ed Scott.	Abubakar A, 2012, HDB ANTHROPOMENTRY P, P2679; Avdi E, 2000, J Health Psychol, V5, P241, DOI 10.1177/135910530000500214; Bakare Muideen Owolabi, 2009, Ann Gen Psychiatry, V8, P6, DOI 10.1186/1744-859X-8-6; Bernier R, 2010, CHILD ADOL PSYCH CL, V19, P855, DOI 10.1016/j.chc.2010.07.005; Daley TC, 2002, J AUTISM DEV DISORD, V32, P13, DOI 10.1023/A:1017947922349; Danseco E. R., 1997, INT J DISABIL DEV ED, V44, P41, DOI [DOI 10.1080/0156655970440104, 10.1080/0156655970440104]; Dyches TT, 2004, J AUTISM DEV DISORD, V34, P211, DOI 10.1023/B:JADD.0000022611.80478.73; Freeth M, 2013, J AUTISM DEV DISORD, V43, P2569, DOI 10.1007/s10803-013-1808-9; Gona JK, 2011, CHILD CARE HLTH DEV, V37, P175, DOI 10.1111/j.1365-2214.2010.01124.x; Gona JK, 2006, RURAL AND REMOTE HEA, V6, P556; Government of Kenya, 2009, HOUS CENS SURV; Greenhalgh T, 1998, BRIT MED J, V316, P978, DOI 10.1136/bmj.316.7136.978; Groce NE, 1999, LANCET, V354, P756, DOI 10.1016/S0140-6736(99)06140-1; Harrington JW, 2006, J DEV BEHAV PEDIATR, V27, pS156, DOI 10.1097/00004703-200604002-00014; Inglese Melissa Dodd, 2009, J Pediatr Nurs, V24, P41, DOI 10.1016/j.pedn.2007.12.006; Ingstad B, 1995, DISABILITY CULTURE; Kendall-Taylor N, 2008, EPILEPSIA, V49, P1638, DOI 10.1111/j.1528-1167.2008.01580_1.x; Kenya Bureau of Statistics, 2009, POP HOUS CENS; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Kumar S, 2009, THEATRE CULTURES AFR, P8; Levy SE, 2003, PEDIATR ANN, V32, P685, DOI 10.3928/0090-4481-20031001-10; Mandell DS, 2002, J AM ACAD CHILD PSY, V41, P1447, DOI 10.1097/00004583-200212000-00016; Pitten K, 2008, REV ACAD J, V4; Shah K, 2001, AUTISM, V5, P127, DOI 10.1177/1362361301005002003; Shaked M, 2006, CULT MED PSYCHIAT, V30, P1, DOI 10.1007/s11013-006-9006-2; Skinner DG, 2001, AM J MENT RETARD, V106, P297, DOI 10.1352/0895-8017(2001)106<0297:RORITL>2.0.CO;2; Taylor-Powel E., 2003, ANAL QUALITATIVE DAT	27	49	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0132729	10.1371/journal.pone.0132729	http://dx.doi.org/10.1371/journal.pone.0132729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267668	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300007
J	Holon, F; Mouquet, N; Boissery, P; Bouchoucha, M; Delaruelle, G; Tribot, AS; Deter, J				Holon, Florian; Mouquet, Nicolas; Boissery, Pierre; Bouchoucha, Marc; Delaruelle, Gwenaelle; Tribot, Anne-Sophie; Deter, Julie			Fine-Scale Cartography of Human Impacts along French Mediterranean Coasts: A Relevant Map for the Management of Marine Ecosystems	PLOS ONE			English	Article							SEAGRASS POSIDONIA-OCEANICA; CORALLIGENOUS ASSEMBLAGES; BIODIVERSITY; SEA; ISLANDS	Ecosystem services provided by oceans and seas support most human needs but are threatened by human activities. Despite existing maps illustrating human impacts on marine ecosystems, information remains either large-scale but rough and insufficient for stakeholders (1 km(2) grid, lack of data along the coast) or fine-scale but fragmentary and heterogeneous in methodology. The objectives of this study are to map and quantify the main pressures exerted on near-coast marine ecosystems, at a large spatial scale though in fine and relevant resolution for managers (one pixel = 20 x 20 m). It focuses on the French Mediterranean coast (1,700 km of coastline including Corsica) at a depth of 0 to 80 m. After completing and homogenizing data presently available under GIS on the bathymetry and anthropogenic pressures but also on the seabed nature and ecosystem vulnerability, we provide a fine modeling of the extent and impacts of 10 anthropogenic pressures on marine habitats. The considered pressures are man-made coastline, boat anchoring, aquaculture, urban effluents, industrial effluents, urbanization, agriculture, coastline erosion, coastal population and fishing. A 1: 10 000 continuous habitat map is provided considering 11 habitat classes. The marine bottom is mostly covered by three habitats: infralittoral soft bottom, Posidonia oceanica meadows and circalittoral soft bottom. Around two thirds of the bottoms are found within medium and medium high cumulative impact categories. Seagrass meadows are the most impacted habitats. The most important pressures (in area and intensity) are urbanization, coastal population, coastal erosion and man-made coastline. We also identified areas in need of a special management interest. This work should contribute to prioritize environmental needs, as well as enhance the development of indicators for the assessment of the ecological status of coastal systems. It could also help better apply and coordinate management measures at a relevant scale for biodiversity conservation.	[Holon, Florian; Delaruelle, Gwenaelle; Tribot, Anne-Sophie; Deter, Julie] Andromede Oceanol, F-34280 Carnon, France; [Holon, Florian; Mouquet, Nicolas; Deter, Julie] Inst Sci Evolut ISEM, CNRS, IRD, UM,UMR 5554, F-34095 Montpellier 5, France; [Boissery, Pierre] Agence Eau Rhone Mediterranee Corse, Delegat Marseille, F-13001 Marseille, France; [Bouchoucha, Marc] Ctr Mediterranee, Lab Ifremer Environm Ressources Provence Azur Cro, F-83507 La Seyne Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Ifremer	Holon, F (corresponding author), Andromede Oceanol, 7 Pl Cassan, F-34280 Carnon, France.	florian.holon@andromede-ocean.com	TRIBOT, Anne-Sophie/ABE-4289-2021; Tribot, Anne-Sophie/X-4482-2019; MOUQUET, Nicolas/AAL-1440-2021; BITOUN, RACHEL Elisabeth/AAC-9538-2021	TRIBOT, Anne-Sophie/0000-0002-8194-5393; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Mouquet, Nicolas/0000-0003-1840-6984	Agence de l'Eau RMC; Andromede Oceanologie; LabEX CeMeb; CNRS; Ifremer; University of Montpellier	Agence de l'Eau RMC; Andromede Oceanologie; LabEX CeMeb; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ifremer; University of Montpellier	This work was essentially funded by the Agence de l'Eau RMC (http://www.eaurmc.fr/) and Andromede Oceanologie (a commercial funder, http://www.andromede-ocean.com/). Florian Holon was supported by a PhD grant from LabEX CeMeb (http://www.labexcemeb.org/) and Andromede Oceanologie. Nicolas Mouquet was funded by CNRS (http://www.cnrs.fr/), Pierre Boissery by Agence de l'Eau RMC, Marc Bouchoucha by Ifremer (http://www.ifremer.fr/), Gwenaelle Delaruelle and Anne-Sophie Tribot by Andromede Oceanologie and Julie Deter by the University of Montpellier (http://www.umontpellier.fr/) and Andromede Oceanologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Andromede Oceanologie, a commercial funder, provided support in the form of salaries for authors (FH, GD, A-ST and JD), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Andromede Oceanologie Agence de leau RMC, 2014, ANDR ED; Andromede Oceanologie RMC Agence de leau, 2015, MEDTR; [Anonymous], 2013, P CARH CART HAB MAR; [Anonymous], 2006, MARINE COASTAL ECOSY; Balestri E, 1998, J EXP MAR BIOL ECOL, V228, P209, DOI 10.1016/S0022-0981(98)00027-6; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Barbera C, 2012, BIODIVERS CONSERV, V21, P701, DOI 10.1007/s10531-011-0210-1; Bavestrello G, 1997, AQUAT CONSERV, V7, P253, DOI 10.1002/(SICI)1099-0755(199709)7:3<253::AID-AQC243>3.0.CO;2-1; Bianchi Carlo Nike, 2012, Diversity-Basel, V4, P419, DOI 10.3390/d4040419; Boissery P, 2014, RAPP AGENCE EAU RHON; Bonacorsi M, 2012, CR BIOL, V335, P668, DOI 10.1016/j.crvi.2012.10.005; Bonhomme P., 2010, SCI REPORTS PORT CRO, V24, P87; Bostrom C, 2011, MAR ECOL PROG SER, V427, P191, DOI 10.3354/meps09051; Boudouresque C.-F., 2012, PROTECTION CONSERVAT; Boudouresque CF, 2009, BOT MAR, V52, P395, DOI 10.1515/BOT.2009.057; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Campagne CS, 2015, MAR POLLUT BULL, V97, P391, DOI 10.1016/j.marpolbul.2015.05.061; Cheminee A, 2014, UNDERWATER SEASCAPES; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Danovaro R, 2010, ZNG, V5, DOI [10.1371/journal.pone.0011832, DOI 10.1371/J0URNAL.P0NE.0011832]; Deter J, 2012, ECOL INDIC, V20, P345, DOI 10.1016/j.ecolind.2012.03.001; Almela ED, 2008, AQUAT BOT, V89, P397, DOI 10.1016/j.aquabot.2008.04.012; Digout D, 2005, VITAL WATER GRPHICS; Eastwood PD, 2007, ICES J MAR SCI, V64, P453, DOI 10.1093/icesjms/fsm001; European Commission, 2015, OUR OC SEAS COASTS; European Environment Agency, 2006, CORINE LAND COV 2006; Frisch AJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051938, DOI 10.1371/J0URNAL.P0NE.0051938]; Gatti Giulia, 2012, Advances in Oceanography and Limnology, V3, P51, DOI 10.1080/19475721.2012.671190; Georgiadis M, 2009, J EXP MAR BIOL ECOL, V368, P44, DOI 10.1016/j.jembe.2008.10.001; Giakoumi S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076449, DOI 10.1371/J0URNAL.P0NE.0076449]; Gobert S, 2009, MAR POLLUT BULL, V58, P1727, DOI 10.1016/j.marpolbul.2009.06.012; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Holon F, 2014, P MED S MAR KEY HAB; Holon F, 2014, DESSOUS MER MEDITERR; Insee, 2012, I NAT STAT ET EC; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Korpinen S, 2013, MAR POLLUT BULL, V74, P311, DOI 10.1016/j.marpolbul.2013.06.036; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Levin N, 2014, MAR ECOL PROG SER, V508, P261, DOI 10.3354/meps10857; Lopez Y, 2008, THESIS U CORSICA PAS; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; Marba N, 2014, BIOL CONSERV, V176, P183, DOI 10.1016/j.biocon.2014.05.024; MARTIN CS, 2014, SCI REP-UK, V4, DOI DOI 10.1038/SREP05073; Martin-Garcia L, 2013, ECOL MODEL, V263, P19, DOI 10.1016/j.ecolmodel.2013.04.005; *MEA, 2005, EC HUM WELL BEING GE; Medam French Mediterranean Coasts, 2014, MED FRENCH MED COAST; Mensa JA, 2011, J ENVIRON MANAGE, V92, P67, DOI 10.1016/j.jenvman.2010.08.003; Miccadei E, 2012, J MAPS, V8, P74, DOI [10.1080/17445647.2012.668765, 10.1080/17445647.2012.668764]; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079889; Ministere de lEcologie du Developpement Durable et de lEnergie, 2011, MIS OEUVR DCE POL LO; Ministere de lecologie et du Developpement Durable et de lEnergie (MEDDE), 2014, COMM PRESS MEDDE 27; Molenaar H, 1995, BOT MAR; Montefalcone M, 2013, AQUAT BOT, V104, P204, DOI 10.1016/j.aquabot.2011.05.009; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Musard O, 2014, UNDERWATER SEASCAPES; Occhipinti-Ambrogi A, 2007, MAR POLLUT BULL, V55, P342, DOI 10.1016/j.marpolbul.2006.11.014; Parravicini V, 2012, ECOL INDIC, V19, P253, DOI 10.1016/j.ecolind.2011.07.027; Pasqualini V, 1998, ESTUAR COAST SHELF S, V47, P359, DOI 10.1006/ecss.1998.0361; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Petrosillo I, 2010, ECOL COMPLEX, V7, P359, DOI 10.1016/j.ecocom.2010.01.001; Pittman SJ, 2011, MAR ECOL PROG SER, V427, P187, DOI 10.3354/meps09139; Rocklin D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087271, DOI 10.1371/J0URNAL.P0NE.0087271]; Rousakis G, 2014, ENVIRON EARTH SCI, V71, P5059, DOI 10.1007/s12665-013-2910-1; Rovere A, 2015, J MAPS, V11, P278, DOI 10.1080/17445647.2014.933134; Rovere A, 2013, J MAPS, V9, P279, DOI 10.1080/17445647.2013.778081; Rovere A, 2011, AQUAT CONSERV, V21, P541, DOI 10.1002/aqc.1214; Rovere A, 2010, J MAPS, V6, P505, DOI 10.4113/jom.2010.1137; RUIZ JM, 1993, OCEAN COAST MANAGE, V19, P241, DOI 10.1016/0964-5691(93)90044-Y; Scherrer D, 2010, GLOBAL CHANGE BIOL, V16, P2602, DOI 10.1111/j.1365-2486.2009.02122.x; Stachowitsch M, 2003, MAR POLLUT BULL, V46, P801, DOI 10.1016/S0025-326X(03)00109-7; Stelzenmuller V, 2010, MAR ECOL PROG SER, V398, P19, DOI 10.3354/meps08345; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Tribot A-S, 2014, THESIS U MONTPELLIER; United Nations Environment Programme (UNEP), 2014, CONV BIOL DIV; Vacchi M, 2014, SPATIAL MODELS SUPPO, P172; Zupo V, 2006, AQUAT BOT, V84, P101, DOI 10.1016/j.aquabot.2005.08.006	79	40	41	3	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135473	10.1371/journal.pone.0135473	http://dx.doi.org/10.1371/journal.pone.0135473			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266542	Green Published, gold			2022-12-27	WOS:000359492300121
J	Lee, NJ; Kang, CG				Lee, Nam-Jin; Kang, Chul-Goo			The Effect of a Variable Disc Pad Friction Coefficient for the Mechanical Brake System of a Railway Vehicle	PLOS ONE			English	Article							CONTACT; WHEEL; FORCES; TIME	A brake hardware-in-the-loop simulation (HILS) system for a railway vehicle is widely applied to estimate and validate braking performance in research studies and field tests. When we develop a simulation model for a full vehicle system, the characteristics of all components are generally properly simplified based on the understanding of each component's purpose and interaction with other components. The friction coefficient between the brake disc and the pad used in simulations has been conventionally considered constant, and the effect of a variable friction coefficient is ignored with the assumption that the variability affects the performance of the vehicle braking very little. However, the friction coefficient of a disc pad changes significantly within a range due to environmental conditions, and thus, the friction coefficient can affect the performance of the brakes considerably, especially on the wheel slide. In this paper, we apply a variable friction coefficient and analyzed the effects of the variable friction coefficient on a mechanical brake system of a railway vehicle. We introduce a mathematical formula for the variable friction coefficient in which the variable friction is represented by two variables and five parameters. The proposed formula is applied to real-time simulations using a brake HILS system, and the effectiveness of the formula is verified experimentally by testing the mechanical braking performance of the brake HILS system.	[Lee, Nam-Jin] Hyundai Rotem Co, Bogie Dev Team, Uiwang Shi, Gyeonggi Do, South Korea; [Kang, Chul-Goo] Konkuk Univ, Dept Mech Engn, Seoul, South Korea	Konkuk University	Kang, CG (corresponding author), Konkuk Univ, Dept Mech Engn, Seoul, South Korea.	cgkang@konkuk.ac.kr	LEE, Nam Jin/GZH-1954-2022; Kang, Chul-Goo/D-4231-2011	Kang, Chul-Goo/0000-0001-7172-9622	Konkuk University [2014-A019-0133]; Hyundai-Rotem Company	Konkuk University; Hyundai-Rotem Company	This work was supported by Konkuk University (http://www.konkuk.ac.kr) in 2014 (Grant number 2014-A019-0133). The funder Konkuk University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Hyundai-Rotem Company (http://www.hyundai-rotem.co.kr) provided support in the form of salaries for author Nam-Jin Lee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chul-Goo Kang, 2009, 2009 ICROS-SICE International Joint Conference. ICCAS-SICE 2009, P4073; Chul-Goo Kang, 2008, 2008 International Conference on Control, Automation and Systems (ICCAS), P7, DOI 10.1109/ICCAS.2008.4694520; Cocci G, 2001, P WORLD C RAILW RES; Cristol-Bulthe AL, 2007, WEAR, V263, P1230, DOI 10.1016/j.wear.2006.12.052; Desplanques Y, 2007, WEAR, V262, P582, DOI 10.1016/j.wear.2006.07.004; Gershenson C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007292; Johnson KL, 1986, CONTACT MECH; KALKER JJ, 1991, WEAR, V144, P243, DOI 10.1016/0043-1648(91)90018-P; Kang CG, 2007, J MECH SCI TECHNOL, V21, P1048, DOI 10.1007/BF03027654; Kim HY, 2010, INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND SYSTEMS (ICCAS 2010), P1318; Kim M., 2012, INT J SYST APPL ENG, V6, P122; Kim SH, 2011, INT J PRECIS ENG MAN, V12, P643, DOI 10.1007/s12541-011-0083-y; Lee K, 1999, SAE T, V108, P897; Lee NJ, 2012, 2012 12TH INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND SYSTEMS (ICCAS), P117; Louf R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102007; Manh-Tuan Ha, 2011, 2011 IEEE/SICE International Symposium on System Integration (SII 2011), P1335, DOI 10.1109/SII.2011.6147642; Meli E, 2014, MULTIBODY SYST DYN, V32, P133, DOI 10.1007/s11044-013-9400-9; Park SH, 2008, IEEE CONTR SYST MAG, V28, P44, DOI 10.1109/MCS.2008.927334; Polach O, 2005, WEAR, V258, P992, DOI 10.1016/j.wear.2004.03.046; Polach O, 2001, VEHICLE SYST DYN, V35, P7; Pugi L, 2006, VEHICLE SYST DYN, V44, P843, DOI 10.1080/00423110600886937; Qi HS, 2007, WEAR, V262, P505, DOI 10.1016/j.wear.2006.08.027; UIC, 2010, 5413 UIC, V7th; Yujin Machinery Ltd, 2010, TECHN DESCR BRAK SYS; Yun D, 2011, INT J PRECIS ENG MAN, V12, P31, DOI 10.1007/s12541-011-0004-0; Zeuner T, 1998, MAT SCI TECHNOL, V14, P9	26	14	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135459	10.1371/journal.pone.0135459	http://dx.doi.org/10.1371/journal.pone.0135459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267883	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300119
J	Wang, ZM; Zhao, ZZ; Lu, J; Chen, ZJ; Mao, AW; Teng, GJ; Liu, FJ				Wang, Zhongmin; Zhao, Zhenzhen; Lu, Jian; Chen, Zhijin; Mao, Aiwu; Teng, Gaojun; Liu, Fenju			A Comparison of the Biological Effects of I-125 Seeds Continuous Low-Dose-Rate Radiation and Co-60 High-Dose-Rate Gamma Radiation on Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							IRRADIATION; BCL-2; P53; BRACHYTHERAPY; MECHANISMS; EXPRESSION; FAMILY; LINES; LIFE	Objectives To compare the biological effects of I-125 seeds continuous low-dose-rate (CLDR) radiation and Co-60 gamma-ray high-dose-rate (HDR) radiation on non-small cell lung cancer (NSCLC) cells. Materials and Methods A549, H1299 and BEAS-2B cells were exposed to I-125 seeds CLDR radiation or Co-60 gamma-ray HDR radiation. The survival fraction was determined using a colony-forming assay. The cell cycle progression and apoptosis were detected by flow cytometry (FCM). The expression of the apoptosis-related proteins caspase-3, cleaved-caspase-3, PARP, cleaved-PARP, BAX and Bcl-2 were detected by western blot assay. Results After irradiation with I-125 seeds CLDR radiation, there was a lower survival fraction, more pronounced cell cycle arrest (G(1) arrest and G(2)/M arrest in A549 and H1299 cells, respectively) and a higher apoptotic ratio for A549 and H1299 cells than after Co-60 gamma-ray HDR radiation. Moreover, western blot assays revealed that I-125 seeds CLDR radiation remarkably up-regulated the expression of Bax, cleaved-caspase-3 and cleaved-PARP proteins and down-regulated the expression of Bcl-2 proteins in A549 and H1299 cells compared with Co-60 gamma-ray HDR radiation. However, there was little change in the apoptotic ratio and expression of apoptosis-related proteins in normal BEAS-2B cells receiving the same treatment. Conclusions I-125 seeds CLDR radiation led to remarkable growth inhibition of A549 and H1299 cells compared with Co-60 HDR gamma-ray radiation; A549 cells were the most sensitive to radiation, followed by H1299 cells. In contrast, normal BEAS-2B cells were relatively radio-resistant. The imbalance of the Bcl-2/Bax ratio and the activation of caspase-3 and PARP proteins might play a key role in the anti-proliferative effects induced by I-125 seeds CLDR radiation, although other possibilities have not been excluded and will be investigated in future studies.	[Wang, Zhongmin; Teng, Gaojun] Southeast Univ, Inst Mol Imaging, Nanjing, Jiangsu, Peoples R China; [Wang, Zhongmin] Shihezi Univ, Coll Med, Affiliated Hosp 3, Dept Intervent Radiol, Xinjiang, Peoples R China; [Wang, Zhongmin; Lu, Jian; Chen, Zhijin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol,Luwan Branch, Shanghai 200030, Peoples R China; [Zhao, Zhenzhen] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Zhao, Zhenzhen; Mao, Aiwu] Shanghai St Lukes Hosp, Dept Intervent Radiol, Shanghai, Peoples R China; [Liu, Fenju] Soochow Univ, Sch Radiol Med & Protect, Dept Radiobiol, Suzhou, Peoples R China	Southeast University - China; Shihezi University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Soochow University - China	Teng, GJ (corresponding author), Southeast Univ, Inst Mol Imaging, Nanjing, Jiangsu, Peoples R China.	gjteng@vip.sina.com			Natural Science Foundation of China [12140901402]; fund of Shanghai city health and Family Planning Commission [20114014]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); fund of Shanghai city health and Family Planning Commission	This work was supported by No. 12140901402, http://www.nsfc.gov.cn, Natural Science Foundation of China, ZMW; and No. 20114014, http://www.wsjsw.gov.cn/wsj/n429/n432/n1487/n1508/userobject1ai79649.html, the fund of Shanghai city health and Family Planning Commission, ZMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird EG, 2001, BRIT J RADIOL, V74, P56, DOI 10.1259/bjr.74.877.740056; Collis SJ, 2004, J BIOL CHEM, V279, P49624, DOI 10.1074/jbc.M409600200; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Fidias P, 2010, J CLIN ONCOL, V28, P5116, DOI 10.1200/JCO.2010.30.7074; Gao F, 2013, EUR J RADIOL, V82, pE70, DOI 10.1016/j.ejrad.2012.09.003; Geyer RK, 2000, CELL GROWTH DIFFER, V11, P149; Groeger AM, 2004, HISTOPATHOLOGY, V44, P54, DOI 10.1111/j.1365-2559.2004.01750.x; Hall EJ, 2011, RADIOBIOLOGY FOR THE; Hashimoto S, 1997, ARTHRITIS RHEUM-US, V40, P1749, DOI 10.1002/art.1780401004; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; JOYCE F, 1990, INT J RADIAT ONCOL, V19, P1049, DOI 10.1016/0360-3016(90)90032-F; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Li Xin-min, 2012, JOURNAL OF SOOCHOW U, V32, P170; Liao AY, 2010, INTEGR CANCER THER, V9, P59, DOI 10.1177/1534735409357758; LING CC, 1995, INT J RADIAT ONCOL, V32, P373, DOI 10.1016/0360-3016(95)00530-C; Mazumder Suparna, 2008, V414, P13; Nishizaki M, 2001, CLIN CANCER RES, V7, P2887; Odonkor CA, 2009, CANCER INVEST, V27, P417, DOI 10.1080/07357900802438585; Park DS, 2013, WORLD J UROL, V31, P1511, DOI 10.1007/s00345-013-1086-3; Qu A, 2014, CANCER INVEST, V32, P209, DOI 10.3109/07357907.2014.905585; Qu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070727; Sachs RK, 1997, INT J RADIAT BIOL, V71, P1, DOI 10.1080/095530097144364; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Taukahara S, 2006, NEUROIMMUNOMODULAT, V13, P63; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wang J, 2009, POWDER DIFFR, V24, P24, DOI 10.1154/1.3079687; Wang JJ, 2009, INT J COLORECTAL DIS, V24, P391, DOI 10.1007/s00384-008-0628-4; Wang ZM, 2011, LUNG CANCER, V74, P253, DOI 10.1016/j.lungcan.2011.03.006; Wera AC, 2012, INT J RADIAT BIOL, V88, P253, DOI 10.3109/09553002.2012.643274; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Zhuang HQ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-12	32	20	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133728	10.1371/journal.pone.0133728	http://dx.doi.org/10.1371/journal.pone.0133728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266801	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300023
J	Srivastava, R; Rai, KM; Pandey, B; Singh, SP; Sawant, SV				Srivastava, Rakesh; Rai, Krishan Mohan; Pandey, Bindu; Singh, Sudhir P.; Sawant, Samir V.			Spt-Ada-Gcn5-Acetyltransferase (SAGA) Complex in Plants: Genome Wide Identification, Evolutionary Conservation and Functional Determination	PLOS ONE			English	Article							INDUCIBLE GENE-EXPRESSION; BOX-BINDING PROTEIN; HISTONE ACETYLTRANSFERASE; TRANSCRIPTION FACTOR; ARABIDOPSIS-THALIANA; YEAST TAF(II)25; CORE PROMOTER; COACTIVATOR; GCN5; CHROMATIN	The recruitment of RNA polymerase II on a promoter is assisted by the assembly of basal transcriptional machinery in eukaryotes. The Spt-Ada-Gcn5-Acetyltransferase (SAGA) complex plays an important role in transcription regulation in eukaryotes. However, even in the advent of genome sequencing of various plants, SAGA complex has been poorly defined for their components and roles in plant development and physiological functions. Computational analysis of Arabidopsis thaliana and Oryza sativa genomes for SAGA complex resulted in the identification of 17 to 18 potential candidates for SAGA subunits. We have further classified the SAGA complex based on the conserved domains. Phylogenetic analysis revealed that the SAGA complex proteins are evolutionary conserved between plants, yeast and mammals. Functional annotation showed that they participate not only in chromatin remodeling and gene regulation, but also in different biological processes, which could be indirect and possibly mediated via the regulation of gene expression. The in silico expression analysis of the SAGA components in Arabidopsis and O. sativa clearly indicates that its components have a distinct expression profile at different developmental stages. The co-expression analysis of the SAGA components suggests that many of these subunits co-express at different developmental stages, during hormonal interaction and in response to stress conditions. Quantitative real-time PCR analysis of SAGA component genes further confirmed their expression in different plant tissues and stresses. The expression of representative salt, heat and light inducible genes were affected in mutant lines of SAGA subunits in Arabidopsis. Altogether, the present study reveals expedient evidences of involvement of the SAGA complex in plant gene regulation and stress responses.	[Srivastava, Rakesh; Rai, Krishan Mohan; Pandey, Bindu; Sawant, Samir V.] Natl Bot Res Inst, Council Sci & Ind Res, Plant Mol Biol & Genet Engn Lab, Lucknow 226001, Uttar Pradesh, India; [Srivastava, Rakesh] Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India; [Singh, Sudhir P.] Natl Agri Food Biotechnol Inst DBT, Mohali, Panjab, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Banaras Hindu University (BHU); Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Sawant, SV (corresponding author), Natl Bot Res Inst, Council Sci & Ind Res, Plant Mol Biol & Genet Engn Lab, Lucknow 226001, Uttar Pradesh, India.	samirsawant@nbri.res.in	Srivastava, Rakesh/ABC-6445-2021; Singh, Sudhir/AAE-5413-2019; Mohan, Krishan/J-1350-2019	Srivastava, Rakesh/0000-0002-6640-1216; Mohan, Krishan/0000-0003-2647-1436; Singh, Sudhir/0000-0001-5437-4292	Council of Scientific and Industrial Research (CSIR), Government of India	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Council of Scientific and Industrial Research (CSIR), Government of India, under the institutional CSIR-EMPOWER (OLP79) project.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Benhamed M, 2008, PLANT J, V56, P493, DOI 10.1111/j.1365-313X.2008.03606.x; Benhamed M, 2006, PLANT CELL, V18, P2893, DOI 10.1105/tpc.106.043489; Bertrand C, 2003, J BIOL CHEM, V278, P28246, DOI 10.1074/jbc.M302787200; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2011, BBA-GENE REGUL MECH, V1809, P97, DOI 10.1016/j.bbagrm.2010.08.009; Birck C, 1998, CELL, V94, P239, DOI 10.1016/S0092-8674(00)81423-3; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bond DM, 2009, MOL PLANT, V2, P724, DOI 10.1093/mp/ssp021; Bonnet J, 2014, GENE DEV, V28, P1999, DOI 10.1101/gad.250225.114; Bonnet J, 2010, EMBO REP, V11, P612, DOI 10.1038/embor.2010.98; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Carre C, 2005, MOL CELL BIOL, V25, P8228, DOI 10.1128/MCB.25.18.8228-8238.2005; Cohen R, 2009, PLANTA, V230, P1207, DOI 10.1007/s00425-009-1012-5; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Durso RJ, 2001, MOL CELL BIOL, V21, P7331, DOI 10.1128/MCB.21.21.7331-7344.2001; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; Endo M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28118; Endo M, 2013, P NATL ACAD SCI USA, V110, P18017, DOI 10.1073/pnas.1310631110; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Furumoto T, 2005, PLANT CELL PHYSIOL, V46, P108, DOI 10.1093/pcp/pci006; Gangloff YG, 2000, MOL CELL BIOL, V20, P340, DOI 10.1128/MCB.20.1.340-351.2000; Gangloff YG, 2001, MOL CELL BIOL, V21, P1841, DOI 10.1128/MCB.21.5.1841-1853.2001; Gao X, 2006, PLANT CELL PHYSIOL, V47, P1285, DOI 10.1093/pcp/pcj099; Garcia-Oliver E, 2012, BBA-GENE REGUL MECH, V1819, P555, DOI 10.1016/j.bbagrm.2011.11.011; Ghosh S, 2011, MOL CELL BIOL, V31, P190, DOI 10.1128/MCB.00317-10; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Gunderson FQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000682; Han Y, 2014, EMBO J, DOI 10.15252/embj.201488638; Hark AT, 2009, BBA-GENE REGUL MECH, V1789, P117, DOI 10.1016/j.bbagrm.2008.09.003; Herrera FJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02559; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jacobson S, 2009, MOL CELL BIOL, V29, P6033, DOI 10.1128/MCB.00542-09; Kaldis A, 2011, PLANTA, V233, P749, DOI 10.1007/s00425-010-1337-0; Kiran K, 2006, PLANT PHYSIOL, V142, P364, DOI 10.1104/pp.106.084319; Kirschner DB, 2002, MOL CELL BIOL, V22, P3178, DOI 10.1128/MCB.22.9.3178-3193.2002; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Kornet N, 2009, PLANT CELL, V21, P1070, DOI 10.1105/tpc.108.065300; Koutelou E, 2010, CURR OPIN CELL BIOL, V22, P374, DOI 10.1016/j.ceb.2010.03.005; Kubo M, 2011, PLANT CELL PHYSIOL, V52, P629, DOI 10.1093/pcp/pcr021; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Lago C, 2005, DEV BIOL, V285, P91, DOI 10.1016/j.ydbio.2005.06.006; Lago C, 2004, GENE, V342, P231, DOI 10.1016/j.gene.2004.08.023; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lindner M, 2013, DEV BIOL, V379, P28, DOI 10.1016/j.ydbio.2013.03.005; Lodhi N, 2008, BBA-GENE REGUL MECH, V1779, P634, DOI 10.1016/j.bbagrm.2008.07.010; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Mao YP, 2006, BBA-GENE STRUCT EXPR, V1759, P69, DOI 10.1016/j.bbaexp.2006.02.006; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Meyers BC, 2004, PLANT PHYSIOL, V135, P801, DOI 10.1104/pp.104.039495; Mishra AK, 2012, J PLANT BIOCHEM BIOT, V21, pS32, DOI 10.1007/s13562-012-0134-1; Mougiou N, 2012, MOL BREEDING, V30, P355, DOI 10.1007/s11032-011-9626-2; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Nagy Z, 2009, MOL CELL BIOL, V29, P1649, DOI 10.1128/MCB.01076-08; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Pankotai T, 2005, MOL CELL BIOL, V25, P8215, DOI 10.1128/MCB.25.18.8215-8227.2005; Pavangadkar K, 2010, PLANT MOL BIOL, V74, P183, DOI 10.1007/s11103-010-9665-9; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Ranjan A, 2009, PLANT PHYSIOL, V151, P2174, DOI 10.1104/pp.109.148064; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Robles LM, 2007, J EXP BOT, V58, P2627, DOI 10.1093/jxb/erm080; Rodriguez-Navarro S, 2009, EMBO REP, V10, P843, DOI 10.1038/embor.2009.168; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; Samara NL, 2011, CURR OPIN STRUC BIOL, V21, P767, DOI 10.1016/j.sbi.2011.09.004; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Servet C, 2010, MOL PLANT, V3, P670, DOI 10.1093/mp/ssq018; Shandilya J, 2012, BBA-GENE REGUL MECH, V1819, P391, DOI 10.1016/j.bbagrm.2012.01.010; Shen Y, 2015, PLANT BIOTECHNOL J, V13, P811, DOI 10.1111/pbi.12315; Sieberer T, 2003, CURR BIOL, V13, P837, DOI 10.1016/S0960-9822(03)00327-0; Singh SP, 2010, PLANT BIOTECHNOL J, V8, P1005, DOI 10.1111/j.1467-7652.2010.00527.x; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Srivastava R, 2014, UNDERSTANDING PATTER, P279; Srivastava R, 2014, MOL PLANT, V7, P626, DOI 10.1093/mp/sst146; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Stockinger EJ, 2001, NUCLEIC ACIDS RES, V29, P1524, DOI 10.1093/nar/29.7.1524; Sun JQ, 2007, PLANT CELL PHYSIOL, V48, P1148, DOI 10.1093/pcp/pcm088; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tamada Y, 2007, PLANT CELL PHYSIOL, V48, P134, DOI 10.1093/pcp/pcl048; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vlachonasios KE, 2003, PLANT CELL, V15, P626, DOI 10.1105/tpc.007922; Vlachonasios KE, 2011, PLANT SIGNAL BEHAV, V6, P1475, DOI 10.4161/psb.6.10.17695; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; Weake VM, 2012, TRENDS CELL BIOL, V22, P177, DOI 10.1016/j.tcb.2011.11.005; Weake VM, 2011, GENE DEV, V25, P1499, DOI 10.1101/gad.2046211; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Winston F, 1999, NAT STRUCT BIOL, V6, P601, DOI 10.1038/10640; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yu JM, 1998, GENOMICS, V53, P90, DOI 10.1006/geno.1998.5500; Zanton SJ, 2004, P NATL ACAD SCI USA, V101, P16843, DOI 10.1073/pnas.0404988101; Zapater M, 2007, MOL CELL BIOL, V27, P3900, DOI 10.1128/MCB.00089-07; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	104	28	30	1	234	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134709	10.1371/journal.pone.0134709	http://dx.doi.org/10.1371/journal.pone.0134709			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263547	Green Submitted, gold, Green Published			2022-12-27	WOS:000359353300038
J	An, CL; Bhetwal, BP; Sanders, KM; Somlyo, AV; Perrino, BA				An, Changlong; Bhetwal, Bhupal P.; Sanders, Kenton M.; Somlyo, Avril V.; Perrino, Brian A.			Role of Telokin in Regulating Murine Gastric Fundus Smooth Muscle Tension	PLOS ONE			English	Article							PHOSPHATASE TARGETING SUBUNIT; RHO-ASSOCIATED KINASE; LIGHT-CHAIN KINASE; MYOSIN PHOSPHATASE; INTERSTITIAL-CELLS; CA2+ SENSITIZATION; NITRIC-OXIDE; NITRERGIC STIMULATION; PHOSPHORYLATION; PROTEIN	Telokin phosphorylation by cyclic GMP-dependent protein kinase facilitates smooth muscle relaxation. In this study we examined the relaxation of gastric fundus smooth muscles from basal tone, or pre-contracted with KCl or carbachol (CCh), and the phosphorylation of telokin S13, myosin light chain (MLC) S19, MYPT1 T853, T696, and CPI-17 T38 in response to 8-Bromo-cGMP, the NO donor sodium nitroprusside (SNP), or nitrergic neurotransmission. We compared MLC phosphorylation and the contraction and relaxation responses of gastric fundus smooth muscles from telokin(-/-) mice and their wild-type littermates to KCl or CCh, and 8-Bromo-cGMP, SNP, or nitrergic neurotransmission, respectively. We compared the relaxation responses and telokin phosphorylation of gastric fundus smooth muscles from wild-type mice and W/W-V mice which lack ICC-IM, to 8-Bromo-cGMP, SNP, or nitrergic neurotransmission. We found that telokin S13 is basally phosphorylated and that 8-BromocGMP and SNP increased basal telokin phosphorylation. In muscles pre-contracted with KCl or CCh, 8-Bromo-cGMP and SNP had no effect on CPI-17 or MYPT1 phosphorylation, but increased telokin phosphorylation and reduced MLC phosphorylation. In telokin(-/-) gastric fundus smooth muscles, basal tone and constitutive MLC S19 phosphorylation were increased. Pre-contracted telokin(-/-) gastric fundus smooth muscles have increased contractile responses to KCl, CCh, or cholinergic neurotransmission and reduced relaxation to 8Bromo- cGMP, SNP, and nitrergic neurotransmission. However, basal telokin phosphorylation was not increased when muscles were stimulated with lower concentrations of SNP or when the muscles were stimulated by nitrergic neurotransmission. SNP, but not nitrergic neurotransmission, increased telokin Ser13 phosphorylation in both wild-type and W/W-V gastric fundus smooth muscles. Our findings indicate that telokin may play a role in attenuating constitutive MLC phosphorylation and provide an additional mechanism to augment gastric fundus mechanical responses to inhibitory neurotransmission.	[An, Changlong; Bhetwal, Bhupal P.; Sanders, Kenton M.; Perrino, Brian A.] Univ Nevada, Dept Physiol & Cell Biol, Ctr Biomed Res Excellence, Sch Med, Reno, NV 89557 USA; [Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Virginia	Perrino, BA (corresponding author), Univ Nevada, Dept Physiol & Cell Biol, Ctr Biomed Res Excellence, Sch Med, Reno, NV 89557 USA.	bperrino@medicine.nevada.edu			National Institute of General Medical Sciences [GM103513]; National Institute of Diabetes and Digestive and Kidney Diseases [DK41315]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103513, R01GM086457] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences, http://www.nigms.nih.gov/, GM103513 BAP; and the National Institute of Diabetes and Digestive and Kidney Diseases, http://www.niddk.nih.gov/, DK41315 KMS.	Bayguinov O, 1998, J PHYSIOL-LONDON, V509, P437, DOI 10.1111/j.1469-7793.1998.437bn.x; Bhetwal BP, 2011, NEUROGASTROENT MOTIL, V23, pE425, DOI 10.1111/j.1365-2982.2011.01769.x; Bhetwal BP, 2013, J PHYSIOL-LONDON, V591, P2971, DOI 10.1113/jphysiol.2013.255745; Burns AJ, 1996, P NATL ACAD SCI USA, V93, P12008, DOI 10.1073/pnas.93.21.12008; Choudhury N, 2004, J MUSCLE RES CELL M, V25, P657, DOI 10.1007/s10974-004-7807-x; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Groneberg D, 2013, GASTROENTEROLOGY, V145, P188, DOI 10.1053/j.gastro.2013.03.042; Herring BP, 2006, AM J PHYSIOL-CELL PH, V291, pC817, DOI 10.1152/ajpcell.00198.2006; Herring BP, 1996, AM J PHYSIOL-CELL PH, V270, pC1656, DOI 10.1152/ajpcell.1996.270.6.C1656; Hirano K, 2007, J PHARMACOL SCI, V104, P109, DOI 10.1254/jphs.CP0070027; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; Iino S, 2008, NEUROSCIENCE, V152, P437, DOI 10.1016/j.neuroscience.2007.12.044; Iino S, 2009, NEUROGASTROENT MOTIL, V21, P553, DOI 10.1111/j.1365-2982.2008.01236.x; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; ITO M, 1989, J BIOL CHEM, V264, P13971; Johnson RP, 2009, J PHYSIOL-LONDON, V587, P2537, DOI 10.1113/jphysiol.2008.168252; Khromov AS, 2012, J BIOL CHEM, V287, P20975, DOI 10.1074/jbc.M112.341479; Khromov AS, 2006, P NATL ACAD SCI USA, V103, P2440, DOI 10.1073/pnas.0508566103; Kim MY, 2008, AM J PHYSIOL-CELL PH, V294, pC432, DOI 10.1152/ajpcell.00418.2007; Kitazawa T, 2003, J PHYSIOL-LONDON, V546, P879, DOI 10.1113/jphysiol.2002.029306; Lee MR, 1997, J BIOL CHEM, V272, P5063, DOI 10.1074/jbc.272.8.5063; Lies B, 2014, NEUROGASTROENT MOTIL, V26, P901, DOI 10.1111/nmo.12367; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; Makhlouf GM, 1997, CELL SIGNAL, V9, P269, DOI 10.1016/S0898-6568(96)00180-5; Matsuda NM, 2010, FUND CLIN PHARMACOL, V24, P261, DOI 10.1111/j.1472-8206.2009.00761.x; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Niiro N, 2001, J BIOL CHEM, V276, P29567, DOI 10.1074/jbc.M102753200; Scherbakova OV, 2012, BIOCHEM J, V429, P291; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Tack J, 2002, GUT, V51, P219, DOI 10.1136/gut.51.2.219; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Walker LA, 2001, J BIOL CHEM, V276, P24519, DOI 10.1074/jbc.M103560200; Walsh MP, 2011, AM J PHYSIOL-RENAL, V300, pF73, DOI 10.1152/ajprenal.00011.2010; Ward SM, 2006, J PHYSIOL-LONDON, V576, P675, DOI 10.1113/jphysiol.2006.117390; Weber LP, 1999, J PHYSIOL-LONDON, V516, P805, DOI 10.1111/j.1469-7793.1999.0805u.x; Wu XQ, 1996, BIOCHEM BIOPH RES CO, V220, P658, DOI 10.1006/bbrc.1996.0460; Wu XQ, 1998, J BIOL CHEM, V273, P11362, DOI 10.1074/jbc.273.18.11362	41	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134876	10.1371/journal.pone.0134876	http://dx.doi.org/10.1371/journal.pone.0134876			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258553	Green Published, Green Submitted, gold			2022-12-27	WOS:000359352600027
J	Lara, FA; Pohl, PC; Gandara, AC; Ferreira, JDS; Nascimento-Silva, MC; Bechara, GH; Sorgine, MHF; Almeida, IC; Vaz , ID; Oliveira, PL				Lara, Flavio Alves; Pohl, Paula C.; Gandara, Ana Caroline; Ferreira, Jessica da Silva; Nascimento-Silva, Maria Clara; Bechara, Gervasio Henrique; Sorgine, Marcos H. F.; Almeida, Igor C.; Vaz, Itabajara da Silva, Jr.; Oliveira, Pedro L.			ATP Binding Cassette Transporter Mediates Both Heme and Pesticide Detoxification in Tick Midgut Cells	PLOS ONE			English	Article							BOOPHILUS-MICROPLUS ACARI; ABC TRANSPORTERS; P-GLYCOPROTEIN; CATTLE; RESISTANCE; IVERMECTIN; IDENTIFICATION; SEQUENCE; EXPORT; MODEL	In ticks, the digestion of blood occurs intracellularly and proteolytic digestion of hemoglobin takes place in a dedicated type of lysosome, the digest vesicle, followed by transfer of the heme moiety of hemoglobin to a specialized organelle that accumulates large heme aggregates, called hemosomes. In the present work, we studied the uptake of fluorescent metalloporphyrins, used as heme analogs, and amitraz, one of the most regularly used acaricides to control cattle tick infestations, by Rhipicephalus (Boophilus) microplus midgut cells. Both compounds were taken up by midgut cells in vitro and accumulated inside the hemosomes. Transport of both molecules was sensitive to cyclosporine A (CsA), a wellknown inhibitor of ATP binding cassette (ABC) transporters. Rhodamine 123, a fluorescent probe that is also a recognized ABC substrate, was similarly directed to the hemosome in a CsA-sensitive manner. Using an antibody against conserved domain of PgP-1-type ABC transporter, we were able to immunolocalize PgP-1 in the digest vesicle membranes. Comparison between two R. microplus strains that were resistant and susceptible to amitraz revealed that the resistant strain detoxified both amitraz and Sn-Pp IX more efficiently than the susceptible strain, a process that was also sensitive to CsA. A transcript containing an ABC transporter signature exhibited 2.5-fold increased expression in the amitraz-resistant strain when compared with the susceptible strain. RNAi-induced down-regulation of this ABC transporter led to the accumulation of metalloporphyrin in the digestive vacuole, interrupting heme traffic to the hemosome. This evidence further confirms that this transcript codes for a heme transporter. This is the first report of heme transport in a blood-feeding organism. While the primary physiological function of the hemosome is to detoxify heme and attenuate its toxicity, we suggest that the use of this acaricide detoxification pathway by ticks may represent a new molecular mechanism of resistance to pesticides.	[Lara, Flavio Alves; Ferreira, Jessica da Silva] Inst Oswaldo Cruz, Lab Microbiol Celular, BR-20001 Rio De Janeiro, Brazil; [Pohl, Paula C.; Vaz, Itabajara da Silva, Jr.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Pohl, Paula C.; Vaz, Itabajara da Silva, Jr.] Univ Fed Rio Grande do Sul, Fac Vet, Porto Alegre, RS, Brazil; [Gandara, Ana Caroline; Nascimento-Silva, Maria Clara; Sorgine, Marcos H. F.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Programa Biol Mol Biotecnol, BR-20001 Rio de Janeiro, Brazil; [Bechara, Gervasio Henrique] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Patol Vet, Jaboticabal, Brazil; [Sorgine, Marcos H. F.; Vaz, Itabajara da Silva, Jr.; Oliveira, Pedro L.] INCTEM, Rio De Janeiro, Brazil; [Almeida, Igor C.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA	Fundacao Oswaldo Cruz; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio de Janeiro; Universidade Estadual Paulista; University of Texas System; University of Texas El Paso	Oliveira, PL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Programa Biol Mol Biotecnol, BR-20001 Rio de Janeiro, Brazil.	pedro@bioqmed.ufrj.br	Pohl, Paula/Z-4816-2019; Silva Vaz Jr., Itabajara/A-5943-2009; Almeida, Igor C./AAF-9409-2019; Pohl, Paula/O-7467-2019; Lara, Flavio Alves/L-1861-2013; Bechara, Gervásio Henrique/E-5023-2015; L. Oliveira, Pedro/A-9438-2010	Pohl, Paula/0000-0001-8569-8150; Silva Vaz Jr., Itabajara/0000-0003-0309-9328; Almeida, Igor C./0000-0002-2443-8213; Bechara, Gervásio Henrique/0000-0003-4619-3744; L. Oliveira, Pedro/0000-0003-0307-354X; Paiva Gandara, Ana Caroline/0000-0003-3194-4453	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul); PRONEX (Programa de Nucleos de Excelencia)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); PRONEX (Programa de Nucleos de Excelencia)	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul), and PRONEX (Programa de Nucleos de Excelencia). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2005, CLIN BIOCHEM, V38, P499, DOI 10.1016/j.clinbiochem.2005.01.010; AGBEDE RIS, 1985, INT J PARASITOL, V15, P147, DOI 10.1016/0020-7519(85)90080-3; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bram RA, 2002, J MED ENTOMOL, V39, P405, DOI 10.1603/0022-2585-39.3.405; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; Brayden DJ, 2008, VET RES COMMUN, V32, P93, DOI 10.1007/s11259-007-9007-9; Braz GRC, 1999, CURR BIOL, V9, P703, DOI 10.1016/S0960-9822(99)80312-1; Burkhard KA, 2008, BIOCHEMISTRY-US, V47, P7977, DOI 10.1021/bi801005u; Buss DS, 2002, MED VET ENTOMOL, V16, P218, DOI 10.1046/j.1365-2915.2002.00365.x; Buss DSC, 2008, PESTICIDE BIOCH PHYS, V90; Choi CH, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-30; Cupello MP, 2011, ACTA TROP, V120, P211, DOI 10.1016/j.actatropica.2011.08.011; Davey RB, 2004, J MED ENTOMOL, V41, P524, DOI 10.1603/0022-2585-41.3.524; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Desuzinges-Mandon E, 2010, J BIOL CHEM, V285, P33123, DOI 10.1074/jbc.M110.139170; DRUMMOND RO, 1973, J ECON ENTOMOL, V66, P130, DOI 10.1093/jee/66.1.130; Dupuy J, 2010, CHEM-BIOL INTERACT, V186, P280, DOI 10.1016/j.cbi.2010.05.013; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goldman BS, 1996, J BACTERIOL, V178, P6338, DOI 10.1128/jb.178.21.6338-6347.1996; Gonsioroski AV, 2012, EXP PARASITOL, V130, P359, DOI 10.1016/j.exppara.2012.02.006; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Homolya L, 2003, BIOFACTORS, V17, P103, DOI 10.1002/biof.5520170111; HULSTAERT CE, 1983, HISTOCHEMISTRY, V78, P71, DOI 10.1007/BF00491113; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Klafke GM, 2006, VET PARASITOL, V142, P386, DOI 10.1016/j.vetpar.2006.07.001; Korolnek T, 2014, CELL METAB, V19, P1008, DOI 10.1016/j.cmet.2014.03.030; Kostaropoulos I, 2001, INSECT BIOCHEM MOLEC, V31, P313, DOI 10.1016/S0965-1748(00)00123-5; Krishnamurthy P, 2005, BIOMETALS, V18, P349, DOI 10.1007/s10534-005-3709-7; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Lara FA, 2007, BIOCHEM BIOPH RES CO, V355, P16, DOI 10.1016/j.bbrc.2006.12.238; Lara FA, 2003, J EXP BIOL, V206, P1707, DOI 10.1242/jeb.00334; Lara FA, 2005, J EXP BIOL, V208, P3093, DOI 10.1242/jeb.01749; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Loor F, 2002, J MED CHEM, V45, P4613, DOI 10.1021/jm010987v; Mans BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023675; Mendiola J, 1996, EXP PARASITOL, V82, P27, DOI 10.1006/expr.1996.0004; Munic V, 2011, EUR J PHARM SCI, V43, P359, DOI 10.1016/j.ejps.2011.05.003; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nobmann S, 2001, BRIT J PHARMACOL, V132, P722, DOI 10.1038/sj.bjp.0703762; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pohl PC, 2014, VET PARASITOL, V204, P316, DOI 10.1016/j.vetpar.2014.05.042; Pohl PC, 2012, PARASITOL RES, V111, P2345, DOI 10.1007/s00436-012-3089-1; Pohl PC, 2011, INT J PARASITOL, V41, P1323, DOI 10.1016/j.ijpara.2011.08.004; Ponte-Sucre A, 2007, APPL MICROBIOL BIOT, V76, P279, DOI 10.1007/s00253-007-1017-6; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shabbir A, 2005, TOXICOL APPL PHARM, V203, P91, DOI 10.1016/j.taap.2004.07.011; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Sinclair J, 2015, BIOMETALS, V28, P481, DOI 10.1007/s10534-015-9841-0; Solazzo M, 2009, CANCER RES, V69, P7235, DOI 10.1158/0008-5472.CAN-08-4315; STAPF V, 1994, ANTICANCER RES, V14, P581; Swain V, 2009, PARASITOL RES, V104, P1307, DOI 10.1007/s00436-008-1326-4; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JM, 1999, INFECT IMMUN, V67, P3879, DOI 10.1128/IAI.67.8.3879-3892.1999; Vaz ID, 2005, VET PARASITOL, V127, P147, DOI 10.1016/j.vetpar.2004.10.002; WALKER AR, 1987, INT J PARASITOL, V17, P1393, DOI 10.1016/0020-7519(87)90075-0; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Yuan XJ, 2013, CURR OPIN CHEM BIOL, V17, P204, DOI 10.1016/j.cbpa.2013.01.010; Yuan XJ, 2012, J BIOL CHEM, V287, P4914, DOI 10.1074/jbc.M111.326785; Zutz A, 2009, BBA-BIOENERGETICS, V1787, P681, DOI 10.1016/j.bbabio.2009.02.009	69	42	45	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134779	10.1371/journal.pone.0134779	http://dx.doi.org/10.1371/journal.pone.0134779			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258982	Green Published, Green Submitted, gold			2022-12-27	WOS:000359352600023
J	Madsen, SM; Thorup, AC; Overgaard, K; Jeppesen, PB				Madsen, Soren Moller; Thorup, Anne Cathrine; Overgaard, Kristian; Jeppesen, Per Bendix			High Intensity Interval Training Improves Glycaemic Control and Pancreatic beta Cell Function of Type 2 Diabetes Patients	PLOS ONE			English	Article							ORAL GLUCOSE-TOLERANCE; CARDIOVASCULAR RISK-FACTORS; HUMAN SKELETAL-MUSCLE; TERM SPRINT INTERVAL; INSULIN SENSITIVITY; AEROBIC EXERCISE; PHYSICAL-ACTIVITY; ADIPOSE-TISSUE; PRESCRIBING EXERCISE; RESISTANCE EXERCISE	Physical activity improves the regulation of glucose homeostasis in both type 2 diabetes (T2D) patients and healthy individuals, but the effect on pancreatic beta cell function is unknown. We investigated glycaemic control, pancreatic function and total fat mass before and after 8 weeks of low volume high intensity interval training (HIIT) on cycle ergometer in T2D patients and matched healthy control individuals. Study design/method: Elderly (56 yrs +/- 2), non-active T2D patients (n = 10) and matched (52 yrs +/- 2) healthy controls (CON) (n = 13) exercised 3 times (10x60 sec. HIIT) a week over an 8 week period on a cycle ergometer. Participants underwent a 2-hour oral glucose tolerance test (OGTT). On a separate day, resting blood pressure measurement was conducted followed by an incremental maximal oxygen uptake (VO2max) cycle ergometer test. Finally, a whole body dual X-ray absorptiometry (DXA) was performed. After 8 weeks of training, the same measurements were performed. Results: in the T2D-group, glycaemic control as determined by average fasting venous glucose concentration (p = 0.01), end point 2-hour OGTT (p = 0.04) and glycosylated haemoglobin (p = 0.04) were significantly reduced. Pancreatic homeostasis as determined by homeostatic model assessment of insulin resistance (HOMA-IR) and HOMA beta cell function (HOMA-%beta) were both significantly ameliorated (p = 0.03 and p = 0.03, respectively). Whole body insulin sensitivity as determined by the disposition index (DI) was significantly increased (p = 0.03). During OGTT, the glucose continuum was significantly reduced at -15 (p = 0.03), 30 (p = 0.03) and 120 min (p = 0.03) and at -10 (p = 0.003) and 0 min (p = 0.003) with an additional improvement (p = 0.03) of its 1st phase (30 min) area under curve (AUC). Significant abdominal fat mass losses were seen in both groups (T2D: p = 0.004 and CON: p = 0.02) corresponding to a percentage change of -17.84%+/- 5.02 and -9.66%+/- 3.07, respectively. Conclusion: these results demonstrate that HIIT improves overall glycaemic control and pancreatic beta cell function in T2D patients. Additionally, both groups experienced abdominal fat mass losses. These findings demonstrate that HIIT is a health beneficial exercise strategy in T2D patients.	[Madsen, Soren Moller; Thorup, Anne Cathrine; Jeppesen, Per Bendix] Aarhus Univ Hosp, Aarhus Sygehus THG, Dept Endocrinol & Internal Med, DK-8000 Aarhus C, Denmark; [Overgaard, Kristian] Aarhus Univ, Dept Publ Hlth, Sect Sport Sci, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Jeppesen, PB (corresponding author), Aarhus Univ Hosp, Aarhus Sygehus THG, Dept Endocrinol & Internal Med, DK-8000 Aarhus C, Denmark.	per.bendix.jeppesen@clin.au.dk		Overgaard, Kristian/0000-0002-3204-509X	Accu Trend, Denmark; Department of Clinical Medicine, Aarhus University	Accu Trend, Denmark; Department of Clinical Medicine, Aarhus University	This work was supported by Accu Trend, Denmark and Department of Clinical Medicine, Aarhus University. Roche Diagnostics has kindly supported the study by giving glucometers (Accu Trend). Neither Roche Diagnostics nor Department of Clinical Medicine, Aarhus University had any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adamson Simon, 2014, Biology (Basel), V3, P333, DOI 10.3390/biology3020333; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Assali AR, 2001, J ENDOCRINOL, V171, P293, DOI 10.1677/joe.0.1710293; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; BJORNTORP P, 1972, METABOLISM, V21, P1037, DOI 10.1016/0026-0495(72)90034-0; Boudou P, 2003, EUR J ENDOCRINOL, V149, P421, DOI 10.1530/eje.0.1490421; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Boule NG, 2011, DIABETES CARE, V34, P1469, DOI 10.2337/dc10-2207; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Burgomaster KA, 2006, J APPL PHYSIOL, V100, P2041, DOI 10.1152/japplphysiol.01220.2005; Castaneda C, 2002, DIABETES CARE, V25, P2335, DOI 10.2337/diacare.25.12.2335; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Coker RH, 2009, J CLIN ENDOCR METAB, V94, P4258, DOI 10.1210/jc.2008-2033; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Croymans DM, 2013, J APPL PHYSIOL, V115, P1245, DOI 10.1152/japplphysiol.00485.2013; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; Dela F, 2004, AM J PHYSIOL-ENDOC M, V287, pE1024, DOI 10.1152/ajpendo.00056.2004; Dengel DR, 1998, AM J HYPERTENS, V11, P1405, DOI 10.1016/S0895-7061(98)00185-X; DiPietro L, 2006, J APPL PHYSIOL, V100, P142, DOI 10.1152/japplphysiol.00474.2005; Duncan GE, 2005, ARCH INTERN MED, V165, P2362, DOI 10.1001/archinte.165.20.2362; El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238; Eriksen L, 2007, DIABETOLOGIA, V50, P2245, DOI 10.1007/s00125-007-0783-0; Fritz T, 2013, DIABETES-METAB RES, V29, P25, DOI 10.1002/dmrr.2321; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gillen JB, 2012, DIABETES OBES METAB, V14, P575, DOI 10.1111/j.1463-1326.2012.01564.x; Gillen JB, 2013, OBESITY, V21, P2249, DOI 10.1002/oby.20379; Goedecke JH, 2009, DIABETES CARE, V32, P860, DOI 10.2337/dc08-2048; Hamed NS, 2014, PHYS THER REHABIL, V1; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Heydari M, 2012, J OBES, V2012, DOI 10.1155/2012/480467; HOLLOSZY JO, 1986, ACTA MED SCAND, P55; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Kang J, 1996, DIABETES CARE, V19, P341, DOI 10.2337/diacare.19.4.341; Karstoft K, 2014, DIABETOLOGIA, V57, P2081, DOI 10.1007/s00125-014-3334-5; Kim JY, 2012, DIABETES CARE, V35, P1925, DOI 10.2337/dc11-2476; KJAER M, 1990, J APPL PHYSIOL, V68, P2067, DOI 10.1152/jappl.1990.68.5.2067; KROTKIEWSKI M, 1985, DIABETOLOGIA, V28, P881, DOI 10.1007/BF00703130; Larsen S, 2014, WORLD J DIABETES, V5, P482, DOI 10.4239/wjd.v5.i4.482; Laursen PB, 2002, MED SCI SPORT EXER, V34, P1801, DOI 10.1097/00005768-200211000-00017; Lazarevic G, 2006, DIABETES METAB, V32, P583, DOI 10.1016/S1262-3636(07)70312-9; Lindsay FH, 1996, MED SCI SPORT EXER, V28, P1427, DOI 10.1097/00005768-199611000-00013; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; Marcus RL, 2008, PHYS THER, V88, P1345, DOI 10.2522/ptj.20080124; Marwick TH, 2009, CIRCULATION, V119, P3244, DOI 10.1161/CIRCULATIONAHA.109.192521; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mikus CR, 2012, DIABETOLOGIA, V55, P1417, DOI 10.1007/s00125-012-2490-8; Mourier A, 1997, DIABETES CARE, V20, P385, DOI 10.2337/diacare.20.3.385; Nelson RK, 2014, APPL PHYSIOL NUTR ME, V39, P811, DOI 10.1139/apnm-2013-0525; Nevill ME, 1996, EUR J APPL PHYSIOL, V72, P460, DOI 10.1007/BF00242276; Oka R, 2012, ENDOCR J, V59, P55, DOI 10.1507/endocrj.EJ11-0157; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Potteiger JA, 2003, METABOLISM, V52, P1175, DOI 10.1016/S0026-0495(03)00146-X; REBUFFESCRIVE M, 1989, METABOLISM, V38, P453, DOI 10.1016/0026-0495(89)90198-4; ROGERS MA, 1988, DIABETES CARE, V11, P613, DOI 10.2337/diacare.11.8.613; Rynders CA, 2014, J CLIN ENDOCR METAB, V99, P220, DOI 10.1210/jc.2013-2687; Saltin B, 1968, CIRCULATION S, V385, pVII1; SCHNEIDER SH, 1984, DIABETOLOGIA, V26, P355, DOI 10.1007/BF00266036; SCHWARTZ RS, 1991, METABOLISM, V40, P545, DOI 10.1016/0026-0495(91)90239-S; Shaban N, 2014, J SPORT MED PHYS FIT, V54, P203; Simonsen L, 2004, DIABETOLOGIA, V47, P652, DOI 10.1007/s00125-004-1374-y; Slentz CA, 2009, DIABETES CARE, V32, P1807, DOI 10.2337/dc09-0032; Slordahl SA, 2004, MED SCI SPORT EXER, V36, P1871, DOI 10.1249/01.MSS.0000145444.01292.3D; Solomon TPJ, 2013, J CLIN ENDOCR METAB, V98, P4176, DOI 10.1210/jc.2013-2232; Solomon TPJ, 2012, J CLIN ENDOCR METAB, V97, P4682, DOI 10.1210/jc.2012-2097; Solomon TPJ, 2010, DIABETES CARE, V33, P1561, DOI 10.2337/dc09-2021; Talanian JL, 2007, J APPL PHYSIOL, V102, P1439, DOI 10.1152/japplphysiol.01098.2006; Tessier D, 2000, ARCH GERONTOL GERIAT, V31, P121, DOI 10.1016/S0167-4943(00)00076-5; Tjonna AE, 2009, CLIN SCI, V116, P317, DOI 10.1042/CS20080249; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; Trapp EG, 2007, AM J PHYSIOL-REG I, V293, pR2370, DOI 10.1152/ajpregu.00780.2006; TROVATI M, 1984, DIABETES CARE, V7, P416, DOI 10.2337/diacare.7.5.416; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; UNGER RH, 1971, NEW ENGL J MED, V285, P443; Wareham N, 2007, OBES REV, V8, P109, DOI 10.1111/j.1467-789X.2007.00328.x; Wareham NJ, 2005, P NUTR SOC, V64, P229, DOI 10.1079/PNS2005423; Whyte LJ, 2013, METABOLISM, V62, P212, DOI 10.1016/j.metabol.2012.07.019; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002; Zouhal H, 2008, SPORTS MED, V38, P401, DOI 10.2165/00007256-200838050-00004	84	71	74	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0133286	10.1371/journal.pone.0133286	http://dx.doi.org/10.1371/journal.pone.0133286			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258597	Green Submitted, Green Published, gold			2022-12-27	WOS:000359352600005
J	Yu, CY; Liu, YH; Zhang, AD; Su, S; Yan, A; Huang, L; Ali, I; Liu, Y; Forde, BG; Gan, YB				Yu, Chunyan; Liu, Yihua; Zhang, Aidong; Su, Sha; Yan, An; Huang, Linli; Ali, Imran; Liu, Yu; Forde, Brian G.; Gan, Yinbo			MADS-box Transcription Factor OsMADS25 Regulates Root Development through Affection of Nitrate Accumulation in Rice	PLOS ONE			English	Article							WIDE IDENTIFICATION; TRANSPORTER FAMILY; ARABIDOPSIS; EXPRESSION; GENE; NITROGEN; SYSTEM; PLANTS; RESPONSES; NUTRIENT	MADS-box transcription factors are vital regulators participating in plant growth and development process and the functions of most of them are still unknown. ANR1 was reported to play a key role in controlling lateral root development through nitrate signal in Arabidopsis. OsMADS25 is one of five ANR1-like genes in Oryza Sativa and belongs to the ANR1 clade. Here we have investigated the role of OsMADS25 in the plant's responses to external nitrate in Oryza Sativa. Our results showed that OsMADS25 protein was found in the nucleus as well as in the cytoplasm. Over-expression of OsMADS25 significantly promoted lateral and primary root growth as well as shoot growth in a nitrate-dependent manner in Arabidopsis. OsMADS25 overexpression in transgenic rice resulted in significantly increased primary root length, lateral root number, lateral root length and shoot fresh weight in the presence of nitrate. Down-regulation of OsMADS25 in transgenic rice exhibited significantly reduced shoot and root growth in the presence of nitrate. Furthermore, over-expression of OsMADS25 in transgenic rice promoted nitrate accumulation and significantly increased the expressions of nitrate transporter genes at high rates of nitrate supply while down-regulation of OsMADS25 produced the opposite effect. Taken together, our findings suggest that OsMADS25 is a positive regulator control lateral and primary root development in rice.	[Yu, Chunyan; Liu, Yihua; Zhang, Aidong; Su, Sha; Yan, An; Huang, Linli; Ali, Imran; Gan, Yinbo] Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Yu] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Forde, Brian G.] Univ Lancaster, Lancaster Environm Ctr, Ctr Sustainable Agr, Lancaster, England	Zhejiang University; Zhejiang University; Lancaster University	Gan, YB (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou 310003, Zhejiang, Peoples R China.	ygan@zju.edu.cn	Gan, Yinbo/N-1480-2015; Forde, Brian G/C-6554-2009	Forde, Brian G/0000-0001-7973-7280	International Scientific and Technological Cooperation Project of Ministry of Science and Technology of China [2010DFA34430]; China Postdoctoral Science Foundation [2014M561769]; National Program on Key Basic Research Project (973 Program) [2015CB150200]; PhD Programs Foundation of Ministry of Education of China [20120101110079]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	International Scientific and Technological Cooperation Project of Ministry of Science and Technology of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); PhD Programs Foundation of Ministry of Education of China(Ministry of Education, China); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was supported by the International Scientific and Technological Cooperation Project of the Ministry of Science and Technology of China (grant number 2010DFA34430), China Postdoctoral Science Foundation (2014M561769), the National Program on Key Basic Research Project (973 Program, grant no. 2015CB150200) and PhD Programs Foundation of Ministry of Education of China (grant no. 20120101110079).	Alboresi A, 2005, PLANT CELL ENVIRON, V28, P500, DOI 10.1111/j.1365-3040.2005.01292.x; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072126; Bao SJ, 2011, BOTANY, V89, P647, DOI [10.1139/B11-053, 10.1139/b11-053]; Cai C, 2008, J INTEGR PLANT BIOL, V50, P443, DOI 10.1111/j.1744-7909.2008.00642.x; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CRAWFORD NM, 1995, PLANT CELL, V7, P859, DOI 10.1105/tpc.7.7.859; Desnos T, 2008, CURR OPIN PLANT BIOL, V11, P82, DOI 10.1016/j.pbi.2007.10.003; Fan XR, 2005, SCI CHINA SER C, V48, P897, DOI 10.1360/062005-281; Fang ZM, 2013, PLANT BIOTECHNOL J, V11, P446, DOI 10.1111/pbi.12031; FITTER AH, 1987, NEW PHYTOL, V106, P61, DOI 10.1111/j.1469-8137.1987.tb04683.x; Forde BG, 1999, ADV BOT RES, V30, P1; Forde BG, 2002, J EXP BOT, V53, P39, DOI 10.1093/jexbot/53.366.39; Gan YB, 2005, PLANTA, V222, P730, DOI 10.1007/s00425-005-0020-3; Gan YB, 2012, PLANT CELL PHYSIOL, V53, P1003, DOI 10.1093/pcp/pcs050; Gojon A, 2011, J EXP BOT, V62, P2299, DOI 10.1093/jxb/erq419; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Kirk GJD, 2005, ANN BOT-LONDON, V96, P639, DOI 10.1093/aob/mci216; Kronzucker HJ, 1999, PLANT PHYSIOL, V119, P1041, DOI 10.1104/pp.119.3.1041; Krouk G, 2011, TRENDS PLANT SCI, V16, P178, DOI 10.1016/j.tplants.2011.02.004; Lee S, 2003, PLANT CELL PHYSIOL, V44, P1403, DOI 10.1093/pcp/pcg156; Leran S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa4829; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Martin K, 2009, PLANT J, V59, P150, DOI 10.1111/j.1365-313X.2009.03850.x; Meng YJ, 2013, NEW PHYTOL, V197, P441, DOI 10.1111/nph.12018; Miller AJ, 2009, CURR OPIN PLANT BIOL, V12, P284, DOI 10.1016/j.pbi.2009.04.010; Mochizuki S, 2014, J EXP BOT, V65, P2307, DOI 10.1093/jxb/eru110; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; Osmont KS, 2007, ANNU REV PLANT BIOL, V58, P93, DOI 10.1146/annurev.arplant.58.032806.104006; Prinsi B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-113; Puig J, 2013, GENE EXPR PATTERNS, V13, P160, DOI 10.1016/j.gep.2013.02.004; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Sun LL, 2013, J ZHEJIANG UNIV-SC B, V14, P563, DOI 10.1631/jzus.B1200349; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Vidal EA, 2008, CURR OPIN PLANT BIOL, V11, P521, DOI 10.1016/j.pbi.2008.07.003; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Walch-Liu P, 2006, ANN BOT-LONDON, V97, P875, DOI 10.1093/aob/mcj601; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Yan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085208; Yan YS, 2014, PLANT J, V78, P44, DOI 10.1111/tpj.12446; Yu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105597; Zhang HM, 1999, P NATL ACAD SCI USA, V96, P6529, DOI 10.1073/pnas.96.11.6529; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095642; Zhou ZJ, 2013, NEW PHYTOL, V198, P699, DOI 10.1111/nph.12211	52	65	74	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135196	10.1371/journal.pone.0135196	http://dx.doi.org/10.1371/journal.pone.0135196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258667	Green Submitted, Green Published, gold			2022-12-27	WOS:000359352600045
J	Chen, FY; Zhang, CJ; Jia, XD; Wang, S; Wang, J; Chen, Y; Zhao, JY; Tian, SG; Han, XL; Han, L				Chen, Fangyan; Zhang, Changjian; Jia, Xiaodong; Wang, Shuo; Wang, Jing; Chen, Yong; Zhao, Jingya; Tian, Shuguang; Han, Xuelin; Han, Li			Transcriptome Profiles of Human Lung Epithelial Cells A549 Interacting with Aspergillus fumigatus by RNA-Seq	PLOS ONE			English	Article							DUAL-SPECIFICITY PHOSPHATASES; LARGE GENE LISTS; INFLAMMATORY RESPONSES; IMMUNE-RESPONSES; CONIDIA; MICE; EXPRESSION; INFECTION; GROWTH; INTERNALIZATION	Lung epithelial cells constitute the first defense line of host against the inhaled Aspergillus fumigatus; however, the transcriptional response of human alveolar type II epithelial cells was still unclear. Here we used RNA-Seq technology to assess the transcriptome profiles of A549 cells following direct interaction with conidia of A. fumigatus. The total number of identified genes was 19118. Compared with uninfected A549 cells, 459 genes were differentially expressed in cells co-incubated with conidia for 8 h, including 302 up-regulated genes and 157 down-regulated genes. GO and KEGG pathway enrichment analysis showed that most of the up-regulated genes were related to immune response, chemotaxis and inflammatory response and enriched in cytokine-cytokine receptor interaction, JAK-STAT and MAPK signaling pathways. The down-regulated genes were mainly enriched for terms associated with development, hemopoiesis and ion transport. Among them, EGR4 and HIST1H4J gene had the maximum of fold change in up-regulated and down-regulated genes, respectively. Fourteen up-regulated genes and three down-regulated genes were further validated and significant increase on expression of IL-6, IL-8 and TNF-alpha in A549 cells were confirmed by qRT-PCR during the interaction of A549 cells with A. fumigatus. Besides, western blot showed that expression of two proteins (ARC, EGR1) significantly increased in A549 cells during interaction with A. fumigatus conidia for 8h. Interference of endogenous expression of ARC or EGR1 protein in A549 cells reduced the internalization of A. fumigatus. These results provided important insights into dynamic changes of gene expression in lung epithelial cells, especially its strong immunological response against A. fumigatus infection.	[Chen, Fangyan; Zhang, Changjian; Jia, Xiaodong; Wang, Shuo; Wang, Jing; Chen, Yong; Zhao, Jingya; Tian, Shuguang; Han, Xuelin; Han, Li] Acad Mil Med Sci, Inst Dis Control & Prevent, PLA, Dept Hosp Infect Control & Res, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Han, XL (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, PLA, Dept Hosp Infect Control & Res, Beijing, Peoples R China.	yilin791228@126.com; hanlicdc@163.com	Hu, Mandong/AAH-1140-2019		973 Program [2013CB531606]; Chinese National Scientific Foundation Committee [81172801, 81101229, 81401305]	973 Program(National Basic Research Program of China); Chinese National Scientific Foundation Committee	This study was supported by grants from the 973 Program (No. 2013CB531606) and from the Chinese National Scientific Foundation Committee (No. 81172801, No. 81101229 and No. 81401305). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Barnes PD, 2006, INFECT DIS CLIN N AM, V20, P545, DOI 10.1016/j.idc.2006.06.001; Bellanger AP, 2009, J MED MICROBIOL, V58, P174, DOI 10.1099/jmm.0.005488-0; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Cheng QQ, 2014, J IMMUNOL, V192, P3686, DOI 10.4049/jimmunol.1301863; Cummings CA, 2000, EMERG INFECT DIS, V6, P513, DOI 10.3201/eid0605.000511; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; DeHart DJ, 1997, J INFECT DIS, V175, P146, DOI 10.1093/infdis/175.1.146; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Gomez P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-358; Gugnani HC, 2003, FRONT BIOSCI-LANDMRK, V8, pS346, DOI 10.2741/1002; Hammer M, 2010, IMMUNOLOGY, V131, P395, DOI 10.1111/j.1365-2567.2010.03313.x; Han XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021468; Hansen JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042645; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Sheng-he, 2002, Functional and Integrative Genomics, V1, P331, DOI 10.1007/s10142-002-0048-4; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Jia XD, 2014, MICROBES INFECT, V16, P491, DOI 10.1016/j.micinf.2014.03.001; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Liu M, 2006, CURR OPIN MICROBIOL, V9, P312, DOI 10.1016/j.mib.2006.04.006; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Morton CO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098279; Oosthuizen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020527; Osherov N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00346; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Qian F, 2012, AM J PHYSIOL-LUNG C, V302, pL866, DOI 10.1152/ajplung.00277.2011; Rios P, 2014, ANTIOXID REDOX SIGN, V20, P2251, DOI 10.1089/ars.2013.5709; Rodriguez N, 2010, J LEUKOCYTE BIOL, V88, P579, DOI 10.1189/jlb.0210083; Royce TE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm549; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Sharon H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017509; Sugui JA, 2007, EUKARYOT CELL, V6, P1562, DOI 10.1128/EC.00141-07; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warris A, 2003, J CLIN MICROBIOL, V41, P4101, DOI 10.1128/JCM.41.9.4101-4106.2003; Wasylnka JA, 2003, J CELL SCI, V116, P1579, DOI 10.1242/jcs.00329; Wieland GD, 2005, J CELL SCI, V118, P3203, DOI 10.1242/jcs.02445; Wiley M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018335; Wu SX, 2011, MYCOPATHOLOGIA, V171, P387, DOI 10.1007/s11046-011-9398-6; Zhang ZH, 2005, J INFECTION, V51, P375, DOI 10.1016/j.jinf.2004.12.012; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	46	38	41	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135720	10.1371/journal.pone.0135720	http://dx.doi.org/10.1371/journal.pone.0135720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26273834	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600102
J	Hinow, P; Nihongi, A; Strickler, JR				Hinow, Peter; Nihongi, Ai; Strickler, J. Rudi			Statistical Mechanics of Zooplankton	PLOS ONE			English	Article							PARAMECIUM	Statistical mechanics provides the link between microscopic properties of many-particle systems and macroscopic properties such as pressure and temperature. Observations of similar "microscopic" quantities exist for the motion of zooplankton, as well as many species of other social animals. Herein, we propose to take average squared velocities as the definition of the "ecological temperature" of a population under different conditions on nutrients, light, oxygen and others. We test the usefulness of this definition on observations of the crustacean zooplankton Daphnia pulicaria. In one set of experiments, D. pulicaria is infested with the pathogen Vibrio cholerae, the causative agent of cholera. We find that infested D. pulicaria under light exposure have a significantly greater ecological temperature, which puts them at a greater risk of detection by visual predators. In a second set of experiments, we observe D. pulicaria in cold and warm water, and in darkness and under light exposure. Overall, our ecological temperature is a good discriminator of the crustacean's swimming behavior.	[Hinow, Peter] Univ Wisconsin, Dept Math Sci, Milwaukee, WI 53201 USA; [Nihongi, Ai; Strickler, J. Rudi] Univ Wisconsin, Sch Freshwater Sci, Global Water Ctr, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee	Hinow, P (corresponding author), Univ Wisconsin, Dept Math Sci, Milwaukee, WI 53201 USA.	hinow@uwm.edu	Strickler, J. Rudi/A-8926-2009					Baierlein R., 1999, THERMAL PHYS; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bell WE, 2007, J EXP BIOL, V210, P357, DOI 10.1242/jeb.02642; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Chiavelli DA, 2001, APPL ENVIRON MICROB, V67, P3220, DOI 10.1128/AEM.67.7.3220-3225.2001; Cressler CE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1087; Francis JT, 1995, J EUKARYOT MICROBIOL, V41, P244; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Jorgensen S. E., 2001, THERMODYNAMICS ECOLO, P373; KERNER EDWARD H., 1957, BULL MATH BIOPHYS, V19, P121, DOI 10.1007/BF02477883; Kim HJ, 2014, INT REV HYDROBIOL, V99, P151, DOI 10.1002/iroh.201301715; Lewis MA, 2013, LECT NOTES MATH, V2071, pIX; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Margalef R., 1968, PERSPECTIVES ECOLOGI; Margalef R., 1980, BIOSFERA ENTRE TERMO; MCCONNELL JV, 1966, ANNU REV PHYSIOL, V28, P107, DOI 10.1146/annurev.ph.28.030166.000543; Mishra S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011901; Nihongi Ai, 2011, P181; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Peters R.H., 1987, DAPHNIA; Press W. H., 1988, NUMERICAL RECIPES; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; Ringelberg J., 2009, DIEL VERTICAL MIGRAT; Seuront L, 2014, P NATL ACAD SCI USA, V111, P2206, DOI 10.1073/pnas.1322363111; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; World Health Organzation, 2010, CHOL VACC BRIEF SUMM; Yang WQ, 1997, J CELL SCI, V110, P2567; Ziarek JJ, 2011, HYDROBIOLOGIA, V661, P317, DOI 10.1007/s10750-010-0540-0	32	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135258	10.1371/journal.pone.0135258	http://dx.doi.org/10.1371/journal.pone.0135258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270537	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800045
J	Hsu, PH; Chiang, PC; Liu, CH; Chang, YW				Hsu, Pang-Hung; Chiang, Pei-Chi; Liu, Chia-Hsun; Chang, Ya-Wen			Characterization of Cell Wall Proteins in Saccharomyces cerevisiae Clinical Isolates Elucidates Hsp150p in Virulence	PLOS ONE			English	Article							CANDIDA-ALBICANS; MASS-SPECTROMETRY; PROTEOMIC ANALYSIS; GENE FAMILY; YEAST; EXPRESSION; IDENTIFICATION; INTEGRITY; BIOFILMS; CONSTRUCTION	The budding yeast Saccharomyces cerevisiae has recently been described as an emerging opportunistic fungal pathogen. Fungal cell wall mannoproteins have been demonstrated to be involved in adhesion to inert surfaces and might be engaged in virulence. In this study, we observed four clinical isolates of S. cerevisiae with relatively hydrophobic cell surfaces. Yeast cell wall subproteome was evaluated quantitatively by liquid chromatography/tandem mass spectrometry. We identified totally 25 cell wall proteins (CWPs) from log-phase cells, within which 15 CWPs were quantified. The abundance of Scw10p, Pst1p, and Hsp150p/Pir2p were at least 2 folds higher in the clinical isolates than in S288c lab strain. Hsp150p is one of the members in Pir family conserved in pathogenic fungi Candida glabrata and Candida albicans. Overexpression of Hsp150p in lab strain increased cell wall integrity and potentially enhanced the virulence of yeast. Altogether, these results demonstrated that quantitative cell wall subproteome was analyzed in clinical isolates of S. cerevisiae, and several CWPs, especially Hsp150p, were found to be expressed at higher levels which presumably contribute to strain virulence and fungal pathogenicity.	[Hsu, Pang-Hung; Liu, Chia-Hsun] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan; [Chiang, Pei-Chi; Chang, Ya-Wen] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Chang, Ya-Wen] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan Ocean University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Hsu, PH (corresponding author), Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan.	panghung.ntou@gmail.com; ywchang364@ntu.edu.tw	Hsu, Pang-Hung/C-5587-2018	Hsu, Pang-Hung/0000-0001-6873-6434; CHANG, YA-WEN/0000-0001-9656-3948	 [100-2113-M-019-002-MY2];  [102-2113-M-019-003-MY2];  [97-2320-B-002-027];  [98-2320-B-002-020-MY3]	; ; ; 	This work was supported by research grants 100-2113-M-019-002-MY2 and 102-2113-M-019-003-MY2 for PH, as well as 97-2320-B-002-027 and 98-2320-B-002-020-MY3 for YC from the Minister of Science and Technology, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendrup MC, 2011, J CLIN MICROBIOL, V49, P3300, DOI 10.1128/JCM.00179-11; Astiz ME, 1998, LANCET, V351, P1501, DOI 10.1016/S0140-6736(98)01134-9; AUCOTT JN, 1990, REV INFECT DIS, V12, P406; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; BYRON JK, 1995, INFECT IMMUN, V63, P478, DOI 10.1128/IAI.63.2.478-485.1995; Cappellaro C, 1998, J BACTERIOL, V180, P5030, DOI 10.1128/JB.180.19.5030-5037.1998; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; Chitasombat MN, 2012, J INFECTION, V64, P68, DOI 10.1016/j.jinf.2011.11.002; CIMOLAI N, 1987, DIAGN MICR INFEC DIS, V8, P113, DOI 10.1016/0732-8893(87)90158-1; CLEMONS KV, 1994, J INFECT DIS, V169, P859, DOI 10.1093/infdis/169.4.859; de Godoy LMF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r50; de Groot PWJ, 2004, EUKARYOT CELL, V3, P955, DOI 10.1128/EC.3.4.955-965.2004; Delgado ML, 2001, MICROBIOL-SGM, V147, P411, DOI 10.1099/00221287-147-2-411; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Galan-Ladero MA, 2013, YEAST, V30, P331, DOI 10.1002/yea.2965; Garcia-Sanchez S, 2004, EUKARYOT CELL, V3, P536, DOI 10.1128/EC.3.2.536-545.2004; HAZEN KC, 1995, CLIN MICROBIOL REV, V8, P462, DOI 10.1128/CMR.8.4.462; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kapteyn JC, 1999, MOL MICROBIOL, V31, P1835, DOI 10.1046/j.1365-2958.1999.01320.x; KIEHN TE, 1980, AM J CLIN PATHOL, V73, P518; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Klotz SA, 2004, INFECT IMMUN, V72, P2029, DOI 10.1128/IAI.72.4.2029-2034.2004; Kovacs M, 2008, FEMS YEAST RES, V8, P1115, DOI 10.1111/j.1567-1364.2008.00413.x; Lin JS, 2010, J LEUKOCYTE BIOL, V88, P95, DOI 10.1189/jlb.1109717; LopezRibot JL, 1996, J BACTERIOL, V178, P4724, DOI 10.1128/jb.178.15.4724-4726.1996; Mansour MK, 2002, CURR OPIN MICROBIOL, V5, P359, DOI 10.1016/S1369-5274(02)00342-9; Martinez AI, 2004, MICROBIOL-SGM, V150, P3151, DOI 10.1099/mic.0.27220-0; Martinez-Lopez R, 2004, MICROBIOL-SGM, V150, P3341, DOI 10.1099/mic.0.27320-0; MCCUSKER JH, 1994, INFECT IMMUN, V62, P5447, DOI 10.1128/IAI.62.12.5447-5455.1994; MCCUSKER JH, 1994, GENETICS, V136, P1261; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; MRSA V, 1993, J BACTERIOL, V175, P2102, DOI 10.1128/JB.175.7.2102-2106.1993; Mrsa V, 1999, YEAST, V15, P813, DOI 10.1002/(SICI)1097-0061(199907)15:10A<813::AID-YEA421>3.0.CO;2-Y; Muller LAH, 2011, MOL ECOL, V20, P4085, DOI 10.1111/j.1365-294X.2011.05225.x; Murphy JW, 1999, MYCOSES, V42, P37, DOI 10.1111/j.1439-0507.1999.tb00011.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; NAKAMURA LT, 1994, INFECT IMMUN, V62, P680, DOI 10.1128/IAI.62.2.680-684.1994; Newport G, 2003, J BIOL CHEM, V278, P1713, DOI 10.1074/jbc.M209713200; Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Bom VLP, 2015, EUKARYOT CELL, V14, P728, DOI 10.1128/EC.00008-15; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Plotnikova T A, 2006, Dokl Biochem Biophys, V409, P244, DOI 10.1134/S1607672906040144; Ponton J, 2000, MED MYCOL, V38, P225, DOI 10.1080/mmy.38.s1.225.236; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Sutherland IW, 1998, TRENDS BIOTECHNOL, V16, P41, DOI 10.1016/S0167-7799(97)01139-6; TAWFIK OW, 1989, J CLIN MICROBIOL, V27, P1689, DOI 10.1128/JCM.27.7.1689-1691.1989; Terashima H, 2000, MOL GEN GENET, V264, P64, DOI 10.1007/s004380000285; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; VANDERMEI HC, 1993, APPL ENVIRON MICROB, V59, P4305, DOI 10.1128/AEM.59.12.4305-4312.1993; Weig M, 2004, MICROBIOL-SGM, V150, P3129, DOI 10.1099/mic.0.27256-0; Wheeler RT, 2003, P NATL ACAD SCI USA, V100, P2766, DOI 10.1073/pnas.0437995100; Xu H, 2010, J PROTEOME RES, V9, P3384, DOI 10.1021/pr100369y; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yin QY, 2005, J BIOL CHEM, V280, P20894, DOI 10.1074/jbc.M500334200	61	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135174	10.1371/journal.pone.0135174	http://dx.doi.org/10.1371/journal.pone.0135174			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270963	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492800039
J	Noll, LW; Shridhar, PB; Dewsbury, DM; Shi, XR; Cernicchiaro, N; Renter, DG; Nagaraja, TG				Noll, Lance W.; Shridhar, Pragathi B.; Dewsbury, Diana M.; Shi, Xiaorong; Cernicchiaro, Natalia; Renter, David G.; Nagaraja, T. G.			A Comparison of Culture- and PCR-Based Methods to Detect Six Major Non-O157 Serogroups of Shiga Toxin-Producing Escherichia coli in Cattle Feces	PLOS ONE			English	Article							FEEDLOT CATTLE; UNITED-STATES; IMMUNOMAGNETIC SEPARATION; O157 SEROGROUPS; BEEF CARCASSES; MULTIPLEX PCR; O26; PREVALENCE; O145; O111	Culture-based methods to detect the six major non-O157 (O26, O45, O103, O111, O121 and O145) Shiga toxin-producing E. coli (STEC) are not well established. Our objectives of this study were to develop a culture-based method to detect the six non-O157 serogroups in cattle feces and compare the detection with a PCR method. Fecal samples (n = 576) were collected in a feedlot from 24 pens during a 12-week period and enriched in E. coli broth at 40 degrees C for 6 h. Enriched samples were subjected to immunomagnetic separation, spread-plated onto a selective chromogenic medium, and initially pooled colonies, and subsequently, single colonies were tested by a multiplex PCR targeting six serogroups and four virulence genes, stx1, stx2, eae, and ehxA (culture method). Fecal suspensions, before and after enrichment, were also tested by a multiplex PCR targeting six serogroups and four virulence genes (PCR method). There was no difference in the proportions of fecal samples that tested positive (74.3 vs. 77.4%) for one or more of the six serogroups by either culture or the PCR method. However, each method detected one or more of the six serogroups in samples that were negative by the other method. Both culture method and PCR indicated that O26, O45, and O103 were the dominant serogroups. Higher proportions (P < 0.05) of fecal samples were positive for O26 (44.4 vs. 22.7%) and O121 (22.9 vs. 2.3%) serogroups by PCR than by the culture method. None of the fecal samples contained more than four serogroups. Only a small proportion of the six serogroups (23/640; 3.6%) isolated carried Shiga toxin genes. The culture method and the PCR method detected all six serogroups in samples negative by the other method, highlighting the importance of subjecting fecal samples to both methods for accurate detection of the six non-O157 STEC in cattle feces.	[Noll, Lance W.; Shridhar, Pragathi B.; Dewsbury, Diana M.; Shi, Xiaorong; Cernicchiaro, Natalia; Renter, David G.; Nagaraja, T. G.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University	Nagaraja, TG (corresponding author), Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	tnagaraj@vet.k-state.edu		Renter, David/0000-0002-9959-0674	Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture National Institute of Food and Agriculture [2012-68003-30155]	Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture National Institute of Food and Agriculture	Agriculture and Food Research Initiative Competitive Grant no. 2012-68003-30155 from the United States Department of Agriculture National Institute of Food and Agriculture.	[Anonymous], 2013, DAILY J US GOVT, P1; Arthur TM, 2002, APPL ENVIRON MICROB, V68, P4847, DOI 10.1128/AEM.68.10.4847-4852.2002; Bai JF, 2012, FOODBORNE PATHOG DIS, V9, P541, DOI 10.1089/fpd.2011.1082; Baltasar P, 2014, J FOOD PROTECT, V77, P722, DOI 10.4315/0362-028X.JFP-13-420; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Burns F, 2011, J AOAC INT, V94, P1117; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET, P1; Cernicchiaro N, 2013, FOODBORNE PATHOG DIS, V10, P835, DOI 10.1089/fpd.2013.1526; Dargatz DA, 2013, FOODBORNE PATHOG DIS, V10, P392, DOI 10.1089/fpd.2012.1289; DebRoy C, 2011, FOODBORNE PATHOG DIS, V8, P651, DOI 10.1089/fpd.2010.0769; Ekiri AB, 2014, J FOOD PROTECT, V77, P1052, DOI 10.4315/0362-028X.JFP-13-373; Ennis C, 2012, J APPL MICROBIOL, V113, P1238, DOI 10.1111/j.1365-2672.2012.05421.x; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Fox JT, 2008, J FOOD PROTECT, V71, P1761, DOI 10.4315/0362-028X-71.9.1761; Fratamico PM, 2011, FOODBORNE PATHOG DIS, V8, P601, DOI 10.1089/fpd.2010.0773; Jacob ME, 2010, J FOOD PROTECT, V73, P1030, DOI 10.4315/0362-028X-73.6.1030; Ju WT, 2012, FOOD MICROBIOL, V32, P371, DOI 10.1016/j.fm.2012.07.017; Kalchayanand N, 2013, J FOOD PROTECT, V76, P192, DOI 10.4315/0362-028X.JFP-12-182; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LeJeune JT, 2006, J CLIN MICROBIOL, V44, P872, DOI 10.1128/JCM.44.3.872-875.2006; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869, DOI 10.1128/JCM.23.5.869-872.1986; Mathusa EC, 2010, J FOOD PROTECT, V73, P1721, DOI 10.4315/0362-028X-73.9.1721; Monaghan I, 2011, APPL ENVIRON MICROB, V77, P8662, DOI 10.1128/AEM.06190-11; Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI 10.1128/AEM.69.5.2444-2447.2003; Paddock ZD, 2014, FOODBORNE PATHOG DIS, V11, P186, DOI 10.1089/fpd.2013.1659; Paddock Z, 2012, VET MICROBIOL, V156, P381, DOI 10.1016/j.vetmic.2011.11.017; Pihkala N., 2012, RISK PROFILE PATHOGE, P1; Posse B, 2008, FEMS MICROBIOL LETT, V282, P124, DOI 10.1111/j.1574-6968.2008.01121.x; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Verstraete K, 2010, VET MICROBIOL, V145, P106, DOI 10.1016/j.vetmic.2010.03.004	33	45	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135446	10.1371/journal.pone.0135446	http://dx.doi.org/10.1371/journal.pone.0135446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270482	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492800071
J	Tomita, S; Oeda, T; Umemura, A; Kohsaka, M; Park, K; Yamamoto, K; Sugiyama, H; Mori, C; Inoue, K; Fujimura, H; Sawada, H				Tomita, Satoshi; Oeda, Tomoko; Umemura, Atsushi; Kohsaka, Masayuki; Park, Kwiyoung; Yamamoto, Kenji; Sugiyama, Hiroshi; Mori, Chiaki; Inoue, Kimiko; Fujimura, Harutoshi; Sawada, Hideyuki			Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study	PLOS ONE			English	Article							RICHARDSON-OLSZEWSKI-SYNDROME; MULTIPLE SYSTEM ATROPHY; NATURAL-HISTORY; PARKINSONS-DISEASE; SWALLOWING FUNCTION; DYSPHAGIA; PREDICTORS; SURVIVAL; GAIT; RESPONSIVENESS	Introduction Although aspiration pneumonia is the most common complication of progressive supranuclear palsy (PSP), the clinical impact of aspiration pneumonia on disease course and survival has not been fully estimated. Thus, we retrospectively analyzed the prognostic factors and clinical consequences of pneumonia in PSP. Methods The clinical course of patients with aspiration pneumonia was surveyed. The association between baseline clinical features (2 years from disease onset) and latency to the initial development of pneumonia was investigated using survival time and Cox regression analyses. Results Ninety patients with a clinical diagnosis of PSP were observed for 5.1 +/- 3.8 years (mean +/- SD), and 22 had aspiration pneumonia. Subsequently, 20 patients (91%) had to discontinue oral feeding entirely and 13 (59%) died, whereas, of 68 patients without pneumonia, only three patients (4%) died. Time to initial development of pneumonia was strongly correlated with survival time (Spearman R = 0.92, P<0.001), with a mean latency of 2.3 years to death. Among baseline clinical features, early fall episodes and cognitive decline were significant predictors of pneumonia (P = 0.001 and P<0.001, respectively, log rank test). Cox regression analysis demonstrated that early fall episodes (adjusted hazard ratio: 3.9, 95% confidence interval: 1.2-12.5, P = 0.03) and cognitive decline (adjusted hazard ratio: 5.2, 95% confidence interval: 1.4-19.3, P = 0.02) independently predicted pneumonia. By contrast, dysphagia was not associated with pneumonia (P = 0.2, log rank test). Conclusion Initial development of pneumonia indicates an unfavorable clinical course and predicts survival time (mean survival time 2.3 years). Patients with early falls and cognitive decline were at high risk of early development of pneumonia.	[Tomita, Satoshi; Oeda, Tomoko; Umemura, Atsushi; Kohsaka, Masayuki; Park, Kwiyoung; Yamamoto, Kenji; Sawada, Hideyuki] Natl Reg Ctr Neurol Disorders, Clin Res Ctr, Kyoto, Japan; [Tomita, Satoshi; Oeda, Tomoko; Umemura, Atsushi; Kohsaka, Masayuki; Park, Kwiyoung; Yamamoto, Kenji; Sugiyama, Hiroshi; Sawada, Hideyuki] Natl Utano Hosp, Kyoto, Japan; [Tomita, Satoshi; Oeda, Tomoko; Umemura, Atsushi; Kohsaka, Masayuki; Park, Kwiyoung; Yamamoto, Kenji; Sugiyama, Hiroshi; Sawada, Hideyuki] Natl Reg Ctr Neurol Disorders, Dept Neurol, Kyoto, Japan; [Mori, Chiaki; Inoue, Kimiko; Fujimura, Harutoshi] Toneyama Natl Hosp, Dept Neurol, Osaka, Japan		Sawada, H (corresponding author), Natl Reg Ctr Neurol Disorders, Clin Res Ctr, Kyoto, Japan.	sawada@unh.hosp.go.jp	Umemura, Atsushi/ABC-4716-2021; Yamamoto, Kenji/AAD-8766-2019	Umemura, Atsushi/0000-0001-8557-6014; Yamamoto, Kenji/0000-0003-1240-6369; Sawada, Hideyuki/0000-0002-5909-3366; Tomita, Satoshi/0000-0003-4410-6539	Grants-in-Aid for Scientific Research [26461287] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ahmed Z, 2008, BRAIN, V131, P460, DOI 10.1093/brain/awm301; Chiu WZ, 2010, J NEUROL NEUROSUR PS, V81, P441, DOI 10.1136/jnnp.2009.195719; Compta Y, 2007, MOVEMENT DISORD, V22, P1954, DOI 10.1002/mds.21612; dell'Aquila C, 2013, PARKINSONISM RELAT D, V19, P980, DOI 10.1016/j.parkreldis.2013.06.014; Dickson DW, 2010, CURR OPIN NEUROL, V23, P394, DOI 10.1097/WCO.0b013e32833be924; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goetz CG, 2003, NEUROLOGY, V60, P917, DOI 10.1212/01.WNL.0000052686.97625.27; GOLBE LI, 1988, NEUROLOGY, V38, P1031, DOI 10.1212/WNL.38.7.1031; HAUW JJ, 1994, NEUROLOGY, V44, P2015, DOI 10.1212/WNL.44.11.2015; Jecmenica-Lukic M, 2014, J NEUROL, V261, P1575, DOI 10.1007/s00415-014-7384-x; Johnston BT, 1997, MOVEMENT DISORD, V12, P322, DOI 10.1002/mds.870120310; Lang AE, 2005, MOVEMENT DISORD, V20, pS83, DOI 10.1002/mds.20545; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; Litvan I, 1997, NEUROLOGY, V48, P1654, DOI 10.1212/WNL.48.6.1654; Litvan I, 1996, J NEUROL NEUROSUR PS, V60, P615, DOI 10.1136/jnnp.60.6.615; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Manor Y, 2007, MOVEMENT DISORD, V22, P1917, DOI 10.1002/mds.21625; Muller J, 2001, ARCH NEUROL-CHICAGO, V58, P259, DOI 10.1001/archneur.58.2.259; Nath U, 2005, J NEUROL NEUROSUR PS, V76, P498, DOI 10.1136/jnnp.2004.039370; Nath U, 2003, NEUROLOGY, V60, P910, DOI 10.1212/01.WNL.0000052991.70149.68; O'Sullivan SS, 2008, BRAIN, V131, P1362, DOI 10.1093/brain/awn065; Papapetropoulos S, 2005, EUR NEUROL, V54, P1, DOI 10.1159/000086754; Respondek G, 2014, MOVEMENT DISORD, V29, P1758, DOI 10.1002/mds.26054; Varanese S, 2014, J NEUROL, V261, P441, DOI 10.1007/s00415-013-7232-4; Warnecke T, 2010, MOVEMENT DISORD, V25, P1239, DOI 10.1002/mds.23060; Williams DR, 2007, MOVEMENT DISORD, V22, P2235, DOI 10.1002/mds.21698; Williams DR, 2007, BRAIN, V130, P1566, DOI 10.1093/brain/awm104; Williams DR, 2005, BRAIN, V128, P1247, DOI 10.1093/brain/awh488	28	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135823	10.1371/journal.pone.0135823	http://dx.doi.org/10.1371/journal.pone.0135823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270456	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492800116
J	Valacchi, G; Sticozzi, C; Belmonte, G; Cervellati, F; Demaude, J; Chen, N; Krol, Y; Oresajo, C				Valacchi, Giuseppe; Sticozzi, Claudia; Belmonte, Giuseppe; Cervellati, Franco; Demaude, Julien; Chen, Nannan; Krol, Yevgeniy; Oresajo, Christian			Vitamin C Compound Mixtures Prevent Ozone-Induced Oxidative Damage in Human Keratinocytes as Initial Assessment of Pollution Protection	PLOS ONE			English	Article							MURINE SKIN; IN-VIVO; ENVIRONMENTAL-POLLUTANTS; STRATUM-CORNEUM; NRF2 ACTIVATION; STRESS; MECHANISM; TOXICITY; EXPOSURE; RESPONSES	Introduction One of the main functions of cutaneous tissues is to protect our body from the outdoor insults. Ozone (O-3) is among the most toxic stressors to which we are continuously exposed and because of its critical location, the skin is one of the most susceptible tissues to the oxidative damaging effect of O-3. O-3 is not able to penetrate the skin, and although it is not a radical per se, the damage is mainly a consequence of its ability to induce oxidative stress via the formation of lipid peroxidation products. Aim of Study In this study we investigated the protective effect of defined "antioxidant" mixtures against O-3 induced oxidative stress damage in human keratinocytes and understand their underlying mechanism of action. Results Results showed that the mixtures tested were able to protect human keratinocytes from O-3-induced cytotoxicity, inhibition of cellular proliferation, decrease the formation of HNE protein adducts, ROS, and carbonyls levels. Furthermore, we have observed the decreased activation of the redox sensitive transcription factor NF-kB, which is involved in transcribing pro-inflammatory cytokines and therefore constitutes one of the main players associated with O-3 induced skin inflammation. Cells exposed to O-3 demonstrated a dose dependent increase in p65 subunit nuclear expression as a marker of NF-kB activation, while pre-treatment with the mixtures abolished NF-kB nuclear translocation. In addition, a significant activation of Nrf2 in keratinocytes treated with the mixtures was also observed. Conclusion Overall this study was able to demonstrate a protective effect of the tested compounds versus O-3-induced cell damage in human keratinocytes. Pre-treatment with the tested compounds significantly reduced the oxidative damage induced by O-3 exposure and this protective effect was correlated to the abolishment of NF-kB nuclear translocation, as well as activation of Nrf2 nuclear translocation activating the downstream defence enzymes involved in cellular detoxification process.	[Valacchi, Giuseppe; Sticozzi, Claudia; Belmonte, Giuseppe; Cervellati, Franco] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Valacchi, Giuseppe] Kyung Hee Univ, Dept Food & Funct, Seoul, South Korea; [Chen, Nannan; Oresajo, Christian] LOreal Res & Innovat, Clark, NJ USA; [Krol, Yevgeniy] Skinceuticals Inc, New York, NY USA; [Demaude, Julien] LOreal Res & Innovat, Paris, France	University of Ferrara; Kyung Hee University; L'Oreal Group; L'Oreal Group	Valacchi, G (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, Via L Borsari, I-44100 Ferrara, Italy.	giuseppe.valacchi@unife.it	Cervellati, Franco/E-6546-2018	Cervellati, Franco/0000-0002-0051-2597	Skinceutical Inc.; L'Oreal Research and Innovation	Skinceutical Inc.; L'Oreal Research and Innovation	The study was funded by Skinceutical Inc. to Prof. Giuseppe Valacchi. Skinceutical Inc. provided support in the form of a salary to YK. The experimental strategy was decided together with the research department of Skinceutical Inc., with the aim of providing information on the protective effects of the products used in the study. Thus Skinceutical Inc. had a role in study design, but did not have any additional role in data collection and analysis, decision to publish, or preparation of the manuscript. L'Oreal Research and Innovation provided support in the form of a salary to JD and NC and CO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all of these authors are articulated in the 'author contributions' section.	Baudouin C, 2002, CELL BIOL TOXICOL, V18, P341, DOI 10.1023/A:1019540316060; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Cervellati F, 2011, REPROD FERT DEVELOP, V23, P319, DOI 10.1071/RD10077; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Farage M. A., 2008, International Journal of Cosmetic Science, V30, P87, DOI 10.1111/j.1468-2494.2007.00415.x; He Q. C., 2006, International Journal of Cosmetic Science, V28, P349, DOI 10.1111/j.1467-2494.2006.00347.x; Health Effects Institute B MA, 2010, 17 HEI; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lin FH, 2005, J INVEST DERMATOL, V125, P826, DOI 10.1111/j.0022-202X.2005.23768.x; Murray JC, 2008, J AM ACAD DERMATOL, V59, P418, DOI 10.1016/j.jaad.2008.05.004; Mustafa MG, 1999, FREE RADIC BIOL MED, V9, P245; NIKI E, 1991, AM J CLIN NUTR, V54, pS1119, DOI 10.1093/ajcn/54.6.1119s; NJUS D, 1991, FEBS LETT, V284, P147, DOI 10.1016/0014-5793(91)80672-P; Paoletti E, 2014, ENVIRON POLLUT, V192, P295, DOI 10.1016/j.envpol.2014.04.040; Pecorelli A, 2013, TOXICOL APPL PHARM, V267, P30, DOI 10.1016/j.taap.2012.12.001; PRYOR WA, 1991, FREE RADICAL BIO MED, V11, P41, DOI 10.1016/0891-5849(91)90186-7; Pryor WA, 1995, TOXICOL LETT, V82-3, P287, DOI 10.1016/0378-4274(95)03563-X; PRYOR WA, 1994, FREE RADICAL BIO MED, V17, P451, DOI 10.1016/0891-5849(94)90172-4; PRYOR WA, 1995, FREE RADICAL BIO MED, V19, P935, DOI 10.1016/0891-5849(95)02033-7; Pryor WA, 1984, FREE RADIC BIOL MED, V17, P451; Rubio V, 2010, ENVIRON SCI POLLUT R, V17, P369, DOI 10.1007/s11356-009-0140-6; SHINDO Y, 1994, J INVEST DERMATOL, V102, P122, DOI 10.1111/1523-1747.ep12371744; Sillman S, 1999, ATMOS ENVIRON, V33, P1821, DOI 10.1016/S1352-2310(98)00345-8; Sticozzi C, 2013, EUR J PHARM SCI, V49, P133, DOI 10.1016/j.ejps.2013.02.009; Sticozzi C, 2011, J SCI IND RES INDIA, V70, P918; Thiele JJ, 1997, BIOL CHEM, V378, P1299; Thiele JJ, 1997, FREE RADICAL BIO MED, V23, P385, DOI 10.1016/S0891-5849(96)00617-X; Ushio H, 1999, TOXICOL LETT, V105, P17, DOI 10.1016/S0378-4274(98)00379-8; Valacchi G, 2004, FREE RADICAL BIO MED, V36, P673, DOI 10.1016/j.freeradbiomed.2003.12.005; Valacchi G, 2003, BIOCHEM BIOPH RES CO, V305, P741, DOI 10.1016/S0006-291X(03)00812-X; Valacchi G, 2002, TOXICOLOGY, V179, P163, DOI 10.1016/S0300-483X(02)00240-8; Valacchi G, 2012, ANN NY ACAD SCI, V1271, P75, DOI 10.1111/j.1749-6632.2012.06724.x; Weber SU, 1999, J INVEST DERMATOL, V113, P1128, DOI 10.1046/j.1523-1747.1999.00789.x; Xu F, 2011, BRIT J DERMATOL, V165, P224, DOI 10.1111/j.1365-2133.2011.10349.x	35	62	62	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0131097	10.1371/journal.pone.0131097	http://dx.doi.org/10.1371/journal.pone.0131097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270818	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800003
J	Bemanian, V; Sauer, T; Touma, J; Lindstedt, BA; Chen, Y; Odegard, HP; Vetvik, KM; Bukholm, IR; Geisler, J				Bemanian, Vahid; Sauer, Torill; Touma, Joel; Lindstedt, Bjorn Arne; Chen, Ying; Odegard, Hilde Presterud; Vetvik, Katja Marjaana; Bukholm, Ida Rashida; Geisler, Jurgen			The Epidermal Growth Factor Receptor (EGFR/HER-1) Gatekeeper Mutation T790M Is Present in European Patients with Early Breast Cancer	PLOS ONE			English	Article							EGFR-ACTIVATING MUTATIONS; GENE COPY NUMBER; MESSENGER-RNA; PHASE-II; RESISTANCE; AMPLIFICATION; EXPRESSION; INHIBITORS; GEFITINIB; TUMORS	The epidermal growth factor receptor (EGFR) is one of the major oncogenes identified in a variety of human malignancies including breast cancer (BC). EGFR-mutations have been studied in lung cancer for some years and are established as important markers in guiding therapy with tyrosine kinase inhibitors (TKIs). In contrast, EGFR-mutations have been reported to be rare if not absent in human BC, although recent evidence has suggested a significant worldwide variation in somatic EGFR-mutations. Therefore, we investigated the presence of EGFR-mutations in 131 norwegian patients diagnosed with early breast cancer using real-time PCR methods. In the present study we identified three patients with an EGFR-T790M-mutation. The PCR-findings were confirmed by direct Sanger sequencing. Two patients had triple-negative BC (TNBC) while the third was classified as luminal-A subtype. The difference in incidence of T790M mutations comparing the TNBC subgroup with the other BC subgroups was statistical significant (P = 0.023). No other EGFR mutations were identified in the entire cohort. Interestingly, none of the patients had received any previous cancer treatment. To our best knowledge, the EGFR-T790M-TKI-resistance mutation has not been previously detected in breast cancer patients. Our findings contrast with the observations made in lung cancer patients where the EGFR-T790M-mutation is classified as a typical, second mutation" causing resistance to TKI-therapy during ongoing anticancer therapy. In conclusion, we have demonstrated for the first time that the EGFR-T790M-mutation occurs in primary human breast cancer patients. In the present study the EGFR-T790M mutation was not accompanied by any simultaneous EGFR-activating mutation.	[Bemanian, Vahid; Lindstedt, Bjorn Arne] Akershus Univ Hosp, Dept Gene Technol, Lorenskog, Norway; [Bemanian, Vahid; Sauer, Torill; Lindstedt, Bjorn Arne; Bukholm, Ida Rashida; Geisler, Jurgen] Univ Oslo, Inst Clin Med, Lorenskog, Norway; [Sauer, Torill; Chen, Ying] Akershus Univ Hosp, Dept Pathol, Lorenskog, Norway; [Touma, Joel; Vetvik, Katja Marjaana; Bukholm, Ida Rashida] Akershus Univ Hosp, Dept Breast & Endocrine Surg, Lorenskog, Norway; [Odegard, Hilde Presterud; Geisler, Jurgen] Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Geisler, J (corresponding author), Univ Oslo, Inst Clin Med, Campus Akershus Univ Hosp, Lorenskog, Norway.	juergen.geisler@medisin.uio.no	Sauer, Torill/H-7041-2019; Geisler, Jurgen/AAI-4613-2020	Geisler, Jurgen/0000-0001-6239-3856	Bodil and Magne's Cancer Research Fund, Oslo, Norway; Akershus University Hospital	Bodil and Magne's Cancer Research Fund, Oslo, Norway; Akershus University Hospital	The present work was supported by scientific grants provided by Bodil and Magne's Cancer Research Fund, Oslo, Norway and the Akershus University Hospital (internal strategic funding).	Barton VN, 2015, MOL CANCER THER, V14, P769, DOI 10.1158/1535-7163.MCT-14-0926; Baselga J, 2005, J CLIN ONCOL, V23, P5323, DOI 10.1200/JCO.2005.08.326; Bhargava R, 2005, MODERN PATHOL, V18, P1027, DOI 10.1038/modpathol.3800438; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Dickler MN, 2009, BREAST CANCER RES TR, V115, P115, DOI 10.1007/s10549-008-0055-9; Generali D, 2007, ANN ONCOL, V18, P203, DOI 10.1093/annonc/mdl322; Gumuskaya B, 2010, CANCER GENET CYTOGEN, V203, P222, DOI 10.1016/j.cancergencyto.2010.07.118; Hrustanovic G, 2013, CANCER BIOL THER, V14, P304, DOI 10.4161/cbt.23627; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jacot W, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3079; Lamy PJ, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-13; Lane A, 2014, ONCOGENE, V33, P5078, DOI 10.1038/onc.2013.452; Lee HR, 2014, JPN J NURS SCI, V11, P112, DOI 10.1111/jjns.12013; Liedtke C, 2015, CURR OPIN OBSTET GYN, V27, P77, DOI 10.1097/GCO.0000000000000137; Liu ZB, 2010, ONCOGENE, V29, P2996, DOI 10.1038/onc.2010.70; Lv N, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-118; Ma Chunyan, 2011, J Thorac Dis, V3, P10, DOI 10.3978/j.issn.2072-1439.2010.12.02; Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Nakajima H, 2014, BREAST CANCER-TOKYO, V21, P66, DOI 10.1007/s12282-012-0354-1; Nieto Y, 2007, J CLIN ONCOL, V25, P4405, DOI 10.1200/JCO.2006.09.8822; Papa A, 2015, EXPERT OPIN THER TAR, V19, P55, DOI 10.1517/14728222.2014.970176; Park HS, 2014, MODERN PATHOL, V27, P1212, DOI 10.1038/modpathol.2013.251; Reis JS, 2006, J PATHOL, V209, P445, DOI 10.1002/path.2004; Santarpia L, 2012, BREAST CANCER RES TR, V134, P333, DOI 10.1007/s10549-012-2035-3; Secq V, 2014, BRIT J CANCER, V110, P1045, DOI 10.1038/bjc.2013.794; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Teng YHF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2857; Tilch E, 2014, BREAST CANCER RES TR, V143, P385, DOI 10.1007/s10549-013-2798-1; Toyama T, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-309; Uramoto H, 2010, ANTICANCER RES, V30, P4219; von Minckwitz G, 2005, BREAST CANCER RES TR, V89, P165, DOI 10.1007/s10549-004-1720-2; Weber F, 2005, BRIT J CANCER, V92, P1922, DOI 10.1038/sj.bjc.6602557; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Willmarth NE, 2009, CELL SIGNAL, V21, P212, DOI 10.1016/j.cellsig.2008.10.003; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhang XS, 2014, EXPERT OPIN PHARMACO, V15, P1277, DOI 10.1517/14656566.2014.913570	38	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134398	10.1371/journal.pone.0134398	http://dx.doi.org/10.1371/journal.pone.0134398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267891	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300043
J	Navascues-Cornago, M; Morgan, PB; Maldonado-Codina, C				Navascues-Cornago, Maria; Morgan, Philip B.; Maldonado-Codina, Carole			Effect of Three Interventions on Contact Lens Comfort in Symptomatic Wearers: A Randomized Clinical Trial	PLOS ONE			English	Article							TFOS INTERNATIONAL WORKSHOP; SILICONE HYDROGEL; DISCOMFORT; DRYNESS; INTERLEUKIN-6; EYE	Purpose To investigate whether carrying out various interventions part way through the day influences comfort in symptomatic daily disposable (DD) contact lens wearers. Methods A subject-masked, randomized, controlled clinical trial was conducted in thirty symptomatic soft lens wearers who wore their habitual DD contact lenses bilaterally for 12 h on two separate days. Five hours after lens application, one of the following three interventions or a control was performed on each eye: replacing the existing lens with a new lens; removing and reapplying the same lens; performing a 'scleral swish'; and no action (control). Comfort scores were recorded using SMS text messages every hour following lens application using a 0 (causes pain) to 100 (excellent comfort) scale. Comfort scores before lens application, at 6 mins post-application, and at 6 mins post-intervention were also recorded. Results There was a significant reduction in comfort from pre-lens application to 6 mins post-application for all groups (all p<0.05). Comfort gradually decreased from 6 mins to 5 h after lens application for each group (p<0.0001) with no significant difference between groups over the 5-h period (p = 0.09). There was no significant difference in comfort 6 mins post-intervention for any group (all p>0.05). After the intervention, comfort continued to decline (p<0.0001) with slightly lower mean scores for the control group compared to the new lens group (p = 0.003). Change in comfort relative to pre-intervention (5 h) was similar for all groups (p = 0.81). There was no difference in comfort at 12 h between groups (p = 0.83). Conclusion This work has confirmed that comfort shows a continual and significant decline over a 12-h wearing period in symptomatic DD contact lens wearers. None of the interventions investigated had any significant impact on end-of-day comfort. These data suggest discomfort in lens wearers is more heavily influenced by changes to the ocular environment rather than to the lens itself.	[Navascues-Cornago, Maria; Morgan, Philip B.; Maldonado-Codina, Carole] Univ Manchester, Fac Life Sci, Eurolens Res, Manchester, Lancs, England	University of Manchester	Navascues-Cornago, M (corresponding author), Univ Manchester, Fac Life Sci, Eurolens Res, Manchester, Lancs, England.	maria.navascuescornago@manchester.ac.uk		Morgan, Philip/0000-0003-0680-8169				Brennan NA, 1997, OPTOMETRY VISION SCI, V74, P609, DOI 10.1097/00006324-199708000-00022; Carney F.P., 1998, CLIN EXP OPTOM, V81, P51, DOI [10.1111/j.1444-0938.1998.tb06626.x, DOI 10.1111/J.1444-0938.1998.TB06626.X]; Chalmers R, 2014, CONTACT LENS ANTERIO, V37, P65, DOI 10.1016/j.clae.2013.08.154; Chalmers Robin L, 2006, Cont Lens Anterior Eye, V29, P25, DOI 10.1016/j.clae.2005.12.004; Chalmers RL, 2012, OPTOMETRY VISION SCI, V89, P1435, DOI 10.1097/OPX.0b013e318269c90d; Dogru M, 2011, CONTACT LENS ANTERIO, V34, P77, DOI 10.1016/j.clae.2010.12.001; Dumbleton K, 2013, EYE CONTACT LENS, V39, P93, DOI 10.1097/ICL.0b013e318271caf4; Efron N, 2001, OPHTHAL PHYSL OPT, V21, P17, DOI 10.1046/j.1475-1313.2001.00575.x; FABER E, 1991, OPTOMETRY VISION SCI, V68, P380, DOI 10.1097/00006324-199105000-00010; Fonn D, 1999, INVEST OPHTH VIS SCI, V40, P3116; Fonn D, 1999, OPTOMETRY VISION SCI, V76, P700, DOI 10.1097/00006324-199910000-00021; Fonn D., 2003, EYE CONTACT LENS S, V29, pS115; Fonn D., 2003, EYE CONTACT LENS S, V29, pS192; Fonn D, 2007, OPTOMETRY VISION SCI, V84, P279, DOI 10.1097/OPX.0b013e31804636af; Fonn Desmond, 2003, Eye Contact Lens, V29, pS101; Glasson M J, 2006, Cont Lens Anterior Eye, V29, P41, DOI 10.1016/j.clae.2005.12.006; Gonzalez-Meijome JM, 2009, J BIOMED MATER RES B, V88B, P75, DOI 10.1002/jbm.b.31153; HENRIQUEZ AS, 1981, BRIT J OPHTHALMOL, V65, P108, DOI 10.1136/bjo.65.2.108; Korb Donald R., 2002, CLAO Journal, V28, P211; KORB DR, 1980, J AM OPTOM ASSOC, V51, P243; Maldonado-Codina C, 2005, OPTOMETRY VISION SCI, V82, P536, DOI 10.1097/00006324-200506000-00018; Mann AM, 2002, ADV EXP MED BIOL, V506, P961; McNamara NA, 1999, AM J OPHTHALMOL, V127, P659, DOI 10.1016/S0002-9394(99)00051-3; Menzies KL, 2011, OPTOMETRY VISION SCI, V88, P493, DOI 10.1097/OPX.0b013e3181ff9d39; Morgan PB, 2013, OPTOMETRY VISION SCI, V90; Morgan PB, 2007, OPTOMETRY VISION SCI, V84; Morgan Philip B, 2002, Clin Exp Optom, V85, P183; Nichols JJ, 2013, INVEST OPHTH VIS SCI, V54, P7, DOI 10.1167/iovs.13-13212; Ozkan J, 2013, CONTACT LENS ANTERIO, V36, P171, DOI 10.1016/j.clae.2013.01.004; Papas EB, 2014, OPTOMETRY VISION SCI, V91, P24, DOI 10.1097/OPX.0000000000000102; Papas EB, 2011, INVEST OPHTH VIS SCI, V52, P4390, DOI 10.1167/iovs.10-7051; Paugh JR, 2001, INVEST OPHTH VIS SCI, V42, P2813; Plowright AJ, 2008, OPTOMETRY VISION SCI, V85; POLSE KA, 1979, INVEST OPHTH VIS SCI, V18, P409; Poyraz C, 2012, EYE CONTACT LENS, V38, P146, DOI 10.1097/ICL.0b013e3182482910; Pult H, 2008, OPTOMETRY VISION SCI, V85, P924, DOI 10.1097/OPX.0b013e3181888909; Richdale K, 2007, CORNEA, V26, P168, DOI 10.1097/01.ico.0000248382.32143.86; Robboy Marc W, 2003, Eye Contact Lens, V29, P146, DOI 10.1097/01.ICL.0000072830.41886.1E; Santodomingo-Rubido J, 2010, EYE CONTACT LENS, V36, P96, DOI 10.1097/ICL.0b013e3181d1d5a5; Schultz CL, 2000, J INTERF CYTOK RES, V20, P309, DOI 10.1089/107999000312441; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; Stapleton F, 2013, INVEST OPHTH VIS SCI, V54, P71, DOI 10.1167/iovs.13-13226; Subbaraman LN, 2012, OPTOMETRY VISION SCI, V89, P1450, DOI 10.1097/OPX.0b013e318269e583; Thakur A, 2000, EXP EYE RES, V70, P255, DOI 10.1006/exer.1999.0767; Tranoudis Ioannis, 2004, Cont Lens Anterior Eye, V27, P115, DOI 10.1016/j.clae.2004.03.001; Varikooty J, 2013, OPTOMETRY VISION SCI, V90, P945, DOI 10.1097/OPX.0b013e31829d8dbf; Woods CA, 2011, OPTOMETRY VISION SCI, V88, P290, DOI 10.1097/OPX.0b013e3181ff9b80; Yeniad B, 2010, EYE CONTACT LENS, V36, P140, DOI 10.1097/ICL.0b013e3181d94e82; Young G, 2011, CONTACT LENS ANTERIO, V34, P64, DOI 10.1016/j.clae.2010.08.005; Zantos SG., 1984, J AM OPTOM ASSOC, V55, P196	50	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135323	10.1371/journal.pone.0135323	http://dx.doi.org/10.1371/journal.pone.0135323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267853	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300097
J	Noel, B; van der Kamp, J; Memmert, D				Noel, Benjamin; van der Kamp, John; Memmert, Daniel			Implicit Goalkeeper Influences on Goal Side Selection in Representative Penalty Kicking Tasks	PLOS ONE			English	Article							SOCCER GOALKEEPERS; VISUAL-SEARCH; ANTICIPATION; ACCURACY; METAANALYSIS; PERCEPTION; SIMULATION; EXPERTISE; BEHAVIORS; DIRECTION	In well-controlled lab situations, marginal displacements of the goalkeeper on the goal line affect goal side selection of penalty takers implicitly, that is, without the penalty takers being consciously aware of the displacement. Whether this effect is retained in more representative real-life situations with competing goalkeepers and penalty takers has not been verified. In the current study, penalty takers were instructed to position the goalkeepers at the centre of the goal. They then performed penalty kicks adopting either a keeper independent or a keeper dependent strategy, while goalkeepers actually attempted to save the ball by strategically diving early or late. Analyses of trials in which penalty takers failed to place the goalkeeper in the centre of the goal (although they incorrectly believed they placed the goalkeeper at the centre of the goal) showed that implicit influences of the goalkeeper's position on goal side selection were overridden by the (conscious) perception of the direction of the goalkeeper's dive, but only if the penalty takers deliberately monitored the goalkeeper's action and the goalkeeper committed early enough for penalty takers to respond. In all other combinations of penalty kick and goalkeeper strategies more than 60% of the kicks were directed to the side of the goal with more space. Most importantly, however, the current study shows that influences of implicit perception on the penalty takers' decision making are rather pervasive considering that many supraliminal sources of information were available. That is, the current study demonstrates that implicit perception retains its influence on decision-making even if other (stronger) stimuli are also present.	[Noel, Benjamin; Memmert, Daniel] German Sport Univ Cologne, Inst Cognit & Team, Racket Sport Res, Cologne, Germany; [van der Kamp, John] Vrije Univ Amsterdam, Fac Human Movement Sci, Res Inst MOVE, Amsterdam, Netherlands; [van der Kamp, John] Univ Hong Kong, Inst Human Performance, Hong Kong, Hong Kong, Peoples R China	German Sport University Cologne; Vrije Universiteit Amsterdam; University of Hong Kong	Noel, B (corresponding author), German Sport Univ Cologne, Inst Cognit & Team, Racket Sport Res, Cologne, Germany.	b.noel@dshs-koeln.de		van der Kamp, John/0000-0002-3826-1973; Noel, Benjamin/0000-0002-0074-4697	grant from the German Research Council (DFG, Deutsche Forschungsgemeinschaft) [ME 2678/14-1]	grant from the German Research Council (DFG, Deutsche Forschungsgemeinschaft)	This research was supported by a grant from the German Research Council (DFG, Deutsche Forschungsgemeinschaft, www.dfg.de) to the third author, ME 2678/14-1. However, the funding source had no involvement in study design, collection, analysis, interpretation of data, writing this paper, and in the decision to submit this article for publication.	Botwell M., 2009, INT J SPORTS SCI ENG, V3, P93; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Dicks M, 2010, ATTEN PERCEPT PSYCHO, V72, P706, DOI 10.3758/APP.72.3.706; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Jordet G, 2012, J APPL SPORT PSYCHOL, V24, P73, DOI 10.1080/10413200.2011.619000; Kuhn W, 1988, SCI FOOTBALL; Masters RSW, 2007, PSYCHOL SCI, V18, P222, DOI 10.1111/j.1467-9280.2007.01878.x; Misirlisoy E, 2014, CURR BIOL, V24, P1918, DOI 10.1016/j.cub.2014.07.013; Navarro M, 2013, J SPORT SCI, V31, P921, DOI 10.1080/02640414.2012.762602; Noel B, 2015, J SPORT SCI, V33, P1, DOI 10.1080/02640414.2014.926383; Noel B, 2012, INT J SPORT PSYCHOL, V43, P326; Savelsbergh GJP, 2005, ERGONOMICS, V48, P1686, DOI 10.1080/00140130500101346; Savelsbergh GJP, 2002, J SPORT SCI, V20, P279, DOI 10.1080/026404102317284826; Travassos B, 2013, PSYCHOL SPORT EXERC, V14, P211, DOI 10.1016/j.psychsport.2012.11.002; Van der Kamp J, 2006, J SPORT SCI, V24, P467, DOI 10.1080/02640410500190841; Van der Kamp J, 2008, INT J SPORT PSYCHOL, V39, P100; van der Kamp J, 2008, PERCEPTION, V37, P951, DOI 10.1068/p6010; van der Kamp J, 2011, MOTOR CONTROL, V15, P342, DOI 10.1123/mcj.15.3.342; Weigelt M, 2012, J COGN PSYCHOL, V24, P942, DOI 10.1080/20445911.2012.719494; Weigelt M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00312; Wilson MR, 2009, J SPORT EXERCISE PSY, V31, P761, DOI 10.1123/jsep.31.6.761; Wood G, 2010, J SPORT SCI, V28, P937, DOI 10.1080/02640414.2010.495995	23	13	14	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135423	10.1371/journal.pone.0135423	http://dx.doi.org/10.1371/journal.pone.0135423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267378	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300115
J	Steenis, LJP; Verhoeven, M; Hessen, DJ; van Baar, AL				Steenis, Leonie J. P.; Verhoeven, Marjolein; Hessen, Dave J.; van Baar, Anneloes L.			Performance of Dutch Children on the Bayley III: A Comparison Study of US and Dutch Norms	PLOS ONE			English	Article							INFANTS; AGE	Background The Bayley Scales of Infant and Toddler Development-third edition (Bayley-III) are frequently used to assess early child development worldwide. However, the original standardization only included US children, and it is still unclear whether or not these norms are adequate for use in other populations. Recently, norms for the Dutch version of the Bayley-III (The Bayley-III-NL) were made. Scores based on Dutch and US norms were compared to study the need for population-specific norms. Methods Scaled scores based on Dutch and US norms were compared for 1912 children between 14 days and 42 months 14 days. Next, the proportions of children scoring < 1-SD and < -2 SD based on the two norms were compared, to identify over-or under-referral for developmental delay resulting from non-population-based norms. Results Scaled scores based on Dutch norms fluctuated around values based on US norms on all subtests. The extent of the deviations differed across ages and subtests. Differences in means were significant across all five subtests (p < .01) with small to large effect sizes (eta(2)(p)) ranging from .03 to .26). Using the US instead of Dutch norms resulted in over-referral regarding gross motor skills, and under-referral regarding cognitive, receptive communication, expressive communication, and fine motor skills. Conclusions The Dutch norms differ from the US norms for all subtests and these differences are clinically relevant. Population specific norms are needed to identify children with low scores for referral and intervention, and to facilitate international comparisons of population data.	[Steenis, Leonie J. P.; Verhoeven, Marjolein; van Baar, Anneloes L.] Univ Utrecht, Child & Adolescent Studies, Utrecht, Netherlands; [Hessen, Dave J.] Univ Utrecht, Methods & Stat, Utrecht, Netherlands	Utrecht University; Utrecht University	Steenis, LJP (corresponding author), Univ Utrecht, Child & Adolescent Studies, Utrecht, Netherlands.	l.j.p.steenis@uu.nl	van Baar, Anneloes/L-8236-2013	van Baar, Anneloes/0000-0002-3498-9019	ZonMW project [15071.3001]	ZonMW project	This research was supported by ZonMW project number 15071.3001. They had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baar AL Van, 2014, TECHNISCHE HANDLEIDI; Bayley N, 1993, BAYLEY SCALES INFANT; Bayley N., 2019, BAYLEY SCALES INFANT; Calvo A, 2014, COGNITION, V130, P278, DOI 10.1016/j.cognition.2013.11.015; Chinta S, 2014, ARCH DIS CHILD; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Duncan AF, 2012, J PEDIATR-US, V160, P966, DOI 10.1016/j.jpeds.2011.12.009; Evers A., 2010, COTAN BEOORDELINGSSY; Kelly Y, 2006, DEV MED CHILD NEUROL, V48, P825, DOI 10.1017/S0012162206001770; Krogh MT, 2012, EUR J DEV PSYCHOL, V9, P730, DOI 10.1080/17405629.2012.688101; Sameroff A, 2010, CHILD DEV, V81, P6, DOI 10.1111/j.1467-8624.2009.01378.x; Steenis L., 2012, ADV PSYCHOL RES, P133; Steenis LJP, 2014, EUR J DEV PSYCHOL, V11, P494, DOI 10.1080/17405629.2013.869207; U.S. Bureau of the Census, 2000, CURR POP SURV OCT 20; Walker K., 2010, AUST ED DEV PSYCHOL, V27, P54, DOI [10.1375/aedp.27.1.54, DOI 10.1375/AEDP.27.1.54]; Westera JJ, 2008, DEV MED CHILD NEUROL, V50, P445, DOI 10.1111/j.1469-8749.2008.02067.x; Yu YT, 2013, RES DEV DISABIL, V34, P3875, DOI 10.1016/j.ridd.2013.07.006	17	44	44	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0132871	10.1371/journal.pone.0132871	http://dx.doi.org/10.1371/journal.pone.0132871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267907	Green Published, gold			2022-12-27	WOS:000359492300010
J	Erwin, A; Sup, FC				Erwin, Andrew; Sup, Frank C.			A Haptic Feedback Scheme to Accurately Position a Virtual Wrist Prosthesis Using a Three-Node Tactor Array	PLOS ONE			English	Article							SENSORY FEEDBACK; HAND; DESIGN; EMG	In this paper, a novel haptic feedback scheme, used for accurately positioning a 1DOF virtual wrist prosthesis through sensory substitution, is presented. The scheme employs a three-node tactor array and discretely and selectively modulates the stimulation frequency of each tactor to relay 11 discrete haptic stimuli to the user. Able-bodied participants were able to move the virtual wrist prosthesis via a surface electromyography based controller. The participants evaluated the feedback scheme without visual or audio feedback and relied solely on the haptic feedback alone to correctly position the hand. The scheme was evaluated through both normal (perpendicular) and shear (lateral) stimulations applied on the forearm. Normal stimulations were applied through a prototype device previously developed by the authors while shear stimulations were generated using an ubiquitous coin motor vibrotactor. Trials with no feedback served as a baseline to compare results within the study and to the literature. The results indicated that using normal and shear stimulations resulted in accurately positioning the virtual wrist, but were not significantly different. Using haptic feedback was substantially better than no feedback. The results found in this study are significant since the feedback scheme allows for using relatively few tactors to relay rich haptic information to the user and can be learned easily despite a relatively short amount of training. Additionally, the results are important for the haptic community since they contradict the common conception in the literature that normal stimulation is inferior to shear. From an ergonomic perspective normal stimulation has the potential to benefit upper limb amputees since it can operate at lower frequencies than shear-based vibrotactors while also generating less noise. Through further tuning of the novel haptic feedback scheme and normal stimulation device, a compact and comfortable sensory substitution device for upper limb amputees might be created.	[Erwin, Andrew] Rice Univ, Dept Mech Engn, Houston, TX 77005 USA; [Sup, Frank C.] Univ Massachusetts, Mech & Ind Engn Dept, Amherst, MA 01003 USA	Rice University; University of Massachusetts System; University of Massachusetts Amherst	Sup, FC (corresponding author), Univ Massachusetts, Mech & Ind Engn Dept, Amherst, MA 01003 USA.	sup@umass.edu		Erwin, Andrew/0000-0002-9587-8670; Sup, Frank/0000-0002-6290-9805	National Science Foundation (NSF) [0850424]; University of Massachusetts Amherst Commonwealth Honors College;  [67]	National Science Foundation (NSF)(National Science Foundation (NSF)); University of Massachusetts Amherst Commonwealth Honors College; 	This work was supported by the National Science Foundation (NSF) under NSF award number 0850424; James M. Smith, '67; and the University of Massachusetts Amherst Commonwealth Honors College.	Antfolk C, 2012, J REHABIL MED, V44, P702, DOI 10.2340/16501977-1001; Antfolk C, 2010, J MED BIOL ENG, V30, P399, DOI 10.5405/jmbe.767; Antfolk C, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-50; Bark K, 2008, SYMPOSIUM ON HAPTICS INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS 2008, PROCEEDINGS, P71; Biggs J, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P121, DOI 10.1109/HAPTIC.2002.998949; Cipriani C, 2008, IEEE T ROBOT, V24, P170, DOI 10.1109/TRO.2007.910708; Cohen J., 2005, CHI 05 EXTENDED ABST, P1296; Damian DD, 2012, IEEE INT CONF ROBOT, P1038, DOI 10.1109/ICRA.2012.6225000; Erwin A, 2014, IEEE HAPTICS SYM, P505, DOI 10.1109/HAPTICS.2014.6775507; Gunstream SE, 2006, ANATOMY PHYSL INTEGR; Ha KH, 2011, IEEE T BIO-MED ENG, V58, P144, DOI 10.1109/TBME.2010.2070840; Jones Lynette A., 2010, 2010 IEEE Haptics Symposium (Formerly known as Symposium on Haptic Interfaces for Virtual Environment and Teleoperator Systems), P91, DOI 10.1109/HAPTIC.2010.5444673; Kim K, 2012, IEEE T NEUR SYS REH, V20, P798, DOI 10.1109/TNSRE.2012.2206080; Kuiken TA, 2005, P ANN INT IEEE EMBS, P7652, DOI 10.1109/IEMBS.2005.1616284; Miller LA, 2008, IEEE T NEUR SYS REH, V16, P46, DOI 10.1109/TNSRE.2007.911817; Ng J, 2004, HUM INT TECHN C; Okamura AM, 2004, IND ROBOT, V31, P499, DOI 10.1108/01439910410566362; Pylatiuk C, 2006, J PROSTHET ORTHOT, V18, P57, DOI DOI 10.1097/00008526-200604000-00007; Pylatiuk C, 2007, PROSTHET ORTHOT INT, V31, P362, DOI 10.1080/03093640601061265; Rupert AH, 2000, AVIAT SPACE ENVIR MD, V71, pA92; SHANNON GF, 1976, MED BIOL ENG, V14, P289, DOI 10.1007/BF02478123; SHANNON GF, 1979, MED PROG TECHNOL, V6, P73; SHANNON GF, 1974, BIOMED ENG, V9, P247; SHERMAN ED, 1964, CAN MED ASSOC J, V91, P1268; Staff N, 2008, AMPUTATION STAT CAUS; Szabo Z, 2011, ASME INT MECH ENG C, P1027; Wheeler J, 2010, IEEE T NEUR SYS REH, V18, P58, DOI 10.1109/TNSRE.2009.2039602; Witteveen HJB, 2012, IEEE T BIO-MED ENG, V59, P2219, DOI 10.1109/TBME.2012.2200678	28	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134095	10.1371/journal.pone.0134095	http://dx.doi.org/10.1371/journal.pone.0134095			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263015	gold, Green Submitted, Green Published			2022-12-27	WOS:000359353300018
J	Hebert, JJ; Moller, NC; Andersen, LB; Wedderkopp, N				Hebert, Jeffrey J.; Moller, Niels C.; Andersen, Lars B.; Wedderkopp, Niels			Organized Sport Participation Is Associated with Higher Levels of Overall Health-Related Physical Activity in Children (CHAMPS Study-DK)	PLOS ONE			English	Article							MOTOR-PERFORMANCE SCHOOL; CHILDHOOD HEALTH; EXERCISE; ADOLESCENTS; OVERWEIGHT; BENEFITS; DENMARK; GROWTH	Introduction Many children fail to meet international guideline recommendations for health-related activity (>= 60 minutes/day of moderate-to-vigorous physical activity [MVPA]), and intervention studies to date have reported negligible effects. Objective Explore the associations of organized leisure-time sport participation with overall physical activity levels and health-related physical activity guideline concordance. Methods This prospective cohort study was nested in the Childhood Health, Activity, and Motor Performance School Study Denmark. Study participants were a representative sample of 1124 primary school students. Organized leisure-time sport participation was reported via text messaging and physical activity was objectively measured over seven days with accelerometry. Associations between sport participation and physical activity level were explored with multilevel mixed-effects regression models and reported with beta coefficients (b) and adjusted odds ratios (aOR). Results Participants were 53% female, with mean(SD) age = 8.4(1.4) years. Boys were more active than girls (p<0.001), and physical activity levels and guideline concordance decreased with age (p<0.001). Soccer participation at any frequency was associated with greater overall MVPA (b[95% CI] = 0.66[0.20,1.13] to 2.44[1.44,3.44]). Depending on participation frequency, this equates to 5-20 minutes more MVPA on the average day and 3 to 15 fold increased odds of achieving recommended levels of health-related physical activity (aOR [95%CI] = 3.04[1.49,6.19] to 14.49[1.97,106.56]). Similar associations were identified among children playing handball at least twice per week. Relationships with other sports (gymnastics, basketball, volleyball) were inconsistent. Conclusions Many children, particularly girls and those in higher grade levels do not adhere to health-related physical activity recommendations. Organized leisure-time sport participation may be a viable strategy to increase overall health-related physical activity levels and international guideline concordance in children.	[Hebert, Jeffrey J.] Murdoch Univ, Sch Psychol & Exercise Sci, Murdoch, WA 6150, Australia; [Moller, Niels C.; Andersen, Lars B.; Wedderkopp, Niels] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Ctr Res Childhood Hlth, Odense, Denmark; [Andersen, Lars B.] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway; [Wedderkopp, Niels] Univ Southern Denmark, Sport Med Clin, Dept Orthoped, Hosp Middelfart,Inst Reg Hlth Serv Res, Middelfart, Denmark	Murdoch University; University of Southern Denmark; Norwegian School of Sport Sciences; University of Southern Denmark	Hebert, JJ (corresponding author), Murdoch Univ, Sch Psychol & Exercise Sci, Murdoch, WA 6150, Australia.	J.Hebert@Murdoch.edu.au	Wedderkopp, Niels/L-9810-2019	Moller, Niels Christian/0000-0001-5842-5595; Wedderkopp, Niels/0000-0002-9660-6618	TRYG Foundation; University College Lillebaelt; University of Southern Denmark; Nordea Foundation; IMK foundation; Region of Southern Denmark; Egmont Foundation; A.J. Andersen Foundation; Danish Rheumatism Association; Ostifternes Foundation, Brd.; Hartmann's Foundation; TEAM Denmark; Danish Chiropractor Foundation; Nordic Institute of Chiropractic and Clinical Biomechanics	TRYG Foundation; University College Lillebaelt; University of Southern Denmark; Nordea Foundation; IMK foundation; Region of Southern Denmark; Egmont Foundation; A.J. Andersen Foundation; Danish Rheumatism Association; Ostifternes Foundation, Brd.; Hartmann's Foundation; TEAM Denmark; Danish Chiropractor Foundation; Nordic Institute of Chiropractic and Clinical Biomechanics	This work was supported by The TRYG Foundation, University College Lillebaelt, University of Southern Denmark, The Nordea Foundation, The IMK foundation, The Region of Southern Denmark, The Egmont Foundation, The A.J. Andersen Foundation, The Danish Rheumatism Association, Ostifternes Foundation, Brd., Hartmann's Foundation, TEAM Denmark, The Danish Chiropractor Foundation, and The Nordic Institute of Chiropractic and Clinical Biomechanics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, 9789241599979 WHO, P60; Baranowski T, 1997, J AM DIET ASSOC, V97, P66, DOI 10.1016/S0002-8223(97)00022-9; Basterfield L, 2015, J SCI MED SPORT, V18, P178, DOI 10.1016/j.jsams.2014.03.005; Cooper AR, 2005, AM J PREV MED, V29, P179, DOI 10.1016/j.amepre.2005.05.009; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Gomersall S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-851; Gomersall SR, 2013, SPORTS MED, V43, P135, DOI 10.1007/s40279-012-0008-7; Guagliano JM, 2013, MED SCI SPORT EXER, V45, P116, DOI 10.1249/MSS.0b013e31826a0a73; Hills AP, 2007, SPORTS MED, V37, P533, DOI 10.2165/00007256-200737060-00006; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Johansen Bendt, 2010, Chiropr Osteopat, V18, P10, DOI 10.1186/1746-1340-18-10; Joy EA, 2008, CURR SPORT MED REP, V7, P367, DOI 10.1249/JSR.0b013e31818ec87b; Khan KM, 2012, LANCET, V380, P59, DOI 10.1016/S0140-6736(12)60865-4; Leek D, 2011, ARCH PEDIAT ADOL MED, V165, P294, DOI 10.1001/archpediatrics.2010.252; Lobelo F, 2014, BRIT J SPORT MED, V48, P1627, DOI 10.1136/bjsports-2013-093080; Marques A, 2016, J SCI MED SPORT, V19, P154, DOI 10.1016/j.jsams.2015.02.007; Metcalf B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5888; Moller NC, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0121-0; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Organization WH, 2009, GLOB HLTH RISKS MORT; Rowland TW, 1998, MED SCI SPORT EXER, V30, P392, DOI 10.1097/00005768-199803000-00009; Sacheck JM, 2011, PEDIATR EXERC SCI, V23, P281, DOI 10.1123/pes.23.2.281; Sallis R, 2011, BRIT J SPORT MED, V45, P473, DOI 10.1136/bjsm.2010.083469; Spinks A, 2006, J PAEDIATR CHILD H, V42, P674, DOI 10.1111/j.1440-1754.2006.00950.x; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Wedderkopp N, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-128; Wichstrom L, 2013, HEALTH PSYCHOL, V32, P775, DOI 10.1037/a0029465	30	73	74	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134621	10.1371/journal.pone.0134621	http://dx.doi.org/10.1371/journal.pone.0134621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262678	gold, Green Published			2022-12-27	WOS:000359353300032
J	Shi, XW; Liu, H; Cao, J; Liu, Q; Tang, GJ; Liu, WL; Liu, HY; Deng, DR; Qiao, FY; Wu, YY				Shi, Xinwei; Liu, Hao; Cao, Jing; Liu, Qing; Tang, Guiju; Liu, Wanlu; Liu, Haiyi; Deng, Dongrui; Qiao, Fuyuan; Wu, Yuanyuan			Promoter Hypomethylation of Maspin Inhibits Migration and Invasion of Extravillous Trophoblast Cells during Placentation	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; HUMAN BREAST-CANCER; TUMOR-SUPPRESSOR; EPIGENETIC MODIFICATION; ABERRANT EXPRESSION; OVARIAN-CARCINOMA; GENE MASPIN; APOPTOSIS; TRANSCRIPTION; PREECLAMPSIA	Objective Extravillous trophoblast (EVT) cells invade the endometrium and the maternal spiral arterioles during the first trimester. Mammary Serine Protease Inhibitor (Maspin, SERPINB5) plays a putative role in regulating the invasive activity of cytotrophoblasts. The maspin gene is silenced in various cancers by an epigenetic mechanism that involves aberrant cytosine methylation. We investigated the effect of the methylation status of the maspin promoter on the maspin expression and the aggressiveness of EVT cells. Methods Western blotting was used to detect the maspin protein expression in EVT cells upon hypoxia. The proliferative ability, the apoptosis rate and the migration and invasiveness were measured with Cell Counting Kit-8 assay, Flow Cytometry technology and Transwell methods. Subsequently, we treated cells with recombinant maspin protein. The methylation degree of maspin promoter region upon hypoxia/decitabine was detected by bisulfite sequencing PCR and methylation-specific PCR. Finally, we explored the effects of decitabine on maspin protein expression and the aggressiveness of EVT cells. Results Hypoxia effectively increased maspin protein expression in EVT cells and significantly inhibited their aggressiveness. The addition of recombinant maspin protein inhibited this aggressiveness. Decitabine reduced the methylation in the maspin promoter region and effectively increased the maspin protein expression, which significantly weakened the migration and invasiveness of EVT cells. Discussion The methylation status of the maspin promoter is an important factor that affects the migration and invasion of EVT cells during early pregnancy. A decrease in the methylation status can inhibit the migration and invasion of EVT cells to affect placentation and can result in the ischemia and hypoxia of placenta.	[Shi, Xinwei; Cao, Jing; Liu, Qing; Liu, Wanlu; Liu, Haiyi; Deng, Dongrui; Qiao, Fuyuan; Wu, Yuanyuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China; [Liu, Hao] Wuhan Third Hosp, Dept Urol, Wuhan, Hubei, Peoples R China; [Tang, Guiju] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wu, YY (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China.	qianmei98@163.com			National Natural Science Foundation of China [81200451]; National Science and Technology Support Plan of China [2014BA105B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Plan of China	This work was funded by the National Natural Science Foundation of China (No. 81200451) and the National Science and Technology Support Plan of China (2014BA105B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beecken W.-D., 2000, J Cell Mol Med, V4, P262, DOI 10.1111/j.1582-4934.2000.tb00125.x; Canning MT, 2001, EXP CELL RES, V267, P88, DOI 10.1006/excr.2001.5243; Cella N, 2006, FASEB J, V20, P1510, DOI 10.1096/fj.05-5500fje; Chen X, 2011, J HUAZHONG U SCI-MED, V31, P235, DOI 10.1007/s11596-011-0259-9; Chen Y, 2013, BIOCHEM BIOPH RES CO, V430, P1083, DOI 10.1016/j.bbrc.2012.12.034; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Dokras A, 2002, PLACENTA, V23, P274, DOI 10.1053/plac.2001.0784; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; Feng Hui Chen, 2005, J Soc Gynecol Investig, V12, pe21, DOI 10.1016/j.jsgi.2005.02.008; Fisher Susan J, 2004, Reprod Biol Endocrinol, V2, P53, DOI 10.1186/1477-7827-2-53; Fitzgerald M, 2003, NEOPLASIA, V5, P427, DOI 10.1016/S1476-5586(03)80045-3; Fujisawa K, 2005, LAB INVEST, V85, P214, DOI 10.1038/labinvest.3700214; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Genbacev O, 1996, J CLIN INVEST, V97, P540, DOI 10.1172/JCI118447; Hong SN, 2009, ONCOL REP, V21, P425, DOI 10.3892/or_00000240; Huppertz B, 2008, J CLIN PATHOL, V61, P1296, DOI 10.1136/jcp.2008.055277; Khalkhali-Ellis Z, 2006, CLIN CANCER RES, V12, P7279, DOI 10.1158/1078-0432.CCR-06-1589; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Li HWR, 2006, GYNECOL ONCOL, V101, P76, DOI 10.1016/j.ygyno.2005.09.037; Li ZG, 2005, ONCOGENE, V24, P2008, DOI 10.1038/sj.onc.1208449; LIANG P, 1992, CANCER RES, V52, P6966; Liu JY, 2004, CANCER RES, V64, P1703, DOI 10.1158/0008-5472.CAN-03-2568; Liu Q, 2014, PLACENTA, V35, P876, DOI 10.1016/j.placenta.2014.08.088; Maass N, 2001, J PATHOL, V195, P321; Maass Nicolai, 2002, Clin Breast Cancer, V3, P281, DOI 10.3816/CBC.2002.n.032; Murai S, 2006, CANCER SCI, V97, P883, DOI 10.1111/j.1349-7006.2006.00266.x; Naves T, 2013, BIOCHEM PHARMACOL, V85, P1153, DOI 10.1016/j.bcp.2013.01.022; Neal CL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-336; Pierson CR, 2002, PROSTATE, V53, P255, DOI 10.1002/pros.10107; Rose SL, 2006, GYNECOL ONCOL, V102, P319, DOI 10.1016/j.ygyno.2005.12.025; Shi HY, 2007, CELL MOTIL CYTOSKEL, V64, P338, DOI 10.1002/cm.20187; Shi HY, 2003, HISTOL HISTOPATHOL, V18, P201, DOI 10.14670/HH-18.201; Shi XW, 2012, J HUAZHONG U SCI-MED, V32, P879, DOI 10.1007/s11596-012-1051-1; Sood AK, 2002, CLIN CANCER RES, V8, P2924; Sugimoto S, 2004, CANCER LETT, V203, P209, DOI 10.1016/j.canlet.2003.09.010; Wada K, 2004, J INVEST DERMATOL, V122, P805, DOI 10.1111/j.0022-202X.2004.22308.x; Wolf N, 2010, ENDOCRINOLOGY, V151, P2835, DOI 10.1210/en.2009-1195; Xu JJ, 2011, J OBSTET GYNAECOL RE, V37, P187, DOI 10.1111/j.1447-0756.2010.01334.x; Yang ZM, 2014, REPROD SCI, V21, P72, DOI 10.1177/1933719113488448; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	41	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135359	10.1371/journal.pone.0135359	http://dx.doi.org/10.1371/journal.pone.0135359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263377	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300076
J	Wegrzyn, M; Bruckhaus, I; Kissler, J				Wegrzyn, Martin; Bruckhaus, Isabelle; Kissler, Johanna			Categorical Perception of Fear and Anger Expressions in Whole, Masked and Composite Faces	PLOS ONE			English	Article							FACIAL EXPRESSIONS; CONTRAST DETECTION; INVERSION; EMOTIONS; HAPPY	Human observers are remarkably proficient at recognizing expressions of emotions and at readily grouping them into distinct categories. When morphing one facial expression into another, the linear changes in low-level features are insufficient to describe the changes in perception, which instead follow an s-shaped function. Important questions are, whether there are single diagnostic regions in the face that drive categorical perception for certain parings of emotion expressions, and how information in those regions interacts when presented together. We report results from two experiments with morphed fear-anger expressions, where (a) half of the face was masked or (b) composite faces made up of different expressions were presented. When isolated upper and lower halves of faces were shown, the eyes were found to be almost as diagnostic as the whole face, with the response function showing a steep category boundary. In contrast, the mouth allowed for a substantially lesser amount of accuracy and responses followed a much flatter psychometric function. When a composite face consisting of mismatched upper and lower halves was used and observers were instructed to exclusively judge either the expression of mouth or eyes, the to-be-ignored part always influenced perception of the target region. In line with experiment 1, the eye region exerted a much stronger influence on mouth judgements than vice versa. Again, categorical perception was significantly more pronounced for upper halves of faces. The present study shows that identification of fear and anger in morphed faces relies heavily on information from the upper half of the face, most likely the eye region. Categorical perception is possible when only the upper face half is present, but compromised when only the lower part is shown. Moreover, observers tend to integrate all available features of a face, even when trying to focus on only one part.	[Wegrzyn, Martin; Bruckhaus, Isabelle; Kissler, Johanna] Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany; [Wegrzyn, Martin; Kissler, Johanna] Univ Bielefeld, Ctr Excellence Cognit Interact Technol CITEC, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Wegrzyn, M (corresponding author), Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany.	martin.wegrzyn@uni-bielefeld.de	Kissler, Johanna/B-7361-2019	Kissler, Johanna/0000-0002-4567-1997	Deutsche Forschungsgemeinschaft (DFG), Cluster of Excellence "Cognitive Interaction Technology" [277]	Deutsche Forschungsgemeinschaft (DFG), Cluster of Excellence "Cognitive Interaction Technology"(German Research Foundation (DFG))	Research was funded by the Deutsche Forschungsgemeinschaft (DFG; www.dfg.de), Cluster of Excellence 277 "Cognitive Interaction Technology", in the form of a scholarship awarded to MW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Bruce V., 2013, FACE PERCEPTION; Calder AJ, 2005, VIS COGN, V12, P495, DOI 10.1080/13506280444000418; Calder AJ, 1996, VIS COGN, V3, P81, DOI 10.1080/713756735; Chen MY, 2010, VISION RES, V50, P1814, DOI 10.1016/j.visres.2010.06.002; deGelder B, 1997, COGNITION EMOTION, V11, P1, DOI 10.1080/026999397380005; Du SC, 2014, P NATL ACAD SCI USA, V111, pE1454, DOI 10.1073/pnas.1322355111; Duda R. O., 1973, PATTERN CLASSIFICATI; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Ekman P., 2002, MANUAL INVESTIGATORS; Ekman P., 2003, UNMASKING FACE GUIDE; ETCOFF NL, 1992, COGNITION, V44, P227, DOI 10.1016/0010-0277(92)90002-Y; Flykt A., 1998, KAROLINSKA DIRECTED, P91, DOI [10.1017/S0048577299971664, DOI 10.1017/S0048577299971664, 10.1037/t27732-000]; FOLEY JM, 1981, VISION RES, V21, P1041, DOI 10.1016/0042-6989(81)90009-2; Fugate JMB, 2013, EMOT REV, V5, P84, DOI 10.1177/1754073912451350; Guo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042585; Harnad S. R., 1990, CATEGORICAL PERCEPTI; Hilborn Ray, 1997, V28; Keltner D, 1999, COGNITION EMOTION, V13, P505, DOI 10.1080/026999399379168; Kingdom F.A.A., 2010, PSYCHOPHYSICS A PRAC; Le Grand R, 2004, PSYCHOL SCI, V15, P762, DOI 10.1111/j.0956-7976.2004.00753.x; Leppanen JM, 2007, VIS COGN, V15, P468, DOI 10.1080/13506280600765333; Matsumoto D., 2008, SCHOLARPEDIA, V3, P4237, DOI [10.4249/scholarpedia.4237, DOI 10.4249/SCHOLARPEDIA.4237]; McKone E, 2010, J VIS, V8, P163, DOI [10.1167/8.6.163, DOI 10.1167/8.6.163]; Newton EM, 2005, IEEE T KNOWL DATA EN, V17, P232, DOI 10.1109/TKDE.2005.32; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Pollux PMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105418; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; SERGENT J, 1984, BRIT J PSYCHOL, V75, P221, DOI 10.1111/j.2044-8295.1984.tb01895.x; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Tanaka JW, 2012, COGNITION EMOTION, V26, P961, DOI 10.1080/02699931.2011.630933; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tipples J, 2002, EMOTION, V2, P288, DOI 10.1037/1528-3542.2.3.288; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	39	13	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134790	10.1371/journal.pone.0134790	http://dx.doi.org/10.1371/journal.pone.0134790			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO7PP	26263000	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300042
J	Bertram, DF; Drever, MC; McAllister, MK; Schroeder, BK; Lindsay, DJ; Faust, DA				Bertram, Douglas F.; Drever, Mark C.; McAllister, Murdoch K.; Schroeder, Bernard K.; Lindsay, David J.; Faust, Deborah A.			Estimation of Coast-Wide Population Trends of Marbled Murrelets in Canada Using a Bayesian Hierarchical Model	PLOS ONE			English	Article							ENDANGERED SEABIRD; ABUNDANCE; PREY; CONSEQUENCES	Species at risk with secretive breeding behaviours, low densities, and wide geographic range pose a significant challenge to conservation actions because population trends are difficult to detect. Such is the case with the Marbled Murrelet (Brachyramphus marmoratus), a seabird listed as 'Threatened' by the Species at Risk Act in Canada largely due to the loss of its old growth forest nesting habitat. We report the first estimates of population trend of Marbled Murrelets in Canada derived from a monitoring program that uses marine radar to detect birds as they enter forest watersheds during 923 dawn surveys at 58 radar monitoring stations within the six Marbled Murrelet Conservation Regions on coastal British Columbia, Canada, 1996-2013. Temporal trends in radar counts were analyzed with a hierarchical Bayesian multivariate modeling approach that controlled for variation in tilt of the radar unit and day of year, included year-specific deviations from the overall trend ('year effects'), and allowed for trends to be estimated at three spatial scales. A negative overall trend of -1.6%/ yr (95% credibility interval: -3.2%, 0.01%) indicated moderate evidence for a coast-wide decline, although trends varied strongly among the six conservation regions. Negative annual trends were detected in East Vancouver Island (-9%/ yr) and South Mainland Coast (-3%/ yr) Conservation Regions. Over a quarter of the year effects were significantly different from zero, and the estimated standard deviation in common-shared year effects between sites within each region was about 50% per year. This large commonshared interannual variation in counts may have been caused by regional movements of birds related to changes in marine conditions that affect the availability of prey.	[Bertram, Douglas F.] Fisheries Oceans Canada Inst Ocean Sci, Environm Canada, Wildlife Res Div, Sidney, BC V8L 4B2, Canada; [Drever, Mark C.] Canadian Wildlife Serv, Environm Canada, Delta, BC, Canada; [McAllister, Murdoch K.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Schroeder, Bernard K.] Bernard K Schroeder Consulting, Nanaimo, BC, Canada; [Lindsay, David J.] TimberWest Forest Corp, Nanaimo, BC, Canada	Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada; Fisheries & Oceans Canada; Environment & Climate Change Canada; Canadian Wildlife Service; University of British Columbia	Bertram, DF (corresponding author), Fisheries Oceans Canada Inst Ocean Sci, Environm Canada, Wildlife Res Div, Sidney, BC V8L 4B2, Canada.	douglas.bertram@dfo-mpo.gc.ca		Drever, Mark/0000-0001-5303-9230	TimberWest Forest Corp.	TimberWest Forest Corp.	DL obtained funds from TimberWest Forest Corp. The funder provided support in the form of a salary for author DL; Bernard K. Schroeder Consulting provided support in the form of a salary for author BKS, but neither company had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arcese P, 2005, MONITORING DESIGNS T; Becker BH, 2007, MAR ECOL PROG SER, V329, P267, DOI 10.3354/meps329267; Beissinger SR, 2007, ECOLOGY, V88, P296, DOI 10.1890/06-0869; Bertram DF, 2001, PROG OCEANOGR, V49, P283, DOI 10.1016/S0079-6611(01)00027-1; Bertram DF, 2009, MAR ECOL PROG SER, V393, P199, DOI 10.3354/meps08223; BirdLife International, 2012, IUCN 2012; Blight LK, 2015, CONDOR, V117, P108, DOI 10.1650/CONDOR-14-113.1; Bower John L., 2009, Marine Ornithology, V37, P9; Burger A. E, 2002, TECHNICAL REPORT SER, V387; Burger AE, 2009, NW NATURALIST, V90, P217, DOI DOI 10.1898/NWN08-50.1; Burger Alan E., 2004, Marine Ornithology, V32, P1; Canadian Marbled Murrelet Recovery Team (CMMRT), 2003, CANADIAN MARBLED MUR; Cooper BA, 2006, CONDOR, V108, P936, DOI 10.1650/0010-5422(2006)108[936:TIRCOM]2.0.CO;2; COSEWIC, 2012, COSEWIC ASSESSMENT A; Cushing DA, 2014, THESIS; Environment Canada, 2014, SPECIES AT RISK ACT; Falxa GA, NW FOREST P IN PRESS; Gutowsky Sarah, 2010, Endangered Species Research, V9, P247, DOI 10.3354/esr00225; Harfenist A, 2006, BASELINE RADAR INVEN; Harper William L., 2004, Marine Ornithology, V32, P35; Harper WL, 2006, LONG TERM RADAR MONI; Hull CL, 2001, AUK, V118, P1036, DOI 10.1642/0004-8038(2001)118[1036:IVICDO]2.0.CO;2; Irvine JR, 2012, CANADIAN SCIENCE ADV; Jones PH, 1993, BRIT COLUMBIA NATURA, V31, P8; Kaiser G, 2012, THE MARBLED MURRELET; Kuletz Katherine J., 2011, Marine Ornithology, V39, P97; Long Jed A., 2011, Endangered Species Research, V14, P49, DOI 10.3354/esr00341; Malt JM, 2009, ECOL APPL, V19, P1274, DOI 10.1890/08-0598.1; Manley IA, 2006, STANDARDS FOR COMPON; Mather Monica, 2010, British Columbia Journal of Ecosystems and Management, V11, P91; Miller SL, 2012, CONDOR, V114, P771, DOI 10.1525/cond.2012.110084; Norris RD, 2007, JOURNAL OF APPLIED E, V44, P875; Pearson SF, 2011, WASHINGTON 2010 AT S; Peery MZ, 2004, CONSERV BIOL, V18, P1088, DOI 10.1111/j.1523-1739.2004.00134.x; Piatt JF, 2007, U S GEOLOGICAL SURVE; Raphael MG, 2002, CONDOR, V104, P331, DOI 10.1650/0010-5422(2002)104[0331:LSRBAO]2.0.CO;2; Rodway Michael S., 1995, Northwestern Naturalist, V76, P82, DOI 10.2307/3536749; Ronconi RA, 2008, MAR ECOL PROG SER, V366, P245, DOI 10.3354/meps07529; Saether BE, 2008, J ANIM ECOL, V77, P869, DOI 10.1111/j.1365-2656.2008.01424.x; Schrimpf MB, 2012, MAR ECOL PROG SER, V460, P247, DOI 10.3354/meps09750; Sydeman WJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026736; Tranquilla LM, 2005, J FIELD ORNITHOL, V76, P357, DOI 10.1648/0273-8570-76.4.357; Vilchis LI, 2015, CONSERV BIOL, V29, P154, DOI 10.1111/cobi.12378; Williams CK, 2003, ECOLOGY, V84, P2654, DOI 10.1890/03-0038; Wilson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065408	45	10	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134891	10.1371/journal.pone.0134891	http://dx.doi.org/10.1371/journal.pone.0134891			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258803	gold, Green Published, Green Submitted			2022-12-27	WOS:000359352600029
J	Barbano, D; Diaz, R; Zhang, L; Sandrin, T; Gerken, H; Dempster, T				Barbano, Duane; Diaz, Regina; Zhang, Lin; Sandrin, Todd; Gerken, Henri; Dempster, Thomas			Rapid Characterization of Microalgae and Microalgae Mixtures Using Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF MS)	PLOS ONE			English	Article							GENUS PROTOTHECA; IDENTIFICATION; BACTERIA; ALGAE; BIOFUELS; YEAST; CLASSIFICATION; LEVEL	Current molecular methods to characterize microalgae are time-intensive and expensive. Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) may represent a rapid and economical alternative approach. The objectives of this study were to determine whether MALDI-TOF MS can be used to: 1) differentiate microalgae at the species and strain levels and 2) characterize simple microalgal mixtures. A common protein extraction sample preparation method was used to facilitate rapid mass spectrometry-based analysis of 31 microalgae. Each yielded spectra containing between 6 and 56 peaks in the m/z 2,000 to 20,000 range. The taxonomic resolution of this approach appeared higher than that of 18S rDNA sequence analysis. For example, two strains of Scenedesmus acutus differed only by two 18S rDNA nucleotides, but yielded distinct MALDI-TOF mass spectra. Mixtures of two and three microalgae yielded relatively complex spectra that contained peaks associated with members of each mixture. Interestingly, though, mixture-specific peaks were observed at m/z 11,048 and 11,230. Our results suggest that MALDI-TOF MS affords rapid characterization of individual microalgae and simple microalgal mixtures.	[Barbano, Duane; Diaz, Regina] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Zhang, Lin; Sandrin, Todd] Arizona State Univ, Sch Math & Nat Sci, MC 2352,POB 37100, Phoenix, AZ USA; [Gerken, Henri; Dempster, Thomas] Arizona State Univ, Arizona Ctr Algae Technol & Innovat, Mesa, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Downtown Phoenix; Arizona State University	Sandrin, T (corresponding author), Arizona State Univ, Sch Math & Nat Sci, MC 2352,POB 37100, Phoenix, AZ USA.	Todd.Sandrin@asu.edu		Sandrin, Todd/0000-0001-5079-2999	Arizona Center for Algae Technology and Innovation; ASU New College of Interdisciplinary Arts Sciences; ASU Lightworks	Arizona Center for Algae Technology and Innovation; ASU New College of Interdisciplinary Arts Sciences; ASU Lightworks	This work was supported by the Arizona Center for Algae Technology and Innovation (http://www.azcati.com), ASU New College of Interdisciplinary Arts & Sciences (https://newcollege.asu.edu), and ASU Lightworks (http://asulightworks.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LM, 2015, RAPID COMMUN MASS SP, V29, P295, DOI 10.1002/rcm.7110; Calderaro A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06803; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; De Bruyne K, 2011, SYST APPL MICROBIOL, V34, P20, DOI 10.1016/j.syapm.2010.11.003; Deak E, 2015, DIAGN MICR INFEC DIS, V81, P27, DOI 10.1016/j.diagmicrobio.2014.09.018; Emami K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10036; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Gerken HG, 2013, PLANTA, V237, P239, DOI 10.1007/s00425-012-1765-0; Giebel R, 2010, ADV APPL MICROBIOL, V71, P149, DOI 10.1016/S0065-2164(10)71006-6; Godhe Anna, 2002, Harmful Algae, V1, P375, DOI 10.1016/S1568-9883(02)00049-5; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hannon M, 2010, BIOFUELS-UK, V1, P763, DOI 10.4155/BFS.10.44; Ho SH, 2014, BIOTECHNOL ADV, V32, P1448, DOI 10.1016/j.biotechadv.2014.09.002; Holland RD, 2014, RAPID COMMUN MASS SP, V28, P2617, DOI 10.1002/rcm.7060; Hsieh SY, 2008, MOL CELL PROTEOMICS, V7, P448, DOI 10.1074/mcp.M700339-MCP200; Jarman KH, 2000, ANAL CHEM, V72, P1217, DOI 10.1021/ac990832j; Knoshaug EP, 2011, CHEM ENG PROG, V107, P37; Lee HW, 2015, TALANTA, V132, P630, DOI 10.1016/j.talanta.2014.08.078; Mahe P, 2014, BIOINFORMATICS, V30, P1280, DOI 10.1093/bioinformatics/btu022; Mandrell RE, 2005, APPL ENVIRON MICROB, V71, P6292, DOI 10.1128/AEM.71.10.6292-6307.2005; Murugaiyan J, 2012, CLIN MICROBIOL INFEC, V18, P461, DOI 10.1111/j.1469-0691.2011.03593.x; Ng W, 2013, J MICROBIOL BIOL EDU, V14, P103, DOI 10.1128/jmbe.v14i1.494; Nicolau A, 2014, AQUAT BIOL, V20, P139, DOI 10.3354/ab00548; Oh HS, 2008, INFECT CONT HOSP EP, V29, P742, DOI 10.1086/589903; Packeu A, 2013, MED MYCOL, V51, P580, DOI 10.3109/13693786.2013.770605; Pavlovic M, 2014, J MICROBIOL METH, V106, P123, DOI 10.1016/j.mimet.2014.08.021; Sandrin TR, 2013, MASS SPECTROM REV, V32, P188, DOI 10.1002/mas.21359; Smith V.H., 2014, IND BIOTECHNOL, V10, P159; Smith VH, 2014, ALGAL RES, V4, P23, DOI 10.1016/j.algal.2013.11.005; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; von Bergen M, 2009, PROTEOM CLIN APPL, V3, P774, DOI 10.1002/prca.200780138; Wahl KL, 2002, ANAL CHEM, V74, P6191, DOI 10.1021/ac0203847; Wei L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-534; Wieme AD, 2014, J I BREWING, V120, P438, DOI 10.1002/jib.149; Wirth H, 2012, J MICROBIOL METH, V88, P83, DOI 10.1016/j.mimet.2011.10.013; Zhang L, 2015, J VIS EXP, V95	36	19	19	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135337	10.1371/journal.pone.0135337	http://dx.doi.org/10.1371/journal.pone.0135337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26271045	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800059
J	Nixon, B; Stanger, SJ; Mihalas, BP; Reilly, JN; Anderson, AL; Dun, MD; Tyagi, S; Holt, JE; McLaughlin, EA				Nixon, Brett; Stanger, Simone J.; Mihalas, Bettina P.; Reilly, Jackson N.; Anderson, Amanda L.; Dun, Matthew D.; Tyagi, Sonika; Holt, Janet E.; McLaughlin, Eileen A.			Next Generation Sequencing Analysis Reveals Segmental Patterns of microRNA Expression in Mouse Epididymal Epithelial Cells	PLOS ONE			English	Article							GENE-EXPRESSION; GERM-CELLS; SPERM; SPERMATOGENESIS; TRANSCRIPTOME; PROTEOME; CANCER; LET-7; ADULT; RNAS	The functional maturation of mammalian spermatozoa is accomplished as the cells descend through the highly specialized microenvironment of the epididymis. This dynamic environment is, in turn, created by the combined secretory and absorptive activity of the surrounding epithelium and displays an extraordinary level of regionalization. Although the regulatory network responsible for spatial coordination of epididymal function remains unclear, recent evidence has highlighted a novel role for the RNA interference pathway. Indeed, as noncanonical regulators of gene expression, small noncoding RNAs have emerged as key elements of the circuitry involved in regulating epididymal function and hence sperm maturation. Herein we have employed next generation sequencing technology to profile the genome-wide miRNA signatures of mouse epididymal cells and characterize segmental patterns of expression. An impressive profile of some 370 miRNAs were detected in the mouse epididymis, with a subset of these specifically identified within the epithelial cells that line the tubule (218). A majority of the latter miRNAs (75%) were detected at equivalent levels along the entire length of the mouse epididymis. We did however identify a small cohort of miRNAs that displayed highly regionalized patterns of expression, including miR-204-5p and miR-196b-5p, which were down-and up-regulated by approximately 39- and 45-fold between the caput/caudal regions, respectively. In addition we identified 79 miRNAs (representing similar to 21% of all miRNAs) as displaying conserved expression within all regions of the mouse, rat and human epididymal tissue. These included 8/14 members of let-7 family of miRNAs that have been widely implicated in the control of androgen signaling and the repression of cell proliferation and oncogenic pathways. Overall these data provide novel insights into the sophistication of the miRNA network that regulates the function of the male reproductive tract.	[Nixon, Brett; Stanger, Simone J.; Mihalas, Bettina P.; Reilly, Jackson N.; Anderson, Amanda L.; McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Fac Sci & IT, Reprod Sci Grp, Callaghan, NSW 2308, Australia; [Dun, Matthew D.; Holt, Janet E.] Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Tyagi, Sonika] Australian Genome Res Facil Ltd, Walter & Eliza Hall Inst, Parkville, Vic, Australia	University of Newcastle; University of Newcastle; Walter & Eliza Hall Institute	Nixon, B (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Fac Sci & IT, Reprod Sci Grp, Callaghan, NSW 2308, Australia.	Brett.Nixon@newcastle.edu.au	Dun, Matthew D./I-3399-2012; McLaughlin, Eileen A/G-7620-2013; Tyagi, Sonika/L-2256-2019; McLaughlin, Eileen/AAF-5588-2021; Nixon, Brett/B-5121-2012	Tyagi, Sonika/0000-0003-0181-6258; Nixon, Brett/0000-0003-2745-8188; Dun, Matthew/0000-0002-9063-5370; McLaughlin, Eileen/0000-0002-5837-3876; Mihalas, Bettina/0000-0002-6006-8475	National Health and Medical Research Council of Australia [APP1062371]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au/) Project Grant (APP1062371) awarded to BN, EAM and JEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2007, ASIAN J ANDROL, V9, P554, DOI 10.1111/j.1745-7262.2007.00280.x; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belleannee C, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110486; Belleannee C, 2013, HUM REPROD, V28, P1455, DOI 10.1093/humrep/det088; Belleannee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034996; Bjorkgren I, 2015, FASEB J, V29, P433, DOI 10.1096/fj.14-259382; Bjorkgren I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038457; Bomgardner D, 2003, BIOL REPROD, V68, P644, DOI 10.1095/biolreprod.102.009324; Bomgardner D, 2001, J ANDROL, V22, P527; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Cooper TG, 1986, EPIDIDYMIS SPERM MAT; Dacheux JL, 2006, MOL CELL ENDOCRINOL, V250, P36, DOI 10.1016/j.mce.2005.12.022; Dacheux JL, 2009, MOL CELL ENDOCRINOL, V306, P45, DOI 10.1016/j.mce.2009.03.007; Dacheux JL, 2005, THERIOGENOLOGY, V63, P319, DOI 10.1016/j.theriogenology.2004.09.015; Dun MD, 2012, INT J ANDROL, V35, P572, DOI 10.1111/j.1365-2605.2011.01235.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Guyonnet B, 2011, J ANDROL, V32, P651, DOI 10.2164/jandrol.111.013086; He ZP, 2009, REPRODUCTION, V137, P901, DOI 10.1530/REP-08-0494; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Jelinsky SA, 2007, BIOL REPROD, V76, P561, DOI 10.1095/biolreprod.106.057323; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnston DS, 2007, ASIAN J ANDROL, V9, P522, DOI 10.1111/j.1745-7262.2007.00317.x; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Kim W, 2013, BIOCHEM J, V450, P9, DOI 10.1042/BJ20121284; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li Y, 2012, GENE, V497, P330, DOI 10.1016/j.gene.2012.01.038; Liu DK, 2012, BIOCHEM BIOPH RES CO, V422, P114, DOI 10.1016/j.bbrc.2012.04.118; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma WB, 2013, J BIOL CHEM, V288, P29369, DOI 10.1074/jbc.M113.454066; Ma WB, 2012, J BIOL CHEM, V287, P10189, DOI 10.1074/jbc.M111.303636; McIver SC, 2012, HUM REPROD UPDATE, V18, P44, DOI 10.1093/humupd/dmr041; McIver SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035553; Miller D, 1999, GENE, V237, P385, DOI 10.1016/S0378-1119(99)00324-8; Miller D, 2006, Gynecol Obstet Fertil, V34, P840, DOI 10.1016/j.gyobfe.2006.07.013; Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705; Nagaraju GP, 2014, CARCINOGENESIS, V35, P967, DOI 10.1093/carcin/bgu072; Ni MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026053; Nicholls PK, 2011, ENDOCRINOLOGY, V152, P1670, DOI 10.1210/en.2010-1341; Ostermeier CG, 2005, FERTIL STERIL, V83, P1687, DOI 10.1016/j.fertnstert.2004.12.046; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sipila P, 2004, ENDOCRINOLOGY, V145, P437, DOI 10.1210/en.2003-0831; Truesdell SS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00842; Wang K, 2013, MOL HUM REPROD, V19, P57, DOI 10.1093/molehr/gas051; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Yeung CH, 2012, ASIAN J ANDROL, V14, P465, DOI 10.1038/aja.2012.20; Zhang JS, 2010, ACTA BIOCH BIOPH SIN, V42, P145, DOI 10.1093/abbs/gmp116; Zhang YL, 2011, J ANDROL, V32, P587, DOI 10.2164/jandrol.111.013060; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106; Zuo WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022283	53	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135605	10.1371/journal.pone.0135605	http://dx.doi.org/10.1371/journal.pone.0135605			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270822	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492800093
J	Plischke, M; Riegersperger, M; Dunkler, D; Heinze, G; Kikic, Z; Winkelmayer, WC; Sunder-Plassmann, G				Plischke, Max; Riegersperger, Markus; Dunkler, Daniela; Heinze, Georg; Kikic, Zeljko; Winkelmayer, Wolfgang C.; Sunder-Plassmann, Gere			Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; MYCOPHENOLATE-MOFETIL; SERUM CREATININE; RENAL-DISEASE; EQUATION; RISK; IMMUNOSUPPRESSION; DIET	Background Tacrolimus (TAC) to ciclosporin A (CSA) conversion studies in stable kidney transplant recipients have reported varying effects on graft function. Here we study graft function (eGFR) trajectories using linear mixed models, which provide effect estimates on both slope and baseline level of GFR and offer increased statistical power. Methods Secondary analysis of a randomized controlled trial of CSA treated kidney transplant recipients with stable graft function assigned to receive 0.1 mg/kg/day TAC (target 5-8 ng/ml) or to continue CSA based immunosuppression (target 70-150 ng/ml) at a 2: 1 ratio. Renal graft function was estimated via the MDRD (eGFRMDRD) and CKD-EPI (eGFRCKD-EPI) formulas. Results Forty-five patients continued CSA and 96 patients were converted to TAC with a median follow up of 24 months. Baseline demographics (except for recipient age) including native kidney disease, transplant characteristics, kidney graft function, medication use and comorbid conditions did not differ between groups. In respect to long-term renal graft function, linear mixed models showed significantly improved eGFR trajectories (eGFR(MDRD): p<0.001, eGFR(CKD-EP)I: p<0.001) in the TAC versus CSA group over 24 months of follow up. Estimated eGFR(CKD-EPI) group differences between TAC and CSA were -3.49 (p = 0.019) at 3 months, -5.50 (p<0.001) at 12 months, and -4.48 ml/min/1.73m(2) (p = 0.003) at 24 months of follow up. Baseline eGFR was a significant predictor of eGFR trajectories (eGFR(MDRD): p<0.001, eGFR(CKD-EPI): p<0.001). Significant effects for randomization group were evident despite short-term trough levels in the supratherapeutic range (27% (n = 26) of TAC patients at week one). Median TAC trough levels were within target range at week 4 after conversion. Conclusion Conversion of CSA treated kidney transplant recipients with stable graft function to TAC (target 5-8 ng/ml) showed significantly improved long-term eGFR trajectories when compared to CSA maintenance (target 70-150 ng/ml).	[Plischke, Max; Riegersperger, Markus; Kikic, Zeljko; Sunder-Plassmann, Gere] Med Univ Vienna, Div Nephrol & Dialysis, Dept Internal Med 3, Vienna, Austria; [Dunkler, Daniela; Heinze, Georg] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Winkelmayer, Wolfgang C.] Baylor Coll Med, Nephrol Sect, Houston, TX 77030 USA	Medical University of Vienna; Medical University of Vienna; Baylor College of Medicine	Sunder-Plassmann, G (corresponding author), Med Univ Vienna, Div Nephrol & Dialysis, Dept Internal Med 3, Vienna, Austria.	gere.sunder-plassmann@meduniwien.ac.at	Dunkler, Daniela/B-2733-2018	Dunkler, Daniela/0000-0003-1339-0311; Riegersperger, Markus/0000-0002-1151-9049; Heinze, Georg/0000-0003-1147-8491; Plischke, Max/0000-0002-7410-2611; Sunder-Plassmann, Gere/0000-0002-9253-9921	Fujisawa/Astellas	Fujisawa/Astellas(Astellas Pharmaceuticals)	This study was supported by a research grant from Fujisawa/Astellas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowicz D, 2005, J AM SOC NEPHROL, V16, P2234, DOI 10.1681/ASN.2004100844; [Anonymous], 2014, R LANG ENV STAT COMP; Artz MA, 2004, AM J TRANSPLANT, V4, P937, DOI 10.1111/j.1600-6143.2004.00427.x; Bolin P, 2008, TRANSPLANTATION, V86, P88, DOI 10.1097/TP.0b013e31817442cf; Cirillo M, 2010, J NEPHROL, V23, P125; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Hueso M, 1998, TRANSPLANTATION, V66, P1727, DOI 10.1097/00007890-199812270-00027; Leffondre K, 2014, NEPHROL DIAL TRANSPL, P1; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levey AS, 2000, J AM SOC NEPHROL, V11, p155A; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Meier M, 2006, TRANSPLANTATION, V81, P1035, DOI 10.1097/01.tp.0000220480.84449.71; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Nankivell BJ, 2011, LANCET, V378, P1428, DOI 10.1016/S0140-6736(11)60699-5; Riegersperger M, 2013, TRANSPLANTATION, V95, P1338, DOI 10.1097/TP.0b013e31828fabb3; SAS, 2010, STAT ANAL SOFTWARE V; Shihab FS, 2008, TRANSPLANTATION, V85, P1261, DOI 10.1097/TP.0b013e31816b4388; Skali H, 2011, AM HEART J, V162, P548, DOI 10.1016/j.ahj.2011.06.006; Stoves J, 2004, NEPHROL DIAL TRANSPL, V19, P2113, DOI 10.1093/ndt/gfh188; van Gelder T, 2001, THER DRUG MONIT, V23, P119, DOI 10.1097/00007691-200104000-00005; Webster AC, 2005, BMJ-BRIT MED J, V331, P810, DOI 10.1136/bmj.38569.471007.AE	23	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135674	10.1371/journal.pone.0135674	http://dx.doi.org/10.1371/journal.pone.0135674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270340	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800097
J	Zhao, TT; Zhang, J; Liang, LS; Ma, QH; Chen, X; Zong, JW; Wang, GX				Zhao, Tian-Tian; Zhang, Jin; Liang, Li-Song; Ma, Qing-Hua; Chen, Xin; Zong, Jian-Wei; Wang, Gui-Xi			Expression and Functional Analysis of WRKY Transcription Factors in Chinese Wild Hazel, Corylus heterophylla Fisch	PLOS ONE			English	Article							ABSCISIC-ACID; DROUGHT TOLERANCE; ABIOTIC STRESS; FACTOR FAMILY; DNA-BINDING; DISEASE RESISTANCE; PLANT DEFENSE; GENE FAMILY; ARABIDOPSIS; RICE	Plant WRKY transcription factors are known to regulate various biotic and abiotic stress responses. In this study we identified a total of 30 putative WRKY unigenes in a transcriptome dataset of the Chinese wild Hazel, Corylus heterophylla, a species that is noted for its cold tolerance. Thirteen full-length of these ChWRKY genes were cloned and found to encode complete protein sequences, and they were divided into three groups, based on the number of WRKY domains and the pattern of zinc finger structures. Representatives of each of the groups, Unigene25835 (group I), Unigene37641 (group II) and Unigene20441 (group III), were transiently expressed as fusion proteins with yellow fluorescent fusion protein in Nicotiana benthamiana, where they were observed to accumulate in the nucleus, in accordance with their predicted roles as transcriptional activators. An analysis of the expression patterns of all 30 WRKY genes revealed differences in transcript abundance profiles following exposure to cold, drought and high salinity conditions. Among the stress-inducible genes, 23 were up-regulated by all three abiotic stresses and the WRKY genes collectively exhibited four different patterns of expression in flower buds during the overwintering period from November to April. The organ/tissue related expression analysis showed that 18 WRKY genes were highly expressed in stem but only 2 (Unigene9262 and Unigene43101) were greatest in male anthotaxies. The expression of Unigene37641, a member of the group II WRKY genes, was substantially up-regulated by cold, drought and salinity treatments, and its overexpression in Arabidopsis thaliana resulted in better seedling growth, compared with wild type plants, under cold treatment conditions. The transgenic lines also had exhibited higher soluble protein content, superoxide dismutase and peroxidase activiety and lower levels of malondialdehyde, which collectively suggets that Unigene37641 expression promotes cold tolerance.	[Zhao, Tian-Tian; Zhang, Jin; Liang, Li-Song; Ma, Qing-Hua; Zong, Jian-Wei; Wang, Gui-Xi] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Chen, Xin] Shandong Inst Pomol, Shandong Prov Key Lab Fruit Tree Biotechnol Breed, Tai An, Shandong, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF	Wang, GX (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	wanggx0114@126.com	Zhang, Jin/J-9618-2019	Zhang, Jin/0000-0002-8397-5078; Zhao, Tiantian/0000-0003-2700-5314	Special Fund for Basic Scientific Research Business of Central Public Research Institutes [RIF2013-10]; Special Fund from State Forestry Administration in the Public Interest [201304710]; Beijing Municipal Natural Science Foundation [6144030]	Special Fund for Basic Scientific Research Business of Central Public Research Institutes; Special Fund from State Forestry Administration in the Public Interest; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	Support was provided by The Special Fund for Basic Scientific Research Business of Central Public Research Institutes (Grant No. RIF2013-10 http://rif.caf.ac.cn/), the Special Fund from State Forestry Administration in the Public Interest (Grant No. 201304710 http://www.forestry.gov.cn/), and Beijing Municipal Natural Science Foundation (Grant No. 6144030 http://www.bjnsf.org/).	Babitha KC, 2013, TRANSGENIC RES, V22, P327, DOI 10.1007/s11248-012-9645-8; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Chen H, 2007, HORTSCIENCE, V42, P466, DOI 10.21273/HORTSCI.42.3.466; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen X, 2013, PLOS ONE, V9; Chen XT, 2013, PLANT CELL REP, V32, P1589, DOI 10.1007/s00299-013-1469-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dang FF, 2013, PLANT CELL ENVIRON, V36, P757, DOI 10.1111/pce.12011; Erdogan V, 2000, SYST BOT, V25, P727, DOI 10.2307/2666730; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fallico B, 2003, FOOD CHEM, V81, P569, DOI 10.1016/S0308-8146(02)00497-1; Gao J., 2006, EXPT GUIDANCE PLANT; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gokirmak T, 2009, GENET RESOUR CROP EV, V56, P147, DOI 10.1007/s10722-008-9352-8; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hara K, 2000, MOL GEN GENET, V263, P30, DOI 10.1007/PL00008673; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512; Huang T, 2002, PLANT MOL BIOL, V48, P339, DOI 10.1023/A:1014062714786; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Jiang YZ, 2014, J EXP BOT, V65, P6629, DOI 10.1093/jxb/eru381; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; Kalde M, 2003, MOL PLANT MICROBE IN, V16, P295, DOI 10.1094/MPMI.2003.16.4.295; Kumar S, 2010, INT J WOMENS HEALTH, V2, P411, DOI 10.2147/IJWH.S7012; Lagace M, 2004, PLANTA, V219, P185, DOI 10.1007/s00425-004-1253-2; Li H, 2013, PLANT GROWTH REGUL, V70, P207, DOI 10.1007/s10725-013-9792-9; Li HE, 2010, PLANTA, V232, P1325, DOI 10.1007/s00425-010-1258-y; Li Shiming, 2010, MODERN MANAGEMENT SC, V12, P1; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Lippok B, 2007, MOL PLANT MICROBE IN, V20, P420, DOI 10.1094/MPMI-20-4-0420; Liu JF, 2013, SCI HORTIC-AMSTERDAM, V150, P348, DOI 10.1016/j.scienta.2012.12.001; Liu JJ, 2009, GENOME, V52, P77, DOI 10.1139/G08-106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo Fan, 2011, Forest Research, V24, P779; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Luo X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073295; Luo X, 2013, J EXP BOT, V64, P2155, DOI 10.1093/jxb/ert073; Ma H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-152; Marchive C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054185; MEHLENBACHER SA, 1991, ACTA HORTIC, V290, P789; Molnar TJ, 2010, PLANT DIS, V94, P1265, DOI 10.1094/PDIS-06-10-0445; Ni B, 2010, FOREST BY PRODUCT SP, V106, P29; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Ozdemir F, 2004, J FOOD ENG, V63, P341, DOI 10.1016/j.jfoodeng.2003.08.006; Ozdemir M, 2001, FOOD CHEM, V73, P191, DOI 10.1016/S0308-8146(00)00273-9; Peng L, 1994, J JILIN FORES U, V3, P166; Proietti S, 2011, J EXP BOT, V62, P1975, DOI 10.1093/jxb/erq396; Qin Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063033; Qiu YP, 2009, ENVIRON EXP BOT, V65, P35, DOI 10.1016/j.envexpbot.2008.07.002; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Rowley ER, 2012, CROP SCI, V52, P2679, DOI 10.2135/cropsci2012.02.0065; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sathiyaraj G, 2011, MOL BIOL REP, V38, P2761, DOI 10.1007/s11033-010-0421-7; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Song Y, 2010, J BIOSCIENCES, V35, P459, DOI 10.1007/s12038-010-0051-1; Song Y, 2010, RICE SCI, V17, P60, DOI 10.1016/S1672-6308(08)60105-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao Z, 2011, J EXP BOT, V62, P4863, DOI 10.1093/jxb/err144; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Wang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065120, 10.1371/journal.pone.0068807]; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Wang LQ, 2014, TREE GENET GENOMES, V10, P157, DOI 10.1007/s11295-013-0672-2; Wilkinson MD, 2013, J CEREAL SCI, V57, P1, DOI 10.1016/j.jcs.2012.09.005; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Wu LT, 2011, AFR J MICROBIOL RES, V5, P5481, DOI 10.5897/AJMR11.781; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xiong X, 2010, MOL BREEDING, V25, P419, DOI 10.1007/s11032-009-9341-4; Yin GJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-148; [张艳波 ZHANG Yanbo], 2007, [吉林农业科学, Journal of Jilin Agricultural Sciences], V32, P56; Zhang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097904; Zhang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/787680; Zhang Z.L., 2003, EXPT GUIDANCE PLANT, V2nd; Zheng HQ, 2005, PLANT CELL, V17, P2020, DOI 10.1105/tpc.105.031112; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x	81	8	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135315	10.1371/journal.pone.0135315	http://dx.doi.org/10.1371/journal.pone.0135315			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270529	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492800054
J	Ashraf, Z; Bais, A; Manir, MM; Niazi, U				Ashraf, Zaman; Bais, Abdul; Manir, Md. Maniruzzaman; Niazi, Umar			Novel Penicillin Analogues as Potential Antimicrobial Agents; Design, Synthesis and Docking Studies	PLOS ONE			English	Article							PROTEIN-LIGAND DOCKING; RESISTANCE; ANTIBACTERIAL; UPDATE	A number of penicillin derivatives (4a-h) were synthesized by the condensation of 6-amino penicillinic acid (6-APA) with non-steroidal anti-inflammatory drugs as antimicrobial agents. In silico docking study of these analogues was performed against Penicillin Binding Protein (PDBID 1CEF) using AutoDock Tools 1.5.6 in order to investigate the antimicrobial data on structural basis. Penicillin binding proteins function as either transpeptidases or carboxy-peptidases and in few cases demonstrate transglycosylase activity in bacteria. The excellent antibacterial potential was depicted by compounds 4c and 4e against Escherichia coli, Staphylococcus epidermidus and Staphylococcus aureus compared to the standard amoxicillin. The most potent penicillin derivative 4e exhibited same activity as standard amoxicillin against S. aureus. In the enzyme inhibitory assay the compound 4e inhibited E. coli MurC with an IC50 value of 12.5 mu M. The docking scores of these compounds 4c and 4e also verified their greater antibacterial potential. The results verified the importance of side chain functionalities along with the presence of central penam nucleus. The binding affinities calculated from docking results expressed in the form of binding energies ranges from -7.8 to -9.2kcal/mol. The carboxylic group of penam nucleus in all these compounds is responsible for strong binding with receptor protein with the bond length ranges from 3.4 to 4.4 angstrom. The results of present work ratify that derivatives 4c and 4e may serve as a structural template for the design and development of potent antimicrobial agents.	[Ashraf, Zaman; Bais, Abdul] Allama Iqbal Open Univ, Dept Chem, Islamabad, Pakistan; [Ashraf, Zaman] Kongju Natl Univ, Coll Nat Sci, Dept Biol, Kong Ju 314701, South Korea; [Manir, Md. Maniruzzaman] Kongju Natl Univ, Dept Chem, Gongju, South Korea; [Niazi, Umar] Natl Univ Sci & Technol, Atta Ur Rehman Sch Modeling & Simulat, Islamabad, Pakistan	Kongju National University; Kongju National University; National University of Sciences & Technology - Pakistan	Ashraf, Z (corresponding author), Allama Iqbal Open Univ, Dept Chem, H-8, Islamabad, Pakistan.	mzchem@yahoo.com		Bais, Abdul/0000-0002-1136-6003; Niazi, Umar/0000-0001-7176-8883				Ashraf Z, 2014, RSC ADV, V4, P53842, DOI 10.1039/c4ra07223e; Babington R, 2012, ANAL BIOANAL CHEM, V403, P1549, DOI 10.1007/s00216-012-5960-4; Baseer M, 2013, PAK J PHARM SCI, V26, P67; Chu DTW, 1996, J MED CHEM, V39, P3853, DOI 10.1021/jm960294s; Faridoon, 2012, BIOORG MED CHEM LETT, V22, P2555, DOI 10.1016/j.bmcl.2012.01.123; JONES RN, 1989, J ANTIMICROB CHEMOTH, V24, P9, DOI 10.1093/jac/24.suppl_A.9; JORGENSEN JH, 1992, CLIN INFECT DIS, V14, P1119, DOI 10.1093/clinids/14.5.1119; KELLY JA, 1986, SCIENCE, V231, P1429, DOI 10.1126/science.3082007; Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s; Krovat EM, 2005, CURR COMPUT-AID DRUG, V1, P102; Kumar S, 2010, J PHARM RES, V7, P1460; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Leatherbarrow RJ, 1998, GRAFIT 4 0 12; Li Albert P, 2005, Drug Discov Today Technol, V2, P179, DOI 10.1016/j.ddtec.2005.05.024; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; LUENGO JM, 1986, J ANTIBIOT, V39, P1754, DOI 10.7164/antibiotics.39.1754; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Marchand-Brynaert J, 2008, COMPREHENSIVE HETERO, V2, P173; Marmor S, 2001, BIOCHEMISTRY-US, V40, P12207, DOI 10.1021/bi015567m; Navratna V, 2010, J BACTERIOL, V192, P134, DOI 10.1128/JB.00822-09; Page M. I., 1992, CHEMISTRY, P79; REID AJ, 1987, J ANTIMICROB CHEMOTH, V20, P645, DOI 10.1093/jac/20.5.645; Saeed A, 2014, J HETEROCYCLIC CHEM, V51, P398, DOI 10.1002/jhet.1681; Sousa SF, 2006, PROTEINS, V65, P15, DOI 10.1002/prot.21082; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Yusuf D, 2008, J CHEM INF MODEL, V48, P1411, DOI 10.1021/ci800084x	27	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135293	10.1371/journal.pone.0135293	http://dx.doi.org/10.1371/journal.pone.0135293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267242	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300092
J	Barthes, J; Crochet, PA; Raymond, M				Barthes, Julien; Crochet, Pierre-Andre; Raymond, Michel			Male Homosexual Preference: Where, When, Why?	PLOS ONE			English	Article							SEXUAL ORIENTATION; MALE ANDROPHILIA; KIN SELECTION; BIRTH-ORDER; EVOLUTION; INHERITANCE; LANGUAGE	Male homosexual preference (MHP) has long been of interest to scholars studying the evolution of human sexuality. Indeed, MHP is partially heritable, induces a reproductive cost and is common. MHP has thus been considered a Darwinian paradox. Several questions arise when MHP is considered in an evolutionary context. At what point did MHP appear in the human evolutionary history? Is MHP present in all human groups? How has MHP evolved, given that MHP is a reproductively costly trait? These questions were addressed here, using data from the anthropological and archaeological literature. Our detailed analysis of the available data challenges the common view of MHP being a "virtually universal" trait present in humans since prehistory. The conditions under which it is possible to affirm that MHP was present in past societies are discussed. Furthermore, using anthropological reports, the presence or absence of MHP was documented for 107 societies, allowing us to conclude that evidence of the absence of MHP is available for some societies. A recent evolutionary hypothesis has argued that social stratification together with hypergyny (the hypergyny hypothesis) are necessary conditions for the evolution of MHP. Here, the link between the level of stratification and the probability of observing MHP was tested using an unprecedented large dataset. Furthermore, the test was performed for the first time by controlling for the phylogenetic non-independence between societies. A positive relationship was observed between the level of social stratification and the probability of observing MHP, supporting the hypergyny hypothesis.	[Barthes, Julien; Raymond, Michel] Univ Montpellier, Human Evolutionary Biol Team, F-34059 Montpellier, France; [Crochet, Pierre-Andre] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Raymond, Michel] CNRS, Inst Evolutionary Sci, UMR 5554, Montpellier, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Barthes, J (corresponding author), Univ Montpellier, Human Evolutionary Biol Team, F-34059 Montpellier, France.	julien.barthes@univ-montp2.fr			Agence Nationale pour la Recherche 'HUMANWAY' project	Agence Nationale pour la Recherche 'HUMANWAY' project(French National Research Agency (ANR))	This work was supported by the Agence Nationale pour la Recherche 'HUMANWAY' project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, RITUALIZED HOMOSEXUA; Bagemihl B, 1999, BIOL EXUBERANCE; Bailey JM, 2000, J PERS SOC PSYCHOL, V78, P524, DOI 10.1037//0022-3514.78.3.524; Bailey NW, 2009, TRENDS ECOL EVOL, V24, P439, DOI 10.1016/j.tree.2009.03.014; Bankoti TS, 2004, ENCY S E ASIAN ETHNO; Barber N, 1998, J CROSS CULT PSYCHOL, V29, P387, DOI 10.1177/0022022198293001; Barthes J, 2013, EVOL HUM BEHAV, V34, P155, DOI 10.1016/j.evolhumbehav.2013.01.001; Bell AP, 1978, HOMOSEXUALITIES STUD; Berman LA, 2003, PUZZLE EXPLORING EVO, P583; BETZIG L, 1992, ETHOL SOCIOBIOL, V13, P309, DOI 10.1016/0162-3095(92)90008-R; Betzig Laura, 1986, DESPOTISM DIFFERENTI; Blanchard R, 2007, ARCH SEX BEHAV, V36, P163, DOI 10.1007/s10508-006-9159-7; Bobrow D, 2001, EVOL HUM BEHAV, V22, P361, DOI 10.1016/S1090-5138(01)00074-5; Bogaert AF, 2011, FRONT NEUROENDOCRIN, V32, P247, DOI 10.1016/j.yfrne.2011.02.004; Bois Du, 1944, PEOPLE ALOR SOCIAL P; Briant Pierre, 1996, HIST EMPIRE PERSE CY; CALLENDER C, 1983, CURR ANTHROPOL, V24, P443, DOI 10.1086/203030; Camperio C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048303; Camperio-Ciani A, 2004, P ROY SOC B-BIOL SCI, V271, P2217, DOI 10.1098/rspb.2004.2872; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Chagnon NA, 1966, YANOMAMI WARFARE SOC; Clastres Pierre, 1972, CHRONIQUE INDIENS GU; Crompton L., 2003, HOMOSEXUALITY CIVILI; Damas D, 1984, HDB N AM INDIANS ARC; Descola Philippe, 1993, LANCES CREPUSCULE; Diamond J., 2011, COLLAPSE SOC CHOOSE; Dixson AF, 2012, PRIMATE SEXUALITY: COMPARATIVE STUDIES OF THE PROSIMIANS, MONKEYS, APES, AND HUMANS, 2ND EDITION, P1, DOI 10.1093/acprof:osobl/9780199544646.001.0001; Ellis L., 1993, SOCIAL STRATIFICATIO, P37; Engh AL, 2000, ANIM BEHAV, V60, P323, DOI 10.1006/anbe.2000.1502; Ford C.S., 1951, PATTERNSEXUAL BEHA; Gamer M, 2012, IRR VARIOUS COEFFICI; Gifford Ew, 1965, THE COAST YUKI; Gjessing G, 1932, ARKTISKTC HALLERISTN; Gjessing Gutorm, 1936, I SAMMENLIGNENDE K B; Gray J., 1999, WORLD CULTURES J, V10, P24; Grimal Navarro A, 1999, INTRO ARTE LEVANTINO; Grimal-Navarro A, 2013, COMMUNICATION; Hallstrom Gustaf., 1938, MONUMENTAL ART NO EU; Hewlett B. L., 2010, AFRICAN STUDY MONOGR, V31, P107; Hill K, 2009, P ROY SOC B-BIOL SCI, V276, P3863, DOI 10.1098/rspb.2009.1061; Holman EW, 2008, FOLIA LINGUIST, V42, P331, DOI 10.1515/FLIN.2008.331; HOLMAN EW, 2011, PROGRAMS CALCULATING; Iemmola F, 2009, ARCH SEX BEHAV, V38, P393, DOI 10.1007/s10508-008-9381-6; Joshi HG, 2004, SIKKIM PRESENT; Kanazawa S, 2012, J BIOSOC SCI, V44, P595, DOI 10.1017/S0021932011000769; King M, 2005, ARCH SEX BEHAV, V34, P117, DOI 10.1007/s10508-005-1006-8; Kirkpatrick RC, 2000, CURR ANTHROPOL, V41, P385, DOI 10.1086/300145; Langstrom N, 2010, ARCH SEX BEHAV, V39, P75, DOI 10.1007/s10508-008-9386-1; Lessa WA, 1950, ETHNOGRAPHY ULITHI A; LeVay S., 2010, GAY STRAIGHT REASON; Levi-Strauss Claude, 1961, TRISTES TROPIQUES; Lukas D, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0418; Mace R, 2005, TRENDS ECOL EVOL, V20, P116, DOI 10.1016/j.tree.2004.12.002; MACE R, 1994, CURR ANTHROPOL, V35, P549, DOI 10.1086/204317; Mathieu Paul, 2003, SEX POTS EROTICISM C; MURDOCK GP, 1967, ETHNOLOGY, V6, P109, DOI 10.2307/3772751; Murray S. O., 1998, BOY WIVES FEMALE HUS; Nash G., 2001, INDECENT EXPOSURE SE, P43; Nettle D, 2008, AM NAT, V172, P658, DOI 10.1086/591690; Pagel M, 2009, NAT REV GENET, V10, P405, DOI 10.1038/nrg2560; Paradis E, 2002, J THEOR BIOL, V218, P175, DOI 10.1006/jtbi.2002.3066; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patton M., 1996, ISLANDS TIME ISLAND; Perkins A, 2007, HORM BEHAV, V52, P70, DOI 10.1016/j.yhbeh.2007.03.016; R Core Team, 2013, R LANG ENV STAT COMP; Rahman Q, 2005, ARCH SEX BEHAV, V34, P461, DOI 10.1007/s10508-005-4345-6; Rahman Q, 2008, ARCH SEX BEHAV, V37, P962, DOI 10.1007/s10508-007-9191-2; Reeder G, 2000, WORLD ARCHAEOL, V32, P193, DOI 10.1080/00438240050131180; Rickard IJ, 2010, ECOLOGY, V91, P3515, DOI 10.1890/10-0019.1; Rieger G, 2012, ARCH SEX BEHAV, V41, P529, DOI 10.1007/s10508-012-9942-6; Roselli CE, 2002, ARCH SEX BEHAV, V31, P43, DOI 10.1023/A:1014027101026; SAGARIN E, 1976, PSYCHIATRY, V39, P245, DOI 10.1080/00332747.1976.11023894; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sax L, 2002, J SEX RES, V39, P174, DOI 10.1080/00224490209552139; Schwartz G, 2010, ARCH SEX BEHAV, V39, P93, DOI 10.1007/s10508-009-9499-1; Spiro ME, 1970, ATOLL CULTURE ETHNOG; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Swadesh M, 1955, INT J AM LINGUIST, V21, P121, DOI 10.1086/464321; Tamisier J-C, 1998, DICT PEUPLES SOC AFR; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Gulik R, 1971, VIE SEXUELLE CHINE A; VANDENBERGHE PL, 1980, AM ETHNOL, V7, P300, DOI 10.1525/ae.1980.7.2.02a00050; VanderLaan DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036088; VanderLaan DP, 2011, ARCH SEX BEHAV, V40, P495, DOI 10.1007/s10508-009-9576-5; VanderLaan DP, 2013, HUMAN NATURE, P1; Vasey PL, 2007, P ROY SOC B-BIOL SCI, V274, P1437, DOI 10.1098/rspb.2007.0120; Vasey PL, 2007, EVOL HUM BEHAV, V28, P159, DOI 10.1016/j.evolhumbehav.2006.08.004; Vasey PL, 2010, EVOL HUM BEHAV, V31, P373, DOI 10.1016/j.evolhumbehav.2010.04.001; Vasey PL, 2010, PSYCHOL SCI, V21, P292, DOI 10.1177/0956797609359623; Vasey PL, 2009, HUM NATURE-INT BIOS, V20, P269, DOI 10.1007/s12110-009-9066-4; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; WHITAM FL, 1983, ARCH SEX BEHAV, V12, P207, DOI 10.1007/BF01542072; WHITAM FL, 1986, MALE HOMOSEXUALITY 4; Wichmann S, 2010, PHYSICA A, V389, P3632, DOI 10.1016/j.physa.2010.05.011; Wichmann Soren, 2012, ASJP DATABASE VERSIO; Wilson E.O., 1975, P1; Yates T., 1993, INTERPRETATIVE ARCHA, P31	97	5	5	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134817	10.1371/journal.pone.0134817	http://dx.doi.org/10.1371/journal.pone.0134817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267276	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492300059
J	Chaddock-Heyman, L; Erickson, KI; Kienzler, C; King, M; Pontifex, MB; Raine, LB; Hillman, CH; Kramer, AF				Chaddock-Heyman, Laura; Erickson, Kirk I.; Kienzler, Caitlin; King, Matthew; Pontifex, Matthew B.; Raine, Lauren B.; Hillman, Charles H.; Kramer, Arthur F.			The Role of Aerobic Fitness in Cortical Thickness and Mathematics Achievement in Preadolescent Children	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; ACADEMIC-ACHIEVEMENT; PHYSICAL-ACTIVITY; PERFORMANCE; VOLUME; EXERCISE; ASSOCIATION; INHIBITION; COGNITION; MEMORY	Growing evidence suggests that aerobic fitness benefits the brain and cognition during childhood. The present study is the first to explore cortical brain structure of higher fit and lower fit 9- and 10-year-old children, and how aerobic fitness and cortical thickness relate to academic achievement. We demonstrate that higher fit children (>70th percentile VO2max) showed decreased gray matter thickness in superior frontal cortex, superior temporal areas, and lateral occipital cortex, coupled with better mathematics achievement, compared to lower fit children (<30th percentile VO2max). Furthermore, cortical gray matter thinning in anterior and superior frontal areas was associated with superior arithmetic performance. Together, these data add to our knowledge of the biological markers of school achievement, particularly mathematics achievement, and raise the possibility that individual differences in aerobic fitness play an important role in cortical gray matter thinning during brain maturation. The establishment of predictors of academic performance is key to helping educators focus on interventions to maximize learning and success across the lifespan.	[Chaddock-Heyman, Laura; Kienzler, Caitlin; King, Matthew; Hillman, Charles H.; Kramer, Arthur F.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Chaddock-Heyman, Laura; Kramer, Arthur F.] Univ Illinois, Dept Psychol, Champaign, IL USA; [Erickson, Kirk I.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Pontifex, Matthew B.] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Raine, Lauren B.; Hillman, Charles H.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Michigan State University; University of Illinois System; University of Illinois Urbana-Champaign	Chaddock-Heyman, L (corresponding author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.	lchaddo2@illinois.edu	Hillman, Charles/AAD-4828-2019; Meijer, Anna/K-5118-2016; Pontifex, Matthew B/A-4474-2009; Kramer, Arthur/AAB-2937-2019	Pontifex, Matthew B/0000-0001-9819-9625; Kramer, Arthur/0000-0001-5870-2724; Hillman, Charles/0000-0002-3722-5612	National Institute on Aging at the National Institute of Health [RO1 AG25032, R37 AG025667]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD055352, R21 HD078566]; National Institutes of Diabetes and Digestive and Kidney Diseases [R01 DK095172]; National Institute for Agriculture [2011-67001-30101]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD078566] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025032, R37AG025667] Funding Source: NIH RePORTER	National Institute on Aging at the National Institute of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute for Agriculture; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by grants from the National Institute on Aging at the National Institute of Health to Arthur Kramer (RO1 AG25032 and R37 AG025667) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD055352) to Charles Hillman. Kirk Erickson was supported by the National Institutes of Diabetes and Digestive and Kidney Diseases (R01 DK095172). Matthew Pontifex was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21 HD078566). Lauren Raine was supported by the National Institute for Agriculture under the Illinois Transdisciplinary Obesity Prevention Program grant (2011-67001-30101) to the Division of Nutritional Sciences at the University of Illinois.	American College., 2006, ACSMS GUID EX TEST P; Bar-Or O., 1983, PEDIAT SPORTS MED PR; Birnbaum AS, 2002, AM J HEALTH BEHAV, V26, P284, DOI 10.5993/AJHB.26.4.5; Buck SM, 2008, MED SCI SPORT EXER, V40, P166, DOI 10.1249/mss.0b013e318159b035; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Castelli DM, 2007, J SPORT EXERCISE PSY, V29, P239, DOI 10.1123/jsep.29.2.239; Chaddock L., 2011, J INT NEUROPSYCH SOC, V17, P1, DOI DOI 10.1017/S1355617711000567; Chaddock L, 2012, BIOL PSYCHOL, V89, P260, DOI 10.1016/j.biopsycho.2011.10.017; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Chaddock L, 2010, DEV NEUROSCI-BASEL, V32, P249, DOI 10.1159/000316648; Chaddock-Heyman L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00072; Chomitz VR, 2009, J SCHOOL HEALTH, V79, P30, DOI 10.1111/j.1746-1561.2008.00371.x; Coe DP, 2006, MED SCI SPORT EXER, V38, P1515, DOI 10.1249/01.mss.0000227537.13175.1b; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis CL, 2011, HEALTH PSYCHOL, V30, P91, DOI 10.1037/a0021766; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Donnelly JE, 2009, PREV MED, V49, P336, DOI 10.1016/j.ypmed.2009.07.022; DuPaul G. J., 1998, ADHD RATING SCALE 4; Erickson KI, 2010, NEUROLOGY, V75, P1415, DOI 10.1212/WNL.0b013e3181f88359; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FREEDSON PS, 1993, PEDIATRIC LABORATORY EXERCISE TESTING, P91; GERNSBACHER MA, 1993, PSYCHOL SCI, V4, P294, DOI 10.1111/j.1467-9280.1993.tb00567.x; Grissom JB., 2005, JEP J ENV PSYCHOL, V8, P11, DOI DOI 10.5297/SER.1403.010; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Hillman CH, 2014, PEDIATRICS, V134, pE1063, DOI 10.1542/peds.2013-3219; Hillman CH, 2012, DEV COGN NEUROS-NETH, V2, pS90, DOI 10.1016/j.dcn.2011.07.004; Institute of Medicine, 2013, ED STUD BOD TAK PHYS; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Kabani N, 2001, NEUROIMAGE, V13, P375, DOI 10.1006/nimg.2000.0652; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Kuncel NR, 2007, SCIENCE, V315, P1080, DOI 10.1126/science.1136618; Kuncel NR, 2004, J PERS SOC PSYCHOL, V86, P148, DOI 10.1037/0022-3514.86.1.148; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Ng SW, 2012, J ACAD NUTR DIET, V112, P41, DOI 10.1016/j.jada.2011.09.015; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Passolunghi MC, 2001, J EXP CHILD PSYCHOL, V80, P44, DOI 10.1006/jecp.2000.2626; Pontifex MB, 2011, J COGNITIVE NEUROSCI, V23, P1332, DOI 10.1162/jocn.2010.21528; SHVARTZ E, 1990, AVIAT SPACE ENVIR MD, V61, P3; Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Taylor SJC, 2001, PAEDIATR PERINAT EP, V15, P88; Tomporowski PD, 2008, EDUC PSYCHOL REV, V20, P111, DOI 10.1007/s10648-007-9057-0; Utter AC, 2002, MED SCI SPORT EXER, V34, P139, DOI 10.1097/00005768-200201000-00021; Vaynman S, 2006, J NEUROSCI RES, V84, P699, DOI 10.1002/jnr.20979; Voss MW, 2011, NEUROSCIENCE, V199, P166, DOI 10.1016/j.neuroscience.2011.10.009; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME	52	61	61	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134115	10.1371/journal.pone.0134115	http://dx.doi.org/10.1371/journal.pone.0134115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267897	Green Published, Green Accepted, gold			2022-12-27	WOS:000359492300032
J	Colliez, F; Safronova, MM; Magat, J; Joudiou, N; Peeters, AP; Jordan, BF; Gallez, B; Duprez, T				Colliez, Florence; Safronova, Marta M.; Magat, Julie; Joudiou, Nicolas; Peeters, Andre P.; Jordan, Benedicte F.; Gallez, Bernard; Duprez, Thierry			Oxygen Mapping within Healthy and Acutely Infarcted Brain Tissue in Humans Using the NMR Relaxation of Lipids: A Proof-Of-Concept Translational Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; LEVEL-DEPENDENT BOLD; TUMOR OXYGENATION; BLOOD OXYGENATION; MRI; CONTRAST; HYPEROXIA; HYPOXIA	The clinical applicability of brain oxygenation mapping using the MOBILE (Mapping of Oxygen By Imaging Lipids relaxation Enhancement) magnetic resonance (MR) technique was assessed in the clinical setting of normal brain and of acute cerebral ischemia as a founding proof-of-concept translational study. Changes in the oxygenation level within healthy brain tissue can be detected by analyzing the spin-lattice proton relaxation ('Global T-1' combining water and lipid protons) because of the paramagnetic properties of molecular oxygen. It was hypothesized that selective measurement of the relaxation of the lipid protons ('Lipids T-1') would result in enhanced sensitivity of pO(2) mapping because of higher solubility of oxygen in lipids than in water, and this was demonstrated in pre-clinical models using the MOBILE technique. In the present study, 12 healthy volunteers and eight patients with acute (48-72 hours) brain infarction were examined with the same clinical 3T MR system. Both Lipids R-1 (R-1 = 1/T-1) and Global R-1 were significantly different in the infarcted area and the contralateral unaffected brain tissue, with a higher statistical significance for Lipids R-1 (median difference: 0.408 s(-1); p<0.0001) than for Global R-1 (median difference: 0.154 s(-1); p = 0.027). Both Lipids R-1 and Global R-1 values in the unaffected contralateral brain tissue of stroke patients were not significantly different from the R-1 values calculated in the brain tissue of healthy volunteers. The main limitations of the present prototypic version of the MOBILE sequence are the long acquisition time (4 min), hampering robustness of data in uncooperative patients, and a 2 mm slice thickness precluding accurate measurements in small infarcts because of partial volume averaging effects.	[Colliez, Florence; Magat, Julie; Joudiou, Nicolas; Jordan, Benedicte F.; Gallez, Bernard] UCL, Louvain Drug Res Inst, Biomed Magnet Resonance Grp, Brussels, Belgium; [Safronova, Marta M.; Duprez, Thierry] Clin Univ UCL St Luc, Dept Radiol & Med Imaging, Brussels, Belgium; [Peeters, Andre P.] Clin Univ UCL St Luc, Dept Neurol, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Duprez, T (corresponding author), Clin Univ UCL St Luc, Dept Radiol & Med Imaging, Brussels, Belgium.	thierry.duprez@uclouvain.be	Magat, Julie/ABC-5523-2021	Jordan, Benedicte F./0000-0002-7126-2206; Duprez, Thierry/0000-0002-1579-0100; Magat, Julie/0000-0002-0967-9625	FRS-FNRS [7.4599.11]; Fournier-Majoie Foundation; Fonds Joseph Maisin; Plan Cancer (Belgian Ministry of Health) [KPC_29_027]; Fondation contre le Cancer [C/2014/255]	FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Fournier-Majoie Foundation; Fonds Joseph Maisin; Plan Cancer (Belgian Ministry of Health); Fondation contre le Cancer	This work was supported by the FRS-FNRS (7.4599.11)(http://www.fnrs.be/), the Fournier-Majoie Foundation(BG, http://www.fournier-majoie.org/en), the Fonds Joseph Maisin (BG, http://www.centreducancer.be/fr/show/index/section/8/page/88), the Plan Cancer (Belgian Ministry of Health, KPC_29_027)(TD, http://health.belgium.be/eportal/Healthcare/Specialisedcare/CancerPlan/19080671?ie2Term = plan%20cancer?&fodnlang = fr#.VMYc5i6LpOh), and the Fondation contre le Cancer (C/2014/255) (BG, http://www.cancer.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudelet C, 2002, MAGN RESON MED, V48, P980, DOI 10.1002/mrm.10318; Burrell JS, 2013, J MAGN RESON IMAGING, V38, P429, DOI 10.1002/jmri.23987; Christen T, 2013, AM J NEURORADIOL, V34, P1113, DOI 10.3174/ajnr.A3070; Christen T, 2014, J CEREBR BLOOD F MET, V34, P1550, DOI 10.1038/jcbfm.2014.116; Christen T, 2011, NMR BIOMED, V24, P393, DOI 10.1002/nbm.1603; Colliez F, 2014, CLIN CANCER RES, V20, P5403, DOI 10.1158/1078-0432.CCR-13-3434; Dani KA, 2010, ANN NEUROL, V68, P37, DOI 10.1002/ana.22032; Gauthier CJ, 2012, NEUROIMAGE, V60, P1212, DOI 10.1016/j.neuroimage.2011.12.056; Gelman N, 2001, MAGNET RESON MED, V45, P71, DOI 10.1002/1522-2594(200101)45:1<71::AID-MRM1011>3.0.CO;2-2; Haddock B, 2013, NEUROIMAGE, V78, P7, DOI 10.1016/j.neuroimage.2013.03.068; Hunjan S, 2001, INT J RADIAT ONCOL, V49, P1097, DOI 10.1016/S0360-3016(00)01460-7; Jordan BF, 2013, MAGN RESON MED, V70, P732, DOI 10.1002/mrm.24511; Lan M, 2004, MAGN RESON MED, V51, P1272, DOI 10.1002/mrm.20077; Matsumoto K, 2006, MAGN RESON MED, V56, P240, DOI 10.1002/mrm.20961; Mendichovszky I, 2011, BRIT J RADIOL, V84, pS145, DOI 10.1259/bjr/82292521; Morita N, 2008, CEREBROVASC DIS, V26, P367, DOI 10.1159/000151640; O'Connor JPB, 2007, MAGN RESON MED, V58, P490, DOI 10.1002/mrm.21357; O'Connor JPB, 2009, INT J RADIAT ONCOL, V75, P1209, DOI 10.1016/j.ijrobp.2008.12.040; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pacheco-Torres J, 2011, NMR BIOMED, V24, P1, DOI 10.1002/nbm.1558; Schwarcz A, 2002, ACTA NEUROCHIR, V144, P811, DOI 10.1007/s00701-002-0935-4; Spielman DM, MAGN RESON MED, V61, P462; Takasawa M, 2008, STROKE, V39, P1629, DOI 10.1161/STROKEAHA.107.485938; Tamura H, 2002, STROKE, V33, P967, DOI 10.1161/01.STR.0000013672.70986.E2; Weiskopf N., 2013, FRONT NEUROSCI, V7, P95; Winter JD, 2011, ACAD RADIOL, V18, P1159, DOI 10.1016/j.acra.2011.04.016; Wright PJ, 2008, MAGN RESON MATER PHY, V21, P121, DOI 10.1007/s10334-008-0104-8; Zhao DW, 2009, MAGN RESON MED, V62, P357, DOI 10.1002/mrm.22020	28	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135248	10.1371/journal.pone.0135248	http://dx.doi.org/10.1371/journal.pone.0135248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267901	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300087
J	Kruse, M; Wildner, R; Barnes, G; Martin, M; Mueller, U; Lo-Coco, F; Pathak, A				Kruse, Morgan; Wildner, Rebecca; Barnes, Gisoo; Martin, Monique; Mueller, Udo; Lo-Coco, Francesco; Pathak, Ashutosh			Budgetary Impact of Treating Acute Promyelocytic Leukemia Patients with First-Line Arsenic Trioxide and Retinoic Acid from an Italian Payer Perspective	PLOS ONE			English	Article							CONSOLIDATION THERAPY; CHEMOTHERAPY; REMISSION; RISK; INTERGROUP; INDUCTION; SURVIVAL; ADULTS; TRIAL	The objective of this study was to estimate the net cost of arsenic trioxide (ATO) added to all-trans retinoic acid (ATRA) compared to ATRA plus chemotherapy when used in first-line acute promyelocytic leukemia (APL) treatment for low to intermediate risk patients from the perspective of the overall Italian healthcare systemA Markov model was developed with 3 health states: stable disease, disease event and death. Each month, patients could move from stable to disease event or die from either state. After a disease event, patients discontinued initial treatment and switched to the other regimen as second-line therapy. Treatment regimens, efficacy and adverse events were derived from published sources and expert opinion; unit costs were collected from standard Italian sources. Clinical outcomes and costs for pre-ATO and post-ATO scenarios were combined with population and product utilization information to calculate the total budgetary impact using a 3-year time horizon; one-way sensitivity analyses were conducted. Three-year cumulative pharmacy costs for ATO+ATRA were (sic)46,700 per-patient versus (sic)6,500 for ATRA+chemotherapy; however, medical costs for ATO+ATRA were (sic)12,300 per-patient versus (sic)30,200 for ATRA+chemotherapy. The total budgetary impact was estimated to be an additional (sic)127,300, (sic)312,500 and (sic)477,800 in the first, second and third years, respectively. The model was most sensitive to changes in the cost of the ATO+ATRA regimen during the consolidation phase. Budgetary impact models are valuable to payers making formulary decisions regarding the access and affordability of new medicines. The cost of treatment analysis showed that pharmacy costs for ATO+ATRA were higher than for ATRA+chemotherapy, while all other evaluated costs were lower for ATO+ATRA treated patients. The average budgetary impact was (sic)305,900 per year overall, representing a 3.5% increase. Further research is needed to determine the cost-effectiveness of ATO+ATRA compared to the current first-line standard of care in APL.	[Kruse, Morgan; Wildner, Rebecca] Optum, Cambridge, MA USA; [Barnes, Gisoo; Pathak, Ashutosh] Teva Pharmaceut, Frazer, PA USA; [Martin, Monique] MapiGroup, Uxbridge, Middx, England; [Mueller, Udo] Teva Pharmaceut, Ulm, Germany; [Lo-Coco, Francesco] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy	Optum; University of Rome Tor Vergata	Lo-Coco, F (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy.	francesco.lo.coco@uniroma2.it			Teva Pharmaceuticals; Optum; MapiGroup	Teva Pharmaceuticals(Teva Pharmaceutical Industries); Optum; MapiGroup	The study was funded by Teva Pharmaceuticals. Co-authors GB, AP and UM are employed by Teva Pharmaceuticals. Teva Pharmaceuticals provided support in the form of salaries for authors GB, AP and UM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Optum and MapiGroup provided support in the form of salaries for authors MK, RW and MM, but did not have an additional direct role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ades L, 2010, BLOOD, V115, P1690, DOI 10.1182/blood-2009-07-233387; AIRTUM ITCAN, 2014, AIRTUM ITCAN CANC IT; [Anonymous], 2014, DEMOGRAPHIC BALANCE; [Anonymous], 2013, NOM TAR ASS SPEC AMB; [Anonymous], 2014, EL FARM FAS H PRINC; Asou N, 2007, BLOOD, V110, P59, DOI 10.1182/blood-2006-08-043992; Au WY, 2003, ANN ONCOL, V14, P752, DOI 10.1093/annonc/mdg208; Avvisati G, 2011, BLOOD, V117, P4716, DOI 10.1182/blood-2010-08-302950; Capri S, 2001, DRUG INF J, V35, P189, DOI 10.1177/009286150103500122; Efficace F, 2014, J CLIN ONCOL, V32, P3406, DOI 10.1200/JCO.2014.55.3453; Estey E, 2006, BLOOD, V107, P3469, DOI 10.1182/blood-2005-10-4006; Ghavamzadeh A, 2011, J CLIN ONCOL, V29, P2753, DOI 10.1200/JCO.2010.32.2107; Iland HJ, 2012, BLOOD, V120, P1570, DOI 10.1182/blood-2012-02-410746; Lengfelder E, 2015, LEUKEMIA, V29, P1084, DOI 10.1038/leu.2015.12; Lengfelder E, 2012, ACUTE PROMYELOCYTIC; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lo-Coco F, 2010, BLOOD, V116, P3171, DOI 10.1182/blood-2010-03-276196; Marchetti M, 2004, CLIN THER, V26, P1546, DOI 10.1016/j.clinthera.2004.09.014; Mathews V, 2006, BLOOD, V107, P2627, DOI 10.1182/blood-2005-08-3532; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Powell BL, 2010, BLOOD, V116, P3751, DOI 10.1182/blood-2010-02-269621; Prontuario farmaceuticoh [ Internet], 2014, PRONT FARM; Raffoux E, 2003, J CLIN ONCOL, V21, P2326, DOI 10.1200/JCO.2003.01.149; Sanz MA, 2000, BLOOD, V96, P1247; Sanz MA, 2010, BLOOD, V115, P5137, DOI 10.1182/blood-2010-01-266007; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Shigeno K, 2005, INT J HEMATOL, V82, P224, DOI 10.1532/IJH97.05044; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Tallman Martin S, 2008, Hematology Am Soc Hematol Educ Program, P391, DOI 10.1182/asheducation-2008.1.391; Tallman MS, 2002, BLOOD, V100, P4298, DOI 10.1182/blood-2002-02-0632; Watts JM, 2014, BLOOD REV, V28, P205, DOI 10.1016/j.blre.2014.07.001	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134587	10.1371/journal.pone.0134587	http://dx.doi.org/10.1371/journal.pone.0134587			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267454	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300050
J	Rodrigues, AS; Pereira, SL; Correia, M; Gomes, A; Perestrelo, T; Ramalho-Santos, J				Rodrigues, Ana Sofia; Pereira, Sandro L.; Correia, Marcelo; Gomes, Andreia; Perestrelo, Tania; Ramalho-Santos, Joao			Differentiate or Die: 3-Bromopyruvate and Pluripotency in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							NUCLEAR ANTIGEN PCNA; SMALL-MOLECULE; CANCER-CELLS; MITOCHONDRIAL; METABOLISM; HYPOXIA; INHIBITION; GLYCOLYSIS; EXPRESSION; CAPACITY	Background Pluripotent embryonic stem cells grown under standard conditions ( ESC) have a markedly glycolytic profile, which is shared with many different types of cancer cells. Thus, some therapeutic strategies suggest that pharmacologically shifting cancer cells towards an oxidative phenotype, using glycolysis inhibitors, may reduce cancer aggressiveness. Given the metabolic parallels between cancer and stemness would chemotherapeutical agents have an effect on pluripotency, and could a strategy involving these agents be envisioned to modulate stem cell fate in an accessible manner? In this manuscript we attempted to determine the effects of 3-bromopyruvate (3BrP) in pluripotency. Although it has other intracellular targets, this compound is a potent inhibitor of glycolysis enzymes thought to be important to maintain a glycolytic profile. The goal was also to determine if we could contribute towards a pharmacologically accessible metabolic strategy to influence cell differentiation. Methodology/Principal Findings Mouse embryonic stem cells (mESC) grown under standard pluripotency conditions (in the presence of Leukemia Inducing Factor-LIF) were treated with 3BrP. As a positive control for differentiation other mESCs were grown without LIF. Overall our results demonstrate that 3BrP negatively affects pluripotency, forcing cells to become less glycolytic and with more active mitochondria. These changes in metabolism are correlated with increased differentiation, even under pluripotency conditions (i.e. in the presence of LIF). However, 3BrP also significantly impaired cell function, and may have other roles besides affecting the metabolic profile of mESCs. Conclusions/Findings Treatment of mESCs with 3BrP triggered a metabolic switch and loss of pluripotency, even in the presence of LIF. Interestingly, the positive control for differentiation allowed for a distinction between 3BrP effects and changes associated with spontaneous differentiation/loss of pluripotency in the absence of LIF. Additionally, there was a slight differentiation bias towards mesoderm in the presence of 3BrP. However, the side effects on cellular function suggest that the use of this drug is probably not adequate to efficiently push cells towards specific differentiation fates.	[Rodrigues, Ana Sofia; Correia, Marcelo; Gomes, Andreia; Perestrelo, Tania] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, PhD Programme Expt Biol & Biomed, Coimbra, Portugal; [Rodrigues, Ana Sofia; Pereira, Sandro L.; Correia, Marcelo; Perestrelo, Tania; Ramalho-Santos, Joao] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Correia, Marcelo; Gomes, Andreia; Perestrelo, Tania] Univ Coimbra, Inst Interdisciplinary Res IIIUC, Coimbra, Portugal; [Gomes, Andreia] Biocant Ctr Innovat Biotechnol, Cantanhede, Portugal; [Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Ramalho-Santos, J (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	jramalho@ci.uc.pt	Rodrigues, Ana Sofia/ABA-9042-2020; Ramalho-Santos, João/F-8641-2012; Santos, João/HHZ-5595-2022; Correia, Marcelo/W-4213-2017; Perestrelo, Tânia Marisa Melim/ABC-5495-2020	Rodrigues, Ana Sofia/0000-0001-7060-879X; Ramalho-Santos, João/0000-0002-1172-4018; Correia, Marcelo/0000-0002-3163-9582; Perestrelo, Tânia Marisa Melim/0000-0001-8995-6620; Cardoso Pereira, Sandro Lino/0000-0001-9498-3965	Fundacao para a Ciencia e a Tecnologia (FCT) Portugal - Compete/FEDER/National Funds [PTDC/EBB-EBI/ 120634/2010, PDTC/QUI-BIQ/120652/2010]; FCT [PEst-C/SAU/LA0001/2011]; QREN [Centro-01-0762-FEDER-00204];  [SFRH/BD/33463/2008];  [SFRH/BD/51681/2011];  [SFRH/BD/51684/2011];  [SFRH/BD/51968/2012];  [SFRH/BPD/98995/2013]	Fundacao para a Ciencia e a Tecnologia (FCT) Portugal - Compete/FEDER/National Funds; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); QREN; ; ; ; ; 	The authors thank Fundacao para a Ciencia e a Tecnologia (FCT) Portugal for grant support (PTDC/EBB-EBI/ 120634/2010 and PDTC/QUI-BIQ/120652/2010) co-funded by Compete/FEDER/National Funds; and scholarships attributed to ASR (SFRH/BD/33463/2008); to MC (SFRH/BD/51681/2011), to TP (SFRH/BD/51684/2011), AG (SFRH/BD/51968/2012) and SLP (SFRH/BPD/98995/2013) and also to QREN (Centro-01-0762-FEDER-00204). Center for Neuroscience and Cell Biology (CNC) funding is also supported by FCT (PEst-C/SAU/LA0001/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral S, 2009, MITOCHONDRION, V9, P41, DOI 10.1016/j.mito.2008.11.005; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Dingley S, 2012, METHODS MOL BIOL, V837, P231, DOI 10.1007/978-1-61779-504-6_16; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; Folmes CDL, 2013, J CARDIOVASC TRANSL, V6, P10, DOI 10.1007/s12265-012-9431-2; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Galina A, 2014, INT J BIOCHEM CELL B, V54, P266, DOI 10.1016/j.biocel.2014.05.013; Glick M, 2014, BIOCHEM BIOPH RES CO, V452, P170, DOI 10.1016/j.bbrc.2014.08.066; Ngo H, 2015, MOL BIOL REP, V42, P825, DOI 10.1007/s11033-014-3764-7; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Isayev O, 2014, ONCOTARGET, V5, P5177, DOI 10.18632/oncotarget.2120; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Kim JS, 2008, J BIOENERG BIOMEMBR, V40, P607, DOI 10.1007/s10863-008-9188-0; Ko YH, 2012, J BIOENERG BIOMEMBR, V44, P163, DOI 10.1007/s10863-012-9417-4; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Kreis NN, 2015, ONCOGENE, V34, P1758, DOI 10.1038/onc.2014.133; Lee S, 2009, AGING CELL, V8, P296, DOI 10.1111/j.1474-9726.2009.00477.x; Macchioni L, 2011, J BIOENERG BIOMEMBR, V43, P507, DOI 10.1007/s10863-011-9375-2; Mahler M, 2012, AUTOIMMUN REV, V11, P771, DOI 10.1016/j.autrev.2012.02.012; Manganelli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029321; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Nair RP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt186; O'Connor MD, 2008, STEM CELLS, V26, P1109, DOI 10.1634/stemcells.2007-0801; O'Connor MD, 2011, METHODS MOL BIOL, V690, P67, DOI 10.1007/978-1-60761-962-8_4; Ohtsuka M, 2006, GENES GENET SYST, V81, P143, DOI 10.1266/ggs.81.143; Peng QP, 2009, HEPATO-GASTROENTEROL, V56, P355; Pereira SL, 2014, HUM REPROD UPDATE, V20, P924, DOI 10.1093/humupd/dmu034; Pereira SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082095; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pietzke M, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-9; Pistollato F, 2009, STEM CELLS, V27, P7, DOI 10.1634/stemcells.2008-0402; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Qin JZ, 2010, BIOCHEM BIOPH RES CO, V396, P495, DOI 10.1016/j.bbrc.2010.04.126; Rodrigues JR-SaAS, 2012, MITOCHONDRIAL DNA MI, P69; Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; STOCCHI V, 1985, ANAL BIOCHEM, V146, P118, DOI 10.1016/0003-2697(85)90405-1; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Tamai M, 2011, J BIOSCI BIOENG, V112, P495, DOI 10.1016/j.jbiosc.2011.07.005; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Xu RH, 2005, CANCER RES, V65, P613; Zhang Qianwen, 2014, Genes Cancer, V5, P100; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	50	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135617	10.1371/journal.pone.0135617	http://dx.doi.org/10.1371/journal.pone.0135617			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266544	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300143
J	Shi, QQ; Zhou, L; Wang, Y; Li, K; Zheng, BQ; Miao, K				Shi, Qianqian; Zhou, Lin; Wang, Yan; Li, Kui; Zheng, Baoqiang; Miao, Kun			Transcriptomic Analysis of Paeonia delavayi Wild Population Flowers to Identify Differentially Expressed Genes Involved in Purple-Red and Yellow Petal Pigmentation	PLOS ONE			English	Article							TREE PEONY; CHALCONE ISOMERASE; FLAVONOID BIOSYNTHESIS; RNA-SEQ; ANTHOCYANIN BIOSYNTHESIS; TOOL; OVEREXPRESSION; SUFFRUTICOSA; ANNOTATION; COLORATION	Tree peony (Paeonia suffruticosa Andrews) is a very famous traditional ornamental plant in China. P. delavayi is a species endemic to Southwest China that has aroused great interest from researchers as a precious genetic resource for flower color breeding. However, the current understanding of the molecular mechanisms of flower pigmentation in this plant is limited, hindering the genetic engineering of novel flower color in tree peonies. In this study, we conducted a large-scale transcriptome analysis based on Illumina HiSeq sequencing of cDNA libraries generated from yellow and purple-red P. delavayi petals. A total of 90,202 unigenes were obtained by de novo assembly, with an average length of 721 nt. Using Blastx, 44,811 unigenes (49.68%) were found to have significant similarity to accessions in the NR, NT, and Swiss-Prot databases. We also examined COG, GO and KEGG annotations to better understand the functions of these unigenes. Further analysis of the two digital transcriptomes revealed that 6,855 unigenes were differentially expressed between yellow and purple-red flower petals, with 3,430 up-regulated and 3,425 down-regulated. According to the RNA-Seq data and qRT-PCR analysis, we proposed that four up-regulated key structural genes, including F3H, DFR, ANS and 3GT, might play an important role in purple-red petal pigmentation, while high co-expression of THC2'GT, CHI and FNS II ensures the accumulation of pigments contributing to the yellow color. We also found 50 differentially expressed transcription factors that might be involved in flavonoid biosynthesis. This study is the first to report genetic information for P. delavayi. The large number of gene sequences produced by transcriptome sequencing and the candidate genes identified using pathway mapping and expression profiles will provide a valuable resource for future association studies aimed at better understanding the molecular mechanisms underlying flower pigmentation in tree peonies.	[Shi, Qianqian; Zhou, Lin; Wang, Yan; Li, Kui; Zheng, Baoqiang; Miao, Kun] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat State Forestry A, Beijing 100091, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF	Wang, Y (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat State Forestry A, Beijing 100091, Peoples R China.	chwy8915@sina.com			National High Technology Research and Development Program of China (863 Program) [2011AA10020701]; National Natural Science Foundation of China [31201654]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National High Technology Research and Development Program of China (863 Program) (2011AA10020701) YW National Natural Science Foundation of China (31201654) LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the munuscript.	Akashi T, 1999, PLANT PHYSIOL, V121, P821, DOI 10.1104/pp.121.3.821; Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; Benjamini Y, 2001, ANN STAT, V29, P1165; Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; Candido E de S, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090487, DOI 10.1371/J0URNAL.P0NE.0090487]; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090842; Chiu LW, 2010, PLANT PHYSIOL, V154, P1470, DOI 10.1104/pp.110.164160; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; FORKMANN G, 1980, BIOCHEM GENET, V18, P519, DOI 10.1007/BF00484399; Fournier-Level A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-179; Gai SP, 2012, GENE, V497, P256, DOI 10.1016/j.gene.2011.12.013; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076890; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Hong DY, 2007, ACTA PHYTOTAXON SIN, V45, P285, DOI 10.1360/aps07043; Hong DY, 2005, ACTA PHYTOTAXON SIN, V43, P284, DOI 10.1360/aps040082; Hong DY, 2005, ACTA PHYTOTAXON SIN, V43, P169, DOI 10.1360/aps040065; Hong DY, 1998, ANN MO BOT GARD, V85, P554, DOI 10.2307/2992016; HONG DY, 1999, ACTA PHYTOTAXONOMICA, V37, P351; HOSOKI T, 1991, J JPN SOC HORTIC SCI, V60, P395, DOI 10.2503/jjshs.60.395; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Itoh Y, 2002, PLANT CELL PHYSIOL, V43, P578, DOI 10.1093/pcp/pcf065; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-657; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Li CH, 2009, J AGR FOOD CHEM, V57, P8496, DOI 10.1021/jf902103b; Li J.Y., 1999, CHINESE TREE PEONY H; Li Kui, 2011, Journal of Beijing Forestry University, V33, P94; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Marinova K, 2007, PLANT PHYSIOL, V144, P432, DOI 10.1104/pp.106.094748; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Morita Y, 2006, PLANT CELL PHYSIOL, V47, P457, DOI 10.1093/pcp/pcj012; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakatsuka T, 2005, PLANT SCI, V168, P1309, DOI 10.1016/j.plantsci.2005.01.009; Nakatsuka T, 2010, J PLANT PHYSIOL, V167, P231, DOI 10.1016/j.jplph.2009.08.007; Natale DA, 2000, GENOME BIOL, V1; Nishihara M, 2011, BIOTECHNOL LETT, V33, P433, DOI 10.1007/s10529-010-0461-z; Noda N, 2004, PHYSIOL PLANTARUM, V122, P305, DOI 10.1111/j.1399-3054.2004.00407.x; Ogata J., 2004, PLANT BIOTECHNOL, V21, P367, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.21.367; Okuhara H, 2004, PLANT CELL PHYSL S, V45, P420; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Park NI, 2011, FUNCT INTEGR GENOMIC, V11, P491, DOI 10.1007/s10142-011-0229-0; Pomar F, 2005, J CHROMATOGR A, V1094, P34, DOI 10.1016/j.chroma.2005.07.096; Tan JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072364; Tanaka Y, 2008, CURR OPIN BIOTECH, V19, P190, DOI 10.1016/j.copbio.2008.02.015; Togami J, 2011, PLANT BIOTECHNOL-NAR, V28, P231, DOI 10.5511/plantbiotechnology.11.0106b; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Tsanakas GF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-554; Uematsu C, 2014, J EXP BOT, V65, P1081, DOI 10.1093/jxb/ert456; Wang LS, 2001, J PLANT RES, V114, P213, DOI 10.1007/PL00013985; Wang LS, 2001, J PLANT RES, V114, P33, DOI 10.1007/PL00013966; Wang X, 2005, J CHROMATOGR A, V1075, P127, DOI 10.1016/j.chroma.2005.04.017; Wang Y, 2014, PLANT CELL TISS ORG, V116, P297, DOI 10.1007/s11240-013-0404-1; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Yamagishi M, 2011, MOL BREEDING, V28, P381, DOI 10.1007/s11032-010-9490-5; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang C, 2014, PLANT CELL REP, V33, P111, DOI 10.1007/s00299-013-1516-0; Zhang JJ, 2007, SCI HORTIC-AMSTERDAM, V114, P104, DOI 10.1016/j.scienta.2007.05.009; Zhao DQ, 2012, MOL BIOL REP, V39, P11263, DOI 10.1007/s11033-012-2036-7; Zhou H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079996; Zhou L, 2014, PLANT CELL TISS ORG, V116, P285, DOI 10.1007/s11240-013-0403-2; Zhou Lin, 2011, Plant Physiology Communications, V47, P885; Zhou Lin, 2011, Journal of Northeast Forestry University, V39, P52; Zhou L, 2011, AFR J BIOTECHNOL, V10, P1275	73	39	44	3	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135038	10.1371/journal.pone.0135038	http://dx.doi.org/10.1371/journal.pone.0135038			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267644	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492300073
J	Taferner, A; Pircher, H; Koziel, R; von Grafenstein, S; Baraldo, G; Palikaras, K; Liedl, KR; Tavernarakis, N; Jansen-Durr, P				Taferner, Andrea; Pircher, Haymo; Koziel, Rafal; von Grafenstein, Susanne; Baraldo, Giorgia; Palikaras, Konstantinos; Liedl, Klaus R.; Tavernarakis, Nektarios; Jansen-Duerr, Pidder			FAH Domain Containing Protein 1 (FAHD-1) Is Required for Mitochondrial Function and Locomotion Activity in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; OXALOACETATE DECARBOXYLASE; SEROTONIN; METABOLISM; MECHANISM; DOPAMINE	The fumarylacetoacetate hydrolase (FAH) protein superfamily of metabolic enzymes comprises a diverse set of enzymatic functions, including beta-diketone hydrolases, decarboxylases, and isomerases. Of note, the FAH superfamily includes many prokaryotic members with very distinct functions that lack homologs in eukaryotes. A prokaryotic member of the FAH superfamily, referred to as Cg1458, was shown to encode a soluble oxaloacetate decarboxylase (ODx). Based on sequence homologies to Cg1458, we recently identified human FAH domain containing protein-1 (FAHD1) as the first eukaryotic oxaloacetate decarboxylase. The physiological functions of ODx in eukaryotes remain unclear. Here we have probed the function of fahd-1, the nematode homolog of FAHD1, in the context of an intact organism. We found that mutation of fahd-1 resulted in reduced brood size, a deregulation of the egg laying process and a severe locomotion deficit, characterized by a reduced frequency of body bends, reduced exploratory movements and reduced performance in an endurance exercise test. Notably, mitochondrial function was altered in the fahd-1(tm5005) mutant strain, as shown by a reduction of mitochondrial membrane potential and a reduced oxygen consumption of fahd-1(tm5005) animals. Mitochondrial dysfunction was accompanied by lifespan extension in worms grown at elevated temperature; however, unlike in mutant worms with a defect in the electron transport chain, the mitochondrial unfolded protein response was not upregulated in worms upon inactivation of fahd-1. Together these data establish a role of fahd-1 to maintain mitochondrial function and consequently physical activity in nematodes.	[Taferner, Andrea; Pircher, Haymo; Koziel, Rafal; Baraldo, Giorgia; Jansen-Duerr, Pidder] Univ Innsbruck, Inst Biomed Aging Res, A-6020 Innsbruck, Austria; [Taferner, Andrea; Pircher, Haymo; Koziel, Rafal; von Grafenstein, Susanne; Baraldo, Giorgia; Liedl, Klaus R.; Jansen-Duerr, Pidder] Univ Innsbruck, Ctr Mol Biosci Innsbruck CMBI, A-6020 Innsbruck, Austria; [von Grafenstein, Susanne; Liedl, Klaus R.] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Austria; [Palikaras, Konstantinos; Tavernarakis, Nektarios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Palikaras, Konstantinos; Tavernarakis, Nektarios] Univ Crete, Fac Med, Dept Basic Sci, Iraklion, Crete, Greece	University of Innsbruck; University of Innsbruck; University of Innsbruck; Foundation for Research & Technology - Hellas (FORTH); University of Crete	Jansen-Durr, P (corresponding author), Univ Innsbruck, Inst Biomed Aging Res, Rennweg 10, A-6020 Innsbruck, Austria.	pidder.jansen-duerr@uibk.ac.at	Liedl, Klaus/ABB-4725-2021; Palikaras, Konstantinos/AAI-1300-2020; Liedl, Klaus R/F-3099-2015; Tavernarakis, Nektarios/B-9684-2013; Jansen-Dürr, Pidder/ABG-2466-2020	Liedl, Klaus/0000-0002-0985-2299; Liedl, Klaus R/0000-0002-0985-2299; Tavernarakis, Nektarios/0000-0002-5253-1466; Jansen-Dürr, Pidder/0000-0001-7771-3429; Palikaras, Konstantinos/0000-0001-6992-5560	Austrian Science Funds (FWF) [NFN S93]; European Union	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); European Union(European Commission)	Work in P. J.'s laboratory was supported by a grant from the Austrian Science Funds (FWF; NFN S93) and by the European Union through the FP6 Integrated Project MiMAGE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Ashrafi Kaveh, 2007, WormBook, P1; Berkowitz LA, 2008, J VIS EXP, P835; BRENNER S, 1974, GENETICS, V77, P71; Brouns SJJ, 2008, J MOL BIOL, V379, P357, DOI 10.1016/j.jmb.2008.03.064; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Jin YS, 1999, PRACT APPROACH SER, V213, P69; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Jovaisaite V, 2014, J EXP BIOL, V217, P137, DOI 10.1242/jeb.090738; Kirstein-Miles J, 2010, DEV DYNAM, V239, P1529, DOI 10.1002/dvdy.22292; Klaffl S, 2010, J BACTERIOL, V192, P2604, DOI 10.1128/JB.01678-09; Munkacsy E, 2014, EXP GERONTOL, V56, P221, DOI 10.1016/j.exger.2014.03.016; Pircher H, 2015, J BIOL CHEM; Pircher H, 2011, J BIOL CHEM, V286, P36500, DOI 10.1074/jbc.M111.264770; Ran TT, 2013, BIOCHEM J, V449, P51, DOI 10.1042/BJ20120913; Rea SL, 2005, EXP GERONTOL, V40, P841, DOI 10.1016/j.exger.2005.06.015; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Stiernagle Theresa, 2006, WormBook, P1; Thomas JH, 1999, PRACT APPROACH SER, V213, P143; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; TRENT C, 1983, GENETICS, V104, P619; WOJTCZAK AB, 1974, BIOCHIM BIOPHYS ACTA, V347, P168, DOI 10.1016/0005-2728(74)90042-5; ZEYLEMAKER WP, 1967, BIOCHIM BIOPHYS ACTA, V132, P210, DOI 10.1016/0005-2744(67)90214-8	27	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134161	10.1371/journal.pone.0134161	http://dx.doi.org/10.1371/journal.pone.0134161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266933	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300035
J	Brasseur, K; Auger, P; Asselin, E; Parent, S; Cote, JC; Sirois, M				Brasseur, Kevin; Auger, Pascal; Asselin, Eric; Parent, Sophie; Cote, Jean-Charles; Sirois, Marc			Parasporin-2 from a New Bacillus thuringiensis 4R2 Strain Induces Caspases Activation and Apoptosis in Human Cancer Cells	PLOS ONE			English	Article							PESTICIDAL CRYSTAL PROTEINS; CISPLATIN-INDUCED APOPTOSIS; ENDOMETRIAL CANCER; SIGNALING PATHWAY; CYTOCIDAL ACTION; CARCINOMA-CELLS; CYT TOXINS; RESISTANCE; EXPRESSION; PAR-4	In previous studies, parasporin-2Aa1, originally isolated from Bacillus thuringiensis strain A1547, was shown to be cytotoxic against specific human cancer cells but the mechanisms of action were not studied. In the present study, we found that proteinase K activated parasporin-2Aa1 protein isolated from a novel B. thuringiensis strain, 4R2, was specifically cytotoxic to endometrial, colon, liver, cervix, breast and prostate cancer. It showed no toxicity against normal cells. Upon treatment with proteinase K-activated parasporin-2Aa1, morphological changes were observed and western blot analysis revealed the cleavage of poly (ADP-Ribose) polymerase, caspase-3 and caspase-9 in cancer cell lines exclusively, indicative of programmed cell death, apoptosis. Flow cytometry analyses, using propidium iodide and annexin V, as well as a caspases 3/7 assay confirmed apoptosis induction. Further analyses were performed to study survival pathways, including AKT, XIAP, ERK1/2 and PAR-4, a known inducer of apoptosis. These results indicate that parasporin-2Aa1 is a selective cytotoxic protein that induces apoptosis in various human cancer cell lines from diverse tissues.	[Brasseur, Kevin; Auger, Pascal; Asselin, Eric; Parent, Sophie; Sirois, Marc] Univ Quebec Trois Rivieres, Dept Med Biol, Res Grp Mol Oncol & Endocrinol, Trois Rivieres, PQ G9A 5H7, Canada; [Cote, Jean-Charles] Agr & Agri Food Canada, Res Ctr, St Jean, PQ J3B 3E6, Canada	University of Quebec; University of Quebec Trois Rivieres; Agriculture & Agri Food Canada	Sirois, M (corresponding author), Univ Quebec Trois Rivieres, Dept Med Biol, Res Grp Mol Oncol & Endocrinol, 3351 Blvd Des Forges,CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	marc.sirois@uqtr.ca			internal UQTR research group; Canadian Institutes of Health Research (CIHR); Canada research chair in molecular gyneco-oncology	internal UQTR research group; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada research chair in molecular gyneco-oncology	This study was funded by the internal UQTR research group. Kevin Brasseur was the holder of a doctoral scholarship from the Canadian Institutes of Health Research (CIHR). Eric Asselin is holder of the Canada research chair in molecular gyneco-oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba T, 2009, J MOL BIOL, V386, P121, DOI 10.1016/j.jmb.2008.12.002; Amano H, 2005, BIOSCI BIOTECH BIOCH, V69, P2063, DOI 10.1271/bbb.69.2063; Asselin E, 2001, CANCER RES, V61, P1862; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; CARMICHAEL J, 1987, CANCER RES, V47, P943; Chapdelaine P, 2006, MOL HUM REPROD, V12, P309, DOI 10.1093/molehr/gal034; Chaudhry P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.7; Chaudhry P, 2012, MOL CELL BIOL, V32, P826, DOI 10.1128/MCB.06321-11; Chaudhry P, 2009, ENDOCR-RELAT CANCER, V16, P363, DOI 10.1677/ERC-08-0266; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; Crickmore N., 2014, BACILLUS THURINGIENS; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Diep DB, 1998, J BIOL CHEM, V273, P2355, DOI 10.1074/jbc.273.4.2355; El-Guendy N, 2003, MOL CELL BIOL, V23, P5516, DOI 10.1128/MCB.23.16.5516-5525.2003; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; FORD CHJ, 1989, CANCER CHEMOTH PHARM, V24, P295, DOI 10.1007/BF00304761; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Gagnon V, 2008, APOPTOSIS, V13, P259, DOI 10.1007/s10495-007-0165-6; Gao LY, 2000, MICROBES INFECT, V2, P1705, DOI 10.1016/S1286-4579(00)01326-5; Girouard J, 2013, GYNECOL ONCOL, V128, P335, DOI 10.1016/j.ygyno.2012.11.016; Gomez I, 2007, PEPTIDES, V28, P169, DOI 10.1016/j.peptides.2006.06.013; Gonzalez E, 2011, CURR MICROBIOL, V62, P1643, DOI 10.1007/s00284-011-9905-5; HAIDER MZ, 1986, EUR J BIOCHEM, V156, P531, DOI 10.1111/j.1432-1033.1986.tb09612.x; Hebbar N, 2012, J CELL PHYSIOL, V227, P3715, DOI 10.1002/jcp.24098; HOFTE H, 1989, MICROBIOL REV, V53, P242; Irby RB, 2013, EXPERT OPIN THER TAR, V17, P77, DOI 10.1517/14728222.2013.731047; Ito A, 2004, J BIOL CHEM, V279, P21282, DOI 10.1074/jbc.M401881200; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; Katayama H, 2007, J BIOL CHEM, V282, P7742, DOI 10.1074/jbc.M611382200; Kitada S, 2006, J BIOL CHEM, V281, P26350, DOI 10.1074/jbc.M602589200; Kitada S, 2009, TOXICOLOGY, V264, P80, DOI 10.1016/j.tox.2009.07.016; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang Y, 2001, ONCOGENE, V20, P6570, DOI 10.1038/sj.onc.1204815; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Mizuki E, 1999, J APPL MICROBIOL, V86, P477, DOI 10.1046/j.1365-2672.1999.00692.x; Mizuki E, 2000, CLIN DIAGN LAB IMMUN, V7, P625, DOI 10.1128/CDLI.7.4.625-634.2000; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Ohba M, 1996, J APPL BACTERIOL, V80, P56, DOI 10.1111/j.1365-2672.1996.tb03190.x; Okumura S., 2010, PARASPORIN NOMENCLAT; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rouette A, 2012, INT J CANCER, V130, P1755, DOI 10.1002/ijc.26183; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sukharev SA, 1997, CELL DEATH DIFFER, V4, P457, DOI 10.1038/sj.cdd.4400263; Tong QS, 2005, CANCER GENE THER, V12, P509, DOI 10.1038/sj.cgt.7700813; VANRIE J, 1990, APPL ENVIRON MICROB, V56, P1378, DOI 10.1128/AEM.56.5.1378-1385.1990; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Yang Y, 2004, INT J BIOCHEM CELL B, V36, P223, DOI 10.1016/S1357-2725(03)00215-2; Yeh PY, 2002, BIOCHEM PHARMACOL, V63, P1423, DOI 10.1016/S0006-2952(02)00908-5	60	38	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135106	10.1371/journal.pone.0135106	http://dx.doi.org/10.1371/journal.pone.0135106			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263002	gold, Green Published, Green Submitted			2022-12-27	WOS:000359353300058
J	Pettigrew, KA; Reeves, E; Leavett, R; Hayiou-Thomas, ME; Sharma, A; Simpson, NH; Martinelli, A; Thompson, P; Hulme, C; Snowling, MJ; Newbury, DF; Paracchini, S				Pettigrew, Kerry A.; Reeves, Emily; Leavett, Ruth; Hayiou-Thomas, Marianna E.; Sharma, Anahita; Simpson, Nuala H.; Martinelli, Angela; Thompson, Paul; Hulme, Charles; Snowling, Margaret J.; Newbury, Dianne F.; Paracchini, Silvia			Copy Number Variation Screen Identifies a Rare De Novo Deletion at Chromosome 15q13.1-13.3 in a Child with Language Impairment	PLOS ONE			English	Article							HIDDEN-MARKOV MODEL; MENTAL-RETARDATION; SINGLE-GENE; 15Q13.3; MICRODELETION; AUTISM; RISK; PREVALENCE; DISORDERS; DYSLEXIA	A significant proportion of children (up to 7% in the UK) present with pronounced language difficulties that cannot be explained by obvious causes like other neurological and medical conditions. A substantial genetic component is predicted to underlie such language problems. Copy number variants (CNVs) have been implicated in neurodevelopmental and psychiatric conditions, such as autism and schizophrenia, but it is not fully established to what extent they might contribute to language disorders. We conducted a CNV screen in a longitudinal cohort of young children with language-related difficulties (n = 85), focusing on single events at candidate loci. We detected a de novo deletion on chromosome 15q13.1-13.3. The adjacent 15q11-13.1 locus is disrupted in Prader-Willi and Angelman syndromes, while disruptions across the breakpoints (BP1-BP6) have previously been implicated in different neurodevelopmental phenotypes including autism, intellectual disability (ID), seizures and developmental delay (DD). This is the first report of a deletion at BP3-BP5 being linked to a deficit confined to language impairment, in the absence of ID, expanding the range of phenotypes that implicate the chromosome 15q13 locus.	[Pettigrew, Kerry A.; Sharma, Anahita; Martinelli, Angela; Paracchini, Silvia] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Reeves, Emily; Leavett, Ruth; Hayiou-Thomas, Marianna E.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Simpson, Nuala H.; Newbury, Dianne F.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Thompson, Paul; Snowling, Margaret J.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Hulme, Charles] UCL, Div Psychol & Language Sci, London, England; [Snowling, Margaret J.] Univ Oxford, St Johns Coll, Oxford, England	University of St Andrews; University of York - UK; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of London; University College London; University of Oxford	Paracchini, S (corresponding author), Univ St Andrews, Sch Med, St Andrews, Fife, Scotland.	sp58@st-andrews.ac.uk	Reeves, Emily/GVT-5690-2022; Pettigrew, Kerry Andrea/AHA-0501-2022; Paracchini, Silvia/AAU-6813-2021; Reeves, Emily/GSO-0062-2022	Paracchini, Silvia/0000-0001-9934-8602; Martinelli, Angela/0000-0001-6442-3190; Thompson, Paul/0000-0001-9940-6913; Hulme, Charles/0000-0001-9499-5958; Pettigrew, Kerry/0000-0002-6027-0462; Hayiou-Thomas, Emma/0000-0003-1163-2671	Royal Society Research Grant [RG110387]; Wellcome Trust Programme Grant [WT082032MA]; Wellcome Trust [090532/Z/09/Z, 097831/Z/11/Z]; Medical Research Council Hub Grant [G0900747 91070]; MRC [G1000569/1, MR/J003719/1]; Wellcome Trust Vacation Scholarship; Medical Research Council [G1000569, MR/J003719/1] Funding Source: researchfish	Royal Society Research Grant(Royal Society of London); Wellcome Trust Programme Grant(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Hub Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Vacation Scholarship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SP is a Royal Society University Research Fellow and this work was supported by a Royal Society Research Grant [RG110387]. This work was supported by a Wellcome Trust Programme Grant to MJS [WT082032MA]. Genotyping at the Wellcome Trust Centre for Human Genetics was supported by the Wellcome Trust [090532/Z/09/Z] and a Medical Research Council Hub Grant [G0900747 91070]. Support to the analysis was provided by the St Andrews Bioinformatics Unit funded by the Wellcome Trust [097831/Z/11/Z]. DFN is an MRC Career Development Fellow and supported by the MRC [G1000569/1 and MR/J003719/1]. AS was funded by a Wellcome Trust Vacation Scholarship.	BEITCHMAN JH, 1986, J AM ACAD CHILD PSY, V25, P528, DOI 10.1016/S0002-7138(10)60013-1; Ben-Shachar S, 2009, J MED GENET, V46, P382, DOI 10.1136/jmg.2008.064378; Botting N, 2005, J CHILD PSYCHOL PSYC, V46, P317, DOI 10.1111/j.1469-7610.2004.00355.x; Ceroni F, 2014, EUR J HUM GENET, V22, P1165, DOI 10.1038/ejhg.2014.4; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conti-Ramsden G, 2006, J CHILD PSYCHOL PSYC, V47, P621, DOI 10.1111/j.1469-7610.2005.01584.x; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Elsea SH, 2008, EUR J HUM GENET, V16, P412, DOI 10.1038/sj.ejhg.5202009; Endris V, 2010, AM J MED GENET A, V152A, P2908, DOI 10.1002/ajmg.a.33692; Ercan-Sencicek AG, 2012, EUR J MED GENET, V55, P128, DOI 10.1016/j.ejmg.2011.12.005; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Hoppman-Chaney N, 2013, CLIN GENET, V83, P345, DOI 10.1111/j.1399-0004.2012.01925.x; Jahn JA, 2014, EPILEPSY RES, V108, P109, DOI 10.1016/j.eplepsyres.2013.10.001; Kjelgaard MM, 2001, LANG COGNITIVE PROC, V16, P287, DOI 10.1080/01690960042000058; Koolen DA, 2005, EUR J HUM GENET, V13, P1019, DOI 10.1038/sj.ejhg.5201456; Law J, 2000, INT J LANG COMM DIS, V35, P165, DOI 10.1080/136828200247133; Lowther C, 2015, GENET MED, V17, P149, DOI 10.1038/gim.2014.83; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Masurel-Paulet A, 2010, CLIN GENET, V78, P149, DOI 10.1111/j.1399-0004.2010.01374.x; McArthur GM, 2000, J CHILD PSYCHOL PSYC, V41, P869, DOI 10.1111/1469-7610.00674; Mignon-Ravix C, 2007, EUR J HUM GENET, V15, P432, DOI 10.1038/sj.ejhg.5201775; Mikhail FM, 2011, AM J MED GENET A, V155A, P2386, DOI 10.1002/ajmg.a.34177; Moll K, 2013, SCI STUD READ, V17, P385, DOI 10.1080/10888438.2012.736439; Muthen L.K., 2010, MPLUS USERS GUIDE; Nash HM, 2013, J CHILD PSYCHOL PSYC, V54, P958, DOI 10.1111/jcpp.12091; Newbury DF, 2014, GENES-BASEL, V5, P285, DOI 10.3390/genes5020285; Nomura Y, 2009, J PEDIATR PSYCHOL, V34, P406, DOI 10.1093/jpepsy/jsn092; Nudel R, 2014, GENES BRAIN BEHAV, V13, P418, DOI 10.1111/gbb.12127; O'Donovan MC, 2008, NAT GENET, V40, P1392, DOI 10.1038/ng1208-1392; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Rosenfeld JA, 2011, EUR J HUM GENET, V19, P547, DOI 10.1038/ejhg.2010.237; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shinawi M, 2009, NAT GENET, V41, P1269, DOI 10.1038/ng.481; Simpson NH, 2015, EUR J HUM GENET; Simpson NH, 2013, DEV MED CHILD NEUROL; Snowling M, 2000, J CHILD PSYCHOL PSYC, V41, P587, DOI 10.1111/1469-7610.00651; St Pourcain B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5831; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Stromswold K, 1998, HUM BIOL, V70, P297; Teune MJ, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.015; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Varela MC, 2005, CLIN GENET, V67, P47, DOI 10.1111/j.1399-0004.2005.00377.x; Varela MC, 2004, EUR J HUM GENET, V12, P987, DOI 10.1038/sj.ejhg.5201264; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907	51	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134997	10.1371/journal.pone.0134997	http://dx.doi.org/10.1371/journal.pone.0134997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262844	Green Submitted, Green Published, gold			2022-12-27	WOS:000359353300049
J	Eichin, D; Laurila, JP; Jalkanen, S; Salmi, M				Eichin, Dominik; Laurila, Juha P.; Jalkanen, Sirpa; Salmi, Marko			CD73 Activity is Dispensable for the Polarization of M2 Macrophages	PLOS ONE			English	Article							T-CELLS; ALTERNATIVE ACTIVATION; MONOCYTES; ADENOSINE; ACCUMULATION; GENERATION; PLASTICITY; SPECTRUM; IMMUNITY; REVEALS	The ectoenzyme CD73 catalyzes the hydrolysis of AMP, and is one of the most important producers of extracellular adenosine. On regulatory T cells, CD73 is necessary for immunosuppressive functions, and on Th17 cells CD73-generated adenosine exerts anti-inflammatory effects. However, the expression and function of CD73 in pro-inflammatory M1 and in immunosuppressive M2 macrophages is largely unknown. Here we show that CD73 expression and enzyme activity were induced in in vitro polarized pro-inflammatory human M(LPS+TNF) monocytes/macrophages, while CD73 was absent from immunosuppressive M(IL-4+M-CSF)-polarized macrophages. Inhibition of CD73 activity with the inhibitor AMPCP did not affect the polarization of human monocytes. In mice, CD73 was present on resident peritoneal macrophages. In striking contrast, elicited peritoneal macrophages remained CD73 negative regardless of their polarization towards either a pro-inflammatory M(LPS) or anti-inflammatory M(IL-4c) direction. Finally, the ability of peritoneal macrophages to polarize to pro-and anti-inflammatory cells was perfectly normal in CD73-deficient mice in vivo. These data indicate that, in contrast to other major leukocyte subpopulations, CD73 activity on macrophages does not play a major role in their polarization and that in mice host CD73 on any cell type is not required in vivo for peritoneal macrophage polarization towards either a pro-or an anti-inflammatory direction.	[Eichin, Dominik; Laurila, Juha P.; Jalkanen, Sirpa; Salmi, Marko] Univ Turku, Med Res Lab, Turku, Finland; [Salmi, Marko] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland	University of Turku; University of Turku	Salmi, M (corresponding author), Univ Turku, Med Res Lab, Turku, Finland.	Marko.Salmi@utu.fi		Eichin, Dominik/0000-0002-6772-1086	Finnish Academy [274009, 272239]; Sigrid Juselius Foundation	Finnish Academy(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	The work was financially supported by the Finnish Academy (SJ MS) (#274009; #272239; http://www.aka.fi) and the Sigrid Juselius Foundation (MS) (http://www.sigridjuselius.fi/foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; BELOSEVIC M, 1990, J IMMUNOL, V145, P831; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; BURGER RM, 1970, J BIOL CHEM, V245, P6274; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Flogel U, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003717; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hasko G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00085; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Hasko G, 2012, ARTERIOSCL THROM VAS, V32, P865, DOI 10.1161/ATVBAHA.111.226852; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Linden J, 2012, ARTERIOSCL THROM VAS, V32, P2097, DOI 10.1161/ATVBAHA.111.226837; Liu GW, 2013, J CELL PHYSIOL, V228, P502, DOI 10.1002/jcp.24157; Liu GW, 2011, IMMUNOL CELL BIOL, V89, P130, DOI 10.1038/icb.2010.70; Lopez-Castejon G, 2011, CELL MOL LIFE SCI, V68, P3095, DOI 10.1007/s00018-010-0609-y; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Piehler AP, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-21; Sciaraffia E, 2014, J LEUKOCYTE BIOL, V96, P113, DOI 10.1189/jlb.3A0513-302RR; Shalhoub J, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-9; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Tomioka H, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/635451; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yegutkin GG, 2011, EUR J IMMUNOL, V41, P1231, DOI 10.1002/eji.201041292; Yegutkin GG, 2002, BIOCHEM J, V367, P121, DOI 10.1042/BJ20020439; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zanin RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031205; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	46	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134721	10.1371/journal.pone.0134721	http://dx.doi.org/10.1371/journal.pone.0134721			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258883	Green Published, Green Submitted, gold			2022-12-27	WOS:000359352600022
J	Lamidi, EO				Lamidi, Esther O.			State Variations in Women's Socioeconomic Status and Use of Modern Contraceptives in Nigeria	PLOS ONE			English	Article							FAMILY-PLANNING PROGRAM; CONTEXTUAL INFLUENCES; ETHIOPIA; BEHAVIOR; AUTONOMY; AFRICA	Background According to the 2014 World Population Data Sheet, Nigeria has one of the highest fertility and lowest contraceptive prevalence rates around the world. However, research suggests that national contraceptive prevalence rate overshadows enormous spatial variations in reproductive behavior in the country. Objective I examined the variations in women's socioeconomic status and modern contraceptive use across states in Nigeria. Methods Using the 2013 Nigeria Demographic and Health Survey data (n = 18,910), I estimated the odds of modern contraceptive use among sexually active married and cohabiting women in a series of multilevel logistic regression models. Results The share of sexually active, married and cohabiting women using modern contraceptives widely varied, from less than one percent in Kano, Yobe, and Jigawa states, to 40 percent in Osun state. Most of the states with low contraceptive prevalence rates also ranked low on women's socioeconomic attributes. Results of multilevel logistic regression analyses showed that women residing in states with greater shares of women with secondary or higher education, higher female labor force participation rates, and more women with health care decision-making power, had significantly higher odds of using modern contraceptives. Differences in women's participation in health care decisions across states remained significantly associated with modern contraceptive use, net of individual-level socioeconomic status and other covariates of modern contraceptive use. Conclusion Understanding of state variations in contraceptive use is crucial to the design and implementation of family planning programs. The findings reinforce the need for state-specific family planning programs in Nigeria.	Bowling Green State Univ, Dept Sociol, Bowling Green, OH 43403 USA	University System of Ohio; Bowling Green State University	Lamidi, EO (corresponding author), Bowling Green State Univ, Dept Sociol, Bowling Green, OH 43403 USA.	elamidi@bgsu.edu						Adejumo AO., 2011, GLOBAL J AFRICAN STU, V1, P24; Agarwal B, 1997, FEM EC, V3, P1, DOI [https://doi.org/10.1080/135457097338799, DOI 10.1080/135457097338799]; Aka E. O., 1995, J SOC DEV AFR, V10, P61; Amin S, 2002, DEMOGRAPHY, V39, P251, DOI 10.2307/3088338; [Anonymous], 2014, NIG DEM HLTH SURV 20; Davis TJ, 2001, J NEGRO HIST, V86, P1, DOI DOI 10.2307/1350175; Dias JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121758; Dynes M, 2012, HEALTH PLACE, V18, P766, DOI 10.1016/j.healthplace.2012.04.006; Elfstrom KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040670; ENTWISLE B, 1986, DEMOGRAPHY, V23, P199, DOI 10.2307/2061616; GAGE AJ, 1995, STUD FAMILY PLANN, V26, P264, DOI 10.2307/2138012; Hill P., 1972, RURAL HAUSA VILLAGE; Hogan DP, 1999, STUD FAMILY PLANN, V30, P302, DOI 10.1111/j.1728-4465.1999.t01-2-.x; Janevic T, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-69; Kishor S., 2008, DHS COMP REPORTS; Kravdal O, 2006, DEMOGR RES, V15, P1, DOI 10.4054/DemRes.2006.15.1; Kritz MM, 1999, SOCIOL FORUM, V14, P399, DOI 10.1023/A:1021495418633; Mberu BU, 2014, POPUL REV, V53, P23; Moursund A, 2003, POP STUD-J DEMOG, V57, P285, DOI 10.1080/0032472032000137817; Okonkwo UU, 2013, J INT WOMENS STUD, V10, P186; OlaOlorun FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098702; Orubuloye I O, 1995, J Int Dev, V7, P135, DOI 10.1002/jid.3380070109; Pittin, 1990, REV AFR POLIT ECON, V17, P7, DOI DOI 10.1080/03056249008703858; Population Reference Bureau, 2014 WORLD POP DAT S; Presser Harriet., 2000, WOMENS EMPOWERMENT D; Sharma SK, 2011, DEMOGR RES, V25, P837, DOI 10.4054/DemRes.2011.25.27; Stephenson R, 2008, HEALTH PLACE, V14, P841, DOI 10.1016/j.healthplace.2008.01.005; Stephenson R, 2007, AM J PUBLIC HEALTH, V97, P1233, DOI 10.2105/AJPH.2005.071522; United Nations Department of Economic and Social Affairs Population Division, STESASERA352 UN POP	29	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135172	10.1371/journal.pone.0135172	http://dx.doi.org/10.1371/journal.pone.0135172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO7PJ	26258578	gold, Green Published, Green Submitted			2022-12-27	WOS:000359352600044
J	Annis, DS; Ma, HQ; Balas, DM; Kumfer, KT; Sandbo, N; Potts, GK; Coon, JJ; Mosher, DF				Annis, Douglas S.; Ma, Hanqing; Balas, Danika M.; Kumfer, Kraig T.; Sandbo, Nathan; Potts, Gregory K.; Coon, Joshua J.; Mosher, Deane F.			Absence of Vitamin K-Dependent gamma-Carboxylation in Human Periostin Extracted from Fibrotic Lung or Secreted from a Cell Line Engineered to Optimize gamma-Carboxylation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; FASCICLIN-I; 2-DIMENSIONAL ELECTROPHORESIS; CARBOXYGLUTAMIC-ACID; EXTRACELLULAR-MATRIX; SEQUENCE-ANALYSIS; BRONCHIAL-ASTHMA; FACTOR-VII; PROTEIN; EXPRESSION	Periostin (PN, gene name POSTN) is an extracellular matrix protein that is up-regulated in bronchial epithelial cells and lung fibroblasts by TH-2 cytokines. Its paralog, TGF-beta-induced protein (beta ig-h3, gene name TGFBI), is also expressed in the lung and up-regulated in bronchial myofibroblasts by TGF-beta. PN and beta ig-h3 contain fasciclin 1 modules that harbor putative recognition sequences for gamma-glutamyl carboxylase and are annotated in UniProt as undergoing vitamin K-dependent gamma-carboxylation of multiple glutamic acid residues. gamma-carboxylation profoundly alters activities of other proteins subject to the modification, e.g., blood coagulation factors, and would be expected to alter the structure and function of PN and beta ig-h3. To analyze for the presence of gamma-carboxylation, proteins extracted from fibrotic lung were reacted with monoclonal antibodies specific for PN, beta ig-h3, or modification with gamma-carboxyglutamic acid (Gla). In Western blots of 1-dimensional gels, bands stained with anti-PN or -beta ig-h3 did not match those stained with anti-Gla. In 2-dimensional gels, anti-PN-positive spots had pIs of 7.0 to > 8, as expected for the unmodified protein, and there was no overlap between anti-PN-positive and anti-Gla-positive spots. Recombinant PN and blood coagulation factor VII were produced in HEK293 cells that had been transfected with vitamin K 2, 3-epoxide reductase C1 to optimize gamma-carboxylation. Recombinant PN secreted from these cells did not react with anti-Gla antibody and had pIs similar to that found in extracts of fibrotic lung whereas secreted factor VII reacted strongly with anti-Gla antibody. Over 67% coverage of recombinant PN was achieved by mass spectrometry, including peptides with 19 of the 24 glutamates considered targets of gamma-carboxylation, but analysis revealed no modification. Over 86% sequence coverage and three modified glutamic acid residues were identified in recombinant fVII. These data indicate that PN and beta ig-h3 are not subject to vitamin K-dependent gamma-carboxylation.	[Annis, Douglas S.; Ma, Hanqing; Balas, Danika M.; Coon, Joshua J.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Kumfer, Kraig T.] Univ Wisconsin, Morgridge Inst Res, Madison, WI USA; [Sandbo, Nathan; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI USA; [Potts, Gregory K.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.	dfm1@medicine.wisc.edu			National Institutes of Health [P01 HL088584]; National Institutes of Health/National Cancer Institute, Comprehensive Cancer Center Support [P30 CA014520-UW, R01 GM080148]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL093367, P01HL088594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Cancer Institute, Comprehensive Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health, Program Project Grant P01 HL088584 (DFM) and in part by National Institutes of Health/National Cancer Institute P30 CA014520-UW Comprehensive Cancer Center Support, Grant Number: R01 GM080148 PI to JJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RB, 2004, BIOCHEMISTRY-US, V43, P16374, DOI 10.1021/bi048589s; Berkner KL, 2008, VITAM HORM, V78, P131, DOI 10.1016/S0083-6729(07)00007-6; Billings PC, 2000, AM J RESP CELL MOL, V22, P352, DOI 10.1165/ajrcmb.22.3.3732; Brown MA, 2000, J BIOL CHEM, V275, P19795, DOI 10.1074/jbc.M002298200; BURGESSCASSLER A, 1989, CLIN CHEM, V35, P2297; Bush KA, 1999, BIOCHEMISTRY-US, V38, P14660, DOI 10.1021/bi991640l; Clout N, 2003, MOL VIS, V9, P440; Clout NJ, 2003, STRUCTURE, V11, P197, DOI 10.1016/S0969-2126(03)00002-9; Colombatti A, 2000, MATRIX BIOL, V19, P289, DOI 10.1016/S0945-053X(00)00074-3; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; DISCIPIO RG, 1979, BIOCHEMISTRY-US, V18, P899, DOI 10.1021/bi00572a026; Doliana R, 2000, FEBS LETT, V484, P164, DOI 10.1016/S0014-5793(00)02140-2; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Johansson MW, 2013, AM J RESP CELL MOL, V48, P503, DOI 10.1165/rcmb.2012-0150OC; Karring H, 2010, EXP EYE RES, V90, P57, DOI 10.1016/j.exer.2009.09.011; Ledvina AR, 2013, J AM SOC MASS SPECTR, V24, P1623, DOI 10.1007/s13361-013-0621-1; MANN KG, 1990, BLOOD, V76, P1; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; Naba A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-518; Naik PK, 2012, AM J PHYSIOL-LUNG C, V303, pL1046, DOI 10.1152/ajplung.00139.2012; NEUENSCHWANDER PF, 1992, J BIOL CHEM, V267, P14477; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PRICE PA, 1987, P NATL ACAD SCI USA, V84, P8335, DOI 10.1073/pnas.84.23.8335; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Stenflo J, 1999, CRIT REV EUKAR GENE, V9, P59, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.50; Sun YM, 2005, BLOOD, V106, P3811, DOI 10.1182/blood-2005-06-2495; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; THIM L, 1988, BIOCHEMISTRY-US, V27, P7785, DOI 10.1021/bi00420a030; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Underhaug J, 2013, BBA-PROTEINS PROTEOM, V1834, P2812, DOI 10.1016/j.bbapap.2013.10.008; Wajih N, 2008, THROMB RES, V122, P405, DOI 10.1016/j.thromres.2007.11.002; Wenger CD, 2011, PROTEOMICS, V11, P1064, DOI 10.1002/pmic.201000616; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Yuyama N, 2002, CYTOKINE, V19, P287, DOI 10.1006/cyto.2002.1972; Zhao YM, 2014, ANAL CHEM, V86, P4873, DOI 10.1021/ac500092q; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	40	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135374	10.1371/journal.pone.0135374	http://dx.doi.org/10.1371/journal.pone.0135374			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26273833	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600062
J	Wang, YY; Chen, JZ; Song, WH; Wang, YX; Chen, Y; Nie, Y; Hui, RT				Wang, Yuyao; Chen, Jingzhou; Song, Weihua; Wang, Yuxuan; Chen, Yu; Nie, Yu; Hui, Rutai			The Human Myotrophin Variant Attenuates MicroRNA-Let-7 Binding Ability but Not Risk of Left Ventricular Hypertrophy in Human Essential Hypertension	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; HEART-FAILURE; NATRIURETIC-PEPTIDE; GENE; POLYMORPHISM; OVEREXPRESSION; ASSOCIATION; TARGETS; SITES; MICE	Myotrophin, known as a myocardial hypertrophy-inducing factor, is responsible for the initiation of cardiac hypertrophy that transits to heart failure. MicroRNAs are small noncoding RNAs that down-regulate posttranscriptional expression of target molecules. We investigated the role of variants of the microRNA-binding site in myotrophin in affecting its expression and any association with cardiac hypertrophy. Bioinformatics demonstrated that variant rs17168525 was identified to be located in the let-7/miR-98-binding site of myotrophin. We further experimentally test to effects of the identified variant on myotrophin translation using luciferase reporter assay and Western blotting. We found that the C allele of rs17168525 suppressed myotrophin translation by facilitating let-7c binding, but not the T allele. Let-7c overexpression caused a significant decrease in the level of myotrophin protein. Next, we investigated the association of the variant with cardiac hypertrophy in 1614 hypertensive patients, including 552 with left ventricular hypertrophy and 1062 without left ventricular hypertrophy, as well as 591 healthy control subjects from a Han Chinese population. No significant association between the variant rs17168525 and left ventricular hypertrophy in hypertensive patients in a Han Chinese population (P>0.05). In conclusion, our experimental results provide evidence that the T allele of rs17168525 in the 30-UTR of myotrophin might influence the level of myotrophin protein by interfering with let-7/miR-98 binding.	[Wang, Yuyao] Shanxi Med Univ, Dept Biochem & Mol Biol, Taiyuan, Peoples R China; [Wang, Yuyao; Chen, Jingzhou; Song, Weihua; Chen, Yu; Nie, Yu; Hui, Rutai] Chinese Acad Med Sci, Sinogerman Lab Mol Med, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Wang, Yuyao; Chen, Jingzhou; Song, Weihua; Chen, Yu; Nie, Yu; Hui, Rutai] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Yuxuan] Shanxi Dayi Hosp, Dept Thorac Surg, Taiyuan, Peoples R China	Shanxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, YY (corresponding author), Shanxi Med Univ, Dept Biochem & Mol Biol, Taiyuan, Peoples R China.	wyybio@163.com; huirutai@gmail.com		NIE, Yu/0000-0002-8744-0046	Ministry of Science and Technology of China [2011CB503901]; Doctoral Startup Foundation of Shanxi Medical University [03201305]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Doctoral Startup Foundation of Shanxi Medical University	This work was supported by grants from the Ministry of Science and Technology of China (2011CB503901 to R. Hui) and from the Doctoral Startup Foundation of Shanxi Medical University (03201305 to Y. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary G, 2005, GENE, V353, P31, DOI 10.1016/j.gene.2005.03.045; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berenji K, 2005, AM J PHYSIOL-HEART C, V289, pH8, DOI 10.1152/ajpheart.01303.2004; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JZ, 2010, HUM MOL GENET, V19, P2524, DOI 10.1093/hmg/ddq131; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Cordes KR, 2009, CIRC RES, V104, P724, DOI 10.1161/CIRCRESAHA.108.192872; Daly AK, 2001, BRIT J CLIN PHARMACO, V52, P489, DOI 10.1046/j.0306-5251.2001.01510.x; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Haider AW, 1998, J AM COLL CARDIOL, V32, P1454, DOI 10.1016/S0735-1097(98)00407-0; Hariharan M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-108; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Khan SQ, 2007, CLIN SCI, V112, P251, DOI 10.1042/CS20060191; LEADON SA, 1982, ANAL BIOCHEM, V120, P282, DOI 10.1016/0003-2697(82)90349-9; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; O'Brien RJ, 2003, J AM COLL CARDIOL, V42, P719, DOI 10.1016/S0735-1097(03)00755-1; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Sarkar S, 2004, J BIOL CHEM, V279, P20422, DOI 10.1074/jbc.M308488200; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; SCHUNKERT H, 1994, NEW ENGL J MED, V330, P1634, DOI 10.1056/NEJM199406093302302; SEN S, 1990, J BIOL CHEM, V265, P16635; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; SIL P, 1993, CIRC RES, V73, P98, DOI 10.1161/01.RES.73.1.98; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Xue H, 2008, CLIN SCI, V114, P131, DOI 10.1042/CS20070109; Yang YF, 2011, CIRC RES, V108, P305, DOI 10.1161/CIRCRESAHA.110.228437	35	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135526	10.1371/journal.pone.0135526	http://dx.doi.org/10.1371/journal.pone.0135526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274321	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600073
J	Goicolea, I; Vives-Cases, C; Hurtig, AK; Marchal, B; Briones-Vozmediano, E; Otero-Garcia, L; Garca-Quinto, M; Sebastian, MS				Goicolea, Isabel; Vives-Cases, Carmen; Hurtig, Anna-Karin; Marchal, Bruno; Briones-Vozmediano, Erica; Otero-Garcia, Laura; Garca-Quinto, Marta; Sebastian, Miguel San			Mechanisms that Trigger a Good Health-Care Response to Intimate Partner Violence in Spain. Combining Realist Evaluation and Qualitative Comparative Analysis Approaches	PLOS ONE			English	Article							DOMESTIC VIOLENCE; CENTERED CARE; WOMEN; SYSTEMS; COMPLEXITY; CHALLENGES; SETTINGS; PROTOCOL; MODELS	Background Health care professionals, especially those working in primary health-care services, can play a key role in preventing and responding to intimate partner violence. However, there are huge variations in the way health care professionals and primary health care teams respond to intimate partner violence. In this study we tested a previously developed programme theory on 15 primary health care center teams located in four different Spanish regions: Murcia, C Valenciana, Castilla-Leon and Cantabria. The aim was to identify the key combinations of contextual factors and mechanisms that trigger a good primary health care center team response to intimate partner violence. Methods A multiple case-study design was used. Qualitative and quantitative information was collected from each of the 15 centers (cases). In order to handle the large amount of information without losing familiarity with each case, qualitative comparative analysis was undertaken. Conditions (context and mechanisms) and outcomes, were identified and assessed for each of the 15 cases, and solution formulae were calculated using qualitative comparative analysis software. Results The emerging programme theory highlighted the importance of the combination of each team's self-efficacy, perceived preparation and women-centredness in generating a good team response to intimate partner violence. The use of the protocol and accumulated experience in primary health care were the most relevant contextual/intervention conditions to trigger a good response. However in order to achieve this, they must be combined with other conditions, such as an enabling team climate, having a champion social worker and having staff with training in intimate partner violence. Conclusions Interventions to improve primary health care teams' response to intimate partner violence should focus on strengthening team's self-efficacy, perceived preparation and the implementation of a woman-centred approach. The use of the protocol combined with a large working experience in primary health care, and other factors such as training, a good team climate, and having a champion social worker on the team, also played a key role. Measures to sustain such interventions and promote these contextual factors should be encouraged.	[Goicolea, Isabel; Hurtig, Anna-Karin; Briones-Vozmediano, Erica; Sebastian, Miguel San] Umea Univ, Dept Clin Med & Publ Hlth, Unit Epidemiol & Global Hlth, Umea, Sweden; [Goicolea, Isabel; Vives-Cases, Carmen; Briones-Vozmediano, Erica; Garca-Quinto, Marta] Univ Alicante, Grp Invest Salud Publ, E-03080 Alicante, Spain; [Vives-Cases, Carmen; Garca-Quinto, Marta] Univ Alicante, Dept Enfermeria Comunitaria Med Prevent & Salud P, E-03080 Alicante, Spain; [Vives-Cases, Carmen] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Marchal, Bruno] Inst Trop Med, B-2000 Antwerp, Belgium; [Otero-Garcia, Laura] Univ Autonoma Madrid, Fac Med, Madrid, Spain	Umea University; Universitat d'Alacant; Universitat d'Alacant; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institute of Tropical Medicine (ITM); Autonomous University of Madrid	Goicolea, I (corresponding author), Umea Univ, Dept Clin Med & Publ Hlth, Unit Epidemiol & Global Hlth, Umea, Sweden.	isabel.goicolea@umu.se	OTERO-GARCIA, LAURA/F-3913-2016; Ciccozzi, Massimo/AAC-3271-2022; Vives-Cases, Carmen/ABC-5170-2021; Briones-Vozmediano, Erica/AAC-8572-2022	Ciccozzi, Massimo/0000-0003-3866-9239; Vives-Cases, Carmen/0000-0002-6797-5051; Briones-Vozmediano, erica/0000-0001-8437-2781; San Sebastian, Miguel/0000-0001-7234-3510; Garcia-Quinto, Marta/0000-0001-8680-9473; Goicolea, Isabel/0000-0002-8114-4705	COFAS grant - COFUND action within the Marie Curie Action People, in the Seventh Framework programme; Swedish Council for Working Life and Social Research/FAS-Forskningsradet for arbetsliv och socialvetenskap	COFAS grant - COFUND action within the Marie Curie Action People, in the Seventh Framework programme; Swedish Council for Working Life and Social Research/FAS-Forskningsradet for arbetsliv och socialvetenskap(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study protocol has been funded through a COFAS grant (supported by COFUND action within the Marie Curie Action People, in the Seventh Framework programme and the Swedish Council for Working Life and Social Research/FAS-Forskningsradet for arbetsliv och socialvetenskap) through a competitive call. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Befani B., 2007, EVALUATION-US, V13, P171, DOI [10.1177/1356389007075222, DOI 10.1177/1356389007075222]; Befani Barabara, 2006, INNOVATIVE COMP METH, P263; Befani B, 2013, EVALUATION-US, V19, P269, DOI 10.1177/1474022213493839; Beynon CE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-473; Blackman T, 2013, EVALUATION-US, V19, P126, DOI 10.1177/1356389013484203; Bonomi AE, 2009, HEALTH SERV RES, V44, P1052, DOI 10.1111/j.1475-6773.2009.00955.x; Colombini M, 2008, B WORLD HEALTH ORGAN, V86, P635, DOI 10.2471/BLT.07.045906; Edin KE, 2010, VIOLENCE AGAINST WOM, V16, P189, DOI 10.1177/1077801209355703; European Institute for Gender Equality (EIGE), 2012, REV IMPL BEIJ PLATF, DOI [10.2839/612, DOI 10.2839/612]; Garcia-Moreno C, 2014, LANCET, V385, P1985; Garcia-Moreno C, 2015, LANCET, V385, P1567, DOI 10.1016/S0140-6736(14)61837-7; Goicolea I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1162; Goicolea I, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-36; Hollingsworth E, 2006, CAN J NURS RES, V38, P54; Iida M, 2012, MIDWIFERY, V28, P458, DOI 10.1016/j.midw.2011.07.002; Joyner K, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-399; Kirst M, 2012, TRAUMA VIOLENCE ABUS, V13, P198, DOI 10.1177/1524838012454942; Loewenberg S, 2005, LANCET, V365, P464, DOI 10.1016/S0140-6736(05)17884-2; Marchal B, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-469; Marchal B, 2012, EVALUATION-US, V18, P192, DOI 10.1177/1356389012442444; Marchal B, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-787; Montero I, 2011, WOMEN HEALTH ISS, V21, P400, DOI 10.1016/j.whi.2011.04.003; Pawson R., 1997, REALISTIC EVALUATION; Pawson R., 2013, RAY PAWSON, DOI 10.4135/9781473913820; Pawson R, 2012, EVALUATION-US, V18, P176, DOI 10.1177/1356389012440912; Pope R, 2001, INT J NURS STUD, V38, P227, DOI 10.1016/S0020-7489(00)00034-1; Pratt-Eriksson D, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.23166; Ragin C, 2004, FSQCA 2 0; Ragin C., 2019, CONSTRUCTING SOCIAL, V3rd; Ragin C. C, 2008, REDESIGNING SOCIAL I; Ragin CC, 1998, INT REV SOC HIST, V43, P105, DOI 10.1017/S0020859000115111; Ragin CC, 1999, HEALTH SERV RES, V34, P1225; Ramsay J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X654623; Rihoux B., 2003, FIELD METHODS, V15, P351, DOI [DOI 10.1177/1525822X03257690, 10.1177/1525822x03257690]; Rihoux B, 2009, CONFIGURATIONAL COMP; Rycroft-Malone J, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-38; Short LN, 2006, AM J PREV MED, V30, P173, DOI 10.1016/j.amepre.2005.10.009; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Starfield B, 1998, PRIMARY CARE BALANCI; Velasco S., 2007, FEMINISMO, V10, P111; Velasco S, 2006, REV ESP SALUD PUBLIC, V80, P317, DOI 10.1590/S1135-57272006000400003; Cases CV, 2015, REV ESP SALUD PUBLIC, V89, P173, DOI 10.4321/S1135-57272015000200006; Vives-Cases C, 2011, J PUBLIC HEALTH-UK, V33, P15, DOI 10.1093/pubmed/fdq101; Wagemann C, 2010, COMP SOCIOL, V9, P376, DOI 10.1163/156913210X12493538729838; *WHO, 2008, WORLD HLTH REP 2007; WHO, 2013, RESPONDING INTIMATE; World Health Organization/London School of Hygiene and Tropical Medicine, 2010, PREV INT PARTN SEX V; Yin RK, 2009, CASE STUDY RES; Zaher E, 2014, CAN FAM PHYSICIAN, V60, P618	50	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135167	10.1371/journal.pone.0135167	http://dx.doi.org/10.1371/journal.pone.0135167			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JX	26270816	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800038
J	Gomez-Baena, G; Dominguez-Martin, MA; Donaldson, RP; Garcia-Fernandez, JM; Diez, J				Gomez-Baena, Guadalupe; Agustina Dominguez-Martin, Maria; Donaldson, Robert P.; Manuel Garcia-Fernandez, Jose; Diez, Jesus			Glutamine Synthetase Sensitivity to Oxidative Modification during Nutrient Starvation in Prochlorococcus marinus PCC 9511	PLOS ONE			English	Article							METAL-CATALYZED OXIDATION; CYANOBACTERIUM PROCHLOROCOCCUS; IN-VIVO; ADAPTIVE-MECHANISMS; IRON STARVATION; GENE-EXPRESSION; STRAIN PCC-9511; CARBONYL GROUPS; SARGASSO SEA; INACTIVATION	Glutamine synthetase plays a key role in nitrogen metabolism, thus the fine regulation of this enzyme in Prochlorococcus, which is especially important in the oligotrophic oceans where this marine cyanobacterium thrives. In this work, we studied the metal-catalyzed oxidation of glutamine synthetase in cultures of Prochlorococcus marinus strain PCC 9511 subjected to nutrient limitation. Nitrogen deprivation caused glutamine synthetase to be more sensitive to metal-catalyzed oxidation (a 36% increase compared to control, non starved samples). Nutrient starvation induced also a clear increase (three-fold in the case of nitrogen) in the concentration of carbonyl derivatives in cell extracts, which was also higher (22%) upon addition of the inhibitor of electron transport, DCMU, to cultures. Our results indicate that nutrient limitations, representative of the natural conditions in the Prochlorococcus habitat, affect the response of glutamine synthetase to oxidative inactivating systems. Implications of these results on the regulation of glutamine synthetase by oxidative alteration prior to degradation of the enzyme in Prochlorococcus are discussed.	[Gomez-Baena, Guadalupe; Agustina Dominguez-Martin, Maria; Manuel Garcia-Fernandez, Jose; Diez, Jesus] Univ Cordoba, Dept Bioquim & Biol Mol, Cordoba, Spain; [Donaldson, Robert P.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	Universidad de Cordoba; George Washington University	Gomez-Baena, G (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Edificio Severo Ochoa, Cordoba, Spain.	v52gobag@uco.es	Gómez-Baena, Guadalupe/N-2368-2013; Diez, Jesús/R-3500-2019; Martin, Maria Agustina Dominguez/F-3929-2016; García Fernández, José Manuel/M-2431-2014	Gómez-Baena, Guadalupe/0000-0003-3796-3874; Diez, Jesús/0000-0002-1346-3528; Martin, Maria Agustina Dominguez/0000-0002-3500-2052; García Fernández, José Manuel/0000-0003-2983-1214	Spanish Ministerio de Ciencia y Tecnologia - European Social Fund from the European Union [BFU2006-10011/BMC, BFU2009-08008/BMC]; Junta de Andalucia (Proyectos de Excelencia) [P07-CVI-3055, P12-BIO-2141]; Universidad de Cordoba (Programa Propio de Investigacion); Junta de Andalucia;  [BFU-2009-08008/BMC]	Spanish Ministerio de Ciencia y Tecnologia - European Social Fund from the European Union; Junta de Andalucia (Proyectos de Excelencia)(Junta de Andalucia); Universidad de Cordoba (Programa Propio de Investigacion); Junta de Andalucia(Junta de Andalucia); 	This work was supported by grants BFU2006-10011/BMC, BFU2009-08008/BMC (Spanish Ministerio de Ciencia y Tecnologia, cofunded by the European Social Fund from the European Union), Junta de Andalucia (Proyectos de Excelencia, P07-CVI-3055 and P12-BIO-2141) and Universidad de Cordoba (Programa Propio de Investigacion). GGB received a PhD fellowship from Junta de Andalucia. MAD-M received a grant funded by projects BFU-2009-08008/BMC and P07-CVI-3055.	AGUIRRE J, 1986, J BACTERIOL, V166, P1040, DOI 10.1128/jb.166.3.1040-1045.1986; Dominguez-Martin MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103380; Rangel OA, 2009, ENV MICROBIOL REP, V1, P56, DOI 10.1111/j.1758-2229.2008.00005.x; Biller SJ, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.34; Biller SJ, 2015, NAT REV MICROBIOL, V13, P13, DOI 10.1038/nrmicro3378; Bragg J, 2010, PLOS ONE, P1; Capone D. G., 2000, MICROBIAL ECOLOGY OC, P455; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Conrad CC, 2001, PROTEOMICS, V1, P829, DOI 10.1002/1615-9861(200107)1:7<829::AID-PROT829>3.0.CO;2-R; Cournac L, 2002, PLANT PHYSIOL, V129, P1921, DOI 10.1104/pp.001636; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Munoz-Marin MD, 2013, P NATL ACAD SCI USA, V110, P8597, DOI 10.1073/pnas.1221775110; Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100; El Alaoui S, 2003, ENVIRON MICROBIOL, V5, P412, DOI 10.1046/j.1462-2920.2003.00433.x; El Alaoui S, 2001, APPL ENVIRON MICROB, V67, P2202, DOI 10.1128/AEM.67.5.2202-2207.2001; Florencio FJ, 2002, ADV PHOTO RESPIRAT, V12, P93; FROHLICH V, 1994, AUST J PLANT PHYSIOL, V21, P303, DOI 10.1071/PP9940303; FULKS RM, 1985, BIOCHIM BIOPHYS ACTA, V843, P214, DOI 10.1016/0304-4165(85)90142-4; Garcia-Fernandez JM, 2004, MICROBIOL MOL BIOL R, V68, P630, DOI 10.1128/MMBR.68.4.630-638.2004; Garcia-Fernandez JM, 2004, RES MICROBIOL, V155, P795, DOI 10.1016/j.resmic.2004.06.009; GOERICKE R, 1993, DEEP-SEA RES PT I, V40, P2283, DOI 10.1016/0967-0637(93)90104-B; Gomez-Baena G, 2001, BBA-GEN SUBJECTS, V1568, P237, DOI 10.1016/S0304-4165(01)00226-4; Gomez-Baena G, 2006, BBA-GEN SUBJECTS, V1760, P930, DOI 10.1016/j.bbagen.2006.01.016; HAEHNEL W, 1982, J BIOENERG BIOMEMBR, V14, P181, DOI 10.1007/BF00745019; HUMANES L, 1995, PLANT SCI, V110, P269, DOI 10.1016/0168-9452(95)04197-3; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; KIMURA K, 1992, J BIOCHEM, V112, P828, DOI 10.1093/oxfordjournals.jbchem.a123984; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latifi A, 2005, J BACTERIOL, V187, P6596, DOI 10.1128/JB.187.18.6596-6598.2005; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Levine RL, 2000, METH MOL B, V99, P15; LEVINE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2120, DOI 10.1073/pnas.78.4.2120; Liu HB, 1997, AQUAT MICROB ECOL, V12, P39, DOI 10.3354/ame012039; Martin G, 1997, J BACTERIOL, V179, P730, DOI 10.1128/jb.179.3.730-734.1997; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; McDonagh B, 2012, ENV MICROBIOL REP, V4, P257, DOI 10.1111/j.1758-2229.2012.00329.x; McDonald AE, 2005, GENE, V349, P15, DOI 10.1016/j.gene.2004.12.049; MEEKS JC, 1977, J BIOL CHEM, V252, P7894; Michel KP, 2004, PHYSIOL PLANTARUM, V120, P36, DOI 10.1111/j.0031-9317.2004.0229.x; Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Nguyen AT, 2005, ARCH BIOCHEM BIOPHYS, V439, P25, DOI 10.1016/j.abb.2005.04.018; Ortega JL, 1999, PLANT PHYSIOL, V119, P1483, DOI 10.1104/pp.119.4.1483; Partensky F, 2010, ANNU REV MAR SCI, V2, P305, DOI 10.1146/annurev-marine-120308-081034; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Reistetter EN, 2013, ENVIRON MICROBIOL, V15, P2129, DOI 10.1111/1462-2920.12129; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Saelices L, 2011, MOL MICROBIOL, V82, P964, DOI 10.1111/j.1365-2958.2011.07865.x; SAHAKIAN JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P411, DOI 10.1006/abbi.1995.1248; Schwarz R, 2005, MICROBIOL-SGM, V151, P2503, DOI 10.1099/mic.0.27883-0; Schwarz R, 1998, P NATL ACAD SCI USA, V95, P11008, DOI 10.1073/pnas.95.18.11008; Sharp JH, 1983, NITROGEN MARINE ENV, P1; Steglich C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r54; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; Trebst A., 1980, METH ENZYMOL, V69, P675, DOI DOI 10.1016/S0076-6879(80)69067-3; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Yousef N, 2003, ARCH MICROBIOL, V180, P471, DOI 10.1007/s00203-003-0618-4	60	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135322	10.1371/journal.pone.0135322	http://dx.doi.org/10.1371/journal.pone.0135322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270653	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800056
J	Ma, YK				Ma, Yong-Ki			Modeling the Dependency Structure of Integrated Intensity Processes	PLOS ONE			English	Article								This paper studies an important issue of dependence structure. To model this structure, the intensities within the Cox processes are driven by dependent shot noise processes, where jumps occur simultaneously and their sizes are correlated. The joint survival probability of the integrated intensities is explicitly obtained from the copula with exponential marginal distributions. Subsequently, this result can provide a very useful guide for credit risk management.	Kongju Natl Univ, Dept Appl Math, Gongju Si, Chungcheongnam, South Korea	Kongju National University	Ma, YK (corresponding author), Kongju Natl Univ, Dept Appl Math, Gongju Si, Chungcheongnam, South Korea.	ykma@kongju.ac.kr			Korea Institute of Science and Technology Information (KISTI) [K-15-L01-C03-S01]	Korea Institute of Science and Technology Information (KISTI)(Korea Institute of Science & Technology Information (KISTI))	This work was supported by Korea Institute of Science and Technology Information (KISTI) under Project No. K-15-L01-C03-S01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choe HJ, 2013, J MATH ANAL APPL, V406, P519, DOI 10.1016/j.jmaa.2013.05.014; COX DR, 1955, J ROY STAT SOC B, V17, P129; COX JC, 1985, ECONOMETRICA, V53, P385, DOI 10.2307/1911242; DAVIS MHA, 1984, J ROY STAT SOC B MET, V46, P353; Demarta S, 2005, INT STAT REV, V73, P111, DOI 10.1111/j.1751-5823.2005.tb00254.x; FREY DIGER U, 2003, J RISK, V6, P59, DOI [DOI 10.21314/J0R.2003.089), DOI 10.21314/JOR.2003.089]; Grandell J., 1976, LECT NOTES MATH; Huang JS, 1999, METRIKA, V49, P135, DOI 10.1007/s001840050030; JARROW RA, 1995, J FINANC, V50, P53, DOI 10.2307/2329239; Kim J-M, 2014, MODEL ASSISTED STAT, V9, P309; Kluppelberg C., 1995, BERNOULLI, P125; Lando D., 1998, REV DERIV RES, V2, P99, DOI DOI 10.1007/BF01531332; Li D., 2000, J FIXED INCOME, V9, P43, DOI DOI 10.3905/JFI.2000.319253; Ma YK, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/567340; Ma YK, 2010, QUANT FINANC, V10, P809, DOI 10.1080/14697680903382768; Nelsen RB., 2007, INTRO COPULAS; RAMLI SITI NORAFIDAH MOHD, 2015, Journal of the Korean Society for Industrial and Applied Mathematics, V19, P23, DOI 10.12941/jksiam.2015.19.023	17	35	35	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134992	10.1371/journal.pone.0134992	http://dx.doi.org/10.1371/journal.pone.0134992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270638	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492800028
J	Melinska, AU; Romaszkiewicz, P; Wagel, J; Sasiadek, M; Iskander, DR				Melinska, Aleksandra U.; Romaszkiewicz, Patryk; Wagel, Justyna; Sasiadek, Marek; Iskander, D. Robert			Statistical, Morphometric, Anatomical Shape Model (Atlas) of Calcaneus	PLOS ONE			English	Article							MEDICAL IMAGE SEGMENTATION; ACTIVE APPEARANCE MODELS; INTRAARTICULAR FRACTURES; AUTOMATIC CONSTRUCTION; SPHERICAL-HARMONICS; BRAIN; FOOT; REPRESENTATION; ULTRASOUND; JOINT	The aim was to develop a morphometric and anatomically accurate atlas (statistical shape model) of calcaneus. The model is based on 18 left foot and 18 right foot computed tomography studies of 28 male individuals aged from 17 to 62 years, with no known foot pathology. A procedure for automatic atlas included extraction and identification of common features, averaging feature position, obtaining mean geometry, mathematical shape description and variability analysis. Expert manual assistance was included for the model to fulfil the accuracy sought by medical professionals. The proposed for the first time statistical shape model of the calcaneus could be of value in many orthopaedic applications including providing support in diagnosing pathological lesions, pre-operative planning, classification and treatment of calcaneus fractures as well as for the development of future implant procedures.	[Melinska, Aleksandra U.; Iskander, D. Robert] Wroclaw Univ Technol, Dept Biomed Engn, PL-50370 Wroclaw, Poland; [Romaszkiewicz, Patryk] Reg Specialist Hosp, Ctr Res & Dev, Wroclaw, Poland; [Wagel, Justyna; Sasiadek, Marek] Wroclaw Med Univ, Dept Gen Radiol Intervent Radiol & Neuroradiol, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw Medical University	Melinska, AU (corresponding author), Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	aleksandra.melinska@pwr.edu.pl	Iskander, D Robert/E-3576-2017	Iskander, D Robert/0000-0002-5962-6206; Sasiadek, Marek/0000-0003-3627-118X	National Centre of Science, Preludium [UMO-2013/09/N/ST7/03418]	National Centre of Science, Preludium	This work was supported by National Centre of Science, Preludium UMO-2013/09/N/ST7/03418.	Acosta O, 2011, I S BIOMED IMAGING, P1966, DOI 10.1109/ISBI.2011.5872795; Bandyopadhyay O, 2011, LECT NOTES COMPUT SC, V6744, P122, DOI 10.1007/978-3-642-21786-9_22; Becker M., 2014, 3D MULTISCALE PHYSL, P81, DOI [10.1007/978-1-4471-6275-9_4, DOI 10.1007/978-1-4471-6275-9_4]; Beinglass A., 1991, Proceedings 1991 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (91CH2983-5), P461, DOI 10.1109/CVPR.1991.139736; Bernstein J, 2010, CLIN ORTHOP RELAT R, V468, P3432, DOI 10.1007/s11999-010-1345-1; Bookstein FL, 1996, PROCEEDINGS OF THE IEEE WORKSHOP ON MATHEMATICAL METHODS IN BIOMEDICAL IMAGE ANALYSIS, P2, DOI 10.1109/MMBIA.1996.534052; BRECHBUHLER C, 1995, COMPUT VIS IMAGE UND, V61, P154, DOI 10.1006/cviu.1995.1013; Brief J, 2001, STUD HEALTH TECHNOL, V81, P103; Brockwell J, 2009, SPORTS MED ARTHROSC, V17, P149, DOI 10.1097/JSA.0b013e3181b12727; Cao LH, 2015, J FOOT ANKLE SURG, V54, P76, DOI 10.1053/j.jfas.2014.09.003; Cash CJC, 2005, BRIT J RADIOL, V78, P587, DOI 10.1259/bjr/29830482; CHANG YL, 1994, IEEE T IMAGE PROCESS, V3, P868, DOI 10.1109/83.336259; Chen Y, 2014, INT J MED ROBOTICS C; Chen YX, 2014, CHINESE MED J-PEKING, V127, P3278, DOI 10.3760/cma.j.issn.0366-6999.20141451; COHEN LD, 1993, IEEE T PATTERN ANAL, V15, P1131, DOI 10.1109/34.244675; COOTES TF, 1994, IMAGE VISION COMPUT, V12, P355, DOI 10.1016/0262-8856(94)90060-4; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Cootes TF, 2001, PROC SPIE, V4322, P236, DOI 10.1117/12.431093; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; CRONIER P, 1988, SURG RADIOL ANAT, V10, P303, DOI 10.1007/BF02107903; Daftary A, 2005, RADIOGRAPHICS, V25, P1215, DOI 10.1148/rg.255045713; Davies RH, 2002, IEEE T MED IMAGING, V21, P525, DOI 10.1109/TMI.2002.1009388; Durrleman S, 2014, NEUROIMAGE, V101, P35, DOI 10.1016/j.neuroimage.2014.06.043; Ebraheim N A, 1991, J Orthop Trauma, V5, P365, DOI 10.1097/00005131-199109000-00017; Frangi AF, 2002, IEEE T MED IMAGING, V21, P1151, DOI 10.1109/TMI.2002.804426; Freedman D, 2005, PROC CVPR IEEE, P755; Gerig G, 2001, IEEE WORKSHOP ON MATHEMATICAL METHODS IN BIOMEDICAL IMAGE ANALYSIS, PROCEEDINGS, P171, DOI 10.1109/MMBIA.2001.991731; Gorres J, 2014, INT J COMPUT ASS RAD, V9, P1045, DOI 10.1007/s11548-014-0998-8; Guimond A, 2000, COMPUT VIS IMAGE UND, V77, P192, DOI 10.1006/cviu.1999.0815; Gutekunst DJ, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-38; GUYER BH, 1985, AM J ROENTGENOL, V145, P911, DOI 10.2214/ajr.145.5.911; Heimann T, 2009, MED IMAGE ANAL, V13, P543, DOI 10.1016/j.media.2009.05.004; Hill A, 1993, BMVC, P1; Isgum I, 2009, IEEE T MED IMAGING, V28, P1000, DOI 10.1109/TMI.2008.2011480; Iskander DR, 2009, OPTOMETRY VISION SCI, V86, P542, DOI 10.1097/OPX.0b013e31819fa8ec; Kang C, 1998, BRIT J RADIOL, V71, P861, DOI 10.1259/bjr.71.848.9828799; Karaolani P, 1989, ALV VIS C CIT, P1; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kazhdan M, 2006, P ACM SPG, V7; Kelemen A, 1999, IEEE T MED IMAGING, V18, P828, DOI 10.1109/42.811260; Kelemen A, 1998, WORKSHOP ON BIOMEDICAL IMAGE ANALYSIS, PROCEEDINGS, P4, DOI 10.1109/BIA.1998.692374; Lamecker H, 2006, INT C PATT RECOG, P371; Lefaix G, 1997, EMBS, V1, P422; LEVENTON ME, 2000, PROC CVPR IEEE, P316, DOI DOI 10.1109/CVPR.2000.855835; Liang JA, 2010, INT C WAVEL ANAL PAT, P67, DOI 10.1109/ICWAPR.2010.5576438; Lu YC, 2013, COMPUT METH PROG BIO, V111, P613, DOI 10.1016/j.cmpb.2013.05.017; MATHENY A, 1995, IEEE T PATTERN ANAL, V17, P967, DOI 10.1109/34.464561; Mitchell SC, 2002, IEEE T MED IMAGING, V21, P1167, DOI 10.1109/TMI.2002.804425; Nikou C, 2001, IEEE T MED IMAGING, V20, P1026, DOI 10.1109/42.959300; Park H, 2003, IEEE T MED IMAGING, V22, P483, DOI 10.1109/TMI.2003.809139; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Pizer SM, 2003, INT J COMPUT VISION, V55, P85, DOI 10.1023/A:1026313132218; Potter MQ, 2009, J BONE JOINT SURG AM, V91A, P1854, DOI 10.2106/JBJS.H.01475; Qiang MF, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-19; Rammelt S, 2014, J ORTHOP TRAUMA, V28, P549, DOI 10.1097/BOT.0000000000000227; Rammelt S, 2010, CLIN ORTHOP RELAT R, V468, P983, DOI 10.1007/s11999-009-0964-x; Revol-Muller C, 2000, IEEE NUCL SCI S, p[3, 19]; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Rueckert D, 2003, IEEE T MED IMAGING, V22, P1014, DOI 10.1109/TMI.2003.815865; Saha PK, 2004, IEEE T MED IMAGING, V23, P53, DOI 10.1109/TMI.2003.819925; Sanders R, 2000, J BONE JOINT SURG AM, V82A, P225, DOI 10.2106/00004623-200002000-00009; Schepers T, 2007, SKELETAL RADIOL, V36, P847, DOI 10.1007/s00256-007-0330-6; Scott GL, 1987, ALV VIS C CIT, P1; Shen L, 2009, EVOLUTION, V63, P1003, DOI 10.1111/j.1558-5646.2008.00557.x; Stagni R, 2003, FOOT ANKLE INT, V24, P402, DOI 10.1177/107110070302400505; Stephan D, 2013, COMPUT METHOD BIOMEC, P1; Stindel E, 1999, COMPUT MED IMAG GRAP, V23, P75, DOI 10.1016/S0895-6111(98)00070-6; Stindel E, 1999, IEEE T MED IMAGING, V18, P753, DOI 10.1109/42.802753; Styner M, 2003, MED IMAGE ANAL, V7, P207, DOI 10.1016/S1361-8415(02)00110-X; Styner M, 2006, INSIGHT J, V1071, P242; Subsol G, 1998, Med Image Anal, V2, P37, DOI 10.1016/S1361-8415(01)80027-X; Tangelder JH, 2008, MULTIMED TOOLS APPL, V39, P441, DOI 10.1007/s11042-007-0181-0; Tao XD, 2002, IEEE T MED IMAGING, V21, P513, DOI 10.1109/TMI.2002.1009387; Trouve A, 1998, INT J COMPUT VISION, V28, P213, DOI 10.1023/A:1008001603737; Tumblin J, 1999, ACM T GRAPHIC, V18, P56, DOI 10.1145/300776.300783; Udupa J. K, 1999, 3D IMAGING MED; van de Giessen M, 2010, J BIOMECH, V43, P1463, DOI 10.1016/j.jbiomech.2010.02.006; van Ginneken B, 2002, IEEE T MED IMAGING, V21, P924, DOI 10.1109/TMI.2002.803121; Wu J, 2011, BIBMW, P600; Yushkevich PA, 2005, LECT NOTES COMPUT SC, V3750, P725, DOI 10.1007/11566489_89; Zhang DS, 2004, PATTERN RECOGN, V37, P1, DOI 10.1016/j.patcog.2003.07.008	81	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134603	10.1371/journal.pone.0134603	http://dx.doi.org/10.1371/journal.pone.0134603			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270812	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492800011
J	Love, JD; Suzuki, T; Robinson, DB; Harris, CM; Johnson, JE; Mohler, PJ; Jerome, WG; Swift, LL				Love, Joseph D.; Suzuki, Takashi; Robinson, Delia B.; Harris, Carla M.; Johnson, Joyce E.; Mohler, Peter J.; Jerome, W. Gray; Swift, Larry L.			Microsomal Triglyceride Transfer Protein (MTP) Associates with Cytosolic Lipid Droplets in 3T3-L1 Adipocytes	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; NUCLEOTIDE EXCHANGE FACTOR; ENDOPLASMIC-RETICULUM; APOLIPOPROTEIN-E; GOLGI; REVEALS; IDENTIFICATION; EXPRESSION; GROWTH; FSP27	Lipid droplets are intracellular energy storage organelles composed of a hydrophobic core of neutral lipid, surrounded by a monolayer of phospholipid and a diverse array of proteins. The function of the vast majority of these proteins with regard to the formation and/or turnover of lipid droplets is unknown. Our laboratory was the first to report that microsomal triglyceride transfer protein (MTP), a lipid transfer protein essential for the assembly of triglyceride-rich lipoproteins, was expressed in adipose tissue of humans and mice. In addition, our studies suggested that MTP was associated with lipid droplets in both brown and white fat. Our observations led us to hypothesize that MTP plays a key role in lipid droplet formation and/or turnover. The objective of these studies was to gain insight into the function of MTP in adipocytes. Using molecular, biochemical, and morphologic approaches we have shown: 1) MTP protein levels increase nearly five-fold as 3T3-L1 cells differentiate into adipocytes. 2) As 3T3-L1 cells undergo differentiation, MTP moves from the juxtanuclear region of the cell to the surface of lipid droplets. MTP and perilipin 2, a major lipid droplet surface protein, are found on the same droplets; however, MTP does not co-localize with perilipin 2. 3) Inhibition of MTP activity has no effect on the movement of triglyceride out of the cell either as a lipid complex or via lipolysis. 4) MTP is found associated with lipid droplets within hepatocytes from human fatty livers, suggesting that association of MTP with lipid droplets is not restricted to adipocytes. In summary, our data demonstrate that MTP is a lipid droplet-associated protein. Its location on the surface of the droplet in adipocytes and hepatocytes, coupled with its known function as a lipid transfer protein and its increased expression during adipocyte differentiation suggest a role in lipid droplet biology.	[Love, Joseph D.; Suzuki, Takashi; Robinson, Delia B.; Harris, Carla M.; Johnson, Joyce E.; Jerome, W. Gray; Swift, Larry L.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Swift, Larry L.] Tennessee Valley Hlth Care Syst, Vet Affairs, Res Serv, Nashville, TN USA	Vanderbilt University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Swift, LL (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.	larry.swift@vanderbilt.edu			VA Merit Award from the Tennessee Valley Health Care System and Department of Veterans Affairs [IBX000735A]; American Heart Association Greater Southeast Affiliate [09GRNT2150107]; NIH [CA68485, DK20593, DK58404, DK59637, EY08126, 2P30-CA068485, DK 059637]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, U24DK059637, P30DK058404, P60DK020593] Funding Source: NIH RePORTER	VA Merit Award from the Tennessee Valley Health Care System and Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association Greater Southeast Affiliate(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a VA Merit Award (IBX000735A) from the Tennessee Valley Health Care System and Department of Veterans Affairs (LS) and a grant from the American Heart Association Greater Southeast Affiliate (09GRNT2150107) (LS). Lipid analyses were done by the Lipid Core of the Mouse Metabolic Phenotyping Center (DK 059637). Confocal and transmission electron microscopy was done using the VUMC Cell Imaging Shared Resource, which is partially supported by NIH grants CA68485, DK20593, DK58404, DK59637 and EY08126. The Translational Pathology Shared Resource is supported by NIH grants 2P30-CA068485 and DK 059637. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037517; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Bouvet S, 2013, J CELL SCI, V126, P4794, DOI 10.1242/jcs.134254; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Ding YB, 2012, ACTA BIOCH BIOPH SIN, V44, P394, DOI 10.1093/abbs/gms008; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; GORDON DA, 1995, TRENDS CELL BIOL, V5, P317, DOI 10.1016/S0962-8924(00)89054-6; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Kimmel AR, 2013, BIOCHIMIE, V96, P96, DOI [10.1016/j.biochi.2013.08.026, DOI 10.1016/J.BI0CHI.2013.08.026]; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; MORRISON WR, 1964, J LIPID RES, V5, P600; Ohsaki Y, 2009, BBA-MOL CELL BIOL L, V1791, P399, DOI 10.1016/j.bbalip.2008.10.002; Olofsson SO, 2008, CURR OPIN LIPIDOL, V19, P441, DOI 10.1097/MOL.0b013e32830dd09b; Read J, 2000, J BIOL CHEM, V275, P30372, DOI 10.1074/jbc.C000364200; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Swift LL, 2005, FEBS LETT, V579, P3183, DOI 10.1016/j.febslet.2005.05.009; Swift LL, 2003, J LIPID RES, V44, P1841, DOI 10.1194/jlr.M300276-JLR200; Swift LL, 2001, J BIOL CHEM, V276, P22965, DOI 10.1074/jbc.M100172200; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Valyi-Nagy K, 2002, LIPIDS, V37, P879, DOI 10.1007/s11745-002-0974-3; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Wilfling F, 2014, ELIFE, V3, DOI 10.7554/eLife.01607; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2005, CURR PROT CELL BIOL, V3; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; ZECHNER R, 1991, J BIOL CHEM, V266, P10583	53	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135598	10.1371/journal.pone.0135598	http://dx.doi.org/10.1371/journal.pone.0135598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267806	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300140
J	Mirakhori, F; Zeynali, B; Rassouli, H; Shahbazi, E; Hashemizadeh, S; Kiani, S; Salekdeh, GH; Baharvand, H				Mirakhori, Fahimeh; Zeynali, Bahman; Rassouli, Hassan; Shahbazi, Ebrahim; Hashemizadeh, Shiva; Kiani, Sahar; Salekdeh, Ghasem Hosseini; Baharvand, Hossein			Induction of Neural Progenitor-Like Cells from Human Fibroblasts via a Genetic Material-Free Approach	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DIRECT CONVERSION; MOUSE FIBROBLASTS; GENERATION; DIFFERENTIATION; NEURONS; GROWTH	Background A number of studies generated induced neural progenitor cells (iNPCs) from human fibroblasts by viral delivering defined transcription factors. However, the potential risks associated with gene delivery systems have limited their clinical use. We propose it would be safer to induce neural progenitor-like cells from human adult fibroblasts via a direct non-genetic alternative approach. Methodology/Principal Findings Here, we have reported that seven rounds of TAT-SOX2 protein transduction in a defined chemical cocktail under a 3D sphere culture gradually morphed fibroblasts into neuroepithelial-like colonies. We were able to expand these cells for up to 20 passages. These cells could give rise to cells that expressed neurons and glia cell markers both in vitro and in vivo. Conclusions/Significance These results show that our approach is beneficial for the genetic material-free generation of iNPCs from human fibroblasts where small chemical molecules can provide a valuable, viable strategy to boost and improve induction in a 3D sphere culture.	[Mirakhori, Fahimeh; Zeynali, Bahman] Univ Tehran, Coll Sci, Sch Biol, Tehran, Iran; [Mirakhori, Fahimeh; Rassouli, Hassan; Shahbazi, Ebrahim; Hashemizadeh, Shiva; Kiani, Sahar; Baharvand, Hossein] Royan Inst Stem Cell Biol & Technol, ACECR, Dept Stem Cells & Dev Biol, Tehran, Iran; [Mirakhori, Fahimeh; Rassouli, Hassan; Shahbazi, Ebrahim; Hashemizadeh, Shiva; Kiani, Sahar; Salekdeh, Ghasem Hosseini; Baharvand, Hossein] Royan Inst Stem Cell Biol & Technol, ACECR, Cell Sci Res Ctr, Tehran, Iran; [Salekdeh, Ghasem Hosseini] Royan Inst Stem Cell Biol & Technol, ACECR, Dept Mol Syst Biol, Tehran, Iran; [Baharvand, Hossein] Univ Sci & Culture, ACECR, Dept Dev Biol, Tehran, Iran	University of Tehran; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Baharvand, H (corresponding author), Royan Inst Stem Cell Biol & Technol, ACECR, Dept Stem Cells & Dev Biol, Tehran, Iran.	Baharvand@RoyanInstitute.org	Kiani, Sahar/AAO-3557-2020; Salekdeh, Ghasem Hosseini/E-4198-2012; Mirakhori, Fahimeh/AAF-5271-2020	Kiani, Sahar/0000-0001-7779-9998; Salekdeh, Ghasem Hosseini/0000-0002-5124-4721; hashemizadeh, shiva/0000-0003-1223-2688	Royan Institute; Iranian Council of Stem Cell Research and Technology; Iran National Science Foundation (INSF)	Royan Institute; Iranian Council of Stem Cell Research and Technology; Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF))	This study was funded by grants provided from Royan Institute, Iranian Council of Stem Cell Research and Technology, the Iran National Science Foundation (INSF).	Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Cheng L, 2014, CELL RES, V24, P665, DOI 10.1038/cr.2014.32; Corti S, 2012, EXP CELL RES, V318, P1528, DOI 10.1016/j.yexcr.2012.02.040; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Fonoudi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055577; Ford KG, 2001, GENE THER, V8, P1, DOI 10.1038/sj.gt.3301383; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Kang PJ, 2014, BIOMATERIALS, V35, P7336, DOI 10.1016/j.biomaterials.2014.05.015; Kim J, 2012, CURR OPIN NEUROBIOL, V22, P778, DOI 10.1016/j.conb.2012.05.001; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Kumar A, 2012, J MOL CELL BIOL, V4, P252, DOI 10.1093/jmcb/mjs015; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Liu GH, 2012, CELL RES, V22, P1087, DOI 10.1038/cr.2012.73; Liu YQ, 2013, STEM CELLS, V31, P1350, DOI 10.1002/stem.1382; Lu JF, 2013, CELL REP, V3, P1580, DOI 10.1016/j.celrep.2013.04.004; Lujan E, 2012, CURR OPIN GENET DEV, V22, P517, DOI 10.1016/j.gde.2012.07.002; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; Mirakhori F, 2014, J CELL PHYSIOL, V229, P728, DOI 10.1002/jcp.24509; Mitchell RR, 2014, STEM CELLS DEV, V23, P1937, DOI 10.1089/scd.2014.0023; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; Nefzger CM, 2012, STEM CELLS, V30, P1349, DOI 10.1002/stem.1105; Phillips MI, 2008, ADV DRUG DELIVER REV, V60, P160, DOI 10.1016/j.addr.2007.08.035; Pouya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027925; Rassouli H, 2013, CELL J, V14, P282; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Sancho-Martinez I, 2012, NAT CELL BIOL, V14, P892, DOI 10.1038/ncb2567; Seifinejad A, 2010, STEM CELL REV REP, V6, P297, DOI 10.1007/s12015-010-9121-x; Sheng C, 2012, CELL RES, V22, P208, DOI 10.1038/cr.2011.175; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Su GN, 2013, BIOMATERIALS, V34, P5897, DOI 10.1016/j.biomaterials.2013.04.040; Tan HK, 2014, BIOMEDICINES, V2, P50; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Zhang M, 2012, ANAL BIOCHEM, V424, P57, DOI 10.1016/j.ab.2012.02.018; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Q, 2012, CELL STEM CELL, V10, P347, DOI 10.1016/j.stem.2012.03.005; Zhou Y, 2012, NEURAL REGEN RES, V7, P2645, DOI 10.3969/j.issn.1673-5374.2012.34.001	41	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135479	10.1371/journal.pone.0135479	http://dx.doi.org/10.1371/journal.pone.0135479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266943	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300123
J	Mukesh; Sharma, LK; Charoo, SA; Sathyakumar, S				Mukesh; Sharma, Lalit Kumar; Charoo, Samina Amin; Sathyakumar, Sambandam			Conflict Bear Translocation: Investigating Population Genetics and Fate of Bear Translocation in Dachigam National Park, Jammu and Kashmir, India	PLOS ONE			English	Article							ASIATIC BLACK BEAR; MICROSATELLITE ANALYSIS; HABITAT USE; BROWN BEAR; DNA; DISTANCE; LOCI	The Asiatic black bear population in Dachigam landscape, Jammu and Kashmir is well recognized as one of the highest density bear populations in India. Increasing incidences of bear-human interactions and the resultant retaliatory killings by locals have become a serious threat to the survivorship of black bears in the Dachigam landscape. The Department of Wildlife Protection in Jammu and Kashmir has been translocating bears involved in conflicts, henceforth 'conflict bears' from different sites in Dachigam landscape to Dachigam National Park as a flagship activity to mitigate conflicts. We undertook this study to investigate the population genetics and the fate of bear translocation in Dachigam National Park. We identified 109 unique genotypes in an area of ca. 650 km(2) and observed bear population under panmixia that showed sound genetic variability. Molecular tracking of translocated bears revealed that mostly bears (7 out of 11 bears) returned to their capture sites, possibly due to homing instincts or habituation to the high quality food available in agricultural croplands and orchards, while only four bears remained in Dachigam National Park after translocation. Results indicated that translocation success was most likely to be season dependent as bears translocated during spring and late autumn returned to their capture sites, perhaps due to the scarcity of food inside Dachigam National Park while bears translocated in summer remained in Dachigam National Park due to availability of surplus food resources. Thus, the current management practices of translocating conflict bears, without taking into account spatio-temporal variability of food resources in Dachigam landscape seemed to be ineffective in mitigating conflicts on a long-term basis. However, the study highlighted the importance of molecular tracking of bears to understand their movement patterns and socio-biology in tough terrains like Dachigam landscape.	[Mukesh; Sharma, Lalit Kumar; Charoo, Samina Amin; Sathyakumar, Sambandam] Wildlife Inst India, Dehra Dun 248001, Uttarakhand, India; [Sharma, Lalit Kumar] Indian Council Forestry Res & Educ, New Forest, Directorate Extens, Dehra Dun 248006, Uttarakhand, India; [Charoo, Samina Amin] Forest Complex, Dept Wildlife Protect, Srinagar 190008, Jammu & Kashmir, India	Wildlife Institute of India; Indian Council of Forestry Research & Education (ICFRE)	Mukesh (corresponding author), Amity Univ, Amity Inst Wildlife Sci, Sect 125, Noida 201313, Uttar Pradesh, India.	thamukesh@gmail.com		Sharma, Lalit Kumar/0000-0003-1214-7416	International Association for Bear Research and Management; Wildlife Institute of India, Dehradun	International Association for Bear Research and Management; Wildlife Institute of India, Dehradun	This study was funded by research grant provided by the International Association for Bear Research and Management and Wildlife Institute of India, Dehradun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; [Anonymous], 1999, POPGENE VERSION 1 3; Beckmann JP, 2004, WILDLIFE SOC B, V32, P1141, DOI 10.2193/0091-7648(2004)032[1141:EODTAD]2.0.CO;2; Beeman L.E., 1976, IUCN Publs (New Series), VNo. 40, P87; Bellemain E, 2007, BIOL CONSERV, V134, P537, DOI 10.1016/j.biocon.2006.09.004; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Boulanger J, 2001, CAN J ZOOL, V79, P642, DOI 10.1139/cjz-79-4-642; Boulanger J, 2008, ECOL APPL, V18, P577, DOI 10.1890/06-1941.1; Campbell S., 1980, CONSERVATION BIOL EV, P263; Can OE, 2014, CONSERV LETT, V7, P501, DOI 10.1111/conl.12117; Carr MM, 2002, URSUS, V13, P1; Charoo SA, 2011, URSUS, V22, P106, DOI 10.2192/URSUS-D-10-00021.1; Fies ML, 1987, URSUS, V7, P369, DOI DOI 10.2307/3872646; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Fredrikkson G, 2005, URSUS, V16, P130, DOI 10.2192/1537-6176(2005)016[0130:HBCIEK]2.0.CO;2; Galpern P, 2012, MOL ECOL RESOUR, V12, P771, DOI 10.1111/j.1755-0998.2012.03137.x; Garshelis DL, 1989, BEAR PEOPLE CONFLICT, P169; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hahn HC, 1945, WHITE TAILED DEER IN; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Harger EM, 1970, THESIS NO MICHIGAN U; Hopkins JB, 2013, URSUS, V24, P120, DOI 10.2192/URSUS-D-12-00018.1; Huygens OC, 1999, WILDLIFE SOC B, V27, P959; Hwang MH, 2002, URSUS, V13, P111; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; Joslin J.K., 1977, Advances in Ecological Research, V10, P63, DOI 10.1016/S0065-2504(08)60234-2; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kitahara E, 2000, MOL ECOL, V9, P1661, DOI 10.1046/j.1365-294x.2000.01030.x; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lorenzini R, 2004, ANIM CONSERV, V7, P199, DOI 10.1017/S1367943004001301; Mazur RL, 2010, J WILDLIFE MANAGE, V74, P48, DOI 10.2193/2008-163; MCARTHUR KL, 1981, J WILDLIFE MANAGE, V45, P102, DOI 10.2307/3807878; Mondol S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-79; Mowat G, 2000, J WILDLIFE MANAGE, V64, P183, DOI 10.2307/3802989; Mukesh, 2015, CONSERV GENET RESOUR, V7, P677, DOI 10.1007/s12686-015-0475-x; Mukesh, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117069; Mukesh, 2013, BMC Res Notes, V6, P326, DOI 10.1186/1756-0500-6-326; Mukesh, 2013, CONSERV GENET RESOUR, V5, P1079, DOI 10.1007/s12686-013-9988-3; Mukesh, 2013, ZOO BIOL, V32, P476, DOI 10.1002/zoo.21081; Mukesh T, 2011, EUR J WILDLIFE RES, V57, P983, DOI 10.1007/s10344-011-0494-1; Paetkau D, 1999, MOL ECOL, V8, P1571, DOI 10.1046/j.1365-294x.1999.00733.x; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pelton MR., 2003, WILD MAMMALS N AM BI, P547; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROGERS LL, 1986, WILDLIFE SOC B, V14, P76; Saito M, 2008, URSUS, V19, P162, DOI 10.2192/08GR006.1; Sathyakumar S, 2001, URSUS-SERIES, V12, P21; Sathyakumar S., 2007, Journal of the Bombay Natural History Society, V104, P316; Sathyakumar S., 2012, NATL BEAR CONSERVATI; Sharma L.K, 2012, RANGING PATTERNS ASI; Sharma S, 2013, URSUS, V24, P164, DOI 10.2192/URSUS-D-13-00001.1; Shih CC, 2009, CONSERV GENET, V10, P1845, DOI 10.1007/s10592-009-9830-3; Shivik JA, 2011, URSUS, V22, P114, DOI 10.2192/URSUS-D-10-00031.1; Singh TP, 2002, CURR SCI INDIA, V83, P1221; Stirling I., 1977, 33 CAN WILDL SERV; Sukumar R., 2003, LIVING ELEPHANTS EVO; TABERLET P, 1992, NATURE, V358, P197, DOI 10.1038/358197a0; Viteri MP, 2009, URSUS, V20, P102, DOI 10.2192/09GR004.1; Waits LP, 1998, BEAR CONSERVATION AC, P25; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yadav B.P., 2009, ASSESSMENT ASI UNPUB; [No title captured]; [No title captured]	67	18	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0132005	10.1371/journal.pone.0132005	http://dx.doi.org/10.1371/journal.pone.0132005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267280	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300004
J	Nguyen, VM; Haddaway, NR; Gutowsky, LFG; Wilson, ADM; Gallagher, AJ; Donaldson, MR; Hammerschlag, N; Cooke, SJ				Nguyen, Vivian M.; Haddaway, Neal R.; Gutowsky, Lee F. G.; Wilson, Alexander D. M.; Gallagher, Austin J.; Donaldson, Michael R.; Hammerschlag, Neil; Cooke, Steven J.			How Long Is Too Long in Contemporary Peer Review? Perspectives from Authors Publishing in Conservation Biology Journals	PLOS ONE			English	Review							QUALITY; INCREASE; SCIENCE; BIAS	Delays in peer reviewed publication may have consequences for both assessment of scientific prowess in academics as well as communication of important information to the knowledge receptor community. We present an analysis on the perspectives of authors publishing in conservation biology journals regarding their opinions on the importance of speed in peer-review as well as how to improve review times. Authors were invited to take part in an online questionnaire, of which the data was subjected to both qualitative (open coding, categorizing) and quantitative analyses (generalized linear models). We received 637 responses to a total of 6,547 e-mail invitations sent. Peer-review speed was generally perceived as slow, with authors experiencing a typical turnaround time of 14 weeks while their perceived optimal review time is six weeks. Male and younger respondents seem to have higher expectations of review speed than females and older respondents. Majority of participants attributed lengthy review times to the 'stress' on the peer-review system (i.e., reviewer and editor fatigue), while editor persistence and journal prestige were believed to speed up the review process. Negative consequences of lengthy review times appear to be greater for early career researchers and can also have impact on author morale (e.g. motivation or frustration). Competition among colleagues were also of concern to respondents. Incentivizing peer review was among the top suggested alterations to the system along with training graduate students in peer review, increased editorial persistence, and changes to the norms of peer-review such as opening the peer-review process to the public. It is clear that authors surveyed in this study view the peer-review system as under stress and we encourage scientists and publishers to push the envelope for new peer review models.	[Nguyen, Vivian M.; Gutowsky, Lee F. G.; Wilson, Alexander D. M.; Donaldson, Michael R.; Cooke, Steven J.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [Haddaway, Neal R.] Royal Swedish Acad Sci, MISTRA EviEM, Stockholm, Sweden; [Gallagher, Austin J.; Hammerschlag, Neil] Univ Miami, Rosenstiel Sch Marline & Atmospher Sci, Miami, FL USA; [Gallagher, Austin J.] Beneath Waves Inc, Syracuse, NY USA; [Cooke, Steven J.] Carleton Univ, Inst Environm Sci, Ottawa, ON K1S 5B6, Canada	Carleton University; Royal Swedish Academy of Sciences; University of Miami; Carleton University	Nguyen, VM (corresponding author), Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada.	Vivian.nguyen@carleton.ca	Wilson, Alexander/B-3329-2011; Cooke, Steven J/F-4193-2010; Nguyen, Vivian/AAO-8682-2020	Wilson, Alexander/0000-0002-7696-1671; Cooke, Steven J/0000-0002-5407-0659; Haddaway, Neal R/0000-0003-3902-2234; Donaldson, Michael/0000-0002-1178-5988; Gutowsky, Lee/0000-0003-1244-9465; Nguyen, Vivian/0000-0002-8666-8137	Natural Sciences and Engineering Research Council [315918-166]; Canada Research Chair [320517-166]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by the Natural Sciences and Engineering Research Council, 315918-166, http://www.nserc-crsng.gc.ca/index_eng.asp and the Canada Research Chair, 320517-166, http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohannon J, 2013, SCIENCE, V342, P60, DOI 10.1126/science.342.6154.60; British Ecological Society, GUID PEER REV EC EV; Budden AE, 2008, TRENDS ECOL EVOL, V23, P4, DOI 10.1016/j.tree.2007.07.008; Chambers J.M., 1992, LINEAR MODELS; Chetty R, 2014, J ECON PERSPECT, V28, P169, DOI 10.1257/jep.28.3.169; Clavero M, 2011, FRONT ECOL ENVIRON, V9, P93, DOI 10.1890/11.WB.001; Davis P., 2013, SOC SCHOLARLY PUBLIS; Fox J., 2010, B ECOL SOC AM, V91, P325, DOI DOI 10.1890/0012-9623-91.3.325; GILBERT GN, 1976, SOC STUD SCI, V6, P281, DOI 10.1177/030631277600600302; Grainger DW, 2007, BIOMATERIALS, V28, P5199, DOI 10.1016/j.biomaterials.2007.07.004; Harnad S, 1996, SCHOLARLY PUBLISHING; Hauser M, 2007, PLOS BIOL, V5, P703, DOI 10.1371/journal.pbio.0050107; Hettyey A, 2012, TRENDS ECOL EVOL, V27, P189, DOI 10.1016/j.tree.2012.01.005; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2786, DOI 10.1001/jama.287.21.2786; Kim HJ, 2001, SERIALS LIBR, V41, P31, DOI 10.1300/J123v41n01_04; Kumar MN, 2014, J ACAD ETHICS, V12, P333, DOI 10.1007/s10805-014-9220-4; Mulligan A, 2013, J AM SOC INF SCI TEC, V64, P132, DOI 10.1002/asi.22798; Ng KH, 2009, SINGAP MED J, V50, P230; Primack RB, 2009, BIOL CONSERV, V142, P2415, DOI 10.1016/j.biocon.2009.06.021; Robertson M, 2009, J BIOL-LONDON, V8, P1, DOI DOI 10.1186/jbiol111; Schafer RB, 2011, FRESHWATER BIOL, V56, P2405, DOI 10.1111/j.1365-2427.2011.02673.x; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Smith R, 2006, J ROY SOC MED, V99, P178, DOI 10.1258/jrsm.99.4.178; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Squazzoni F, 2013, RES POLICY, V42, P287, DOI 10.1016/j.respol.2012.04.014; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Strauss A., 1998, BASICS QUALITATIVE R; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Tananbaum Greg, 2008, Learned Publishing, V21, P300, DOI 10.1087/095315108X356734; Tregenza T, 2002, TRENDS ECOL EVOL, V17, P349, DOI 10.1016/S0169-5347(02)02545-4; Wiley Online Library, TRANSF PEER REV PIL; Wood D, 1998, LEARN PUBL, V11, P193, DOI 10.1087/09531519850146364; Zuur Alain F., 2009, P1	33	321	329	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0132557	10.1371/journal.pone.0132557	http://dx.doi.org/10.1371/journal.pone.0132557			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9JT	26267491	Green Submitted, Green Published, gold			2022-12-27	WOS:000359492300006
J	Brito, RBO; Malta, CS; Souza, DM; Matheus, LHG; Matos, YST; Silva, CS; Ferreira, JM; Nunes, VS; Franca, CM; Delle, H				Oliveira Brito, Rodrigo Barbosa; Malta, Camila Soares; Souza, Diego Mota; Gomes Matheus, Luiz Henrique; Teles Matos, Yves Silva; Silva, Chrisna Souza; Ferreira, Janaina Mendes; Nunes, Valeria Sutti; Franca, Cristiane Miranda; Delle, Humberto			1-Methyl-D-Tryptophan Potentiates TGF-beta-Induced Epithelial-Mesenchymal Transition in T24 Human Bladder Cancer Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; EXPRESSION; INHIBITION; PROGRESSION; MODULATION; INDUCTION; TOLERANCE; MECHANISM	Immune escape and metastasis are the hallmarks of several types of cancer including bladder cancer. One of the mechanisms involved in these processes has been linked to indoleamine 2,3-dioxygenase (IDO). Although IDO is classically recognized for its immunomodulatory property, it has presented nonimmunological effects in some tumors. TGF-beta 1 is believed to contribute to carcinoma development by modulating immunossupressive molecules, including IDO. In addition, TGF-beta 1 induces the epithelial-mesenchymal transition (EMT), which is a critical step in the tumor invasiveness and metastasis. We investigated the role of MT and IDO modulation in the induction of EMT by TGF-beta 1 in T24 human bladder carcinoma cells. When T24 cells were incubated with the IDO inhibitor (MT, 1-methyl-D-tryptophan), with TGF-beta 1, and with MT+TGF-beta 1, a significant decrease of IDO expression and activity was observed. In addition, downregulation of e-cadherin and upregulation of n-cadherin and EMT transcription factors were induced by the treatments, confirming the induction of EMT. siRNA-mediated knockdown of IDO decreased e-cadherin expression, but had no effect on EMT transcription factors. In the scratch-wound assay, the heightened migration process was intensified when the cells were incubated with MT+TGF-beta 1. These effects were associated with a robust inhibition of Akt activation. After inoculation of T24 cells under the kidney capsule of Balb/c nude, the cells were positive for IDO in the center of the cell infiltrate, being negative in the periphery, where EMT is high. In conclusion, inhibition of IDO by TGF-beta 1 and MT is associated with EMT in T24 human bladder carcinoma cells. MT has potentiating effect in TGF-beta 1-induced EMT, independently of IDO. This nonimmunological effect of MT should be considered if IDO is the target to avoid immune escape in bladder cancer.	[Oliveira Brito, Rodrigo Barbosa; Malta, Camila Soares; Souza, Diego Mota; Gomes Matheus, Luiz Henrique; Teles Matos, Yves Silva; Silva, Chrisna Souza; Ferreira, Janaina Mendes; Delle, Humberto] Univ Nove Julho UNINOVE, Programa Posgrad Med, Sao Paulo, Brazil; [Nunes, Valeria Sutti] Univ Sao Paulo, Fac Med Sci, Endocrinol & Metab Div Hosp Clin, Lipids Lab LIM 10, Sao Paulo, Brazil; [Franca, Cristiane Miranda] Univ Nove Julho UNINOVE, Programa Posgrad Biofoton Ciencias Saude, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade de Sao Paulo; Universidade Nove de Julho	Delle, H (corresponding author), Univ Nove Julho UNINOVE, Programa Posgrad Med, Sao Paulo, Brazil.	hdelle@usp.br	Dellê, Humberto/N-6353-2019; Nunes, Valeria S./G-4778-2012; Franca, Cristiane/B-2563-2014; Matheus, Luiz/GMX-3619-2022	Dellê, Humberto/0000-0001-6072-3671; Nunes, Valeria S./0000-0002-6769-5412; Franca, Cristiane/0000-0002-9285-4622; Matheus, Luiz/0000-0001-6047-971X; Matos, Yves/0000-0002-0714-6307	Sao Paulo Research Foundation (FAPESP) [2012/04423-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Sao Paulo Research Foundation (FAPESP), grant 2012/04423-0, http://www.fapesp.br/.	Agaugue S, 2006, J IMMUNOL, V177, P2061, DOI 10.4049/jimmunol.177.4.2061; Al-Azayzih A, 2012, BIOCHEM BIOPH RES CO, V427, P165, DOI 10.1016/j.bbrc.2012.09.035; Astigiano S, 2005, NEOPLASIA, V7, P390, DOI 10.1593/neo.04658; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Brody JR, 2009, CELL CYCLE, V8, P1930, DOI 10.4161/cc.8.12.8745; Bryan RT, 2010, J UROLOGY, V184, P423, DOI 10.1016/j.juro.2010.04.016; BYRNE GI, 1986, INFECT IMMUN, V53, P347, DOI 10.1128/IAI.53.2.347-351.1986; Delle H, 2010, AM J TRANSPLANT, V10, P1918, DOI 10.1111/j.1600-6143.2010.03190.x; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Geng J, 2014, ONCOTARGET, V5, P5700, DOI 10.18632/oncotarget.2144; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Inaba T, 2009, GYNECOL ONCOL, V115, P185, DOI 10.1016/j.ygyno.2009.07.015; Ino K, 2006, BRIT J CANCER, V95, P1555, DOI 10.1038/sj.bjc.6603477; Ishio T, 2004, J GASTROEN HEPATOL, V19, P319, DOI 10.1111/j.1440-1746.2003.03259.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Levina V, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/173029; Li YB, 2010, INT UROL NEPHROL, V42, P315, DOI 10.1007/s11255-009-9620-3; Mansfield AS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-231; Metz R, 2012, ONCOIMMUNOLOGY, V1, P1460, DOI 10.4161/onci.21716; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nakamura T, 2007, CANCER SCI, V98, P874, DOI 10.1111/j.1349-7006.2007.00470.x; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Riesenberg R, 2007, CLIN CANCER RES, V13, P6993, DOI 10.1158/1078-0432.CCR-07-0942; Shariat SF, 2001, CANCER-AM CANCER SOC, V92, P2985, DOI 10.1002/1097-0142(20011215)92:12<2985::AID-CNCR10175>3.0.CO;2-5; Shorning BY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016209; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soliman HH, 2014, ONCOTARGET, V5, P8136, DOI 10.18632/oncotarget.2357; Song JG, 2007, CELL RES, V17, P289, DOI 10.1038/cr.2007.25; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; van der Horst G, 2012, MOL CANCER RES, V10, P995, DOI 10.1158/1541-7786.MCR-12-0274; Wei H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051758; Yuan WH, 1998, J CELL PHYSIOL, V177, P174, DOI 10.1002/(SICI)1097-4652(199810)177:1<174::AID-JCP18>3.0.CO;2-D	35	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0134858	10.1371/journal.pone.0134858	http://dx.doi.org/10.1371/journal.pone.0134858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267811	Green Submitted, gold, Green Published			2022-12-27	WOS:000359492300063
J	Hadebe, S; Kirstein, F; Fierens, K; Chen, K; Drummond, RA; Vautier, S; Sajaniemi, S; Murray, G; Williams, DL; Redelinghuys, P; Reinhart, TA; Junecko, BAF; Kolls, JK; Lambrecht, BN; Brombacher, F; Brown, GD				Hadebe, Sabelo; Kirstein, Frank; Fierens, Kaat; Chen, Kong; Drummond, Rebecca A.; Vautier, Simon; Sajaniemi, Sara; Murray, Graeme; Williams, David L.; Redelinghuys, Pierre; Reinhart, Todd A.; Junecko, Beth A. Fallert; Kolls, Jay K.; Lambrecht, Bart N.; Brombacher, Frank; Brown, Gordon D.			Microbial Ligand Costimulation Drives Neutrophilic Steroid-Refractory Asthma	PLOS ONE			English	Article							HOUSE-DUST MITE; ALLERGIC AIRWAY INFLAMMATION; DENDRITIC CELLS; CLADOSPORIUM-CLADOSPORIOIDES; RECEPTOR DECTIN-1; IMMUNE-RESPONSE; INHALED ANTIGEN; INNATE IMMUNITY; BETA-GLUCANS; DISEASE	Asthma is a heterogeneous disease whose etiology is poorly understood but is likely to involve innate responses to inhaled microbial components that are found in allergens. The influence of these components on pulmonary inflammation has been largely studied in the context of individual agonists, despite knowledge that they can have synergistic effects when used in combination. Here we have explored the effects of LPS and beta-glucan, two commonly-encountered microbial agonists, on the pathogenesis of allergic and non-allergic respiratory responses to house dust mite allergen. Notably, sensitization with these microbial components in combination acted synergistically to promote robust neutrophilic inflammation, which involved both Dectin-1 and TLR-4. This pulmonary neutrophilic inflammation was corticosteroid-refractory, resembling that found in patients with severe asthma. Thus our results provide key new insights into how microbial components influence the development of respiratory pathology.	[Hadebe, Sabelo; Drummond, Rebecca A.; Vautier, Simon; Sajaniemi, Sara; Redelinghuys, Pierre; Brown, Gordon D.] Univ Cape Town, Aberdeen Fungal Grp, Immun & Inflammat Programme, Inst Infect Dis & Mol Med,Fac Hlth Sci, ZA-7700 Rondebosch, South Africa; [Kirstein, Frank; Brombacher, Frank] Univ Cape Town, Int Ctr Genet Engn & Biotechnol, Fac Hlth Sci, ZA-7700 Rondebosch, South Africa; [Kirstein, Frank; Brombacher, Frank] Univ Cape Town, Div Immunol, Fac Hlth Sci, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, South Africa; [Fierens, Kaat; Lambrecht, Bart N.] Univ Ghent, Lab Immunoregulat & Mucosal Immunol, VIB Inflammat Res Ctr, B-9000 Ghent, Belgium; [Chen, Kong; Kolls, Jay K.] Univ Pittsburgh, Sch Med, Dept Paediat, Pittsburgh, PA USA; [Murray, Graeme] Univ Aberdeen, Pathol, Div Appl Med, Inst Med Sci,Foresterhill, Aberdeen, Scotland; [Williams, David L.] E Tennessee State Univ, James H Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA; [Williams, David L.] E Tennessee State Univ, James H Quillen Coll Med, Ctr Inflammat Infect Dis & Immun, Johnson City, TN 37614 USA; [Reinhart, Todd A.; Junecko, Beth A. Fallert] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Lambrecht, Bart N.] ErasmusMC, Dept Pulm Med, Rotterdam, Netherlands	University of Cape Town; University of Cape Town; University of Cape Town; Flanders Institute for Biotechnology (VIB); Ghent University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Aberdeen; East Tennessee State University; East Tennessee State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Erasmus University Rotterdam; Erasmus MC	Brown, GD (corresponding author), Univ Cape Town, Aberdeen Fungal Grp, Immun & Inflammat Programme, Inst Infect Dis & Mol Med,Fac Hlth Sci, ZA-7700 Rondebosch, South Africa.	gordon.brown@abdn.ac.uk	Drummond, Rebecca/I-3155-2019; Lambrecht, Bart N/K-2484-2014; Kolls, Jay/AAH-1829-2019	Drummond, Rebecca/0000-0001-5424-7074; Lambrecht, Bart N/0000-0003-4376-6834; Kolls, Jay/0000-0001-5151-6304; Hadebe, Sabelo/0000-0002-6049-8395; Vautier, Simon/0000-0002-1694-7034	Wellcome Trust [102705]; Universities of Aberdeen and Cape Town; National Institutes of Health [GM53522, GM083016]; Fonds Wetenschappelijk Onderzoek; European Research Commission; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083016, R01GM053522] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Universities of Aberdeen and Cape Town; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds Wetenschappelijk Onderzoek(FWO); European Research Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Wellcome Trust (102705) and the Universities of Aberdeen and Cape Town for funding. This research was also supported, in part, by National Institutes of Health GM53522 and GM083016 to DLW. KF and BNL are funded by the Fonds Wetenschappelijk Onderzoek, BNL is the recipient of an European Research Commission consolidator grant and participates in the European Union FP7 programs EUBIOPRED and MedALL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agache I, 2010, RESP MED, V104, P1131, DOI 10.1016/j.rmed.2010.02.018; Allard JB, 2009, EUR J IMMUNOL, V39, P776, DOI 10.1002/eji.200838932; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Ano S, 2013, J IMMUNOL, V190, P1056, DOI 10.4049/jimmunol.1202386; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bessa SSED, 2012, ARCH MED RES, V43, P36, DOI 10.1016/j.arcmed.2012.01.009; Bonlokke JH, 2006, SCAND J WORK ENV HEA, V32, P374, DOI 10.5271/sjweh.1033; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Dong L, 2009, J ASTHMA, V46, P229, DOI 10.1080/02770900802610050; Douwes J, 2005, INDOOR AIR, V15, P160, DOI 10.1111/j.1600-0668.2005.00333.x; Drummond RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003417; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; ENSLEY HE, 1994, CARBOHYD RES, V258, P307, DOI 10.1016/0008-6215(94)84098-9; Fallert BA, 2002, J VIROL METHODS, V99, P23, DOI 10.1016/S0166-0934(01)00378-0; Fogli LK, 2013, J IMMUNOL, V191, P3100, DOI 10.4049/jimmunol.1301360; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Jarjour NN, 2012, AM J RESP CRIT CARE, V185, P356, DOI 10.1164/rccm.201107-1317PP; Kirstein F, 2010, J ALLERGY CLIN IMMUN, V126, P347, DOI 10.1016/j.jaci.2010.04.028; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Laan M, 1999, J IMMUNOL, V162, P2347; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Lilly LM, 2012, J IMMUNOL, V189, P3653, DOI 10.4049/jimmunol.1201797; Martin RA, 2014, RESPIROLOGY, V19, P823, DOI 10.1111/resp.12315; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Mintz-Cole RA, 2013, J ALLERGY CLIN IMMUN, V132, P159, DOI 10.1016/j.jaci.2013.01.003; Mintz-Cole RA, 2012, J IMMUNOL, V189, P3609, DOI 10.4049/jimmunol.1200589; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Newcomb DC, 2013, CURR OPIN IMMUNOL, V25, P755, DOI 10.1016/j.coi.2013.08.002; O'Driscoll B Ronan, 2005, BMC Pulm Med, V5, P4, DOI 10.1186/1471-2466-5-4; Pan ZZ, 2000, AM J PHYSIOL-LUNG C, V279, pL658, DOI 10.1152/ajplung.2000.279.4.L658; Pearce N, 1999, THORAX, V54, P268, DOI 10.1136/thx.54.3.268; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Porter PC, 2014, J ALLERGY CLIN IMMUN, V134, P325, DOI 10.1016/j.jaci.2014.04.028; Reed CE, 2001, J ALLERGY CLIN IMMUN, V108, P157, DOI 10.1067/mai.2001.116862; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Rylander R, 2000, TOXICOLOGY, V152, P47, DOI 10.1016/S0300-483X(00)00291-2; Schaub B, 2006, J ALLERGY CLIN IMMUN, V117, P969, DOI 10.1016/j.jaci.2006.03.003; Simpson JL, 2008, PAEDIATR RESPIR REV, V9, P263, DOI 10.1016/j.prrv.2008.05.007; Thorn J, 2001, MEDIAT INFLAMM, V10, P173, DOI 10.1080/09629350124119; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Zhao J, 2013, MUCOSAL IMMUNOL, V6, P335, DOI 10.1038/mi.2012.76	55	34	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0134219	10.1371/journal.pone.0134219	http://dx.doi.org/10.1371/journal.pone.0134219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26261989	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000359353300023
J	Hwang, JH; Byun, MR; Kim, AR; Kim, KM; Cho, HJ; Lee, YH; Kim, J; Jeong, MG; Hwang, ES; Hong, JH				Hwang, Jun-Ha; Byun, Mi Ran; Kim, A. Rum; Kim, Kyung Min; Cho, Hang Jun; Lee, Yo Han; Kim, Juwon; Jeong, Mi Gyeong; Hwang, Eun Sook; Hong, Jeong-Ho			Extracellular Matrix Stiffness Regulates Osteogenic Differentiation through MAPK Activation	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; TAZ; PATHWAYS; YAP/TAZ; YAP	Mesenchymal stem cell (MSC) differentiation is regulated by the extracellular matrix (ECM) through activation of intracellular signaling mediators. The stiffness of the ECM was shown to be an important regulatory factor for MSC differentiation, and transcriptional coactivator with PDZ-binding motif (TAZ) was identified as an effector protein for MSC differentiation. However, the detailed underlying mechanism regarding the role of ECM stiffness and TAZ in MSC differentiation is not yet fully understood. In this report, we showed that ECM stiffness regulates MSC fate through ERK or JNK activation. Specifically, a stiff hydrogel matrix stimulates osteogenic differentiation concomitant with increased nuclear localization of TAZ, but inhibits adipogenic differentiation. ERK and JNK activity was significantly increased in cells cultured on a stiff hydrogel. TAZ activation was induced by ERK or JNK activation on a stiff hydrogel because exposure to an ERK or JNK inhibitor significantly decreased the nuclear localization of TAZ, indicating that ECM stiffness-induced ERK or JNK activation is important for TAZ-driven osteogenic differentiation. Taken together, these results suggest that ECM stiffness regulates MSC differentiation through ERK or JNK activation.	[Hwang, Jun-Ha; Byun, Mi Ran; Kim, A. Rum; Kim, Kyung Min; Cho, Hang Jun; Lee, Yo Han; Kim, Juwon; Hong, Jeong-Ho] Korea Univ, Sch Life Sci & Biotechnol, Dept Life Sci, Seoul, South Korea; [Jeong, Mi Gyeong; Hwang, Eun Sook] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Jeong, Mi Gyeong; Hwang, Eun Sook] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea	Korea University; Ewha Womans University; Ewha Womans University	Hwang, ES (corresponding author), Ewha Womans Univ, Coll Pharm, Seoul, South Korea.	eshwang@ewha.ac.kr; jh_hong@korea.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A2A2A01006547, 2014R1A1A2057408]; Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI); Ministry for Health & Welfare, Republic of Korea [HI14C3266]; Korea University	National Research Foundation of Korea (NRF) - Ministry of Education; Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI); Ministry for Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea University	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant nos. 2014R1A2A2A01006547 and 2014R1A1A2057408) and by a grant from the Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry for Health & Welfare (grant no. HI14C3266), Republic of Korea. This work was also supported by a grant from Korea University.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Byun MR, 2014, CELL DEATH DIFFER, V21, P854, DOI 10.1038/cdd.2014.8; Byun MR, 2014, BONE, V58, P72, DOI 10.1016/j.bone.2013.09.024; Byun MR, 2012, FEBS LETT, V586, P1086, DOI 10.1016/j.febslet.2012.03.008; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Halder A, 2000, CLIN BIOMECH, V15, P456, DOI 10.1016/S0268-0033(99)00095-9; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huang C, 2015, BBA-GEN SUBJECTS, V1850, P1261, DOI 10.1016/j.bbagen.2015.02.011; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jeong H, 2010, FASEB J, V24, P3310, DOI 10.1096/fj.09-151324; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kim KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092427; Lee J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05188; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049	33	54	57	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135519	10.1371/journal.pone.0135519	http://dx.doi.org/10.1371/journal.pone.0135519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26262877	Green Submitted, Green Published, gold			2022-12-27	WOS:000359353300089
J	Kwon, E; Cho, JH; Jang, HM; Kim, YS; Kang, SW; Yang, CW; Kim, NH; Kim, HJ; Park, JM; Lee, JE; Jung, HY; Choi, JY; Park, SH; Kim, CD; Kim, YL				Kwon, Eugene; Cho, Jang-Hee; Jang, Hye Min; Kim, Yon Su; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Kim, Hyun-Ji; Park, Jeung-Min; Lee, Ji-Eun; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Chan-Duck; Kim, Yong-Lim		Clinical Res Ctr End Stage Renal D	Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study	PLOS ONE			English	Article							C VIRUS-INFECTION; CHRONIC-RENAL-FAILURE; HEMODIALYSIS-PATIENTS; B-VIRUS; PERITONEAL-DIALYSIS; HCV INFECTION; KIDNEY-TRANSPLANTATION; POSITIVE PATIENTS; CAPD PATIENTS; LAMIVUDINE	The role of infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) in terms of survival among dialysis patients remains incompletely understood. In the present multicenter prospective cohort study, we investigated the prevalences of HBV and HCV infection among 3,321 patients receiving maintenance dialysis in Korea, and assessed the impacts of these infections on survival. All included patients underwent hepatitis B antigen (HBsAg) and HCV antibody (Ab) testing, which revealed that 236 patients (7.1%) were HBsAg-positive, and 123 patients (3.7%) were HCV Ab-positive. HBsAg-positive and HCV Ab-positive patients were matched to hepatitis virus-negative patients using a propensity score at a ratio of 1: 2. The prevalences of HBV and HCV infection did not significantly differ according to dialysis modality. Linear-by-linear association analysis revealed that hepatitis B prevalence significantly increased with increasing dialysis vintage (p = 0.001), and hepatitis C prevalence tended to be higher with increasing dialysis vintage (p = 0.074). We compared the survival of HBsAg-positive and HCV Ab-positive patients to that of hepatitis virus-negative patients. After propensity score matching, cumulative survival did not differ between HBsAg-positive and HBsAg-negative patients (p = 0.37), while HCV Ab-positive patients showed significantly lower survival than HCV Ab-negative patients (p = 0.03). The main conclusions of the present study are that HBV infection prevalence increased with longer dialysis vintage, and that both HBV and HCV infections were most prevalent among patients with the longest dialysis vintage. Additionally, HCV infection among maintenance dialysis patients is associated with an increased risk of mortality.	[Kwon, Eugene; Cho, Jang-Hee; Kim, Hyun-Ji; Park, Jeung-Min; Lee, Ji-Eun; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Chan-Duck; Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Jang, Hye Min] Kyungpook Natl Univ, Dept Stat, Daegu, South Korea; [Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea; [Kwon, Eugene; Cho, Jang-Hee; Jang, Hye Min; Kim, Yon Su; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Kim, Hyun-Ji; Park, Jeung-Min; Lee, Ji-Eun; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Chan-Duck; Kim, Yong-Lim] Clin Res Ctr End Stage Renal Dis, Daegu, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Dept Biomed Sci, KNU Biomed Convergence Program BK21Plus, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Catholic University of Korea; Chonnam National University; Kyungpook National University	Kim, YL (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea.	ylkim@knu.ac.kr	Cho, Jang-hee/ABD-3534-2020	Cho, Jang-hee/0000-0002-7031-5214; Jung, Hee-Yeon/0000-0003-0232-7202	Biomedical Research Institute grant, Kyungpook National University Hospital [15-28]	Biomedical Research Institute grant, Kyungpook National University Hospital	This work was supported by the Biomedical Research Institute grant, Kyungpook National University Hospital (2015). The assigned project number is 15-28. E. Kwon received the funding.	Ben-Ari Z, 2000, AM J GASTROENTEROL, V95, P3579, DOI 10.1111/j.1572-0241.2000.03296.x; Boyacioglu S, 2002, TRANSPL P, V34, P2131, DOI 10.1016/S0041-1345(02)02879-8; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Di Napoli A, 2006, AM J KIDNEY DIS, V48, P629, DOI 10.1053/j.ajkd.2006.07.004; Edey M, 2010, NEPHROLOGY, V15, P137, DOI 10.1111/j.1440-1797.2009.01268.x; Espinosa M, 2002, CLIN NEPHROL, V58, P143; Espinosa M, 2001, NEPHROL DIAL TRANSPL, V16, P1669, DOI 10.1093/ndt/16.8.1669; Fabrizi F, 2007, J VIRAL HEPATITIS, V14, P697, DOI 10.1111/1365-2893.2007.00868.x; Fabrizi F, 2007, INT J ARTIF ORGANS, V30, P6, DOI 10.1177/039139880703000103; Fabrizi F, 2003, INT J ARTIF ORGANS, V26, P1048, DOI 10.1177/039139880302601202; Fabrizi F, 2010, NAT REV NEPHROL, V6, P395, DOI 10.1038/nrneph.2010.37; Fontaine H, 2000, TRANSPLANTATION, V69, P2090, DOI 10.1097/00007890-200005270-00020; Gordon CE, 2008, AM J KIDNEY DIS, V52, P811, DOI 10.1053/j.ajkd.2008.08.005; HARNETT JD, 1988, AM J KIDNEY DIS, V11, P210, DOI 10.1016/S0272-6386(88)80151-3; Hung KY, 1997, BLOOD PURIFICAT, V15, P195, DOI 10.1159/000170332; Hwang EW, 2011, N AM J MED SCI BOSTO, V4; JHA R, 1993, J NEPHROL, V6, P98; Johnson DW, 2009, NEPHROL DIAL TRANSPL, V24, P1598, DOI 10.1093/ndt/gfn684; JOSSELSON J, 1987, AM J KIDNEY DIS, V9, P456, DOI 10.1016/S0272-6386(87)80071-9; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P290, DOI 10.1053/j.ajkd.2005.05.006; Kalantar-Zadeh K, 2005, NEPHROL DIAL TRANSPL, V20, P1662, DOI 10.1093/ndt/gfh895; Kalantar-Zadeh K, 2007, J AM SOC NEPHROL, V18, P1584, DOI 10.1681/ASN.2006070736; Khan N, 2004, J CLIN VIROL, V30, P175, DOI 10.1016/j.jcv.2003.10.004; Lapinski TW, 2005, WORLD J GASTROENTERO, V11, P400, DOI 10.3748/wjg.v11.i3.400; Lim Young Suk, 2009, Korean J Hepatol, V15 Suppl 6, pS25, DOI 10.3350/kjhep.2009.15.S6.S25; McMurray RW, 1997, SEMIN ARTHRITIS RHEU, V26, P689, DOI 10.1016/S0049-0172(97)80005-4; Meyers CM, 2003, AM J KIDNEY DIS, V42, P631, DOI 10.1016/S0272-6386(03)00828-X; Nakayama E, 2000, J AM SOC NEPHROL, V11, P1896, DOI 10.1681/ASN.V11101896; NETO MC, 1995, NEPHROL DIAL TRANSPL, V10, P240; Nocente R, 2003, HEPATO-GASTROENTEROL, V50, P1149; Ohsawa M, 2011, J EPIDEMIOL, V21, P491, DOI 10.2188/jea.JE20100187; Ow MMG, 2014, NEW ZEAL MED J, V127, P34; Pawlak K, 2004, CYTOKINE, V28, P197, DOI 10.1016/j.cyto.2004.07.007; Pereira BJG, 1998, KIDNEY INT, V53, P1374, DOI 10.1046/j.1523-1755.1998.00883.x; Pereira BJG, 1997, KIDNEY INT, V51, P981, DOI 10.1038/ki.1997.139; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Puttinger H, 2002, SEMIN NEPHROL, V22, P351, DOI 10.1053/snep.2002.33676; Santoro D, 2009, RENAL FAILURE, V31, P6, DOI 10.1080/08860220802546289; Sayiner AA, 1999, NEPHROL DIAL TRANSPL, V14, P256, DOI 10.1093/ndt/14.1.256; Schmilovitz-Weiss H, 2003, J CLIN GASTROENTEROL, V37, P64, DOI 10.1097/00004836-200307000-00016; Stehman-Breen CO, 1998, AM J KIDNEY DIS, V32, P629, DOI 10.1016/S0272-6386(98)70027-7; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Sulowicz Wladyslaw, 2007, Hemodial Int, V11, P286, DOI 10.1111/j.1542-4758.2007.00181.x; Sun JH, 2009, RENAL FAILURE, V31, P610, DOI 10.1080/08860220903003446; Thanachartwet V, 2007, NEPHROLOGY, V12, P399, DOI 10.1111/j.1440-1797.2007.00815.x; Wang CY, 2010, RENAL FAILURE, V32, P1255, DOI 10.3109/0886022X.2010.517354; Wang SM, 2008, PERITON DIALYSIS INT, V28, P183; Weclawiak H, 2010, HEPAT RES TREAT, V2010	48	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135476	10.1371/journal.pone.0135476	http://dx.doi.org/10.1371/journal.pone.0135476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263373	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300084
J	Liu, W; Xiao, ZD; Bao, XL; Yang, XY; Fang, J; Xiang, X				Liu, Wei; Xiao, Zhidan; Bao, Xiuli; Yang, Xiaoyan; Fang, Jing; Xiang, Xu			Identifying Litchi (Litchi chinensis Sonn.) Cultivars and Their Genetic Relationships Using Single Nucleotide Polymorphism (SNP) Markers	PLOS ONE			English	Article							LYCHEE CULTIVARS; DIVERSITY; IDENTIFICATION; SOFTWARE; L.; PARENTAGE; SET	Litchi is an important fruit tree in tropical and subtropical areas of the world. However, there is widespread confusion regarding litchi cultivar nomenclature and detailed information of genetic relationships among litchi germplasm is unclear. In the present study, the potential of single nucleotide polymorphism (SNP) for the identification of 96 representative litchi accessions and their genetic relationships in China was evaluated using 155 SNPs that were evenly spaced across litchi genome. Ninety SNPs with minor allele frequencies above 0.05 and a good genotyping success rate were used for further analysis. A relatively high level of genetic variation was observed among litchi accessions, as quantified by the expected heterozygosity (He = 0.305). The SNP based multilocus matching identified two synonymous groups, 'Heiye' and 'Wuye', and 'Chengtuo' and 'Baitangli 1'. A subset of 14 SNPs was sufficient to distinguish all the non-redundant litchi genotypes, and these SNPs were proven to be highly stable by repeated analyses of a selected group of cultivars. Unweighted pair-group method of arithmetic averages (UPGMA) cluster analysis divided the litchi accessions analyzed into four main groups, which corresponded to the traits of extremely early-maturing, early-maturing, middle-maturing, and late-maturing, indicating that the fruit maturation period should be considered as the primary criterion for litchi taxonomy. Two subpopulations were detected among litchi accessions by STRUCTURE analysis, and accessions with extremely early-and late-maturing traits showed membership coefficients above 0.99 for Cluster 1 and Cluster 2, respectively. Accessions with early- and middle-maturing traits were identified as admixture forms with varying levels of membership shared between the two clusters, indicating their hybrid origin during litchi domestication. The results of this study will benefit litchi germplasm conservation programs and facilitate maximum genetic gains in litchi breeding programs.	[Liu, Wei; Xiao, Zhidan; Bao, Xiuli; Yang, Xiaoyan; Fang, Jing; Xiang, Xu] Guangdong Acad Agr Sci, Inst Fruit Tree Res, Guangzhou, Guangdong, Peoples R China; [Liu, Wei; Xiao, Zhidan; Bao, Xiuli; Yang, Xiaoyan; Fang, Jing; Xiang, Xu] Minist Agr, Key Lab South Subtrop Fruit Biol & Genet Resource, Guangzhou, Guangdong, Peoples R China; [Liu, Wei; Xiao, Zhidan; Bao, Xiuli; Yang, Xiaoyan; Fang, Jing; Xiang, Xu] Guangdong Prov Key Lab Trop & Subtrop Fruit Tree, Guangzhou, Guangdong, Peoples R China; [Xiao, Zhidan] S China Normal Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Bao, Xiuli] Huazhong Agr Univ, Coll Hort & Forestry Sci, Wuhan, Peoples R China	Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; South China Normal University; Huazhong Agricultural University	Xiang, X (corresponding author), Guangdong Acad Agr Sci, Inst Fruit Tree Res, Guangzhou, Guangdong, Peoples R China.	xiangxu@vip.163.com			National Natural Science Foundation of China [31272135, 31401829]; Guangdong Provincial Department of Science and Technology [2014B070706018]; Natural Science Foundation of Guangdong Province, China [2014A030310467]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Department of Science and Technology; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/)(Grant No: 31272135) for XX, Guangdong Provincial Department of Science and Technology (http://www.gdstc.gov.cn) (Grant No: 2014B070706018) for XX, National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Grant No: 31401829) for WL, and Natural Science Foundation of Guangdong Province, China (http://www.gdstc.gov.cn/) (Grant No: 2014A030310467) for WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuntalabhochai R., 2002, ACTA HORTIC, V575, P253, DOI DOI 10.17660/ActaHortic.2002.575.27; ARADHYA MK, 1995, SCI HORTIC-AMSTERDAM, V63, P21, DOI 10.1016/0304-4238(95)00788-U; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Cabezas JA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-153; Chagne D., 2007, Association mapping in plants, P77, DOI 10.1007/978-0-387-36011-9_5; Chen YeYuan, 2004, Acta Horticulturae Sinica, V31, P224; Chen YY, 2012, THESIS HAINAN U; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Oliveira EJ, 2014, THEOR APPL GENET, V127, P1423, DOI 10.1007/s00122-014-2309-8; DEGANI C, 1995, J AM SOC HORTIC SCI, V120, P307, DOI 10.21273/JASHS.120.2.307; Degani C, 2003, J AM SOC HORTIC SCI, V128, P838, DOI 10.21273/JASHS.128.6.0838; Deleu W, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-90; Ding Xiao-dong, 2000, Journal of Tropical and Subtropical Botany, V8, P49; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu JX, 2010, THESIS S CHINA AGR U; Ganopoulos I, 2013, PLANT MOL BIOL REP, V31, P763, DOI 10.1007/s11105-012-0538-z; Ghaffari S, 2014, TREE GENET GENOMES, V10, P1103, DOI 10.1007/s11295-014-0746-9; Huang XM, 2005, LITCHI AND LONGAN: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9780851996967.0001; Ji K, 2013, GENET RESOUR CROP EV, V60, P441, DOI 10.1007/s10722-012-9847-1; Jiang D, 2010, AGR SCI CHINA, V9, P179, DOI 10.1016/S1671-2927(09)60082-1; Jung JK, 2010, EUPHYTICA, V175, P91, DOI 10.1007/s10681-010-0191-2; Kaya HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073674; Kwon SJ, 2012, MOL BREEDING, V29, P887, DOI 10.1007/s11032-011-9623-5; Li CQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-552; Li JG, 2008, THE LITCHI; Liu C, 2005, ACTA HORTIC, P149, DOI 10.17660/ActaHortic.2005.665.17; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Madhou M, 2014, ACTA HORTIC, V1029, P93, DOI 10.17660/ActaHortic.2014.1029.10; Madhou M, 2010, FRUITS, V65, P141, DOI 10.1051/fruits/2010009; Menzel C., 2002, LYCHEE CROP ASIA PAC; Moriya S, 2011, EUPHYTICA, V177, P135, DOI 10.1007/s10681-010-0295-8; Morton J., 1987, FRUITS WARM CLIMATES, P328; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nielsen G., 1985, ISOZYMES CURRENT TOP, P569; Ophir R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088998; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peng HongXiang, 2006, Southwest China Journal of Agricultural Sciences, V19, P108; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Viruel MA, 2004, THEOR APPL GENET, V108, P896, DOI 10.1007/s00122-003-1497-4; Wang JiaBao, 2006, Journal of Agricultural Biotechnology, V14, P391; [魏守兴 Wei Shouxing], 2006, [热带作物学报, Chinese Journal of Tropical Crops], V27, P51; Wu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094506; Wu SX, 1998, ENCY CHINA FRUITS LI; Xie RJ, 2011, PLANT MOL BIOL REP, V29, P554, DOI 10.1007/s11105-010-0261-6; Xu XiAng, 2010, Genomics and Applied Biology, V29, P1082; Yao QingRong, 2009, Bulletin of Botanical Research, V29, P628; Yi GanJun, 2003, Acta Horticulturae Sinica, V30, P399; Yoon MS, 2007, THEOR APPL GENET, V114, P885, DOI 10.1007/s00122-006-0487-8; [昝逢刚 Zan Fenggang], 2009, [分子植物育种, Molecular Plant Breeding], V7, P562	54	17	19	6	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135390	10.1371/journal.pone.0135390	http://dx.doi.org/10.1371/journal.pone.0135390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26261993	Green Submitted, Green Published, gold			2022-12-27	WOS:000359353300079
J	Wang, S; Cao, Y				Wang, Shuo; Cao, Yang			The Abridgment and Relaxation Time for a Linear Multi-Scale Model Based on Multiple Site Phosphorylation	PLOS ONE			English	Article							STOCHASTIC SIMULATION; ASSUMPTION; NOISE	Random effect in cellular systems is an important topic in systems biology and often simulated with Gillespie's stochastic simulation algorithm (SSA). Abridgment refers to model reduction that approximates a group of reactions by a smaller group with fewer species and reactions. This paper presents a theoretical analysis, based on comparison of the first exit time, for the abridgment on a linear chain reaction model motivated by systems with multiple phosphorylation sites. The analysis shows that if the relaxation time of the fast subsystem is much smaller than the mean firing time of the slow reactions, the abridgment can be applied with little error. This analysis is further verified with numerical experiments for models of bistable switch and oscillations in which linear chain system plays a critical role.	[Wang, Shuo; Cao, Yang] Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Cao, Y (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA.	ycao@cs.vt.edu			National Science Foundation [DMS-1225160, CCF-0953590]; National Institutes of Health [GM078989]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078989] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [0953590] Funding Source: National Science Foundation; Direct For Mathematical & Physical Scien [1225160] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [1526666] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Y Cao received funding from National Science Foundation under award DMS-1225160 and CCF-0953590 and the National Institutes of Health under award GM078989.	Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Cao Y, 2005, J CHEM PHYS, V122, DOI [10.1063/1.1824902, 10.1063/1.1924598]; Cao Y, 2005, J COMPUT PHYS, V206, P395, DOI 10.1016/j.jcp.2004.12.014; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Eisenstat SC, 1998, SIAM J MATRIX ANAL A, V20, P149, DOI 10.1137/S0895479897323282; Gillespie DT, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3072704; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Kapuy O, 2005, PROG BIOPHYS MOL BIO; Kar S, 2009, P NATL ACAD SCI USA, V106, P6471, DOI 10.1073/pnas.0810034106; Kijima M, 1997, MARKOV PROCESSES STO; LEDERMANN W, 1954, PHILOS TR R SOC S-A, V246, P321, DOI 10.1098/rsta.1954.0001; Qu ZL, 2003, AM J PHYSIOL-CELL PH, V284, pC349, DOI 10.1152/ajpcell.00066.2002; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Thomas P, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3661156; Wilkinson JH, 1965, ALGEBRAIC EIGENVALUE	17	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0133295	10.1371/journal.pone.0133295	http://dx.doi.org/10.1371/journal.pone.0133295			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263559	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300006
J	Yu, T; Taussig, MD; DiPatrizio, NV; Astarita, G; Piomelli, D; Bergman, BC; Dell'Acqua, ML; Eckel, RH; Wang, H				Yu, Tian; Taussig, Matthew D.; DiPatrizio, Nicholas V.; Astarita, Giuseppe; Piomelli, Daniele; Bergman, Bryan C.; Dell'Acqua, Mark L.; Eckel, Robert H.; Wang, Hong			Deficiency of Lipoprotein Lipase in Neurons Decreases AMPA Receptor Phosphorylation and Leads to Neurobehavioral Abnormalities in Mice	PLOS ONE			English	Article							APOLIPOPROTEIN-E RECEPTOR; DOCOSAHEXAENOIC ACID; SYNAPTIC PLASTICITY; CHOLESTEROL LEVELS; GLUR1 SUBUNIT; GENE; AGE; BRAIN; TRAFFICKING; KNOCKOUT	Alterations in lipid metabolism have been found in several neurodegenerative disorders, including Alzheimer's disease. Lipoprotein lipase (LPL) hydrolyzes triacylglycerides in lipoproteins and regulates lipid metabolism in multiple organs and tissues, including the central nervous system (CNS). Though many brain regions express LPL, the functions of this lipase in the CNS remain largely unknown. We developed mice with neuron-specific LPL deficiency that became obese on chow by 16 wks in homozygous mutant mice (NEXLPL-/-) and 10 mo in heterozygous mice (NEXLPL+/-). In the present study, we show that 21 mo NEXLPL+/- mice display substantial cognitive function decline including poorer learning and memory, and increased anxiety with no difference in general motor activities and exploratory behavior. These neurobehavioral abnormalities are associated with a reduction in the 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl) propanoic acid (AMPA) receptor subunit GluA1 and its phosphorylation, without any alterations in amyloid beta accumulation. Importantly, a marked deficit in omega-3 and omega-6 polyunsaturated fatty acids (PUFA) in the hippocampus precedes the development of the neurobehavioral phenotype of NEXLPL+/- mice. And, a diet supplemented with n-3 PUFA can improve the learning and memory of NEXLPL+/- mice at both 10 mo and 21 mo of age. We interpret these findings to indicate that LPL regulates the availability of PUFA in the CNS and, this in turn, impacts the strength of synaptic plasticity in the brain of aging mice through the modification of AMPA receptor and its phosphorylation.	[Yu, Tian; Taussig, Matthew D.; Bergman, Bryan C.; Eckel, Robert H.; Wang, Hong] Univ Colorado, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO 80045 USA; [DiPatrizio, Nicholas V.; Astarita, Giuseppe; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92617 USA; [Dell'Acqua, Mark L.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; University of Colorado System; University of Colorado Anschutz Medical Campus	Eckel, RH (corresponding author), Univ Colorado, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO 80045 USA.	Robert.Eckel@ucdenver.edu; hong.wang@ucdenver.edu	Astarita, Giuseppe/AAD-1239-2019; Bergman, Bryan/T-8055-2019; DiPatrizio, NIcholas/AAV-1865-2021; Astarita, Giuseppe/N-7346-2014	DiPatrizio, NIcholas/0000-0001-8423-0695; Astarita, Giuseppe/0000-0001-6700-301X; Bergman, Bryan/0000-0002-9561-1052	mentored BIRCWH training grant [NIH-K12 HD057022]; American Diabetes Association Basic Science Research Award [1-10-BS-45]; NIH [DK089309, NS040701, DK073955]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD057022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073955, R01DK089309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS040701, P30NS048154, R01NS040701] Funding Source: NIH RePORTER	mentored BIRCWH training grant; American Diabetes Association Basic Science Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH-K12 HD057022, a mentored BIRCWH training grant (HW); American Diabetes Association Basic Science Research Award (#1-10-BS-45) (RHE); NIH grants DK089309 (RHE), NS040701 (MD), and DK073955 (DP).	Astarita G, 2009, METHODS MOL BIOL, V579, P201, DOI 10.1007/978-1-60761-322-0_10; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bergman BC, 2009, DIABETES, V58, P2220, DOI 10.2337/db09-0481; Bijvoet S, 1996, J LIPID RES, V37, P640; BIRCH EE, 1992, INVEST OPHTH VIS SCI, V33, P3242; Blain JF, 2006, EUR J NEUROSCI, V24, P1245, DOI 10.1111/j.1460-9568.2006.05007.x; Bonifati DM, 2007, MOL IMMUNOL, V44, P999, DOI 10.1016/j.molimm.2006.03.007; Breslow JL, 2006, AM J CLIN NUTR, V83, p1477S, DOI 10.1093/ajcn/83.6.1477S; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Calderon F, 2004, J NEUROCHEM, V90, P979, DOI 10.1111/j.1471-4159.2004.02520.x; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Christie RH, 1996, J NEUROPATH EXP NEUR, V55, P491, DOI 10.1097/00005072-199604000-00012; da Costa KA, 2010, J BIOL CHEM, V285, P1008, DOI 10.1074/jbc.M109.017137; Danik M, 1999, CRIT REV NEUROBIOL, V13, P357, DOI 10.1615/CritRevNeurobiol.v13.i4.20; de Oliveira J, 2011, NEUROSCIENCE, V197, P99, DOI 10.1016/j.neuroscience.2011.09.009; Dyall SC, 2007, NEUROBIOL AGING, V28, P424, DOI 10.1016/j.neurobiolaging.2006.01.002; Elder GA, 2008, BEHAV BRAIN RES, V191, P256, DOI 10.1016/j.bbr.2008.03.036; Fernandez-Monreal M, 2012, J NEUROSCI, V32, P13200, DOI 10.1523/JNEUROSCI.0061-12.2012; Moreira ELG, 2012, J ALZHEIMERS DIS, V32, P495, DOI 10.3233/JAD-2012-120541; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; JEMAA R, 1995, J LIPID RES, V36, P2141; KALUZNY MA, 1985, J LIPID RES, V26, P135; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Luscher C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005710; MAILLY F, 1995, ARTERIOSCL THROM VAS, V15, P468, DOI 10.1161/01.ATV.15.4.468; Marshall BA, 1999, J BIOL CHEM, V274, P27426, DOI 10.1074/jbc.274.39.27426; McGahon BM, 1999, NEUROSCIENCE, V94, P305, DOI 10.1016/S0306-4522(99)00219-5; MCGEER PL, 1992, BRAIN RES, V579, P337, DOI 10.1016/0006-8993(92)90071-G; Menard C, 2009, J NEUROSCI RES, V87, P876, DOI 10.1002/jnr.21916; NEVIN DN, 1994, ARTERIOSCLER THROMB, V14, P869, DOI 10.1161/01.ATV.14.6.869; Nishitsuji K, 2011, J BIOL CHEM, V286, P6393, DOI 10.1074/jbc.M110.172106; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; REBECK GW, 1995, ANN NEUROL, V37, P211, DOI 10.1002/ana.410370212; REYMER PWA, 1995, NAT GENET, V10, P28, DOI 10.1038/ng0595-28; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Santamarina-Fojo S, 1998, ENDOCRIN METAB CLIN, V27, P551, DOI 10.1016/S0889-8529(05)70025-6; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; SVENNERHOLM L, 1994, J NEUROCHEM, V62, P1039; Terrisse L, 1998, J NEUROCHEM, V71, P1643; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/825364; Wang H, 2014, TRENDS ENDOCRIN MET, V25, P8, DOI 10.1016/j.tem.2013.10.003; Wang H, 2012, ANNU REV NUTR, V32, P147, DOI 10.1146/annurev-nutr-071811-150703; Wang H, 2011, CELL METAB, V13, P105, DOI 10.1016/j.cmet.2010.12.006; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang H, 2009, DIABETES, V58, P116, DOI 10.2337/db07-1839; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Xian XD, 2009, J NEUROSCI, V29, P4681, DOI 10.1523/JNEUROSCI.0297-09.2009	55	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135113	10.1371/journal.pone.0135113	http://dx.doi.org/10.1371/journal.pone.0135113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263173	Green Published, gold			2022-12-27	WOS:000359353300059
J	Yuan, YY; Pan, BF; Sun, HP; Chen, GQ; Su, B; Huang, Y				Yuan, Yuanyang; Pan, Bangfen; Sun, Haipeng; Chen, Guoqiang; Su, Bing; Huang, Ying			Characterization of Sin1 Isoforms Reveals an mTOR-Dependent and Independent Function of Sin1 gamma	PLOS ONE			English	Article							AGC KINASES; PROTEIN; COMPLEX; BINDING; PHOSPHORYLATION; LOCALIZATION; COMPONENT; PATHWAY; STRESS; CANCER	Sin1 or MAPKAP1 is a key component of mTORC2 signaling complex which is necessary for AKT phosphorylation at the S473 and T450 sites, and also for AKT downstream signaling as well. A number of Sin1 splicing variants have been reported that can produce different Sin1 isoforms due to exon skipping or alternative transcription initiation. In this report, we characterized four Sin1 isoforms, including a novel Sin1 isoform due to alternative 3' termination of the exon 9a, termed Sin1 gamma. Sin1 gamma expression can be detected in multiple adult mouse tissues, and it encodes a C-terminal truncated protein comparing to the full length Sin1 beta isoform. In contrast to Sin1 beta, Sin1 gamma overexpression in Sin1 deficient mouse embryonic fibroblasts has no significant impact on mTORC2 activity or mTORC2 subunits protein level, although it still can interact with mTORC2 components. More interestingly, Sin1 gamma was detected in a specific cytosolic location with a distinct feature in structure, and its localization was transiently disrupted during cell cycle. Therefore, Sin1 gamma is a novel Sin1 isoform and may have distinct properties in cell signaling and intracellular localization from other Sin1 isoforms.	[Yuan, Yuanyang; Pan, Bangfen; Sun, Haipeng; Chen, Guoqiang; Huang, Ying] Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis,Natl Minist, Shanghai 200025, Peoples R China; [Su, Bing] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Huang, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis,Natl Minist, Shanghai 200025, Peoples R China.	daphnehy@sjtu.edu.cn		Sun, Haipeng/0000-0003-2128-3209	National Natural Science Foundation of China [31101017, 30973462]; Science and Technology Commission of Shanghai Municipality [11QA1403700]; China Postdoctoral Science Foundation [20110409740]; Innovation Program of Shanghai Municipal Education Commission [14ZZ109]; ministry of Science and Technology of China Grant [2012BAI02B05]; Shanghai Jiaotong University K. C. Wong Medical Fellowship Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); ministry of Science and Technology of China Grant; Shanghai Jiaotong University K. C. Wong Medical Fellowship Fund	This manuscript was supported by National Natural Science Foundation of China (31101017 and 30973462), Science and Technology Commission of Shanghai Municipality (11QA1403700), China Postdoctoral Science Foundation (20110409740), Innovation Program of Shanghai Municipal Education Commission(14ZZ109), ministry of Science and Technology of China Grant (2012BAI02B05) and Shanghai Jiaotong University K. C. Wong Medical Fellowship Fund.	Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034; Cameron AJM, 2011, BIOCHEM J, V439, P287, DOI 10.1042/BJ20110678; Cardenas-Rodriguez M, 2013, HUM MOL GENET, V22, P4031, DOI 10.1093/hmg/ddt253; Cheng J, 2005, MOL CELL BIOL, V25, P5955, DOI 10.1128/MCB.25.14.5955-5964.2005; COLICELLI J, 1991, P NATL ACAD SCI USA, V88, P2913, DOI 10.1073/pnas.88.7.2913; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Schroder W, 2005, CELL SIGNAL, V17, P761, DOI 10.1016/j.cellsig.2004.10.015; Schroder W, 2004, GENE, V339, P17, DOI 10.1016/j.gene.2004.07.001; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shang YH, 2005, J CELL BIOL, V171, P1035, DOI 10.1083/jcb.200508184; Su B, 2011, CRIT REV BIOCHEM MOL, V46, P527, DOI 10.3109/10409238.2011.618113; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; Wang X, 2008, DEV CELL, V14, P331, DOI 10.1016/j.devcel.2007.12.007; Wilkinson MG, 1999, EMBO J, V18, P4210, DOI 10.1093/emboj/18.15.4210; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yuan SAL, 2012, P NATL ACAD SCI USA, V109, P2021, DOI 10.1073/pnas.1112834109; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	26	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135017	10.1371/journal.pone.0135017	http://dx.doi.org/10.1371/journal.pone.0135017			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263164	Green Published, Green Submitted, gold			2022-12-27	WOS:000359353300051
J	Pan, CW; Li, J; Zhong, H; Shen, W; Niu, ZQ; Yuan, YS; Chen, Q				Pan, Chen-Wei; Li, Jun; Zhong, Hua; Shen, Wei; Niu, Zhiqiang; Yuan, Yuansheng; Chen, Qin			Ethnic Variations in Central Corneal Thickness in a Rural Population in China: The Yunnan Minority Eye Studies	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; SINGAPORE-EPIDEMIOLOGY; BAI NATIONALITY; ADULT CHINESE; RISK-FACTORS; GLAUCOMA; PREVALENCE; DALI	Purpose To describe the ethnic differences in central corneal thickness (CCT) in population-based samples of ethnic Bai, Yi and Han people living in rural China. Methods 6504 adults (2119 ethnic Bai, 2202 ethnic Yi and 2183 ethnic Han) aged 50 years or older participated in the study. Each subject underwent standardized ocular examinations and interviewer-administered questionnaires for risk factor assessment. CCT was measured for both eyes using an ultrasound pachymeter. Regression and principal component analysis were performed to examine the relationship of ethnicity and other factors with CCT. Results The mean CCT readings were 536.4 +/- 34.2 mu m in ethnic Bai, 532.1 +/- 32.1 mu m in ethnic Yi and 529.6 +/- 32.7 mu m in ethnic Han adults (P<0.001), respectively. There was a decreasing trend of mean CCT with increasing age across all ethnic groups. In multivariate linear regression models, increasing CCT was associated with younger age (P<0.001), male gender (P<0.001), Bai (P<0.001) or Yi (P<0.001) ethnicity, greater body mass index (P<0.001), higher systolic blood pressure (P<0.001), greater corneal curvature (P<0.001), deeper anterior chamber (P < 0.001), and thicker lens (P<0.001). Ethnicity contributed significantly to presence of thin cornea (60%; P<0.001) compared with other factors. CCT had similar impact on intraocular pressure readings across all ethnic groups. Conclusions This study of more than 6500 multiethnic participants demonstrates significant ethnic variations in CCT, with Han ethnicity having the thinnest cornea compared with ethnic minorities. These data are essential to guide future multiethnic clinical trials on CCT-related ocular conditions such as glaucoma.	[Pan, Chen-Wei] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Sch Publ Hlth, Coll Med, Suzhou, Peoples R China; [Li, Jun; Shen, Wei] Second Peoples Hosp Yunnan Prov, Kunming, Peoples R China; [Zhong, Hua; Niu, Zhiqiang; Yuan, Yuansheng] Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China; [Chen, Qin] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Kunming Medical University; Nanjing Medical University	Chen, Q (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	chenkmu@163.com	Pan, Chen-Wei/L-7174-2019	Pan, Chen-Wei/0000-0003-3362-4613; Chen, Qin/0000-0002-0526-2005	National Natural Science Foundation of China [81460085, 81160121, 81371016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China under grant No. 81460085, No. 81160121 and No. 81371016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy D, 2014, CAN J OPHTHALMOL, V49, P152, DOI 10.1016/j.jcjo.2013.12.010; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Brandt JD, 2001, OPHTHALMOLOGY, V108, P1779, DOI 10.1016/S0161-6420(01)00760-6; Brandt JD, 2004, AM J OPHTHALMOL, V138, P717, DOI 10.1016/j.ajo.2004.07.036; Carbonaro F, 2014, AM J OPHTHALMOL, V157, P441, DOI 10.1016/j.ajo.2013.10.017; Chua J, 2014, OPHTHALMOLOGY, V121, P2013, DOI 10.1016/j.ophtha.2014.04.041; Day AC, 2011, INVEST OPHTH VIS SCI, V52, P8407, DOI 10.1167/iovs.11-7927; Herndon LW, 2004, ARCH OPHTHALMOL-CHIC, V122, P17, DOI 10.1001/archopht.122.1.17; Hwang YH, 2012, INVEST OPHTH VIS SCI, V53, P6851, DOI 10.1167/iovs.12-10173; Li J, 2012, INVEST OPHTH VIS SCI, V53, P4498, DOI 10.1167/iovs.12-9429; Nalcacioglu-Yuksekkaya P, 2014, EUR J OPHTHALMOL, V24, P309, DOI 10.5301/ejo.5000390; Nangia V, 2010, OPHTHALMOLOGY, V117, P705, DOI 10.1016/j.ophtha.2009.09.003; Pan CW, 2015, INVEST OPHTH VIS SCI, V56, P3235, DOI 10.1167/iovs.14-16357; Pan CW, 2013, INVEST OPHTH VIS SCI, V54, P2590, DOI 10.1167/iovs.13-11725; Shen W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060236; Suh W, 2012, AM J OPHTHALMOL, V154, P99, DOI 10.1016/j.ajo.2012.01.009; Tandon A, 2014, JAMA OPHTHALMOL, V132, P782, DOI 10.1001/jamaophthalmol.2014.306; Tomidokoro A, 2007, AM J OPHTHALMOL, V144, P152, DOI 10.1016/j.ajo.2007.02.031; Wang DD, 2011, AM J OPHTHALMOL, V152, P454, DOI 10.1016/j.ajo.2011.03.005; Wang SY, 2014, J GLAUCOMA, V23, P606, DOI 10.1097/IJG.0000000000000088; Xu L, 2008, ARCH OPHTHALMOL-CHIC, V126, P435, DOI 10.1001/archopht.126.3.435; Xu L, 2010, GRAEF ARCH CLIN EXP, V248, P759, DOI 10.1007/s00417-009-1217-0; Zhang HT, 2008, GRAEF ARCH CLIN EXP, V246, P587, DOI 10.1007/s00417-007-0760-9; Zhong H, 2012, INVEST OPHTH VIS SCI, V53, P6617, DOI 10.1167/iovs.11-8947; Zhong H, 2012, INVEST OPHTH VIS SCI, V53, P3221, DOI 10.1167/iovs.11-9306; Zhou Q, 2012, OPHTHAL EPIDEMIOL, V19, P278, DOI 10.3109/09286586.2012.708084	26	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135913	10.1371/journal.pone.0135913	http://dx.doi.org/10.1371/journal.pone.0135913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274328	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600133
J	Pan, Y; Zhang, YS; Peng, Y; Zhao, QH; Sun, SC				Pan, Ying; Zhang, Yunshu; Peng, Yan; Zhao, Qinghua; Sun, Shucun			Increases of Chamber Height and Base Diameter Have Contrasting Effects on Grazing Rate of Two Cladoceran Species: Implications for Microcosm Studies	PLOS ONE			English	Article							MOINA-MICRURA KURZ; SWIMMING BEHAVIOR; DAPHNIA-MAGNA; MICROCYSTIS-AERUGINOSA; FOOD; SIZE; OXYGEN; PREDATION; MOTILITY; PRODUCTIVITY	Aquatic microcosm studies often increase either chamber height or base diameter (to increase water volume) to test spatial ecology theories such as "scale" effects on ecological processes, but it is unclear whether the increase of chamber height or base diameter have the same effect on the processes, i.e., whether the effect of the shape of three-dimensional spaces is significant. We orthogonally manipulated chamber height and base diameter and determined swimming activity, average swimming velocity and grazing rates of the cladocerans Daphnia magna and Moina micrura (on two algae Scenedesmus quadricauda and Chlorella vulgaris; leading to four aquatic algae-cladoceran systems in total) under different microcosm conditions. Across all the four aquatic systems, increasing chamber height at a given base diameter significantly decreased the duration and velocity of horizontal swimming, and it tended to increase the duration but decrease the velocity of vertical swimming. These collectively led to decreases in both average swimming velocity and grazing rate of the cladocerans in the tall chambers (at a given base diameter), in accordance with the positive relationship between average swimming velocity and grazing rate. In contrast, an increase of base diameter at a given chamber height showed contrasting effects on the above parameters. Consistently, at a given chamber volume increasing ratio of chamber height to base diameter decreased the average swimming velocity and grazing rate across all the aquatic systems. In general, increasing chamber depth and base diameter may exert contrasting effects on zooplankton behavior and thus phytoplankton-zooplankton interactions. We suggest that spatial shape plays an important role in determining ecological process and thus should be considered in a theoretical framework of spatial ecology and also the physical setting of aquatic microcosm experiments.	[Pan, Ying; Zhang, Yunshu; Zhao, Qinghua; Sun, Shucun] Nanjing Univ, Dept Biol, Nanjing 210093, Jiangsu, Peoples R China; [Pan, Ying] Yunnan Univ, Sch Ecol & Environm Sci, Kunming 650031, Peoples R China; [Sun, Shucun] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat S, Chengdu 610041, Peoples R China; [Peng, Yan] Changjiang Inst Technol, Dept Surveying & Mapping Engn, Wuhan 430212, Peoples R China	Nanjing University; Yunnan University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Sun, SC (corresponding author), Nanjing Univ, Dept Biol, Nanjing 210093, Jiangsu, Peoples R China.	shcs@nju.edu.cn			National Special Transgenic Project [2011ZX08012-005]; National Natural Science Foundation of China [31300361, 31325004]	National Special Transgenic Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Special Transgenic Project (2011ZX08012-005) and the National Natural Science Foundation of China (31300361 and 31325004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva-Martinez AF, 2001, CRUSTACEANA, V74, P749, DOI 10.1163/156854001317015571; Artells E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071260; Atkinson A, 2002, LIMNOL OCEANOGR, V47, P953, DOI 10.4319/lo.2002.47.4.0953; BALCIUNAS D, 1995, ECOLOGY, V76, P1327, DOI 10.2307/1940939; BOUDRIAS MA, 1991, HYDROBIOLOGIA, V223, P11, DOI 10.1007/BF00047624; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; BUCHANAN C, 1982, HYDROBIOLOGIA, V94, P77, DOI 10.1007/BF00008635; CARPENTER SR, 1995, SCIENCE, V269, P324, DOI 10.1126/science.269.5222.324; Christensen BT, 2005, AQUAT TOXICOL, V73, P210, DOI 10.1016/j.aquatox.2005.03.011; CUDDINGTON KM, 1994, CAN J ZOOL, V72, P1217, DOI 10.1139/z94-163; Dodson SI, 1997, J PLANKTON RES, V19, P1537, DOI 10.1093/plankt/19.10.1537; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; FOGG GE, 1989, HYDROBIOLOGIA, V173, P89, DOI 10.1007/BF00015518; GASCON C, 1992, ECOLOGY, V73, P2237, DOI 10.2307/1941471; Ghadouani A, 2004, LIMNOL OCEANOGR, V49, P666, DOI 10.4319/lo.2004.49.3.0666; Gorski PR, 1996, LIMNOL OCEANOGR, V41, P1815, DOI 10.4319/lo.1996.41.8.1815; GRANATA TC, 1991, PROG OCEANOGR, V26, P243, DOI 10.1016/0079-6611(91)90003-5; GREEN J., 1956, PROC ZOOL SOC LONDON, V126, P173; Hammes F, 2010, APPL ENVIRON MICROB, V76, P1278, DOI 10.1128/AEM.01914-09; HOMER DH, 1983, WATER AIR SOIL POLL, V20, P23, DOI 10.1007/BF00279493; KHALAF AN, 1979, HYDROBIOLOGIA, V62, P75, DOI 10.1007/BF00012566; Komin N, 2004, FLUCT NOISE LETT, V4, pL151, DOI 10.1142/S0219477504001756; KRING RL, 1976, ECOLOGY, V57, P808, DOI 10.2307/1936194; Lampert W., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P143; Larsson P, 2011, LIMNOL OCEANOGR, V56, P1682, DOI 10.4319/lo.2011.56.5.1682; LISS PS, 1973, DEEP-SEA RES, V20, P221, DOI 10.1016/0011-7471(73)90013-2; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Lurling M, 2003, LIMNOL OCEANOGR, V48, P2214; Manenti R, 2013, ANIM BEHAV, V86, P375, DOI 10.1016/j.anbehav.2013.05.028; Martinez-Jeronimo F, 2007, HYDROBIOLOGIA, V594, P69, DOI 10.1007/s10750-007-9081-6; Moison M, 2012, AQUAT BIOL, V16, P149, DOI 10.3354/ab00438; NEARY J, 1994, FUNCT ECOL, V8, P377, DOI 10.2307/2389831; O'Donnell DR, 2013, J PLANKTON RES, V35, P191, DOI 10.1093/plankt/fbs083; PACE ML, 1983, ECOLOGY, V64, P1145, DOI 10.2307/1937825; Pagano M, 2008, J PLANKTON RES, V30, P401, DOI 10.1093/plankt/fbn014; Panosso R, 2010, J PLANKTON RES, V32, P1393, DOI 10.1093/plankt/fbq057; Sarnelle O, 1997, ECOLOGY, V78, P913; Schatz GS, 2007, OECOLOGIA, V153, P1021, DOI 10.1007/s00442-007-0793-0; Schladow SG, 2002, LIMNOL OCEANOGR, V47, P1394, DOI 10.4319/lo.2002.47.5.1394; Seuront L, 2006, J PLANKTON RES, V28, P805, DOI 10.1093/plankt/fbl012; Spencer M, 1996, OIKOS, V75, P419, DOI 10.2307/3545882; Svetlichny LS, 2005, J PLANKTON RES, V27, P671, DOI 10.1093/plankt/fbi041; Titelman J, 2003, MAR ECOL PROG SER, V247, P123, DOI 10.3354/meps247123; VANDONK E, 1993, OECOLOGIA, V93, P508, DOI 10.1007/BF00328958; Visser AW, 2006, OECOLOGIA, V148, P538, DOI 10.1007/s00442-006-0385-4; Visser AW, 2003, J PLANKTON RES, V25, P1157, DOI 10.1093/plankt/25.9.1157; Wallace WG, 2004, AQUAT TOXICOL, V69, P289, DOI 10.1016/j.aquatox.2004.05.010; Weber A, 2002, J PLANKTON RES, V24, P1335, DOI 10.1093/plankt/24.12.1335; Wilhelm FM, 2000, J PLANKTON RES, V22, P1719, DOI 10.1093/plankt/22.9.1719; Wolf G, 1998, COMP BIOCHEM PHYS A, V120, P99, DOI 10.1016/S1095-6433(98)10016-8	50	13	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135786	10.1371/journal.pone.0135786	http://dx.doi.org/10.1371/journal.pone.0135786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26273836	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600112
J	Huang, CY; Wei, ZH				Huang, Chen-Yu; Wei, Zung-Hang			Concentric Magnetic Structures for Magnetophoretic Bead Collection, Cell Trapping and Analysis of Cell Morphological Changes Caused by Local Magnetic Forces	PLOS ONE			English	Article							NANOPARTICLES; MANIPULATION; APOPTOSIS	Concentric magnetic structures (ring and square) with domain wall (DW) pinning geometry are designed for biological manipulation. Magnetic beads collection was firstly demonstrated to analyse the local magnetic field generated by DWs and the effective regions to capture magnetic targets of size 1 mu m. Primary mouse embryonic fibroblasts (MEFs) are magnetically labeled by internalizing poly (styrene sulfonic acid) stabilized magnetic nanoparticles (PSS-MNPs) and then are selectively trapped by head-to-tail DWs (HH DWs) or tail-to-tail DWs (TT DWs) to be arranged into linear shape or cross shape. The morphologies and the nuclear geometry of the cells growing on two kinds of concentric magnetic structures are shown to be distinctive. The intracellular magnetic forces generated by the local magnetic field of DWs are found to influence the behaviour of cells.	[Huang, Chen-Yu; Wei, Zung-Hang] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan	National Tsing Hua University	Wei, ZH (corresponding author), Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan.	wei@pme.nthu.edu.tw	HUANG, CHEN-YU/F-7226-2018; HUANG, CHENYU/GVT-7299-2022	HUANG, CHEN-YU/0000-0002-9932-5651; 	Ministry of Science and Technology, Taiwan [NSC 102-2112-M-007-012-MY3, NSC 103-2221-E-007-017-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology, Taiwan, Grant Numbers NSC 102-2112-M-007-012-MY3, NSC 103-2221-E-007-017-MY2.	Ahmad S, 2009, J INORG ORGANOMET P, V19, P355, DOI 10.1007/s10904-009-9276-6; Anandakumar S, 2010, BIOSENS BIOELECTRON, V26, P1755, DOI 10.1016/j.bios.2010.08.033; Barbee KD, 2009, LAB CHIP, V9, P3268, DOI 10.1039/b912876j; Basavaiah K., 2012, CHEM SCI T, V2, P382, DOI [10.7598/cst2012.4790, DOI 10.7598/CST2012.4790]; Bradshaw M, 2015, NANOSCALE, V7, P4884, DOI 10.1039/c4nr06594h; CHANTRELL RW, 1978, IEEE T MAGN, V14, P975, DOI 10.1109/TMAG.1978.1059918; Chiou PY, 2005, NATURE, V436, P370, DOI [10.1038/nature03831, 10.1038/nature0383l]; Crane MM, 2009, LAB CHIP, V9, P38, DOI 10.1039/b813730g; Donolato M, 2011, LAB CHIP, V11, P2976, DOI 10.1039/c1lc20300b; Fonnum G, 2005, J MAGN MAGN MATER, V293, P41, DOI 10.1016/j.jmmm.2005.01.041; Gertz F, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4730945; Huang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096550; Huang NT, 2012, LAB CHIP, V12, P4093, DOI 10.1039/c2lc40619e; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Johnson MT, 1996, REP PROG PHYS, V59, P1409, DOI 10.1088/0034-4885/59/11/002; Konstantinovic Z, 2006, NANOTECHNOLOGY, V17, P4106, DOI 10.1088/0957-4484/17/16/019; Lai MF, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.104419; Lai MF, 2003, J APPL PHYS, V93, P7426, DOI 10.1063/1.1558588; Lamm GM, 1997, NUCLEIC ACIDS RES, V25, P4855, DOI 10.1093/nar/25.23.4855; Nilsson J, 2009, ANAL CHIM ACTA, V649, P141, DOI 10.1016/j.aca.2009.07.017; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Riggio C, 2014, NANOMED-NANOTECHNOL, V10, P1549, DOI 10.1016/j.nano.2013.12.008; Sims CE, 2007, LAB CHIP, V7, P423, DOI 10.1039/b615235j; Strebel A, 2001, CYTOMETRY, V43, P126, DOI 10.1002/1097-0320(20010201)43:2<126::AID-CYTO1027>3.0.CO;2-J; Vishavkarma R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107895; Whitehill J, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3298741; Zeng J, 2013, J MAGN MAGN MATER, V346, P118, DOI 10.1016/j.jmmm.2013.07.021	27	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0135299	10.1371/journal.pone.0135299	http://dx.doi.org/10.1371/journal.pone.0135299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270332	gold, Green Published, Green Submitted			2022-12-27	WOS:000359492800052
J	Pan, CX; Zhang, HY; Tepper, CG; Lin, TY; Davis, RR; Keck, J; Ghosh, PM; Gill, P; Airhart, S; Bult, C; Gandara, DR; Liu, E; White, RWD				Pan, Chong-xian; Zhang, Hongyong; Tepper, Clifford G.; Lin, Tzu-yin; Davis, Ryan R.; Keck, James; Ghosh, Paramita M.; Gill, Parkash; Airhart, Susan; Bult, Carol; Gandara, David R.; Liu, Edison; White, Ralph W. de Vere			Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; METASTATIC BREAST-CANCER; CHRONIC MYELOID-LEUKEMIA; DNA-SEQUENCING DATA; LUNG-CANCER; RNA-SEQ; 1ST-LINE TREATMENT; TUMOR XENOGRAFTS; MOUSE MODELS; IN-VITRO	Background The overarching goal of this project is to establish a patient-derived bladder cancer xenograft (PDX) platform, annotated with deep sequencing and patient clinical information, to accelerate the development of new treatment options for bladder cancer patients. Herein, we describe the creation, initial characterization and use of the platform for this purpose. Methods and Findings Twenty-two PDXs with annotated clinical information were established from uncultured unselected clinical bladder cancer specimens in immunodeficient NSG mice. The morphological fidelity was maintained in PDXs. Whole exome sequencing revealed that PDXs and parental patient cancers shared 92-97% of genetic aberrations, including multiple druggable targets. For drug repurposing, an EGFR/HER2 dual inhibitor lapatinib was effective in PDX BL0440 (progression-free survival or PFS of 25.4 days versus 18.4 days in the control, p = 0.007), but not in PDX BL0269 (12 days versus 13 days in the control, p = 0.16) although both expressed HER2. To screen for the most effective MTT, we evaluated three drugs (lapatinib, ponatinib, and BEZ235) matched with aberrations in PDX BL0269; but only a PIK3CA inhibitor BEZ235 was effective (p<0.0001). To study the mechanisms of secondary resistance, a fibroblast growth factor receptor 3 inhibitor BGJ398 prolonged PFS of PDX BL0293 from 9.5 days of the control to 18.5 days (p<0.0001), and serial biopsies revealed that the MAPK/ERK and PIK3CA-AKT pathways were activated upon resistance. Inhibition of these pathways significantly prolonged PFS from 12 day of the control to 22 days (p = 0.001). To screen for effective chemotherapeutic drugs, four of the first six PDXs were sensitive to the cisplatin/gemcitabine combination, and chemoresistance to one drug could be overcome by the other drug. Conclusion The PDX models described here show good correlation with the patient at the genomic level and known patient response to treatment. This supports further evaluation of the PDXs for their ability to accurately predict a patient's response to new targeted and combination strategies for bladder cancer.	[Pan, Chong-xian; Zhang, Hongyong; Lin, Tzu-yin; Gandara, David R.] Univ Calif Davis, Dept Internal Med, Div Hematol Oncol, Sacramento, CA 95817 USA; [Pan, Chong-xian; Ghosh, Paramita M.; White, Ralph W. de Vere] Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA; [Pan, Chong-xian; Ghosh, Paramita M.] VA Northern Calif Hlth Care Syst, Mather, CA 95655 USA; [Tepper, Clifford G.; Ghosh, Paramita M.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Davis, Ryan R.] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Keck, James; Airhart, Susan; Bult, Carol; Liu, Edison] Jackson Lab, Sacramento, CA 95838 USA; [Gill, Parkash] Univ So Calif, Los Angeles, CA 90089 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Jackson Laboratory; University of Southern California	Pan, CX (corresponding author), Univ Calif Davis, Dept Internal Med, Div Hematol Oncol, Sacramento, CA 95817 USA.	cxpan@ucdavis.edu; rwdeverewhite@ucdavis.edu		Davis, Ryan/0000-0001-7439-6683	Veteran Administration Career Development Award; Veteran Administration Merit [1I01BA001784]; NCI Cancer Center Support Grant [2 P30 CA 0933730]; Laney Foundation; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001784] Funding Source: NIH RePORTER	Veteran Administration Career Development Award; Veteran Administration Merit; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Laney Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by: Veteran Administration Career Development Award (PI: Pan); Veteran Administration Merit (PI: Pan; Grant #: 1I01BA001784); NCI Cancer Center Support Grant (PI: de Vere White; Grant #: 2 P30 CA 0933730); The Laney Foundation (PI: de Vere White). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2014, LANCET ONCOL, V15, P267, DOI 10.1016/S1470-2045(13)70611-9; Avis NE, 2008, CANCER, V113, P3519, DOI 10.1002/cncr.23941; Avis NE, 2005, QUAL LIFE RES, V14, P1007, DOI 10.1007/s11136-004-2147-2; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Carter AJR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-526; Chamie K, 2013, CANCER-AM CANCER SOC, V119, P3219, DOI 10.1002/cncr.28147; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; HERR HW, 1989, J UROLOGY, V141, P22, DOI 10.1016/S0022-5347(17)40575-1; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; HOUGHTON JA, 1978, BRIT J CANCER, V37, P213, DOI 10.1038/bjc.1978.29; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Malmstrom PU, 1999, J UROLOGY, V161, P1124, DOI 10.1016/S0022-5347(01)61607-0; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsimberidou AM, 2014, CLIN CANCER RES, V20, P4827, DOI 10.1158/1078-0432.CCR-14-0603; Turo R, 2014, J UROL; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; Walrath JC, 2010, ADV CANCER RES, V106, P113, DOI 10.1016/S0065-230X(10)06004-5; Wang SS, 2010, ANTICANCER RES, V30, P4573; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081	51	50	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134346	10.1371/journal.pone.0134346	http://dx.doi.org/10.1371/journal.pone.0134346			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270481	gold, Green Published			2022-12-27	WOS:000359492800008
J	Zeniou, M; Feve, M; Mameri, S; Dong, JH; Salome, C; Chen, WY; El-Habr, EA; Bousson, F; Sy, M; Obszynski, J; Boh, A; Villa, P; Kahn, SA; Didier, B; Bagnard, D; Junier, MP; Chneiweiss, H; Haiech, J; Hibert, M; Kilhoffer, MC				Zeniou, Maria; Feve, Marie; Mameri, Samir; Dong, Jihu; Salome, Christophe; Chen, Wanyin; El-Habr, Elias A.; Bousson, Fanny; Sy, Mohamadou; Obszynski, Julie; Boh, Alexandre; Villa, Pascal; Kahn, Suzana Assad; Didier, Bruno; Bagnard, Dominique; Junier, Marie-Pierre; Chneiweiss, Herve; Haiech, Jacques; Hibert, Marcel; Kilhoffer, Marie-Claude			Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; ACUTE MYELOID-LEUKEMIA; HUMAN OVARIAN-CANCER; DNA ADDUCT FORMATION; IN-VITRO; INDUCED APOPTOSIS; ETHACRYNIC-ACID; MELANOMA-CELLS; THERAPEUTIC TARGET; POTASSIUM CHANNELS	Cancer stem-like cells reside in hypoxic and slightly acidic tumor niches. Such microenvironments favor more aggressive undifferentiated phenotypes and a slow growing "quiescent state" which preserves them from chemotherapeutic agents that essentially target proliferating cells. Our objective was to identify compounds active on glioblastoma stem-like cells, including under conditions that mimick those found in vivo within this most severe and incurable form of brain malignancy. We screened the Prestwick Library to identify cytotoxic compounds towards glioblastoma stem-like cells, either in a proliferating state or in more slow-growing "quiescent" phenotype resulting from non-renewal of the culture medium in vitro. Compound effects were assessed by ATP-level determination using a cell-based assay. Twenty active molecules belonging to different pharmacological classes have thus been identified. Among those, the stimulant laxative drug bisacodyl was the sole to inhibit in a potent and specific manner the survival of quiescent glioblastoma stem-like cells. Subsequent structure-function relationship studies led to identification of 4,4'-dihydroxydiphenyl-2-pyridyl-methane (DDPM), the deacetylated form of bisacodyl, as the pharmacophore. To our knowledge, bisacodyl is currently the only known compound targeting glioblastoma cancer stem-like cells in their quiescent, more resistant state. Due to its known non-toxicity in humans, bisacodyl appears as a new potential anti-tumor agent that may, in association with classical chemotherapeutic compounds, participate in tumor eradication.	[Zeniou, Maria; Feve, Marie; Mameri, Samir; Dong, Jihu; Salome, Christophe; Chen, Wanyin; Bousson, Fanny; Sy, Mohamadou; Obszynski, Julie; Boh, Alexandre; Didier, Bruno; Haiech, Jacques; Hibert, Marcel; Kilhoffer, Marie-Claude] Univ Strasbourg, CNRS, Lab Excellence Medalis, Lab Innovat Therapeut,Fac Pharm,UMR7200, F-67401 Illkirch Graffenstaden, France; [El-Habr, Elias A.; Kahn, Suzana Assad; Junier, Marie-Pierre; Chneiweiss, Herve] UPMC, Neurosci Paris Seine IBPS, CNRS, UMR 8246,Inserm,U1130,UMCR18, F-75005 Paris, France; [Villa, Pascal; Didier, Bruno] Univ Strasbourg, CNRS, Lab Excellence Medalis,Pole API, Plateforme Chim Biol Integrat PCBIS,UMS 3286,ESBS, F-67401 Illkirch Graffenstaden, France; [Bagnard, Dominique] Univ Strasbourg, INSERM, U682, F-67200 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Zeniou, M (corresponding author), Univ Strasbourg, CNRS, Lab Excellence Medalis, Lab Innovat Therapeut,Fac Pharm,UMR7200, 74 Route Rhin, F-67401 Illkirch Graffenstaden, France.	zeniou@unistra.fr	herve, chneiweiss/Q-6818-2019; Bagnard, Dominique/I-6535-2013; Villa, Pascal/GRE-9521-2022; haiech, jacques J/F-2890-2010; El-Habr, Elias/H-5511-2019	herve, chneiweiss/0000-0001-7675-5061; Villa, Pascal/0000-0003-3466-4852; El-Habr, Elias/0000-0002-4531-9707; haiech, jacques/0000-0003-2908-8053; Bagnard, Dominique/0000-0002-5261-902X; CHEN, Wanyin/0000-0002-2045-3854	drug research center Labex (Laboratory of Excellence) Medalis; La Ligue contre le Cancer; Agence Nationale pour la Recherche (ANR); SATT Conectus Alsace (Technology Transfer Office of the University of Strasbourg); University of Strasbourg; CNRS; French "Ministere de l'Enseignement Superieur et de la Recherche"; "Region Ile de France-Cancerople" (EAEH fellowships)	drug research center Labex (Laboratory of Excellence) Medalis; La Ligue contre le Cancer(Ligue nationale contre le cancer); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); SATT Conectus Alsace (Technology Transfer Office of the University of Strasbourg); University of Strasbourg; CNRS(Centre National de la Recherche Scientifique (CNRS)); French "Ministere de l'Enseignement Superieur et de la Recherche"; "Region Ile de France-Cancerople" (EAEH fellowships)(Region Ile-de-France)	This work was supported by the drug research center Labex (Laboratory of Excellence) Medalis, "La Ligue contre le Cancer", the "Agence Nationale pour la Recherche (ANR)", SATT Conectus Alsace (Technology Transfer Office of the University of Strasbourg), University of Strasbourg, CNRS, the French "Ministere de l'Enseignement Superieur et de la Recherche" and by "Region Ile de France-Cancerople" (EAEH fellowships). Marie Feve is indebted to French "Ministere de l'Enseignement Superieur et de la Recherche" for doctoral fellowship. Wanyin Chen received PhD funding from "La Ligue contre le Cancer".	Abdul M, 2002, CANCER LETT, V186, P99, DOI 10.1016/S0304-3835(02)00348-8; Alifieris C, 2015, GLIOBLASTOMA MULTIFO; Anderson KN, 2008, J PHARMACOL SCI, V106, P318, DOI 10.1254/jphs.SC0060164; Andrews WJ, 2013, J BIOL CHEM, V288, P4567, DOI 10.1074/jbc.M112.411611; Aneknan P, 2014, ASIAN PAC J CANCER P, V15, P5071, DOI 10.7314/APJCP.2014.15.12.5071; Asher V, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-113; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; BATRA S, 1991, ANTICANCER RES, V11, P1221; Blaya Bruno, 2010, Inflammation & Allergy Drug Targets, V9, P146; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Braconi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015195; Butts A, 2013, EUKARYOT CELL, V12, P278, DOI 10.1128/EC.00314-12; Byun SS, 2005, BJU INT, V95, P1086, DOI 10.1111/j.1464-410X.2005.05472.x; Carlisi D, 2014, ONCOL REP, V32, P167, DOI 10.3892/or.2014.3212; Caudill JS, 2011, AM J CLIN ONCOL-CANC, V34, P385, DOI 10.1097/COC.0b013e3181e8461a; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng WY, 2013, MOL BIOL REP, V40, P5315, DOI 10.1007/s11033-013-2632-1; COULDWELL WT, 1994, FEBS LETT, V345, P43, DOI 10.1016/0014-5793(94)00415-3; Cruz M H, 2012, ISRN Oncol, V2012, P392647, DOI 10.5402/2012/392647; Chavez-Lopez MD, 2014, INT J GYNECOL CANCER, V24, P824, DOI 10.1097/IGC.0000000000000151; Dembinski JL, 2009, CLIN EXP METASTAS, V26, P611, DOI 10.1007/s10585-009-9260-0; Depeille P, 2005, BRIT J CANCER, V93, P216, DOI 10.1038/sj.bjc.6602681; Di Cristofori A, 2013, ANTICANCER RES, V33, P3383; Ding SX, 2014, TUMOR BIOL, V35, P3053, DOI 10.1007/s13277-013-1396-5; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fareh M, 2012, CELL DEATH DIFFER; Feng X, 2012, MOL MED REP, V6, P1117, DOI 10.3892/mmr.2012.1040; Feng Y, 2010, ONCOL REP, V24, P1561, DOI 10.3892/or_00001018; Feve M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091519; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Frosina G, 2011, EUR J CANCER, V47, P496, DOI 10.1016/j.ejca.2010.11.017; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gabor M, 1986, Prog Clin Biol Res, V213, P471; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Garbett Nichola C., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P149, DOI 10.2174/1568011043482070; Garcia-Quiroz J, 2011, ANTI-CANCER AGENT ME, V11, P307, DOI 10.2174/187152011795347513; Germain AR, 2012, BIOORG MED CHEM LETT, V22, P3571, DOI 10.1016/j.bmcl.2012.01.035; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Guo WZ, 2013, BIOCHEM PHARMACOL, V86, P1272, DOI 10.1016/j.bcp.2013.08.020; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gupta SC, 2014, ARCH BIOCH BIOPHYS; Hadzijusufovic E, 2010, EXP HEMATOL, V38, P896, DOI 10.1016/j.exphem.2010.05.008; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Harikumar KB, 2010, MOL PHARMACOL, V77, P818, DOI 10.1124/mol.109.062760; Hashimoto H, 2009, DRUG DISCOV THER, V3, P243; Hashimoto H, 2010, DRUG DISCOV THER, V4, P1; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Hey JA, 1996, ARZNEIMITTEL-FORSCH, V46, P153; HOFFMANN JJ, 1977, J PHARM SCI, V66, P883, DOI 10.1002/jps.2600660642; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Hong Z, 2014, BRIT J PHARMACOL, V171, P2842, DOI 10.1111/bph.12610; Hothi P, 2012, ONCOTARGET, V3, P1124; Huang CC, 2009, HUM EXP TOXICOL, V28, P41, DOI 10.1177/0960327108097436; Huang JK, 2011, BASIC CLIN PHARMACOL, V109, P103, DOI 10.1111/j.1742-7843.2011.00690.x; HYTTEL J, 1983, J NEURAL TRANSM, P157; Jagtap JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088505; Janganati V, 2014, BIOORG MED CHEM LETT, V24, P3499, DOI 10.1016/j.bmcl.2014.05.059; Jangi SM, 2008, CARCINOGENESIS, V29, P500, DOI 10.1093/carcin/bgm292; JAUCH R, 1975, ARZNEIMITTEL-FORSCH, V25, P1796; Ji DB, 2011, MOL CARCINOGEN, V50, P945, DOI 10.1002/mc.20762; Juillerat-Jeanneret L, 2008, CANCER INVEST, V26, P597, DOI 10.1080/07357900802072913; Kanadaswami C, 2005, IN VIVO, V19, P895; Kast RE, 2013, ONCOTARGET, V4, P502, DOI 10.18632/oncotarget.969; Khan HY, 2014, MOL NUTR FOOD RES, V58, P437, DOI 10.1002/mnfr.201300417; Kim Y, 2012, LEUKEMIA RES, V36, P598, DOI 10.1016/j.leukres.2012.01.025; Koller CM, 2013, ANTICANCER RES, V33, P2435; Komm BS, 2014, J STEROID BIOCH MOL; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027053; Lin KL, 2013, DRUG CHEM TOXICOL, V36, P231, DOI 10.3109/01480545.2012.710625; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Liu JD, 2003, MOL CARCINOGEN, V37, P39, DOI 10.1002/mc.10118; Lokich E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05500; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Lu DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008294; Martinkova E, 2010, INT J CANCER, V127, P1240, DOI 10.1002/ijc.25187; Martinkova E, 2009, NEUROENDOCRINOL LETT, V30, P60; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Musdal Y, 2013, CHEM-BIOL INTERACT, V205, P53, DOI 10.1016/j.cbi.2013.06.003; Nakabayashi H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-453; Nelson Michael P, 2013, Curr Pathobiol Rep, V1, P239; Nicolau-Galmes F, 2011, APOPTOSIS, V16, P1253, DOI 10.1007/s10495-011-0640-y; Niu YP, 2008, LEUKEMIA LYMPHOMA, V49, P1384, DOI 10.1080/10428190802090151; Obrero M, 2002, J BIOL CHEM, V277, P45695, DOI 10.1074/jbc.M208092200; OHASHI M, 1995, JPN J CANCER RES, V86, P819, DOI 10.1111/j.1349-7006.1995.tb03091.x; Paakkari I, 2002, TOXICOL LETT, V127, P279, DOI 10.1016/S0378-4274(01)00510-0; Pandrangi SL, 2014, TUMOR BIOL, V35, P723, DOI 10.1007/s13277-013-1099-y; Pardo LA, 2008, EXPERT OPIN THER TAR, V12, P837, DOI 10.1517/14728222.12.7.837 ; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Perucca P, 2009, CELL CYCLE, V8, P105, DOI 10.4161/cc.8.1.7507; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; POPPER LD, 1993, CANCER LETT, V71, P5, DOI 10.1016/0304-3835(93)90089-R; Prudent R, 2010, CANCER RES, V70, P9865, DOI 10.1158/0008-5472.CAN-10-0917; Qian JY, 2010, TOXICOL IN VITRO, V24, P960, DOI 10.1016/j.tiv.2009.12.027; Reddy KK, 2008, PIGM CELL MELANOMA R, V21, P451, DOI 10.1111/j.1755-148X.2008.00481.x; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rimmon A, 2013, BIOCHEM RES INT, V2013, DOI 10.1155/2013/251752; Roberts DJ, 1999, DRUGS, V57, P1033, DOI 10.2165/00003495-199957060-00018; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Roy J, 2008, ONCOL REP, V19, P1511; Sakurai MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100124; Schmeel LC, 2013, ANTICANCER RES, V33, P4719; Schmidt M, 2009, BRIT J HAEMATOL, V144, P796, DOI 10.1111/j.1365-2141.2008.07503.x; Seelinger G, 2008, PLANTA MED, V74, P1667, DOI 10.1055/s-0028-1088314; Sengupta A, 2010, J CELL PHYSIOL, V225, P7, DOI 10.1002/jcp.22213; Seweryn E, 2014, NAT PROD COMMUN, V9, P387; Sharmeen S, 2010, BLOOD, V116, P3593, DOI 10.1182/blood-2010-01-262675; Shen DY, 2011, PHYTOTHER RES, V25, P1519, DOI 10.1002/ptr.3435; Somberg JC, 2009, AM J THER, V16, P102, DOI 10.1097/MJT.0b013e3181961264; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Stiborova M, 2003, INT J CANCER, V107, P885, DOI 10.1002/ijc.11511; Stiborova M, 2014, CURR MED CHEM, V21, P575, DOI 10.2174/09298673113206660272; Stiborova Marie, 2011, Interdiscip Toxicol, V4, P98, DOI 10.2478/v10102-011-0017-7; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun J, 2014, ASIAN PAC J CANCER P, V15, P4897, DOI 10.7314/APJCP.2014.15.12.4897; Tai CI, 2013, J CELL SCI, V126, P1093, DOI 10.1242/jcs.118273; Tan SML, 2010, J PHARMACOL EXP THER, V334, P285, DOI 10.1124/jpet.110.165498; Thirant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016375; Tzadok S, 2010, INT J ONCOL, V37, P1043, DOI 10.3892/ijo_00000756; van der Hoeven D, 2013, MOL CELL BIOL, V33, P237, DOI 10.1128/MCB.00884-12; Varga A, 2001, ANTICANCER RES, V21, P2709; Visnyei K, 2011, MOL CANCER THER, V10, P1818, DOI 10.1158/1535-7163.MCT-11-0268; Walker AJ, 2012, CANCER CAUSE CONTROL, V23, P1959, DOI 10.1007/s10552-012-0073-0; Wang R, 2012, CLIN CANCER RES, V18, P6690, DOI 10.1158/1078-0432.CCR-12-0770; Wang SH, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-29; Wang WT, 2014, N-S ARCH PHARMACOL, V387, P33, DOI 10.1007/s00210-013-0912-x; Weng CJ, 2012, CANCER METAST REV, V31, P323, DOI 10.1007/s10555-012-9347-y; WIEDHOPF RM, 1973, J PHARM SCI, V62, P345, DOI 10.1002/jps.2600620244; Wu H, 2014, TECHNOL CANC RES TRE; Yang G, 2007, ONCOGENE, V26, P594, DOI 10.1038/sj.onc.1209807; Yu F, 2011, J NEURO-ONCOL, V103, P187, DOI 10.1007/s11060-010-0377-4; Zanotto A, 2011, BIOCHEM PHARMACOL, V81, P412, DOI 10.1016/j.bcp.2010.10.014; Zhang H, 2014, EUR ARCH OTO-RHINO-L, V271, P1653, DOI 10.1007/s00405-014-2903-z; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang ZZ, 2011, PHYTOTHER RES, V25, P1747, DOI 10.1002/ptr.3457; Zhao XF, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-3; Zhou XY, 2009, PLANTA MED, V75, P1580, DOI 10.1055/s-0029-1185838	139	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2015	10	8							e0134793	10.1371/journal.pone.0134793	http://dx.doi.org/10.1371/journal.pone.0134793			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JX	26270679	gold, Green Submitted, Green Published			2022-12-27	WOS:000359492800020
J	Braun, P; Grass, G; Aceti, A; Serrecchia, L; Affuso, A; Marino, L; Grimaldi, S; Pagano, S; Hanczaruk, M; Georgi, E; Northoff, B; Schoeler, A; Schloter, M; Antwerpen, M; Fasanella, A				Braun, Peter; Grass, Gregor; Aceti, Angela; Serrecchia, Luigina; Affuso, Alessia; Marino, Leonardo; Grimaldi, Stefania; Pagano, Stefania; Hanczaruk, Matthias; Georgi, Enrico; Northoff, Bernd; Schoeler, Anne; Schloter, Michael; Antwerpen, Markus; Fasanella, Antonio			Microevolution of Anthrax from a Young Ancestor (MAYA) Suggests a Soil-Borne Life Cycle of Bacillus anthracis	PLOS ONE			English	Article							NUCLEOTIDE REPEAT ANALYSIS; COPY NUMBER; OUTBREAK; CEREUS; DIVERSITY; EPIDEMIOLOGY; RHIZOSPHERE; GERMINATION; SEQUENCE; MARKER	During an anthrax outbreak at the Pollino National Park (Basilicata, Italy) in 2004, diseased cattle were buried and from these anthrax-foci Bacillus anthracis endospores still diffuse to the surface resulting in local accumulations. Recent data suggest that B. anthracis multiplies in soil outside the animal-host body. This notion is supported by the frequent isolation of B. anthracis from soil lacking one or both virulence plasmids. Such strains represent an evolutionary dead end, as they are likely no longer able to successfully infect new hosts. This loss of virulence plasmids is explained most simply by postulating a soil-borne life cycle of the pathogen. To test this hypothesis we investigated possible microevolution at two natural anthrax foci from the 2004 outbreak. If valid, then genotypes of strains isolated from near the surface at these foci should be on a different evolutionary trajectory from those below residing in deeper-laying horizons close to the carcass. Thus, the genetic diversity of B. anthracis isolates was compared conducting Progressive Hierarchical Resolving Assays using Nucleic Acids (PHRANA) and next generation Whole Genome Sequencing (WGS). PHRANA was not discriminatory enough to resolve the fine genetic relationships between the isolates. Conversely, WGS of nine isolates from near-surface and nine from near-carcass revealed five isolate specific SNPs, four of which were found only in different near-surface isolates. In support of our hypothesis, one surface-isolate lacked plasmid pXO1 and also harbored one of the unique SNPs. Taken together, our results suggest a limited soil-borne life cycle of B. anthracis.	[Braun, Peter; Grass, Gregor; Hanczaruk, Matthias; Georgi, Enrico; Northoff, Bernd; Antwerpen, Markus] Bundeswehr Inst Microbiol, Munich, Germany; [Braun, Peter; Schloter, Michael] Tech Univ Munich, Wissenschaftszentrum Weihenstephan, Chair Soil Ecol, Freising Weihenstephan, Germany; [Aceti, Angela; Serrecchia, Luigina; Affuso, Alessia; Marino, Leonardo; Grimaldi, Stefania; Pagano, Stefania; Fasanella, Antonio] Anthrax Reference Inst Italy, Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy; [Schoeler, Anne; Schloter, Michael] German Res Ctr Environm Hlth, Res Unit Environm Genom, Neuherberg, Germany; [Northoff, Bernd] Univ Munich, Inst Lab Med, Munich, Germany	Bundeswehr Institute of Microbiology (IMB); Technical University of Munich; IZS Puglia e Basilicata; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Grass, G (corresponding author), Bundeswehr Inst Microbiol, Munich, Germany.	gregorgrass@bundeswehr.org	Schloter, 1Michael/H-9151-2013; Grass, Gregor/A-9981-2009	Grass, Gregor/0000-0002-8002-7718; Antwerpen, Markus/0000-0003-4013-8808; Northoff, Bernd/0000-0002-7333-3231; Braun, Peter/0000-0003-4502-0489	German Ministry of Defense [Sonderforschungsprojekt 25Z1-S-431214]; Ministry of Health of Italy, Ricerca Corrente	German Ministry of Defense; Ministry of Health of Italy, Ricerca Corrente	GG MA received budgetary funds from the German Ministry of Defense. Work by MA was supported by funds from the German Ministry of Defense (Sonderforschungsprojekt 25Z1-S-431214). AF was supported by the Ministry of Health of Italy, Ricerca Corrente 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN J, 2014, PLOS ONE, V0009; Aikembayev AM, 2010, EMERGING INFECT DIS; Antwerpen M, 2011, EUR J CLIN MICROBIOL, V30, P923, DOI 10.1007/s10096-011-1177-2; Antwerpen MH, 2008, MOL CELL PROBE, V22, P313, DOI 10.1016/j.mcp.2008.06.001; Bellan SE, 2013, APPL ENVIRON MICROB, V79, P3756, DOI 10.1128/AEM.00181-13; Beyer W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001534; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Brahmbhatt TN, 2007, INFECT IMMUN, V75, P5233, DOI 10.1128/IAI.00660-07; Chakraborty A, 2012, AM J TROP MED HYG, V86, P703, DOI 10.4269/ajtmh.2012.11-0234; Dey R, 2012, APPL ENVIRON MICROB, V78, P8075, DOI 10.1128/AEM.02034-12; Dhanda M.R., 1941, INDIAN J VET SCI, V11, P308; Fasanella A, 2005, J CLIN MICROBIOL, V43, P3398, DOI 10.1128/JCM.43.7.3398-3401.2005; Fasanella A, 2015, GENOME ANNOUNC, P3; Fasanella A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-167; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fowler R. A., 2011, J BIOTERRORISM BIODE, V02, DOI DOI 10.4172/2157-2526.1000107; Ganz HH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002903; Garofolo G, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-11; Girault G, 2014, GENOME ANNOUNC, P2; Hahn KR, 2014, VET MICROBIOL, V169, P228, DOI 10.1016/j.vetmic.2013.12.020; HALVERSON LJ, 1993, SOIL BIOL BIOCHEM, V25, P485, DOI 10.1016/0038-0717(93)90074-L; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1111, DOI 10.3201/eid0810.020394; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Hughes-Jones M, 1999, J APPL MICROBIOL, V87, P189, DOI 10.1046/j.1365-2672.1999.00867.x; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jacob D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039928; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Johansen TB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/189649; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Keim P, 2009, MOL ASPECTS MED, V30, P397, DOI 10.1016/j.mam.2009.08.005; Kenefic LJ, 2008, J MICROBIOL METH, V73, P269, DOI 10.1016/j.mimet.2007.11.014; Kenefic LJ, 2008, LETT APPL MICROBIOL, V46, P600, DOI 10.1111/j.1472-765X.2008.02353.x; Kupferschmidt K, 2011, SCIENCE, V333, P1818, DOI 10.1126/science.333.6051.1818; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leonard C, 1997, MICROBIOL-UK, V143, P2537, DOI 10.1099/00221287-143-8-2537; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Marston CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028274; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Okello A, 2014, HLTH POLICY PLAN; Okinaka RT, 1999, J BACTERIOL, V181, P6509, DOI 10.1128/JB.181.20.6509-6515.1999; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Peculi A., 2015, J BIOTERROR BIODEF, V6, DOI [10.4127/2157-2526.1000131, DOI 10.4127/2157-2526.1000131]; Price EP, 2012, EMERG INFECT DIS, V18, P1307, DOI 10.3201/eid1808.111343; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Saile E, 2006, APPL ENVIRON MICROB, V72, P3168, DOI 10.1128/AEM.72.5.3168-3174.2006; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Smart KF, 2010, NAT PROTOC, V5, P1709, DOI 10.1038/nprot.2010.108; Sterne M., 1959, INFECT DIS ANIMALS, VVolume 1, P16; Stratilo CW, 2012, APPL ENVIRON MICROB, V78, P6433, DOI 10.1128/AEM.01036-12; Stratilo CW, 2006, J CLIN MICROBIOL, V44, P777, DOI 10.1128/JCM.44.3.777-782.2006; Straub T, 2013, J MICROBIOL METH, V92, P9, DOI 10.1016/j.mimet.2012.10.013; Turnbull PC, 2013, LETT APPL MICROBIOL; TURNBULL PCB, 1992, J APPL BACTERIOL, V72, P21; Turnbull PCB, 2008, ANTHRAX HUMANS ANIMA; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; VANNESS GB, 1971, SCIENCE, V172, P1303, DOI 10.1126/science.172.3990.1303; Vilain S, 2006, APPL ENVIRON MICROB, V72, P4970, DOI 10.1128/AEM.03076-05; Vogler AJ, 2006, J BACTERIOL, V188, P4253, DOI 10.1128/JB.00001-06; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	62	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135346	10.1371/journal.pone.0135346	http://dx.doi.org/10.1371/journal.pone.0135346			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266934	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300101
J	Kai, K; Hashimoto, M; Amano, K; Tanaka, H; Fukuhara, R; Ikeda, M				Kai, Kyoko; Hashimoto, Mamoru; Amano, Koichiro; Tanaka, Hibiki; Fukuhara, Ryuji; Ikeda, Manabu			Relationship between Eating Disturbance and Dementia Severity in Patients with Alzheimer's Disease	PLOS ONE			English	Article							LOW BODY-WEIGHT; FRONTOTEMPORAL DEMENTIA; SYMPTOMS; APPETITE; TASTE	Background Eating is one of the most important daily activities in managing patients with dementia. Although various eating disturbance occur as dementia progresses, to our knowledge, most of the studies focused on a part of eating disturbance such as swallowing and appetite. There have been few comprehensive studies including eating habits and food preference in patients with Alzheimer's disease (AD). The aims of this study were to investigate almost all eating disturbance and to examine the relationship of eating disturbance to dementia stage in AD. Methods A total of 220 patients with AD and 30 normal elderly (NE) subjects were recruited. Eating disturbance was assessed by a comprehensive questionnaire that had been previously validated. Potential relationships between the characteristics of eating disturbance and dementia stage as classified by the Clinical Dementia Rating (CDR) were assessed. Results Overall, 81.4% of patients with AD showed some eating and swallowing disturbance, whereas only 26.7% of the NE subjects had such a disturbance. Even in an early stage, patients with AD hadmany types of eating disturbance; "Appetite change" was shown in nearly half of the mild AD patients (49.5%). In the moderate stage, the scores of "change of eating habits and food preference" were highest, and in the severe stage "swallowing disturbance" became critical. Conclusion In AD, the relationship of dementia stage to eating disturbance differs according to the type of eating disturbance. The relationships between various eating disturbance and the severity of dementia should be considered.	[Kai, Kyoko; Tanaka, Hibiki] Kumamoto Univ, Grad Sch Med Sci, Dept Neuropsychiat, Kumamoto, Japan; [Hashimoto, Mamoru; Fukuhara, Ryuji; Ikeda, Manabu] Kumamoto Univ, Fac Life Sci, Dept Neuropsychiat, Kumamoto, Japan; [Kai, Kyoko; Amano, Koichiro] Nozaki Hosp, Dept Psychiat, Miyazaki, Japan	Kumamoto University; Kumamoto University	Ikeda, M (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Neuropsychiat, Kumamoto, Japan.	mikeda@kumamoto-u.ac.jp			Ministry of Health, Labour, and Welfare [23591718]; Ministry of Education, Culture, Sports, Science and Technology [24249100]; Grants-in-Aid for Scientific Research [26461750] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Health, Labour, and Welfare (Grant No. 23591718, www.mhlw.go.jp) and the Ministry of Education, Culture, Sports, Science and Technology (Grant No. 24249100, www.mext.go.jp).	Bozeat S, 2000, J NEUROL NEUROSUR PS, V69, P178, DOI 10.1136/jnnp.69.2.178; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Charernboon Thammanard, 2014, Journal of the Medical Association of Thailand, V97, P560; Edahiro Ayako, 2013, Nihon Ronen Igakkai Zasshi, V50, P651; Enomoto Reiko, 2007, Nihon Ronen Igakkai Zasshi, V44, P95, DOI 10.3143/geriatrics.44.95; Farooqi IS, 2014, CLIN MED, V14, P286, DOI 10.7861/clinmedicine.14-3-286; Fernandez-Martinez M, 2010, CURR ALZHEIMER RES, V7, P517, DOI 10.2174/156720510792231748; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRISSONI GB, 1998, SPR S ETH LAW AG, P48; Gao SJ, 2011, J AM GERIATR SOC, V59, P18, DOI 10.1111/j.1532-5415.2010.03169.x; Grundman M, 1996, NEUROLOGY, V46, P1585, DOI 10.1212/WNL.46.6.1585; Harwood DG, 2000, INT J GERIATR PSYCH, V15, P393, DOI 10.1002/(SICI)1099-1166(200005)15:5<393::AID-GPS120>3.0.CO;2-O; Holm B, 2003, CLIN NUTR, V22, P385, DOI 10.1016/S0261-5614(03)00035-9; Hu XS, 2002, PROG NEURO-PSYCHOPH, V26, P1285, DOI 10.1016/S0278-5846(02)00291-9; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Humbert IA, 2010, J ALZHEIMERS DIS, V19, P1185, DOI 10.3233/JAD-2010-1316; Igoumenou Artemis, 2012, Practitioner, V256, P13; Ikeda M, 2002, J NEUROL NEUROSUR PS, V73, P371, DOI 10.1136/jnnp.73.4.371; Iwamoto Toshihiko, 2011, Nihon Ronen Igakkai Zasshi, V48, P466; Lang CJG, 2006, J NEUROL SCI, V248, P177, DOI 10.1016/j.jns.2006.05.020; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Schiffman SS, 2002, NEUROBIOL AGING, V23, P397, DOI 10.1016/S0197-4580(01)00337-2; Shinagawa S, 2009, J NEUROL NEUROSUR PS, V80, P1413, DOI 10.1136/jnnp.2008.165332; Srikanth S, 2005, J NEUROL SCI, V236, P43, DOI 10.1016/j.jns.2005.04.014; Steinbach S, 2010, J NEUROL, V257, P238, DOI 10.1007/s00415-009-5300-6; Taemeeyapradit Unchulee, 2014, Journal of the Medical Association of Thailand, V97, P423; Youn JC, 2011, ARCH GERONTOL GERIAT, V52, P258, DOI 10.1016/j.archger.2010.04.015	27	73	76	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133666	10.1371/journal.pone.0133666	http://dx.doi.org/10.1371/journal.pone.0133666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26266531	Green Published, gold, Green Submitted			2022-12-27	WOS:000359492300022
J	Kim, JW; Kim, HJ; Lee, WH; Kim, DK; Kim, SW; Kim, YH; Nam, JG; Park, SW; Park, CS; Bae, WY; Yeo, NK; Won, TB; Lee, SH; Lee, TH; Lee, HJ; Kim, SW; Jeong, SW; Choi, JS; Han, DH; Choi, JH				Kim, Jeong-Whun; Kim, Hong Joong; Lee, Woo Hyun; Kim, Dong-Kyu; Kim, Sung Wan; Kim, Young Hyo; Nam, Jung Gwon; Park, Seok-Won; Park, Chan-Soon; Bae, Woo Yong; Yeo, Nam-Kyung; Won, Tae-Bin; Lee, Seung Hoon; Lee, Tae-Hoon; Lee, Hyoung Joo; Kim, Sang-Wook; Jeong, Sung-Wook; Choi, Jeong-Seok; Han, Doo Hee; Choi, Ji Ho			Comparative Study for Efficacy and Safety of Adenoidectomy according to the Surgical Method: A Prospective Multicenter Study	PLOS ONE			English	Article							PEDIATRIC ADENOIDECTOMY	Background/Objective There have been several operative techniques for adenoidectomy and their efficacy and morbidity are different according to the technique. This prospective multicenter study was aimed to compare the efficacy and morbidity of coblation adenoidectomy (CA) with those of power-assisted adenoidectomy. Study Design Prospective multi-institutional study. Methods Children who underwent CA, power-assisted adenoidectomy with cauterization (PAA+C) or without cauterization (PAA-C) due to adenoid hypertrophy were enrolled from 13 hospitals between July 2013 and June 2014. Mean operation time, degree of intraoperative bleeding and postoperative bleeding rate were evaluated. Results A total of 388 children (mean age +/- standard deviation = 6.6 +/- 2.5 years; 245 males and 143 females) were included. According to the adenoidectomy technique, the children were classified into 3 groups: (1) CA (n = 116); (2) PAA+C (n = 153); and (3) PAA-C (n = 119). Significant differences were not found in age and sex among three groups. In the CA group, mean operation time was significantly shorter (P < 0.001) and degree of intraoperative bleeding was significantly less (P < 0.001) compared to PAA+ C or PAA-C group. Delayed postoperative bleeding rate of PAA-C group was significantly higher than that of CA or PAA+ C group (P = 0.016). Conclusions This prospective multicenter study showed that CA was superior to PAA in terms of mean operation time and degree of intraoperative bleeding.	[Kim, Jeong-Whun; Lee, Woo Hyun] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Otorhinolaryngol, Songnam, South Korea; [Kim, Hong Joong] Bundang Jesaeng Gen Hosp, Daejin Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Africa; [Kim, Dong-Kyu] Hallym Univ, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Chuncheon, South Africa; [Kim, Sung Wan] Kyung Hee Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Young Hyo; Choi, Jeong-Seok] Inha Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Inchon, South Africa; [Nam, Jung Gwon; Lee, Tae-Hoon] Univ Ulsan, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Ulsan Univ Hosp, Ulsan 680749, South Korea; [Park, Seok-Won] Dongguk Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Ilsan Hosp, Goyang, South Korea; [Park, Chan-Soon] Catholic Univ Korea, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, St Vincents Hosp, Suwon, South Korea; [Bae, Woo Yong; Jeong, Sung-Wook] Dong A Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Busan, South Korea; [Yeo, Nam-Kyung] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Otorhinolaryngol, Gangneung, South Africa; [Lee, Tae-Hoon; Han, Doo Hee] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Otorhinolaryngol, Seoul, South Korea; [Lee, Seung Hoon; Choi, Ji Ho] Korea Univ, Coll Med, Ansan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ansan, South Korea; [Lee, Hyoung Joo] Busan St Marys Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Busan, South Korea; [Kim, Sang-Wook] Gyeongsang Natl Univ Hosp, Dept Otorhinolaryngol, Jinju, South Africa	Seoul National University (SNU); Kyung Hee University; University of Ulsan; Ulsan University Hospital; Dongguk University; NHIS Ilsan Hospital; Catholic University of Korea; Dong A University; Seoul National University (SNU); Seoul National University Hospital; Korea University; Korea University Medicine (KU Medicine); Gyeongsang National University; Gyeongsang National University Hospital	Choi, JH (corresponding author), Korea Univ, Coll Med, Ansan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ansan, South Korea.	handsomemd@korea.ac.kr	Kim, Sang-Wook/AAT-1042-2020; Wan, Kim Sung/AAI-8744-2020; , 이승훈[ 교수 / 의학과 ]/GLN-6251-2022	Kim, Young Hyo/0000-0002-3623-1770; Kim, Sung Wan/0000-0002-6100-8634; Kim, Dong-Kyu/0000-0003-4917-0177				Benninger Michael, 2007, Clin Cornerstone, V9 Suppl 1, pS13, DOI 10.1016/S1098-3597(07)80005-6; BOEZAART AP, 1995, CAN J ANAESTH, V42, P373, DOI 10.1007/BF03015479; Businco LD, 2012, ACTA OTORHINOLARYNGO, V32, P124; Darrow DH, 2002, LARYNGOSCOPE, V112, P6; Hartley BEJ, 1998, CLIN OTOLARYNGOL, V23, P308, DOI 10.1046/j.1365-2273.1998.00148.x; Huang HM, 1998, LARYNGOSCOPE, V108, P1104, DOI 10.1097/00005537-199807000-00028; Jonas NE, 2007, INT J PEDIATR OTORHI, V71, P1555, DOI 10.1016/j.ijporl.2007.06.008; KAVANAGH KT, 1988, SOUTHERN MED J, V81, P507, DOI 10.1097/00007611-198804000-00023; Kim SY, 2013, LARYNGOSCOPE, V123, P2567, DOI 10.1002/lary.23984; Koltai PJ, 1997, ARCH OTOLARYNGOL, V123, P685; Lowe D, 2011, OTOLARYNG HEAD NECK, V145, P314, DOI 10.1177/0194599811403119; Murray N, 2002, ARCH OTOLARYNGOL, V128, P792, DOI 10.1001/archotol.128.7.792; Ozkiris M, 2013, INT J PEDIATR OTORHI, V77, P389, DOI 10.1016/j.ijporl.2012.11.033; Ozturk O, 2012, ADV THER, V29, P708, DOI 10.1007/s12325-012-0036-6; Regmi D, 2011, J LARYNGOL OTOL, V125, P53, DOI 10.1017/S0022215110002100; Walker P, 2001, LARYNGOSCOPE, V111, P2173, DOI 10.1097/00005537-200112000-00019; Worley NK, 2007, LARYNGOSCOPE, V117, P2026, DOI 10.1097/MLG.0b013e31812e95fa	17	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135304	10.1371/journal.pone.0135304	http://dx.doi.org/10.1371/journal.pone.0135304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267337	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300093
J	Liu, YL; Lei, HB; Zhang, JX; Wang, J; Li, K; Dong, WG				Liu, Yulan; Lei, Hongbo; Zhang, Jixiang; Wang, Jun; Li, Kui; Dong, Weiguo			Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis	PLOS ONE			English	Article							CELL LUNG-CANCER; GASTRIC-CANCER; OPN EXPRESSION; BREAST-CANCER; MARKER; METASTASIS; SURVIVAL; DISEASE; COHORT; RISK	Background and Aim Several studies have been conducted to examine the associations between osteopontin (OPN) promoter gene SPP1 polymorphisms with human cancers in Chinese population, but the results remain inconsistent. The aim of this meta-analysis is to clarify the associations between SPP1 polymorphisms and cancer susceptibility. Methods All eligible case-control studies published up to March 2015 were identified by searching PubMed, Web of Science, Embase, and Cochrane Library without language restrictions. Pooled odds ratio (OR) and 95% confidence interval (95% CI) were calculated using fixed- or random-effect model. Results A total of 11 case-control studies were included; of those, there were eleven studies (3130 cases and 3828 controls) for -443T>C polymorphism, ten studies (3019 cases and 3615 controls) for -156G>GG polymorphism, eight studies (2258 cases and 2846 controls) for -66T>G polymorphism. Overall, no evidence indicated that the -443T>C polymorphism was associated with cancer risk (OR = 0.93, 95% CI 0.62-1.38 for dominant model, OR = 1.06, 95% CI 0.73-1.55 for recessive model, OR = 0.88, 95% CI 0.62-1.26 for CT vs TT model, OR = 1.03, 95% CI 0.61-1.73 for CC vs TT model). While, a significantly increase risk was found for -156 G>GG polymorphism (OR = 1.22, 95% CI 1.10-1.35 for dominant model, OR = 1.25, 95% CI 1.10-1.41 for recessive model, OR = 1.18, 95% CI 1.06-1.32 for GGG vs GG model, OR = 1.35, 95% CI 1.09-1.68 for GGGG vs GG model). For -66T>G polymorphism, we found a decrease risk of cancer (OR = 0.84, 95% CI 0.71-0.98 for dominant model), but this result changed (OR = 0.93, 95% CI 0.77-1.12 for dominant model) when we excluded a study. Conclusion This meta-analysis suggests that in Chinese population the - 156G>GG polymorphism of SPP1 might be a risk factor for human cancers, while - 443T>C mutation is not associated with cancer risk. For - 66T>G polymorphism, it may be a protective factor for human cancers.	[Liu, Yulan; Zhang, Jixiang; Wang, Jun; Li, Kui; Dong, Weiguo] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China; [Lei, Hongbo] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Dong, WG (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China.	dwg@whu.edu.cn		Liu, Yulan/0000-0001-8748-9803				Alain K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-444; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chang YS, 2007, LUNG CANCER, V57, P373, DOI 10.1016/j.lungcan.2007.04.005; Chen JX, 2010, J HUM GENET, V55, P456, DOI 10.1038/jhg.2010.48; Chen YZ, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-45; Chiu YW, 2010, ORAL ONCOL, V46, P302, DOI 10.1016/j.oraloncology.2010.01.018; Chu H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018108, DOI 10.1371/J0URNAL.P0NE.0018108]; Chu ML, 2011, INVEST OPHTH VIS SCI, V52, P7084, DOI 10.1167/iovs.11-7539; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dudemaine PL, 2014, ANIM GENET, V45, P629, DOI 10.1111/age.12176; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan Y, 2013, DNA CELL BIOL, V32, P594, DOI 10.1089/dna.2013.2090; Hashiguchi Y, 2006, MED ONCOL, V23, P205, DOI 10.1385/MO:23:2:205; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HIJIYA N, 1994, BIOCHEM J, V303, P255, DOI 10.1042/bj3030255; Hudson TJ, 2013, J INTERN MED, V274, P440, DOI 10.1111/joim.12097; Irita J, 2011, AM J PHYSIOL-RENAL, V301, pF833, DOI 10.1152/ajprenal.00557.2010; Kato R, 2009, CIRC J, V73, P152, DOI 10.1253/circj.CJ-08-0687; Lee TY, 2013, J CLIN GASTROENTEROL, V47, pE55, DOI 10.1097/MCG.0b013e31827b9325; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mirza M, 2008, INT J CANCER, V122, P889, DOI 10.1002/ijc.23204; Mu GY, 2013, CELL PHYSIOL BIOCHEM, V32, P171, DOI 10.1159/000350133; Ramchandani D, 2013, ONCOL REP, V30, P1860, DOI 10.3892/or.2013.2632; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Schultz J, 2009, MOL CARCINOGEN, V48, P14, DOI 10.1002/mc.20452; SENGER DR, 1979, CELL, V16, P885, DOI 10.1016/0092-8674(79)90103-X; Shen ZP, 2014, CELL PHYSIOL BIOCHEM, V34, P1190, DOI 10.1159/000366331; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stepien E, 2011, CLIN BIOCHEM, V44, P826, DOI 10.1016/j.clinbiochem.2011.04.016; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang JD, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0211-5; Weber GF, 2010, BRIT J CANCER, V103, P861, DOI 10.1038/sj.bjc.6605834; Weber GF, 2011, ONCOL REP, V25, P433, DOI 10.3892/or.2010.1106; Wu CY, 2007, GUT, V56, P782, DOI 10.1136/gut.2006.109868; Xu Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065208, DOI 10.1371/J0URNAL.P0NE.0065208]; Xu Q, 2011, CANCER BIOMARK, V10, P233, DOI 10.3233/CBM-2012-0251; Zhang R, 2015, CELL PHYSIOL BIOCHEM, V35, P175, DOI 10.1159/000369685; Zhao FJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-477; Zhao XQ, 2014, INT J CLIN EXP PATHO, V7, P6914	40	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0135318	10.1371/journal.pone.0135318	http://dx.doi.org/10.1371/journal.pone.0135318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267616	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300095
J	Zhou, XL; Li, L; Jiang, C; Xu, B; Wang, HL; Xiong, D; Sheng, LP; Yang, QS; Jiang, S; Xu, P; Chen, ZQ; Zhao, Y				Zhou, Xian-Long; Li, Lei; Jiang, Cheng; Xu, Bing; Wang, Huang-Lei; Xiong, Dan; Sheng, Li-Pin; Yang, Qi-Sheng; Jiang, Shan; Xu, Peng; Chen, Zhi-Qiao; Zhao, Yan			Up-Down Hand Position Switch May Delay the Fatigue of Non-Dominant Hand Position Rescuers and Improve Chest Compression Quality during Cardiopulmonary Resuscitation: A Randomized Crossover Manikin Study	PLOS ONE			English	Article							HEART-ASSOCIATION GUIDELINES; CPR; DOMINANT; RATIO	Previous studies have shown improved external chest compression (ECC) quality and delayed rescuer fatigue when the dominant hand (DH) was in contact with the sternum. However, many rescuers prefer placing the non-dominant hand (NH) in contact with the sternum during ECC. We aimed to investigate the effects of up-down hand position switch on the quality of ECC and the fatigue of rescuers during cardiopulmonary resuscitation (CPR). After completion of a review of the standard adult basic life support (BLS) course, every candidate performed 10 cycles of single adult CPR twice on an adult manikin with either a constant hand position (CH) or a switched hand position (SH) in random order at 7-day intervals. The rescuers' general characteristics, hand positions, physiological signs, fatigue appearance and ECC qualities were recorded. Our results showed no significant differences in chest compression quality for the DH position rescuers between the CH and SH sessions (p>0.05, resp.). And also no significant differences were found for Borg score (p = 0.437) or cycle number (p = 0.127) of fatigue appearance after chest compressions between the two sessions. However, for NH position rescuers, the appearance of fatigue was delayed (p = 0.046), with a lower Borg score in the SH session (12.67 +/- 2.03) compared to the CH session (13.33 +/- 1.95) (p = 0.011). Moreover, the compression depth was significantly greater in the SH session (39.3 +/- 7.2 mm) compared to the CH session (36.3 +/- 8.1 mm) (p = 0.015). Our data suggest that the up-down hand position switch during CPR may delay the fatigue of non-dominant hand position rescuers and improve the quality of chest compressions.	[Zhou, Xian-Long; Li, Lei; Jiang, Cheng; Xu, Bing; Wang, Huang-Lei; Xiong, Dan; Sheng, Li-Pin; Yang, Qi-Sheng; Jiang, Shan; Xu, Peng; Chen, Zhi-Qiao; Zhao, Yan] Wuhan Univ, Zhongnan Hosp, Emergency Ctr, Wuhan 430071, Hubei, Peoples R China	Wuhan University	Zhao, Y (corresponding author), Wuhan Univ, Zhongnan Hosp, Emergency Ctr, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	doctoryanzhao@163.com		Zhou, Xianlong/0000-0002-6163-5320	Emergency Diagnostic & Therapeutic Center of Central China (Wuhan, Hubei, China)	Emergency Diagnostic & Therapeutic Center of Central China (Wuhan, Hubei, China)	This study was financially supported by the Emergency Diagnostic & Therapeutic Center of Central China (Wuhan, Hubei, China).	Abella BS, 2005, CIRCULATION, V111, P428, DOI 10.1161/01.CIR.0000153811.84257.59; Berg RA, 2010, CIRCULATION, V122, pS685, DOI 10.1161/CIRCULATIONAHA.110.970939; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Chung TN, 2012, J EMERG MED, V43, P1049, DOI 10.1016/j.jemermed.2012.01.021; Edelson DP, 2012, RESUSCITATION, V83, P874, DOI 10.1016/j.resuscitation.2012.03.005; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Foo NP, 2010, RESUSCITATION, V81, P579, DOI 10.1016/j.resuscitation.2010.02.006; Haque IU, 2008, RESUSCITATION, V79, P82, DOI 10.1016/j.resuscitation.2008.04.026; Hong MY, 2014, AM J EMERG MED; Jiang C, 2015, J EMERG MED, V48, P436, DOI 10.1016/j.jemermed.2014.12.034; Kern KB, 2005, RESUSCITATION, V64, P261, DOI 10.1016/j.resuscitation.2004.08.009; Kovic I, 2013, J EMERG MED, V45, P570, DOI 10.1016/j.jemermed.2013.04.021; Kundra P, 2000, BRIT J ANAESTH, V84, P491, DOI 10.1093/oxfordjournals.bja.a013475; McDonald CH, 2013, EMERG MED J, V30, P623, DOI 10.1136/emermed-2012-201610; Monsieurs KG, 2012, RESUSCITATION, V83, P1319, DOI 10.1016/j.resuscitation.2012.07.015; Nikandish R, 2008, RESUSCITATION, V76, P256, DOI 10.1016/j.resuscitation.2007.07.032; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; Odegaard S, 2007, RESUSCITATION, V74, P127, DOI 10.1016/j.resuscitation.2006.12.006; R Core Team, 2014, R A LANGUAGE AND ENV; Trojan DA, 1997, NEUROREHABILITATION, V8, P93, DOI 10.3233/NRE-1997-8204; Vaillancourt C, 2011, RESUSCITATION, V82, P51, DOI 10.1016/j.resuscitation.2010.09.003; Wik L, 2005, JAMA-J AM MED ASSOC, V293, P299, DOI 10.1001/jama.293.3.299; Yang Z, 2013, CRITICAL CARE MED, V41, pA116	23	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2015	10	8							e0133483	10.1371/journal.pone.0133483	http://dx.doi.org/10.1371/journal.pone.0133483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9JT	26267353	Green Published, Green Submitted, gold			2022-12-27	WOS:000359492300016
J	Lv, D; Shen, YQ; Peng, YQ; Liu, JN; Miao, FQ; Zhang, JQ				Lv, Dan; Shen, Yuqing; Peng, Yaqin; Liu, Jiane; Miao, Fengqin; Zhang, Jianqiong			Neuronal MHC Class I Expression Is Regulated by Activity Driven Calcium Signaling	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; MOLECULES; CNS; FAMILIES; NLRC5; RNA	MHC class I (MHC-I) molecules are important components of the immune system. Recently MHC-I have been reported to also play important roles in brain development and synaptic plasticity. In this study, we examine the molecular mechanism(s) underlying activity-dependent MHC-I expression using hippocampal neurons. Here we report that neuronal expression level of MHC-I is dynamically regulated during hippocampal development after birth in vivo. Kainic acid (KA) treatment significantly increases the expression of MHC-I in cultured hippocampal neurons in vitro, suggesting that MHC-I expression is regulated by neuronal activity. In addition, KA stimulation decreased the expression of pre- and post-synaptic proteins. This down-regulation is prevented by addition of an MHC-I antibody to KA treated neurons. Further studies demonstrate that calcium-dependent protein kinase C (PKC) is important in relaying KA simulation activation signals to up-regulated MHC-I expression. This signaling cascade relies on activation of the MAPK pathway, which leads to increased phosphorylation of CREB and NF-kappa B p65 while also enhancing the expression of IRF-1. Together, these results suggest that expression of MHC-I in hippocampal neurons is driven by Ca2+ regulated activation of the MAPK signaling transduction cascade.	[Lv, Dan; Shen, Yuqing; Peng, Yaqin; Liu, Jiane; Miao, Fengqin; Zhang, Jianqiong] Southeast Univ, Sch Med, Dept Microbiol & Immunol, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Zhang, JQ (corresponding author), Southeast Univ, Sch Med, Dept Microbiol & Immunol, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing, Jiangsu, Peoples R China.	zhjq@seu.edu.cn			National Nature Science Foundation of China [31100649]; Scientific Innovation Research of College Graduate in Jiangsu Province [CXZZ12-0091]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Innovation Research of College Graduate in Jiangsu Province	The work was supported by National Nature Science Foundation of China (31100649, http://www.nsfc.gov.cn/,S.Y) and Scientific Innovation Research of College Graduate in Jiangsu Province (CXZZ12-0091, http://www.ec.js.edu.cn/,L.D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cebrian C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4633; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Fourgeaud L, 2007, CELL, V131, P1034, DOI 10.1016/j.cell.2007.11.031; Ghosh S, 2013, MOL CELL BIOL, V33, P2718, DOI 10.1128/MCB.01254-12; Girdlestone J, 1996, EUR J IMMUNOGENET, V23, P395; Glynn MW, 2011, NAT NEUROSCI, V14, P442, DOI 10.1038/nn.2764; Gobin SJP, 1998, J IMMUNOL, V161, P2276; Gobin SJP, 2000, HUM IMMUNOL, V61, P1102, DOI 10.1016/S0198-8859(00)00198-1; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Guglielmetti F, 1997, MOL BRAIN RES, V49, P188, DOI 10.1016/S0169-328X(97)00142-3; Howcroft TK, 2005, J IMMUNOL, V174, P2106, DOI 10.4049/jimmunol.174.4.2106; Howcroft TK, 2003, IMMUNOL RES, V27, P1, DOI 10.1385/IR:27:1:1; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Jarosinski KW, 2002, J NEUROIMMUNOL, V122, P74, DOI 10.1016/S0165-5728(01)00467-2; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; LEBOUTEILLER P, 1994, CRIT REV IMMUNOL, V14, P89, DOI 10.1615/CritRevImmunol.v14.i2.10; Liu JN, 2013, NEUROCHEM RES, V38, P290, DOI 10.1007/s11064-012-0920-0; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Lv D, 2014, NEUROCHEM RES, V39, P180, DOI 10.1007/s11064-013-1204-z; McAllister AK, 2014, BIOL PSYCHIAT, V75, P262, DOI 10.1016/j.biopsych.2013.10.003; McConnell MJ, 2009, P NATL ACAD SCI USA, V106, P6784, DOI 10.1073/pnas.0902018106; Meissner TB, 2012, MICROBES INFECT, V14, P477, DOI 10.1016/j.micinf.2011.12.007; Meissner TB, 2012, J IMMUNOL, V188, P4951, DOI 10.4049/jimmunol.1103160; Miralves J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001354; Morimoto K, 1997, BRAIN RES BULL, V43, P375, DOI 10.1016/S0361-9230(97)00022-1; Needleman LA, 2012, DEV NEUROBIOL, V72, P1288, DOI 10.1002/dneu.22046; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; Prabowo AS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-12; Rall GF, 1995, CURR TOP MICROBIOL, V202, P261; Ribic A, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-1; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; SINGER DS, 1988, CURR TOP MICROBIOL, V137, P148; Singer DS, 1997, CRIT REV IMMUNOL, V17, P463; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; VanDeMark KL, 2009, ALCOHOL CLIN EXP RES, V33, P1945, DOI 10.1111/j.1530-0277.2009.01032.x; Zhang AF, 2013, BRAIN RES, V1529, P26, DOI 10.1016/j.brainres.2013.07.001; Zhang AF, 2013, NEUROCHEM RES, V38, P273, DOI 10.1007/s11064-012-0916-9	41	10	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2015	10	8							e0135223	10.1371/journal.pone.0135223	http://dx.doi.org/10.1371/journal.pone.0135223			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PP	26263390	Green Submitted, Green Published, gold			2022-12-27	WOS:000359353300068
